The 30- and 60-s denaturation times resulted in identical profiles, while a band at the bottom of the 10-s profile, possibly derived from a member of the genus Bifidobacterium (whose members have high G+C contents [55 to 67%]), was not visible (data not shown).	[]	['The', '30', '-', 'and', '60', '-', 's', 'den', '##at', '##uration', 'times', 'resulted', 'in', 'identical', 'profiles', ',', 'while', 'a', 'band', 'at', 'the', 'bottom', 'of', 'the', '10', '-', 's', 'profile', ',', 'possibly', 'derived', 'from', 'a', 'member', 'of', 'the', 'genus', 'B', '##if', '##ido', '##ba', '##cter', '##ium', '(', 'whose', 'members', 'have', 'high', 'G', '+', 'C', 'contents', '[', '55', 'to', '67', '%', ']', ')', ',', 'was', 'not', 'visible', '(', 'data', 'not', 'shown', ')', '.']	[0, 4, 6, 8, 12, 14, 15, 17, 20, 22, 30, 36, 45, 48, 58, 66, 68, 74, 76, 81, 84, 88, 95, 98, 102, 104, 105, 107, 114, 116, 125, 133, 138, 140, 147, 150, 154, 160, 161, 163, 166, 168, 172, 176, 177, 183, 191, 196, 201, 202, 203, 205, 214, 215, 218, 221, 223, 224, 225, 226, 228, 232, 236, 244, 245, 250, 254, 259, 260]	[3, 6, 7, 11, 14, 15, 16, 20, 22, 29, 35, 44, 47, 57, 66, 67, 73, 75, 80, 83, 87, 94, 97, 101, 104, 105, 106, 114, 115, 124, 132, 137, 139, 146, 149, 153, 159, 161, 163, 166, 168, 172, 175, 177, 182, 190, 195, 200, 202, 203, 204, 213, 215, 217, 220, 223, 224, 225, 226, 227, 231, 235, 243, 245, 249, 253, 259, 260, 261]	['The', '30-', 'and', '60-s', 'denaturation', 'times', 'resulted', 'in', 'identical', 'profiles', ',', 'while', 'a', 'band', 'at', 'the', 'bottom', 'of', 'the', '10-s', 'profile', ',', 'possibly', 'derived', 'from', 'a', 'member', 'of', 'the', 'genus', 'Bifidobacterium', '(', 'whose', 'members', 'have', 'high', 'G', '+', 'C', 'contents', '[', '55', 'to', '67%', ']', ')', ',', 'was', 'not', 'visible', '(', 'data', 'not', 'shown', ')', '.']	[1, 2, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At the later (120 min) stage of invasion, cercariae released enzymes implicated in protection against oxidative stress, including GST-26, thioredoxin peroxidase and superoxide dismutase [21],[37],[38].	[('PMC2467291', 'D04000', 138, 160, 'thioredoxin peroxidase')]	['At', 'the', 'later', '(', '120', 'min', ')', 'stage', 'of', 'invasion', ',', 'c', '##er', '##car', '##iae', 'released', 'enzymes', 'implicated', 'in', 'protection', 'against', 'o', '##xi', '##da', '##tive', 'stress', ',', 'including', 'G', '##ST', '-', '26', ',', 'th', '##ior', '##ed', '##ox', '##in', 'per', '##ox', '##idas', '##e', 'and', 'super', '##oxide', 'di', '##sm', '##uta', '##se', '[', '21', ']', ',', '[', '37', ']', ',', '[', '38', ']', '.']	[0, 3, 7, 13, 14, 18, 21, 23, 29, 32, 40, 42, 43, 45, 48, 52, 61, 69, 80, 83, 94, 102, 103, 105, 107, 112, 118, 120, 130, 131, 133, 134, 136, 138, 140, 143, 145, 147, 150, 153, 155, 159, 161, 165, 170, 176, 178, 180, 183, 186, 187, 189, 190, 191, 192, 194, 195, 196, 197, 199, 200]	[2, 6, 12, 14, 17, 21, 22, 28, 31, 40, 41, 43, 45, 48, 51, 60, 68, 79, 82, 93, 101, 103, 105, 107, 111, 118, 119, 129, 131, 133, 134, 136, 137, 140, 143, 145, 147, 149, 153, 155, 159, 160, 164, 170, 175, 178, 180, 183, 185, 187, 189, 190, 191, 192, 194, 195, 196, 197, 199, 200, 201]	['At', 'the', 'later', '(', '120', 'min', ')', 'stage', 'of', 'invasion', ',', 'cercariae', 'released', 'enzymes', 'implicated', 'in', 'protection', 'against', 'oxidative', 'stress', ',', 'including', 'GST-26', ',', 'thioredoxin', 'peroxidase', 'and', 'superoxide', 'dismutase', '[21],[37],[38]', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 5, 4, 1, 2, 4, 11, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, it was noteworthy that α-1-antitrypsin and elastase were present in higher molecular weight forms in the same gel slice, consistent with a complex between this inhibitor and the cercarial elastase.	[('PMC2467291', 'D10000', 52, 60, 'elastase')]	['Finally', ',', 'it', 'was', 'noteworthy', 'that', 'α', '-', '1', '-', 'anti', '##try', '##ps', '##in', 'and', 'el', '##ast', '##ase', 'were', 'present', 'in', 'higher', 'molecular', 'weight', 'forms', 'in', 'the', 'same', 'gel', 'slice', ',', 'consistent', 'with', 'a', 'complex', 'between', 'this', 'inhibitor', 'and', 'the', 'c', '##er', '##car', '##ial', 'el', '##ast', '##ase', '.']	[0, 7, 9, 12, 16, 27, 32, 33, 34, 35, 36, 40, 43, 45, 48, 52, 54, 57, 61, 66, 74, 77, 84, 94, 101, 107, 110, 114, 119, 123, 128, 130, 141, 146, 148, 156, 164, 169, 179, 183, 187, 188, 190, 193, 197, 199, 202, 205]	[7, 8, 11, 15, 26, 31, 33, 34, 35, 36, 40, 43, 45, 47, 51, 54, 57, 60, 65, 73, 76, 83, 93, 100, 106, 109, 113, 118, 122, 128, 129, 140, 145, 147, 155, 163, 168, 178, 182, 186, 188, 190, 193, 196, 199, 202, 205, 206]	['Finally', ',', 'it', 'was', 'noteworthy', 'that', 'α-1-antitrypsin', 'and', 'elastase', 'were', 'present', 'in', 'higher', 'molecular', 'weight', 'forms', 'in', 'the', 'same', 'gel', 'slice', ',', 'consistent', 'with', 'a', 'complex', 'between', 'this', 'inhibitor', 'and', 'the', 'cercarial', 'elastase', '.']	[1, 1, 1, 1, 1, 1, 8, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In vitro studies had shown that α-1-antitrypsin was indeed a potent cercarial elastase inhibitor [31].	[('PMC2467291', 'D10001', 78, 86, 'elastase')]	['In', 'v', '##it', '##ro', 'studies', 'had', 'shown', 'that', 'α', '-', '1', '-', 'anti', '##try', '##ps', '##in', 'was', 'indeed', 'a', 'potent', 'c', '##er', '##car', '##ial', 'el', '##ast', '##ase', 'inhibitor', '[', '31', ']', '.']	[0, 3, 4, 6, 9, 17, 21, 27, 32, 33, 34, 35, 36, 40, 43, 45, 48, 52, 59, 61, 68, 69, 71, 74, 78, 80, 83, 87, 97, 98, 100, 101]	[2, 4, 6, 8, 16, 20, 26, 31, 33, 34, 35, 36, 40, 43, 45, 47, 51, 58, 60, 67, 69, 71, 74, 77, 80, 83, 86, 96, 98, 100, 101, 102]	['In', 'vitro', 'studies', 'had', 'shown', 'that', 'α-1-antitrypsin', 'was', 'indeed', 'a', 'potent', 'cercarial', 'elastase', 'inhibitor', '[', '31', ']', '.']	[1, 3, 1, 1, 1, 1, 8, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Two schistosome-specific proteins, Sm20.8 and Sm21.7, previously reported to be components of the schistosome surface or subjacent tegument [19],[20], and two glutathione-S-transferases, GST 26 and GST 28, were released from the parasite.	[('PMC2467291', 'R01000', 159, 185, 'glutathione-S-transferases')]	['Two', 's', '##chi', '##sto', '##some', '-', 'specific', 'proteins', ',', 'S', '##m', '##20', '.', '8', 'and', 'S', '##m', '##21', '.', '7', ',', 'previously', 'reported', 'to', 'be', 'components', 'of', 'the', 's', '##chi', '##sto', '##some', 'surface', 'or', 'sub', '##ja', '##cent', 'te', '##gum', '##ent', '[', '19', ']', ',', '[', '20', ']', ',', 'and', 'two', 'g', '##lut', '##ath', '##ione', '-', 'S', '-', 'transfer', '##ases', ',', 'G', '##ST', '26', 'and', 'G', '##ST', '28', ',', 'were', 'released', 'from', 'the', 'parasite', '.']	[0, 4, 5, 8, 11, 15, 16, 25, 33, 35, 36, 37, 39, 40, 42, 46, 47, 48, 50, 51, 52, 54, 65, 74, 77, 80, 91, 94, 98, 99, 102, 105, 110, 118, 121, 124, 126, 131, 133, 136, 140, 141, 143, 144, 145, 146, 148, 149, 151, 155, 159, 160, 163, 166, 170, 171, 172, 173, 181, 185, 187, 188, 191, 194, 198, 199, 202, 204, 206, 211, 220, 225, 229, 237]	[3, 5, 8, 11, 15, 16, 24, 33, 34, 36, 37, 39, 40, 41, 45, 47, 48, 50, 51, 52, 53, 64, 73, 76, 79, 90, 93, 97, 99, 102, 105, 109, 117, 120, 124, 126, 130, 133, 136, 139, 141, 143, 144, 145, 146, 148, 149, 150, 154, 158, 160, 163, 166, 170, 171, 172, 173, 181, 185, 186, 188, 190, 193, 197, 199, 201, 204, 205, 210, 219, 224, 228, 237, 238]	['Two', 'schistosome', '-', 'specific', 'proteins', ',', 'Sm20.8', 'and', 'Sm21.7', ',', 'previously', 'reported', 'to', 'be', 'components', 'of', 'the', 'schistosome', 'surface', 'or', 'subjacent', 'tegument', '[19],[20]', ',', 'and', 'two', 'glutathione-S-transferases', ',', 'GST', '26', 'and', 'GST', '28', ',', 'were', 'released', 'from', 'the', 'parasite', '.']	[1, 4, 1, 1, 1, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 3, 7, 1, 1, 1, 9, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, a group of schistosome glycolytic enzymes and kinases, known to be abundant in the cytoplasm of larval gland cells were identified.	[('PMC2467291', 'R01001', 55, 62, 'kinases')]	['Finally', ',', 'a', 'group', 'of', 's', '##chi', '##sto', '##some', 'g', '##ly', '##co', '##ly', '##tic', 'enzymes', 'and', 'kinase', '##s', ',', 'known', 'to', 'be', 'abundant', 'in', 'the', 'c', '##yt', '##op', '##las', '##m', 'of', 'la', '##rva', '##l', 'g', '##land', 'cells', 'were', 'identified', '.']	[0, 7, 9, 11, 17, 20, 21, 24, 27, 32, 33, 35, 37, 39, 43, 51, 55, 61, 62, 64, 70, 73, 76, 85, 88, 92, 93, 95, 97, 100, 102, 105, 107, 110, 112, 113, 118, 124, 129, 139]	[7, 8, 10, 16, 19, 21, 24, 27, 31, 33, 35, 37, 39, 42, 50, 54, 61, 62, 63, 69, 72, 75, 84, 87, 91, 93, 95, 97, 100, 101, 104, 107, 110, 111, 113, 117, 123, 128, 139, 140]	['Finally', ',', 'a', 'group', 'of', 'schistosome', 'glycolytic', 'enzymes', 'and', 'kinases', ',', 'known', 'to', 'be', 'abundant', 'in', 'the', 'cytoplasm', 'of', 'larval', 'gland', 'cells', 'were', 'identified', '.']	[1, 1, 1, 1, 1, 4, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These are presumbably released as holosecretion from the acetabular cells [11],[12] and included glyceraldehyde-3-phosphate-dehydrogenase, glycerol phosphorylase, triose phosphate isomerase, fructose-1-6 adolase, cytosolic ATP-guanidine kinase, and enolase.	[('PMC2467291', 'R01002', 97, 137, 'glyceraldehyde-3-phosphate-dehydrogenase')]	['These', 'are', 'pre', '##su', '##mba', '##bly', 'released', 'as', 'ho', '##lose', '##cre', '##tion', 'from', 'the', 'ace', '##ta', '##bula', '##r', 'cells', '[', '11', ']', ',', '[', '12', ']', 'and', 'included', 'g', '##ly', '##cer', '##ald', '##eh', '##yd', '##e', '-', '3', '-', 'phosphate', '-', 'de', '##hy', '##dr', '##ogen', '##ase', ',', 'g', '##ly', '##cer', '##ol', 'p', '##hos', '##ph', '##ory', '##lase', ',', 'trio', '##se', 'phosphate', 'is', '##omer', '##ase', ',', 'f', '##ru', '##ct', '##ose', '-', '1', '-', '6', 'ad', '##ola', '##se', ',', 'c', '##yt', '##oso', '##lic', 'ATP', '-', 'g', '##uan', '##id', '##ine', 'kinase', ',', 'and', 'en', '##ola', '##se', '.']	[0, 6, 10, 13, 15, 18, 22, 31, 34, 36, 40, 43, 48, 53, 57, 60, 62, 66, 68, 74, 75, 77, 78, 79, 80, 82, 84, 88, 97, 98, 100, 103, 106, 108, 110, 111, 112, 113, 114, 123, 124, 126, 128, 130, 134, 137, 139, 140, 142, 145, 148, 149, 152, 154, 157, 161, 163, 167, 170, 180, 182, 186, 189, 191, 192, 194, 196, 199, 200, 201, 202, 204, 206, 209, 211, 213, 214, 216, 219, 223, 226, 227, 228, 231, 233, 237, 243, 245, 249, 251, 254, 256]	[5, 9, 13, 15, 18, 21, 30, 33, 36, 40, 43, 47, 52, 56, 60, 62, 66, 67, 73, 75, 77, 78, 79, 80, 82, 83, 87, 96, 98, 100, 103, 106, 108, 110, 111, 112, 113, 114, 123, 124, 126, 128, 130, 134, 137, 138, 140, 142, 145, 147, 149, 152, 154, 157, 161, 162, 167, 169, 179, 182, 186, 189, 190, 192, 194, 196, 199, 200, 201, 202, 203, 206, 209, 211, 212, 214, 216, 219, 222, 226, 227, 228, 231, 233, 236, 243, 244, 248, 251, 254, 256, 257]	['These', 'are', 'presumbably', 'released', 'as', 'holosecretion', 'from', 'the', 'acetabular', 'cells', '[11],[12]', 'and', 'included', 'glyceraldehyde-3-phosphate', '-', 'dehydrogenase', ',', 'glycerol', 'phosphorylase', ',', 'triose', 'phosphate', 'isomerase', ',', 'fructose-1-6', 'adolase', ',', 'cytosolic', 'ATP-guanidine', 'kinase', ',', 'and', 'enolase', '.']	[1, 1, 4, 1, 1, 4, 1, 1, 4, 1, 7, 1, 1, 11, 1, 5, 1, 4, 5, 1, 2, 1, 3, 1, 8, 3, 1, 4, 6, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At two hours post invasion, many larval proteins increased in abundance including GST 28, GST 26, the elastase isoforms, and the glycolytic enzymes.	[('PMC2467291', 'R02000', 102, 110, 'elastase')]	['At', 'two', 'hours', 'post', 'invasion', ',', 'many', 'la', '##rva', '##l', 'proteins', 'increased', 'in', 'abundance', 'including', 'G', '##ST', '28', ',', 'G', '##ST', '26', ',', 'the', 'el', '##ast', '##ase', 'is', '##of', '##orms', ',', 'and', 'the', 'g', '##ly', '##co', '##ly', '##tic', 'enzymes', '.']	[0, 3, 7, 13, 18, 26, 28, 33, 35, 38, 40, 49, 59, 62, 72, 82, 83, 86, 88, 90, 91, 94, 96, 98, 102, 104, 107, 111, 113, 115, 119, 121, 125, 129, 130, 132, 134, 136, 140, 147]	[2, 6, 12, 17, 26, 27, 32, 35, 38, 39, 48, 58, 61, 71, 81, 83, 85, 88, 89, 91, 93, 96, 97, 101, 104, 107, 110, 113, 115, 119, 120, 124, 128, 130, 132, 134, 136, 139, 147, 148]	['At', 'two', 'hours', 'post', 'invasion', ',', 'many', 'larval', 'proteins', 'increased', 'in', 'abundance', 'including', 'GST', '28', ',', 'GST', '26', ',', 'the', 'elastase', 'isoforms', ',', 'and', 'the', 'glycolytic', 'enzymes', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 3, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
New proteins were detected at 120 minutes, notably schistosome-derived thioredoxin, thioredoxin peroxidase and superoxide dismutase [21].	[('PMC2467291', 'R02001', 84, 106, 'thioredoxin peroxidase')]	['New', 'proteins', 'were', 'detected', 'at', '120', 'minutes', ',', 'notably', 's', '##chi', '##sto', '##some', '-', 'derived', 'th', '##ior', '##ed', '##ox', '##in', ',', 'th', '##ior', '##ed', '##ox', '##in', 'per', '##ox', '##idas', '##e', 'and', 'super', '##oxide', 'di', '##sm', '##uta', '##se', '[', '21', ']', '.']	[0, 4, 13, 18, 27, 30, 34, 41, 43, 51, 52, 55, 58, 62, 63, 71, 73, 76, 78, 80, 82, 84, 86, 89, 91, 93, 96, 99, 101, 105, 107, 111, 116, 122, 124, 126, 129, 132, 133, 135, 136]	[3, 12, 17, 26, 29, 33, 41, 42, 50, 52, 55, 58, 62, 63, 70, 73, 76, 78, 80, 82, 83, 86, 89, 91, 93, 95, 99, 101, 105, 106, 110, 116, 121, 124, 126, 129, 131, 133, 135, 136, 137]	['New', 'proteins', 'were', 'detected', 'at', '120', 'minutes', ',', 'notably', 'schistosome', '-', 'derived', 'thioredoxin', ',', 'thioredoxin', 'peroxidase', 'and', 'superoxide', 'dismutase', '[', '21', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 5, 4, 1, 2, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There was a striking accumulation of host serine protease inhibitors (serpins) in both control and experimental skin samples.	[('PMC2467291', 'R06000', 42, 57, 'serine protease')]	['There', 'was', 'a', 'striking', 'accumulation', 'of', 'host', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '##s', '(', 'se', '##rp', '##ins', ')', 'in', 'both', 'control', 'and', 'experimental', 'skin', 'samples', '.']	[0, 6, 10, 12, 21, 34, 37, 42, 44, 49, 52, 54, 58, 67, 69, 70, 72, 74, 77, 79, 82, 87, 95, 99, 112, 117, 124]	[5, 9, 11, 20, 33, 36, 41, 44, 48, 52, 54, 57, 67, 68, 70, 72, 74, 77, 78, 81, 86, 94, 98, 111, 116, 124, 125]	['There', 'was', 'a', 'striking', 'accumulation', 'of', 'host', 'serine', 'protease', 'inhibitors', '(', 'serpins', ')', 'in', 'both', 'control', 'and', 'experimental', 'skin', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 3, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, it has been reported that many cancer cells upregulate the embryonic M2 form of pyruvate kinase (PK) which is defective in catalyzing pyruvate production [26], so alternative substrates must be oxidized to generate ATP	[('PMC2577687', 'I04000', 89, 104, 'pyruvate kinase')]	['However', ',', 'it', 'has', 'been', 'reported', 'that', 'many', 'cancer', 'cells', 'up', '##re', '##gu', '##late', 'the', 'em', '##b', '##ryo', '##nic', 'M', '##2', 'form', 'of', 'p', '##yr', '##u', '##vate', 'kinase', '(', 'P', '##K', ')', 'which', 'is', 'defect', '##ive', 'in', 'cat', '##aly', '##zing', 'p', '##yr', '##u', '##vate', 'production', '[', '26', ']', ',', 'so', 'alternative', 'substrates', 'must', 'be', 'o', '##xi', '##dized', 'to', 'generate', 'ATP']	[0, 7, 9, 12, 16, 21, 30, 35, 40, 47, 53, 55, 57, 59, 64, 68, 70, 71, 74, 78, 79, 81, 86, 89, 90, 92, 93, 98, 105, 106, 107, 108, 110, 116, 119, 125, 129, 132, 135, 138, 143, 144, 146, 147, 152, 163, 164, 166, 167, 169, 172, 184, 195, 200, 203, 204, 206, 212, 215, 224]	[7, 8, 11, 15, 20, 29, 34, 39, 46, 52, 55, 57, 59, 63, 67, 70, 71, 74, 77, 79, 80, 85, 88, 90, 92, 93, 97, 104, 106, 107, 108, 109, 115, 118, 125, 128, 131, 135, 138, 142, 144, 146, 147, 151, 162, 164, 166, 167, 168, 171, 183, 194, 199, 202, 204, 206, 211, 214, 223, 227]	['However', ',', 'it', 'has', 'been', 'reported', 'that', 'many', 'cancer', 'cells', 'upregulate', 'the', 'embryonic', 'M2', 'form', 'of', 'pyruvate', 'kinase', '(', 'PK', ')', 'which', 'is', 'defective', 'in', 'catalyzing', 'pyruvate', 'production', '[', '26', ']', ',', 'so', 'alternative', 'substrates', 'must', 'be', 'oxidized', 'to', 'generate', 'ATP']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 2, 1, 1, 4, 1, 1, 2, 1, 1, 1, 2, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Free glucose is not expected to be present in cells where the activity of hexokinase exceeds that of glucose transport [49].	[('PMC2577687', 'R21000', 74, 84, 'hexokinase')]	['Free', 'glucose', 'is', 'not', 'expected', 'to', 'be', 'present', 'in', 'cells', 'where', 'the', 'activity', 'of', 'he', '##x', '##oki', '##nas', '##e', 'exceeds', 'that', 'of', 'glucose', 'transport', '[', '49', ']', '.']	[0, 5, 13, 16, 20, 29, 32, 35, 43, 46, 52, 58, 62, 71, 74, 76, 77, 80, 83, 85, 93, 98, 101, 109, 119, 120, 122, 123]	[4, 12, 15, 19, 28, 31, 34, 42, 45, 51, 57, 61, 70, 73, 76, 77, 80, 83, 84, 92, 97, 100, 108, 118, 120, 122, 123, 124]	['Free', 'glucose', 'is', 'not', 'expected', 'to', 'be', 'present', 'in', 'cells', 'where', 'the', 'activity', 'of', 'hexokinase', 'exceeds', 'that', 'of', 'glucose', 'transport', '[', '49', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pyruvate dehydrogenase E1 is an enzyme involved in the pyruvate dehydrogenase complex (43).	[('PMC2679092', 'D08000', 0, 25, 'Pyruvate dehydrogenase E1')]	['P', '##yr', '##u', '##vate', 'de', '##hy', '##dr', '##ogen', '##ase', 'E', '##1', 'is', 'an', 'enzyme', 'involved', 'in', 'the', 'p', '##yr', '##u', '##vate', 'de', '##hy', '##dr', '##ogen', '##ase', 'complex', '(', '43', ')', '.']	[0, 1, 3, 4, 9, 11, 13, 15, 19, 23, 24, 26, 29, 32, 39, 48, 51, 55, 56, 58, 59, 64, 66, 68, 70, 74, 78, 86, 87, 89, 90]	[1, 3, 4, 8, 11, 13, 15, 19, 22, 24, 25, 28, 31, 38, 47, 50, 54, 56, 58, 59, 63, 66, 68, 70, 74, 77, 85, 87, 89, 90, 91]	['Pyruvate', 'dehydrogenase', 'E1', 'is', 'an', 'enzyme', 'involved', 'in', 'the', 'pyruvate', 'dehydrogenase', 'complex', '(', '43', ')', '.']	[4, 5, 2, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition to HMGA2, which encodes a chromatin-binding protein, we found associations with a SNP (rs10946808) in a histone cluster on chromosome 6, a SNP (rs12986413) in the histone methyltransferase DOT1L gene and a SNP (rs724016) in an intron of the methyl-DNA-binding transcriptional repressor gene ZBTB38.	[]	['In', 'addition', 'to', 'HM', '##GA', '##2', ',', 'which', 'en', '##codes', 'a', 'ch', '##roma', '##tin', '-', 'binding', 'protein', ',', 'we', 'found', 'associations', 'with', 'a', 'S', '##NP', '(', 'r', '##s', '##10', '##9', '##46', '##80', '##8', ')', 'in', 'a', 'his', '##tone', 'cluster', 'on', 'chromosome', '6', ',', 'a', 'S', '##NP', '(', 'r', '##s', '##12', '##9', '##86', '##41', '##3', ')', 'in', 'the', 'his', '##tone', 'met', '##hyl', '##tra', '##ns', '##fer', '##ase', 'D', '##OT', '##1', '##L', 'gene', 'and', 'a', 'S', '##NP', '(', 'r', '##s', '##7', '##24', '##01', '##6', ')', 'in', 'an', 'intro', '##n', 'of', 'the', 'met', '##hyl', '-', 'DNA', '-', 'binding', 'transcription', '##al', 're', '##press', '##or', 'gene', 'Z', '##B', '##T', '##B', '##38', '.']	[0, 3, 12, 15, 17, 19, 20, 22, 28, 30, 36, 38, 40, 44, 47, 48, 56, 63, 65, 68, 74, 87, 92, 94, 95, 98, 99, 100, 101, 103, 104, 106, 108, 109, 111, 114, 116, 119, 124, 132, 135, 146, 147, 149, 151, 152, 155, 156, 157, 158, 160, 161, 163, 165, 166, 168, 171, 175, 178, 183, 186, 189, 192, 194, 197, 201, 202, 204, 205, 207, 212, 216, 218, 219, 222, 223, 224, 225, 226, 228, 230, 231, 233, 236, 239, 244, 246, 249, 253, 256, 259, 260, 263, 264, 272, 285, 288, 290, 295, 298, 303, 304, 305, 306, 307, 309]	[2, 11, 14, 17, 19, 20, 21, 27, 30, 35, 37, 40, 44, 47, 48, 55, 63, 64, 67, 73, 86, 91, 93, 95, 97, 99, 100, 101, 103, 104, 106, 108, 109, 110, 113, 115, 119, 123, 131, 134, 145, 147, 148, 150, 152, 154, 156, 157, 158, 160, 161, 163, 165, 166, 167, 170, 174, 178, 182, 186, 189, 192, 194, 197, 200, 202, 204, 205, 206, 211, 215, 217, 219, 221, 223, 224, 225, 226, 228, 230, 231, 232, 235, 238, 244, 245, 248, 252, 256, 259, 260, 263, 264, 271, 285, 287, 290, 295, 297, 302, 304, 305, 306, 307, 309, 310]	['In', 'addition', 'to', 'HMGA2', ',', 'which', 'encodes', 'a', 'chromatin', '-', 'binding', 'protein', ',', 'we', 'found', 'associations', 'with', 'a', 'SNP', '(', 'rs10946808', ')', 'in', 'a', 'histone', 'cluster', 'on', 'chromosome', '6', ',', 'a', 'SNP', '(', 'rs12986413', ')', 'in', 'the', 'histone', 'methyltransferase', 'DOT1L', 'gene', 'and', 'a', 'SNP', '(', 'rs724016', ')', 'in', 'an', 'intron', 'of', 'the', 'methyl-DNA', '-', 'binding', 'transcriptional', 'repressor', 'gene', 'ZBTB38', '.']	[1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 7, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 7, 1, 1, 1, 2, 6, 4, 1, 1, 1, 2, 1, 6, 1, 1, 1, 2, 1, 1, 4, 1, 1, 2, 3, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A SNP 28 kb upstream of PRKG2 (rs1662845), which encodes the cGMP-dependent protein kinase II (cGKII), showed strong association with height in our meta-analysis of GWA scans (P = 5.7 × 10-5), and in the same direction in the European American height panel (P = 8.5 × 10-6) and the FUSION stage 2 sample (P = 0.001), but not in the FINRISK97 (P = 0.93, opposite direction) and PPP (P = 0.16, opposite direction) panels.	[]	['A', 'S', '##NP', '28', 'k', '##b', 'upstream', 'of', 'PR', '##K', '##G', '##2', '(', 'r', '##s', '##16', '##6', '##28', '##45', ')', ',', 'which', 'en', '##codes', 'the', 'c', '##GM', '##P', '-', 'dependent', 'protein', 'kinase', 'II', '(', 'c', '##G', '##K', '##II', ')', ',', 'showed', 'strong', 'association', 'with', 'height', 'in', 'our', 'meta', '-', 'analysis', 'of', 'G', '##WA', 'scan', '##s', '(', 'P', '=', '5', '.', '7', '×', '10', '-', '5', ')', ',', 'and', 'in', 'the', 'same', 'direction', 'in', 'the', 'European', 'American', 'height', 'panel', '(', 'P', '=', '8', '.', '5', '×', '10', '-', '6', ')', 'and', 'the', 'F', '##US', '##ION', 'stage', '2', 'sample', '(', 'P', '=', '0', '.', '00', '##1', ')', ',', 'but', 'not', 'in', 'the', 'F', '##IN', '##RI', '##S', '##K', '##9', '##7', '(', 'P', '=', '0', '.', '93', ',', 'opposite', 'direction', ')', 'and', 'PP', '##P', '(', 'P', '=', '0', '.', '16', ',', 'opposite', 'direction', ')', 'panels', '.']	[0, 2, 3, 6, 9, 10, 12, 21, 24, 26, 27, 28, 30, 31, 32, 33, 35, 36, 38, 40, 41, 43, 49, 51, 57, 61, 62, 64, 65, 66, 76, 84, 91, 94, 95, 96, 97, 98, 100, 101, 103, 110, 117, 129, 134, 141, 144, 148, 152, 153, 162, 165, 166, 169, 173, 175, 176, 178, 180, 181, 182, 184, 186, 188, 189, 190, 191, 193, 197, 200, 204, 209, 219, 222, 226, 235, 244, 251, 257, 258, 260, 262, 263, 264, 266, 268, 270, 271, 272, 274, 278, 282, 283, 285, 289, 295, 297, 304, 305, 307, 309, 310, 311, 313, 314, 315, 317, 321, 325, 328, 332, 333, 335, 337, 338, 339, 340, 342, 343, 345, 347, 348, 349, 351, 353, 362, 371, 373, 377, 379, 381, 382, 384, 386, 387, 388, 390, 392, 401, 410, 412, 418]	[1, 3, 5, 8, 10, 11, 20, 23, 26, 27, 28, 29, 31, 32, 33, 35, 36, 38, 40, 41, 42, 48, 51, 56, 60, 62, 64, 65, 66, 75, 83, 90, 93, 95, 96, 97, 98, 100, 101, 102, 109, 116, 128, 133, 140, 143, 147, 152, 153, 161, 164, 166, 168, 173, 174, 176, 177, 179, 181, 182, 183, 185, 188, 189, 190, 191, 192, 196, 199, 203, 208, 218, 221, 225, 234, 243, 250, 256, 258, 259, 261, 263, 264, 265, 267, 270, 271, 272, 273, 277, 281, 283, 285, 288, 294, 296, 303, 305, 306, 308, 310, 311, 313, 314, 315, 316, 320, 324, 327, 331, 333, 335, 337, 338, 339, 340, 341, 343, 344, 346, 348, 349, 351, 352, 361, 371, 372, 376, 379, 380, 382, 383, 385, 387, 388, 390, 391, 400, 410, 411, 418, 419]	['A', 'SNP', '28', 'kb', 'upstream', 'of', 'PRKG2', '(', 'rs1662845', ')', ',', 'which', 'encodes', 'the', 'cGMP-dependent', 'protein', 'kinase', 'II', '(', 'cGKII', ')', ',', 'showed', 'strong', 'association', 'with', 'height', 'in', 'our', 'meta-', 'analysis', 'of', 'GWA', 'scans', '(', 'P', '=', '5.7', '×', '10-5', ')', ',', 'and', 'in', 'the', 'same', 'direction', 'in', 'the', 'European', 'American', 'height', 'panel', '(', 'P', '=', '8.5', '×', '10-6', ')', 'and', 'the', 'FUSION', 'stage', '2', 'sample', '(', 'P', '=', '0.001', ')', ',', 'but', 'not', 'in', 'the', 'FINRISK97', '(', 'P', '=', '0.93', ',', 'opposite', 'direction', ')', 'and', 'PPP', '(', 'P', '=', '0.16', ',', 'opposite', 'direction', ')', 'panels', '.']	[1, 2, 1, 2, 1, 1, 4, 1, 6, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 2, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several newly identified loci associated with height are located near genes with less immediately apparent connections to stature, including the G protein-coupled receptor gene GPR126, a locus that encompasses the thyroid hormone receptor interactor TRIP11 and the ataxin ATXN3 genes, a locus with the Huntingtin-interacting gene SH3GL3 and the glycoprotein metalloprotease gene ADAMTSL3 (the later often mutated in colon cancer31), a locus with gene CHCHD7, frequently fused to the PLAG1 oncogene in salivary gland adenomas32, and the epidermal retinal dehydrogenase 2 gene RDHE2.	[('PMC2687076', 'D05000', 345, 373, 'glycoprotein metalloprotease')]	['Several', 'newly', 'identified', 'lo', '##ci', 'associated', 'with', 'height', 'are', 'located', 'near', 'genes', 'with', 'less', 'immediately', 'apparent', 'connections', 'to', 'stature', ',', 'including', 'the', 'G', 'protein', '-', 'coupled', 'receptor', 'gene', 'GP', '##R', '##12', '##6', ',', 'a', 'lo', '##cus', 'that', 'encompasses', 'the', 'thy', '##roid', 'hormone', 'receptor', 'interact', '##or', 'T', '##RI', '##P', '##11', 'and', 'the', 'at', '##ax', '##in', 'AT', '##X', '##N', '##3', 'genes', ',', 'a', 'lo', '##cus', 'with', 'the', 'Hunting', '##tin', '-', 'interacting', 'gene', 'SH', '##3', '##G', '##L', '##3', 'and', 'the', 'g', '##ly', '##co', '##p', '##rote', '##in', 'metal', '##lop', '##rote', '##ase', 'gene', 'AD', '##AM', '##TS', '##L', '##3', '(', 'the', 'later', 'often', 'm', '##uta', '##ted', 'in', 'co', '##lon', 'cancer', '##31', ')', ',', 'a', 'lo', '##cus', 'with', 'gene', 'CH', '##CH', '##D', '##7', ',', 'frequently', 'fused', 'to', 'the', 'P', '##LA', '##G', '##1', 'on', '##co', '##gene', 'in', 'sa', '##liva', '##ry', 'g', '##land', 'ad', '##eno', '##mas', '##32', ',', 'and', 'the', 'e', '##pid', '##er', '##mal', 're', '##tina', '##l', 'de', '##hy', '##dr', '##ogen', '##ase', '2', 'gene', 'R', '##D', '##H', '##E', '##2', '.']	[0, 8, 14, 25, 27, 30, 41, 46, 53, 57, 65, 70, 76, 81, 86, 98, 107, 119, 122, 129, 131, 141, 145, 147, 154, 155, 163, 172, 177, 179, 180, 182, 183, 185, 187, 189, 193, 198, 210, 214, 217, 222, 230, 239, 247, 250, 251, 253, 254, 257, 261, 265, 267, 269, 272, 274, 275, 276, 278, 283, 285, 287, 289, 293, 298, 302, 309, 312, 313, 325, 330, 332, 333, 334, 335, 337, 341, 345, 346, 348, 350, 351, 355, 358, 363, 366, 370, 374, 379, 381, 383, 385, 386, 388, 389, 393, 399, 405, 406, 409, 413, 416, 418, 422, 428, 430, 431, 433, 435, 437, 441, 446, 451, 453, 455, 456, 457, 459, 470, 476, 479, 483, 484, 486, 487, 489, 491, 493, 498, 501, 503, 507, 510, 511, 516, 518, 521, 524, 526, 528, 532, 536, 537, 540, 542, 546, 548, 552, 554, 556, 558, 560, 564, 568, 570, 575, 576, 577, 578, 579, 580]	[7, 13, 24, 27, 29, 40, 45, 52, 56, 64, 69, 75, 80, 85, 97, 106, 118, 121, 129, 130, 140, 144, 146, 154, 155, 162, 171, 176, 179, 180, 182, 183, 184, 186, 189, 192, 197, 209, 213, 217, 221, 229, 238, 247, 249, 251, 253, 254, 256, 260, 264, 267, 269, 271, 274, 275, 276, 277, 283, 284, 286, 289, 292, 297, 301, 309, 312, 313, 324, 329, 332, 333, 334, 335, 336, 340, 344, 346, 348, 350, 351, 355, 357, 363, 366, 370, 373, 378, 381, 383, 385, 386, 387, 389, 392, 398, 404, 406, 409, 412, 415, 418, 421, 428, 430, 431, 432, 434, 437, 440, 445, 450, 453, 455, 456, 457, 458, 469, 475, 478, 482, 484, 486, 487, 488, 491, 493, 497, 500, 503, 507, 509, 511, 515, 518, 521, 524, 526, 527, 531, 535, 537, 540, 542, 545, 548, 552, 553, 556, 558, 560, 564, 567, 569, 574, 576, 577, 578, 579, 580, 581]	['Several', 'newly', 'identified', 'loci', 'associated', 'with', 'height', 'are', 'located', 'near', 'genes', 'with', 'less', 'immediately', 'apparent', 'connections', 'to', 'stature', ',', 'including', 'the', 'G', 'protein', '-', 'coupled', 'receptor', 'gene', 'GPR126', ',', 'a', 'locus', 'that', 'encompasses', 'the', 'thyroid', 'hormone', 'receptor', 'interactor', 'TRIP11', 'and', 'the', 'ataxin', 'ATXN3', 'genes', ',', 'a', 'locus', 'with', 'the', 'Huntingtin', '-', 'interacting', 'gene', 'SH3GL3', 'and', 'the', 'glycoprotein', 'metalloprotease', 'gene', 'ADAMTSL3', '(', 'the', 'later', 'often', 'mutated', 'in', 'colon', 'cancer31', ')', ',', 'a', 'locus', 'with', 'gene', 'CHCHD7', ',', 'frequently', 'fused', 'to', 'the', 'PLAG1', 'oncogene', 'in', 'salivary', 'gland', 'adenomas32', ',', 'and', 'the', 'epidermal', 'retinal', 'dehydrogenase', '2', 'gene', 'RDHE2', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 2, 1, 1, 2, 4, 1, 1, 3, 4, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 5, 1, 1, 6, 4, 1, 5, 1, 1, 1, 1, 3, 1, 2, 2, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 4, 3, 1, 3, 2, 4, 1, 1, 1, 4, 3, 5, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Baum et al.6, using DNA pooling, identified a SNP located in DGKH (diacylglycerol kinase eta) that was associated with bipolar disorder in 1,233 cases and 1,439 controls with a P value of 1.5 × 10-8.	[]	['Ba', '##um', 'et', 'al', '.', '6', ',', 'using', 'DNA', 'pool', '##ing', ',', 'identified', 'a', 'S', '##NP', 'located', 'in', 'D', '##G', '##K', '##H', '(', 'di', '##acy', '##l', '##gly', '##cer', '##ol', 'kinase', 'et', '##a', ')', 'that', 'was', 'associated', 'with', 'bi', '##pol', '##ar', 'disorder', 'in', '1', ',', '233', 'cases', 'and', '1', ',', '43', '##9', 'controls', 'with', 'a', 'P', 'value', 'of', '1', '.', '5', '×', '10', '-', '8', '.']	[0, 2, 5, 8, 10, 11, 12, 14, 20, 24, 28, 31, 33, 44, 46, 47, 50, 58, 61, 62, 63, 64, 66, 67, 69, 72, 73, 76, 79, 82, 89, 91, 92, 94, 99, 103, 114, 119, 121, 124, 127, 136, 139, 140, 141, 145, 151, 155, 156, 157, 159, 161, 170, 175, 177, 179, 185, 188, 189, 190, 192, 194, 196, 197, 198]	[2, 4, 7, 10, 11, 12, 13, 19, 23, 28, 31, 32, 43, 45, 47, 49, 57, 60, 62, 63, 64, 65, 67, 69, 72, 73, 76, 79, 81, 88, 91, 92, 93, 98, 102, 113, 118, 121, 124, 126, 135, 138, 140, 141, 144, 150, 154, 156, 157, 159, 160, 169, 174, 176, 178, 184, 187, 189, 190, 191, 193, 196, 197, 198, 199]	['Baum', 'et', 'al.6', ',', 'using', 'DNA', 'pooling', ',', 'identified', 'a', 'SNP', 'located', 'in', 'DGKH', '(', 'diacylglycerol', 'kinase', 'eta', ')', 'that', 'was', 'associated', 'with', 'bipolar', 'disorder', 'in', '1', ',', '233', 'cases', 'and', '1', ',', '439', 'controls', 'with', 'a', 'P', 'value', 'of', '1.5', '×', '10-8', '.']	[2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 4, 1, 6, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An intronic SNP in ADAMTS17 (a disintegrin and metalloproteinase with thrombospondin motifs 17), which showed modest association (rs1994016; P=1.1×10-4) in our primary analysis, showed a much stronger association in the expanded reference group analysis (see below and Supplementary Table 9).	[('PMC2719288', 'I41000', 47, 64, 'metalloproteinase')]	['An', 'intro', '##nic', 'S', '##NP', 'in', 'AD', '##AM', '##TS', '##17', '(', 'a', 'di', '##sin', '##te', '##g', '##rin', 'and', 'metal', '##lop', '##rote', '##inas', '##e', 'with', 'th', '##rom', '##bos', '##po', '##ndi', '##n', 'motifs', '17', ')', ',', 'which', 'showed', 'modest', 'association', '(', 'r', '##s', '##19', '##9', '##40', '##16', ';', 'P', '=', '1', '.', '1', '##×', '##10', '-', '4', ')', 'in', 'our', 'primary', 'analysis', ',', 'showed', 'a', 'much', 'stronger', 'association', 'in', 'the', 'expanded', 'reference', 'group', 'analysis', '(', 'see', 'below', 'and', 'Su', '##pp', '##lement', '##ary', 'Table', '9', ')', '.']	[0, 3, 8, 12, 13, 16, 19, 21, 23, 25, 28, 29, 31, 33, 36, 38, 39, 43, 47, 52, 55, 59, 63, 65, 70, 72, 75, 78, 80, 83, 85, 92, 94, 95, 97, 103, 110, 117, 129, 130, 131, 132, 134, 135, 137, 139, 141, 142, 143, 144, 145, 146, 147, 149, 150, 151, 153, 156, 160, 168, 176, 178, 185, 187, 192, 201, 213, 216, 220, 229, 239, 245, 254, 255, 259, 265, 269, 271, 273, 279, 283, 289, 290, 291]	[2, 8, 11, 13, 15, 18, 21, 23, 25, 27, 29, 30, 33, 36, 38, 39, 42, 46, 52, 55, 59, 63, 64, 69, 72, 75, 78, 80, 83, 84, 91, 94, 95, 96, 102, 109, 116, 128, 130, 131, 132, 134, 135, 137, 139, 140, 142, 143, 144, 145, 146, 147, 149, 150, 151, 152, 155, 159, 167, 176, 177, 184, 186, 191, 200, 212, 215, 219, 228, 238, 244, 253, 255, 258, 264, 268, 271, 273, 279, 282, 288, 290, 291, 292]	['An', 'intronic', 'SNP', 'in', 'ADAMTS17', '(', 'a', 'disintegrin', 'and', 'metalloproteinase', 'with', 'thrombospondin', 'motifs', '17', ')', ',', 'which', 'showed', 'modest', 'association', '(', 'rs1994016', ';', 'P=1.1×10-4', ')', 'in', 'our', 'primary', 'analysis', ',', 'showed', 'a', 'much', 'stronger', 'association', 'in', 'the', 'expanded', 'reference', 'group', 'analysis', '(', 'see', 'below', 'and', 'Supplementary', 'Table', '9', ')', '.']	[1, 2, 2, 1, 4, 1, 1, 5, 1, 5, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 9, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A second association, on chromosome 5q31 (ref. 62) has been widely replicated, although the identity of the causative gene is disputed owing to extensive regional linkage disequilibrium63.	[]	['A', 'second', 'association', ',', 'on', 'chromosome', '5', '##q', '##31', '(', 're', '##f', '.', '62', ')', 'has', 'been', 'widely', 'replica', '##ted', ',', 'although', 'the', 'identity', 'of', 'the', 'ca', '##usa', '##tive', 'gene', 'is', 'disputed', 'owing', 'to', 'extensive', 'regional', 'link', '##age', 'di', '##se', '##qui', '##li', '##bri', '##um', '##6', '##3', '.']	[0, 2, 9, 20, 22, 25, 36, 37, 38, 41, 42, 44, 45, 47, 49, 51, 55, 60, 67, 74, 77, 79, 88, 92, 101, 104, 108, 110, 113, 118, 123, 126, 135, 141, 144, 154, 163, 167, 171, 173, 175, 178, 180, 183, 185, 186, 187]	[1, 8, 20, 21, 24, 35, 37, 38, 40, 42, 44, 45, 46, 49, 50, 54, 59, 66, 74, 77, 78, 87, 91, 100, 103, 107, 110, 113, 117, 122, 125, 134, 140, 143, 153, 162, 167, 170, 173, 175, 178, 180, 183, 185, 186, 187, 188]	['A', 'second', 'association', ',', 'on', 'chromosome', '5q31', '(', 'ref', '.', '62', ')', 'has', 'been', 'widely', 'replicated', ',', 'although', 'the', 'identity', 'of', 'the', 'causative', 'gene', 'is', 'disputed', 'owing', 'to', 'extensive', 'regional', 'linkage', 'disequilibrium63', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 8, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The first of these includes several SNPs around IRGM (immunity-related guanosine triphosphatase; the human homologue of the mouse Irgm/Lrg47), the strongest singal being at rs1000113 (P=5.1×10-8).	[('PMC2719288', 'I46000', 71, 95, 'guanosine triphosphatase')]	['The', 'first', 'of', 'these', 'includes', 'several', 'S', '##NP', '##s', 'around', 'I', '##R', '##GM', '(', 'immunity', '-', 'related', 'g', '##uan', '##os', '##ine', 'trip', '##hos', '##pha', '##tase', ';', 'the', 'human', 'ho', '##mo', '##logue', 'of', 'the', 'mouse', 'I', '##rg', '##m', '/', 'L', '##rg', '##47', ')', ',', 'the', 'strongest', 'sing', '##al', 'being', 'at', 'r', '##s', '##100', '##01', '##13', '(', 'P', '=', '5', '.', '1', '##×', '##10', '-', '8', ')', '.']	[0, 4, 10, 13, 19, 28, 36, 37, 39, 41, 48, 49, 50, 53, 54, 62, 63, 71, 72, 75, 77, 81, 85, 88, 91, 95, 97, 101, 107, 109, 111, 117, 120, 124, 130, 131, 133, 134, 135, 136, 138, 140, 141, 143, 147, 157, 161, 164, 170, 173, 174, 175, 178, 180, 183, 184, 185, 186, 187, 188, 189, 190, 192, 193, 194, 195]	[3, 9, 12, 18, 27, 35, 37, 39, 40, 47, 49, 50, 52, 54, 62, 63, 70, 72, 75, 77, 80, 85, 88, 91, 95, 96, 100, 106, 109, 111, 116, 119, 123, 129, 131, 133, 134, 135, 136, 138, 140, 141, 142, 146, 156, 161, 163, 169, 172, 174, 175, 178, 180, 182, 184, 185, 186, 187, 188, 189, 190, 192, 193, 194, 195, 196]	['The', 'first', 'of', 'these', 'includes', 'several', 'SNPs', 'around', 'IRGM', '(', 'immunity', '-', 'related', 'guanosine', 'triphosphatase', ';', 'the', 'human', 'homologue', 'of', 'the', 'mouse', 'Irgm', '/', 'Lrg47', ')', ',', 'the', 'strongest', 'singal', 'being', 'at', 'rs1000113', '(', 'P=5.1×10-8', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 4, 4, 1, 1, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 2, 1, 1, 5, 1, 9, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The final novel association, at rs2542151 (P=4.6×10-8) maps 5.5-kb upstream of PTPN2 (protein tyrosine phosphatase, non-receptor type 2) on chromosome 18p11.	[('PMC2719288', 'I49000', 86, 114, 'protein tyrosine phosphatase')]	['The', 'final', 'novel', 'association', ',', 'at', 'r', '##s', '##25', '##42', '##15', '##1', '(', 'P', '=', '4', '.', '6', '##×', '##10', '-', '8', ')', 'maps', '5', '.', '5', '-', 'k', '##b', 'upstream', 'of', 'PT', '##P', '##N', '##2', '(', 'protein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', ',', 'non', '-', 'receptor', 'type', '2', ')', 'on', 'chromosome', '18', '##p', '##11', '.']	[0, 4, 10, 16, 27, 29, 32, 33, 34, 36, 38, 40, 42, 43, 44, 45, 46, 47, 48, 49, 51, 52, 53, 55, 60, 61, 62, 63, 64, 65, 67, 76, 79, 81, 82, 83, 85, 86, 94, 95, 97, 99, 103, 104, 107, 110, 114, 116, 119, 120, 129, 134, 135, 137, 140, 151, 153, 154, 156]	[3, 9, 15, 27, 28, 31, 33, 34, 36, 38, 40, 41, 43, 44, 45, 46, 47, 48, 49, 51, 52, 53, 54, 59, 61, 62, 63, 64, 65, 66, 75, 78, 81, 82, 83, 84, 86, 93, 95, 97, 99, 102, 104, 107, 110, 114, 115, 119, 120, 128, 133, 135, 136, 139, 150, 153, 154, 156, 157]	['The', 'final', 'novel', 'association', ',', 'at', 'rs2542151', '(', 'P=4.6×10-8', ')', 'maps', '5.5-kb', 'upstream', 'of', 'PTPN2', '(', 'protein', 'tyrosine', 'phosphatase', ',', 'non', '-', 'receptor', 'type', '2', ')', 'on', 'chromosome', '18p11', '.']	[1, 1, 1, 1, 1, 1, 6, 1, 9, 1, 1, 6, 1, 1, 4, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PTPN2 encodes the T cell protein tyrosine phosphatase TCPTP, a key negative regulator of inflammatory responses.	[('PMC2719288', 'I49001', 25, 53, 'protein tyrosine phosphatase')]	['PT', '##P', '##N', '##2', 'en', '##codes', 'the', 'T', 'cell', 'protein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'T', '##CP', '##TP', ',', 'a', 'key', 'negative', 'regulator', 'of', 'inflammatory', 'responses', '.']	[0, 2, 3, 4, 6, 8, 14, 18, 20, 25, 33, 34, 36, 38, 42, 43, 46, 49, 54, 55, 57, 59, 61, 63, 67, 76, 86, 89, 102, 111]	[2, 3, 4, 5, 8, 13, 17, 19, 24, 32, 34, 36, 38, 41, 43, 46, 49, 53, 55, 57, 59, 60, 62, 66, 75, 85, 88, 101, 111, 112]	['PTPN2', 'encodes', 'the', 'T', 'cell', 'protein', 'tyrosine', 'phosphatase', 'TCPTP', ',', 'a', 'key', 'negative', 'regulator', 'of', 'inflammatory', 'responses', '.']	[4, 2, 1, 1, 1, 1, 4, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
None of the variants previously associated with HT showed evidence for association in our study although we note that some, such as promoter of the WNK1 (WNK lysine deficient protein kinase 1) gene78,79, are not well tagged by the Affymetrix chip.	[('PMC2719288', 'I54000', 158, 191, 'lysine deficient protein kinase 1')]	['None', 'of', 'the', 'variants', 'previously', 'associated', 'with', 'H', '##T', 'showed', 'evidence', 'for', 'association', 'in', 'our', 'study', 'although', 'we', 'note', 'that', 'some', ',', 'such', 'as', 'promoter', 'of', 'the', 'W', '##N', '##K', '##1', '(', 'W', '##N', '##K', 'l', '##ys', '##ine', 'def', '##icient', 'protein', 'kinase', '1', ')', 'gene', '##7', '##8', ',', '79', ',', 'are', 'not', 'well', 'tag', '##ged', 'by', 'the', 'A', '##ffy', '##met', '##rix', 'chip', '.']	[0, 5, 8, 12, 21, 32, 43, 48, 49, 51, 58, 67, 71, 83, 86, 90, 96, 105, 108, 113, 118, 122, 124, 129, 132, 141, 144, 148, 149, 150, 151, 153, 154, 155, 156, 158, 159, 161, 165, 168, 175, 183, 190, 191, 193, 197, 198, 199, 200, 202, 204, 208, 212, 217, 220, 224, 227, 231, 232, 235, 238, 242, 246]	[4, 7, 11, 20, 31, 42, 47, 49, 50, 57, 66, 70, 82, 85, 89, 95, 104, 107, 112, 117, 122, 123, 128, 131, 140, 143, 147, 149, 150, 151, 152, 154, 155, 156, 157, 159, 161, 164, 168, 174, 182, 189, 191, 192, 197, 198, 199, 200, 202, 203, 207, 211, 216, 220, 223, 226, 230, 232, 235, 238, 241, 246, 247]	['None', 'of', 'the', 'variants', 'previously', 'associated', 'with', 'HT', 'showed', 'evidence', 'for', 'association', 'in', 'our', 'study', 'although', 'we', 'note', 'that', 'some', ',', 'such', 'as', 'promoter', 'of', 'the', 'WNK1', '(', 'WNK', 'lysine', 'deficient', 'protein', 'kinase', '1', ')', 'gene78', ',', '79', ',', 'are', 'not', 'well', 'tagged', 'by', 'the', 'Affymetrix', 'chip', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 3, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The issue of whether tHcy is causally related to atherothrombotic events has been addressed by genetic association studies of the 677C>T single nucleotide polymorphism (SNP) in the methylenetetrahydrofolate reductase (MTHFR) gene (rs1801133).	[('PMC2727417', 'I01000', 181, 216, 'methylenetetrahydrofolate reductase')]	['The', 'issue', 'of', 'whether', 't', '##H', '##cy', 'is', 'ca', '##usal', '##ly', 'related', 'to', 'at', '##her', '##oth', '##rom', '##bot', '##ic', 'events', 'has', 'been', 'addressed', 'by', 'genetic', 'association', 'studies', 'of', 'the', '67', '##7', '##C', '>', 'T', 'single', 'n', '##uc', '##leo', '##tide', 'p', '##oly', '##mor', '##phism', '(', 'S', '##NP', ')', 'in', 'the', 'met', '##hyl', '##ene', '##te', '##tra', '##hy', '##dr', '##of', '##olate', 'red', '##uc', '##tase', '(', 'M', '##TH', '##F', '##R', ')', 'gene', '(', 'r', '##s', '##18', '##01', '##13', '##3', ')', '.']	[0, 4, 10, 13, 21, 22, 23, 26, 29, 31, 35, 38, 46, 49, 51, 54, 57, 60, 63, 66, 73, 77, 82, 92, 95, 103, 115, 123, 126, 130, 132, 133, 134, 135, 137, 144, 145, 147, 150, 155, 156, 159, 162, 168, 169, 170, 172, 174, 177, 181, 184, 187, 190, 192, 195, 197, 199, 201, 207, 210, 212, 217, 218, 219, 221, 222, 223, 225, 230, 231, 232, 233, 235, 237, 239, 240, 241]	[3, 9, 12, 20, 22, 23, 25, 28, 31, 35, 37, 45, 48, 51, 54, 57, 60, 63, 65, 72, 76, 81, 91, 94, 102, 114, 122, 125, 129, 132, 133, 134, 135, 136, 143, 145, 147, 150, 154, 156, 159, 162, 167, 169, 170, 172, 173, 176, 180, 184, 187, 190, 192, 195, 197, 199, 201, 206, 210, 212, 216, 218, 219, 221, 222, 223, 224, 229, 231, 232, 233, 235, 237, 239, 240, 241, 242]	['The', 'issue', 'of', 'whether', 'tHcy', 'is', 'causally', 'related', 'to', 'atherothrombotic', 'events', 'has', 'been', 'addressed', 'by', 'genetic', 'association', 'studies', 'of', 'the', '677C', '>', 'T', 'single', 'nucleotide', 'polymorphism', '(', 'SNP', ')', 'in', 'the', 'methylenetetrahydrofolate', 'reductase', '(', 'MTHFR', ')', 'gene', '(', 'rs1801133', ')', '.']	[1, 1, 1, 1, 3, 1, 3, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 4, 1, 2, 1, 1, 1, 9, 3, 1, 4, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NEK10 (Never-in mitosis related kinase 10) is one of a family of 11 NIMA (never in mitosis a) related kinases that are involved in cell cycle control7.	[]	['NE', '##K', '##10', '(', 'Never', '-', 'in', 'mit', '##osis', 'related', 'kinase', '10', ')', 'is', 'one', 'of', 'a', 'family', 'of', '11', 'N', '##IM', '##A', '(', 'never', 'in', 'mit', '##osis', 'a', ')', 'related', 'kinase', '##s', 'that', 'are', 'involved', 'in', 'cell', 'cycle', 'control', '##7', '.']	[0, 2, 3, 6, 7, 12, 13, 16, 19, 24, 32, 39, 41, 43, 46, 50, 53, 55, 62, 65, 68, 69, 71, 73, 74, 80, 83, 86, 91, 92, 94, 102, 108, 110, 115, 119, 128, 131, 136, 142, 149, 150]	[2, 3, 5, 7, 12, 13, 15, 19, 23, 31, 38, 41, 42, 45, 49, 52, 54, 61, 64, 67, 69, 71, 72, 74, 79, 82, 86, 90, 92, 93, 101, 108, 109, 114, 118, 127, 130, 135, 141, 149, 150, 151]	['NEK10', '(', 'Never', '-', 'in', 'mitosis', 'related', 'kinase', '10', ')', 'is', 'one', 'of', 'a', 'family', 'of', '11', 'NIMA', '(', 'never', 'in', 'mitosis', 'a', ')', 'related', 'kinases', 'that', 'are', 'involved', 'in', 'cell', 'cycle', 'control7', '.']	[3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
No function has been ascribed to NEK10, but NEK2, NEK6, NEK7 and NEK9 seem to be involved in regulation of mitosis, whereas NEK1 and NEK8 have been associated with polycystic kidney disease8.	[]	['No', 'function', 'has', 'been', 'as', '##cribed', 'to', 'NE', '##K', '##10', ',', 'but', 'NE', '##K', '##2', ',', 'NE', '##K', '##6', ',', 'NE', '##K', '##7', 'and', 'NE', '##K', '##9', 'seem', 'to', 'be', 'involved', 'in', 'regulation', 'of', 'mit', '##osis', ',', 'whereas', 'NE', '##K', '##1', 'and', 'NE', '##K', '##8', 'have', 'been', 'associated', 'with', 'p', '##oly', '##cy', '##stic', 'kidney', 'disease', '##8', '.']	[0, 3, 12, 16, 21, 23, 30, 33, 35, 36, 38, 40, 44, 46, 47, 48, 50, 52, 53, 54, 56, 58, 59, 61, 65, 67, 68, 70, 75, 78, 81, 90, 93, 104, 107, 110, 114, 116, 124, 126, 127, 129, 133, 135, 136, 138, 143, 148, 159, 164, 165, 168, 170, 175, 182, 189, 190]	[2, 11, 15, 20, 23, 29, 32, 35, 36, 38, 39, 43, 46, 47, 48, 49, 52, 53, 54, 55, 58, 59, 60, 64, 67, 68, 69, 74, 77, 80, 89, 92, 103, 106, 110, 114, 115, 123, 126, 127, 128, 132, 135, 136, 137, 142, 147, 158, 163, 165, 168, 170, 174, 181, 189, 190, 191]	['No', 'function', 'has', 'been', 'ascribed', 'to', 'NEK10', ',', 'but', 'NEK2', ',', 'NEK6', ',', 'NEK7', 'and', 'NEK9', 'seem', 'to', 'be', 'involved', 'in', 'regulation', 'of', 'mitosis', ',', 'whereas', 'NEK1', 'and', 'NEK8', 'have', 'been', 'associated', 'with', 'polycystic', 'kidney', 'disease8', '.']	[1, 1, 1, 1, 2, 1, 3, 1, 1, 3, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 4, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SLC4A7 (solute carrier family 4, sodium bicarbonate cotransporter, member 7) is a potential tyrosine kinase substrate that has been shown to have reduced expression in breast tumor sections and cell lines9.	[]	['SL', '##C', '##4', '##A', '##7', '(', 'so', '##lut', '##e', 'carrier', 'family', '4', ',', 'sodium', 'bi', '##car', '##bon', '##ate', 'co', '##tra', '##ns', '##port', '##er', ',', 'member', '7', ')', 'is', 'a', 'potential', 't', '##yr', '##os', '##ine', 'kinase', 'substrate', 'that', 'has', 'been', 'shown', 'to', 'have', 'reduced', 'expression', 'in', 'breast', 'tumor', 'sections', 'and', 'cell', 'lines', '##9', '.']	[0, 2, 3, 4, 5, 7, 8, 10, 13, 15, 23, 30, 31, 33, 40, 42, 45, 48, 52, 54, 57, 59, 63, 65, 67, 74, 75, 77, 80, 82, 92, 93, 95, 97, 101, 108, 118, 123, 127, 132, 138, 141, 146, 154, 165, 168, 175, 181, 190, 194, 199, 204, 205]	[2, 3, 4, 5, 6, 8, 10, 13, 14, 22, 29, 31, 32, 39, 42, 45, 48, 51, 54, 57, 59, 63, 65, 66, 73, 75, 76, 79, 81, 91, 93, 95, 97, 100, 107, 117, 122, 126, 131, 137, 140, 145, 153, 164, 167, 174, 180, 189, 193, 198, 204, 205, 206]	['SLC4A7', '(', 'solute', 'carrier', 'family', '4', ',', 'sodium', 'bicarbonate', 'cotransporter', ',', 'member', '7', ')', 'is', 'a', 'potential', 'tyrosine', 'kinase', 'substrate', 'that', 'has', 'been', 'shown', 'to', 'have', 'reduced', 'expression', 'in', 'breast', 'tumor', 'sections', 'and', 'cell', 'lines9', '.']	[5, 1, 3, 1, 1, 1, 1, 1, 4, 5, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We excluded the data on a SNP for a given study that failed to achieve prespecified quality control criteria: these included an overall call rate of > 95%, duplicate concordance and concordance of test plate genotypes of > 98%, and no evidence of deviation from Hardy-Weinberg equilibrium at P < 0.005.	[]	['We', 'excluded', 'the', 'data', 'on', 'a', 'S', '##NP', 'for', 'a', 'given', 'study', 'that', 'failed', 'to', 'achieve', 'pre', '##sp', '##ec', '##ified', 'quality', 'control', 'criteria', ':', 'these', 'included', 'an', 'overall', 'call', 'rate', 'of', '>', '95', '%', ',', 'du', '##plicate', 'con', '##cor', '##dance', 'and', 'con', '##cor', '##dance', 'of', 'test', 'plate', 'g', '##eno', '##type', '##s', 'of', '>', '98', '%', ',', 'and', 'no', 'evidence', 'of', 'de', '##viation', 'from', 'Hardy', '-', 'Wei', '##nberg', 'equilibrium', 'at', 'P', '<', '0', '.', '00', '##5', '.']	[0, 3, 12, 16, 21, 24, 26, 27, 30, 34, 36, 42, 48, 53, 60, 63, 71, 74, 76, 78, 84, 92, 100, 108, 110, 116, 125, 128, 136, 141, 146, 149, 151, 153, 154, 156, 158, 166, 169, 172, 178, 182, 185, 188, 194, 197, 202, 208, 209, 212, 216, 218, 221, 223, 225, 226, 228, 232, 235, 244, 247, 249, 257, 262, 267, 268, 271, 277, 289, 292, 294, 296, 297, 298, 300, 301]	[2, 11, 15, 20, 23, 25, 27, 29, 33, 35, 41, 47, 52, 59, 62, 70, 74, 76, 78, 83, 91, 99, 108, 109, 115, 124, 127, 135, 140, 145, 148, 150, 153, 154, 155, 158, 165, 169, 172, 177, 181, 185, 188, 193, 196, 201, 207, 209, 212, 216, 217, 220, 222, 225, 226, 227, 231, 234, 243, 246, 249, 256, 261, 267, 268, 271, 276, 288, 291, 293, 295, 297, 298, 300, 301, 302]	['We', 'excluded', 'the', 'data', 'on', 'a', 'SNP', 'for', 'a', 'given', 'study', 'that', 'failed', 'to', 'achieve', 'prespecified', 'quality', 'control', 'criteria', ':', 'these', 'included', 'an', 'overall', 'call', 'rate', 'of', '>', '95%', ',', 'duplicate', 'concordance', 'and', 'concordance', 'of', 'test', 'plate', 'genotypes', 'of', '>', '98%', ',', 'and', 'no', 'evidence', 'of', 'deviation', 'from', 'Hardy-Weinberg', 'equilibrium', 'at', 'P', '<', '0.005', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 3, 1, 3, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In particular, previous studies of the p40phox protein encoded by the NCF4 gene have demonstrated that it plays an important role in NADPH oxidase activity and the generation of reactive oxygen species (ROS) production upon phagocytosis17,18; both important for mounting an effective anti-microbial response.	[]	['In', 'particular', ',', 'previous', 'studies', 'of', 'the', 'p', '##40', '##ph', '##ox', 'protein', 'encoded', 'by', 'the', 'NC', '##F', '##4', 'gene', 'have', 'demonstrated', 'that', 'it', 'plays', 'an', 'important', 'role', 'in', 'N', '##AD', '##P', '##H', 'o', '##xi', '##das', '##e', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'R', '##OS', ')', 'production', 'upon', 'p', '##ha', '##go', '##cy', '##tosis', '##17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti', '-', 'micro', '##bial', 'response', '.']	[0, 3, 13, 15, 24, 32, 35, 39, 40, 42, 44, 47, 55, 63, 66, 70, 72, 73, 75, 80, 85, 98, 103, 106, 112, 115, 125, 130, 133, 134, 136, 137, 139, 140, 142, 145, 147, 156, 160, 164, 175, 178, 187, 194, 202, 203, 204, 206, 208, 219, 224, 225, 227, 229, 231, 236, 238, 239, 241, 243, 248, 258, 262, 271, 274, 284, 288, 289, 294, 299, 307]	[2, 13, 14, 23, 31, 34, 38, 40, 42, 44, 46, 54, 62, 65, 69, 72, 73, 74, 79, 84, 97, 102, 105, 111, 114, 124, 129, 132, 134, 136, 137, 138, 140, 142, 145, 146, 155, 159, 163, 174, 177, 186, 193, 201, 203, 204, 206, 207, 218, 223, 225, 227, 229, 231, 236, 238, 239, 241, 242, 247, 257, 261, 270, 273, 283, 288, 289, 294, 298, 307, 308]	['In', 'particular', ',', 'previous', 'studies', 'of', 'the', 'p40phox', 'protein', 'encoded', 'by', 'the', 'NCF4', 'gene', 'have', 'demonstrated', 'that', 'it', 'plays', 'an', 'important', 'role', 'in', 'NADPH', 'oxidase', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'production', 'upon', 'phagocytosis17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti-', 'microbial', 'response', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NCF4 encodes the 7 p40phox protein that has previously been demonstrated to play an important role in NADPH oxidase activity and the generation of reactive oxygen species (ROS) production upon phagocytosis17,18; both important for mounting an effective anti-microbial response.	[]	['NC', '##F', '##4', 'en', '##codes', 'the', '7', 'p', '##40', '##ph', '##ox', 'protein', 'that', 'has', 'previously', 'been', 'demonstrated', 'to', 'play', 'an', 'important', 'role', 'in', 'N', '##AD', '##P', '##H', 'o', '##xi', '##das', '##e', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'R', '##OS', ')', 'production', 'upon', 'p', '##ha', '##go', '##cy', '##tosis', '##17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti', '-', 'micro', '##bial', 'response', '.']	[0, 2, 3, 5, 7, 13, 17, 19, 20, 22, 24, 27, 35, 40, 44, 55, 60, 73, 76, 81, 84, 94, 99, 102, 103, 105, 106, 108, 109, 111, 114, 116, 125, 129, 133, 144, 147, 156, 163, 171, 172, 173, 175, 177, 188, 193, 194, 196, 198, 200, 205, 207, 208, 210, 212, 217, 227, 231, 240, 243, 253, 257, 258, 263, 268, 276]	[2, 3, 4, 7, 12, 16, 18, 20, 22, 24, 26, 34, 39, 43, 54, 59, 72, 75, 80, 83, 93, 98, 101, 103, 105, 106, 107, 109, 111, 114, 115, 124, 128, 132, 143, 146, 155, 162, 170, 172, 173, 175, 176, 187, 192, 194, 196, 198, 200, 205, 207, 208, 210, 211, 216, 226, 230, 239, 242, 252, 257, 258, 263, 267, 276, 277]	['NCF4', 'encodes', 'the', '7', 'p40phox', 'protein', 'that', 'has', 'previously', 'been', 'demonstrated', 'to', 'play', 'an', 'important', 'role', 'in', 'NADPH', 'oxidase', 'activity', 'and', 'the', 'generation', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'production', 'upon', 'phagocytosis17', ',', '18', ';', 'both', 'important', 'for', 'mounting', 'an', 'effective', 'anti-', 'microbial', 'response', '.']	[3, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NCF4 encodes p40phox, a component of the NADPH oxidase complex required for optimal ROS generation in immune cells.	[('PMC2757939', 'R12000', 41, 54, 'NADPH oxidase')]	['NC', '##F', '##4', 'en', '##codes', 'p', '##40', '##ph', '##ox', ',', 'a', 'component', 'of', 'the', 'N', '##AD', '##P', '##H', 'o', '##xi', '##das', '##e', 'complex', 'required', 'for', 'optimal', 'R', '##OS', 'generation', 'in', 'immune', 'cells', '.']	[0, 2, 3, 5, 7, 13, 14, 16, 18, 20, 22, 24, 34, 37, 41, 42, 44, 45, 47, 48, 50, 53, 55, 63, 72, 76, 84, 85, 88, 99, 102, 109, 114]	[2, 3, 4, 7, 12, 14, 16, 18, 20, 21, 23, 33, 36, 40, 42, 44, 45, 46, 48, 50, 53, 54, 62, 71, 75, 83, 85, 87, 98, 101, 108, 114, 115]	['NCF4', 'encodes', 'p40phox', ',', 'a', 'component', 'of', 'the', 'NADPH', 'oxidase', 'complex', 'required', 'for', 'optimal', 'ROS', 'generation', 'in', 'immune', 'cells', '.']	[3, 2, 4, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In a genome-wide association study (GWAS) to identify genetic variants influencing LDL-C in an isolated population from Kosrae, we observed associations for SNPs in the gene encoding HMG-CoA reductase (HMGCR).	[('PMC2764366', 'A01000', 183, 200, 'HMG-CoA reductase')]	['In', 'a', 'genome', '-', 'wide', 'association', 'study', '(', 'G', '##WA', '##S', ')', 'to', 'identify', 'genetic', 'variants', 'in', '##f', '##lue', '##ncing', 'L', '##D', '##L', '-', 'C', 'in', 'an', 'isolated', 'population', 'from', 'Ko', '##s', '##rae', ',', 'we', 'observed', 'associations', 'for', 'S', '##NP', '##s', 'in', 'the', 'gene', 'encoding', 'HM', '##G', '-', 'Co', '##A', 'red', '##uc', '##tase', '(', 'HM', '##GC', '##R', ')', '.']	[0, 3, 5, 11, 12, 17, 29, 35, 36, 37, 39, 40, 42, 45, 54, 62, 71, 73, 74, 77, 83, 84, 85, 86, 87, 89, 92, 95, 104, 115, 120, 122, 123, 126, 128, 131, 140, 153, 157, 158, 160, 162, 165, 169, 174, 183, 185, 186, 187, 189, 191, 194, 196, 201, 202, 204, 206, 207, 208]	[2, 4, 11, 12, 16, 28, 34, 36, 37, 39, 40, 41, 44, 53, 61, 70, 73, 74, 77, 82, 84, 85, 86, 87, 88, 91, 94, 103, 114, 119, 122, 123, 126, 127, 130, 139, 152, 156, 158, 160, 161, 164, 168, 173, 182, 185, 186, 187, 189, 190, 194, 196, 200, 202, 204, 206, 207, 208, 209]	['In', 'a', 'genome', '-', 'wide', 'association', 'study', '(', 'GWAS', ')', 'to', 'identify', 'genetic', 'variants', 'influencing', 'LDL-C', 'in', 'an', 'isolated', 'population', 'from', 'Kosrae', ',', 'we', 'observed', 'associations', 'for', 'SNPs', 'in', 'the', 'gene', 'encoding', 'HMG-CoA', 'reductase', '(', 'HMGCR', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 5, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 5, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
HMG-CoA reductase is a key enzyme in cholesterol homeostasis and catalyzes the rate limiting step in cholesterol biosynthesis 21.	[('PMC2764366', 'D01000', 0, 17, 'HMG-CoA reductase')]	['HM', '##G', '-', 'Co', '##A', 'red', '##uc', '##tase', 'is', 'a', 'key', 'enzyme', 'in', 'ch', '##ole', '##ster', '##ol', 'home', '##ost', '##asis', 'and', 'cat', '##aly', '##zes', 'the', 'rate', 'limiting', 'step', 'in', 'ch', '##ole', '##ster', '##ol', 'bio', '##sy', '##nt', '##hesis', '21', '.']	[0, 2, 3, 4, 6, 8, 11, 13, 18, 21, 23, 27, 34, 37, 39, 42, 46, 49, 53, 56, 61, 65, 68, 71, 75, 79, 84, 93, 98, 101, 103, 106, 110, 113, 116, 118, 120, 126, 128]	[2, 3, 4, 6, 7, 11, 13, 17, 20, 22, 26, 33, 36, 39, 42, 46, 48, 53, 56, 60, 64, 68, 71, 74, 78, 83, 92, 97, 100, 103, 106, 110, 112, 116, 118, 120, 125, 128, 129]	['HMG-CoA', 'reductase', 'is', 'a', 'key', 'enzyme', 'in', 'cholesterol', 'homeostasis', 'and', 'catalyzes', 'the', 'rate', 'limiting', 'step', 'in', 'cholesterol', 'biosynthesis', '21', '.']	[5, 3, 1, 1, 1, 1, 1, 4, 3, 1, 3, 1, 1, 1, 1, 1, 4, 4, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Russell DeBose-Boyd and Michael Brown, UT Southwestern Medical Center) are mutant chinese hamster ovary (CHO) cells that lack HMG-CoA reductase and require mevalonate for growth.	[]	['Russell', 'De', '##B', '##ose', '-', 'Boyd', 'and', 'Michael', 'Brown', ',', 'U', '##T', 'Southwestern', 'Medical', 'Center', ')', 'are', 'mutant', 'chin', '##ese', 'ha', '##ms', '##ter', 'o', '##vary', '(', 'CH', '##O', ')', 'cells', 'that', 'lack', 'HM', '##G', '-', 'Co', '##A', 'red', '##uc', '##tase', 'and', 'require', 'me', '##val', '##ona', '##te', 'for', 'growth', '.']	[0, 8, 10, 11, 14, 15, 20, 24, 32, 37, 39, 40, 42, 55, 63, 69, 71, 75, 82, 86, 90, 92, 94, 98, 99, 104, 105, 107, 108, 110, 116, 121, 126, 128, 129, 130, 132, 134, 137, 139, 144, 148, 156, 158, 161, 164, 167, 171, 177]	[7, 10, 11, 14, 15, 19, 23, 31, 37, 38, 40, 41, 54, 62, 69, 70, 74, 81, 86, 89, 92, 94, 97, 99, 103, 105, 107, 108, 109, 115, 120, 125, 128, 129, 130, 132, 133, 137, 139, 143, 147, 155, 158, 161, 164, 166, 170, 177, 178]	['Russell', 'DeBose-Boyd', 'and', 'Michael', 'Brown', ',', 'UT', 'Southwestern', 'Medical', 'Center', ')', 'are', 'mutant', 'chinese', 'hamster', 'ovary', '(', 'CHO', ')', 'cells', 'that', 'lack', 'HMG-CoA', 'reductase', 'and', 'require', 'mevalonate', 'for', 'growth', '.']	[1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 3, 2, 1, 2, 1, 1, 1, 1, 5, 3, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
HMG-CoA reductase activity was measured in detergent solubilized cell extracts as described 17 except that mevalonolactone was separated by ion exchange chromatography 18.	[]	['HM', '##G', '-', 'Co', '##A', 'red', '##uc', '##tase', 'activity', 'was', 'measured', 'in', 'de', '##ter', '##gent', 'so', '##lub', '##ilized', 'cell', 'extract', '##s', 'as', 'described', '17', 'except', 'that', 'me', '##val', '##ono', '##la', '##cton', '##e', 'was', 'separated', 'by', 'ion', 'exchange', 'ch', '##roma', '##tography', '18', '.']	[0, 2, 3, 4, 6, 8, 11, 13, 18, 27, 31, 40, 43, 45, 48, 53, 55, 58, 65, 70, 77, 79, 82, 92, 95, 102, 107, 109, 112, 115, 117, 121, 123, 127, 137, 140, 144, 153, 155, 159, 168, 170]	[2, 3, 4, 6, 7, 11, 13, 17, 26, 30, 39, 42, 45, 48, 52, 55, 58, 64, 69, 77, 78, 81, 91, 94, 101, 106, 109, 112, 115, 117, 121, 122, 126, 136, 139, 143, 152, 155, 159, 167, 170, 171]	['HMG-CoA', 'reductase', 'activity', 'was', 'measured', 'in', 'detergent', 'solubilized', 'cell', 'extracts', 'as', 'described', '17', 'except', 'that', 'mevalonolactone', 'was', 'separated', 'by', 'ion', 'exchange', 'chromatography', '18', '.']	[5, 3, 1, 1, 1, 1, 3, 3, 1, 2, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We successfully expressed a recombinant form of the Sar s 3 serine protease in a yeast expression system.	[('PMC2797209', 'D01000', 67, 75, 'protease')]	['We', 'successfully', 'expressed', 'a', 're', '##comb', '##ina', '##nt', 'form', 'of', 'the', 'Sa', '##r', 's', '3', 'se', '##rine', 'pro', '##te', '##ase', 'in', 'a', 'yeast', 'expression', 'system', '.']	[0, 3, 16, 26, 28, 30, 34, 37, 40, 45, 48, 52, 54, 56, 58, 60, 62, 67, 70, 72, 76, 79, 81, 87, 98, 104]	[2, 15, 25, 27, 30, 34, 37, 39, 44, 47, 51, 54, 55, 57, 59, 62, 66, 70, 72, 75, 78, 80, 86, 97, 104, 105]	['We', 'successfully', 'expressed', 'a', 'recombinant', 'form', 'of', 'the', 'Sar', 's', '3', 'serine', 'protease', 'in', 'a', 'yeast', 'expression', 'system', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The rSar s 3 was not inhibited by a number of host protease inhibitors, although α2-macroglobulin was capable of inhibiting the enzyme.	[('PMC2797209', 'D02000', 51, 59, 'protease')]	['The', 'r', '##S', '##ar', 's', '3', 'was', 'not', 'in', '##hibit', '##ed', 'by', 'a', 'number', 'of', 'host', 'pro', '##te', '##ase', 'inhibitor', '##s', ',', 'although', 'α', '##2', '-', 'mac', '##rog', '##lo', '##bul', '##in', 'was', 'capable', 'of', 'in', '##hibit', '##ing', 'the', 'enzyme', '.']	[0, 4, 5, 6, 9, 11, 13, 17, 21, 23, 28, 31, 34, 36, 43, 46, 51, 54, 56, 60, 69, 70, 72, 81, 82, 83, 84, 87, 90, 92, 95, 98, 102, 110, 113, 115, 120, 124, 128, 134]	[3, 5, 6, 8, 10, 12, 16, 20, 23, 28, 30, 33, 35, 42, 45, 50, 54, 56, 59, 69, 70, 71, 80, 82, 83, 84, 87, 90, 92, 95, 97, 101, 109, 112, 115, 120, 123, 127, 134, 135]	['The', 'rSar', 's', '3', 'was', 'not', 'inhibited', 'by', 'a', 'number', 'of', 'host', 'protease', 'inhibitors', ',', 'although', 'α2-macroglobulin', 'was', 'capable', 'of', 'inhibiting', 'the', 'enzyme', '.']	[1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 2, 1, 1, 8, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The excretion of the protease in the mite feces would be expected to allow the protease access to the proteins found in the epidermal layer.	[('PMC2797209', 'D04000', 21, 29, 'protease')]	['The', 'ex', '##cre', '##tion', 'of', 'the', 'pro', '##te', '##ase', 'in', 'the', 'mit', '##e', 'f', '##ec', '##es', 'would', 'be', 'expected', 'to', 'allow', 'the', 'pro', '##te', '##ase', 'access', 'to', 'the', 'proteins', 'found', 'in', 'the', 'e', '##pid', '##er', '##mal', 'layer', '.']	[0, 4, 6, 9, 14, 17, 21, 24, 26, 30, 33, 37, 40, 42, 43, 45, 48, 54, 57, 66, 69, 75, 79, 82, 84, 88, 95, 98, 102, 111, 117, 120, 124, 125, 128, 130, 134, 139]	[3, 6, 9, 13, 16, 20, 24, 26, 29, 32, 36, 40, 41, 43, 45, 47, 53, 56, 65, 68, 74, 78, 82, 84, 87, 94, 97, 101, 110, 116, 119, 123, 125, 128, 130, 133, 139, 140]	['The', 'excretion', 'of', 'the', 'protease', 'in', 'the', 'mite', 'feces', 'would', 'be', 'expected', 'to', 'allow', 'the', 'protease', 'access', 'to', 'the', 'proteins', 'found', 'in', 'the', 'epidermal', 'layer', '.']	[1, 3, 1, 1, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As proteins in house dust mite feces have been found to gain considerable access to lung tissue of allergy sufferers (35), it is similarly likely that the protease in the mite fecal matter might gain such access to skin.	[('PMC2797209', 'D04001', 155, 163, 'protease')]	['As', 'proteins', 'in', 'house', 'dust', 'mit', '##e', 'f', '##ec', '##es', 'have', 'been', 'found', 'to', 'gain', 'considerable', 'access', 'to', 'lung', 'tissue', 'of', 'all', '##er', '##gy', 'suffer', '##ers', '(', '35', ')', ',', 'it', 'is', 'similarly', 'likely', 'that', 'the', 'pro', '##te', '##ase', 'in', 'the', 'mit', '##e', 'f', '##eca', '##l', 'matter', 'might', 'gain', 'such', 'access', 'to', 'skin', '.']	[0, 3, 12, 15, 21, 26, 29, 31, 32, 34, 37, 42, 47, 53, 56, 61, 74, 81, 84, 89, 96, 99, 102, 104, 107, 113, 117, 118, 120, 121, 123, 126, 129, 139, 146, 151, 155, 158, 160, 164, 167, 171, 174, 176, 177, 180, 182, 189, 195, 200, 205, 212, 215, 219]	[2, 11, 14, 20, 25, 29, 30, 32, 34, 36, 41, 46, 52, 55, 60, 73, 80, 83, 88, 95, 98, 102, 104, 106, 113, 116, 118, 120, 121, 122, 125, 128, 138, 145, 150, 154, 158, 160, 163, 166, 170, 174, 175, 177, 180, 181, 188, 194, 199, 204, 211, 214, 219, 220]	['As', 'proteins', 'in', 'house', 'dust', 'mite', 'feces', 'have', 'been', 'found', 'to', 'gain', 'considerable', 'access', 'to', 'lung', 'tissue', 'of', 'allergy', 'sufferers', '(', '35', ')', ',', 'it', 'is', 'similarly', 'likely', 'that', 'the', 'protease', 'in', 'the', 'mite', 'fecal', 'matter', 'might', 'gain', 'such', 'access', 'to', 'skin', '.']	[1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The actions of this protease would be anticipated to cause considerable disruption to the proper assembly and structure of the epidermal layer.	[('PMC2797209', 'D04002', 20, 28, 'protease')]	['The', 'actions', 'of', 'this', 'pro', '##te', '##ase', 'would', 'be', 'anticipated', 'to', 'cause', 'considerable', 'disruption', 'to', 'the', 'proper', 'assembly', 'and', 'structure', 'of', 'the', 'e', '##pid', '##er', '##mal', 'layer', '.']	[0, 4, 12, 15, 20, 23, 25, 29, 35, 38, 50, 53, 59, 72, 83, 86, 90, 97, 106, 110, 120, 123, 127, 128, 131, 133, 137, 142]	[3, 11, 14, 19, 23, 25, 28, 34, 37, 49, 52, 58, 71, 82, 85, 89, 96, 105, 109, 119, 122, 126, 128, 131, 133, 136, 142, 143]	['The', 'actions', 'of', 'this', 'protease', 'would', 'be', 'anticipated', 'to', 'cause', 'considerable', 'disruption', 'to', 'the', 'proper', 'assembly', 'and', 'structure', 'of', 'the', 'epidermal', 'layer', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Disruption of the structure of this protein, which has been shown here to be a substrate of the Sar s 3 protease, would be expected to substantially disrupt the CE, and indeed such disruption of the epidermis is commonly observed in sufferers of scabies mite infestations.	[]	['Di', '##s', '##rup', '##tion', 'of', 'the', 'structure', 'of', 'this', 'protein', ',', 'which', 'has', 'been', 'shown', 'here', 'to', 'be', 'a', 'substrate', 'of', 'the', 'Sa', '##r', 's', '3', 'pro', '##te', '##ase', ',', 'would', 'be', 'expected', 'to', 'substantially', 'disrupt', 'the', 'CE', ',', 'and', 'indeed', 'such', 'disruption', 'of', 'the', 'e', '##pid', '##er', '##mis', 'is', 'commonly', 'observed', 'in', 'suffer', '##ers', 'of', 's', '##ca', '##bies', 'mit', '##e', 'in', '##fest', '##ations', '.']	[0, 2, 3, 6, 11, 14, 18, 28, 31, 36, 43, 45, 51, 55, 60, 66, 71, 74, 77, 79, 89, 92, 96, 98, 100, 102, 104, 107, 109, 112, 114, 120, 123, 132, 135, 149, 157, 161, 163, 165, 169, 176, 181, 192, 195, 199, 200, 203, 205, 209, 212, 221, 230, 233, 239, 243, 246, 247, 249, 254, 257, 259, 261, 265, 271]	[2, 3, 6, 10, 13, 17, 27, 30, 35, 43, 44, 50, 54, 59, 65, 70, 73, 76, 78, 88, 91, 95, 98, 99, 101, 103, 107, 109, 112, 113, 119, 122, 131, 134, 148, 156, 160, 163, 164, 168, 175, 180, 191, 194, 198, 200, 203, 205, 208, 211, 220, 229, 232, 239, 242, 245, 247, 249, 253, 257, 258, 261, 265, 271, 272]	['Disruption', 'of', 'the', 'structure', 'of', 'this', 'protein', ',', 'which', 'has', 'been', 'shown', 'here', 'to', 'be', 'a', 'substrate', 'of', 'the', 'Sar', 's', '3', 'protease', ',', 'would', 'be', 'expected', 'to', 'substantially', 'disrupt', 'the', 'CE', ',', 'and', 'indeed', 'such', 'disruption', 'of', 'the', 'epidermis', 'is', 'commonly', 'observed', 'in', 'sufferers', 'of', 'scabies', 'mite', 'infestations', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 3, 2, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mite gut proteases involved in host protein digestion offer an avenue for interfering with parasite establishment.	[('PMC2797209', 'I01000', 9, 18, 'proteases')]	['Mi', '##te', 'gut', 'pro', '##te', '##ases', 'involved', 'in', 'host', 'protein', 'dig', '##est', '##ion', 'offer', 'an', 'avenue', 'for', 'interfering', 'with', 'parasite', 'establishment', '.']	[0, 2, 5, 9, 12, 14, 19, 28, 31, 36, 44, 47, 50, 54, 60, 63, 70, 74, 86, 91, 100, 113]	[2, 4, 8, 12, 14, 18, 27, 30, 35, 43, 47, 50, 53, 59, 62, 69, 73, 85, 90, 99, 113, 114]	['Mite', 'gut', 'proteases', 'involved', 'in', 'host', 'protein', 'digestion', 'offer', 'an', 'avenue', 'for', 'interfering', 'with', 'parasite', 'establishment', '.']	[2, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In scabies mite-related but non-parasitic astigmatid house dust mites, serine and cysteine proteases have been implicated in skin protein digestion (7,–11).	[('PMC2797209', 'I01001', 82, 100, 'cysteine proteases')]	['In', 's', '##ca', '##bies', 'mit', '##e', '-', 'related', 'but', 'non', '-', 'para', '##sitic', 'as', '##ti', '##gma', '##ti', '##d', 'house', 'dust', 'mit', '##es', ',', 'se', '##rine', 'and', 'c', '##ys', '##tein', '##e', 'pro', '##te', '##ases', 'have', 'been', 'implicated', 'in', 'skin', 'protein', 'dig', '##est', '##ion', '(', '7', ',', '–', '11', ')', '.']	[0, 3, 4, 6, 11, 14, 15, 16, 24, 28, 31, 32, 36, 42, 44, 46, 49, 51, 53, 59, 64, 67, 69, 71, 73, 78, 82, 83, 85, 89, 91, 94, 96, 101, 106, 111, 122, 125, 130, 138, 141, 144, 148, 149, 150, 151, 152, 154, 155]	[2, 4, 6, 10, 14, 15, 16, 23, 27, 31, 32, 36, 41, 44, 46, 49, 51, 52, 58, 63, 67, 69, 70, 73, 77, 81, 83, 85, 89, 90, 94, 96, 100, 105, 110, 121, 124, 129, 137, 141, 144, 147, 149, 150, 151, 152, 154, 155, 156]	['In', 'scabies', 'mite', '-', 'related', 'but', 'non', '-', 'parasitic', 'astigmatid', 'house', 'dust', 'mites', ',', 'serine', 'and', 'cysteine', 'proteases', 'have', 'been', 'implicated', 'in', 'skin', 'protein', 'digestion', '(', '7', ',', '–11', ')', '.']	[1, 3, 2, 1, 1, 1, 1, 1, 2, 5, 1, 1, 2, 1, 2, 1, 4, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Group 3 allergens, typified by Der p 3 from Dermatophagoides pteronyssinus, are abundant serine proteases of the S1 family (12).	[('PMC2797209', 'I01002', 89, 105, 'serine proteases')]	['Group', '3', 'all', '##er', '##gens', ',', 't', '##y', '##pi', '##fied', 'by', 'Der', 'p', '3', 'from', 'Der', '##mat', '##op', '##ha', '##go', '##ides', 'p', '##tero', '##ny', '##ssin', '##us', ',', 'are', 'abundant', 'se', '##rine', 'pro', '##te', '##ases', 'of', 'the', 'S', '##1', 'family', '(', '12', ')', '.']	[0, 6, 8, 11, 13, 17, 19, 20, 21, 23, 28, 31, 35, 37, 39, 44, 47, 50, 52, 54, 56, 61, 62, 66, 68, 72, 74, 76, 80, 89, 91, 96, 99, 101, 106, 109, 113, 114, 116, 123, 124, 126, 127]	[5, 7, 11, 13, 17, 18, 20, 21, 23, 27, 30, 34, 36, 38, 43, 47, 50, 52, 54, 56, 60, 62, 66, 68, 72, 74, 75, 79, 88, 91, 95, 99, 101, 105, 108, 112, 114, 115, 122, 124, 126, 127, 128]	['Group', '3', 'allergens', ',', 'typified', 'by', 'Der', 'p', '3', 'from', 'Dermatophagoides', 'pteronyssinus', ',', 'are', 'abundant', 'serine', 'proteases', 'of', 'the', 'S1', 'family', '(', '12', ')', '.']	[1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 6, 5, 1, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recombinant rSar s 3 and a series of three scabies mite-inactivated protease paralogues were expressed as insoluble products using an E. coli system, and the resolubilized rSar s 3 was used to raise polyclonal antibodies in mice.	[('PMC2797209', 'R00000', 68, 76, 'protease')]	['Re', '##comb', '##ina', '##nt', 'r', '##S', '##ar', 's', '3', 'and', 'a', 'series', 'of', 'three', 's', '##ca', '##bies', 'mit', '##e', '-', 'inactivated', 'pro', '##te', '##ase', 'para', '##logue', '##s', 'were', 'expressed', 'as', 'ins', '##ol', '##ub', '##le', 'products', 'using', 'an', 'E', '.', 'co', '##li', 'system', ',', 'and', 'the', 're', '##sol', '##ubi', '##li', '##zed', 'r', '##S', '##ar', 's', '3', 'was', 'used', 'to', 'raise', 'p', '##oly', '##c', '##lon', '##al', 'antibodies', 'in', 'mice', '.']	[0, 2, 6, 9, 12, 13, 14, 17, 19, 21, 25, 27, 34, 37, 43, 44, 46, 51, 54, 55, 56, 68, 71, 73, 77, 81, 86, 88, 93, 103, 106, 109, 111, 113, 116, 125, 131, 134, 135, 137, 139, 142, 148, 150, 154, 158, 160, 163, 166, 168, 172, 173, 174, 177, 179, 181, 185, 190, 193, 199, 200, 203, 204, 207, 210, 221, 224, 228]	[2, 6, 9, 11, 13, 14, 16, 18, 20, 24, 26, 33, 36, 42, 44, 46, 50, 54, 55, 56, 67, 71, 73, 76, 81, 86, 87, 92, 102, 105, 109, 111, 113, 115, 124, 130, 133, 135, 136, 139, 141, 148, 149, 153, 157, 160, 163, 166, 168, 171, 173, 174, 176, 178, 180, 184, 189, 192, 198, 200, 203, 204, 207, 209, 220, 223, 228, 229]	['Recombinant', 'rSar', 's', '3', 'and', 'a', 'series', 'of', 'three', 'scabies', 'mite', '-', 'inactivated', 'protease', 'paralogues', 'were', 'expressed', 'as', 'insoluble', 'products', 'using', 'an', 'E', '.', 'coli', 'system', ',', 'and', 'the', 'resolubilized', 'rSar', 's', '3', 'was', 'used', 'to', 'raise', 'polyclonal', 'antibodies', 'in', 'mice', '.']	[4, 3, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 3, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Testing of the antibodies using immunoblotting analysis revealed that the antibodies against rSar s 3 were specific to the enzyme and did not cross-react with scabies mite-inactivated protease paralogues from the scabies mite (data not shown).	[('PMC2797209', 'R00001', 184, 192, 'protease')]	['Testing', 'of', 'the', 'antibodies', 'using', 'im', '##mu', '##nob', '##lot', '##ting', 'analysis', 'revealed', 'that', 'the', 'antibodies', 'against', 'r', '##S', '##ar', 's', '3', 'were', 'specific', 'to', 'the', 'enzyme', 'and', 'did', 'not', 'cross', '-', 'react', 'with', 's', '##ca', '##bies', 'mit', '##e', '-', 'inactivated', 'pro', '##te', '##ase', 'para', '##logue', '##s', 'from', 'the', 's', '##ca', '##bies', 'mit', '##e', '(', 'data', 'not', 'shown', ')', '.']	[0, 8, 11, 15, 26, 32, 34, 36, 39, 42, 47, 56, 65, 70, 74, 85, 93, 94, 95, 98, 100, 102, 107, 116, 119, 123, 130, 134, 138, 142, 147, 148, 154, 159, 160, 162, 167, 170, 171, 172, 184, 187, 189, 193, 197, 202, 204, 209, 213, 214, 216, 221, 224, 226, 227, 232, 236, 241, 242]	[7, 10, 14, 25, 31, 34, 36, 39, 42, 46, 55, 64, 69, 73, 84, 92, 94, 95, 97, 99, 101, 106, 115, 118, 122, 129, 133, 137, 141, 147, 148, 153, 158, 160, 162, 166, 170, 171, 172, 183, 187, 189, 192, 197, 202, 203, 208, 212, 214, 216, 220, 224, 225, 227, 231, 235, 241, 242, 243]	['Testing', 'of', 'the', 'antibodies', 'using', 'immunoblotting', 'analysis', 'revealed', 'that', 'the', 'antibodies', 'against', 'rSar', 's', '3', 'were', 'specific', 'to', 'the', 'enzyme', 'and', 'did', 'not', 'cross', '-', 'react', 'with', 'scabies', 'mite', '-', 'inactivated', 'protease', 'paralogues', 'from', 'the', 'scabies', 'mite', '(', 'data', 'not', 'shown', ')', '.']	[1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 3, 3, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recombinant rSar s 3 WT exhibited trypsin-like protease activity of variable magnitude against 8 of the 10 fluorogenic substrates tested (Fig. 2C).	[('PMC2797209', 'R04000', 47, 55, 'protease')]	['Re', '##comb', '##ina', '##nt', 'r', '##S', '##ar', 's', '3', 'W', '##T', 'exhibited', 'try', '##ps', '##in', '-', 'like', 'pro', '##te', '##ase', 'activity', 'of', 'variable', 'magnitude', 'against', '8', 'of', 'the', '10', 'flu', '##oro', '##genic', 'substrates', 'tested', '(', 'Fi', '##g', '.', '2', '##C', ')', '.']	[0, 2, 6, 9, 12, 13, 14, 17, 19, 21, 22, 24, 34, 37, 39, 41, 42, 47, 50, 52, 56, 65, 68, 77, 87, 95, 97, 100, 104, 107, 110, 113, 119, 130, 137, 138, 140, 141, 143, 144, 145, 146]	[2, 6, 9, 11, 13, 14, 16, 18, 20, 22, 23, 33, 37, 39, 41, 42, 46, 50, 52, 55, 64, 67, 76, 86, 94, 96, 99, 103, 106, 110, 113, 118, 129, 136, 138, 140, 141, 142, 144, 145, 146, 147]	['Recombinant', 'rSar', 's', '3', 'WT', 'exhibited', 'trypsin', '-', 'like', 'protease', 'activity', 'of', 'variable', 'magnitude', 'against', '8', 'of', 'the', '10', 'fluorogenic', 'substrates', 'tested', '(', 'Fig', '.', '2C', ')', '.']	[4, 3, 1, 1, 2, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Classical effectors of proteases were used to characterize Sar s 3 activity.	[('PMC2797209', 'R06000', 23, 32, 'proteases')]	['Classical', 'effect', '##ors', 'of', 'pro', '##te', '##ases', 'were', 'used', 'to', 'character', '##ize', 'Sa', '##r', 's', '3', 'activity', '.']	[0, 10, 16, 20, 23, 26, 28, 33, 38, 43, 46, 55, 59, 61, 63, 65, 67, 75]	[9, 16, 19, 22, 26, 28, 32, 37, 42, 45, 55, 58, 61, 62, 64, 66, 75, 76]	['Classical', 'effectors', 'of', 'proteases', 'were', 'used', 'to', 'characterize', 'Sar', 's', '3', 'activity', '.']	[1, 2, 1, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Calcium, often necessary as activator and/or stabilizer of serine proteases, did not stimulate but, rather, inhibited rSar s 3 enzyme activity (Fig. 3C).	[]	['Cal', '##ci', '##um', ',', 'often', 'necessary', 'as', 'act', '##iva', '##tor', 'and', '/', 'or', 'stab', '##ilizer', 'of', 'se', '##rine', 'pro', '##te', '##ases', ',', 'did', 'not', 'stimulate', 'but', ',', 'rather', ',', 'in', '##hibit', '##ed', 'r', '##S', '##ar', 's', '3', 'enzyme', 'activity', '(', 'Fi', '##g', '.', '3', '##C', ')', '.']	[0, 3, 5, 7, 9, 15, 25, 28, 31, 34, 38, 41, 42, 45, 49, 56, 59, 61, 66, 69, 71, 75, 77, 81, 85, 95, 98, 100, 106, 108, 110, 115, 118, 119, 120, 123, 125, 127, 134, 143, 144, 146, 147, 149, 150, 151, 152]	[3, 5, 7, 8, 14, 24, 27, 31, 34, 37, 41, 42, 44, 49, 55, 58, 61, 65, 69, 71, 75, 76, 80, 84, 94, 98, 99, 106, 107, 110, 115, 117, 119, 120, 122, 124, 126, 133, 142, 144, 146, 147, 148, 150, 151, 152, 153]	['Calcium', ',', 'often', 'necessary', 'as', 'activator', 'and', '/', 'or', 'stabilizer', 'of', 'serine', 'proteases', ',', 'did', 'not', 'stimulate', 'but', ',', 'rather', ',', 'inhibited', 'rSar', 's', '3', 'enzyme', 'activity', '(', 'Fig', '.', '3C', ')', '.']	[3, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ZnCl2 did not affect Sar s 3 activity at physiological concentrations in the micromolar range, whereas excess concentrations revealed inhibition up to 90% (Fig. 3D).	[]	['Z', '##n', '##C', '##l', '##2', 'did', 'not', 'affect', 'Sa', '##r', 's', '3', 'activity', 'at', 'physiological', 'concentrations', 'in', 'the', 'micro', '##mo', '##lar', 'range', ',', 'whereas', 'excess', 'concentrations', 'revealed', 'in', '##hibition', 'up', 'to', '90', '%', '(', 'Fi', '##g', '.', '3D', ')', '.']	[0, 1, 2, 3, 4, 6, 10, 14, 21, 23, 25, 27, 29, 38, 41, 55, 70, 73, 77, 82, 84, 88, 93, 95, 103, 110, 125, 134, 136, 145, 148, 151, 153, 155, 156, 158, 159, 161, 163, 164]	[1, 2, 3, 4, 5, 9, 13, 20, 23, 24, 26, 28, 37, 40, 54, 69, 72, 76, 82, 84, 87, 93, 94, 102, 109, 124, 133, 136, 144, 147, 150, 153, 154, 156, 158, 159, 160, 163, 164, 165]	['ZnCl2', 'did', 'not', 'affect', 'Sar', 's', '3', 'activity', 'at', 'physiological', 'concentrations', 'in', 'the', 'micromolar', 'range', ',', 'whereas', 'excess', 'concentrations', 'revealed', 'inhibition', 'up', 'to', '90%', '(', 'Fig', '.', '3D', ')', '.']	[5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The covalent complex formed between α2-macroglobulin and endopeptidases can be useful to characterize novel proteases.	[('PMC2797209', 'R07000', 57, 71, 'endopeptidases')]	['The', 'co', '##valent', 'complex', 'formed', 'between', 'α', '##2', '-', 'mac', '##rog', '##lo', '##bul', '##in', 'and', 'end', '##ope', '##pt', '##idas', '##es', 'can', 'be', 'useful', 'to', 'character', '##ize', 'novel', 'pro', '##te', '##ases', '.']	[0, 4, 6, 13, 21, 28, 36, 37, 38, 39, 42, 45, 47, 50, 53, 57, 60, 63, 65, 69, 72, 76, 79, 86, 89, 98, 102, 108, 111, 113, 117]	[3, 6, 12, 20, 27, 35, 37, 38, 39, 42, 45, 47, 50, 52, 56, 60, 63, 65, 69, 71, 75, 78, 85, 88, 98, 101, 107, 111, 113, 117, 118]	['The', 'covalent', 'complex', 'formed', 'between', 'α2-macroglobulin', 'and', 'endopeptidases', 'can', 'be', 'useful', 'to', 'characterize', 'novel', 'proteases', '.']	[1, 2, 1, 1, 1, 8, 1, 5, 1, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteinase entrapment by α2-macroglobulin is irreversible; however, the complexed enzyme retains substantial activity against small peptides but is almost completely inactive against proteins larger than 25 kDa (25).	[('PMC2797209', 'R07001', 0, 10, 'Proteinase')]	['Pro', '##tein', '##ase', 'en', '##tra', '##pment', 'by', 'α', '##2', '-', 'mac', '##rog', '##lo', '##bul', '##in', 'is', 'i', '##rre', '##versible', ';', 'however', ',', 'the', 'complex', '##ed', 'enzyme', 'retains', 'substantial', 'activity', 'against', 'small', 'p', '##eptide', '##s', 'but', 'is', 'almost', 'completely', 'inactive', 'against', 'proteins', 'larger', 'than', '25', 'k', '##D', '##a', '(', '25', ')', '.']	[0, 3, 7, 11, 13, 16, 22, 25, 26, 27, 28, 31, 34, 36, 39, 42, 45, 46, 49, 57, 59, 66, 68, 72, 79, 82, 89, 97, 109, 118, 126, 132, 133, 139, 141, 145, 148, 155, 166, 175, 183, 192, 199, 204, 207, 208, 209, 211, 212, 214, 215]	[3, 7, 10, 13, 16, 21, 24, 26, 27, 28, 31, 34, 36, 39, 41, 44, 46, 49, 57, 58, 66, 67, 71, 79, 81, 88, 96, 108, 117, 125, 131, 133, 139, 140, 144, 147, 154, 165, 174, 182, 191, 198, 203, 206, 208, 209, 210, 212, 214, 215, 216]	['Proteinase', 'entrapment', 'by', 'α2-macroglobulin', 'is', 'irreversible', ';', 'however', ',', 'the', 'complexed', 'enzyme', 'retains', 'substantial', 'activity', 'against', 'small', 'peptides', 'but', 'is', 'almost', 'completely', 'inactive', 'against', 'proteins', 'larger', 'than', '25', 'kDa', '(', '25', ')', '.']	[3, 3, 1, 8, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In a similar reaction, one might predict that 6 could be metabolized by the concerted action of cysteine S-conjugate β-lyase, S-methyltransferase and N-acetyltransferase to S-[1-(5-acetylamino-5-carboxypentyl)-1H-pyrrol-3-yl]methanethiol (7, Scheme 2).	[]	['In', 'a', 'similar', 'reaction', ',', 'one', 'might', 'predict', 'that', '6', 'could', 'be', 'meta', '##bol', '##ized', 'by', 'the', 'concert', '##ed', 'action', 'of', 'c', '##ys', '##tein', '##e', 'S', '-', 'con', '##ju', '##gate', 'β', '-', 'l', '##yas', '##e', ',', 'S', '-', 'met', '##hyl', '##tra', '##ns', '##fer', '##ase', 'and', 'N', '-', 'ace', '##ty', '##lt', '##ran', '##s', '##fer', '##ase', 'to', 'S', '-', '[', '1', '-', '(', '5', '-', 'ace', '##ty', '##lam', '##ino', '-', '5', '-', 'car', '##box', '##ype', '##nt', '##yl', ')', '-', '1', '##H', '-', 'p', '##yr', '##rol', '-', '3', '-', 'y', '##l', ']', 'met', '##hane', '##thi', '##ol', '(', '7', ',', 'Scheme', '2', ')', '.']	[0, 3, 5, 13, 21, 23, 27, 33, 41, 46, 48, 54, 57, 61, 64, 69, 72, 76, 83, 86, 93, 96, 97, 99, 103, 105, 106, 107, 110, 112, 117, 118, 119, 120, 123, 124, 126, 127, 128, 131, 134, 137, 139, 142, 146, 150, 151, 152, 155, 157, 159, 162, 163, 166, 170, 173, 174, 175, 176, 177, 178, 179, 180, 181, 184, 186, 189, 192, 193, 194, 195, 198, 201, 204, 206, 208, 209, 210, 211, 212, 213, 214, 216, 219, 220, 221, 222, 223, 224, 225, 228, 232, 235, 238, 239, 240, 242, 249, 250, 251]	[2, 4, 12, 21, 22, 26, 32, 40, 45, 47, 53, 56, 61, 64, 68, 71, 75, 83, 85, 92, 95, 97, 99, 103, 104, 106, 107, 110, 112, 116, 118, 119, 120, 123, 124, 125, 127, 128, 131, 134, 137, 139, 142, 145, 149, 151, 152, 155, 157, 159, 162, 163, 166, 169, 172, 174, 175, 176, 177, 178, 179, 180, 181, 184, 186, 189, 192, 193, 194, 195, 198, 201, 204, 206, 208, 209, 210, 211, 212, 213, 214, 216, 219, 220, 221, 222, 223, 224, 225, 228, 232, 235, 237, 239, 240, 241, 248, 250, 251, 252]	['In', 'a', 'similar', 'reaction', ',', 'one', 'might', 'predict', 'that', '6', 'could', 'be', 'metabolized', 'by', 'the', 'concerted', 'action', 'of', 'cysteine', 'S-conjugate', 'β-lyase', ',', 'S-methyltransferase', 'and', 'N-acetyltransferase', 'to', 'S-[1-(5-acetylamino-5-carboxypentyl)-1H-pyrrol-3-yl]methanethiol', '(', '7', ',', 'Scheme', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 4, 5, 5, 1, 8, 1, 9, 1, 38, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Oxidation of the thiol group will led to S-[1-(5-acetylamino-5-carboxypentyl)-1H-pyrrol-3-yl]methanethiol sulfoxide (8, Scheme 2), another potential metabolite.	[]	['O', '##xi', '##dation', 'of', 'the', 'th', '##iol', 'group', 'will', 'led', 'to', 'S', '-', '[', '1', '-', '(', '5', '-', 'ace', '##ty', '##lam', '##ino', '-', '5', '-', 'car', '##box', '##ype', '##nt', '##yl', ')', '-', '1', '##H', '-', 'p', '##yr', '##rol', '-', '3', '-', 'y', '##l', ']', 'met', '##hane', '##thi', '##ol', 'su', '##lf', '##oxide', '(', '8', ',', 'Scheme', '2', ')', ',', 'another', 'potential', 'meta', '##bol', '##ite', '.']	[0, 1, 3, 10, 13, 17, 19, 23, 29, 34, 38, 41, 42, 43, 44, 45, 46, 47, 48, 49, 52, 54, 57, 60, 61, 62, 63, 66, 69, 72, 74, 76, 77, 78, 79, 80, 81, 82, 84, 87, 88, 89, 90, 91, 92, 93, 96, 100, 103, 106, 108, 110, 116, 117, 118, 120, 127, 128, 129, 131, 139, 149, 153, 156, 159]	[1, 3, 9, 12, 16, 19, 22, 28, 33, 37, 40, 42, 43, 44, 45, 46, 47, 48, 49, 52, 54, 57, 60, 61, 62, 63, 66, 69, 72, 74, 76, 77, 78, 79, 80, 81, 82, 84, 87, 88, 89, 90, 91, 92, 93, 96, 100, 103, 105, 108, 110, 115, 117, 118, 119, 126, 128, 129, 130, 138, 148, 153, 156, 159, 160]	['Oxidation', 'of', 'the', 'thiol', 'group', 'will', 'led', 'to', 'S-[1-(5-acetylamino-5-carboxypentyl)-1H-pyrrol-3-yl]methanethiol', 'sulfoxide', '(', '8', ',', 'Scheme', '2', ')', ',', 'another', 'potential', 'metabolite', '.']	[3, 1, 1, 2, 1, 1, 1, 1, 38, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Metabolism of 14 by a transaminase leads to N-acetyl-S-[1-(5-oxo-5-carboxypentyl)-1H-pyrrol-3-yl]-L-cysteine (15, Scheme 3).	[('PMC2826838', 'R10000', 22, 34, 'transaminase')]	['Met', '##ab', '##olis', '##m', 'of', '14', 'by', 'a', 'trans', '##ami', '##nas', '##e', 'leads', 'to', 'N', '-', 'ace', '##ty', '##l', '-', 'S', '-', '[', '1', '-', '(', '5', '-', 'o', '##x', '##o', '-', '5', '-', 'car', '##box', '##ype', '##nt', '##yl', ')', '-', '1', '##H', '-', 'p', '##yr', '##rol', '-', '3', '-', 'y', '##l', ']', '-', 'L', '-', 'c', '##ys', '##tein', '##e', '(', '15', ',', 'Scheme', '3', ')', '.']	[0, 3, 5, 9, 11, 14, 17, 20, 22, 27, 30, 33, 35, 41, 44, 45, 46, 49, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 70, 73, 76, 78, 80, 81, 82, 83, 84, 85, 86, 88, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 103, 107, 109, 110, 112, 114, 121, 122, 123]	[3, 5, 9, 10, 13, 16, 19, 21, 27, 30, 33, 34, 40, 43, 45, 46, 49, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 70, 73, 76, 78, 80, 81, 82, 83, 84, 85, 86, 88, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 103, 107, 108, 110, 112, 113, 120, 122, 123, 124]	['Metabolism', 'of', '14', 'by', 'a', 'transaminase', 'leads', 'to', 'N-acetyl-S-[1-(5-oxo-5-carboxypentyl)-1H-pyrrol-3-yl]-L-cysteine', '(', '15', ',', 'Scheme', '3', ')', '.']	[4, 1, 1, 1, 1, 4, 1, 1, 46, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We hypothesized that a serum proteomic profile predictive of survival benefit in non–small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) reflects tumor EGFR dependency regardless of site of origin or class of therapeutic agent.	[('PMC2846615', 'A00000', 163, 178, 'tyrosine kinase')]	['We', 'h', '##y', '##pot', '##hes', '##ized', 'that', 'a', 'serum', 'pro', '##te', '##omi', '##c', 'profile', 'predict', '##ive', 'of', 'survival', 'benefit', 'in', 'non', '–', 'small', 'cell', 'lung', 'cancer', 'patients', 'treated', 'with', 'e', '##pid', '##er', '##mal', 'growth', 'factor', 'receptor', 't', '##yr', '##os', '##ine', 'kinase', 'inhibitor', '##s', '(', 'E', '##G', '##F', '##R', '-', 'T', '##K', '##I', ')', 'reflects', 'tumor', 'E', '##G', '##F', '##R', 'depend', '##ency', 'regardless', 'of', 'site', 'of', 'origin', 'or', 'class', 'of', 'therapeutic', 'agent', '.']	[0, 3, 4, 5, 8, 11, 16, 21, 23, 29, 32, 34, 37, 39, 47, 54, 58, 61, 70, 78, 81, 84, 85, 91, 96, 101, 108, 117, 125, 130, 131, 134, 136, 140, 147, 154, 163, 164, 166, 168, 172, 179, 188, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 201, 210, 216, 217, 218, 219, 221, 227, 232, 243, 246, 251, 254, 261, 264, 270, 273, 285, 290]	[2, 4, 5, 8, 11, 15, 20, 22, 28, 32, 34, 37, 38, 46, 54, 57, 60, 69, 77, 80, 84, 85, 90, 95, 100, 107, 116, 124, 129, 131, 134, 136, 139, 146, 153, 162, 164, 166, 168, 171, 178, 188, 189, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 209, 215, 217, 218, 219, 220, 227, 231, 242, 245, 250, 253, 260, 263, 269, 272, 284, 290, 291]	['We', 'hypothesized', 'that', 'a', 'serum', 'proteomic', 'profile', 'predictive', 'of', 'survival', 'benefit', 'in', 'non', '–', 'small', 'cell', 'lung', 'cancer', 'patients', 'treated', 'with', 'epidermal', 'growth', 'factor', 'receptor', 'tyrosine', 'kinase', 'inhibitors', '(', 'EGFR-TKI', ')', 'reflects', 'tumor', 'EGFR', 'dependency', 'regardless', 'of', 'site', 'of', 'origin', 'or', 'class', 'of', 'therapeutic', 'agent', '.']	[1, 5, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 2, 1, 8, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The role of other genetic alterations, e.g., KRAS mutations and increased EGFR copy number, in NSCLC is also not very clear: the latest large randomized clinical trials [Gefitinib (Iressa) versus Taxotere as a second line therapy (INTEREST) and Gefitinib (Iressa) versus vinorelbine in chemonaive elderly patients (INVITE)] did not confirm their correlation with progression-free survival (PFS) or overall survival (OS; refs.	[]	['The', 'role', 'of', 'other', 'genetic', 'alterations', ',', 'e', '.', 'g', '.', ',', 'K', '##RA', '##S', 'mutations', 'and', 'increased', 'E', '##G', '##F', '##R', 'copy', 'number', ',', 'in', 'N', '##SC', '##LC', 'is', 'also', 'not', 'very', 'clear', ':', 'the', 'latest', 'large', 'random', '##ized', 'clinical', 'trials', '[', 'G', '##ef', '##iti', '##ni', '##b', '(', 'I', '##ress', '##a', ')', 'versus', 'Tax', '##oter', '##e', 'as', 'a', 'second', 'line', 'therapy', '(', 'IN', '##TE', '##RE', '##ST', ')', 'and', 'G', '##ef', '##iti', '##ni', '##b', '(', 'I', '##ress', '##a', ')', 'versus', 'v', '##ino', '##rel', '##bine', 'in', 'ch', '##emon', '##ai', '##ve', 'elderly', 'patients', '(', 'IN', '##VI', '##TE', ')', ']', 'did', 'not', 'confirm', 'their', 'correlation', 'with', 'progression', '-', 'free', 'survival', '(', 'P', '##FS', ')', 'or', 'overall', 'survival', '(', 'OS', ';', 're', '##fs', '.']	[0, 4, 9, 12, 18, 26, 37, 39, 40, 41, 42, 43, 45, 46, 48, 50, 60, 64, 74, 75, 76, 77, 79, 84, 90, 92, 95, 96, 98, 101, 104, 109, 113, 118, 123, 125, 129, 136, 142, 148, 153, 162, 169, 170, 171, 173, 176, 178, 180, 181, 182, 186, 187, 189, 196, 199, 203, 205, 208, 210, 217, 222, 230, 231, 233, 235, 237, 239, 241, 245, 246, 248, 251, 253, 255, 256, 257, 261, 262, 264, 271, 272, 275, 278, 283, 286, 288, 292, 294, 297, 305, 314, 315, 317, 319, 321, 322, 324, 328, 332, 340, 346, 358, 363, 374, 375, 380, 389, 390, 391, 393, 395, 398, 406, 415, 416, 418, 420, 422, 424]	[3, 8, 11, 17, 25, 37, 38, 40, 41, 42, 43, 44, 46, 48, 49, 59, 63, 73, 75, 76, 77, 78, 83, 90, 91, 94, 96, 98, 100, 103, 108, 112, 117, 123, 124, 128, 135, 141, 148, 152, 161, 168, 170, 171, 173, 176, 178, 179, 181, 182, 186, 187, 188, 195, 199, 203, 204, 207, 209, 216, 221, 229, 231, 233, 235, 237, 239, 240, 244, 246, 248, 251, 253, 254, 256, 257, 261, 262, 263, 270, 272, 275, 278, 282, 285, 288, 292, 294, 296, 304, 313, 315, 317, 319, 321, 322, 323, 327, 331, 339, 345, 357, 362, 374, 375, 379, 388, 390, 391, 393, 394, 397, 405, 414, 416, 418, 419, 422, 424, 425]	['The', 'role', 'of', 'other', 'genetic', 'alterations', ',', 'e.g', '.', ',', 'KRAS', 'mutations', 'and', 'increased', 'EGFR', 'copy', 'number', ',', 'in', 'NSCLC', 'is', 'also', 'not', 'very', 'clear', ':', 'the', 'latest', 'large', 'randomized', 'clinical', 'trials', '[', 'Gefitinib', '(', 'Iressa', ')', 'versus', 'Taxotere', 'as', 'a', 'second', 'line', 'therapy', '(', 'INTEREST', ')', 'and', 'Gefitinib', '(', 'Iressa', ')', 'versus', 'vinorelbine', 'in', 'chemonaive', 'elderly', 'patients', '(', 'INVITE', ')', ']', 'did', 'not', 'confirm', 'their', 'correlation', 'with', 'progression', '-', 'free', 'survival', '(', 'PFS', ')', 'or', 'overall', 'survival', '(', 'OS', ';', 'refs', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 3, 1, 1, 4, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Relatively little is known about GSTCD, but the presence of the C-terminal α-helical domain common to the glutathione S-transferase (GST) family of enzymes suggests this protein is involved in cellular detoxification by catalyzing conjugation of glutathione to products of oxidative stress14.	[]	['Re', '##lative', '##ly', 'little', 'is', 'known', 'about', 'G', '##ST', '##CD', ',', 'but', 'the', 'presence', 'of', 'the', 'C', '-', 'terminal', 'α', '-', 'he', '##lica', '##l', 'domain', 'common', 'to', 'the', 'g', '##lut', '##ath', '##ione', 'S', '-', 'transfer', '##ase', '(', 'G', '##ST', ')', 'family', 'of', 'enzymes', 'suggests', 'this', 'protein', 'is', 'involved', 'in', 'cellular', 'de', '##to', '##xi', '##fication', 'by', 'cat', '##aly', '##zing', 'con', '##ju', '##gation', 'of', 'g', '##lut', '##ath', '##ione', 'to', 'products', 'of', 'o', '##xi', '##da', '##tive', 'stress', '##14', '.']	[0, 2, 8, 11, 18, 21, 27, 33, 34, 36, 38, 40, 44, 48, 57, 60, 64, 65, 66, 75, 76, 77, 79, 83, 85, 92, 99, 102, 106, 107, 110, 113, 118, 119, 120, 128, 132, 133, 134, 136, 138, 145, 148, 156, 165, 170, 178, 181, 190, 193, 202, 204, 206, 208, 217, 220, 223, 226, 231, 234, 236, 243, 246, 247, 250, 253, 258, 261, 270, 273, 274, 276, 278, 283, 289, 291]	[2, 8, 10, 17, 20, 26, 32, 34, 36, 38, 39, 43, 47, 56, 59, 63, 65, 66, 74, 76, 77, 79, 83, 84, 91, 98, 101, 105, 107, 110, 113, 117, 119, 120, 128, 131, 133, 134, 136, 137, 144, 147, 155, 164, 169, 177, 180, 189, 192, 201, 204, 206, 208, 216, 219, 223, 226, 230, 234, 236, 242, 245, 247, 250, 253, 257, 260, 269, 272, 274, 276, 278, 282, 289, 291, 292]	['Relatively', 'little', 'is', 'known', 'about', 'GSTCD', ',', 'but', 'the', 'presence', 'of', 'the', 'C-', 'terminal', 'α-helical', 'domain', 'common', 'to', 'the', 'glutathione', 'S-transferase', '(', 'GST', ')', 'family', 'of', 'enzymes', 'suggests', 'this', 'protein', 'is', 'involved', 'in', 'cellular', 'detoxification', 'by', 'catalyzing', 'conjugation', 'of', 'glutathione', 'to', 'products', 'of', 'oxidative', 'stress14', '.']	[3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 4, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 3, 1, 4, 1, 1, 1, 4, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To explore the potential function of GSTCD, we conducted a protein homology search and identified homology with chloride intracellular channels 1, 3, 4, 5 and 6, suggesting a role for GSTCD beyond the GST enzyme family.	[]	['To', 'explore', 'the', 'potential', 'function', 'of', 'G', '##ST', '##CD', ',', 'we', 'conducted', 'a', 'protein', 'ho', '##mology', 'search', 'and', 'identified', 'ho', '##mology', 'with', 'chloride', 'in', '##tra', '##cellular', 'channels', '1', ',', '3', ',', '4', ',', '5', 'and', '6', ',', 'suggesting', 'a', 'role', 'for', 'G', '##ST', '##CD', 'beyond', 'the', 'G', '##ST', 'enzyme', 'family', '.']	[0, 3, 11, 15, 25, 34, 37, 38, 40, 42, 44, 47, 57, 59, 67, 69, 76, 83, 87, 98, 100, 107, 112, 121, 123, 126, 135, 144, 145, 147, 148, 150, 151, 153, 155, 159, 160, 162, 173, 175, 180, 184, 185, 187, 190, 197, 201, 202, 205, 212, 218]	[2, 10, 14, 24, 33, 36, 38, 40, 42, 43, 46, 56, 58, 66, 69, 75, 82, 86, 97, 100, 106, 111, 120, 123, 126, 134, 143, 145, 146, 148, 149, 151, 152, 154, 158, 160, 161, 172, 174, 179, 183, 185, 187, 189, 196, 200, 202, 204, 211, 218, 219]	['To', 'explore', 'the', 'potential', 'function', 'of', 'GSTCD', ',', 'we', 'conducted', 'a', 'protein', 'homology', 'search', 'and', 'identified', 'homology', 'with', 'chloride', 'intracellular', 'channels', '1', ',', '3', ',', '4', ',', '5', 'and', '6', ',', 'suggesting', 'a', 'role', 'for', 'GSTCD', 'beyond', 'the', 'GST', 'enzyme', 'family', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several factors may contribute to rising acetate levels with insulin deprivation, including 1) impaired mitochondrial substrate oxidation, 2) induction of acetyl-CoA synthetase 2 under ketogenic conditions [32], 3) increased acetate release from the liver [32], and 4) a defective acetate switch and exogenous acetate production by gut microbes [6].	[]	['Several', 'factors', 'may', 'contribute', 'to', 'rising', 'ace', '##tate', 'levels', 'with', 'insulin', 'de', '##p', '##ri', '##vation', ',', 'including', '1', ')', 'impaired', 'mitochondrial', 'substrate', 'oxidation', ',', '2', ')', 'induction', 'of', 'ace', '##ty', '##l', '-', 'Co', '##A', 's', '##ynth', '##eta', '##se', '2', 'under', 'k', '##eto', '##genic', 'conditions', '[', '32', ']', ',', '3', ')', 'increased', 'ace', '##tate', 'release', 'from', 'the', 'liver', '[', '32', ']', ',', 'and', '4', ')', 'a', 'defect', '##ive', 'ace', '##tate', 'switch', 'and', 'ex', '##ogen', '##ous', 'ace', '##tate', 'production', 'by', 'gut', 'micro', '##bes', '[', '6', ']', '.']	[0, 8, 16, 20, 31, 34, 41, 44, 49, 56, 61, 69, 71, 72, 74, 80, 82, 92, 93, 95, 104, 118, 128, 137, 139, 140, 142, 152, 155, 158, 160, 161, 162, 164, 166, 167, 171, 174, 177, 179, 185, 186, 189, 195, 206, 207, 209, 210, 212, 213, 215, 225, 228, 233, 241, 246, 250, 256, 257, 259, 260, 262, 266, 267, 269, 271, 277, 281, 284, 289, 296, 300, 302, 306, 310, 313, 318, 329, 332, 336, 341, 345, 346, 347, 348]	[7, 15, 19, 30, 33, 40, 44, 48, 55, 60, 68, 71, 72, 74, 80, 81, 91, 93, 94, 103, 117, 127, 137, 138, 140, 141, 151, 154, 158, 160, 161, 162, 164, 165, 167, 171, 174, 176, 178, 184, 186, 189, 194, 205, 207, 209, 210, 211, 213, 214, 224, 228, 232, 240, 245, 249, 255, 257, 259, 260, 261, 265, 267, 268, 270, 277, 280, 284, 288, 295, 299, 302, 306, 309, 313, 317, 328, 331, 335, 341, 344, 346, 347, 348, 349]	['Several', 'factors', 'may', 'contribute', 'to', 'rising', 'acetate', 'levels', 'with', 'insulin', 'deprivation', ',', 'including', '1', ')', 'impaired', 'mitochondrial', 'substrate', 'oxidation', ',', '2', ')', 'induction', 'of', 'acetyl-CoA', 'synthetase', '2', 'under', 'ketogenic', 'conditions', '[', '32', ']', ',', '3', ')', 'increased', 'acetate', 'release', 'from', 'the', 'liver', '[', '32', ']', ',', 'and', '4', ')', 'a', 'defective', 'acetate', 'switch', 'and', 'exogenous', 'acetate', 'production', 'by', 'gut', 'microbes', '[', '6', ']', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 3, 2, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The top signal of association for BMI was observed for SNP rs7001819 (P = 1.53 × 10−7), and the nearest gene is FDFT1 (farnesyl-diphosphate farnesyltransferase 1).	[('PMC2900891', 'R00000', 119, 161, 'farnesyl-diphosphate farnesyltransferase 1')]	['The', 'top', 'signal', 'of', 'association', 'for', 'B', '##MI', 'was', 'observed', 'for', 'S', '##NP', 'r', '##s', '##70', '##01', '##8', '##19', '(', 'P', '=', '1', '.', '53', '×', '10', '##−', '##7', ')', ',', 'and', 'the', 'nearest', 'gene', 'is', 'F', '##DF', '##T', '##1', '(', 'far', '##nes', '##yl', '-', 'dip', '##hos', '##phate', 'far', '##nes', '##yl', '##tra', '##ns', '##fer', '##ase', '1', ')', '.']	[0, 4, 8, 15, 18, 30, 34, 35, 38, 42, 51, 55, 56, 59, 60, 61, 63, 65, 66, 69, 70, 72, 74, 75, 76, 79, 81, 83, 84, 85, 86, 88, 92, 96, 104, 109, 112, 113, 115, 116, 118, 119, 122, 125, 127, 128, 131, 134, 140, 143, 146, 148, 151, 153, 156, 160, 161, 162]	[3, 7, 14, 17, 29, 33, 35, 37, 41, 50, 54, 56, 58, 60, 61, 63, 65, 66, 68, 70, 71, 73, 75, 76, 78, 80, 83, 84, 85, 86, 87, 91, 95, 103, 108, 111, 113, 115, 116, 117, 119, 122, 125, 127, 128, 131, 134, 139, 143, 146, 148, 151, 153, 156, 159, 161, 162, 163]	['The', 'top', 'signal', 'of', 'association', 'for', 'BMI', 'was', 'observed', 'for', 'SNP', 'rs7001819', '(', 'P', '=', '1.53', '×', '10−7', ')', ',', 'and', 'the', 'nearest', 'gene', 'is', 'FDFT1', '(', 'farnesyl', '-', 'diphosphate', 'farnesyltransferase', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 6, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 3, 7, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
The UDP-glycosyltransferase 1 family, polypeptide A1 (UGT1A1) and solute carrier organic anion transporter family enzymes SLCO1B1 and SLCO1B3 are responsible for glucuronidation and cellular uptake of bilirubin, respectively, and play an important role in regulating the bilirubin levels (5–7).	[('PMC2928134', 'I01000', 4, 29, 'UDP-glycosyltransferase 1')]	['The', 'U', '##DP', '-', 'g', '##ly', '##cos', '##yl', '##tra', '##ns', '##fer', '##ase', '1', 'family', ',', 'p', '##oly', '##pe', '##pt', '##ide', 'A1', '(', 'U', '##G', '##T', '##1', '##A', '##1', ')', 'and', 'so', '##lut', '##e', 'carrier', 'organic', 'an', '##ion', 'transport', '##er', 'family', 'enzymes', 'SL', '##CO', '##1', '##B', '##1', 'and', 'SL', '##CO', '##1', '##B', '##3', 'are', 'responsible', 'for', 'g', '##lu', '##cu', '##ron', '##ida', '##tion', 'and', 'cellular', 'up', '##take', 'of', 'bi', '##li', '##ru', '##bin', ',', 'respectively', ',', 'and', 'play', 'an', 'important', 'role', 'in', 'regulating', 'the', 'bi', '##li', '##ru', '##bin', 'levels', '(', '5', '–', '7', ')', '.']	[0, 4, 5, 7, 8, 9, 11, 14, 16, 19, 21, 24, 28, 30, 36, 38, 39, 42, 44, 46, 50, 53, 54, 55, 56, 57, 58, 59, 60, 62, 66, 68, 71, 73, 81, 89, 91, 95, 104, 107, 114, 122, 124, 126, 127, 128, 130, 134, 136, 138, 139, 140, 142, 146, 158, 162, 163, 165, 167, 170, 173, 178, 182, 191, 193, 198, 201, 203, 205, 207, 210, 212, 224, 226, 230, 235, 238, 248, 253, 256, 267, 271, 273, 275, 277, 281, 288, 289, 290, 291, 292, 293]	[3, 5, 7, 8, 9, 11, 14, 16, 19, 21, 24, 27, 29, 36, 37, 39, 42, 44, 46, 49, 52, 54, 55, 56, 57, 58, 59, 60, 61, 65, 68, 71, 72, 80, 88, 91, 94, 104, 106, 113, 121, 124, 126, 127, 128, 129, 133, 136, 138, 139, 140, 141, 145, 157, 161, 163, 165, 167, 170, 173, 177, 181, 190, 193, 197, 200, 203, 205, 207, 210, 211, 224, 225, 229, 234, 237, 247, 252, 255, 266, 270, 273, 275, 277, 280, 287, 289, 290, 291, 292, 293, 294]	['The', 'UDP-glycosyltransferase', '1', 'family', ',', 'polypeptide', 'A1', '(', 'UGT1A1', ')', 'and', 'solute', 'carrier', 'organic', 'anion', 'transporter', 'family', 'enzymes', 'SLCO1B1', 'and', 'SLCO1B3', 'are', 'responsible', 'for', 'glucuronidation', 'and', 'cellular', 'uptake', 'of', 'bilirubin', ',', 'respectively', ',', 'and', 'play', 'an', 'important', 'role', 'in', 'regulating', 'the', 'bilirubin', 'levels', '(', '5–', '7', ')', '.']	[1, 11, 1, 1, 1, 5, 1, 1, 6, 1, 1, 3, 1, 1, 2, 2, 1, 1, 5, 1, 5, 1, 1, 1, 6, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The criteria for selecting these proteins included number of peptides, antibody availability, and functional group as described in the Materials and Methods section, Among the functional groups, for structural we tested L-plastin; for trafficking we tested cathepsin A and Rap 1A; for apoptosis we tested apoptosis inducing factor like (AIF-L) and DNA fragmentation factor (DFF-40; CAD); and for redox we tested ferritin heavy chain (FHC) and lactate dehydrogenase (LDH).	[]	['The', 'criteria', 'for', 'selecting', 'these', 'proteins', 'included', 'number', 'of', 'p', '##eptide', '##s', ',', 'anti', '##body', 'availability', ',', 'and', 'functional', 'group', 'as', 'described', 'in', 'the', 'Materials', 'and', 'Method', '##s', 'section', ',', 'Among', 'the', 'functional', 'groups', ',', 'for', 'structural', 'we', 'tested', 'L', '-', 'p', '##last', '##in', ';', 'for', 'trafficking', 'we', 'tested', 'cat', '##he', '##ps', '##in', 'A', 'and', 'Rap', '1A', ';', 'for', 'a', '##pop', '##tosis', 'we', 'tested', 'a', '##pop', '##tosis', 'in', '##ducing', 'factor', 'like', '(', 'AI', '##F', '-', 'L', ')', 'and', 'DNA', 'fragment', '##ation', 'factor', '(', 'D', '##FF', '-', '40', ';', 'CA', '##D', ')', ';', 'and', 'for', 'red', '##ox', 'we', 'tested', 'f', '##er', '##rit', '##in', 'heavy', 'chain', '(', 'F', '##HC', ')', 'and', 'la', '##ct', '##ate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'L', '##D', '##H', ')', '.']	[0, 4, 13, 17, 27, 33, 42, 51, 58, 61, 62, 68, 69, 71, 75, 80, 92, 94, 98, 109, 115, 118, 128, 131, 135, 145, 149, 155, 157, 164, 166, 172, 176, 187, 193, 195, 199, 210, 213, 220, 221, 222, 223, 227, 229, 231, 235, 247, 250, 257, 260, 262, 264, 267, 269, 273, 277, 279, 281, 285, 286, 289, 295, 298, 305, 306, 309, 315, 317, 324, 331, 336, 337, 339, 340, 341, 342, 344, 348, 352, 360, 366, 373, 374, 375, 377, 378, 380, 382, 384, 385, 386, 388, 392, 396, 399, 402, 405, 412, 413, 415, 418, 421, 427, 433, 434, 435, 437, 439, 443, 445, 447, 451, 453, 455, 457, 461, 465, 466, 467, 468, 469, 470]	[3, 12, 16, 26, 32, 41, 50, 57, 60, 62, 68, 69, 70, 75, 79, 92, 93, 97, 108, 114, 117, 127, 130, 134, 144, 148, 155, 156, 164, 165, 171, 175, 186, 193, 194, 198, 209, 212, 219, 221, 222, 223, 227, 229, 230, 234, 246, 249, 256, 260, 262, 264, 266, 268, 272, 276, 279, 280, 284, 286, 289, 294, 297, 304, 306, 309, 314, 317, 323, 330, 335, 337, 339, 340, 341, 342, 343, 347, 351, 360, 365, 372, 374, 375, 377, 378, 380, 381, 384, 385, 386, 387, 391, 395, 399, 401, 404, 411, 413, 415, 418, 420, 426, 432, 434, 435, 437, 438, 442, 445, 447, 450, 453, 455, 457, 461, 464, 466, 467, 468, 469, 470, 471]	['The', 'criteria', 'for', 'selecting', 'these', 'proteins', 'included', 'number', 'of', 'peptides', ',', 'antibody', 'availability', ',', 'and', 'functional', 'group', 'as', 'described', 'in', 'the', 'Materials', 'and', 'Methods', 'section', ',', 'Among', 'the', 'functional', 'groups', ',', 'for', 'structural', 'we', 'tested', 'L-plastin', ';', 'for', 'trafficking', 'we', 'tested', 'cathepsin', 'A', 'and', 'Rap', '1A', ';', 'for', 'apoptosis', 'we', 'tested', 'apoptosis', 'inducing', 'factor', 'like', '(', 'AIF-L', ')', 'and', 'DNA', 'fragmentation', 'factor', '(', 'DFF-40', ';', 'CAD', ')', ';', 'and', 'for', 'redox', 'we', 'tested', 'ferritin', 'heavy', 'chain', '(', 'FHC', ')', 'and', 'lactate', 'dehydrogenase', '(', 'LDH', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 4, 1, 2, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 2, 1, 1, 3, 5, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fractionation of MDM lysates was performed to positively detect low abundant proteins by cationic exchange chromatography using Ciphergen CM Ceramic HyperD spin columns (C540-0026; Ciphergen Biosystems), These columns isolated positively charged proteins that bound to the resin from the unbound negatively charged proteins that were eluted.	[]	['Fr', '##action', '##ation', 'of', 'MD', '##M', 'l', '##ys', '##ates', 'was', 'performed', 'to', 'positively', 'detect', 'low', 'abundant', 'proteins', 'by', 'cat', '##ion', '##ic', 'exchange', 'ch', '##roma', '##tography', 'using', 'C', '##ip', '##her', '##gen', 'C', '##M', 'Ce', '##ram', '##ic', 'H', '##yper', '##D', 'spin', 'columns', '(', 'C', '##5', '##40', '-', '00', '##26', ';', 'C', '##ip', '##her', '##gen', 'B', '##ios', '##ys', '##tem', '##s', ')', ',', 'These', 'columns', 'isolated', 'positively', 'charged', 'proteins', 'that', 'bound', 'to', 'the', 're', '##sin', 'from', 'the', 'un', '##bound', 'negatively', 'charged', 'proteins', 'that', 'were', 'el', '##uted', '.']	[0, 2, 8, 14, 17, 19, 21, 22, 24, 29, 33, 43, 46, 57, 64, 68, 77, 86, 89, 92, 95, 98, 107, 109, 113, 122, 128, 129, 131, 134, 138, 139, 141, 143, 146, 149, 150, 154, 156, 161, 169, 170, 171, 172, 174, 175, 177, 179, 181, 182, 184, 187, 191, 192, 195, 197, 200, 201, 202, 204, 210, 218, 227, 238, 246, 255, 260, 266, 269, 273, 275, 279, 284, 288, 290, 296, 307, 315, 324, 329, 334, 336, 340]	[2, 8, 13, 16, 19, 20, 22, 24, 28, 32, 42, 45, 56, 63, 67, 76, 85, 88, 92, 95, 97, 106, 109, 113, 121, 127, 129, 131, 134, 137, 139, 140, 143, 146, 148, 150, 154, 155, 160, 168, 170, 171, 172, 174, 175, 177, 179, 180, 182, 184, 187, 190, 192, 195, 197, 200, 201, 202, 203, 209, 217, 226, 237, 245, 254, 259, 265, 268, 272, 275, 278, 283, 287, 290, 295, 306, 314, 323, 328, 333, 336, 340, 341]	['Fractionation', 'of', 'MDM', 'lysates', 'was', 'performed', 'to', 'positively', 'detect', 'low', 'abundant', 'proteins', 'by', 'cationic', 'exchange', 'chromatography', 'using', 'Ciphergen', 'CM', 'Ceramic', 'HyperD', 'spin', 'columns', '(', 'C540-0026', ';', 'Ciphergen', 'Biosystems', ')', ',', 'These', 'columns', 'isolated', 'positively', 'charged', 'proteins', 'that', 'bound', 'to', 'the', 'resin', 'from', 'the', 'unbound', 'negatively', 'charged', 'proteins', 'that', 'were', 'eluted', '.']	[3, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 4, 2, 3, 3, 1, 1, 1, 6, 1, 4, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Immunoblot detection was performed for selected proteins from the different functional groups with the following antibodies: goat anti-human L-plastin (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-human apoptosis inducing factor like (AIF-L) was provided by Dr. Joseph Bonanno, Indiana University (Xie et al, 2005), mouse anti-DNA fragmentation factor subunit beta (DFF-40; CAD) (Novus Biologicals, Littleton, CO), mouse anti-cathepsin A (R&D Systems, Minneapolis, MN), mouse anti-Ras-related protein Rap 1A (BD Biosciences, Franklin Lakes, NJ), goat anti-1-lactate dehydrogenase A chain (LDH) (Santa Cruz Biotechnology), rabbit anti-ferritin heavy chain (FHC) (Novus Biologicals), and sheep anti-Cu/Zn superoxide dismutase (SOD-1) (Calbio-chem, San Diego, CA).	[]	['I', '##mm', '##uno', '##b', '##lot', 'detection', 'was', 'performed', 'for', 'selected', 'proteins', 'from', 'the', 'different', 'functional', 'groups', 'with', 'the', 'following', 'antibodies', ':', 'goat', 'anti', '-', 'human', 'L', '-', 'p', '##last', '##in', '(', 'Santa', 'Cruz', 'B', '##iot', '##ech', '##nology', ',', 'Santa', 'Cruz', ',', 'CA', ')', ',', 'rabbit', 'anti', '-', 'human', 'a', '##pop', '##tosis', 'in', '##ducing', 'factor', 'like', '(', 'AI', '##F', '-', 'L', ')', 'was', 'provided', 'by', 'Dr', '.', 'Joseph', 'Bon', '##ann', '##o', ',', 'Indiana', 'University', '(', 'Xi', '##e', 'et', 'al', ',', '2005', ')', ',', 'mouse', 'anti', '-', 'DNA', 'fragment', '##ation', 'factor', 'subunit', 'beta', '(', 'D', '##FF', '-', '40', ';', 'CA', '##D', ')', '(', 'Nov', '##us', 'Biological', '##s', ',', 'Little', '##ton', ',', 'CO', ')', ',', 'mouse', 'anti', '-', 'cat', '##he', '##ps', '##in', 'A', '(', 'R', '&', 'D', 'Systems', ',', 'Minneapolis', ',', 'M', '##N', ')', ',', 'mouse', 'anti', '-', 'Ra', '##s', '-', 'related', 'protein', 'Rap', '1A', '(', 'B', '##D', 'B', '##ios', '##cie', '##nces', ',', 'Franklin', 'Lakes', ',', 'NJ', ')', ',', 'goat', 'anti', '-', '1', '-', 'la', '##ct', '##ate', 'de', '##hy', '##dr', '##ogen', '##ase', 'A', 'chain', '(', 'L', '##D', '##H', ')', '(', 'Santa', 'Cruz', 'B', '##iot', '##ech', '##nology', ')', ',', 'rabbit', 'anti', '-', 'f', '##er', '##rit', '##in', 'heavy', 'chain', '(', 'F', '##HC', ')', '(', 'Nov', '##us', 'Biological', '##s', ')', ',', 'and', 'sheep', 'anti', '-', 'C', '##u', '/', 'Z', '##n', 'super', '##oxide', 'di', '##sm', '##uta', '##se', '(', 'S', '##OD', '-', '1', ')', '(', 'Cal', '##bio', '-', 'ch', '##em', ',', 'San', 'Diego', ',', 'CA', ')', '.']	[0, 1, 3, 6, 7, 11, 21, 25, 35, 39, 48, 57, 62, 66, 76, 87, 94, 99, 103, 113, 123, 125, 130, 134, 135, 141, 142, 143, 144, 148, 151, 152, 158, 163, 164, 167, 170, 176, 178, 184, 188, 190, 192, 193, 195, 202, 206, 207, 213, 214, 217, 223, 225, 232, 239, 244, 245, 247, 248, 249, 250, 252, 256, 265, 268, 270, 272, 279, 282, 285, 286, 288, 296, 307, 308, 310, 312, 315, 317, 319, 323, 324, 326, 332, 336, 337, 341, 349, 355, 362, 370, 375, 376, 377, 379, 380, 382, 384, 386, 387, 389, 390, 393, 396, 406, 407, 409, 415, 418, 420, 422, 423, 425, 431, 435, 436, 439, 441, 443, 446, 448, 449, 450, 451, 453, 460, 462, 473, 475, 476, 477, 478, 480, 486, 490, 491, 493, 494, 495, 503, 511, 515, 518, 519, 520, 522, 523, 526, 529, 533, 535, 544, 549, 551, 553, 554, 556, 561, 565, 566, 567, 568, 570, 572, 576, 578, 580, 582, 586, 590, 592, 598, 599, 600, 601, 602, 604, 605, 611, 616, 617, 620, 623, 629, 630, 632, 639, 643, 644, 645, 647, 650, 653, 659, 665, 666, 667, 669, 671, 672, 675, 678, 688, 689, 690, 692, 696, 702, 706, 707, 708, 709, 710, 711, 713, 718, 724, 726, 728, 731, 734, 735, 736, 738, 739, 740, 742, 743, 746, 749, 750, 752, 754, 756, 760, 765, 767, 769, 770]	[1, 3, 6, 7, 10, 20, 24, 34, 38, 47, 56, 61, 65, 75, 86, 93, 98, 102, 112, 123, 124, 129, 134, 135, 140, 142, 143, 144, 148, 150, 152, 157, 162, 164, 167, 170, 176, 177, 183, 188, 189, 192, 193, 194, 201, 206, 207, 212, 214, 217, 222, 225, 231, 238, 243, 245, 247, 248, 249, 250, 251, 255, 264, 267, 270, 271, 278, 282, 285, 286, 287, 295, 306, 308, 310, 311, 314, 317, 318, 323, 324, 325, 331, 336, 337, 340, 349, 354, 361, 369, 374, 376, 377, 379, 380, 382, 383, 386, 387, 388, 390, 393, 395, 406, 407, 408, 415, 418, 419, 422, 423, 424, 430, 435, 436, 439, 441, 443, 445, 447, 449, 450, 451, 452, 460, 461, 473, 474, 476, 477, 478, 479, 485, 490, 491, 493, 494, 495, 502, 510, 514, 517, 519, 520, 521, 523, 526, 529, 533, 534, 543, 549, 550, 553, 554, 555, 560, 565, 566, 567, 568, 570, 572, 575, 578, 580, 582, 586, 589, 591, 597, 599, 600, 601, 602, 603, 605, 610, 615, 617, 620, 623, 629, 630, 631, 638, 643, 644, 645, 647, 650, 652, 658, 664, 666, 667, 669, 670, 672, 675, 677, 688, 689, 690, 691, 695, 701, 706, 707, 708, 709, 710, 711, 712, 718, 723, 726, 728, 731, 733, 735, 736, 738, 739, 740, 741, 743, 746, 749, 750, 752, 754, 755, 759, 765, 766, 769, 770, 771]	['Immunoblot', 'detection', 'was', 'performed', 'for', 'selected', 'proteins', 'from', 'the', 'different', 'functional', 'groups', 'with', 'the', 'following', 'antibodies', ':', 'goat', 'anti-', 'human', 'L-plastin', '(', 'Santa', 'Cruz', 'Biotechnology', ',', 'Santa', 'Cruz', ',', 'CA', ')', ',', 'rabbit', 'anti-', 'human', 'apoptosis', 'inducing', 'factor', 'like', '(', 'AIF-L', ')', 'was', 'provided', 'by', 'Dr', '.', 'Joseph', 'Bonanno', ',', 'Indiana', 'University', '(', 'Xie', 'et', 'al', ',', '2005', ')', ',', 'mouse', 'anti-DNA', 'fragmentation', 'factor', 'subunit', 'beta', '(', 'DFF-40', ';', 'CAD', ')', '(', 'Novus', 'Biologicals', ',', 'Littleton', ',', 'CO', ')', ',', 'mouse', 'anti-', 'cathepsin', 'A', '(', 'R&D', 'Systems', ',', 'Minneapolis', ',', 'MN', ')', ',', 'mouse', 'anti-Ras-', 'related', 'protein', 'Rap', '1A', '(', 'BD', 'Biosciences', ',', 'Franklin', 'Lakes', ',', 'NJ', ')', ',', 'goat', 'anti-1-lactate', 'dehydrogenase', 'A', 'chain', '(', 'LDH', ')', '(', 'Santa', 'Cruz', 'Biotechnology', ')', ',', 'rabbit', 'anti-', 'ferritin', 'heavy', 'chain', '(', 'FHC', ')', '(', 'Novus', 'Biologicals', ')', ',', 'and', 'sheep', 'anti-Cu', '/', 'Zn', 'superoxide', 'dismutase', '(', 'SOD-1', ')', '(', 'Calbio', '-', 'chem', ',', 'San', 'Diego', ',', 'CA', ')', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 4, 1, 2, 1, 1, 2, 2, 1, 2, 1, 1, 1, 1, 1, 2, 4, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 7, 5, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 2, 4, 1, 1, 1, 2, 1, 1, 2, 2, 1, 1, 1, 1, 4, 1, 2, 2, 4, 1, 4, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All membranes were incubated for 1 h at room temperature with the corresponding secondary antibody conjugated to horseradish peroxidase enzyme (HRP), Expressed proteins were detected using the Super Signal West Femto Maximum Sensitivity Substrate (Thermo Scientific-Pierce Biotechnology, Rockford, IL), enhanced chemiluminescent substrate.	[]	['All', 'membrane', '##s', 'were', 'in', '##cu', '##bate', '##d', 'for', '1', 'h', 'at', 'room', 'temperature', 'with', 'the', 'corresponding', 'secondary', 'anti', '##body', 'con', '##ju', '##gated', 'to', 'horse', '##rad', '##ish', 'per', '##ox', '##idas', '##e', 'enzyme', '(', 'H', '##RP', ')', ',', 'Express', '##ed', 'proteins', 'were', 'detected', 'using', 'the', 'Super', 'Signal', 'West', 'Fe', '##m', '##to', 'Maximum', 'Sen', '##si', '##ti', '##vity', 'Sub', '##stra', '##te', '(', 'The', '##rm', '##o', 'Scientific', '-', 'Pierce', 'B', '##iot', '##ech', '##nology', ',', 'Rock', '##ford', ',', 'IL', ')', ',', 'enhanced', 'ch', '##em', '##il', '##umi', '##nes', '##cent', 'substrate', '.']	[0, 4, 12, 14, 19, 21, 23, 27, 29, 33, 35, 37, 40, 45, 57, 62, 66, 80, 90, 94, 99, 102, 104, 110, 113, 118, 121, 125, 128, 130, 134, 136, 143, 144, 145, 147, 148, 150, 157, 160, 169, 174, 183, 189, 193, 199, 206, 211, 213, 214, 217, 225, 228, 230, 232, 237, 240, 244, 247, 248, 251, 253, 255, 265, 266, 273, 274, 277, 280, 286, 288, 292, 296, 298, 300, 301, 303, 312, 314, 316, 318, 321, 324, 329, 338]	[3, 12, 13, 18, 21, 23, 27, 28, 32, 34, 36, 39, 44, 56, 61, 65, 79, 89, 94, 98, 102, 104, 109, 112, 118, 121, 124, 128, 130, 134, 135, 142, 144, 145, 147, 148, 149, 157, 159, 168, 173, 182, 188, 192, 198, 205, 210, 213, 214, 216, 224, 228, 230, 232, 236, 240, 244, 246, 248, 251, 253, 254, 265, 266, 272, 274, 277, 280, 286, 287, 292, 296, 297, 300, 301, 302, 311, 314, 316, 318, 321, 324, 328, 338, 339]	['All', 'membranes', 'were', 'incubated', 'for', '1', 'h', 'at', 'room', 'temperature', 'with', 'the', 'corresponding', 'secondary', 'antibody', 'conjugated', 'to', 'horseradish', 'peroxidase', 'enzyme', '(', 'HRP', ')', ',', 'Expressed', 'proteins', 'were', 'detected', 'using', 'the', 'Super', 'Signal', 'West', 'Femto', 'Maximum', 'Sensitivity', 'Substrate', '(', 'Thermo', 'Scientific-Pierce', 'Biotechnology', ',', 'Rockford', ',', 'IL', ')', ',', 'enhanced', 'chemiluminescent', 'substrate', '.']	[1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 3, 4, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 3, 1, 3, 3, 4, 1, 2, 1, 1, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
When we compared HIV-1–infected MDMs with the different isolates, three proteins (A-kinase anchor protein 9, annexin V, and ubiquitin) were common to MDMs infected with SF162, CI, and NC viruses (Table 2).	[('PMC2947716', 'R03000', 82, 90, 'A-kinase')]	['When', 'we', 'compared', 'HIV', '-', '1', '–', 'infected', 'MD', '##Ms', 'with', 'the', 'different', 'is', '##olate', '##s', ',', 'three', 'proteins', '(', 'A', '-', 'kinase', 'anchor', 'protein', '9', ',', 'an', '##nex', '##in', 'V', ',', 'and', 'u', '##bi', '##qui', '##tin', ')', 'were', 'common', 'to', 'MD', '##Ms', 'infected', 'with', 'SF', '##16', '##2', ',', 'C', '##I', ',', 'and', 'NC', 'viruses', '(', 'Table', '2', ')', '.']	[0, 5, 8, 17, 20, 21, 22, 23, 32, 34, 37, 42, 46, 56, 58, 63, 64, 66, 72, 81, 82, 83, 84, 91, 98, 106, 107, 109, 111, 114, 117, 118, 120, 124, 125, 127, 130, 133, 135, 140, 147, 150, 152, 155, 164, 169, 171, 173, 174, 176, 177, 178, 180, 184, 187, 195, 196, 202, 203, 204]	[4, 7, 16, 20, 21, 22, 23, 31, 34, 36, 41, 45, 55, 58, 63, 64, 65, 71, 80, 82, 83, 84, 90, 97, 105, 107, 108, 111, 114, 116, 118, 119, 123, 125, 127, 130, 133, 134, 139, 146, 149, 152, 154, 163, 168, 171, 173, 174, 175, 177, 178, 179, 183, 186, 194, 196, 201, 203, 204, 205]	['When', 'we', 'compared', 'HIV-1', '–', 'infected', 'MDMs', 'with', 'the', 'different', 'isolates', ',', 'three', 'proteins', '(', 'A-kinase', 'anchor', 'protein', '9', ',', 'annexin', 'V', ',', 'and', 'ubiquitin', ')', 'were', 'common', 'to', 'MDMs', 'infected', 'with', 'SF162', ',', 'CI', ',', 'and', 'NC', 'viruses', '(', 'Table', '2', ')', '.']	[1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two of these, A-kinase anchor protein 9 and ubiquitin, are important in HIV-1 trafficking, whereas annexin 5 is important in prevention of HIV infection and apoptosis (Munoz et al, 2007).	[('PMC2947716', 'R03001', 14, 22, 'A-kinase')]	['Two', 'of', 'these', ',', 'A', '-', 'kinase', 'anchor', 'protein', '9', 'and', 'u', '##bi', '##qui', '##tin', ',', 'are', 'important', 'in', 'HIV', '-', '1', 'trafficking', ',', 'whereas', 'an', '##nex', '##in', '5', 'is', 'important', 'in', 'prevention', 'of', 'HIV', 'infection', 'and', 'a', '##pop', '##tosis', '(', 'Mu', '##no', '##z', 'et', 'al', ',', '2007', ')', '.']	[0, 4, 7, 12, 14, 15, 16, 23, 30, 38, 40, 44, 45, 47, 50, 53, 55, 59, 69, 72, 75, 76, 78, 89, 91, 99, 101, 104, 107, 109, 112, 122, 125, 136, 139, 143, 153, 157, 158, 161, 167, 168, 170, 172, 174, 177, 179, 181, 185, 186]	[3, 6, 12, 13, 15, 16, 22, 29, 37, 39, 43, 45, 47, 50, 53, 54, 58, 68, 71, 75, 76, 77, 89, 90, 98, 101, 104, 106, 108, 111, 121, 124, 135, 138, 142, 152, 156, 158, 161, 166, 168, 170, 172, 173, 176, 179, 180, 185, 186, 187]	['Two', 'of', 'these', ',', 'A-kinase', 'anchor', 'protein', '9', 'and', 'ubiquitin', ',', 'are', 'important', 'in', 'HIV-1', 'trafficking', ',', 'whereas', 'annexin', '5', 'is', 'important', 'in', 'prevention', 'of', 'HIV', 'infection', 'and', 'apoptosis', '(', 'Munoz', 'et', 'al', ',', '2007', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Three proteins (myotrophin, protein kinase C inhibitor protein 1, and thymosin beta-4) were identified only in MDMs infected with SF162 and CI viruses (Table 2).	[('PMC2947716', 'R03002', 28, 44, 'protein kinase C')]	['Three', 'proteins', '(', 'my', '##ot', '##rop', '##hin', ',', 'protein', 'kinase', 'C', 'inhibitor', 'protein', '1', ',', 'and', 'thy', '##mos', '##in', 'beta', '-', '4', ')', 'were', 'identified', 'only', 'in', 'MD', '##Ms', 'infected', 'with', 'SF', '##16', '##2', 'and', 'C', '##I', 'viruses', '(', 'Table', '2', ')', '.']	[0, 6, 15, 16, 18, 20, 23, 26, 28, 36, 43, 45, 55, 63, 64, 66, 70, 73, 76, 79, 83, 84, 85, 87, 92, 103, 108, 111, 113, 116, 125, 130, 132, 134, 136, 140, 141, 143, 151, 152, 158, 159, 160]	[5, 14, 16, 18, 20, 23, 26, 27, 35, 42, 44, 54, 62, 64, 65, 69, 73, 76, 78, 83, 84, 85, 86, 91, 102, 107, 110, 113, 115, 124, 129, 132, 134, 135, 139, 141, 142, 150, 152, 157, 159, 160, 161]	['Three', 'proteins', '(', 'myotrophin', ',', 'protein', 'kinase', 'C', 'inhibitor', 'protein', '1', ',', 'and', 'thymosin', 'beta-4', ')', 'were', 'identified', 'only', 'in', 'MDMs', 'infected', 'with', 'SF162', 'and', 'CI', 'viruses', '(', 'Table', '2', ')', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Myotrophin is a cystoplasmic protein related to muscle differentiation whereas protein kinase C inhibitor protein 1 and thymosin beta-4 have a common function in macrophage migration and inflammation.	[('PMC2947716', 'R03003', 79, 95, 'protein kinase C')]	['My', '##ot', '##rop', '##hin', 'is', 'a', 'c', '##ys', '##top', '##las', '##mic', 'protein', 'related', 'to', 'muscle', 'differentiation', 'whereas', 'protein', 'kinase', 'C', 'inhibitor', 'protein', '1', 'and', 'thy', '##mos', '##in', 'beta', '-', '4', 'have', 'a', 'common', 'function', 'in', 'mac', '##rop', '##hage', 'migration', 'and', 'inflammation', '.']	[0, 2, 4, 7, 11, 14, 16, 17, 19, 22, 25, 29, 37, 45, 48, 55, 71, 79, 87, 94, 96, 106, 114, 116, 120, 123, 126, 129, 133, 134, 136, 141, 143, 150, 159, 162, 165, 168, 173, 183, 187, 199]	[2, 4, 7, 10, 13, 15, 17, 19, 22, 25, 28, 36, 44, 47, 54, 70, 78, 86, 93, 95, 105, 113, 115, 119, 123, 126, 128, 133, 134, 135, 140, 142, 149, 158, 161, 165, 168, 172, 182, 186, 199, 200]	['Myotrophin', 'is', 'a', 'cystoplasmic', 'protein', 'related', 'to', 'muscle', 'differentiation', 'whereas', 'protein', 'kinase', 'C', 'inhibitor', 'protein', '1', 'and', 'thymosin', 'beta-4', 'have', 'a', 'common', 'function', 'in', 'macrophage', 'migration', 'and', 'inflammation', '.']	[4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Seven proteins were identified only in MDMs infected with SF162: alpha-1 protease inhibitor, aspartylglucosaminidase, DNA-directed RNA polymerase III subunit, genome polyprotein, heparan sulfate proteoglycan 2, mannose 6 phosphate receptor binding protein 1, and triosephosphate isomerase (Table 2).	[('PMC2947716', 'R03004', 65, 81, 'alpha-1 protease')]	['Seven', 'proteins', 'were', 'identified', 'only', 'in', 'MD', '##Ms', 'infected', 'with', 'SF', '##16', '##2', ':', 'alpha', '-', '1', 'pro', '##te', '##ase', 'inhibitor', ',', 'as', '##par', '##ty', '##l', '##g', '##lu', '##cos', '##ami', '##ni', '##das', '##e', ',', 'DNA', '-', 'directed', 'RNA', 'polymer', '##ase', 'III', 'subunit', ',', 'genome', 'p', '##oly', '##p', '##rote', '##in', ',', 'he', '##par', '##an', 'su', '##lf', '##ate', 'pro', '##te', '##og', '##ly', '##can', '2', ',', 'man', '##nose', '6', 'phosphate', 'receptor', 'binding', 'protein', '1', ',', 'and', 'trio', '##se', '##ph', '##os', '##phate', 'is', '##omer', '##ase', '(', 'Table', '2', ')', '.']	[0, 6, 15, 20, 31, 36, 39, 41, 44, 53, 58, 60, 62, 63, 65, 70, 71, 73, 76, 78, 82, 91, 93, 95, 98, 100, 101, 102, 104, 107, 110, 112, 115, 116, 118, 121, 122, 131, 135, 142, 146, 150, 157, 159, 166, 167, 170, 171, 175, 177, 179, 181, 184, 187, 189, 191, 195, 198, 200, 202, 204, 208, 209, 211, 214, 219, 221, 231, 240, 248, 256, 257, 259, 263, 267, 269, 271, 273, 279, 281, 285, 289, 290, 296, 297, 298]	[5, 14, 19, 30, 35, 38, 41, 43, 52, 57, 60, 62, 63, 64, 70, 71, 72, 76, 78, 81, 91, 92, 95, 98, 100, 101, 102, 104, 107, 110, 112, 115, 116, 117, 121, 122, 130, 134, 142, 145, 149, 157, 158, 165, 167, 170, 171, 175, 177, 178, 181, 184, 186, 189, 191, 194, 198, 200, 202, 204, 207, 209, 210, 214, 218, 220, 230, 239, 247, 255, 257, 258, 262, 267, 269, 271, 273, 278, 281, 285, 288, 290, 295, 297, 298, 299]	['Seven', 'proteins', 'were', 'identified', 'only', 'in', 'MDMs', 'infected', 'with', 'SF162', ':', 'alpha-1', 'protease', 'inhibitor', ',', 'aspartylglucosaminidase', ',', 'DNA-directed', 'RNA', 'polymerase', 'III', 'subunit', ',', 'genome', 'polyprotein', ',', 'heparan', 'sulfate', 'proteoglycan', '2', ',', 'mannose', '6', 'phosphate', 'receptor', 'binding', 'protein', '1', ',', 'and', 'triosephosphate', 'isomerase', '(', 'Table', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 3, 1, 1, 11, 1, 3, 1, 2, 1, 1, 1, 1, 5, 1, 3, 3, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This gene encodes PMCA1, a plasma membrane calcium/calmodulin dependent ATPase that is expressed in vascular endothelium and is involved in calcium pumping from the cytosol to the extracellular compartment.24 An investigation of cultured rat aortic smooth muscle cells found elevated PMCA1 mRNA levels in spontaneously hypertensive rats compared to nonhypertensive controls, consistent with a role of ATP2B1 in blood pressure regulation.25	[]	['This', 'gene', 'en', '##codes', 'PM', '##CA', '##1', ',', 'a', 'plasma', 'membrane', 'calcium', '/', 'calm', '##od', '##ulin', 'dependent', 'ATP', '##ase', 'that', 'is', 'expressed', 'in', 'vascular', 'end', '##oth', '##eli', '##um', 'and', 'is', 'involved', 'in', 'calcium', 'pumping', 'from', 'the', 'c', '##yt', '##oso', '##l', 'to', 'the', 'extra', '##cellular', 'compartment', '.', '24', 'An', 'investigation', 'of', 'culture', '##d', 'rat', 'a', '##ort', '##ic', 'smooth', 'muscle', 'cells', 'found', 'elevated', 'PM', '##CA', '##1', 'm', '##RNA', 'levels', 'in', 'spontaneous', '##ly', 'h', '##yper', '##tensive', 'rats', 'compared', 'to', 'non', '##hy', '##pert', '##ens', '##ive', 'controls', ',', 'consistent', 'with', 'a', 'role', 'of', 'ATP', '##2', '##B', '##1', 'in', 'blood', 'pressure', 'regulation', '.', '25']	[0, 5, 10, 12, 18, 20, 22, 23, 25, 27, 34, 43, 50, 51, 55, 57, 62, 72, 75, 79, 84, 87, 97, 100, 109, 112, 115, 118, 121, 125, 128, 137, 140, 148, 156, 161, 165, 166, 168, 171, 173, 176, 180, 185, 194, 205, 206, 209, 212, 226, 229, 236, 238, 242, 243, 246, 249, 256, 263, 269, 275, 284, 286, 288, 290, 291, 295, 302, 305, 316, 319, 320, 324, 332, 337, 346, 349, 352, 354, 358, 361, 365, 373, 375, 386, 391, 393, 398, 401, 404, 405, 406, 408, 411, 417, 426, 436, 437]	[4, 9, 12, 17, 20, 22, 23, 24, 26, 33, 42, 50, 51, 55, 57, 61, 71, 75, 78, 83, 86, 96, 99, 108, 112, 115, 118, 120, 124, 127, 136, 139, 147, 155, 160, 164, 166, 168, 171, 172, 175, 179, 185, 193, 205, 206, 208, 211, 225, 228, 236, 237, 241, 243, 246, 248, 255, 262, 268, 274, 283, 286, 288, 289, 291, 294, 301, 304, 316, 318, 320, 324, 331, 336, 345, 348, 352, 354, 358, 361, 364, 373, 374, 385, 390, 392, 397, 400, 404, 405, 406, 407, 410, 416, 425, 436, 437, 439]	['This', 'gene', 'encodes', 'PMCA1', ',', 'a', 'plasma', 'membrane', 'calcium', '/', 'calmodulin', 'dependent', 'ATPase', 'that', 'is', 'expressed', 'in', 'vascular', 'endothelium', 'and', 'is', 'involved', 'in', 'calcium', 'pumping', 'from', 'the', 'cytosol', 'to', 'the', 'extracellular', 'compartment.24', 'An', 'investigation', 'of', 'cultured', 'rat', 'aortic', 'smooth', 'muscle', 'cells', 'found', 'elevated', 'PMCA1', 'mRNA', 'levels', 'in', 'spontaneously', 'hypertensive', 'rats', 'compared', 'to', 'nonhypertensive', 'controls', ',', 'consistent', 'with', 'a', 'role', 'of', 'ATP2B1', 'in', 'blood', 'pressure', 'regulation.25']	[1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 3, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 2, 1, 1, 2, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A SNP (rs1004467) attaining genome-wide significance is in CYP17A1, encoding steroid 17-alpha-hydroxylase, an enzyme necessary for steroidogenesis.	[('PMC2998712', 'D03000', 85, 105, '17-alpha-hydroxylase')]	['A', 'S', '##NP', '(', 'r', '##s', '##100', '##44', '##6', '##7', ')', 'attain', '##ing', 'genome', '-', 'wide', 'significance', 'is', 'in', 'C', '##YP', '##17', '##A', '##1', ',', 'encoding', 's', '##tero', '##id', '17', '-', 'alpha', '-', 'h', '##ydro', '##xy', '##lase', ',', 'an', 'enzyme', 'necessary', 'for', 's', '##tero', '##ido', '##genesis', '.']	[0, 2, 3, 6, 7, 8, 9, 12, 14, 15, 16, 18, 24, 28, 34, 35, 40, 53, 56, 59, 60, 62, 64, 65, 66, 68, 77, 78, 82, 85, 87, 88, 93, 94, 95, 99, 101, 105, 107, 110, 117, 127, 131, 132, 136, 139, 146]	[1, 3, 5, 7, 8, 9, 12, 14, 15, 16, 17, 24, 27, 34, 35, 39, 52, 55, 58, 60, 62, 64, 65, 66, 67, 76, 78, 82, 84, 87, 88, 93, 94, 95, 99, 101, 105, 106, 109, 116, 126, 130, 132, 136, 139, 146, 147]	['A', 'SNP', '(', 'rs1004467', ')', 'attaining', 'genome', '-', 'wide', 'significance', 'is', 'in', 'CYP17A1', ',', 'encoding', 'steroid', '17-alpha-', 'hydroxylase', ',', 'an', 'enzyme', 'necessary', 'for', 'steroidogenesis', '.']	[1, 2, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 4, 4, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mutations in CYP17A1 are found in patients with 17α-hydroxylase deficiency, which is characterized by congenital adrenal hyperplasia with apparent mineralocorticoid excess, salt retention, hypokalemia, and hypertension.31 Numerous mutations in CYP17A1 have been identified in patients with 17α-hydroxylase deficiency leading to a spectrum of phenotypic severity.32 Although mutations in CYP17A1 causing phenotypic 17α-hydroxylase deficiency are rare, our data suggest that common variants in CYP17A1 may also be associated with blood pressure by promoting mild forms of enzyme deficiency or dysfunction.	[('PMC2998712', 'D03001', 48, 63, '17α-hydroxylase')]	['Mu', '##tations', 'in', 'C', '##YP', '##17', '##A', '##1', 'are', 'found', 'in', 'patients', 'with', '17', '##α', '-', 'h', '##ydro', '##xy', '##lase', 'deficiency', ',', 'which', 'is', 'characterized', 'by', 'con', '##gen', '##ital', 'ad', '##rena', '##l', 'h', '##yper', '##p', '##lasia', 'with', 'apparent', 'mineral', '##oc', '##ort', '##ico', '##id', 'excess', ',', 'salt', 'retention', ',', 'h', '##y', '##po', '##kal', '##emia', ',', 'and', 'h', '##yper', '##tens', '##ion', '.', '31', 'Numerous', 'mutations', 'in', 'C', '##YP', '##17', '##A', '##1', 'have', 'been', 'identified', 'in', 'patients', 'with', '17', '##α', '-', 'h', '##ydro', '##xy', '##lase', 'deficiency', 'leading', 'to', 'a', 'spectrum', 'of', 'p', '##hen', '##otypic', 'severity', '.', '32', 'Although', 'mutations', 'in', 'C', '##YP', '##17', '##A', '##1', 'causing', 'p', '##hen', '##otypic', '17', '##α', '-', 'h', '##ydro', '##xy', '##lase', 'deficiency', 'are', 'rare', ',', 'our', 'data', 'suggest', 'that', 'common', 'variants', 'in', 'C', '##YP', '##17', '##A', '##1', 'may', 'also', 'be', 'associated', 'with', 'blood', 'pressure', 'by', 'promoting', 'mild', 'forms', 'of', 'enzyme', 'deficiency', 'or', 'd', '##ys', '##function', '.']	[0, 2, 10, 13, 14, 16, 18, 19, 21, 25, 31, 34, 43, 48, 50, 51, 52, 53, 57, 59, 64, 74, 76, 82, 85, 99, 102, 105, 108, 113, 115, 119, 121, 122, 126, 127, 133, 138, 147, 154, 156, 159, 162, 165, 171, 173, 178, 187, 189, 190, 191, 193, 196, 200, 202, 206, 207, 211, 215, 218, 219, 222, 231, 241, 244, 245, 247, 249, 250, 252, 257, 262, 273, 276, 285, 290, 292, 293, 294, 295, 299, 301, 306, 317, 325, 328, 330, 339, 342, 343, 346, 353, 361, 362, 365, 374, 384, 387, 388, 390, 392, 393, 395, 403, 404, 407, 414, 416, 417, 418, 419, 423, 425, 430, 441, 445, 449, 451, 455, 460, 468, 473, 480, 489, 492, 493, 495, 497, 498, 500, 504, 509, 512, 523, 528, 534, 543, 546, 556, 561, 567, 570, 577, 588, 591, 592, 594, 602]	[2, 9, 12, 14, 16, 18, 19, 20, 24, 30, 33, 42, 47, 50, 51, 52, 53, 57, 59, 63, 74, 75, 81, 84, 98, 101, 105, 108, 112, 115, 119, 120, 122, 126, 127, 132, 137, 146, 154, 156, 159, 162, 164, 171, 172, 177, 187, 188, 190, 191, 193, 196, 200, 201, 205, 207, 211, 215, 218, 219, 221, 230, 240, 243, 245, 247, 249, 250, 251, 256, 261, 272, 275, 284, 289, 292, 293, 294, 295, 299, 301, 305, 316, 324, 327, 329, 338, 341, 343, 346, 352, 361, 362, 364, 373, 383, 386, 388, 390, 392, 393, 394, 402, 404, 407, 413, 416, 417, 418, 419, 423, 425, 429, 440, 444, 449, 450, 454, 459, 467, 472, 479, 488, 491, 493, 495, 497, 498, 499, 503, 508, 511, 522, 527, 533, 542, 545, 555, 560, 566, 569, 576, 587, 590, 592, 594, 602, 603]	['Mutations', 'in', 'CYP17A1', 'are', 'found', 'in', 'patients', 'with', '17α-hydroxylase', 'deficiency', ',', 'which', 'is', 'characterized', 'by', 'congenital', 'adrenal', 'hyperplasia', 'with', 'apparent', 'mineralocorticoid', 'excess', ',', 'salt', 'retention', ',', 'hypokalemia', ',', 'and', 'hypertension.31', 'Numerous', 'mutations', 'in', 'CYP17A1', 'have', 'been', 'identified', 'in', 'patients', 'with', '17α-hydroxylase', 'deficiency', 'leading', 'to', 'a', 'spectrum', 'of', 'phenotypic', 'severity.32', 'Although', 'mutations', 'in', 'CYP17A1', 'causing', 'phenotypic', '17α-hydroxylase', 'deficiency', 'are', 'rare', ',', 'our', 'data', 'suggest', 'that', 'common', 'variants', 'in', 'CYP17A1', 'may', 'also', 'be', 'associated', 'with', 'blood', 'pressure', 'by', 'promoting', 'mild', 'forms', 'of', 'enzyme', 'deficiency', 'or', 'dysfunction', '.']	[2, 1, 5, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 3, 3, 4, 1, 1, 5, 1, 1, 1, 1, 1, 5, 1, 1, 6, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 5, 1, 3, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cerivastatin, an HMG-CoA reductase inhibitor (statin), was withdrawn from the market in 2001 because of a pronounced increase in the risk of rhabdomyolysis, which causes muscle pain and weakness and sometimes renal failure and death [5].	[('PMC3076530', 'I01000', 17, 34, 'HMG-CoA reductase')]	['Ce', '##ri', '##vas', '##tat', '##in', ',', 'an', 'HM', '##G', '-', 'Co', '##A', 'red', '##uc', '##tase', 'inhibitor', '(', 's', '##tat', '##in', ')', ',', 'was', 'withdrawn', 'from', 'the', 'market', 'in', '2001', 'because', 'of', 'a', 'pronounced', 'increase', 'in', 'the', 'risk', 'of', 'r', '##hab', '##dom', '##yo', '##lysis', ',', 'which', 'causes', 'muscle', 'pain', 'and', 'weakness', 'and', 'sometimes', 're', '##nal', 'failure', 'and', 'death', '[', '5', ']', '.']	[0, 2, 4, 7, 10, 12, 14, 17, 19, 20, 21, 23, 25, 28, 30, 35, 45, 46, 47, 50, 52, 53, 55, 59, 69, 74, 78, 85, 88, 93, 101, 104, 106, 117, 126, 129, 133, 138, 141, 142, 145, 148, 150, 155, 157, 163, 170, 177, 182, 186, 195, 199, 209, 211, 215, 223, 227, 233, 234, 235, 236]	[2, 4, 7, 10, 12, 13, 16, 19, 20, 21, 23, 24, 28, 30, 34, 44, 46, 47, 50, 52, 53, 54, 58, 68, 73, 77, 84, 87, 92, 100, 103, 105, 116, 125, 128, 132, 137, 140, 142, 145, 148, 150, 155, 156, 162, 169, 176, 181, 185, 194, 198, 208, 211, 214, 222, 226, 232, 234, 235, 236, 237]	['Cerivastatin', ',', 'an', 'HMG-CoA', 'reductase', 'inhibitor', '(', 'statin', ')', ',', 'was', 'withdrawn', 'from', 'the', 'market', 'in', '2001', 'because', 'of', 'a', 'pronounced', 'increase', 'in', 'the', 'risk', 'of', 'rhabdomyolysis', ',', 'which', 'causes', 'muscle', 'pain', 'and', 'weakness', 'and', 'sometimes', 'renal', 'failure', 'and', 'death', '[', '5', ']', '.']	[5, 1, 1, 5, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
RNA quality was analyzed with the Agilent 2100 Bioanalyzer; 100 ng RNA was used for cDNA synthesis performed using the Invitrogen SuperScript III first-strand synthesis kit according to the manufacturer's instructions with a mix of random hexamers and Oligo(dT).	[]	"['RNA', 'quality', 'was', 'analyzed', 'with', 'the', 'A', '##gi', '##lent', '210', '##0', 'B', '##io', '##ana', '##ly', '##zer', ';', '100', 'ng', 'RNA', 'was', 'used', 'for', 'c', '##D', '##NA', 'synthesis', 'performed', 'using', 'the', 'In', '##vi', '##tro', '##gen', 'Super', '##Script', 'III', 'first', '-', 'strand', 'synthesis', 'kit', 'according', 'to', 'the', 'manufacturer', ""'"", 's', 'instructions', 'with', 'a', 'mix', 'of', 'random', 'he', '##xa', '##mers', 'and', 'O', '##li', '##go', '(', 'd', '##T', ')', '.']"	[0, 4, 12, 16, 25, 30, 34, 35, 37, 42, 45, 47, 48, 50, 53, 55, 58, 60, 64, 67, 71, 75, 80, 84, 85, 86, 89, 99, 109, 115, 119, 121, 123, 126, 130, 135, 142, 146, 151, 152, 159, 169, 173, 183, 186, 190, 202, 203, 205, 218, 223, 225, 229, 232, 239, 241, 243, 248, 252, 253, 255, 257, 258, 259, 260, 261]	[3, 11, 15, 24, 29, 33, 35, 37, 41, 45, 46, 48, 50, 53, 55, 58, 59, 63, 66, 70, 74, 79, 83, 85, 86, 88, 98, 108, 114, 118, 121, 123, 126, 129, 135, 141, 145, 151, 152, 158, 168, 172, 182, 185, 189, 202, 203, 204, 217, 222, 224, 228, 231, 238, 241, 243, 247, 251, 253, 255, 257, 258, 259, 260, 261, 262]	"['RNA', 'quality', 'was', 'analyzed', 'with', 'the', 'Agilent', '2100', 'Bioanalyzer', ';', '100', 'ng', 'RNA', 'was', 'used', 'for', 'cDNA', 'synthesis', 'performed', 'using', 'the', 'Invitrogen', 'SuperScript', 'III', 'first', '-', 'strand', 'synthesis', 'kit', 'according', 'to', 'the', ""manufacturer's"", 'instructions', 'with', 'a', 'mix', 'of', 'random', 'hexamers', 'and', 'Oligo(dT)', '.']"	[1, 1, 1, 1, 1, 1, 3, 2, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 7, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Initial PCR amplification was performed using HotStar Taq DNA polymerase (Qiagen) in a total volume of 12 μL containing 0.25 μM both forward and reverse primer and 24 ng genomic DNA.	[]	['Initial', 'PC', '##R', 'am', '##p', '##lification', 'was', 'performed', 'using', 'Hot', '##S', '##tar', 'Ta', '##q', 'DNA', 'polymer', '##ase', '(', 'Qi', '##age', '##n', ')', 'in', 'a', 'total', 'volume', 'of', '12', 'μ', '##L', 'containing', '0', '.', '25', 'μ', '##M', 'both', 'forward', 'and', 'reverse', 'prime', '##r', 'and', '24', 'ng', 'g', '##eno', '##mic', 'DNA', '.']	[0, 8, 10, 12, 14, 15, 26, 30, 40, 46, 49, 50, 54, 56, 58, 62, 69, 73, 74, 76, 79, 80, 82, 85, 87, 93, 100, 103, 106, 107, 109, 120, 121, 122, 125, 126, 128, 133, 141, 145, 153, 158, 160, 164, 167, 170, 171, 174, 178, 181]	[7, 10, 11, 14, 15, 25, 29, 39, 45, 49, 50, 53, 56, 57, 61, 69, 72, 74, 76, 79, 80, 81, 84, 86, 92, 99, 102, 105, 107, 108, 119, 121, 122, 124, 126, 127, 132, 140, 144, 152, 158, 159, 163, 166, 169, 171, 174, 177, 181, 182]	['Initial', 'PCR', 'amplification', 'was', 'performed', 'using', 'HotStar', 'Taq', 'DNA', 'polymerase', '(', 'Qiagen', ')', 'in', 'a', 'total', 'volume', 'of', '12', 'μL', 'containing', '0.25', 'μM', 'both', 'forward', 'and', 'reverse', 'primer', 'and', '24', 'ng', 'genomic', 'DNA', '.']	[1, 2, 3, 1, 1, 1, 3, 2, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SNPs rs7590720 and rs1344694 downstream of the peroxisomal trans-2-enoyl-CoA reductase (PECR) gene have previously been reported to attain genome-wide significance in alcohol dependence (9).	[('PMC3084048', 'R04000', 47, 86, 'peroxisomal trans-2-enoyl-CoA reductase')]	['S', '##NP', '##s', 'r', '##s', '##75', '##90', '##7', '##20', 'and', 'r', '##s', '##13', '##44', '##6', '##9', '##4', 'downstream', 'of', 'the', 'per', '##ox', '##is', '##oma', '##l', 'trans', '-', '2', '-', 'en', '##oy', '##l', '-', 'Co', '##A', 'red', '##uc', '##tase', '(', 'P', '##EC', '##R', ')', 'gene', 'have', 'previously', 'been', 'reported', 'to', 'attain', 'genome', '-', 'wide', 'significance', 'in', 'alcohol', 'dependence', '(', '9', ')', '.']	[0, 1, 3, 5, 6, 7, 9, 11, 12, 15, 19, 20, 21, 23, 25, 26, 27, 29, 40, 43, 47, 50, 52, 54, 57, 59, 64, 65, 66, 67, 69, 71, 72, 73, 75, 77, 80, 82, 87, 88, 89, 91, 92, 94, 99, 104, 115, 120, 129, 132, 139, 145, 146, 151, 164, 167, 175, 186, 187, 188, 189]	[1, 3, 4, 6, 7, 9, 11, 12, 14, 18, 20, 21, 23, 25, 26, 27, 28, 39, 42, 46, 50, 52, 54, 57, 58, 64, 65, 66, 67, 69, 71, 72, 73, 75, 76, 80, 82, 86, 88, 89, 91, 92, 93, 98, 103, 114, 119, 128, 131, 138, 145, 146, 150, 163, 166, 174, 185, 187, 188, 189, 190]	['SNPs', 'rs7590720', 'and', 'rs1344694', 'downstream', 'of', 'the', 'peroxisomal', 'trans-2-enoyl-CoA', 'reductase', '(', 'PECR', ')', 'gene', 'have', 'previously', 'been', 'reported', 'to', 'attain', 'genome', '-', 'wide', 'significance', 'in', 'alcohol', 'dependence', '(', '9', ')', '.']	[3, 6, 1, 7, 1, 1, 1, 5, 10, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Others have identified several HDL proteins belonging to the serine protease inhibitor (SERPIN	[('PMC3100175', 'D03000', 61, 76, 'serine protease')]	['Others', 'have', 'identified', 'several', 'HD', '##L', 'proteins', 'belonging', 'to', 'the', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '(', 'SE', '##RP', '##IN']	[0, 7, 12, 23, 31, 33, 35, 44, 54, 57, 61, 63, 68, 71, 73, 77, 87, 88, 90, 92]	[6, 11, 22, 30, 33, 34, 43, 53, 56, 60, 63, 67, 71, 73, 76, 86, 88, 90, 92, 94]	['Others', 'have', 'identified', 'several', 'HDL', 'proteins', 'belonging', 'to', 'the', 'serine', 'protease', 'inhibitor', '(', 'SERPIN']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 3, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
The second, pigment epithelium derived factor (PEDF), is a member of the serine protease superfamily but has no known protease inhibitor activity.30 GO analysis annotated this protein as a positive regulator of neurogenesis, promoting the development and maintenance of motor neurons.31 Recently, a causal role for PEDF in obesity induced insulin resistance has been identified.32	[]	['The', 'second', ',', 'pig', '##ment', 'e', '##pit', '##hel', '##ium', 'derived', 'factor', '(', 'P', '##ED', '##F', ')', ',', 'is', 'a', 'member', 'of', 'the', 'se', '##rine', 'pro', '##te', '##ase', 'super', '##family', 'but', 'has', 'no', 'known', 'pro', '##te', '##ase', 'inhibitor', 'activity', '.', '30', 'GO', 'analysis', 'an', '##not', '##ated', 'this', 'protein', 'as', 'a', 'positive', 'regulator', 'of', 'ne', '##uro', '##genesis', ',', 'promoting', 'the', 'development', 'and', 'maintenance', 'of', 'motor', 'neurons', '.', '31', 'Recently', ',', 'a', 'ca', '##usal', 'role', 'for', 'P', '##ED', '##F', 'in', 'o', '##besity', 'induced', 'insulin', 'resistance', 'has', 'been', 'identified', '.', '32']	[0, 4, 10, 12, 15, 20, 21, 24, 27, 31, 39, 46, 47, 48, 50, 51, 52, 54, 57, 59, 66, 69, 73, 75, 80, 83, 85, 89, 94, 101, 105, 109, 112, 118, 121, 123, 127, 137, 145, 146, 149, 152, 161, 163, 166, 171, 176, 184, 187, 189, 198, 208, 211, 213, 216, 223, 225, 235, 239, 251, 255, 267, 270, 276, 283, 284, 287, 295, 297, 299, 301, 306, 311, 315, 316, 318, 320, 323, 324, 331, 339, 347, 358, 362, 367, 377, 378]	[3, 10, 11, 15, 19, 21, 24, 27, 30, 38, 45, 47, 48, 50, 51, 52, 53, 56, 58, 65, 68, 72, 75, 79, 83, 85, 88, 94, 100, 104, 108, 111, 117, 121, 123, 126, 136, 145, 146, 148, 151, 160, 163, 166, 170, 175, 183, 186, 188, 197, 207, 210, 213, 216, 223, 224, 234, 238, 250, 254, 266, 269, 275, 283, 284, 286, 295, 296, 298, 301, 305, 310, 314, 316, 318, 319, 322, 324, 330, 338, 346, 357, 361, 366, 377, 378, 380]	['The', 'second', ',', 'pigment', 'epithelium', 'derived', 'factor', '(', 'PEDF', ')', ',', 'is', 'a', 'member', 'of', 'the', 'serine', 'protease', 'superfamily', 'but', 'has', 'no', 'known', 'protease', 'inhibitor', 'activity.30', 'GO', 'analysis', 'annotated', 'this', 'protein', 'as', 'a', 'positive', 'regulator', 'of', 'neurogenesis', ',', 'promoting', 'the', 'development', 'and', 'maintenance', 'of', 'motor', 'neurons.31', 'Recently', ',', 'a', 'causal', 'role', 'for', 'PEDF', 'in', 'obesity', 'induced', 'insulin', 'resistance', 'has', 'been', 'identified.32']	[1, 1, 1, 2, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 3, 2, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The major findings of this study were the following: (i) associations between SLE and several new and previously reported autoantigens/autoantibodies were demonstrated using multiple proteomic analyses: two-dimensional-PAGE/WB/MALDI-TOF/MS analysis and immunoprecipitation followed by LC-MS/MS shotgun analysis; and (ii) statistically significant associations between anti-esterase D antibodies and CNS syndromes as well as between anti-APEX nuclease 1 antibodies and psychiatric disorders in SLE were also shown by ELISAs, although the associations of other autoantibodies with CNS syndromes were unexpectedly unclear.	[('PMC3108835', 'D00000', 373, 383, 'esterase D')]	['The', 'major', 'findings', 'of', 'this', 'study', 'were', 'the', 'following', ':', '(', 'i', ')', 'associations', 'between', 'SL', '##E', 'and', 'several', 'new', 'and', 'previously', 'reported', 'auto', '##anti', '##gens', '/', 'auto', '##anti', '##bo', '##dies', 'were', 'demonstrated', 'using', 'multiple', 'pro', '##te', '##omi', '##c', 'analyses', ':', 'two', '-', 'dimensional', '-', 'PA', '##GE', '/', 'W', '##B', '/', 'MA', '##LD', '##I', '-', 'TO', '##F', '/', 'MS', 'analysis', 'and', 'im', '##mu', '##no', '##p', '##re', '##ci', '##pit', '##ation', 'followed', 'by', 'L', '##C', '-', 'MS', '/', 'MS', 'shotgun', 'analysis', ';', 'and', '(', 'ii', ')', 'statistical', '##ly', 'significant', 'associations', 'between', 'anti', '-', 'est', '##era', '##se', 'D', 'antibodies', 'and', 'C', '##NS', 'syndrome', '##s', 'as', 'well', 'as', 'between', 'anti', '-', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', 'antibodies', 'and', 'psychiatric', 'disorders', 'in', 'SL', '##E', 'were', 'also', 'shown', 'by', 'E', '##L', '##IS', '##As', ',', 'although', 'the', 'associations', 'of', 'other', 'auto', '##anti', '##bo', '##dies', 'with', 'C', '##NS', 'syndrome', '##s', 'were', 'unexpectedly', 'unclear', '.']	[0, 4, 10, 19, 22, 27, 33, 38, 42, 51, 53, 54, 55, 57, 70, 78, 80, 82, 86, 94, 98, 102, 113, 122, 126, 130, 134, 135, 139, 143, 145, 150, 155, 168, 174, 183, 186, 188, 191, 193, 201, 203, 206, 207, 218, 219, 221, 223, 224, 225, 226, 227, 229, 231, 232, 233, 235, 236, 237, 240, 249, 253, 255, 257, 259, 260, 262, 264, 267, 273, 282, 285, 286, 287, 288, 290, 291, 294, 302, 310, 312, 316, 317, 319, 321, 332, 335, 347, 360, 368, 372, 373, 376, 379, 382, 384, 395, 399, 400, 403, 411, 413, 416, 421, 424, 432, 436, 437, 439, 442, 443, 445, 448, 451, 453, 464, 468, 480, 490, 493, 495, 497, 502, 507, 513, 516, 517, 518, 520, 522, 524, 533, 537, 550, 553, 559, 563, 567, 569, 574, 579, 580, 583, 591, 593, 598, 611, 618]	[3, 9, 18, 21, 26, 32, 37, 41, 51, 52, 54, 55, 56, 69, 77, 80, 81, 85, 93, 97, 101, 112, 121, 126, 130, 134, 135, 139, 143, 145, 149, 154, 167, 173, 182, 186, 188, 191, 192, 201, 202, 206, 207, 218, 219, 221, 223, 224, 225, 226, 227, 229, 231, 232, 233, 235, 236, 237, 239, 248, 252, 255, 257, 259, 260, 262, 264, 267, 272, 281, 284, 286, 287, 288, 290, 291, 293, 301, 310, 311, 315, 317, 319, 320, 332, 334, 346, 359, 367, 372, 373, 376, 379, 381, 383, 394, 398, 400, 402, 411, 412, 415, 420, 423, 431, 436, 437, 439, 441, 443, 445, 448, 450, 452, 463, 467, 479, 489, 492, 495, 496, 501, 506, 512, 515, 517, 518, 520, 522, 523, 532, 536, 549, 552, 558, 563, 567, 569, 573, 578, 580, 582, 591, 592, 597, 610, 618, 619]	['The', 'major', 'findings', 'of', 'this', 'study', 'were', 'the', 'following', ':', '(i)', 'associations', 'between', 'SLE', 'and', 'several', 'new', 'and', 'previously', 'reported', 'autoantigens', '/', 'autoantibodies', 'were', 'demonstrated', 'using', 'multiple', 'proteomic', 'analyses', ':', 'two-dimensional-PAGE', '/', 'WB', '/', 'MALDI-TOF', '/', 'MS', 'analysis', 'and', 'immunoprecipitation', 'followed', 'by', 'LC-MS', '/', 'MS', 'shotgun', 'analysis', ';', 'and', '(ii)', 'statistically', 'significant', 'associations', 'between', 'anti-', 'esterase', 'D', 'antibodies', 'and', 'CNS', 'syndromes', 'as', 'well', 'as', 'between', 'anti-APEX', 'nuclease', '1', 'antibodies', 'and', 'psychiatric', 'disorders', 'in', 'SLE', 'were', 'also', 'shown', 'by', 'ELISAs', ',', 'although', 'the', 'associations', 'of', 'other', 'autoantibodies', 'with', 'CNS', 'syndromes', 'were', 'unexpectedly', 'unclear', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 4, 1, 1, 6, 1, 2, 1, 6, 1, 1, 1, 1, 8, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 2, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 2, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found new, previously unreported associations of three serum autoantibodies with SLE, demonstrating reactivity against crystallin αB, esterase D, and APEX nuclease 1.	[('PMC3108835', 'D01000', 137, 147, 'esterase D')]	['We', 'found', 'new', ',', 'previously', 'un', '##re', '##port', '##ed', 'associations', 'of', 'three', 'serum', 'auto', '##anti', '##bo', '##dies', 'with', 'SL', '##E', ',', 'demonstrating', 'react', '##ivity', 'against', 'crystal', '##lin', 'α', '##B', ',', 'est', '##era', '##se', 'D', ',', 'and', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', '.']	[0, 3, 9, 12, 14, 25, 27, 29, 33, 36, 49, 52, 58, 64, 68, 72, 74, 79, 84, 86, 87, 89, 103, 108, 114, 122, 129, 133, 134, 135, 137, 140, 143, 146, 147, 149, 153, 155, 158, 159, 161, 164, 167, 168]	[2, 8, 12, 13, 24, 27, 29, 33, 35, 48, 51, 57, 63, 68, 72, 74, 78, 83, 86, 87, 88, 102, 108, 113, 121, 129, 132, 134, 135, 136, 140, 143, 145, 147, 148, 152, 155, 157, 159, 161, 164, 166, 168, 169]	['We', 'found', 'new', ',', 'previously', 'unreported', 'associations', 'of', 'three', 'serum', 'autoantibodies', 'with', 'SLE', ',', 'demonstrating', 'reactivity', 'against', 'crystallin', 'αB', ',', 'esterase', 'D', ',', 'and', 'APEX', 'nuclease', '1', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 2, 2, 1, 3, 1, 1, 1, 2, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Statistically significant associations between anti-esterase D antibodies and CNS syndromes as well as between anti-APEX nuclease 1 antibodies and psychiatric disorders in SLE were also demonstrated for the first time.	[('PMC3108835', 'D03000', 52, 62, 'esterase D')]	['Statistical', '##ly', 'significant', 'associations', 'between', 'anti', '-', 'est', '##era', '##se', 'D', 'antibodies', 'and', 'C', '##NS', 'syndrome', '##s', 'as', 'well', 'as', 'between', 'anti', '-', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', 'antibodies', 'and', 'psychiatric', 'disorders', 'in', 'SL', '##E', 'were', 'also', 'demonstrated', 'for', 'the', 'first', 'time', '.']	[0, 11, 14, 26, 39, 47, 51, 52, 55, 58, 61, 63, 74, 78, 79, 82, 90, 92, 95, 100, 103, 111, 115, 116, 118, 121, 122, 124, 127, 130, 132, 143, 147, 159, 169, 172, 174, 176, 181, 186, 199, 203, 207, 213, 217]	[11, 13, 25, 38, 46, 51, 52, 55, 58, 60, 62, 73, 77, 79, 81, 90, 91, 94, 99, 102, 110, 115, 116, 118, 120, 122, 124, 127, 129, 131, 142, 146, 158, 168, 171, 174, 175, 180, 185, 198, 202, 206, 212, 217, 218]	['Statistically', 'significant', 'associations', 'between', 'anti-', 'esterase', 'D', 'antibodies', 'and', 'CNS', 'syndromes', 'as', 'well', 'as', 'between', 'anti-APEX', 'nuclease', '1', 'antibodies', 'and', 'psychiatric', 'disorders', 'in', 'SLE', 'were', 'also', 'demonstrated', 'for', 'the', 'first', 'time', '.']	[2, 1, 1, 1, 2, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, although promising, these novel findings require cautious interpretation and further investigation to allow for decisive conclusions because most of the O.D. values of anti-esterase D antibodies in the present study were not very high and there were several samples from patients without psychiatric disorders that had high-titer anti-APEX1 antibodies and vice versa.	[('PMC3108835', 'D03001', 182, 192, 'esterase D')]	['However', ',', 'although', 'promising', ',', 'these', 'novel', 'findings', 'require', 'cautious', 'interpretation', 'and', 'further', 'investigation', 'to', 'allow', 'for', 'decisive', 'conclusions', 'because', 'most', 'of', 'the', 'O', '.', 'D', '.', 'values', 'of', 'anti', '-', 'est', '##era', '##se', 'D', 'antibodies', 'in', 'the', 'present', 'study', 'were', 'not', 'very', 'high', 'and', 'there', 'were', 'several', 'samples', 'from', 'patients', 'without', 'psychiatric', 'disorders', 'that', 'had', 'high', '-', 't', '##iter', 'anti', '-', 'AP', '##EX', '##1', 'antibodies', 'and', 'vice', 'versa', '.']	[0, 7, 9, 18, 27, 29, 35, 41, 50, 58, 67, 82, 86, 94, 108, 111, 117, 121, 130, 142, 150, 155, 158, 162, 163, 164, 165, 167, 174, 177, 181, 182, 185, 188, 191, 193, 204, 207, 211, 219, 225, 230, 234, 239, 244, 248, 254, 259, 267, 275, 280, 289, 297, 309, 319, 324, 328, 332, 333, 334, 339, 343, 344, 346, 348, 350, 361, 365, 370, 375]	[7, 8, 17, 27, 28, 34, 40, 49, 57, 66, 81, 85, 93, 107, 110, 116, 120, 129, 141, 149, 154, 157, 161, 163, 164, 165, 166, 173, 176, 181, 182, 185, 188, 190, 192, 203, 206, 210, 218, 224, 229, 233, 238, 243, 247, 253, 258, 266, 274, 279, 288, 296, 308, 318, 323, 327, 332, 333, 334, 338, 343, 344, 346, 348, 349, 360, 364, 369, 375, 376]	['However', ',', 'although', 'promising', ',', 'these', 'novel', 'findings', 'require', 'cautious', 'interpretation', 'and', 'further', 'investigation', 'to', 'allow', 'for', 'decisive', 'conclusions', 'because', 'most', 'of', 'the', 'O.D', '.', 'values', 'of', 'anti-', 'esterase', 'D', 'antibodies', 'in', 'the', 'present', 'study', 'were', 'not', 'very', 'high', 'and', 'there', 'were', 'several', 'samples', 'from', 'patients', 'without', 'psychiatric', 'disorders', 'that', 'had', 'high', '-', 'titer', 'anti-APEX1', 'antibodies', 'and', 'vice', 'versa', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among them, statistically significant associations between anti-esterase D antibodies and CNS syndromes as well as between anti-APEX nuclease 1 antibodies and psychiatric disorders in SLE were also shown.	[]	['Among', 'them', ',', 'statistical', '##ly', 'significant', 'associations', 'between', 'anti', '-', 'est', '##era', '##se', 'D', 'antibodies', 'and', 'C', '##NS', 'syndrome', '##s', 'as', 'well', 'as', 'between', 'anti', '-', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', 'antibodies', 'and', 'psychiatric', 'disorders', 'in', 'SL', '##E', 'were', 'also', 'shown', '.']	[0, 6, 10, 12, 23, 26, 38, 51, 59, 63, 64, 67, 70, 73, 75, 86, 90, 91, 94, 102, 104, 107, 112, 115, 123, 127, 128, 130, 133, 134, 136, 139, 142, 144, 155, 159, 171, 181, 184, 186, 188, 193, 198, 203]	[5, 10, 11, 23, 25, 37, 50, 58, 63, 64, 67, 70, 72, 74, 85, 89, 91, 93, 102, 103, 106, 111, 114, 122, 127, 128, 130, 132, 134, 136, 139, 141, 143, 154, 158, 170, 180, 183, 186, 187, 192, 197, 203, 204]	['Among', 'them', ',', 'statistically', 'significant', 'associations', 'between', 'anti-', 'esterase', 'D', 'antibodies', 'and', 'CNS', 'syndromes', 'as', 'well', 'as', 'between', 'anti-APEX', 'nuclease', '1', 'antibodies', 'and', 'psychiatric', 'disorders', 'in', 'SLE', 'were', 'also', 'shown', '.']	[1, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This study demonstrates that the immunoproteomic approach used in this study combining two-dimensional-PAGE/WB/MALDI-TOF/MS analysis and immunoprecipitation followed by LC-MS/MS shotgun analysis is a reliable and effective method for the identification of autoantigens in SLE.	[]	['This', 'study', 'demonstrates', 'that', 'the', 'im', '##mu', '##no', '##p', '##rote', '##omi', '##c', 'approach', 'used', 'in', 'this', 'study', 'combining', 'two', '-', 'dimensional', '-', 'PA', '##GE', '/', 'W', '##B', '/', 'MA', '##LD', '##I', '-', 'TO', '##F', '/', 'MS', 'analysis', 'and', 'im', '##mu', '##no', '##p', '##re', '##ci', '##pit', '##ation', 'followed', 'by', 'L', '##C', '-', 'MS', '/', 'MS', 'shotgun', 'analysis', 'is', 'a', 'reliable', 'and', 'effective', 'method', 'for', 'the', 'identification', 'of', 'auto', '##anti', '##gens', 'in', 'SL', '##E', '.']	[0, 5, 11, 24, 29, 33, 35, 37, 39, 40, 44, 47, 49, 58, 63, 66, 71, 77, 87, 90, 91, 102, 103, 105, 107, 108, 109, 110, 111, 113, 115, 116, 117, 119, 120, 121, 124, 133, 137, 139, 141, 143, 144, 146, 148, 151, 157, 166, 169, 170, 171, 172, 174, 175, 178, 186, 195, 198, 200, 209, 213, 223, 230, 234, 238, 253, 256, 260, 264, 269, 272, 274, 275]	[4, 10, 23, 28, 32, 35, 37, 39, 40, 44, 47, 48, 57, 62, 65, 70, 76, 86, 90, 91, 102, 103, 105, 107, 108, 109, 110, 111, 113, 115, 116, 117, 119, 120, 121, 123, 132, 136, 139, 141, 143, 144, 146, 148, 151, 156, 165, 168, 170, 171, 172, 174, 175, 177, 185, 194, 197, 199, 208, 212, 222, 229, 233, 237, 252, 255, 260, 264, 268, 271, 274, 275, 276]	['This', 'study', 'demonstrates', 'that', 'the', 'immunoproteomic', 'approach', 'used', 'in', 'this', 'study', 'combining', 'two-dimensional-PAGE', '/', 'WB', '/', 'MALDI-TOF', '/', 'MS', 'analysis', 'and', 'immunoprecipitation', 'followed', 'by', 'LC-MS', '/', 'MS', 'shotgun', 'analysis', 'is', 'a', 'reliable', 'and', 'effective', 'method', 'for', 'the', 'identification', 'of', 'autoantigens', 'in', 'SLE', '.']	[1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 6, 1, 1, 1, 1, 8, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Differentially reacted protein spots specific to the CNS group were excised from the blotted membranes and subjected to digestion with lysine endopeptidase, followed by peptide-mass fingerprinting and MALDI-TOF/MS.	[('PMC3108835', 'R02000', 135, 155, 'lysine endopeptidase')]	['Different', '##ially', 'reacted', 'protein', 'spots', 'specific', 'to', 'the', 'C', '##NS', 'group', 'were', 'ex', '##cise', '##d', 'from', 'the', 'b', '##lot', '##ted', 'membrane', '##s', 'and', 'subjected', 'to', 'dig', '##est', '##ion', 'with', 'l', '##ys', '##ine', 'end', '##ope', '##pt', '##idas', '##e', ',', 'followed', 'by', 'p', '##eptide', '-', 'mass', 'finger', '##print', '##ing', 'and', 'MA', '##LD', '##I', '-', 'TO', '##F', '/', 'MS', '.']	[0, 9, 15, 23, 31, 37, 46, 49, 53, 54, 57, 63, 68, 70, 74, 76, 81, 85, 86, 89, 93, 101, 103, 107, 117, 120, 123, 126, 130, 135, 136, 138, 142, 145, 148, 150, 154, 155, 157, 166, 169, 170, 176, 177, 182, 188, 193, 197, 201, 203, 205, 206, 207, 209, 210, 211, 213]	[9, 14, 22, 30, 36, 45, 48, 52, 54, 56, 62, 67, 70, 74, 75, 80, 84, 86, 89, 92, 101, 102, 106, 116, 119, 123, 126, 129, 134, 136, 138, 141, 145, 148, 150, 154, 155, 156, 165, 168, 170, 176, 177, 181, 188, 193, 196, 200, 203, 205, 206, 207, 209, 210, 211, 213, 214]	['Differentially', 'reacted', 'protein', 'spots', 'specific', 'to', 'the', 'CNS', 'group', 'were', 'excised', 'from', 'the', 'blotted', 'membranes', 'and', 'subjected', 'to', 'digestion', 'with', 'lysine', 'endopeptidase', ',', 'followed', 'by', 'peptide', '-', 'mass', 'fingerprinting', 'and', 'MALDI-TOF', '/', 'MS', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 2, 1, 1, 1, 3, 1, 3, 5, 1, 1, 1, 2, 1, 1, 3, 1, 6, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although some of the proteomic data (e.g. esterase D) were insufficient for protein identification by themselves (supplemental data), we selected possible antigens based on not only the results of the two proteomic approaches described above but also literature information.	[('PMC3108835', 'R05000', 42, 52, 'esterase D')]	['Although', 'some', 'of', 'the', 'pro', '##te', '##omi', '##c', 'data', '(', 'e', '.', 'g', '.', 'est', '##era', '##se', 'D', ')', 'were', 'insufficient', 'for', 'protein', 'identification', 'by', 'themselves', '(', 'supplement', '##al', 'data', ')', ',', 'we', 'selected', 'possible', 'anti', '##gens', 'based', 'on', 'not', 'only', 'the', 'results', 'of', 'the', 'two', 'pro', '##te', '##omi', '##c', 'approaches', 'described', 'above', 'but', 'also', 'literature', 'information', '.']	[0, 9, 14, 17, 21, 24, 26, 29, 31, 36, 37, 38, 39, 40, 42, 45, 48, 51, 52, 54, 59, 72, 76, 84, 99, 102, 113, 114, 124, 127, 131, 132, 134, 137, 146, 155, 159, 164, 170, 173, 177, 182, 186, 194, 197, 201, 205, 208, 210, 213, 215, 226, 236, 242, 246, 251, 262, 273]	[8, 13, 16, 20, 24, 26, 29, 30, 35, 37, 38, 39, 40, 41, 45, 48, 50, 52, 53, 58, 71, 75, 83, 98, 101, 112, 114, 124, 126, 131, 132, 133, 136, 145, 154, 159, 163, 169, 172, 176, 181, 185, 193, 196, 200, 204, 208, 210, 213, 214, 225, 235, 241, 245, 250, 261, 273, 274]	['Although', 'some', 'of', 'the', 'proteomic', 'data', '(', 'e.g', '.', 'esterase', 'D', ')', 'were', 'insufficient', 'for', 'protein', 'identification', 'by', 'themselves', '(', 'supplemental', 'data', ')', ',', 'we', 'selected', 'possible', 'antigens', 'based', 'on', 'not', 'only', 'the', 'results', 'of', 'the', 'two', 'proteomic', 'approaches', 'described', 'above', 'but', 'also', 'literature', 'information', '.']	[1, 1, 1, 1, 4, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among the many candidate antigens screened, 11 recombinant antigens showed positive reactions against the pooled sera of 28 patients with active CNS lupus by WB analysis: crystallin αB, esterase D, APEX nuclease 1, 60S acidic ribosomal protein P0 (ribosomal protein P0), proteasome activator complex subunit 3 (PA28γ), triosephosphate isomerase, phosphoglycerate kinase 1 (cell migration-inducing gene 10 protein), phosphatidylethanolamine-binding protein 1, phosphoglycerate mutase 1, 3-hydroxyacyl-CoA dehydrogenase type-2, and glial fibrillary acidic protein (Fig. 2).	[('PMC3108835', 'R05001', 186, 196, 'esterase D')]	['Among', 'the', 'many', 'candidate', 'anti', '##gens', 'screened', ',', '11', 're', '##comb', '##ina', '##nt', 'anti', '##gens', 'showed', 'positive', 'reactions', 'against', 'the', 'pool', '##ed', 'se', '##ra', 'of', '28', 'patients', 'with', 'active', 'C', '##NS', 'l', '##up', '##us', 'by', 'W', '##B', 'analysis', ':', 'crystal', '##lin', 'α', '##B', ',', 'est', '##era', '##se', 'D', ',', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', ',', '60', '##S', 'acidic', 'rib', '##oso', '##mal', 'protein', 'P', '##0', '(', 'rib', '##oso', '##mal', 'protein', 'P', '##0', ')', ',', 'pro', '##te', '##as', '##ome', 'act', '##iva', '##tor', 'complex', 'subunit', '3', '(', 'PA', '##28', '##γ', ')', ',', 'trio', '##se', '##ph', '##os', '##phate', 'is', '##omer', '##ase', ',', 'p', '##hos', '##ph', '##og', '##ly', '##cer', '##ate', 'kinase', '1', '(', 'cell', 'migration', '-', 'in', '##ducing', 'gene', '10', 'protein', ')', ',', 'p', '##hos', '##pha', '##ti', '##dy', '##let', '##han', '##ola', '##mine', '-', 'binding', 'protein', '1', ',', 'p', '##hos', '##ph', '##og', '##ly', '##cer', '##ate', 'm', '##uta', '##se', '1', ',', '3', '-', 'h', '##ydro', '##xy', '##acy', '##l', '-', 'Co', '##A', 'de', '##hy', '##dr', '##ogen', '##ase', 'type', '-', '2', ',', 'and', 'g', '##lial', 'fi', '##bri', '##llar', '##y', 'acidic', 'protein', '(', 'Fi', '##g', '.', '2', ')', '.']	[0, 6, 10, 15, 25, 29, 34, 42, 44, 47, 49, 53, 56, 59, 63, 68, 75, 84, 94, 102, 106, 110, 113, 115, 118, 121, 124, 133, 138, 145, 146, 149, 150, 152, 155, 158, 159, 161, 169, 171, 178, 182, 183, 184, 186, 189, 192, 195, 196, 198, 200, 203, 204, 206, 209, 212, 213, 215, 217, 219, 226, 229, 232, 236, 244, 245, 247, 248, 251, 254, 258, 266, 267, 268, 269, 271, 274, 276, 278, 282, 285, 288, 292, 300, 308, 310, 311, 313, 315, 316, 317, 319, 323, 325, 327, 329, 335, 337, 341, 344, 346, 347, 350, 352, 354, 356, 359, 363, 370, 372, 373, 378, 387, 388, 390, 397, 402, 405, 412, 413, 415, 416, 419, 422, 424, 426, 429, 432, 435, 439, 440, 448, 456, 457, 459, 460, 463, 465, 467, 469, 472, 476, 477, 480, 483, 484, 486, 487, 488, 489, 493, 495, 498, 499, 500, 502, 504, 506, 508, 510, 514, 518, 522, 523, 524, 526, 530, 531, 536, 538, 541, 545, 547, 554, 562, 563, 565, 566, 568, 569, 570]	[5, 9, 14, 24, 29, 33, 42, 43, 46, 49, 53, 56, 58, 63, 67, 74, 83, 93, 101, 105, 110, 112, 115, 117, 120, 123, 132, 137, 144, 146, 148, 150, 152, 154, 157, 159, 160, 169, 170, 178, 181, 183, 184, 185, 189, 192, 194, 196, 197, 200, 202, 204, 206, 209, 211, 213, 214, 217, 218, 225, 229, 232, 235, 243, 245, 246, 248, 251, 254, 257, 265, 267, 268, 269, 270, 274, 276, 278, 281, 285, 288, 291, 299, 307, 309, 311, 313, 315, 316, 317, 318, 323, 325, 327, 329, 334, 337, 341, 344, 345, 347, 350, 352, 354, 356, 359, 362, 369, 371, 373, 377, 387, 388, 390, 396, 401, 404, 412, 413, 414, 416, 419, 422, 424, 426, 429, 432, 435, 439, 440, 447, 455, 457, 458, 460, 463, 465, 467, 469, 472, 475, 477, 480, 482, 484, 485, 487, 488, 489, 493, 495, 498, 499, 500, 502, 503, 506, 508, 510, 514, 517, 522, 523, 524, 525, 529, 531, 535, 538, 541, 545, 546, 553, 561, 563, 565, 566, 567, 569, 570, 571]	['Among', 'the', 'many', 'candidate', 'antigens', 'screened', ',', '11', 'recombinant', 'antigens', 'showed', 'positive', 'reactions', 'against', 'the', 'pooled', 'sera', 'of', '28', 'patients', 'with', 'active', 'CNS', 'lupus', 'by', 'WB', 'analysis', ':', 'crystallin', 'αB', ',', 'esterase', 'D', ',', 'APEX', 'nuclease', '1', ',', '60S', 'acidic', 'ribosomal', 'protein', 'P0', '(', 'ribosomal', 'protein', 'P0', ')', ',', 'proteasome', 'activator', 'complex', 'subunit', '3', '(', 'PA28γ', ')', ',', 'triosephosphate', 'isomerase', ',', 'phosphoglycerate', 'kinase', '1', '(', 'cell', 'migration', '-', 'inducing', 'gene', '10', 'protein', ')', ',', 'phosphatidylethanolamine', '-', 'binding', 'protein', '1', ',', 'phosphoglycerate', 'mutase', '1', ',', '3-hydroxyacyl-CoA', 'dehydrogenase', 'type-2', ',', 'and', 'glial', 'fibrillary', 'acidic', 'protein', '(', 'Fig', '.', '2', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 2, 3, 1, 2, 1, 1, 2, 2, 1, 3, 1, 1, 2, 4, 1, 1, 2, 1, 3, 1, 2, 1, 3, 1, 2, 1, 1, 4, 3, 1, 1, 1, 1, 3, 1, 1, 5, 3, 1, 7, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 9, 1, 1, 1, 1, 1, 7, 3, 1, 1, 10, 5, 3, 1, 1, 2, 4, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among these, APEX nuclease 1, PA28γ, phosphoglycerate mutase 1, 3-hydroxyacyl-CoA dehydrogenase type-2, and glial fibrillary acidic protein were identified exclusively by immunoprecipitation followed by LC-MS/MS shotgun analysis.	[('PMC3108835', 'R05002', 18, 28, 'nuclease 1')]	['Among', 'these', ',', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', ',', 'PA', '##28', '##γ', ',', 'p', '##hos', '##ph', '##og', '##ly', '##cer', '##ate', 'm', '##uta', '##se', '1', ',', '3', '-', 'h', '##ydro', '##xy', '##acy', '##l', '-', 'Co', '##A', 'de', '##hy', '##dr', '##ogen', '##ase', 'type', '-', '2', ',', 'and', 'g', '##lial', 'fi', '##bri', '##llar', '##y', 'acidic', 'protein', 'were', 'identified', 'exclusively', 'by', 'im', '##mu', '##no', '##p', '##re', '##ci', '##pit', '##ation', 'followed', 'by', 'L', '##C', '-', 'MS', '/', 'MS', 'shotgun', 'analysis', '.']	[0, 6, 11, 13, 15, 18, 19, 21, 24, 27, 28, 30, 32, 34, 35, 37, 38, 41, 43, 45, 47, 50, 54, 55, 58, 61, 62, 64, 65, 66, 67, 71, 73, 76, 77, 78, 80, 82, 84, 86, 88, 92, 96, 100, 101, 102, 104, 108, 109, 114, 116, 119, 123, 125, 132, 140, 145, 156, 168, 171, 173, 175, 177, 178, 180, 182, 185, 191, 200, 203, 204, 205, 206, 208, 209, 212, 220, 228]	[5, 11, 12, 15, 17, 19, 21, 24, 26, 28, 29, 32, 34, 35, 36, 38, 41, 43, 45, 47, 50, 53, 55, 58, 60, 62, 63, 65, 66, 67, 71, 73, 76, 77, 78, 80, 81, 84, 86, 88, 92, 95, 100, 101, 102, 103, 107, 109, 113, 116, 119, 123, 124, 131, 139, 144, 155, 167, 170, 173, 175, 177, 178, 180, 182, 185, 190, 199, 202, 204, 205, 206, 208, 209, 211, 219, 228, 229]	['Among', 'these', ',', 'APEX', 'nuclease', '1', ',', 'PA28γ', ',', 'phosphoglycerate', 'mutase', '1', ',', '3-hydroxyacyl-CoA', 'dehydrogenase', 'type-2', ',', 'and', 'glial', 'fibrillary', 'acidic', 'protein', 'were', 'identified', 'exclusively', 'by', 'immunoprecipitation', 'followed', 'by', 'LC-MS', '/', 'MS', 'shotgun', 'analysis', '.']	[1, 1, 1, 2, 4, 1, 1, 3, 1, 7, 3, 1, 1, 10, 5, 3, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 8, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The O.D. values of sera from the CNS group were significantly higher than those from the non-CNS group in ELISAs using esterase D (p = 0.016), although most of them show low O.D. values (< 0.1; Fig. 5A).	[('PMC3108835', 'R07000', 119, 129, 'esterase D')]	['The', 'O', '.', 'D', '.', 'values', 'of', 'se', '##ra', 'from', 'the', 'C', '##NS', 'group', 'were', 'significantly', 'higher', 'than', 'those', 'from', 'the', 'non', '-', 'C', '##NS', 'group', 'in', 'E', '##L', '##IS', '##As', 'using', 'est', '##era', '##se', 'D', '(', 'p', '=', '0', '.', '01', '##6', ')', ',', 'although', 'most', 'of', 'them', 'show', 'low', 'O', '.', 'D', '.', 'values', '(', '<', '0', '.', '1', ';', 'Fi', '##g', '.', '5', '##A', ')', '.']	[0, 4, 5, 6, 7, 9, 16, 19, 21, 24, 29, 33, 34, 37, 43, 48, 62, 69, 74, 80, 85, 89, 92, 93, 94, 97, 103, 106, 107, 108, 110, 113, 119, 122, 125, 128, 130, 131, 133, 135, 136, 137, 139, 140, 141, 143, 152, 157, 160, 165, 170, 174, 175, 176, 177, 179, 186, 187, 189, 190, 191, 192, 194, 196, 197, 199, 200, 201, 202]	[3, 5, 6, 7, 8, 15, 18, 21, 23, 28, 32, 34, 36, 42, 47, 61, 68, 73, 79, 84, 88, 92, 93, 94, 96, 102, 105, 107, 108, 110, 112, 118, 122, 125, 127, 129, 131, 132, 134, 136, 137, 139, 140, 141, 142, 151, 156, 159, 164, 169, 173, 175, 176, 177, 178, 185, 187, 188, 190, 191, 192, 193, 196, 197, 198, 200, 201, 202, 203]	['The', 'O.D', '.', 'values', 'of', 'sera', 'from', 'the', 'CNS', 'group', 'were', 'significantly', 'higher', 'than', 'those', 'from', 'the', 'non-CNS', 'group', 'in', 'ELISAs', 'using', 'esterase', 'D', '(', 'p', '=', '0.016', ')', ',', 'although', 'most', 'of', 'them', 'show', 'low', 'O.D', '.', 'values', '(', '<', '0.1', ';', 'Fig', '.', '5A', ')', '.']	[1, 3, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Unexpectedly, no O.D. values in ELISAs of other autoantibodies differed significantly between SLE patients with or without active CNS syndromes when tested in larger sample sizes: crystallin αB (p = 0.75), APEX nuclease 1 (p = 0.18), ribosomal protein P0 (p = 0.89), or PA28γ (p = 0.58).	[('PMC3108835', 'R07001', 211, 221, 'nuclease 1')]	['Un', '##ex', '##pect', '##edly', ',', 'no', 'O', '.', 'D', '.', 'values', 'in', 'E', '##L', '##IS', '##As', 'of', 'other', 'auto', '##anti', '##bo', '##dies', 'differed', 'significantly', 'between', 'SL', '##E', 'patients', 'with', 'or', 'without', 'active', 'C', '##NS', 'syndrome', '##s', 'when', 'tested', 'in', 'larger', 'sample', 'sizes', ':', 'crystal', '##lin', 'α', '##B', '(', 'p', '=', '0', '.', '75', ')', ',', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', '(', 'p', '=', '0', '.', '18', ')', ',', 'rib', '##oso', '##mal', 'protein', 'P', '##0', '(', 'p', '=', '0', '.', '89', ')', ',', 'or', 'PA', '##28', '##γ', '(', 'p', '=', '0', '.', '58', ')', '.']	[0, 2, 4, 8, 12, 14, 17, 18, 19, 20, 22, 29, 32, 33, 34, 36, 39, 42, 48, 52, 56, 58, 63, 72, 86, 94, 96, 98, 107, 112, 115, 123, 130, 131, 134, 142, 144, 149, 156, 159, 166, 173, 178, 180, 187, 191, 192, 194, 195, 197, 199, 200, 201, 203, 204, 206, 208, 211, 212, 214, 217, 220, 222, 223, 225, 227, 228, 229, 231, 232, 234, 237, 240, 244, 252, 253, 255, 256, 258, 260, 261, 262, 264, 265, 267, 270, 272, 274, 276, 277, 279, 281, 282, 283, 285, 286]	[2, 4, 8, 12, 13, 16, 18, 19, 20, 21, 28, 31, 33, 34, 36, 38, 41, 47, 52, 56, 58, 62, 71, 85, 93, 96, 97, 106, 111, 114, 122, 129, 131, 133, 142, 143, 148, 155, 158, 165, 172, 178, 179, 187, 190, 192, 193, 195, 196, 198, 200, 201, 203, 204, 205, 208, 210, 212, 214, 217, 219, 221, 223, 224, 226, 228, 229, 231, 232, 233, 237, 240, 243, 251, 253, 254, 256, 257, 259, 261, 262, 264, 265, 266, 269, 272, 274, 275, 277, 278, 280, 282, 283, 285, 286, 287]	['Unexpectedly', ',', 'no', 'O.D', '.', 'values', 'in', 'ELISAs', 'of', 'other', 'autoantibodies', 'differed', 'significantly', 'between', 'SLE', 'patients', 'with', 'or', 'without', 'active', 'CNS', 'syndromes', 'when', 'tested', 'in', 'larger', 'sample', 'sizes', ':', 'crystallin', 'αB', '(', 'p', '=', '0.75', ')', ',', 'APEX', 'nuclease', '1', '(', 'p', '=', '0.18', ')', ',', 'ribosomal', 'protein', 'P0', '(', 'p', '=', '0.89', ')', ',', 'or', 'PA28γ', '(', 'p', '=', '0.58', ')', '.']	[4, 1, 1, 3, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 1, 2, 4, 1, 1, 1, 1, 3, 1, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, when the CNS group with neurologic disorders and the CNS group with psychiatric disorders were separately compared with SLE patients without those disorders, the levels of anti-APEX nuclease 1 antibodies were significantly elevated in SLE patients with psychiatric disorders compared with the levels in SLE patients without psychiatric disorders (p = 0.037;	[('PMC3108835', 'R07002', 191, 201, 'nuclease 1')]	['However', ',', 'when', 'the', 'C', '##NS', 'group', 'with', 'ne', '##uro', '##log', '##ic', 'disorders', 'and', 'the', 'C', '##NS', 'group', 'with', 'psychiatric', 'disorders', 'were', 'separately', 'compared', 'with', 'SL', '##E', 'patients', 'without', 'those', 'disorders', ',', 'the', 'levels', 'of', 'anti', '-', 'AP', '##EX', 'n', '##uc', '##lea', '##se', '1', 'antibodies', 'were', 'significantly', 'elevated', 'in', 'SL', '##E', 'patients', 'with', 'psychiatric', 'disorders', 'compared', 'with', 'the', 'levels', 'in', 'SL', '##E', 'patients', 'without', 'psychiatric', 'disorders', '(', 'p', '=', '0', '.', '03', '##7', ';']	[0, 7, 9, 14, 18, 19, 22, 28, 33, 35, 38, 41, 44, 54, 58, 62, 63, 66, 72, 77, 89, 99, 104, 115, 124, 129, 131, 133, 142, 150, 156, 165, 167, 171, 178, 181, 185, 186, 188, 191, 192, 194, 197, 200, 202, 213, 218, 232, 241, 244, 246, 248, 257, 262, 274, 284, 293, 298, 302, 309, 312, 314, 316, 325, 333, 345, 355, 356, 358, 360, 361, 362, 364, 365]	[7, 8, 13, 17, 19, 21, 27, 32, 35, 38, 41, 43, 53, 57, 61, 63, 65, 71, 76, 88, 98, 103, 114, 123, 128, 131, 132, 141, 149, 155, 165, 166, 170, 177, 180, 185, 186, 188, 190, 192, 194, 197, 199, 201, 212, 217, 231, 240, 243, 246, 247, 256, 261, 273, 283, 292, 297, 301, 308, 311, 314, 315, 324, 332, 344, 354, 356, 357, 359, 361, 362, 364, 365, 366]	['However', ',', 'when', 'the', 'CNS', 'group', 'with', 'neurologic', 'disorders', 'and', 'the', 'CNS', 'group', 'with', 'psychiatric', 'disorders', 'were', 'separately', 'compared', 'with', 'SLE', 'patients', 'without', 'those', 'disorders', ',', 'the', 'levels', 'of', 'anti-APEX', 'nuclease', '1', 'antibodies', 'were', 'significantly', 'elevated', 'in', 'SLE', 'patients', 'with', 'psychiatric', 'disorders', 'compared', 'with', 'the', 'levels', 'in', 'SLE', 'patients', 'without', 'psychiatric', 'disorders', '(', 'p', '=', '0.037', ';']	[1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Six pairs of C-terminal isotopically labeled peptides containing U-13C6, U-15N4-arginine or U-13C6, U-15N2-lysine and corresponding unlabeled peptides derived from AP and BG were supplied by New England Peptide, LLC (Gardner, MA) at over 95% chemical purity according to amino acid analysis (shown in Table I).	[]	['Six', 'pairs', 'of', 'C', '-', 'terminal', 'is', '##oto', '##pical', '##ly', 'labeled', 'p', '##eptide', '##s', 'containing', 'U', '-', '13', '##C', '##6', ',', 'U', '-', '15', '##N', '##4', '-', 'a', '##rg', '##ini', '##ne', 'or', 'U', '-', '13', '##C', '##6', ',', 'U', '-', '15', '##N', '##2', '-', 'l', '##ys', '##ine', 'and', 'corresponding', 'un', '##la', '##bel', '##ed', 'p', '##eptide', '##s', 'derived', 'from', 'AP', 'and', 'B', '##G', 'were', 'supplied', 'by', 'New', 'England', 'P', '##eptide', ',', 'LLC', '(', 'Gardner', ',', 'MA', ')', 'at', 'over', '95', '%', 'chemical', 'purity', 'according', 'to', 'amino', 'acid', 'analysis', '(', 'shown', 'in', 'Table', 'I', ')', '.']	[0, 4, 10, 13, 14, 15, 24, 26, 29, 34, 37, 45, 46, 52, 54, 65, 66, 67, 69, 70, 71, 73, 74, 75, 77, 78, 79, 80, 81, 83, 86, 89, 92, 93, 94, 96, 97, 98, 100, 101, 102, 104, 105, 106, 107, 108, 110, 114, 118, 132, 134, 136, 139, 142, 143, 149, 151, 159, 164, 167, 171, 172, 174, 179, 188, 191, 195, 203, 204, 210, 212, 216, 217, 224, 226, 228, 230, 233, 238, 240, 242, 251, 258, 268, 271, 277, 282, 291, 292, 298, 301, 307, 308, 309]	[3, 9, 12, 14, 15, 23, 26, 29, 34, 36, 44, 46, 52, 53, 64, 66, 67, 69, 70, 71, 72, 74, 75, 77, 78, 79, 80, 81, 83, 86, 88, 91, 93, 94, 96, 97, 98, 99, 101, 102, 104, 105, 106, 107, 108, 110, 113, 117, 131, 134, 136, 139, 141, 143, 149, 150, 158, 163, 166, 170, 172, 173, 178, 187, 190, 194, 202, 204, 210, 211, 215, 217, 224, 225, 228, 229, 232, 237, 240, 241, 250, 257, 267, 270, 276, 281, 290, 292, 297, 300, 306, 308, 309, 310]	['Six', 'pairs', 'of', 'C-', 'terminal', 'isotopically', 'labeled', 'peptides', 'containing', 'U-13C6', ',', 'U-15N4-arginine', 'or', 'U-13C6', ',', 'U-15N2-lysine', 'and', 'corresponding', 'unlabeled', 'peptides', 'derived', 'from', 'AP', 'and', 'BG', 'were', 'supplied', 'by', 'New', 'England', 'Peptide', ',', 'LLC', '(', 'Gardner', ',', 'MA', ')', 'at', 'over', '95%', 'chemical', 'purity', 'according', 'to', 'amino', 'acid', 'analysis', '(', 'shown', 'in', 'Table', 'I', ')', '.']	[1, 1, 1, 2, 1, 4, 1, 3, 1, 5, 1, 10, 1, 5, 1, 9, 1, 1, 4, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the peptide-spike experiment (Study I), 11 synthetic peptides derived from seven proteins (bovine aprotinin, murine leptin, equine myoglobin, bovine myelin basic protein, human prostate specific antigen horseradish peroxidase, and human C-reactive protein) were spiked into digested human plasma (1 μg/μl) at concentrations ranging from 1 to 500 fmol/μl.	[]	['In', 'the', 'p', '##eptide', '-', 'spike', 'experiment', '(', 'Study', 'I', ')', ',', '11', 'synthetic', 'p', '##eptide', '##s', 'derived', 'from', 'seven', 'proteins', '(', 'b', '##ov', '##ine', 'a', '##p', '##rot', '##ini', '##n', ',', 'm', '##uri', '##ne', 'le', '##pt', '##in', ',', 'e', '##quin', '##e', 'my', '##og', '##lo', '##bin', ',', 'b', '##ov', '##ine', 'my', '##elin', 'basic', 'protein', ',', 'human', 'pro', '##state', 'specific', 'anti', '##gen', 'horse', '##rad', '##ish', 'per', '##ox', '##idas', '##e', ',', 'and', 'human', 'C', '-', 'reactive', 'protein', ')', 'were', 'spike', '##d', 'into', 'dig', '##ested', 'human', 'plasma', '(', '1', 'μ', '##g', '/', 'μ', '##l', ')', 'at', 'concentrations', 'ranging', 'from', '1', 'to', '500', 'f', '##mo', '##l', '/', 'μ', '##l', '.']	[0, 3, 7, 8, 14, 15, 21, 32, 33, 39, 40, 41, 43, 46, 56, 57, 63, 65, 73, 78, 84, 93, 94, 95, 97, 101, 102, 103, 106, 109, 110, 112, 113, 116, 119, 121, 123, 125, 127, 128, 132, 134, 136, 138, 140, 143, 145, 146, 148, 152, 154, 159, 165, 172, 174, 180, 183, 189, 198, 202, 206, 211, 214, 218, 221, 223, 227, 228, 230, 234, 240, 241, 242, 251, 258, 260, 265, 270, 272, 277, 280, 286, 292, 299, 300, 302, 303, 304, 305, 306, 307, 309, 312, 327, 335, 340, 342, 345, 349, 350, 352, 353, 354, 355, 356]	[2, 6, 8, 14, 15, 20, 31, 33, 38, 40, 41, 42, 45, 55, 57, 63, 64, 72, 77, 83, 92, 94, 95, 97, 100, 102, 103, 106, 109, 110, 111, 113, 116, 118, 121, 123, 125, 126, 128, 132, 133, 136, 138, 140, 143, 144, 146, 148, 151, 154, 158, 164, 172, 173, 179, 183, 188, 197, 202, 205, 211, 214, 217, 221, 223, 227, 228, 229, 233, 239, 241, 242, 250, 258, 259, 264, 270, 271, 276, 280, 285, 291, 298, 300, 301, 303, 304, 305, 306, 307, 308, 311, 326, 334, 339, 341, 344, 348, 350, 352, 353, 354, 355, 356, 357]	['In', 'the', 'peptide', '-', 'spike', 'experiment', '(', 'Study', 'I', ')', ',', '11', 'synthetic', 'peptides', 'derived', 'from', 'seven', 'proteins', '(', 'bovine', 'aprotinin', ',', 'murine', 'leptin', ',', 'equine', 'myoglobin', ',', 'bovine', 'myelin', 'basic', 'protein', ',', 'human', 'prostate', 'specific', 'antigen', 'horseradish', 'peroxidase', ',', 'and', 'human', 'C-reactive', 'protein', ')', 'were', 'spiked', 'into', 'digested', 'human', 'plasma', '(', '1', 'μg', '/', 'μl', ')', 'at', 'concentrations', 'ranging', 'from', '1', 'to', '500', 'fmol', '/', 'μl', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 5, 1, 3, 3, 1, 3, 4, 1, 3, 2, 1, 1, 1, 1, 2, 1, 2, 3, 4, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Case definitions included (i) acute liver injury defined as presenting symptoms suggestive of liver disorder (nausea, vomiting, abdominal pain and/or jaundice) referred to a specialist or admitted to hospital, and (ii) ALT >2× ULN or (iii) aspartate aminotransferase (AST), ALP and total bilirubin >2× ULN.	[('PMC3129430', 'M03000', 240, 266, 'aspartate aminotransferase')]	['Case', 'definitions', 'included', '(', 'i', ')', 'acute', 'liver', 'injury', 'defined', 'as', 'presenting', 'symptoms', 'suggest', '##ive', 'of', 'liver', 'disorder', '(', 'nausea', ',', 'vomit', '##ing', ',', 'abdominal', 'pain', 'and', '/', 'or', 'j', '##au', '##ndi', '##ce', ')', 'referred', 'to', 'a', 'specialist', 'or', 'admitted', 'to', 'hospital', ',', 'and', '(', 'ii', ')', 'AL', '##T', '>', '2', '##×', 'U', '##L', '##N', 'or', '(', 'ii', '##i', ')', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'AL', '##P', 'and', 'total', 'bi', '##li', '##ru', '##bin', '>', '2', '##×', 'U', '##L', '##N', '.']	[0, 5, 17, 26, 27, 28, 30, 36, 42, 49, 57, 60, 71, 80, 87, 91, 94, 100, 109, 110, 116, 118, 123, 126, 128, 138, 143, 146, 147, 150, 151, 153, 156, 158, 160, 169, 172, 174, 185, 188, 197, 200, 208, 210, 214, 215, 217, 219, 221, 223, 224, 225, 227, 228, 229, 231, 234, 235, 237, 238, 240, 242, 245, 250, 255, 258, 260, 263, 267, 268, 270, 271, 272, 274, 276, 278, 282, 288, 290, 292, 294, 298, 299, 300, 302, 303, 304, 305]	[4, 16, 25, 27, 28, 29, 35, 41, 48, 56, 59, 70, 79, 87, 90, 93, 99, 108, 110, 116, 117, 123, 126, 127, 137, 142, 146, 147, 149, 151, 153, 156, 158, 159, 168, 171, 173, 184, 187, 196, 199, 208, 209, 213, 215, 217, 218, 221, 222, 224, 225, 226, 228, 229, 230, 233, 235, 237, 238, 239, 242, 245, 249, 255, 258, 260, 263, 266, 268, 270, 271, 272, 273, 276, 277, 281, 287, 290, 292, 294, 297, 299, 300, 301, 303, 304, 305, 306]	['Case', 'definitions', 'included', '(i)', 'acute', 'liver', 'injury', 'defined', 'as', 'presenting', 'symptoms', 'suggestive', 'of', 'liver', 'disorder', '(', 'nausea', ',', 'vomiting', ',', 'abdominal', 'pain', 'and', '/', 'or', 'jaundice', ')', 'referred', 'to', 'a', 'specialist', 'or', 'admitted', 'to', 'hospital', ',', 'and', '(ii)', 'ALT', '>', '2×', 'ULN', 'or', '(iii)', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'ALP', 'and', 'total', 'bilirubin', '>', '2×', 'ULN', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 3, 1, 4, 3, 5, 1, 2, 1, 1, 2, 1, 1, 4, 1, 2, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We investigated the relationship between the top-associated HLA alleles and clinical features of AC-DILI, including age-at-onset, pattern of liver damage and disease severity as assessed by magnitude of transaminase or bilirubin elevation (Table S5).	[('PMC3129430', 'R10000', 203, 215, 'transaminase')]	['We', 'investigated', 'the', 'relationship', 'between', 'the', 'top', '-', 'associated', 'H', '##LA', 'all', '##ele', '##s', 'and', 'clinical', 'features', 'of', 'AC', '-', 'D', '##IL', '##I', ',', 'including', 'age', '-', 'at', '-', 'onset', ',', 'pattern', 'of', 'liver', 'damage', 'and', 'disease', 'severity', 'as', 'assessed', 'by', 'magnitude', 'of', 'trans', '##ami', '##nas', '##e', 'or', 'bi', '##li', '##ru', '##bin', 'elevation', '(', 'Table', 'S', '##5', ')', '.']	[0, 3, 16, 20, 33, 41, 45, 48, 49, 60, 61, 64, 67, 70, 72, 76, 85, 94, 97, 99, 100, 101, 103, 104, 106, 116, 119, 120, 122, 123, 128, 130, 138, 141, 147, 154, 158, 166, 175, 178, 187, 190, 200, 203, 208, 211, 214, 216, 219, 221, 223, 225, 229, 239, 240, 246, 247, 248, 249]	[2, 15, 19, 32, 40, 44, 48, 49, 59, 61, 63, 67, 70, 71, 75, 84, 93, 96, 99, 100, 101, 103, 104, 105, 115, 119, 120, 122, 123, 128, 129, 137, 140, 146, 153, 157, 165, 174, 177, 186, 189, 199, 202, 208, 211, 214, 215, 218, 221, 223, 225, 228, 238, 240, 245, 247, 248, 249, 250]	['We', 'investigated', 'the', 'relationship', 'between', 'the', 'top', '-', 'associated', 'HLA', 'alleles', 'and', 'clinical', 'features', 'of', 'AC-DILI', ',', 'including', 'age', '-', 'at', '-', 'onset', ',', 'pattern', 'of', 'liver', 'damage', 'and', 'disease', 'severity', 'as', 'assessed', 'by', 'magnitude', 'of', 'transaminase', 'or', 'bilirubin', 'elevation', '(', 'Table', 'S5', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
First strand cDNA was prepared from total RNA from human spinal cord, skeletal muscle, brain, and retina (Clontech, Mountain View, CA) with AffinityScript reverse transcriptase (Stratagene, La Jolla, CA).	[('PMC3175321', 'M11000', 155, 176, 'reverse transcriptase')]	['First', 'strand', 'c', '##D', '##NA', 'was', 'prepared', 'from', 'total', 'RNA', 'from', 'human', 'spinal', 'cord', ',', 'skeletal', 'muscle', ',', 'brain', ',', 'and', 're', '##tina', '(', 'C', '##lon', '##tech', ',', 'Mountain', 'View', ',', 'CA', ')', 'with', 'A', '##ffin', '##ity', '##Script', 'reverse', 'trans', '##cript', '##ase', '(', 'St', '##rata', '##gene', ',', 'La', 'Jo', '##lla', ',', 'CA', ')', '.']	[0, 6, 13, 14, 15, 18, 22, 31, 36, 42, 46, 51, 57, 64, 68, 70, 79, 85, 87, 92, 94, 98, 100, 105, 106, 107, 110, 114, 116, 125, 129, 131, 133, 135, 140, 141, 145, 148, 155, 163, 168, 173, 177, 178, 180, 184, 188, 190, 193, 195, 198, 200, 202, 203]	[5, 12, 14, 15, 17, 21, 30, 35, 41, 45, 50, 56, 63, 68, 69, 78, 85, 86, 92, 93, 97, 100, 104, 106, 107, 110, 114, 115, 124, 129, 130, 133, 134, 139, 141, 145, 148, 154, 162, 168, 173, 176, 178, 180, 184, 188, 189, 192, 195, 198, 199, 202, 203, 204]	['First', 'strand', 'cDNA', 'was', 'prepared', 'from', 'total', 'RNA', 'from', 'human', 'spinal', 'cord', ',', 'skeletal', 'muscle', ',', 'brain', ',', 'and', 'retina', '(', 'Clontech', ',', 'Mountain', 'View', ',', 'CA', ')', 'with', 'AffinityScript', 'reverse', 'transcriptase', '(', 'Stratagene', ',', 'La', 'Jolla', ',', 'CA', ')', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nucleoside reverse transcriptase inhibitors (NRTI) require intracellular phosphorylation, which involves multiple enzymatic steps to inhibit the human immunodeficiency virus type 1 (HIV-1).	[('PMC3182105', 'A00000', 11, 32, 'reverse transcriptase')]	['N', '##uc', '##leo', '##side', 'reverse', 'trans', '##cript', '##ase', 'inhibitor', '##s', '(', 'N', '##RT', '##I', ')', 'require', 'in', '##tra', '##cellular', 'p', '##hos', '##ph', '##ory', '##lation', ',', 'which', 'involves', 'multiple', 'en', '##zy', '##matic', 'steps', 'to', 'in', '##hibit', 'the', 'human', 'im', '##mu', '##no', '##de', '##ficiency', 'virus', 'type', '1', '(', 'HIV', '-', '1', ')', '.']	[0, 1, 3, 6, 11, 19, 24, 29, 33, 42, 44, 45, 46, 48, 49, 51, 59, 61, 64, 73, 74, 77, 79, 82, 88, 90, 96, 105, 114, 116, 118, 124, 130, 133, 135, 141, 145, 151, 153, 155, 157, 159, 168, 174, 179, 181, 182, 185, 186, 187, 188]	[1, 3, 6, 10, 18, 24, 29, 32, 42, 43, 45, 46, 48, 49, 50, 58, 61, 64, 72, 74, 77, 79, 82, 88, 89, 95, 104, 113, 116, 118, 123, 129, 132, 135, 140, 144, 150, 153, 155, 157, 159, 167, 173, 178, 180, 182, 185, 186, 187, 188, 189]	['Nucleoside', 'reverse', 'transcriptase', 'inhibitors', '(', 'NRTI', ')', 'require', 'intracellular', 'phosphorylation', ',', 'which', 'involves', 'multiple', 'enzymatic', 'steps', 'to', 'inhibit', 'the', 'human', 'immunodeficiency', 'virus', 'type', '1', '(', 'HIV-1', ')', '.']	[4, 1, 3, 2, 1, 3, 1, 1, 3, 5, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NRTI-triphosphates (NRTI-TP) compete with endogenous 2′-deoxyribonucleosides-5′-triphosphates (dNTP) for incorporation by the HIV-1 reverse transcriptase (RT).	[('PMC3182105', 'A00001', 132, 153, 'reverse transcriptase')]	['N', '##RT', '##I', '-', 'trip', '##hos', '##phate', '##s', '(', 'N', '##RT', '##I', '-', 'T', '##P', ')', 'compete', 'with', 'end', '##ogen', '##ous', '2', '′', '-', 'de', '##ox', '##yr', '##ib', '##on', '##uc', '##leo', '##side', '##s', '-', '5', '′', '-', 'trip', '##hos', '##phate', '##s', '(', 'd', '##NT', '##P', ')', 'for', 'incorporation', 'by', 'the', 'HIV', '-', '1', 'reverse', 'trans', '##cript', '##ase', '(', 'R', '##T', ')', '.']	[0, 1, 3, 4, 5, 9, 12, 17, 19, 20, 21, 23, 24, 25, 26, 27, 29, 37, 42, 45, 49, 53, 54, 55, 56, 58, 60, 62, 64, 66, 68, 71, 75, 76, 77, 78, 79, 80, 84, 87, 92, 94, 95, 96, 98, 99, 101, 105, 119, 122, 126, 129, 130, 132, 140, 145, 150, 154, 155, 156, 157, 158]	[1, 3, 4, 5, 9, 12, 17, 18, 20, 21, 23, 24, 25, 26, 27, 28, 36, 41, 45, 49, 52, 54, 55, 56, 58, 60, 62, 64, 66, 68, 71, 75, 76, 77, 78, 79, 80, 84, 87, 92, 93, 95, 96, 98, 99, 100, 104, 118, 121, 125, 129, 130, 131, 139, 145, 150, 153, 155, 156, 157, 158, 159]	['NRTI-triphosphates', '(', 'NRTI-TP', ')', 'compete', 'with', 'endogenous', '2′-deoxyribonucleosides-5′-triphosphates', '(', 'dNTP', ')', 'for', 'incorporation', 'by', 'the', 'HIV-1', 'reverse', 'transcriptase', '(', 'RT', ')', '.']	[8, 1, 6, 1, 1, 1, 3, 20, 1, 3, 1, 1, 1, 1, 1, 3, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Nucleoside reverse transcriptase inhibitors (NRTI) remain key components of highly active antiretroviral therapy (HAART) for first line therapy for the treatment of human immunodeficiency virus type 1 (HIV-1).	[('PMC3182105', 'I00000', 11, 32, 'reverse transcriptase')]	['N', '##uc', '##leo', '##side', 'reverse', 'trans', '##cript', '##ase', 'inhibitor', '##s', '(', 'N', '##RT', '##I', ')', 'remain', 'key', 'components', 'of', 'highly', 'active', 'anti', '##ret', '##rov', '##ira', '##l', 'therapy', '(', 'H', '##AA', '##RT', ')', 'for', 'first', 'line', 'therapy', 'for', 'the', 'treatment', 'of', 'human', 'im', '##mu', '##no', '##de', '##ficiency', 'virus', 'type', '1', '(', 'HIV', '-', '1', ')', '.']	[0, 1, 3, 6, 11, 19, 24, 29, 33, 42, 44, 45, 46, 48, 49, 51, 58, 62, 73, 76, 83, 90, 94, 97, 100, 103, 105, 113, 114, 115, 117, 119, 121, 125, 131, 136, 144, 148, 152, 162, 165, 171, 173, 175, 177, 179, 188, 194, 199, 201, 202, 205, 206, 207, 208]	[1, 3, 6, 10, 18, 24, 29, 32, 42, 43, 45, 46, 48, 49, 50, 57, 61, 72, 75, 82, 89, 94, 97, 100, 103, 104, 112, 114, 115, 117, 119, 120, 124, 130, 135, 143, 147, 151, 161, 164, 170, 173, 175, 177, 179, 187, 193, 198, 200, 202, 205, 206, 207, 208, 209]	['Nucleoside', 'reverse', 'transcriptase', 'inhibitors', '(', 'NRTI', ')', 'remain', 'key', 'components', 'of', 'highly', 'active', 'antiretroviral', 'therapy', '(', 'HAART', ')', 'for', 'first', 'line', 'therapy', 'for', 'the', 'treatment', 'of', 'human', 'immunodeficiency', 'virus', 'type', '1', '(', 'HIV-1', ')', '.']	[4, 1, 3, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Understanding their uptake and metabolism in human peripheral blood mononuclear (PBM) cells and macrophages can provide insights on their potency as antiviral agents.1-4 Although plasma levels of nucleosides are important in terms of maximum concentration (Cmax), which represents the loading dose, it is well established that the triphosphate (TP) of the NRTI, which interacts with the viral polymerase, is the active metabolite and more relevant for this class of drugs.	[('PMC3182105', 'I00001', 393, 403, 'polymerase')]	['Understanding', 'their', 'up', '##take', 'and', 'metabolism', 'in', 'human', 'peripheral', 'blood', 'mon', '##on', '##uc', '##lea', '##r', '(', 'P', '##BM', ')', 'cells', 'and', 'mac', '##rop', '##hage', '##s', 'can', 'provide', 'insights', 'on', 'their', 'pot', '##ency', 'as', 'anti', '##vir', '##al', 'agents', '.', '1', '-', '4', 'Although', 'plasma', 'levels', 'of', 'n', '##uc', '##leo', '##side', '##s', 'are', 'important', 'in', 'terms', 'of', 'maximum', 'concentration', '(', 'C', '##max', ')', ',', 'which', 'represents', 'the', 'loading', 'dose', ',', 'it', 'is', 'well', 'established', 'that', 'the', 'trip', '##hos', '##phate', '(', 'T', '##P', ')', 'of', 'the', 'N', '##RT', '##I', ',', 'which', 'interact', '##s', 'with', 'the', 'viral', 'polymer', '##ase', ',', 'is', 'the', 'active', 'meta', '##bol', '##ite', 'and', 'more', 'relevant', 'for', 'this', 'class', 'of', 'drugs', '.']	[0, 14, 20, 22, 27, 31, 42, 45, 51, 62, 68, 71, 73, 75, 78, 80, 81, 82, 84, 86, 92, 96, 99, 102, 106, 108, 112, 120, 129, 132, 138, 141, 146, 149, 153, 156, 159, 165, 166, 167, 168, 170, 179, 186, 193, 196, 197, 199, 202, 206, 208, 212, 222, 225, 231, 234, 242, 256, 257, 258, 261, 262, 264, 270, 281, 285, 293, 297, 299, 302, 305, 310, 322, 327, 331, 335, 338, 344, 345, 346, 347, 349, 352, 356, 357, 359, 360, 362, 368, 376, 378, 383, 387, 393, 400, 403, 405, 408, 412, 419, 423, 426, 430, 434, 439, 448, 452, 457, 463, 466, 471]	[13, 19, 22, 26, 30, 41, 44, 50, 61, 67, 71, 73, 75, 78, 79, 81, 82, 84, 85, 91, 95, 99, 102, 106, 107, 111, 119, 128, 131, 137, 141, 145, 148, 153, 156, 158, 165, 166, 167, 168, 169, 178, 185, 192, 195, 197, 199, 202, 206, 207, 211, 221, 224, 230, 233, 241, 255, 257, 258, 261, 262, 263, 269, 280, 284, 292, 297, 298, 301, 304, 309, 321, 326, 330, 335, 338, 343, 345, 346, 347, 348, 351, 355, 357, 359, 360, 361, 367, 376, 377, 382, 386, 392, 400, 403, 404, 407, 411, 418, 423, 426, 429, 433, 438, 447, 451, 456, 462, 465, 471, 472]	['Understanding', 'their', 'uptake', 'and', 'metabolism', 'in', 'human', 'peripheral', 'blood', 'mononuclear', '(', 'PBM', ')', 'cells', 'and', 'macrophages', 'can', 'provide', 'insights', 'on', 'their', 'potency', 'as', 'antiviral', 'agents.1-4', 'Although', 'plasma', 'levels', 'of', 'nucleosides', 'are', 'important', 'in', 'terms', 'of', 'maximum', 'concentration', '(', 'Cmax', ')', ',', 'which', 'represents', 'the', 'loading', 'dose', ',', 'it', 'is', 'well', 'established', 'that', 'the', 'triphosphate', '(', 'TP', ')', 'of', 'the', 'NRTI', ',', 'which', 'interacts', 'with', 'the', 'viral', 'polymerase', ',', 'is', 'the', 'active', 'metabolite', 'and', 'more', 'relevant', 'for', 'this', 'class', 'of', 'drugs', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 3, 5, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The increase in ChoCC has been associated with progressive alteration of membrane choline phospholipid metabolism during malignant transformation.62 It has been reported that the activity of phosphatidylcholine-specific phospholipase C (PLC) and phospholipase D (PLD), the enzymes responsible for the degradation of phosphatidylcholine was higher in human mammary epithelial and epithelial ovarian carcinoma cell lines.62, 63 These findings suggest that both biosynthetic and catabolic pathways of the phosphatidylcholine cycle contribute to the accumulation of ChoCC in tumor tissues.	[]	['The', 'increase', 'in', 'Cho', '##CC', 'has', 'been', 'associated', 'with', 'progressive', 'alter', '##ation', 'of', 'membrane', 'ch', '##olin', '##e', 'p', '##hos', '##ph', '##oli', '##pid', 'metabolism', 'during', 'ma', '##li', '##gnant', 'transformation', '.', '62', 'It', 'has', 'been', 'reported', 'that', 'the', 'activity', 'of', 'p', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##line', '-', 'specific', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'C', '(', 'P', '##LC', ')', 'and', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'D', '(', 'P', '##LD', ')', ',', 'the', 'enzymes', 'responsible', 'for', 'the', 'degradation', 'of', 'p', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##line', 'was', 'higher', 'in', 'human', 'ma', '##mma', '##ry', 'e', '##pit', '##hel', '##ial', 'and', 'e', '##pit', '##hel', '##ial', 'o', '##var', '##ian', 'car', '##cin', '##oma', 'cell', 'lines', '.', '62', ',', '63', 'These', 'findings', 'suggest', 'that', 'both', 'bio', '##sy', '##nt', '##hetic', 'and', 'cat', '##ab', '##olic', 'pathways', 'of', 'the', 'p', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##line', 'cycle', 'contribute', 'to', 'the', 'accumulation', 'of', 'Cho', '##CC', 'in', 'tumor', 'tissues', '.']	[0, 4, 13, 16, 19, 22, 26, 31, 42, 47, 59, 64, 70, 73, 82, 84, 88, 90, 91, 94, 96, 99, 103, 114, 121, 123, 125, 131, 145, 146, 149, 152, 156, 161, 170, 175, 179, 188, 191, 192, 195, 198, 200, 202, 203, 206, 210, 211, 220, 221, 224, 226, 229, 232, 234, 236, 237, 238, 240, 242, 246, 247, 250, 252, 255, 258, 260, 262, 263, 264, 266, 267, 269, 273, 281, 293, 297, 301, 313, 316, 317, 320, 323, 325, 327, 328, 331, 336, 340, 347, 350, 356, 358, 361, 364, 365, 368, 371, 375, 379, 380, 383, 386, 390, 391, 394, 398, 401, 404, 408, 413, 418, 419, 421, 423, 426, 432, 441, 449, 454, 459, 462, 464, 466, 472, 476, 479, 481, 486, 495, 498, 502, 503, 506, 509, 511, 513, 514, 517, 522, 528, 539, 542, 546, 559, 562, 565, 568, 571, 577, 584]	[3, 12, 15, 19, 21, 25, 30, 41, 46, 58, 64, 69, 72, 81, 84, 88, 89, 91, 94, 96, 99, 102, 113, 120, 123, 125, 130, 145, 146, 148, 151, 155, 160, 169, 174, 178, 187, 190, 192, 195, 198, 200, 202, 203, 206, 210, 211, 219, 221, 224, 226, 229, 232, 233, 235, 237, 238, 240, 241, 245, 247, 250, 252, 255, 258, 259, 261, 263, 264, 266, 267, 268, 272, 280, 292, 296, 300, 312, 315, 317, 320, 323, 325, 327, 328, 331, 335, 339, 346, 349, 355, 358, 361, 363, 365, 368, 371, 374, 378, 380, 383, 386, 389, 391, 394, 397, 401, 404, 407, 412, 418, 419, 421, 422, 425, 431, 440, 448, 453, 458, 462, 464, 466, 471, 475, 479, 481, 485, 494, 497, 501, 503, 506, 509, 511, 513, 514, 517, 521, 527, 538, 541, 545, 558, 561, 565, 567, 570, 576, 584, 585]	['The', 'increase', 'in', 'ChoCC', 'has', 'been', 'associated', 'with', 'progressive', 'alteration', 'of', 'membrane', 'choline', 'phospholipid', 'metabolism', 'during', 'malignant', 'transformation.62', 'It', 'has', 'been', 'reported', 'that', 'the', 'activity', 'of', 'phosphatidylcholine', '-', 'specific', 'phospholipase', 'C', '(', 'PLC', ')', 'and', 'phospholipase', 'D', '(', 'PLD', ')', ',', 'the', 'enzymes', 'responsible', 'for', 'the', 'degradation', 'of', 'phosphatidylcholine', 'was', 'higher', 'in', 'human', 'mammary', 'epithelial', 'and', 'epithelial', 'ovarian', 'carcinoma', 'cell', 'lines.62', ',', '63', 'These', 'findings', 'suggest', 'that', 'both', 'biosynthetic', 'and', 'catabolic', 'pathways', 'of', 'the', 'phosphatidylcholine', 'cycle', 'contribute', 'to', 'the', 'accumulation', 'of', 'ChoCC', 'in', 'tumor', 'tissues', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 5, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 6, 1, 1, 2, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 1, 1, 3, 4, 1, 4, 3, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 8, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Due to a strong association of these phospholipases (choline kinase, PLC, PLD) in malignant transformation of most of the human cancers, these enzymes may provide molecular targets for anticancer chemotherapies.64 The alteration in the levels of ChoCC compounds were detected in-vivo in breast cancer patients using quantitative MRS techniques and used for the diagnosis/prognosis of breast cancer.65	[]	['Due', 'to', 'a', 'strong', 'association', 'of', 'these', 'p', '##hos', '##ph', '##oli', '##pas', '##es', '(', 'ch', '##olin', '##e', 'kinase', ',', 'P', '##LC', ',', 'P', '##LD', ')', 'in', 'ma', '##li', '##gnant', 'transformation', 'of', 'most', 'of', 'the', 'human', 'cancer', '##s', ',', 'these', 'enzymes', 'may', 'provide', 'molecular', 'targets', 'for', 'anti', '##can', '##cer', 'ch', '##em', '##oth', '##era', '##pies', '.', '64', 'The', 'alter', '##ation', 'in', 'the', 'levels', 'of', 'Cho', '##CC', 'compounds', 'were', 'detected', 'in', '-', 'v', '##ivo', 'in', 'breast', 'cancer', 'patients', 'using', 'quantitative', 'MR', '##S', 'techniques', 'and', 'used', 'for', 'the', 'diagnosis', '/', 'pro', '##gno', '##sis', 'of', 'breast', 'cancer', '.', '65']	[0, 4, 7, 9, 16, 28, 31, 37, 38, 41, 43, 46, 49, 52, 53, 55, 59, 61, 67, 69, 70, 72, 74, 75, 77, 79, 82, 84, 86, 92, 107, 110, 115, 118, 122, 128, 134, 135, 137, 143, 151, 155, 163, 173, 181, 185, 189, 192, 196, 198, 200, 203, 206, 210, 211, 214, 218, 223, 229, 232, 236, 243, 246, 249, 252, 262, 267, 276, 278, 279, 280, 284, 287, 294, 301, 310, 316, 329, 331, 333, 344, 348, 353, 357, 361, 370, 371, 374, 377, 381, 384, 391, 397, 398]	[3, 6, 8, 15, 27, 30, 36, 38, 41, 43, 46, 49, 51, 53, 55, 59, 60, 67, 68, 70, 72, 73, 75, 77, 78, 81, 84, 86, 91, 106, 109, 114, 117, 121, 127, 134, 135, 136, 142, 150, 154, 162, 172, 180, 184, 189, 192, 195, 198, 200, 203, 206, 210, 211, 213, 217, 223, 228, 231, 235, 242, 245, 249, 251, 261, 266, 275, 278, 279, 280, 283, 286, 293, 300, 309, 315, 328, 331, 332, 343, 347, 352, 356, 360, 370, 371, 374, 377, 380, 383, 390, 397, 398, 400]	['Due', 'to', 'a', 'strong', 'association', 'of', 'these', 'phospholipases', '(', 'choline', 'kinase', ',', 'PLC', ',', 'PLD', ')', 'in', 'malignant', 'transformation', 'of', 'most', 'of', 'the', 'human', 'cancers', ',', 'these', 'enzymes', 'may', 'provide', 'molecular', 'targets', 'for', 'anticancer', 'chemotherapies.64', 'The', 'alteration', 'in', 'the', 'levels', 'of', 'ChoCC', 'compounds', 'were', 'detected', 'in', '-', 'vivo', 'in', 'breast', 'cancer', 'patients', 'using', 'quantitative', 'MRS', 'techniques', 'and', 'used', 'for', 'the', 'diagnosis', '/', 'prognosis', 'of', 'breast', 'cancer.65']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 3, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 7, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SNP rs10811661 near cyclin-dependent kinase inhibitors CDKN2A and CDKN2B showed modest evidence for T2D association in our stage 1 + 2 sample (OR = 1.20, P = 0.0022) (Table 1 and table S5) and showed genome-wide significance in the all-data meta-analysis (OR = 1.20, P = 7.8 × 10−15).	[('PMC3214617', 'I10000', 20, 43, 'cyclin-dependent kinase')]	['S', '##NP', 'r', '##s', '##10', '##8', '##11', '##6', '##6', '##1', 'near', 'c', '##y', '##c', '##lin', '-', 'dependent', 'kinase', 'inhibitor', '##s', 'CD', '##K', '##N', '##2', '##A', 'and', 'CD', '##K', '##N', '##2', '##B', 'showed', 'modest', 'evidence', 'for', 'T', '##2', '##D', 'association', 'in', 'our', 'stage', '1', '+', '2', 'sample', '(', 'OR', '=', '1', '.', '20', ',', 'P', '=', '0', '.', '00', '##22', ')', '(', 'Table', '1', 'and', 'table', 'S', '##5', ')', 'and', 'showed', 'genome', '-', 'wide', 'significance', 'in', 'the', 'all', '-', 'data', 'meta', '-', 'analysis', '(', 'OR', '=', '1', '.', '20', ',', 'P', '=', '7', '.', '8', '×', '10', '##−', '##15', ')', '.']	[0, 1, 4, 5, 6, 8, 9, 11, 12, 13, 15, 20, 21, 22, 23, 26, 27, 37, 44, 53, 55, 57, 58, 59, 60, 62, 66, 68, 69, 70, 71, 73, 80, 87, 96, 100, 101, 102, 104, 116, 119, 123, 129, 131, 133, 135, 142, 143, 146, 148, 149, 150, 152, 154, 156, 158, 159, 160, 162, 164, 166, 167, 173, 175, 179, 185, 186, 187, 189, 193, 200, 206, 207, 212, 225, 228, 232, 235, 236, 241, 245, 246, 255, 256, 259, 261, 262, 263, 265, 267, 269, 271, 272, 273, 275, 277, 279, 280, 282, 283]	[1, 3, 5, 6, 8, 9, 11, 12, 13, 14, 19, 21, 22, 23, 26, 27, 36, 43, 53, 54, 57, 58, 59, 60, 61, 65, 68, 69, 70, 71, 72, 79, 86, 95, 99, 101, 102, 103, 115, 118, 122, 128, 130, 132, 134, 141, 143, 145, 147, 149, 150, 152, 153, 155, 157, 159, 160, 162, 164, 165, 167, 172, 174, 178, 184, 186, 187, 188, 192, 199, 206, 207, 211, 224, 227, 231, 235, 236, 240, 245, 246, 254, 256, 258, 260, 262, 263, 265, 266, 268, 270, 272, 273, 274, 276, 279, 280, 282, 283, 284]	['SNP', 'rs10811661', 'near', 'cyclin', '-', 'dependent', 'kinase', 'inhibitors', 'CDKN2A', 'and', 'CDKN2B', 'showed', 'modest', 'evidence', 'for', 'T2D', 'association', 'in', 'our', 'stage', '1', '+', '2', 'sample', '(', 'OR', '=', '1.20', ',', 'P', '=', '0.0022', ')', '(', 'Table', '1', 'and', 'table', 'S5', ')', 'and', 'showed', 'genome', '-', 'wide', 'significance', 'in', 'the', 'all', '-', 'data', 'meta-', 'analysis', '(', 'OR', '=', '1.20', ',', 'P', '=', '7.8', '×', '10−15', ')', '.']	[2, 8, 1, 4, 1, 1, 1, 2, 5, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to assess the prevalence of prophages in H. pylori, we performed a PCR screen for the integrase gene and found this gene in a surprisingly high proportion of screened isolates (21.4%, 73/341).	[('PMC3221604', 'D04000', 95, 104, 'integrase')]	['In', 'order', 'to', 'assess', 'the', 'prevalence', 'of', 'prop', '##hage', '##s', 'in', 'H', '.', 'p', '##yl', '##ori', ',', 'we', 'performed', 'a', 'PC', '##R', 'screen', 'for', 'the', 'in', '##te', '##gra', '##se', 'gene', 'and', 'found', 'this', 'gene', 'in', 'a', 'surprisingly', 'high', 'proportion', 'of', 'screened', 'is', '##olate', '##s', '(', '21', '.', '4', '%', ',', '73', '/', '34', '##1', ')', '.']	[0, 3, 9, 12, 19, 23, 34, 37, 41, 45, 47, 50, 51, 53, 54, 56, 59, 61, 64, 74, 76, 78, 80, 87, 91, 95, 97, 99, 102, 105, 110, 114, 120, 125, 130, 133, 135, 148, 153, 164, 167, 176, 178, 183, 185, 186, 188, 189, 190, 191, 193, 195, 196, 198, 199, 200]	[2, 8, 11, 18, 22, 33, 36, 41, 45, 46, 49, 51, 52, 54, 56, 59, 60, 63, 73, 75, 78, 79, 86, 90, 94, 97, 99, 102, 104, 109, 113, 119, 124, 129, 132, 134, 147, 152, 163, 166, 175, 178, 183, 184, 186, 188, 189, 190, 191, 192, 195, 196, 198, 199, 200, 201]	['In', 'order', 'to', 'assess', 'the', 'prevalence', 'of', 'prophages', 'in', 'H', '.', 'pylori', ',', 'we', 'performed', 'a', 'PCR', 'screen', 'for', 'the', 'integrase', 'gene', 'and', 'found', 'this', 'gene', 'in', 'a', 'surprisingly', 'high', 'proportion', 'of', 'screened', 'isolates', '(', '21.4%', ',', '73', '/', '341', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It is possible that they shape the genome at least in terms of the diversity of strains found worldwide as well as contributing to virulence evolution.	[]	['It', 'is', 'possible', 'that', 'they', 'shape', 'the', 'genome', 'at', 'least', 'in', 'terms', 'of', 'the', 'diversity', 'of', 'strains', 'found', 'worldwide', 'as', 'well', 'as', 'contributing', 'to', 'v', '##ir', '##ule', '##nce', 'evolution', '.']	[0, 3, 6, 15, 20, 25, 31, 35, 42, 45, 51, 54, 60, 63, 67, 77, 80, 88, 94, 104, 107, 112, 115, 128, 131, 132, 134, 137, 141, 150]	[2, 5, 14, 19, 24, 30, 34, 41, 44, 50, 53, 59, 62, 66, 76, 79, 87, 93, 103, 106, 111, 114, 127, 130, 132, 134, 137, 140, 150, 151]	['It', 'is', 'possible', 'that', 'they', 'shape', 'the', 'genome', 'at', 'least', 'in', 'terms', 'of', 'the', 'diversity', 'of', 'strains', 'found', 'worldwide', 'as', 'well', 'as', 'contributing', 'to', 'virulence', 'evolution', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genomic DNA from the B45 strain was extracted from cultures originating from a single colony, by using a commercial kit (Qiagen SA, Courtaboeuf, France) including an RNase step.	[('PMC3221604', 'M02000', 166, 171, 'RNase')]	['Gen', '##omi', '##c', 'DNA', 'from', 'the', 'B', '##45', 'strain', 'was', 'extracted', 'from', 'cultures', 'originating', 'from', 'a', 'single', 'colony', ',', 'by', 'using', 'a', 'commercial', 'kit', '(', 'Qi', '##age', '##n', 'SA', ',', 'Court', '##ab', '##oe', '##uf', ',', 'France', ')', 'including', 'an', 'R', '##N', '##ase', 'step', '.']	[0, 3, 6, 8, 12, 17, 21, 22, 25, 32, 36, 46, 51, 60, 72, 77, 79, 86, 92, 94, 97, 103, 105, 116, 120, 121, 123, 126, 128, 130, 132, 137, 139, 141, 143, 145, 151, 153, 163, 166, 167, 168, 172, 176]	[3, 6, 7, 11, 16, 20, 22, 24, 31, 35, 45, 50, 59, 71, 76, 78, 85, 92, 93, 96, 102, 104, 115, 119, 121, 123, 126, 127, 130, 131, 137, 139, 141, 143, 144, 151, 152, 162, 165, 167, 168, 171, 176, 177]	['Genomic', 'DNA', 'from', 'the', 'B45', 'strain', 'was', 'extracted', 'from', 'cultures', 'originating', 'from', 'a', 'single', 'colony', ',', 'by', 'using', 'a', 'commercial', 'kit', '(', 'Qiagen', 'SA', ',', 'Courtaboeuf', ',', 'France', ')', 'including', 'an', 'RNase', 'step', '.']	[3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
To identify the prevalence of prophage sequences in H. pylori strains, a PCR screening strategy was used with degenerated primers F1, AAGYTTTTTAGMGTTTTGYG, and R1, CGCCCTGGCTTAGCATC, designed using Primer 3 (http://frodo.wi.mit.edu/primer3/) on the aligned integrase sequences of B38 (HELPY_1521), B45, and H. acinonychis strain Sheeba (Hac_1606) obtained using multiple sequence alignment with hierarchical clustering (71).	[('PMC3221604', 'M13000', 257, 266, 'integrase')]	['To', 'identify', 'the', 'prevalence', 'of', 'prop', '##hage', 'sequences', 'in', 'H', '.', 'p', '##yl', '##ori', 'strains', ',', 'a', 'PC', '##R', 'screening', 'strategy', 'was', 'used', 'with', 'de', '##generate', '##d', 'prime', '##rs', 'F1', ',', 'AA', '##G', '##Y', '##TT', '##TT', '##TA', '##GM', '##G', '##TT', '##TT', '##G', '##Y', '##G', ',', 'and', 'R', '##1', ',', 'C', '##GC', '##CC', '##T', '##G', '##GC', '##TT', '##AG', '##CA', '##TC', ',', 'designed', 'using', 'Prime', '##r', '3', '(', 'http', ':', '/', '/', 'f', '##rod', '##o', '.', 'w', '##i', '.', 'mit', '.', 'ed', '##u', '/', 'prime', '##r', '##3', '/', ')', 'on', 'the', 'aligned', 'in', '##te', '##gra', '##se', 'sequences', 'of', 'B', '##38', '(', 'H', '##EL', '##P', '##Y', '_', '152', '##1', ')', ',', 'B', '##45', ',', 'and', 'H', '.', 'a', '##cin', '##ony', '##chi', '##s', 'strain', 'She', '##eb', '##a', '(', 'Ha', '##c', '_', '160', '##6', ')', 'obtained', 'using', 'multiple', 'sequence', 'alignment', 'with', 'hi', '##era', '##rch', '##ical', 'cluster', '##ing', '(', '71', ')', '.']	[0, 3, 12, 16, 27, 30, 34, 39, 49, 52, 53, 55, 56, 58, 62, 69, 71, 73, 75, 77, 87, 96, 100, 105, 110, 112, 120, 122, 127, 130, 132, 134, 136, 137, 138, 140, 142, 144, 146, 147, 149, 151, 152, 153, 154, 156, 160, 161, 162, 164, 165, 167, 169, 170, 171, 173, 175, 177, 179, 181, 183, 192, 198, 203, 205, 207, 208, 212, 213, 214, 215, 216, 219, 220, 221, 222, 223, 224, 227, 228, 230, 231, 232, 237, 238, 239, 240, 242, 245, 249, 257, 259, 261, 264, 267, 277, 280, 281, 284, 285, 286, 288, 289, 290, 291, 294, 295, 296, 298, 299, 301, 303, 307, 308, 310, 311, 314, 317, 320, 322, 329, 332, 334, 336, 337, 339, 340, 341, 344, 345, 347, 356, 362, 371, 380, 390, 395, 397, 400, 403, 408, 415, 419, 420, 422, 423]	[2, 11, 15, 26, 29, 34, 38, 48, 51, 53, 54, 56, 58, 61, 69, 70, 72, 75, 76, 86, 95, 99, 104, 109, 112, 120, 121, 127, 129, 132, 133, 136, 137, 138, 140, 142, 144, 146, 147, 149, 151, 152, 153, 154, 155, 159, 161, 162, 163, 165, 167, 169, 170, 171, 173, 175, 177, 179, 181, 182, 191, 197, 203, 204, 206, 208, 212, 213, 214, 215, 216, 219, 220, 221, 222, 223, 224, 227, 228, 230, 231, 232, 237, 238, 239, 240, 241, 244, 248, 256, 259, 261, 264, 266, 276, 279, 281, 283, 285, 286, 288, 289, 290, 291, 294, 295, 296, 297, 299, 301, 302, 306, 308, 309, 311, 314, 317, 320, 321, 328, 332, 334, 335, 337, 339, 340, 341, 344, 345, 346, 355, 361, 370, 379, 389, 394, 397, 400, 403, 407, 415, 418, 420, 422, 423, 424]	['To', 'identify', 'the', 'prevalence', 'of', 'prophage', 'sequences', 'in', 'H', '.', 'pylori', 'strains', ',', 'a', 'PCR', 'screening', 'strategy', 'was', 'used', 'with', 'degenerated', 'primers', 'F1', ',', 'AAGYTTTTTAGMGTTTTGYG', ',', 'and', 'R1', ',', 'CGCCCTGGCTTAGCATC', ',', 'designed', 'using', 'Primer', '3', '(', 'http', ':', '/', '/', 'frodo.wi.mit.edu', '/', 'primer3/', ')', 'on', 'the', 'aligned', 'integrase', 'sequences', 'of', 'B38', '(', 'HELPY_1521', ')', ',', 'B45', ',', 'and', 'H', '.', 'acinonychis', 'strain', 'Sheeba', '(', 'Hac_1606', ')', 'obtained', 'using', 'multiple', 'sequence', 'alignment', 'with', 'hierarchical', 'clustering', '(', '71', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 2, 1, 1, 13, 1, 1, 2, 1, 10, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 11, 1, 4, 1, 1, 1, 1, 4, 1, 1, 2, 1, 7, 1, 1, 2, 1, 1, 1, 1, 5, 1, 3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Phylogeny analysis was performed on the integrase sequences obtained on the 73 positive strains screened in the present study: a 442-bp sequence was available for each sequenced PCR product.	[('PMC3221604', 'M14000', 40, 49, 'integrase')]	['Ph', '##yl', '##ogen', '##y', 'analysis', 'was', 'performed', 'on', 'the', 'in', '##te', '##gra', '##se', 'sequences', 'obtained', 'on', 'the', '73', 'positive', 'strains', 'screened', 'in', 'the', 'present', 'study', ':', 'a', '44', '##2', '-', 'b', '##p', 'sequence', 'was', 'available', 'for', 'each', 'sequence', '##d', 'PC', '##R', 'product', '.']	[0, 2, 4, 8, 10, 19, 23, 33, 36, 40, 42, 44, 47, 50, 60, 69, 72, 76, 79, 88, 96, 105, 108, 112, 120, 125, 127, 129, 131, 132, 133, 134, 136, 145, 149, 159, 163, 168, 176, 178, 180, 182, 189]	[2, 4, 8, 9, 18, 22, 32, 35, 39, 42, 44, 47, 49, 59, 68, 71, 75, 78, 87, 95, 104, 107, 111, 119, 125, 126, 128, 131, 132, 133, 134, 135, 144, 148, 158, 162, 167, 176, 177, 180, 181, 189, 190]	['Phylogeny', 'analysis', 'was', 'performed', 'on', 'the', 'integrase', 'sequences', 'obtained', 'on', 'the', '73', 'positive', 'strains', 'screened', 'in', 'the', 'present', 'study', ':', 'a', '442-bp', 'sequence', 'was', 'available', 'for', 'each', 'sequenced', 'PCR', 'product', '.']	[4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We also included the internal fragment of the Hac_1606 integrase sequence (YP_665314.1|) corresponding to the amplified product.	[('PMC3221604', 'M14001', 55, 64, 'integrase')]	['We', 'also', 'included', 'the', 'internal', 'fragment', 'of', 'the', 'Ha', '##c', '_', '160', '##6', 'in', '##te', '##gra', '##se', 'sequence', '(', 'Y', '##P', '_', '66', '##53', '##14', '.', '1', '|', ')', 'corresponding', 'to', 'the', 'am', '##plified', 'product', '.']	[0, 3, 8, 17, 21, 30, 39, 42, 46, 48, 49, 50, 53, 55, 57, 59, 62, 65, 74, 75, 76, 77, 78, 80, 82, 84, 85, 86, 87, 89, 103, 106, 110, 112, 120, 127]	[2, 7, 16, 20, 29, 38, 41, 45, 48, 49, 50, 53, 54, 57, 59, 62, 64, 73, 75, 76, 77, 78, 80, 82, 84, 85, 86, 87, 88, 102, 105, 109, 112, 119, 127, 128]	['We', 'also', 'included', 'the', 'internal', 'fragment', 'of', 'the', 'Hac_1606', 'integrase', 'sequence', '(', 'YP_665314.1|', ')', 'corresponding', 'to', 'the', 'amplified', 'product', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 5, 4, 1, 1, 9, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The evolutionary history of phage integrase genes was inferred using the neighbor-joining method.	[('PMC3221604', 'M15000', 34, 43, 'integrase')]	['The', 'evolutionary', 'history', 'of', 'p', '##hage', 'in', '##te', '##gra', '##se', 'genes', 'was', 'in', '##ferred', 'using', 'the', 'neighbor', '-', 'joining', 'method', '.']	[0, 4, 17, 25, 28, 29, 34, 36, 38, 41, 44, 50, 54, 56, 63, 69, 73, 81, 82, 90, 96]	[3, 16, 24, 27, 29, 33, 36, 38, 41, 43, 49, 53, 56, 62, 68, 72, 81, 82, 89, 96, 97]	['The', 'evolutionary', 'history', 'of', 'phage', 'integrase', 'genes', 'was', 'inferred', 'using', 'the', 'neighbor', '-', 'joining', 'method', '.']	[1, 1, 1, 1, 2, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to estimate the prevalence of this prophage type in H. pylori genomes, we screened 341 strains, isolated in different geographic regions and from patients presenting different pathologies, using degenerate PCR primers targeting the B38, B45, and H. acinonychis strain Sheeba prophage II integrase genes.	[('PMC3221604', 'R10000', 296, 305, 'integrase')]	['In', 'order', 'to', 'estimate', 'the', 'prevalence', 'of', 'this', 'prop', '##hage', 'type', 'in', 'H', '.', 'p', '##yl', '##ori', 'genome', '##s', ',', 'we', 'screened', '34', '##1', 'strains', ',', 'isolated', 'in', 'different', 'geographic', 'regions', 'and', 'from', 'patients', 'presenting', 'different', 'path', '##ologies', ',', 'using', 'de', '##generate', 'PC', '##R', 'prime', '##rs', 'targeting', 'the', 'B', '##38', ',', 'B', '##45', ',', 'and', 'H', '.', 'a', '##cin', '##ony', '##chi', '##s', 'strain', 'She', '##eb', '##a', 'prop', '##hage', 'II', 'in', '##te', '##gra', '##se', 'genes', '.']	[0, 3, 9, 12, 21, 25, 36, 39, 44, 48, 53, 58, 61, 62, 64, 65, 67, 71, 77, 78, 80, 83, 92, 94, 96, 103, 105, 114, 117, 127, 138, 146, 150, 155, 164, 175, 185, 189, 196, 198, 204, 206, 215, 217, 219, 224, 227, 237, 241, 242, 244, 246, 247, 249, 251, 255, 256, 258, 259, 262, 265, 268, 270, 277, 280, 282, 284, 288, 293, 296, 298, 300, 303, 306, 311]	[2, 8, 11, 20, 24, 35, 38, 43, 48, 52, 57, 60, 62, 63, 65, 67, 70, 77, 78, 79, 82, 91, 94, 95, 103, 104, 113, 116, 126, 137, 145, 149, 154, 163, 174, 184, 189, 196, 197, 203, 206, 214, 217, 218, 224, 226, 236, 240, 242, 244, 245, 247, 249, 250, 254, 256, 257, 259, 262, 265, 268, 269, 276, 280, 282, 283, 288, 292, 295, 298, 300, 303, 305, 311, 312]	['In', 'order', 'to', 'estimate', 'the', 'prevalence', 'of', 'this', 'prophage', 'type', 'in', 'H', '.', 'pylori', 'genomes', ',', 'we', 'screened', '341', 'strains', ',', 'isolated', 'in', 'different', 'geographic', 'regions', 'and', 'from', 'patients', 'presenting', 'different', 'pathologies', ',', 'using', 'degenerate', 'PCR', 'primers', 'targeting', 'the', 'B38', ',', 'B45', ',', 'and', 'H', '.', 'acinonychis', 'strain', 'Sheeba', 'prophage', 'II', 'integrase', 'genes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 2, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 5, 1, 3, 2, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
Surprisingly, 21.4% of the isolates (73/341) had an integrase gene (GenBank accession numbers JF734912 to JF734984), suggesting that this is a much more frequent phenomenon than initially estimated.	[('PMC3221604', 'R10001', 52, 61, 'integrase')]	['Sur', '##p', '##rising', '##ly', ',', '21', '.', '4', '%', 'of', 'the', 'is', '##olate', '##s', '(', '73', '/', '34', '##1', ')', 'had', 'an', 'in', '##te', '##gra', '##se', 'gene', '(', 'Gen', '##B', '##an', '##k', 'accession', 'numbers', 'J', '##F', '##7', '##34', '##9', '##12', 'to', 'J', '##F', '##7', '##34', '##9', '##8', '##4', ')', ',', 'suggesting', 'that', 'this', 'is', 'a', 'much', 'more', 'frequent', 'phenomenon', 'than', 'initially', 'estimated', '.']	[0, 3, 4, 10, 12, 14, 16, 17, 18, 20, 23, 27, 29, 34, 36, 37, 39, 40, 42, 43, 45, 49, 52, 54, 56, 59, 62, 67, 68, 71, 72, 74, 76, 86, 94, 95, 96, 97, 99, 100, 103, 106, 107, 108, 109, 111, 112, 113, 114, 115, 117, 128, 133, 138, 141, 143, 148, 153, 162, 173, 178, 188, 197]	[3, 4, 10, 12, 13, 16, 17, 18, 19, 22, 26, 29, 34, 35, 37, 39, 40, 42, 43, 44, 48, 51, 54, 56, 59, 61, 66, 68, 71, 72, 74, 75, 85, 93, 95, 96, 97, 99, 100, 102, 105, 107, 108, 109, 111, 112, 113, 114, 115, 116, 127, 132, 137, 140, 142, 147, 152, 161, 172, 177, 187, 197, 198]	['Surprisingly', ',', '21.4%', 'of', 'the', 'isolates', '(', '73', '/', '341', ')', 'had', 'an', 'integrase', 'gene', '(', 'GenBank', 'accession', 'numbers', 'JF734912', 'to', 'JF734984', ')', ',', 'suggesting', 'that', 'this', 'is', 'a', 'much', 'more', 'frequent', 'phenomenon', 'than', 'initially', 'estimated', '.']	[4, 1, 4, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 4, 1, 1, 6, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, the first one (cluster A), which included the B45 integrase, was comprised of 81.0% (17/21) French isolates and the second (cluster B) was composed of 70.6% (12/17) Swedish isolates.	[]	['Interest', '##ingly', ',', 'the', 'first', 'one', '(', 'cluster', 'A', ')', ',', 'which', 'included', 'the', 'B', '##45', 'in', '##te', '##gra', '##se', ',', 'was', 'comprised', 'of', '81', '.', '0', '%', '(', '17', '/', '21', ')', 'French', 'is', '##olate', '##s', 'and', 'the', 'second', '(', 'cluster', 'B', ')', 'was', 'composed', 'of', '70', '.', '6', '%', '(', '12', '/', '17', ')', 'Swedish', 'is', '##olate', '##s', '.']	[0, 8, 13, 15, 19, 25, 29, 30, 38, 39, 40, 42, 48, 57, 61, 62, 65, 67, 69, 72, 74, 76, 80, 90, 93, 95, 96, 97, 99, 100, 102, 103, 105, 107, 114, 116, 121, 123, 127, 131, 138, 139, 147, 148, 150, 154, 163, 166, 168, 169, 170, 172, 173, 175, 176, 178, 180, 188, 190, 195, 196]	[8, 13, 14, 18, 24, 28, 30, 37, 39, 40, 41, 47, 56, 60, 62, 64, 67, 69, 72, 74, 75, 79, 89, 92, 95, 96, 97, 98, 100, 102, 103, 105, 106, 113, 116, 121, 122, 126, 130, 137, 139, 146, 148, 149, 153, 162, 165, 168, 169, 170, 171, 173, 175, 176, 178, 179, 187, 190, 195, 196, 197]	['Interestingly', ',', 'the', 'first', 'one', '(', 'cluster', 'A', ')', ',', 'which', 'included', 'the', 'B45', 'integrase', ',', 'was', 'comprised', 'of', '81.0%', '(', '17', '/', '21', ')', 'French', 'isolates', 'and', 'the', 'second', '(', 'cluster', 'B', ')', 'was', 'composed', 'of', '70.6%', '(', '12', '/', '17', ')', 'Swedish', 'isolates', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The H. acinonychis strain Sheeba prophage II integrase formed a sister group with these two clusters.	[]	['The', 'H', '.', 'a', '##cin', '##ony', '##chi', '##s', 'strain', 'She', '##eb', '##a', 'prop', '##hage', 'II', 'in', '##te', '##gra', '##se', 'formed', 'a', 'sister', 'group', 'with', 'these', 'two', 'clusters', '.']	[0, 4, 5, 7, 8, 11, 14, 17, 19, 26, 29, 31, 33, 37, 42, 45, 47, 49, 52, 55, 62, 64, 71, 77, 82, 88, 92, 100]	[3, 5, 6, 8, 11, 14, 17, 18, 25, 29, 31, 32, 37, 41, 44, 47, 49, 52, 54, 61, 63, 70, 76, 81, 87, 91, 100, 101]	['The', 'H', '.', 'acinonychis', 'strain', 'Sheeba', 'prophage', 'II', 'integrase', 'formed', 'a', 'sister', 'group', 'with', 'these', 'two', 'clusters', '.']	[1, 1, 1, 5, 1, 3, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The last cluster (cluster D), found at the extremity of the second branch, was more heterogeneous in geographic composition and was comprised of 6 French, 4 German, 3 Portuguese, and 3 Swedish strains.	[]	['The', 'last', 'cluster', '(', 'cluster', 'D', ')', ',', 'found', 'at', 'the', 'ex', '##tre', '##mity', 'of', 'the', 'second', 'branch', ',', 'was', 'more', 'he', '##tero', '##gene', '##ous', 'in', 'geographic', 'composition', 'and', 'was', 'comprised', 'of', '6', 'French', ',', '4', 'German', ',', '3', 'Portuguese', ',', 'and', '3', 'Swedish', 'strains', '.']	[0, 4, 9, 17, 18, 26, 27, 28, 30, 36, 39, 43, 45, 48, 53, 56, 60, 67, 73, 75, 79, 84, 86, 90, 94, 98, 101, 112, 124, 128, 132, 142, 145, 147, 153, 155, 157, 163, 165, 167, 177, 179, 183, 185, 193, 200]	[3, 8, 16, 18, 25, 27, 28, 29, 35, 38, 42, 45, 48, 52, 55, 59, 66, 73, 74, 78, 83, 86, 90, 94, 97, 100, 111, 123, 127, 131, 141, 144, 146, 153, 154, 156, 163, 164, 166, 177, 178, 182, 184, 192, 200, 201]	['The', 'last', 'cluster', '(', 'cluster', 'D', ')', ',', 'found', 'at', 'the', 'extremity', 'of', 'the', 'second', 'branch', ',', 'was', 'more', 'heterogeneous', 'in', 'geographic', 'composition', 'and', 'was', 'comprised', 'of', '6', 'French', ',', '4', 'German', ',', '3', 'Portuguese', ',', 'and', '3', 'Swedish', 'strains', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The strongest association signal (P = 2.12 10−6) in the combined analysis was found with marker rs7045881 × located in the first intron of the PLAA gene on 9p21, encoding phospholipase A2-activating protein (PLAP).	[('PMC3224994', 'D01000', 171, 187, 'phospholipase A2')]	['The', 'strongest', 'association', 'signal', '(', 'P', '=', '2', '.', '12', '10', '##−', '##6', ')', 'in', 'the', 'combined', 'analysis', 'was', 'found', 'with', 'marker', 'r', '##s', '##70', '##45', '##8', '##8', '##1', '×', 'located', 'in', 'the', 'first', 'intro', '##n', 'of', 'the', 'P', '##LA', '##A', 'gene', 'on', '9', '##p', '##21', ',', 'encoding', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'A2', '-', 'act', '##ivating', 'protein', '(', 'P', '##LA', '##P', ')', '.']	[0, 4, 14, 26, 33, 34, 36, 38, 39, 40, 43, 45, 46, 47, 49, 52, 56, 65, 74, 78, 84, 89, 96, 97, 98, 100, 102, 103, 104, 106, 108, 116, 119, 123, 129, 134, 136, 139, 143, 144, 146, 148, 153, 156, 157, 158, 160, 162, 171, 172, 175, 177, 180, 183, 185, 187, 188, 191, 199, 207, 208, 209, 211, 212, 213]	[3, 13, 25, 32, 34, 35, 37, 39, 40, 42, 45, 46, 47, 48, 51, 55, 64, 73, 77, 83, 88, 95, 97, 98, 100, 102, 103, 104, 105, 107, 115, 118, 122, 128, 134, 135, 138, 142, 144, 146, 147, 152, 155, 157, 158, 160, 161, 170, 172, 175, 177, 180, 183, 184, 187, 188, 191, 198, 206, 208, 209, 211, 212, 213, 214]	['The', 'strongest', 'association', 'signal', '(', 'P', '=', '2.12', '10−6', ')', 'in', 'the', 'combined', 'analysis', 'was', 'found', 'with', 'marker', 'rs7045881', '×', 'located', 'in', 'the', 'first', 'intron', 'of', 'the', 'PLAA', 'gene', 'on', '9p21', ',', 'encoding', 'phospholipase', 'A2-activating', 'protein', '(', 'PLAP', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1, 6, 4, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The polymorphism rs4316429 within the glutamate dehydrogenase pseudogene 5 (GLUDP5) on 10p11 shows nominal association (P = 3.59 × 10−2) in the replication analysis and in the combined analysis (P = 1.90 × 10−5).	[]	['The', 'p', '##oly', '##mor', '##phism', 'r', '##s', '##43', '##16', '##42', '##9', 'within', 'the', 'g', '##lut', '##ama', '##te', 'de', '##hy', '##dr', '##ogen', '##ase', 'pseudo', '##gene', '5', '(', 'G', '##L', '##U', '##DP', '##5', ')', 'on', '10', '##p', '##11', 'shows', 'nominal', 'association', '(', 'P', '=', '3', '.', '59', '×', '10', '##−', '##2', ')', 'in', 'the', 'replication', 'analysis', 'and', 'in', 'the', 'combined', 'analysis', '(', 'P', '=', '1', '.', '90', '×', '10', '##−', '##5', ')', '.']	[0, 4, 5, 8, 11, 17, 18, 19, 21, 23, 25, 27, 34, 38, 39, 42, 45, 48, 50, 52, 54, 58, 62, 68, 73, 75, 76, 77, 78, 79, 81, 82, 84, 87, 89, 90, 93, 99, 107, 119, 120, 122, 124, 125, 126, 129, 131, 133, 134, 135, 137, 140, 144, 156, 165, 169, 172, 176, 185, 194, 195, 197, 199, 200, 201, 204, 206, 208, 209, 210, 211]	[3, 5, 8, 11, 16, 18, 19, 21, 23, 25, 26, 33, 37, 39, 42, 45, 47, 50, 52, 54, 58, 61, 68, 72, 74, 76, 77, 78, 79, 81, 82, 83, 86, 89, 90, 92, 98, 106, 118, 120, 121, 123, 125, 126, 128, 130, 133, 134, 135, 136, 139, 143, 155, 164, 168, 171, 175, 184, 193, 195, 196, 198, 200, 201, 203, 205, 208, 209, 210, 211, 212]	['The', 'polymorphism', 'rs4316429', 'within', 'the', 'glutamate', 'dehydrogenase', 'pseudogene', '5', '(', 'GLUDP5', ')', 'on', '10p11', 'shows', 'nominal', 'association', '(', 'P', '=', '3.59', '×', '10−2', ')', 'in', 'the', 'replication', 'analysis', 'and', 'in', 'the', 'combined', 'analysis', '(', 'P', '=', '1.90', '×', '10−5', ')', '.']	[1, 4, 6, 1, 1, 4, 5, 2, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Muglia and colleagues (2008) reported that the protein tyrosine phosphatase receptor PTPRN was significantly associated with major depression: in the current report, two other protein tyrosine phosphatase receptors, PTPRD and PTPRS, are significantly associated with the comorbid phenotype.	[('PMC3241912', 'D03000', 47, 75, 'protein tyrosine phosphatase')]	['Mu', '##glia', 'and', 'colleagues', '(', '2008', ')', 'reported', 'that', 'the', 'protein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'receptor', 'PT', '##PR', '##N', 'was', 'significantly', 'associated', 'with', 'major', 'depression', ':', 'in', 'the', 'current', 'report', ',', 'two', 'other', 'protein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'receptors', ',', 'PT', '##PR', '##D', 'and', 'PT', '##PR', '##S', ',', 'are', 'significantly', 'associated', 'with', 'the', 'com', '##or', '##bid', 'p', '##hen', '##otype', '.']	[0, 2, 7, 11, 22, 23, 27, 29, 38, 43, 47, 55, 56, 58, 60, 64, 65, 68, 71, 76, 85, 87, 89, 91, 95, 109, 120, 125, 131, 141, 143, 146, 150, 158, 164, 166, 170, 176, 184, 185, 187, 189, 193, 194, 197, 200, 205, 214, 216, 218, 220, 222, 226, 228, 230, 231, 233, 237, 251, 262, 267, 271, 274, 276, 280, 281, 284, 289]	[2, 6, 10, 21, 23, 27, 28, 37, 42, 46, 54, 56, 58, 60, 63, 65, 68, 71, 75, 84, 87, 89, 90, 94, 108, 119, 124, 130, 141, 142, 145, 149, 157, 164, 165, 169, 175, 183, 185, 187, 189, 192, 194, 197, 200, 204, 214, 215, 218, 220, 221, 225, 228, 230, 231, 232, 236, 250, 261, 266, 270, 274, 276, 279, 281, 284, 289, 290]	['Muglia', 'and', 'colleagues', '(', '2008', ')', 'reported', 'that', 'the', 'protein', 'tyrosine', 'phosphatase', 'receptor', 'PTPRN', 'was', 'significantly', 'associated', 'with', 'major', 'depression', ':', 'in', 'the', 'current', 'report', ',', 'two', 'other', 'protein', 'tyrosine', 'phosphatase', 'receptors', ',', 'PTPRD', 'and', 'PTPRS', ',', 'are', 'significantly', 'associated', 'with', 'the', 'comorbid', 'phenotype', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 3, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Growth was also detected for most F. prausnitzii strains on the host-derived sugar N-acetylglucosamine and for some strains on d-glucosamine and d-glucuronic acid, while β-glucuronidase activity has been reported previously in some F. prausnitzii isolates (8).	[('PMC3255724', 'R03000', 170, 185, 'β-glucuronidase')]	['Growth', 'was', 'also', 'detected', 'for', 'most', 'F', '.', 'p', '##ra', '##us', '##nitz', '##ii', 'strains', 'on', 'the', 'host', '-', 'derived', 'sugar', 'N', '-', 'ace', '##ty', '##l', '##g', '##lu', '##cos', '##amine', 'and', 'for', 'some', 'strains', 'on', 'd', '-', 'g', '##lu', '##cos', '##amine', 'and', 'd', '-', 'g', '##lu', '##cu', '##ronic', 'acid', ',', 'while', 'β', '-', 'g', '##lu', '##cu', '##ron', '##idas', '##e', 'activity', 'has', 'been', 'reported', 'previously', 'in', 'some', 'F', '.', 'p', '##ra', '##us', '##nitz', '##ii', 'is', '##olate', '##s', '(', '8', ')', '.']	[0, 7, 11, 16, 25, 29, 34, 35, 37, 38, 40, 42, 46, 49, 57, 60, 64, 68, 69, 77, 83, 84, 85, 88, 90, 91, 92, 94, 97, 103, 107, 111, 116, 124, 127, 128, 129, 130, 132, 135, 141, 145, 146, 147, 148, 150, 152, 158, 162, 164, 170, 171, 172, 173, 175, 177, 180, 184, 186, 195, 199, 204, 213, 224, 227, 232, 233, 235, 236, 238, 240, 244, 247, 249, 254, 256, 257, 258, 259]	[6, 10, 15, 24, 28, 33, 35, 36, 38, 40, 42, 46, 48, 56, 59, 63, 68, 69, 76, 82, 84, 85, 88, 90, 91, 92, 94, 97, 102, 106, 110, 115, 123, 126, 128, 129, 130, 132, 135, 140, 144, 146, 147, 148, 150, 152, 157, 162, 163, 169, 171, 172, 173, 175, 177, 180, 184, 185, 194, 198, 203, 212, 223, 226, 231, 233, 234, 236, 238, 240, 244, 246, 249, 254, 255, 257, 258, 259, 260]	['Growth', 'was', 'also', 'detected', 'for', 'most', 'F', '.', 'prausnitzii', 'strains', 'on', 'the', 'host', '-', 'derived', 'sugar', 'N-acetylglucosamine', 'and', 'for', 'some', 'strains', 'on', 'd-glucosamine', 'and', 'd-glucuronic', 'acid', ',', 'while', 'β-glucuronidase', 'activity', 'has', 'been', 'reported', 'previously', 'in', 'some', 'F', '.', 'prausnitzii', 'isolates', '(', '8', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 9, 1, 1, 1, 1, 1, 6, 1, 6, 1, 1, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the absence of medium chain acyl-CoA dehydroxygenase (MCAD) phenylpropionacid is converted to phenylpropionglycine instead of benzoic acid.	[]	['In', 'the', 'absence', 'of', 'medium', 'chain', 'a', '##cy', '##l', '-', 'Co', '##A', 'de', '##hy', '##dr', '##ox', '##y', '##gen', '##ase', '(', 'MCA', '##D', ')', 'p', '##hen', '##yl', '##p', '##rop', '##ion', '##ac', '##id', 'is', 'converted', 'to', 'p', '##hen', '##yl', '##p', '##rop', '##ion', '##gly', '##cine', 'instead', 'of', 'ben', '##zoic', 'acid', '.']	[0, 3, 7, 15, 18, 25, 31, 32, 34, 35, 36, 38, 40, 42, 44, 46, 48, 49, 52, 56, 57, 60, 61, 63, 64, 67, 69, 70, 73, 76, 78, 81, 84, 94, 97, 98, 101, 103, 104, 107, 110, 113, 118, 126, 129, 132, 137, 141]	[2, 6, 14, 17, 24, 30, 32, 34, 35, 36, 38, 39, 42, 44, 46, 48, 49, 52, 55, 57, 60, 61, 62, 64, 67, 69, 70, 73, 76, 78, 80, 83, 93, 96, 98, 101, 103, 104, 107, 110, 113, 117, 125, 128, 132, 136, 141, 142]	['In', 'the', 'absence', 'of', 'medium', 'chain', 'acyl-CoA', 'dehydroxygenase', '(', 'MCAD', ')', 'phenylpropionacid', 'is', 'converted', 'to', 'phenylpropionglycine', 'instead', 'of', 'benzoic', 'acid', '.']	[1, 1, 1, 1, 1, 1, 6, 7, 1, 2, 1, 8, 1, 1, 1, 8, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum gamma-glutamyl transferase (GGT) activity is a marker of liver disease which is also prospectively associated with the risk of all-cause mortality, cardiovascular disease, type 2 diabetes and cancers.	[('PMC3276286', 'A00000', 6, 32, 'gamma-glutamyl transferase')]	['Ser', '##um', 'gamma', '-', 'g', '##lut', '##am', '##yl', 'transfer', '##ase', '(', 'G', '##G', '##T', ')', 'activity', 'is', 'a', 'marker', 'of', 'liver', 'disease', 'which', 'is', 'also', 'prospective', '##ly', 'associated', 'with', 'the', 'risk', 'of', 'all', '-', 'cause', 'mortality', ',', 'card', '##iovascular', 'disease', ',', 'type', '2', 'diabetes', 'and', 'cancer', '##s', '.']	[0, 3, 6, 11, 12, 13, 16, 18, 21, 29, 33, 34, 35, 36, 37, 39, 48, 51, 53, 60, 63, 69, 77, 83, 86, 91, 102, 105, 116, 121, 125, 130, 133, 136, 137, 143, 152, 154, 158, 169, 176, 178, 183, 185, 194, 198, 204, 205]	[3, 5, 11, 12, 13, 16, 18, 20, 29, 32, 34, 35, 36, 37, 38, 47, 50, 52, 59, 62, 68, 76, 82, 85, 90, 102, 104, 115, 120, 124, 129, 132, 136, 137, 142, 152, 153, 158, 168, 176, 177, 182, 184, 193, 197, 204, 205, 206]	['Serum', 'gamma', '-', 'glutamyl', 'transferase', '(', 'GGT', ')', 'activity', 'is', 'a', 'marker', 'of', 'liver', 'disease', 'which', 'is', 'also', 'prospectively', 'associated', 'with', 'the', 'risk', 'of', 'all', '-', 'cause', 'mortality', ',', 'cardiovascular', 'disease', ',', 'type', '2', 'diabetes', 'and', 'cancers', '.']	[2, 1, 1, 4, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gamma-glutamyl transferase (GGT) is a membrane-bound enzyme which transfers glutamyl groups linked through the gamma-carboxylic acid from peptides such as glutathione to acceptors.	[('PMC3276286', 'I00000', 0, 26, 'Gamma-glutamyl transferase')]	['Gamma', '-', 'g', '##lut', '##am', '##yl', 'transfer', '##ase', '(', 'G', '##G', '##T', ')', 'is', 'a', 'membrane', '-', 'bound', 'enzyme', 'which', 'transfers', 'g', '##lut', '##am', '##yl', 'groups', 'linked', 'through', 'the', 'gamma', '-', 'car', '##box', '##yl', '##ic', 'acid', 'from', 'p', '##eptide', '##s', 'such', 'as', 'g', '##lut', '##ath', '##ione', 'to', 'accept', '##ors', '.']	[0, 5, 6, 7, 10, 12, 15, 23, 27, 28, 29, 30, 31, 33, 36, 38, 46, 47, 53, 60, 66, 76, 77, 80, 82, 85, 92, 99, 107, 111, 116, 117, 120, 123, 125, 128, 133, 138, 139, 145, 147, 152, 155, 156, 159, 162, 167, 170, 176, 179]	[5, 6, 7, 10, 12, 14, 23, 26, 28, 29, 30, 31, 32, 35, 37, 46, 47, 52, 59, 65, 75, 77, 80, 82, 84, 91, 98, 106, 110, 116, 117, 120, 123, 125, 127, 132, 137, 139, 145, 146, 151, 154, 156, 159, 162, 166, 169, 176, 179, 180]	['Gamma', '-', 'glutamyl', 'transferase', '(', 'GGT', ')', 'is', 'a', 'membrane', '-', 'bound', 'enzyme', 'which', 'transfers', 'glutamyl', 'groups', 'linked', 'through', 'the', 'gamma', '-', 'carboxylic', 'acid', 'from', 'peptides', 'such', 'as', 'glutathione', 'to', 'acceptors', '.']	[1, 1, 4, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 4, 1, 2, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the cyclooxygenase pathway, arachidonic acid is converted into various bioactive lipid molecules including prostaglandin E2 (8).	[]	['In', 'the', 'c', '##y', '##c', '##lo', '##ox', '##y', '##gen', '##ase', 'pathway', ',', 'a', '##rac', '##hi', '##don', '##ic', 'acid', 'is', 'converted', 'into', 'various', 'bio', '##active', 'lip', '##id', 'molecules', 'including', 'pro', '##sta', '##g', '##land', '##in', 'E', '##2', '(', '8', ')', '.']	[0, 3, 7, 8, 9, 10, 12, 14, 15, 18, 22, 29, 31, 32, 35, 37, 40, 43, 48, 51, 61, 66, 74, 77, 84, 87, 90, 100, 110, 113, 116, 117, 121, 124, 125, 127, 128, 129, 130]	[2, 6, 8, 9, 10, 12, 14, 15, 18, 21, 29, 30, 32, 35, 37, 40, 42, 47, 50, 60, 65, 73, 77, 83, 87, 89, 99, 109, 113, 116, 117, 121, 123, 125, 126, 128, 129, 130, 131]	['In', 'the', 'cyclooxygenase', 'pathway', ',', 'arachidonic', 'acid', 'is', 'converted', 'into', 'various', 'bioactive', 'lipid', 'molecules', 'including', 'prostaglandin', 'E2', '(', '8', ')', '.']	[1, 1, 8, 1, 1, 5, 1, 1, 1, 1, 1, 2, 2, 1, 1, 5, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
β-Carotene is the major dietary source of provitamin A. Central cleavage of β-carotene catalyzed by β-carotene oxygenase 1 yields two molecules of retinaldehyde.	[('PMC3346154', 'A00000', 100, 122, 'β-carotene oxygenase 1')]	['β', '-', 'Car', '##ote', '##ne', 'is', 'the', 'major', 'diet', '##ary', 'source', 'of', 'pro', '##vi', '##tam', '##in', 'A', '.', 'Central', 'c', '##lea', '##vage', 'of', 'β', '-', 'car', '##ote', '##ne', 'cat', '##aly', '##zed', 'by', 'β', '-', 'car', '##ote', '##ne', 'oxygen', '##ase', '1', 'yields', 'two', 'molecules', 'of', 're', '##tina', '##lde', '##hy', '##de', '.']	[0, 1, 2, 5, 8, 11, 14, 18, 24, 28, 32, 39, 42, 45, 47, 50, 53, 54, 56, 64, 65, 68, 73, 76, 77, 78, 81, 84, 87, 90, 93, 97, 100, 101, 102, 105, 108, 111, 117, 121, 123, 130, 134, 144, 147, 149, 153, 156, 158, 160]	[1, 2, 5, 8, 10, 13, 17, 23, 28, 31, 38, 41, 45, 47, 50, 52, 54, 55, 63, 65, 68, 72, 75, 77, 78, 81, 84, 86, 90, 93, 96, 99, 101, 102, 105, 108, 110, 117, 120, 122, 129, 133, 143, 146, 149, 153, 156, 158, 160, 161]	['β-Carotene', 'is', 'the', 'major', 'dietary', 'source', 'of', 'provitamin', 'A', '.', 'Central', 'cleavage', 'of', 'β-carotene', 'catalyzed', 'by', 'β-carotene', 'oxygenase', '1', 'yields', 'two', 'molecules', 'of', 'retinaldehyde', '.']	[5, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 3, 1, 5, 3, 1, 5, 2, 1, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Reporter vectors used were Renilla luciferase under the control of the thymidine kinase promoter and firefly luciferase under the control of RARE.	[]	['Reporter', 'vectors', 'used', 'were', 'Ren', '##illa', 'l', '##uc', '##ifer', '##ase', 'under', 'the', 'control', 'of', 'the', 'thy', '##mi', '##dine', 'kinase', 'promoter', 'and', 'fire', '##fly', 'l', '##uc', '##ifer', '##ase', 'under', 'the', 'control', 'of', 'RA', '##RE', '.']	[0, 9, 17, 22, 27, 30, 35, 36, 38, 42, 46, 52, 56, 64, 67, 71, 74, 76, 81, 88, 97, 101, 105, 109, 110, 112, 116, 120, 126, 130, 138, 141, 143, 145]	[8, 16, 21, 26, 30, 34, 36, 38, 42, 45, 51, 55, 63, 66, 70, 74, 76, 80, 87, 96, 100, 105, 108, 110, 112, 116, 119, 125, 129, 137, 140, 143, 145, 146]	['Reporter', 'vectors', 'used', 'were', 'Renilla', 'luciferase', 'under', 'the', 'control', 'of', 'the', 'thymidine', 'kinase', 'promoter', 'and', 'firefly', 'luciferase', 'under', 'the', 'control', 'of', 'RARE', '.']	[1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 4, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Plasmids with cDNAs for retinoic acid receptors α, β, and γ were cotransfected in individual experiments.	[]	['P', '##las', '##mi', '##ds', 'with', 'c', '##D', '##NA', '##s', 'for', 're', '##tino', '##ic', 'acid', 'receptors', 'α', ',', 'β', ',', 'and', 'γ', 'were', 'co', '##tra', '##ns', '##fected', 'in', 'individual', 'experiments', '.']	[0, 1, 4, 6, 9, 14, 15, 16, 18, 20, 24, 26, 30, 33, 38, 48, 49, 51, 52, 54, 58, 60, 65, 67, 70, 72, 79, 82, 93, 104]	[1, 4, 6, 8, 13, 15, 16, 18, 19, 23, 26, 30, 32, 37, 47, 49, 50, 52, 53, 57, 59, 64, 67, 70, 72, 78, 81, 92, 104, 105]	['Plasmids', 'with', 'cDNAs', 'for', 'retinoic', 'acid', 'receptors', 'α', ',', 'β', ',', 'and', 'γ', 'were', 'cotransfected', 'in', 'individual', 'experiments', '.']	[4, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Four hours after transfection, cells were treated with test compounds that were dissolved in ethanol or with 0.1% ethanol alone for an additional 24 h. Cell lysates were then assayed for luciferase activities using a GloMax 96 microplate luminometer (Promega) and the Dual-Luciferase reporter assay system (Promega).	[]	['Four', 'hours', 'after', 'trans', '##fect', '##ion', ',', 'cells', 'were', 'treated', 'with', 'test', 'compounds', 'that', 'were', 'dissolved', 'in', 'ethanol', 'or', 'with', '0', '.', '1', '%', 'ethanol', 'alone', 'for', 'an', 'additional', '24', 'h', '.', 'Cell', 'l', '##ys', '##ates', 'were', 'then', 'ass', '##ay', '##ed', 'for', 'l', '##uc', '##ifer', '##ase', 'activities', 'using', 'a', 'G', '##lo', '##M', '##ax', '96', 'micro', '##plate', 'l', '##umi', '##no', '##meter', '(', 'Pro', '##me', '##ga', ')', 'and', 'the', 'Dual', '-', 'Lucifer', '##ase', 'reporter', 'ass', '##ay', 'system', '(', 'Pro', '##me', '##ga', ')', '.']	[0, 5, 11, 17, 22, 26, 29, 31, 37, 42, 50, 55, 60, 70, 75, 80, 90, 93, 101, 104, 109, 110, 111, 112, 114, 122, 128, 132, 135, 146, 149, 150, 152, 157, 158, 160, 165, 170, 175, 178, 180, 183, 187, 188, 190, 194, 198, 209, 215, 217, 218, 220, 221, 224, 227, 232, 238, 239, 242, 244, 250, 251, 254, 256, 258, 260, 264, 268, 272, 273, 280, 284, 293, 296, 299, 306, 307, 310, 312, 314, 315]	[4, 10, 16, 22, 26, 29, 30, 36, 41, 49, 54, 59, 69, 74, 79, 89, 92, 100, 103, 108, 110, 111, 112, 113, 121, 127, 131, 134, 145, 148, 150, 151, 156, 158, 160, 164, 169, 174, 178, 180, 182, 186, 188, 190, 194, 197, 208, 214, 216, 218, 220, 221, 223, 226, 232, 237, 239, 242, 244, 249, 251, 254, 256, 258, 259, 263, 267, 272, 273, 280, 283, 292, 296, 298, 305, 307, 310, 312, 314, 315, 316]	['Four', 'hours', 'after', 'transfection', ',', 'cells', 'were', 'treated', 'with', 'test', 'compounds', 'that', 'were', 'dissolved', 'in', 'ethanol', 'or', 'with', '0.1%', 'ethanol', 'alone', 'for', 'an', 'additional', '24', 'h', '.', 'Cell', 'lysates', 'were', 'then', 'assayed', 'for', 'luciferase', 'activities', 'using', 'a', 'GloMax', '96', 'microplate', 'luminometer', '(', 'Promega', ')', 'and', 'the', 'Dual-Luciferase', 'reporter', 'assay', 'system', '(', 'Promega', ')', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 4, 1, 1, 1, 4, 1, 2, 4, 1, 3, 1, 1, 1, 4, 1, 2, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For each experiment, the firefly luciferase activity (experimental reporter) was normalized to Renilla luciferase (control reporter) activity.	[]	['For', 'each', 'experiment', ',', 'the', 'fire', '##fly', 'l', '##uc', '##ifer', '##ase', 'activity', '(', 'experimental', 'reporter', ')', 'was', 'normal', '##ized', 'to', 'Ren', '##illa', 'l', '##uc', '##ifer', '##ase', '(', 'control', 'reporter', ')', 'activity', '.']	[0, 4, 9, 19, 21, 25, 29, 33, 34, 36, 40, 44, 53, 54, 67, 75, 77, 81, 87, 92, 95, 98, 103, 104, 106, 110, 114, 115, 123, 131, 133, 141]	[3, 8, 19, 20, 24, 29, 32, 34, 36, 40, 43, 52, 54, 66, 75, 76, 80, 87, 91, 94, 98, 102, 104, 106, 110, 113, 115, 122, 131, 132, 141, 142]	['For', 'each', 'experiment', ',', 'the', 'firefly', 'luciferase', 'activity', '(', 'experimental', 'reporter', ')', 'was', 'normalized', 'to', 'Renilla', 'luciferase', '(', 'control', 'reporter', ')', 'activity', '.']	[1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 2, 1, 2, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The change in normalized firefly luciferase activity was calculated relative to that for cells that were transfected with vehicle (ethanol), which was set as 1.	[]	['The', 'change', 'in', 'normal', '##ized', 'fire', '##fly', 'l', '##uc', '##ifer', '##ase', 'activity', 'was', 'calculated', 'relative', 'to', 'that', 'for', 'cells', 'that', 'were', 'trans', '##fected', 'with', 'vehicle', '(', 'ethanol', ')', ',', 'which', 'was', 'set', 'as', '1', '.']	[0, 4, 11, 14, 20, 25, 29, 33, 34, 36, 40, 44, 53, 57, 68, 77, 80, 85, 89, 95, 100, 105, 110, 117, 122, 130, 131, 138, 139, 141, 147, 151, 155, 158, 159]	[3, 10, 13, 20, 24, 29, 32, 34, 36, 40, 43, 52, 56, 67, 76, 79, 84, 88, 94, 99, 104, 110, 116, 121, 129, 131, 138, 139, 140, 146, 150, 154, 157, 159, 160]	['The', 'change', 'in', 'normalized', 'firefly', 'luciferase', 'activity', 'was', 'calculated', 'relative', 'to', 'that', 'for', 'cells', 'that', 'were', 'transfected', 'with', 'vehicle', '(', 'ethanol', ')', ',', 'which', 'was', 'set', 'as', '1', '.']	[1, 1, 1, 2, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We first screened all of the compounds for their potential to activate RARα, RARβ, and RARγ, using Cos-1 cells transiently transfected with cDNAs for the individual RARs and with a RARE-luciferase reporter.	[('PMC3346154', 'R01000', 186, 196, 'luciferase')]	['We', 'first', 'screened', 'all', 'of', 'the', 'compounds', 'for', 'their', 'potential', 'to', 'activate', 'RA', '##R', '##α', ',', 'RA', '##R', '##β', ',', 'and', 'RA', '##R', '##γ', ',', 'using', 'Co', '##s', '-', '1', 'cells', 'trans', '##ient', '##ly', 'trans', '##fected', 'with', 'c', '##D', '##NA', '##s', 'for', 'the', 'individual', 'RA', '##R', '##s', 'and', 'with', 'a', 'RA', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'reporter', '.']	[0, 3, 9, 18, 22, 25, 29, 39, 43, 49, 59, 62, 71, 73, 74, 75, 77, 79, 80, 81, 83, 87, 89, 90, 91, 93, 99, 101, 102, 103, 105, 111, 116, 120, 123, 128, 135, 140, 141, 142, 144, 146, 150, 154, 165, 167, 168, 170, 174, 179, 181, 183, 185, 186, 187, 189, 193, 197, 205]	[2, 8, 17, 21, 24, 28, 38, 42, 48, 58, 61, 70, 73, 74, 75, 76, 79, 80, 81, 82, 86, 89, 90, 91, 92, 98, 101, 102, 103, 104, 110, 116, 120, 122, 128, 134, 139, 141, 142, 144, 145, 149, 153, 164, 167, 168, 169, 173, 178, 180, 183, 185, 186, 187, 189, 193, 196, 205, 206]	['We', 'first', 'screened', 'all', 'of', 'the', 'compounds', 'for', 'their', 'potential', 'to', 'activate', 'RARα', ',', 'RARβ', ',', 'and', 'RARγ', ',', 'using', 'Cos-1', 'cells', 'transiently', 'transfected', 'with', 'cDNAs', 'for', 'the', 'individual', 'RARs', 'and', 'with', 'a', 'RARE-luciferase', 'reporter', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 4, 1, 3, 2, 1, 4, 1, 1, 1, 3, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O']
Genome-wide association studies (GWASs) have reported genome-wide significant single-nucleotide polymorphisms (SNPs) across a 70-kilobase (kb) region that includes APOE and several neighboring genes,5 namely, poliovirus receptor–related 2 (PVRL2 [OMIM *600798]), translocase of outer mitochondrial membrane 40 yeast homologue (TOMM40	[('PMC3356921', 'I01000', 263, 274, 'translocase')]	['Gen', '##ome', '-', 'wide', 'association', 'studies', '(', 'G', '##WA', '##S', '##s', ')', 'have', 'reported', 'genome', '-', 'wide', 'significant', 'single', '-', 'n', '##uc', '##leo', '##tide', 'p', '##oly', '##mor', '##phism', '##s', '(', 'S', '##NP', '##s', ')', 'across', 'a', '70', '-', 'k', '##ilo', '##base', '(', 'k', '##b', ')', 'region', 'that', 'includes', 'AP', '##OE', 'and', 'several', 'neighboring', 'genes', ',', '5', 'namely', ',', 'p', '##olio', '##virus', 'receptor', '–', 'related', '2', '(', 'P', '##VR', '##L', '##2', '[', 'O', '##MI', '##M', '*', '600', '##7', '##9', '##8', ']', ')', ',', 'trans', '##loc', '##ase', 'of', 'outer', 'mitochondrial', 'membrane', '40', 'yeast', 'ho', '##mo', '##logue', '(', 'TO', '##MM', '##40']	[0, 3, 6, 7, 12, 24, 32, 33, 34, 36, 37, 38, 40, 45, 54, 60, 61, 66, 78, 84, 85, 86, 88, 91, 96, 97, 100, 103, 108, 110, 111, 112, 114, 115, 117, 124, 126, 128, 129, 130, 133, 138, 139, 140, 141, 143, 150, 155, 164, 166, 169, 173, 181, 193, 198, 199, 201, 207, 209, 210, 214, 220, 228, 229, 237, 239, 240, 241, 243, 244, 246, 247, 248, 250, 252, 253, 256, 257, 258, 259, 260, 261, 263, 268, 271, 275, 278, 284, 298, 307, 310, 316, 318, 320, 326, 327, 329, 331]	[3, 6, 7, 11, 23, 31, 33, 34, 36, 37, 38, 39, 44, 53, 60, 61, 65, 77, 84, 85, 86, 88, 91, 95, 97, 100, 103, 108, 109, 111, 112, 114, 115, 116, 123, 125, 128, 129, 130, 133, 137, 139, 140, 141, 142, 149, 154, 163, 166, 168, 172, 180, 192, 198, 199, 200, 207, 208, 210, 214, 219, 228, 229, 236, 238, 240, 241, 243, 244, 245, 247, 248, 250, 251, 253, 256, 257, 258, 259, 260, 261, 262, 268, 271, 274, 277, 283, 297, 306, 309, 315, 318, 320, 325, 327, 329, 331, 333]	['Genome', '-', 'wide', 'association', 'studies', '(', 'GWASs', ')', 'have', 'reported', 'genome', '-', 'wide', 'significant', 'single', '-', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', 'across', 'a', '70-kilobase', '(', 'kb', ')', 'region', 'that', 'includes', 'APOE', 'and', 'several', 'neighboring', 'genes', ',', '5', 'namely', ',', 'poliovirus', 'receptor', '–', 'related', '2', '(', 'PVRL2', '[', 'OMIM', '*600798', ']', ')', ',', 'translocase', 'of', 'outer', 'mitochondrial', 'membrane', '40', 'yeast', 'homologue', '(', 'TOMM40']	[2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 3, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 3, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Amplification of the V4 region was performed in 50-μl reactions composed of 1 × polymerase buffer, 200 μM each dNTP, 2.5 mM MgSO4, 500 nM forward primers, 300 nM reverse primer, 1 U of Platinum Taq DNA Polymerase High-Fidelity enzyme (Life Technologies, Grand Island, NY, USA) and 20–50 ng of gDNA.	[('PMC3358035', 'M04000', 80, 90, 'polymerase')]	['Am', '##p', '##lification', 'of', 'the', 'V', '##4', 'region', 'was', 'performed', 'in', '50', '-', 'μ', '##l', 'reactions', 'composed', 'of', '1', '×', 'polymer', '##ase', 'buffer', ',', '200', 'μ', '##M', 'each', 'd', '##NT', '##P', ',', '2', '.', '5', 'm', '##M', 'M', '##g', '##SO', '##4', ',', '500', 'n', '##M', 'forward', 'prime', '##rs', ',', '300', 'n', '##M', 'reverse', 'prime', '##r', ',', '1', 'U', 'of', 'Platinum', 'Ta', '##q', 'DNA', 'Pol', '##yme', '##rase', 'High', '-', 'Fi', '##delity', 'enzyme', '(', 'Life', 'Technologies', ',', 'Grand', 'Island', ',', 'NY', ',', 'USA', ')', 'and', '20', '–', '50', 'ng', 'of', 'g', '##D', '##NA', '.']	[0, 2, 3, 14, 17, 21, 22, 24, 31, 35, 45, 48, 50, 51, 52, 54, 64, 73, 76, 78, 80, 87, 91, 97, 99, 103, 104, 106, 111, 112, 114, 115, 117, 118, 119, 121, 122, 124, 125, 126, 128, 129, 131, 135, 136, 138, 146, 151, 153, 155, 159, 160, 162, 170, 175, 176, 178, 180, 182, 185, 194, 196, 198, 202, 205, 208, 213, 217, 218, 220, 227, 234, 235, 240, 252, 254, 260, 266, 268, 270, 272, 275, 277, 281, 283, 284, 287, 290, 293, 294, 295, 297]	[2, 3, 13, 16, 20, 22, 23, 30, 34, 44, 47, 50, 51, 52, 53, 63, 72, 75, 77, 79, 87, 90, 97, 98, 102, 104, 105, 110, 112, 114, 115, 116, 118, 119, 120, 122, 123, 125, 126, 128, 129, 130, 134, 136, 137, 145, 151, 153, 154, 158, 160, 161, 169, 175, 176, 177, 179, 181, 184, 193, 196, 197, 201, 205, 208, 212, 217, 218, 220, 226, 233, 235, 239, 252, 253, 259, 266, 267, 270, 271, 275, 276, 280, 283, 284, 286, 289, 292, 294, 295, 297, 298]	['Amplification', 'of', 'the', 'V4', 'region', 'was', 'performed', 'in', '50-μl', 'reactions', 'composed', 'of', '1', '×', 'polymerase', 'buffer', ',', '200', 'μM', 'each', 'dNTP', ',', '2.5', 'mM', 'MgSO4', ',', '500', 'nM', 'forward', 'primers', ',', '300', 'nM', 'reverse', 'primer', ',', '1', 'U', 'of', 'Platinum', 'Taq', 'DNA', 'Polymerase', 'High-Fidelity', 'enzyme', '(', 'Life', 'Technologies', ',', 'Grand', 'Island', ',', 'NY', ',', 'USA', ')', 'and', '20–', '50', 'ng', 'of', 'gDNA', '.']	[3, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 3, 1, 3, 2, 4, 1, 1, 2, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We utilized a vaccinia-specific neutralization assay using β-galactosidase expressing vaccinia virus, as previously described [12;13].	[('PMC3367131', 'M01000', 59, 74, 'β-galactosidase')]	['We', 'utilized', 'a', 'v', '##ac', '##cini', '##a', '-', 'specific', 'neutral', '##ization', 'ass', '##ay', 'using', 'β', '-', 'gal', '##act', '##os', '##idas', '##e', 'expressing', 'v', '##ac', '##cini', '##a', 'virus', ',', 'as', 'previously', 'described', '[', '12', ';', '13', ']', '.']	[0, 3, 12, 14, 15, 17, 21, 22, 23, 32, 39, 47, 50, 53, 59, 60, 61, 64, 67, 69, 73, 75, 86, 87, 89, 93, 95, 100, 102, 105, 116, 126, 127, 129, 130, 132, 133]	[2, 11, 13, 15, 17, 21, 22, 23, 31, 39, 46, 50, 52, 58, 60, 61, 64, 67, 69, 73, 74, 85, 87, 89, 93, 94, 100, 101, 104, 115, 125, 127, 129, 130, 132, 133, 134]	['We', 'utilized', 'a', 'vaccinia', '-', 'specific', 'neutralization', 'assay', 'using', 'β-galactosidase', 'expressing', 'vaccinia', 'virus', ',', 'as', 'previously', 'described', '[', '12', ';', '13', ']', '.']	[1, 1, 1, 4, 1, 1, 2, 2, 1, 7, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alanine and tyrosine, which are the substrates of alanine transaminase (ALT) and aspartate aminotransferase (AST), respectively, were upregulated in HBCG.	[('PMC3368351', 'R02000', 50, 70, 'alanine transaminase')]	['Alan', '##ine', 'and', 't', '##yr', '##os', '##ine', ',', 'which', 'are', 'the', 'substrates', 'of', 'al', '##ani', '##ne', 'trans', '##ami', '##nas', '##e', '(', 'AL', '##T', ')', 'and', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'respectively', ',', 'were', 'up', '##re', '##gu', '##lated', 'in', 'H', '##BC', '##G', '.']	[0, 4, 8, 12, 13, 15, 17, 20, 22, 28, 32, 36, 47, 50, 52, 55, 58, 63, 66, 69, 71, 72, 74, 75, 77, 81, 83, 86, 91, 96, 99, 101, 104, 108, 109, 111, 112, 113, 115, 127, 129, 134, 136, 138, 140, 146, 149, 150, 152, 153]	[4, 7, 11, 13, 15, 17, 20, 21, 27, 31, 35, 46, 49, 52, 55, 57, 63, 66, 69, 70, 72, 74, 75, 76, 80, 83, 86, 90, 96, 99, 101, 104, 107, 109, 111, 112, 113, 114, 127, 128, 133, 136, 138, 140, 145, 148, 150, 152, 153, 154]	['Alanine', 'and', 'tyrosine', ',', 'which', 'are', 'the', 'substrates', 'of', 'alanine', 'transaminase', '(', 'ALT', ')', 'and', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'respectively', ',', 'were', 'upregulated', 'in', 'HBCG', '.']	[2, 1, 4, 1, 1, 1, 1, 1, 1, 3, 4, 1, 2, 1, 1, 3, 5, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The association between an intronic SNP in ubiquitin-specific peptidase 8 (USP8 [MIM 603158], also referred to as USPy), rs7174015, and five sperm parameters (total volume, total sperm count, total motile sperm count, average velocity, and mean ALH) is particularly noteworthy.	[]	['The', 'association', 'between', 'an', 'intro', '##nic', 'S', '##NP', 'in', 'u', '##bi', '##qui', '##tin', '-', 'specific', 'p', '##ept', '##idas', '##e', '8', '(', 'US', '##P', '##8', '[', 'MI', '##M', '60', '##31', '##5', '##8', ']', ',', 'also', 'referred', 'to', 'as', 'US', '##P', '##y', ')', ',', 'r', '##s', '##7', '##17', '##40', '##15', ',', 'and', 'five', 'sperm', 'parameters', '(', 'total', 'volume', ',', 'total', 'sperm', 'count', ',', 'total', 'm', '##ot', '##ile', 'sperm', 'count', ',', 'average', 'velocity', ',', 'and', 'mean', 'AL', '##H', ')', 'is', 'particularly', 'noteworthy', '.']	[0, 4, 16, 24, 27, 32, 36, 37, 40, 43, 44, 46, 49, 52, 53, 62, 63, 66, 70, 72, 74, 75, 77, 78, 80, 81, 83, 85, 87, 89, 90, 91, 92, 94, 99, 108, 111, 114, 116, 117, 118, 119, 121, 122, 123, 124, 126, 128, 130, 132, 136, 141, 147, 158, 159, 165, 171, 173, 179, 185, 190, 192, 198, 199, 201, 205, 211, 216, 218, 226, 234, 236, 240, 245, 247, 248, 250, 253, 266, 276]	[3, 15, 23, 26, 32, 35, 37, 39, 42, 44, 46, 49, 52, 53, 61, 63, 66, 70, 71, 73, 75, 77, 78, 79, 81, 83, 84, 87, 89, 90, 91, 92, 93, 98, 107, 110, 113, 116, 117, 118, 119, 120, 122, 123, 124, 126, 128, 130, 131, 135, 140, 146, 157, 159, 164, 171, 172, 178, 184, 190, 191, 197, 199, 201, 204, 210, 216, 217, 225, 234, 235, 239, 244, 247, 248, 249, 252, 265, 276, 277]	['The', 'association', 'between', 'an', 'intronic', 'SNP', 'in', 'ubiquitin', '-', 'specific', 'peptidase', '8', '(', 'USP8', '[', 'MIM', '603158', ']', ',', 'also', 'referred', 'to', 'as', 'USPy', ')', ',', 'rs7174015', ',', 'and', 'five', 'sperm', 'parameters', '(', 'total', 'volume', ',', 'total', 'sperm', 'count', ',', 'total', 'motile', 'sperm', 'count', ',', 'average', 'velocity', ',', 'and', 'mean', 'ALH', ')', 'is', 'particularly', 'noteworthy', '.']	[1, 1, 1, 1, 2, 2, 1, 4, 1, 1, 4, 1, 1, 3, 1, 2, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
They can be generated from the different precursor PUFAs by three main classes of enzymes—cyclooxygenase (COX), lipoxygenase (LOX), and cytochrome P450 (CYP450)—and thus form a complex pool of bioactive components (Fig. 1).	[]	['They', 'can', 'be', 'generated', 'from', 'the', 'different', 'precursor', 'P', '##U', '##FA', '##s', 'by', 'three', 'main', 'classes', 'of', 'enzymes', '—', 'c', '##y', '##c', '##lo', '##ox', '##y', '##gen', '##ase', '(', 'CO', '##X', ')', ',', 'lip', '##ox', '##y', '##gen', '##ase', '(', 'L', '##OX', ')', ',', 'and', 'c', '##yt', '##och', '##rome', 'P', '##45', '##0', '(', 'C', '##YP', '##45', '##0', ')', '—', 'and', 'thus', 'form', 'a', 'complex', 'pool', 'of', 'bio', '##active', 'components', '(', 'Fi', '##g', '.', '1', ')', '.']	[0, 5, 9, 12, 22, 27, 31, 41, 51, 52, 53, 55, 57, 60, 66, 71, 79, 82, 89, 90, 91, 92, 93, 95, 97, 98, 101, 105, 106, 108, 109, 110, 112, 115, 117, 118, 121, 125, 126, 127, 129, 130, 132, 136, 137, 139, 142, 147, 148, 150, 152, 153, 154, 156, 158, 159, 160, 161, 165, 170, 175, 177, 185, 190, 193, 196, 203, 214, 215, 217, 218, 220, 221, 222]	[4, 8, 11, 21, 26, 30, 40, 50, 52, 53, 55, 56, 59, 65, 70, 78, 81, 89, 90, 91, 92, 93, 95, 97, 98, 101, 104, 106, 108, 109, 110, 111, 115, 117, 118, 121, 124, 126, 127, 129, 130, 131, 135, 137, 139, 142, 146, 148, 150, 151, 153, 154, 156, 158, 159, 160, 161, 164, 169, 174, 176, 184, 189, 192, 196, 202, 213, 215, 217, 218, 219, 221, 222, 223]	['They', 'can', 'be', 'generated', 'from', 'the', 'different', 'precursor', 'PUFAs', 'by', 'three', 'main', 'classes', 'of', 'enzymes', '—', 'cyclooxygenase', '(', 'COX', ')', ',', 'lipoxygenase', '(', 'LOX', ')', ',', 'and', 'cytochrome', 'P450', '(', 'CYP450', ')', '—', 'and', 'thus', 'form', 'a', 'complex', 'pool', 'of', 'bioactive', 'components', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 8, 1, 2, 1, 1, 5, 1, 2, 1, 1, 1, 4, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Prostaglandins (PG) and thromboxanes (TX) are generated via the initial oxidation through COX pathways [4].	[]	['Pro', '##sta', '##g', '##land', '##ins', '(', 'P', '##G', ')', 'and', 'th', '##rom', '##box', '##ane', '##s', '(', 'TX', ')', 'are', 'generated', 'via', 'the', 'initial', 'oxidation', 'through', 'CO', '##X', 'pathways', '[', '4', ']', '.']	[0, 3, 6, 7, 11, 15, 16, 17, 18, 20, 24, 26, 29, 32, 35, 37, 38, 40, 42, 46, 56, 60, 64, 72, 82, 90, 92, 94, 103, 104, 105, 106]	[3, 6, 7, 11, 14, 16, 17, 18, 19, 23, 26, 29, 32, 35, 36, 38, 40, 41, 45, 55, 59, 63, 71, 81, 89, 92, 93, 102, 104, 105, 106, 107]	['Prostaglandins', '(', 'PG', ')', 'and', 'thromboxanes', '(', 'TX', ')', 'are', 'generated', 'via', 'the', 'initial', 'oxidation', 'through', 'COX', 'pathways', '[', '4', ']', '.']	[5, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To avoid any effects of heparin, such as increased levels of oxylipins by heparin induced phopholipase A2 activity, described in literature [40, 41], samples collected during the period in which heparin was administered to the patient were not used.	[('PMC3426673', 'M02000', 90, 105, 'phopholipase A2')]	['To', 'avoid', 'any', 'effects', 'of', 'he', '##par', '##in', ',', 'such', 'as', 'increased', 'levels', 'of', 'o', '##xy', '##lip', '##ins', 'by', 'he', '##par', '##in', 'induced', 'p', '##hop', '##hol', '##ip', '##ase', 'A2', 'activity', ',', 'described', 'in', 'literature', '[', '40', ',', '41', ']', ',', 'samples', 'collected', 'during', 'the', 'period', 'in', 'which', 'he', '##par', '##in', 'was', 'administered', 'to', 'the', 'patient', 'were', 'not', 'used', '.']	[0, 3, 9, 13, 21, 24, 26, 29, 31, 33, 38, 41, 51, 58, 61, 62, 64, 67, 71, 74, 76, 79, 82, 90, 91, 94, 97, 99, 103, 106, 114, 116, 126, 129, 140, 141, 143, 145, 147, 148, 150, 158, 168, 175, 179, 186, 189, 195, 197, 200, 203, 207, 220, 223, 227, 235, 240, 244, 248]	[2, 8, 12, 20, 23, 26, 29, 31, 32, 37, 40, 50, 57, 60, 62, 64, 67, 70, 73, 76, 79, 81, 89, 91, 94, 97, 99, 102, 105, 114, 115, 125, 128, 139, 141, 143, 144, 147, 148, 149, 157, 167, 174, 178, 185, 188, 194, 197, 200, 202, 206, 219, 222, 226, 234, 239, 243, 248, 249]	['To', 'avoid', 'any', 'effects', 'of', 'heparin', ',', 'such', 'as', 'increased', 'levels', 'of', 'oxylipins', 'by', 'heparin', 'induced', 'phopholipase', 'A2', 'activity', ',', 'described', 'in', 'literature', '[', '40', ',', '41', ']', ',', 'samples', 'collected', 'during', 'the', 'period', 'in', 'which', 'heparin', 'was', 'administered', 'to', 'the', 'patient', 'were', 'not', 'used', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We genotyped rs2075650 and APOE SNP rs429358 in our replication samples (Supplementary Material, Table S2) and confirmed the known protective effect of the C allele of rs429358 (P = 2.8 × 10−6; heterogeneity P = 0.04; OR = 0.68; 95% CI = 0.58–0.80) and the association with rs2075650 (P = 0.0037; OR = 0.78; 95% CI = 0.67–0.92 for allele G), although some heterogeneity across the follow-up samples was observed (P = 0.03) (Table 3).	[]	['We', 'g', '##eno', '##type', '##d', 'r', '##s', '##20', '##75', '##65', '##0', 'and', 'AP', '##OE', 'S', '##NP', 'r', '##s', '##42', '##9', '##35', '##8', 'in', 'our', 'replication', 'samples', '(', 'Su', '##pp', '##lement', '##ary', 'Material', ',', 'Table', 'S', '##2', ')', 'and', 'confirmed', 'the', 'known', 'protective', 'effect', 'of', 'the', 'C', 'all', '##ele', 'of', 'r', '##s', '##42', '##9', '##35', '##8', '(', 'P', '=', '2', '.', '8', '×', '10', '##−', '##6', ';', 'he', '##tero', '##gene', '##ity', 'P', '=', '0', '.', '04', ';', 'OR', '=', '0', '.', '68', ';', '95', '%', 'C', '##I', '=', '0', '.', '58', '–', '0', '.', '80', ')', 'and', 'the', 'association', 'with', 'r', '##s', '##20', '##75', '##65', '##0', '(', 'P', '=', '0', '.', '00', '##37', ';', 'OR', '=', '0', '.', '78', ';', '95', '%', 'C', '##I', '=', '0', '.', '67', '–', '0', '.', '92', 'for', 'all', '##ele', 'G', ')', ',', 'although', 'some', 'he', '##tero', '##gene', '##ity', 'across', 'the', 'follow', '-', 'up', 'samples', 'was', 'observed', '(', 'P', '=', '0', '.', '03', ')', '(', 'Table', '3', ')', '.']	[0, 3, 4, 7, 11, 13, 14, 15, 17, 19, 21, 23, 27, 29, 32, 33, 36, 37, 38, 40, 41, 43, 45, 48, 52, 64, 72, 73, 75, 77, 83, 87, 95, 97, 103, 104, 105, 107, 111, 121, 125, 131, 142, 149, 152, 156, 158, 161, 165, 168, 169, 170, 172, 173, 175, 177, 178, 180, 182, 183, 184, 186, 188, 190, 191, 192, 194, 196, 200, 204, 208, 210, 212, 213, 214, 216, 218, 221, 223, 224, 225, 227, 229, 231, 233, 234, 236, 238, 239, 240, 242, 243, 244, 245, 247, 249, 253, 257, 269, 274, 275, 276, 278, 280, 282, 284, 285, 287, 289, 290, 291, 293, 295, 297, 300, 302, 303, 304, 306, 308, 310, 312, 313, 315, 317, 318, 319, 321, 322, 323, 324, 327, 331, 334, 338, 339, 340, 342, 351, 356, 358, 362, 366, 370, 377, 381, 387, 388, 391, 399, 403, 412, 413, 415, 417, 418, 419, 421, 423, 424, 430, 431, 432]	[2, 4, 7, 11, 12, 14, 15, 17, 19, 21, 22, 26, 29, 31, 33, 35, 37, 38, 40, 41, 43, 44, 47, 51, 63, 71, 73, 75, 77, 83, 86, 95, 96, 102, 104, 105, 106, 110, 120, 124, 130, 141, 148, 151, 155, 157, 161, 164, 167, 169, 170, 172, 173, 175, 176, 178, 179, 181, 183, 184, 185, 187, 190, 191, 192, 193, 196, 200, 204, 207, 209, 211, 213, 214, 216, 217, 220, 222, 224, 225, 227, 228, 231, 232, 234, 235, 237, 239, 240, 242, 243, 244, 245, 247, 248, 252, 256, 268, 273, 275, 276, 278, 280, 282, 283, 285, 286, 288, 290, 291, 293, 295, 296, 299, 301, 303, 304, 306, 307, 310, 311, 313, 314, 316, 318, 319, 321, 322, 323, 324, 326, 330, 334, 337, 339, 340, 341, 350, 355, 358, 362, 366, 369, 376, 380, 387, 388, 390, 398, 402, 411, 413, 414, 416, 418, 419, 421, 422, 424, 429, 431, 432, 433]	['We', 'genotyped', 'rs2075650', 'and', 'APOE', 'SNP', 'rs429358', 'in', 'our', 'replication', 'samples', '(', 'Supplementary', 'Material', ',', 'Table', 'S2', ')', 'and', 'confirmed', 'the', 'known', 'protective', 'effect', 'of', 'the', 'C', 'allele', 'of', 'rs429358', '(', 'P', '=', '2.8', '×', '10−6', ';', 'heterogeneity', 'P', '=', '0.04', ';', 'OR', '=', '0.68', ';', '95%', 'CI', '=', '0.58', '–', '0.80', ')', 'and', 'the', 'association', 'with', 'rs2075650', '(', 'P', '=', '0.0037', ';', 'OR', '=', '0.78', ';', '95%', 'CI', '=', '0.67', '–', '0.92', 'for', 'allele', 'G', ')', ',', 'although', 'some', 'heterogeneity', 'across', 'the', 'follow', '-', 'up', 'samples', 'was', 'observed', '(', 'P', '=', '0.03', ')', '(', 'Table', '3', ')', '.']	[1, 4, 6, 1, 2, 2, 6, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 6, 1, 1, 1, 3, 1, 3, 1, 4, 1, 1, 3, 1, 1, 1, 3, 1, 2, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 4, 1, 1, 1, 3, 1, 2, 2, 1, 3, 1, 3, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
First, the sterol-C4-Methyl oxidase-like (SC4MOL) gene has been shown to be under-expressed in an animal model of T2D and to play a key role in cholesterol biosynthesis with implications for the regulation of energy metabolism, obesity and dyslipidemia (11–15).	[('PMC3459464', 'D01000', 11, 35, 'sterol-C4-Methyl oxidase')]	['First', ',', 'the', 's', '##tero', '##l', '-', 'C', '##4', '-', 'Met', '##hyl', 'o', '##xi', '##das', '##e', '-', 'like', '(', 'SC', '##4', '##MO', '##L', ')', 'gene', 'has', 'been', 'shown', 'to', 'be', 'under', '-', 'expressed', 'in', 'an', 'animal', 'model', 'of', 'T', '##2', '##D', 'and', 'to', 'play', 'a', 'key', 'role', 'in', 'ch', '##ole', '##ster', '##ol', 'bio', '##sy', '##nt', '##hesis', 'with', 'implications', 'for', 'the', 'regulation', 'of', 'energy', 'metabolism', ',', 'o', '##besity', 'and', 'd', '##ys', '##lip', '##ide', '##mia', '(', '11', '–', '15', ')', '.']	[0, 5, 7, 11, 12, 16, 17, 18, 19, 20, 21, 24, 28, 29, 31, 34, 35, 36, 41, 42, 44, 45, 47, 48, 50, 55, 59, 64, 70, 73, 76, 81, 82, 92, 95, 98, 105, 111, 114, 115, 116, 118, 122, 125, 130, 132, 136, 141, 144, 146, 149, 153, 156, 159, 161, 163, 169, 174, 187, 191, 195, 206, 209, 216, 226, 228, 229, 236, 240, 241, 243, 246, 249, 253, 254, 256, 257, 259, 260]	[5, 6, 10, 12, 16, 17, 18, 19, 20, 21, 24, 27, 29, 31, 34, 35, 36, 40, 42, 44, 45, 47, 48, 49, 54, 58, 63, 69, 72, 75, 81, 82, 91, 94, 97, 104, 110, 113, 115, 116, 117, 121, 124, 129, 131, 135, 140, 143, 146, 149, 153, 155, 159, 161, 163, 168, 173, 186, 190, 194, 205, 208, 215, 226, 227, 229, 235, 239, 241, 243, 246, 249, 252, 254, 256, 257, 259, 260, 261]	['First', ',', 'the', 'sterol-C4-Methyl', 'oxidase', '-', 'like', '(', 'SC4MOL', ')', 'gene', 'has', 'been', 'shown', 'to', 'be', 'under', '-', 'expressed', 'in', 'an', 'animal', 'model', 'of', 'T2D', 'and', 'to', 'play', 'a', 'key', 'role', 'in', 'cholesterol', 'biosynthesis', 'with', 'implications', 'for', 'the', 'regulation', 'of', 'energy', 'metabolism', ',', 'obesity', 'and', 'dyslipidemia', '(', '11–', '15', ')', '.']	[1, 1, 1, 9, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Forward primers were tagged with 10 bp unique barcode labels at the 5′ end along with the adaptor sequence (5′-CCATCTCATCCCTGCGTGTCTCCGACTCAG-3′) to allow multiple samples to be included in a single 454 GS FLX Titanium sequencing plate as previously described [15].	[]	['Forward', 'prime', '##rs', 'were', 'tag', '##ged', 'with', '10', 'b', '##p', 'unique', 'bar', '##code', 'labels', 'at', 'the', '5', '′', 'end', 'along', 'with', 'the', 'adapt', '##or', 'sequence', '(', '5', '′', '-', 'CC', '##AT', '##CT', '##CA', '##TC', '##CC', '##T', '##GC', '##G', '##T', '##G', '##TC', '##TC', '##C', '##GA', '##CT', '##CA', '##G', '-', '3', '′', ')', 'to', 'allow', 'multiple', 'samples', 'to', 'be', 'included', 'in', 'a', 'single', '45', '##4', 'G', '##S', 'FL', '##X', 'Titan', '##ium', 'se', '##quencing', 'plate', 'as', 'previously', 'described', '[', '15', ']', '.']	[0, 8, 13, 16, 21, 24, 28, 33, 36, 37, 39, 46, 49, 54, 61, 64, 68, 69, 71, 75, 81, 86, 90, 95, 98, 107, 108, 109, 110, 111, 113, 115, 117, 119, 121, 123, 124, 126, 127, 128, 129, 131, 133, 134, 136, 138, 140, 141, 142, 143, 144, 146, 149, 155, 164, 172, 175, 178, 187, 190, 192, 199, 201, 203, 204, 206, 208, 210, 215, 219, 221, 230, 236, 239, 250, 260, 261, 263, 264]	[7, 13, 15, 20, 24, 27, 32, 35, 37, 38, 45, 49, 53, 60, 63, 67, 69, 70, 74, 80, 85, 89, 95, 97, 106, 108, 109, 110, 111, 113, 115, 117, 119, 121, 123, 124, 126, 127, 128, 129, 131, 133, 134, 136, 138, 140, 141, 142, 143, 144, 145, 148, 154, 163, 171, 174, 177, 186, 189, 191, 198, 201, 202, 204, 205, 208, 209, 215, 218, 221, 229, 235, 238, 249, 259, 261, 263, 264, 265]	['Forward', 'primers', 'were', 'tagged', 'with', '10', 'bp', 'unique', 'barcode', 'labels', 'at', 'the', '5′', 'end', 'along', 'with', 'the', 'adaptor', 'sequence', '(', '5′-CCATCTCATCCCTGCGTGTCTCCGACTCAG-3′', ')', 'to', 'allow', 'multiple', 'samples', 'to', 'be', 'included', 'in', 'a', 'single', '454', 'GS', 'FLX', 'Titanium', 'sequencing', 'plate', 'as', 'previously', 'described', '[', '15', ']', '.']	[1, 2, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 24, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The first 500 bp of the 16S rRNA genes were amplified with the universal eubacterial primers 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) and 338R (5′-GCCTTGCCAGCCCGCTCAGGC-3′) using the high-fidelity AB-gene DNA polymerase (Thermo Scientific) with an annealing temperature of 52°C and 20 cycles to minimize PCR biases (41).	[('PMC3486223', 'M05000', 197, 211, 'DNA polymerase')]	['The', 'first', '500', 'b', '##p', 'of', 'the', '16', '##S', 'r', '##RNA', 'genes', 'were', 'am', '##plified', 'with', 'the', 'universal', 'e', '##uba', '##cter', '##ial', 'prime', '##rs', '27', '##F', '(', '5', '′', '-', 'AG', '##AG', '##TT', '##T', '##GA', '##TC', '##MT', '##G', '##GC', '##TC', '##AG', '-', '3', '′', ')', 'and', '33', '##8', '##R', '(', '5', '′', '-', 'G', '##CC', '##TT', '##GC', '##CA', '##GC', '##CC', '##GC', '##TC', '##AG', '##GC', '-', '3', '′', ')', 'using', 'the', 'high', '-', 'fi', '##delity', 'AB', '-', 'gene', 'DNA', 'polymer', '##ase', '(', 'The', '##rm', '##o', 'Scientific', ')', 'with', 'an', 'an', '##nea', '##ling', 'temperature', 'of', '52', '##°', '##C', 'and', '20', 'cycles', 'to', 'minimize', 'PC', '##R', 'bias', '##es', '(', '41', ')', '.']	[0, 4, 10, 14, 15, 17, 20, 24, 26, 28, 29, 33, 39, 44, 46, 54, 59, 63, 73, 74, 77, 81, 85, 90, 93, 95, 97, 98, 99, 100, 101, 103, 105, 107, 108, 110, 112, 114, 115, 117, 119, 121, 122, 123, 124, 126, 130, 132, 133, 135, 136, 137, 138, 139, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 161, 162, 163, 165, 171, 175, 179, 180, 182, 189, 191, 192, 197, 201, 208, 212, 213, 216, 218, 220, 230, 232, 237, 240, 242, 245, 250, 262, 265, 267, 268, 270, 274, 277, 284, 287, 296, 298, 300, 304, 307, 308, 310, 311]	[3, 9, 13, 15, 16, 19, 23, 26, 27, 29, 32, 38, 43, 46, 53, 58, 62, 72, 74, 77, 81, 84, 90, 92, 95, 96, 98, 99, 100, 101, 103, 105, 107, 108, 110, 112, 114, 115, 117, 119, 121, 122, 123, 124, 125, 129, 132, 133, 134, 136, 137, 138, 139, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 161, 162, 163, 164, 170, 174, 179, 180, 182, 188, 191, 192, 196, 200, 208, 211, 213, 216, 218, 219, 230, 231, 236, 239, 242, 245, 249, 261, 264, 267, 268, 269, 273, 276, 283, 286, 295, 298, 299, 304, 306, 308, 310, 311, 312]	['The', 'first', '500', 'bp', 'of', 'the', '16S', 'rRNA', 'genes', 'were', 'amplified', 'with', 'the', 'universal', 'eubacterial', 'primers', '27F', '(', '5′-AGAGTTTGATCMTGGCTCAG-3′', ')', 'and', '338R', '(', '5′-GCCTTGCCAGCCCGCTCAGGC-3′', ')', 'using', 'the', 'high', '-', 'fidelity', 'AB-gene', 'DNA', 'polymerase', '(', 'Thermo', 'Scientific', ')', 'with', 'an', 'annealing', 'temperature', 'of', '52°C', 'and', '20', 'cycles', 'to', 'minimize', 'PCR', 'biases', '(', '41', ')', '.']	[1, 1, 1, 2, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 4, 2, 2, 1, 17, 1, 1, 3, 1, 17, 1, 1, 1, 1, 1, 2, 3, 1, 2, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PYGL, glycogen phosphorylase, is a target of adenosine monophosphate (http://www.drugbank.ca/drugs/DB00131), which plays a critical role in response to antileukemic agents such as mercaptopurine and methotrexate.27 Interestingly, PYGL expression in diagnostic ALL blasts was shown to be positively correlated with in vitro response to prednisolone in 173 children with ALL (P = .002).28	[]	['P', '##Y', '##G', '##L', ',', 'g', '##ly', '##co', '##gen', 'p', '##hos', '##ph', '##ory', '##lase', ',', 'is', 'a', 'target', 'of', 'ad', '##eno', '##sin', '##e', 'mon', '##op', '##hos', '##phate', '(', 'http', ':', '/', '/', 'www', '.', 'drug', '##bank', '.', 'ca', '/', 'drugs', '/', 'DB', '##00', '##13', '##1', ')', ',', 'which', 'plays', 'a', 'critical', 'role', 'in', 'response', 'to', 'anti', '##le', '##uke', '##mic', 'agents', 'such', 'as', 'me', '##rca', '##pt', '##op', '##uri', '##ne', 'and', 'met', '##hot', '##re', '##xa', '##te', '.', '27', 'Interest', '##ingly', ',', 'P', '##Y', '##G', '##L', 'expression', 'in', 'diagnostic', 'AL', '##L', 'blast', '##s', 'was', 'shown', 'to', 'be', 'positively', 'correlated', 'with', 'in', 'v', '##it', '##ro', 'response', 'to', 'pre', '##dn', '##is', '##olo', '##ne', 'in', '173', 'children', 'with', 'AL', '##L', '(', 'P', '=', '.', '00', '##2', ')', '.', '28']	[0, 1, 2, 3, 4, 6, 7, 9, 11, 15, 16, 19, 21, 24, 28, 30, 33, 35, 42, 45, 47, 50, 53, 55, 58, 60, 63, 69, 70, 74, 75, 76, 77, 80, 81, 85, 89, 90, 92, 93, 98, 99, 101, 103, 105, 106, 107, 109, 115, 121, 123, 132, 137, 140, 149, 152, 156, 158, 161, 165, 172, 177, 180, 182, 185, 187, 189, 192, 195, 199, 202, 205, 207, 209, 211, 212, 215, 223, 228, 230, 231, 232, 233, 235, 246, 249, 260, 262, 264, 269, 271, 275, 281, 284, 287, 298, 309, 314, 317, 318, 320, 323, 332, 335, 338, 340, 342, 345, 348, 351, 355, 364, 369, 371, 373, 374, 376, 378, 379, 381, 382, 383, 384]	[1, 2, 3, 4, 5, 7, 9, 11, 14, 16, 19, 21, 24, 28, 29, 32, 34, 41, 44, 47, 50, 53, 54, 58, 60, 63, 68, 70, 74, 75, 76, 77, 80, 81, 85, 89, 90, 92, 93, 98, 99, 101, 103, 105, 106, 107, 108, 114, 120, 122, 131, 136, 139, 148, 151, 156, 158, 161, 164, 171, 176, 179, 182, 185, 187, 189, 192, 194, 198, 202, 205, 207, 209, 211, 212, 214, 223, 228, 229, 231, 232, 233, 234, 245, 248, 259, 262, 263, 269, 270, 274, 280, 283, 286, 297, 308, 313, 316, 318, 320, 322, 331, 334, 338, 340, 342, 345, 347, 350, 354, 363, 368, 371, 372, 374, 375, 377, 379, 381, 382, 383, 384, 386]	['PYGL', ',', 'glycogen', 'phosphorylase', ',', 'is', 'a', 'target', 'of', 'adenosine', 'monophosphate', '(', 'http', ':', '/', '/', 'www.drugbank.ca', '/', 'drugs', '/', 'DB00131', ')', ',', 'which', 'plays', 'a', 'critical', 'role', 'in', 'response', 'to', 'antileukemic', 'agents', 'such', 'as', 'mercaptopurine', 'and', 'methotrexate.27', 'Interestingly', ',', 'PYGL', 'expression', 'in', 'diagnostic', 'ALL', 'blasts', 'was', 'shown', 'to', 'be', 'positively', 'correlated', 'with', 'in', 'vitro', 'response', 'to', 'prednisolone', 'in', '173', 'children', 'with', 'ALL', '(', 'P', '=', '.', '002).28']	[4, 1, 4, 5, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 6, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 6, 1, 7, 2, 1, 4, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PYGL has also been shown to be significantly overexpressed in a multidrug-resistant cancer cell line.29 Another interesting hit among the top-ranking genes is PDE4B, which encodes phosphodiesterase 4B, the primary regulator of cyclic AMP signaling in B lymphocytes.30,31 Prior studies have already shown that inhibition of PDE4B induces apoptosis in chronic lymphoblastic leukemia and diffuse large cell lymphoma32,33 and sensitizes cells to glucocorticoid-induced cell death.34,35	[]	['P', '##Y', '##G', '##L', 'has', 'also', 'been', 'shown', 'to', 'be', 'significantly', 'over', '##ex', '##pressed', 'in', 'a', 'multi', '##dr', '##ug', '-', 'resistant', 'cancer', 'cell', 'line', '.', '29', 'Another', 'interesting', 'hit', 'among', 'the', 'top', '-', 'ranking', 'genes', 'is', 'PD', '##E', '##4', '##B', ',', 'which', 'en', '##codes', 'p', '##hos', '##ph', '##odies', '##tera', '##se', '4', '##B', ',', 'the', 'primary', 'regulator', 'of', 'c', '##yclic', 'AM', '##P', 'signaling', 'in', 'B', 'l', '##ymph', '##ocytes', '.', '30', ',', '31', 'Prior', 'studies', 'have', 'already', 'shown', 'that', 'in', '##hibition', 'of', 'PD', '##E', '##4', '##B', 'induce', '##s', 'a', '##pop', '##tosis', 'in', 'chronic', 'l', '##ymph', '##ob', '##lastic', 'le', '##uke', '##mia', 'and', 'di', '##ff', '##use', 'large', 'cell', 'l', '##ymph', '##oma', '##32', ',', '33', 'and', 'se', '##ns', '##iti', '##zes', 'cells', 'to', 'g', '##lu', '##co', '##cor', '##tic', '##oid', '-', 'induced', 'cell', 'death', '.', '34', ',', '35']	[0, 1, 2, 3, 5, 9, 14, 19, 25, 28, 31, 45, 49, 51, 59, 62, 64, 69, 71, 73, 74, 84, 91, 96, 100, 101, 104, 112, 124, 128, 134, 138, 141, 142, 150, 156, 159, 161, 162, 163, 164, 166, 172, 174, 180, 181, 184, 186, 191, 195, 198, 199, 200, 202, 206, 214, 224, 227, 228, 234, 236, 238, 248, 251, 253, 254, 258, 264, 265, 267, 268, 271, 277, 285, 290, 298, 304, 309, 311, 320, 323, 325, 326, 327, 329, 335, 337, 338, 341, 347, 350, 358, 359, 363, 365, 372, 374, 377, 381, 385, 387, 389, 393, 399, 404, 405, 409, 412, 414, 415, 418, 422, 424, 426, 429, 433, 439, 442, 443, 445, 447, 450, 453, 456, 457, 465, 470, 475, 476, 478, 479]	[1, 2, 3, 4, 8, 13, 18, 24, 27, 30, 44, 49, 51, 58, 61, 63, 69, 71, 73, 74, 83, 90, 95, 100, 101, 103, 111, 123, 127, 133, 137, 141, 142, 149, 155, 158, 161, 162, 163, 164, 165, 171, 174, 179, 181, 184, 186, 191, 195, 197, 199, 200, 201, 205, 213, 223, 226, 228, 233, 236, 237, 247, 250, 252, 254, 258, 264, 265, 267, 268, 270, 276, 284, 289, 297, 303, 308, 311, 319, 322, 325, 326, 327, 328, 335, 336, 338, 341, 346, 349, 357, 359, 363, 365, 371, 374, 377, 380, 384, 387, 389, 392, 398, 403, 405, 409, 412, 414, 415, 417, 421, 424, 426, 429, 432, 438, 441, 443, 445, 447, 450, 453, 456, 457, 464, 469, 475, 476, 478, 479, 481]	['PYGL', 'has', 'also', 'been', 'shown', 'to', 'be', 'significantly', 'overexpressed', 'in', 'a', 'multidrug', '-', 'resistant', 'cancer', 'cell', 'line.29', 'Another', 'interesting', 'hit', 'among', 'the', 'top', '-', 'ranking', 'genes', 'is', 'PDE4B', ',', 'which', 'encodes', 'phosphodiesterase', '4B', ',', 'the', 'primary', 'regulator', 'of', 'cyclic', 'AMP', 'signaling', 'in', 'B', 'lymphocytes.30', ',', '31', 'Prior', 'studies', 'have', 'already', 'shown', 'that', 'inhibition', 'of', 'PDE4B', 'induces', 'apoptosis', 'in', 'chronic', 'lymphoblastic', 'leukemia', 'and', 'diffuse', 'large', 'cell', 'lymphoma32', ',', '33', 'and', 'sensitizes', 'cells', 'to', 'glucocorticoid', '-', 'induced', 'cell', 'death.34', ',', '35']	[4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 6, 2, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 2, 3, 1, 1, 4, 3, 1, 3, 1, 1, 4, 1, 1, 1, 4, 1, 1, 6, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To explore the mechanisms by which SNPs might influence treatment outcome of ALL, we examined the association of the 134 relapse SNPs with 4 pharmacokinetic and pharmacodynamic endophenotypes available in a subset of patients: methotrexate plasma clearance, intracellular accumulation of polyglutamated (active) methotrexate, dexamethasone plasma clearance, and asparaginase antibody levels.	[('PMC3501717', 'R04000', 362, 374, 'asparaginase')]	['To', 'explore', 'the', 'mechanisms', 'by', 'which', 'S', '##NP', '##s', 'might', 'influence', 'treatment', 'outcome', 'of', 'AL', '##L', ',', 'we', 'examined', 'the', 'association', 'of', 'the', '134', 're', '##lap', '##se', 'S', '##NP', '##s', 'with', '4', 'p', '##har', '##ma', '##co', '##kin', '##etic', 'and', 'p', '##har', '##ma', '##co', '##dynamic', 'end', '##op', '##hen', '##otype', '##s', 'available', 'in', 'a', 'subset', 'of', 'patients', ':', 'met', '##hot', '##re', '##xa', '##te', 'plasma', 'clearance', ',', 'in', '##tra', '##cellular', 'accumulation', 'of', 'p', '##oly', '##g', '##lut', '##ama', '##ted', '(', 'active', ')', 'met', '##hot', '##re', '##xa', '##te', ',', 'de', '##xa', '##met', '##has', '##one', 'plasma', 'clearance', ',', 'and', 'as', '##par', '##agi', '##nas', '##e', 'anti', '##body', 'levels', '.']	[0, 3, 11, 15, 26, 29, 35, 36, 38, 40, 46, 56, 66, 74, 77, 79, 80, 82, 85, 94, 98, 110, 113, 117, 121, 123, 126, 129, 130, 132, 134, 139, 141, 142, 145, 147, 149, 152, 157, 161, 162, 165, 167, 169, 177, 180, 182, 185, 190, 192, 202, 205, 207, 214, 217, 225, 227, 230, 233, 235, 237, 240, 247, 256, 258, 260, 263, 272, 285, 288, 289, 292, 293, 296, 299, 303, 304, 310, 312, 315, 318, 320, 322, 324, 326, 328, 330, 333, 336, 340, 347, 356, 358, 362, 364, 367, 370, 373, 375, 379, 384, 390]	[2, 10, 14, 25, 28, 34, 36, 38, 39, 45, 55, 65, 73, 76, 79, 80, 81, 84, 93, 97, 109, 112, 116, 120, 123, 126, 128, 130, 132, 133, 138, 140, 142, 145, 147, 149, 152, 156, 160, 162, 165, 167, 169, 176, 180, 182, 185, 190, 191, 201, 204, 206, 213, 216, 225, 226, 230, 233, 235, 237, 239, 246, 256, 257, 260, 263, 271, 284, 287, 289, 292, 293, 296, 299, 302, 304, 310, 311, 315, 318, 320, 322, 324, 325, 328, 330, 333, 336, 339, 346, 356, 357, 361, 364, 367, 370, 373, 374, 379, 383, 390, 391]	['To', 'explore', 'the', 'mechanisms', 'by', 'which', 'SNPs', 'might', 'influence', 'treatment', 'outcome', 'of', 'ALL', ',', 'we', 'examined', 'the', 'association', 'of', 'the', '134', 'relapse', 'SNPs', 'with', '4', 'pharmacokinetic', 'and', 'pharmacodynamic', 'endophenotypes', 'available', 'in', 'a', 'subset', 'of', 'patients', ':', 'methotrexate', 'plasma', 'clearance', ',', 'intracellular', 'accumulation', 'of', 'polyglutamated', '(', 'active', ')', 'methotrexate', ',', 'dexamethasone', 'plasma', 'clearance', ',', 'and', 'asparaginase', 'antibody', 'levels', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 6, 1, 5, 5, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 6, 1, 1, 1, 5, 1, 5, 1, 1, 1, 1, 5, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
The serum proteomic test VeriStrat has been shown to be able to classify advancednon-small cell lung cancer (NSCLC) patients for overall survival (OS) after treatmentwith epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs).	[('PMC3505013', 'A00000', 213, 228, 'rosine kinase i')]	['The', 'serum', 'pro', '##te', '##omi', '##c', 'test', 'V', '##eri', '##S', '##tra', '##t', 'has', 'been', 'shown', 'to', 'be', 'able', 'to', 'class', '##ify', 'advanced', '##non', '-', 'small', 'cell', 'lung', 'cancer', '(', 'N', '##SC', '##LC', ')', 'patients', 'for', 'overall', 'survival', '(', 'OS', ')', 'after', 'treatment', '##with', 'e', '##pid', '##er', '##mal', 'growth', 'factor', 'receptor', '(', 'E', '##G', '##F', '##R', ')', 't', '##yr', '##os', '##ine', 'kinase', 'inhibitor', '##s', '(', 'T', '##K', '##I', '##s', ')', '.']	[0, 4, 10, 13, 15, 18, 20, 25, 26, 29, 30, 33, 35, 39, 44, 50, 53, 56, 61, 64, 69, 73, 81, 84, 85, 91, 96, 101, 108, 109, 110, 112, 114, 116, 125, 129, 137, 146, 147, 149, 151, 157, 166, 171, 172, 175, 177, 181, 188, 195, 204, 205, 206, 207, 208, 209, 211, 212, 214, 216, 220, 227, 236, 238, 239, 240, 241, 242, 243, 244]	[3, 9, 13, 15, 18, 19, 24, 26, 29, 30, 33, 34, 38, 43, 49, 52, 55, 60, 63, 69, 72, 81, 84, 85, 90, 95, 100, 107, 109, 110, 112, 114, 115, 124, 128, 136, 145, 147, 149, 150, 156, 166, 170, 172, 175, 177, 180, 187, 194, 203, 205, 206, 207, 208, 209, 210, 212, 214, 216, 219, 226, 236, 237, 239, 240, 241, 242, 243, 244, 245]	['The', 'serum', 'proteomic', 'test', 'VeriStrat', 'has', 'been', 'shown', 'to', 'be', 'able', 'to', 'classify', 'advancednon', '-', 'small', 'cell', 'lung', 'cancer', '(', 'NSCLC', ')', 'patients', 'for', 'overall', 'survival', '(', 'OS', ')', 'after', 'treatmentwith', 'epidermal', 'growth', 'factor', 'receptor', '(', 'EGFR', ')', 'tyrosine', 'kinase', 'inhibitors', '(', 'TKIs', ')', '.']	[1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 4, 1, 4, 1, 2, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inhibition of the EGFR pathway with tyrosine kinaseinhibitors (TKIs), such as erlotinib in patients with advanced NSCLC, leads to improvedsurvival compared with placebo (Shepherd et al,2005).	[]	['In', '##hibition', 'of', 'the', 'E', '##G', '##F', '##R', 'pathway', 'with', 't', '##yr', '##os', '##ine', 'kinase', '##in', '##hibit', '##ors', '(', 'T', '##K', '##I', '##s', ')', ',', 'such', 'as', 'er', '##lot', '##ini', '##b', 'in', 'patients', 'with', 'advanced', 'N', '##SC', '##LC', ',', 'leads', 'to', 'improved', '##su', '##r', '##vi', '##val', 'compared', 'with', 'place', '##bo', '(', 'Shepherd', 'et', 'al', ',', '2005', ')', '.']	[0, 2, 11, 14, 18, 19, 20, 21, 23, 31, 36, 37, 39, 41, 45, 51, 53, 58, 62, 63, 64, 65, 66, 67, 68, 70, 75, 78, 80, 83, 86, 88, 91, 100, 105, 114, 115, 117, 119, 121, 127, 130, 138, 140, 141, 143, 147, 156, 161, 166, 169, 170, 179, 182, 184, 185, 189, 190]	[2, 10, 13, 17, 19, 20, 21, 22, 30, 35, 37, 39, 41, 44, 51, 53, 58, 61, 63, 64, 65, 66, 67, 68, 69, 74, 77, 80, 83, 86, 87, 90, 99, 104, 113, 115, 117, 119, 120, 126, 129, 138, 140, 141, 143, 146, 155, 160, 166, 168, 170, 178, 181, 184, 185, 189, 190, 191]	['Inhibition', 'of', 'the', 'EGFR', 'pathway', 'with', 'tyrosine', 'kinaseinhibitors', '(', 'TKIs', ')', ',', 'such', 'as', 'erlotinib', 'in', 'patients', 'with', 'advanced', 'NSCLC', ',', 'leads', 'to', 'improvedsurvival', 'compared', 'with', 'placebo', '(', 'Shepherd', 'et', 'al', ',', '2005', ')', '.']	[2, 1, 1, 4, 1, 1, 4, 4, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the first approach, SA samples modified with metabolites of PhIP were enzymatically digested with a mixture of Pronase E, leucine aminopeptidase, and prolidase, to produce amino acid containing adducts.37,38 Data-dependent scanning of NO2-PhIP-modified SA revealed that adducts were formed with Cys, Lys, and Tyr.	[]	['In', 'the', 'first', 'approach', ',', 'SA', 'samples', 'modified', 'with', 'meta', '##bol', '##ites', 'of', 'Ph', '##IP', 'were', 'en', '##zy', '##matical', '##ly', 'dig', '##ested', 'with', 'a', 'mixture', 'of', 'Pro', '##nas', '##e', 'E', ',', 'le', '##uc', '##ine', 'amino', '##pe', '##pt', '##idas', '##e', ',', 'and', 'pro', '##lid', '##ase', ',', 'to', 'produce', 'amino', 'acid', 'containing', 'add', '##uc', '##ts', '.', '37', ',', '38', 'Data', '-', 'dependent', 'scanning', 'of', 'NO', '##2', '-', 'Ph', '##IP', '-', 'modified', 'SA', 'revealed', 'that', 'add', '##uc', '##ts', 'were', 'formed', 'with', 'Cy', '##s', ',', 'L', '##ys', ',', 'and', 'Ty', '##r', '.']	[0, 3, 7, 13, 21, 23, 26, 34, 43, 48, 52, 55, 60, 63, 65, 68, 73, 75, 77, 84, 87, 90, 96, 101, 103, 111, 114, 117, 120, 122, 123, 125, 127, 129, 133, 138, 140, 142, 146, 147, 149, 153, 156, 159, 162, 164, 167, 175, 181, 186, 197, 200, 202, 204, 205, 207, 208, 211, 215, 216, 226, 235, 238, 240, 241, 242, 244, 246, 247, 256, 259, 268, 273, 276, 278, 281, 286, 293, 298, 300, 301, 303, 304, 306, 308, 312, 314, 315]	[2, 6, 12, 21, 22, 25, 33, 42, 47, 52, 55, 59, 62, 65, 67, 72, 75, 77, 84, 86, 90, 95, 100, 102, 110, 113, 117, 120, 121, 123, 124, 127, 129, 132, 138, 140, 142, 146, 147, 148, 152, 156, 159, 162, 163, 166, 174, 180, 185, 196, 200, 202, 204, 205, 207, 208, 210, 215, 216, 225, 234, 237, 240, 241, 242, 244, 246, 247, 255, 258, 267, 272, 276, 278, 280, 285, 292, 297, 300, 301, 302, 304, 306, 307, 311, 314, 315, 316]	['In', 'the', 'first', 'approach', ',', 'SA', 'samples', 'modified', 'with', 'metabolites', 'of', 'PhIP', 'were', 'enzymatically', 'digested', 'with', 'a', 'mixture', 'of', 'Pronase', 'E', ',', 'leucine', 'aminopeptidase', ',', 'and', 'prolidase', ',', 'to', 'produce', 'amino', 'acid', 'containing', 'adducts.37', ',', '38', 'Data', '-', 'dependent', 'scanning', 'of', 'NO2-PhIP', '-', 'modified', 'SA', 'revealed', 'that', 'adducts', 'were', 'formed', 'with', 'Cys', ',', 'Lys', ',', 'and', 'Tyr', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 4, 2, 1, 1, 1, 1, 3, 1, 1, 3, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Trypsin/chymotrypsin digestion: The denatured and alkylated PhIP-modified SA (5 μg, 75 pmol, in 35 μL 50 mM ammonium bicarbonate buffer (pH 8.5) containing CaCl2 (1 mM) was digested with trypsin at a protease:protein ratio of 1:50 (w/w) and chymotrypsin at a protease:SA ratio of 1:12.5 (w/w).	[('PMC3544159', 'M10000', 200, 208, 'protease')]	['Try', '##ps', '##in', '/', 'ch', '##ym', '##ot', '##ry', '##ps', '##in', 'dig', '##est', '##ion', ':', 'The', 'den', '##ature', '##d', 'and', 'al', '##ky', '##lated', 'Ph', '##IP', '-', 'modified', 'SA', '(', '5', 'μ', '##g', ',', '75', 'pm', '##ol', ',', 'in', '35', 'μ', '##L', '50', 'm', '##M', 'am', '##mon', '##ium', 'bi', '##car', '##bon', '##ate', 'buffer', '(', 'pH', '8', '.', '5', ')', 'containing', 'C', '##a', '##C', '##l', '##2', '(', '1', 'm', '##M', ')', 'was', 'dig', '##ested', 'with', 'try', '##ps', '##in', 'at', 'a', 'pro', '##te', '##ase', ':', 'protein', 'ratio', 'of', '1', ':', '50', '(', 'w', '/', 'w', ')', 'and', 'ch', '##ym', '##ot', '##ry', '##ps', '##in', 'at', 'a', 'pro', '##te', '##ase', ':', 'SA', 'ratio', 'of', '1', ':', '12', '.', '5', '(', 'w', '/', 'w', ')', '.']	[0, 3, 5, 7, 8, 10, 12, 14, 16, 18, 21, 24, 27, 30, 32, 36, 39, 44, 46, 50, 52, 54, 60, 62, 64, 65, 74, 77, 78, 80, 81, 82, 84, 87, 89, 91, 93, 96, 99, 100, 102, 105, 106, 108, 110, 113, 117, 119, 122, 125, 129, 136, 137, 140, 141, 142, 143, 145, 156, 157, 158, 159, 160, 162, 163, 165, 166, 167, 169, 173, 176, 182, 187, 190, 192, 195, 198, 200, 203, 205, 208, 209, 217, 223, 226, 227, 228, 231, 232, 233, 234, 235, 237, 241, 243, 245, 247, 249, 251, 254, 257, 259, 262, 264, 267, 268, 271, 277, 280, 281, 282, 284, 285, 287, 288, 289, 290, 291, 292]	[3, 5, 7, 8, 10, 12, 14, 16, 18, 20, 24, 27, 30, 31, 35, 39, 44, 45, 49, 52, 54, 59, 62, 64, 65, 73, 76, 78, 79, 81, 82, 83, 86, 89, 91, 92, 95, 98, 100, 101, 104, 106, 107, 110, 113, 116, 119, 122, 125, 128, 135, 137, 139, 141, 142, 143, 144, 155, 157, 158, 159, 160, 161, 163, 164, 166, 167, 168, 172, 176, 181, 186, 190, 192, 194, 197, 199, 203, 205, 208, 209, 216, 222, 225, 227, 228, 230, 232, 233, 234, 235, 236, 240, 243, 245, 247, 249, 251, 253, 256, 258, 262, 264, 267, 268, 270, 276, 279, 281, 282, 284, 285, 286, 288, 289, 290, 291, 292, 293]	['Trypsin', '/', 'chymotrypsin', 'digestion', ':', 'The', 'denatured', 'and', 'alkylated', 'PhIP', '-', 'modified', 'SA', '(', '5', 'μg', ',', '75', 'pmol', ',', 'in', '35', 'μL', '50', 'mM', 'ammonium', 'bicarbonate', 'buffer', '(', 'pH', '8.5', ')', 'containing', 'CaCl2', '(', '1', 'mM', ')', 'was', 'digested', 'with', 'trypsin', 'at', 'a', 'protease', ':', 'protein', 'ratio', 'of', '1', ':', '50', '(', 'w', '/', 'w', ')', 'and', 'chymotrypsin', 'at', 'a', 'protease', ':', 'SA', 'ratio', 'of', '1', ':', '12.5', '(', 'w', '/', 'w', ')', '.']	[3, 1, 6, 3, 1, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 2, 3, 4, 1, 1, 1, 3, 1, 1, 5, 1, 1, 2, 1, 1, 2, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pronase E/leucine aminopeptidase/prolidase digestion: This enzymatic digestion was performed as described previously.24 In brief, the PhIP-modified SA (5 μg, 75 pmol) in 50 mM ammonium bicarbonate buffer (pH 8.5) containing 1 mM MnCl2 was treated with Pronase E at a protease:protein ratio of 1:2 (w/w), leucine aminopeptidase at a protease:protein ratio of 1:30 (w/w), and prolidase at a protease:SA ratio of 1:8 (w/w).	[('PMC3544159', 'M11000', 0, 9, 'Pronase E')]	['Pro', '##nas', '##e', 'E', '/', 'le', '##uc', '##ine', 'amino', '##pe', '##pt', '##idas', '##e', '/', 'pro', '##lid', '##ase', 'dig', '##est', '##ion', ':', 'This', 'en', '##zy', '##matic', 'dig', '##est', '##ion', 'was', 'performed', 'as', 'described', 'previously', '.', '24', 'In', 'brief', ',', 'the', 'Ph', '##IP', '-', 'modified', 'SA', '(', '5', 'μ', '##g', ',', '75', 'pm', '##ol', ')', 'in', '50', 'm', '##M', 'am', '##mon', '##ium', 'bi', '##car', '##bon', '##ate', 'buffer', '(', 'pH', '8', '.', '5', ')', 'containing', '1', 'm', '##M', 'M', '##n', '##C', '##l', '##2', 'was', 'treated', 'with', 'Pro', '##nas', '##e', 'E', 'at', 'a', 'pro', '##te', '##ase', ':', 'protein', 'ratio', 'of', '1', ':', '2', '(', 'w', '/', 'w', ')', ',', 'le', '##uc', '##ine', 'amino', '##pe', '##pt', '##idas', '##e', 'at', 'a', 'pro', '##te', '##ase', ':', 'protein', 'ratio', 'of', '1', ':', '30', '(', 'w', '/', 'w', ')', ',', 'and', 'pro', '##lid', '##ase', 'at', 'a', 'pro', '##te', '##ase', ':', 'SA', 'ratio', 'of', '1', ':', '8', '(', 'w', '/', 'w', ')', '.']	[0, 3, 6, 8, 9, 10, 12, 14, 18, 23, 25, 27, 31, 32, 33, 36, 39, 43, 46, 49, 52, 54, 59, 61, 63, 69, 72, 75, 79, 83, 93, 96, 106, 116, 117, 120, 123, 128, 130, 134, 136, 138, 139, 148, 151, 152, 154, 155, 156, 158, 161, 163, 165, 167, 170, 173, 174, 176, 178, 181, 185, 187, 190, 193, 197, 204, 205, 208, 209, 210, 211, 213, 224, 226, 227, 229, 230, 231, 232, 233, 235, 239, 247, 252, 255, 258, 260, 262, 265, 267, 270, 272, 275, 276, 284, 290, 293, 294, 295, 297, 298, 299, 300, 301, 302, 304, 306, 308, 312, 317, 319, 321, 325, 327, 330, 332, 335, 337, 340, 341, 349, 355, 358, 359, 360, 363, 364, 365, 366, 367, 368, 370, 374, 377, 380, 384, 387, 389, 392, 394, 397, 398, 401, 407, 410, 411, 412, 414, 415, 416, 417, 418, 419]	[3, 6, 7, 9, 10, 12, 14, 17, 23, 25, 27, 31, 32, 33, 36, 39, 42, 46, 49, 52, 53, 58, 61, 63, 68, 72, 75, 78, 82, 92, 95, 105, 116, 117, 119, 122, 128, 129, 133, 136, 138, 139, 147, 150, 152, 153, 155, 156, 157, 160, 163, 165, 166, 169, 172, 174, 175, 178, 181, 184, 187, 190, 193, 196, 203, 205, 207, 209, 210, 211, 212, 223, 225, 227, 228, 230, 231, 232, 233, 234, 238, 246, 251, 255, 258, 259, 261, 264, 266, 270, 272, 275, 276, 283, 289, 292, 294, 295, 296, 298, 299, 300, 301, 302, 303, 306, 308, 311, 317, 319, 321, 325, 326, 329, 331, 335, 337, 340, 341, 348, 354, 357, 359, 360, 362, 364, 365, 366, 367, 368, 369, 373, 377, 380, 383, 386, 388, 392, 394, 397, 398, 400, 406, 409, 411, 412, 413, 415, 416, 417, 418, 419, 420]	['Pronase', 'E', '/', 'leucine', 'aminopeptidase', '/', 'prolidase', 'digestion', ':', 'This', 'enzymatic', 'digestion', 'was', 'performed', 'as', 'described', 'previously.24', 'In', 'brief', ',', 'the', 'PhIP', '-', 'modified', 'SA', '(', '5', 'μg', ',', '75', 'pmol', ')', 'in', '50', 'mM', 'ammonium', 'bicarbonate', 'buffer', '(', 'pH', '8.5', ')', 'containing', '1', 'mM', 'MnCl2', 'was', 'treated', 'with', 'Pronase', 'E', 'at', 'a', 'protease', ':', 'protein', 'ratio', 'of', '1', ':', '2', '(', 'w', '/', 'w', ')', ',', 'leucine', 'aminopeptidase', 'at', 'a', 'protease', ':', 'protein', 'ratio', 'of', '1', ':', '30', '(', 'w', '/', 'w', ')', ',', 'and', 'prolidase', 'at', 'a', 'protease', ':', 'SA', 'ratio', 'of', '1', ':', '8', '(', 'w', '/', 'w', ')', '.']	[3, 1, 1, 3, 5, 1, 3, 3, 1, 1, 3, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 3, 4, 1, 1, 1, 3, 1, 1, 1, 2, 5, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The enzymatic digestion of HONH-PhIP- and HONH-[2H5]-PhIP-modified SA with Pronase E, leucine aminopeptidase, and prolidase resulted in extensive hydrolysis of the sulfinamide linkage, and targeted MS/MS analyses of the protein digest showed that PhIP was recovered in high yields.24	[]	['The', 'en', '##zy', '##matic', 'dig', '##est', '##ion', 'of', 'H', '##ON', '##H', '-', 'Ph', '##IP', '-', 'and', 'H', '##ON', '##H', '-', '[', '2', '##H', '##5', ']', '-', 'Ph', '##IP', '-', 'modified', 'SA', 'with', 'Pro', '##nas', '##e', 'E', ',', 'le', '##uc', '##ine', 'amino', '##pe', '##pt', '##idas', '##e', ',', 'and', 'pro', '##lid', '##ase', 'resulted', 'in', 'extensive', 'h', '##ydro', '##lysis', 'of', 'the', 'su', '##lf', '##ina', '##mi', '##de', 'link', '##age', ',', 'and', 'targeted', 'MS', '/', 'MS', 'analyses', 'of', 'the', 'protein', 'dig', '##est', 'showed', 'that', 'Ph', '##IP', 'was', 'recovered', 'in', 'high', 'yields', '.', '24']	[0, 4, 6, 8, 14, 17, 20, 24, 27, 28, 30, 31, 32, 34, 36, 38, 42, 43, 45, 46, 47, 48, 49, 50, 51, 52, 53, 55, 57, 58, 67, 70, 75, 78, 81, 83, 84, 86, 88, 90, 94, 99, 101, 103, 107, 108, 110, 114, 117, 120, 124, 133, 136, 146, 147, 151, 157, 160, 164, 166, 168, 171, 173, 176, 180, 183, 185, 189, 198, 200, 201, 204, 213, 216, 220, 228, 231, 235, 242, 247, 249, 252, 256, 266, 269, 274, 280, 281]	[3, 6, 8, 13, 17, 20, 23, 26, 28, 30, 31, 32, 34, 36, 37, 41, 43, 45, 46, 47, 48, 49, 50, 51, 52, 53, 55, 57, 58, 66, 69, 74, 78, 81, 82, 84, 85, 88, 90, 93, 99, 101, 103, 107, 108, 109, 113, 117, 120, 123, 132, 135, 145, 147, 151, 156, 159, 163, 166, 168, 171, 173, 175, 180, 183, 184, 188, 197, 200, 201, 203, 212, 215, 219, 227, 231, 234, 241, 246, 249, 251, 255, 265, 268, 273, 280, 281, 283]	['The', 'enzymatic', 'digestion', 'of', 'HONH-PhIP-', 'and', 'HONH-[2H5]-PhIP', '-', 'modified', 'SA', 'with', 'Pronase', 'E', ',', 'leucine', 'aminopeptidase', ',', 'and', 'prolidase', 'resulted', 'in', 'extensive', 'hydrolysis', 'of', 'the', 'sulfinamide', 'linkage', ',', 'and', 'targeted', 'MS', '/', 'MS', 'analyses', 'of', 'the', 'protein', 'digest', 'showed', 'that', 'PhIP', 'was', 'recovered', 'in', 'high', 'yields.24']	[1, 3, 3, 1, 7, 1, 12, 1, 1, 1, 1, 3, 1, 1, 3, 5, 1, 1, 3, 1, 1, 1, 3, 1, 1, 5, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The amino acid adduct N2-cysteinesulfinyl-PhIP was not detected in the 3-enzyme digest; however, data-dependent scanning identified two pairs of HONH-PhIP-tripeptide adducts (tR =17.8 and 19.3 min) (Supporting Information, Figure S-9, Table 3).	[]	['The', 'amino', 'acid', 'add', '##uc', '##t', 'N', '##2', '-', 'c', '##ys', '##tein', '##es', '##ulf', '##in', '##yl', '-', 'Ph', '##IP', 'was', 'not', 'detected', 'in', 'the', '3', '-', 'enzyme', 'dig', '##est', ';', 'however', ',', 'data', '-', 'dependent', 'scanning', 'identified', 'two', 'pairs', 'of', 'H', '##ON', '##H', '-', 'Ph', '##IP', '-', 'trip', '##eptide', 'add', '##uc', '##ts', '(', 't', '##R', '=', '17', '.', '8', 'and', '19', '.', '3', 'min', ')', '(', 'Supporting', 'Information', ',', 'Figure', 'S', '-', '9', ',', 'Table', '3', ')', '.']	[0, 4, 10, 15, 18, 20, 22, 23, 24, 25, 26, 28, 32, 34, 37, 39, 41, 42, 44, 47, 51, 55, 64, 67, 71, 72, 73, 80, 83, 86, 88, 95, 97, 101, 102, 112, 121, 132, 136, 142, 145, 146, 148, 149, 150, 152, 154, 155, 159, 166, 169, 171, 174, 175, 176, 178, 179, 181, 182, 184, 188, 190, 191, 193, 196, 198, 199, 210, 221, 223, 230, 231, 232, 233, 235, 241, 242, 243]	[3, 9, 14, 18, 20, 21, 23, 24, 25, 26, 28, 32, 34, 37, 39, 41, 42, 44, 46, 50, 54, 63, 66, 70, 72, 73, 79, 83, 86, 87, 95, 96, 101, 102, 111, 120, 131, 135, 141, 144, 146, 148, 149, 150, 152, 154, 155, 159, 165, 169, 171, 173, 175, 176, 177, 179, 181, 182, 183, 187, 190, 191, 192, 196, 197, 199, 209, 221, 222, 229, 231, 232, 233, 234, 240, 242, 243, 244]	['The', 'amino', 'acid', 'adduct', 'N2-cysteinesulfinyl-PhIP', 'was', 'not', 'detected', 'in', 'the', '3-', 'enzyme', 'digest', ';', 'however', ',', 'data', '-', 'dependent', 'scanning', 'identified', 'two', 'pairs', 'of', 'HONH-PhIP', '-', 'tripeptide', 'adducts', '(', 'tR', '=', '17.8', 'and', '19.3', 'min', ')', '(', 'Supporting', 'Information', ',', 'Figure', 'S-9', ',', 'Table', '3', ')', '.']	[1, 1, 1, 3, 13, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 2, 3, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This contention is corroborated by our observation that the protease mutant strain is more sensitive to AMPs.	[('PMC3584211', 'D02000', 60, 68, 'protease')]	['This', 'contention', 'is', 'co', '##rro', '##bor', '##ated', 'by', 'our', 'observation', 'that', 'the', 'pro', '##te', '##ase', 'mutant', 'strain', 'is', 'more', 'sensitive', 'to', 'AM', '##Ps', '.']	[0, 5, 16, 19, 21, 24, 27, 32, 35, 39, 51, 56, 60, 63, 65, 69, 76, 83, 86, 91, 101, 104, 106, 108]	[4, 15, 18, 21, 24, 27, 31, 34, 38, 50, 55, 59, 63, 65, 68, 75, 82, 85, 90, 100, 103, 106, 108, 109]	['This', 'contention', 'is', 'corroborated', 'by', 'our', 'observation', 'that', 'the', 'protease', 'mutant', 'strain', 'is', 'more', 'sensitive', 'to', 'AMPs', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Herein, we show that extracellular proteases facilitate resistance to agents other than LL-37, as we observed increased sensitivity to both indolicidin and histatin-5.	[]	['Here', '##in', ',', 'we', 'show', 'that', 'extra', '##cellular', 'pro', '##te', '##ases', 'facilitate', 'resistance', 'to', 'agents', 'other', 'than', 'LL', '-', '37', ',', 'as', 'we', 'observed', 'increased', 'sensitivity', 'to', 'both', 'in', '##do', '##lic', '##id', '##in', 'and', 'his', '##tat', '##in', '-', '5', '.']	[0, 4, 6, 8, 11, 16, 21, 26, 35, 38, 40, 45, 56, 67, 70, 77, 83, 88, 90, 91, 93, 95, 98, 101, 110, 120, 132, 135, 140, 142, 144, 147, 149, 152, 156, 159, 162, 164, 165, 166]	[4, 6, 7, 10, 15, 20, 26, 34, 38, 40, 44, 55, 66, 69, 76, 82, 87, 90, 91, 93, 94, 97, 100, 109, 119, 131, 134, 139, 142, 144, 147, 149, 151, 155, 159, 162, 164, 165, 166, 167]	['Herein', ',', 'we', 'show', 'that', 'extracellular', 'proteases', 'facilitate', 'resistance', 'to', 'agents', 'other', 'than', 'LL-37', ',', 'as', 'we', 'observed', 'increased', 'sensitivity', 'to', 'both', 'indolicidin', 'and', 'histatin-5', '.']	[2, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To further understand these findings, we performed FACS analyses using GFP-labeled variants of the wild-type and protease-null strain grown in human blood.	[('PMC3584211', 'D03000', 113, 121, 'protease')]	['To', 'further', 'understand', 'these', 'findings', ',', 'we', 'performed', 'FA', '##CS', 'analyses', 'using', 'G', '##FP', '-', 'labeled', 'variants', 'of', 'the', 'wild', '-', 'type', 'and', 'pro', '##te', '##ase', '-', 'null', 'strain', 'grown', 'in', 'human', 'blood', '.']	[0, 3, 11, 22, 28, 36, 38, 41, 51, 53, 56, 65, 71, 72, 74, 75, 83, 92, 95, 99, 103, 104, 109, 113, 116, 118, 121, 122, 127, 134, 140, 143, 149, 154]	[2, 10, 21, 27, 36, 37, 40, 50, 53, 55, 64, 70, 72, 74, 75, 82, 91, 94, 98, 103, 104, 108, 112, 116, 118, 121, 122, 126, 133, 139, 142, 148, 154, 155]	['To', 'further', 'understand', 'these', 'findings', ',', 'we', 'performed', 'FACS', 'analyses', 'using', 'GFP-labeled', 'variants', 'of', 'the', 'wild', '-', 'type', 'and', 'protease', '-', 'null', 'strain', 'grown', 'in', 'human', 'blood', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After 4 h of incubation we observed increased phagocytosis of protease-null cells compared with the parental strain.	[('PMC3584211', 'D03001', 62, 70, 'protease')]	['After', '4', 'h', 'of', 'in', '##cu', '##bation', 'we', 'observed', 'increased', 'p', '##ha', '##go', '##cy', '##tosis', 'of', 'pro', '##te', '##ase', '-', 'null', 'cells', 'compared', 'with', 'the', 'parental', 'strain', '.']	[0, 6, 8, 10, 13, 15, 17, 24, 27, 36, 46, 47, 49, 51, 53, 59, 62, 65, 67, 70, 71, 76, 82, 91, 96, 100, 109, 115]	[5, 7, 9, 12, 15, 17, 23, 26, 35, 45, 47, 49, 51, 53, 58, 61, 65, 67, 70, 71, 75, 81, 90, 95, 99, 108, 115, 116]	['After', '4', 'h', 'of', 'incubation', 'we', 'observed', 'increased', 'phagocytosis', 'of', 'protease', '-', 'null', 'cells', 'compared', 'with', 'the', 'parental', 'strain', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We also observed significant influence of the secreted proteases on in vivo pathogenesis.	[('PMC3584211', 'D04000', 55, 64, 'proteases')]	['We', 'also', 'observed', 'significant', 'influence', 'of', 'the', 'secret', '##ed', 'pro', '##te', '##ases', 'on', 'in', 'v', '##ivo', 'path', '##ogen', '##esis', '.']	[0, 3, 8, 17, 29, 39, 42, 46, 52, 55, 58, 60, 65, 68, 71, 72, 76, 80, 84, 88]	[2, 7, 16, 28, 38, 41, 45, 52, 54, 58, 60, 64, 67, 70, 72, 75, 80, 84, 88, 89]	['We', 'also', 'observed', 'significant', 'influence', 'of', 'the', 'secreted', 'proteases', 'on', 'in', 'vivo', 'pathogenesis', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In stark contrast to this, we in fact observe increased killing by the protease-null mutant when mortality was used as a measure of infection.	[('PMC3584211', 'D06000', 71, 79, 'protease')]	['In', 'stark', 'contrast', 'to', 'this', ',', 'we', 'in', 'fact', 'observe', 'increased', 'killing', 'by', 'the', 'pro', '##te', '##ase', '-', 'null', 'mutant', 'when', 'mortality', 'was', 'used', 'as', 'a', 'measure', 'of', 'infection', '.']	[0, 3, 9, 18, 21, 25, 27, 30, 33, 38, 46, 56, 64, 67, 71, 74, 76, 79, 80, 85, 92, 97, 107, 111, 116, 119, 121, 129, 132, 141]	[2, 8, 17, 20, 25, 26, 29, 32, 37, 45, 55, 63, 66, 70, 74, 76, 79, 80, 84, 91, 96, 106, 110, 115, 118, 120, 128, 131, 141, 142]	['In', 'stark', 'contrast', 'to', 'this', ',', 'we', 'in', 'fact', 'observe', 'increased', 'killing', 'by', 'the', 'protease', '-', 'null', 'mutant', 'when', 'mortality', 'was', 'used', 'as', 'a', 'measure', 'of', 'infection', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This finding is of primary importance, and speaks strongly to a major role for the secreted proteases in controlling, and tightly regulating the infectious process.	[('PMC3584211', 'D06001', 92, 101, 'proteases')]	['This', 'finding', 'is', 'of', 'primary', 'importance', ',', 'and', 'speaks', 'strongly', 'to', 'a', 'major', 'role', 'for', 'the', 'secret', '##ed', 'pro', '##te', '##ases', 'in', 'controlling', ',', 'and', 'tightly', 'regulating', 'the', 'infectious', 'process', '.']	[0, 5, 13, 16, 19, 27, 37, 39, 43, 50, 59, 62, 64, 70, 75, 79, 83, 89, 92, 95, 97, 102, 105, 116, 118, 122, 130, 141, 145, 156, 163]	[4, 12, 15, 18, 26, 37, 38, 42, 49, 58, 61, 63, 69, 74, 78, 82, 89, 91, 95, 97, 101, 104, 116, 117, 121, 129, 140, 144, 155, 163, 164]	['This', 'finding', 'is', 'of', 'primary', 'importance', ',', 'and', 'speaks', 'strongly', 'to', 'a', 'major', 'role', 'for', 'the', 'secreted', 'proteases', 'in', 'controlling', ',', 'and', 'tightly', 'regulating', 'the', 'infectious', 'process', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Herein, we show major increases in virulence-determinant stability upon inactivation of extracellular proteases.	[('PMC3584211', 'D06002', 102, 111, 'proteases')]	['Here', '##in', ',', 'we', 'show', 'major', 'increases', 'in', 'v', '##ir', '##ule', '##nce', '-', 'de', '##ter', '##mina', '##nt', 'stability', 'upon', 'in', '##act', '##ivation', 'of', 'extra', '##cellular', 'pro', '##te', '##ases', '.']	[0, 4, 6, 8, 11, 16, 22, 32, 35, 36, 38, 41, 44, 45, 47, 50, 54, 57, 67, 72, 74, 77, 85, 88, 93, 102, 105, 107, 111]	[4, 6, 7, 10, 15, 21, 31, 34, 36, 38, 41, 44, 45, 47, 50, 54, 56, 66, 71, 74, 77, 84, 87, 93, 101, 105, 107, 111, 112]	['Herein', ',', 'we', 'show', 'major', 'increases', 'in', 'virulence', '-', 'determinant', 'stability', 'upon', 'inactivation', 'of', 'extracellular', 'proteases', '.']	[2, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 3, 1, 2, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O']
Specifically, we show that α-toxin, γ-hemolysin, PSMs, LukE, LukAB, PVL, and others are all more abundant in the protease-null strain.	[('PMC3584211', 'D06003', 113, 121, 'protease')]	['Specifically', ',', 'we', 'show', 'that', 'α', '-', 'to', '##xin', ',', 'γ', '-', 'hem', '##oly', '##sin', ',', 'PS', '##Ms', ',', 'Lu', '##k', '##E', ',', 'Lu', '##k', '##AB', ',', 'P', '##V', '##L', ',', 'and', 'others', 'are', 'all', 'more', 'abundant', 'in', 'the', 'pro', '##te', '##ase', '-', 'null', 'strain', '.']	[0, 12, 14, 17, 22, 27, 28, 29, 31, 34, 36, 37, 38, 41, 44, 47, 49, 51, 53, 55, 57, 58, 59, 61, 63, 64, 66, 68, 69, 70, 71, 73, 77, 84, 88, 92, 97, 106, 109, 113, 116, 118, 121, 122, 127, 133]	[12, 13, 16, 21, 26, 28, 29, 31, 34, 35, 37, 38, 41, 44, 47, 48, 51, 53, 54, 57, 58, 59, 60, 63, 64, 66, 67, 69, 70, 71, 72, 76, 83, 87, 91, 96, 105, 108, 112, 116, 118, 121, 122, 126, 133, 134]	['Specifically', ',', 'we', 'show', 'that', 'α-toxin', ',', 'γ-hemolysin', ',', 'PSMs', ',', 'LukE', ',', 'LukAB', ',', 'PVL', ',', 'and', 'others', 'are', 'all', 'more', 'abundant', 'in', 'the', 'protease', '-', 'null', 'strain', '.']	[1, 1, 1, 1, 1, 4, 1, 5, 1, 2, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
A major consideration with each of our phenotypic and growth-related studies is that the data presented may be skewed by elevated aggregation of the protease-null strain.	[('PMC3584211', 'D07000', 149, 157, 'protease')]	['A', 'major', 'consideration', 'with', 'each', 'of', 'our', 'p', '##hen', '##otypic', 'and', 'growth', '-', 'related', 'studies', 'is', 'that', 'the', 'data', 'presented', 'may', 'be', 's', '##ke', '##wed', 'by', 'elevated', 'a', '##gg', '##regation', 'of', 'the', 'pro', '##te', '##ase', '-', 'null', 'strain', '.']	[0, 2, 8, 22, 27, 32, 35, 39, 40, 43, 50, 54, 60, 61, 69, 77, 80, 85, 89, 94, 104, 108, 111, 112, 114, 118, 121, 130, 131, 133, 142, 145, 149, 152, 154, 157, 158, 163, 169]	[1, 7, 21, 26, 31, 34, 38, 40, 43, 49, 53, 60, 61, 68, 76, 79, 84, 88, 93, 103, 107, 110, 112, 114, 117, 120, 129, 131, 133, 141, 144, 148, 152, 154, 157, 158, 162, 169, 170]	['A', 'major', 'consideration', 'with', 'each', 'of', 'our', 'phenotypic', 'and', 'growth', '-', 'related', 'studies', 'is', 'that', 'the', 'data', 'presented', 'may', 'be', 'skewed', 'by', 'elevated', 'aggregation', 'of', 'the', 'protease', '-', 'null', 'strain', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
It has previously been reported that secreted extracellular proteases have been shown to cleave surface and adhesive proteins by other groups (McGavin et al.	[('PMC3584211', 'D07001', 60, 69, 'proteases')]	['It', 'has', 'previously', 'been', 'reported', 'that', 'secret', '##ed', 'extra', '##cellular', 'pro', '##te', '##ases', 'have', 'been', 'shown', 'to', 'c', '##lea', '##ve', 'surface', 'and', 'ad', '##hesive', 'proteins', 'by', 'other', 'groups', '(', 'M', '##c', '##G', '##avi', '##n', 'et', 'al', '.']	[0, 3, 7, 18, 23, 32, 37, 43, 46, 51, 60, 63, 65, 70, 75, 80, 86, 89, 90, 93, 96, 104, 108, 110, 117, 126, 129, 135, 142, 143, 144, 145, 146, 149, 151, 154, 156]	[2, 6, 17, 22, 31, 36, 43, 45, 51, 59, 63, 65, 69, 74, 79, 85, 88, 90, 93, 95, 103, 107, 110, 116, 125, 128, 134, 141, 143, 144, 145, 146, 149, 150, 153, 156, 157]	['It', 'has', 'previously', 'been', 'reported', 'that', 'secreted', 'extracellular', 'proteases', 'have', 'been', 'shown', 'to', 'cleave', 'surface', 'and', 'adhesive', 'proteins', 'by', 'other', 'groups', '(', 'McGavin', 'et', 'al', '.']	[1, 1, 1, 1, 1, 1, 2, 2, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Therefore it is reasonable to project that the protease-null strain may display elevated clumping compared with the parental strain, as we intimate above.	[]	['Therefore', 'it', 'is', 'reasonable', 'to', 'project', 'that', 'the', 'pro', '##te', '##ase', '-', 'null', 'strain', 'may', 'display', 'elevated', 'c', '##lump', '##ing', 'compared', 'with', 'the', 'parental', 'strain', ',', 'as', 'we', 'intimate', 'above', '.']	[0, 10, 13, 16, 27, 30, 38, 43, 47, 50, 52, 55, 56, 61, 68, 72, 80, 89, 90, 94, 98, 107, 112, 116, 125, 131, 133, 136, 139, 148, 153]	[9, 12, 15, 26, 29, 37, 42, 46, 50, 52, 55, 56, 60, 67, 71, 79, 88, 90, 94, 97, 106, 111, 115, 124, 131, 132, 135, 138, 147, 153, 154]	['Therefore', 'it', 'is', 'reasonable', 'to', 'project', 'that', 'the', 'protease', '-', 'null', 'strain', 'may', 'display', 'elevated', 'clumping', 'compared', 'with', 'the', 'parental', 'strain', ',', 'as', 'we', 'intimate', 'above', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Therefore, this presents a scenario where, in addition to their own, independent virulence-affecting roles, the secreted proteases exist as key check point enzymes to control the severity and intensity of infection via modulating the stability of other toxins and virulence determinants.	[('PMC3584211', 'D08000', 121, 130, 'proteases')]	['Therefore', ',', 'this', 'presents', 'a', 'scenario', 'where', ',', 'in', 'addition', 'to', 'their', 'own', ',', 'independent', 'v', '##ir', '##ule', '##nce', '-', 'affecting', 'roles', ',', 'the', 'secret', '##ed', 'pro', '##te', '##ases', 'exist', 'as', 'key', 'check', 'point', 'enzymes', 'to', 'control', 'the', 'severity', 'and', 'intensity', 'of', 'infection', 'via', 'm', '##od', '##ulating', 'the', 'stability', 'of', 'other', 'to', '##xin', '##s', 'and', 'v', '##ir', '##ule', '##nce', 'de', '##ter', '##mina', '##nts', '.']	[0, 9, 11, 16, 25, 27, 36, 41, 43, 46, 55, 58, 64, 67, 69, 81, 82, 84, 87, 90, 91, 101, 106, 108, 112, 118, 121, 124, 126, 131, 137, 140, 144, 150, 156, 164, 167, 175, 179, 188, 192, 202, 205, 215, 219, 220, 222, 230, 234, 244, 247, 253, 255, 258, 260, 264, 265, 267, 270, 274, 276, 279, 283, 286]	[9, 10, 15, 24, 26, 35, 41, 42, 45, 54, 57, 63, 67, 68, 80, 82, 84, 87, 90, 91, 100, 106, 107, 111, 118, 120, 124, 126, 130, 136, 139, 143, 149, 155, 163, 166, 174, 178, 187, 191, 201, 204, 214, 218, 220, 222, 229, 233, 243, 246, 252, 255, 258, 259, 263, 265, 267, 270, 273, 276, 279, 283, 286, 287]	['Therefore', ',', 'this', 'presents', 'a', 'scenario', 'where', ',', 'in', 'addition', 'to', 'their', 'own', ',', 'independent', 'virulence', '-', 'affecting', 'roles', ',', 'the', 'secreted', 'proteases', 'exist', 'as', 'key', 'check', 'point', 'enzymes', 'to', 'control', 'the', 'severity', 'and', 'intensity', 'of', 'infection', 'via', 'modulating', 'the', 'stability', 'of', 'other', 'toxins', 'and', 'virulence', 'determinants', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Indeed, one could suggest that the regulatory control of secreted proteases by the agr system is no accident, but in fact evolutionary design.	[('PMC3584211', 'D08001', 66, 75, 'proteases')]	['Indeed', ',', 'one', 'could', 'suggest', 'that', 'the', 'regulatory', 'control', 'of', 'secret', '##ed', 'pro', '##te', '##ases', 'by', 'the', 'a', '##g', '##r', 'system', 'is', 'no', 'accident', ',', 'but', 'in', 'fact', 'evolutionary', 'design', '.']	[0, 6, 8, 12, 18, 26, 31, 35, 46, 54, 57, 63, 66, 69, 71, 76, 79, 83, 84, 85, 87, 94, 97, 100, 108, 110, 114, 117, 122, 135, 141]	[6, 7, 11, 17, 25, 30, 34, 45, 53, 56, 63, 65, 69, 71, 75, 78, 82, 84, 85, 86, 93, 96, 99, 108, 109, 113, 116, 121, 134, 141, 142]	['Indeed', ',', 'one', 'could', 'suggest', 'that', 'the', 'regulatory', 'control', 'of', 'secreted', 'proteases', 'by', 'the', 'agr', 'system', 'is', 'no', 'accident', ',', 'but', 'in', 'fact', 'evolutionary', 'design', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In summary, we demonstrate that the extracellular proteases of S. aureus play a variety of key roles in the virulence process.	[('PMC3584211', 'D09000', 50, 59, 'proteases')]	['In', 'summary', ',', 'we', 'demonstrate', 'that', 'the', 'extra', '##cellular', 'pro', '##te', '##ases', 'of', 'S', '.', 'au', '##reus', 'play', 'a', 'variety', 'of', 'key', 'roles', 'in', 'the', 'v', '##ir', '##ule', '##nce', 'process', '.']	[0, 3, 10, 12, 15, 27, 32, 36, 41, 50, 53, 55, 60, 63, 64, 66, 68, 73, 78, 80, 88, 91, 95, 101, 104, 108, 109, 111, 114, 118, 125]	[2, 10, 11, 14, 26, 31, 35, 41, 49, 53, 55, 59, 62, 64, 65, 68, 72, 77, 79, 87, 90, 94, 100, 103, 107, 109, 111, 114, 117, 125, 126]	['In', 'summary', ',', 'we', 'demonstrate', 'that', 'the', 'extracellular', 'proteases', 'of', 'S', '.', 'aureus', 'play', 'a', 'variety', 'of', 'key', 'roles', 'in', 'the', 'virulence', 'process', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A number of studies have been conducted to determine the contribution of extracellular proteases to the disease process; however, many have been contradictory.	[('PMC3584211', 'I02000', 87, 96, 'proteases')]	['A', 'number', 'of', 'studies', 'have', 'been', 'conducted', 'to', 'determine', 'the', 'contribution', 'of', 'extra', '##cellular', 'pro', '##te', '##ases', 'to', 'the', 'disease', 'process', ';', 'however', ',', 'many', 'have', 'been', 'con', '##tra', '##dict', '##ory', '.']	[0, 2, 9, 12, 20, 25, 30, 40, 43, 53, 57, 70, 73, 78, 87, 90, 92, 97, 100, 104, 112, 119, 121, 128, 130, 135, 140, 145, 148, 151, 155, 158]	[1, 8, 11, 19, 24, 29, 39, 42, 52, 56, 69, 72, 78, 86, 90, 92, 96, 99, 103, 111, 119, 120, 128, 129, 134, 139, 144, 148, 151, 155, 158, 159]	['A', 'number', 'of', 'studies', 'have', 'been', 'conducted', 'to', 'determine', 'the', 'contribution', 'of', 'extracellular', 'proteases', 'to', 'the', 'disease', 'process', ';', 'however', ',', 'many', 'have', 'been', 'contradictory', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition to these more general functions, S. aureus exoproteases have been shown to cleave specific host proteins.	[('PMC3584211', 'I03000', 55, 67, 'exoproteases')]	['In', 'addition', 'to', 'these', 'more', 'general', 'functions', ',', 'S', '.', 'au', '##reus', 'ex', '##op', '##rote', '##ases', 'have', 'been', 'shown', 'to', 'c', '##lea', '##ve', 'specific', 'host', 'proteins', '.']	[0, 3, 12, 15, 21, 26, 34, 43, 45, 46, 48, 50, 55, 57, 59, 63, 68, 73, 78, 84, 87, 88, 91, 94, 103, 108, 116]	[2, 11, 14, 20, 25, 33, 43, 44, 46, 47, 50, 54, 57, 59, 63, 67, 72, 77, 83, 86, 88, 91, 93, 102, 107, 116, 117]	['In', 'addition', 'to', 'these', 'more', 'general', 'functions', ',', 'S', '.', 'aureus', 'exoproteases', 'have', 'been', 'shown', 'to', 'cleave', 'specific', 'host', 'proteins', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Secreted proteases can also cleave human α1-proteinase inhibitor (Potempa et al. 1986), the heavy chains of all human immunoglobulin classes (Prokesova et al. 1992), and elastin (Potempa et al. 1988), which aids in tissue invasion.	[]	['Secret', '##ed', 'pro', '##te', '##ases', 'can', 'also', 'c', '##lea', '##ve', 'human', 'α', '##1', '-', 'protein', '##ase', 'inhibitor', '(', 'Po', '##tem', '##pa', 'et', 'al', '.', '1986', ')', ',', 'the', 'heavy', 'chains', 'of', 'all', 'human', 'im', '##mu', '##no', '##g', '##lo', '##bul', '##in', 'classes', '(', 'Pro', '##kes', '##ova', 'et', 'al', '.', '1992', ')', ',', 'and', 'el', '##ast', '##in', '(', 'Po', '##tem', '##pa', 'et', 'al', '.', '1988', ')', ',', 'which', 'aids', 'in', 'tissue', 'invasion', '.']	[0, 6, 9, 12, 14, 19, 23, 28, 29, 32, 35, 41, 42, 43, 44, 51, 55, 65, 66, 68, 71, 74, 77, 79, 81, 85, 86, 88, 92, 98, 105, 108, 112, 118, 120, 122, 124, 125, 127, 130, 133, 141, 142, 145, 148, 152, 155, 157, 159, 163, 164, 166, 170, 172, 175, 178, 179, 181, 184, 187, 190, 192, 194, 198, 199, 201, 207, 212, 215, 222, 230]	[6, 8, 12, 14, 18, 22, 27, 29, 32, 34, 40, 42, 43, 44, 51, 54, 64, 66, 68, 71, 73, 76, 79, 80, 85, 86, 87, 91, 97, 104, 107, 111, 117, 120, 122, 124, 125, 127, 130, 132, 140, 142, 145, 148, 151, 154, 157, 158, 163, 164, 165, 169, 172, 175, 177, 179, 181, 184, 186, 189, 192, 193, 198, 199, 200, 206, 211, 214, 221, 230, 231]	['Secreted', 'proteases', 'can', 'also', 'cleave', 'human', 'α1', '-', 'proteinase', 'inhibitor', '(', 'Potempa', 'et', 'al', '.', '1986', ')', ',', 'the', 'heavy', 'chains', 'of', 'all', 'human', 'immunoglobulin', 'classes', '(', 'Prokesova', 'et', 'al', '.', '1992', ')', ',', 'and', 'elastin', '(', 'Potempa', 'et', 'al', '.', '1988', ')', ',', 'which', 'aids', 'in', 'tissue', 'invasion', '.']	[2, 3, 1, 1, 3, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Consequently, while there is a wealth of information on the role of secreted proteases in S. aureus disease causation, the specific role of these enzymes as virulence factors remains unclear.	[('PMC3584211', 'I04000', 77, 86, 'proteases')]	['Consequently', ',', 'while', 'there', 'is', 'a', 'wealth', 'of', 'information', 'on', 'the', 'role', 'of', 'secret', '##ed', 'pro', '##te', '##ases', 'in', 'S', '.', 'au', '##reus', 'disease', 'ca', '##usa', '##tion', ',', 'the', 'specific', 'role', 'of', 'these', 'enzymes', 'as', 'v', '##ir', '##ule', '##nce', 'factors', 'remains', 'unclear', '.']	[0, 12, 14, 20, 26, 29, 31, 38, 41, 53, 56, 60, 65, 68, 74, 77, 80, 82, 87, 90, 91, 93, 95, 100, 108, 110, 113, 117, 119, 123, 132, 137, 140, 146, 154, 157, 158, 160, 163, 167, 175, 183, 190]	[12, 13, 19, 25, 28, 30, 37, 40, 52, 55, 59, 64, 67, 74, 76, 80, 82, 86, 89, 91, 92, 95, 99, 107, 110, 113, 117, 118, 122, 131, 136, 139, 145, 153, 156, 158, 160, 163, 166, 174, 182, 190, 191]	['Consequently', ',', 'while', 'there', 'is', 'a', 'wealth', 'of', 'information', 'on', 'the', 'role', 'of', 'secreted', 'proteases', 'in', 'S', '.', 'aureus', 'disease', 'causation', ',', 'the', 'specific', 'role', 'of', 'these', 'enzymes', 'as', 'virulence', 'factors', 'remains', 'unclear', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Once confirmed, this strain was used for the subsequent inactivation of sspAB, followed by scpA, using the pJB38 plasmids referred to above, and a protocol established for pKOR1 gene inactivation (Bae and Schneewind 2006).	[]	['Once', 'confirmed', ',', 'this', 'strain', 'was', 'used', 'for', 'the', 'subsequent', 'in', '##act', '##ivation', 'of', 's', '##sp', '##AB', ',', 'followed', 'by', 's', '##c', '##p', '##A', ',', 'using', 'the', 'p', '##J', '##B', '##38', 'p', '##las', '##mi', '##ds', 'referred', 'to', 'above', ',', 'and', 'a', 'protocol', 'established', 'for', 'p', '##KO', '##R', '##1', 'gene', 'in', '##act', '##ivation', '(', 'Ba', '##e', 'and', 'Sc', '##hn', '##ee', '##wind', '2006', ')', '.']	[0, 5, 14, 16, 21, 28, 32, 37, 41, 45, 56, 58, 61, 69, 72, 73, 75, 77, 79, 88, 91, 92, 93, 94, 95, 97, 103, 107, 108, 109, 110, 113, 114, 117, 119, 122, 131, 134, 139, 141, 145, 147, 156, 168, 172, 173, 175, 176, 178, 183, 185, 188, 196, 197, 199, 201, 205, 207, 209, 211, 216, 220, 221]	[4, 14, 15, 20, 27, 31, 36, 40, 44, 55, 58, 61, 68, 71, 73, 75, 77, 78, 87, 90, 92, 93, 94, 95, 96, 102, 106, 108, 109, 110, 112, 114, 117, 119, 121, 130, 133, 139, 140, 144, 146, 155, 167, 171, 173, 175, 176, 177, 182, 185, 188, 195, 197, 199, 200, 204, 207, 209, 211, 215, 220, 221, 222]	['Once', 'confirmed', ',', 'this', 'strain', 'was', 'used', 'for', 'the', 'subsequent', 'inactivation', 'of', 'sspAB', ',', 'followed', 'by', 'scpA', ',', 'using', 'the', 'pJB38', 'plasmids', 'referred', 'to', 'above', ',', 'and', 'a', 'protocol', 'established', 'for', 'pKOR1', 'gene', 'inactivation', '(', 'Bae', 'and', 'Schneewind', '2006', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 2, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Phagocytosis of the wild-type and protease-null mutant was analyzed using pooled, whole human blood coupled with flow cytometry.	[('PMC3584211', 'M05000', 34, 42, 'protease')]	['Ph', '##ago', '##cy', '##tosis', 'of', 'the', 'wild', '-', 'type', 'and', 'pro', '##te', '##ase', '-', 'null', 'mutant', 'was', 'analyzed', 'using', 'pool', '##ed', ',', 'whole', 'human', 'blood', 'coupled', 'with', 'flow', 'c', '##yt', '##ome', '##try', '.']	[0, 2, 5, 7, 13, 16, 20, 24, 25, 30, 34, 37, 39, 42, 43, 48, 55, 59, 68, 74, 78, 80, 82, 88, 94, 100, 108, 113, 118, 119, 121, 124, 127]	[2, 5, 7, 12, 15, 19, 24, 25, 29, 33, 37, 39, 42, 43, 47, 54, 58, 67, 73, 78, 80, 81, 87, 93, 99, 107, 112, 117, 119, 121, 124, 127, 128]	['Phagocytosis', 'of', 'the', 'wild', '-', 'type', 'and', 'protease', '-', 'null', 'mutant', 'was', 'analyzed', 'using', 'pooled', ',', 'whole', 'human', 'blood', 'coupled', 'with', 'flow', 'cytometry', '.']	[4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Liquid cultures of LAC and its protease-null mutant were grown in Luria–Bertani (LB) media without NaCl.	[('PMC3584211', 'M06000', 31, 39, 'protease')]	['Li', '##quid', 'cultures', 'of', 'LA', '##C', 'and', 'its', 'pro', '##te', '##ase', '-', 'null', 'mutant', 'were', 'grown', 'in', 'Lu', '##ria', '–', 'Bert', '##ani', '(', 'L', '##B', ')', 'media', 'without', 'Na', '##C', '##l', '.']	[0, 2, 7, 16, 19, 21, 23, 27, 31, 34, 36, 39, 40, 45, 52, 57, 63, 66, 68, 71, 72, 76, 80, 81, 82, 83, 85, 91, 99, 101, 102, 103]	[2, 6, 15, 18, 21, 22, 26, 30, 34, 36, 39, 40, 44, 51, 56, 62, 65, 68, 71, 72, 76, 79, 81, 82, 83, 84, 90, 98, 101, 102, 103, 104]	['Liquid', 'cultures', 'of', 'LAC', 'and', 'its', 'protease', '-', 'null', 'mutant', 'were', 'grown', 'in', 'Luria', '–', 'Bertani', '(', 'LB', ')', 'media', 'without', 'NaCl', '.']	[2, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An extracellular protease-null strain of S. aureus has previously been generated and described in USA300 LAC (Wormann et al. 2011).	[('PMC3584211', 'R00000', 17, 25, 'protease')]	['An', 'extra', '##cellular', 'pro', '##te', '##ase', '-', 'null', 'strain', 'of', 'S', '.', 'au', '##reus', 'has', 'previously', 'been', 'generated', 'and', 'described', 'in', 'USA', '##30', '##0', 'LA', '##C', '(', 'W', '##orm', '##ann', 'et', 'al', '.', '2011', ')', '.']	[0, 3, 8, 17, 20, 22, 25, 26, 31, 38, 41, 42, 44, 46, 51, 55, 66, 71, 81, 85, 95, 98, 101, 103, 105, 107, 109, 110, 111, 114, 118, 121, 123, 125, 129, 130]	[2, 8, 16, 20, 22, 25, 26, 30, 37, 40, 42, 43, 46, 50, 54, 65, 70, 80, 84, 94, 97, 101, 103, 104, 107, 108, 110, 111, 114, 117, 120, 123, 124, 129, 130, 131]	['An', 'extracellular', 'protease', '-', 'null', 'strain', 'of', 'S', '.', 'aureus', 'has', 'previously', 'been', 'generated', 'and', 'described', 'in', 'USA300', 'LAC', '(', 'Wormann', 'et', 'al', '.', '2011', ')', '.']	[1, 2, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As it forms the basis of the work described herein, we first set out to confirm the lack of secreted proteases in this strain using a targeted proteomics method.	[('PMC3584211', 'R00001', 101, 110, 'proteases')]	['As', 'it', 'forms', 'the', 'basis', 'of', 'the', 'work', 'described', 'here', '##in', ',', 'we', 'first', 'set', 'out', 'to', 'confirm', 'the', 'lack', 'of', 'secret', '##ed', 'pro', '##te', '##ases', 'in', 'this', 'strain', 'using', 'a', 'targeted', 'pro', '##te', '##omi', '##cs', 'method', '.']	[0, 3, 6, 12, 16, 22, 25, 29, 34, 44, 48, 50, 52, 55, 61, 65, 69, 72, 80, 84, 89, 92, 98, 101, 104, 106, 111, 114, 119, 126, 132, 134, 143, 146, 148, 151, 154, 160]	[2, 5, 11, 15, 21, 24, 28, 33, 43, 48, 50, 51, 54, 60, 64, 68, 71, 79, 83, 88, 91, 98, 100, 104, 106, 110, 113, 118, 125, 131, 133, 142, 146, 148, 151, 153, 160, 161]	['As', 'it', 'forms', 'the', 'basis', 'of', 'the', 'work', 'described', 'herein', ',', 'we', 'first', 'set', 'out', 'to', 'confirm', 'the', 'lack', 'of', 'secreted', 'proteases', 'in', 'this', 'strain', 'using', 'a', 'targeted', 'proteomics', 'method', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We first sought to assess whether loss of extracellular proteases affected viability of the USA300 LAC strain.	[('PMC3584211', 'R01000', 56, 65, 'proteases')]	['We', 'first', 'sought', 'to', 'assess', 'whether', 'loss', 'of', 'extra', '##cellular', 'pro', '##te', '##ases', 'affected', 'via', '##bility', 'of', 'the', 'USA', '##30', '##0', 'LA', '##C', 'strain', '.']	[0, 3, 9, 16, 19, 26, 34, 39, 42, 47, 56, 59, 61, 66, 75, 78, 85, 88, 92, 95, 97, 99, 101, 103, 109]	[2, 8, 15, 18, 25, 33, 38, 41, 47, 55, 59, 61, 65, 74, 78, 84, 87, 91, 95, 97, 98, 101, 102, 109, 110]	['We', 'first', 'sought', 'to', 'assess', 'whether', 'loss', 'of', 'extracellular', 'proteases', 'affected', 'viability', 'of', 'the', 'USA300', 'LAC', 'strain', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 2, 1, 1, 3, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We next set out to assess the fitness of the wild type and protease mutant during growth in a more pathogenically relevant medium, in this case pig serum.	[('PMC3584211', 'R02000', 59, 67, 'protease')]	['We', 'next', 'set', 'out', 'to', 'assess', 'the', 'fitness', 'of', 'the', 'wild', 'type', 'and', 'pro', '##te', '##ase', 'mutant', 'during', 'growth', 'in', 'a', 'more', 'path', '##ogenic', '##ally', 'relevant', 'medium', ',', 'in', 'this', 'case', 'pig', 'serum', '.']	[0, 3, 8, 12, 16, 19, 26, 30, 38, 41, 45, 50, 55, 59, 62, 64, 68, 75, 82, 89, 92, 94, 99, 103, 109, 114, 123, 129, 131, 134, 139, 144, 148, 153]	[2, 7, 11, 15, 18, 25, 29, 37, 40, 44, 49, 54, 58, 62, 64, 67, 74, 81, 88, 91, 93, 98, 103, 109, 113, 122, 129, 130, 133, 138, 143, 147, 153, 154]	['We', 'next', 'set', 'out', 'to', 'assess', 'the', 'fitness', 'of', 'the', 'wild', 'type', 'and', 'protease', 'mutant', 'during', 'growth', 'in', 'a', 'more', 'pathogenically', 'relevant', 'medium', ',', 'in', 'this', 'case', 'pig', 'serum', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The specific mechanism by which the reduced viability of the protease-null strain in serum is mediated is unclear.	[('PMC3584211', 'R03000', 61, 69, 'protease')]	['The', 'specific', 'mechanism', 'by', 'which', 'the', 'reduced', 'via', '##bility', 'of', 'the', 'pro', '##te', '##ase', '-', 'null', 'strain', 'in', 'serum', 'is', 'mediated', 'is', 'unclear', '.']	[0, 4, 13, 23, 26, 32, 36, 44, 47, 54, 57, 61, 64, 66, 69, 70, 75, 82, 85, 91, 94, 103, 106, 113]	[3, 12, 22, 25, 31, 35, 43, 47, 53, 56, 60, 64, 66, 69, 70, 74, 81, 84, 90, 93, 102, 105, 113, 114]	['The', 'specific', 'mechanism', 'by', 'which', 'the', 'reduced', 'viability', 'of', 'the', 'protease', '-', 'null', 'strain', 'in', 'serum', 'is', 'mediated', 'is', 'unclear', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Specifically, we observed a twofold decrease in protease-null cells compared with the parental strain at a concentration of 45 μg/mL, which increased to >fourfold at 65 μg/mL, and more than 7.5-fold at 85 μg/mL. Similar findings were observed with indolicidin, with a 2.5-fold decrease in viability observed for the mutant strain at 4 μg/mL, a more than sevenfold observed at 6 μg/mL, and >10-fold at 7 μg/mL. Finally, when these analyses were performed using histatin-5 we observed a >2.5-fold decrease in mutant viability at 3 μg/mL, a >8.5-fold at 5 μg/mL, and >11-fold at 6 μg/mL.	[]	['Specifically', ',', 'we', 'observed', 'a', 'two', '##fold', 'decrease', 'in', 'pro', '##te', '##ase', '-', 'null', 'cells', 'compared', 'with', 'the', 'parental', 'strain', 'at', 'a', 'concentration', 'of', '45', 'μ', '##g', '/', 'm', '##L', ',', 'which', 'increased', 'to', '>', 'four', '##fold', 'at', '65', 'μ', '##g', '/', 'm', '##L', ',', 'and', 'more', 'than', '7', '.', '5', '-', 'fold', 'at', '85', 'μ', '##g', '/', 'm', '##L', '.', 'Similar', 'findings', 'were', 'observed', 'with', 'in', '##do', '##lic', '##id', '##in', ',', 'with', 'a', '2', '.', '5', '-', 'fold', 'decrease', 'in', 'via', '##bility', 'observed', 'for', 'the', 'mutant', 'strain', 'at', '4', 'μ', '##g', '/', 'm', '##L', ',', 'a', 'more', 'than', 'seven', '##fold', 'observed', 'at', '6', 'μ', '##g', '/', 'm', '##L', ',', 'and', '>', '10', '-', 'fold', 'at', '7', 'μ', '##g', '/', 'm', '##L', '.', 'Finally', ',', 'when', 'these', 'analyses', 'were', 'performed', 'using', 'his', '##tat', '##in', '-', '5', 'we', 'observed', 'a', '>', '2', '.', '5', '-', 'fold', 'decrease', 'in', 'mutant', 'via', '##bility', 'at', '3', 'μ', '##g', '/', 'm', '##L', ',', 'a', '>', '8', '.', '5', '-', 'fold', 'at', '5', 'μ', '##g', '/', 'm', '##L', ',', 'and', '>', '11', '-', 'fold', 'at', '6', 'μ', '##g', '/', 'm', '##L', '.']	[0, 12, 14, 17, 26, 28, 31, 36, 45, 48, 51, 53, 56, 57, 62, 68, 77, 82, 86, 95, 102, 105, 107, 121, 124, 127, 128, 129, 130, 131, 132, 134, 140, 150, 153, 154, 158, 163, 166, 169, 170, 171, 172, 173, 174, 176, 180, 185, 190, 191, 192, 193, 194, 199, 202, 205, 206, 207, 208, 209, 210, 212, 220, 229, 234, 243, 248, 250, 252, 255, 257, 259, 261, 266, 268, 269, 270, 271, 272, 277, 286, 289, 292, 299, 308, 312, 316, 323, 330, 333, 335, 336, 337, 338, 339, 340, 342, 344, 349, 354, 359, 364, 373, 376, 378, 379, 380, 381, 382, 383, 385, 389, 390, 392, 393, 398, 401, 403, 404, 405, 406, 407, 408, 410, 417, 419, 424, 430, 439, 444, 454, 460, 463, 466, 468, 469, 471, 474, 483, 485, 486, 487, 488, 489, 490, 495, 504, 507, 514, 517, 524, 527, 529, 530, 531, 532, 533, 534, 536, 538, 539, 540, 541, 542, 543, 548, 551, 553, 554, 555, 556, 557, 558, 560, 564, 565, 567, 568, 573, 576, 578, 579, 580, 581, 582, 583]	[12, 13, 16, 25, 27, 31, 35, 44, 47, 51, 53, 56, 57, 61, 67, 76, 81, 85, 94, 101, 104, 106, 120, 123, 126, 128, 129, 130, 131, 132, 133, 139, 149, 152, 154, 158, 162, 165, 168, 170, 171, 172, 173, 174, 175, 179, 184, 189, 191, 192, 193, 194, 198, 201, 204, 206, 207, 208, 209, 210, 211, 219, 228, 233, 242, 247, 250, 252, 255, 257, 259, 260, 265, 267, 269, 270, 271, 272, 276, 285, 288, 292, 298, 307, 311, 315, 322, 329, 332, 334, 336, 337, 338, 339, 340, 341, 343, 348, 353, 359, 363, 372, 375, 377, 379, 380, 381, 382, 383, 384, 388, 390, 392, 393, 397, 400, 402, 404, 405, 406, 407, 408, 409, 417, 418, 423, 429, 438, 443, 453, 459, 463, 466, 468, 469, 470, 473, 482, 484, 486, 487, 488, 489, 490, 494, 503, 506, 513, 517, 523, 526, 528, 530, 531, 532, 533, 534, 535, 537, 539, 540, 541, 542, 543, 547, 550, 552, 554, 555, 556, 557, 558, 559, 563, 565, 567, 568, 572, 575, 577, 579, 580, 581, 582, 583, 584]	['Specifically', ',', 'we', 'observed', 'a', 'twofold', 'decrease', 'in', 'protease', '-', 'null', 'cells', 'compared', 'with', 'the', 'parental', 'strain', 'at', 'a', 'concentration', 'of', '45', 'μg', '/', 'mL', ',', 'which', 'increased', 'to', '>', 'fourfold', 'at', '65', 'μg', '/', 'mL', ',', 'and', 'more', 'than', '7.5-fold', 'at', '85', 'μg', '/', 'mL', '.', 'Similar', 'findings', 'were', 'observed', 'with', 'indolicidin', ',', 'with', 'a', '2.5-fold', 'decrease', 'in', 'viability', 'observed', 'for', 'the', 'mutant', 'strain', 'at', '4', 'μg', '/', 'mL', ',', 'a', 'more', 'than', 'sevenfold', 'observed', 'at', '6', 'μg', '/', 'mL', ',', 'and', '>', '10-fold', 'at', '7', 'μg', '/', 'mL', '.', 'Finally', ',', 'when', 'these', 'analyses', 'were', 'performed', 'using', 'histatin-5', 'we', 'observed', 'a', '>', '2.5-fold', 'decrease', 'in', 'mutant', 'viability', 'at', '3', 'μg', '/', 'mL', ',', 'a', '>', '8.5-fold', 'at', '5', 'μg', '/', 'mL', ',', 'and', '>', '11-fold', 'at', '6', 'μg', '/', 'mL', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 5, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 5, 1, 1, 2, 1, 2, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Collectively, it is apparent that extracellular protease deletion results in heightened sensitivity of S. aureus cells to the effects of antimicrobial peptides; and that this observation is not limited to a single peptide example.	[]	['Collective', '##ly', ',', 'it', 'is', 'apparent', 'that', 'extra', '##cellular', 'pro', '##te', '##ase', 'del', '##eti', '##on', 'results', 'in', 'heightened', 'sensitivity', 'of', 'S', '.', 'au', '##reus', 'cells', 'to', 'the', 'effects', 'of', 'anti', '##mic', '##ro', '##bial', 'p', '##eptide', '##s', ';', 'and', 'that', 'this', 'observation', 'is', 'not', 'limited', 'to', 'a', 'single', 'p', '##eptide', 'example', '.']	[0, 10, 12, 14, 17, 20, 29, 34, 39, 48, 51, 53, 57, 60, 63, 66, 74, 77, 88, 100, 103, 104, 106, 108, 113, 119, 122, 126, 134, 137, 141, 144, 146, 151, 152, 158, 159, 161, 165, 170, 175, 187, 190, 194, 202, 205, 207, 214, 215, 222, 229]	[10, 12, 13, 16, 19, 28, 33, 39, 47, 51, 53, 56, 60, 63, 65, 73, 76, 87, 99, 102, 104, 105, 108, 112, 118, 121, 125, 133, 136, 141, 144, 146, 150, 152, 158, 159, 160, 164, 169, 174, 186, 189, 193, 201, 204, 206, 213, 215, 221, 229, 230]	['Collectively', ',', 'it', 'is', 'apparent', 'that', 'extracellular', 'protease', 'deletion', 'results', 'in', 'heightened', 'sensitivity', 'of', 'S', '.', 'aureus', 'cells', 'to', 'the', 'effects', 'of', 'antimicrobial', 'peptides', ';', 'and', 'that', 'this', 'observation', 'is', 'not', 'limited', 'to', 'a', 'single', 'peptide', 'example', '.']	[2, 1, 1, 1, 1, 1, 2, 3, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As such, these findings strongly suggest that secreted proteases are a major mechanism by which S. aureus resists the toxic effects of AMPs.	[]	['As', 'such', ',', 'these', 'findings', 'strongly', 'suggest', 'that', 'secret', '##ed', 'pro', '##te', '##ases', 'are', 'a', 'major', 'mechanism', 'by', 'which', 'S', '.', 'au', '##reus', 'resist', '##s', 'the', 'toxic', 'effects', 'of', 'AM', '##Ps', '.']	[0, 3, 7, 9, 15, 24, 33, 41, 46, 52, 55, 58, 60, 65, 69, 71, 77, 87, 90, 96, 97, 99, 101, 106, 112, 114, 118, 124, 132, 135, 137, 139]	[2, 7, 8, 14, 23, 32, 40, 45, 52, 54, 58, 60, 64, 68, 70, 76, 86, 89, 95, 97, 98, 101, 105, 112, 113, 117, 123, 131, 134, 137, 139, 140]	['As', 'such', ',', 'these', 'findings', 'strongly', 'suggest', 'that', 'secreted', 'proteases', 'are', 'a', 'major', 'mechanism', 'by', 'which', 'S', '.', 'aureus', 'resists', 'the', 'toxic', 'effects', 'of', 'AMPs', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The in vitro AMP sensitivity assays suggest that extracellular proteases are important for survival during interaction with elements of the immune system.	[('PMC3584211', 'R04000', 63, 72, 'proteases')]	['The', 'in', 'v', '##it', '##ro', 'AM', '##P', 'sensitivity', 'ass', '##ays', 'suggest', 'that', 'extra', '##cellular', 'pro', '##te', '##ases', 'are', 'important', 'for', 'survival', 'during', 'interaction', 'with', 'elements', 'of', 'the', 'immune', 'system', '.']	[0, 4, 7, 8, 10, 13, 15, 17, 29, 32, 36, 44, 49, 54, 63, 66, 68, 73, 77, 87, 91, 100, 107, 119, 124, 133, 136, 140, 147, 153]	[3, 6, 8, 10, 12, 15, 16, 28, 32, 35, 43, 48, 54, 62, 66, 68, 72, 76, 86, 90, 99, 106, 118, 123, 132, 135, 139, 146, 153, 154]	['The', 'in', 'vitro', 'AMP', 'sensitivity', 'assays', 'suggest', 'that', 'extracellular', 'proteases', 'are', 'important', 'for', 'survival', 'during', 'interaction', 'with', 'elements', 'of', 'the', 'immune', 'system', '.']	[1, 1, 3, 2, 1, 2, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These strains were incubated under identical conditions to the whole human blood survival assay, before white blood cells were isolated and subjected to separation and analysis by FACS (Fig. 3).	[]	['These', 'strains', 'were', 'in', '##cu', '##bate', '##d', 'under', 'identical', 'conditions', 'to', 'the', 'whole', 'human', 'blood', 'survival', 'ass', '##ay', ',', 'before', 'white', 'blood', 'cells', 'were', 'isolated', 'and', 'subjected', 'to', 'separation', 'and', 'analysis', 'by', 'FA', '##CS', '(', 'Fi', '##g', '.', '3', ')', '.']	[0, 6, 14, 19, 21, 23, 27, 29, 35, 45, 56, 59, 63, 69, 75, 81, 90, 93, 95, 97, 104, 110, 116, 122, 127, 136, 140, 150, 153, 164, 168, 177, 180, 182, 185, 186, 188, 189, 191, 192, 193]	[5, 13, 18, 21, 23, 27, 28, 34, 44, 55, 58, 62, 68, 74, 80, 89, 93, 95, 96, 103, 109, 115, 121, 126, 135, 139, 149, 152, 163, 167, 176, 179, 182, 184, 186, 188, 189, 190, 192, 193, 194]	['These', 'strains', 'were', 'incubated', 'under', 'identical', 'conditions', 'to', 'the', 'whole', 'human', 'blood', 'survival', 'assay', ',', 'before', 'white', 'blood', 'cells', 'were', 'isolated', 'and', 'subjected', 'to', 'separation', 'and', 'analysis', 'by', 'FACS', '(', 'Fig', '.', '3', ')', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There are conflicting results regarding the role of extracellular proteases in S. aureus virulence (Coulter et al. 1998;	[('PMC3584211', 'R05000', 66, 75, 'proteases')]	['There', 'are', 'conflicting', 'results', 'regarding', 'the', 'role', 'of', 'extra', '##cellular', 'pro', '##te', '##ases', 'in', 'S', '.', 'au', '##reus', 'v', '##ir', '##ule', '##nce', '(', 'Co', '##ulter', 'et', 'al', '.', '1998', ';']	[0, 6, 10, 22, 30, 40, 44, 49, 52, 57, 66, 69, 71, 76, 79, 80, 82, 84, 89, 90, 92, 95, 99, 100, 102, 108, 111, 113, 115, 119]	[5, 9, 21, 29, 39, 43, 48, 51, 57, 65, 69, 71, 75, 78, 80, 81, 84, 88, 90, 92, 95, 98, 100, 102, 107, 110, 113, 114, 119, 120]	['There', 'are', 'conflicting', 'results', 'regarding', 'the', 'role', 'of', 'extracellular', 'proteases', 'in', 'S', '.', 'aureus', 'virulence', '(', 'Coulter', 'et', 'al', '.', '1998', ';']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 4, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Accordingly, 10 mice were subcutaneously inoculated with either the LAC wild type or protease-null mutant, and the infection was allowed to proceed for 6 days.	[]	['Accordingly', ',', '10', 'mice', 'were', 'sub', '##cut', '##aneous', '##ly', 'in', '##oc', '##ulated', 'with', 'either', 'the', 'LA', '##C', 'wild', 'type', 'or', 'pro', '##te', '##ase', '-', 'null', 'mutant', ',', 'and', 'the', 'infection', 'was', 'allowed', 'to', 'proceed', 'for', '6', 'days', '.']	[0, 11, 13, 16, 21, 26, 29, 32, 38, 41, 43, 45, 52, 57, 64, 68, 70, 72, 77, 82, 85, 88, 90, 93, 94, 99, 105, 107, 111, 115, 125, 129, 137, 140, 148, 152, 154, 158]	[11, 12, 15, 20, 25, 29, 32, 38, 40, 43, 45, 51, 56, 63, 67, 70, 71, 76, 81, 84, 88, 90, 93, 94, 98, 105, 106, 110, 114, 124, 128, 136, 139, 147, 151, 153, 158, 159]	['Accordingly', ',', '10', 'mice', 'were', 'subcutaneously', 'inoculated', 'with', 'either', 'the', 'LAC', 'wild', 'type', 'or', 'protease', '-', 'null', 'mutant', ',', 'and', 'the', 'infection', 'was', 'allowed', 'to', 'proceed', 'for', '6', 'days', '.']	[1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Other well-known virulence determinants were also found to be more abundant in the protease-null strain, including two Lipases (Geh = 3.8-fold, SAUSA300_2603 = 2.5-fold), components of the γ-hemolysin (HlgA = 2.4-fold, HlgC = 2.1-fold), α-toxin (twofold), leukotoxin LukE (twofold), and enterotoxin Q (1.5-fold).	[]	['Other', 'well', '-', 'known', 'v', '##ir', '##ule', '##nce', 'de', '##ter', '##mina', '##nts', 'were', 'also', 'found', 'to', 'be', 'more', 'abundant', 'in', 'the', 'pro', '##te', '##ase', '-', 'null', 'strain', ',', 'including', 'two', 'Li', '##pas', '##es', '(', 'G', '##eh', '=', '3', '.', '8', '-', 'fold', ',', 'SA', '##US', '##A', '##30', '##0', '_', '260', '##3', '=', '2', '.', '5', '-', 'fold', ')', ',', 'components', 'of', 'the', 'γ', '-', 'hem', '##oly', '##sin', '(', 'H', '##l', '##g', '##A', '=', '2', '.', '4', '-', 'fold', ',', 'H', '##l', '##g', '##C', '=', '2', '.', '1', '-', 'fold', ')', ',', 'α', '-', 'to', '##xin', '(', 'two', '##fold', ')', ',', 'le', '##uk', '##oto', '##xin', 'Lu', '##k', '##E', '(', 'two', '##fold', ')', ',', 'and', 'enter', '##oto', '##xin', 'Q', '(', '1', '.', '5', '-', 'fold', ')', '.']	[0, 6, 10, 11, 17, 18, 20, 23, 27, 29, 32, 36, 40, 45, 50, 56, 59, 62, 67, 76, 79, 83, 86, 88, 91, 92, 97, 103, 105, 115, 119, 121, 124, 127, 128, 129, 132, 134, 135, 136, 137, 138, 142, 144, 146, 148, 149, 151, 152, 153, 156, 158, 160, 161, 162, 163, 164, 168, 169, 171, 182, 185, 189, 190, 191, 194, 197, 201, 202, 203, 204, 205, 207, 209, 210, 211, 212, 213, 217, 219, 220, 221, 222, 224, 226, 227, 228, 229, 230, 234, 235, 237, 238, 239, 241, 245, 246, 249, 253, 254, 256, 258, 260, 263, 267, 269, 270, 272, 273, 276, 280, 281, 283, 287, 292, 295, 299, 301, 302, 303, 304, 305, 306, 310, 311]	[5, 10, 11, 16, 18, 20, 23, 26, 29, 32, 36, 39, 44, 49, 55, 58, 61, 66, 75, 78, 82, 86, 88, 91, 92, 96, 103, 104, 114, 118, 121, 124, 126, 128, 129, 131, 133, 135, 136, 137, 138, 142, 143, 146, 148, 149, 151, 152, 153, 156, 157, 159, 161, 162, 163, 164, 168, 169, 170, 181, 184, 188, 190, 191, 194, 197, 200, 202, 203, 204, 205, 206, 208, 210, 211, 212, 213, 217, 218, 220, 221, 222, 223, 225, 227, 228, 229, 230, 234, 235, 236, 238, 239, 241, 244, 246, 249, 253, 254, 255, 258, 260, 263, 266, 269, 270, 271, 273, 276, 280, 281, 282, 286, 292, 295, 298, 300, 302, 303, 304, 305, 306, 310, 311, 312]	['Other', 'well', '-', 'known', 'virulence', 'determinants', 'were', 'also', 'found', 'to', 'be', 'more', 'abundant', 'in', 'the', 'protease', '-', 'null', 'strain', ',', 'including', 'two', 'Lipases', '(', 'Geh', '=', '3.8-fold', ',', 'SAUSA300_2603', '=', '2.5-fold', ')', ',', 'components', 'of', 'the', 'γ-hemolysin', '(', 'HlgA', '=', '2.4-fold', ',', 'HlgC', '=', '2.1-fold', ')', ',', 'α-toxin', '(', 'twofold', ')', ',', 'leukotoxin', 'LukE', '(', 'twofold', ')', ',', 'and', 'enterotoxin', 'Q', '(', '1.5-fold', ')', '.']	[1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 5, 1, 8, 1, 5, 1, 1, 1, 1, 1, 5, 1, 4, 1, 5, 1, 4, 1, 5, 1, 1, 4, 1, 2, 1, 1, 4, 3, 1, 2, 1, 1, 1, 3, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our analysis also revealed increased abundance of certain proteins in the wild-type strain, including all 10 secreted proteases, as expected, along with catalase (ninefold), the CamS pheromone (twofold), and two putative lipoproteins (SAUSA300_2403 = twofold, SAUSA300_0411 = threefold).	[]	['Our', 'analysis', 'also', 'revealed', 'increased', 'abundance', 'of', 'certain', 'proteins', 'in', 'the', 'wild', '-', 'type', 'strain', ',', 'including', 'all', '10', 'secret', '##ed', 'pro', '##te', '##ases', ',', 'as', 'expected', ',', 'along', 'with', 'cat', '##ala', '##se', '(', 'nine', '##fold', ')', ',', 'the', 'Cam', '##S', 'p', '##her', '##omo', '##ne', '(', 'two', '##fold', ')', ',', 'and', 'two', 'put', '##ative', 'lip', '##op', '##rote', '##ins', '(', 'SA', '##US', '##A', '##30', '##0', '_', '240', '##3', '=', 'two', '##fold', ',', 'SA', '##US', '##A', '##30', '##0', '_', '04', '##11', '=', 'three', '##fold', ')', '.']	[0, 4, 13, 18, 27, 37, 47, 50, 58, 67, 70, 74, 78, 79, 84, 90, 92, 102, 106, 109, 115, 118, 121, 123, 127, 129, 132, 140, 142, 148, 153, 156, 159, 162, 163, 167, 171, 172, 174, 178, 181, 183, 184, 187, 190, 193, 194, 197, 201, 202, 204, 208, 212, 215, 221, 224, 226, 230, 234, 235, 237, 239, 240, 242, 243, 244, 247, 249, 251, 254, 258, 260, 262, 264, 265, 267, 268, 269, 271, 274, 276, 281, 285, 286]	[3, 12, 17, 26, 36, 46, 49, 57, 66, 69, 73, 78, 79, 83, 90, 91, 101, 105, 108, 115, 117, 121, 123, 127, 128, 131, 140, 141, 147, 152, 156, 159, 161, 163, 167, 171, 172, 173, 177, 181, 182, 184, 187, 190, 192, 194, 197, 201, 202, 203, 207, 211, 215, 220, 224, 226, 230, 233, 235, 237, 239, 240, 242, 243, 244, 247, 248, 250, 254, 258, 259, 262, 264, 265, 267, 268, 269, 271, 273, 275, 281, 285, 286, 287]	['Our', 'analysis', 'also', 'revealed', 'increased', 'abundance', 'of', 'certain', 'proteins', 'in', 'the', 'wild', '-', 'type', 'strain', ',', 'including', 'all', '10', 'secreted', 'proteases', ',', 'as', 'expected', ',', 'along', 'with', 'catalase', '(', 'ninefold', ')', ',', 'the', 'CamS', 'pheromone', '(', 'twofold', ')', ',', 'and', 'two', 'putative', 'lipoproteins', '(', 'SAUSA300_2403', '=', 'twofold', ',', 'SAUSA300_0411', '=', 'threefold', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 2, 4, 1, 2, 1, 1, 1, 1, 2, 4, 1, 8, 1, 2, 1, 8, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A consideration with this pooled analysis is that a protein may be processed by secreted proteases into potentially inactive fragments, as a result of endoproteolysis.	[('PMC3584211', 'R09000', 89, 98, 'proteases')]	['A', 'consideration', 'with', 'this', 'pool', '##ed', 'analysis', 'is', 'that', 'a', 'protein', 'may', 'be', 'processed', 'by', 'secret', '##ed', 'pro', '##te', '##ases', 'into', 'potentially', 'inactive', 'fragments', ',', 'as', 'a', 'result', 'of', 'end', '##op', '##rote', '##oly', '##sis', '.']	[0, 2, 16, 21, 26, 30, 33, 42, 45, 50, 52, 60, 64, 67, 77, 80, 86, 89, 92, 94, 99, 104, 116, 125, 134, 136, 139, 141, 148, 151, 154, 156, 160, 163, 166]	[1, 15, 20, 25, 30, 32, 41, 44, 49, 51, 59, 63, 66, 76, 79, 86, 88, 92, 94, 98, 103, 115, 124, 134, 135, 138, 140, 147, 150, 154, 156, 160, 163, 166, 167]	['A', 'consideration', 'with', 'this', 'pooled', 'analysis', 'is', 'that', 'a', 'protein', 'may', 'be', 'processed', 'by', 'secreted', 'proteases', 'into', 'potentially', 'inactive', 'fragments', ',', 'as', 'a', 'result', 'of', 'endoproteolysis', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We also performed specific fraction analysis as detailed above to determine those proteins with altered protein stability upon deletion of the extracellular proteases (Fig. 8 and Table S4).	[]	['We', 'also', 'performed', 'specific', 'fraction', 'analysis', 'as', 'detailed', 'above', 'to', 'determine', 'those', 'proteins', 'with', 'altered', 'protein', 'stability', 'upon', 'del', '##eti', '##on', 'of', 'the', 'extra', '##cellular', 'pro', '##te', '##ases', '(', 'Fi', '##g', '.', '8', 'and', 'Table', 'S', '##4', ')', '.']	[0, 3, 8, 18, 27, 36, 45, 48, 57, 63, 66, 76, 82, 91, 96, 104, 112, 122, 127, 130, 133, 136, 139, 143, 148, 157, 160, 162, 167, 168, 170, 171, 173, 175, 179, 185, 186, 187, 188]	[2, 7, 17, 26, 35, 44, 47, 56, 62, 65, 75, 81, 90, 95, 103, 111, 121, 126, 130, 133, 135, 138, 142, 148, 156, 160, 162, 166, 168, 170, 171, 172, 174, 178, 184, 186, 187, 188, 189]	['We', 'also', 'performed', 'specific', 'fraction', 'analysis', 'as', 'detailed', 'above', 'to', 'determine', 'those', 'proteins', 'with', 'altered', 'protein', 'stability', 'upon', 'deletion', 'of', 'the', 'extracellular', 'proteases', '(', 'Fig', '.', '8', 'and', 'Table', 'S4', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 3, 1, 2, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the current cohort study, we further investigated several newly found candidates, ceruloplasmin, myeloperoxidase, complement factor H and alpha-1-acid glycoprotein, by comparing their plasma levels during the active phase of aGvHD and after the complete response to aGvHD therapy.	[]	['In', 'the', 'current', 'co', '##hor', '##t', 'study', ',', 'we', 'further', 'investigated', 'several', 'newly', 'found', 'candidates', ',', 'c', '##er', '##ulo', '##p', '##las', '##min', ',', 'my', '##elo', '##per', '##ox', '##idas', '##e', ',', 'complement', 'factor', 'H', 'and', 'alpha', '-', '1', '-', 'acid', 'g', '##ly', '##co', '##p', '##rote', '##in', ',', 'by', 'comparing', 'their', 'plasma', 'levels', 'during', 'the', 'active', 'phase', 'of', 'a', '##G', '##v', '##HD', 'and', 'after', 'the', 'complete', 'response', 'to', 'a', '##G', '##v', '##HD', 'therapy', '.']	[0, 3, 7, 15, 17, 20, 22, 27, 29, 32, 40, 53, 61, 67, 73, 83, 85, 86, 88, 91, 92, 95, 98, 100, 102, 105, 108, 110, 114, 115, 117, 128, 135, 137, 141, 146, 147, 148, 149, 154, 155, 157, 159, 160, 164, 166, 168, 171, 181, 187, 194, 201, 208, 212, 219, 225, 228, 229, 230, 231, 234, 238, 244, 248, 257, 266, 269, 270, 271, 272, 275, 282]	[2, 6, 14, 17, 20, 21, 27, 28, 31, 39, 52, 60, 66, 72, 83, 84, 86, 88, 91, 92, 95, 98, 99, 102, 105, 108, 110, 114, 115, 116, 127, 134, 136, 140, 146, 147, 148, 149, 153, 155, 157, 159, 160, 164, 166, 167, 170, 180, 186, 193, 200, 207, 211, 218, 224, 227, 229, 230, 231, 233, 237, 243, 247, 256, 265, 268, 270, 271, 272, 274, 282, 283]	['In', 'the', 'current', 'cohort', 'study', ',', 'we', 'further', 'investigated', 'several', 'newly', 'found', 'candidates', ',', 'ceruloplasmin', ',', 'myeloperoxidase', ',', 'complement', 'factor', 'H', 'and', 'alpha-1-acid', 'glycoprotein', ',', 'by', 'comparing', 'their', 'plasma', 'levels', 'during', 'the', 'active', 'phase', 'of', 'aGvHD', 'and', 'after', 'the', 'complete', 'response', 'to', 'aGvHD', 'therapy', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 6, 1, 1, 1, 1, 1, 5, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The samples were diluted, and the target proteins were measured using ELISA kits at the following antibody concentrations, according to each manufacturer's protocol: ceruloplasmin, 1:400 (Assaypro, EC4001-1); myeloperoxidase, 1:20 (Bender, BMS2038INST); complement factor H, 1:20000 (Hycult Biotech, HK342); and alpha-1-acid glycoprotein, 1:2000 (Assaypro, EG5001-1).	[('PMC3591372', 'M10000', 209, 224, 'myeloperoxidase')]	"['The', 'samples', 'were', 'di', '##lut', '##ed', ',', 'and', 'the', 'target', 'proteins', 'were', 'measured', 'using', 'E', '##L', '##IS', '##A', 'kits', 'at', 'the', 'following', 'anti', '##body', 'concentrations', ',', 'according', 'to', 'each', 'manufacturer', ""'"", 's', 'protocol', ':', 'c', '##er', '##ulo', '##p', '##las', '##min', ',', '1', ':', '400', '(', 'As', '##say', '##p', '##ro', ',', 'EC', '##40', '##01', '-', '1', ')', ';', 'my', '##elo', '##per', '##ox', '##idas', '##e', ',', '1', ':', '20', '(', 'Bend', '##er', ',', 'B', '##MS', '##20', '##38', '##IN', '##ST', ')', ';', 'complement', 'factor', 'H', ',', '1', ':', '2000', '##0', '(', 'H', '##y', '##cu', '##lt', 'B', '##iot', '##ech', ',', 'HK', '##34', '##2', ')', ';', 'and', 'alpha', '-', '1', '-', 'acid', 'g', '##ly', '##co', '##p', '##rote', '##in', ',', '1', ':', '2000', '(', 'As', '##say', '##p', '##ro', ',', 'E', '##G', '##500', '##1', '-', '1', ')', '.']"	[0, 4, 12, 17, 19, 22, 24, 26, 30, 34, 41, 50, 55, 64, 70, 71, 72, 74, 76, 81, 84, 88, 98, 102, 107, 121, 123, 133, 136, 141, 153, 154, 156, 164, 166, 167, 169, 172, 173, 176, 179, 181, 182, 183, 187, 188, 190, 193, 194, 196, 198, 200, 202, 204, 205, 206, 207, 209, 211, 214, 217, 219, 223, 224, 226, 227, 228, 231, 232, 236, 238, 240, 241, 243, 245, 247, 249, 251, 252, 254, 265, 272, 273, 275, 276, 277, 281, 283, 284, 285, 286, 288, 291, 292, 295, 298, 300, 302, 304, 305, 306, 308, 312, 317, 318, 319, 320, 325, 326, 328, 330, 331, 335, 337, 339, 340, 341, 346, 347, 349, 352, 353, 355, 357, 358, 359, 362, 363, 364, 365, 366]	[3, 11, 16, 19, 22, 24, 25, 29, 33, 40, 49, 54, 63, 69, 71, 72, 74, 75, 80, 83, 87, 97, 102, 106, 121, 122, 132, 135, 140, 153, 154, 155, 164, 165, 167, 169, 172, 173, 176, 179, 180, 182, 183, 186, 188, 190, 193, 194, 196, 197, 200, 202, 204, 205, 206, 207, 208, 211, 214, 217, 219, 223, 224, 225, 227, 228, 230, 232, 236, 238, 239, 241, 243, 245, 247, 249, 251, 252, 253, 264, 271, 273, 274, 276, 277, 281, 282, 284, 285, 286, 288, 290, 292, 295, 298, 299, 302, 304, 305, 306, 307, 311, 317, 318, 319, 320, 324, 326, 328, 330, 331, 335, 337, 338, 340, 341, 345, 347, 349, 352, 353, 355, 356, 358, 359, 362, 363, 364, 365, 366, 367]	"['The', 'samples', 'were', 'diluted', ',', 'and', 'the', 'target', 'proteins', 'were', 'measured', 'using', 'ELISA', 'kits', 'at', 'the', 'following', 'antibody', 'concentrations', ',', 'according', 'to', 'each', ""manufacturer's"", 'protocol', ':', 'ceruloplasmin', ',', '1', ':', '400', '(', 'Assaypro', ',', 'EC4001-1', ')', ';', 'myeloperoxidase', ',', '1', ':', '20', '(', 'Bender', ',', 'BMS2038INST', ')', ';', 'complement', 'factor', 'H', ',', '1', ':', '20000', '(', 'Hycult', 'Biotech', ',', 'HK342', ')', ';', 'and', 'alpha-1-acid', 'glycoprotein', ',', '1', ':', '2000', '(', 'Assaypro', ',', 'EG5001-1', ')', '.']"	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 6, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 3, 1, 3, 1, 1, 1, 5, 6, 1, 1, 1, 1, 1, 4, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We carried out a genome-wide association study of serum aspartate aminotransferase (AST) activity in 866 Amish participants of the Heredity and Phenotype Intervention Heart Study and identified significant association of AST activity with a cluster of single nucleotide polymorphisms located on chromosome 10q24.1 (peak association was rs17109512; P=2.80E-14), in the vicinity of GOT1, the gene encoding cytosolic AST (cAST).	[('PMC3608855', 'A00000', 56, 82, 'aspartate aminotransferase')]	['We', 'carried', 'out', 'a', 'genome', '-', 'wide', 'association', 'study', 'of', 'serum', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', 'activity', 'in', '86', '##6', 'Am', '##ish', 'participants', 'of', 'the', 'Here', '##dit', '##y', 'and', 'Ph', '##eno', '##type', 'Inter', '##vention', 'Heart', 'Study', 'and', 'identified', 'significant', 'association', 'of', 'AS', '##T', 'activity', 'with', 'a', 'cluster', 'of', 'single', 'n', '##uc', '##leo', '##tide', 'p', '##oly', '##mor', '##phism', '##s', 'located', 'on', 'chromosome', '10', '##q', '##24', '.', '1', '(', 'peak', 'association', 'was', 'r', '##s', '##17', '##10', '##9', '##51', '##2', ';', 'P', '=', '2', '.', '80', '##E', '-', '14', ')', ',', 'in', 'the', 'vicinity', 'of', 'GO', '##T', '##1', ',', 'the', 'gene', 'encoding', 'c', '##yt', '##oso', '##lic', 'AS', '##T', '(', 'c', '##AS', '##T', ')', '.']	[0, 3, 11, 15, 17, 23, 24, 29, 41, 47, 50, 56, 58, 61, 66, 71, 74, 76, 79, 83, 84, 86, 87, 89, 98, 101, 103, 105, 107, 111, 124, 127, 131, 135, 138, 140, 144, 146, 149, 154, 159, 167, 173, 179, 183, 194, 206, 218, 221, 223, 225, 234, 239, 241, 249, 252, 259, 260, 262, 265, 270, 271, 274, 277, 282, 284, 292, 295, 306, 308, 309, 311, 312, 314, 315, 320, 332, 336, 337, 338, 340, 342, 343, 345, 346, 348, 349, 350, 351, 352, 354, 355, 356, 358, 359, 361, 364, 368, 377, 380, 382, 383, 384, 386, 390, 395, 404, 405, 407, 410, 414, 416, 418, 419, 420, 422, 423, 424]	[2, 10, 14, 16, 23, 24, 28, 40, 46, 49, 55, 58, 61, 65, 71, 74, 76, 79, 82, 84, 86, 87, 88, 97, 100, 103, 104, 107, 110, 123, 126, 130, 135, 138, 139, 143, 146, 149, 153, 159, 166, 172, 178, 182, 193, 205, 217, 220, 223, 224, 233, 238, 240, 248, 251, 258, 260, 262, 265, 269, 271, 274, 277, 282, 283, 291, 294, 305, 308, 309, 311, 312, 313, 315, 319, 331, 335, 337, 338, 340, 342, 343, 345, 346, 347, 349, 350, 351, 352, 354, 355, 356, 358, 359, 360, 363, 367, 376, 379, 382, 383, 384, 385, 389, 394, 403, 405, 407, 410, 413, 416, 417, 419, 420, 422, 423, 424, 425]	['We', 'carried', 'out', 'a', 'genome', '-', 'wide', 'association', 'study', 'of', 'serum', 'aspartate', 'aminotransferase', '(', 'AST', ')', 'activity', 'in', '866', 'Amish', 'participants', 'of', 'the', 'Heredity', 'and', 'Phenotype', 'Intervention', 'Heart', 'Study', 'and', 'identified', 'significant', 'association', 'of', 'AST', 'activity', 'with', 'a', 'cluster', 'of', 'single', 'nucleotide', 'polymorphisms', 'located', 'on', 'chromosome', '10q24.1', '(', 'peak', 'association', 'was', 'rs17109512', ';', 'P=2.80E-14', ')', ',', 'in', 'the', 'vicinity', 'of', 'GOT1', ',', 'the', 'gene', 'encoding', 'cytosolic', 'AST', '(', 'cAST', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 2, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 1, 5, 1, 1, 1, 1, 7, 1, 8, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 2, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aspartate aminotransferase (AST; EC 2.6.1.1) catalyzes the reversible conversion between aspartate/α-ketoglutarate and oxaloacetate/glutamate, and has an important role in amino acid metabolism and in the urea and tricarboxylic acid cycles.1 AST is conserved from all prokaryotic to eukaryotic organisms and is expressed in many types of cells/tissues including liver, red blood cells and cardiac/skeletal muscles.	[('PMC3608855', 'I00000', 0, 26, 'Aspartate aminotransferase')]	['As', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ';', 'EC', '2', '.', '6', '.', '1', '.', '1', ')', 'cat', '##aly', '##zes', 'the', 're', '##versible', 'conversion', 'between', 'as', '##par', '##tate', '/', 'α', '-', 'k', '##eto', '##g', '##lut', '##arate', 'and', 'o', '##xa', '##lo', '##ace', '##tate', '/', 'g', '##lut', '##ama', '##te', ',', 'and', 'has', 'an', 'important', 'role', 'in', 'amino', 'acid', 'metabolism', 'and', 'in', 'the', 'u', '##rea', 'and', 't', '##rica', '##rb', '##ox', '##yl', '##ic', 'acid', 'cycles', '.', '1', 'AS', '##T', 'is', 'conserved', 'from', 'all', 'pro', '##kar', '##yo', '##tic', 'to', 'e', '##uka', '##ryo', '##tic', 'organisms', 'and', 'is', 'expressed', 'in', 'many', 'types', 'of', 'cells', '/', 'tissues', 'including', 'liver', ',', 'red', 'blood', 'cells', 'and', 'cardiac', '/', 'skeletal', 'muscles', '.']	[0, 2, 5, 10, 15, 18, 20, 23, 27, 28, 30, 31, 33, 36, 37, 38, 39, 40, 41, 42, 43, 45, 48, 51, 55, 59, 61, 70, 81, 89, 91, 94, 98, 99, 100, 101, 102, 105, 106, 109, 115, 119, 120, 122, 124, 127, 131, 132, 133, 136, 139, 141, 143, 147, 151, 154, 164, 169, 172, 178, 183, 194, 198, 201, 205, 206, 210, 214, 215, 219, 221, 223, 225, 228, 233, 239, 240, 242, 244, 246, 249, 259, 264, 268, 271, 274, 276, 280, 283, 284, 287, 290, 294, 304, 308, 311, 321, 324, 329, 335, 338, 343, 344, 352, 362, 367, 369, 373, 379, 385, 389, 396, 397, 406, 413]	[2, 5, 9, 15, 18, 20, 23, 26, 28, 30, 31, 32, 35, 37, 38, 39, 40, 41, 42, 43, 44, 48, 51, 54, 58, 61, 69, 80, 88, 91, 94, 98, 99, 100, 101, 102, 105, 106, 109, 114, 118, 120, 122, 124, 127, 131, 132, 133, 136, 139, 141, 142, 146, 150, 153, 163, 168, 171, 177, 182, 193, 197, 200, 204, 206, 209, 213, 215, 219, 221, 223, 225, 227, 232, 239, 240, 241, 244, 245, 248, 258, 263, 267, 271, 274, 276, 279, 282, 284, 287, 290, 293, 303, 307, 310, 320, 323, 328, 334, 337, 343, 344, 351, 361, 367, 368, 372, 378, 384, 388, 396, 397, 405, 413, 414]	['Aspartate', 'aminotransferase', '(', 'AST', ';', 'EC', '2.6.1.1', ')', 'catalyzes', 'the', 'reversible', 'conversion', 'between', 'aspartate', '/', 'α-ketoglutarate', 'and', 'oxaloacetate', '/', 'glutamate', ',', 'and', 'has', 'an', 'important', 'role', 'in', 'amino', 'acid', 'metabolism', 'and', 'in', 'the', 'urea', 'and', 'tricarboxylic', 'acid', 'cycles.1', 'AST', 'is', 'conserved', 'from', 'all', 'prokaryotic', 'to', 'eukaryotic', 'organisms', 'and', 'is', 'expressed', 'in', 'many', 'types', 'of', 'cells', '/', 'tissues', 'including', 'liver', ',', 'red', 'blood', 'cells', 'and', 'cardiac', '/', 'skeletal', 'muscles', '.']	[3, 5, 1, 2, 1, 1, 7, 1, 3, 1, 2, 1, 1, 3, 1, 7, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 6, 1, 3, 2, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For construction of cASTmut (c.1165_1167delAAC), three fragment In-Fusion cloning was carried out with mutant 5′-end fragment (PCR amplified with upstream primer p2254 and downstream primer p2323 5′-ccactcacgattcgaccacttggcagcag-3′ on wild-type cAST cDNA template), mutant 3′-end fragment (PCR amplified with upstream primer p2313 5′-ggtcgaatcgtgagtggcttaaccaccaaa-3′ and downstream primer p2255 on wtAST template), and fragment of HindIII and Xba-precut pFlag-CMV2, to make the mutant cAST expression vector pFlag-CMV2-cASTmut.	[]	['For', 'construction', 'of', 'c', '##AS', '##T', '##mu', '##t', '(', 'c', '.', '116', '##5', '_', '116', '##7', '##del', '##AA', '##C', ')', ',', 'three', 'fragment', 'In', '-', 'Fusion', 'c', '##lon', '##ing', 'was', 'carried', 'out', 'with', 'mutant', '5', '′', '-', 'end', 'fragment', '(', 'PC', '##R', 'am', '##plified', 'with', 'upstream', 'prime', '##r', 'p', '##22', '##5', '##4', 'and', 'downstream', 'prime', '##r', 'p', '##23', '##23', '5', '′', '-', 'cc', '##act', '##ca', '##c', '##gat', '##t', '##c', '##ga', '##cca', '##ct', '##t', '##gg', '##ca', '##g', '##ca', '##g', '-', '3', '′', 'on', 'wild', '-', 'type', 'c', '##AS', '##T', 'c', '##D', '##NA', 'template', ')', ',', 'mutant', '3', '′', '-', 'end', 'fragment', '(', 'PC', '##R', 'am', '##plified', 'with', 'upstream', 'prime', '##r', 'p', '##23', '##13', '5', '′', '-', 'g', '##gt', '##c', '##ga', '##at', '##c', '##gt', '##ga', '##gt', '##gg', '##ct', '##ta', '##ac', '##ca', '##cca', '##aa', '-', '3', '′', 'and', 'downstream', 'prime', '##r', 'p', '##22', '##55', 'on', 'w', '##t', '##AS', '##T', 'template', ')', ',', 'and', 'fragment', 'of', 'Hi', '##nd', '##II', '##I', 'and', 'X', '##ba', '-', 'pre', '##cut', 'p', '##F', '##lag', '-', 'C', '##M', '##V', '##2', ',', 'to', 'make', 'the', 'mutant', 'c', '##AS', '##T', 'expression', 'vector', 'p', '##F', '##lag', '-', 'C', '##M', '##V', '##2', '-', 'c', '##AS', '##T', '##mu', '##t', '.']	[0, 4, 17, 20, 21, 23, 24, 26, 28, 29, 30, 31, 34, 35, 36, 39, 40, 43, 45, 46, 47, 49, 55, 64, 66, 67, 74, 75, 78, 82, 86, 94, 98, 103, 110, 111, 112, 113, 117, 126, 127, 129, 131, 133, 141, 146, 155, 160, 162, 163, 165, 166, 168, 172, 183, 188, 190, 191, 193, 196, 197, 198, 199, 201, 204, 206, 207, 210, 211, 212, 214, 217, 219, 220, 222, 224, 225, 227, 228, 229, 230, 232, 235, 239, 240, 245, 246, 248, 250, 251, 252, 255, 263, 264, 266, 273, 274, 275, 276, 280, 289, 290, 292, 294, 296, 304, 309, 318, 323, 325, 326, 328, 331, 332, 333, 334, 335, 337, 338, 340, 342, 343, 345, 347, 349, 351, 353, 355, 357, 359, 362, 364, 365, 366, 368, 372, 383, 388, 390, 391, 393, 396, 399, 400, 401, 403, 405, 413, 414, 416, 420, 429, 432, 434, 436, 438, 440, 444, 445, 447, 448, 451, 455, 456, 457, 460, 461, 462, 463, 464, 465, 467, 470, 475, 479, 486, 487, 489, 491, 502, 509, 510, 511, 514, 515, 516, 517, 518, 519, 520, 521, 523, 524, 526, 527]	[3, 16, 19, 21, 23, 24, 26, 27, 29, 30, 31, 34, 35, 36, 39, 40, 43, 45, 46, 47, 48, 54, 63, 66, 67, 73, 75, 78, 81, 85, 93, 97, 102, 109, 111, 112, 113, 116, 125, 127, 129, 130, 133, 140, 145, 154, 160, 161, 163, 165, 166, 167, 171, 182, 188, 189, 191, 193, 195, 197, 198, 199, 201, 204, 206, 207, 210, 211, 212, 214, 217, 219, 220, 222, 224, 225, 227, 228, 229, 230, 231, 234, 239, 240, 244, 246, 248, 249, 251, 252, 254, 263, 264, 265, 272, 274, 275, 276, 279, 288, 290, 292, 293, 296, 303, 308, 317, 323, 324, 326, 328, 330, 332, 333, 334, 335, 337, 338, 340, 342, 343, 345, 347, 349, 351, 353, 355, 357, 359, 362, 364, 365, 366, 367, 371, 382, 388, 389, 391, 393, 395, 398, 400, 401, 403, 404, 413, 414, 415, 419, 428, 431, 434, 436, 438, 439, 443, 445, 447, 448, 451, 454, 456, 457, 460, 461, 462, 463, 464, 465, 466, 469, 474, 478, 485, 487, 489, 490, 501, 508, 510, 511, 514, 515, 516, 517, 518, 519, 520, 521, 523, 524, 526, 527, 528]	['For', 'construction', 'of', 'cASTmut', '(', 'c.1165_1167delAAC', ')', ',', 'three', 'fragment', 'In-Fusion', 'cloning', 'was', 'carried', 'out', 'with', 'mutant', '5′-end', 'fragment', '(', 'PCR', 'amplified', 'with', 'upstream', 'primer', 'p2254', 'and', 'downstream', 'primer', 'p2323', '5′-ccactcacgattcgaccacttggcagcag-3′', 'on', 'wild', '-', 'type', 'cAST', 'cDNA', 'template', ')', ',', 'mutant', '3′-end', 'fragment', '(', 'PCR', 'amplified', 'with', 'upstream', 'primer', 'p2313', '5′-ggtcgaatcgtgagtggcttaaccaccaaa-3′', 'and', 'downstream', 'primer', 'p2255', 'on', 'wtAST', 'template', ')', ',', 'and', 'fragment', 'of', 'HindIII', 'and', 'Xba', '-', 'precut', 'pFlag-CMV2', ',', 'to', 'make', 'the', 'mutant', 'cAST', 'expression', 'vector', 'pFlag-CMV2-cASTmut', '.']	[1, 1, 1, 5, 1, 10, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 4, 1, 1, 2, 2, 1, 1, 2, 4, 1, 1, 2, 3, 22, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 4, 1, 1, 2, 2, 1, 1, 2, 3, 22, 1, 1, 2, 3, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 2, 8, 1, 1, 1, 1, 1, 3, 1, 1, 14, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The lack of replication was not explained by differences in the allele frequency between discovery and replication control cohorts (P ≥ 0.1 for the difference in frequency between control datasets for all SNPs, except rs17862876, which showed a slightly lower risk allele frequency in the replication controls (P = 0.018) and thus would be biased toward association in the same direction as in the discovery set).	[]	['The', 'lack', 'of', 'replication', 'was', 'not', 'explained', 'by', 'differences', 'in', 'the', 'all', '##ele', 'frequency', 'between', 'discovery', 'and', 'replication', 'control', 'co', '##hor', '##ts', '(', 'P', '≥', '0', '.', '1', 'for', 'the', 'difference', 'in', 'frequency', 'between', 'control', 'data', '##sets', 'for', 'all', 'S', '##NP', '##s', ',', 'except', 'r', '##s', '##17', '##86', '##28', '##7', '##6', ',', 'which', 'showed', 'a', 'slightly', 'lower', 'risk', 'all', '##ele', 'frequency', 'in', 'the', 'replication', 'controls', '(', 'P', '=', '0', '.', '01', '##8', ')', 'and', 'thus', 'would', 'be', 'bias', '##ed', 'toward', 'association', 'in', 'the', 'same', 'direction', 'as', 'in', 'the', 'discovery', 'set', ')', '.']	[0, 4, 9, 12, 24, 28, 32, 42, 45, 57, 60, 64, 67, 71, 81, 89, 99, 103, 115, 123, 125, 128, 131, 132, 134, 136, 137, 138, 140, 144, 148, 159, 162, 172, 180, 188, 192, 197, 201, 205, 206, 208, 209, 211, 218, 219, 220, 222, 224, 226, 227, 228, 230, 236, 243, 245, 254, 260, 265, 268, 272, 282, 285, 289, 301, 310, 311, 313, 315, 316, 317, 319, 320, 322, 326, 331, 337, 340, 344, 347, 354, 366, 369, 373, 378, 388, 391, 394, 398, 408, 411, 412]	[3, 8, 11, 23, 27, 31, 41, 44, 56, 59, 63, 67, 70, 80, 88, 98, 102, 114, 122, 125, 128, 130, 132, 133, 135, 137, 138, 139, 143, 147, 158, 161, 171, 179, 187, 192, 196, 200, 204, 206, 208, 209, 210, 217, 219, 220, 222, 224, 226, 227, 228, 229, 235, 242, 244, 253, 259, 264, 268, 271, 281, 284, 288, 300, 309, 311, 312, 314, 316, 317, 319, 320, 321, 325, 330, 336, 339, 344, 346, 353, 365, 368, 372, 377, 387, 390, 393, 397, 407, 411, 412, 413]	['The', 'lack', 'of', 'replication', 'was', 'not', 'explained', 'by', 'differences', 'in', 'the', 'allele', 'frequency', 'between', 'discovery', 'and', 'replication', 'control', 'cohorts', '(', 'P', '≥', '0.1', 'for', 'the', 'difference', 'in', 'frequency', 'between', 'control', 'datasets', 'for', 'all', 'SNPs', ',', 'except', 'rs17862876', ',', 'which', 'showed', 'a', 'slightly', 'lower', 'risk', 'allele', 'frequency', 'in', 'the', 'replication', 'controls', '(', 'P', '=', '0.018', ')', 'and', 'thus', 'would', 'be', 'biased', 'toward', 'association', 'in', 'the', 'same', 'direction', 'as', 'in', 'the', 'discovery', 'set', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A total of 500 ng of genomic DNA, 330 femtomoles of probe mixture (ignoring the contribution of the spiked-in poor performers), and 1 μL of 10× Ampligase DNA ligase buffer (Epicentre) were added to molecular biology-grade water for a total of 10 μL.	[]	['A', 'total', 'of', '500', 'ng', 'of', 'g', '##eno', '##mic', 'DNA', ',', '330', 'f', '##em', '##tom', '##ole', '##s', 'of', 'probe', 'mixture', '(', 'ignoring', 'the', 'contribution', 'of', 'the', 'spike', '##d', '-', 'in', 'poor', 'performers', ')', ',', 'and', '1', 'μ', '##L', 'of', '10', '##×', 'Am', '##p', '##liga', '##se', 'DNA', 'l', '##iga', '##se', 'buffer', '(', 'Epic', '##ent', '##re', ')', 'were', 'added', 'to', 'molecular', 'biology', '-', 'grade', 'water', 'for', 'a', 'total', 'of', '10', 'μ', '##L', '.']	[0, 2, 8, 11, 15, 18, 21, 22, 25, 29, 32, 34, 38, 39, 41, 44, 47, 49, 52, 58, 66, 67, 76, 80, 93, 96, 100, 105, 106, 107, 110, 115, 125, 126, 128, 132, 134, 135, 137, 140, 142, 144, 146, 147, 151, 154, 158, 159, 162, 165, 172, 173, 177, 180, 182, 184, 189, 195, 198, 208, 215, 216, 222, 228, 232, 234, 240, 243, 246, 247, 248]	[1, 7, 10, 14, 17, 20, 22, 25, 28, 32, 33, 37, 39, 41, 44, 47, 48, 51, 57, 65, 67, 75, 79, 92, 95, 99, 105, 106, 107, 109, 114, 125, 126, 127, 131, 133, 135, 136, 139, 142, 143, 146, 147, 151, 153, 157, 159, 162, 164, 171, 173, 177, 180, 182, 183, 188, 194, 197, 207, 215, 216, 221, 227, 231, 233, 239, 242, 245, 247, 248, 249]	['A', 'total', 'of', '500', 'ng', 'of', 'genomic', 'DNA', ',', '330', 'femtomoles', 'of', 'probe', 'mixture', '(', 'ignoring', 'the', 'contribution', 'of', 'the', 'spiked', '-', 'in', 'poor', 'performers', ')', ',', 'and', '1', 'μL', 'of', '10×', 'Ampligase', 'DNA', 'ligase', 'buffer', '(', 'Epicentre', ')', 'were', 'added', 'to', 'molecular', 'biology', '-', 'grade', 'water', 'for', 'a', 'total', 'of', '10', 'μL', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 4, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Following the gap-fill and ligation phase, the reactions were cooled to 37°C, and to each reaction we added 20 units of Exonuclease I (NEB) and 100 units of Exonuclease III (NEB) to degrade uncircularized probe and genomic DNA.	[('PMC3638140', 'M03000', 120, 133, 'Exonuclease I')]	['Following', 'the', 'gap', '-', 'fill', 'and', 'l', '##iga', '##tion', 'phase', ',', 'the', 'reactions', 'were', 'cooled', 'to', '37', '##°', '##C', ',', 'and', 'to', 'each', 'reaction', 'we', 'added', '20', 'units', 'of', 'Ex', '##on', '##uc', '##lea', '##se', 'I', '(', 'NE', '##B', ')', 'and', '100', 'units', 'of', 'Ex', '##on', '##uc', '##lea', '##se', 'III', '(', 'NE', '##B', ')', 'to', 'de', '##grade', 'un', '##ci', '##rc', '##ular', '##ized', 'probe', 'and', 'g', '##eno', '##mic', 'DNA', '.']	[0, 10, 14, 17, 18, 23, 27, 28, 31, 36, 41, 43, 47, 57, 62, 69, 72, 74, 75, 76, 78, 82, 85, 90, 99, 102, 108, 111, 117, 120, 122, 124, 126, 129, 132, 134, 135, 137, 138, 140, 144, 148, 154, 157, 159, 161, 163, 166, 169, 173, 174, 176, 177, 179, 182, 184, 190, 192, 194, 196, 200, 205, 211, 215, 216, 219, 223, 226]	[9, 13, 17, 18, 22, 26, 28, 31, 35, 41, 42, 46, 56, 61, 68, 71, 74, 75, 76, 77, 81, 84, 89, 98, 101, 107, 110, 116, 119, 122, 124, 126, 129, 131, 133, 135, 137, 138, 139, 143, 147, 153, 156, 159, 161, 163, 166, 168, 172, 174, 176, 177, 178, 181, 184, 189, 192, 194, 196, 200, 204, 210, 214, 216, 219, 222, 226, 227]	['Following', 'the', 'gap', '-', 'fill', 'and', 'ligation', 'phase', ',', 'the', 'reactions', 'were', 'cooled', 'to', '37°C', ',', 'and', 'to', 'each', 'reaction', 'we', 'added', '20', 'units', 'of', 'Exonuclease', 'I', '(', 'NEB', ')', 'and', '100', 'units', 'of', 'Exonuclease', 'III', '(', 'NEB', ')', 'to', 'degrade', 'uncircularized', 'probe', 'and', 'genomic', 'DNA', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 2, 5, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The digestion was incubated at 37°C for 45 min, heated to 80°C, and incubated for 20 min to inactivate the exonucleases.	[('PMC3638140', 'M03001', 107, 119, 'exonucleases')]	['The', 'dig', '##est', '##ion', 'was', 'in', '##cu', '##bate', '##d', 'at', '37', '##°', '##C', 'for', '45', 'min', ',', 'heated', 'to', '80', '##°', '##C', ',', 'and', 'in', '##cu', '##bate', '##d', 'for', '20', 'min', 'to', 'in', '##act', '##ivate', 'the', 'ex', '##on', '##uc', '##lea', '##ses', '.']	[0, 4, 7, 10, 14, 18, 20, 22, 26, 28, 31, 33, 34, 36, 40, 43, 46, 48, 55, 58, 60, 61, 62, 64, 68, 70, 72, 76, 78, 82, 85, 89, 92, 94, 97, 103, 107, 109, 111, 113, 116, 119]	[3, 7, 10, 13, 17, 20, 22, 26, 27, 30, 33, 34, 35, 39, 42, 46, 47, 54, 57, 60, 61, 62, 63, 67, 70, 72, 76, 77, 81, 84, 88, 91, 94, 97, 102, 106, 109, 111, 113, 116, 119, 120]	['The', 'digestion', 'was', 'incubated', 'at', '37°C', 'for', '45', 'min', ',', 'heated', 'to', '80°C', ',', 'and', 'incubated', 'for', '20', 'min', 'to', 'inactivate', 'the', 'exonucleases', '.']	[1, 3, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 3, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
After exonuclease treatment and heat-inactivation, the samples were cooled on ice and, optionally, stored at −20°C.	[('PMC3638140', 'M04000', 6, 17, 'exonuclease')]	['After', 'ex', '##on', '##uc', '##lea', '##se', 'treatment', 'and', 'heat', '-', 'in', '##act', '##ivation', ',', 'the', 'samples', 'were', 'cooled', 'on', 'ice', 'and', ',', 'optional', '##ly', ',', 'stored', 'at', '−', '##20', '##°', '##C', '.']	[0, 6, 8, 10, 12, 15, 18, 28, 32, 36, 37, 39, 42, 49, 51, 55, 63, 68, 75, 78, 82, 85, 87, 95, 97, 99, 106, 109, 110, 112, 113, 114]	[5, 8, 10, 12, 15, 17, 27, 31, 36, 37, 39, 42, 49, 50, 54, 62, 67, 74, 77, 81, 85, 86, 95, 97, 98, 105, 108, 110, 112, 113, 114, 115]	['After', 'exonuclease', 'treatment', 'and', 'heat', '-', 'inactivation', ',', 'the', 'samples', 'were', 'cooled', 'on', 'ice', 'and', ',', 'optionally', ',', 'stored', 'at', '−20°C', '.']	[1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1]	['O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For each capture reaction, two PCR reactions were prepared, each with Phusion HF buffer to 1× (Fermentas), forward primer and indexed reverse PCR primers to 500 nM, SYBR green (Invitrogen) to 0.5×, dNTPs to 200 μm each (NEB), 2 units of Phusion Hot-Start II polymerase, 10 μL of capture reaction, and nuclease-free water to 50 μL. PCR cycling conditions were an initial denaturation step for 2 min at 95°C, followed by 26 cycles of: 15 sec at 98°C, 15 sec at 65°C, and 45 sec at 72°C.	[('PMC3638140', 'M04001', 258, 268, 'polymerase')]	['For', 'each', 'capture', 'reaction', ',', 'two', 'PC', '##R', 'reactions', 'were', 'prepared', ',', 'each', 'with', 'Ph', '##usion', 'H', '##F', 'buffer', 'to', '1', '##×', '(', 'Fe', '##rm', '##ent', '##as', ')', ',', 'forward', 'prime', '##r', 'and', 'index', '##ed', 'reverse', 'PC', '##R', 'prime', '##rs', 'to', '500', 'n', '##M', ',', 'S', '##Y', '##BR', 'green', '(', 'In', '##vi', '##tro', '##gen', ')', 'to', '0', '.', '5', '##×', ',', 'd', '##NT', '##Ps', 'to', '200', 'μ', '##m', 'each', '(', 'NE', '##B', ')', ',', '2', 'units', 'of', 'Ph', '##usion', 'Hot', '-', 'Start', 'II', 'polymer', '##ase', ',', '10', 'μ', '##L', 'of', 'capture', 'reaction', ',', 'and', 'n', '##uc', '##lea', '##se', '-', 'free', 'water', 'to', '50', 'μ', '##L', '.', 'PC', '##R', 'cycling', 'conditions', 'were', 'an', 'initial', 'den', '##at', '##uration', 'step', 'for', '2', 'min', 'at', '95', '##°', '##C', ',', 'followed', 'by', '26', 'cycles', 'of', ':', '15', 'se', '##c', 'at', '98', '##°', '##C', ',', '15', 'se', '##c', 'at', '65', '##°', '##C', ',', 'and', '45', 'se', '##c', 'at', '72', '##°', '##C', '.']	[0, 4, 9, 17, 25, 27, 31, 33, 35, 45, 50, 58, 60, 65, 70, 72, 78, 79, 81, 88, 91, 92, 94, 95, 97, 99, 102, 104, 105, 107, 115, 120, 122, 126, 131, 134, 142, 144, 146, 151, 154, 157, 161, 162, 163, 165, 166, 167, 170, 176, 177, 179, 181, 184, 187, 189, 192, 193, 194, 195, 196, 198, 199, 201, 204, 207, 211, 212, 214, 219, 220, 222, 223, 224, 226, 228, 234, 237, 239, 245, 248, 249, 255, 258, 265, 268, 270, 273, 274, 276, 279, 287, 295, 297, 301, 302, 304, 307, 309, 310, 315, 321, 324, 327, 328, 329, 331, 333, 335, 343, 354, 359, 362, 370, 373, 375, 383, 388, 392, 394, 398, 401, 403, 404, 405, 407, 416, 419, 422, 429, 431, 433, 436, 438, 440, 443, 445, 446, 447, 449, 452, 454, 456, 459, 461, 462, 463, 465, 469, 472, 474, 476, 479, 481, 482, 483]	[3, 8, 16, 25, 26, 30, 33, 34, 44, 49, 58, 59, 64, 69, 72, 77, 79, 80, 87, 90, 92, 93, 95, 97, 99, 102, 104, 105, 106, 114, 120, 121, 125, 131, 133, 141, 144, 145, 151, 153, 156, 160, 162, 163, 164, 166, 167, 169, 175, 177, 179, 181, 184, 187, 188, 191, 193, 194, 195, 196, 197, 199, 201, 203, 206, 210, 212, 213, 218, 220, 222, 223, 224, 225, 227, 233, 236, 239, 244, 248, 249, 254, 257, 265, 268, 269, 272, 274, 275, 278, 286, 295, 296, 300, 302, 304, 307, 309, 310, 314, 320, 323, 326, 328, 329, 330, 333, 334, 342, 353, 358, 361, 369, 373, 375, 382, 387, 391, 393, 397, 400, 403, 404, 405, 406, 415, 418, 421, 428, 431, 432, 435, 438, 439, 442, 445, 446, 447, 448, 451, 454, 455, 458, 461, 462, 463, 464, 468, 471, 474, 475, 478, 481, 482, 483, 484]	['For', 'each', 'capture', 'reaction', ',', 'two', 'PCR', 'reactions', 'were', 'prepared', ',', 'each', 'with', 'Phusion', 'HF', 'buffer', 'to', '1×', '(', 'Fermentas', ')', ',', 'forward', 'primer', 'and', 'indexed', 'reverse', 'PCR', 'primers', 'to', '500', 'nM', ',', 'SYBR', 'green', '(', 'Invitrogen', ')', 'to', '0.5×', ',', 'dNTPs', 'to', '200', 'μm', 'each', '(', 'NEB', ')', ',', '2', 'units', 'of', 'Phusion', 'Hot-Start', 'II', 'polymerase', ',', '10', 'μL', 'of', 'capture', 'reaction', ',', 'and', 'nuclease', '-', 'free', 'water', 'to', '50', 'μL', '.', 'PCR', 'cycling', 'conditions', 'were', 'an', 'initial', 'denaturation', 'step', 'for', '2', 'min', 'at', '95°C', ',', 'followed', 'by', '26', 'cycles', 'of', ':', '15', 'sec', 'at', '98°C', ',', '15', 'sec', 'at', '65°C', ',', 'and', '45', 'sec', 'at', '72°C', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 4, 1, 1, 1, 2, 1, 2, 1, 2, 2, 1, 1, 2, 1, 3, 1, 1, 4, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 3, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
LysoPCs were derived from partial hydrolysis of glycerophospholipids by phospholipase.	[('PMC3645730', 'R07000', 72, 85, 'phospholipase')]	['L', '##ys', '##o', '##PC', '##s', 'were', 'derived', 'from', 'partial', 'h', '##ydro', '##lysis', 'of', 'g', '##ly', '##cer', '##op', '##hos', '##ph', '##oli', '##pid', '##s', 'by', 'p', '##hos', '##ph', '##oli', '##pas', '##e', '.']	[0, 1, 3, 4, 6, 8, 13, 21, 26, 34, 35, 39, 45, 48, 49, 51, 54, 56, 59, 61, 64, 67, 69, 72, 73, 76, 78, 81, 84, 85]	[1, 3, 4, 6, 7, 12, 20, 25, 33, 35, 39, 44, 47, 49, 51, 54, 56, 59, 61, 64, 67, 68, 71, 73, 76, 78, 81, 84, 85, 86]	['LysoPCs', 'were', 'derived', 'from', 'partial', 'hydrolysis', 'of', 'glycerophospholipids', 'by', 'phospholipase', '.']	[5, 1, 1, 1, 1, 3, 1, 9, 1, 6, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
Myristic acid, urease, N, O-bis (trimethylsilyl)trifluoroacetamide, and methoxyamine hydrochloride were obtained from Sigma-Aldrich (St. Louis, MO, USA).	[]	['My', '##rist', '##ic', 'acid', ',', 'u', '##rease', ',', 'N', ',', 'O', '-', 'bi', '##s', '(', 'trim', '##eth', '##yl', '##si', '##ly', '##l', ')', 't', '##ri', '##f', '##lu', '##oro', '##ace', '##tam', '##ide', ',', 'and', 'met', '##ho', '##xy', '##amine', 'h', '##ydro', '##ch', '##lor', '##ide', 'were', 'obtained', 'from', 'Sigma', '-', 'Al', '##dric', '##h', '(', 'St', '.', 'Louis', ',', 'M', '##O', ',', 'USA', ')', '.']	[0, 2, 6, 9, 13, 15, 16, 21, 23, 24, 26, 27, 28, 30, 32, 33, 37, 40, 42, 44, 46, 47, 48, 49, 51, 52, 54, 57, 60, 63, 66, 68, 72, 75, 77, 79, 85, 86, 90, 92, 95, 99, 104, 113, 118, 123, 124, 126, 130, 132, 133, 135, 137, 142, 144, 145, 146, 148, 151, 152]	[2, 6, 8, 13, 14, 16, 21, 22, 24, 25, 27, 28, 30, 31, 33, 37, 40, 42, 44, 46, 47, 48, 49, 51, 52, 54, 57, 60, 63, 66, 67, 71, 75, 77, 79, 84, 86, 90, 92, 95, 98, 103, 112, 117, 123, 124, 126, 130, 131, 133, 135, 136, 142, 143, 145, 146, 147, 151, 152, 153]	['Myristic', 'acid', ',', 'urease', ',', 'N', ',', 'O-bis', '(trimethylsilyl)trifluoroacetamide', ',', 'and', 'methoxyamine', 'hydrochloride', 'were', 'obtained', 'from', 'Sigma-Aldrich', '(', 'St', '.', 'Louis', ',', 'MO', ',', 'USA', ')', '.']	[3, 1, 1, 2, 1, 1, 1, 4, 16, 1, 1, 4, 5, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum levels of total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IDBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma glutamyl transferase (GGT), alkaline phosphatase (ALP), total protein (TP), albumin (ALB), total bile acid (TBA), HBsAg, HBeAg, and DNA were measured in Shuguang Hospital.	[]	['Ser', '##um', 'levels', 'of', 'total', 'bi', '##li', '##ru', '##bin', '(', 'T', '##BI', '##L', ')', ',', 'direct', 'bi', '##li', '##ru', '##bin', '(', 'DB', '##IL', ')', ',', 'indirect', 'bi', '##li', '##ru', '##bin', '(', 'ID', '##BI', '##L', ')', ',', 'al', '##ani', '##ne', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AL', '##T', ')', ',', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'gamma', 'g', '##lut', '##am', '##yl', 'transfer', '##ase', '(', 'G', '##G', '##T', ')', ',', 'al', '##kal', '##ine', 'p', '##hos', '##pha', '##tase', '(', 'AL', '##P', ')', ',', 'total', 'protein', '(', 'T', '##P', ')', ',', 'album', '##in', '(', 'AL', '##B', ')', ',', 'total', 'bi', '##le', 'acid', '(', 'T', '##BA', ')', ',', 'H', '##B', '##s', '##A', '##g', ',', 'H', '##B', '##e', '##A', '##g', ',', 'and', 'DNA', 'were', 'measured', 'in', 'Shu', '##gua', '##ng', 'Hospital', '.']	[0, 3, 6, 13, 16, 22, 24, 26, 28, 32, 33, 34, 36, 37, 38, 40, 47, 49, 51, 53, 57, 58, 60, 62, 63, 65, 74, 76, 78, 80, 84, 85, 87, 89, 90, 91, 93, 95, 98, 101, 106, 109, 111, 114, 118, 119, 121, 122, 123, 125, 127, 130, 135, 140, 143, 145, 148, 152, 153, 155, 156, 157, 159, 165, 166, 169, 171, 174, 182, 186, 187, 188, 189, 190, 191, 193, 195, 198, 202, 203, 206, 209, 214, 215, 217, 218, 219, 221, 227, 235, 236, 237, 238, 239, 241, 246, 249, 250, 252, 253, 254, 256, 262, 264, 267, 272, 273, 274, 276, 277, 279, 280, 281, 282, 283, 284, 286, 287, 288, 289, 290, 291, 293, 297, 301, 306, 315, 318, 321, 324, 327, 335]	[3, 5, 12, 15, 21, 24, 26, 28, 31, 33, 34, 36, 37, 38, 39, 46, 49, 51, 53, 56, 58, 60, 62, 63, 64, 73, 76, 78, 80, 83, 85, 87, 89, 90, 91, 92, 95, 98, 100, 106, 109, 111, 114, 117, 119, 121, 122, 123, 124, 127, 130, 134, 140, 143, 145, 148, 151, 153, 155, 156, 157, 158, 164, 166, 169, 171, 173, 182, 185, 187, 188, 189, 190, 191, 192, 195, 198, 201, 203, 206, 209, 213, 215, 217, 218, 219, 220, 226, 234, 236, 237, 238, 239, 240, 246, 248, 250, 252, 253, 254, 255, 261, 264, 266, 271, 273, 274, 276, 277, 278, 280, 281, 282, 283, 284, 285, 287, 288, 289, 290, 291, 292, 296, 300, 305, 314, 317, 321, 324, 326, 335, 336]	['Serum', 'levels', 'of', 'total', 'bilirubin', '(', 'TBIL', ')', ',', 'direct', 'bilirubin', '(', 'DBIL', ')', ',', 'indirect', 'bilirubin', '(', 'IDBIL', ')', ',', 'alanine', 'aminotransferase', '(', 'ALT', ')', ',', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'gamma', 'glutamyl', 'transferase', '(', 'GGT', ')', ',', 'alkaline', 'phosphatase', '(', 'ALP', ')', ',', 'total', 'protein', '(', 'TP', ')', ',', 'albumin', '(', 'ALB', ')', ',', 'total', 'bile', 'acid', '(', 'TBA', ')', ',', 'HBsAg', ',', 'HBeAg', ',', 'and', 'DNA', 'were', 'measured', 'in', 'Shuguang', 'Hospital', '.']	[2, 1, 1, 1, 4, 1, 3, 1, 1, 1, 4, 1, 2, 1, 1, 1, 4, 1, 3, 1, 1, 3, 5, 1, 2, 1, 1, 3, 5, 1, 2, 1, 1, 1, 4, 2, 1, 3, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dried extracts were methoximated in pyridine with 50 μL of 15 mg/μL of methoxyamine at 30°C for 1.5 h. Metabolites were subsequently trimethylsilylated at 70°C for 1 hour with 50 μL MSTFA with 1% TMCS.	[]	['Dr', '##ied', 'extract', '##s', 'were', 'met', '##ho', '##xi', '##mated', 'in', 'p', '##yr', '##id', '##ine', 'with', '50', 'μ', '##L', 'of', '15', 'mg', '/', 'μ', '##L', 'of', 'met', '##ho', '##xy', '##amine', 'at', '30', '##°', '##C', 'for', '1', '.', '5', 'h', '.', 'Met', '##ab', '##oli', '##tes', 'were', 'subsequently', 'trim', '##eth', '##yl', '##si', '##ly', '##lated', 'at', '70', '##°', '##C', 'for', '1', 'hour', 'with', '50', 'μ', '##L', 'MS', '##TF', '##A', 'with', '1', '%', 'T', '##MC', '##S', '.']	[0, 2, 6, 13, 15, 20, 23, 25, 27, 33, 36, 37, 39, 41, 45, 50, 53, 54, 56, 59, 62, 64, 65, 66, 68, 71, 74, 76, 78, 84, 87, 89, 90, 92, 96, 97, 98, 100, 101, 103, 106, 108, 111, 115, 120, 133, 137, 140, 142, 144, 146, 152, 155, 157, 158, 160, 164, 166, 171, 176, 179, 180, 182, 184, 186, 188, 193, 194, 196, 197, 199, 200]	[2, 5, 13, 14, 19, 23, 25, 27, 32, 35, 37, 39, 41, 44, 49, 52, 54, 55, 58, 61, 64, 65, 66, 67, 70, 74, 76, 78, 83, 86, 89, 90, 91, 95, 97, 98, 99, 101, 102, 106, 108, 111, 114, 119, 132, 137, 140, 142, 144, 146, 151, 154, 157, 158, 159, 163, 165, 170, 175, 178, 180, 181, 184, 186, 187, 192, 194, 195, 197, 199, 200, 201]	['Dried', 'extracts', 'were', 'methoximated', 'in', 'pyridine', 'with', '50', 'μL', 'of', '15', 'mg', '/', 'μL', 'of', 'methoxyamine', 'at', '30°C', 'for', '1.5', 'h', '.', 'Metabolites', 'were', 'subsequently', 'trimethylsilylated', 'at', '70°C', 'for', '1', 'hour', 'with', '50', 'μL', 'MSTFA', 'with', '1%', 'TMCS', '.']	[2, 2, 1, 4, 1, 4, 1, 1, 2, 1, 1, 1, 1, 2, 1, 4, 1, 3, 1, 3, 1, 1, 4, 1, 1, 6, 1, 3, 1, 1, 1, 1, 1, 2, 3, 1, 2, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Samples were separated on 7.5% polyacrylamide gels at 125 V, and transferred to nitrocellulose membranes (BioRad, Hercules, CA) for 1 hr at 50 V. Membranes were blocked for 1 hr in Superblock (Thermo Scientific, Rockford, IL) and then incubated with primary antibodies against VCAM (1:200) and ICAM (1:200) followed by the appropriate HRP-conjugated secondary antibodies.	[]	['Sam', '##ples', 'were', 'separated', 'on', '7', '.', '5', '%', 'p', '##oly', '##ac', '##ryl', '##ami', '##de', 'gel', '##s', 'at', '125', 'V', ',', 'and', 'transferred', 'to', 'ni', '##tro', '##cell', '##ulos', '##e', 'membrane', '##s', '(', 'B', '##io', '##R', '##ad', ',', 'Hercules', ',', 'CA', ')', 'for', '1', 'h', '##r', 'at', '50', 'V', '.', 'Me', '##mb', '##rane', '##s', 'were', 'blocked', 'for', '1', 'h', '##r', 'in', 'Super', '##block', '(', 'The', '##rm', '##o', 'Scientific', ',', 'Rock', '##ford', ',', 'IL', ')', 'and', 'then', 'in', '##cu', '##bate', '##d', 'with', 'primary', 'antibodies', 'against', 'VC', '##AM', '(', '1', ':', '200', ')', 'and', 'I', '##CA', '##M', '(', '1', ':', '200', ')', 'followed', 'by', 'the', 'appropriate', 'H', '##RP', '-', 'con', '##ju', '##gated', 'secondary', 'antibodies', '.']	[0, 3, 8, 13, 23, 26, 27, 28, 29, 31, 32, 35, 37, 40, 43, 46, 49, 51, 54, 58, 59, 61, 65, 77, 80, 82, 85, 89, 93, 95, 103, 105, 106, 107, 109, 110, 112, 114, 122, 124, 126, 128, 132, 134, 135, 137, 140, 143, 144, 146, 148, 150, 154, 156, 161, 169, 173, 175, 176, 178, 181, 186, 192, 193, 196, 198, 200, 210, 212, 216, 220, 222, 224, 226, 230, 235, 237, 239, 243, 245, 250, 258, 269, 277, 279, 282, 283, 284, 285, 288, 290, 294, 295, 297, 299, 300, 301, 302, 305, 307, 316, 319, 323, 335, 336, 338, 339, 342, 344, 350, 360, 370]	[3, 7, 12, 22, 25, 27, 28, 29, 30, 32, 35, 37, 40, 43, 45, 49, 50, 53, 57, 59, 60, 64, 76, 79, 82, 85, 89, 93, 94, 103, 104, 106, 107, 109, 110, 112, 113, 122, 123, 126, 127, 131, 133, 135, 136, 139, 142, 144, 145, 148, 150, 154, 155, 160, 168, 172, 174, 176, 177, 180, 186, 191, 193, 196, 198, 199, 210, 211, 216, 220, 221, 224, 225, 229, 234, 237, 239, 243, 244, 249, 257, 268, 276, 279, 281, 283, 284, 285, 288, 289, 293, 295, 297, 298, 300, 301, 302, 305, 306, 315, 318, 322, 334, 336, 338, 339, 342, 344, 349, 359, 370, 371]	['Samples', 'were', 'separated', 'on', '7.5%', 'polyacrylamide', 'gels', 'at', '125', 'V', ',', 'and', 'transferred', 'to', 'nitrocellulose', 'membranes', '(', 'BioRad', ',', 'Hercules', ',', 'CA', ')', 'for', '1', 'hr', 'at', '50', 'V', '.', 'Membranes', 'were', 'blocked', 'for', '1', 'hr', 'in', 'Superblock', '(', 'Thermo', 'Scientific', ',', 'Rockford', ',', 'IL', ')', 'and', 'then', 'incubated', 'with', 'primary', 'antibodies', 'against', 'VCAM', '(', '1', ':', '200', ')', 'and', 'ICAM', '(', '1', ':', '200', ')', 'followed', 'by', 'the', 'appropriate', 'HRP-conjugated', 'secondary', 'antibodies', '.']	[2, 1, 1, 1, 4, 6, 2, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
On the other hand, once released the depurinating adducts could pass through cell membrane and enter in to blood stream and finally get excreted in urine, allowing their identification and quantification as biomarkers of risk of developing breast and other human cancers [21]–[23].	[]	['On', 'the', 'other', 'hand', ',', 'once', 'released', 'the', 'de', '##pur', '##inating', 'add', '##uc', '##ts', 'could', 'pass', 'through', 'cell', 'membrane', 'and', 'enter', 'in', 'to', 'blood', 'stream', 'and', 'finally', 'get', 'ex', '##cre', '##ted', 'in', 'urine', ',', 'allowing', 'their', 'identification', 'and', 'q', '##uant', '##ification', 'as', 'bio', '##mark', '##ers', 'of', 'risk', 'of', 'developing', 'breast', 'and', 'other', 'human', 'cancer', '##s', '[', '21', ']', '–', '[', '23', ']', '.']	[0, 3, 7, 13, 17, 19, 24, 33, 37, 39, 42, 50, 53, 55, 58, 64, 69, 77, 82, 91, 95, 101, 104, 107, 113, 120, 124, 132, 136, 138, 141, 145, 148, 153, 155, 164, 170, 185, 189, 190, 194, 204, 207, 210, 214, 218, 221, 226, 229, 240, 247, 251, 257, 263, 269, 271, 272, 274, 275, 276, 277, 279, 280]	[2, 6, 12, 17, 18, 23, 32, 36, 39, 42, 49, 53, 55, 57, 63, 68, 76, 81, 90, 94, 100, 103, 106, 112, 119, 123, 131, 135, 138, 141, 144, 147, 153, 154, 163, 169, 184, 188, 190, 194, 203, 206, 210, 214, 217, 220, 225, 228, 239, 246, 250, 256, 262, 269, 270, 272, 274, 275, 276, 277, 279, 280, 281]	['On', 'the', 'other', 'hand', ',', 'once', 'released', 'the', 'depurinating', 'adducts', 'could', 'pass', 'through', 'cell', 'membrane', 'and', 'enter', 'in', 'to', 'blood', 'stream', 'and', 'finally', 'get', 'excreted', 'in', 'urine', ',', 'allowing', 'their', 'identification', 'and', 'quantification', 'as', 'biomarkers', 'of', 'risk', 'of', 'developing', 'breast', 'and', 'other', 'human', 'cancers', '[', '21', ']', '–', '[', '23', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In conclusion, a potential peroxidase mediated oxidation of estrogens to very reactive carcinogenic quinone methides has been demonstrated in humans.	[('PMC3675060', 'D04000', 27, 37, 'peroxidase')]	['In', 'conclusion', ',', 'a', 'potential', 'per', '##ox', '##idas', '##e', 'mediated', 'oxidation', 'of', 'est', '##rogen', '##s', 'to', 'very', 'reactive', 'car', '##cin', '##ogenic', 'q', '##uin', '##one', 'met', '##hi', '##des', 'has', 'been', 'demonstrated', 'in', 'humans', '.']	[0, 3, 13, 15, 17, 27, 30, 32, 36, 38, 47, 57, 60, 63, 68, 70, 73, 78, 87, 90, 93, 100, 101, 104, 108, 111, 113, 117, 121, 126, 139, 142, 148]	[2, 13, 14, 16, 26, 30, 32, 36, 37, 46, 56, 59, 63, 68, 69, 72, 77, 86, 90, 93, 99, 101, 104, 107, 111, 113, 116, 120, 125, 138, 141, 148, 149]	['In', 'conclusion', ',', 'a', 'potential', 'peroxidase', 'mediated', 'oxidation', 'of', 'estrogens', 'to', 'very', 'reactive', 'carcinogenic', 'quinone', 'methides', 'has', 'been', 'demonstrated', 'in', 'humans', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 3, 3, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In vitro estrogen metabolism was investigated in presence of Lactoperoxidase (LPO)/H2O2 system; catalytic products were analyzed by using very sensitive tandem mass spectrometry in MS/MS and MRM mode (Figs. 4, ​,5).5).	[('PMC3675060', 'R02000', 62, 77, 'actoperoxidase ')]	['In', 'v', '##it', '##ro', 'est', '##rogen', 'metabolism', 'was', 'investigated', 'in', 'presence', 'of', 'Lac', '##top', '##ero', '##xi', '##das', '##e', '(', 'LP', '##O', ')', '/', 'H', '##2', '##O', '##2', 'system', ';', 'cat', '##alytic', 'products', 'were', 'analyzed', 'by', 'using', 'very', 'sensitive', 'tandem', 'mass', 's', '##pect', '##rome', '##try', 'in', 'MS', '/', 'MS', 'and', 'MR', '##M', 'mode', '(', 'Fi', '##gs', '.', '4', ',', ',', '5', ')', '.', '5', ')', '.']	[0, 3, 4, 6, 9, 12, 18, 29, 33, 46, 49, 58, 61, 64, 67, 70, 72, 75, 77, 78, 80, 81, 82, 83, 84, 85, 86, 88, 94, 96, 99, 106, 115, 120, 129, 132, 138, 143, 153, 160, 165, 166, 170, 174, 178, 181, 183, 184, 187, 191, 193, 195, 200, 201, 203, 205, 207, 208, 211, 212, 213, 214, 215, 216, 217]	[2, 4, 6, 8, 12, 17, 28, 32, 45, 48, 57, 60, 64, 67, 70, 72, 75, 76, 78, 80, 81, 82, 83, 84, 85, 86, 87, 94, 95, 99, 105, 114, 119, 128, 131, 137, 142, 152, 159, 164, 166, 170, 174, 177, 180, 183, 184, 186, 190, 193, 194, 199, 201, 203, 205, 206, 208, 209, 212, 213, 214, 215, 216, 217, 218]	['In', 'vitro', 'estrogen', 'metabolism', 'was', 'investigated', 'in', 'presence', 'of', 'Lactoperoxidase', '(', 'LPO', ')', '/', 'H2O2', 'system', ';', 'catalytic', 'products', 'were', 'analyzed', 'by', 'using', 'very', 'sensitive', 'tandem', 'mass', 'spectrometry', 'in', 'MS', '/', 'MS', 'and', 'MRM', 'mode', '(', 'Figs', '.', '4', ',', '\u200b', ',', '5).5', ')', '.']	[1, 3, 2, 1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 0, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
UQCC gene encodes a trans-membrane protein ubiquinol-cytochrome c reductase complex chaperone.	[('PMC3682469', 'D01000', 43, 75, 'ubiquinol-cytochrome c reductase')]	['U', '##Q', '##CC', 'gene', 'en', '##codes', 'a', 'trans', '-', 'membrane', 'protein', 'u', '##bi', '##quin', '##ol', '-', 'c', '##yt', '##och', '##rome', 'c', 'red', '##uc', '##tase', 'complex', 'ch', '##aper', '##one', '.']	[0, 1, 2, 5, 10, 12, 18, 20, 25, 26, 35, 43, 44, 46, 50, 52, 53, 54, 56, 59, 64, 66, 69, 71, 76, 84, 86, 90, 93]	[1, 2, 4, 9, 12, 17, 19, 25, 26, 34, 42, 44, 46, 50, 52, 53, 54, 56, 59, 63, 65, 69, 71, 75, 83, 86, 90, 93, 94]	['UQCC', 'gene', 'encodes', 'a', 'trans-', 'membrane', 'protein', 'ubiquinol', '-', 'cytochrome', 'c', 'reductase', 'complex', 'chaperone', '.']	[3, 1, 2, 1, 2, 1, 1, 4, 1, 4, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
The UGT1A gene cluster encodes the set of uridine diphosphate-glucuronosyltransferase enzymes which are important components of the glucuronidation pathway necessary for the conversion of lipophilic to water soluble molecules for excretion	[]	['The', 'U', '##G', '##T', '##1', '##A', 'gene', 'cluster', 'en', '##codes', 'the', 'set', 'of', 'u', '##rid', '##ine', 'dip', '##hos', '##phate', '-', 'g', '##lu', '##cu', '##ron', '##osy', '##lt', '##ran', '##s', '##fer', '##ase', 'enzymes', 'which', 'are', 'important', 'components', 'of', 'the', 'g', '##lu', '##cu', '##ron', '##ida', '##tion', 'pathway', 'necessary', 'for', 'the', 'conversion', 'of', 'lip', '##op', '##hil', '##ic', 'to', 'water', 'soluble', 'molecules', 'for', 'ex', '##cre', '##tion']	[0, 4, 5, 6, 7, 8, 10, 15, 23, 25, 31, 35, 39, 42, 43, 46, 50, 53, 56, 61, 62, 63, 65, 67, 70, 73, 75, 78, 79, 82, 86, 94, 100, 104, 114, 125, 128, 132, 133, 135, 137, 140, 143, 148, 156, 166, 170, 174, 185, 188, 191, 193, 196, 199, 202, 208, 216, 226, 230, 232, 235]	[3, 5, 6, 7, 8, 9, 14, 22, 25, 30, 34, 38, 41, 43, 46, 49, 53, 56, 61, 62, 63, 65, 67, 70, 73, 75, 78, 79, 82, 85, 93, 99, 103, 113, 124, 127, 131, 133, 135, 137, 140, 143, 147, 155, 165, 169, 173, 184, 187, 191, 193, 196, 198, 201, 207, 215, 225, 229, 232, 235, 239]	['The', 'UGT1A', 'gene', 'cluster', 'encodes', 'the', 'set', 'of', 'uridine', 'diphosphate', '-', 'glucuronosyltransferase', 'enzymes', 'which', 'are', 'important', 'components', 'of', 'the', 'glucuronidation', 'pathway', 'necessary', 'for', 'the', 'conversion', 'of', 'lipophilic', 'to', 'water', 'soluble', 'molecules', 'for', 'excretion']	[1, 5, 1, 1, 2, 1, 1, 1, 3, 3, 1, 10, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nearly all 54 milk samples showed some colonies that are Gram-positive and catalase-positive cocci resembling Staphylococcus aureus on the GM17 agar.	[]	['Nearly', 'all', '54', 'milk', 'samples', 'showed', 'some', 'colonies', 'that', 'are', 'Gram', '-', 'positive', 'and', 'cat', '##ala', '##se', '-', 'positive', 'co', '##cci', 'resembling', 'St', '##aph', '##yl', '##oc', '##oc', '##cus', 'au', '##reus', 'on', 'the', 'GM', '##17', 'a', '##gar', '.']	[0, 7, 11, 14, 19, 27, 34, 39, 48, 53, 57, 61, 62, 71, 75, 78, 81, 83, 84, 93, 95, 99, 110, 112, 115, 117, 119, 121, 125, 127, 132, 135, 139, 141, 144, 145, 148]	[6, 10, 13, 18, 26, 33, 38, 47, 52, 56, 61, 62, 70, 74, 78, 81, 83, 84, 92, 95, 98, 109, 112, 115, 117, 119, 121, 124, 127, 131, 134, 138, 141, 143, 145, 148, 149]	['Nearly', 'all', '54', 'milk', 'samples', 'showed', 'some', 'colonies', 'that', 'are', 'Gram', '-', 'positive', 'and', 'catalase', '-', 'positive', 'cocci', 'resembling', 'Staphylococcus', 'aureus', 'on', 'the', 'GM17', 'agar', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 6, 2, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As our focus was on lactic acid bacteria, only Gram-positive and catalase-negative strains were isolated and further analyzed for the whole-cell protein profiles and 16S rDNA analyses.	[]	['As', 'our', 'focus', 'was', 'on', 'la', '##ctic', 'acid', 'bacteria', ',', 'only', 'Gram', '-', 'positive', 'and', 'cat', '##ala', '##se', '-', 'negative', 'strains', 'were', 'isolated', 'and', 'further', 'analyzed', 'for', 'the', 'whole', '-', 'cell', 'protein', 'profiles', 'and', '16', '##S', 'r', '##D', '##NA', 'analyses', '.']	[0, 3, 7, 13, 17, 20, 22, 27, 32, 40, 42, 47, 51, 52, 61, 65, 68, 71, 73, 74, 83, 91, 96, 105, 109, 117, 126, 130, 134, 139, 140, 145, 153, 162, 166, 168, 170, 171, 172, 175, 183]	[2, 6, 12, 16, 19, 22, 26, 31, 40, 41, 46, 51, 52, 60, 64, 68, 71, 73, 74, 82, 90, 95, 104, 108, 116, 125, 129, 133, 139, 140, 144, 152, 161, 165, 168, 169, 171, 172, 174, 183, 184]	['As', 'our', 'focus', 'was', 'on', 'lactic', 'acid', 'bacteria', ',', 'only', 'Gram', '-', 'positive', 'and', 'catalase', '-', 'negative', 'strains', 'were', 'isolated', 'and', 'further', 'analyzed', 'for', 'the', 'whole', '-', 'cell', 'protein', 'profiles', 'and', '16S', 'rDNA', 'analyses', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another force diversifying bacteriophage genomes are diversity-generating retroelements (DGRs), which are reverse transcriptase-based systems that introduce mutations at adenines in specific repeated sequences using a copy–paste targeting mechanism (6, 30–33).	[('PMC3725073', 'R15000', 106, 127, 'reverse transcriptase')]	['Another', 'force', 'divers', '##ifying', 'b', '##act', '##eri', '##op', '##hage', 'genome', '##s', 'are', 'diversity', '-', 'generating', 're', '##tro', '##ele', '##ments', '(', 'D', '##GR', '##s', ')', ',', 'which', 'are', 'reverse', 'trans', '##cript', '##ase', '-', 'based', 'systems', 'that', 'introduce', 'mutations', 'at', 'ad', '##eni', '##nes', 'in', 'specific', 'repeated', 'sequences', 'using', 'a', 'copy', '–', 'paste', 'targeting', 'mechanism', '(', '6', ',', '30', '–', '33', ')', '.']	[0, 8, 14, 20, 27, 28, 31, 34, 36, 41, 47, 49, 53, 62, 63, 74, 76, 79, 82, 88, 89, 90, 92, 93, 94, 96, 102, 106, 114, 119, 124, 127, 128, 134, 142, 147, 157, 167, 170, 172, 175, 179, 182, 191, 200, 210, 216, 218, 222, 223, 229, 239, 249, 250, 251, 253, 255, 256, 258, 259]	[7, 13, 20, 26, 28, 31, 34, 36, 40, 47, 48, 52, 62, 63, 73, 76, 79, 82, 87, 89, 90, 92, 93, 94, 95, 101, 105, 113, 119, 124, 127, 128, 133, 141, 146, 156, 166, 169, 172, 175, 178, 181, 190, 199, 209, 215, 217, 222, 223, 228, 238, 248, 250, 251, 252, 255, 256, 258, 259, 260]	['Another', 'force', 'diversifying', 'bacteriophage', 'genomes', 'are', 'diversity', '-', 'generating', 'retroelements', '(', 'DGRs', ')', ',', 'which', 'are', 'reverse', 'transcriptase', '-', 'based', 'systems', 'that', 'introduce', 'mutations', 'at', 'adenines', 'in', 'specific', 'repeated', 'sequences', 'using', 'a', 'copy', '–', 'paste', 'targeting', 'mechanism', '(', '6', ',', '30–', '33', ')', '.']	[1, 1, 2, 5, 2, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
DGRs were identified by searching contigs for regions that matched three criteria: (i) they contained protein-coding regions resembling reverse transcriptases, (ii) they encompassed short repeat regions containing mismatches in adenine positions, and (iii) they contained hypervariable regions.	[]	['D', '##GR', '##s', 'were', 'identified', 'by', 'searching', 'con', '##ti', '##gs', 'for', 'regions', 'that', 'matched', 'three', 'criteria', ':', '(', 'i', ')', 'they', 'contained', 'protein', '-', 'coding', 'regions', 'resembling', 'reverse', 'trans', '##cript', '##ases', ',', '(', 'ii', ')', 'they', 'encompassed', 'short', 'repeat', 'regions', 'containing', 'mi', '##sma', '##tches', 'in', 'ad', '##eni', '##ne', 'positions', ',', 'and', '(', 'ii', '##i', ')', 'they', 'contained', 'h', '##yper', '##var', '##iable', 'regions', '.']	[0, 1, 3, 5, 10, 21, 24, 34, 37, 39, 42, 46, 54, 59, 67, 73, 81, 83, 84, 85, 87, 92, 102, 109, 110, 117, 125, 136, 144, 149, 154, 158, 160, 161, 163, 165, 170, 182, 188, 195, 203, 214, 216, 219, 225, 228, 230, 233, 236, 245, 247, 251, 252, 254, 255, 257, 262, 272, 273, 277, 280, 286, 293]	[1, 3, 4, 9, 20, 23, 33, 37, 39, 41, 45, 53, 58, 66, 72, 81, 82, 84, 85, 86, 91, 101, 109, 110, 116, 124, 135, 143, 149, 154, 158, 159, 161, 163, 164, 169, 181, 187, 194, 202, 213, 216, 219, 224, 227, 230, 233, 235, 245, 246, 250, 252, 254, 255, 256, 261, 271, 273, 277, 280, 285, 293, 294]	['DGRs', 'were', 'identified', 'by', 'searching', 'contigs', 'for', 'regions', 'that', 'matched', 'three', 'criteria', ':', '(i)', 'they', 'contained', 'protein', '-', 'coding', 'regions', 'resembling', 'reverse', 'transcriptases', ',', '(ii)', 'they', 'encompassed', 'short', 'repeat', 'regions', 'containing', 'mismatches', 'in', 'adenine', 'positions', ',', 'and', '(iii)', 'they', 'contained', 'hypervariable', 'regions', '.']	[3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of the 20 contigs with both a reverse transcriptase and an adenine-mismatched repeat, six were associated with hypervariable regions (located no more than 100 bp away; Table S3) and were selected for further study.	[]	['Of', 'the', '20', 'con', '##ti', '##gs', 'with', 'both', 'a', 'reverse', 'trans', '##cript', '##ase', 'and', 'an', 'ad', '##eni', '##ne', '-', 'mi', '##sma', '##tched', 'repeat', ',', 'six', 'were', 'associated', 'with', 'h', '##yper', '##var', '##iable', 'regions', '(', 'located', 'no', 'more', 'than', '100', 'b', '##p', 'away', ';', 'Table', 'S', '##3', ')', 'and', 'were', 'selected', 'for', 'further', 'study', '.']	[0, 3, 7, 10, 13, 15, 18, 23, 28, 30, 38, 43, 48, 52, 56, 59, 61, 64, 66, 67, 69, 72, 78, 84, 86, 90, 95, 106, 111, 112, 116, 119, 125, 133, 134, 142, 145, 150, 155, 159, 160, 162, 166, 168, 174, 175, 176, 178, 182, 187, 196, 200, 208, 213]	[2, 6, 9, 13, 15, 17, 22, 27, 29, 37, 43, 48, 51, 55, 58, 61, 64, 66, 67, 69, 72, 77, 84, 85, 89, 94, 105, 110, 112, 116, 119, 124, 132, 134, 141, 144, 149, 154, 158, 160, 161, 166, 167, 173, 175, 176, 177, 181, 186, 195, 199, 207, 213, 214]	['Of', 'the', '20', 'contigs', 'with', 'both', 'a', 'reverse', 'transcriptase', 'and', 'an', 'adenine', '-', 'mismatched', 'repeat', ',', 'six', 'were', 'associated', 'with', 'hypervariable', 'regions', '(', 'located', 'no', 'more', 'than', '100', 'bp', 'away', ';', 'Table', 'S3', ')', 'and', 'were', 'selected', 'for', 'further', 'study', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thymidylate synthase (TS) catalyzes the conversion of deoxyuridylate (dUMP) and 5,10-methylenetetrahydrofolate to dTMP and 7,8-dihydrofolate.	[('PMC3760386', 'I00000', 0, 20, 'Thymidylate synthase')]	['T', '##hy', '##mi', '##dy', '##late', 's', '##ynth', '##ase', '(', 'T', '##S', ')', 'cat', '##aly', '##zes', 'the', 'conversion', 'of', 'de', '##ox', '##yu', '##rid', '##yla', '##te', '(', 'd', '##UM', '##P', ')', 'and', '5', ',', '10', '-', 'met', '##hyl', '##ene', '##te', '##tra', '##hy', '##dr', '##of', '##olate', 'to', 'd', '##TM', '##P', 'and', '7', ',', '8', '-', 'di', '##hy', '##dr', '##of', '##olate', '.']	[0, 1, 3, 5, 7, 12, 13, 17, 21, 22, 23, 24, 26, 29, 32, 36, 40, 51, 54, 56, 58, 60, 63, 66, 69, 70, 71, 73, 74, 76, 80, 81, 82, 84, 85, 88, 91, 94, 96, 99, 101, 103, 105, 111, 114, 115, 117, 119, 123, 124, 125, 126, 127, 129, 131, 133, 135, 140]	[1, 3, 5, 7, 11, 13, 17, 20, 22, 23, 24, 25, 29, 32, 35, 39, 50, 53, 56, 58, 60, 63, 66, 68, 70, 71, 73, 74, 75, 79, 81, 82, 84, 85, 88, 91, 94, 96, 99, 101, 103, 105, 110, 113, 115, 117, 118, 122, 124, 125, 126, 127, 129, 131, 133, 135, 140, 141]	['Thymidylate', 'synthase', '(', 'TS', ')', 'catalyzes', 'the', 'conversion', 'of', 'deoxyuridylate', '(', 'dUMP', ')', 'and', '5', ',', '10-methylenetetrahydrofolate', 'to', 'dTMP', 'and', '7', ',', '8-dihydrofolate', '.']	[5, 3, 1, 2, 1, 3, 1, 1, 1, 6, 1, 3, 1, 1, 1, 1, 11, 1, 3, 1, 1, 1, 7, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
FAU has been shown to be readily transported into several cell lines and converted by intracellular thymidine kinase (TK) to its monophosphate, 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) uracil monophosphate (FAUMP), which is then methylated by TS in the 5-position to form the methylated product FMAUMP	[]	['FA', '##U', 'has', 'been', 'shown', 'to', 'be', 'readily', 'transported', 'into', 'several', 'cell', 'lines', 'and', 'converted', 'by', 'in', '##tra', '##cellular', 'thy', '##mi', '##dine', 'kinase', '(', 'T', '##K', ')', 'to', 'its', 'mon', '##op', '##hos', '##phate', ',', '1', '-', '(', '2', '-', 'de', '##ox', '##y', '-', '2', '-', 'flu', '##oro', '-', 'β', '-', 'D', '-', 'a', '##rab', '##ino', '##fu', '##rano', '##sy', '##l', ')', 'u', '##rac', '##il', 'mon', '##op', '##hos', '##phate', '(', 'FA', '##UM', '##P', ')', ',', 'which', 'is', 'then', 'met', '##hyl', '##ated', 'by', 'T', '##S', 'in', 'the', '5', '-', 'position', 'to', 'form', 'the', 'met', '##hyl', '##ated', 'product', 'FM', '##A', '##UM', '##P']	[0, 2, 4, 8, 13, 19, 22, 25, 33, 45, 50, 58, 63, 69, 73, 83, 86, 88, 91, 100, 103, 105, 110, 117, 118, 119, 120, 122, 125, 129, 132, 134, 137, 142, 144, 145, 146, 147, 148, 149, 151, 153, 154, 155, 156, 157, 160, 163, 164, 165, 166, 167, 168, 169, 172, 175, 177, 181, 183, 184, 186, 187, 190, 193, 196, 198, 201, 207, 208, 210, 212, 213, 214, 216, 222, 225, 230, 233, 236, 241, 244, 245, 247, 250, 254, 255, 256, 265, 268, 273, 277, 280, 283, 288, 296, 298, 299, 301]	[2, 3, 7, 12, 18, 21, 24, 32, 44, 49, 57, 62, 68, 72, 82, 85, 88, 91, 99, 103, 105, 109, 116, 118, 119, 120, 121, 124, 128, 132, 134, 137, 142, 143, 145, 146, 147, 148, 149, 151, 153, 154, 155, 156, 157, 160, 163, 164, 165, 166, 167, 168, 169, 172, 175, 177, 181, 183, 184, 185, 187, 190, 192, 196, 198, 201, 206, 208, 210, 212, 213, 214, 215, 221, 224, 229, 233, 236, 240, 243, 245, 246, 249, 253, 255, 256, 264, 267, 272, 276, 280, 283, 287, 295, 298, 299, 301, 302]	['FAU', 'has', 'been', 'shown', 'to', 'be', 'readily', 'transported', 'into', 'several', 'cell', 'lines', 'and', 'converted', 'by', 'intracellular', 'thymidine', 'kinase', '(', 'TK', ')', 'to', 'its', 'monophosphate', ',', '1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)', 'uracil', 'monophosphate', '(', 'FAUMP', ')', ',', 'which', 'is', 'then', 'methylated', 'by', 'TS', 'in', 'the', '5-', 'position', 'to', 'form', 'the', 'methylated', 'product', 'FMAUMP']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 2, 1, 1, 1, 4, 1, 26, 3, 4, 1, 3, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 2, 1, 1, 1, 1, 3, 1, 4]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Three candidate biomarkers were identified, mesothelin, fms-like tyrosine kinase-4 (FLT4) and α1-acid glycoprotein (AGP).	[('PMC3780518', 'A02000', 65, 82, 'tyrosine kinase-4')]	['Three', 'candidate', 'bio', '##mark', '##ers', 'were', 'identified', ',', 'me', '##so', '##the', '##lin', ',', 'f', '##ms', '-', 'like', 't', '##yr', '##os', '##ine', 'kinase', '-', '4', '(', 'FL', '##T', '##4', ')', 'and', 'α', '##1', '-', 'acid', 'g', '##ly', '##co', '##p', '##rote', '##in', '(', 'AG', '##P', ')', '.']	[0, 6, 16, 19, 23, 27, 32, 42, 44, 46, 48, 51, 54, 56, 57, 59, 60, 65, 66, 68, 70, 74, 80, 81, 83, 84, 86, 87, 88, 90, 94, 95, 96, 97, 102, 103, 105, 107, 108, 112, 115, 116, 118, 119, 120]	[5, 15, 19, 23, 26, 31, 42, 43, 46, 48, 51, 54, 55, 57, 59, 60, 64, 66, 68, 70, 73, 80, 81, 82, 84, 86, 87, 88, 89, 93, 95, 96, 97, 101, 103, 105, 107, 108, 112, 114, 116, 118, 119, 120, 121]	['Three', 'candidate', 'biomarkers', 'were', 'identified', ',', 'mesothelin', ',', 'fms', '-', 'like', 'tyrosine', 'kinase-4', '(', 'FLT4', ')', 'and', 'α1-acid', 'glycoprotein', '(', 'AGP', ')', '.']	[1, 1, 3, 1, 1, 1, 4, 1, 2, 1, 1, 4, 3, 1, 3, 1, 1, 4, 6, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our results suggest that most of the detectable bacterial DNA in the lung parenchyma is DNase I sensitive and corresponds to dead bacteria.	[('PMC3811377', 'D01000', 88, 95, 'DNase I')]	['Our', 'results', 'suggest', 'that', 'most', 'of', 'the', 'detect', '##able', 'bacterial', 'DNA', 'in', 'the', 'lung', 'par', '##en', '##chy', '##ma', 'is', 'D', '##N', '##ase', 'I', 'sensitive', 'and', 'corresponds', 'to', 'dead', 'bacteria', '.']	[0, 4, 12, 20, 25, 30, 33, 37, 43, 48, 58, 62, 65, 69, 74, 77, 79, 82, 85, 88, 89, 90, 94, 96, 106, 110, 122, 125, 130, 138]	[3, 11, 19, 24, 29, 32, 36, 43, 47, 57, 61, 64, 68, 73, 77, 79, 82, 84, 87, 89, 90, 93, 95, 105, 109, 121, 124, 129, 138, 139]	['Our', 'results', 'suggest', 'that', 'most', 'of', 'the', 'detectable', 'bacterial', 'DNA', 'in', 'the', 'lung', 'parenchyma', 'is', 'DNase', 'I', 'sensitive', 'and', 'corresponds', 'to', 'dead', 'bacteria', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although there is some intrinsic DNase activity in the airway surface (41), DNA can remain in the lungs for a significant time under certain conditions.	[('PMC3811377', 'D03000', 33, 38, 'DNase')]	['Although', 'there', 'is', 'some', 'intrinsic', 'D', '##N', '##ase', 'activity', 'in', 'the', 'air', '##way', 'surface', '(', '41', ')', ',', 'DNA', 'can', 'remain', 'in', 'the', 'lungs', 'for', 'a', 'significant', 'time', 'under', 'certain', 'conditions', '.']	[0, 9, 15, 18, 23, 33, 34, 35, 39, 48, 51, 55, 58, 62, 70, 71, 73, 74, 76, 80, 84, 91, 94, 98, 104, 108, 110, 122, 127, 133, 141, 151]	[8, 14, 17, 22, 32, 34, 35, 38, 47, 50, 54, 58, 61, 69, 71, 73, 74, 75, 79, 83, 90, 93, 97, 103, 107, 109, 121, 126, 132, 140, 151, 152]	['Although', 'there', 'is', 'some', 'intrinsic', 'DNase', 'activity', 'in', 'the', 'airway', 'surface', '(', '41', ')', ',', 'DNA', 'can', 'remain', 'in', 'the', 'lungs', 'for', 'a', 'significant', 'time', 'under', 'certain', 'conditions', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five hundred microliters of BAL fluid or a homogenate (02-542; Fisher Healthcare, Houston, TX) of 100 mg lung tissue in 2 ml of 0.9% NaCl was incubated with 500 μg/ml DNase I (10104159001; Roche Diagnostics GmbH, Manheim, Germany) or DNase I buffer at 37°C for 10 min, followed by DNase I inactivation at 75°C for 10 min.	[('PMC3811377', 'M03000', 167, 174, 'DNase I')]	['Five', 'hundred', 'micro', '##lite', '##rs', 'of', 'BA', '##L', 'fluid', 'or', 'a', 'ho', '##mo', '##gen', '##ate', '(', '02', '-', '54', '##2', ';', 'Fisher', 'Healthcare', ',', 'Houston', ',', 'TX', ')', 'of', '100', 'mg', 'lung', 'tissue', 'in', '2', 'm', '##l', 'of', '0', '.', '9', '%', 'Na', '##C', '##l', 'was', 'in', '##cu', '##bate', '##d', 'with', '500', 'μ', '##g', '/', 'm', '##l', 'D', '##N', '##ase', 'I', '(', '101', '##0', '##41', '##5', '##90', '##01', ';', 'Roche', 'Di', '##ag', '##nos', '##tics', 'GmbH', ',', 'Man', '##heim', ',', 'Germany', ')', 'or', 'D', '##N', '##ase', 'I', 'buffer', 'at', '37', '##°', '##C', 'for', '10', 'min', ',', 'followed', 'by', 'D', '##N', '##ase', 'I', 'in', '##act', '##ivation', 'at', '75', '##°', '##C', 'for', '10', 'min', '.']	[0, 5, 13, 18, 22, 25, 28, 30, 32, 38, 41, 43, 45, 47, 50, 54, 55, 57, 58, 60, 61, 63, 70, 80, 82, 89, 91, 93, 95, 98, 102, 105, 110, 117, 120, 122, 123, 125, 128, 129, 130, 131, 133, 135, 136, 138, 142, 144, 146, 150, 152, 157, 161, 162, 163, 164, 165, 167, 168, 169, 173, 175, 176, 179, 180, 182, 183, 185, 187, 189, 195, 197, 199, 202, 207, 211, 213, 216, 220, 222, 229, 231, 234, 235, 236, 240, 242, 249, 252, 254, 255, 257, 261, 264, 267, 269, 278, 281, 282, 283, 287, 289, 291, 294, 302, 305, 307, 308, 310, 314, 317, 320]	[4, 12, 18, 22, 24, 27, 30, 31, 37, 40, 42, 45, 47, 50, 53, 55, 57, 58, 60, 61, 62, 69, 80, 81, 89, 90, 93, 94, 97, 101, 104, 109, 116, 119, 121, 123, 124, 127, 129, 130, 131, 132, 135, 136, 137, 141, 144, 146, 150, 151, 156, 160, 162, 163, 164, 165, 166, 168, 169, 172, 174, 176, 179, 180, 182, 183, 185, 187, 188, 194, 197, 199, 202, 206, 211, 212, 216, 220, 221, 229, 230, 233, 235, 236, 239, 241, 248, 251, 254, 255, 256, 260, 263, 267, 268, 277, 280, 282, 283, 286, 288, 291, 294, 301, 304, 307, 308, 309, 313, 316, 320, 321]	['Five', 'hundred', 'microliters', 'of', 'BAL', 'fluid', 'or', 'a', 'homogenate', '(', '02-542', ';', 'Fisher', 'Healthcare', ',', 'Houston', ',', 'TX', ')', 'of', '100', 'mg', 'lung', 'tissue', 'in', '2', 'ml', 'of', '0.9%', 'NaCl', 'was', 'incubated', 'with', '500', 'μg', '/', 'ml', 'DNase', 'I', '(', '10104159001', ';', 'Roche', 'Diagnostics', 'GmbH', ',', 'Manheim', ',', 'Germany', ')', 'or', 'DNase', 'I', 'buffer', 'at', '37°C', 'for', '10', 'min', ',', 'followed', 'by', 'DNase', 'I', 'inactivation', 'at', '75°C', 'for', '10', 'min', '.']	[1, 1, 3, 1, 2, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 3, 1, 4, 1, 1, 2, 1, 2, 3, 1, 1, 6, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
DNase I has been used to purify intact DNA in viruses with capsids and/or envelopes from mixtures containing DNase I-sensitive free and protein-associated DNA without a capsid (31).	[('PMC3811377', 'R03000', 0, 7, 'DNase I')]	['D', '##N', '##ase', 'I', 'has', 'been', 'used', 'to', 'pu', '##ri', '##fy', 'intact', 'DNA', 'in', 'viruses', 'with', 'caps', '##ids', 'and', '/', 'or', 'envelope', '##s', 'from', 'mixture', '##s', 'containing', 'D', '##N', '##ase', 'I', '-', 'sensitive', 'free', 'and', 'protein', '-', 'associated', 'DNA', 'without', 'a', 'caps', '##id', '(', '31', ')', '.']	[0, 1, 2, 6, 8, 12, 17, 22, 25, 27, 29, 32, 39, 43, 46, 54, 59, 63, 67, 70, 71, 74, 82, 84, 89, 96, 98, 109, 110, 111, 115, 116, 117, 127, 132, 136, 143, 144, 155, 159, 167, 169, 173, 176, 177, 179, 180]	[1, 2, 5, 7, 11, 16, 21, 24, 27, 29, 31, 38, 42, 45, 53, 58, 63, 66, 70, 71, 73, 82, 83, 88, 96, 97, 108, 110, 111, 114, 116, 117, 126, 131, 135, 143, 144, 154, 158, 166, 168, 173, 175, 177, 179, 180, 181]	['DNase', 'I', 'has', 'been', 'used', 'to', 'purify', 'intact', 'DNA', 'in', 'viruses', 'with', 'capsids', 'and', '/', 'or', 'envelopes', 'from', 'mixtures', 'containing', 'DNase', 'I-sensitive', 'free', 'and', 'protein', '-', 'associated', 'DNA', 'without', 'a', 'capsid', '(', '31', ')', '.']	[3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the food industry, DNase-treated DNA PCR (DTD-PCR) has been used to detect DNA from live bacteria contaminating food accurately and with minimal cytotoxic effects on bacteria (32, 33).	[('PMC3811377', 'R03001', 22, 27, 'DNase')]	['In', 'the', 'food', 'industry', ',', 'D', '##N', '##ase', '-', 'treated', 'DNA', 'PC', '##R', '(', 'D', '##T', '##D', '-', 'PC', '##R', ')', 'has', 'been', 'used', 'to', 'detect', 'DNA', 'from', 'live', 'bacteria', 'con', '##tam', '##inating', 'food', 'accurately', 'and', 'with', 'minimal', 'c', '##yt', '##oto', '##xi', '##c', 'effects', 'on', 'bacteria', '(', '32', ',', '33', ')', '.']	[0, 3, 7, 12, 20, 22, 23, 24, 27, 28, 36, 40, 42, 44, 45, 46, 47, 48, 49, 51, 52, 54, 58, 63, 68, 71, 78, 82, 87, 92, 101, 104, 107, 115, 120, 131, 135, 140, 148, 149, 151, 154, 156, 158, 166, 169, 178, 179, 181, 183, 185, 186]	[2, 6, 11, 20, 21, 23, 24, 27, 28, 35, 39, 42, 43, 45, 46, 47, 48, 49, 51, 52, 53, 57, 62, 67, 70, 77, 81, 86, 91, 100, 104, 107, 114, 119, 130, 134, 139, 147, 149, 151, 154, 156, 157, 165, 168, 177, 179, 181, 182, 185, 186, 187]	['In', 'the', 'food', 'industry', ',', 'DNase', '-', 'treated', 'DNA', 'PCR', '(', 'DTD-PCR', ')', 'has', 'been', 'used', 'to', 'detect', 'DNA', 'from', 'live', 'bacteria', 'contaminating', 'food', 'accurately', 'and', 'with', 'minimal', 'cytotoxic', 'effects', 'on', 'bacteria', '(', '32', ',', '33', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to determine whether bacterial DNA quantified with qPCR corresponded to intact or dead bacteria, we treated samples with DNase I and followed this with heat inactivation before cell lysis as the initial step for sample DNA extraction; comparison of treated and untreated samples would determine the ratio of DNA from intact bacteria to that from total bacteria.	[('PMC3811377', 'R03002', 130, 137, 'DNase I')]	['In', 'order', 'to', 'determine', 'whether', 'bacterial', 'DNA', 'q', '##uant', '##ified', 'with', 'q', '##PC', '##R', 'correspond', '##ed', 'to', 'intact', 'or', 'dead', 'bacteria', ',', 'we', 'treated', 'samples', 'with', 'D', '##N', '##ase', 'I', 'and', 'followed', 'this', 'with', 'heat', 'in', '##act', '##ivation', 'before', 'cell', 'l', '##ys', '##is', 'as', 'the', 'initial', 'step', 'for', 'sample', 'DNA', 'extraction', ';', 'comparison', 'of', 'treated', 'and', 'un', '##tre', '##ated', 'samples', 'would', 'determine', 'the', 'ratio', 'of', 'DNA', 'from', 'intact', 'bacteria', 'to', 'that', 'from', 'total', 'bacteria', '.']	[0, 3, 9, 12, 22, 30, 40, 44, 45, 49, 55, 60, 61, 63, 65, 75, 78, 81, 88, 91, 96, 104, 106, 109, 117, 125, 130, 131, 132, 136, 138, 142, 151, 156, 161, 166, 168, 171, 179, 186, 191, 192, 194, 197, 200, 204, 212, 217, 221, 228, 232, 242, 244, 255, 258, 266, 270, 272, 275, 280, 288, 294, 304, 308, 314, 317, 321, 326, 333, 342, 345, 350, 355, 361, 369]	[2, 8, 11, 21, 29, 39, 43, 45, 49, 54, 59, 61, 63, 64, 75, 77, 80, 87, 90, 95, 104, 105, 108, 116, 124, 129, 131, 132, 135, 137, 141, 150, 155, 160, 165, 168, 171, 178, 185, 190, 192, 194, 196, 199, 203, 211, 216, 220, 227, 231, 242, 243, 254, 257, 265, 269, 272, 275, 279, 287, 293, 303, 307, 313, 316, 320, 325, 332, 341, 344, 349, 354, 360, 369, 370]	['In', 'order', 'to', 'determine', 'whether', 'bacterial', 'DNA', 'quantified', 'with', 'qPCR', 'corresponded', 'to', 'intact', 'or', 'dead', 'bacteria', ',', 'we', 'treated', 'samples', 'with', 'DNase', 'I', 'and', 'followed', 'this', 'with', 'heat', 'inactivation', 'before', 'cell', 'lysis', 'as', 'the', 'initial', 'step', 'for', 'sample', 'DNA', 'extraction', ';', 'comparison', 'of', 'treated', 'and', 'untreated', 'samples', 'would', 'determine', 'the', 'ratio', 'of', 'DNA', 'from', 'intact', 'bacteria', 'to', 'that', 'from', 'total', 'bacteria', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To determine whether DNase I treatment directly results in bacterial death, we incubated S. aureus with DNase I and determined viability after incubation by dilution plating (Fig. 3C).	[('PMC3811377', 'R05000', 21, 28, 'DNase I')]	['To', 'determine', 'whether', 'D', '##N', '##ase', 'I', 'treatment', 'directly', 'results', 'in', 'bacterial', 'death', ',', 'we', 'in', '##cu', '##bate', '##d', 'S', '.', 'au', '##reus', 'with', 'D', '##N', '##ase', 'I', 'and', 'determined', 'via', '##bility', 'after', 'in', '##cu', '##bation', 'by', 'di', '##lution', 'p', '##lating', '(', 'Fi', '##g', '.', '3', '##C', ')', '.']	[0, 3, 13, 21, 22, 23, 27, 29, 39, 48, 56, 59, 69, 74, 76, 79, 81, 83, 87, 89, 90, 92, 94, 99, 104, 105, 106, 110, 112, 116, 127, 130, 137, 143, 145, 147, 154, 157, 159, 166, 167, 174, 175, 177, 178, 180, 181, 182, 183]	[2, 12, 20, 22, 23, 26, 28, 38, 47, 55, 58, 68, 74, 75, 78, 81, 83, 87, 88, 90, 91, 94, 98, 103, 105, 106, 109, 111, 115, 126, 130, 136, 142, 145, 147, 153, 156, 159, 165, 167, 173, 175, 177, 178, 179, 181, 182, 183, 184]	['To', 'determine', 'whether', 'DNase', 'I', 'treatment', 'directly', 'results', 'in', 'bacterial', 'death', ',', 'we', 'incubated', 'S', '.', 'aureus', 'with', 'DNase', 'I', 'and', 'determined', 'viability', 'after', 'incubation', 'by', 'dilution', 'plating', '(', 'Fig', '.', '3C', ')', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 3, 1, 2, 2, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
DNase I treatment of S. aureus resulted in an increase of 15 to 20% in counts using the plate dilution method.	[('PMC3811377', 'R05001', 0, 7, 'DNase I')]	['D', '##N', '##ase', 'I', 'treatment', 'of', 'S', '.', 'au', '##reus', 'resulted', 'in', 'an', 'increase', 'of', '15', 'to', '20', '%', 'in', 'counts', 'using', 'the', 'plate', 'di', '##lution', 'method', '.']	[0, 1, 2, 6, 8, 18, 21, 22, 24, 26, 31, 40, 43, 46, 55, 58, 61, 64, 66, 68, 71, 78, 84, 88, 94, 96, 103, 109]	[1, 2, 5, 7, 17, 20, 22, 23, 26, 30, 39, 42, 45, 54, 57, 60, 63, 66, 67, 70, 77, 83, 87, 93, 96, 102, 109, 110]	['DNase', 'I', 'treatment', 'of', 'S', '.', 'aureus', 'resulted', 'in', 'an', 'increase', 'of', '15', 'to', '20%', 'in', 'counts', 'using', 'the', 'plate', 'dilution', 'method', '.']	[3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We speculate that this effect could be caused by DNase improving individual cell dispersion prior to plating, perhaps by dissolving biofilms, but this does not seem to enhance bacterial growth.	[]	['We', 's', '##pec', '##ulate', 'that', 'this', 'effect', 'could', 'be', 'caused', 'by', 'D', '##N', '##ase', 'improving', 'individual', 'cell', 'di', '##sper', '##sion', 'prior', 'to', 'p', '##lating', ',', 'perhaps', 'by', 'di', '##sso', '##lving', 'bio', '##film', '##s', ',', 'but', 'this', 'does', 'not', 'seem', 'to', 'enhance', 'bacterial', 'growth', '.']	[0, 3, 4, 7, 13, 18, 23, 30, 36, 39, 46, 49, 50, 51, 55, 65, 76, 81, 83, 87, 92, 98, 101, 102, 108, 110, 118, 121, 123, 126, 132, 135, 139, 140, 142, 146, 151, 156, 160, 165, 168, 176, 186, 192]	[2, 4, 7, 12, 17, 22, 29, 35, 38, 45, 48, 50, 51, 54, 64, 75, 80, 83, 87, 91, 97, 100, 102, 108, 109, 117, 120, 123, 126, 131, 135, 139, 140, 141, 145, 150, 155, 159, 164, 167, 175, 185, 192, 193]	['We', 'speculate', 'that', 'this', 'effect', 'could', 'be', 'caused', 'by', 'DNase', 'improving', 'individual', 'cell', 'dispersion', 'prior', 'to', 'plating', ',', 'perhaps', 'by', 'dissolving', 'biofilms', ',', 'but', 'this', 'does', 'not', 'seem', 'to', 'enhance', 'bacterial', 'growth', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We conclude that DNase treatment before cell lysis is not cytotoxic to bacteria and allows discernment of DNA of intact bacteria from that of dead bacteria and free bacterial DNA.	[]	['We', 'conclude', 'that', 'D', '##N', '##ase', 'treatment', 'before', 'cell', 'l', '##ys', '##is', 'is', 'not', 'c', '##yt', '##oto', '##xi', '##c', 'to', 'bacteria', 'and', 'allows', 'disc', '##ern', '##ment', 'of', 'DNA', 'of', 'intact', 'bacteria', 'from', 'that', 'of', 'dead', 'bacteria', 'and', 'free', 'bacterial', 'DNA', '.']	[0, 3, 12, 17, 18, 19, 23, 33, 40, 45, 46, 48, 51, 54, 58, 59, 61, 64, 66, 68, 71, 80, 84, 91, 95, 98, 103, 106, 110, 113, 120, 129, 134, 139, 142, 147, 156, 160, 165, 175, 178]	[2, 11, 16, 18, 19, 22, 32, 39, 44, 46, 48, 50, 53, 57, 59, 61, 64, 66, 67, 70, 79, 83, 90, 95, 98, 102, 105, 109, 112, 119, 128, 133, 138, 141, 146, 155, 159, 164, 174, 178, 179]	['We', 'conclude', 'that', 'DNase', 'treatment', 'before', 'cell', 'lysis', 'is', 'not', 'cytotoxic', 'to', 'bacteria', 'and', 'allows', 'discernment', 'of', 'DNA', 'of', 'intact', 'bacteria', 'from', 'that', 'of', 'dead', 'bacteria', 'and', 'free', 'bacterial', 'DNA', '.']	[1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to determine the load of DNA from live bacteria in the lungs, we used DNase I treatment before cell lysis followed by 16S rRNA qPCR in BAL fluid samples and compared them to lung homogenates from healthy pigs.	[('PMC3811377', 'R06000', 79, 86, 'DNase I')]	['In', 'order', 'to', 'determine', 'the', 'load', 'of', 'DNA', 'from', 'live', 'bacteria', 'in', 'the', 'lungs', ',', 'we', 'used', 'D', '##N', '##ase', 'I', 'treatment', 'before', 'cell', 'l', '##ys', '##is', 'followed', 'by', '16', '##S', 'r', '##RNA', 'q', '##PC', '##R', 'in', 'BA', '##L', 'fluid', 'samples', 'and', 'compared', 'them', 'to', 'lung', 'ho', '##mo', '##gen', '##ates', 'from', 'healthy', 'pigs', '.']	[0, 3, 9, 12, 22, 26, 31, 34, 38, 43, 48, 57, 60, 64, 69, 71, 74, 79, 80, 81, 85, 87, 97, 104, 109, 110, 112, 115, 124, 127, 129, 131, 132, 136, 137, 139, 141, 144, 146, 148, 154, 162, 166, 175, 180, 183, 188, 190, 192, 195, 200, 205, 213, 217]	[2, 8, 11, 21, 25, 30, 33, 37, 42, 47, 56, 59, 63, 69, 70, 73, 78, 80, 81, 84, 86, 96, 103, 108, 110, 112, 114, 123, 126, 129, 130, 132, 135, 137, 139, 140, 143, 146, 147, 153, 161, 165, 174, 179, 182, 187, 190, 192, 195, 199, 204, 212, 217, 218]	['In', 'order', 'to', 'determine', 'the', 'load', 'of', 'DNA', 'from', 'live', 'bacteria', 'in', 'the', 'lungs', ',', 'we', 'used', 'DNase', 'I', 'treatment', 'before', 'cell', 'lysis', 'followed', 'by', '16S', 'rRNA', 'qPCR', 'in', 'BAL', 'fluid', 'samples', 'and', 'compared', 'them', 'to', 'lung', 'homogenates', 'from', 'healthy', 'pigs', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 2, 2, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found that all BAL fluid samples had a mixture of DNase I-sensitive and -resistant DNA, with DNase I treatment reducing the measured bacterial load in BAL fluid samples by 63%, to an average of 1.05 × 106 ± 6.5 × 105 CFU/ml (Fig. 4A).	[('PMC3811377', 'R07000', 53, 60, 'DNase I')]	['We', 'found', 'that', 'all', 'BA', '##L', 'fluid', 'samples', 'had', 'a', 'mixture', 'of', 'D', '##N', '##ase', 'I', '-', 'sensitive', 'and', '-', 'resistant', 'DNA', ',', 'with', 'D', '##N', '##ase', 'I', 'treatment', 'reducing', 'the', 'measured', 'bacterial', 'load', 'in', 'BA', '##L', 'fluid', 'samples', 'by', '63', '%', ',', 'to', 'an', 'average', 'of', '1', '.', '05', '×', '106', '±', '6', '.', '5', '×', '105', 'CF', '##U', '/', 'm', '##l', '(', 'Fi', '##g', '.', '4', '##A', ')', '.']	[0, 3, 9, 14, 18, 20, 22, 28, 36, 40, 42, 50, 53, 54, 55, 59, 60, 61, 71, 75, 76, 86, 89, 91, 96, 97, 98, 102, 104, 114, 123, 127, 136, 146, 151, 154, 156, 158, 164, 172, 175, 177, 178, 180, 183, 186, 194, 197, 198, 199, 202, 204, 208, 210, 211, 212, 214, 216, 220, 222, 223, 224, 225, 227, 228, 230, 231, 233, 234, 235, 236]	[2, 8, 13, 17, 20, 21, 27, 35, 39, 41, 49, 52, 54, 55, 58, 60, 61, 70, 74, 76, 85, 89, 90, 95, 97, 98, 101, 103, 113, 122, 126, 135, 145, 150, 153, 156, 157, 163, 171, 174, 177, 178, 179, 182, 185, 193, 196, 198, 199, 201, 203, 207, 209, 211, 212, 213, 215, 219, 222, 223, 224, 225, 226, 228, 230, 231, 232, 234, 235, 236, 237]	['We', 'found', 'that', 'all', 'BAL', 'fluid', 'samples', 'had', 'a', 'mixture', 'of', 'DNase', 'I-sensitive', 'and', '-', 'resistant', 'DNA', ',', 'with', 'DNase', 'I', 'treatment', 'reducing', 'the', 'measured', 'bacterial', 'load', 'in', 'BAL', 'fluid', 'samples', 'by', '63%', ',', 'to', 'an', 'average', 'of', '1.05', '×', '106', '±', '6.5', '×', '105', 'CFU', '/', 'ml', '(', 'Fig', '.', '4A', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In 6 out of the 11 lung homogenates, all DNA was DNase I sensitive, suggesting the absence of live bacteria (Fig. 4B).	[('PMC3811377', 'R07001', 49, 56, 'DNase I')]	['In', '6', 'out', 'of', 'the', '11', 'lung', 'ho', '##mo', '##gen', '##ates', ',', 'all', 'DNA', 'was', 'D', '##N', '##ase', 'I', 'sensitive', ',', 'suggesting', 'the', 'absence', 'of', 'live', 'bacteria', '(', 'Fi', '##g', '.', '4', '##B', ')', '.']	[0, 3, 5, 9, 12, 16, 19, 24, 26, 28, 31, 35, 37, 41, 45, 49, 50, 51, 55, 57, 66, 68, 79, 83, 91, 94, 99, 108, 109, 111, 112, 114, 115, 116, 117]	[2, 4, 8, 11, 15, 18, 23, 26, 28, 31, 35, 36, 40, 44, 48, 50, 51, 54, 56, 66, 67, 78, 82, 90, 93, 98, 107, 109, 111, 112, 113, 115, 116, 117, 118]	['In', '6', 'out', 'of', 'the', '11', 'lung', 'homogenates', ',', 'all', 'DNA', 'was', 'DNase', 'I', 'sensitive', ',', 'suggesting', 'the', 'absence', 'of', 'live', 'bacteria', '(', 'Fig', '.', '4B', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
On average, 94.4% of the bacterial DNA was DNase I sensitive in lung homogenates.	[('PMC3811377', 'R07002', 43, 50, 'DNase I')]	['On', 'average', ',', '94', '.', '4', '%', 'of', 'the', 'bacterial', 'DNA', 'was', 'D', '##N', '##ase', 'I', 'sensitive', 'in', 'lung', 'ho', '##mo', '##gen', '##ates', '.']	[0, 3, 10, 12, 14, 15, 16, 18, 21, 25, 35, 39, 43, 44, 45, 49, 51, 61, 64, 69, 71, 73, 76, 80]	[2, 10, 11, 14, 15, 16, 17, 20, 24, 34, 38, 42, 44, 45, 48, 50, 60, 63, 68, 71, 73, 76, 80, 81]	['On', 'average', ',', '94.4%', 'of', 'the', 'bacterial', 'DNA', 'was', 'DNase', 'I', 'sensitive', 'in', 'lung', 'homogenates', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found that bacteria in transbronchial BAL fluid samples were similar to those in transoral BAL fluid samples, with clear dominance from bacteria in the Sphingobacteriales order and Mycoplasmataceae, Xanthomonadaceae, and Pasteurellaceae families and with some samples containing abundant Streptococcaceae and Lactobacillaceae, among others.	[]	['We', 'found', 'that', 'bacteria', 'in', 'trans', '##bro', '##nch', '##ial', 'BA', '##L', 'fluid', 'samples', 'were', 'similar', 'to', 'those', 'in', 'trans', '##oral', 'BA', '##L', 'fluid', 'samples', ',', 'with', 'clear', 'dominance', 'from', 'bacteria', 'in', 'the', 'S', '##phi', '##ngo', '##ba', '##cter', '##ial', '##es', 'order', 'and', 'My', '##co', '##p', '##las', '##mata', '##ceae', ',', 'X', '##ant', '##hom', '##ona', '##da', '##ceae', ',', 'and', 'Past', '##eur', '##ella', '##ceae', 'families', 'and', 'with', 'some', 'samples', 'containing', 'abundant', 'St', '##re', '##pt', '##oc', '##oc', '##ca', '##ceae', 'and', 'Lac', '##to', '##ba', '##cilla', '##ceae', ',', 'among', 'others', '.']	[0, 3, 9, 14, 23, 26, 31, 34, 37, 41, 43, 45, 51, 59, 64, 72, 75, 81, 84, 89, 94, 96, 98, 104, 111, 113, 118, 124, 134, 139, 148, 151, 155, 156, 159, 162, 164, 168, 171, 174, 180, 184, 186, 188, 189, 192, 196, 200, 202, 203, 206, 209, 212, 214, 218, 220, 224, 228, 231, 235, 240, 249, 253, 258, 263, 271, 282, 291, 293, 295, 297, 299, 301, 303, 308, 312, 315, 317, 319, 324, 328, 330, 336, 342]	[2, 8, 13, 22, 25, 31, 34, 37, 40, 43, 44, 50, 58, 63, 71, 74, 80, 83, 89, 93, 96, 97, 103, 111, 112, 117, 123, 133, 138, 147, 150, 154, 156, 159, 162, 164, 168, 171, 173, 179, 183, 186, 188, 189, 192, 196, 200, 201, 203, 206, 209, 212, 214, 218, 219, 223, 228, 231, 235, 239, 248, 252, 257, 262, 270, 281, 290, 293, 295, 297, 299, 301, 303, 307, 311, 315, 317, 319, 324, 328, 329, 335, 342, 343]	['We', 'found', 'that', 'bacteria', 'in', 'transbronchial', 'BAL', 'fluid', 'samples', 'were', 'similar', 'to', 'those', 'in', 'transoral', 'BAL', 'fluid', 'samples', ',', 'with', 'clear', 'dominance', 'from', 'bacteria', 'in', 'the', 'Sphingobacteriales', 'order', 'and', 'Mycoplasmataceae', ',', 'Xanthomonadaceae', ',', 'and', 'Pasteurellaceae', 'families', 'and', 'with', 'some', 'samples', 'containing', 'abundant', 'Streptococcaceae', 'and', 'Lactobacillaceae', ',', 'among', 'others', '.']	[1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 6, 1, 6, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 7, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The presence of a small amount of DNase I-resistant DNA in some but not all of the lung homogenate samples may represent a community of symbiotic bacteria.	[('PMC3811377', 'R09000', 34, 41, 'DNase I')]	['The', 'presence', 'of', 'a', 'small', 'amount', 'of', 'D', '##N', '##ase', 'I', '-', 'resistant', 'DNA', 'in', 'some', 'but', 'not', 'all', 'of', 'the', 'lung', 'ho', '##mo', '##gen', '##ate', 'samples', 'may', 'represent', 'a', 'community', 'of', 's', '##ym', '##biotic', 'bacteria', '.']	[0, 4, 13, 16, 18, 24, 31, 34, 35, 36, 40, 41, 42, 52, 56, 59, 64, 68, 72, 76, 79, 83, 88, 90, 92, 95, 99, 107, 111, 121, 123, 133, 136, 137, 139, 146, 154]	[3, 12, 15, 17, 23, 30, 33, 35, 36, 39, 41, 42, 51, 55, 58, 63, 67, 71, 75, 78, 82, 87, 90, 92, 95, 98, 106, 110, 120, 122, 132, 135, 137, 139, 145, 154, 155]	['The', 'presence', 'of', 'a', 'small', 'amount', 'of', 'DNase', 'I-resistant', 'DNA', 'in', 'some', 'but', 'not', 'all', 'of', 'the', 'lung', 'homogenate', 'samples', 'may', 'represent', 'a', 'community', 'of', 'symbiotic', 'bacteria', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We hypothesized that DNase I-resistant DNA would show an overrepresentation of specific taxa compared to DNase I-untreated samples.	[('PMC3811377', 'R09001', 21, 28, 'DNase I')]	['We', 'h', '##y', '##pot', '##hes', '##ized', 'that', 'D', '##N', '##ase', 'I', '-', 'resistant', 'DNA', 'would', 'show', 'an', 'over', '##re', '##p', '##res', '##entation', 'of', 'specific', 'taxa', 'compared', 'to', 'D', '##N', '##ase', 'I', '-', 'un', '##tre', '##ated', 'samples', '.']	[0, 3, 4, 5, 8, 11, 16, 21, 22, 23, 27, 28, 29, 39, 43, 49, 54, 57, 61, 63, 64, 67, 76, 79, 88, 93, 102, 105, 106, 107, 111, 112, 113, 115, 118, 123, 130]	[2, 4, 5, 8, 11, 15, 20, 22, 23, 26, 28, 29, 38, 42, 48, 53, 56, 61, 63, 64, 67, 75, 78, 87, 92, 101, 104, 106, 107, 110, 112, 113, 115, 118, 122, 130, 131]	['We', 'hypothesized', 'that', 'DNase', 'I-resistant', 'DNA', 'would', 'show', 'an', 'overrepresentation', 'of', 'specific', 'taxa', 'compared', 'to', 'DNase', 'I', '-', 'untreated', 'samples', '.']	[1, 5, 1, 3, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found that in samples in which bacteria were detectable by qPCR, most 16S rRNA gene sequences corresponded to the Bacteroidaceae, Lactobacillaceae, Lachnospiraceae, and Ruminococcaceae families, with similar proportions in DNase-treated and untreated samples (Fig. 5, lung).	[('PMC3811377', 'R10000', 226, 231, 'DNase')]	['We', 'found', 'that', 'in', 'samples', 'in', 'which', 'bacteria', 'were', 'detect', '##able', 'by', 'q', '##PC', '##R', ',', 'most', '16', '##S', 'r', '##RNA', 'gene', 'sequences', 'correspond', '##ed', 'to', 'the', 'Ba', '##cter', '##oid', '##aceae', ',', 'Lac', '##to', '##ba', '##cilla', '##ceae', ',', 'Lac', '##hn', '##os', '##pi', '##race', '##ae', ',', 'and', 'R', '##umi', '##no', '##co', '##cca', '##ceae', 'families', ',', 'with', 'similar', 'proportions', 'in', 'D', '##N', '##ase', '-', 'treated', 'and', 'un', '##tre', '##ated', 'samples', '(', 'Fi', '##g', '.', '5', ',', 'lung', ')', '.']	[0, 3, 9, 14, 17, 25, 28, 34, 43, 48, 54, 59, 62, 63, 65, 66, 68, 73, 75, 77, 78, 82, 87, 97, 107, 110, 113, 117, 119, 123, 126, 131, 133, 136, 138, 140, 145, 149, 151, 154, 156, 158, 160, 164, 166, 168, 172, 173, 176, 178, 180, 183, 188, 196, 198, 203, 211, 223, 226, 227, 228, 231, 232, 240, 244, 246, 249, 254, 262, 263, 265, 266, 268, 269, 271, 275, 276]	[2, 8, 13, 16, 24, 27, 33, 42, 47, 54, 58, 61, 63, 65, 66, 67, 72, 75, 76, 78, 81, 86, 96, 107, 109, 112, 116, 119, 123, 126, 131, 132, 136, 138, 140, 145, 149, 150, 154, 156, 158, 160, 164, 166, 167, 171, 173, 176, 178, 180, 183, 187, 196, 197, 202, 210, 222, 225, 227, 228, 231, 232, 239, 243, 246, 249, 253, 261, 263, 265, 266, 267, 269, 270, 275, 276, 277]	['We', 'found', 'that', 'in', 'samples', 'in', 'which', 'bacteria', 'were', 'detectable', 'by', 'qPCR', ',', 'most', '16S', 'rRNA', 'gene', 'sequences', 'corresponded', 'to', 'the', 'Bacteroidaceae', ',', 'Lactobacillaceae', ',', 'Lachnospiraceae', ',', 'and', 'Ruminococcaceae', 'families', ',', 'with', 'similar', 'proportions', 'in', 'DNase', '-', 'treated', 'and', 'untreated', 'samples', '(', 'Fig', '.', '5', ',', 'lung', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 2, 1, 1, 2, 1, 1, 4, 1, 5, 1, 6, 1, 1, 6, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similar to the known tumor suppressor gene phosphatase and tensin homolog (PTEN),[29] MTMR proteins function as phosphoinositide- 3-phosphatases and antagonize the activity of specific classes of phosphatidylinositol 3-kinases.[30] Although it contains an inactive phosphatase domain, SBF2 enhances the catalytic activity of and may alter the cellular localization of MTMR2, a phosphatase-competent member of the MTMR family.[31]	[]	['Similar', 'to', 'the', 'known', 'tumor', 'suppress', '##or', 'gene', 'p', '##hos', '##pha', '##tase', 'and', 'tens', '##in', 'ho', '##mo', '##log', '(', 'PT', '##EN', ')', ',', '[', '29', ']', 'M', '##TM', '##R', 'proteins', 'function', 'as', 'p', '##hos', '##ph', '##oi', '##nos', '##iti', '##de', '-', '3', '-', 'p', '##hos', '##pha', '##tase', '##s', 'and', 'ant', '##agon', '##ize', 'the', 'activity', 'of', 'specific', 'classes', 'of', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '3', '-', 'kinase', '##s', '.', '[', '30', ']', 'Although', 'it', 'contains', 'an', 'inactive', 'p', '##hos', '##pha', '##tase', 'domain', ',', 'S', '##BF', '##2', 'enhance', '##s', 'the', 'cat', '##alytic', 'activity', 'of', 'and', 'may', 'alter', 'the', 'cellular', 'local', '##ization', 'of', 'M', '##TM', '##R', '##2', ',', 'a', 'p', '##hos', '##pha', '##tase', '-', 'competent', 'member', 'of', 'the', 'M', '##TM', '##R', 'family', '.', '[', '31', ']']	[0, 8, 11, 15, 21, 27, 35, 38, 43, 44, 47, 50, 55, 59, 63, 66, 68, 70, 74, 75, 77, 79, 80, 81, 82, 84, 86, 87, 89, 91, 100, 109, 112, 113, 116, 118, 120, 123, 126, 128, 130, 131, 132, 133, 136, 139, 143, 145, 149, 152, 156, 160, 164, 173, 176, 185, 193, 196, 197, 200, 203, 205, 207, 211, 213, 215, 217, 218, 219, 225, 226, 227, 228, 230, 232, 241, 244, 253, 256, 265, 266, 269, 272, 277, 283, 285, 286, 288, 290, 297, 299, 303, 306, 313, 322, 325, 329, 333, 339, 343, 352, 357, 365, 368, 369, 371, 372, 373, 375, 377, 378, 381, 384, 388, 389, 399, 406, 409, 413, 414, 416, 418, 424, 425, 426, 428]	[7, 10, 14, 20, 26, 35, 37, 42, 44, 47, 50, 54, 58, 63, 65, 68, 70, 73, 75, 77, 79, 80, 81, 82, 84, 85, 87, 89, 90, 99, 108, 111, 113, 116, 118, 120, 123, 126, 128, 129, 131, 132, 133, 136, 139, 143, 144, 148, 152, 156, 159, 163, 172, 175, 184, 192, 195, 197, 200, 203, 205, 207, 211, 213, 215, 216, 218, 219, 225, 226, 227, 228, 230, 231, 240, 243, 252, 255, 264, 266, 269, 272, 276, 283, 284, 286, 288, 289, 297, 298, 302, 306, 312, 321, 324, 328, 332, 338, 342, 351, 357, 364, 367, 369, 371, 372, 373, 374, 376, 378, 381, 384, 388, 389, 398, 405, 408, 412, 414, 416, 417, 424, 425, 426, 428, 429]	['Similar', 'to', 'the', 'known', 'tumor', 'suppressor', 'gene', 'phosphatase', 'and', 'tensin', 'homolog', '(PTEN),[29]', 'MTMR', 'proteins', 'function', 'as', 'phosphoinositide-', '3-phosphatases', 'and', 'antagonize', 'the', 'activity', 'of', 'specific', 'classes', 'of', 'phosphatidylinositol', '3-kinases.[30]', 'Although', 'it', 'contains', 'an', 'inactive', 'phosphatase', 'domain', ',', 'SBF2', 'enhances', 'the', 'catalytic', 'activity', 'of', 'and', 'may', 'alter', 'the', 'cellular', 'localization', 'of', 'MTMR2', ',', 'a', 'phosphatase', '-', 'competent', 'member', 'of', 'the', 'MTMR', 'family.[31]']	[1, 1, 1, 1, 1, 2, 1, 4, 1, 2, 3, 8, 3, 1, 1, 1, 8, 7, 1, 3, 1, 1, 1, 1, 1, 1, 9, 8, 1, 1, 1, 1, 1, 4, 1, 1, 3, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 3, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Other loci identified in the Hispanic/DIAGRAM+ meta-analysis and reported in previous GWA studies are CDKN2A/CDKN2B (cyclin-dependent kinase inhibitor 2A and 2B) on chromosome 9 and IGF2BP2 (insulin-like growth factor 2 mRNA binding protein 2) on chromosome 3.	[('PMC3818640', 'D04000', 117, 140, 'cyclin-dependent kinase')]	['Other', 'lo', '##ci', 'identified', 'in', 'the', 'Hispanic', '/', 'D', '##IA', '##GR', '##AM', '+', 'meta', '-', 'analysis', 'and', 'reported', 'in', 'previous', 'G', '##WA', 'studies', 'are', 'CD', '##K', '##N', '##2', '##A', '/', 'CD', '##K', '##N', '##2', '##B', '(', 'c', '##y', '##c', '##lin', '-', 'dependent', 'kinase', 'inhibitor', '2', '##A', 'and', '2', '##B', ')', 'on', 'chromosome', '9', 'and', 'I', '##G', '##F', '##2', '##B', '##P', '##2', '(', 'insulin', '-', 'like', 'growth', 'factor', '2', 'm', '##RNA', 'binding', 'protein', '2', ')', 'on', 'chromosome', '3', '.']	[0, 6, 8, 11, 22, 25, 29, 37, 38, 39, 41, 43, 45, 47, 51, 52, 61, 65, 74, 77, 86, 87, 90, 98, 102, 104, 105, 106, 107, 108, 109, 111, 112, 113, 114, 116, 117, 118, 119, 120, 123, 124, 134, 141, 151, 152, 154, 158, 159, 160, 162, 165, 176, 178, 182, 183, 184, 185, 186, 187, 188, 190, 191, 198, 199, 204, 211, 218, 220, 221, 225, 233, 241, 242, 244, 247, 258, 259]	[5, 8, 10, 21, 24, 28, 37, 38, 39, 41, 43, 45, 46, 51, 52, 60, 64, 73, 76, 85, 87, 89, 97, 101, 104, 105, 106, 107, 108, 109, 111, 112, 113, 114, 115, 117, 118, 119, 120, 123, 124, 133, 140, 150, 152, 153, 157, 159, 160, 161, 164, 175, 177, 181, 183, 184, 185, 186, 187, 188, 189, 191, 198, 199, 203, 210, 217, 219, 221, 224, 232, 240, 242, 243, 246, 257, 259, 260]	['Other', 'loci', 'identified', 'in', 'the', 'Hispanic', '/', 'DIAGRAM+', 'meta-', 'analysis', 'and', 'reported', 'in', 'previous', 'GWA', 'studies', 'are', 'CDKN2A', '/', 'CDKN2B', '(', 'cyclin', '-', 'dependent', 'kinase', 'inhibitor', '2A', 'and', '2B', ')', 'on', 'chromosome', '9', 'and', 'IGF2BP2', '(', 'insulin', '-', 'like', 'growth', 'factor', '2', 'mRNA', 'binding', 'protein', '2', ')', 'on', 'chromosome', '3', '.']	[1, 2, 1, 1, 1, 1, 1, 5, 2, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 5, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
DNASE1L3 codes for deoxyribonuclease 1-like 3, a member of the human DNase 1 family, which is expressed primarily in the liver and spleen and secreted by macrophages.60 This protein plays a role in DNA fragmentation during apoptosis and in the generation of resected double-strand breaks in immunoglobulin-encoding genes.61–63 Moreover, it has been implicated in susceptibility to SLE and RA.17,64	[('PMC3882906', 'D03000', 19, 38, 'deoxyribonuclease 1')]	['DNA', '##SE', '##1', '##L', '##3', 'codes', 'for', 'de', '##ox', '##yr', '##ib', '##on', '##uc', '##lea', '##se', '1', '-', 'like', '3', ',', 'a', 'member', 'of', 'the', 'human', 'D', '##N', '##ase', '1', 'family', ',', 'which', 'is', 'expressed', 'primarily', 'in', 'the', 'liver', 'and', 's', '##ple', '##en', 'and', 'secret', '##ed', 'by', 'mac', '##rop', '##hage', '##s', '.', '60', 'This', 'protein', 'plays', 'a', 'role', 'in', 'DNA', 'fragment', '##ation', 'during', 'a', '##pop', '##tosis', 'and', 'in', 'the', 'generation', 'of', 're', '##sect', '##ed', 'double', '-', 'strand', 'breaks', 'in', 'im', '##mu', '##no', '##g', '##lo', '##bul', '##in', '-', 'encoding', 'genes', '.', '61', '–', '63', 'Moreover', ',', 'it', 'has', 'been', 'implicated', 'in', 'su', '##s', '##ce', '##pt', '##ibility', 'to', 'SL', '##E', 'and', 'RA', '.', '17', ',', '64']	[0, 3, 5, 6, 7, 9, 15, 19, 21, 23, 25, 27, 29, 31, 34, 37, 38, 39, 44, 45, 47, 49, 56, 59, 63, 69, 70, 71, 75, 77, 83, 85, 91, 94, 104, 114, 117, 121, 127, 131, 132, 135, 138, 142, 148, 151, 154, 157, 160, 164, 165, 166, 169, 174, 182, 188, 190, 195, 198, 202, 210, 216, 223, 224, 227, 233, 237, 240, 244, 255, 258, 260, 264, 267, 273, 274, 281, 288, 291, 293, 295, 297, 298, 300, 303, 305, 306, 315, 320, 321, 323, 324, 327, 335, 337, 340, 344, 349, 360, 363, 365, 366, 368, 370, 378, 381, 383, 385, 389, 391, 392, 394, 395]	[3, 5, 6, 7, 8, 14, 18, 21, 23, 25, 27, 29, 31, 34, 36, 38, 39, 43, 45, 46, 48, 55, 58, 62, 68, 70, 71, 74, 76, 83, 84, 90, 93, 103, 113, 116, 120, 126, 130, 132, 135, 137, 141, 148, 150, 153, 157, 160, 164, 165, 166, 168, 173, 181, 187, 189, 194, 197, 201, 210, 215, 222, 224, 227, 232, 236, 239, 243, 254, 257, 260, 264, 266, 273, 274, 280, 287, 290, 293, 295, 297, 298, 300, 303, 305, 306, 314, 320, 321, 323, 324, 326, 335, 336, 339, 343, 348, 359, 362, 365, 366, 368, 370, 377, 380, 383, 384, 388, 391, 392, 394, 395, 397]	['DNASE1L3', 'codes', 'for', 'deoxyribonuclease', '1-', 'like', '3', ',', 'a', 'member', 'of', 'the', 'human', 'DNase', '1', 'family', ',', 'which', 'is', 'expressed', 'primarily', 'in', 'the', 'liver', 'and', 'spleen', 'and', 'secreted', 'by', 'macrophages.60', 'This', 'protein', 'plays', 'a', 'role', 'in', 'DNA', 'fragmentation', 'during', 'apoptosis', 'and', 'in', 'the', 'generation', 'of', 'resected', 'double', '-', 'strand', 'breaks', 'in', 'immunoglobulin', '-', 'encoding', 'genes.61', '–', '63', 'Moreover', ',', 'it', 'has', 'been', 'implicated', 'in', 'susceptibility', 'to', 'SLE', 'and', 'RA.17', ',', '64']	[5, 1, 1, 8, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 7, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, vascular injury and immune deregulation, which are both SSc hallmarks, are related to cell damage and deregulated apoptosis.66 Therefore, the association between SSc (especially ACA+ SSc) and the rs35677470 loss-of-function variant in DNASE1L3 might provide a link between a defective apoptotic DNA breakdown and the production of ACA.	[]	['Interest', '##ingly', ',', 'vascular', 'injury', 'and', 'immune', 'der', '##eg', '##ulation', ',', 'which', 'are', 'both', 'SS', '##c', 'hall', '##marks', ',', 'are', 'related', 'to', 'cell', 'damage', 'and', 'der', '##eg', '##ulated', 'a', '##pop', '##tosis', '.', '66', 'Therefore', ',', 'the', 'association', 'between', 'SS', '##c', '(', 'especially', 'AC', '##A', '+', 'SS', '##c', ')', 'and', 'the', 'r', '##s', '##35', '##6', '##7', '##7', '##47', '##0', 'loss', '-', 'of', '-', 'function', 'variant', 'in', 'DNA', '##SE', '##1', '##L', '##3', 'might', 'provide', 'a', 'link', 'between', 'a', 'defect', '##ive', 'a', '##pop', '##to', '##tic', 'DNA', 'breakdown', 'and', 'the', 'production', 'of', 'AC', '##A', '.']	[0, 8, 13, 15, 24, 31, 35, 42, 45, 47, 54, 56, 62, 66, 71, 73, 75, 79, 84, 86, 90, 98, 101, 106, 113, 117, 120, 122, 129, 130, 133, 138, 139, 142, 151, 153, 157, 169, 177, 179, 181, 182, 193, 195, 196, 198, 200, 201, 203, 207, 211, 212, 213, 215, 216, 217, 218, 220, 222, 226, 227, 229, 230, 239, 247, 250, 253, 255, 256, 257, 259, 265, 273, 275, 280, 288, 290, 296, 300, 301, 304, 306, 310, 314, 324, 328, 332, 343, 346, 348, 349]	[8, 13, 14, 23, 30, 34, 41, 45, 47, 54, 55, 61, 65, 70, 73, 74, 79, 84, 85, 89, 97, 100, 105, 112, 116, 120, 122, 128, 130, 133, 138, 139, 141, 151, 152, 156, 168, 176, 179, 180, 182, 192, 195, 196, 197, 200, 201, 202, 206, 210, 212, 213, 215, 216, 217, 218, 220, 221, 226, 227, 229, 230, 238, 246, 249, 253, 255, 256, 257, 258, 264, 272, 274, 279, 287, 289, 296, 299, 301, 304, 306, 309, 313, 323, 327, 331, 342, 345, 348, 349, 350]	['Interestingly', ',', 'vascular', 'injury', 'and', 'immune', 'deregulation', ',', 'which', 'are', 'both', 'SSc', 'hallmarks', ',', 'are', 'related', 'to', 'cell', 'damage', 'and', 'deregulated', 'apoptosis.66', 'Therefore', ',', 'the', 'association', 'between', 'SSc', '(', 'especially', 'ACA+', 'SSc', ')', 'and', 'the', 'rs35677470', 'loss', '-', 'of', '-', 'function', 'variant', 'in', 'DNASE1L3', 'might', 'provide', 'a', 'link', 'between', 'a', 'defective', 'apoptotic', 'DNA', 'breakdown', 'and', 'the', 'production', 'of', 'ACA', '.']	[2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 8, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We used the Regulome, Genevar, and Blood eQTL browser resources to explore the evidence of transcription factor binding sites, DNase hypersensitivity sites, and expression quantitative trait loci (eQTLs) in the publicly available ENCODE database and additional eQTL databases.42–44 Molecular graphics and analyses of DNASE1L3, HLA-DPAβ1, HLA-DQα1, and HLA-DRβ1 structure were performed with the UCSF Chimera package.45	[]	['We', 'used', 'the', 'Reg', '##ulo', '##me', ',', 'Geneva', '##r', ',', 'and', 'Blood', 'e', '##Q', '##TL', 'browser', 'resources', 'to', 'explore', 'the', 'evidence', 'of', 'transcription', 'factor', 'binding', 'sites', ',', 'D', '##N', '##ase', 'h', '##yper', '##sen', '##si', '##ti', '##vity', 'sites', ',', 'and', 'expression', 'quantitative', 'trait', 'lo', '##ci', '(', 'e', '##Q', '##TL', '##s', ')', 'in', 'the', 'publicly', 'available', 'E', '##NC', '##OD', '##E', 'database', 'and', 'additional', 'e', '##Q', '##TL', 'databases', '.', '42', '–', '44', 'Molecular', 'graphics', 'and', 'analyses', 'of', 'DNA', '##SE', '##1', '##L', '##3', ',', 'H', '##LA', '-', 'D', '##PA', '##β', '##1', ',', 'H', '##LA', '-', 'D', '##Q', '##α', '##1', ',', 'and', 'H', '##LA', '-', 'DR', '##β', '##1', 'structure', 'were', 'performed', 'with', 'the', 'UC', '##SF', 'Chi', '##mer', '##a', 'package', '.', '45']	[0, 3, 8, 12, 15, 18, 20, 22, 28, 29, 31, 35, 41, 42, 43, 46, 54, 64, 67, 75, 79, 88, 91, 105, 112, 120, 125, 127, 128, 129, 133, 134, 138, 141, 143, 145, 150, 155, 157, 161, 172, 185, 191, 193, 196, 197, 198, 199, 201, 202, 204, 207, 211, 220, 230, 231, 233, 235, 237, 246, 250, 261, 262, 263, 266, 275, 276, 278, 279, 282, 292, 301, 305, 314, 317, 320, 322, 323, 324, 325, 327, 328, 330, 331, 332, 334, 335, 336, 338, 339, 341, 342, 343, 344, 345, 346, 348, 352, 353, 355, 356, 358, 359, 361, 371, 376, 386, 391, 395, 397, 400, 403, 406, 408, 415, 416]	[2, 7, 11, 15, 18, 20, 21, 28, 29, 30, 34, 40, 42, 43, 45, 53, 63, 66, 74, 78, 87, 90, 104, 111, 119, 125, 126, 128, 129, 132, 134, 138, 141, 143, 145, 149, 155, 156, 160, 171, 184, 190, 193, 195, 197, 198, 199, 201, 202, 203, 206, 210, 219, 229, 231, 233, 235, 236, 245, 249, 260, 262, 263, 265, 275, 276, 278, 279, 281, 291, 300, 304, 313, 316, 320, 322, 323, 324, 325, 326, 328, 330, 331, 332, 334, 335, 336, 337, 339, 341, 342, 343, 344, 345, 346, 347, 351, 353, 355, 356, 358, 359, 360, 370, 375, 385, 390, 394, 397, 399, 403, 406, 407, 415, 416, 418]	['We', 'used', 'the', 'Regulome', ',', 'Genevar', ',', 'and', 'Blood', 'eQTL', 'browser', 'resources', 'to', 'explore', 'the', 'evidence', 'of', 'transcription', 'factor', 'binding', 'sites', ',', 'DNase', 'hypersensitivity', 'sites', ',', 'and', 'expression', 'quantitative', 'trait', 'loci', '(', 'eQTLs', ')', 'in', 'the', 'publicly', 'available', 'ENCODE', 'database', 'and', 'additional', 'eQTL', 'databases.42', '–', '44', 'Molecular', 'graphics', 'and', 'analyses', 'of', 'DNASE1L3', ',', 'HLA-DPAβ1', ',', 'HLA-DQα1', ',', 'and', 'HLA-DRβ1', 'structure', 'were', 'performed', 'with', 'the', 'UCSF', 'Chimera', 'package.45']	[1, 1, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 6, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 7, 1, 7, 1, 1, 6, 1, 1, 1, 1, 1, 2, 3, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In conjunction with termination of the proteolysis by rapid inactivation of plasmin by α-2-antiplasmin and other polypeptide inhibitors, this feedback mechanism may emphasize the benefits of these PUFA in regulation of the initiation of fibrinolysis on the surface of ECs.	[]	['In', 'conjunction', 'with', 'termination', 'of', 'the', 'pro', '##te', '##oly', '##sis', 'by', 'rapid', 'in', '##act', '##ivation', 'of', 'p', '##las', '##min', 'by', 'α', '-', '2', '-', 'anti', '##p', '##las', '##min', 'and', 'other', 'p', '##oly', '##pe', '##pt', '##ide', 'inhibitor', '##s', ',', 'this', 'feedback', 'mechanism', 'may', 'emphasize', 'the', 'benefits', 'of', 'these', 'P', '##U', '##FA', 'in', 'regulation', 'of', 'the', 'initiation', 'of', 'fi', '##bri', '##no', '##lysis', 'on', 'the', 'surface', 'of', 'EC', '##s', '.']	[0, 3, 15, 20, 32, 35, 39, 42, 44, 47, 51, 54, 60, 62, 65, 73, 76, 77, 80, 84, 87, 88, 89, 90, 91, 95, 96, 99, 103, 107, 113, 114, 117, 119, 121, 125, 134, 135, 137, 142, 151, 161, 165, 175, 179, 188, 191, 197, 198, 199, 202, 205, 216, 219, 223, 234, 237, 239, 242, 244, 250, 253, 257, 265, 268, 270, 271]	[2, 14, 19, 31, 34, 38, 42, 44, 47, 50, 53, 59, 62, 65, 72, 75, 77, 80, 83, 86, 88, 89, 90, 91, 95, 96, 99, 102, 106, 112, 114, 117, 119, 121, 124, 134, 135, 136, 141, 150, 160, 164, 174, 178, 187, 190, 196, 198, 199, 201, 204, 215, 218, 222, 233, 236, 239, 242, 244, 249, 252, 256, 264, 267, 270, 271, 272]	['In', 'conjunction', 'with', 'termination', 'of', 'the', 'proteolysis', 'by', 'rapid', 'inactivation', 'of', 'plasmin', 'by', 'α-2-antiplasmin', 'and', 'other', 'polypeptide', 'inhibitors', ',', 'this', 'feedback', 'mechanism', 'may', 'emphasize', 'the', 'benefits', 'of', 'these', 'PUFA', 'in', 'regulation', 'of', 'the', 'initiation', 'of', 'fibrinolysis', 'on', 'the', 'surface', 'of', 'ECs', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 3, 1, 8, 1, 1, 5, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The concentrations of plasminogen in normal human and fetal bovine sera are both approximately 1.4 µM [43], [44], while the concentration in the human conceptus is ≤50% of that found in maternal serum [45].	[]	['The', 'concentrations', 'of', 'p', '##las', '##min', '##ogen', 'in', 'normal', 'human', 'and', 'f', '##etal', 'b', '##ov', '##ine', 'se', '##ra', 'are', 'both', 'approximately', '1', '.', '4', 'µ', '##M', '[', '43', ']', ',', '[', '44', ']', ',', 'while', 'the', 'concentration', 'in', 'the', 'human', 'concept', '##us', 'is', '≤', '50', '%', 'of', 'that', 'found', 'in', 'maternal', 'serum', '[', '45', ']', '.']	[0, 4, 19, 22, 23, 26, 29, 34, 37, 44, 50, 54, 55, 60, 61, 63, 67, 69, 72, 76, 81, 95, 96, 97, 99, 100, 102, 103, 105, 106, 108, 109, 111, 112, 114, 120, 124, 138, 141, 145, 151, 158, 161, 164, 165, 167, 169, 172, 177, 183, 186, 195, 201, 202, 204, 205]	[3, 18, 21, 23, 26, 29, 33, 36, 43, 49, 53, 55, 59, 61, 63, 66, 69, 71, 75, 80, 94, 96, 97, 98, 100, 101, 103, 105, 106, 107, 109, 111, 112, 113, 119, 123, 137, 140, 144, 150, 158, 160, 163, 165, 167, 168, 171, 176, 182, 185, 194, 200, 202, 204, 205, 206]	['The', 'concentrations', 'of', 'plasminogen', 'in', 'normal', 'human', 'and', 'fetal', 'bovine', 'sera', 'are', 'both', 'approximately', '1.4', 'µM', '[', '43', ']', ',', '[', '44', ']', ',', 'while', 'the', 'concentration', 'in', 'the', 'human', 'conceptus', 'is', '≤', '50%', 'of', 'that', 'found', 'in', 'maternal', 'serum', '[', '45', ']', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 2, 3, 2, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
tPA is secreted from primary cultures of HUVEC without stimulation [37].	[]	['t', '##PA', 'is', 'secret', '##ed', 'from', 'primary', 'cultures', 'of', 'H', '##U', '##VE', '##C', 'without', 'stimulation', '[', '37', ']', '.']	[0, 1, 4, 7, 13, 16, 21, 29, 38, 41, 42, 43, 45, 47, 55, 67, 68, 70, 71]	[1, 3, 6, 13, 15, 20, 28, 37, 40, 42, 43, 45, 46, 54, 66, 68, 70, 71, 72]	['tPA', 'is', 'secreted', 'from', 'primary', 'cultures', 'of', 'HUVEC', 'without', 'stimulation', '[', '37', ']', '.']	[2, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proteases analyzed in this study could readily dissociate the tetramer by removing this residue.	[]	['The', 'pro', '##te', '##ases', 'analyzed', 'in', 'this', 'study', 'could', 'readily', 'di', '##sso', '##cia', '##te', 'the', 'te', '##tra', '##mer', 'by', 'removing', 'this', 'residue', '.']	[0, 4, 7, 9, 14, 23, 26, 31, 37, 43, 51, 53, 56, 59, 62, 66, 68, 71, 75, 78, 87, 92, 99]	[3, 7, 9, 13, 22, 25, 30, 36, 42, 50, 53, 56, 59, 61, 65, 68, 71, 74, 77, 86, 91, 99, 100]	['The', 'proteases', 'analyzed', 'in', 'this', 'study', 'could', 'readily', 'dissociate', 'the', 'tetramer', 'by', 'removing', 'this', 'residue', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ECs express a large repertoire of receptor tyrosine kinases (RTKs) and G-protein coupled receptors (GPCRs) for inflammatory or angiogenic ligands [1], [2].	[]	['EC', '##s', 'express', 'a', 'large', 'repertoire', 'of', 'receptor', 't', '##yr', '##os', '##ine', 'kinase', '##s', '(', 'R', '##T', '##K', '##s', ')', 'and', 'G', '-', 'protein', 'coupled', 'receptors', '(', 'GP', '##CR', '##s', ')', 'for', 'inflammatory', 'or', 'an', '##gio', '##genic', 'l', '##igan', '##ds', '[', '1', ']', ',', '[', '2', ']', '.']	[0, 2, 4, 12, 14, 20, 31, 34, 43, 44, 46, 48, 52, 58, 60, 61, 62, 63, 64, 65, 67, 71, 72, 73, 81, 89, 99, 100, 102, 104, 105, 107, 111, 124, 127, 129, 132, 138, 139, 143, 146, 147, 148, 149, 151, 152, 153, 154]	[2, 3, 11, 13, 19, 30, 33, 42, 44, 46, 48, 51, 58, 59, 61, 62, 63, 64, 65, 66, 70, 72, 73, 80, 88, 98, 100, 102, 104, 105, 106, 110, 123, 126, 129, 132, 137, 139, 143, 145, 147, 148, 149, 150, 152, 153, 154, 155]	['ECs', 'express', 'a', 'large', 'repertoire', 'of', 'receptor', 'tyrosine', 'kinases', '(', 'RTKs', ')', 'and', 'G', '-', 'protein', 'coupled', 'receptors', '(', 'GPCRs', ')', 'for', 'inflammatory', 'or', 'angiogenic', 'ligands', '[', '1', ']', ',', '[', '2', ']', '.']	[2, 1, 1, 1, 1, 1, 1, 4, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Having identified multilayered controls of ANXA2 processing by serine proteases, we addressed the effect of EPA and DHA on cells pretreated with EGTA.	[('PMC3897403', 'R11000', 63, 79, 'serine proteases')]	['Having', 'identified', 'multi', '##layer', '##ed', 'controls', 'of', 'AN', '##X', '##A', '##2', 'processing', 'by', 'se', '##rine', 'pro', '##te', '##ases', ',', 'we', 'addressed', 'the', 'effect', 'of', 'EPA', 'and', 'D', '##HA', 'on', 'cells', 'pre', '##tre', '##ated', 'with', 'E', '##G', '##TA', '.']	[0, 7, 18, 23, 28, 31, 40, 43, 45, 46, 47, 49, 60, 63, 65, 70, 73, 75, 79, 81, 84, 94, 98, 105, 108, 112, 116, 117, 120, 123, 129, 132, 135, 140, 145, 146, 147, 149]	[6, 17, 23, 28, 30, 39, 42, 45, 46, 47, 48, 59, 62, 65, 69, 73, 75, 79, 80, 83, 93, 97, 104, 107, 111, 115, 117, 119, 122, 128, 132, 135, 139, 144, 146, 147, 149, 150]	['Having', 'identified', 'multilayered', 'controls', 'of', 'ANXA2', 'processing', 'by', 'serine', 'proteases', ',', 'we', 'addressed', 'the', 'effect', 'of', 'EPA', 'and', 'DHA', 'on', 'cells', 'pretreated', 'with', 'EGTA', '.']	[1, 1, 3, 1, 1, 4, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Src Tyr kinase has been implicated in Tyr-phosphorylation of ANXA2	[('PMC3897403', 'R16000', 4, 14, 'Tyr kinase')]	['Sr', '##c', 'Ty', '##r', 'kinase', 'has', 'been', 'implicated', 'in', 'Ty', '##r', '-', 'p', '##hos', '##ph', '##ory', '##lation', 'of', 'AN', '##X', '##A', '##2']	[0, 2, 4, 6, 8, 15, 19, 24, 35, 38, 40, 41, 42, 43, 46, 48, 51, 58, 61, 63, 64, 65]	[2, 3, 6, 7, 14, 18, 23, 34, 37, 40, 41, 42, 43, 46, 48, 51, 57, 60, 63, 64, 65, 66]	['Src', 'Tyr', 'kinase', 'has', 'been', 'implicated', 'in', 'Tyr', '-', 'phosphorylation', 'of', 'ANXA2']	[2, 2, 1, 1, 1, 1, 1, 2, 1, 5, 1, 4]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein analysis identified a major band with molecular weight of approximately 58 kDa, later identified as salivary alpha-amylase; it was detected in SDS-PAGE protein profiles of all samples.	[('PMC3899019', 'R02000', 117, 130, 'alpha-amylase')]	['Pro', '##tein', 'analysis', 'identified', 'a', 'major', 'band', 'with', 'molecular', 'weight', 'of', 'approximately', '58', 'k', '##D', '##a', ',', 'later', 'identified', 'as', 'sa', '##liva', '##ry', 'alpha', '-', 'am', '##yla', '##se', ';', 'it', 'was', 'detected', 'in', 'SD', '##S', '-', 'PA', '##GE', 'protein', 'profiles', 'of', 'all', 'samples', '.']	[0, 3, 8, 17, 28, 30, 36, 41, 46, 56, 63, 66, 80, 83, 84, 85, 86, 88, 94, 105, 108, 110, 114, 117, 122, 123, 125, 128, 130, 132, 135, 139, 148, 151, 153, 154, 155, 157, 160, 168, 177, 180, 184, 191]	[3, 7, 16, 27, 29, 35, 40, 45, 55, 62, 65, 79, 82, 84, 85, 86, 87, 93, 104, 107, 110, 114, 116, 122, 123, 125, 128, 130, 131, 134, 138, 147, 150, 153, 154, 155, 157, 159, 167, 176, 179, 183, 191, 192]	['Protein', 'analysis', 'identified', 'a', 'major', 'band', 'with', 'molecular', 'weight', 'of', 'approximately', '58', 'kDa', ',', 'later', 'identified', 'as', 'salivary', 'alpha', '-', 'amylase', ';', 'it', 'was', 'detected', 'in', 'SDS-PAGE', 'protein', 'profiles', 'of', 'all', 'samples', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Phostensin, a protein phosphatase-1 F-actin cytoskeleton targeting subunit, is encoded by KIAA1949 [1–3].	[('PMC3907856', 'I00000', 14, 35, 'protein phosphatase-1')]	['Ph', '##ost', '##ens', '##in', ',', 'a', 'protein', 'p', '##hos', '##pha', '##tase', '-', '1', 'F', '-', 'act', '##in', 'c', '##yt', '##os', '##kel', '##eton', 'targeting', 'subunit', ',', 'is', 'encoded', 'by', 'K', '##IA', '##A', '##19', '##4', '##9', '[', '1', '–', '3', ']', '.']	[0, 2, 5, 8, 10, 12, 14, 22, 23, 26, 29, 33, 34, 36, 37, 38, 41, 44, 45, 47, 49, 52, 57, 67, 74, 76, 79, 87, 90, 91, 93, 94, 96, 97, 99, 100, 101, 102, 103, 104]	[2, 5, 8, 10, 11, 13, 21, 23, 26, 29, 33, 34, 35, 37, 38, 41, 43, 45, 47, 49, 52, 56, 66, 74, 75, 78, 86, 89, 91, 93, 94, 96, 97, 98, 100, 101, 102, 103, 104, 105]	['Phostensin', ',', 'a', 'protein', 'phosphatase-1', 'F-actin', 'cytoskeleton', 'targeting', 'subunit', ',', 'is', 'encoded', 'by', 'KIAA1949', '[', '1–', '3', ']', '.']	[4, 1, 1, 1, 6, 4, 5, 1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Phostensin binds to the pointed ends of actin filaments but not to actin monomers, sides of filaments, or barbed ends of filaments, retarding the elongation and depolymerization rates of gelsolin-actin seeds and reducing the rate of G-actin addition at the pointed ends [4,6].	[]	['Ph', '##ost', '##ens', '##in', 'binds', 'to', 'the', 'pointed', 'ends', 'of', 'act', '##in', 'fi', '##lam', '##ents', 'but', 'not', 'to', 'act', '##in', 'mon', '##omer', '##s', ',', 'sides', 'of', 'fi', '##lam', '##ents', ',', 'or', 'bar', '##bed', 'ends', 'of', 'fi', '##lam', '##ents', ',', 're', '##tar', '##ding', 'the', 'el', '##ong', '##ation', 'and', 'de', '##pol', '##yme', '##riz', '##ation', 'rates', 'of', 'gel', '##sol', '##in', '-', 'act', '##in', 'seeds', 'and', 'reducing', 'the', 'rate', 'of', 'G', '-', 'act', '##in', 'addition', 'at', 'the', 'pointed', 'ends', '[', '4', ',', '6', ']', '.']	[0, 2, 5, 8, 11, 17, 20, 24, 32, 37, 40, 43, 46, 48, 51, 56, 60, 64, 67, 70, 73, 76, 80, 81, 83, 89, 92, 94, 97, 101, 103, 106, 109, 113, 118, 121, 123, 126, 130, 132, 134, 137, 142, 146, 148, 151, 157, 161, 163, 166, 169, 172, 178, 184, 187, 190, 193, 195, 196, 199, 202, 208, 212, 221, 225, 230, 233, 234, 235, 238, 241, 250, 253, 257, 265, 270, 271, 272, 273, 274, 275]	[2, 5, 8, 10, 16, 19, 23, 31, 36, 39, 43, 45, 48, 51, 55, 59, 63, 66, 70, 72, 76, 80, 81, 82, 88, 91, 94, 97, 101, 102, 105, 109, 112, 117, 120, 123, 126, 130, 131, 134, 137, 141, 145, 148, 151, 156, 160, 163, 166, 169, 172, 177, 183, 186, 190, 193, 195, 196, 199, 201, 207, 211, 220, 224, 229, 232, 234, 235, 238, 240, 249, 252, 256, 264, 269, 271, 272, 273, 274, 275, 276]	['Phostensin', 'binds', 'to', 'the', 'pointed', 'ends', 'of', 'actin', 'filaments', 'but', 'not', 'to', 'actin', 'monomers', ',', 'sides', 'of', 'filaments', ',', 'or', 'barbed', 'ends', 'of', 'filaments', ',', 'retarding', 'the', 'elongation', 'and', 'depolymerization', 'rates', 'of', 'gelsolin', '-', 'actin', 'seeds', 'and', 'reducing', 'the', 'rate', 'of', 'G-actin', 'addition', 'at', 'the', 'pointed', 'ends', '[', '4', ',', '6', ']', '.']	[4, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 3, 1, 3, 1, 5, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dithiothreitol (DTT), Tris, Luria-Bertani (LB) broth, cycloheximide, amplicillin, imidazole, ATP, glucose, glucose oxidase, isopropyl β-d-1-thiogalactopyranoside (IPTG), phenylmethylsulfonyl fluoride (PMSF), and glycine were obtained from Sigma-Aldrich (St. Louis, MO, USA).	[('PMC3907856', 'M00000', 107, 122, 'glucose oxidase')]	['Di', '##thi', '##oth', '##re', '##ito', '##l', '(', 'D', '##TT', ')', ',', 'Tri', '##s', ',', 'Lu', '##ria', '-', 'Bert', '##ani', '(', 'L', '##B', ')', 'br', '##oth', ',', 'c', '##y', '##c', '##lo', '##he', '##xi', '##mi', '##de', ',', 'am', '##p', '##lic', '##ill', '##in', ',', 'im', '##ida', '##zo', '##le', ',', 'ATP', ',', 'glucose', ',', 'glucose', 'o', '##xi', '##das', '##e', ',', 'is', '##op', '##rop', '##yl', 'β', '-', 'd', '-', '1', '-', 'th', '##io', '##gal', '##act', '##opy', '##rano', '##side', '(', 'IP', '##T', '##G', ')', ',', 'p', '##hen', '##yl', '##met', '##hyl', '##sul', '##fo', '##ny', '##l', 'flu', '##ori', '##de', '(', 'PM', '##SF', ')', ',', 'and', 'g', '##ly', '##cine', 'were', 'obtained', 'from', 'Sigma', '-', 'Al', '##dric', '##h', '(', 'St', '.', 'Louis', ',', 'M', '##O', ',', 'USA', ')', '.']	[0, 2, 5, 8, 10, 13, 15, 16, 17, 19, 20, 22, 25, 26, 28, 30, 33, 34, 38, 42, 43, 44, 45, 47, 49, 52, 54, 55, 56, 57, 59, 61, 63, 65, 67, 69, 71, 72, 75, 78, 80, 82, 84, 87, 89, 91, 93, 96, 98, 105, 107, 115, 116, 118, 121, 122, 124, 126, 128, 131, 134, 135, 136, 137, 138, 139, 140, 142, 144, 147, 150, 153, 157, 162, 163, 165, 166, 167, 168, 170, 171, 174, 176, 179, 182, 185, 187, 189, 191, 194, 197, 200, 201, 203, 205, 206, 208, 212, 213, 215, 220, 225, 234, 239, 244, 245, 247, 251, 253, 254, 256, 258, 263, 265, 266, 267, 269, 272, 273]	[2, 5, 8, 10, 13, 14, 16, 17, 19, 20, 21, 25, 26, 27, 30, 33, 34, 38, 41, 43, 44, 45, 46, 49, 52, 53, 55, 56, 57, 59, 61, 63, 65, 67, 68, 71, 72, 75, 78, 80, 81, 84, 87, 89, 91, 92, 96, 97, 105, 106, 114, 116, 118, 121, 122, 123, 126, 128, 131, 133, 135, 136, 137, 138, 139, 140, 142, 144, 147, 150, 153, 157, 161, 163, 165, 166, 167, 168, 169, 171, 174, 176, 179, 182, 185, 187, 189, 190, 194, 197, 199, 201, 203, 205, 206, 207, 211, 213, 215, 219, 224, 233, 238, 244, 245, 247, 251, 252, 254, 256, 257, 263, 264, 266, 267, 268, 272, 273, 274]	['Dithiothreitol', '(', 'DTT', ')', ',', 'Tris', ',', 'Luria-Bertani', '(', 'LB', ')', 'broth', ',', 'cycloheximide', ',', 'amplicillin', ',', 'imidazole', ',', 'ATP', ',', 'glucose', ',', 'glucose', 'oxidase', ',', 'isopropyl', 'β-d-1-thiogalactopyranoside', '(', 'IPTG', ')', ',', 'phenylmethylsulfonyl', 'fluoride', '(', 'PMSF', ')', ',', 'and', 'glycine', 'were', 'obtained', 'from', 'Sigma-Aldrich', '(', 'St', '.', 'Louis', ',', 'MO', ',', 'USA', ')', '.']	[6, 1, 2, 1, 1, 2, 1, 5, 1, 2, 1, 2, 1, 8, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 4, 13, 1, 3, 1, 1, 9, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We have developed a high throughput liquid chromatography-tandem mass spectrometry method for quantitative analysis of 3-HPMA and HMPMA in large numbers of small urine samples, as would be required in molecular epidemiology and clinical studies relating levels of these metabolites to cancer risk.	[]	['We', 'have', 'developed', 'a', 'high', 'through', '##put', 'liquid', 'ch', '##roma', '##tography', '-', 'tandem', 'mass', 's', '##pect', '##rome', '##try', 'method', 'for', 'quantitative', 'analysis', 'of', '3', '-', 'HP', '##MA', 'and', 'HM', '##PM', '##A', 'in', 'large', 'numbers', 'of', 'small', 'urine', 'samples', ',', 'as', 'would', 'be', 'required', 'in', 'molecular', 'e', '##pid', '##em', '##iology', 'and', 'clinical', 'studies', 'relating', 'levels', 'of', 'these', 'meta', '##bol', '##ites', 'to', 'cancer', 'risk', '.']	[0, 3, 8, 18, 20, 25, 32, 36, 43, 45, 49, 57, 58, 65, 70, 71, 75, 79, 83, 90, 94, 107, 116, 119, 120, 121, 123, 126, 130, 132, 134, 136, 139, 145, 153, 156, 162, 168, 175, 177, 180, 186, 189, 198, 201, 211, 212, 215, 217, 224, 228, 237, 245, 254, 261, 264, 270, 274, 277, 282, 285, 292, 296]	[2, 7, 17, 19, 24, 32, 35, 42, 45, 49, 57, 58, 64, 69, 71, 75, 79, 82, 89, 93, 106, 115, 118, 120, 121, 123, 125, 129, 132, 134, 135, 138, 144, 152, 155, 161, 167, 175, 176, 179, 185, 188, 197, 200, 210, 212, 215, 217, 223, 227, 236, 244, 253, 260, 263, 269, 274, 277, 281, 284, 291, 296, 297]	['We', 'have', 'developed', 'a', 'high', 'throughput', 'liquid', 'chromatography', '-', 'tandem', 'mass', 'spectrometry', 'method', 'for', 'quantitative', 'analysis', 'of', '3-HPMA', 'and', 'HMPMA', 'in', 'large', 'numbers', 'of', 'small', 'urine', 'samples', ',', 'as', 'would', 'be', 'required', 'in', 'molecular', 'epidemiology', 'and', 'clinical', 'studies', 'relating', 'levels', 'of', 'these', 'metabolites', 'to', 'cancer', 'risk', '.']	[1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A number of findings indicate that this mechanism may be working in the generation of MP in TI patients: (i) HMC are contained in MP found in patients’ plasma or are released from TI-RBC in vitro; (ii) the degree of band 3 oxidation and phosphorylation in TI-RBC correlates with the amount of membrane-bound HMC; (iii) in TI-RBC and phenylhydrazine-treated RBC there was microscopy evidence that HMC are bound to protruding areas of the membrane that can be easily shed following moderate mechanical stress; (iv) in TI-RBC, Syk inhibitors diminished both band 3 phosphorylation and the rate of MP release; and (v) phenylhydrazine, which induces HMC formation in control RBC without directly oxidizing band 3, caused a Syk kinase-dependent release of MP accompanied by oxidation, phosphorylation and clustering of band 3.	[('PMC3943323', 'D03000', 718, 728, 'Syk kinase')]	['A', 'number', 'of', 'findings', 'indicate', 'that', 'this', 'mechanism', 'may', 'be', 'working', 'in', 'the', 'generation', 'of', 'MP', 'in', 'T', '##I', 'patients', ':', '(', 'i', ')', 'HM', '##C', 'are', 'contained', 'in', 'MP', 'found', 'in', 'patients', '’', 'plasma', 'or', 'are', 'released', 'from', 'T', '##I', '-', 'RB', '##C', 'in', 'v', '##it', '##ro', ';', '(', 'ii', ')', 'the', 'degree', 'of', 'band', '3', 'oxidation', 'and', 'p', '##hos', '##ph', '##ory', '##lation', 'in', 'T', '##I', '-', 'RB', '##C', 'co', '##rrel', '##ates', 'with', 'the', 'amount', 'of', 'membrane', '-', 'bound', 'HM', '##C', ';', '(', 'ii', '##i', ')', 'in', 'T', '##I', '-', 'RB', '##C', 'and', 'p', '##hen', '##yl', '##hy', '##dra', '##zine', '-', 'treated', 'RB', '##C', 'there', 'was', 'micro', '##sco', '##py', 'evidence', 'that', 'HM', '##C', 'are', 'bound', 'to', 'protruding', 'areas', 'of', 'the', 'membrane', 'that', 'can', 'be', 'easily', 'shed', 'following', 'moderate', 'mechanical', 'stress', ';', '(', 'i', '##v', ')', 'in', 'T', '##I', '-', 'RB', '##C', ',', 'S', '##yk', 'inhibitor', '##s', 'diminished', 'both', 'band', '3', 'p', '##hos', '##ph', '##ory', '##lation', 'and', 'the', 'rate', 'of', 'MP', 'release', ';', 'and', '(', 'v', ')', 'p', '##hen', '##yl', '##hy', '##dra', '##zine', ',', 'which', 'induce', '##s', 'HM', '##C', 'formation', 'in', 'control', 'RB', '##C', 'without', 'directly', 'o', '##xi', '##di', '##zing', 'band', '3', ',', 'caused', 'a', 'S', '##yk', 'kinase', '-', 'dependent', 'release', 'of', 'MP', 'accompanied', 'by', 'oxidation', ',', 'p', '##hos', '##ph', '##ory', '##lation', 'and', 'cluster', '##ing', 'of', 'band', '3', '.']	[0, 2, 9, 12, 21, 30, 35, 40, 50, 54, 57, 65, 68, 72, 83, 86, 89, 92, 93, 95, 103, 105, 106, 107, 109, 111, 113, 117, 127, 130, 133, 139, 142, 150, 152, 159, 162, 166, 175, 180, 181, 182, 183, 185, 187, 190, 191, 193, 195, 197, 198, 200, 202, 206, 213, 216, 221, 223, 233, 237, 238, 241, 243, 246, 253, 256, 257, 258, 259, 261, 263, 265, 269, 274, 279, 283, 290, 293, 301, 302, 308, 310, 311, 313, 314, 316, 317, 319, 322, 323, 324, 325, 327, 329, 333, 334, 337, 339, 341, 344, 348, 349, 357, 359, 361, 367, 371, 376, 379, 382, 391, 396, 398, 400, 404, 410, 413, 424, 430, 433, 437, 446, 451, 455, 458, 465, 470, 480, 489, 500, 506, 508, 509, 510, 511, 513, 516, 517, 518, 519, 521, 522, 524, 525, 528, 537, 539, 550, 555, 560, 562, 563, 566, 568, 571, 578, 582, 586, 591, 594, 597, 604, 606, 610, 611, 612, 614, 615, 618, 620, 622, 625, 629, 631, 637, 643, 645, 647, 649, 659, 662, 670, 672, 674, 682, 691, 692, 694, 696, 701, 706, 707, 709, 716, 718, 719, 722, 728, 729, 739, 747, 750, 753, 765, 768, 777, 779, 780, 783, 785, 788, 795, 799, 806, 810, 813, 818, 819]	[1, 8, 11, 20, 29, 34, 39, 49, 53, 56, 64, 67, 71, 82, 85, 88, 91, 93, 94, 103, 104, 106, 107, 108, 111, 112, 116, 126, 129, 132, 138, 141, 150, 151, 158, 161, 165, 174, 179, 181, 182, 183, 185, 186, 189, 191, 193, 195, 196, 198, 200, 201, 205, 212, 215, 220, 222, 232, 236, 238, 241, 243, 246, 252, 255, 257, 258, 259, 261, 262, 265, 269, 273, 278, 282, 289, 292, 301, 302, 307, 310, 311, 312, 314, 316, 317, 318, 321, 323, 324, 325, 327, 328, 332, 334, 337, 339, 341, 344, 348, 349, 356, 359, 360, 366, 370, 376, 379, 381, 390, 395, 398, 399, 403, 409, 412, 423, 429, 432, 436, 445, 450, 454, 457, 464, 469, 479, 488, 499, 506, 507, 509, 510, 511, 512, 515, 517, 518, 519, 521, 522, 523, 525, 527, 537, 538, 549, 554, 559, 561, 563, 566, 568, 571, 577, 581, 585, 590, 593, 596, 604, 605, 609, 611, 612, 613, 615, 618, 620, 622, 625, 629, 630, 636, 643, 644, 647, 648, 658, 661, 669, 672, 673, 681, 690, 692, 694, 696, 700, 705, 707, 708, 715, 717, 719, 721, 728, 729, 738, 746, 749, 752, 764, 767, 777, 778, 780, 783, 785, 788, 794, 798, 806, 809, 812, 817, 819, 820]	['A', 'number', 'of', 'findings', 'indicate', 'that', 'this', 'mechanism', 'may', 'be', 'working', 'in', 'the', 'generation', 'of', 'MP', 'in', 'TI', 'patients', ':', '(i)', 'HMC', 'are', 'contained', 'in', 'MP', 'found', 'in', 'patients', '’', 'plasma', 'or', 'are', 'released', 'from', 'TI-RBC', 'in', 'vitro', ';', '(ii)', 'the', 'degree', 'of', 'band', '3', 'oxidation', 'and', 'phosphorylation', 'in', 'TI-RBC', 'correlates', 'with', 'the', 'amount', 'of', 'membrane', '-', 'bound', 'HMC', ';', '(iii)', 'in', 'TI-RBC', 'and', 'phenylhydrazine', '-', 'treated', 'RBC', 'there', 'was', 'microscopy', 'evidence', 'that', 'HMC', 'are', 'bound', 'to', 'protruding', 'areas', 'of', 'the', 'membrane', 'that', 'can', 'be', 'easily', 'shed', 'following', 'moderate', 'mechanical', 'stress', ';', '(iv)', 'in', 'TI-RBC', ',', 'Syk', 'inhibitors', 'diminished', 'both', 'band', '3', 'phosphorylation', 'and', 'the', 'rate', 'of', 'MP', 'release', ';', 'and', '(v)', 'phenylhydrazine', ',', 'which', 'induces', 'HMC', 'formation', 'in', 'control', 'RBC', 'without', 'directly', 'oxidizing', 'band', '3', ',', 'caused', 'a', 'Syk', 'kinase', '-', 'dependent', 'release', 'of', 'MP', 'accompanied', 'by', 'oxidation', ',', 'phosphorylation', 'and', 'clustering', 'of', 'band', '3', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 5, 1, 6, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 2, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 6, 1, 1, 2, 2, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR amplifications (in a volume of 50 µL) were performed using 1× FastStart High Fidelity Reaction Buffer, 1.8 mM MgCl2, 1 mM dNTP solution, 5 U FastStart High Fidelity Blend Polymerase (from the High Fidelity PCR System (Roche, Indianapolis, USA)), 0.2 µM reverse primer, 0.2 µM of the barcoded forward primer (unique for each sample) and 1 µL of template DNA.	[('PMC3946581', 'M08000', 175, 185, 'Polymerase')]	['PC', '##R', 'am', '##p', '##lification', '##s', '(', 'in', 'a', 'volume', 'of', '50', 'µ', '##L', ')', 'were', 'performed', 'using', '1', '##×', 'Fast', '##S', '##tar', '##t', 'High', 'Fi', '##delity', 'Re', '##action', 'B', '##uff', '##er', ',', '1', '.', '8', 'm', '##M', 'M', '##g', '##C', '##l', '##2', ',', '1', 'm', '##M', 'd', '##NT', '##P', 'solution', ',', '5', 'U', 'Fast', '##S', '##tar', '##t', 'High', 'Fi', '##delity', 'B', '##len', '##d', 'Pol', '##yme', '##rase', '(', 'from', 'the', 'High', 'Fi', '##delity', 'PC', '##R', 'System', '(', 'Roche', ',', 'Indianapolis', ',', 'USA', ')', ')', ',', '0', '.', '2', 'µ', '##M', 'reverse', 'prime', '##r', ',', '0', '.', '2', 'µ', '##M', 'of', 'the', 'bar', '##code', '##d', 'forward', 'prime', '##r', '(', 'unique', 'for', 'each', 'sample', ')', 'and', '1', 'µ', '##L', 'of', 'template', 'DNA', '.']	[0, 2, 4, 6, 7, 17, 19, 20, 23, 25, 32, 35, 38, 39, 40, 42, 47, 57, 63, 64, 66, 70, 71, 74, 76, 81, 83, 90, 92, 99, 100, 103, 105, 107, 108, 109, 111, 112, 114, 115, 116, 117, 118, 119, 121, 123, 124, 126, 127, 129, 131, 139, 141, 143, 145, 149, 150, 153, 155, 160, 162, 169, 170, 173, 175, 178, 181, 186, 187, 192, 196, 201, 203, 210, 212, 214, 221, 222, 227, 229, 241, 243, 246, 247, 248, 250, 251, 252, 254, 255, 257, 265, 270, 271, 273, 274, 275, 277, 278, 280, 283, 287, 290, 294, 296, 304, 309, 311, 312, 319, 323, 328, 334, 336, 340, 342, 343, 345, 348, 357, 360]	[2, 3, 6, 7, 17, 18, 20, 22, 24, 31, 34, 37, 39, 40, 41, 46, 56, 62, 64, 65, 70, 71, 74, 75, 80, 83, 89, 92, 98, 100, 103, 105, 106, 108, 109, 110, 112, 113, 115, 116, 117, 118, 119, 120, 122, 124, 125, 127, 129, 130, 139, 140, 142, 144, 149, 150, 153, 154, 159, 162, 168, 170, 173, 174, 178, 181, 185, 187, 191, 195, 200, 203, 209, 212, 213, 220, 222, 227, 228, 241, 242, 246, 247, 248, 249, 251, 252, 253, 255, 256, 264, 270, 271, 272, 274, 275, 276, 278, 279, 282, 286, 290, 294, 295, 303, 309, 310, 312, 318, 322, 327, 334, 335, 339, 341, 343, 344, 347, 356, 360, 361]	['PCR', 'amplifications', '(', 'in', 'a', 'volume', 'of', '50', 'µL', ')', 'were', 'performed', 'using', '1×', 'FastStart', 'High', 'Fidelity', 'Reaction', 'Buffer', ',', '1.8', 'mM', 'MgCl2', ',', '1', 'mM', 'dNTP', 'solution', ',', '5', 'U', 'FastStart', 'High', 'Fidelity', 'Blend', 'Polymerase', '(', 'from', 'the', 'High', 'Fidelity', 'PCR', 'System', '(', 'Roche', ',', 'Indianapolis', ',', 'USA', ')', ')', ',', '0.2', 'µM', 'reverse', 'primer', ',', '0.2', 'µM', 'of', 'the', 'barcoded', 'forward', 'primer', '(', 'unique', 'for', 'each', 'sample', ')', 'and', '1', 'µL', 'of', 'template', 'DNA', '.']	[2, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 4, 1, 2, 2, 3, 1, 3, 2, 5, 1, 1, 2, 3, 1, 1, 1, 1, 4, 1, 2, 3, 3, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 1, 3, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Only pyruvate carboxyl transferase (EC 6.4.1.1), and two forms of glyoxylate reductase (EC 1.1.1.26; EC 1.1.1.79) were found in lower abundance in the pre-NEC sample.	[('PMC3971604', 'D07000', 5, 34, 'pyruvate carboxyl transferase')]	['Only', 'p', '##yr', '##u', '##vate', 'car', '##box', '##yl', 'transfer', '##ase', '(', 'EC', '6', '.', '4', '.', '1', '.', '1', ')', ',', 'and', 'two', 'forms', 'of', 'g', '##ly', '##ox', '##yla', '##te', 'red', '##uc', '##tase', '(', 'EC', '1', '.', '1', '.', '1', '.', '26', ';', 'EC', '1', '.', '1', '.', '1', '.', '79', ')', 'were', 'found', 'in', 'lower', 'abundance', 'in', 'the', 'pre', '-', 'NE', '##C', 'sample', '.']	[0, 5, 6, 8, 9, 14, 17, 20, 23, 31, 35, 36, 39, 40, 41, 42, 43, 44, 45, 46, 47, 49, 53, 57, 63, 66, 67, 69, 71, 74, 77, 80, 82, 87, 88, 91, 92, 93, 94, 95, 96, 97, 99, 101, 104, 105, 106, 107, 108, 109, 110, 112, 114, 119, 125, 128, 134, 144, 147, 151, 154, 155, 157, 159, 165]	[4, 6, 8, 9, 13, 17, 20, 22, 31, 34, 36, 38, 40, 41, 42, 43, 44, 45, 46, 47, 48, 52, 56, 62, 65, 67, 69, 71, 74, 76, 80, 82, 86, 88, 90, 92, 93, 94, 95, 96, 97, 99, 100, 103, 105, 106, 107, 108, 109, 110, 112, 113, 118, 124, 127, 133, 143, 146, 150, 154, 155, 157, 158, 165, 166]	['Only', 'pyruvate', 'carboxyl', 'transferase', '(', 'EC', '6.4.1.1', ')', ',', 'and', 'two', 'forms', 'of', 'glyoxylate', 'reductase', '(', 'EC', '1.1.1.26', ';', 'EC', '1.1.1.79', ')', 'were', 'found', 'in', 'lower', 'abundance', 'in', 'the', 'pre-NEC', 'sample', '.']	[1, 4, 3, 2, 1, 1, 7, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 7, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pyruvate carboxyl transferase catalyzes the conversion of pyruvate to oxaloacetate while glyoxylate reductase is an enzyme in the oxalate synthesis pathway responsible for converting glyoxylate to glycolate [15].	[]	['P', '##yr', '##u', '##vate', 'car', '##box', '##yl', 'transfer', '##ase', 'cat', '##aly', '##zes', 'the', 'conversion', 'of', 'p', '##yr', '##u', '##vate', 'to', 'o', '##xa', '##lo', '##ace', '##tate', 'while', 'g', '##ly', '##ox', '##yla', '##te', 'red', '##uc', '##tase', 'is', 'an', 'enzyme', 'in', 'the', 'o', '##xa', '##late', 'synthesis', 'pathway', 'responsible', 'for', 'converting', 'g', '##ly', '##ox', '##yla', '##te', 'to', 'g', '##ly', '##cola', '##te', '[', '15', ']', '.']	[0, 1, 3, 4, 9, 12, 15, 18, 26, 30, 33, 36, 40, 44, 55, 58, 59, 61, 62, 67, 70, 71, 73, 75, 78, 83, 89, 90, 92, 94, 97, 100, 103, 105, 110, 113, 116, 123, 126, 130, 131, 133, 138, 148, 156, 168, 172, 183, 184, 186, 188, 191, 194, 197, 198, 200, 204, 207, 208, 210, 211]	[1, 3, 4, 8, 12, 15, 17, 26, 29, 33, 36, 39, 43, 54, 57, 59, 61, 62, 66, 69, 71, 73, 75, 78, 82, 88, 90, 92, 94, 97, 99, 103, 105, 109, 112, 115, 122, 125, 129, 131, 133, 137, 147, 155, 167, 171, 182, 184, 186, 188, 191, 193, 196, 198, 200, 204, 206, 208, 210, 211, 212]	['Pyruvate', 'carboxyl', 'transferase', 'catalyzes', 'the', 'conversion', 'of', 'pyruvate', 'to', 'oxaloacetate', 'while', 'glyoxylate', 'reductase', 'is', 'an', 'enzyme', 'in', 'the', 'oxalate', 'synthesis', 'pathway', 'responsible', 'for', 'converting', 'glyoxylate', 'to', 'glycolate', '[', '15', ']', '.']	[4, 3, 2, 3, 1, 1, 1, 4, 1, 5, 1, 5, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alterations in these gene sets may be markers of the health of the microbial community.	[]	['Alt', '##eration', '##s', 'in', 'these', 'gene', 'sets', 'may', 'be', 'markers', 'of', 'the', 'health', 'of', 'the', 'micro', '##bial', 'community', '.']	[0, 3, 10, 12, 15, 21, 26, 31, 35, 38, 46, 49, 53, 60, 63, 67, 72, 77, 86]	[3, 10, 11, 14, 20, 25, 30, 34, 37, 45, 48, 52, 59, 62, 66, 72, 76, 86, 87]	['Alterations', 'in', 'these', 'gene', 'sets', 'may', 'be', 'markers', 'of', 'the', 'health', 'of', 'the', 'microbial', 'community', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Additionally, a deficiency in glyoxylate reductase may result in increased levels of glyoxylate which has been shown to inhibit the interaction of the Vitamin D receptor (VDR) with vitamin D response elements (VDREs)	[]	['Additionally', ',', 'a', 'deficiency', 'in', 'g', '##ly', '##ox', '##yla', '##te', 'red', '##uc', '##tase', 'may', 'result', 'in', 'increased', 'levels', 'of', 'g', '##ly', '##ox', '##yla', '##te', 'which', 'has', 'been', 'shown', 'to', 'in', '##hibit', 'the', 'interaction', 'of', 'the', 'Vita', '##min', 'D', 'receptor', '(', 'V', '##DR', ')', 'with', 'vitamin', 'D', 'response', 'elements', '(', 'V', '##DR', '##Es', ')']	[0, 12, 14, 16, 27, 30, 31, 33, 35, 38, 41, 44, 46, 51, 55, 62, 65, 75, 82, 85, 86, 88, 90, 93, 96, 102, 106, 111, 117, 120, 122, 128, 132, 144, 147, 151, 155, 159, 161, 170, 171, 172, 174, 176, 181, 189, 191, 200, 209, 210, 211, 213, 215]	[12, 13, 15, 26, 29, 31, 33, 35, 38, 40, 44, 46, 50, 54, 61, 64, 74, 81, 84, 86, 88, 90, 93, 95, 101, 105, 110, 116, 119, 122, 127, 131, 143, 146, 150, 155, 158, 160, 169, 171, 172, 174, 175, 180, 188, 190, 199, 208, 210, 211, 213, 215, 216]	['Additionally', ',', 'a', 'deficiency', 'in', 'glyoxylate', 'reductase', 'may', 'result', 'in', 'increased', 'levels', 'of', 'glyoxylate', 'which', 'has', 'been', 'shown', 'to', 'inhibit', 'the', 'interaction', 'of', 'the', 'Vitamin', 'D', 'receptor', '(', 'VDR', ')', 'with', 'vitamin', 'D', 'response', 'elements', '(', 'VDREs', ')']	[1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, inspection of the taxonomic assignments of the annotated genes (via phylogenomic inference) across all four samples revealed a lower relative abundance of known SRBs when compared to the other three samples, indicating that a sulfide-mediated phenomenon may not be a key requirement for the onset of NEC.	[]	['However', ',', 'inspection', 'of', 'the', 'tax', '##ono', '##mic', 'assignments', 'of', 'the', 'an', '##not', '##ated', 'genes', '(', 'via', 'p', '##hyl', '##ogen', '##omi', '##c', 'in', '##ference', ')', 'across', 'all', 'four', 'samples', 'revealed', 'a', 'lower', 'relative', 'abundance', 'of', 'known', 'SR', '##B', '##s', 'when', 'compared', 'to', 'the', 'other', 'three', 'samples', ',', 'indicating', 'that', 'a', 'su', '##lf', '##ide', '-', 'mediated', 'phenomenon', 'may', 'not', 'be', 'a', 'key', 'requirement', 'for', 'the', 'onset', 'of', 'NE', '##C', '.']	[0, 7, 9, 20, 23, 27, 30, 33, 37, 49, 52, 56, 58, 61, 66, 72, 73, 77, 78, 81, 85, 88, 90, 92, 99, 101, 108, 112, 117, 125, 134, 136, 142, 151, 161, 164, 170, 172, 173, 175, 180, 189, 192, 196, 202, 208, 215, 217, 228, 233, 235, 237, 239, 242, 243, 252, 263, 267, 271, 274, 276, 280, 292, 296, 300, 306, 309, 311, 312]	[7, 8, 19, 22, 26, 30, 33, 36, 48, 51, 55, 58, 61, 65, 71, 73, 76, 78, 81, 85, 88, 89, 92, 99, 100, 107, 111, 116, 124, 133, 135, 141, 150, 160, 163, 169, 172, 173, 174, 179, 188, 191, 195, 201, 207, 215, 216, 227, 232, 234, 237, 239, 242, 243, 251, 262, 266, 270, 273, 275, 279, 291, 295, 299, 305, 308, 311, 312, 313]	['However', ',', 'inspection', 'of', 'the', 'taxonomic', 'assignments', 'of', 'the', 'annotated', 'genes', '(', 'via', 'phylogenomic', 'inference', ')', 'across', 'all', 'four', 'samples', 'revealed', 'a', 'lower', 'relative', 'abundance', 'of', 'known', 'SRBs', 'when', 'compared', 'to', 'the', 'other', 'three', 'samples', ',', 'indicating', 'that', 'a', 'sulfide', '-', 'mediated', 'phenomenon', 'may', 'not', 'be', 'a', 'key', 'requirement', 'for', 'the', 'onset', 'of', 'NEC', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 5, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of the cofactors, vitamins, prosthetic groups, and pigment subsystems represented within the Group A of higher abundance genes detected in the pre-NEC sample, two sets were associated with tetrapyrroles (specifically heme and siroheme biosynthesis; precorrin-2 oxidase [EC 1.3.1.76] and sirohydrochlorin ferrochelatase [EC 4.99.1.4]) while the third was associated with folate and pterines (YgfZ; S-(hydroxymethyl)glutathione dehydrogenase [EC 1.1.1.284]).	[('PMC3971604', 'R08000', 249, 268, 'precorrin-2 oxidase')]	['Of', 'the', 'co', '##fa', '##ctors', ',', 'vitamin', '##s', ',', 'pro', '##st', '##hetic', 'groups', ',', 'and', 'pig', '##ment', 'sub', '##sy', '##ste', '##ms', 'represented', 'within', 'the', 'Group', 'A', 'of', 'higher', 'abundance', 'genes', 'detected', 'in', 'the', 'pre', '-', 'NE', '##C', 'sample', ',', 'two', 'sets', 'were', 'associated', 'with', 'te', '##tra', '##py', '##rro', '##les', '(', 'specifically', 'hem', '##e', 'and', 'sir', '##oh', '##em', '##e', 'bio', '##sy', '##nt', '##hesis', ';', 'pre', '##cor', '##rin', '-', '2', 'o', '##xi', '##das', '##e', '[', 'EC', '1', '.', '3', '.', '1', '.', '76', ']', 'and', 'sir', '##oh', '##ydro', '##ch', '##lor', '##in', 'f', '##er', '##ro', '##chel', '##ata', '##se', '[', 'EC', '4', '.', '99', '.', '1', '.', '4', ']', ')', 'while', 'the', 'third', 'was', 'associated', 'with', 'f', '##olate', 'and', 'p', '##ter', '##ines', '(', 'Y', '##g', '##f', '##Z', ';', 'S', '-', '(', 'h', '##ydro', '##xy', '##met', '##hyl', ')', 'g', '##lut', '##ath', '##ione', 'de', '##hy', '##dr', '##ogen', '##ase', '[', 'EC', '1', '.', '1', '.', '1', '.', '28', '##4', ']', ')', '.']	[0, 3, 7, 9, 11, 16, 18, 25, 26, 28, 31, 33, 39, 45, 47, 51, 54, 59, 62, 64, 67, 70, 82, 89, 93, 99, 101, 104, 111, 121, 127, 136, 139, 143, 146, 147, 149, 151, 157, 159, 163, 168, 173, 184, 189, 191, 194, 196, 199, 203, 204, 217, 220, 222, 226, 229, 231, 233, 235, 238, 240, 242, 247, 249, 252, 255, 258, 259, 261, 262, 264, 267, 269, 270, 273, 274, 275, 276, 277, 278, 279, 281, 283, 287, 290, 292, 296, 298, 301, 304, 305, 307, 309, 313, 316, 319, 320, 323, 324, 325, 327, 328, 329, 330, 331, 332, 334, 340, 344, 350, 354, 365, 370, 371, 377, 381, 382, 385, 390, 391, 392, 393, 394, 395, 397, 398, 399, 400, 401, 405, 407, 410, 413, 414, 415, 418, 421, 426, 428, 430, 432, 436, 440, 441, 444, 445, 446, 447, 448, 449, 450, 452, 453, 454, 455]	[2, 6, 9, 11, 16, 17, 25, 26, 27, 31, 33, 38, 45, 46, 50, 54, 58, 62, 64, 67, 69, 81, 88, 92, 98, 100, 103, 110, 120, 126, 135, 138, 142, 146, 147, 149, 150, 157, 158, 162, 167, 172, 183, 188, 191, 194, 196, 199, 202, 204, 216, 220, 221, 225, 229, 231, 233, 234, 238, 240, 242, 247, 248, 252, 255, 258, 259, 260, 262, 264, 267, 268, 270, 272, 274, 275, 276, 277, 278, 279, 281, 282, 286, 290, 292, 296, 298, 301, 303, 305, 307, 309, 313, 316, 318, 320, 322, 324, 325, 327, 328, 329, 330, 331, 332, 333, 339, 343, 349, 353, 364, 369, 371, 376, 380, 382, 385, 389, 391, 392, 393, 394, 395, 396, 398, 399, 400, 401, 405, 407, 410, 413, 414, 415, 418, 421, 425, 428, 430, 432, 436, 439, 441, 443, 445, 446, 447, 448, 449, 450, 452, 453, 454, 455, 456]	['Of', 'the', 'cofactors', ',', 'vitamins', ',', 'prosthetic', 'groups', ',', 'and', 'pigment', 'subsystems', 'represented', 'within', 'the', 'Group', 'A', 'of', 'higher', 'abundance', 'genes', 'detected', 'in', 'the', 'pre-NEC', 'sample', ',', 'two', 'sets', 'were', 'associated', 'with', 'tetrapyrroles', '(', 'specifically', 'heme', 'and', 'siroheme', 'biosynthesis', ';', 'precorrin-2', 'oxidase', '[', 'EC', '1.3.1.76', ']', 'and', 'sirohydrochlorin', 'ferrochelatase', '[', 'EC', '4.99.1.4', ']', ')', 'while', 'the', 'third', 'was', 'associated', 'with', 'folate', 'and', 'pterines', '(', 'YgfZ', ';', 'S-(hydroxymethyl)glutathione', 'dehydrogenase', '[', 'EC', '1.1.1.284', ']', ')', '.']	[1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 4, 4, 1, 5, 4, 1, 1, 7, 1, 1, 6, 6, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 4, 1, 13, 5, 1, 1, 8, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Within the Group C set of higher abundance genes only those identified as pyridoxine related were detected (pyridoxine (Vitamin B6) biosynthesis; 4-hydroxythreonine-4-phosphate dehydrogenase [EC 1.1.1.262]).	[('PMC3971604', 'R08001', 146, 190, '4-hydroxythreonine-4-phosphate dehydrogenase')]	['Within', 'the', 'Group', 'C', 'set', 'of', 'higher', 'abundance', 'genes', 'only', 'those', 'identified', 'as', 'p', '##yr', '##ido', '##xin', '##e', 'related', 'were', 'detected', '(', 'p', '##yr', '##ido', '##xin', '##e', '(', 'Vita', '##min', 'B', '##6', ')', 'bio', '##sy', '##nt', '##hesis', ';', '4', '-', 'h', '##ydro', '##xy', '##th', '##re', '##oni', '##ne', '-', '4', '-', 'phosphate', 'de', '##hy', '##dr', '##ogen', '##ase', '[', 'EC', '1', '.', '1', '.', '1', '.', '262', ']', ')', '.']	[0, 7, 11, 17, 19, 23, 26, 33, 43, 49, 54, 60, 71, 74, 75, 77, 80, 83, 85, 93, 98, 107, 108, 109, 111, 114, 117, 119, 120, 124, 128, 129, 130, 132, 135, 137, 139, 144, 146, 147, 148, 149, 153, 155, 157, 159, 162, 164, 165, 166, 167, 177, 179, 181, 183, 187, 191, 192, 195, 196, 197, 198, 199, 200, 201, 204, 205, 206]	[6, 10, 16, 18, 22, 25, 32, 42, 48, 53, 59, 70, 73, 75, 77, 80, 83, 84, 92, 97, 106, 108, 109, 111, 114, 117, 118, 120, 124, 127, 129, 130, 131, 135, 137, 139, 144, 145, 147, 148, 149, 153, 155, 157, 159, 162, 164, 165, 166, 167, 176, 179, 181, 183, 187, 190, 192, 194, 196, 197, 198, 199, 200, 201, 204, 205, 206, 207]	['Within', 'the', 'Group', 'C', 'set', 'of', 'higher', 'abundance', 'genes', 'only', 'those', 'identified', 'as', 'pyridoxine', 'related', 'were', 'detected', '(', 'pyridoxine', '(', 'Vitamin', 'B6', ')', 'biosynthesis', ';', '4-hydroxythreonine-4-phosphate', 'dehydrogenase', '[', 'EC', '1.1.1.262', ']', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 5, 1, 2, 2, 1, 4, 1, 13, 5, 1, 1, 7, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacterial community composition in isolated DNA samples was characterized by amplification of the V1-3 (forward, 8f:5′-AGAGTTTGATCMTGGCTCAG-3′; reverse 518r: 5′-ATTACCGCGGCTGCTGG-3′) and V6 (forward, 8f:5′-AGGATTAGATACCCTGGTA-3′; reverse 518r: 5′-CRRCACGAGCTGACGAC-3′) variable regions of the 16S rRNA gene by polymerase chain reaction (PCR).	[('PMC3975596', 'M04000', 310, 320, 'polymerase')]	['Ba', '##cter', '##ial', 'community', 'composition', 'in', 'isolated', 'DNA', 'samples', 'was', 'characterized', 'by', 'am', '##p', '##lification', 'of', 'the', 'V', '##1', '-', '3', '(', 'forward', ',', '8', '##f', ':', '5', '′', '-', 'AG', '##AG', '##TT', '##T', '##GA', '##TC', '##MT', '##G', '##GC', '##TC', '##AG', '-', '3', '′', ';', 'reverse', '51', '##8', '##r', ':', '5', '′', '-', 'AT', '##TA', '##CC', '##GC', '##G', '##GC', '##T', '##GC', '##T', '##G', '##G', '-', '3', '′', ')', 'and', 'V', '##6', '(', 'forward', ',', '8', '##f', ':', '5', '′', '-', 'AG', '##GA', '##TT', '##AG', '##AT', '##AC', '##CC', '##T', '##G', '##G', '##TA', '-', '3', '′', ';', 'reverse', '51', '##8', '##r', ':', '5', '′', '-', 'CR', '##RC', '##AC', '##GA', '##GC', '##T', '##GA', '##C', '##GA', '##C', '-', '3', '′', ')', 'variable', 'regions', 'of', 'the', '16', '##S', 'r', '##RNA', 'gene', 'by', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', '.']	[0, 2, 6, 10, 20, 32, 35, 44, 48, 56, 60, 74, 77, 79, 80, 91, 94, 98, 99, 100, 101, 103, 104, 111, 113, 114, 115, 116, 117, 118, 119, 121, 123, 125, 126, 128, 130, 132, 133, 135, 137, 139, 140, 141, 142, 144, 152, 154, 155, 156, 158, 159, 160, 161, 163, 165, 167, 169, 170, 172, 173, 175, 176, 177, 178, 179, 180, 181, 183, 187, 188, 190, 191, 198, 200, 201, 202, 203, 204, 205, 206, 208, 210, 212, 214, 216, 218, 220, 221, 222, 223, 225, 226, 227, 228, 230, 238, 240, 241, 242, 244, 245, 246, 247, 249, 251, 253, 255, 257, 258, 260, 261, 263, 264, 265, 266, 267, 269, 278, 286, 289, 293, 295, 297, 298, 302, 307, 310, 317, 321, 327, 336, 337, 339, 340, 341]	[2, 6, 9, 19, 31, 34, 43, 47, 55, 59, 73, 76, 79, 80, 90, 93, 97, 99, 100, 101, 102, 104, 111, 112, 114, 115, 116, 117, 118, 119, 121, 123, 125, 126, 128, 130, 132, 133, 135, 137, 139, 140, 141, 142, 143, 151, 154, 155, 156, 157, 159, 160, 161, 163, 165, 167, 169, 170, 172, 173, 175, 176, 177, 178, 179, 180, 181, 182, 186, 188, 189, 191, 198, 199, 201, 202, 203, 204, 205, 206, 208, 210, 212, 214, 216, 218, 220, 221, 222, 223, 225, 226, 227, 228, 229, 237, 240, 241, 242, 243, 245, 246, 247, 249, 251, 253, 255, 257, 258, 260, 261, 263, 264, 265, 266, 267, 268, 277, 285, 288, 292, 295, 296, 298, 301, 306, 309, 317, 320, 326, 335, 337, 339, 340, 341, 342]	['Bacterial', 'community', 'composition', 'in', 'isolated', 'DNA', 'samples', 'was', 'characterized', 'by', 'amplification', 'of', 'the', 'V1-3', '(', 'forward', ',', '8f', ':', '5′-AGAGTTTGATCMTGGCTCAG-3′', ';', 'reverse', '518r', ':', '5′-ATTACCGCGGCTGCTGG-3′', ')', 'and', 'V6', '(', 'forward', ',', '8f', ':', '5′-AGGATTAGATACCCTGGTA-3′', ';', 'reverse', '518r', ':', '5′-CRRCACGAGCTGACGAC-3′', ')', 'variable', 'regions', 'of', 'the', '16S', 'rRNA', 'gene', 'by', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 2, 1, 17, 1, 1, 3, 1, 17, 1, 1, 2, 1, 1, 1, 2, 1, 17, 1, 1, 3, 1, 16, 1, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Conclusions: Our results suggest that some genes previously identified as influencing lung function are independently associated with emphysema rather than lung function, and that genes related to α-mannosidase may influence risk of emphysema.	[('PMC3977717', 'A04000', 197, 210, 'α-mannosidase')]	['Con', '##c', '##lusion', '##s', ':', 'Our', 'results', 'suggest', 'that', 'some', 'genes', 'previously', 'identified', 'as', 'in', '##f', '##lue', '##ncing', 'lung', 'function', 'are', 'independently', 'associated', 'with', 'em', '##phy', '##se', '##ma', 'rather', 'than', 'lung', 'function', ',', 'and', 'that', 'genes', 'related', 'to', 'α', '-', 'man', '##nos', '##idas', '##e', 'may', 'influence', 'risk', 'of', 'em', '##phy', '##se', '##ma', '.']	[0, 3, 4, 10, 11, 13, 17, 25, 33, 38, 43, 49, 60, 71, 74, 76, 77, 80, 86, 91, 100, 104, 118, 129, 134, 136, 139, 141, 144, 151, 156, 161, 169, 171, 175, 180, 186, 194, 197, 198, 199, 202, 205, 209, 211, 215, 225, 230, 233, 235, 238, 240, 242]	[3, 4, 10, 11, 12, 16, 24, 32, 37, 42, 48, 59, 70, 73, 76, 77, 80, 85, 90, 99, 103, 117, 128, 133, 136, 139, 141, 143, 150, 155, 160, 169, 170, 174, 179, 185, 193, 196, 198, 199, 202, 205, 209, 210, 214, 224, 229, 232, 235, 238, 240, 242, 243]	['Conclusions', ':', 'Our', 'results', 'suggest', 'that', 'some', 'genes', 'previously', 'identified', 'as', 'influencing', 'lung', 'function', 'are', 'independently', 'associated', 'with', 'emphysema', 'rather', 'than', 'lung', 'function', ',', 'and', 'that', 'genes', 'related', 'to', 'α-mannosidase', 'may', 'influence', 'risk', 'of', 'emphysema', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, DHX15 is an ATP-dependent RNA helicase that plays a regulatory role in pre-mRNA splicing and has been shown to interact with RBM15 (47), a gene in the 3p21.3 genetic locus for breast and lung cancers (48, 49).	[('PMC3977717', 'D04000', 25, 51, 'ATP-dependent RNA helicase')]	['In', 'addition', ',', 'D', '##H', '##X', '##15', 'is', 'an', 'ATP', '-', 'dependent', 'RNA', 'he', '##lica', '##se', 'that', 'plays', 'a', 'regulatory', 'role', 'in', 'pre', '-', 'm', '##RNA', 's', '##p', '##licing', 'and', 'has', 'been', 'shown', 'to', 'interact', 'with', 'RB', '##M', '##15', '(', '47', ')', ',', 'a', 'gene', 'in', 'the', '3', '##p', '##21', '.', '3', 'genetic', 'lo', '##cus', 'for', 'breast', 'and', 'lung', 'cancer', '##s', '(', '48', ',', '49', ')', '.']	[0, 3, 11, 13, 14, 15, 16, 19, 22, 25, 28, 29, 39, 43, 45, 49, 52, 57, 63, 65, 76, 81, 84, 87, 88, 89, 93, 94, 95, 102, 106, 110, 115, 121, 124, 133, 138, 140, 141, 144, 145, 147, 148, 150, 152, 157, 160, 164, 165, 166, 168, 169, 171, 179, 181, 185, 189, 196, 200, 205, 211, 213, 214, 216, 218, 220, 221]	[2, 11, 12, 14, 15, 16, 18, 21, 24, 28, 29, 38, 42, 45, 49, 51, 56, 62, 64, 75, 80, 83, 87, 88, 89, 92, 94, 95, 101, 105, 109, 114, 120, 123, 132, 137, 140, 141, 143, 145, 147, 148, 149, 151, 156, 159, 163, 165, 166, 168, 169, 170, 178, 181, 184, 188, 195, 199, 204, 211, 212, 214, 216, 217, 220, 221, 222]	['In', 'addition', ',', 'DHX15', 'is', 'an', 'ATP-dependent', 'RNA', 'helicase', 'that', 'plays', 'a', 'regulatory', 'role', 'in', 'pre-mRNA', 'splicing', 'and', 'has', 'been', 'shown', 'to', 'interact', 'with', 'RBM15', '(', '47', ')', ',', 'a', 'gene', 'in', 'the', '3p21.3', 'genetic', 'locus', 'for', 'breast', 'and', 'lung', 'cancers', '(', '48', ',', '49', ')', '.']	[1, 1, 1, 4, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The MAN2B1 SNP rs10411619 minor allele (C) is somewhat common in Hispanics (minor allele frequency [MAF], 4.4%) and African Americans (MAF, 20.6%) but quite rare in the other race/ethnic groups (MAF < 1%) (Table 3).	[]	['The', 'MA', '##N', '##2', '##B', '##1', 'S', '##NP', 'r', '##s', '##10', '##41', '##16', '##19', 'minor', 'all', '##ele', '(', 'C', ')', 'is', 'somewhat', 'common', 'in', 'Hispanic', '##s', '(', 'minor', 'all', '##ele', 'frequency', '[', 'MA', '##F', ']', ',', '4', '.', '4', '%', ')', 'and', 'African', 'Americans', '(', 'MA', '##F', ',', '20', '.', '6', '%', ')', 'but', 'quite', 'rare', 'in', 'the', 'other', 'race', '/', 'ethnic', 'groups', '(', 'MA', '##F', '<', '1', '%', ')', '(', 'Table', '3', ')', '.']	[0, 4, 6, 7, 8, 9, 11, 12, 15, 16, 17, 19, 21, 23, 26, 32, 35, 39, 40, 41, 43, 46, 55, 62, 65, 73, 75, 76, 82, 85, 89, 99, 100, 102, 103, 104, 106, 107, 108, 109, 110, 112, 116, 124, 134, 135, 137, 138, 140, 142, 143, 144, 145, 147, 151, 157, 162, 165, 169, 175, 179, 180, 187, 194, 195, 197, 199, 201, 202, 203, 205, 206, 212, 213, 214]	[3, 6, 7, 8, 9, 10, 12, 14, 16, 17, 19, 21, 23, 25, 31, 35, 38, 40, 41, 42, 45, 54, 61, 64, 73, 74, 76, 81, 85, 88, 98, 100, 102, 103, 104, 105, 107, 108, 109, 110, 111, 115, 123, 133, 135, 137, 138, 139, 142, 143, 144, 145, 146, 150, 156, 161, 164, 168, 174, 179, 180, 186, 193, 195, 197, 198, 200, 202, 203, 204, 206, 211, 213, 214, 215]	['The', 'MAN2B1', 'SNP', 'rs10411619', 'minor', 'allele', '(', 'C', ')', 'is', 'somewhat', 'common', 'in', 'Hispanics', '(', 'minor', 'allele', 'frequency', '[', 'MAF', ']', ',', '4.4%', ')', 'and', 'African', 'Americans', '(', 'MAF', ',', '20.6%', ')', 'but', 'quite', 'rare', 'in', 'the', 'other', 'race', '/', 'ethnic', 'groups', '(', 'MAF', '<', '1%', ')', '(', 'Table', '3', ')', '.']	[1, 5, 2, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
α-Mannosidase degrades mannose but also accelerates degradation of A1AT (42).	[('PMC3977717', 'R14000', 0, 13, 'α-Mannosidase')]	['α', '-', 'Mann', '##os', '##idas', '##e', 'de', '##grade', '##s', 'man', '##nose', 'but', 'also', 'accelerate', '##s', 'degradation', 'of', 'A1', '##AT', '(', '42', ')', '.']	[0, 1, 2, 6, 8, 12, 14, 16, 21, 23, 26, 31, 35, 40, 50, 52, 64, 67, 69, 72, 73, 75, 76]	[1, 2, 6, 8, 12, 13, 16, 21, 22, 26, 30, 34, 39, 50, 51, 63, 66, 69, 71, 73, 75, 76, 77]	['α-Mannosidase', 'degrades', 'mannose', 'but', 'also', 'accelerates', 'degradation', 'of', 'A1AT', '(', '42', ')', '.']	[6, 3, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Altered α-mannosidase isoenzymes have been reported in individuals carrying rare severe deficiency mutations (PiZZ) associated with A1AT deficiency (43) and mutations in an α-mannosidase–related gene have been implicated in the onset of end-stage liver disease in individuals with PiZZ (44).	[('PMC3977717', 'R14001', 8, 21, 'α-mannosidase')]	['Alt', '##ered', 'α', '-', 'man', '##nos', '##idas', '##e', 'is', '##oe', '##nz', '##yme', '##s', 'have', 'been', 'reported', 'in', 'individuals', 'carrying', 'rare', 'severe', 'deficiency', 'mutations', '(', 'Pi', '##Z', '##Z', ')', 'associated', 'with', 'A1', '##AT', 'deficiency', '(', '43', ')', 'and', 'mutations', 'in', 'an', 'α', '-', 'man', '##nos', '##idas', '##e', '–', 'related', 'gene', 'have', 'been', 'implicated', 'in', 'the', 'onset', 'of', 'end', '-', 'stage', 'liver', 'disease', 'in', 'individuals', 'with', 'Pi', '##Z', '##Z', '(', '44', ')', '.']	[0, 3, 8, 9, 10, 13, 16, 20, 22, 24, 26, 28, 31, 33, 38, 43, 52, 55, 67, 76, 81, 88, 99, 109, 110, 112, 113, 114, 116, 127, 132, 134, 137, 148, 149, 151, 153, 157, 167, 170, 173, 174, 175, 178, 181, 185, 186, 187, 195, 200, 205, 210, 221, 224, 228, 234, 237, 240, 241, 247, 253, 261, 264, 276, 281, 283, 284, 286, 287, 289, 290]	[3, 7, 9, 10, 13, 16, 20, 21, 24, 26, 28, 31, 32, 37, 42, 51, 54, 66, 75, 80, 87, 98, 108, 110, 112, 113, 114, 115, 126, 131, 134, 136, 147, 149, 151, 152, 156, 166, 169, 172, 174, 175, 178, 181, 185, 186, 187, 194, 199, 204, 209, 220, 223, 227, 233, 236, 240, 241, 246, 252, 260, 263, 275, 280, 283, 284, 285, 287, 289, 290, 291]	['Altered', 'α-mannosidase', 'isoenzymes', 'have', 'been', 'reported', 'in', 'individuals', 'carrying', 'rare', 'severe', 'deficiency', 'mutations', '(', 'PiZZ', ')', 'associated', 'with', 'A1AT', 'deficiency', '(', '43', ')', 'and', 'mutations', 'in', 'an', 'α-mannosidase–', 'related', 'gene', 'have', 'been', 'implicated', 'in', 'the', 'onset', 'of', 'end', '-', 'stage', 'liver', 'disease', 'in', 'individuals', 'with', 'PiZZ', '(', '44', ')', '.']	[2, 6, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The parasite nicotinamidase and NMNAT exhibit transcriptional peaks around 20 and 40 hours post invasion, while the nicotinate phosphoribosyltransferase and NAD+ synthase enzymes are maximally transcribed between 25–28 hours.	[]	['The', 'parasite', 'ni', '##cot', '##ina', '##mi', '##das', '##e', 'and', 'N', '##M', '##NA', '##T', 'exhibit', 'transcription', '##al', 'peaks', 'around', '20', 'and', '40', 'hours', 'post', 'invasion', ',', 'while', 'the', 'ni', '##cot', '##inate', 'p', '##hos', '##ph', '##ori', '##bos', '##yl', '##tra', '##ns', '##fer', '##ase', 'and', 'N', '##AD', '+', 's', '##ynth', '##ase', 'enzymes', 'are', 'ma', '##ximal', '##ly', 'trans', '##cribed', 'between', '25', '–', '28', 'hours', '.']	[0, 4, 13, 15, 18, 21, 23, 26, 28, 32, 33, 34, 36, 38, 46, 59, 62, 68, 75, 78, 82, 85, 91, 96, 104, 106, 112, 116, 118, 121, 127, 128, 131, 133, 136, 139, 141, 144, 146, 149, 153, 157, 158, 160, 162, 163, 167, 171, 179, 183, 185, 190, 193, 198, 205, 213, 215, 216, 219, 224]	[3, 12, 15, 18, 21, 23, 26, 27, 31, 33, 34, 36, 37, 45, 59, 61, 67, 74, 77, 81, 84, 90, 95, 104, 105, 111, 115, 118, 121, 126, 128, 131, 133, 136, 139, 141, 144, 146, 149, 152, 156, 158, 160, 161, 163, 167, 170, 178, 182, 185, 190, 192, 198, 204, 212, 215, 216, 218, 224, 225]	['The', 'parasite', 'nicotinamidase', 'and', 'NMNAT', 'exhibit', 'transcriptional', 'peaks', 'around', '20', 'and', '40', 'hours', 'post', 'invasion', ',', 'while', 'the', 'nicotinate', 'phosphoribosyltransferase', 'and', 'NAD+', 'synthase', 'enzymes', 'are', 'maximally', 'transcribed', 'between', '25–', '28', 'hours', '.']	[1, 1, 6, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 10, 1, 3, 3, 1, 1, 3, 2, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although it has been proposed [41] that NAD+ synthesis would peak with NAD+ synthase expression, we observe steady NAD+ production throughout the IDC.	[]	['Although', 'it', 'has', 'been', 'proposed', '[', '41', ']', 'that', 'N', '##AD', '+', 'synthesis', 'would', 'peak', 'with', 'N', '##AD', '+', 's', '##ynth', '##ase', 'expression', ',', 'we', 'observe', 'steady', 'N', '##AD', '+', 'production', 'throughout', 'the', 'ID', '##C', '.']	[0, 9, 12, 16, 21, 30, 31, 33, 35, 40, 41, 43, 45, 55, 61, 66, 71, 72, 74, 76, 77, 81, 85, 95, 97, 100, 108, 115, 116, 118, 120, 131, 142, 146, 148, 149]	[8, 11, 15, 20, 29, 31, 33, 34, 39, 41, 43, 44, 54, 60, 65, 70, 72, 74, 75, 77, 81, 84, 95, 96, 99, 107, 114, 116, 118, 119, 130, 141, 145, 148, 149, 150]	['Although', 'it', 'has', 'been', 'proposed', '[', '41', ']', 'that', 'NAD+', 'synthesis', 'would', 'peak', 'with', 'NAD+', 'synthase', 'expression', ',', 'we', 'observe', 'steady', 'NAD+', 'production', 'throughout', 'the', 'IDC', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is likely necessary to maintain NAD+ pools to replace the NAD+ that is lost to turnover and provides a sufficient increase in total NAD+ required for the development of new merozoites.	[]	['This', 'is', 'likely', 'necessary', 'to', 'maintain', 'N', '##AD', '+', 'pools', 'to', 'replace', 'the', 'N', '##AD', '+', 'that', 'is', 'lost', 'to', 'turnover', 'and', 'provides', 'a', 'sufficient', 'increase', 'in', 'total', 'N', '##AD', '+', 'required', 'for', 'the', 'development', 'of', 'new', 'me', '##ro', '##zo', '##ites', '.']	[0, 5, 8, 15, 25, 28, 37, 38, 40, 42, 48, 51, 59, 63, 64, 66, 68, 73, 76, 81, 84, 93, 97, 106, 108, 119, 128, 131, 137, 138, 140, 142, 151, 155, 159, 171, 174, 178, 180, 182, 184, 188]	[4, 7, 14, 24, 27, 36, 38, 40, 41, 47, 50, 58, 62, 64, 66, 67, 72, 75, 80, 83, 92, 96, 105, 107, 118, 127, 130, 136, 138, 140, 141, 150, 154, 158, 170, 173, 177, 180, 182, 184, 188, 189]	['This', 'is', 'likely', 'necessary', 'to', 'maintain', 'NAD+', 'pools', 'to', 'replace', 'the', 'NAD+', 'that', 'is', 'lost', 'to', 'turnover', 'and', 'provides', 'a', 'sufficient', 'increase', 'in', 'total', 'NAD+', 'required', 'for', 'the', 'development', 'of', 'new', 'merozoites', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NaMN adenylyltransferase reaction: NaMN+ATP→NaAD++PPi	[('PMC3991606', 'M08000', 5, 24, 'adenylyltransferase')]	['Na', '##M', '##N', 'ad', '##en', '##yl', '##yl', '##tra', '##ns', '##fer', '##ase', 'reaction', ':', 'Na', '##M', '##N', '+', 'ATP', '##→', '##N', '##a', '##AD', '+', '+', 'PP', '##i']	[0, 2, 3, 5, 7, 9, 11, 13, 16, 18, 21, 25, 33, 35, 37, 38, 39, 40, 43, 44, 45, 46, 48, 49, 50, 52]	[2, 3, 4, 7, 9, 11, 13, 16, 18, 21, 24, 33, 34, 37, 38, 39, 40, 43, 44, 45, 46, 48, 49, 50, 52, 53]	['NaMN', 'adenylyltransferase', 'reaction', ':', 'NaMN', '+', 'ATP→NaAD', '+', '+PPi']	[3, 8, 1, 1, 3, 1, 5, 1, 3]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inorganic pyrophosphatase reaction: PPi+H2O→2Pi	[('PMC3991606', 'M09000', 10, 25, 'pyrophosphatase')]	['In', '##or', '##gan', '##ic', 'p', '##yr', '##op', '##hos', '##pha', '##tase', 'reaction', ':', 'PP', '##i', '+', 'H', '##2', '##O', '##→', '##2', '##P', '##i']	[0, 2, 4, 7, 10, 11, 13, 15, 18, 21, 26, 34, 36, 38, 39, 40, 41, 42, 43, 44, 45, 46]	[2, 4, 7, 9, 11, 13, 15, 18, 21, 25, 34, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47]	['Inorganic', 'pyrophosphatase', 'reaction', ':', 'PPi', '+', 'H2O→2Pi']	[4, 6, 1, 1, 2, 1, 7]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To demonstrate that the predicted PfNMNAT (PF13_0159) was functional we established a discontinuous in vitro assay to measure the adenylyltransferase activity using purified recombinant His6×-tagged protein (Figure 3A).	[('PMC3991606', 'R04000', 130, 149, 'adenylyltransferase')]	['To', 'demonstrate', 'that', 'the', 'predicted', 'P', '##f', '##N', '##M', '##NA', '##T', '(', 'P', '##F', '##13', '_', '01', '##5', '##9', ')', 'was', 'functional', 'we', 'established', 'a', 'disco', '##ntin', '##uous', 'in', 'v', '##it', '##ro', 'ass', '##ay', 'to', 'measure', 'the', 'ad', '##en', '##yl', '##yl', '##tra', '##ns', '##fer', '##ase', 'activity', 'using', 'pu', '##rified', 're', '##comb', '##ina', '##nt', 'His', '##6', '##×', '-', 'tag', '##ged', 'protein', '(', 'Figure', '3', '##A', ')', '.']	[0, 3, 15, 20, 24, 34, 35, 36, 37, 38, 40, 42, 43, 44, 45, 47, 48, 50, 51, 52, 54, 58, 69, 72, 84, 86, 91, 95, 100, 103, 104, 106, 109, 112, 115, 118, 126, 130, 132, 134, 136, 138, 141, 143, 146, 150, 159, 165, 167, 174, 176, 180, 183, 186, 189, 190, 191, 192, 195, 199, 207, 208, 215, 216, 217, 218]	[2, 14, 19, 23, 33, 35, 36, 37, 38, 40, 41, 43, 44, 45, 47, 48, 50, 51, 52, 53, 57, 68, 71, 83, 85, 91, 95, 99, 102, 104, 106, 108, 112, 114, 117, 125, 129, 132, 134, 136, 138, 141, 143, 146, 149, 158, 164, 167, 173, 176, 180, 183, 185, 189, 190, 191, 192, 195, 198, 206, 208, 214, 216, 217, 218, 219]	['To', 'demonstrate', 'that', 'the', 'predicted', 'PfNMNAT', '(', 'PF13_0159', ')', 'was', 'functional', 'we', 'established', 'a', 'discontinuous', 'in', 'vitro', 'assay', 'to', 'measure', 'the', 'adenylyltransferase', 'activity', 'using', 'purified', 'recombinant', 'His6×-tagged', 'protein', '(', 'Figure', '3A', ')', '.']	[1, 1, 1, 1, 1, 6, 1, 7, 1, 1, 1, 1, 1, 1, 3, 1, 3, 2, 1, 1, 1, 8, 1, 1, 2, 4, 6, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The strongest association evidence we observed was between variants in ADAMTS16 (ADAM metallopeptidase with thrombospondin type 1 motif, 16) and physical health-related quality of life (PCS) (p=5.87 × 10−8).	[('PMC4019336', 'D02000', 86, 102, 'metallopeptidase')]	['The', 'strongest', 'association', 'evidence', 'we', 'observed', 'was', 'between', 'variants', 'in', 'AD', '##AM', '##TS', '##16', '(', 'AD', '##AM', 'metal', '##lop', '##ept', '##idas', '##e', 'with', 'th', '##rom', '##bos', '##po', '##ndi', '##n', 'type', '1', 'motif', ',', '16', ')', 'and', 'physical', 'health', '-', 'related', 'quality', 'of', 'life', '(', 'PC', '##S', ')', '(', 'p', '=', '5', '.', '87', '×', '10', '##−', '##8', ')', '.']	[0, 4, 14, 26, 35, 38, 47, 51, 59, 68, 71, 73, 75, 77, 80, 81, 83, 86, 91, 94, 97, 101, 103, 108, 110, 113, 116, 118, 121, 123, 128, 130, 135, 137, 139, 141, 145, 154, 160, 161, 169, 177, 180, 185, 186, 188, 189, 191, 192, 193, 194, 195, 196, 199, 201, 203, 204, 205, 206]	[3, 13, 25, 34, 37, 46, 50, 58, 67, 70, 73, 75, 77, 79, 81, 83, 85, 91, 94, 97, 101, 102, 107, 110, 113, 116, 118, 121, 122, 127, 129, 135, 136, 139, 140, 144, 153, 160, 161, 168, 176, 179, 184, 186, 188, 189, 190, 192, 193, 194, 195, 196, 198, 200, 203, 204, 205, 206, 207]	['The', 'strongest', 'association', 'evidence', 'we', 'observed', 'was', 'between', 'variants', 'in', 'ADAMTS16', '(', 'ADAM', 'metallopeptidase', 'with', 'thrombospondin', 'type', '1', 'motif', ',', '16', ')', 'and', 'physical', 'health', '-', 'related', 'quality', 'of', 'life', '(', 'PCS', ')', '(', 'p=5.87', '×', '10−8', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 5, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alpha-1-antitrypsin is an acute phase protein member of the serpin family that inhibits a wide variety of proteases and thereby protects tissues from enzymes of inflammatory cells, especially neutrophil elastase.	[]	['Alpha', '-', '1', '-', 'anti', '##try', '##ps', '##in', 'is', 'an', 'acute', 'phase', 'protein', 'member', 'of', 'the', 'se', '##rp', '##in', 'family', 'that', 'in', '##hibit', '##s', 'a', 'wide', 'variety', 'of', 'pro', '##te', '##ases', 'and', 'thereby', 'protects', 'tissues', 'from', 'enzymes', 'of', 'inflammatory', 'cells', ',', 'especially', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', '.']	[0, 5, 6, 7, 8, 12, 15, 17, 20, 23, 26, 32, 38, 46, 53, 56, 60, 62, 64, 67, 74, 79, 81, 86, 88, 90, 95, 103, 106, 109, 111, 116, 120, 128, 137, 145, 150, 158, 161, 174, 179, 181, 192, 194, 196, 199, 203, 205, 208, 211]	[5, 6, 7, 8, 12, 15, 17, 19, 22, 25, 31, 37, 45, 52, 55, 59, 62, 64, 66, 73, 78, 81, 86, 87, 89, 94, 102, 105, 109, 111, 115, 119, 127, 136, 144, 149, 157, 160, 173, 179, 180, 191, 194, 196, 199, 202, 205, 208, 211, 212]	['Alpha-1-antitrypsin', 'is', 'an', 'acute', 'phase', 'protein', 'member', 'of', 'the', 'serpin', 'family', 'that', 'inhibits', 'a', 'wide', 'variety', 'of', 'proteases', 'and', 'thereby', 'protects', 'tissues', 'from', 'enzymes', 'of', 'inflammatory', 'cells', ',', 'especially', 'neutrophil', 'elastase', '.']	[8, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is the first time that increased alpha-1-antitrypsin abundance in vitreous has been associated with AMD.	[]	['This', 'is', 'the', 'first', 'time', 'that', 'increased', 'alpha', '-', '1', '-', 'anti', '##try', '##ps', '##in', 'abundance', 'in', 'v', '##it', '##re', '##ous', 'has', 'been', 'associated', 'with', 'AM', '##D', '.']	[0, 5, 8, 12, 18, 23, 28, 38, 43, 44, 45, 46, 50, 53, 55, 58, 68, 71, 72, 74, 76, 80, 84, 89, 100, 105, 107, 108]	[4, 7, 11, 17, 22, 27, 37, 43, 44, 45, 46, 50, 53, 55, 57, 67, 70, 72, 74, 76, 79, 83, 88, 99, 104, 107, 108, 109]	['This', 'is', 'the', 'first', 'time', 'that', 'increased', 'alpha-1-antitrypsin', 'abundance', 'in', 'vitreous', 'has', 'been', 'associated', 'with', 'AMD', '.']	[1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 4, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In humans, prostaglandin H2-D isomerase catalyzes the conversion of prostaglandin H2 to prostaglandin D2, which functions as a neuromodulator and as a trophic factor in the central nervous system for fatty acid biosynthesis.	[('PMC4020801', 'D08000', 11, 39, 'prostaglandin H2-D isomerase')]	['In', 'humans', ',', 'pro', '##sta', '##g', '##land', '##in', 'H', '##2', '-', 'D', 'is', '##omer', '##ase', 'cat', '##aly', '##zes', 'the', 'conversion', 'of', 'pro', '##sta', '##g', '##land', '##in', 'H', '##2', 'to', 'pro', '##sta', '##g', '##land', '##in', 'D', '##2', ',', 'which', 'functions', 'as', 'a', 'ne', '##uro', '##mo', '##du', '##lator', 'and', 'as', 'a', 't', '##rop', '##hic', 'factor', 'in', 'the', 'central', 'nervous', 'system', 'for', 'fatty', 'acid', 'bio', '##sy', '##nt', '##hesis', '.']	[0, 3, 9, 11, 14, 17, 18, 22, 25, 26, 27, 28, 30, 32, 36, 40, 43, 46, 50, 54, 65, 68, 71, 74, 75, 79, 82, 83, 85, 88, 91, 94, 95, 99, 102, 103, 104, 106, 112, 122, 125, 127, 129, 132, 134, 136, 142, 146, 149, 151, 152, 155, 159, 166, 169, 173, 181, 189, 196, 200, 206, 211, 214, 216, 218, 223]	[2, 9, 10, 14, 17, 18, 22, 24, 26, 27, 28, 29, 32, 36, 39, 43, 46, 49, 53, 64, 67, 71, 74, 75, 79, 81, 83, 84, 87, 91, 94, 95, 99, 101, 103, 104, 105, 111, 121, 124, 126, 129, 132, 134, 136, 141, 145, 148, 150, 152, 155, 158, 165, 168, 172, 180, 188, 195, 199, 205, 210, 214, 216, 218, 223, 224]	['In', 'humans', ',', 'prostaglandin', 'H2-D', 'isomerase', 'catalyzes', 'the', 'conversion', 'of', 'prostaglandin', 'H2', 'to', 'prostaglandin', 'D2', ',', 'which', 'functions', 'as', 'a', 'neuromodulator', 'and', 'as', 'a', 'trophic', 'factor', 'in', 'the', 'central', 'nervous', 'system', 'for', 'fatty', 'acid', 'biosynthesis', '.']	[1, 1, 1, 5, 4, 3, 3, 1, 1, 1, 5, 2, 1, 5, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The bioinformatic analyses using GO-term clustering, physical interaction module assembly, and KEGG pathway data mapping have shown an involvement of pathways consisting of fatty acid binding and transport, exocytosis, and protease inhibitory activity, which are also partially involved in Complement and coagulation cascades.	[('PMC4020801', 'D09000', 223, 231, 'protease')]	['The', 'bio', '##in', '##form', '##atic', 'analyses', 'using', 'GO', '-', 'term', 'cluster', '##ing', ',', 'physical', 'interaction', 'module', 'assembly', ',', 'and', 'K', '##EG', '##G', 'pathway', 'data', 'mapping', 'have', 'shown', 'an', 'involvement', 'of', 'pathways', 'consisting', 'of', 'fatty', 'acid', 'binding', 'and', 'transport', ',', 'ex', '##oc', '##yt', '##osis', ',', 'and', 'pro', '##te', '##ase', 'inhibitor', '##y', 'activity', ',', 'which', 'are', 'also', 'partially', 'involved', 'in', 'Co', '##mple', '##ment', 'and', 'co', '##agu', '##lation', 'ca', '##sca', '##des', '.']	[0, 4, 7, 9, 13, 18, 27, 33, 35, 36, 41, 48, 51, 53, 62, 74, 81, 89, 91, 95, 96, 98, 100, 108, 113, 121, 126, 132, 135, 147, 150, 159, 170, 173, 179, 184, 192, 196, 205, 207, 209, 211, 213, 217, 219, 223, 226, 228, 232, 241, 243, 251, 253, 259, 263, 268, 278, 287, 290, 292, 296, 301, 305, 307, 310, 317, 319, 322, 325]	[3, 7, 9, 13, 17, 26, 32, 35, 36, 40, 48, 51, 52, 61, 73, 80, 89, 90, 94, 96, 98, 99, 107, 112, 120, 125, 131, 134, 146, 149, 158, 169, 172, 178, 183, 191, 195, 205, 206, 209, 211, 213, 217, 218, 222, 226, 228, 231, 241, 242, 251, 252, 258, 262, 267, 277, 286, 289, 292, 296, 300, 304, 307, 310, 316, 319, 322, 325, 326]	['The', 'bioinformatic', 'analyses', 'using', 'GO-term', 'clustering', ',', 'physical', 'interaction', 'module', 'assembly', ',', 'and', 'KEGG', 'pathway', 'data', 'mapping', 'have', 'shown', 'an', 'involvement', 'of', 'pathways', 'consisting', 'of', 'fatty', 'acid', 'binding', 'and', 'transport', ',', 'exocytosis', ',', 'and', 'protease', 'inhibitory', 'activity', ',', 'which', 'are', 'also', 'partially', 'involved', 'in', 'Complement', 'and', 'coagulation', 'cascades', '.']	[1, 4, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The interactome analysis surprisingly showed a highly interconnected network of 18 of the 19 relevant proteins, where only 36 additional molecules were needed to generate a specific molecular network, suggesting that the up-regulated proteins form a potential dysregulated functional cluster encompassing immune responses and complement cascade proteins, protease cascades maybe linked to the membrane attack complex or possibly to counteract the enzymatic effect of up-regulated molecules such as GPX3, RBP3 and PTGDS, or as modulators of gene activation cascades.	[('PMC4020801', 'D10000', 355, 363, 'protease')]	['The', 'interact', '##ome', 'analysis', 'surprisingly', 'showed', 'a', 'highly', 'inter', '##connected', 'network', 'of', '18', 'of', 'the', '19', 'relevant', 'proteins', ',', 'where', 'only', '36', 'additional', 'molecules', 'were', 'needed', 'to', 'generate', 'a', 'specific', 'molecular', 'network', ',', 'suggesting', 'that', 'the', 'up', '-', 'regulated', 'proteins', 'form', 'a', 'potential', 'd', '##ys', '##re', '##gu', '##lated', 'functional', 'cluster', 'encompassing', 'immune', 'responses', 'and', 'complement', 'ca', '##sca', '##de', 'proteins', ',', 'pro', '##te', '##ase', 'ca', '##sca', '##des', 'maybe', 'linked', 'to', 'the', 'membrane', 'attack', 'complex', 'or', 'possibly', 'to', 'counter', '##act', 'the', 'en', '##zy', '##matic', 'effect', 'of', 'up', '-', 'regulated', 'molecules', 'such', 'as', 'GP', '##X', '##3', ',', 'RB', '##P', '##3', 'and', 'PT', '##G', '##DS', ',', 'or', 'as', 'm', '##od', '##ulator', '##s', 'of', 'gene', 'activation', 'ca', '##sca', '##des', '.']	[0, 4, 12, 16, 25, 38, 45, 47, 54, 59, 69, 77, 80, 83, 86, 90, 93, 102, 110, 112, 118, 123, 126, 137, 147, 152, 159, 162, 171, 173, 182, 192, 199, 201, 212, 217, 221, 223, 224, 234, 243, 248, 250, 260, 261, 263, 265, 267, 273, 284, 292, 305, 312, 322, 326, 337, 339, 342, 345, 353, 355, 358, 360, 364, 366, 369, 373, 379, 386, 389, 393, 402, 409, 417, 420, 429, 432, 439, 443, 447, 449, 451, 457, 464, 467, 469, 470, 480, 490, 495, 498, 500, 501, 502, 504, 506, 507, 509, 513, 515, 516, 518, 520, 523, 526, 527, 529, 535, 537, 540, 545, 556, 558, 561, 564]	[3, 12, 15, 24, 37, 44, 46, 53, 59, 68, 76, 79, 82, 85, 89, 92, 101, 110, 111, 117, 122, 125, 136, 146, 151, 158, 161, 170, 172, 181, 191, 199, 200, 211, 216, 220, 223, 224, 233, 242, 247, 249, 259, 261, 263, 265, 267, 272, 283, 291, 304, 311, 321, 325, 336, 339, 342, 344, 353, 354, 358, 360, 363, 366, 369, 372, 378, 385, 388, 392, 401, 408, 416, 419, 428, 431, 439, 442, 446, 449, 451, 456, 463, 466, 469, 470, 479, 489, 494, 497, 500, 501, 502, 503, 506, 507, 508, 512, 515, 516, 518, 519, 522, 525, 527, 529, 535, 536, 539, 544, 555, 558, 561, 564, 565]	['The', 'interactome', 'analysis', 'surprisingly', 'showed', 'a', 'highly', 'interconnected', 'network', 'of', '18', 'of', 'the', '19', 'relevant', 'proteins', ',', 'where', 'only', '36', 'additional', 'molecules', 'were', 'needed', 'to', 'generate', 'a', 'specific', 'molecular', 'network', ',', 'suggesting', 'that', 'the', 'up', '-', 'regulated', 'proteins', 'form', 'a', 'potential', 'dysregulated', 'functional', 'cluster', 'encompassing', 'immune', 'responses', 'and', 'complement', 'cascade', 'proteins', ',', 'protease', 'cascades', 'maybe', 'linked', 'to', 'the', 'membrane', 'attack', 'complex', 'or', 'possibly', 'to', 'counteract', 'the', 'enzymatic', 'effect', 'of', 'up', '-', 'regulated', 'molecules', 'such', 'as', 'GPX3', ',', 'RBP3', 'and', 'PTGDS', ',', 'or', 'as', 'modulators', 'of', 'gene', 'activation', 'cascades', '.']	[1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The up-regulation of GPX3 is of particular interest, since it was shown previously that cataracts contain elevated levels of oxidants such as dehydroascorbic acid (DHA), indicative of oxidative stress, linked to a potentially elevated level of extracellular glutathione peroxidase GPX3 [42].	[('PMC4020801', 'D11000', 258, 280, 'glutathione peroxidase')]	['The', 'up', '-', 'regulation', 'of', 'GP', '##X', '##3', 'is', 'of', 'particular', 'interest', ',', 'since', 'it', 'was', 'shown', 'previously', 'that', 'cat', '##ara', '##cts', 'contain', 'elevated', 'levels', 'of', 'o', '##xi', '##dant', '##s', 'such', 'as', 'de', '##hy', '##dr', '##oa', '##sco', '##rb', '##ic', 'acid', '(', 'D', '##HA', ')', ',', 'in', '##dicative', 'of', 'o', '##xi', '##da', '##tive', 'stress', ',', 'linked', 'to', 'a', 'potentially', 'elevated', 'level', 'of', 'extra', '##cellular', 'g', '##lut', '##ath', '##ione', 'per', '##ox', '##idas', '##e', 'GP', '##X', '##3', '[', '42', ']', '.']	[0, 4, 6, 7, 18, 21, 23, 24, 26, 29, 32, 43, 51, 53, 59, 62, 66, 72, 83, 88, 91, 94, 98, 106, 115, 122, 125, 126, 128, 132, 134, 139, 142, 144, 146, 148, 150, 153, 155, 158, 163, 164, 165, 167, 168, 170, 172, 181, 184, 185, 187, 189, 194, 200, 202, 209, 212, 214, 226, 235, 241, 244, 249, 258, 259, 262, 265, 270, 273, 275, 279, 281, 283, 284, 286, 287, 289, 290]	[3, 6, 7, 17, 20, 23, 24, 25, 28, 31, 42, 51, 52, 58, 61, 65, 71, 82, 87, 91, 94, 97, 105, 114, 121, 124, 126, 128, 132, 133, 138, 141, 144, 146, 148, 150, 153, 155, 157, 162, 164, 165, 167, 168, 169, 172, 180, 183, 185, 187, 189, 193, 200, 201, 208, 211, 213, 225, 234, 240, 243, 249, 257, 259, 262, 265, 269, 273, 275, 279, 280, 283, 284, 285, 287, 289, 290, 291]	['The', 'up', '-', 'regulation', 'of', 'GPX3', 'is', 'of', 'particular', 'interest', ',', 'since', 'it', 'was', 'shown', 'previously', 'that', 'cataracts', 'contain', 'elevated', 'levels', 'of', 'oxidants', 'such', 'as', 'dehydroascorbic', 'acid', '(', 'DHA', ')', ',', 'indicative', 'of', 'oxidative', 'stress', ',', 'linked', 'to', 'a', 'potentially', 'elevated', 'level', 'of', 'extracellular', 'glutathione', 'peroxidase', 'GPX3', '[', '42', ']', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 7, 1, 1, 2, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 4, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There have been a handful of “candidate gene” studies proposing a link between specific genetic variants and specific political traits, including monoamine oxidase (MAO) with behavioral aggression (McDermott et al. 2009), serotonin and MAO with voting participation (Fowler and Dawes 2008) and dopamine with partisanship (Dawes and Fowler 2009).	[('PMC4038932', 'I08000', 146, 163, 'monoamine oxidase')]	['There', 'have', 'been', 'a', 'handful', 'of', '“', 'candidate', 'gene', '”', 'studies', 'proposing', 'a', 'link', 'between', 'specific', 'genetic', 'variants', 'and', 'specific', 'political', 'traits', ',', 'including', 'mon', '##oam', '##ine', 'o', '##xi', '##das', '##e', '(', 'MA', '##O', ')', 'with', 'behavioral', 'aggression', '(', 'M', '##c', '##D', '##er', '##mott', 'et', 'al', '.', '2009', ')', ',', 'se', '##rot', '##oni', '##n', 'and', 'MA', '##O', 'with', 'voting', 'participation', '(', 'Fowler', 'and', 'Da', '##wes', '2008', ')', 'and', 'do', '##pa', '##mine', 'with', 'partisan', '##ship', '(', 'Da', '##wes', 'and', 'Fowler', '2009', ')', '.']	[0, 6, 11, 16, 18, 26, 29, 30, 40, 44, 46, 54, 64, 66, 71, 79, 88, 96, 105, 109, 118, 128, 134, 136, 146, 149, 152, 156, 157, 159, 162, 164, 165, 167, 168, 170, 175, 186, 197, 198, 199, 200, 201, 203, 208, 211, 213, 215, 219, 220, 222, 224, 227, 230, 232, 236, 238, 240, 245, 252, 266, 267, 274, 278, 280, 284, 288, 290, 294, 296, 298, 303, 308, 316, 321, 322, 324, 328, 332, 339, 343, 344]	[5, 10, 15, 17, 25, 28, 30, 39, 44, 45, 53, 63, 65, 70, 78, 87, 95, 104, 108, 117, 127, 134, 135, 145, 149, 152, 155, 157, 159, 162, 163, 165, 167, 168, 169, 174, 185, 196, 198, 199, 200, 201, 203, 207, 210, 213, 214, 219, 220, 221, 224, 227, 230, 231, 235, 238, 239, 244, 251, 265, 267, 273, 277, 280, 283, 288, 289, 293, 296, 298, 302, 307, 316, 320, 322, 324, 327, 331, 338, 343, 344, 345]	['There', 'have', 'been', 'a', 'handful', 'of', '“', 'candidate', 'gene', '”', 'studies', 'proposing', 'a', 'link', 'between', 'specific', 'genetic', 'variants', 'and', 'specific', 'political', 'traits', ',', 'including', 'monoamine', 'oxidase', '(', 'MAO', ')', 'with', 'behavioral', 'aggression', '(', 'McDermott', 'et', 'al', '.', '2009', ')', ',', 'serotonin', 'and', 'MAO', 'with', 'voting', 'participation', '(', 'Fowler', 'and', 'Dawes', '2008', ')', 'and', 'dopamine', 'with', 'partisanship', '(', 'Dawes', 'and', 'Fowler', '2009', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The other candidate gene on Xq28, ARHGAP4, encodes the Rho GTPase activating protein which plays a role in controlling axonal outgrowth and cell motility.	[('PMC4059435', 'D04000', 59, 65, 'GTPase')]	['The', 'other', 'candidate', 'gene', 'on', 'X', '##q', '##28', ',', 'AR', '##H', '##GA', '##P', '##4', ',', 'en', '##codes', 'the', 'R', '##ho', 'GT', '##P', '##ase', 'act', '##ivating', 'protein', 'which', 'plays', 'a', 'role', 'in', 'controlling', 'a', '##xon', '##al', 'out', '##gro', '##wth', 'and', 'cell', 'm', '##ot', '##ility', '.']	[0, 4, 10, 20, 25, 28, 29, 30, 32, 34, 36, 37, 39, 40, 41, 43, 45, 51, 55, 56, 59, 61, 62, 66, 69, 77, 85, 91, 97, 99, 104, 107, 119, 120, 123, 126, 129, 132, 136, 140, 145, 146, 148, 153]	[3, 9, 19, 24, 27, 29, 30, 32, 33, 36, 37, 39, 40, 41, 42, 45, 50, 54, 56, 58, 61, 62, 65, 69, 76, 84, 90, 96, 98, 103, 106, 118, 120, 123, 125, 129, 132, 135, 139, 144, 146, 148, 153, 154]	['The', 'other', 'candidate', 'gene', 'on', 'Xq28', ',', 'ARHGAP4', ',', 'encodes', 'the', 'Rho', 'GTPase', 'activating', 'protein', 'which', 'plays', 'a', 'role', 'in', 'controlling', 'axonal', 'outgrowth', 'and', 'cell', 'motility', '.']	[1, 1, 1, 1, 1, 3, 1, 5, 1, 2, 1, 2, 3, 2, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Open chromatin regions, recognized by DNase I hypersensitive site sequencing (DNase-seq) are associated with gene regulatory elements, including promoters, enhancers, silencers, insulators and locus control region.	[]	['Open', 'ch', '##roma', '##tin', 'regions', ',', 'recognized', 'by', 'D', '##N', '##ase', 'I', 'h', '##yper', '##sen', '##sitive', 'site', 'se', '##quencing', '(', 'D', '##N', '##ase', '-', 'se', '##q', ')', 'are', 'associated', 'with', 'gene', 'regulatory', 'elements', ',', 'including', 'promoter', '##s', ',', 'enhance', '##rs', ',', 'silence', '##rs', ',', 'ins', '##ulator', '##s', 'and', 'lo', '##cus', 'control', 'region', '.']	[0, 5, 7, 11, 15, 22, 24, 35, 38, 39, 40, 44, 46, 47, 51, 54, 61, 66, 68, 77, 78, 79, 80, 83, 84, 86, 87, 89, 93, 104, 109, 114, 125, 133, 135, 145, 153, 154, 156, 163, 165, 167, 174, 176, 178, 181, 187, 189, 193, 195, 199, 207, 213]	[4, 7, 11, 14, 22, 23, 34, 37, 39, 40, 43, 45, 47, 51, 54, 60, 65, 68, 76, 78, 79, 80, 83, 84, 86, 87, 88, 92, 103, 108, 113, 124, 133, 134, 144, 153, 154, 155, 163, 165, 166, 174, 176, 177, 181, 187, 188, 192, 195, 198, 206, 213, 214]	['Open', 'chromatin', 'regions', ',', 'recognized', 'by', 'DNase', 'I', 'hypersensitive', 'site', 'sequencing', '(', 'DNase', '-', 'seq', ')', 'are', 'associated', 'with', 'gene', 'regulatory', 'elements', ',', 'including', 'promoters', ',', 'enhancers', ',', 'silencers', ',', 'insulators', 'and', 'locus', 'control', 'region', '.']	[1, 3, 1, 1, 1, 1, 3, 1, 4, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 3, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Putative exonic splicing enhancer motifs specific for human Ser/Arg-rich proteins (SR proteins) were predicted by ESEfinder3.0(see ‘URLs’).The extent by which the SNPs affect microRNAs binding was predicted by Patrocles (see ‘URLs’).	[]	['Put', '##ative', 'ex', '##onic', 's', '##p', '##licing', 'enhance', '##r', 'motifs', 'specific', 'for', 'human', 'Ser', '/', 'A', '##rg', '-', 'rich', 'proteins', '(', 'SR', 'proteins', ')', 'were', 'predicted', 'by', 'E', '##SE', '##finder', '##3', '.', '0', '(', 'see', '‘', 'U', '##RL', '##s', '’', ')', '.', 'The', 'extent', 'by', 'which', 'the', 'S', '##NP', '##s', 'affect', 'micro', '##RNA', '##s', 'binding', 'was', 'predicted', 'by', 'Pat', '##ro', '##cles', '(', 'see', '‘', 'U', '##RL', '##s', '’', ')', '.']	[0, 3, 9, 11, 16, 17, 18, 25, 32, 34, 41, 50, 54, 60, 63, 64, 65, 67, 68, 73, 82, 83, 86, 94, 96, 101, 111, 114, 115, 117, 123, 124, 125, 126, 127, 131, 132, 133, 135, 136, 137, 138, 139, 143, 150, 153, 159, 163, 164, 166, 168, 175, 180, 183, 185, 193, 197, 207, 210, 213, 215, 220, 221, 225, 226, 227, 229, 230, 231, 232]	[3, 8, 11, 15, 17, 18, 24, 32, 33, 40, 49, 53, 59, 63, 64, 65, 67, 68, 72, 81, 83, 85, 94, 95, 100, 110, 113, 115, 117, 123, 124, 125, 126, 127, 130, 132, 133, 135, 136, 137, 138, 139, 142, 149, 152, 158, 162, 164, 166, 167, 174, 180, 183, 184, 192, 196, 206, 209, 213, 215, 219, 221, 224, 226, 227, 229, 230, 231, 232, 233]	['Putative', 'exonic', 'splicing', 'enhancer', 'motifs', 'specific', 'for', 'human', 'Ser', '/', 'Arg', '-', 'rich', 'proteins', '(', 'SR', 'proteins', ')', 'were', 'predicted', 'by', 'ESEfinder3.0(see', '‘', 'URLs’).The', 'extent', 'by', 'which', 'the', 'SNPs', 'affect', 'microRNAs', 'binding', 'was', 'predicted', 'by', 'Patrocles', '(', 'see', '‘', 'URLs', '’', ')', '.']	[2, 2, 3, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 7, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Decreased glomerular filtration rate (GFR) leads to reduced production of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), the active vitamin D hormone, from 25-hydroxyvitamin D3 (25(OH)D3).1,2 Reduced 1,25(OH)2D3 production is due to reduced renal mass as well as downregulation of the renal 1-α hydroxylase enzyme (CYP27B1) by fibroblast growth factor 23 (FGF-23), phosphorous excess, and metabolic acidosis.3–5	[('PMC4111986', 'I00000', 284, 299, '1-α hydroxylase')]	['Dec', '##reased', 'g', '##lo', '##mer', '##ular', 'fi', '##ltration', 'rate', '(', 'G', '##F', '##R', ')', 'leads', 'to', 'reduced', 'production', 'of', '1', ',', '25', '-', 'di', '##hy', '##dr', '##ox', '##y', '##vi', '##tam', '##in', 'D', '##3', '(', '1', ',', '25', '(', 'OH', ')', '2D', '##3', ')', ',', 'the', 'active', 'vitamin', 'D', 'hormone', ',', 'from', '25', '-', 'h', '##ydro', '##xy', '##vi', '##tam', '##in', 'D', '##3', '(', '25', '(', 'OH', ')', 'D', '##3', ')', '.', '1', ',', '2', 'Red', '##uce', '##d', '1', ',', '25', '(', 'OH', ')', '2D', '##3', 'production', 'is', 'due', 'to', 'reduced', 're', '##nal', 'mass', 'as', 'well', 'as', 'down', '##re', '##gu', '##lation', 'of', 'the', 're', '##nal', '1', '-', 'α', 'h', '##ydro', '##xy', '##lase', 'enzyme', '(', 'C', '##YP', '##27', '##B', '##1', ')', 'by', 'fi', '##bro', '##blast', 'growth', 'factor', '23', '(', 'F', '##G', '##F', '-', '23', ')', ',', 'p', '##hos', '##ph', '##orous', 'excess', ',', 'and', 'metabolic', 'acid', '##osis', '.', '3', '–', '5']	[0, 3, 10, 11, 13, 16, 21, 23, 32, 37, 38, 39, 40, 41, 43, 49, 52, 60, 71, 74, 75, 76, 78, 79, 81, 83, 85, 87, 88, 90, 93, 96, 97, 99, 100, 101, 102, 104, 105, 107, 108, 110, 111, 112, 114, 118, 125, 133, 135, 142, 144, 149, 151, 152, 153, 157, 159, 161, 164, 167, 168, 170, 171, 173, 174, 176, 177, 178, 179, 180, 181, 182, 183, 185, 188, 191, 193, 194, 195, 197, 198, 200, 201, 203, 205, 216, 219, 223, 226, 234, 236, 240, 245, 248, 253, 256, 260, 262, 264, 271, 274, 278, 280, 284, 285, 286, 288, 289, 293, 295, 300, 307, 308, 309, 311, 313, 314, 315, 317, 320, 322, 325, 331, 338, 345, 348, 349, 350, 351, 352, 353, 355, 356, 358, 359, 362, 364, 370, 376, 378, 382, 392, 396, 400, 401, 402, 403]	[3, 9, 11, 13, 16, 20, 23, 31, 36, 38, 39, 40, 41, 42, 48, 51, 59, 70, 73, 75, 76, 78, 79, 81, 83, 85, 87, 88, 90, 93, 95, 97, 98, 100, 101, 102, 104, 105, 107, 108, 110, 111, 112, 113, 117, 124, 132, 134, 142, 143, 148, 151, 152, 153, 157, 159, 161, 164, 166, 168, 169, 171, 173, 174, 176, 177, 178, 179, 180, 181, 182, 183, 184, 188, 191, 192, 194, 195, 197, 198, 200, 201, 203, 204, 215, 218, 222, 225, 233, 236, 239, 244, 247, 252, 255, 260, 262, 264, 270, 273, 277, 280, 283, 285, 286, 287, 289, 293, 295, 299, 306, 308, 309, 311, 313, 314, 315, 316, 319, 322, 325, 330, 337, 344, 347, 349, 350, 351, 352, 353, 355, 356, 357, 359, 362, 364, 369, 376, 377, 381, 391, 396, 400, 401, 402, 403, 404]	['Decreased', 'glomerular', 'filtration', 'rate', '(', 'GFR', ')', 'leads', 'to', 'reduced', 'production', 'of', '1', ',', '25-dihydroxyvitamin', 'D3', '(', '1', ',', '25(OH)2D3', ')', ',', 'the', 'active', 'vitamin', 'D', 'hormone', ',', 'from', '25-hydroxyvitamin', 'D3', '(25(OH)D3).1,2', 'Reduced', '1', ',', '25(OH)2D3', 'production', 'is', 'due', 'to', 'reduced', 'renal', 'mass', 'as', 'well', 'as', 'downregulation', 'of', 'the', 'renal', '1-α', 'hydroxylase', 'enzyme', '(', 'CYP27B1', ')', 'by', 'fibroblast', 'growth', 'factor', '23', '(', 'FGF-23', ')', ',', 'phosphorous', 'excess', ',', 'and', 'metabolic', 'acidosis.3', '–', '5']	[2, 4, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 10, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 2, 12, 3, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 2, 3, 4, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 5, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In particular, the C allele of rs174547 in FADS1 was associated with a higher proportion of LA and lower GLA (consistent with lower delta-6 desaturase activity), and a higher proportion of DGLA and lower AA (consistent with lower delta-5 desaturase activity).	[]	['In', 'particular', ',', 'the', 'C', 'all', '##ele', 'of', 'r', '##s', '##17', '##45', '##47', 'in', 'FA', '##DS', '##1', 'was', 'associated', 'with', 'a', 'higher', 'proportion', 'of', 'LA', 'and', 'lower', 'G', '##LA', '(', 'consistent', 'with', 'lower', 'delta', '-', '6', 'des', '##at', '##ura', '##se', 'activity', ')', ',', 'and', 'a', 'higher', 'proportion', 'of', 'D', '##G', '##LA', 'and', 'lower', 'AA', '(', 'consistent', 'with', 'lower', 'delta', '-', '5', 'des', '##at', '##ura', '##se', 'activity', ')', '.']	[0, 3, 13, 15, 19, 21, 24, 28, 31, 32, 33, 35, 37, 40, 43, 45, 47, 49, 53, 64, 69, 71, 78, 89, 92, 95, 99, 105, 106, 109, 110, 121, 126, 132, 137, 138, 140, 143, 145, 148, 151, 159, 160, 162, 166, 168, 175, 186, 189, 190, 191, 194, 198, 204, 207, 208, 219, 224, 230, 235, 236, 238, 241, 243, 246, 249, 257, 258]	[2, 13, 14, 18, 20, 24, 27, 30, 32, 33, 35, 37, 39, 42, 45, 47, 48, 52, 63, 68, 70, 77, 88, 91, 94, 98, 104, 106, 108, 110, 120, 125, 131, 137, 138, 139, 143, 145, 148, 150, 159, 160, 161, 165, 167, 174, 185, 188, 190, 191, 193, 197, 203, 206, 208, 218, 223, 229, 235, 236, 237, 241, 243, 246, 248, 257, 258, 259]	['In', 'particular', ',', 'the', 'C', 'allele', 'of', 'rs174547', 'in', 'FADS1', 'was', 'associated', 'with', 'a', 'higher', 'proportion', 'of', 'LA', 'and', 'lower', 'GLA', '(', 'consistent', 'with', 'lower', 'delta-6', 'desaturase', 'activity', ')', ',', 'and', 'a', 'higher', 'proportion', 'of', 'DGLA', 'and', 'lower', 'AA', '(', 'consistent', 'with', 'lower', 'delta-5', 'desaturase', 'activity', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This polymorphism has previously been recognized for its association with n6 PUFAs and desaturase activities22, and our findings build upon and extend these prior observations by documenting additional inverse associations with GLA and DGLA.	[]	['This', 'p', '##oly', '##mor', '##phism', 'has', 'previously', 'been', 'recognized', 'for', 'its', 'association', 'with', 'n', '##6', 'P', '##U', '##FA', '##s', 'and', 'des', '##at', '##ura', '##se', 'activities', '##22', ',', 'and', 'our', 'findings', 'build', 'upon', 'and', 'extend', 'these', 'prior', 'observations', 'by', 'documenting', 'additional', 'inverse', 'associations', 'with', 'G', '##LA', 'and', 'D', '##G', '##LA', '.']	[0, 5, 6, 9, 12, 18, 22, 33, 38, 49, 53, 57, 69, 74, 75, 77, 78, 79, 81, 83, 87, 90, 92, 95, 98, 108, 110, 112, 116, 120, 129, 135, 140, 144, 151, 157, 163, 176, 179, 191, 202, 210, 223, 228, 229, 232, 236, 237, 238, 240]	[4, 6, 9, 12, 17, 21, 32, 37, 48, 52, 56, 68, 73, 75, 76, 78, 79, 81, 82, 86, 90, 92, 95, 97, 108, 110, 111, 115, 119, 128, 134, 139, 143, 150, 156, 162, 175, 178, 190, 201, 209, 222, 227, 229, 231, 235, 237, 238, 240, 241]	['This', 'polymorphism', 'has', 'previously', 'been', 'recognized', 'for', 'its', 'association', 'with', 'n6', 'PUFAs', 'and', 'desaturase', 'activities22', ',', 'and', 'our', 'findings', 'build', 'upon', 'and', 'extend', 'these', 'prior', 'observations', 'by', 'documenting', 'additional', 'inverse', 'associations', 'with', 'GLA', 'and', 'DGLA', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The AGPAT1-encoded protein, 1-acyl-sn-glycerol-3-phosphate acyltransferase α, is a critical enzyme in phospholipid and triglyceride biosynthesis, catalyzing the conversion of lysophosphatidic acid to phosphatidic acid45.	[]	['The', 'AG', '##PA', '##T', '##1', '-', 'encoded', 'protein', ',', '1', '-', 'a', '##cy', '##l', '-', 's', '##n', '-', 'g', '##ly', '##cer', '##ol', '-', '3', '-', 'phosphate', 'a', '##cy', '##lt', '##ran', '##s', '##fer', '##ase', 'α', ',', 'is', 'a', 'critical', 'enzyme', 'in', 'p', '##hos', '##ph', '##oli', '##pid', 'and', 't', '##rig', '##ly', '##cer', '##ide', 'bio', '##sy', '##nt', '##hesis', ',', 'cat', '##aly', '##zing', 'the', 'conversion', 'of', 'l', '##ys', '##op', '##hos', '##pha', '##ti', '##dic', 'acid', 'to', 'p', '##hos', '##pha', '##ti', '##dic', 'acid', '##45', '.']	[0, 4, 6, 8, 9, 10, 11, 19, 26, 28, 29, 30, 31, 33, 34, 35, 36, 37, 38, 39, 41, 44, 46, 47, 48, 49, 59, 60, 62, 64, 67, 68, 71, 75, 76, 78, 81, 83, 92, 99, 102, 103, 106, 108, 111, 115, 119, 120, 123, 125, 128, 132, 135, 137, 139, 144, 146, 149, 152, 157, 161, 172, 175, 176, 178, 180, 183, 186, 188, 192, 197, 200, 201, 204, 207, 209, 213, 217, 219]	[3, 6, 8, 9, 10, 11, 18, 26, 27, 29, 30, 31, 33, 34, 35, 36, 37, 38, 39, 41, 44, 46, 47, 48, 49, 58, 60, 62, 64, 67, 68, 71, 74, 76, 77, 80, 82, 91, 98, 101, 103, 106, 108, 111, 114, 118, 120, 123, 125, 128, 131, 135, 137, 139, 144, 145, 149, 152, 156, 160, 171, 174, 176, 178, 180, 183, 186, 188, 191, 196, 199, 201, 204, 207, 209, 212, 217, 219, 220]	['The', 'AGPAT1-encoded', 'protein', ',', '1-acyl-sn-glycerol-3-phosphate', 'acyltransferase', 'α', ',', 'is', 'a', 'critical', 'enzyme', 'in', 'phospholipid', 'and', 'triglyceride', 'biosynthesis', ',', 'catalyzing', 'the', 'conversion', 'of', 'lysophosphatidic', 'acid', 'to', 'phosphatidic', 'acid45', '.']	[1, 6, 1, 1, 17, 7, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 4, 1, 3, 1, 1, 1, 7, 1, 1, 5, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To date, the best characterized genes shown to affect plasma and membrane PUFA composition are the fatty acid desaturase (FADS) genes, FADS1 and FADS2.	[('PMC4123862', 'I01000', 99, 120, 'fatty acid desaturase')]	['To', 'date', ',', 'the', 'best', 'characterized', 'genes', 'shown', 'to', 'affect', 'plasma', 'and', 'membrane', 'P', '##U', '##FA', 'composition', 'are', 'the', 'fatty', 'acid', 'des', '##at', '##ura', '##se', '(', 'FA', '##DS', ')', 'genes', ',', 'FA', '##DS', '##1', 'and', 'FA', '##DS', '##2', '.']	[0, 3, 7, 9, 13, 18, 32, 38, 44, 47, 54, 61, 65, 74, 75, 76, 79, 91, 95, 99, 105, 110, 113, 115, 118, 121, 122, 124, 126, 128, 133, 135, 137, 139, 141, 145, 147, 149, 150]	[2, 7, 8, 12, 17, 31, 37, 43, 46, 53, 60, 64, 73, 75, 76, 78, 90, 94, 98, 104, 109, 113, 115, 118, 120, 122, 124, 126, 127, 133, 134, 137, 139, 140, 144, 147, 149, 150, 151]	['To', 'date', ',', 'the', 'best', 'characterized', 'genes', 'shown', 'to', 'affect', 'plasma', 'and', 'membrane', 'PUFA', 'composition', 'are', 'the', 'fatty', 'acid', 'desaturase', '(', 'FADS', ')', 'genes', ',', 'FADS1', 'and', 'FADS2', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These biologically relevant candidate genes encode the delta-5 and delta-6 desaturases which participate in the metabolic conversion of the essential fatty acid linoleic acid (LA) to longer chain n6 PUFAs (Figure 1).	[('PMC4123862', 'I01001', 55, 86, 'delta-5 and delta-6 desaturases')]	['These', 'biological', '##ly', 'relevant', 'candidate', 'genes', 'en', '##code', 'the', 'delta', '-', '5', 'and', 'delta', '-', '6', 'des', '##at', '##ura', '##ses', 'which', 'participate', 'in', 'the', 'metabolic', 'conversion', 'of', 'the', 'essential', 'fatty', 'acid', 'l', '##ino', '##le', '##ic', 'acid', '(', 'LA', ')', 'to', 'longer', 'chain', 'n', '##6', 'P', '##U', '##FA', '##s', '(', 'Figure', '1', ')', '.']	[0, 6, 16, 19, 28, 38, 44, 46, 51, 55, 60, 61, 63, 67, 72, 73, 75, 78, 80, 83, 87, 93, 105, 108, 112, 122, 133, 136, 140, 150, 156, 161, 162, 165, 167, 170, 175, 176, 178, 180, 183, 190, 196, 197, 199, 200, 201, 203, 205, 206, 213, 214, 215]	[5, 16, 18, 27, 37, 43, 46, 50, 54, 60, 61, 62, 66, 72, 73, 74, 78, 80, 83, 86, 92, 104, 107, 111, 121, 132, 135, 139, 149, 155, 160, 162, 165, 167, 169, 174, 176, 178, 179, 182, 189, 195, 197, 198, 200, 201, 203, 204, 206, 212, 214, 215, 216]	['These', 'biologically', 'relevant', 'candidate', 'genes', 'encode', 'the', 'delta-5', 'and', 'delta-6', 'desaturases', 'which', 'participate', 'in', 'the', 'metabolic', 'conversion', 'of', 'the', 'essential', 'fatty', 'acid', 'linoleic', 'acid', '(', 'LA', ')', 'to', 'longer', 'chain', 'n6', 'PUFAs', '(', 'Figure', '1', ')', '.']	[1, 2, 1, 1, 1, 2, 1, 3, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alcohol dependence (AD) is a moderately heritable disorder for which two major families of risk genes have been mapped via linkage and candidate gene association studies: the alcohol dehydrogenase (ADH) family, which contributes to variation in speed of ethanol metabolism and yields a variable concentration of acetaldehyde following alcohol consumption; and the aldehyde dehydrogenase (ALDH) gene family, which mediates acetaldehyde clearance (Edenberg 2007; Li et al. 2011, 2012a, 2012b).	[('PMC4149216', 'I00000', 175, 196, 'alcohol dehydrogenase')]	['Al', '##co', '##hol', 'dependence', '(', 'AD', ')', 'is', 'a', 'moderately', 'her', '##ita', '##ble', 'disorder', 'for', 'which', 'two', 'major', 'families', 'of', 'risk', 'genes', 'have', 'been', 'mapped', 'via', 'link', '##age', 'and', 'candidate', 'gene', 'association', 'studies', ':', 'the', 'alcohol', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'AD', '##H', ')', 'family', ',', 'which', 'contributes', 'to', 'variation', 'in', 'speed', 'of', 'ethanol', 'metabolism', 'and', 'yields', 'a', 'variable', 'concentration', 'of', 'ace', '##tal', '##de', '##hy', '##de', 'following', 'alcohol', 'consumption', ';', 'and', 'the', 'al', '##de', '##hy', '##de', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'AL', '##D', '##H', ')', 'gene', 'family', ',', 'which', 'media', '##tes', 'ace', '##tal', '##de', '##hy', '##de', 'clearance', '(', 'Eden', '##berg', '2007', ';', 'Li', 'et', 'al', '.', '2011', ',', '2012', '##a', ',', '2012', '##b', ')', '.']	[0, 2, 4, 8, 19, 20, 22, 24, 27, 29, 40, 43, 46, 50, 59, 63, 69, 73, 79, 88, 91, 96, 102, 107, 112, 119, 123, 127, 131, 135, 145, 150, 162, 169, 171, 175, 183, 185, 187, 189, 193, 197, 198, 200, 201, 203, 209, 211, 217, 229, 232, 242, 245, 251, 254, 262, 273, 277, 284, 286, 295, 309, 312, 315, 318, 320, 322, 325, 335, 343, 354, 356, 360, 364, 366, 368, 370, 373, 375, 377, 379, 383, 387, 388, 390, 391, 392, 394, 399, 405, 407, 413, 418, 422, 425, 428, 430, 432, 435, 445, 446, 450, 455, 459, 461, 464, 467, 469, 471, 475, 477, 481, 482, 484, 488, 489, 490]	[2, 4, 7, 18, 20, 22, 23, 26, 28, 39, 43, 46, 49, 58, 62, 68, 72, 78, 87, 90, 95, 101, 106, 111, 118, 122, 127, 130, 134, 144, 149, 161, 169, 170, 174, 182, 185, 187, 189, 193, 196, 198, 200, 201, 202, 209, 210, 216, 228, 231, 241, 244, 250, 253, 261, 272, 276, 283, 285, 294, 308, 311, 315, 318, 320, 322, 324, 334, 342, 354, 355, 359, 363, 366, 368, 370, 372, 375, 377, 379, 383, 386, 388, 390, 391, 392, 393, 398, 405, 406, 412, 418, 421, 425, 428, 430, 432, 434, 444, 446, 450, 454, 459, 460, 463, 466, 469, 470, 475, 476, 481, 482, 483, 488, 489, 490, 491]	['Alcohol', 'dependence', '(', 'AD', ')', 'is', 'a', 'moderately', 'heritable', 'disorder', 'for', 'which', 'two', 'major', 'families', 'of', 'risk', 'genes', 'have', 'been', 'mapped', 'via', 'linkage', 'and', 'candidate', 'gene', 'association', 'studies', ':', 'the', 'alcohol', 'dehydrogenase', '(', 'ADH', ')', 'family', ',', 'which', 'contributes', 'to', 'variation', 'in', 'speed', 'of', 'ethanol', 'metabolism', 'and', 'yields', 'a', 'variable', 'concentration', 'of', 'acetaldehyde', 'following', 'alcohol', 'consumption', ';', 'and', 'the', 'aldehyde', 'dehydrogenase', '(', 'ALDH', ')', 'gene', 'family', ',', 'which', 'mediates', 'acetaldehyde', 'clearance', '(', 'Edenberg', '2007', ';', 'Li', 'et', 'al', '.', '2011', ',', '2012a', ',', '2012b', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 4, 5, 1, 3, 1, 1, 1, 1, 1, 2, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
AD, flushing response, and maximum drinks all show multiple significant associations in males in the region of chromosome 12 containing aldehyde dehydrogenase gene, ALDH2.	[('PMC4149216', 'R02000', 136, 158, 'aldehyde dehydrogenase')]	['AD', ',', 'flush', '##ing', 'response', ',', 'and', 'maximum', 'drinks', 'all', 'show', 'multiple', 'significant', 'associations', 'in', 'males', 'in', 'the', 'region', 'of', 'chromosome', '12', 'containing', 'al', '##de', '##hy', '##de', 'de', '##hy', '##dr', '##ogen', '##ase', 'gene', ',', 'AL', '##D', '##H', '##2', '.']	[0, 2, 4, 9, 13, 21, 23, 27, 35, 42, 46, 51, 60, 72, 85, 88, 94, 97, 101, 108, 111, 122, 125, 136, 138, 140, 142, 145, 147, 149, 151, 155, 159, 163, 165, 167, 168, 169, 170]	[2, 3, 9, 12, 21, 22, 26, 34, 41, 45, 50, 59, 71, 84, 87, 93, 96, 100, 107, 110, 121, 124, 135, 138, 140, 142, 144, 147, 149, 151, 155, 158, 163, 164, 167, 168, 169, 170, 171]	['AD', ',', 'flushing', 'response', ',', 'and', 'maximum', 'drinks', 'all', 'show', 'multiple', 'significant', 'associations', 'in', 'males', 'in', 'the', 'region', 'of', 'chromosome', '12', 'containing', 'aldehyde', 'dehydrogenase', 'gene', ',', 'ALDH2', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thiamine or vitamin B1 has an important role in cancer cells as shown by investigations using the thiamine-degrading enzyme, thiaminase.	[('PMC4150403', 'D03000', 125, 135, 'thiaminase')]	['T', '##hia', '##mine', 'or', 'vitamin', 'B', '##1', 'has', 'an', 'important', 'role', 'in', 'cancer', 'cells', 'as', 'shown', 'by', 'investigations', 'using', 'the', 'th', '##iam', '##ine', '-', 'de', '##grading', 'enzyme', ',', 'th', '##iam', '##inas', '##e', '.']	[0, 1, 4, 9, 12, 20, 21, 23, 27, 30, 40, 45, 48, 55, 61, 64, 70, 73, 88, 94, 98, 100, 103, 106, 107, 109, 117, 123, 125, 127, 130, 134, 135]	[1, 4, 8, 11, 19, 21, 22, 26, 29, 39, 44, 47, 54, 60, 63, 69, 72, 87, 93, 97, 100, 103, 106, 107, 109, 116, 123, 124, 127, 130, 134, 135, 136]	['Thiamine', 'or', 'vitamin', 'B1', 'has', 'an', 'important', 'role', 'in', 'cancer', 'cells', 'as', 'shown', 'by', 'investigations', 'using', 'the', 'thiamine', '-', 'degrading', 'enzyme', ',', 'thiaminase', '.']	[3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O']
Liu et al. showed that the addition of thiaminase into cell culture media containing thiamine had a significant inhibitory effect on growth of breast cancer cells [28].	[('PMC4150403', 'D03001', 39, 49, 'thiaminase')]	['Liu', 'et', 'al', '.', 'showed', 'that', 'the', 'addition', 'of', 'th', '##iam', '##inas', '##e', 'into', 'cell', 'culture', 'media', 'containing', 'th', '##iam', '##ine', 'had', 'a', 'significant', 'inhibitor', '##y', 'effect', 'on', 'growth', 'of', 'breast', 'cancer', 'cells', '[', '28', ']', '.']	[0, 4, 7, 9, 11, 18, 23, 27, 36, 39, 41, 44, 48, 50, 55, 60, 68, 74, 85, 87, 90, 94, 98, 100, 112, 121, 123, 130, 133, 140, 143, 150, 157, 163, 164, 166, 167]	[3, 6, 9, 10, 17, 22, 26, 35, 38, 41, 44, 48, 49, 54, 59, 67, 73, 84, 87, 90, 93, 97, 99, 111, 121, 122, 129, 132, 139, 142, 149, 156, 162, 164, 166, 167, 168]	['Liu', 'et', 'al', '.', 'showed', 'that', 'the', 'addition', 'of', 'thiaminase', 'into', 'cell', 'culture', 'media', 'containing', 'thiamine', 'had', 'a', 'significant', 'inhibitory', 'effect', 'on', 'growth', 'of', 'breast', 'cancer', 'cells', '[', '28', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Also a pegylated version of thiaminase was capable in delaying tumor growth and prolonging survival in an RS4 leukemia xenograft model [29, 30] and it is seen that the increased glycine and thiamine are linked.	[('PMC4150403', 'D03002', 28, 38, 'thiaminase')]	['Also', 'a', 'p', '##eg', '##yla', '##ted', 'version', 'of', 'th', '##iam', '##inas', '##e', 'was', 'capable', 'in', 'delay', '##ing', 'tumor', 'growth', 'and', 'pro', '##long', '##ing', 'survival', 'in', 'an', 'RS', '##4', 'le', '##uke', '##mia', 'x', '##eno', '##gra', '##ft', 'model', '[', '29', ',', '30', ']', 'and', 'it', 'is', 'seen', 'that', 'the', 'increased', 'g', '##ly', '##cine', 'and', 'th', '##iam', '##ine', 'are', 'linked', '.']	[0, 5, 7, 8, 10, 13, 17, 25, 28, 30, 33, 37, 39, 43, 51, 54, 59, 63, 69, 76, 80, 83, 87, 91, 100, 103, 106, 108, 110, 112, 115, 119, 120, 123, 126, 129, 135, 136, 138, 140, 142, 144, 148, 151, 154, 159, 164, 168, 178, 179, 181, 186, 190, 192, 195, 199, 203, 209]	[4, 6, 8, 10, 13, 16, 24, 27, 30, 33, 37, 38, 42, 50, 53, 59, 62, 68, 75, 79, 83, 87, 90, 99, 102, 105, 108, 109, 112, 115, 118, 120, 123, 126, 128, 134, 136, 138, 139, 142, 143, 147, 150, 153, 158, 163, 167, 177, 179, 181, 185, 189, 192, 195, 198, 202, 209, 210]	['Also', 'a', 'pegylated', 'version', 'of', 'thiaminase', 'was', 'capable', 'in', 'delaying', 'tumor', 'growth', 'and', 'prolonging', 'survival', 'in', 'an', 'RS4', 'leukemia', 'xenograft', 'model', '[', '29', ',', '30', ']', 'and', 'it', 'is', 'seen', 'that', 'the', 'increased', 'glycine', 'and', 'thiamine', 'are', 'linked', '.']	[1, 1, 4, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To date, studies of candidate genes in relation to the emotion-modulated startle response have found that single nucleotide polymorphisms (SNPs) or other variants in several genes are related to aspects of the blink response: the serotonin transporter (5-hydroxytryptamine transporter gene-linked region—5-HTTLPR; Brocke et al., 2006), dopamine transporter (DAT; Pauli et al., 2010), catechol-O-methyltransferase (COMT; Montag et al., 2008), and monoamine oxidase A (MAOA; Larson, Taubitz, & Robinson, 2010).	[('PMC4231542', 'I10000', 384, 412, 'catechol-O-methyltransferase')]	['To', 'date', ',', 'studies', 'of', 'candidate', 'genes', 'in', 'relation', 'to', 'the', 'emotion', '-', 'm', '##od', '##ulated', 'start', '##le', 'response', 'have', 'found', 'that', 'single', 'n', '##uc', '##leo', '##tide', 'p', '##oly', '##mor', '##phism', '##s', '(', 'S', '##NP', '##s', ')', 'or', 'other', 'variants', 'in', 'several', 'genes', 'are', 'related', 'to', 'aspects', 'of', 'the', 'blink', 'response', ':', 'the', 'se', '##rot', '##oni', '##n', 'transport', '##er', '(', '5', '-', 'h', '##ydro', '##xy', '##try', '##pta', '##mine', 'transport', '##er', 'gene', '-', 'linked', 'region', '—', '5', '-', 'H', '##TT', '##LP', '##R', ';', 'Brock', '##e', 'et', 'al', '.', ',', '2006', ')', ',', 'do', '##pa', '##mine', 'transport', '##er', '(', 'D', '##AT', ';', 'Paul', '##i', 'et', 'al', '.', ',', '2010', ')', ',', 'cat', '##ech', '##ol', '-', 'O', '-', 'met', '##hyl', '##tra', '##ns', '##fer', '##ase', '(', 'CO', '##MT', ';', 'Mont', '##ag', 'et', 'al', '.', ',', '2008', ')', ',', 'and', 'mon', '##oam', '##ine', 'o', '##xi', '##das', '##e', 'A', '(', 'MA', '##OA', ';', 'Larson', ',', 'Tau', '##bit', '##z', ',', '&', 'Robinson', ',', '2010', ')', '.']	[0, 3, 7, 9, 17, 20, 30, 36, 39, 48, 51, 55, 62, 63, 64, 66, 73, 78, 81, 90, 95, 101, 106, 113, 114, 116, 119, 124, 125, 128, 131, 136, 138, 139, 140, 142, 143, 145, 148, 154, 163, 166, 174, 180, 184, 192, 195, 203, 206, 210, 216, 224, 226, 230, 232, 235, 238, 240, 249, 252, 253, 254, 255, 256, 260, 262, 265, 268, 273, 282, 285, 289, 290, 297, 303, 304, 305, 306, 307, 309, 311, 312, 314, 319, 321, 324, 326, 327, 329, 333, 334, 336, 338, 340, 345, 354, 357, 358, 359, 361, 363, 367, 369, 372, 374, 375, 377, 381, 382, 384, 387, 390, 392, 393, 394, 395, 398, 401, 404, 406, 409, 413, 414, 416, 418, 420, 424, 427, 430, 432, 433, 435, 439, 440, 442, 446, 449, 452, 456, 457, 459, 462, 464, 466, 467, 469, 471, 473, 479, 481, 484, 487, 488, 490, 492, 500, 502, 506, 507]	[2, 7, 8, 16, 19, 29, 35, 38, 47, 50, 54, 62, 63, 64, 66, 72, 78, 80, 89, 94, 100, 105, 112, 114, 116, 119, 123, 125, 128, 131, 136, 137, 139, 140, 142, 143, 144, 147, 153, 162, 165, 173, 179, 183, 191, 194, 202, 205, 209, 215, 224, 225, 229, 232, 235, 238, 239, 249, 251, 253, 254, 255, 256, 260, 262, 265, 268, 272, 282, 284, 289, 290, 296, 303, 304, 305, 306, 307, 309, 311, 312, 313, 319, 320, 323, 326, 327, 328, 333, 334, 335, 338, 340, 344, 354, 356, 358, 359, 361, 362, 367, 368, 371, 374, 375, 376, 381, 382, 383, 387, 390, 392, 393, 394, 395, 398, 401, 404, 406, 409, 412, 414, 416, 418, 419, 424, 426, 429, 432, 433, 434, 439, 440, 441, 445, 449, 452, 455, 457, 459, 462, 463, 465, 467, 469, 471, 472, 479, 480, 484, 487, 488, 489, 491, 500, 501, 506, 507, 508]	['To', 'date', ',', 'studies', 'of', 'candidate', 'genes', 'in', 'relation', 'to', 'the', 'emotion', '-', 'modulated', 'startle', 'response', 'have', 'found', 'that', 'single', 'nucleotide', 'polymorphisms', '(', 'SNPs', ')', 'or', 'other', 'variants', 'in', 'several', 'genes', 'are', 'related', 'to', 'aspects', 'of', 'the', 'blink', 'response', ':', 'the', 'serotonin', 'transporter', '(', '5-hydroxytryptamine', 'transporter', 'gene', '-', 'linked', 'region', '—', '5-HTTLPR', ';', 'Brocke', 'et', 'al', '.', ',', '2006', ')', ',', 'dopamine', 'transporter', '(', 'DAT', ';', 'Pauli', 'et', 'al', '.', ',', '2010', ')', ',', 'catechol-O-methyltransferase', '(', 'COMT', ';', 'Montag', 'et', 'al', '.', ',', '2008', ')', ',', 'and', 'monoamine', 'oxidase', 'A', '(', 'MAOA', ';', 'Larson', ',', 'Taubitz', ',', '&', 'Robinson', ',', '2010', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 4, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 8, 2, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 12, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Senescent hepatocytes were characterised by gene expression arrays and quantitative polymerase chain reaction (qPCR), and conditioned media was used in proteomic analyses, a human chemokine protein array, and cell migration assays to characterise the composition and function of the hepatocyte SASP.	[]	['Sen', '##es', '##cent', 'he', '##pa', '##to', '##cy', '##tes', 'were', 'characterised', 'by', 'gene', 'expression', 'array', '##s', 'and', 'quantitative', 'polymer', '##ase', 'chain', 'reaction', '(', 'q', '##PC', '##R', ')', ',', 'and', 'conditioned', 'media', 'was', 'used', 'in', 'pro', '##te', '##omi', '##c', 'analyses', ',', 'a', 'human', 'ch', '##em', '##oki', '##ne', 'protein', 'array', ',', 'and', 'cell', 'migration', 'ass', '##ays', 'to', 'character', '##ise', 'the', 'composition', 'and', 'function', 'of', 'the', 'he', '##pa', '##to', '##cy', '##te', 'SAS', '##P', '.']	[0, 3, 5, 10, 12, 14, 16, 18, 22, 27, 41, 44, 49, 60, 65, 67, 71, 84, 91, 95, 101, 110, 111, 112, 114, 115, 116, 118, 122, 134, 140, 144, 149, 152, 155, 157, 160, 162, 170, 172, 174, 180, 182, 184, 187, 190, 198, 203, 205, 209, 214, 224, 227, 231, 234, 243, 247, 251, 263, 267, 276, 279, 283, 285, 287, 289, 291, 294, 297, 298]	[3, 5, 9, 12, 14, 16, 18, 21, 26, 40, 43, 48, 59, 65, 66, 70, 83, 91, 94, 100, 109, 111, 112, 114, 115, 116, 117, 121, 133, 139, 143, 148, 151, 155, 157, 160, 161, 170, 171, 173, 179, 182, 184, 187, 189, 197, 203, 204, 208, 213, 223, 227, 230, 233, 243, 246, 250, 262, 266, 275, 278, 282, 285, 287, 289, 291, 293, 297, 298, 299]	['Senescent', 'hepatocytes', 'were', 'characterised', 'by', 'gene', 'expression', 'arrays', 'and', 'quantitative', 'polymerase', 'chain', 'reaction', '(', 'qPCR', ')', ',', 'and', 'conditioned', 'media', 'was', 'used', 'in', 'proteomic', 'analyses', ',', 'a', 'human', 'chemokine', 'protein', 'array', ',', 'and', 'cell', 'migration', 'assays', 'to', 'characterise', 'the', 'composition', 'and', 'function', 'of', 'the', 'hepatocyte', 'SASP', '.']	[3, 5, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 5, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Senescent hepatocytes induced classical markers of senescence (p21, heterochromatin protein 1β, and senescence-associated-β-galactosidase activity); and downregulated the proliferation marker, Ki67.	[]	['Sen', '##es', '##cent', 'he', '##pa', '##to', '##cy', '##tes', 'induced', 'classical', 'markers', 'of', 'se', '##nes', '##cence', '(', 'p', '##21', ',', 'he', '##tero', '##ch', '##roma', '##tin', 'protein', '1', '##β', ',', 'and', 'se', '##nes', '##cence', '-', 'associated', '-', 'β', '-', 'gal', '##act', '##os', '##idas', '##e', 'activity', ')', ';', 'and', 'down', '##re', '##gu', '##lated', 'the', 'proliferation', 'marker', ',', 'Ki', '##6', '##7', '.']	[0, 3, 5, 10, 12, 14, 16, 18, 22, 30, 40, 48, 51, 53, 56, 62, 63, 64, 66, 68, 70, 74, 76, 80, 84, 92, 93, 94, 96, 100, 102, 105, 110, 111, 121, 122, 123, 124, 127, 130, 132, 136, 138, 146, 147, 149, 153, 157, 159, 161, 167, 171, 185, 191, 193, 195, 196, 197]	[3, 5, 9, 12, 14, 16, 18, 21, 29, 39, 47, 50, 53, 56, 61, 63, 64, 66, 67, 70, 74, 76, 80, 83, 91, 93, 94, 95, 99, 102, 105, 110, 111, 121, 122, 123, 124, 127, 130, 132, 136, 137, 146, 147, 148, 152, 157, 159, 161, 166, 170, 184, 191, 192, 195, 196, 197, 198]	['Senescent', 'hepatocytes', 'induced', 'classical', 'markers', 'of', 'senescence', '(', 'p21', ',', 'heterochromatin', 'protein', '1β', ',', 'and', 'senescence-associated-β-galactosidase', 'activity', ')', ';', 'and', 'downregulated', 'the', 'proliferation', 'marker', ',', 'Ki67', '.']	[3, 5, 1, 1, 1, 1, 3, 1, 2, 1, 5, 1, 2, 1, 1, 13, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
RNA was reverse-transcribed to cDNA using SuperScriptIII Reverse Transcriptase (Invitrogen).	[('PMC4273135', 'M04000', 57, 78, 'Reverse Transcriptase')]	['RNA', 'was', 'reverse', '-', 'trans', '##cribed', 'to', 'c', '##D', '##NA', 'using', 'Super', '##Script', '##II', '##I', 'Rev', '##erse', 'Trans', '##cript', '##ase', '(', 'In', '##vi', '##tro', '##gen', ')', '.']	[0, 4, 8, 15, 16, 21, 28, 31, 32, 33, 36, 42, 47, 53, 55, 57, 60, 65, 70, 75, 79, 80, 82, 84, 87, 90, 91]	[3, 7, 15, 16, 21, 27, 30, 32, 33, 35, 41, 47, 53, 55, 56, 60, 64, 70, 75, 78, 80, 82, 84, 87, 90, 91, 92]	['RNA', 'was', 'reverse', '-', 'transcribed', 'to', 'cDNA', 'using', 'SuperScriptIII', 'Reverse', 'Transcriptase', '(', 'Invitrogen', ')', '.']	[1, 1, 1, 1, 2, 1, 3, 1, 4, 2, 3, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PRKRA encodes protein kinase interferon-inducible double-stranded RNA-dependent activator (PACT), a cellular dsRNA-binding protein originally identified as a binding partner and activator of PKR in response to extracellular stress.46 More recently, it has been shown to be an essential factor in the PKR-independent initiation of RIG-I-induced antiviral response.47 Of note, individuals with AD are known to be susceptible to viral skin infections, but cutaneous infections rarely occur in psoriasis.48 MicroRNAs play a role in posttranscriptional regulation of gene expression by affecting the stability and translation of mRNAs, but the specific role of miRNA548n has not been defined.	[]	['PR', '##K', '##RA', 'en', '##codes', 'protein', 'kinase', 'inter', '##fer', '##on', '-', 'in', '##du', '##cible', 'double', '-', 'stranded', 'RNA', '-', 'dependent', 'act', '##iva', '##tor', '(', 'PA', '##CT', ')', ',', 'a', 'cellular', 'd', '##s', '##RNA', '-', 'binding', 'protein', 'originally', 'identified', 'as', 'a', 'binding', 'partner', 'and', 'act', '##iva', '##tor', 'of', 'P', '##K', '##R', 'in', 'response', 'to', 'extra', '##cellular', 'stress', '.', '46', 'More', 'recently', ',', 'it', 'has', 'been', 'shown', 'to', 'be', 'an', 'essential', 'factor', 'in', 'the', 'P', '##K', '##R', '-', 'independent', 'initiation', 'of', 'R', '##IG', '-', 'I', '-', 'induced', 'anti', '##vir', '##al', 'response', '.', '47', 'Of', 'note', ',', 'individuals', 'with', 'AD', 'are', 'known', 'to', 'be', 'susceptible', 'to', 'viral', 'skin', 'infections', ',', 'but', 'cut', '##aneous', 'infections', 'rarely', 'occur', 'in', 'ps', '##oria', '##sis', '.', '48', 'Micro', '##RNA', '##s', 'play', 'a', 'role', 'in', 'post', '##tra', '##ns', '##cription', '##al', 'regulation', 'of', 'gene', 'expression', 'by', 'affecting', 'the', 'stability', 'and', 'translation', 'of', 'm', '##RNA', '##s', ',', 'but', 'the', 'specific', 'role', 'of', 'mi', '##RNA', '##5', '##48', '##n', 'has', 'not', 'been', 'defined', '.']	[0, 2, 3, 6, 8, 14, 22, 29, 34, 37, 39, 40, 42, 44, 50, 56, 57, 66, 69, 70, 80, 83, 86, 90, 91, 93, 95, 96, 98, 100, 109, 110, 111, 114, 115, 123, 131, 142, 153, 156, 158, 166, 174, 178, 181, 184, 188, 191, 192, 193, 195, 198, 207, 210, 215, 224, 230, 231, 234, 239, 247, 249, 252, 256, 261, 267, 270, 273, 276, 286, 293, 296, 300, 301, 302, 303, 304, 316, 327, 330, 331, 333, 334, 335, 336, 344, 348, 351, 354, 362, 363, 366, 369, 373, 375, 387, 392, 395, 399, 405, 408, 411, 423, 426, 432, 437, 447, 449, 453, 456, 463, 474, 481, 487, 490, 492, 496, 499, 500, 503, 508, 511, 513, 518, 520, 525, 528, 532, 535, 537, 545, 548, 559, 562, 567, 578, 581, 591, 595, 605, 609, 621, 624, 625, 628, 629, 631, 635, 639, 648, 653, 656, 658, 661, 662, 664, 666, 670, 674, 679, 686]	[2, 3, 5, 8, 13, 21, 28, 34, 37, 39, 40, 42, 44, 49, 56, 57, 65, 69, 70, 79, 83, 86, 89, 91, 93, 95, 96, 97, 99, 108, 110, 111, 114, 115, 122, 130, 141, 152, 155, 157, 165, 173, 177, 181, 184, 187, 190, 192, 193, 194, 197, 206, 209, 215, 223, 230, 231, 233, 238, 247, 248, 251, 255, 260, 266, 269, 272, 275, 285, 292, 295, 299, 301, 302, 303, 304, 315, 326, 329, 331, 333, 334, 335, 336, 343, 348, 351, 353, 362, 363, 365, 368, 373, 374, 386, 391, 394, 398, 404, 407, 410, 422, 425, 431, 436, 447, 448, 452, 456, 462, 473, 480, 486, 489, 492, 496, 499, 500, 502, 508, 511, 512, 517, 519, 524, 527, 532, 535, 537, 545, 547, 558, 561, 566, 577, 580, 590, 594, 604, 608, 620, 623, 625, 628, 629, 630, 634, 638, 647, 652, 655, 658, 661, 662, 664, 665, 669, 673, 678, 686, 687]	['PRKRA', 'encodes', 'protein', 'kinase', 'interferon', '-', 'inducible', 'double', '-', 'stranded', 'RNA-dependent', 'activator', '(', 'PACT', ')', ',', 'a', 'cellular', 'dsRNA', '-', 'binding', 'protein', 'originally', 'identified', 'as', 'a', 'binding', 'partner', 'and', 'activator', 'of', 'PKR', 'in', 'response', 'to', 'extracellular', 'stress.46', 'More', 'recently', ',', 'it', 'has', 'been', 'shown', 'to', 'be', 'an', 'essential', 'factor', 'in', 'the', 'PKR', '-', 'independent', 'initiation', 'of', 'RIG-I-induced', 'antiviral', 'response.47', 'Of', 'note', ',', 'individuals', 'with', 'AD', 'are', 'known', 'to', 'be', 'susceptible', 'to', 'viral', 'skin', 'infections', ',', 'but', 'cutaneous', 'infections', 'rarely', 'occur', 'in', 'psoriasis.48', 'MicroRNAs', 'play', 'a', 'role', 'in', 'posttranscriptional', 'regulation', 'of', 'gene', 'expression', 'by', 'affecting', 'the', 'stability', 'and', 'translation', 'of', 'mRNAs', ',', 'but', 'the', 'specific', 'role', 'of', 'miRNA548n', 'has', 'not', 'been', 'defined', '.']	[3, 2, 1, 1, 3, 1, 3, 1, 1, 1, 3, 3, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 6, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The concentrations of HX and X in sera were quantified using the Amplex Red Xanthine/Xanthine Oxidase Assay Kit (Molecular Probes Inc., Eugene, OR) and the level of PEP in serum was determined using the PEP Colorimetric/Fluorometric Assay Kit (BioVision Inc., Milpitas, CA) according to the manufacturers’ instructions.	[]	['The', 'concentrations', 'of', 'H', '##X', 'and', 'X', 'in', 'se', '##ra', 'were', 'q', '##uant', '##ified', 'using', 'the', 'Am', '##plex', 'Red', 'X', '##ant', '##hine', '/', 'X', '##ant', '##hine', 'O', '##xi', '##das', '##e', 'As', '##say', 'Kit', '(', 'Molecular', 'Pro', '##bes', 'Inc', '.', ',', 'Eugene', ',', 'OR', ')', 'and', 'the', 'level', 'of', 'P', '##EP', 'in', 'serum', 'was', 'determined', 'using', 'the', 'P', '##EP', 'Color', '##ime', '##tric', '/', 'F', '##lu', '##oro', '##metric', 'As', '##say', 'Kit', '(', 'B', '##io', '##V', '##ision', 'Inc', '.', ',', 'Mi', '##l', '##pit', '##as', ',', 'CA', ')', 'according', 'to', 'the', 'manufacturers', '’', 'instructions', '.']	[0, 4, 19, 22, 23, 25, 29, 31, 34, 36, 39, 44, 45, 49, 55, 61, 65, 67, 72, 76, 77, 80, 84, 85, 86, 89, 94, 95, 97, 100, 102, 104, 108, 112, 113, 123, 126, 130, 133, 134, 136, 142, 144, 146, 148, 152, 156, 162, 165, 166, 169, 172, 178, 182, 193, 199, 203, 204, 207, 212, 215, 219, 220, 221, 223, 226, 233, 235, 239, 243, 244, 245, 247, 248, 254, 257, 258, 260, 262, 263, 266, 268, 270, 272, 274, 284, 287, 291, 304, 306, 318]	[3, 18, 21, 23, 24, 28, 30, 33, 36, 38, 43, 45, 49, 54, 60, 64, 67, 71, 75, 77, 80, 84, 85, 86, 89, 93, 95, 97, 100, 101, 104, 107, 111, 113, 122, 126, 129, 133, 134, 135, 142, 143, 146, 147, 151, 155, 161, 164, 166, 168, 171, 177, 181, 192, 198, 202, 204, 206, 212, 215, 219, 220, 221, 223, 226, 232, 235, 238, 242, 244, 245, 247, 248, 253, 257, 258, 259, 262, 263, 266, 268, 269, 272, 273, 283, 286, 290, 304, 305, 318, 319]	['The', 'concentrations', 'of', 'HX', 'and', 'X', 'in', 'sera', 'were', 'quantified', 'using', 'the', 'Amplex', 'Red', 'Xanthine', '/', 'Xanthine', 'Oxidase', 'Assay', 'Kit', '(', 'Molecular', 'Probes', 'Inc', '.', ',', 'Eugene', ',', 'OR', ')', 'and', 'the', 'level', 'of', 'PEP', 'in', 'serum', 'was', 'determined', 'using', 'the', 'PEP', 'Colorimetric', '/', 'Fluorometric', 'Assay', 'Kit', '(', 'BioVision', 'Inc', '.', ',', 'Milpitas', ',', 'CA', ')', 'according', 'to', 'the', 'manufacturers', '’', 'instructions', '.']	[1, 1, 1, 2, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 3, 1, 3, 4, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 2, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Results: Among European-ancestry participants, 31 SNPs in or near the fatty acid desaturase (FADS) 1 and 2 cluster were associated with cis/trans-18:2; a top hit was rs174548 (β = 0.0035, P = 4.90 × 10−15), an SNP previously associated with circulating n–3 and n–6 polyunsaturated fatty acid concentrations.	[('PMC4307209', 'A03000', 70, 91, 'fatty acid desaturase')]	['Results', ':', 'Among', 'European', '-', 'ancestry', 'participants', ',', '31', 'S', '##NP', '##s', 'in', 'or', 'near', 'the', 'fatty', 'acid', 'des', '##at', '##ura', '##se', '(', 'FA', '##DS', ')', '1', 'and', '2', 'cluster', 'were', 'associated', 'with', 'c', '##is', '/', 'trans', '-', '18', ':', '2', ';', 'a', 'top', 'hit', 'was', 'r', '##s', '##17', '##45', '##48', '(', 'β', '=', '0', '.', '00', '##35', ',', 'P', '=', '4', '.', '90', '×', '10', '##−', '##15', ')', ',', 'an', 'S', '##NP', 'previously', 'associated', 'with', 'circulating', 'n', '–', '3', 'and', 'n', '–', '6', 'p', '##oly', '##uns', '##at', '##ura', '##ted', 'fatty', 'acid', 'concentrations', '.']	[0, 7, 9, 15, 23, 24, 33, 45, 47, 50, 51, 53, 55, 58, 61, 66, 70, 76, 81, 84, 86, 89, 92, 93, 95, 97, 99, 101, 105, 107, 115, 120, 131, 136, 137, 139, 140, 145, 146, 148, 149, 150, 152, 154, 158, 162, 166, 167, 168, 170, 172, 175, 176, 178, 180, 181, 182, 184, 186, 188, 190, 192, 193, 194, 197, 199, 201, 202, 204, 205, 207, 210, 211, 214, 225, 236, 241, 253, 254, 255, 257, 261, 262, 263, 265, 266, 269, 272, 274, 277, 281, 287, 292, 306]	[7, 8, 14, 23, 24, 32, 45, 46, 49, 51, 53, 54, 57, 60, 65, 69, 75, 80, 84, 86, 89, 91, 93, 95, 97, 98, 100, 104, 106, 114, 119, 130, 135, 137, 139, 140, 145, 146, 148, 149, 150, 151, 153, 157, 161, 165, 167, 168, 170, 172, 174, 176, 177, 179, 181, 182, 184, 186, 187, 189, 191, 193, 194, 196, 198, 201, 202, 204, 205, 206, 209, 211, 213, 224, 235, 240, 252, 254, 255, 256, 260, 262, 263, 264, 266, 269, 272, 274, 277, 280, 286, 291, 306, 307]	['Results', ':', 'Among', 'European', '-', 'ancestry', 'participants', ',', '31', 'SNPs', 'in', 'or', 'near', 'the', 'fatty', 'acid', 'desaturase', '(', 'FADS', ')', '1', 'and', '2', 'cluster', 'were', 'associated', 'with', 'cis', '/', 'trans-18', ':', '2', ';', 'a', 'top', 'hit', 'was', 'rs174548', '(', 'β', '=', '0.0035', ',', 'P', '=', '4.90', '×', '10−15', ')', ',', 'an', 'SNP', 'previously', 'associated', 'with', 'circulating', 'n', '–', '3', 'and', 'n', '–', '6', 'polyunsaturated', 'fatty', 'acid', 'concentrations', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 4, 1, 1, 1, 3, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The FADS1/2 cluster encodes fatty acid desaturase enzymes that regulate endogenous metabolism of cis n–3 and n–6 PUFA (20, 22).	[('PMC4307209', 'D01000', 28, 49, 'fatty acid desaturase')]	['The', 'FA', '##DS', '##1', '/', '2', 'cluster', 'en', '##codes', 'fatty', 'acid', 'des', '##at', '##ura', '##se', 'enzymes', 'that', 'regulate', 'end', '##ogen', '##ous', 'metabolism', 'of', 'c', '##is', 'n', '–', '3', 'and', 'n', '–', '6', 'P', '##U', '##FA', '(', '20', ',', '22', ')', '.']	[0, 4, 6, 8, 9, 10, 12, 20, 22, 28, 34, 39, 42, 44, 47, 50, 58, 63, 72, 75, 79, 83, 94, 97, 98, 101, 102, 103, 105, 109, 110, 111, 113, 114, 115, 118, 119, 121, 123, 125, 126]	[3, 6, 8, 9, 10, 11, 19, 22, 27, 33, 38, 42, 44, 47, 49, 57, 62, 71, 75, 79, 82, 93, 96, 98, 100, 102, 103, 104, 108, 110, 111, 112, 114, 115, 117, 119, 121, 122, 125, 126, 127]	['The', 'FADS1', '/', '2', 'cluster', 'encodes', 'fatty', 'acid', 'desaturase', 'enzymes', 'that', 'regulate', 'endogenous', 'metabolism', 'of', 'cis', 'n', '–', '3', 'and', 'n', '–', '6', 'PUFA', '(', '20', ',', '22', ')', '.']	[1, 3, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
HTAU is a product of enzyme cysteamine dioxygenase in taurine and hypotaurine metabolic pathway.	[('PMC4312632', 'D04000', 28, 50, 'cysteamine dioxygenase')]	['H', '##TA', '##U', 'is', 'a', 'product', 'of', 'enzyme', 'c', '##ys', '##te', '##amine', 'di', '##ox', '##y', '##gen', '##ase', 'in', 'ta', '##uri', '##ne', 'and', 'h', '##y', '##pot', '##au', '##rine', 'metabolic', 'pathway', '.']	[0, 1, 3, 5, 8, 10, 18, 21, 28, 29, 31, 33, 39, 41, 43, 44, 47, 51, 54, 56, 59, 62, 66, 67, 68, 71, 73, 78, 88, 95]	[1, 3, 4, 7, 9, 17, 20, 27, 29, 31, 33, 38, 41, 43, 44, 47, 50, 53, 56, 59, 61, 65, 67, 68, 71, 73, 77, 87, 95, 96]	['HTAU', 'is', 'a', 'product', 'of', 'enzyme', 'cysteamine', 'dioxygenase', 'in', 'taurine', 'and', 'hypotaurine', 'metabolic', 'pathway', '.']	[3, 1, 1, 1, 1, 1, 4, 5, 1, 3, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our analysis revealed two notable variants: rs9839776 (P=3.01×10-7) in SOX2OT (SOX2 overlapping transcript) and rs17030795 (P=5.84×10-6) in PPP3CA (protein phosphatase 3, catalytic subunit, alpha isozyme) (Table 2).	[('PMC4325090', 'R02000', 148, 169, 'protein phosphatase 3')]	['Our', 'analysis', 'revealed', 'two', 'notable', 'variants', ':', 'r', '##s', '##9', '##8', '##39', '##7', '##7', '##6', '(', 'P', '=', '3', '.', '01', '##×', '##10', '-', '7', ')', 'in', 'S', '##OX', '##2', '##OT', '(', 'S', '##OX', '##2', 'overlapping', 'trans', '##cript', ')', 'and', 'r', '##s', '##17', '##0', '##30', '##7', '##9', '##5', '(', 'P', '=', '5', '.', '84', '##×', '##10', '-', '6', ')', 'in', 'PP', '##P', '##3', '##CA', '(', 'protein', 'p', '##hos', '##pha', '##tase', '3', ',', 'cat', '##alytic', 'subunit', ',', 'alpha', 'is', '##oz', '##yme', ')', '(', 'Table', '2', ')', '.']	[0, 4, 13, 22, 26, 34, 42, 44, 45, 46, 47, 48, 50, 51, 52, 54, 55, 56, 57, 58, 59, 61, 62, 64, 65, 66, 68, 71, 72, 74, 75, 78, 79, 80, 82, 84, 96, 101, 106, 108, 112, 113, 114, 116, 117, 119, 120, 121, 123, 124, 125, 126, 127, 128, 130, 131, 133, 134, 135, 137, 140, 142, 143, 144, 147, 148, 156, 157, 160, 163, 168, 169, 171, 174, 181, 188, 190, 196, 198, 200, 203, 205, 206, 212, 213, 214]	[3, 12, 21, 25, 33, 42, 43, 45, 46, 47, 48, 50, 51, 52, 53, 55, 56, 57, 58, 59, 61, 62, 64, 65, 66, 67, 70, 72, 74, 75, 77, 79, 80, 82, 83, 95, 101, 106, 107, 111, 113, 114, 116, 117, 119, 120, 121, 122, 124, 125, 126, 127, 128, 130, 131, 133, 134, 135, 136, 139, 142, 143, 144, 146, 148, 155, 157, 160, 163, 167, 169, 170, 174, 180, 188, 189, 195, 198, 200, 203, 204, 206, 211, 213, 214, 215]	['Our', 'analysis', 'revealed', 'two', 'notable', 'variants', ':', 'rs9839776', '(', 'P=3.01×10-7', ')', 'in', 'SOX2OT', '(', 'SOX2', 'overlapping', 'transcript', ')', 'and', 'rs17030795', '(', 'P=5.84×10-6', ')', 'in', 'PPP3CA', '(', 'protein', 'phosphatase', '3', ',', 'catalytic', 'subunit', ',', 'alpha', 'isozyme', ')', '(', 'Table', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 8, 1, 9, 1, 1, 4, 1, 3, 1, 2, 1, 1, 8, 1, 9, 1, 1, 4, 1, 1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the AN restricting subtype analyses, the two most significant signals were rs1523921 (as in the main analysis, P=8.39×10-5) and rs10777211 (P=8.95×10-5) located 333kb from ATP2B1 (ATPase, calcium transporting, plasma membrane 1), both detected in the European-only analysis (Table S6).	[('PMC4325090', 'R03000', 183, 189, 'ATPase')]	['In', 'the', 'AN', 'restrict', '##ing', 'sub', '##type', 'analyses', ',', 'the', 'two', 'most', 'significant', 'signals', 'were', 'r', '##s', '##15', '##23', '##9', '##21', '(', 'as', 'in', 'the', 'main', 'analysis', ',', 'P', '=', '8', '.', '39', '##×', '##10', '-', '5', ')', 'and', 'r', '##s', '##10', '##7', '##7', '##7', '##21', '##1', '(', 'P', '=', '8', '.', '95', '##×', '##10', '-', '5', ')', 'located', '333', '##k', '##b', 'from', 'ATP', '##2', '##B', '##1', '(', 'ATP', '##ase', ',', 'calcium', 'transporting', ',', 'plasma', 'membrane', '1', ')', ',', 'both', 'detected', 'in', 'the', 'European', '-', 'only', 'analysis', '(', 'Table', 'S', '##6', ')', '.']	[0, 3, 7, 10, 18, 22, 25, 30, 38, 40, 44, 48, 53, 65, 73, 78, 79, 80, 82, 84, 85, 88, 89, 92, 95, 99, 104, 112, 114, 115, 116, 117, 118, 120, 121, 123, 124, 125, 127, 131, 132, 133, 135, 136, 137, 138, 140, 142, 143, 144, 145, 146, 147, 149, 150, 152, 153, 154, 156, 164, 167, 168, 170, 175, 178, 179, 180, 182, 183, 186, 189, 191, 199, 211, 213, 220, 229, 230, 231, 233, 238, 247, 250, 254, 262, 263, 268, 277, 278, 284, 285, 286, 287]	[2, 6, 9, 18, 21, 25, 29, 38, 39, 43, 47, 52, 64, 72, 77, 79, 80, 82, 84, 85, 87, 89, 91, 94, 98, 103, 112, 113, 115, 116, 117, 118, 120, 121, 123, 124, 125, 126, 130, 132, 133, 135, 136, 137, 138, 140, 141, 143, 144, 145, 146, 147, 149, 150, 152, 153, 154, 155, 163, 167, 168, 169, 174, 178, 179, 180, 181, 183, 186, 189, 190, 198, 211, 212, 219, 228, 230, 231, 232, 237, 246, 249, 253, 262, 263, 267, 276, 278, 283, 285, 286, 287, 288]	['In', 'the', 'AN', 'restricting', 'subtype', 'analyses', ',', 'the', 'two', 'most', 'significant', 'signals', 'were', 'rs1523921', '(', 'as', 'in', 'the', 'main', 'analysis', ',', 'P=8.39×10-5', ')', 'and', 'rs10777211', '(', 'P=8.95×10-5', ')', 'located', '333kb', 'from', 'ATP2B1', '(', 'ATPase', ',', 'calcium', 'transporting', ',', 'plasma', 'membrane', '1', ')', ',', 'both', 'detected', 'in', 'the', 'European', '-', 'only', 'analysis', '(', 'Table', 'S6', ')', '.']	[1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 9, 1, 1, 8, 1, 9, 1, 1, 3, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each PCR reaction contained: 2.5 μL 10X High Fidelity PCR Buffer, 1 μL 50 mM magnesium sulfate, 0.5 μL 2.5 mM dNTPs, 0.1 μL Platinum® Taq DNA Polymerase High Fidelity, 18.4 μL PCR-grade autoclaved water, and 0.5 μL 10 μM 515 F primer (5′—AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT ATG GTA ATT GTG TGC CAG CMG CCG CGG TAA—3′ Caporaso et al., 2010c) composed of an Illumina adapter, a forward primer pad, a two-base linker sequence (“GT”) and the 16S rRNA gene-targeting primer (underlined).	[]	['Each', 'PC', '##R', 'reaction', 'contained', ':', '2', '.', '5', 'μ', '##L', '10', '##X', 'High', 'Fi', '##delity', 'PC', '##R', 'B', '##uff', '##er', ',', '1', 'μ', '##L', '50', 'm', '##M', 'ma', '##gnesium', 'su', '##lf', '##ate', ',', '0', '.', '5', 'μ', '##L', '2', '.', '5', 'm', '##M', 'd', '##NT', '##Ps', ',', '0', '.', '1', 'μ', '##L', 'Platinum', '®', 'Ta', '##q', 'DNA', 'Pol', '##yme', '##rase', 'High', 'Fi', '##delity', ',', '18', '.', '4', 'μ', '##L', 'PC', '##R', '-', 'grade', 'auto', '##clave', '##d', 'water', ',', 'and', '0', '.', '5', 'μ', '##L', '10', 'μ', '##M', '51', '##5', 'F', 'prime', '##r', '(', '5', '′', '—', 'AA', '##T', 'GA', '##T', 'AC', '##G', 'G', '##C', '##G', 'ACC', 'ACC', 'GA', '##G', 'AT', '##C', 'T', '##AC', 'ACT', 'AT', '##G', 'GT', '##A', 'AT', '##T', 'GT', '##G', 'T', '##GC', 'CA', '##G', 'C', '##MG', 'CC', '##G', 'C', '##G', '##G', 'T', '##AA', '—', '3', '′', 'Cap', '##ora', '##so', 'et', 'al', '.', ',', '2010', '##c', ')', 'composed', 'of', 'an', 'Il', '##lum', '##ina', 'adapt', '##er', ',', 'a', 'forward', 'prime', '##r', 'pad', ',', 'a', 'two', '-', 'base', 'link', '##er', 'sequence', '(', '“', 'GT', '”', ')', 'and', 'the', '16', '##S', 'r', '##RNA', 'gene', '-', 'targeting', 'prime', '##r', '(', 'under', '##lined', ')', '.']	[0, 5, 7, 9, 18, 27, 29, 30, 31, 33, 34, 36, 38, 40, 45, 47, 54, 56, 58, 59, 62, 64, 66, 68, 69, 71, 74, 75, 77, 79, 87, 89, 91, 94, 96, 97, 98, 100, 101, 103, 104, 105, 107, 108, 110, 111, 113, 115, 117, 118, 119, 121, 122, 124, 132, 134, 136, 138, 142, 145, 148, 153, 158, 160, 166, 168, 170, 171, 173, 174, 176, 178, 179, 180, 186, 190, 195, 197, 202, 204, 208, 209, 210, 212, 213, 215, 218, 219, 221, 223, 225, 227, 232, 234, 235, 236, 237, 238, 240, 242, 244, 246, 248, 250, 251, 252, 254, 258, 262, 264, 266, 268, 270, 271, 274, 278, 280, 282, 284, 286, 288, 290, 292, 294, 295, 298, 300, 302, 303, 306, 308, 310, 311, 312, 314, 315, 317, 318, 319, 321, 324, 327, 330, 333, 335, 336, 338, 342, 343, 345, 354, 357, 360, 362, 365, 369, 374, 376, 378, 380, 388, 393, 395, 398, 400, 402, 405, 406, 411, 415, 418, 427, 428, 429, 431, 432, 434, 438, 442, 444, 446, 447, 451, 455, 456, 466, 471, 473, 474, 479, 484, 485]	[4, 7, 8, 17, 27, 28, 30, 31, 32, 34, 35, 38, 39, 44, 47, 53, 56, 57, 59, 62, 64, 65, 67, 69, 70, 73, 75, 76, 79, 86, 89, 91, 94, 95, 97, 98, 99, 101, 102, 104, 105, 106, 108, 109, 111, 113, 115, 116, 118, 119, 120, 122, 123, 132, 133, 136, 137, 141, 145, 148, 152, 157, 160, 166, 167, 170, 171, 172, 174, 175, 178, 179, 180, 185, 190, 195, 196, 202, 203, 207, 209, 210, 211, 213, 214, 217, 219, 220, 223, 224, 226, 232, 233, 235, 236, 237, 238, 240, 241, 244, 245, 248, 249, 251, 252, 253, 257, 261, 264, 265, 268, 269, 271, 273, 277, 280, 281, 284, 285, 288, 289, 292, 293, 295, 297, 300, 301, 303, 305, 308, 309, 311, 312, 313, 315, 317, 318, 319, 320, 324, 327, 329, 332, 335, 336, 337, 342, 343, 344, 353, 356, 359, 362, 365, 368, 374, 376, 377, 379, 387, 393, 394, 398, 399, 401, 405, 406, 410, 415, 417, 426, 428, 429, 431, 432, 433, 437, 441, 444, 445, 447, 450, 455, 456, 465, 471, 472, 474, 479, 484, 485, 486]	['Each', 'PCR', 'reaction', 'contained', ':', '2.5', 'μL', '10X', 'High', 'Fidelity', 'PCR', 'Buffer', ',', '1', 'μL', '50', 'mM', 'magnesium', 'sulfate', ',', '0.5', 'μL', '2.5', 'mM', 'dNTPs', ',', '0.1', 'μL', 'Platinum', '®', 'Taq', 'DNA', 'Polymerase', 'High', 'Fidelity', ',', '18.4', 'μL', 'PCR-grade', 'autoclaved', 'water', ',', 'and', '0.5', 'μL', '10', 'μM', '515', 'F', 'primer', '(', '5′—', 'AAT', 'GAT', 'ACG', 'GCG', 'ACC', 'ACC', 'GAG', 'ATC', 'TAC', 'ACT', 'ATG', 'GTA', 'ATT', 'GTG', 'TGC', 'CAG', 'CMG', 'CCG', 'CGG', 'TAA', '—', '3′', 'Caporaso', 'et', 'al', '.', ',', '2010c', ')', 'composed', 'of', 'an', 'Illumina', 'adapter', ',', 'a', 'forward', 'primer', 'pad', ',', 'a', 'two', '-', 'base', 'linker', 'sequence', '(', '“', 'GT', '”', ')', 'and', 'the', '16S', 'rRNA', 'gene', '-', 'targeting', 'primer', '(', 'underlined', ')', '.']	[1, 2, 1, 1, 1, 3, 2, 2, 1, 2, 2, 3, 1, 1, 2, 1, 2, 2, 3, 1, 3, 2, 3, 2, 3, 1, 3, 2, 1, 1, 2, 1, 3, 1, 2, 1, 3, 2, 4, 3, 1, 1, 1, 3, 2, 1, 2, 2, 1, 2, 1, 3, 2, 2, 2, 3, 1, 1, 2, 2, 2, 1, 2, 2, 2, 2, 2, 2, 2, 2, 3, 2, 1, 2, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Regorafenib, a multi-kinase inhibitor, is used in the treatment of patients with metastatic colorectal cancer refractory to standard therapy.	[('PMC4332724', 'A00000', 15, 27, 'multi-kinase')]	['Reg', '##ora', '##fen', '##ib', ',', 'a', 'multi', '-', 'kinase', 'inhibitor', ',', 'is', 'used', 'in', 'the', 'treatment', 'of', 'patients', 'with', 'meta', '##static', 'color', '##ec', '##tal', 'cancer', 're', '##fra', '##ctor', '##y', 'to', 'standard', 'therapy', '.']	[0, 3, 6, 9, 11, 13, 15, 20, 21, 28, 37, 39, 42, 47, 50, 54, 64, 67, 76, 81, 85, 92, 97, 99, 103, 110, 112, 115, 119, 121, 124, 133, 140]	[3, 6, 9, 11, 12, 14, 20, 21, 27, 37, 38, 41, 46, 49, 53, 63, 66, 75, 80, 85, 91, 97, 99, 102, 109, 112, 115, 119, 120, 123, 132, 140, 141]	['Regorafenib', ',', 'a', 'multi', '-', 'kinase', 'inhibitor', ',', 'is', 'used', 'in', 'the', 'treatment', 'of', 'patients', 'with', 'metastatic', 'colorectal', 'cancer', 'refractory', 'to', 'standard', 'therapy', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Regorafenib is a multi-kinase inhibitor with activity in nanomolar concentration range against VEGFR1-3, PDGFR, C-KIT, RET, TIE-2, C-RAF, B-RAF, p38-αand FGFR1.	[('PMC4332724', 'I00000', 17, 29, 'multi-kinase')]	['Reg', '##ora', '##fen', '##ib', 'is', 'a', 'multi', '-', 'kinase', 'inhibitor', 'with', 'activity', 'in', 'na', '##no', '##mo', '##lar', 'concentration', 'range', 'against', 'V', '##EG', '##F', '##R', '##1', '-', '3', ',', 'PD', '##G', '##F', '##R', ',', 'C', '-', 'K', '##IT', ',', 'R', '##ET', ',', 'T', '##IE', '-', '2', ',', 'C', '-', 'RAF', ',', 'B', '-', 'RAF', ',', 'p', '##38', '-', 'α', '##and', 'F', '##G', '##F', '##R', '##1', '.']	[0, 3, 6, 9, 12, 15, 17, 22, 23, 30, 40, 45, 54, 57, 59, 61, 63, 67, 81, 87, 95, 96, 98, 99, 100, 101, 102, 103, 105, 107, 108, 109, 110, 112, 113, 114, 115, 117, 119, 120, 122, 124, 125, 127, 128, 129, 131, 132, 133, 136, 138, 139, 140, 143, 145, 146, 148, 149, 150, 154, 155, 156, 157, 158, 159]	[3, 6, 9, 11, 14, 16, 22, 23, 29, 39, 44, 53, 56, 59, 61, 63, 66, 80, 86, 94, 96, 98, 99, 100, 101, 102, 103, 104, 107, 108, 109, 110, 111, 113, 114, 115, 117, 118, 120, 122, 123, 125, 127, 128, 129, 130, 132, 133, 136, 137, 139, 140, 143, 144, 146, 148, 149, 150, 153, 155, 156, 157, 158, 159, 160]	['Regorafenib', 'is', 'a', 'multi', '-', 'kinase', 'inhibitor', 'with', 'activity', 'in', 'nanomolar', 'concentration', 'range', 'against', 'VEGFR1-3', ',', 'PDGFR', ',', 'C-KIT', ',', 'RET', ',', 'TIE-2', ',', 'C-RAF', ',', 'B-RAF', ',', 'p38-αand', 'FGFR1', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 7, 1, 4, 1, 4, 1, 2, 1, 4, 1, 3, 1, 3, 1, 5, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
IHC stains used included phosphorylated VEGFR2 (pVEGFR2), total VEGFR2, phosphorylated ERK (pERK), total ERK, CD31, phosphorylated c-Kit (pKIT), total c-Kit, phosphorylated MEK (pMEK), phosphorylated JUN (pJUN), phosphorylated JNK (pJNK), podoplanin, phosphorylated STAT3 (pSTAT3), total STAT3, phosphorylated AKT (pAKT), total AKT, phosphorylated MET (pMET), cMET, HGF, phosphorylated p70 S6 kinase Thr389 (pp70S6K), phosphorylated SRC (pSRC), and total SRC.	[('PMC4332724', 'M06000', 390, 399, 'S6 kinase')]	['I', '##HC', 'stain', '##s', 'used', 'included', 'p', '##hos', '##ph', '##ory', '##lated', 'V', '##EG', '##F', '##R', '##2', '(', 'p', '##VE', '##G', '##F', '##R', '##2', ')', ',', 'total', 'V', '##EG', '##F', '##R', '##2', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'ER', '##K', '(', 'p', '##ER', '##K', ')', ',', 'total', 'ER', '##K', ',', 'CD', '##31', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'c', '-', 'Kit', '(', 'p', '##K', '##IT', ')', ',', 'total', 'c', '-', 'Kit', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'ME', '##K', '(', 'p', '##ME', '##K', ')', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'J', '##UN', '(', 'p', '##J', '##UN', ')', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'J', '##N', '##K', '(', 'p', '##J', '##N', '##K', ')', ',', 'pod', '##op', '##lani', '##n', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'ST', '##AT', '##3', '(', 'p', '##ST', '##AT', '##3', ')', ',', 'total', 'ST', '##AT', '##3', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'AK', '##T', '(', 'p', '##A', '##K', '##T', ')', ',', 'total', 'AK', '##T', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'ME', '##T', '(', 'p', '##ME', '##T', ')', ',', 'c', '##ME', '##T', ',', 'H', '##G', '##F', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'p', '##70', 'S', '##6', 'kinase', 'T', '##hr', '##38', '##9', '(', 'pp', '##70', '##S', '##6', '##K', ')', ',', 'p', '##hos', '##ph', '##ory', '##lated', 'SR', '##C', '(', 'p', '##SR', '##C', ')', ',', 'and', 'total', 'SR', '##C', '.']	[0, 1, 4, 9, 11, 16, 25, 26, 29, 31, 34, 40, 41, 43, 44, 45, 47, 48, 49, 51, 52, 53, 54, 55, 56, 58, 64, 65, 67, 68, 69, 70, 72, 73, 76, 78, 81, 87, 89, 91, 92, 93, 95, 96, 97, 99, 105, 107, 108, 110, 112, 114, 116, 117, 120, 122, 125, 131, 132, 133, 137, 138, 139, 140, 142, 143, 145, 151, 152, 153, 156, 158, 159, 162, 164, 167, 173, 175, 177, 178, 179, 181, 182, 183, 185, 186, 189, 191, 194, 200, 201, 204, 205, 206, 207, 209, 210, 212, 213, 216, 218, 221, 227, 228, 229, 231, 232, 233, 234, 235, 236, 237, 239, 242, 244, 248, 249, 251, 252, 255, 257, 260, 266, 268, 270, 272, 273, 274, 276, 278, 279, 280, 282, 288, 290, 292, 293, 295, 296, 299, 301, 304, 310, 312, 314, 315, 316, 317, 318, 319, 320, 322, 328, 330, 331, 333, 334, 337, 339, 342, 348, 350, 352, 353, 354, 356, 357, 358, 360, 361, 363, 364, 366, 367, 368, 369, 371, 372, 375, 377, 380, 386, 387, 390, 391, 393, 400, 401, 403, 405, 407, 408, 410, 412, 413, 414, 415, 416, 418, 419, 422, 424, 427, 433, 435, 437, 438, 439, 441, 442, 443, 445, 449, 455, 457, 458]	[1, 3, 9, 10, 15, 24, 26, 29, 31, 34, 39, 41, 43, 44, 45, 46, 48, 49, 51, 52, 53, 54, 55, 56, 57, 63, 65, 67, 68, 69, 70, 71, 73, 76, 78, 81, 86, 89, 90, 92, 93, 95, 96, 97, 98, 104, 107, 108, 109, 112, 114, 115, 117, 120, 122, 125, 130, 132, 133, 136, 138, 139, 140, 142, 143, 144, 150, 152, 153, 156, 157, 159, 162, 164, 167, 172, 175, 176, 178, 179, 181, 182, 183, 184, 186, 189, 191, 194, 199, 201, 203, 205, 206, 207, 209, 210, 211, 213, 216, 218, 221, 226, 228, 229, 230, 232, 233, 234, 235, 236, 237, 238, 242, 244, 248, 249, 250, 252, 255, 257, 260, 265, 268, 270, 271, 273, 274, 276, 278, 279, 280, 281, 287, 290, 292, 293, 294, 296, 299, 301, 304, 309, 312, 313, 315, 316, 317, 318, 319, 320, 321, 327, 330, 331, 332, 334, 337, 339, 342, 347, 350, 351, 353, 354, 356, 357, 358, 359, 361, 363, 364, 365, 367, 368, 369, 370, 372, 375, 377, 380, 385, 387, 389, 391, 392, 399, 401, 403, 405, 406, 408, 410, 412, 413, 414, 415, 416, 417, 419, 422, 424, 427, 432, 435, 436, 438, 439, 441, 442, 443, 444, 448, 454, 457, 458, 459]	['IHC', 'stains', 'used', 'included', 'phosphorylated', 'VEGFR2', '(', 'pVEGFR2', ')', ',', 'total', 'VEGFR2', ',', 'phosphorylated', 'ERK', '(', 'pERK', ')', ',', 'total', 'ERK', ',', 'CD31', ',', 'phosphorylated', 'c-Kit', '(', 'pKIT', ')', ',', 'total', 'c-Kit', ',', 'phosphorylated', 'MEK', '(', 'pMEK', ')', ',', 'phosphorylated', 'JUN', '(', 'pJUN', ')', ',', 'phosphorylated', 'JNK', '(', 'pJNK', ')', ',', 'podoplanin', ',', 'phosphorylated', 'STAT3', '(', 'pSTAT3', ')', ',', 'total', 'STAT3', ',', 'phosphorylated', 'AKT', '(', 'pAKT', ')', ',', 'total', 'AKT', ',', 'phosphorylated', 'MET', '(', 'pMET', ')', ',', 'cMET', ',', 'HGF', ',', 'phosphorylated', 'p70', 'S6', 'kinase', 'Thr389', '(', 'pp70S6K', ')', ',', 'phosphorylated', 'SRC', '(', 'pSRC', ')', ',', 'and', 'total', 'SRC', '.']	[2, 2, 1, 1, 5, 5, 1, 6, 1, 1, 1, 5, 1, 5, 2, 1, 3, 1, 1, 1, 2, 1, 2, 1, 5, 3, 1, 3, 1, 1, 1, 3, 1, 5, 2, 1, 3, 1, 1, 5, 2, 1, 3, 1, 1, 5, 3, 1, 4, 1, 1, 4, 1, 5, 3, 1, 4, 1, 1, 1, 3, 1, 5, 2, 1, 4, 1, 1, 1, 2, 1, 5, 2, 1, 3, 1, 1, 3, 1, 3, 1, 5, 2, 2, 1, 4, 1, 5, 1, 1, 5, 2, 1, 3, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Staphylococcus aureus and other coagulase-positive staphylococci (CPS) colonize skin and mucous membrane sites and can cause skin and soft tissue infections (SSTIs) in humans and animals.	[('PMC4335418', 'A00000', 32, 41, 'coagulase')]	['St', '##aph', '##yl', '##oc', '##oc', '##cus', 'au', '##reus', 'and', 'other', 'co', '##agu', '##lase', '-', 'positive', 's', '##ta', '##phy', '##loc', '##oc', '##ci', '(', 'CP', '##S', ')', 'co', '##lon', '##ize', 'skin', 'and', 'm', '##uc', '##ous', 'membrane', 'sites', 'and', 'can', 'cause', 'skin', 'and', 'soft', 'tissue', 'infections', '(', 'SS', '##TI', '##s', ')', 'in', 'humans', 'and', 'animals', '.']	[0, 2, 5, 7, 9, 11, 15, 17, 22, 26, 32, 34, 37, 41, 42, 51, 52, 54, 57, 60, 62, 65, 66, 68, 69, 71, 73, 76, 80, 85, 89, 90, 92, 96, 105, 111, 115, 119, 125, 130, 134, 139, 146, 157, 158, 160, 162, 163, 165, 168, 175, 179, 186]	[2, 5, 7, 9, 11, 14, 17, 21, 25, 31, 34, 37, 41, 42, 50, 52, 54, 57, 60, 62, 64, 66, 68, 69, 70, 73, 76, 79, 84, 88, 90, 92, 95, 104, 110, 114, 118, 124, 129, 133, 138, 145, 156, 158, 160, 162, 163, 164, 167, 174, 178, 186, 187]	['Staphylococcus', 'aureus', 'and', 'other', 'coagulase', '-', 'positive', 'staphylococci', '(', 'CPS', ')', 'colonize', 'skin', 'and', 'mucous', 'membrane', 'sites', 'and', 'can', 'cause', 'skin', 'and', 'soft', 'tissue', 'infections', '(', 'SSTIs', ')', 'in', 'humans', 'and', 'animals', '.']	[6, 2, 1, 1, 3, 1, 1, 6, 1, 2, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Coagulase-negative staphylococcal isolates from the MRSA arm of the enrichment protocol and CPS isolates from both arms of the enrichment protocol (MS- and MR-) were archived and available for additional testing.	[]	['Co', '##agu', '##lase', '-', 'negative', 's', '##ta', '##phy', '##loc', '##oc', '##cal', 'is', '##olate', '##s', 'from', 'the', 'MR', '##SA', 'arm', 'of', 'the', 'en', '##rich', '##ment', 'protocol', 'and', 'CP', '##S', 'is', '##olate', '##s', 'from', 'both', 'arms', 'of', 'the', 'en', '##rich', '##ment', 'protocol', '(', 'MS', '-', 'and', 'MR', '-', ')', 'were', 'archive', '##d', 'and', 'available', 'for', 'additional', 'testing', '.']	[0, 2, 5, 9, 10, 19, 20, 22, 25, 28, 30, 34, 36, 41, 43, 48, 52, 54, 57, 61, 64, 68, 70, 74, 79, 88, 92, 94, 96, 98, 103, 105, 110, 115, 120, 123, 127, 129, 133, 138, 147, 148, 150, 152, 156, 158, 159, 161, 166, 173, 175, 179, 189, 193, 204, 211]	[2, 5, 9, 10, 18, 20, 22, 25, 28, 30, 33, 36, 41, 42, 47, 51, 54, 56, 60, 63, 67, 70, 74, 78, 87, 91, 94, 95, 98, 103, 104, 109, 114, 119, 122, 126, 129, 133, 137, 146, 148, 150, 151, 155, 158, 159, 160, 165, 173, 174, 178, 188, 192, 203, 211, 212]	['Coagulase', '-', 'negative', 'staphylococcal', 'isolates', 'from', 'the', 'MRSA', 'arm', 'of', 'the', 'enrichment', 'protocol', 'and', 'CPS', 'isolates', 'from', 'both', 'arms', 'of', 'the', 'enrichment', 'protocol', '(', 'MS-', 'and', 'MR-', ')', 'were', 'archived', 'and', 'available', 'for', 'additional', 'testing', '.']	[3, 1, 1, 6, 3, 1, 1, 2, 1, 1, 1, 3, 1, 1, 2, 3, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A subset (nares and lesion site isolates only) of coagulase-negative staphylococcal isolates and CPS isolates not identified through the nuc PCR protocol were submitted for species identification and antimicrobial susceptibility testing using the BD Phoenix system (BD Diagnostics, Sparks, MD).	[]	['A', 'subset', '(', 'na', '##res', 'and', 'les', '##ion', 'site', 'is', '##olate', '##s', 'only', ')', 'of', 'co', '##agu', '##lase', '-', 'negative', 's', '##ta', '##phy', '##loc', '##oc', '##cal', 'is', '##olate', '##s', 'and', 'CP', '##S', 'is', '##olate', '##s', 'not', 'identified', 'through', 'the', 'n', '##uc', 'PC', '##R', 'protocol', 'were', 'submitted', 'for', 'species', 'identification', 'and', 'anti', '##mic', '##ro', '##bial', 'su', '##s', '##ce', '##pt', '##ibility', 'testing', 'using', 'the', 'B', '##D', 'Phoenix', 'system', '(', 'B', '##D', 'Di', '##ag', '##nos', '##tics', ',', 'Sparks', ',', 'MD', ')', '.']	[0, 2, 9, 10, 12, 16, 20, 23, 27, 32, 34, 39, 41, 45, 47, 50, 52, 55, 59, 60, 69, 70, 72, 75, 78, 80, 84, 86, 91, 93, 97, 99, 101, 103, 108, 110, 114, 125, 133, 137, 138, 141, 143, 145, 154, 159, 169, 173, 181, 196, 200, 204, 207, 209, 214, 216, 217, 219, 221, 229, 237, 243, 247, 248, 250, 258, 265, 266, 267, 269, 271, 273, 276, 280, 282, 288, 290, 292, 293]	[1, 8, 10, 12, 15, 19, 23, 26, 31, 34, 39, 40, 45, 46, 49, 52, 55, 59, 60, 68, 70, 72, 75, 78, 80, 83, 86, 91, 92, 96, 99, 100, 103, 108, 109, 113, 124, 132, 136, 138, 140, 143, 144, 153, 158, 168, 172, 180, 195, 199, 204, 207, 209, 213, 216, 217, 219, 221, 228, 236, 242, 246, 248, 249, 257, 264, 266, 267, 268, 271, 273, 276, 280, 281, 288, 289, 292, 293, 294]	['A', 'subset', '(', 'nares', 'and', 'lesion', 'site', 'isolates', 'only', ')', 'of', 'coagulase', '-', 'negative', 'staphylococcal', 'isolates', 'and', 'CPS', 'isolates', 'not', 'identified', 'through', 'the', 'nuc', 'PCR', 'protocol', 'were', 'submitted', 'for', 'species', 'identification', 'and', 'antimicrobial', 'susceptibility', 'testing', 'using', 'the', 'BD', 'Phoenix', 'system', '(', 'BD', 'Diagnostics', ',', 'Sparks', ',', 'MD', ')', '.']	[1, 1, 1, 2, 1, 2, 1, 3, 1, 1, 1, 3, 1, 1, 6, 3, 1, 2, 3, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 4, 5, 1, 1, 1, 2, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Expectorated and induced sputum samples were processed as previously described (26) and analyzed for total cell counts and differentials, free neutrophil elastase activity (Sigma Diagnostics) (lower limit of detection [LLD], 0.5 μg/ml), and the following cytokines (R&D Systems, Minneapolis, MN): IL-1β (LLD, 2.5 pg/ml), IL-1ra (LLD, 40 pg/ml), IL-6 (LLD, 2.0 pg/ml), IL-8 (LLD, 1.0 pg/ml), TNF-α (LLD, 4.0 pg/ml), and vascular endothelial growth factor (VEGF) (LLD, 12 pg/ml).	[('PMC4342834', 'M04000', 143, 162, 'neutrophil elastase')]	['Ex', '##pect', '##ora', '##ted', 'and', 'induced', 's', '##put', '##um', 'samples', 'were', 'processed', 'as', 'previously', 'described', '(', '26', ')', 'and', 'analyzed', 'for', 'total', 'cell', 'counts', 'and', 'differential', '##s', ',', 'free', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', 'activity', '(', 'Sigma', 'Di', '##ag', '##nos', '##tics', ')', '(', 'lower', 'limit', 'of', 'detection', '[', 'LL', '##D', ']', ',', '0', '.', '5', 'μ', '##g', '/', 'm', '##l', ')', ',', 'and', 'the', 'following', 'c', '##yt', '##oki', '##nes', '(', 'R', '&', 'D', 'Systems', ',', 'Minneapolis', ',', 'M', '##N', ')', ':', 'IL', '-', '1', '##β', '(', 'LL', '##D', ',', '2', '.', '5', 'p', '##g', '/', 'm', '##l', ')', ',', 'IL', '-', '1', '##ra', '(', 'LL', '##D', ',', '40', 'p', '##g', '/', 'm', '##l', ')', ',', 'IL', '-', '6', '(', 'LL', '##D', ',', '2', '.', '0', 'p', '##g', '/', 'm', '##l', ')', ',', 'IL', '-', '8', '(', 'LL', '##D', ',', '1', '.', '0', 'p', '##g', '/', 'm', '##l', ')', ',', 'T', '##NF', '-', 'α', '(', 'LL', '##D', ',', '4', '.', '0', 'p', '##g', '/', 'm', '##l', ')', ',', 'and', 'vascular', 'end', '##oth', '##eli', '##al', 'growth', 'factor', '(', 'V', '##EG', '##F', ')', '(', 'LL', '##D', ',', '12', 'p', '##g', '/', 'm', '##l', ')', '.']	[0, 2, 6, 9, 13, 17, 25, 26, 29, 32, 40, 45, 55, 58, 69, 79, 80, 82, 84, 88, 97, 101, 107, 112, 119, 123, 135, 136, 138, 143, 145, 147, 150, 154, 156, 159, 163, 172, 173, 179, 181, 183, 186, 190, 192, 193, 199, 205, 208, 218, 219, 221, 222, 223, 225, 226, 227, 229, 230, 231, 232, 233, 234, 235, 237, 241, 245, 255, 256, 258, 261, 265, 266, 267, 268, 270, 277, 279, 290, 292, 293, 294, 295, 297, 299, 300, 301, 303, 304, 306, 307, 309, 310, 311, 313, 314, 315, 316, 317, 318, 319, 321, 323, 324, 325, 328, 329, 331, 332, 334, 337, 338, 339, 340, 341, 342, 343, 345, 347, 348, 350, 351, 353, 354, 356, 357, 358, 360, 361, 362, 363, 364, 365, 366, 368, 370, 371, 373, 374, 376, 377, 379, 380, 381, 383, 384, 385, 386, 387, 388, 389, 391, 392, 394, 395, 397, 398, 400, 401, 403, 404, 405, 407, 408, 409, 410, 411, 412, 413, 415, 419, 428, 431, 434, 437, 440, 447, 454, 455, 456, 458, 459, 461, 462, 464, 465, 467, 470, 471, 472, 473, 474, 475, 476]	[2, 6, 9, 12, 16, 24, 26, 29, 31, 39, 44, 54, 57, 68, 78, 80, 82, 83, 87, 96, 100, 106, 111, 118, 122, 135, 136, 137, 142, 145, 147, 150, 153, 156, 159, 162, 171, 173, 178, 181, 183, 186, 190, 191, 193, 198, 204, 207, 217, 219, 221, 222, 223, 224, 226, 227, 228, 230, 231, 232, 233, 234, 235, 236, 240, 244, 254, 256, 258, 261, 264, 266, 267, 268, 269, 277, 278, 290, 291, 293, 294, 295, 296, 299, 300, 301, 302, 304, 306, 307, 308, 310, 311, 312, 314, 315, 316, 317, 318, 319, 320, 323, 324, 325, 327, 329, 331, 332, 333, 336, 338, 339, 340, 341, 342, 343, 344, 347, 348, 349, 351, 353, 354, 355, 357, 358, 359, 361, 362, 363, 364, 365, 366, 367, 370, 371, 372, 374, 376, 377, 378, 380, 381, 382, 384, 385, 386, 387, 388, 389, 390, 392, 394, 395, 396, 398, 400, 401, 402, 404, 405, 406, 408, 409, 410, 411, 412, 413, 414, 418, 427, 431, 434, 437, 439, 446, 453, 455, 456, 458, 459, 460, 462, 464, 465, 466, 469, 471, 472, 473, 474, 475, 476, 477]	['Expectorated', 'and', 'induced', 'sputum', 'samples', 'were', 'processed', 'as', 'previously', 'described', '(', '26', ')', 'and', 'analyzed', 'for', 'total', 'cell', 'counts', 'and', 'differentials', ',', 'free', 'neutrophil', 'elastase', 'activity', '(', 'Sigma', 'Diagnostics', ')', '(', 'lower', 'limit', 'of', 'detection', '[', 'LLD', ']', ',', '0.5', 'μg', '/', 'ml', ')', ',', 'and', 'the', 'following', 'cytokines', '(', 'R&D', 'Systems', ',', 'Minneapolis', ',', 'MN', ')', ':', 'IL-1β', '(', 'LLD', ',', '2.5', 'pg', '/', 'ml', ')', ',', 'IL-1ra', '(', 'LLD', ',', '40', 'pg', '/', 'ml', ')', ',', 'IL-6', '(', 'LLD', ',', '2.0', 'pg', '/', 'ml', ')', ',', 'IL-8', '(', 'LLD', ',', '1.0', 'pg', '/', 'ml', ')', ',', 'TNF-α', '(', 'LLD', ',', '4.0', 'pg', '/', 'ml', ')', ',', 'and', 'vascular', 'endothelial', 'growth', 'factor', '(', 'VEGF', ')', '(', 'LLD', ',', '12', 'pg', '/', 'ml', ')', '.']	[4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 2, 1, 1, 4, 1, 2, 1, 3, 2, 1, 2, 1, 1, 4, 1, 2, 1, 1, 2, 1, 2, 1, 1, 3, 1, 2, 1, 3, 2, 1, 2, 1, 1, 3, 1, 2, 1, 3, 2, 1, 2, 1, 1, 4, 1, 2, 1, 3, 2, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inflammatory markers measured from 14 ES and IS pairs were highly correlated, with the exception of IL-1ra: neutrophil elastase (r = 0.64; P = 0.01), IL-6 (r = 0.61; P = 0.02), IL-8 (r = 0.58; P = 0.03), IL-1β (r = 0.69; P = 0.005), TNF-α (r = 0.71; P = 0.003), VEGF (r = 0.65; P = 0.01), and IL-1ra (r = −0.1; P = 0.8) (Figure E6).	[('PMC4342834', 'R07000', 108, 127, 'neutrophil elastase')]	['In', '##f', '##lam', '##mat', '##ory', 'markers', 'measured', 'from', '14', 'E', '##S', 'and', 'IS', 'pairs', 'were', 'highly', 'correlated', ',', 'with', 'the', 'exception', 'of', 'IL', '-', '1', '##ra', ':', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', '(', 'r', '=', '0', '.', '64', ';', 'P', '=', '0', '.', '01', ')', ',', 'IL', '-', '6', '(', 'r', '=', '0', '.', '61', ';', 'P', '=', '0', '.', '02', ')', ',', 'IL', '-', '8', '(', 'r', '=', '0', '.', '58', ';', 'P', '=', '0', '.', '03', ')', ',', 'IL', '-', '1', '##β', '(', 'r', '=', '0', '.', '69', ';', 'P', '=', '0', '.', '00', '##5', ')', ',', 'T', '##NF', '-', 'α', '(', 'r', '=', '0', '.', '71', ';', 'P', '=', '0', '.', '00', '##3', ')', ',', 'V', '##EG', '##F', '(', 'r', '=', '0', '.', '65', ';', 'P', '=', '0', '.', '01', ')', ',', 'and', 'IL', '-', '1', '##ra', '(', 'r', '=', '−', '##0', '.', '1', ';', 'P', '=', '0', '.', '8', ')', '(', 'Figure', 'E', '##6', ')', '.']	[0, 2, 3, 6, 9, 13, 21, 30, 35, 38, 39, 41, 45, 48, 54, 59, 66, 76, 78, 83, 87, 97, 100, 102, 103, 104, 106, 108, 110, 112, 115, 119, 121, 124, 128, 129, 131, 133, 134, 135, 137, 139, 141, 143, 144, 145, 147, 148, 150, 152, 153, 155, 156, 158, 160, 161, 162, 164, 166, 168, 170, 171, 172, 174, 175, 177, 179, 180, 182, 183, 185, 187, 188, 189, 191, 193, 195, 197, 198, 199, 201, 202, 204, 206, 207, 208, 210, 211, 213, 215, 216, 217, 219, 221, 223, 225, 226, 227, 229, 230, 231, 233, 234, 236, 237, 239, 240, 242, 244, 245, 246, 248, 250, 252, 254, 255, 256, 258, 259, 260, 262, 263, 265, 267, 268, 270, 272, 273, 274, 276, 278, 280, 282, 283, 284, 286, 287, 289, 293, 295, 296, 297, 300, 301, 303, 305, 306, 307, 308, 309, 311, 313, 315, 316, 317, 318, 320, 321, 328, 329, 330, 331]	[2, 3, 6, 9, 12, 20, 29, 34, 37, 39, 40, 44, 47, 53, 58, 65, 76, 77, 82, 86, 96, 99, 102, 103, 104, 106, 107, 110, 112, 115, 118, 121, 124, 127, 129, 130, 132, 134, 135, 137, 138, 140, 142, 144, 145, 147, 148, 149, 152, 153, 154, 156, 157, 159, 161, 162, 164, 165, 167, 169, 171, 172, 174, 175, 176, 179, 180, 181, 183, 184, 186, 188, 189, 191, 192, 194, 196, 198, 199, 201, 202, 203, 206, 207, 208, 209, 211, 212, 214, 216, 217, 219, 220, 222, 224, 226, 227, 229, 230, 231, 232, 234, 236, 237, 238, 240, 241, 243, 245, 246, 248, 249, 251, 253, 255, 256, 258, 259, 260, 261, 263, 265, 266, 268, 269, 271, 273, 274, 276, 277, 279, 281, 283, 284, 286, 287, 288, 292, 295, 296, 297, 299, 301, 302, 304, 306, 307, 308, 309, 310, 312, 314, 316, 317, 318, 319, 321, 327, 329, 330, 331, 332]	['Inflammatory', 'markers', 'measured', 'from', '14', 'ES', 'and', 'IS', 'pairs', 'were', 'highly', 'correlated', ',', 'with', 'the', 'exception', 'of', 'IL-1ra', ':', 'neutrophil', 'elastase', '(', 'r', '=', '0.64', ';', 'P', '=', '0.01', ')', ',', 'IL-6', '(', 'r', '=', '0.61', ';', 'P', '=', '0.02', ')', ',', 'IL-8', '(', 'r', '=', '0.58', ';', 'P', '=', '0.03', ')', ',', 'IL-1β', '(', 'r', '=', '0.69', ';', 'P', '=', '0.005', ')', ',', 'TNF-α', '(', 'r', '=', '0.71', ';', 'P', '=', '0.003', ')', ',', 'VEGF', '(', 'r', '=', '0.65', ';', 'P', '=', '0.01', ')', ',', 'and', 'IL-1ra', '(', 'r', '=', '−0.1', ';', 'P', '=', '0.8', ')', '(', 'Figure', 'E6', ')', '.']	[5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although not statistically significant, there was a trend toward lower neutrophil elastase in ES compared with IS samples (P = 0.08), with a median difference of −0.15 log10 μg/ml.	[('PMC4342834', 'R07001', 71, 90, 'neutrophil elastase')]	['Although', 'not', 'statistical', '##ly', 'significant', ',', 'there', 'was', 'a', 'trend', 'toward', 'lower', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', 'in', 'E', '##S', 'compared', 'with', 'IS', 'samples', '(', 'P', '=', '0', '.', '08', ')', ',', 'with', 'a', 'median', 'difference', 'of', '−', '##0', '.', '15', 'log', '##10', 'μ', '##g', '/', 'm', '##l', '.']	[0, 9, 13, 24, 27, 38, 40, 46, 50, 52, 58, 65, 71, 73, 75, 78, 82, 84, 87, 91, 94, 95, 97, 106, 111, 114, 122, 123, 125, 127, 128, 129, 131, 132, 134, 139, 141, 148, 159, 162, 163, 164, 165, 168, 171, 174, 175, 176, 177, 178, 179]	[8, 12, 24, 26, 38, 39, 45, 49, 51, 57, 64, 70, 73, 75, 78, 81, 84, 87, 90, 93, 95, 96, 105, 110, 113, 121, 123, 124, 126, 128, 129, 131, 132, 133, 138, 140, 147, 158, 161, 163, 164, 165, 167, 171, 173, 175, 176, 177, 178, 179, 180]	['Although', 'not', 'statistically', 'significant', ',', 'there', 'was', 'a', 'trend', 'toward', 'lower', 'neutrophil', 'elastase', 'in', 'ES', 'compared', 'with', 'IS', 'samples', '(', 'P', '=', '0.08', ')', ',', 'with', 'a', 'median', 'difference', 'of', '−0.15', 'log10', 'μg', '/', 'ml', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 2, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
By qPCR, P. aeruginosa load was associated with increased sputum neutrophil elastase (r = 0.53; P = 0.04), whereas S. aureus was associated with increased IL-1β (r = 0.61;	[('PMC4342834', 'R08000', 65, 84, 'neutrophil elastase')]	['By', 'q', '##PC', '##R', ',', 'P', '.', 'a', '##er', '##ug', '##ino', '##sa', 'load', 'was', 'associated', 'with', 'increased', 's', '##put', '##um', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', '(', 'r', '=', '0', '.', '53', ';', 'P', '=', '0', '.', '04', ')', ',', 'whereas', 'S', '.', 'au', '##reus', 'was', 'associated', 'with', 'increased', 'IL', '-', '1', '##β', '(', 'r', '=', '0', '.', '61', ';']	[0, 3, 4, 6, 7, 9, 10, 12, 13, 15, 17, 20, 23, 28, 32, 43, 48, 58, 59, 62, 65, 67, 69, 72, 76, 78, 81, 85, 86, 88, 90, 91, 92, 94, 96, 98, 100, 101, 102, 104, 105, 107, 115, 116, 118, 120, 125, 129, 140, 145, 155, 157, 158, 159, 161, 162, 164, 166, 167, 168, 170]	[2, 4, 6, 7, 8, 10, 11, 13, 15, 17, 20, 22, 27, 31, 42, 47, 57, 59, 62, 64, 67, 69, 72, 75, 78, 81, 84, 86, 87, 89, 91, 92, 94, 95, 97, 99, 101, 102, 104, 105, 106, 114, 116, 117, 120, 124, 128, 139, 144, 154, 157, 158, 159, 160, 162, 163, 165, 167, 168, 170, 171]	['By', 'qPCR', ',', 'P', '.', 'aeruginosa', 'load', 'was', 'associated', 'with', 'increased', 'sputum', 'neutrophil', 'elastase', '(', 'r', '=', '0.53', ';', 'P', '=', '0.04', ')', ',', 'whereas', 'S', '.', 'aureus', 'was', 'associated', 'with', 'increased', 'IL-1β', '(', 'r', '=', '0.61', ';']	[1, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 3, 4, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
P = 0.02) and VEGF (r = 0.59; P = 0.02) and was marginally associated with neutrophil elastase (r = 0.47;	[('PMC4342834', 'R08001', 75, 94, 'neutrophil elastase')]	['P', '=', '0', '.', '02', ')', 'and', 'V', '##EG', '##F', '(', 'r', '=', '0', '.', '59', ';', 'P', '=', '0', '.', '02', ')', 'and', 'was', 'marginal', '##ly', 'associated', 'with', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', '(', 'r', '=', '0', '.', '47', ';']	[0, 2, 4, 5, 6, 8, 10, 14, 15, 17, 19, 20, 22, 24, 25, 26, 28, 30, 32, 34, 35, 36, 38, 40, 44, 48, 56, 59, 70, 75, 77, 79, 82, 86, 88, 91, 95, 96, 98, 100, 101, 102, 104]	[1, 3, 5, 6, 8, 9, 13, 15, 17, 18, 20, 21, 23, 25, 26, 28, 29, 31, 33, 35, 36, 38, 39, 43, 47, 56, 58, 69, 74, 77, 79, 82, 85, 88, 91, 94, 96, 97, 99, 101, 102, 104, 105]	['P', '=', '0.02', ')', 'and', 'VEGF', '(', 'r', '=', '0.59', ';', 'P', '=', '0.02', ')', 'and', 'was', 'marginally', 'associated', 'with', 'neutrophil', 'elastase', '(', 'r', '=', '0.47', ';']	[1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 4, 3, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Increased β-diversity, suggesting divergence in airway bacterial communities in different niches within the same subject, was associated with increased neutrophil elastase (r = 0.65;	[]	['Inc', '##reased', 'β', '-', 'diversity', ',', 'suggesting', 'diver', '##gence', 'in', 'air', '##way', 'bacterial', 'communities', 'in', 'different', 'niche', '##s', 'within', 'the', 'same', 'subject', ',', 'was', 'associated', 'with', 'increased', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', '(', 'r', '=', '0', '.', '65', ';']	[0, 3, 10, 11, 12, 21, 23, 34, 39, 45, 48, 51, 55, 65, 77, 80, 90, 95, 97, 104, 108, 113, 120, 122, 126, 137, 142, 152, 154, 156, 159, 163, 165, 168, 172, 173, 175, 177, 178, 179, 181]	[3, 9, 11, 12, 21, 22, 33, 39, 44, 47, 51, 54, 64, 76, 79, 89, 95, 96, 103, 107, 112, 120, 121, 125, 136, 141, 151, 154, 156, 159, 162, 165, 168, 171, 173, 174, 176, 178, 179, 181, 182]	['Increased', 'β-diversity', ',', 'suggesting', 'divergence', 'in', 'airway', 'bacterial', 'communities', 'in', 'different', 'niches', 'within', 'the', 'same', 'subject', ',', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elastase', '(', 'r', '=', '0.65', ';']	[2, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Consistent with qPCR results, Pseudomonas RA determined by sequencing was associated with increased neutrophil elastase (r = 0.52; P = 0.06).	[('PMC4342834', 'R10000', 100, 119, 'neutrophil elastase')]	['Con', '##sist', '##ent', 'with', 'q', '##PC', '##R', 'results', ',', 'P', '##se', '##udo', '##mona', '##s', 'RA', 'determined', 'by', 'se', '##quencing', 'was', 'associated', 'with', 'increased', 'ne', '##ut', '##rop', '##hil', 'el', '##ast', '##ase', '(', 'r', '=', '0', '.', '52', ';', 'P', '=', '0', '.', '06', ')', '.']	[0, 3, 7, 11, 16, 17, 19, 21, 28, 30, 31, 33, 36, 40, 42, 45, 56, 59, 61, 70, 74, 85, 90, 100, 102, 104, 107, 111, 113, 116, 120, 121, 123, 125, 126, 127, 129, 131, 133, 135, 136, 137, 139, 140]	[3, 7, 10, 15, 17, 19, 20, 28, 29, 31, 33, 36, 40, 41, 44, 55, 58, 61, 69, 73, 84, 89, 99, 102, 104, 107, 110, 113, 116, 119, 121, 122, 124, 126, 127, 129, 130, 132, 134, 136, 137, 139, 140, 141]	['Consistent', 'with', 'qPCR', 'results', ',', 'Pseudomonas', 'RA', 'determined', 'by', 'sequencing', 'was', 'associated', 'with', 'increased', 'neutrophil', 'elastase', '(', 'r', '=', '0.52', ';', 'P', '=', '0.06', ')', '.']	[3, 1, 3, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 4, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PTPRG is a widely expressed protein tyrosine phosphatase present in various isoforms.	[('PMC4361625', 'A00000', 28, 56, 'protein tyrosine phosphatase')]	['PT', '##PR', '##G', 'is', 'a', 'widely', 'expressed', 'protein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'present', 'in', 'various', 'is', '##of', '##orms', '.']	[0, 2, 4, 6, 9, 11, 18, 28, 36, 37, 39, 41, 45, 46, 49, 52, 57, 65, 68, 76, 78, 80, 84]	[2, 4, 5, 8, 10, 17, 27, 35, 37, 39, 41, 44, 46, 49, 52, 56, 64, 67, 75, 78, 80, 84, 85]	['PTPRG', 'is', 'a', 'widely', 'expressed', 'protein', 'tyrosine', 'phosphatase', 'present', 'in', 'various', 'isoforms', '.']	[3, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatases gamma (PTPRG) belongs to a family of enzymes that remove phosphate groups from phosphotyrosine residues of specific intracellular targets.	[('PMC4361625', 'I00000', 0, 29, 'Protein tyrosine phosphatases')]	['Pro', '##tein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', '##s', 'gamma', '(', 'PT', '##PR', '##G', ')', 'belongs', 'to', 'a', 'family', 'of', 'enzymes', 'that', 'remove', 'phosphate', 'groups', 'from', 'p', '##hos', '##ph', '##ot', '##yr', '##os', '##ine', 'residues', 'of', 'specific', 'in', '##tra', '##cellular', 'targets', '.']	[0, 3, 8, 9, 11, 13, 17, 18, 21, 24, 28, 30, 36, 37, 39, 41, 42, 44, 52, 55, 57, 64, 67, 75, 80, 87, 97, 104, 109, 110, 113, 115, 117, 119, 121, 125, 134, 137, 146, 148, 151, 160, 167]	[3, 7, 9, 11, 13, 16, 18, 21, 24, 28, 29, 35, 37, 39, 41, 42, 43, 51, 54, 56, 63, 66, 74, 79, 86, 96, 103, 108, 110, 113, 115, 117, 119, 121, 124, 133, 136, 145, 148, 151, 159, 167, 168]	['Protein', 'tyrosine', 'phosphatases', 'gamma', '(', 'PTPRG', ')', 'belongs', 'to', 'a', 'family', 'of', 'enzymes', 'that', 'remove', 'phosphate', 'groups', 'from', 'phosphotyrosine', 'residues', 'of', 'specific', 'intracellular', 'targets', '.']	[2, 4, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 3, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PTPRG maps to chr 3p14.2/21, and its mRNA (5787 bp coding sequence) encodes for a transmembrane protein with three different domains in the extracellular amino terminus region: a carbonic anhydrase-homologous, a fibronectin type III domain, a transmembrane region and an intra-cytoplasmatic region composed of two intracellular PTPase catalytic domains.	[('PMC4361625', 'I00001', 179, 197, 'carbonic anhydrase')]	['PT', '##PR', '##G', 'maps', 'to', 'ch', '##r', '3', '##p', '##14', '.', '2', '/', '21', ',', 'and', 'its', 'm', '##RNA', '(', '57', '##8', '##7', 'b', '##p', 'coding', 'sequence', ')', 'en', '##codes', 'for', 'a', 'trans', '##me', '##mb', '##rane', 'protein', 'with', 'three', 'different', 'domains', 'in', 'the', 'extra', '##cellular', 'amino', 'terminus', 'region', ':', 'a', 'carbon', '##ic', 'an', '##hy', '##dra', '##se', '-', 'ho', '##mo', '##log', '##ous', ',', 'a', 'fi', '##bro', '##nect', '##in', 'type', 'III', 'domain', ',', 'a', 'trans', '##me', '##mb', '##rane', 'region', 'and', 'an', 'in', '##tra', '-', 'c', '##yt', '##op', '##las', '##matic', 'region', 'composed', 'of', 'two', 'in', '##tra', '##cellular', 'PT', '##P', '##ase', 'cat', '##alytic', 'domains', '.']	[0, 2, 4, 6, 11, 14, 16, 18, 19, 20, 22, 23, 24, 25, 27, 29, 33, 37, 38, 42, 43, 45, 46, 48, 49, 51, 58, 66, 68, 70, 76, 80, 82, 87, 89, 91, 96, 104, 109, 115, 125, 133, 136, 140, 145, 154, 160, 169, 175, 177, 179, 185, 188, 190, 192, 195, 197, 198, 200, 202, 205, 208, 210, 212, 214, 217, 221, 224, 229, 233, 239, 241, 243, 248, 250, 252, 257, 264, 268, 271, 273, 276, 277, 278, 280, 282, 285, 291, 298, 307, 310, 314, 316, 319, 328, 330, 331, 335, 338, 345, 352]	[2, 4, 5, 10, 13, 16, 17, 19, 20, 22, 23, 24, 25, 27, 28, 32, 36, 38, 41, 43, 45, 46, 47, 49, 50, 57, 66, 67, 70, 75, 79, 81, 87, 89, 91, 95, 103, 108, 114, 124, 132, 135, 139, 145, 153, 159, 168, 175, 176, 178, 185, 187, 190, 192, 195, 197, 198, 200, 202, 205, 208, 209, 211, 214, 217, 221, 223, 228, 232, 239, 240, 242, 248, 250, 252, 256, 263, 267, 270, 273, 276, 277, 278, 280, 282, 285, 290, 297, 306, 309, 313, 316, 319, 327, 330, 331, 334, 338, 344, 352, 353]	['PTPRG', 'maps', 'to', 'chr', '3p14.2', '/', '21', ',', 'and', 'its', 'mRNA', '(', '5787', 'bp', 'coding', 'sequence', ')', 'encodes', 'for', 'a', 'transmembrane', 'protein', 'with', 'three', 'different', 'domains', 'in', 'the', 'extracellular', 'amino', 'terminus', 'region', ':', 'a', 'carbonic', 'anhydrase', '-', 'homologous', ',', 'a', 'fibronectin', 'type', 'III', 'domain', ',', 'a', 'transmembrane', 'region', 'and', 'an', 'intra', '-', 'cytoplasmatic', 'region', 'composed', 'of', 'two', 'intracellular', 'PTPase', 'catalytic', 'domains', '.']	[3, 1, 1, 2, 5, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 4, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 3, 3, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Deglycosylation of purified recombinant extracellular domain of PTPRG linked to Fc (ECD-PTPRG-Fc) and the immunoprecipitated plasmatic PTPRG was carried out with the use of PNGase F (Boehringer, Mannheim, Germany) according to the manufacturer’s protocol.	[('PMC4361625', 'M10000', 173, 181, 'PNGase F')]	['De', '##gly', '##cos', '##yla', '##tion', 'of', 'pu', '##rified', 're', '##comb', '##ina', '##nt', 'extra', '##cellular', 'domain', 'of', 'PT', '##PR', '##G', 'linked', 'to', 'F', '##c', '(', 'EC', '##D', '-', 'PT', '##PR', '##G', '-', 'F', '##c', ')', 'and', 'the', 'im', '##mu', '##no', '##p', '##re', '##ci', '##pit', '##ated', 'plasma', '##tic', 'PT', '##PR', '##G', 'was', 'carried', 'out', 'with', 'the', 'use', 'of', 'P', '##NG', '##ase', 'F', '(', 'Bo', '##eh', '##ring', '##er', ',', 'Mann', '##heim', ',', 'Germany', ')', 'according', 'to', 'the', 'manufacturer', '’', 's', 'protocol', '.']	[0, 2, 5, 8, 11, 16, 19, 21, 28, 30, 34, 37, 40, 45, 54, 61, 64, 66, 68, 70, 77, 80, 81, 83, 84, 86, 87, 88, 90, 92, 93, 94, 95, 96, 98, 102, 106, 108, 110, 112, 113, 115, 117, 120, 125, 131, 135, 137, 139, 141, 145, 153, 157, 162, 166, 170, 173, 174, 176, 180, 182, 183, 185, 187, 191, 193, 195, 199, 203, 205, 212, 214, 224, 227, 231, 243, 244, 246, 254]	[2, 5, 8, 11, 15, 18, 21, 27, 30, 34, 37, 39, 45, 53, 60, 63, 66, 68, 69, 76, 79, 81, 82, 84, 86, 87, 88, 90, 92, 93, 94, 95, 96, 97, 101, 105, 108, 110, 112, 113, 115, 117, 120, 124, 131, 134, 137, 139, 140, 144, 152, 156, 161, 165, 169, 172, 174, 176, 179, 181, 183, 185, 187, 191, 193, 194, 199, 203, 204, 212, 213, 223, 226, 230, 243, 244, 245, 254, 255]	['Deglycosylation', 'of', 'purified', 'recombinant', 'extracellular', 'domain', 'of', 'PTPRG', 'linked', 'to', 'Fc', '(', 'ECD-PTPRG-Fc', ')', 'and', 'the', 'immunoprecipitated', 'plasmatic', 'PTPRG', 'was', 'carried', 'out', 'with', 'the', 'use', 'of', 'PNGase', 'F', '(', 'Boehringer', ',', 'Mannheim', ',', 'Germany', ')', 'according', 'to', 'the', 'manufacturer’s', 'protocol', '.']	[5, 1, 2, 4, 2, 1, 1, 3, 1, 1, 2, 1, 9, 1, 1, 1, 8, 2, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One of the genome-wide significant SNPs for PAE in subjects with COPD was rs7140285 on 14q31.3 near GALC, which encodes galactosylceramidase, which was the most significant SNP in the analysis of COPD with PAE relative to those without PAE with adjustment for FEV1 % predicted.	[('PMC4370263', 'D04000', 120, 140, 'galactosylceramidase')]	['One', 'of', 'the', 'genome', '-', 'wide', 'significant', 'S', '##NP', '##s', 'for', 'PA', '##E', 'in', 'subjects', 'with', 'CO', '##PD', 'was', 'r', '##s', '##7', '##14', '##0', '##28', '##5', 'on', '14', '##q', '##31', '.', '3', 'near', 'GA', '##LC', ',', 'which', 'en', '##codes', 'gal', '##act', '##osy', '##l', '##cer', '##ami', '##das', '##e', ',', 'which', 'was', 'the', 'most', 'significant', 'S', '##NP', 'in', 'the', 'analysis', 'of', 'CO', '##PD', 'with', 'PA', '##E', 'relative', 'to', 'those', 'without', 'PA', '##E', 'with', 'adjustment', 'for', 'F', '##E', '##V', '##1', '%', 'predicted', '.']	[0, 4, 7, 11, 17, 18, 23, 35, 36, 38, 40, 44, 46, 48, 51, 60, 65, 67, 70, 74, 75, 76, 77, 79, 80, 82, 84, 87, 89, 90, 92, 93, 95, 100, 102, 104, 106, 112, 114, 120, 123, 126, 129, 130, 133, 136, 139, 140, 142, 148, 152, 156, 161, 173, 174, 177, 180, 184, 193, 196, 198, 201, 206, 208, 210, 219, 222, 228, 236, 238, 240, 245, 256, 260, 261, 262, 263, 265, 267, 276]	[3, 6, 10, 17, 18, 22, 34, 36, 38, 39, 43, 46, 47, 50, 59, 64, 67, 69, 73, 75, 76, 77, 79, 80, 82, 83, 86, 89, 90, 92, 93, 94, 99, 102, 104, 105, 111, 114, 119, 123, 126, 129, 130, 133, 136, 139, 140, 141, 147, 151, 155, 160, 172, 174, 176, 179, 183, 192, 195, 198, 200, 205, 208, 209, 218, 221, 227, 235, 238, 239, 244, 255, 259, 261, 262, 263, 264, 266, 276, 277]	['One', 'of', 'the', 'genome', '-', 'wide', 'significant', 'SNPs', 'for', 'PAE', 'in', 'subjects', 'with', 'COPD', 'was', 'rs7140285', 'on', '14q31.3', 'near', 'GALC', ',', 'which', 'encodes', 'galactosylceramidase', ',', 'which', 'was', 'the', 'most', 'significant', 'SNP', 'in', 'the', 'analysis', 'of', 'COPD', 'with', 'PAE', 'relative', 'to', 'those', 'without', 'PAE', 'with', 'adjustment', 'for', 'FEV1', '%', 'predicted', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 2, 1, 7, 1, 5, 1, 2, 1, 1, 2, 8, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We identified one novel additional locus on 14q31.3 near the GALC gene encoding galactosylceramidase; the top SNP at this locus was rs7140285, with a P value of 3.75 × 10−8.	[('PMC4370263', 'R02000', 80, 100, 'galactosylceramidase')]	['We', 'identified', 'one', 'novel', 'additional', 'lo', '##cus', 'on', '14', '##q', '##31', '.', '3', 'near', 'the', 'GA', '##LC', 'gene', 'encoding', 'gal', '##act', '##osy', '##l', '##cer', '##ami', '##das', '##e', ';', 'the', 'top', 'S', '##NP', 'at', 'this', 'lo', '##cus', 'was', 'r', '##s', '##7', '##14', '##0', '##28', '##5', ',', 'with', 'a', 'P', 'value', 'of', '3', '.', '75', '×', '10', '##−', '##8', '.']	[0, 3, 14, 18, 24, 35, 37, 41, 44, 46, 47, 49, 50, 52, 57, 61, 63, 66, 71, 80, 83, 86, 89, 90, 93, 96, 99, 100, 102, 106, 110, 111, 114, 117, 122, 124, 128, 132, 133, 134, 135, 137, 138, 140, 141, 143, 148, 150, 152, 158, 161, 162, 163, 166, 168, 170, 171, 172]	[2, 13, 17, 23, 34, 37, 40, 43, 46, 47, 49, 50, 51, 56, 60, 63, 65, 70, 79, 83, 86, 89, 90, 93, 96, 99, 100, 101, 105, 109, 111, 113, 116, 121, 124, 127, 131, 133, 134, 135, 137, 138, 140, 141, 142, 147, 149, 151, 157, 160, 162, 163, 165, 167, 170, 171, 172, 173]	['We', 'identified', 'one', 'novel', 'additional', 'locus', 'on', '14q31.3', 'near', 'the', 'GALC', 'gene', 'encoding', 'galactosylceramidase', ';', 'the', 'top', 'SNP', 'at', 'this', 'locus', 'was', 'rs7140285', ',', 'with', 'a', 'P', 'value', 'of', '3.75', '×', '10−8', '.']	[1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 2, 1, 1, 8, 1, 1, 1, 2, 1, 1, 2, 1, 7, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR-TKIs) are standard treatments for advanced non-small-cell lung cancer (NSCLC) patients harboring activating epidermal growth factor receptor (EGFR) mutations.	[('PMC4521383', 'A00000', 0, 15, 'Tyrosine kinase')]	['Ty', '##ros', '##ine', 'kinase', 'inhibitor', '##s', 'of', 'e', '##pid', '##er', '##mal', 'growth', 'factor', 'receptor', '(', 'E', '##G', '##F', '##R', '-', 'T', '##K', '##I', '##s', ')', 'are', 'standard', 'treatments', 'for', 'advanced', 'non', '-', 'small', '-', 'cell', 'lung', 'cancer', '(', 'N', '##SC', '##LC', ')', 'patients', 'harbor', '##ing', 'act', '##ivating', 'e', '##pid', '##er', '##mal', 'growth', 'factor', 'receptor', '(', 'E', '##G', '##F', '##R', ')', 'mutations', '.']	[0, 2, 5, 9, 16, 25, 27, 30, 31, 34, 36, 40, 47, 54, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 75, 79, 88, 99, 103, 112, 115, 116, 121, 122, 127, 132, 139, 140, 141, 143, 145, 147, 156, 162, 166, 169, 177, 178, 181, 183, 187, 194, 201, 210, 211, 212, 213, 214, 215, 217, 226]	[2, 5, 8, 15, 25, 26, 29, 31, 34, 36, 39, 46, 53, 62, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 78, 87, 98, 102, 111, 115, 116, 121, 122, 126, 131, 138, 140, 141, 143, 145, 146, 155, 162, 165, 169, 176, 178, 181, 183, 186, 193, 200, 209, 211, 212, 213, 214, 215, 216, 226, 227]	['Tyrosine', 'kinase', 'inhibitors', 'of', 'epidermal', 'growth', 'factor', 'receptor', '(', 'EGFR-TKIs', ')', 'are', 'standard', 'treatments', 'for', 'advanced', 'non', '-', 'small', '-', 'cell', 'lung', 'cancer', '(', 'NSCLC', ')', 'patients', 'harboring', 'activating', 'epidermal', 'growth', 'factor', 'receptor', '(', 'EGFR', ')', 'mutations', '.']	[3, 1, 2, 1, 4, 1, 1, 1, 1, 9, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 2, 4, 1, 1, 1, 1, 4, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
 M. tuberculosis gene expression was quantified via reverse-transcription polymerase chain reaction in serial sputa from 17 Ugandans treated for drug-susceptible pulmonary tuberculosis.	[]	['M', '.', 'tuberculosis', 'gene', 'expression', 'was', 'q', '##uant', '##ified', 'via', 'reverse', '-', 'transcription', 'polymer', '##ase', 'chain', 'reaction', 'in', 'serial', 's', '##put', '##a', 'from', '17', 'Uganda', '##ns', 'treated', 'for', 'drug', '-', 'susceptible', 'pulmonary', 'tuberculosis', '.']	[1, 2, 4, 17, 22, 33, 37, 38, 42, 48, 52, 59, 60, 74, 81, 85, 91, 100, 103, 110, 111, 114, 116, 121, 124, 130, 133, 141, 145, 149, 150, 162, 172, 184]	[2, 3, 16, 21, 32, 36, 38, 42, 47, 51, 59, 60, 73, 81, 84, 90, 99, 102, 109, 111, 114, 115, 120, 123, 130, 132, 140, 144, 149, 150, 161, 171, 184, 185]	['M', '.', 'tuberculosis', 'gene', 'expression', 'was', 'quantified', 'via', 'reverse', '-', 'transcription', 'polymerase', 'chain', 'reaction', 'in', 'serial', 'sputa', 'from', '17', 'Ugandans', 'treated', 'for', 'drug', '-', 'susceptible', 'pulmonary', 'tuberculosis', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We used multiplex reverse-transcription polymerase chain reaction (RT-PCR) gene expression profiling to characterize the metabolic state and adaptive mechanisms of drug-tolerant M. tuberculosis remaining in sputum after the early bactericidal phase of treatment.	[('PMC4548467', 'I03000', 40, 50, 'polymerase')]	['We', 'used', 'multiple', '##x', 'reverse', '-', 'transcription', 'polymer', '##ase', 'chain', 'reaction', '(', 'R', '##T', '-', 'PC', '##R', ')', 'gene', 'expression', 'pro', '##fi', '##ling', 'to', 'character', '##ize', 'the', 'metabolic', 'state', 'and', 'adaptive', 'mechanisms', 'of', 'drug', '-', 'tolerant', 'M', '.', 'tuberculosis', 'remaining', 'in', 's', '##put', '##um', 'after', 'the', 'early', 'b', '##act', '##eric', '##idal', 'phase', 'of', 'treatment', '.']	[0, 3, 8, 16, 18, 25, 26, 40, 47, 51, 57, 66, 67, 68, 69, 70, 72, 73, 75, 80, 91, 94, 96, 101, 104, 113, 117, 121, 131, 137, 141, 150, 161, 164, 168, 169, 178, 179, 181, 194, 204, 207, 208, 211, 214, 220, 224, 230, 231, 234, 238, 243, 249, 252, 261]	[2, 7, 16, 17, 25, 26, 39, 47, 50, 56, 65, 67, 68, 69, 70, 72, 73, 74, 79, 90, 94, 96, 100, 103, 113, 116, 120, 130, 136, 140, 149, 160, 163, 168, 169, 177, 179, 180, 193, 203, 206, 208, 211, 213, 219, 223, 229, 231, 234, 238, 242, 248, 251, 261, 262]	['We', 'used', 'multiplex', 'reverse', '-', 'transcription', 'polymerase', 'chain', 'reaction', '(', 'RT-PCR', ')', 'gene', 'expression', 'profiling', 'to', 'characterize', 'the', 'metabolic', 'state', 'and', 'adaptive', 'mechanisms', 'of', 'drug', '-', 'tolerant', 'M', '.', 'tuberculosis', 'remaining', 'in', 'sputum', 'after', 'the', 'early', 'bactericidal', 'phase', 'of', 'treatment', '.']	[1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 5, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genes coding for the ESX/Type VII secretion system (ESX), which secretes highly immunogenic virulence factors (including ESAT-6), were highly expressed prior to treatment but were downregulated with treatment, particularly at days 7–14.	[]	['Gene', '##s', 'coding', 'for', 'the', 'E', '##S', '##X', '/', 'Type', 'VII', 'secret', '##ion', 'system', '(', 'E', '##S', '##X', ')', ',', 'which', 'secret', '##es', 'highly', 'im', '##mu', '##no', '##genic', 'v', '##ir', '##ule', '##nce', 'factors', '(', 'including', 'E', '##SA', '##T', '-', '6', ')', ',', 'were', 'highly', 'expressed', 'prior', 'to', 'treatment', 'but', 'were', 'down', '##re', '##gu', '##lated', 'with', 'treatment', ',', 'particularly', 'at', 'days', '7', '–', '14', '.']	[0, 4, 6, 13, 17, 21, 22, 23, 24, 25, 30, 34, 40, 44, 51, 52, 53, 54, 55, 56, 58, 64, 70, 73, 80, 82, 84, 86, 92, 93, 95, 98, 102, 110, 111, 121, 122, 124, 125, 126, 127, 128, 130, 135, 142, 152, 158, 161, 171, 175, 180, 184, 186, 188, 194, 199, 208, 210, 223, 226, 231, 232, 233, 235]	[4, 5, 12, 16, 20, 22, 23, 24, 25, 29, 33, 40, 43, 50, 52, 53, 54, 55, 56, 57, 63, 70, 72, 79, 82, 84, 86, 91, 93, 95, 98, 101, 109, 111, 120, 122, 124, 125, 126, 127, 128, 129, 134, 141, 151, 157, 160, 170, 174, 179, 184, 186, 188, 193, 198, 208, 209, 222, 225, 230, 232, 233, 235, 236]	['Genes', 'coding', 'for', 'the', 'ESX', '/', 'Type', 'VII', 'secretion', 'system', '(', 'ESX', ')', ',', 'which', 'secretes', 'highly', 'immunogenic', 'virulence', 'factors', '(', 'including', 'ESAT-6', ')', ',', 'were', 'highly', 'expressed', 'prior', 'to', 'treatment', 'but', 'were', 'downregulated', 'with', 'treatment', ',', 'particularly', 'at', 'days', '7–', '14', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 2, 1, 4, 4, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Expression of the gene for rifampicin target DNA-dependent RNA polymerase (RpoB) was significantly induced at all intervals after treatment initiation.	[]	['Express', '##ion', 'of', 'the', 'gene', 'for', 'r', '##if', '##amp', '##ici', '##n', 'target', 'DNA', '-', 'dependent', 'RNA', 'polymer', '##ase', '(', 'R', '##po', '##B', ')', 'was', 'significantly', 'induced', 'at', 'all', 'intervals', 'after', 'treatment', 'initiation', '.']	[0, 7, 11, 14, 18, 23, 27, 28, 30, 33, 36, 38, 45, 48, 49, 59, 63, 70, 74, 75, 76, 78, 79, 81, 85, 99, 107, 110, 114, 124, 130, 140, 150]	[7, 10, 13, 17, 22, 26, 28, 30, 33, 36, 37, 44, 48, 49, 58, 62, 70, 73, 75, 76, 78, 79, 80, 84, 98, 106, 109, 113, 123, 129, 139, 150, 151]	['Expression', 'of', 'the', 'gene', 'for', 'rifampicin', 'target', 'DNA-dependent', 'RNA', 'polymerase', '(', 'RpoB', ')', 'was', 'significantly', 'induced', 'at', 'all', 'intervals', 'after', 'treatment', 'initiation', '.']	[2, 1, 1, 1, 1, 5, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, genes for DNA gyrase subunits (GyrA, GyrB), which are targeted by fluoroquinolones (drugs these patients did not receive), had progressively decreased expression, consistent with decreased replication.	[]	['In', 'contrast', ',', 'genes', 'for', 'DNA', 'g', '##yra', '##se', 'subunit', '##s', '(', 'G', '##yr', '##A', ',', 'G', '##yr', '##B', ')', ',', 'which', 'are', 'targeted', 'by', 'flu', '##oro', '##quin', '##olo', '##nes', '(', 'drugs', 'these', 'patients', 'did', 'not', 'receive', ')', ',', 'had', 'progressively', 'decreased', 'expression', ',', 'consistent', 'with', 'decreased', 'replication', '.']	[0, 3, 11, 13, 19, 23, 27, 28, 31, 34, 41, 43, 44, 45, 47, 48, 50, 51, 53, 54, 55, 57, 63, 67, 76, 79, 82, 85, 89, 92, 96, 97, 103, 109, 118, 122, 126, 133, 134, 136, 140, 154, 164, 174, 176, 187, 192, 202, 213]	[2, 11, 12, 18, 22, 26, 28, 31, 33, 41, 42, 44, 45, 47, 48, 49, 51, 53, 54, 55, 56, 62, 66, 75, 78, 82, 85, 89, 92, 95, 97, 102, 108, 117, 121, 125, 133, 134, 135, 139, 153, 163, 174, 175, 186, 191, 201, 213, 214]	['In', 'contrast', ',', 'genes', 'for', 'DNA', 'gyrase', 'subunits', '(', 'GyrA', ',', 'GyrB', ')', ',', 'which', 'are', 'targeted', 'by', 'fluoroquinolones', '(', 'drugs', 'these', 'patients', 'did', 'not', 'receive', ')', ',', 'had', 'progressively', 'decreased', 'expression', ',', 'consistent', 'with', 'decreased', 'replication', '.']	[1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To evaluate the effects of low AIPL1, expression on paclitaxel-induced neurotoxicity, we modulated the gene in neurons through transient siRNA transfection and verified with quantitative polymerase chain reaction (qPCR), a reduction of expression in AIPL1 to 62% and 14% relative to control at 24 and 48 hours post transfection relative to non-targeting control (Figure 3A).	[]	['To', 'evaluate', 'the', 'effects', 'of', 'low', 'AI', '##PL', '##1', ',', 'expression', 'on', 'p', '##ac', '##lit', '##ax', '##el', '-', 'induced', 'ne', '##uro', '##to', '##xi', '##city', ',', 'we', 'm', '##od', '##ulated', 'the', 'gene', 'in', 'neurons', 'through', 'trans', '##ient', 'si', '##RNA', 'trans', '##fect', '##ion', 'and', 'verified', 'with', 'quantitative', 'polymer', '##ase', 'chain', 'reaction', '(', 'q', '##PC', '##R', ')', ',', 'a', 'reduction', 'of', 'expression', 'in', 'AI', '##PL', '##1', 'to', '62', '%', 'and', '14', '%', 'relative', 'to', 'control', 'at', '24', 'and', '48', 'hours', 'post', 'trans', '##fect', '##ion', 'relative', 'to', 'non', '-', 'targeting', 'control', '(', 'Figure', '3', '##A', ')', '.']	[0, 3, 12, 16, 24, 27, 31, 33, 35, 36, 38, 49, 52, 53, 55, 58, 60, 62, 63, 71, 73, 76, 78, 80, 84, 86, 89, 90, 92, 99, 103, 108, 111, 119, 127, 132, 137, 139, 143, 148, 152, 156, 160, 169, 174, 187, 194, 198, 204, 213, 214, 215, 217, 218, 219, 221, 223, 233, 236, 247, 250, 252, 254, 256, 259, 261, 263, 267, 269, 271, 280, 283, 291, 294, 297, 301, 304, 310, 315, 320, 324, 328, 337, 340, 343, 344, 354, 362, 363, 370, 371, 372, 373]	[2, 11, 15, 23, 26, 30, 33, 35, 36, 37, 48, 51, 53, 55, 58, 60, 62, 63, 70, 73, 76, 78, 80, 84, 85, 88, 90, 92, 98, 102, 107, 110, 118, 126, 132, 136, 139, 142, 148, 152, 155, 159, 168, 173, 186, 194, 197, 203, 212, 214, 215, 217, 218, 219, 220, 222, 232, 235, 246, 249, 252, 254, 255, 258, 261, 262, 266, 269, 270, 279, 282, 290, 293, 296, 300, 303, 309, 314, 320, 324, 327, 336, 339, 343, 344, 353, 361, 363, 369, 371, 372, 373, 374]	['To', 'evaluate', 'the', 'effects', 'of', 'low', 'AIPL1', ',', 'expression', 'on', 'paclitaxel', '-', 'induced', 'neurotoxicity', ',', 'we', 'modulated', 'the', 'gene', 'in', 'neurons', 'through', 'transient', 'siRNA', 'transfection', 'and', 'verified', 'with', 'quantitative', 'polymerase', 'chain', 'reaction', '(', 'qPCR', ')', ',', 'a', 'reduction', 'of', 'expression', 'in', 'AIPL1', 'to', '62%', 'and', '14%', 'relative', 'to', 'control', 'at', '24', 'and', '48', 'hours', 'post', 'transfection', 'relative', 'to', 'non', '-', 'targeting', 'control', '(', 'Figure', '3A', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 2, 2, 3, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among the 173 bacterial species identified in the 15 bile samples, we extracted 34 species harbouring genes encoding these enzymes by searching the KEGG (Kyoto Encyclopedia of Genes and Genomes) GENOME Database.	[]	['Among', 'the', '173', 'bacterial', 'species', 'identified', 'in', 'the', '15', 'bi', '##le', 'samples', ',', 'we', 'extracted', '34', 'species', 'harbour', '##ing', 'genes', 'encoding', 'these', 'enzymes', 'by', 'searching', 'the', 'K', '##EG', '##G', '(', 'Kyoto', 'Encyclopedia', 'of', 'Gene', '##s', 'and', 'Gen', '##ome', '##s', ')', 'GE', '##N', '##OM', '##E', 'Database', '.']	[0, 6, 10, 14, 24, 32, 43, 46, 50, 53, 55, 58, 65, 67, 70, 80, 83, 91, 98, 102, 108, 117, 123, 131, 134, 144, 148, 149, 151, 153, 154, 160, 173, 176, 180, 182, 186, 189, 192, 193, 195, 197, 198, 200, 202, 210]	[5, 9, 13, 23, 31, 42, 45, 49, 52, 55, 57, 65, 66, 69, 79, 82, 90, 98, 101, 107, 116, 122, 130, 133, 143, 147, 149, 151, 152, 154, 159, 172, 175, 180, 181, 185, 189, 192, 193, 194, 197, 198, 200, 201, 210, 211]	['Among', 'the', '173', 'bacterial', 'species', 'identified', 'in', 'the', '15', 'bile', 'samples', ',', 'we', 'extracted', '34', 'species', 'harbouring', 'genes', 'encoding', 'these', 'enzymes', 'by', 'searching', 'the', 'KEGG', '(', 'Kyoto', 'Encyclopedia', 'of', 'Genes', 'and', 'Genomes', ')', 'GENOME', 'Database', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 3, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using WMS sequencing, we also validated gene existence through metagenomic assemblies and metabolic reconstruction.	[]	['Using', 'W', '##MS', 'se', '##quencing', ',', 'we', 'also', 'valid', '##ated', 'gene', 'existence', 'through', 'meta', '##gen', '##omi', '##c', 'assemblies', 'and', 'metabolic', 'reconstruction', '.']	[0, 6, 7, 10, 12, 20, 22, 25, 30, 35, 40, 45, 55, 63, 67, 70, 73, 75, 86, 90, 100, 114]	[5, 7, 9, 12, 20, 21, 24, 29, 35, 39, 44, 54, 62, 67, 70, 73, 74, 85, 89, 99, 114, 115]	['Using', 'WMS', 'sequencing', ',', 'we', 'also', 'validated', 'gene', 'existence', 'through', 'metagenomic', 'assemblies', 'and', 'metabolic', 'reconstruction', '.']	[1, 2, 2, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
β-glucuronidase and phospholipase hydrolyse biliary bilirubin and phosphatidylcholine, respectively, leading to precipitation of calcium bilirubinate and calcium palmitate and thereby facilitating pigment solid formation6.	[('PMC4667190', 'R10000', 0, 15, 'β-glucuronidase')]	['β', '-', 'g', '##lu', '##cu', '##ron', '##idas', '##e', 'and', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'h', '##ydro', '##ly', '##se', 'bi', '##lia', '##ry', 'bi', '##li', '##ru', '##bin', 'and', 'p', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##line', ',', 'respectively', ',', 'leading', 'to', 'precipitation', 'of', 'calcium', 'bi', '##li', '##ru', '##bina', '##te', 'and', 'calcium', 'palm', '##itate', 'and', 'thereby', 'f', '##ac', '##ilitating', 'pig', '##ment', 'solid', 'formation', '##6', '.']	[0, 1, 2, 3, 5, 7, 10, 14, 16, 20, 21, 24, 26, 29, 32, 34, 35, 39, 41, 44, 46, 49, 52, 54, 56, 58, 62, 66, 67, 70, 73, 75, 77, 78, 81, 85, 87, 99, 101, 109, 112, 126, 129, 137, 139, 141, 143, 147, 150, 154, 162, 166, 172, 176, 184, 185, 187, 197, 200, 205, 211, 220, 221]	[1, 2, 3, 5, 7, 10, 14, 15, 19, 21, 24, 26, 29, 32, 33, 35, 39, 41, 43, 46, 49, 51, 54, 56, 58, 61, 65, 67, 70, 73, 75, 77, 78, 81, 85, 86, 99, 100, 108, 111, 125, 128, 136, 139, 141, 143, 147, 149, 153, 161, 166, 171, 175, 183, 185, 187, 196, 200, 204, 210, 220, 221, 222]	['β-glucuronidase', 'and', 'phospholipase', 'hydrolyse', 'biliary', 'bilirubin', 'and', 'phosphatidylcholine', ',', 'respectively', ',', 'leading', 'to', 'precipitation', 'of', 'calcium', 'bilirubinate', 'and', 'calcium', 'palmitate', 'and', 'thereby', 'facilitating', 'pigment', 'solid', 'formation6', '.']	[8, 1, 6, 4, 3, 4, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 3, 2, 1, 2, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Seven and ten individuals had samples containing ≥3 species harbouring genes uidA (encoding β-glucuronidase) and pldA (encoding phospholipase A1), respectively (Fig. 4a; Supplementary Table S5).	[('PMC4667190', 'R10001', 92, 107, 'β-glucuronidase')]	['Seven', 'and', 'ten', 'individuals', 'had', 'samples', 'containing', '≥', '3', 'species', 'harbour', '##ing', 'genes', 'u', '##id', '##A', '(', 'encoding', 'β', '-', 'g', '##lu', '##cu', '##ron', '##idas', '##e', ')', 'and', 'p', '##ld', '##A', '(', 'encoding', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'A1', ')', ',', 'respectively', '(', 'Fi', '##g', '.', '4', '##a', ';', 'Su', '##pp', '##lement', '##ary', 'Table', 'S', '##5', ')', '.']	[0, 6, 10, 14, 26, 30, 38, 49, 50, 52, 60, 67, 71, 77, 78, 80, 82, 83, 92, 93, 94, 95, 97, 99, 102, 106, 107, 109, 113, 114, 116, 118, 119, 128, 129, 132, 134, 137, 140, 142, 144, 145, 147, 160, 161, 163, 164, 166, 167, 168, 170, 172, 174, 180, 184, 190, 191, 192, 193]	[5, 9, 13, 25, 29, 37, 48, 50, 51, 59, 67, 70, 76, 78, 80, 81, 83, 91, 93, 94, 95, 97, 99, 102, 106, 107, 108, 112, 114, 116, 117, 119, 127, 129, 132, 134, 137, 140, 141, 144, 145, 146, 159, 161, 163, 164, 165, 167, 168, 169, 172, 174, 180, 183, 189, 191, 192, 193, 194]	['Seven', 'and', 'ten', 'individuals', 'had', 'samples', 'containing', '≥', '3', 'species', 'harbouring', 'genes', 'uidA', '(', 'encoding', 'β-glucuronidase', ')', 'and', 'pldA', '(', 'encoding', 'phospholipase', 'A1', ')', ',', 'respectively', '(', 'Fig', '.', '4a', ';', 'Supplementary', 'Table', 'S5', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 8, 1, 1, 3, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 2, 1, 4, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In summary, the mean levels of AFP, alkaline phosphatase (ALP), and gamma-glutamyl transpeptidase (GGT) were significantly higher in the HCC group, while prothrombin time (PT) was lower.	[]	['In', 'summary', ',', 'the', 'mean', 'levels', 'of', 'A', '##FP', ',', 'al', '##kal', '##ine', 'p', '##hos', '##pha', '##tase', '(', 'AL', '##P', ')', ',', 'and', 'gamma', '-', 'g', '##lut', '##am', '##yl', 'trans', '##pe', '##pt', '##idas', '##e', '(', 'G', '##G', '##T', ')', 'were', 'significantly', 'higher', 'in', 'the', 'HC', '##C', 'group', ',', 'while', 'pro', '##th', '##rom', '##bin', 'time', '(', 'PT', ')', 'was', 'lower', '.']	[0, 3, 10, 12, 16, 21, 28, 31, 32, 34, 36, 38, 41, 45, 46, 49, 52, 57, 58, 60, 61, 62, 64, 68, 73, 74, 75, 78, 80, 83, 88, 90, 92, 96, 98, 99, 100, 101, 102, 104, 109, 123, 130, 133, 137, 139, 141, 146, 148, 154, 157, 159, 162, 166, 171, 172, 174, 176, 180, 185]	[2, 10, 11, 15, 20, 27, 30, 32, 34, 35, 38, 41, 44, 46, 49, 52, 56, 58, 60, 61, 62, 63, 67, 73, 74, 75, 78, 80, 82, 88, 90, 92, 96, 97, 99, 100, 101, 102, 103, 108, 122, 129, 132, 136, 139, 140, 146, 147, 153, 157, 159, 162, 165, 170, 172, 174, 175, 179, 185, 186]	['In', 'summary', ',', 'the', 'mean', 'levels', 'of', 'AFP', ',', 'alkaline', 'phosphatase', '(', 'ALP', ')', ',', 'and', 'gamma', '-', 'glutamyl', 'transpeptidase', '(', 'GGT', ')', 'were', 'significantly', 'higher', 'in', 'the', 'HCC', 'group', ',', 'while', 'prothrombin', 'time', '(', 'PT', ')', 'was', 'lower', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 4, 1, 2, 1, 1, 1, 1, 1, 4, 5, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
rs62405954 is in LD with rs1002011, which overlaps a DNase hypersensitive site in megakaryocytes and lies within a putative enhancer overlapping the 5′ UTR of VPS52 (MIM: 603443), a gene that encodes an intracellular protein involved in endocytic recycling and is highly expressed in hematopoietic cells of erythroid and megakaryocyte lineages.	[]	['r', '##s', '##6', '##24', '##0', '##5', '##9', '##5', '##4', 'is', 'in', 'L', '##D', 'with', 'r', '##s', '##100', '##20', '##11', ',', 'which', 'overlap', '##s', 'a', 'D', '##N', '##ase', 'h', '##yper', '##sen', '##sitive', 'site', 'in', 'me', '##ga', '##kar', '##yo', '##cy', '##tes', 'and', 'lies', 'within', 'a', 'put', '##ative', 'enhance', '##r', 'overlapping', 'the', '5', '′', 'U', '##TR', 'of', 'VP', '##S', '##5', '##2', '(', 'MI', '##M', ':', '60', '##34', '##43', ')', ',', 'a', 'gene', 'that', 'en', '##codes', 'an', 'in', '##tra', '##cellular', 'protein', 'involved', 'in', 'end', '##oc', '##ytic', 'recycling', 'and', 'is', 'highly', 'expressed', 'in', 'hem', '##ato', '##po', '##iet', '##ic', 'cells', 'of', 'er', '##yt', '##hr', '##oid', 'and', 'me', '##ga', '##kar', '##yo', '##cy', '##te', 'lineage', '##s', '.']	[0, 1, 2, 3, 5, 6, 7, 8, 9, 11, 14, 17, 18, 20, 25, 26, 27, 30, 32, 34, 36, 42, 49, 51, 53, 54, 55, 59, 60, 64, 67, 74, 79, 82, 84, 86, 89, 91, 93, 97, 101, 106, 113, 115, 118, 124, 131, 133, 145, 149, 150, 152, 153, 156, 159, 161, 162, 163, 165, 166, 168, 169, 171, 173, 175, 177, 178, 180, 182, 187, 192, 194, 200, 203, 205, 208, 217, 225, 234, 237, 240, 242, 247, 257, 261, 264, 271, 281, 284, 287, 290, 292, 295, 298, 304, 307, 309, 311, 313, 317, 321, 323, 325, 328, 330, 332, 335, 342, 343]	[1, 2, 3, 5, 6, 7, 8, 9, 10, 13, 16, 18, 19, 24, 26, 27, 30, 32, 34, 35, 41, 49, 50, 52, 54, 55, 58, 60, 64, 67, 73, 78, 81, 84, 86, 89, 91, 93, 96, 100, 105, 112, 114, 118, 123, 131, 132, 144, 148, 150, 151, 153, 155, 158, 161, 162, 163, 164, 166, 168, 169, 170, 173, 175, 177, 178, 179, 181, 186, 191, 194, 199, 202, 205, 208, 216, 224, 233, 236, 240, 242, 246, 256, 260, 263, 270, 280, 283, 287, 290, 292, 295, 297, 303, 306, 309, 311, 313, 316, 320, 323, 325, 328, 330, 332, 334, 342, 343, 344]	['rs62405954', 'is', 'in', 'LD', 'with', 'rs1002011', ',', 'which', 'overlaps', 'a', 'DNase', 'hypersensitive', 'site', 'in', 'megakaryocytes', 'and', 'lies', 'within', 'a', 'putative', 'enhancer', 'overlapping', 'the', '5′', 'UTR', 'of', 'VPS52', '(', 'MIM', ':', '603443', ')', ',', 'a', 'gene', 'that', 'encodes', 'an', 'intracellular', 'protein', 'involved', 'in', 'endocytic', 'recycling', 'and', 'is', 'highly', 'expressed', 'in', 'hematopoietic', 'cells', 'of', 'erythroid', 'and', 'megakaryocyte', 'lineages', '.']	[9, 1, 1, 2, 1, 5, 1, 1, 2, 1, 3, 4, 1, 1, 6, 1, 1, 1, 1, 2, 2, 1, 1, 2, 2, 1, 4, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 4, 1, 6, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Since the mitochondrial respiratory complex I was identified as an essential source of reactive oxygen species (ROS) generation upon TCR stimulation mitochondria could function as oxidative signaling organelles during T cell activation [41, 42].	[]	['Since', 'the', 'mitochondrial', 'respiratory', 'complex', 'I', 'was', 'identified', 'as', 'an', 'essential', 'source', 'of', 'reactive', 'oxygen', 'species', '(', 'R', '##OS', ')', 'generation', 'upon', 'T', '##CR', 'stimulation', 'mit', '##och', '##ond', '##ria', 'could', 'function', 'as', 'o', '##xi', '##da', '##tive', 'signaling', 'organ', '##elles', 'during', 'T', 'cell', 'activation', '[', '41', ',', '42', ']', '.']	[0, 6, 10, 24, 36, 44, 46, 50, 61, 64, 67, 77, 84, 87, 96, 103, 111, 112, 113, 115, 117, 128, 133, 134, 137, 149, 152, 155, 158, 162, 168, 177, 180, 181, 183, 185, 190, 200, 205, 211, 218, 220, 225, 236, 237, 239, 241, 243, 244]	[5, 9, 23, 35, 43, 45, 49, 60, 63, 66, 76, 83, 86, 95, 102, 110, 112, 113, 115, 116, 127, 132, 134, 136, 148, 152, 155, 158, 161, 167, 176, 179, 181, 183, 185, 189, 199, 205, 210, 217, 219, 224, 235, 237, 239, 240, 243, 244, 245]	['Since', 'the', 'mitochondrial', 'respiratory', 'complex', 'I', 'was', 'identified', 'as', 'an', 'essential', 'source', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'generation', 'upon', 'TCR', 'stimulation', 'mitochondria', 'could', 'function', 'as', 'oxidative', 'signaling', 'organelles', 'during', 'T', 'cell', 'activation', '[', '41', ',', '42', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 4, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
cDNA was synthesized from 3 μg RNA treated with DNase I (Invitrogen GmbH, Karlsruhe, Germany) using oligo dT primers (Fermentas, Mannheim, Germany) and the RevertAid™ H Minus First Strand cDNA synthesis kit (Fermentas, St. Ingbert, Germany) before qPCR was performed with target-specific primers (Table S1) using Platinum® SYBR® Green qPCR	[]	['c', '##D', '##NA', 'was', 'synthesized', 'from', '3', 'μ', '##g', 'RNA', 'treated', 'with', 'D', '##N', '##ase', 'I', '(', 'In', '##vi', '##tro', '##gen', 'GmbH', ',', 'Karl', '##s', '##ru', '##he', ',', 'Germany', ')', 'using', 'o', '##li', '##go', 'd', '##T', 'prime', '##rs', '(', 'Fe', '##rm', '##ent', '##as', ',', 'Mann', '##heim', ',', 'Germany', ')', 'and', 'the', 'Rev', '##ert', '##A', '##id', '[UNK]', 'H', 'Min', '##us', 'First', 'Strand', 'c', '##D', '##NA', 'synthesis', 'kit', '(', 'Fe', '##rm', '##ent', '##as', ',', 'St', '.', 'In', '##g', '##bert', ',', 'Germany', ')', 'before', 'q', '##PC', '##R', 'was', 'performed', 'with', 'target', '-', 'specific', 'prime', '##rs', '(', 'Table', 'S', '##1', ')', 'using', 'Platinum', '®', 'S', '##Y', '##BR', '®', 'Green', 'q', '##PC', '##R']	[0, 1, 2, 5, 9, 21, 26, 28, 29, 31, 35, 43, 48, 49, 50, 54, 56, 57, 59, 61, 64, 68, 72, 74, 78, 79, 81, 83, 85, 92, 94, 100, 101, 103, 106, 107, 109, 114, 117, 118, 120, 122, 125, 127, 129, 133, 137, 139, 146, 148, 152, 156, 159, 162, 163, -1, 167, 169, 172, 175, 181, 188, 189, 190, 193, 203, 207, 208, 210, 212, 215, 217, 219, 221, 223, 225, 226, 230, 232, 239, 241, 248, 249, 251, 253, 257, 267, 272, 278, 279, 288, 293, 296, 297, 303, 304, 305, 307, 313, 321, 323, 324, 325, 327, 329, 335, 336, 338]	[1, 2, 4, 8, 20, 25, 27, 29, 30, 34, 42, 47, 49, 50, 53, 55, 57, 59, 61, 64, 67, 72, 73, 78, 79, 81, 83, 84, 92, 93, 99, 101, 103, 105, 107, 108, 114, 116, 118, 120, 122, 125, 127, 128, 133, 137, 138, 146, 147, 151, 155, 159, 162, 163, 165, 4, 168, 172, 174, 180, 187, 189, 190, 192, 202, 206, 208, 210, 212, 215, 217, 218, 221, 222, 225, 226, 230, 231, 239, 240, 247, 249, 251, 252, 256, 266, 271, 278, 279, 287, 293, 295, 297, 302, 304, 305, 306, 312, 321, 322, 324, 325, 327, 328, 334, 336, 338, 339]	['cDNA', 'was', 'synthesized', 'from', '3', 'μg', 'RNA', 'treated', 'with', 'DNase', 'I', '(', 'Invitrogen', 'GmbH', ',', 'Karlsruhe', ',', 'Germany', ')', 'using', 'oligo', 'dT', 'primers', '(', 'Fermentas', ',', 'Mannheim', ',', 'Germany', ')', 'and', 'the', 'RevertAid', '™', 'H', 'Minus', 'First', 'Strand', 'cDNA', 'synthesis', 'kit', '(', 'Fermentas', ',', 'St', '.', 'Ingbert', ',', 'Germany', ')', 'before', 'qPCR', 'was', 'performed', 'with', 'target', '-', 'specific', 'primers', '(', 'Table', 'S1', ')', 'using', 'Platinum', '®', 'SYBR', '®', 'Green', 'qPCR']	[3, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 3, 2, 2, 1, 4, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
MnSOD2 activity of conditioned media was analyzed using the Superoxide Dismutase Activity Colorimetric Assay Kit (Abcam, Cambridge, UK) according to the manufacturer's protocol using freshly prepared and undiluted 786-0VHL−- and 786-0VHL+-conditioned media.	[('PMC4791241', 'M24000', 60, 80, 'Superoxide Dismutase')]	"['M', '##n', '##SO', '##D', '##2', 'activity', 'of', 'conditioned', 'media', 'was', 'analyzed', 'using', 'the', 'Super', '##oxide', 'Di', '##sm', '##uta', '##se', 'Act', '##ivity', 'Color', '##ime', '##tric', 'As', '##say', 'Kit', '(', 'A', '##b', '##cam', ',', 'Cambridge', ',', 'UK', ')', 'according', 'to', 'the', 'manufacturer', ""'"", 's', 'protocol', 'using', 'freshly', 'prepared', 'and', 'und', '##il', '##uted', '78', '##6', '-', '0', '##V', '##HL', '##−', '-', 'and', '78', '##6', '-', '0', '##V', '##HL', '+', '-', 'conditioned', 'media', '.']"	[0, 1, 2, 4, 5, 7, 16, 19, 31, 37, 41, 50, 56, 60, 65, 71, 73, 75, 78, 81, 84, 90, 95, 98, 103, 105, 109, 113, 114, 115, 116, 119, 121, 130, 132, 134, 136, 146, 149, 153, 165, 166, 168, 177, 183, 191, 200, 204, 207, 209, 214, 216, 217, 218, 219, 220, 222, 223, 225, 229, 231, 232, 233, 234, 235, 237, 238, 239, 251, 256]	[1, 2, 4, 5, 6, 15, 18, 30, 36, 40, 49, 55, 59, 65, 70, 73, 75, 78, 80, 84, 89, 95, 98, 102, 105, 108, 112, 114, 115, 116, 119, 120, 130, 131, 134, 135, 145, 148, 152, 165, 166, 167, 176, 182, 190, 199, 203, 207, 209, 213, 216, 217, 218, 219, 220, 222, 223, 224, 228, 231, 232, 233, 234, 235, 237, 238, 239, 250, 256, 257]	"['MnSOD2', 'activity', 'of', 'conditioned', 'media', 'was', 'analyzed', 'using', 'the', 'Superoxide', 'Dismutase', 'Activity', 'Colorimetric', 'Assay', 'Kit', '(', 'Abcam', ',', 'Cambridge', ',', 'UK', ')', 'according', 'to', 'the', ""manufacturer's"", 'protocol', 'using', 'freshly', 'prepared', 'and', 'undiluted', '786-0VHL−-', 'and', '786-0VHL', '+', '-', 'conditioned', 'media', '.']"	[5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 2, 3, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 8, 1, 6, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Labeled DNA was then applied to microbial microarrays (280 species) generated by the Human Oral Microbial Identification Microarray Laboratory (Forsyth Institute, Cambridge, MA).	[]	['Label', '##ed', 'DNA', 'was', 'then', 'applied', 'to', 'micro', '##bial', 'micro', '##arra', '##ys', '(', '280', 'species', ')', 'generated', 'by', 'the', 'Human', 'Oral', 'Micro', '##bial', 'I', '##dent', '##ification', 'Micro', '##arra', '##y', 'Laboratory', '(', 'For', '##sy', '##th', 'Institute', ',', 'Cambridge', ',', 'MA', ')', '.']	[0, 5, 8, 12, 16, 21, 29, 32, 37, 42, 47, 51, 54, 55, 59, 66, 68, 78, 81, 85, 91, 96, 101, 106, 107, 111, 121, 126, 130, 132, 143, 144, 147, 149, 152, 161, 163, 172, 174, 176, 177]	[5, 7, 11, 15, 20, 28, 31, 37, 41, 47, 51, 53, 55, 58, 66, 67, 77, 80, 84, 90, 95, 101, 105, 107, 111, 120, 126, 130, 131, 142, 144, 147, 149, 151, 161, 162, 172, 173, 176, 177, 178]	['Labeled', 'DNA', 'was', 'then', 'applied', 'to', 'microbial', 'microarrays', '(', '280', 'species', ')', 'generated', 'by', 'the', 'Human', 'Oral', 'Microbial', 'Identification', 'Microarray', 'Laboratory', '(', 'Forsyth', 'Institute', ',', 'Cambridge', ',', 'MA', ')', '.']	[2, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Siqueira and Rôcas (5) have identified five levels of experimentation analyzing the microorganisms contained within acute apical abscesses: 1) culture methods targeting cultivable bacteria (open-ended or broad-range culture approach), 2) molecular identification tools, including polymerase chain reaction (PCR) and the checkerboard hybridization assay (using genomic probes to detect cultivable bacteria; closed-ended molecular detection approach), 3) broad-range PCR in addition to cloning and sequencing of targeted amplicons (open-ended molecular approach), 4) molecular analysis using PCR or DNA hybridization, including reverse checkerboard hybridization, and the use of human participants in large-scale clinical studies to assess prevalence and association of diverse bacterial strains (close-ended molecular approach), and 5) the use of next-generation sequencing (NGS) for extensive, open-ended analysis of abscess specimens.	[('PMC4794734', 'I01000', 280, 290, 'polymerase')]	['Si', '##que', '##ira', 'and', 'R', '##ô', '##cas', '(', '5', ')', 'have', 'identified', 'five', 'levels', 'of', 'experimentation', 'analyzing', 'the', 'micro', '##or', '##gan', '##isms', 'contained', 'within', 'acute', 'a', '##pical', 'a', '##bs', '##cess', '##es', ':', '1', ')', 'culture', 'methods', 'targeting', 'cult', '##ivable', 'bacteria', '(', 'open', '-', 'ended', 'or', 'broad', '-', 'range', 'culture', 'approach', ')', ',', '2', ')', 'molecular', 'identification', 'tools', ',', 'including', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'and', 'the', 'check', '##er', '##board', 'hybrid', '##ization', 'ass', '##ay', '(', 'using', 'g', '##eno', '##mic', 'probe', '##s', 'to', 'detect', 'cult', '##ivable', 'bacteria', ';', 'closed', '-', 'ended', 'molecular', 'detection', 'approach', ')', ',', '3', ')', 'broad', '-', 'range', 'PC', '##R', 'in', 'addition', 'to', 'c', '##lon', '##ing', 'and', 'se', '##quencing', 'of', 'targeted', 'am', '##p', '##lic', '##ons', '(', 'open', '-', 'ended', 'molecular', 'approach', ')', ',', '4', ')', 'molecular', 'analysis', 'using', 'PC', '##R', 'or', 'DNA', 'hybrid', '##ization', ',', 'including', 'reverse', 'check', '##er', '##board', 'hybrid', '##ization', ',', 'and', 'the', 'use', 'of', 'human', 'participants', 'in', 'large', '-', 'scale', 'clinical', 'studies', 'to', 'assess', 'prevalence', 'and', 'association', 'of', 'diverse', 'bacterial', 'strains', '(', 'close', '-', 'ended', 'molecular', 'approach', ')', ',', 'and', '5', ')', 'the', 'use', 'of', 'next', '-', 'generation', 'se', '##quencing', '(', 'N', '##GS', ')', 'for', 'extensive', ',', 'open', '-', 'ended', 'analysis', 'of', 'a', '##bs', '##cess', 'specimens', '.']	[0, 2, 5, 9, 13, 14, 15, 19, 20, 21, 23, 28, 39, 44, 51, 54, 70, 80, 84, 89, 91, 94, 99, 109, 116, 122, 123, 129, 130, 132, 136, 138, 140, 141, 143, 151, 159, 169, 173, 180, 189, 190, 194, 195, 201, 204, 209, 210, 216, 224, 232, 233, 235, 236, 238, 248, 263, 268, 270, 280, 287, 291, 297, 306, 307, 309, 310, 312, 316, 320, 325, 327, 333, 339, 347, 350, 353, 354, 360, 361, 364, 368, 373, 375, 378, 385, 389, 396, 404, 406, 412, 413, 419, 429, 439, 447, 448, 450, 451, 453, 458, 459, 465, 467, 469, 472, 481, 484, 485, 488, 492, 496, 498, 507, 510, 519, 521, 522, 525, 529, 530, 534, 535, 541, 551, 559, 560, 562, 563, 565, 575, 584, 590, 592, 594, 597, 601, 607, 614, 616, 626, 634, 639, 641, 647, 653, 660, 662, 666, 670, 674, 677, 683, 696, 699, 704, 705, 711, 720, 728, 731, 738, 749, 753, 765, 768, 776, 786, 794, 795, 800, 801, 807, 817, 825, 826, 828, 832, 833, 835, 839, 843, 846, 850, 851, 862, 864, 873, 874, 875, 877, 879, 883, 892, 894, 898, 899, 905, 914, 917, 918, 920, 925, 934]	[2, 5, 8, 12, 14, 15, 18, 20, 21, 22, 27, 38, 43, 50, 53, 69, 79, 83, 89, 91, 94, 98, 108, 115, 121, 123, 128, 130, 132, 136, 138, 139, 141, 142, 150, 158, 168, 173, 179, 188, 190, 194, 195, 200, 203, 209, 210, 215, 223, 232, 233, 234, 236, 237, 247, 262, 268, 269, 279, 287, 290, 296, 305, 307, 309, 310, 311, 315, 319, 325, 327, 332, 339, 346, 350, 352, 354, 359, 361, 364, 367, 373, 374, 377, 384, 389, 395, 404, 405, 412, 413, 418, 428, 438, 447, 448, 449, 451, 452, 458, 459, 464, 467, 468, 471, 480, 483, 485, 488, 491, 495, 498, 506, 509, 518, 521, 522, 525, 528, 530, 534, 535, 540, 550, 559, 560, 561, 563, 564, 574, 583, 589, 592, 593, 596, 600, 607, 614, 615, 625, 633, 639, 641, 646, 653, 660, 661, 665, 669, 673, 676, 682, 695, 698, 704, 705, 710, 719, 727, 730, 737, 748, 752, 764, 767, 775, 785, 793, 795, 800, 801, 806, 816, 825, 826, 827, 831, 833, 834, 838, 842, 845, 850, 851, 861, 864, 872, 874, 875, 877, 878, 882, 892, 893, 898, 899, 904, 913, 916, 918, 920, 924, 934, 935]	['Siqueira', 'and', 'Rôcas', '(', '5', ')', 'have', 'identified', 'five', 'levels', 'of', 'experimentation', 'analyzing', 'the', 'microorganisms', 'contained', 'within', 'acute', 'apical', 'abscesses', ':', '1', ')', 'culture', 'methods', 'targeting', 'cultivable', 'bacteria', '(', 'open', '-', 'ended', 'or', 'broad', '-', 'range', 'culture', 'approach', ')', ',', '2', ')', 'molecular', 'identification', 'tools', ',', 'including', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'and', 'the', 'checkerboard', 'hybridization', 'assay', '(', 'using', 'genomic', 'probes', 'to', 'detect', 'cultivable', 'bacteria', ';', 'closed', '-', 'ended', 'molecular', 'detection', 'approach', ')', ',', '3', ')', 'broad', '-', 'range', 'PCR', 'in', 'addition', 'to', 'cloning', 'and', 'sequencing', 'of', 'targeted', 'amplicons', '(', 'open', '-', 'ended', 'molecular', 'approach', ')', ',', '4', ')', 'molecular', 'analysis', 'using', 'PCR', 'or', 'DNA', 'hybridization', ',', 'including', 'reverse', 'checkerboard', 'hybridization', ',', 'and', 'the', 'use', 'of', 'human', 'participants', 'in', 'large', '-', 'scale', 'clinical', 'studies', 'to', 'assess', 'prevalence', 'and', 'association', 'of', 'diverse', 'bacterial', 'strains', '(', 'close', '-', 'ended', 'molecular', 'approach', ')', ',', 'and', '5', ')', 'the', 'use', 'of', 'next', '-', 'generation', 'sequencing', '(', 'NGS', ')', 'for', 'extensive', ',', 'open', '-', 'ended', 'analysis', 'of', 'abscess', 'specimens', '.']	[3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 2, 2, 1, 1, 3, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In our study, microbial enrichment was achieved by reducing the amount of host endogenous DNA by centrifugation and filtration followed by nuclease treatment of fluid samples or tissue homogenates.	[('PMC4809928', 'D02000', 139, 147, 'nuclease')]	['In', 'our', 'study', ',', 'micro', '##bial', 'en', '##rich', '##ment', 'was', 'achieved', 'by', 'reducing', 'the', 'amount', 'of', 'host', 'end', '##ogen', '##ous', 'DNA', 'by', 'cent', '##ri', '##fu', '##gation', 'and', 'fi', '##ltration', 'followed', 'by', 'n', '##uc', '##lea', '##se', 'treatment', 'of', 'fluid', 'samples', 'or', 'tissue', 'ho', '##mo', '##gen', '##ates', '.']	[0, 3, 7, 12, 14, 19, 24, 26, 30, 35, 39, 48, 51, 60, 64, 71, 74, 79, 82, 86, 90, 94, 97, 101, 103, 105, 112, 116, 118, 127, 136, 139, 140, 142, 145, 148, 158, 161, 167, 175, 178, 185, 187, 189, 192, 196]	[2, 6, 12, 13, 19, 23, 26, 30, 34, 38, 47, 50, 59, 63, 70, 73, 78, 82, 86, 89, 93, 96, 101, 103, 105, 111, 115, 118, 126, 135, 138, 140, 142, 145, 147, 157, 160, 166, 174, 177, 184, 187, 189, 192, 196, 197]	['In', 'our', 'study', ',', 'microbial', 'enrichment', 'was', 'achieved', 'by', 'reducing', 'the', 'amount', 'of', 'host', 'endogenous', 'DNA', 'by', 'centrifugation', 'and', 'filtration', 'followed', 'by', 'nuclease', 'treatment', 'of', 'fluid', 'samples', 'or', 'tissue', 'homogenates', '.']	[1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At GCKR, the index SNP (rs1260326; C>T) encodes an amino acid change from proline to leucine (P446L) in the glucokinase regulator protein (GKRP).	[('PMC4819009', 'D01000', 108, 119, 'glucokinase')]	['At', 'G', '##C', '##K', '##R', ',', 'the', 'index', 'S', '##NP', '(', 'r', '##s', '##12', '##60', '##32', '##6', ';', 'C', '>', 'T', ')', 'en', '##codes', 'an', 'amino', 'acid', 'change', 'from', 'pro', '##line', 'to', 'le', '##uc', '##ine', '(', 'P', '##44', '##6', '##L', ')', 'in', 'the', 'g', '##lu', '##co', '##kin', '##ase', 'regulator', 'protein', '(', 'G', '##K', '##RP', ')', '.']	[0, 3, 4, 5, 6, 7, 9, 13, 19, 20, 23, 24, 25, 26, 28, 30, 32, 33, 35, 36, 37, 38, 40, 42, 48, 51, 57, 62, 69, 74, 77, 82, 85, 87, 89, 93, 94, 95, 97, 98, 99, 101, 104, 108, 109, 111, 113, 116, 120, 130, 138, 139, 140, 141, 143, 144]	[2, 4, 5, 6, 7, 8, 12, 18, 20, 22, 24, 25, 26, 28, 30, 32, 33, 34, 36, 37, 38, 39, 42, 47, 50, 56, 61, 68, 73, 77, 81, 84, 87, 89, 92, 94, 95, 97, 98, 99, 100, 103, 107, 109, 111, 113, 116, 119, 129, 137, 139, 140, 141, 143, 144, 145]	['At', 'GCKR', ',', 'the', 'index', 'SNP', '(', 'rs1260326', ';', 'C', '>', 'T', ')', 'encodes', 'an', 'amino', 'acid', 'change', 'from', 'proline', 'to', 'leucine', '(', 'P446L', ')', 'in', 'the', 'glucokinase', 'regulator', 'protein', '(', 'GKRP', ')', '.']	[1, 4, 1, 1, 1, 2, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 3, 1, 4, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Notably, higher blood lactate levels are associated with a higher risk of incident diabetes [4,18]; therefore, the positive association between lactate and incident diabetes probably reflects mechanisms independent of the GCKR pathway.	[]	['Not', '##ably', ',', 'higher', 'blood', 'la', '##ct', '##ate', 'levels', 'are', 'associated', 'with', 'a', 'higher', 'risk', 'of', 'incident', 'diabetes', '[', '4', ',', '18', ']', ';', 'therefore', ',', 'the', 'positive', 'association', 'between', 'la', '##ct', '##ate', 'and', 'incident', 'diabetes', 'probably', 'reflects', 'mechanisms', 'independent', 'of', 'the', 'G', '##C', '##K', '##R', 'pathway', '.']	[0, 3, 7, 9, 16, 22, 24, 26, 30, 37, 41, 52, 57, 59, 66, 71, 74, 83, 92, 93, 94, 95, 97, 98, 100, 109, 111, 115, 124, 136, 144, 146, 148, 152, 156, 165, 174, 183, 192, 203, 215, 218, 222, 223, 224, 225, 227, 234]	[3, 7, 8, 15, 21, 24, 26, 29, 36, 40, 51, 56, 58, 65, 70, 73, 82, 91, 93, 94, 95, 97, 98, 99, 109, 110, 114, 123, 135, 143, 146, 148, 151, 155, 164, 173, 182, 191, 202, 214, 217, 221, 223, 224, 225, 226, 234, 235]	['Notably', ',', 'higher', 'blood', 'lactate', 'levels', 'are', 'associated', 'with', 'a', 'higher', 'risk', 'of', 'incident', 'diabetes', '[', '4', ',', '18', ']', ';', 'therefore', ',', 'the', 'positive', 'association', 'between', 'lactate', 'and', 'incident', 'diabetes', 'probably', 'reflects', 'mechanisms', 'independent', 'of', 'the', 'GCKR', 'pathway', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Additionally, genomic analysis revealed that there were two different homologs of arginine kinase and eight different heat-shock protein 70 (HSP70) homologs, with the predicted sequences of the various homologs differing.	[('PMC4892810', 'R04000', 82, 97, 'arginine kinase')]	['Additionally', ',', 'g', '##eno', '##mic', 'analysis', 'revealed', 'that', 'there', 'were', 'two', 'different', 'ho', '##mo', '##log', '##s', 'of', 'a', '##rg', '##ini', '##ne', 'kinase', 'and', 'eight', 'different', 'heat', '-', 'shock', 'protein', '70', '(', 'H', '##SP', '##70', ')', 'ho', '##mo', '##log', '##s', ',', 'with', 'the', 'predicted', 'sequences', 'of', 'the', 'various', 'ho', '##mo', '##log', '##s', 'differing', '.']	[0, 12, 14, 15, 18, 22, 31, 40, 45, 51, 56, 60, 70, 72, 74, 77, 79, 82, 83, 85, 88, 91, 98, 102, 108, 118, 122, 123, 129, 137, 140, 141, 142, 144, 146, 148, 150, 152, 155, 156, 158, 163, 167, 177, 187, 190, 194, 202, 204, 206, 209, 211, 220]	[12, 13, 15, 18, 21, 30, 39, 44, 50, 55, 59, 69, 72, 74, 77, 78, 81, 83, 85, 88, 90, 97, 101, 107, 117, 122, 123, 128, 136, 139, 141, 142, 144, 146, 147, 150, 152, 155, 156, 157, 162, 166, 176, 186, 189, 193, 201, 204, 206, 209, 210, 220, 221]	['Additionally', ',', 'genomic', 'analysis', 'revealed', 'that', 'there', 'were', 'two', 'different', 'homologs', 'of', 'arginine', 'kinase', 'and', 'eight', 'different', 'heat', '-', 'shock', 'protein', '70', '(', 'HSP70', ')', 'homologs', ',', 'with', 'the', 'predicted', 'sequences', 'of', 'the', 'various', 'homologs', 'differing', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Both proteins were present on 2D gels as a group of similarly migrating spots and tryptic fragment sequences aligning to both arginine kinase homologs and to six of the eight HSP70 homologs were identified, confirming that most of the various homologs of these two proteins were translated into protein.	[('PMC4892810', 'R04001', 126, 141, 'arginine kinase')]	['Both', 'proteins', 'were', 'present', 'on', '2D', 'gel', '##s', 'as', 'a', 'group', 'of', 'similarly', 'mi', '##grating', 'spots', 'and', 'try', '##ptic', 'fragment', 'sequences', 'al', '##ign', '##ing', 'to', 'both', 'a', '##rg', '##ini', '##ne', 'kinase', 'ho', '##mo', '##log', '##s', 'and', 'to', 'six', 'of', 'the', 'eight', 'H', '##SP', '##70', 'ho', '##mo', '##log', '##s', 'were', 'identified', ',', 'confirming', 'that', 'most', 'of', 'the', 'various', 'ho', '##mo', '##log', '##s', 'of', 'these', 'two', 'proteins', 'were', 'translated', 'into', 'protein', '.']	[0, 5, 14, 19, 27, 30, 33, 36, 38, 41, 43, 49, 52, 62, 64, 72, 78, 82, 85, 90, 99, 109, 111, 114, 118, 121, 126, 127, 129, 132, 135, 142, 144, 146, 149, 151, 155, 158, 162, 165, 169, 175, 176, 178, 181, 183, 185, 188, 190, 195, 205, 207, 218, 223, 228, 231, 235, 243, 245, 247, 250, 252, 255, 261, 265, 274, 279, 290, 295, 302]	[4, 13, 18, 26, 29, 32, 36, 37, 40, 42, 48, 51, 61, 64, 71, 77, 81, 85, 89, 98, 108, 111, 114, 117, 120, 125, 127, 129, 132, 134, 141, 144, 146, 149, 150, 154, 157, 161, 164, 168, 174, 176, 178, 180, 183, 185, 188, 189, 194, 205, 206, 217, 222, 227, 230, 234, 242, 245, 247, 250, 251, 254, 260, 264, 273, 278, 289, 294, 302, 303]	['Both', 'proteins', 'were', 'present', 'on', '2D', 'gels', 'as', 'a', 'group', 'of', 'similarly', 'migrating', 'spots', 'and', 'tryptic', 'fragment', 'sequences', 'aligning', 'to', 'both', 'arginine', 'kinase', 'homologs', 'and', 'to', 'six', 'of', 'the', 'eight', 'HSP70', 'homologs', 'were', 'identified', ',', 'confirming', 'that', 'most', 'of', 'the', 'various', 'homologs', 'of', 'these', 'two', 'proteins', 'were', 'translated', 'into', 'protein', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The source of suggested prognostic value of serum lipase levels is somewhat unclear.	[('PMC4893679', 'D03000', 50, 56, 'lipase')]	['The', 'source', 'of', 'suggested', 'pro', '##gno', '##stic', 'value', 'of', 'serum', 'lip', '##ase', 'levels', 'is', 'somewhat', 'unclear', '.']	[0, 4, 11, 14, 24, 27, 30, 35, 41, 44, 50, 53, 57, 64, 67, 76, 83]	[3, 10, 13, 23, 27, 30, 34, 40, 43, 49, 53, 56, 63, 66, 75, 83, 84]	['The', 'source', 'of', 'suggested', 'prognostic', 'value', 'of', 'serum', 'lipase', 'levels', 'is', 'somewhat', 'unclear', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
It has been shown that serum lipase levels are more accurate than serum amylase levels in the diagnosis of AP.32 Although there was no difference in the incidence of AP in their medical history (6/9 AP vs. 8/18	[('PMC4893679', 'D03001', 29, 35, 'lipase')]	['It', 'has', 'been', 'shown', 'that', 'serum', 'lip', '##ase', 'levels', 'are', 'more', 'accurate', 'than', 'serum', 'am', '##yla', '##se', 'levels', 'in', 'the', 'diagnosis', 'of', 'AP', '.', '32', 'Although', 'there', 'was', 'no', 'difference', 'in', 'the', 'incidence', 'of', 'AP', 'in', 'their', 'medical', 'history', '(', '6', '/', '9', 'AP', 'vs', '.', '8', '/', '18']	[0, 3, 7, 12, 18, 23, 29, 32, 36, 43, 47, 52, 61, 66, 72, 74, 77, 80, 87, 90, 94, 104, 107, 109, 110, 113, 122, 128, 132, 135, 146, 149, 153, 163, 166, 169, 172, 178, 186, 194, 195, 196, 197, 199, 202, 204, 206, 207, 208]	[2, 6, 11, 17, 22, 28, 32, 35, 42, 46, 51, 60, 65, 71, 74, 77, 79, 86, 89, 93, 103, 106, 109, 110, 112, 121, 127, 131, 134, 145, 148, 152, 162, 165, 168, 171, 177, 185, 193, 195, 196, 197, 198, 201, 204, 205, 207, 208, 210]	['It', 'has', 'been', 'shown', 'that', 'serum', 'lipase', 'levels', 'are', 'more', 'accurate', 'than', 'serum', 'amylase', 'levels', 'in', 'the', 'diagnosis', 'of', 'AP.32', 'Although', 'there', 'was', 'no', 'difference', 'in', 'the', 'incidence', 'of', 'AP', 'in', 'their', 'medical', 'history', '(', '6', '/', '9', 'AP', 'vs', '.', '8', '/', '18']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patients who developed AP had significantly higher levels of amylase (P=0.006) and lipase (P=0.004) after ERCP than those who did not (Table 2 and Figure 3).	[('PMC4893679', 'R03000', 61, 68, 'amylase')]	['Pat', '##ients', 'who', 'developed', 'AP', 'had', 'significantly', 'higher', 'levels', 'of', 'am', '##yla', '##se', '(', 'P', '=', '0', '.', '00', '##6', ')', 'and', 'lip', '##ase', '(', 'P', '=', '0', '.', '00', '##4', ')', 'after', 'ER', '##CP', 'than', 'those', 'who', 'did', 'not', '(', 'Table', '2', 'and', 'Figure', '3', ')', '.']	[0, 3, 9, 13, 23, 26, 30, 44, 51, 58, 61, 63, 66, 69, 70, 71, 72, 73, 74, 76, 77, 79, 83, 86, 90, 91, 92, 93, 94, 95, 97, 98, 100, 106, 108, 111, 116, 122, 126, 130, 134, 135, 141, 143, 147, 154, 155, 156]	[3, 8, 12, 22, 25, 29, 43, 50, 57, 60, 63, 66, 68, 70, 71, 72, 73, 74, 76, 77, 78, 82, 86, 89, 91, 92, 93, 94, 95, 97, 98, 99, 105, 108, 110, 115, 121, 125, 129, 133, 135, 140, 142, 146, 153, 155, 156, 157]	['Patients', 'who', 'developed', 'AP', 'had', 'significantly', 'higher', 'levels', 'of', 'amylase', '(', 'P=0.006', ')', 'and', 'lipase', '(', 'P=0.004', ')', 'after', 'ERCP', 'than', 'those', 'who', 'did', 'not', '(', 'Table', '2', 'and', 'Figure', '3', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 1, 2, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is in accord with the use of amylase and lipase levels to diagnose pancreatitis as stated in the Methods.	[('PMC4893679', 'R03001', 34, 41, 'amylase')]	['This', 'is', 'in', 'accord', 'with', 'the', 'use', 'of', 'am', '##yla', '##se', 'and', 'lip', '##ase', 'levels', 'to', 'di', '##ag', '##nose', 'pan', '##cre', '##ati', '##tis', 'as', 'stated', 'in', 'the', 'Method', '##s', '.']	[0, 5, 8, 11, 18, 23, 27, 31, 34, 36, 39, 42, 46, 49, 53, 60, 63, 65, 67, 72, 75, 78, 81, 85, 88, 95, 98, 102, 108, 109]	[4, 7, 10, 17, 22, 26, 30, 33, 36, 39, 41, 45, 49, 52, 59, 62, 65, 67, 71, 75, 78, 81, 84, 87, 94, 97, 101, 108, 109, 110]	['This', 'is', 'in', 'accord', 'with', 'the', 'use', 'of', 'amylase', 'and', 'lipase', 'levels', 'to', 'diagnose', 'pancreatitis', 'as', 'stated', 'in', 'the', 'Methods', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 3, 4, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patients who went on to develop AP showed a trend toward higher pre-ERCP lipase levels relative to those who did not develop AP (P=0.09, Table 2 and Figure 3).	[('PMC4893679', 'R05000', 73, 79, 'lipase')]	['Pat', '##ients', 'who', 'went', 'on', 'to', 'develop', 'AP', 'showed', 'a', 'trend', 'toward', 'higher', 'pre', '-', 'ER', '##CP', 'lip', '##ase', 'levels', 'relative', 'to', 'those', 'who', 'did', 'not', 'develop', 'AP', '(', 'P', '=', '0', '.', '09', ',', 'Table', '2', 'and', 'Figure', '3', ')', '.']	[0, 3, 9, 13, 18, 21, 24, 32, 35, 42, 44, 50, 57, 64, 67, 68, 70, 73, 76, 80, 87, 96, 99, 105, 109, 113, 117, 125, 128, 129, 130, 131, 132, 133, 135, 137, 143, 145, 149, 156, 157, 158]	[3, 8, 12, 17, 20, 23, 31, 34, 41, 43, 49, 56, 63, 67, 68, 70, 72, 76, 79, 86, 95, 98, 104, 108, 112, 116, 124, 127, 129, 130, 131, 132, 133, 135, 136, 142, 144, 148, 155, 157, 158, 159]	['Patients', 'who', 'went', 'on', 'to', 'develop', 'AP', 'showed', 'a', 'trend', 'toward', 'higher', 'pre-ERCP', 'lipase', 'levels', 'relative', 'to', 'those', 'who', 'did', 'not', 'develop', 'AP', '(', 'P=0.09', ',', 'Table', '2', 'and', 'Figure', '3', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Other transport systems that increased in abundance after RYGB are the phosphotransferase systems (PTS; Fig. 4), which are only found in bacteria.	[('PMC4908688', 'R09000', 71, 89, 'phosphotransferase')]	['Other', 'transport', 'systems', 'that', 'increased', 'in', 'abundance', 'after', 'R', '##Y', '##GB', 'are', 'the', 'p', '##hos', '##ph', '##ot', '##ran', '##s', '##fer', '##ase', 'systems', '(', 'PT', '##S', ';', 'Fi', '##g', '.', '4', ')', ',', 'which', 'are', 'only', 'found', 'in', 'bacteria', '.']	[0, 6, 16, 24, 29, 39, 42, 52, 58, 59, 60, 63, 67, 71, 72, 75, 77, 79, 82, 83, 86, 90, 98, 99, 101, 102, 104, 106, 107, 109, 110, 111, 113, 119, 123, 128, 134, 137, 145]	[5, 15, 23, 28, 38, 41, 51, 57, 59, 60, 62, 66, 70, 72, 75, 77, 79, 82, 83, 86, 89, 97, 99, 101, 102, 103, 106, 107, 108, 110, 111, 112, 118, 122, 127, 133, 136, 145, 146]	['Other', 'transport', 'systems', 'that', 'increased', 'in', 'abundance', 'after', 'RYGB', 'are', 'the', 'phosphotransferase', 'systems', '(', 'PTS', ';', 'Fig', '.', '4', ')', ',', 'which', 'are', 'only', 'found', 'in', 'bacteria', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 8, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The KEGG module for cytochrome c oxidase complex and the module for prokaryotic biosynthesis of ubiquinone also increased in abundance after RYGB.	[('PMC4908688', 'R10000', 20, 40, 'cytochrome c oxidase')]	['The', 'K', '##EG', '##G', 'module', 'for', 'c', '##yt', '##och', '##rome', 'c', 'o', '##xi', '##das', '##e', 'complex', 'and', 'the', 'module', 'for', 'pro', '##kar', '##yo', '##tic', 'bio', '##sy', '##nt', '##hesis', 'of', 'u', '##bi', '##quin', '##one', 'also', 'increased', 'in', 'abundance', 'after', 'R', '##Y', '##GB', '.']	[0, 4, 5, 7, 9, 16, 20, 21, 23, 26, 31, 33, 34, 36, 39, 41, 49, 53, 57, 64, 68, 71, 74, 76, 80, 83, 85, 87, 93, 96, 97, 99, 103, 107, 112, 122, 125, 135, 141, 142, 143, 145]	[3, 5, 7, 8, 15, 19, 21, 23, 26, 30, 32, 34, 36, 39, 40, 48, 52, 56, 63, 67, 71, 74, 76, 79, 83, 85, 87, 92, 95, 97, 99, 103, 106, 111, 121, 124, 134, 140, 142, 143, 145, 146]	['The', 'KEGG', 'module', 'for', 'cytochrome', 'c', 'oxidase', 'complex', 'and', 'the', 'module', 'for', 'prokaryotic', 'biosynthesis', 'of', 'ubiquinone', 'also', 'increased', 'in', 'abundance', 'after', 'RYGB', '.']	[1, 3, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 4, 4, 1, 4, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our results suggest that, since kynurenine monoxygenase diverts the kynurenine pathway toward the synthesis of xanthurenic acid, its inhibition may also contribute to glucose homeostasis.	[]	['Our', 'results', 'suggest', 'that', ',', 'since', 'k', '##yn', '##uren', '##ine', 'mon', '##ox', '##y', '##gen', '##ase', 'diver', '##ts', 'the', 'k', '##yn', '##uren', '##ine', 'pathway', 'toward', 'the', 'synthesis', 'of', 'x', '##ant', '##hur', '##eni', '##c', 'acid', ',', 'its', 'in', '##hibition', 'may', 'also', 'contribute', 'to', 'glucose', 'home', '##ost', '##asis', '.']	[0, 4, 12, 20, 24, 26, 32, 33, 35, 39, 43, 46, 48, 49, 52, 56, 61, 64, 68, 69, 71, 75, 79, 87, 94, 98, 108, 111, 112, 115, 118, 121, 123, 127, 129, 133, 135, 144, 148, 153, 164, 167, 175, 179, 182, 186]	[3, 11, 19, 24, 25, 31, 33, 35, 39, 42, 46, 48, 49, 52, 55, 61, 63, 67, 69, 71, 75, 78, 86, 93, 97, 107, 110, 112, 115, 118, 121, 122, 127, 128, 132, 135, 143, 147, 152, 163, 166, 174, 179, 182, 186, 187]	['Our', 'results', 'suggest', 'that', ',', 'since', 'kynurenine', 'monoxygenase', 'diverts', 'the', 'kynurenine', 'pathway', 'toward', 'the', 'synthesis', 'of', 'xanthurenic', 'acid', ',', 'its', 'inhibition', 'may', 'also', 'contribute', 'to', 'glucose', 'homeostasis', '.']	[1, 1, 1, 1, 1, 1, 4, 5, 2, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The enzyme kynurenine 3-monooxygenase (KMO) is located at a critical branching point in the kynurenine pathway such that the inhibition of this enzyme by either pharmacological or genetic means may shift the flux towards the formation of kynurenic acid rather than to the synthesis of xanthurenic acid.	[('PMC4915629', 'D03000', 11, 37, 'kynurenine 3-monooxygenase')]	['The', 'enzyme', 'k', '##yn', '##uren', '##ine', '3', '-', 'mon', '##oo', '##xy', '##gen', '##ase', '(', 'K', '##MO', ')', 'is', 'located', 'at', 'a', 'critical', 'branching', 'point', 'in', 'the', 'k', '##yn', '##uren', '##ine', 'pathway', 'such', 'that', 'the', 'in', '##hibition', 'of', 'this', 'enzyme', 'by', 'either', 'p', '##har', '##ma', '##cological', 'or', 'genetic', 'means', 'may', 'shift', 'the', 'flux', 'towards', 'the', 'formation', 'of', 'k', '##yn', '##uren', '##ic', 'acid', 'rather', 'than', 'to', 'the', 'synthesis', 'of', 'x', '##ant', '##hur', '##eni', '##c', 'acid', '.']	[0, 4, 11, 12, 14, 18, 22, 23, 24, 27, 29, 31, 34, 38, 39, 40, 42, 44, 47, 55, 58, 60, 69, 79, 85, 88, 92, 93, 95, 99, 103, 111, 116, 121, 125, 127, 136, 139, 144, 151, 154, 161, 162, 165, 167, 177, 180, 188, 194, 198, 204, 208, 213, 221, 225, 235, 238, 239, 241, 245, 248, 253, 260, 265, 268, 272, 282, 285, 286, 289, 292, 295, 297, 301]	[3, 10, 12, 14, 18, 21, 23, 24, 27, 29, 31, 34, 37, 39, 40, 42, 43, 46, 54, 57, 59, 68, 78, 84, 87, 91, 93, 95, 99, 102, 110, 115, 120, 124, 127, 135, 138, 143, 150, 153, 160, 162, 165, 167, 176, 179, 187, 193, 197, 203, 207, 212, 220, 224, 234, 237, 239, 241, 245, 247, 252, 259, 264, 267, 271, 281, 284, 286, 289, 292, 295, 296, 301, 302]	['The', 'enzyme', 'kynurenine', '3-monooxygenase', '(', 'KMO', ')', 'is', 'located', 'at', 'a', 'critical', 'branching', 'point', 'in', 'the', 'kynurenine', 'pathway', 'such', 'that', 'the', 'inhibition', 'of', 'this', 'enzyme', 'by', 'either', 'pharmacological', 'or', 'genetic', 'means', 'may', 'shift', 'the', 'flux', 'towards', 'the', 'formation', 'of', 'kynurenic', 'acid', 'rather', 'than', 'to', 'the', 'synthesis', 'of', 'xanthurenic', 'acid', '.']	[1, 1, 4, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our group and others previously showed that obesity is associated with an increased expression of the IDO1 gene in the human adipose tissue and with increased concentrations of circulating kynurenines and kynurenine to tryptophan (K/T) ratio reflecting the increased enzymatic activity of IDO1, that also correlates with the increased expression of inflammatory markers in the adipose tissue	[]	['Our', 'group', 'and', 'others', 'previously', 'showed', 'that', 'o', '##besity', 'is', 'associated', 'with', 'an', 'increased', 'expression', 'of', 'the', 'ID', '##O', '##1', 'gene', 'in', 'the', 'human', 'ad', '##ip', '##ose', 'tissue', 'and', 'with', 'increased', 'concentrations', 'of', 'circulating', 'k', '##yn', '##uren', '##ines', 'and', 'k', '##yn', '##uren', '##ine', 'to', 'try', '##pt', '##op', '##han', '(', 'K', '/', 'T', ')', 'ratio', 'reflecting', 'the', 'increased', 'en', '##zy', '##matic', 'activity', 'of', 'ID', '##O', '##1', ',', 'that', 'also', 'co', '##rrel', '##ates', 'with', 'the', 'increased', 'expression', 'of', 'inflammatory', 'markers', 'in', 'the', 'ad', '##ip', '##ose', 'tissue']	[0, 4, 10, 14, 21, 32, 39, 44, 45, 52, 55, 66, 71, 74, 84, 95, 98, 102, 104, 105, 107, 112, 115, 119, 125, 127, 129, 133, 140, 144, 149, 159, 174, 177, 189, 190, 192, 196, 201, 205, 206, 208, 212, 216, 219, 222, 224, 226, 230, 231, 232, 233, 234, 236, 242, 253, 257, 267, 269, 271, 277, 286, 289, 291, 292, 293, 295, 300, 305, 307, 311, 316, 321, 325, 335, 346, 349, 362, 370, 373, 377, 379, 381, 385]	[3, 9, 13, 20, 31, 38, 43, 45, 51, 54, 65, 70, 73, 83, 94, 97, 101, 104, 105, 106, 111, 114, 118, 124, 127, 129, 132, 139, 143, 148, 158, 173, 176, 188, 190, 192, 196, 200, 204, 206, 208, 212, 215, 218, 222, 224, 226, 229, 231, 232, 233, 234, 235, 241, 252, 256, 266, 269, 271, 276, 285, 288, 291, 292, 293, 294, 299, 304, 307, 311, 315, 320, 324, 334, 345, 348, 361, 369, 372, 376, 379, 381, 384, 391]	['Our', 'group', 'and', 'others', 'previously', 'showed', 'that', 'obesity', 'is', 'associated', 'with', 'an', 'increased', 'expression', 'of', 'the', 'IDO1', 'gene', 'in', 'the', 'human', 'adipose', 'tissue', 'and', 'with', 'increased', 'concentrations', 'of', 'circulating', 'kynurenines', 'and', 'kynurenine', 'to', 'tryptophan', '(', 'K', '/', 'T', ')', 'ratio', 'reflecting', 'the', 'increased', 'enzymatic', 'activity', 'of', 'IDO1', ',', 'that', 'also', 'correlates', 'with', 'the', 'increased', 'expression', 'of', 'inflammatory', 'markers', 'in', 'the', 'adipose', 'tissue']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The following reagents were purchased from Sigma-Aldrich (St. Louis, MO): acetaminophen, 3-amino-1,2,4-triazole, ammonium acetate, bupropion HCl, chlorzoxazone, coumarin, dextromethorphan, dextrorphan, diclofenac, DMSO, furafylline, glucose-6-phosphate, glucose-6-phosphate dehydrogenase, ethylenediaminetetraacetic acid, tetrasodium salt (EDTA), 6-hydroxychlorzoxazone, 7 hydroxycoumarin (umbelliferone), 4′-hydroxydiclofenac, (±)-4′-hydroxymephenytoin, 6β-hydroxytestosterone, ketoconazole, magnesium chloride, 8-methoxypsoralen, 4 methylpyrazole, midazolam, modafinil, α-naphtho-flavone, β-nicotinamide-adenine dinucleotide phosphate (NADP), nicotine, orphenadrine, paroxetine, phenacetin, phencyclidine, quercetin, quinidine, sucrose, sulfaphenazole, testosterone, ticlopidine, Trizma® base and troleandomycin.	[('PMC4937660', 'M01000', 254, 287, 'glucose-6-phosphate dehydrogenase')]	['The', 'following', 're', '##age', '##nts', 'were', 'purchased', 'from', 'Sigma', '-', 'Al', '##dric', '##h', '(', 'St', '.', 'Louis', ',', 'M', '##O', ')', ':', 'ace', '##tam', '##ino', '##phe', '##n', ',', '3', '-', 'amino', '-', '1', ',', '2', ',', '4', '-', 't', '##ria', '##zo', '##le', ',', 'am', '##mon', '##ium', 'ace', '##tate', ',', 'b', '##up', '##rop', '##ion', 'HC', '##l', ',', 'ch', '##lor', '##zo', '##xa', '##zone', ',', 'co', '##uma', '##rin', ',', 'de', '##x', '##trom', '##eth', '##or', '##pha', '##n', ',', 'de', '##x', '##tro', '##rp', '##han', ',', 'di', '##c', '##lo', '##fen', '##ac', ',', 'D', '##MS', '##O', ',', 'fur', '##af', '##yl', '##line', ',', 'glucose', '-', '6', '-', 'phosphate', ',', 'glucose', '-', '6', '-', 'phosphate', 'de', '##hy', '##dr', '##ogen', '##ase', ',', 'et', '##hyl', '##ened', '##iam', '##inet', '##et', '##ra', '##ace', '##tic', 'acid', ',', 'te', '##tras', '##od', '##ium', 'salt', '(', 'E', '##D', '##TA', ')', ',', '6', '-', 'h', '##ydro', '##xy', '##ch', '##lor', '##zo', '##xa', '##zone', ',', '7', 'h', '##ydro', '##xy', '##co', '##uma', '##rin', '(', 'um', '##bell', '##ifer', '##one', ')', ',', '4', '′', '-', 'h', '##ydro', '##xy', '##dic', '##lo', '##fen', '##ac', ',', '(', '±', ')', '-', '4', '′', '-', 'h', '##ydro', '##xy', '##me', '##phe', '##ny', '##to', '##in', ',', '6', '##β', '-', 'h', '##ydro', '##xy', '##test', '##osterone', ',', 'k', '##eto', '##cona', '##zo', '##le', ',', 'ma', '##gnesium', 'chloride', ',', '8', '-', 'met', '##ho', '##xy', '##ps', '##oral', '##en', ',', '4', 'met', '##hyl', '##py', '##raz', '##ole', ',', 'mid', '##az', '##ola', '##m', ',', 'm', '##oda', '##fin', '##il', ',', 'α', '-', 'nap', '##ht', '##ho', '-', 'fl', '##av', '##one', ',', 'β', '-', 'ni', '##cot', '##ina', '##mi', '##de', '-', 'ad', '##eni', '##ne', 'din', '##uc']	[0, 4, 14, 16, 19, 23, 28, 38, 43, 48, 49, 51, 55, 57, 58, 60, 62, 67, 69, 70, 71, 72, 74, 77, 80, 83, 86, 87, 89, 90, 91, 96, 97, 98, 99, 100, 101, 102, 103, 104, 107, 109, 111, 113, 115, 118, 122, 125, 129, 131, 132, 134, 137, 141, 143, 144, 146, 148, 151, 153, 155, 159, 161, 163, 166, 169, 171, 173, 174, 178, 181, 183, 186, 187, 189, 191, 192, 195, 197, 200, 202, 204, 205, 207, 210, 212, 214, 215, 217, 218, 220, 223, 225, 227, 231, 233, 240, 241, 242, 243, 252, 254, 261, 262, 263, 264, 274, 276, 278, 280, 284, 287, 289, 291, 294, 298, 301, 305, 307, 309, 312, 316, 320, 322, 324, 328, 330, 334, 339, 340, 341, 342, 344, 345, 347, 348, 349, 350, 354, 356, 358, 361, 363, 365, 369, 371, 373, 374, 378, 380, 382, 385, 389, 390, 392, 396, 400, 403, 404, 406, 407, 408, 409, 410, 414, 416, 419, 421, 424, 426, 428, 429, 430, 431, 432, 433, 434, 435, 436, 440, 442, 444, 447, 449, 451, 453, 455, 456, 457, 458, 459, 463, 465, 469, 477, 479, 480, 483, 487, 489, 491, 493, 495, 503, 511, 513, 514, 515, 518, 520, 522, 524, 528, 530, 532, 534, 537, 540, 542, 545, 548, 550, 553, 555, 558, 559, 561, 562, 565, 568, 570, 572, 573, 574, 577, 579, 581, 582, 584, 586, 589, 591, 592, 593, 595, 598, 601, 603, 605, 606, 608, 704, 724, 731]	[3, 13, 16, 19, 22, 27, 37, 42, 48, 49, 51, 55, 56, 58, 60, 61, 67, 68, 70, 71, 72, 73, 77, 80, 83, 86, 87, 88, 90, 91, 96, 97, 98, 99, 100, 101, 102, 103, 104, 107, 109, 111, 112, 115, 118, 121, 125, 129, 130, 132, 134, 137, 140, 143, 144, 145, 148, 151, 153, 155, 159, 160, 163, 166, 169, 170, 173, 174, 178, 181, 183, 186, 187, 188, 191, 192, 195, 197, 200, 201, 204, 205, 207, 210, 212, 213, 215, 217, 218, 219, 223, 225, 227, 231, 232, 240, 241, 242, 243, 252, 253, 261, 262, 263, 264, 273, 276, 278, 280, 284, 287, 288, 291, 294, 298, 301, 305, 307, 309, 312, 315, 320, 321, 324, 328, 330, 333, 338, 340, 341, 342, 344, 345, 346, 348, 349, 350, 354, 356, 358, 361, 363, 365, 369, 370, 372, 374, 378, 380, 382, 385, 388, 390, 392, 396, 400, 403, 404, 405, 407, 408, 409, 410, 414, 416, 419, 421, 424, 426, 427, 429, 430, 431, 432, 433, 434, 435, 436, 440, 442, 444, 447, 449, 451, 453, 454, 456, 457, 458, 459, 463, 465, 469, 477, 478, 480, 483, 487, 489, 491, 492, 495, 502, 511, 512, 514, 515, 518, 520, 522, 524, 528, 530, 531, 533, 537, 540, 542, 545, 548, 549, 553, 555, 558, 559, 560, 562, 565, 568, 570, 571, 573, 574, 577, 579, 581, 582, 584, 586, 589, 590, 592, 593, 595, 598, 601, 603, 605, 606, 608, 611, 706, 727, 733]	['The', 'following', 'reagents', 'were', 'purchased', 'from', 'Sigma-Aldrich', '(', 'St', '.', 'Louis', ',', 'MO', ')', ':', 'acetaminophen', ',', '3-amino-1,2,4-triazole', ',', 'ammonium', 'acetate', ',', 'bupropion', 'HCl', ',', 'chlorzoxazone', ',', 'coumarin', ',', 'dextromethorphan', ',', 'dextrorphan', ',', 'diclofenac', ',', 'DMSO', ',', 'furafylline', ',', 'glucose-6-phosphate', ',', 'glucose-6-phosphate', 'dehydrogenase', ',', 'ethylenediaminetetraacetic', 'acid', ',', 'tetrasodium', 'salt', '(', 'EDTA', ')', ',', '6-hydroxychlorzoxazone', ',', '7', 'hydroxycoumarin', '(', 'umbelliferone', ')', ',', '4′-hydroxydiclofenac', ',', '(±)-4′-hydroxymephenytoin', ',', '6β-hydroxytestosterone', ',', 'ketoconazole', ',', 'magnesium', 'chloride', ',', '8-methoxypsoralen', ',', '4', 'methylpyrazole', ',', 'midazolam', ',', 'modafinil', ',', 'α-naphtho-', 'flavone', ',', 'β-nicotinamide-', 'adenine']	[1, 1, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 14, 1, 3, 2, 1, 4, 2, 1, 5, 1, 3, 1, 7, 1, 5, 1, 5, 1, 3, 1, 4, 1, 5, 1, 5, 5, 1, 9, 1, 1, 4, 1, 1, 3, 1, 1, 10, 1, 1, 6, 1, 4, 1, 1, 10, 1, 15, 1, 8, 1, 5, 1, 2, 1, 1, 8, 1, 1, 5, 1, 4, 1, 4, 1, 6, 3, 1, 8, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[19], the present study showed that functional pathway genes, including phosphotransferase system (PTS) pathway, amino acid metabolism pathway, cofactors and vitamin metabolism pathway, and carbohydrate digestion and absorption pathway genes, were enriched in infant microbiota prior to 1 year of age.	[]	['[', '19', ']', ',', 'the', 'present', 'study', 'showed', 'that', 'functional', 'pathway', 'genes', ',', 'including', 'p', '##hos', '##ph', '##ot', '##ran', '##s', '##fer', '##ase', 'system', '(', 'PT', '##S', ')', 'pathway', ',', 'amino', 'acid', 'metabolism', 'pathway', ',', 'co', '##fa', '##ctors', 'and', 'vitamin', 'metabolism', 'pathway', ',', 'and', 'car', '##bo', '##hy', '##dra', '##te', 'dig', '##est', '##ion', 'and', 'absorption', 'pathway', 'genes', ',', 'were', 'en', '##rich', '##ed', 'in', 'infant', 'micro', '##bio', '##ta', 'prior', 'to', '1', 'year', 'of', 'age', '.']	[0, 1, 3, 4, 6, 10, 18, 24, 31, 36, 47, 55, 60, 62, 72, 73, 76, 78, 80, 83, 84, 87, 91, 98, 99, 101, 102, 104, 111, 113, 119, 124, 135, 142, 144, 146, 148, 154, 158, 166, 177, 184, 186, 190, 193, 195, 197, 200, 203, 206, 209, 213, 217, 228, 236, 241, 243, 248, 250, 254, 257, 260, 267, 272, 275, 278, 284, 287, 289, 294, 297, 300]	[1, 3, 4, 5, 9, 17, 23, 30, 35, 46, 54, 60, 61, 71, 73, 76, 78, 80, 83, 84, 87, 90, 97, 99, 101, 102, 103, 111, 112, 118, 123, 134, 142, 143, 146, 148, 153, 157, 165, 176, 184, 185, 189, 193, 195, 197, 200, 202, 206, 209, 212, 216, 227, 235, 241, 242, 247, 250, 254, 256, 259, 266, 272, 275, 277, 283, 286, 288, 293, 296, 300, 301]	['[', '19', ']', ',', 'the', 'present', 'study', 'showed', 'that', 'functional', 'pathway', 'genes', ',', 'including', 'phosphotransferase', 'system', '(', 'PTS', ')', 'pathway', ',', 'amino', 'acid', 'metabolism', 'pathway', ',', 'cofactors', 'and', 'vitamin', 'metabolism', 'pathway', ',', 'and', 'carbohydrate', 'digestion', 'and', 'absorption', 'pathway', 'genes', ',', 'were', 'enriched', 'in', 'infant', 'microbiota', 'prior', 'to', '1', 'year', 'of', 'age', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recent studies suggest that uremic by-products induce toxicity by increasing the production of reactive oxygen species (ROS) through NADPH oxidase (membrane-bound enzyme complex that generate superoxide).	[('PMC5027112', 'D10000', 133, 146, 'NADPH oxidase')]	['Recent', 'studies', 'suggest', 'that', 'u', '##rem', '##ic', 'by', '-', 'products', 'induce', 'toxicity', 'by', 'increasing', 'the', 'production', 'of', 'reactive', 'oxygen', 'species', '(', 'R', '##OS', ')', 'through', 'N', '##AD', '##P', '##H', 'o', '##xi', '##das', '##e', '(', 'membrane', '-', 'bound', 'enzyme', 'complex', 'that', 'generate', 'super', '##oxide', ')', '.']	[0, 7, 15, 23, 28, 29, 32, 35, 37, 38, 47, 54, 63, 66, 77, 81, 92, 95, 104, 111, 119, 120, 121, 123, 125, 133, 134, 136, 137, 139, 140, 142, 145, 147, 148, 156, 157, 163, 170, 178, 183, 192, 197, 202, 203]	[6, 14, 22, 27, 29, 32, 34, 37, 38, 46, 53, 62, 65, 76, 80, 91, 94, 103, 110, 118, 120, 121, 123, 124, 132, 134, 136, 137, 138, 140, 142, 145, 146, 148, 156, 157, 162, 169, 177, 182, 191, 197, 202, 203, 204]	['Recent', 'studies', 'suggest', 'that', 'uremic', 'by', '-', 'products', 'induce', 'toxicity', 'by', 'increasing', 'the', 'production', 'of', 'reactive', 'oxygen', 'species', '(', 'ROS', ')', 'through', 'NADPH', 'oxidase', '(', 'membrane', '-', 'bound', 'enzyme', 'complex', 'that', 'generate', 'superoxide', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ROS production generates the mitogen-activated protein kinase (MAPK)/NF-kB (nuclear factor kB) pathway which leads to the production of pro-inflammatory cytokines, chemokines and adhesion molecules [51, 52].	[('PMC5027112', 'D10001', 29, 61, 'mitogen-activated protein kinase')]	['R', '##OS', 'production', 'generates', 'the', 'mit', '##ogen', '-', 'activated', 'protein', 'kinase', '(', 'MA', '##P', '##K', ')', '/', 'N', '##F', '-', 'k', '##B', '(', 'nuclear', 'factor', 'k', '##B', ')', 'pathway', 'which', 'leads', 'to', 'the', 'production', 'of', 'pro', '-', 'inflammatory', 'c', '##yt', '##oki', '##nes', ',', 'ch', '##em', '##oki', '##nes', 'and', 'ad', '##hesion', 'molecules', '[', '51', ',', '52', ']', '.']	[0, 1, 4, 15, 25, 29, 32, 36, 37, 47, 55, 62, 63, 65, 66, 67, 68, 69, 70, 71, 72, 73, 75, 76, 84, 91, 92, 93, 95, 103, 109, 115, 118, 122, 133, 136, 139, 140, 153, 154, 156, 159, 162, 164, 166, 168, 171, 175, 179, 181, 188, 198, 199, 201, 203, 205, 206]	[1, 3, 14, 24, 28, 32, 36, 37, 46, 54, 61, 63, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 83, 90, 92, 93, 94, 102, 108, 114, 117, 121, 132, 135, 139, 140, 152, 154, 156, 159, 162, 163, 166, 168, 171, 174, 178, 181, 187, 197, 199, 201, 202, 205, 206, 207]	['ROS', 'production', 'generates', 'the', 'mitogen', '-', 'activated', 'protein', 'kinase', '(', 'MAPK', ')', '/', 'NF-kB', '(', 'nuclear', 'factor', 'kB', ')', 'pathway', 'which', 'leads', 'to', 'the', 'production', 'of', 'pro', '-', 'inflammatory', 'cytokines', ',', 'chemokines', 'and', 'adhesion', 'molecules', '[', '51', ',', '52', ']', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An operational taxonomic unit belonging to the Enterococcus genus is positively correlated with the levels of alkaline phosphatase.	[('PMC5036217', 'A09000', 110, 130, 'alkaline phosphatase')]	['An', 'operational', 'tax', '##ono', '##mic', 'unit', 'belonging', 'to', 'the', 'En', '##tero', '##co', '##cc', '##us', 'genus', 'is', 'positively', 'correlated', 'with', 'the', 'levels', 'of', 'al', '##kal', '##ine', 'p', '##hos', '##pha', '##tase', '.']	[0, 3, 15, 18, 21, 25, 30, 40, 43, 47, 49, 53, 55, 57, 60, 66, 69, 80, 91, 96, 100, 107, 110, 112, 115, 119, 120, 123, 126, 130]	[2, 14, 18, 21, 24, 29, 39, 42, 46, 49, 53, 55, 57, 59, 65, 68, 79, 90, 95, 99, 106, 109, 112, 115, 118, 120, 123, 126, 130, 131]	['An', 'operational', 'taxonomic', 'unit', 'belonging', 'to', 'the', 'Enterococcus', 'genus', 'is', 'positively', 'correlated', 'with', 'the', 'levels', 'of', 'alkaline', 'phosphatase', '.']	[1, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O']
Since disease severity groups provided hints of a possible association between severity and the amplitude of the microbiota signature, we next evaluated the correlation between the three PSC-associated genera and serum γ-glutamyl transpeptidase (GGT) and alkaline phosphatase (ALP), two clinical markers of cholestasis.	[('PMC5036217', 'R12000', 219, 244, 'γ-glutamyl transpeptidase')]	['Since', 'disease', 'severity', 'groups', 'provided', 'hints', 'of', 'a', 'possible', 'association', 'between', 'severity', 'and', 'the', 'amplitude', 'of', 'the', 'micro', '##bio', '##ta', 'signature', ',', 'we', 'next', 'evaluated', 'the', 'correlation', 'between', 'the', 'three', 'PS', '##C', '-', 'associated', 'genera', 'and', 'serum', 'γ', '-', 'g', '##lut', '##am', '##yl', 'trans', '##pe', '##pt', '##idas', '##e', '(', 'G', '##G', '##T', ')', 'and', 'al', '##kal', '##ine', 'p', '##hos', '##pha', '##tase', '(', 'AL', '##P', ')', ',', 'two', 'clinical', 'markers', 'of', 'ch', '##ole', '##sta', '##sis', '.']	[0, 6, 14, 23, 30, 39, 45, 48, 50, 59, 71, 79, 88, 92, 96, 106, 109, 113, 118, 121, 124, 133, 135, 138, 143, 153, 157, 169, 177, 181, 187, 189, 190, 191, 202, 209, 213, 219, 220, 221, 222, 225, 227, 230, 235, 237, 239, 243, 245, 246, 247, 248, 249, 251, 255, 257, 260, 264, 265, 268, 271, 276, 277, 279, 280, 281, 283, 287, 296, 304, 307, 309, 312, 315, 318]	[5, 13, 22, 29, 38, 44, 47, 49, 58, 70, 78, 87, 91, 95, 105, 108, 112, 118, 121, 123, 133, 134, 137, 142, 152, 156, 168, 176, 180, 186, 189, 190, 191, 201, 208, 212, 218, 220, 221, 222, 225, 227, 229, 235, 237, 239, 243, 244, 246, 247, 248, 249, 250, 254, 257, 260, 263, 265, 268, 271, 275, 277, 279, 280, 281, 282, 286, 295, 303, 306, 309, 312, 315, 318, 319]	['Since', 'disease', 'severity', 'groups', 'provided', 'hints', 'of', 'a', 'possible', 'association', 'between', 'severity', 'and', 'the', 'amplitude', 'of', 'the', 'microbiota', 'signature', ',', 'we', 'next', 'evaluated', 'the', 'correlation', 'between', 'the', 'three', 'PSC-associated', 'genera', 'and', 'serum', 'γ-glutamyl', 'transpeptidase', '(', 'GGT', ')', 'and', 'alkaline', 'phosphatase', '(', 'ALP', ')', ',', 'two', 'clinical', 'markers', 'of', 'cholestasis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 6, 5, 1, 3, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Corynebacteria, Propionibacteria, and coagulase-negative Staphylococci were the predominant organisms identified by all three techniques.	[('PMC5054734', 'A02000', 38, 47, 'coagulase')]	['Cory', '##ne', '##ba', '##cter', '##ia', ',', 'Pro', '##pion', '##iba', '##cter', '##ia', ',', 'and', 'co', '##agu', '##lase', '-', 'negative', 'St', '##aph', '##yl', '##oc', '##oc', '##ci', 'were', 'the', 'predominant', 'organisms', 'identified', 'by', 'all', 'three', 'techniques', '.']	[0, 4, 6, 8, 12, 14, 16, 19, 23, 26, 30, 32, 34, 38, 40, 43, 47, 48, 57, 59, 62, 64, 66, 68, 71, 76, 80, 92, 102, 113, 116, 120, 126, 136]	[4, 6, 8, 12, 14, 15, 19, 23, 26, 30, 32, 33, 37, 40, 43, 47, 48, 56, 59, 62, 64, 66, 68, 70, 75, 79, 91, 101, 112, 115, 119, 125, 136, 137]	['Corynebacteria', ',', 'Propionibacteria', ',', 'and', 'coagulase', '-', 'negative', 'Staphylococci', 'were', 'the', 'predominant', 'organisms', 'identified', 'by', 'all', 'three', 'techniques', '.']	[5, 1, 5, 1, 1, 3, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It has long been apparent that cultures of the ocular surface typically yield relatively few bacteria.11,14,35,36 These organisms are predominantly coagulase-negative Staphylococcus, diphtheroids, and Propionibacterium acnes.11,14,35,36 However, recent analyses with 16S rDNA sequencing have suggested substantially greater microbial diversity on the ocular surface.13–15 Shin et al.15 recently studied the ocular surface by 16S metagenomics techniques in healthy subjects and contact lens wearers.	[('PMC5054734', 'D01000', 148, 157, 'coagulase')]	['It', 'has', 'long', 'been', 'apparent', 'that', 'cultures', 'of', 'the', 'o', '##cular', 'surface', 'typically', 'yield', 'relatively', 'few', 'bacteria', '.', '11', ',', '14', ',', '35', ',', '36', 'These', 'organisms', 'are', 'predominantly', 'co', '##agu', '##lase', '-', 'negative', 'St', '##aph', '##yl', '##oc', '##oc', '##cus', ',', 'dip', '##ht', '##her', '##oids', ',', 'and', 'Pro', '##pion', '##iba', '##cter', '##ium', 'a', '##c', '##nes', '.', '11', ',', '14', ',', '35', ',', '36', 'However', ',', 'recent', 'analyses', 'with', '16', '##S', 'r', '##D', '##NA', 'se', '##quencing', 'have', 'suggested', 'substantially', 'greater', 'micro', '##bial', 'diversity', 'on', 'the', 'o', '##cular', 'surface', '.', '13', '–', '15', 'Shin', 'et', 'al', '.', '15', 'recently', 'studied', 'the', 'o', '##cular', 'surface', 'by', '16', '##S', 'meta', '##gen', '##omi', '##cs', 'techniques', 'in', 'healthy', 'subjects', 'and', 'contact', 'lens', 'wear', '##ers', '.']	[0, 3, 7, 12, 17, 26, 31, 40, 43, 47, 48, 54, 62, 72, 78, 89, 93, 101, 102, 104, 105, 107, 108, 110, 111, 114, 120, 130, 134, 148, 150, 153, 157, 158, 167, 169, 172, 174, 176, 178, 181, 183, 186, 188, 191, 195, 197, 201, 204, 208, 211, 215, 219, 220, 221, 224, 225, 227, 228, 230, 231, 233, 234, 237, 244, 246, 253, 262, 267, 269, 271, 272, 273, 276, 278, 287, 292, 302, 316, 324, 329, 334, 344, 347, 351, 352, 358, 365, 366, 368, 369, 372, 377, 380, 382, 383, 386, 395, 403, 407, 408, 414, 422, 425, 427, 429, 433, 436, 439, 442, 453, 456, 464, 473, 477, 485, 490, 494, 497]	[2, 6, 11, 16, 25, 30, 39, 42, 46, 48, 53, 61, 71, 77, 88, 92, 101, 102, 104, 105, 107, 108, 110, 111, 113, 119, 129, 133, 147, 150, 153, 157, 158, 166, 169, 172, 174, 176, 178, 181, 182, 186, 188, 191, 195, 196, 200, 204, 208, 211, 215, 218, 220, 221, 224, 225, 227, 228, 230, 231, 233, 234, 236, 244, 245, 252, 261, 266, 269, 270, 272, 273, 275, 278, 286, 291, 301, 315, 323, 329, 333, 343, 346, 350, 352, 357, 365, 366, 368, 369, 371, 376, 379, 382, 383, 385, 394, 402, 406, 408, 413, 421, 424, 427, 428, 433, 436, 439, 441, 452, 455, 463, 472, 476, 484, 489, 494, 497, 498]	['It', 'has', 'long', 'been', 'apparent', 'that', 'cultures', 'of', 'the', 'ocular', 'surface', 'typically', 'yield', 'relatively', 'few', 'bacteria.11', ',', '14', ',', '35', ',', '36', 'These', 'organisms', 'are', 'predominantly', 'coagulase', '-', 'negative', 'Staphylococcus', ',', 'diphtheroids', ',', 'and', 'Propionibacterium', 'acnes.11', ',', '14', ',', '35', ',', '36', 'However', ',', 'recent', 'analyses', 'with', '16S', 'rDNA', 'sequencing', 'have', 'suggested', 'substantially', 'greater', 'microbial', 'diversity', 'on', 'the', 'ocular', 'surface.13', '–', '15', 'Shin', 'et', 'al.15', 'recently', 'studied', 'the', 'ocular', 'surface', 'by', '16S', 'metagenomics', 'techniques', 'in', 'healthy', 'subjects', 'and', 'contact', 'lens', 'wearers', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 6, 1, 4, 1, 1, 5, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 2, 1, 1, 1, 1, 2, 1, 1, 1, 2, 3, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Four proteins showed a higher abundance in SUI samples compared with controls: plasma serine protease inhibitor (logFC 1.11), leucine-rich alpha-2-glycoprotein (logFC 3.91), lysosomal alpha-glucosidase (logFC 1.24), and peptidyl-prolyl cis- trans isomerase A (logFC 1.96).	[]	['Four', 'proteins', 'showed', 'a', 'higher', 'abundance', 'in', 'S', '##UI', 'samples', 'compared', 'with', 'controls', ':', 'plasma', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '(', 'log', '##FC', '1', '.', '11', ')', ',', 'le', '##uc', '##ine', '-', 'rich', 'alpha', '-', '2', '-', 'g', '##ly', '##co', '##p', '##rote', '##in', '(', 'log', '##FC', '3', '.', '91', ')', ',', 'l', '##ys', '##oso', '##mal', 'alpha', '-', 'g', '##lu', '##cos', '##idas', '##e', '(', 'log', '##FC', '1', '.', '24', ')', ',', 'and', 'p', '##ept', '##idy', '##l', '-', 'pro', '##ly', '##l', 'c', '##is', '-', 'trans', 'is', '##omer', '##ase', 'A', '(', 'log', '##FC', '1', '.', '96', ')', '.']	[0, 5, 14, 21, 23, 30, 40, 43, 44, 47, 55, 64, 69, 77, 79, 86, 88, 93, 96, 98, 102, 112, 113, 116, 119, 120, 121, 123, 124, 126, 128, 130, 133, 134, 139, 144, 145, 146, 147, 148, 150, 152, 153, 157, 160, 161, 164, 167, 168, 169, 171, 172, 174, 175, 177, 180, 184, 189, 190, 191, 193, 196, 200, 202, 203, 206, 209, 210, 211, 213, 214, 216, 220, 221, 224, 227, 228, 229, 232, 234, 236, 237, 239, 241, 247, 249, 253, 257, 259, 260, 263, 266, 267, 268, 270, 271]	[4, 13, 20, 22, 29, 39, 42, 44, 46, 54, 63, 68, 77, 78, 85, 88, 92, 96, 98, 101, 111, 113, 116, 118, 120, 121, 123, 124, 125, 128, 130, 133, 134, 138, 144, 145, 146, 147, 148, 150, 152, 153, 157, 159, 161, 164, 166, 168, 169, 171, 172, 173, 175, 177, 180, 183, 189, 190, 191, 193, 196, 200, 201, 203, 206, 208, 210, 211, 213, 214, 215, 219, 221, 224, 227, 228, 229, 232, 234, 235, 237, 239, 240, 246, 249, 253, 256, 258, 260, 263, 265, 267, 268, 270, 271, 272]	['Four', 'proteins', 'showed', 'a', 'higher', 'abundance', 'in', 'SUI', 'samples', 'compared', 'with', 'controls', ':', 'plasma', 'serine', 'protease', 'inhibitor', '(', 'logFC', '1.11', ')', ',', 'leucine', '-', 'rich', 'alpha-2-glycoprotein', '(', 'logFC', '3.91', ')', ',', 'lysosomal', 'alpha', '-', 'glucosidase', '(', 'logFC', '1.24', ')', ',', 'and', 'peptidyl', '-', 'prolyl', 'cis-', 'trans', 'isomerase', 'A', '(', 'logFC', '1.96', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1, 1, 3, 1, 1, 10, 1, 2, 3, 1, 1, 4, 1, 1, 5, 1, 2, 3, 1, 1, 1, 4, 1, 3, 3, 1, 3, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We identified two proteins in lower abundance in SUI samples compared with controls: uromodulin (logFC −4.87) and TALPID3 (logFC −1.99).	[]	['We', 'identified', 'two', 'proteins', 'in', 'lower', 'abundance', 'in', 'S', '##UI', 'samples', 'compared', 'with', 'controls', ':', 'u', '##rom', '##od', '##ulin', '(', 'log', '##FC', '−', '##4', '.', '87', ')', 'and', 'T', '##AL', '##PI', '##D', '##3', '(', 'log', '##FC', '−', '##1', '.', '99', ')', '.']	[0, 3, 14, 18, 27, 30, 36, 46, 49, 50, 53, 61, 70, 75, 83, 85, 86, 89, 91, 96, 97, 100, 103, 104, 105, 106, 108, 110, 114, 115, 117, 119, 120, 122, 123, 126, 129, 130, 131, 132, 134, 135]	[2, 13, 17, 26, 29, 35, 45, 48, 50, 52, 60, 69, 74, 83, 84, 86, 89, 91, 95, 97, 100, 102, 104, 105, 106, 108, 109, 113, 115, 117, 119, 120, 121, 123, 126, 128, 130, 131, 132, 134, 135, 136]	['We', 'identified', 'two', 'proteins', 'in', 'lower', 'abundance', 'in', 'SUI', 'samples', 'compared', 'with', 'controls', ':', 'uromodulin', '(', 'logFC', '−4.87', ')', 'and', 'TALPID3', '(', 'logFC', '−1.99', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 2, 4, 1, 1, 5, 1, 2, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Overexpression of plasma serine protease inhibitor, leucine-rich alpha-2-glycoprotein, lysosomal alpha-glucosidase, and peptidyl-prolyl cis- trans isomerase A, and lower expression of uromodulin and TALPID3, in urine may be associated with female SUI.	[('PMC5065895', 'A03000', 25, 40, 'serine protease')]	['Over', '##ex', '##press', '##ion', 'of', 'plasma', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', ',', 'le', '##uc', '##ine', '-', 'rich', 'alpha', '-', '2', '-', 'g', '##ly', '##co', '##p', '##rote', '##in', ',', 'l', '##ys', '##oso', '##mal', 'alpha', '-', 'g', '##lu', '##cos', '##idas', '##e', ',', 'and', 'p', '##ept', '##idy', '##l', '-', 'pro', '##ly', '##l', 'c', '##is', '-', 'trans', 'is', '##omer', '##ase', 'A', ',', 'and', 'lower', 'expression', 'of', 'u', '##rom', '##od', '##ulin', 'and', 'T', '##AL', '##PI', '##D', '##3', ',', 'in', 'urine', 'may', 'be', 'associated', 'with', 'female', 'S', '##UI', '.']	[0, 4, 6, 11, 15, 18, 25, 27, 32, 35, 37, 41, 50, 52, 54, 56, 59, 60, 65, 70, 71, 72, 73, 74, 76, 78, 79, 83, 85, 87, 88, 90, 93, 97, 102, 103, 104, 106, 109, 113, 114, 116, 120, 121, 124, 127, 128, 129, 132, 134, 136, 137, 139, 141, 147, 149, 153, 157, 158, 160, 164, 170, 181, 184, 185, 188, 190, 195, 199, 200, 202, 204, 205, 206, 208, 211, 217, 221, 224, 235, 240, 247, 248, 250]	[4, 6, 11, 14, 17, 24, 27, 31, 35, 37, 40, 50, 51, 54, 56, 59, 60, 64, 70, 71, 72, 73, 74, 76, 78, 79, 83, 85, 86, 88, 90, 93, 96, 102, 103, 104, 106, 109, 113, 114, 115, 119, 121, 124, 127, 128, 129, 132, 134, 135, 137, 139, 140, 146, 149, 153, 156, 158, 159, 163, 169, 180, 183, 185, 188, 190, 194, 198, 200, 202, 204, 205, 206, 207, 210, 216, 220, 223, 234, 239, 246, 248, 250, 251]	['Overexpression', 'of', 'plasma', 'serine', 'protease', 'inhibitor', ',', 'leucine', '-', 'rich', 'alpha-2-glycoprotein', ',', 'lysosomal', 'alpha', '-', 'glucosidase', ',', 'and', 'peptidyl', '-', 'prolyl', 'cis-', 'trans', 'isomerase', 'A', ',', 'and', 'lower', 'expression', 'of', 'uromodulin', 'and', 'TALPID3', ',', 'in', 'urine', 'may', 'be', 'associated', 'with', 'female', 'SUI', '.']	[4, 1, 1, 2, 3, 1, 1, 3, 1, 1, 10, 1, 4, 1, 1, 5, 1, 1, 4, 1, 3, 3, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Plasma serine protease inhibitor (SERPINA5), leucine-rich alpha-2-glycoprotein (LRG1), lysosomal alpha-glucosidase (GAA) and peptidyl-prolyl cis-trans isomerase A (PPIA) were more highly expressed in urine samples from women with SUI.	[('PMC5065895', 'D01000', 7, 22, 'serine protease')]	['P', '##las', '##ma', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '(', 'SE', '##RP', '##IN', '##A', '##5', ')', ',', 'le', '##uc', '##ine', '-', 'rich', 'alpha', '-', '2', '-', 'g', '##ly', '##co', '##p', '##rote', '##in', '(', 'L', '##R', '##G', '##1', ')', ',', 'l', '##ys', '##oso', '##mal', 'alpha', '-', 'g', '##lu', '##cos', '##idas', '##e', '(', 'GAA', ')', 'and', 'p', '##ept', '##idy', '##l', '-', 'pro', '##ly', '##l', 'c', '##is', '-', 'trans', 'is', '##omer', '##ase', 'A', '(', 'PP', '##IA', ')', 'were', 'more', 'highly', 'expressed', 'in', 'urine', 'samples', 'from', 'women', 'with', 'S', '##UI', '.']	[0, 1, 4, 7, 9, 14, 17, 19, 23, 33, 34, 36, 38, 40, 41, 42, 43, 45, 47, 49, 52, 53, 58, 63, 64, 65, 66, 67, 69, 71, 72, 76, 79, 80, 81, 82, 83, 84, 85, 87, 88, 90, 93, 97, 102, 103, 104, 106, 109, 113, 115, 116, 119, 121, 125, 126, 129, 132, 133, 134, 137, 139, 141, 142, 144, 145, 151, 153, 157, 161, 163, 164, 166, 168, 170, 175, 180, 187, 197, 200, 206, 214, 219, 225, 230, 231, 233]	[1, 4, 6, 9, 13, 17, 19, 22, 32, 34, 36, 38, 40, 41, 42, 43, 44, 47, 49, 52, 53, 57, 63, 64, 65, 66, 67, 69, 71, 72, 76, 78, 80, 81, 82, 83, 84, 85, 86, 88, 90, 93, 96, 102, 103, 104, 106, 109, 113, 114, 116, 119, 120, 124, 126, 129, 132, 133, 134, 137, 139, 140, 142, 144, 145, 150, 153, 157, 160, 162, 164, 166, 168, 169, 174, 179, 186, 196, 199, 205, 213, 218, 224, 229, 231, 233, 234]	['Plasma', 'serine', 'protease', 'inhibitor', '(', 'SERPINA5', ')', ',', 'leucine', '-', 'rich', 'alpha-2-glycoprotein', '(', 'LRG1', ')', ',', 'lysosomal', 'alpha', '-', 'glucosidase', '(', 'GAA', ')', 'and', 'peptidyl', '-', 'prolyl', 'cis-', 'trans', 'isomerase', 'A', '(', 'PPIA', ')', 'were', 'more', 'highly', 'expressed', 'in', 'urine', 'samples', 'from', 'women', 'with', 'SUI', '.']	[3, 2, 3, 1, 1, 5, 1, 1, 3, 1, 1, 10, 1, 4, 1, 1, 4, 1, 1, 5, 1, 1, 1, 1, 4, 1, 3, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Plasma serine protease inhibitor (SERPINA5) is usually present in urine in very low concentrations and serves, among other functions, as a pro-inflammatory factor.	[('PMC5065895', 'D01001', 7, 22, 'serine protease')]	['P', '##las', '##ma', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '(', 'SE', '##RP', '##IN', '##A', '##5', ')', 'is', 'usually', 'present', 'in', 'urine', 'in', 'very', 'low', 'concentrations', 'and', 'serves', ',', 'among', 'other', 'functions', ',', 'as', 'a', 'pro', '-', 'inflammatory', 'factor', '.']	[0, 1, 4, 7, 9, 14, 17, 19, 23, 33, 34, 36, 38, 40, 41, 42, 44, 47, 55, 63, 66, 72, 75, 80, 84, 99, 103, 109, 111, 117, 123, 132, 134, 137, 139, 142, 143, 156, 162]	[1, 4, 6, 9, 13, 17, 19, 22, 32, 34, 36, 38, 40, 41, 42, 43, 46, 54, 62, 65, 71, 74, 79, 83, 98, 102, 109, 110, 116, 122, 132, 133, 136, 138, 142, 143, 155, 162, 163]	['Plasma', 'serine', 'protease', 'inhibitor', '(', 'SERPINA5', ')', 'is', 'usually', 'present', 'in', 'urine', 'in', 'very', 'low', 'concentrations', 'and', 'serves', ',', 'among', 'other', 'functions', ',', 'as', 'a', 'pro', '-', 'inflammatory', 'factor', '.']	[3, 2, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lysosomal alpha-glucosidase (GAA) is a protein essential for the degradation of glycogen to glucose in lysosomes, which is present in all tissue cell types.	[('PMC5065895', 'D02000', 0, 27, 'Lysosomal alpha-glucosidase')]	['L', '##ys', '##oso', '##mal', 'alpha', '-', 'g', '##lu', '##cos', '##idas', '##e', '(', 'GAA', ')', 'is', 'a', 'protein', 'essential', 'for', 'the', 'degradation', 'of', 'g', '##ly', '##co', '##gen', 'to', 'glucose', 'in', 'l', '##ys', '##oso', '##mes', ',', 'which', 'is', 'present', 'in', 'all', 'tissue', 'cell', 'types', '.']	[0, 1, 3, 6, 10, 15, 16, 17, 19, 22, 26, 28, 29, 32, 34, 37, 39, 47, 57, 61, 65, 77, 80, 81, 83, 85, 89, 92, 100, 103, 104, 106, 109, 112, 114, 120, 123, 131, 134, 138, 145, 150, 155]	[1, 3, 6, 9, 15, 16, 17, 19, 22, 26, 27, 29, 32, 33, 36, 38, 46, 56, 60, 64, 76, 79, 81, 83, 85, 88, 91, 99, 102, 104, 106, 109, 112, 113, 119, 122, 130, 133, 137, 144, 149, 155, 156]	['Lysosomal', 'alpha', '-', 'glucosidase', '(', 'GAA', ')', 'is', 'a', 'protein', 'essential', 'for', 'the', 'degradation', 'of', 'glycogen', 'to', 'glucose', 'in', 'lysosomes', ',', 'which', 'is', 'present', 'in', 'all', 'tissue', 'cell', 'types', '.']	[4, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mutations in the respective gene result in Pompe disease, a condition in which a lack of lysosomal alpha-glucosidase leads to the intralysosomal accumulation of glycogen, which consequently disables heart and skeletal muscles.	[('PMC5065895', 'D02001', 89, 116, 'lysosomal alpha-glucosidase')]	['Mu', '##tations', 'in', 'the', 'respective', 'gene', 'result', 'in', 'Po', '##mp', '##e', 'disease', ',', 'a', 'condition', 'in', 'which', 'a', 'lack', 'of', 'l', '##ys', '##oso', '##mal', 'alpha', '-', 'g', '##lu', '##cos', '##idas', '##e', 'leads', 'to', 'the', 'in', '##tral', '##ys', '##oso', '##mal', 'accumulation', 'of', 'g', '##ly', '##co', '##gen', ',', 'which', 'consequently', 'di', '##sable', '##s', 'heart', 'and', 'skeletal', 'muscles', '.']	[0, 2, 10, 13, 17, 28, 33, 40, 43, 45, 47, 49, 56, 58, 60, 70, 73, 79, 81, 86, 89, 90, 92, 95, 99, 104, 105, 106, 108, 111, 115, 117, 123, 126, 130, 132, 136, 138, 141, 145, 158, 161, 162, 164, 166, 169, 171, 177, 190, 192, 197, 199, 205, 209, 218, 225]	[2, 9, 12, 16, 27, 32, 39, 42, 45, 47, 48, 56, 57, 59, 69, 72, 78, 80, 85, 88, 90, 92, 95, 98, 104, 105, 106, 108, 111, 115, 116, 122, 125, 129, 132, 136, 138, 141, 144, 157, 160, 162, 164, 166, 169, 170, 176, 189, 192, 197, 198, 204, 208, 217, 225, 226]	['Mutations', 'in', 'the', 'respective', 'gene', 'result', 'in', 'Pompe', 'disease', ',', 'a', 'condition', 'in', 'which', 'a', 'lack', 'of', 'lysosomal', 'alpha', '-', 'glucosidase', 'leads', 'to', 'the', 'intralysosomal', 'accumulation', 'of', 'glycogen', ',', 'which', 'consequently', 'disables', 'heart', 'and', 'skeletal', 'muscles', '.']	[2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 1, 1, 5, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Peptidyl-prolyl cis-trans isomerase A is involved in inflammatory processes/immunomodulation and induction of interleukin-6 release from macrophages.	[('PMC5065895', 'D03000', 0, 37, 'Peptidyl-prolyl cis-trans isomerase A')]	['P', '##ept', '##idy', '##l', '-', 'pro', '##ly', '##l', 'c', '##is', '-', 'trans', 'is', '##omer', '##ase', 'A', 'is', 'involved', 'in', 'inflammatory', 'processes', '/', 'im', '##mu', '##no', '##mo', '##du', '##lation', 'and', 'induction', 'of', 'inter', '##le', '##uki', '##n', '-', '6', 'release', 'from', 'mac', '##rop', '##hage', '##s', '.']	[0, 1, 4, 7, 8, 9, 12, 14, 16, 17, 19, 20, 26, 28, 32, 36, 38, 41, 50, 53, 66, 75, 76, 78, 80, 82, 84, 86, 93, 97, 107, 110, 115, 117, 120, 121, 122, 124, 132, 137, 140, 143, 147, 148]	[1, 4, 7, 8, 9, 12, 14, 15, 17, 19, 20, 25, 28, 32, 35, 37, 40, 49, 52, 65, 75, 76, 78, 80, 82, 84, 86, 92, 96, 106, 109, 115, 117, 120, 121, 122, 123, 131, 136, 140, 143, 147, 148, 149]	['Peptidyl', '-', 'prolyl', 'cis-', 'trans', 'isomerase', 'A', 'is', 'involved', 'in', 'inflammatory', 'processes', '/', 'immunomodulation', 'and', 'induction', 'of', 'interleukin-6', 'release', 'from', 'macrophages', '.']	[4, 1, 3, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 6, 1, 1, 4, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Four proteins showed a higher abundance in SUI samples compared with controls: plasma serine protease inhibitor (logFC 1.11), leucine-rich alpha-2-glycoprotein (logFC 3.91), lysosomal alpha-glucosidase (logFC 1.24), and peptidyl-prolyl cis- trans isomerase A (logFC 1.96).	[]	['Four', 'proteins', 'showed', 'a', 'higher', 'abundance', 'in', 'S', '##UI', 'samples', 'compared', 'with', 'controls', ':', 'plasma', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '(', 'log', '##FC', '1', '.', '11', ')', ',', 'le', '##uc', '##ine', '-', 'rich', 'alpha', '-', '2', '-', 'g', '##ly', '##co', '##p', '##rote', '##in', '(', 'log', '##FC', '3', '.', '91', ')', ',', 'l', '##ys', '##oso', '##mal', 'alpha', '-', 'g', '##lu', '##cos', '##idas', '##e', '(', 'log', '##FC', '1', '.', '24', ')', ',', 'and', 'p', '##ept', '##idy', '##l', '-', 'pro', '##ly', '##l', 'c', '##is', '-', 'trans', 'is', '##omer', '##ase', 'A', '(', 'log', '##FC', '1', '.', '96', ')', '.']	[0, 5, 14, 21, 23, 30, 40, 43, 44, 47, 55, 64, 69, 77, 79, 86, 88, 93, 96, 98, 102, 112, 113, 116, 119, 120, 121, 123, 124, 126, 128, 130, 133, 134, 139, 144, 145, 146, 147, 148, 150, 152, 153, 157, 160, 161, 164, 167, 168, 169, 171, 172, 174, 175, 177, 180, 184, 189, 190, 191, 193, 196, 200, 202, 203, 206, 209, 210, 211, 213, 214, 216, 220, 221, 224, 227, 228, 229, 232, 234, 236, 237, 239, 241, 247, 249, 253, 257, 259, 260, 263, 266, 267, 268, 270, 271]	[4, 13, 20, 22, 29, 39, 42, 44, 46, 54, 63, 68, 77, 78, 85, 88, 92, 96, 98, 101, 111, 113, 116, 118, 120, 121, 123, 124, 125, 128, 130, 133, 134, 138, 144, 145, 146, 147, 148, 150, 152, 153, 157, 159, 161, 164, 166, 168, 169, 171, 172, 173, 175, 177, 180, 183, 189, 190, 191, 193, 196, 200, 201, 203, 206, 208, 210, 211, 213, 214, 215, 219, 221, 224, 227, 228, 229, 232, 234, 235, 237, 239, 240, 246, 249, 253, 256, 258, 260, 263, 265, 267, 268, 270, 271, 272]	['Four', 'proteins', 'showed', 'a', 'higher', 'abundance', 'in', 'SUI', 'samples', 'compared', 'with', 'controls', ':', 'plasma', 'serine', 'protease', 'inhibitor', '(', 'logFC', '1.11', ')', ',', 'leucine', '-', 'rich', 'alpha-2-glycoprotein', '(', 'logFC', '3.91', ')', ',', 'lysosomal', 'alpha', '-', 'glucosidase', '(', 'logFC', '1.24', ')', ',', 'and', 'peptidyl', '-', 'prolyl', 'cis-', 'trans', 'isomerase', 'A', '(', 'logFC', '1.96', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1, 1, 3, 1, 1, 10, 1, 2, 3, 1, 1, 4, 1, 1, 5, 1, 2, 3, 1, 1, 1, 4, 1, 3, 3, 1, 3, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two proteins (gene symbol: UMOD; gene symbol: KIAA0586) presented a lower abundance in SUI samples compared with controls: uromodulin (logFC −4.87) and TALPID3 (logFC −1.99).	[]	['Two', 'proteins', '(', 'gene', 'symbol', ':', 'U', '##MO', '##D', ';', 'gene', 'symbol', ':', 'K', '##IA', '##A', '##0', '##5', '##86', ')', 'presented', 'a', 'lower', 'abundance', 'in', 'S', '##UI', 'samples', 'compared', 'with', 'controls', ':', 'u', '##rom', '##od', '##ulin', '(', 'log', '##FC', '−', '##4', '.', '87', ')', 'and', 'T', '##AL', '##PI', '##D', '##3', '(', 'log', '##FC', '−', '##1', '.', '99', ')', '.']	[0, 4, 13, 14, 19, 25, 27, 28, 30, 31, 33, 38, 44, 46, 47, 49, 50, 51, 52, 54, 56, 66, 68, 74, 84, 87, 88, 91, 99, 108, 113, 121, 123, 124, 127, 129, 134, 135, 138, 141, 142, 143, 144, 146, 148, 152, 153, 155, 157, 158, 160, 161, 164, 167, 168, 169, 170, 172, 173]	[3, 12, 14, 18, 25, 26, 28, 30, 31, 32, 37, 44, 45, 47, 49, 50, 51, 52, 54, 55, 65, 67, 73, 83, 86, 88, 90, 98, 107, 112, 121, 122, 124, 127, 129, 133, 135, 138, 140, 142, 143, 144, 146, 147, 151, 153, 155, 157, 158, 159, 161, 164, 166, 168, 169, 170, 172, 173, 174]	['Two', 'proteins', '(', 'gene', 'symbol', ':', 'UMOD', ';', 'gene', 'symbol', ':', 'KIAA0586', ')', 'presented', 'a', 'lower', 'abundance', 'in', 'SUI', 'samples', 'compared', 'with', 'controls', ':', 'uromodulin', '(', 'logFC', '−4.87', ')', 'and', 'TALPID3', '(', 'logFC', '−1.99', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 2, 4, 1, 1, 5, 1, 2, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ARDs not only showed the highest levels of oxidative stress in terms of ROS and lipid peroxidase activity but also had the lowest proportion of catalase, superoxide dismutase and glutathione peroxidase activity.	[('PMC5073280', 'D04000', 86, 96, 'peroxidase')]	['AR', '##Ds', 'not', 'only', 'showed', 'the', 'highest', 'levels', 'of', 'o', '##xi', '##da', '##tive', 'stress', 'in', 'terms', 'of', 'R', '##OS', 'and', 'lip', '##id', 'per', '##ox', '##idas', '##e', 'activity', 'but', 'also', 'had', 'the', 'lowest', 'proportion', 'of', 'cat', '##ala', '##se', ',', 'super', '##oxide', 'di', '##sm', '##uta', '##se', 'and', 'g', '##lut', '##ath', '##ione', 'per', '##ox', '##idas', '##e', 'activity', '.']	[0, 2, 5, 9, 14, 21, 25, 33, 40, 43, 44, 46, 48, 53, 60, 63, 69, 72, 73, 76, 80, 83, 86, 89, 91, 95, 97, 106, 110, 115, 119, 123, 130, 141, 144, 147, 150, 152, 154, 159, 165, 167, 169, 172, 175, 179, 180, 183, 186, 191, 194, 196, 200, 202, 210]	[2, 4, 8, 13, 20, 24, 32, 39, 42, 44, 46, 48, 52, 59, 62, 68, 71, 73, 75, 79, 83, 85, 89, 91, 95, 96, 105, 109, 114, 118, 122, 129, 140, 143, 147, 150, 152, 153, 159, 164, 167, 169, 172, 174, 178, 180, 183, 186, 190, 194, 196, 200, 201, 210, 211]	['ARDs', 'not', 'only', 'showed', 'the', 'highest', 'levels', 'of', 'oxidative', 'stress', 'in', 'terms', 'of', 'ROS', 'and', 'lipid', 'peroxidase', 'activity', 'but', 'also', 'had', 'the', 'lowest', 'proportion', 'of', 'catalase', ',', 'superoxide', 'dismutase', 'and', 'glutathione', 'peroxidase', 'activity', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 4, 1, 4, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Undiluted serum sample (25 μL) and 100 μL of 2 mM hydrogen peroxide was added to freshly prepared reaction mixture consisting of 755 μL of 0.1 M sodium phosphate buffer (pH 7.0), 100 μL of 2 mM nicotinamide adenine dinucleotide phosphate (NADPH), 10 μL glutathione reductase (2 μL in 500 μL buffer) and 10 μL reduced glutathione (9.22 mg/mL) kept in cuvette of 1 mL capacity.	[('PMC5073280', 'M07000', 253, 274, 'glutathione reductase')]	['Un', '##di', '##lut', '##ed', 'serum', 'sample', '(', '25', 'μ', '##L', ')', 'and', '100', 'μ', '##L', 'of', '2', 'm', '##M', 'hydrogen', 'per', '##oxide', 'was', 'added', 'to', 'freshly', 'prepared', 'reaction', 'mixture', 'consisting', 'of', '75', '##5', 'μ', '##L', 'of', '0', '.', '1', 'M', 'sodium', 'phosphate', 'buffer', '(', 'pH', '7', '.', '0', ')', ',', '100', 'μ', '##L', 'of', '2', 'm', '##M', 'ni', '##cot', '##ina', '##mi', '##de', 'ad', '##eni', '##ne', 'din', '##uc', '##leo', '##tide', 'phosphate', '(', 'N', '##AD', '##P', '##H', ')', ',', '10', 'μ', '##L', 'g', '##lut', '##ath', '##ione', 'red', '##uc', '##tase', '(', '2', 'μ', '##L', 'in', '500', 'μ', '##L', 'buffer', ')', 'and', '10', 'μ', '##L', 'reduced', 'g', '##lut', '##ath', '##ione', '(', '9', '.', '22', 'mg', '/', 'm', '##L', ')', 'kept', 'in', 'cu', '##vet', '##te', 'of', '1', 'm', '##L', 'capacity', '.']	[0, 2, 4, 7, 10, 16, 23, 24, 27, 28, 29, 31, 35, 39, 40, 42, 45, 47, 48, 50, 59, 62, 68, 72, 78, 81, 89, 98, 107, 115, 126, 129, 131, 133, 134, 136, 139, 140, 141, 143, 145, 152, 162, 169, 170, 173, 174, 175, 176, 177, 179, 183, 184, 186, 189, 191, 192, 194, 196, 199, 202, 204, 207, 209, 212, 215, 218, 220, 223, 228, 238, 239, 240, 242, 243, 244, 245, 247, 250, 251, 253, 254, 257, 260, 265, 268, 270, 275, 276, 278, 279, 281, 284, 288, 289, 291, 297, 299, 303, 306, 307, 309, 317, 318, 321, 324, 329, 330, 331, 332, 335, 337, 338, 339, 340, 342, 347, 350, 352, 355, 358, 361, 363, 364, 366, 374]	[2, 4, 7, 9, 15, 22, 24, 26, 28, 29, 30, 34, 38, 40, 41, 44, 46, 48, 49, 58, 62, 67, 71, 77, 80, 88, 97, 106, 114, 125, 128, 131, 132, 134, 135, 138, 140, 141, 142, 144, 151, 161, 168, 170, 172, 174, 175, 176, 177, 178, 182, 184, 185, 188, 190, 192, 193, 196, 199, 202, 204, 206, 209, 212, 214, 218, 220, 223, 227, 237, 239, 240, 242, 243, 244, 245, 246, 249, 251, 252, 254, 257, 260, 264, 268, 270, 274, 276, 277, 279, 280, 283, 287, 289, 290, 297, 298, 302, 305, 307, 308, 316, 318, 321, 324, 328, 330, 331, 332, 334, 337, 338, 339, 340, 341, 346, 349, 352, 355, 357, 360, 362, 364, 365, 374, 375]	['Undiluted', 'serum', 'sample', '(', '25', 'μL', ')', 'and', '100', 'μL', 'of', '2', 'mM', 'hydrogen', 'peroxide', 'was', 'added', 'to', 'freshly', 'prepared', 'reaction', 'mixture', 'consisting', 'of', '755', 'μL', 'of', '0.1', 'M', 'sodium', 'phosphate', 'buffer', '(', 'pH', '7.0', ')', ',', '100', 'μL', 'of', '2', 'mM', 'nicotinamide', 'adenine', 'dinucleotide', 'phosphate', '(', 'NADPH', ')', ',', '10', 'μL', 'glutathione', 'reductase', '(', '2', 'μL', 'in', '500', 'μL', 'buffer', ')', 'and', '10', 'μL', 'reduced', 'glutathione', '(', '9.22', 'mg', '/', 'mL', ')', 'kept', 'in', 'cuvette', 'of', '1', 'mL', 'capacity', '.']	[4, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 2, 5, 3, 4, 1, 1, 4, 1, 1, 1, 2, 4, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 2, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Superoxide dismutase (SOD) activity was determined following standard method18.	[('PMC5073280', 'M09000', 0, 20, 'Superoxide dismutase')]	['Super', '##oxide', 'di', '##sm', '##uta', '##se', '(', 'S', '##OD', ')', 'activity', 'was', 'determined', 'following', 'standard', 'method', '##18', '.']	[0, 5, 11, 13, 15, 18, 21, 22, 23, 25, 27, 36, 40, 51, 61, 70, 76, 78]	[5, 10, 13, 15, 18, 20, 22, 23, 25, 26, 35, 39, 50, 60, 69, 76, 78, 79]	['Superoxide', 'dismutase', '(', 'SOD', ')', 'activity', 'was', 'determined', 'following', 'standard', 'method18', '.']	[2, 4, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We also observed significant differences in serum SOD activity between ARD (2.82 ± 0.23 U/mg protein) and TC (3.39 ± 0.24 U/mg protein).	[]	['We', 'also', 'observed', 'significant', 'differences', 'in', 'serum', 'S', '##OD', 'activity', 'between', 'AR', '##D', '(', '2', '.', '82', '±', '0', '.', '23', 'U', '/', 'mg', 'protein', ')', 'and', 'T', '##C', '(', '3', '.', '39', '±', '0', '.', '24', 'U', '/', 'mg', 'protein', ')', '.']	[0, 3, 8, 17, 29, 41, 44, 50, 51, 54, 63, 71, 73, 75, 76, 77, 78, 81, 83, 84, 85, 88, 89, 90, 93, 100, 102, 106, 107, 109, 110, 111, 112, 115, 117, 118, 119, 122, 123, 124, 127, 134, 135]	[2, 7, 16, 28, 40, 43, 49, 51, 53, 62, 70, 73, 74, 76, 77, 78, 80, 82, 84, 85, 87, 89, 90, 92, 100, 101, 105, 107, 108, 110, 111, 112, 114, 116, 118, 119, 121, 123, 124, 126, 134, 135, 136]	['We', 'also', 'observed', 'significant', 'differences', 'in', 'serum', 'SOD', 'activity', 'between', 'ARD', '(', '2.82', '±', '0.23', 'U', '/', 'mg', 'protein', ')', 'and', 'TC', '(', '3.39', '±', '0.24', 'U', '/', 'mg', 'protein', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
HPV DNA was detected with a L1 consensus primer MY09/MY11/HMB01 polymerase chain reaction (PCR) assay.	[('PMC5079369', 'M03000', 64, 74, 'polymerase')]	['HP', '##V', 'DNA', 'was', 'detected', 'with', 'a', 'L', '##1', 'consensus', 'prime', '##r', 'M', '##Y', '##0', '##9', '/', 'M', '##Y', '##11', '/', 'HM', '##B', '##01', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'ass', '##ay', '.']	[0, 2, 4, 8, 12, 21, 26, 28, 29, 31, 41, 46, 48, 49, 50, 51, 52, 53, 54, 55, 57, 58, 60, 61, 64, 71, 75, 81, 90, 91, 93, 94, 96, 99, 101]	[2, 3, 7, 11, 20, 25, 27, 29, 30, 40, 46, 47, 49, 50, 51, 52, 53, 54, 55, 57, 58, 60, 61, 63, 71, 74, 80, 89, 91, 93, 94, 95, 99, 101, 102]	['HPV', 'DNA', 'was', 'detected', 'with', 'a', 'L1', 'consensus', 'primer', 'MY09', '/', 'MY11', '/', 'HMB01', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'assay', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 2, 4, 1, 3, 1, 3, 2, 1, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although mRNA and protein expression of aldolase A were detected in all tested cell lines (Fig. ​(Fig.7a7a and d), aldolase A protein was not detected in the culture medium of the three CRC cell lines, while it was clearly detected in the culture medium of normal colon epithelial cells (Fig. ​(Fig.7e).7e).	[('PMC5097088', 'D03000', 40, 50, 'aldolase A')]	['Although', 'm', '##RNA', 'and', 'protein', 'expression', 'of', 'al', '##do', '##lase', 'A', 'were', 'detected', 'in', 'all', 'tested', 'cell', 'lines', '(', 'Fi', '##g', '.', '(', 'Fi', '##g', '.', '7', '##a', '##7', '##a', 'and', 'd', ')', ',', 'al', '##do', '##lase', 'A', 'protein', 'was', 'not', 'detected', 'in', 'the', 'culture', 'medium', 'of', 'the', 'three', 'CR', '##C', 'cell', 'lines', ',', 'while', 'it', 'was', 'clearly', 'detected', 'in', 'the', 'culture', 'medium', 'of', 'normal', 'co', '##lon', 'e', '##pit', '##hel', '##ial', 'cells', '(', 'Fi', '##g', '.', '(', 'Fi', '##g', '.', '7', '##e', ')', '.', '7', '##e', ')', '.']	[0, 9, 10, 14, 18, 26, 37, 40, 42, 44, 49, 51, 56, 65, 68, 72, 79, 84, 90, 91, 93, 94, 97, 98, 100, 101, 102, 103, 104, 105, 107, 111, 112, 113, 115, 117, 119, 124, 126, 134, 138, 142, 151, 154, 158, 166, 173, 176, 180, 186, 188, 190, 195, 200, 202, 208, 211, 215, 223, 232, 235, 239, 247, 254, 257, 264, 266, 270, 271, 274, 277, 281, 287, 288, 290, 291, 294, 295, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306]	[8, 10, 13, 17, 25, 36, 39, 42, 44, 48, 50, 55, 64, 67, 71, 78, 83, 89, 91, 93, 94, 95, 98, 100, 101, 102, 103, 104, 105, 106, 110, 112, 113, 114, 117, 119, 123, 125, 133, 137, 141, 150, 153, 157, 165, 172, 175, 179, 185, 188, 189, 194, 200, 201, 207, 210, 214, 222, 231, 234, 238, 246, 253, 256, 263, 266, 269, 271, 274, 277, 280, 286, 288, 290, 291, 292, 295, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307]	['Although', 'mRNA', 'and', 'protein', 'expression', 'of', 'aldolase', 'A', 'were', 'detected', 'in', 'all', 'tested', 'cell', 'lines', '(', 'Fig', '.', '\u200b(Fig.7a7a', 'and', 'd', ')', ',', 'aldolase', 'A', 'protein', 'was', 'not', 'detected', 'in', 'the', 'culture', 'medium', 'of', 'the', 'three', 'CRC', 'cell', 'lines', ',', 'while', 'it', 'was', 'clearly', 'detected', 'in', 'the', 'culture', 'medium', 'of', 'normal', 'colon', 'epithelial', 'cells', '(', 'Fig', '.', '\u200b(Fig.7e).7e', ')', '.']	[1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 8, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 2, 1, 10, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, aldolase A was detected in normal human serum (Fig.	[('PMC5097088', 'D03001', 10, 20, 'aldolase A')]	['Moreover', ',', 'al', '##do', '##lase', 'A', 'was', 'detected', 'in', 'normal', 'human', 'serum', '(', 'Fi', '##g', '.']	[0, 8, 10, 12, 14, 19, 21, 25, 34, 37, 44, 50, 56, 57, 59, 60]	[8, 9, 12, 14, 18, 20, 24, 33, 36, 43, 49, 55, 57, 59, 60, 61]	['Moreover', ',', 'aldolase', 'A', 'was', 'detected', 'in', 'normal', 'human', 'serum', '(', 'Fig', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These results suggest that secretion of aldolase A may be suppressed by dysfunction of aldolase A due to accumulated genetic mutations during the carcinogenesis process of CRC.	[]	['These', 'results', 'suggest', 'that', 'secret', '##ion', 'of', 'al', '##do', '##lase', 'A', 'may', 'be', 'suppressed', 'by', 'd', '##ys', '##function', 'of', 'al', '##do', '##lase', 'A', 'due', 'to', 'accumulated', 'genetic', 'mutations', 'during', 'the', 'car', '##cin', '##ogen', '##esis', 'process', 'of', 'CR', '##C', '.']	[0, 6, 14, 22, 27, 33, 37, 40, 42, 44, 49, 51, 55, 58, 69, 72, 73, 75, 84, 87, 89, 91, 96, 98, 102, 105, 117, 125, 135, 142, 146, 149, 152, 156, 161, 169, 172, 174, 175]	[5, 13, 21, 26, 33, 36, 39, 42, 44, 48, 50, 54, 57, 68, 71, 73, 75, 83, 86, 89, 91, 95, 97, 101, 104, 116, 124, 134, 141, 145, 149, 152, 156, 160, 168, 171, 174, 175, 176]	['These', 'results', 'suggest', 'that', 'secretion', 'of', 'aldolase', 'A', 'may', 'be', 'suppressed', 'by', 'dysfunction', 'of', 'aldolase', 'A', 'due', 'to', 'accumulated', 'genetic', 'mutations', 'during', 'the', 'carcinogenesis', 'process', 'of', 'CRC', '.']	[1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Therefore, decreased aldolase A levels in blood may be useful as a biomarker for the early diagnosis of CRC.	[]	['Therefore', ',', 'decreased', 'al', '##do', '##lase', 'A', 'levels', 'in', 'blood', 'may', 'be', 'useful', 'as', 'a', 'bio', '##mark', '##er', 'for', 'the', 'early', 'diagnosis', 'of', 'CR', '##C', '.']	[0, 9, 11, 21, 23, 25, 30, 32, 39, 42, 48, 52, 55, 62, 65, 67, 70, 74, 77, 81, 85, 91, 101, 104, 106, 107]	[9, 10, 20, 23, 25, 29, 31, 38, 41, 47, 51, 54, 61, 64, 66, 70, 74, 76, 80, 84, 90, 100, 103, 106, 107, 108]	['Therefore', ',', 'decreased', 'aldolase', 'A', 'levels', 'in', 'blood', 'may', 'be', 'useful', 'as', 'a', 'biomarker', 'for', 'the', 'early', 'diagnosis', 'of', 'CRC', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aldolase A is a glycolytic enzyme and contributes to various cellular functions related to muscle maintenance, cell shape and mobility regulation, striated muscle contraction, actin filament organization, and ATP biosynthesis [30–40].	[('PMC5097088', 'D04000', 0, 10, 'Aldolase A')]	['Al', '##do', '##lase', 'A', 'is', 'a', 'g', '##ly', '##co', '##ly', '##tic', 'enzyme', 'and', 'contributes', 'to', 'various', 'cellular', 'functions', 'related', 'to', 'muscle', 'maintenance', ',', 'cell', 'shape', 'and', 'mobility', 'regulation', ',', 's', '##tri', '##ated', 'muscle', 'contraction', ',', 'act', '##in', 'fi', '##lam', '##ent', 'organization', ',', 'and', 'ATP', 'bio', '##sy', '##nt', '##hesis', '[', '30', '–', '40', ']', '.']	[0, 2, 4, 9, 11, 14, 16, 17, 19, 21, 23, 27, 34, 38, 50, 53, 61, 70, 80, 88, 91, 98, 109, 111, 116, 122, 126, 135, 145, 147, 148, 151, 156, 163, 174, 176, 179, 182, 184, 187, 191, 203, 205, 209, 213, 216, 218, 220, 226, 227, 229, 230, 232, 233]	[2, 4, 8, 10, 13, 15, 17, 19, 21, 23, 26, 33, 37, 49, 52, 60, 69, 79, 87, 90, 97, 109, 110, 115, 121, 125, 134, 145, 146, 148, 151, 155, 162, 174, 175, 179, 181, 184, 187, 190, 203, 204, 208, 212, 216, 218, 220, 225, 227, 229, 230, 232, 233, 234]	['Aldolase', 'A', 'is', 'a', 'glycolytic', 'enzyme', 'and', 'contributes', 'to', 'various', 'cellular', 'functions', 'related', 'to', 'muscle', 'maintenance', ',', 'cell', 'shape', 'and', 'mobility', 'regulation', ',', 'striated', 'muscle', 'contraction', ',', 'actin', 'filament', 'organization', ',', 'and', 'ATP', 'biosynthesis', '[', '30–', '40', ']', '.']	[3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There are several reports of elevated expression of aldolase A in the serum of patients with malignant tumors, such as those with lung and renal cancer [41, 42].	[('PMC5097088', 'D04001', 52, 62, 'aldolase A')]	['There', 'are', 'several', 'reports', 'of', 'elevated', 'expression', 'of', 'al', '##do', '##lase', 'A', 'in', 'the', 'serum', 'of', 'patients', 'with', 'ma', '##li', '##gnant', 'tumors', ',', 'such', 'as', 'those', 'with', 'lung', 'and', 're', '##nal', 'cancer', '[', '41', ',', '42', ']', '.']	[0, 6, 10, 18, 26, 29, 38, 49, 52, 54, 56, 61, 63, 66, 70, 76, 79, 88, 93, 95, 97, 103, 109, 111, 116, 119, 125, 130, 135, 139, 141, 145, 152, 153, 155, 157, 159, 160]	[5, 9, 17, 25, 28, 37, 48, 51, 54, 56, 60, 62, 65, 69, 75, 78, 87, 92, 95, 97, 102, 109, 110, 115, 118, 124, 129, 134, 138, 141, 144, 151, 153, 155, 156, 159, 160, 161]	['There', 'are', 'several', 'reports', 'of', 'elevated', 'expression', 'of', 'aldolase', 'A', 'in', 'the', 'serum', 'of', 'patients', 'with', 'malignant', 'tumors', ',', 'such', 'as', 'those', 'with', 'lung', 'and', 'renal', 'cancer', '[', '41', ',', '42', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the expression kinetics and functions of aldolase A in CRC are not well understood.	[('PMC5097088', 'D04002', 50, 60, 'aldolase A')]	['However', ',', 'the', 'expression', 'kinetic', '##s', 'and', 'functions', 'of', 'al', '##do', '##lase', 'A', 'in', 'CR', '##C', 'are', 'not', 'well', 'understood', '.']	[0, 7, 9, 13, 24, 31, 33, 37, 47, 50, 52, 54, 59, 61, 64, 66, 68, 72, 76, 81, 91]	[7, 8, 12, 23, 31, 32, 36, 46, 49, 52, 54, 58, 60, 63, 66, 67, 71, 75, 80, 91, 92]	['However', ',', 'the', 'expression', 'kinetics', 'and', 'functions', 'of', 'aldolase', 'A', 'in', 'CRC', 'are', 'not', 'well', 'understood', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To our knowledge, this is the first report of decreased secretion of aldolase A in CRC.	[('PMC5097088', 'D04003', 69, 79, 'aldolase A')]	['To', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'report', 'of', 'decreased', 'secret', '##ion', 'of', 'al', '##do', '##lase', 'A', 'in', 'CR', '##C', '.']	[0, 3, 7, 16, 18, 23, 26, 30, 36, 43, 46, 56, 62, 66, 69, 71, 73, 78, 80, 83, 85, 86]	[2, 6, 16, 17, 22, 25, 29, 35, 42, 45, 55, 62, 65, 68, 71, 73, 77, 79, 82, 85, 86, 87]	['To', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'report', 'of', 'decreased', 'secretion', 'of', 'aldolase', 'A', 'in', 'CRC', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Thus, further studies are necessary to clarify the decrease in aldolase A levels in the blood of CRC patients in order to determine if this protein can be used as an early detection biomarker for CRC.	[('PMC5097088', 'D04004', 63, 73, 'aldolase A')]	['Thus', ',', 'further', 'studies', 'are', 'necessary', 'to', 'c', '##lar', '##ify', 'the', 'decrease', 'in', 'al', '##do', '##lase', 'A', 'levels', 'in', 'the', 'blood', 'of', 'CR', '##C', 'patients', 'in', 'order', 'to', 'determine', 'if', 'this', 'protein', 'can', 'be', 'used', 'as', 'an', 'early', 'detection', 'bio', '##mark', '##er', 'for', 'CR', '##C', '.']	[0, 4, 6, 14, 22, 26, 36, 39, 40, 43, 47, 51, 60, 63, 65, 67, 72, 74, 81, 84, 88, 94, 97, 99, 101, 110, 113, 119, 122, 132, 135, 140, 148, 152, 155, 160, 163, 166, 172, 182, 185, 189, 192, 196, 198, 199]	[4, 5, 13, 21, 25, 35, 38, 40, 43, 46, 50, 59, 62, 65, 67, 71, 73, 80, 83, 87, 93, 96, 99, 100, 109, 112, 118, 121, 131, 134, 139, 147, 151, 154, 159, 162, 165, 171, 181, 185, 189, 191, 195, 198, 199, 200]	['Thus', ',', 'further', 'studies', 'are', 'necessary', 'to', 'clarify', 'the', 'decrease', 'in', 'aldolase', 'A', 'levels', 'in', 'the', 'blood', 'of', 'CRC', 'patients', 'in', 'order', 'to', 'determine', 'if', 'this', 'protein', 'can', 'be', 'used', 'as', 'an', 'early', 'detection', 'biomarker', 'for', 'CRC', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraffin-embedded tissue sections (3 μm) were subjected to immunostaining using a Histofine Simple Stain MAX-PO (R) kit (Nichirei, Tokyo, Japan) for identifying aldolase A, annexin A2, and cyclophilin A. After deparaffinization, sections were pretreated in an autoclave at 121 °C for 15 min in 10 mM citrate buffer (pH 6.0) for cyclophilin A. Endogenous peroxidase activity was blocked by incubation for 30 min with 0.3 % hydrogen peroxide in methanol.	[]	['Para', '##ffin', '-', 'embedded', 'tissue', 'sections', '(', '3', 'μ', '##m', ')', 'were', 'subjected', 'to', 'im', '##mu', '##nos', '##taining', 'using', 'a', 'His', '##to', '##fine', 'Simple', 'St', '##ain', 'MA', '##X', '-', 'P', '##O', '(', 'R', ')', 'kit', '(', 'Ni', '##chi', '##re', '##i', ',', 'Tokyo', ',', 'Japan', ')', 'for', 'identifying', 'al', '##do', '##lase', 'A', ',', 'an', '##nex', '##in', 'A2', ',', 'and', 'c', '##y', '##c', '##lop', '##hil', '##in', 'A', '.', 'After', 'de', '##par', '##af', '##fin', '##ization', ',', 'sections', 'were', 'pre', '##tre', '##ated', 'in', 'an', 'auto', '##clave', 'at', '121', '°C', 'for', '15', 'min', 'in', '10', 'm', '##M', 'c', '##it', '##rate', 'buffer', '(', 'pH', '6', '.', '0', ')', 'for', 'c', '##y', '##c', '##lop', '##hil', '##in', 'A', '.', 'End', '##ogen', '##ous', 'per', '##ox', '##idas', '##e', 'activity', 'was', 'blocked', 'by', 'in', '##cu', '##bation', 'for', '30', 'min', 'with', '0', '.', '3', '%', 'hydrogen', 'per', '##oxide', 'in', 'met', '##han', '##ol', '.']	[0, 4, 8, 9, 18, 25, 34, 35, 37, 38, 39, 41, 46, 56, 59, 61, 63, 66, 74, 80, 82, 85, 87, 92, 99, 101, 105, 107, 108, 109, 110, 112, 113, 114, 116, 120, 121, 123, 126, 128, 129, 131, 136, 138, 143, 145, 149, 161, 163, 165, 170, 171, 173, 175, 178, 181, 183, 185, 189, 190, 191, 192, 195, 198, 201, 202, 204, 210, 212, 215, 217, 220, 227, 229, 238, 243, 246, 249, 254, 257, 260, 264, 270, 273, 277, 280, 284, 287, 291, 294, 297, 298, 300, 301, 303, 308, 315, 316, 319, 320, 321, 322, 324, 328, 329, 330, 331, 334, 337, 340, 341, 343, 346, 350, 354, 357, 359, 363, 365, 374, 378, 386, 389, 391, 393, 400, 404, 407, 411, 416, 417, 418, 420, 422, 431, 434, 440, 443, 446, 449, 451]	[4, 8, 9, 17, 24, 33, 35, 36, 38, 39, 40, 45, 55, 58, 61, 63, 66, 73, 79, 81, 85, 87, 91, 98, 101, 104, 107, 108, 109, 110, 111, 113, 114, 115, 119, 121, 123, 126, 128, 129, 130, 136, 137, 143, 144, 148, 160, 163, 165, 169, 171, 172, 175, 178, 180, 183, 184, 188, 190, 191, 192, 195, 198, 200, 202, 203, 209, 212, 215, 217, 220, 227, 228, 237, 242, 246, 249, 253, 256, 259, 264, 269, 272, 276, 279, 283, 286, 290, 293, 296, 298, 299, 301, 303, 307, 314, 316, 318, 320, 321, 322, 323, 327, 329, 330, 331, 334, 337, 339, 341, 342, 346, 350, 353, 357, 359, 363, 364, 373, 377, 385, 388, 391, 393, 399, 403, 406, 410, 415, 417, 418, 419, 421, 430, 434, 439, 442, 446, 449, 451, 452]	['Paraffin', '-', 'embedded', 'tissue', 'sections', '(', '3', 'μm', ')', 'were', 'subjected', 'to', 'immunostaining', 'using', 'a', 'Histofine', 'Simple', 'Stain', 'MAX-PO', '(', 'R', ')', 'kit', '(', 'Nichirei', ',', 'Tokyo', ',', 'Japan', ')', 'for', 'identifying', 'aldolase', 'A', ',', 'annexin', 'A2', ',', 'and', 'cyclophilin', 'A', '.', 'After', 'deparaffinization', ',', 'sections', 'were', 'pretreated', 'in', 'an', 'autoclave', 'at', '121', '°C', 'for', '15', 'min', 'in', '10', 'mM', 'citrate', 'buffer', '(', 'pH', '6.0', ')', 'for', 'cyclophilin', 'A', '.', 'Endogenous', 'peroxidase', 'activity', 'was', 'blocked', 'by', 'incubation', 'for', '30', 'min', 'with', '0.3', '%', 'hydrogen', 'peroxide', 'in', 'methanol', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 3, 1, 2, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 6, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 3, 1, 1, 6, 1, 1, 3, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Tissue sections were then incubated with the anti-ALDOA antibody (1:150 dilution; Atlas Antibodies, Stockholm, Sweden) for aldolase A, anti-cyclophilin A antibody (1:150 dilution; Novus Biologicals, Littleton, CO, USA), or anti-annexin A2 antibody (1:400 dilution; Cell Signaling Technology, Inc., Danvers, MA, USA) in phosphate-buffered saline containing 1 % bovine serum albumin for 16 h at 4 °C.	[]	['T', '##iss', '##ue', 'sections', 'were', 'then', 'in', '##cu', '##bate', '##d', 'with', 'the', 'anti', '-', 'AL', '##D', '##OA', 'anti', '##body', '(', '1', ':', '150', 'di', '##lution', ';', 'Atlas', 'Anti', '##bo', '##dies', ',', 'Stockholm', ',', 'Sweden', ')', 'for', 'al', '##do', '##lase', 'A', ',', 'anti', '-', 'c', '##y', '##c', '##lop', '##hil', '##in', 'A', 'anti', '##body', '(', '1', ':', '150', 'di', '##lution', ';', 'Nov', '##us', 'Biological', '##s', ',', 'Little', '##ton', ',', 'CO', ',', 'USA', ')', ',', 'or', 'anti', '-', 'an', '##nex', '##in', 'A2', 'anti', '##body', '(', '1', ':', '400', 'di', '##lution', ';', 'Cell', 'Signal', '##ing', 'Technology', ',', 'Inc', '.', ',', 'Dan', '##vers', ',', 'MA', ',', 'USA', ')', 'in', 'phosphate', '-', 'buffer', '##ed', 'sa', '##line', 'containing', '1', '%', 'b', '##ov', '##ine', 'serum', 'album', '##in', 'for', '16', 'h', 'at', '4', '°C', '.']	[0, 1, 4, 7, 16, 21, 26, 28, 30, 34, 36, 41, 45, 49, 50, 52, 53, 56, 60, 65, 66, 67, 68, 72, 74, 80, 82, 88, 92, 94, 98, 100, 109, 111, 117, 119, 123, 125, 127, 132, 133, 135, 139, 140, 141, 142, 143, 146, 149, 152, 154, 158, 163, 164, 165, 166, 170, 172, 178, 180, 183, 186, 196, 197, 199, 205, 208, 210, 212, 214, 217, 218, 220, 223, 227, 228, 230, 233, 236, 239, 243, 248, 249, 250, 251, 255, 257, 263, 265, 270, 276, 280, 290, 292, 295, 296, 298, 301, 305, 307, 309, 311, 314, 316, 319, 328, 329, 335, 338, 340, 345, 356, 358, 360, 361, 363, 367, 373, 378, 381, 385, 388, 390, 393, 395, 397]	[1, 4, 6, 15, 20, 25, 28, 30, 34, 35, 40, 44, 49, 50, 52, 53, 55, 60, 64, 66, 67, 68, 71, 74, 80, 81, 87, 92, 94, 98, 99, 109, 110, 117, 118, 122, 125, 127, 131, 133, 134, 139, 140, 141, 142, 143, 146, 149, 151, 153, 158, 162, 164, 165, 166, 169, 172, 178, 179, 183, 185, 196, 197, 198, 205, 208, 209, 212, 213, 217, 218, 219, 222, 227, 228, 230, 233, 235, 238, 243, 247, 249, 250, 251, 254, 257, 263, 264, 269, 276, 279, 290, 291, 295, 296, 297, 301, 305, 306, 309, 310, 314, 315, 318, 328, 329, 335, 337, 340, 344, 355, 357, 359, 361, 363, 366, 372, 378, 380, 384, 387, 389, 392, 394, 397, 398]	['Tissue', 'sections', 'were', 'then', 'incubated', 'with', 'the', 'anti-ALDOA', 'antibody', '(', '1', ':', '150', 'dilution', ';', 'Atlas', 'Antibodies', ',', 'Stockholm', ',', 'Sweden', ')', 'for', 'aldolase', 'A', ',', 'anti-', 'cyclophilin', 'A', 'antibody', '(', '1', ':', '150', 'dilution', ';', 'Novus', 'Biologicals', ',', 'Littleton', ',', 'CO', ',', 'USA', ')', ',', 'or', 'anti-', 'annexin', 'A2', 'antibody', '(', '1', ':', '400', 'dilution', ';', 'Cell', 'Signaling', 'Technology', ',', 'Inc', '.', ',', 'Danvers', ',', 'MA', ',', 'USA', ')', 'in', 'phosphate', '-', 'buffered', 'saline', 'containing', '1', '%', 'bovine', 'serum', 'albumin', 'for', '16', 'h', 'at', '4', '°C', '.']	[3, 1, 1, 1, 4, 1, 1, 5, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 6, 1, 2, 1, 1, 1, 1, 2, 1, 2, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 2, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Fructose-bisphosphate aldolase A (aldolase A), peptidyl-prolyl cis-trans isomerase A (also known as cyclophilin A), and annexin A2 were upregulated in cancer regions (Table ​(Table3)3) and consequently selected as candidate diagnostic biomarkers.	[('PMC5097088', 'R04000', 0, 32, 'Fructose-bisphosphate aldolase A')]	['Fr', '##uc', '##tos', '##e', '-', 'bi', '##sp', '##hos', '##phate', 'al', '##do', '##lase', 'A', '(', 'al', '##do', '##lase', 'A', ')', ',', 'p', '##ept', '##idy', '##l', '-', 'pro', '##ly', '##l', 'c', '##is', '-', 'trans', 'is', '##omer', '##ase', 'A', '(', 'also', 'known', 'as', 'c', '##y', '##c', '##lop', '##hil', '##in', 'A', ')', ',', 'and', 'an', '##nex', '##in', 'A2', 'were', 'up', '##re', '##gu', '##lated', 'in', 'cancer', 'regions', '(', 'Table', '(', 'Table', '##3', ')', '3', ')', 'and', 'consequently', 'selected', 'as', 'candidate', 'diagnostic', 'bio', '##mark', '##ers', '.']	[0, 2, 4, 7, 8, 9, 11, 13, 16, 22, 24, 26, 31, 33, 34, 36, 38, 43, 44, 45, 47, 48, 51, 54, 55, 56, 59, 61, 63, 64, 66, 67, 73, 75, 79, 83, 85, 86, 91, 97, 100, 101, 102, 103, 106, 109, 112, 113, 114, 116, 120, 122, 125, 128, 131, 136, 138, 140, 142, 148, 151, 158, 166, 167, 174, 175, 180, 181, 182, 183, 185, 189, 202, 211, 214, 224, 235, 238, 242, 245]	[2, 4, 7, 8, 9, 11, 13, 16, 21, 24, 26, 30, 32, 34, 36, 38, 42, 44, 45, 46, 48, 51, 54, 55, 56, 59, 61, 62, 64, 66, 67, 72, 75, 79, 82, 84, 86, 90, 96, 99, 101, 102, 103, 106, 109, 111, 113, 114, 115, 119, 122, 125, 127, 130, 135, 138, 140, 142, 147, 150, 157, 165, 167, 172, 175, 180, 181, 182, 183, 184, 188, 201, 210, 213, 223, 234, 238, 242, 245, 246]	['Fructose', '-', 'bisphosphate', 'aldolase', 'A', '(', 'aldolase', 'A', ')', ',', 'peptidyl', '-', 'prolyl', 'cis-', 'trans', 'isomerase', 'A', '(', 'also', 'known', 'as', 'cyclophilin', 'A', ')', ',', 'and', 'annexin', 'A2', 'were', 'upregulated', 'in', 'cancer', 'regions', '(', 'Table', '\u200b(Table3)3', ')', 'and', 'consequently', 'selected', 'as', 'candidate', 'diagnostic', 'biomarkers', '.']	[4, 1, 4, 3, 1, 1, 3, 1, 1, 1, 4, 1, 3, 3, 1, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genes associated with biofilm formation (glycosylases and glycosyltransferases) and epithelial adhesion (fimbria/pili) were identified in all four genomes; however, type-1 fimbrial precursors were found only within the genomes of G26-12 and G30-4.	[]	['Gene', '##s', 'associated', 'with', 'bio', '##film', 'formation', '(', 'g', '##ly', '##cos', '##yla', '##ses', 'and', 'g', '##ly', '##cos', '##yl', '##tra', '##ns', '##fer', '##ases', ')', 'and', 'e', '##pit', '##hel', '##ial', 'ad', '##hesion', '(', 'fi', '##mb', '##ria', '/', 'p', '##ili', ')', 'were', 'identified', 'in', 'all', 'four', 'genome', '##s', ';', 'however', ',', 'type', '-', '1', 'fi', '##mb', '##rial', 'precursor', '##s', 'were', 'found', 'only', 'within', 'the', 'genome', '##s', 'of', 'G', '##26', '-', '12', 'and', 'G', '##30', '-', '4', '.']	[0, 4, 6, 17, 22, 25, 30, 40, 41, 42, 44, 47, 50, 54, 58, 59, 61, 64, 66, 69, 71, 74, 78, 80, 84, 85, 88, 91, 95, 97, 104, 105, 107, 109, 112, 113, 114, 117, 119, 124, 135, 138, 142, 147, 153, 154, 156, 163, 165, 169, 170, 172, 174, 176, 181, 190, 192, 197, 203, 208, 215, 219, 225, 227, 230, 231, 233, 234, 237, 241, 242, 244, 245, 246]	[4, 5, 16, 21, 25, 29, 39, 41, 42, 44, 47, 50, 53, 57, 59, 61, 64, 66, 69, 71, 74, 78, 79, 83, 85, 88, 91, 94, 97, 103, 105, 107, 109, 112, 113, 114, 117, 118, 123, 134, 137, 141, 146, 153, 154, 155, 163, 164, 169, 170, 171, 174, 176, 180, 190, 191, 196, 202, 207, 214, 218, 225, 226, 229, 231, 233, 234, 236, 240, 242, 244, 245, 246, 247]	['Genes', 'associated', 'with', 'biofilm', 'formation', '(', 'glycosylases', 'and', 'glycosyltransferases', ')', 'and', 'epithelial', 'adhesion', '(', 'fimbria', '/', 'pili', ')', 'were', 'identified', 'in', 'all', 'four', 'genomes', ';', 'however', ',', 'type-1', 'fimbrial', 'precursors', 'were', 'found', 'only', 'within', 'the', 'genomes', 'of', 'G26-12', 'and', 'G30-4', '.']	[2, 1, 1, 2, 1, 1, 5, 1, 8, 1, 1, 4, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 3, 2, 1, 1, 1, 1, 1, 2, 1, 4, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genes associated with antibiotic/antimicrobial resistance, including those that encode the ABC-type multidrug transport system and the DedA protein (which has been shown to be required for drug resistance in E. coli [34]) were present within all four genomes.	[]	['Gene', '##s', 'associated', 'with', 'anti', '##biotic', '/', 'anti', '##mic', '##ro', '##bial', 'resistance', ',', 'including', 'those', 'that', 'en', '##code', 'the', 'ABC', '-', 'type', 'multi', '##dr', '##ug', 'transport', 'system', 'and', 'the', 'De', '##d', '##A', 'protein', '(', 'which', 'has', 'been', 'shown', 'to', 'be', 'required', 'for', 'drug', 'resistance', 'in', 'E', '.', 'co', '##li', '[', '34', ']', ')', 'were', 'present', 'within', 'all', 'four', 'genome', '##s', '.']	[0, 4, 6, 17, 22, 26, 32, 33, 37, 40, 42, 47, 57, 59, 69, 75, 80, 82, 87, 91, 94, 95, 100, 105, 107, 110, 120, 127, 131, 135, 137, 138, 140, 148, 149, 155, 159, 164, 170, 173, 176, 185, 189, 194, 205, 208, 209, 211, 213, 216, 217, 219, 220, 222, 227, 235, 242, 246, 251, 257, 258]	[4, 5, 16, 21, 26, 32, 33, 37, 40, 42, 46, 57, 58, 68, 74, 79, 82, 86, 90, 94, 95, 99, 105, 107, 109, 119, 126, 130, 134, 137, 138, 139, 147, 149, 154, 158, 163, 169, 172, 175, 184, 188, 193, 204, 207, 209, 210, 213, 215, 217, 219, 220, 221, 226, 234, 241, 245, 250, 257, 258, 259]	['Genes', 'associated', 'with', 'antibiotic', '/', 'antimicrobial', 'resistance', ',', 'including', 'those', 'that', 'encode', 'the', 'ABC', '-', 'type', 'multidrug', 'transport', 'system', 'and', 'the', 'DedA', 'protein', '(', 'which', 'has', 'been', 'shown', 'to', 'be', 'required', 'for', 'drug', 'resistance', 'in', 'E', '.', 'coli', '[', '34', ']', ')', 'were', 'present', 'within', 'all', 'four', 'genomes', '.']	[2, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Abiraterone [abi; 17-(3-pyridyl)-androsta-5,16-dien-3β-ol] is a 17-heteroazole steroidal compound and a potent inhibitor of steroid 17α-hydroxylase/17,20-lyase (CYP17A1), an enzyme required for androgen synthesis [9].	[('PMC5124534', 'I01000', 132, 147, '17α-hydroxylase')]	['A', '##bir', '##ater', '##one', '[', 'a', '##bi', ';', '17', '-', '(', '3', '-', 'p', '##yr', '##idy', '##l', ')', '-', 'and', '##ros', '##ta', '-', '5', ',', '16', '-', 'die', '##n', '-', '3', '##β', '-', 'o', '##l', ']', 'is', 'a', '17', '-', 'he', '##tero', '##az', '##ole', 's', '##tero', '##idal', 'compound', 'and', 'a', 'potent', 'inhibitor', 'of', 's', '##tero', '##id', '17', '##α', '-', 'h', '##ydro', '##xy', '##lase', '/', '17', ',', '20', '-', 'l', '##yas', '##e', '(', 'C', '##YP', '##17', '##A', '##1', ')', ',', 'an', 'enzyme', 'required', 'for', 'and', '##rogen', 'synthesis', '[', '9', ']', '.']	[0, 1, 4, 8, 12, 13, 14, 16, 18, 20, 21, 22, 23, 24, 25, 27, 30, 31, 32, 33, 36, 39, 41, 42, 43, 44, 46, 47, 50, 51, 52, 53, 54, 55, 56, 57, 59, 62, 64, 66, 67, 69, 73, 75, 79, 80, 84, 89, 98, 102, 104, 111, 121, 124, 125, 129, 132, 134, 135, 136, 137, 141, 143, 147, 148, 150, 151, 153, 154, 155, 158, 160, 161, 162, 164, 166, 167, 168, 169, 171, 174, 181, 190, 194, 197, 203, 213, 214, 215, 216]	[1, 4, 8, 11, 13, 14, 16, 17, 20, 21, 22, 23, 24, 25, 27, 30, 31, 32, 33, 36, 39, 41, 42, 43, 44, 46, 47, 50, 51, 52, 53, 54, 55, 56, 57, 58, 61, 63, 66, 67, 69, 73, 75, 78, 80, 84, 88, 97, 101, 103, 110, 120, 123, 125, 129, 131, 134, 135, 136, 137, 141, 143, 147, 148, 150, 151, 153, 154, 155, 158, 159, 161, 162, 164, 166, 167, 168, 169, 170, 173, 180, 189, 193, 197, 202, 212, 214, 215, 216, 217]	['Abiraterone', '[', 'abi', ';', '17-(3-pyridyl)-androsta-5,16-dien-3β-ol', ']', 'is', 'a', '17-heteroazole', 'steroidal', 'compound', 'and', 'a', 'potent', 'inhibitor', 'of', 'steroid', '17α-hydroxylase', '/', '17', ',', '20-lyase', '(', 'CYP17A1', ')', ',', 'an', 'enzyme', 'required', 'for', 'androgen', 'synthesis', '[', '9', ']', '.']	[4, 1, 2, 1, 27, 1, 1, 1, 6, 3, 1, 1, 1, 1, 1, 1, 3, 7, 1, 1, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Either the 5α-reductase or 5β-reductase enzymes could initiate the downstream metabolism of D4A. The 5α-reduced metabolites are 3-keto-5α-Abi, 3α-OH-5α-Abi and 3β-OH-5α-Abi, while the corresponding 5β-reduced metabolites are 3-keto-5β-Abi, 3α-OH-5β-Abi and 3β-OH-5β-Abi (Fig. 1).	[]	['Either', 'the', '5', '##α', '-', 'red', '##uc', '##tase', 'or', '5', '##β', '-', 'red', '##uc', '##tase', 'enzymes', 'could', 'initiate', 'the', 'downstream', 'metabolism', 'of', 'D', '##4', '##A', '.', 'The', '5', '##α', '-', 'reduced', 'meta', '##bol', '##ites', 'are', '3', '-', 'k', '##eto', '-', '5', '##α', '-', 'A', '##bi', ',', '3', '##α', '-', 'OH', '-', '5', '##α', '-', 'A', '##bi', 'and', '3', '##β', '-', 'OH', '-', '5', '##α', '-', 'A', '##bi', ',', 'while', 'the', 'corresponding', '5', '##β', '-', 'reduced', 'meta', '##bol', '##ites', 'are', '3', '-', 'k', '##eto', '-', '5', '##β', '-', 'A', '##bi', ',', '3', '##α', '-', 'OH', '-', '5', '##β', '-', 'A', '##bi', 'and', '3', '##β', '-', 'OH', '-', '5', '##β', '-', 'A', '##bi', '(', 'Fi', '##g', '.', '1', ')', '.']	[0, 7, 11, 12, 13, 14, 17, 19, 24, 27, 28, 29, 30, 33, 35, 40, 48, 54, 63, 67, 78, 89, 92, 93, 94, 95, 97, 101, 102, 103, 104, 112, 116, 119, 124, 128, 129, 130, 131, 134, 135, 136, 137, 138, 139, 141, 143, 144, 145, 146, 148, 149, 150, 151, 152, 153, 156, 160, 161, 162, 163, 165, 166, 167, 168, 169, 170, 172, 174, 180, 184, 198, 199, 200, 201, 209, 213, 216, 221, 225, 226, 227, 228, 231, 232, 233, 234, 235, 236, 238, 240, 241, 242, 243, 245, 246, 247, 248, 249, 250, 253, 257, 258, 259, 260, 262, 263, 264, 265, 266, 267, 270, 271, 273, 274, 276, 277, 278]	[6, 10, 12, 13, 14, 17, 19, 23, 26, 28, 29, 30, 33, 35, 39, 47, 53, 62, 66, 77, 88, 91, 93, 94, 95, 96, 100, 102, 103, 104, 111, 116, 119, 123, 127, 129, 130, 131, 134, 135, 136, 137, 138, 139, 141, 142, 144, 145, 146, 148, 149, 150, 151, 152, 153, 155, 159, 161, 162, 163, 165, 166, 167, 168, 169, 170, 172, 173, 179, 183, 197, 199, 200, 201, 208, 213, 216, 220, 224, 226, 227, 228, 231, 232, 233, 234, 235, 236, 238, 239, 241, 242, 243, 245, 246, 247, 248, 249, 250, 252, 256, 258, 259, 260, 262, 263, 264, 265, 266, 267, 269, 271, 273, 274, 275, 277, 278, 279]	['Either', 'the', '5α-reductase', 'or', '5β-reductase', 'enzymes', 'could', 'initiate', 'the', 'downstream', 'metabolism', 'of', 'D4A', '.', 'The', '5α-reduced', 'metabolites', 'are', '3-keto-5α-Abi', ',', '3α-OH-5α-Abi', 'and', '3β-OH-5α-Abi', ',', 'while', 'the', 'corresponding', '5β-reduced', 'metabolites', 'are', '3-keto-5β-Abi', ',', '3α-OH-5β-Abi', 'and', '3β-OH-5β-Abi', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 6, 1, 6, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 3, 1, 10, 1, 10, 1, 10, 1, 1, 1, 1, 4, 3, 1, 10, 1, 10, 1, 10, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The major function of AIs is to reduce estrogen levels by the inhibition of aromatase, the rate-limiting step in estrogen biosynthesis.	[('PMC5135610', 'R11000', 76, 85, 'aromatase')]	['The', 'major', 'function', 'of', 'AI', '##s', 'is', 'to', 'reduce', 'est', '##rogen', 'levels', 'by', 'the', 'in', '##hibition', 'of', 'a', '##roma', '##tase', ',', 'the', 'rate', '-', 'limiting', 'step', 'in', 'est', '##rogen', 'bio', '##sy', '##nt', '##hesis', '.']	[0, 4, 10, 19, 22, 24, 26, 29, 32, 39, 42, 48, 55, 58, 62, 64, 73, 76, 77, 81, 85, 87, 91, 95, 96, 105, 110, 113, 116, 122, 125, 127, 129, 134]	[3, 9, 18, 21, 24, 25, 28, 31, 38, 42, 47, 54, 57, 61, 64, 72, 75, 77, 81, 85, 86, 90, 95, 96, 104, 109, 112, 116, 121, 125, 127, 129, 134, 135]	['The', 'major', 'function', 'of', 'AIs', 'is', 'to', 'reduce', 'estrogen', 'levels', 'by', 'the', 'inhibition', 'of', 'aromatase', ',', 'the', 'rate', '-', 'limiting', 'step', 'in', 'estrogen', 'biosynthesis', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, there was a significant decline in sphingosine‐1‐phosphate phosphatase 1 activity (SGPP1, SYNE2 locus) after treatment, particularly among INR, when evaluated by the ratio PC aa C28:1/PC ae C40:2 (p = 8.4667E-7, -log10(p) =	[('PMC5152829', 'R04000', 48, 85, 'sphingosine‐1‐phosphate phosphatase 1')]	['Furthermore', ',', 'there', 'was', 'a', 'significant', 'decline', 'in', 's', '##phi', '##ngo', '##sin', '##e', '‐', '1', '‐', 'phosphate', 'p', '##hos', '##pha', '##tase', '1', 'activity', '(', 'S', '##GP', '##P', '##1', ',', 'S', '##Y', '##NE', '##2', 'lo', '##cus', ')', 'after', 'treatment', ',', 'particularly', 'among', 'IN', '##R', ',', 'when', 'evaluated', 'by', 'the', 'ratio', 'PC', 'a', '##a', 'C', '##28', ':', '1', '/', 'PC', 'a', '##e', 'C', '##40', ':', '2', '(', 'p', '=', '8', '.', '46', '##6', '##7', '##E', '-', '7', ',', '-', 'log', '##10', '(', 'p', ')', '=']	[0, 11, 13, 19, 23, 25, 37, 45, 48, 49, 52, 55, 58, 59, 60, 61, 62, 72, 73, 76, 79, 84, 86, 95, 96, 97, 99, 100, 101, 103, 104, 105, 107, 109, 111, 114, 116, 122, 131, 133, 146, 152, 154, 155, 157, 162, 172, 175, 179, 185, 188, 189, 191, 192, 194, 195, 196, 197, 200, 201, 203, 204, 206, 207, 209, 210, 212, 214, 215, 216, 218, 219, 220, 221, 222, 223, 225, 226, 229, 231, 232, 233, 235]	[11, 12, 18, 22, 24, 36, 44, 47, 49, 52, 55, 58, 59, 60, 61, 62, 71, 73, 76, 79, 83, 85, 94, 96, 97, 99, 100, 101, 102, 104, 105, 107, 108, 111, 114, 115, 121, 131, 132, 145, 151, 154, 155, 156, 161, 171, 174, 178, 184, 187, 189, 190, 192, 194, 195, 196, 197, 199, 201, 202, 204, 206, 207, 208, 210, 211, 213, 215, 216, 218, 219, 220, 221, 222, 223, 224, 226, 229, 231, 232, 233, 234, 236]	['Furthermore', ',', 'there', 'was', 'a', 'significant', 'decline', 'in', 'sphingosine‐1‐phosphate', 'phosphatase', '1', 'activity', '(', 'SGPP1', ',', 'SYNE2', 'locus', ')', 'after', 'treatment', ',', 'particularly', 'among', 'INR', ',', 'when', 'evaluated', 'by', 'the', 'ratio', 'PC', 'aa', 'C28', ':', '1', '/', 'PC', 'ae', 'C40', ':', '2', '(', 'p', '=', '8.4667E-7', ',', '-', 'log10(p)', '=']	[1, 1, 1, 1, 1, 1, 1, 1, 9, 4, 1, 1, 1, 4, 1, 4, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 8, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Importantly, Sphingosine-1-Phosphate (S1P) is involved in lymphocyte egress from lymphoid organs[26, 27] and bone marrow[28, 29] into circulatory fluids via a gradient of S1P. Because SGPP1 (SYNE2 Locus) is correlated to CD4+ T cell counts (p = 0.0071195; FDR = 0.16446, Fig 3), it is tempting to speculate the existence of a link between Sphingosine‐1‐Phosphate Phosphatase 1 activity and INR.	[]	['Important', '##ly', ',', 'S', '##phi', '##ngo', '##sin', '##e', '-', '1', '-', 'Ph', '##os', '##phate', '(', 'S', '##1', '##P', ')', 'is', 'involved', 'in', 'l', '##ymph', '##oc', '##yte', 'e', '##g', '##ress', 'from', 'l', '##ymph', '##oid', 'organs', '[', '26', ',', '27', ']', 'and', 'bone', 'ma', '##rrow', '[', '28', ',', '29', ']', 'into', 'c', '##ir', '##cula', '##tory', 'fluids', 'via', 'a', 'gradient', 'of', 'S', '##1', '##P', '.', 'Because', 'S', '##GP', '##P', '##1', '(', 'S', '##Y', '##NE', '##2', 'Lo', '##cus', ')', 'is', 'correlated', 'to', 'CD', '##4', '+', 'T', 'cell', 'counts', '(', 'p', '=', '0', '.', '00', '##7', '##11', '##9', '##5', ';', 'F', '##DR', '=', '0', '.', '1644', '##6', ',', 'Fi', '##g', '3', ')', ',', 'it', 'is', 'tempting', 'to', 's', '##pec', '##ulate', 'the', 'existence', 'of', 'a', 'link', 'between', 'S', '##phi', '##ngo', '##sin', '##e', '‐', '1', '‐', 'Ph', '##os', '##phate', 'Ph', '##os', '##pha', '##tase', '1', 'activity', 'and', 'IN', '##R', '.']	[0, 9, 11, 13, 14, 17, 20, 23, 24, 25, 26, 27, 29, 31, 37, 38, 39, 40, 41, 43, 46, 55, 58, 59, 63, 65, 69, 70, 71, 76, 81, 82, 86, 90, 96, 97, 99, 101, 103, 105, 109, 114, 116, 120, 121, 123, 125, 127, 129, 134, 135, 137, 141, 146, 153, 157, 159, 168, 171, 172, 173, 174, 176, 184, 185, 187, 188, 190, 191, 192, 193, 195, 197, 199, 202, 204, 207, 218, 221, 223, 224, 226, 228, 233, 240, 241, 243, 245, 246, 247, 249, 250, 252, 253, 254, 256, 257, 260, 262, 263, 264, 268, 269, 271, 273, 275, 276, 277, 279, 282, 285, 294, 297, 298, 301, 307, 311, 321, 324, 326, 331, 339, 340, 343, 346, 349, 350, 351, 352, 353, 355, 357, 363, 365, 367, 370, 375, 377, 386, 390, 392, 393]	[9, 11, 12, 14, 17, 20, 23, 24, 25, 26, 27, 29, 31, 36, 38, 39, 40, 41, 42, 45, 54, 57, 59, 63, 65, 68, 70, 71, 75, 80, 82, 86, 89, 96, 97, 99, 100, 103, 104, 108, 113, 116, 120, 121, 123, 124, 127, 128, 133, 135, 137, 141, 145, 152, 156, 158, 167, 170, 172, 173, 174, 175, 183, 185, 187, 188, 189, 191, 192, 193, 195, 196, 199, 202, 203, 206, 217, 220, 223, 224, 225, 227, 232, 239, 241, 242, 244, 246, 247, 249, 250, 252, 253, 254, 255, 257, 259, 261, 263, 264, 268, 269, 270, 273, 274, 276, 277, 278, 281, 284, 293, 296, 298, 301, 306, 310, 320, 323, 325, 330, 338, 340, 343, 346, 349, 350, 351, 352, 353, 355, 357, 362, 365, 367, 370, 374, 376, 385, 389, 392, 393, 394]	['Importantly', ',', 'Sphingosine-1-Phosphate', '(', 'S1P', ')', 'is', 'involved', 'in', 'lymphocyte', 'egress', 'from', 'lymphoid', 'organs[26', ',', '27', ']', 'and', 'bone', 'marrow[28', ',', '29', ']', 'into', 'circulatory', 'fluids', 'via', 'a', 'gradient', 'of', 'S1P', '.', 'Because', 'SGPP1', '(', 'SYNE2', 'Locus', ')', 'is', 'correlated', 'to', 'CD4+', 'T', 'cell', 'counts', '(', 'p', '=', '0.0071195', ';', 'FDR', '=', '0.16446', ',', 'Fig', '3', ')', ',', 'it', 'is', 'tempting', 'to', 'speculate', 'the', 'existence', 'of', 'a', 'link', 'between', 'Sphingosine‐1‐Phosphate', 'Phosphatase', '1', 'activity', 'and', 'INR', '.']	[2, 1, 11, 1, 3, 1, 1, 1, 1, 4, 3, 1, 3, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 4, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 7, 1, 2, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 11, 4, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Manycarcinogen adducts formed with human Alb samples have been measuredfollowing chemical hydrolysis or pronase digestion of Alb.	[('PMC5241710', 'C00000', 106, 113, 'onase d')]	['Many', '##car', '##cin', '##ogen', 'add', '##uc', '##ts', 'formed', 'with', 'human', 'Al', '##b', 'samples', 'have', 'been', 'measured', '##fo', '##llow', '##ing', 'chemical', 'h', '##ydro', '##lysis', 'or', 'pro', '##nas', '##e', 'dig', '##est', '##ion', 'of', 'Al', '##b', '.']	[0, 4, 7, 10, 15, 18, 20, 23, 30, 35, 41, 43, 45, 53, 58, 63, 71, 73, 77, 81, 90, 91, 95, 101, 104, 107, 110, 112, 115, 118, 122, 125, 127, 128]	[4, 7, 10, 14, 18, 20, 22, 29, 34, 40, 43, 44, 52, 57, 62, 71, 73, 77, 80, 89, 91, 95, 100, 103, 107, 110, 111, 115, 118, 121, 124, 127, 128, 129]	['Manycarcinogen', 'adducts', 'formed', 'with', 'human', 'Alb', 'samples', 'have', 'been', 'measuredfollowing', 'chemical', 'hydrolysis', 'or', 'pronase', 'digestion', 'of', 'Alb', '.']	[4, 3, 1, 1, 1, 2, 1, 1, 1, 4, 1, 3, 1, 3, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The MS analyses have revealed that thesites of adduct formation with Alb are driven not only by the reactivityof nucleophilic amino acid sites and their accessibility but alsoby the noncovalent interactions of the toxicant within the differentmicroenvironments of Alb, which guide the sites of toxicant adduction.	[]	['The', 'MS', 'analyses', 'have', 'revealed', 'that', 'the', '##site', '##s', 'of', 'add', '##uc', '##t', 'formation', 'with', 'Al', '##b', 'are', 'driven', 'not', 'only', 'by', 'the', 'react', '##ivity', '##of', 'n', '##uc', '##leo', '##phi', '##lic', 'amino', 'acid', 'sites', 'and', 'their', 'access', '##ibility', 'but', 'also', '##by', 'the', 'non', '##co', '##valent', 'interactions', 'of', 'the', 'toxic', '##ant', 'within', 'the', 'different', '##mic', '##ro', '##en', '##vir', '##on', '##ments', 'of', 'Al', '##b', ',', 'which', 'guide', 'the', 'sites', 'of', 'toxic', '##ant', 'add', '##uction', '.']	[0, 4, 7, 16, 21, 30, 35, 38, 42, 44, 47, 50, 52, 54, 64, 69, 71, 73, 77, 84, 88, 93, 96, 100, 105, 110, 113, 114, 116, 119, 122, 126, 132, 137, 143, 147, 153, 159, 167, 171, 175, 178, 182, 185, 187, 194, 207, 210, 214, 219, 223, 230, 234, 243, 246, 248, 250, 253, 255, 261, 264, 266, 267, 269, 275, 281, 285, 291, 294, 299, 303, 306, 312]	[3, 6, 15, 20, 29, 34, 38, 42, 43, 46, 50, 52, 53, 63, 68, 71, 72, 76, 83, 87, 92, 95, 99, 105, 110, 112, 114, 116, 119, 122, 125, 131, 136, 142, 146, 152, 159, 166, 170, 175, 177, 181, 185, 187, 193, 206, 209, 213, 219, 222, 229, 233, 243, 246, 248, 250, 253, 255, 260, 263, 266, 267, 268, 274, 280, 284, 290, 293, 299, 302, 306, 312, 313]	['The', 'MS', 'analyses', 'have', 'revealed', 'that', 'thesites', 'of', 'adduct', 'formation', 'with', 'Alb', 'are', 'driven', 'not', 'only', 'by', 'the', 'reactivityof', 'nucleophilic', 'amino', 'acid', 'sites', 'and', 'their', 'accessibility', 'but', 'alsoby', 'the', 'noncovalent', 'interactions', 'of', 'the', 'toxicant', 'within', 'the', 'differentmicroenvironments', 'of', 'Alb', ',', 'which', 'guide', 'the', 'sites', 'of', 'toxicant', 'adduction', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 2, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
many Alb adducts were assayedafter acid or base hydrolysis or by proteolysis with pronase, andthe adducted amino acids or the carcinogen hydrolysis products weredetected by GC-MS, HPLC with UV, fluorescence, or radioactive detection(Figure ​Figure33).20,71,88,109,112−114 LC-MS methods69,115 have supplanted many of theseearlier analytical methods.	[]	['many', 'Al', '##b', 'add', '##uc', '##ts', 'were', 'ass', '##ay', '##eda', '##fter', 'acid', 'or', 'base', 'h', '##ydro', '##lysis', 'or', 'by', 'pro', '##te', '##oly', '##sis', 'with', 'pro', '##nas', '##e', ',', 'and', '##the', 'add', '##uc', '##ted', 'amino', 'acids', 'or', 'the', 'car', '##cin', '##ogen', 'h', '##ydro', '##lysis', 'products', 'were', '##det', '##ec', '##ted', 'by', 'G', '##C', '-', 'MS', ',', 'HP', '##LC', 'with', 'UV', ',', 'flu', '##ores', '##cence', ',', 'or', 'radioactive', 'detection', '(', 'Figure', 'Figure', '##33', ')', '.', '20', ',', '71', ',', '88', ',', '109', ',', '112', '##−', '##11', '##4', 'L', '##C', '-', 'MS', 'methods', '##6', '##9', ',', '115', 'have', 'su', '##pp', '##lanted', 'many', 'of', 'these', '##ear', '##lier', 'analytical', 'methods', '.']	[0, 5, 7, 9, 12, 14, 17, 22, 25, 27, 30, 35, 40, 43, 48, 49, 53, 59, 62, 65, 68, 70, 73, 77, 82, 85, 88, 89, 91, 94, 98, 101, 103, 107, 113, 119, 122, 126, 129, 132, 137, 138, 142, 148, 157, 161, 164, 166, 170, 173, 174, 175, 176, 178, 180, 182, 185, 190, 192, 194, 197, 201, 206, 208, 211, 223, 232, 233, 241, 247, 249, 250, 251, 253, 254, 256, 257, 259, 260, 263, 264, 267, 268, 270, 272, 273, 274, 275, 278, 285, 286, 287, 288, 292, 297, 299, 301, 308, 313, 316, 321, 324, 329, 340, 347]	[4, 7, 8, 12, 14, 16, 21, 25, 27, 30, 34, 39, 42, 47, 49, 53, 58, 61, 64, 68, 70, 73, 76, 81, 85, 88, 89, 90, 94, 97, 101, 103, 106, 112, 118, 121, 125, 129, 132, 136, 138, 142, 147, 156, 161, 164, 166, 169, 172, 174, 175, 176, 178, 179, 182, 184, 189, 192, 193, 197, 201, 206, 207, 210, 222, 232, 233, 239, 247, 249, 250, 251, 253, 254, 256, 257, 259, 260, 263, 264, 267, 268, 270, 271, 273, 274, 275, 277, 285, 286, 287, 288, 291, 296, 299, 301, 307, 312, 315, 321, 324, 328, 339, 347, 348]	['many', 'Alb', 'adducts', 'were', 'assayedafter', 'acid', 'or', 'base', 'hydrolysis', 'or', 'by', 'proteolysis', 'with', 'pronase', ',', 'andthe', 'adducted', 'amino', 'acids', 'or', 'the', 'carcinogen', 'hydrolysis', 'products', 'weredetected', 'by', 'GC-MS', ',', 'HPLC', 'with', 'UV', ',', 'fluorescence', ',', 'or', 'radioactive', 'detection(Figure', '\u200bFigure33).20', ',', '71', ',', '88', ',', '109', ',', '112−114', 'LC-MS', 'methods69', ',', '115', 'have', 'supplanted', 'many', 'of', 'theseearlier', 'analytical', 'methods', '.']	[1, 2, 3, 1, 4, 1, 1, 1, 3, 1, 1, 4, 1, 3, 1, 2, 3, 1, 1, 1, 1, 3, 3, 1, 4, 1, 4, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 1, 1, 4, 4, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pronase (synonym: actinase E and pronaseE), a mixture of a broad spectrum of proteases from Streptomycesgriseus, has often been used to digest Alb.	[]	['Pro', '##nas', '##e', '(', 'synonym', ':', 'act', '##inas', '##e', 'E', 'and', 'pro', '##nas', '##e', '##E', ')', ',', 'a', 'mixture', 'of', 'a', 'broad', 'spectrum', 'of', 'pro', '##te', '##ases', 'from', 'St', '##re', '##pt', '##omy', '##ces', '##g', '##rise', '##us', ',', 'has', 'often', 'been', 'used', 'to', 'dig', '##est', 'Al', '##b', '.']	[0, 3, 6, 8, 9, 16, 18, 21, 25, 27, 29, 33, 36, 39, 40, 41, 42, 44, 46, 54, 57, 59, 65, 74, 77, 80, 82, 87, 92, 94, 96, 98, 101, 104, 105, 109, 111, 113, 117, 123, 128, 133, 136, 139, 143, 145, 146]	[3, 6, 7, 9, 16, 17, 21, 25, 26, 28, 32, 36, 39, 40, 41, 42, 43, 45, 53, 56, 58, 64, 73, 76, 80, 82, 86, 91, 94, 96, 98, 101, 104, 105, 109, 111, 112, 116, 122, 127, 132, 135, 139, 142, 145, 146, 147]	['Pronase', '(', 'synonym', ':', 'actinase', 'E', 'and', 'pronaseE', ')', ',', 'a', 'mixture', 'of', 'a', 'broad', 'spectrum', 'of', 'proteases', 'from', 'Streptomycesgriseus', ',', 'has', 'often', 'been', 'used', 'to', 'digest', 'Alb', '.']	[3, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 8, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mono-, di-, tri-,or tetra-peptides containing adducts were recovered, depending upon the structure ofthe adduct and conditions of digestion.20,88,116−118 Different pronase preparationsare commercially available.	[]	['Mon', '##o', '-', ',', 'di', '-', ',', 't', '##ri', '-', ',', 'or', 'te', '##tra', '-', 'p', '##eptide', '##s', 'containing', 'add', '##uc', '##ts', 'were', 'recovered', ',', 'depending', 'upon', 'the', 'structure', 'of', '##the', 'add', '##uc', '##t', 'and', 'conditions', 'of', 'dig', '##est', '##ion', '.', '20', ',', '88', ',', '116', '##−', '##11', '##8', 'Different', 'pro', '##nas', '##e', 'preparations', '##are', 'commercially', 'available', '.']	[0, 3, 4, 5, 7, 9, 10, 12, 13, 15, 16, 17, 20, 22, 25, 26, 27, 33, 35, 46, 49, 51, 54, 59, 68, 70, 80, 85, 89, 99, 101, 105, 108, 110, 112, 116, 127, 130, 133, 136, 139, 140, 142, 143, 145, 146, 149, 150, 152, 154, 164, 167, 170, 172, 184, 188, 201, 210]	[3, 4, 5, 6, 9, 10, 11, 13, 15, 16, 17, 19, 22, 25, 26, 27, 33, 34, 45, 49, 51, 53, 58, 68, 69, 79, 84, 88, 98, 101, 104, 108, 110, 111, 115, 126, 129, 133, 136, 139, 140, 142, 143, 145, 146, 149, 150, 152, 153, 163, 167, 170, 171, 184, 187, 200, 210, 211]	['Mono-', ',', 'di-', ',', 'tri-,or', 'tetra', '-', 'peptides', 'containing', 'adducts', 'were', 'recovered', ',', 'depending', 'upon', 'the', 'structure', 'ofthe', 'adduct', 'and', 'conditions', 'of', 'digestion.20', ',', '88', ',', '116−118', 'Different', 'pronase', 'preparationsare', 'commercially', 'available', '.']	[3, 1, 2, 1, 5, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 5, 1, 1, 1, 4, 1, 3, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Delatour et al.119 compareddifferent approaches to digest bovine Alb using 6 M HCl at 110 °C,pronase digest for 24 or 48 h (Alb/pronase = 30:1), or a cocktailof enzymes (pepsin, pronase, aminopeptidase, and prolidase).	[('PMC5241710', 'I18000', 95, 102, 'onase d')]	['Del', '##ato', '##ur', 'et', 'al', '.', '119', 'compared', '##different', 'approaches', 'to', 'dig', '##est', 'b', '##ov', '##ine', 'Al', '##b', 'using', '6', 'M', 'HC', '##l', 'at', '110', '°C', ',', 'pro', '##nas', '##e', 'dig', '##est', 'for', '24', 'or', '48', 'h', '(', 'Al', '##b', '/', 'pro', '##nas', '##e', '=', '30', ':', '1', ')', ',', 'or', 'a', 'cocktail', '##of', 'enzymes', '(', 'p', '##ep', '##sin', ',', 'pro', '##nas', '##e', ',', 'amino', '##pe', '##pt', '##idas', '##e', ',', 'and', 'pro', '##lid', '##ase', ')', '.']	[0, 3, 6, 9, 12, 14, 15, 19, 27, 37, 48, 51, 54, 58, 59, 61, 65, 67, 69, 75, 77, 79, 81, 83, 86, 90, 92, 93, 96, 99, 101, 104, 108, 112, 115, 118, 121, 123, 124, 126, 127, 128, 131, 134, 136, 138, 140, 141, 142, 143, 145, 148, 150, 158, 161, 169, 170, 171, 173, 176, 178, 181, 184, 185, 187, 192, 194, 196, 200, 201, 203, 207, 210, 213, 216, 217]	[3, 6, 8, 11, 14, 15, 18, 27, 36, 47, 50, 54, 57, 59, 61, 64, 67, 68, 74, 76, 78, 81, 82, 85, 89, 92, 93, 96, 99, 100, 104, 107, 111, 114, 117, 120, 122, 124, 126, 127, 128, 131, 134, 135, 137, 140, 141, 142, 143, 144, 147, 149, 158, 160, 168, 170, 171, 173, 176, 177, 181, 184, 185, 186, 192, 194, 196, 200, 201, 202, 206, 210, 213, 216, 217, 218]	['Delatour', 'et', 'al.119', 'compareddifferent', 'approaches', 'to', 'digest', 'bovine', 'Alb', 'using', '6', 'M', 'HCl', 'at', '110', '°C', ',', 'pronase', 'digest', 'for', '24', 'or', '48', 'h', '(', 'Alb', '/', 'pronase', '=', '30', ':', '1', ')', ',', 'or', 'a', 'cocktailof', 'enzymes', '(', 'pepsin', ',', 'pronase', ',', 'aminopeptidase', ',', 'and', 'prolidase', ')', '.']	[3, 1, 3, 2, 1, 1, 2, 3, 2, 1, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 5, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The HCl-basedhydrolysis yielded a digestion efficiency of 95%, while only 25 and75% efficiencies were achieved with pronase and the cocktail of enzymes,respectively, when the digestion efficiency was measured by aminoacid analysis.	[('PMC5241710', 'I18001', 118, 125, 'onase a')]	['The', 'HC', '##l', '-', 'based', '##hy', '##dr', '##oly', '##sis', 'yielded', 'a', 'dig', '##est', '##ion', 'efficiency', 'of', '95', '%', ',', 'while', 'only', '25', 'and', '##75', '%', 'e', '##ff', '##ici', '##encies', 'were', 'achieved', 'with', 'pro', '##nas', '##e', 'and', 'the', 'cocktail', 'of', 'enzymes', ',', 'respectively', ',', 'when', 'the', 'dig', '##est', '##ion', 'efficiency', 'was', 'measured', 'by', 'amino', '##ac', '##id', 'analysis', '.']	[0, 4, 6, 7, 8, 13, 15, 17, 20, 24, 32, 34, 37, 40, 44, 55, 58, 60, 61, 63, 69, 74, 77, 80, 82, 84, 85, 87, 90, 97, 102, 111, 116, 119, 122, 124, 128, 132, 141, 144, 151, 152, 164, 166, 171, 175, 178, 181, 185, 196, 200, 209, 212, 217, 219, 222, 230]	[3, 6, 7, 8, 13, 15, 17, 20, 23, 31, 33, 37, 40, 43, 54, 57, 60, 61, 62, 68, 73, 76, 80, 82, 83, 85, 87, 90, 96, 101, 110, 115, 119, 122, 123, 127, 131, 140, 143, 151, 152, 164, 165, 170, 174, 178, 181, 184, 195, 199, 208, 211, 217, 219, 221, 230, 231]	['The', 'HCl', '-', 'basedhydrolysis', 'yielded', 'a', 'digestion', 'efficiency', 'of', '95%', ',', 'while', 'only', '25', 'and75%', 'efficiencies', 'were', 'achieved', 'with', 'pronase', 'and', 'the', 'cocktail', 'of', 'enzymes', ',', 'respectively', ',', 'when', 'the', 'digestion', 'efficiency', 'was', 'measured', 'by', 'aminoacid', 'analysis', '.']	[1, 2, 1, 5, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These data on pronase digestion are not comparableto many other studies, which used much larger amounts of Pronase inrelation to Alb.	[('PMC5241710', 'I18002', 14, 21, 'pronase')]	['These', 'data', 'on', 'pro', '##nas', '##e', 'dig', '##est', '##ion', 'are', 'not', 'comparable', '##to', 'many', 'other', 'studies', ',', 'which', 'used', 'much', 'larger', 'amounts', 'of', 'Pro', '##nas', '##e', 'in', '##rel', '##ation', 'to', 'Al', '##b', '.']	[0, 6, 11, 14, 17, 20, 22, 25, 28, 32, 36, 40, 50, 53, 58, 64, 71, 73, 79, 84, 89, 96, 104, 107, 110, 113, 115, 117, 120, 126, 129, 131, 132]	[5, 10, 13, 17, 20, 21, 25, 28, 31, 35, 39, 50, 52, 57, 63, 71, 72, 78, 83, 88, 95, 103, 106, 110, 113, 114, 117, 120, 125, 128, 131, 132, 133]	['These', 'data', 'on', 'pronase', 'digestion', 'are', 'not', 'comparableto', 'many', 'other', 'studies', ',', 'which', 'used', 'much', 'larger', 'amounts', 'of', 'Pronase', 'inrelation', 'to', 'Alb', '.']	[1, 1, 1, 3, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sabbioni et al.120 performedexperiments with different ratios of Alb/pronase 10:1, 3:1, and 1:1at pH 7.4.	[('PMC5241710', 'I18003', 70, 77, 'ronase ')]	['Sa', '##bb', '##ion', '##i', 'et', 'al', '.', '120', 'performed', '##ex', '##per', '##iment', '##s', 'with', 'different', 'ratios', 'of', 'Al', '##b', '/', 'pro', '##nas', '##e', '10', ':', '1', ',', '3', ':', '1', ',', 'and', '1', ':', '1', '##at', 'pH', '7', '.', '4', '.']	[0, 2, 4, 7, 9, 12, 14, 15, 19, 28, 30, 33, 38, 40, 45, 55, 62, 65, 67, 68, 69, 72, 75, 77, 79, 80, 81, 83, 84, 85, 86, 88, 92, 93, 94, 95, 98, 101, 102, 103, 104]	[2, 4, 7, 8, 11, 14, 15, 18, 28, 30, 33, 38, 39, 44, 54, 61, 64, 67, 68, 69, 72, 75, 76, 79, 80, 81, 82, 84, 85, 86, 87, 91, 93, 94, 95, 97, 100, 102, 103, 104, 105]	['Sabbioni', 'et', 'al.120', 'performedexperiments', 'with', 'different', 'ratios', 'of', 'Alb', '/', 'pronase', '10', ':', '1', ',', '3', ':', '1', ',', 'and', '1', ':', '1at', 'pH', '7.4', '.']	[4, 1, 3, 5, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The highest recovery of the main adduct of AFB with Albwas obtained after the enzymatic hydrolysis using an Alb/pronase ratioof 3:1.	[('PMC5241710', 'I18004', 113, 120, 'ronase ')]	['The', 'highest', 'recovery', 'of', 'the', 'main', 'add', '##uc', '##t', 'of', 'AFB', 'with', 'Al', '##b', '##was', 'obtained', 'after', 'the', 'en', '##zy', '##matic', 'h', '##ydro', '##lysis', 'using', 'an', 'Al', '##b', '/', 'pro', '##nas', '##e', 'ratio', '##of', '3', ':', '1', '.']	[0, 4, 12, 21, 24, 28, 33, 36, 38, 40, 43, 47, 52, 54, 55, 59, 68, 74, 78, 80, 82, 88, 89, 93, 99, 105, 108, 110, 111, 112, 115, 118, 120, 125, 128, 129, 130, 131]	[3, 11, 20, 23, 27, 32, 36, 38, 39, 42, 46, 51, 54, 55, 58, 67, 73, 77, 80, 82, 87, 89, 93, 98, 104, 107, 110, 111, 112, 115, 118, 119, 125, 127, 129, 130, 131, 132]	['The', 'highest', 'recovery', 'of', 'the', 'main', 'adduct', 'of', 'AFB', 'with', 'Albwas', 'obtained', 'after', 'the', 'enzymatic', 'hydrolysis', 'using', 'an', 'Alb', '/', 'pronase', 'ratioof', '3', ':', '1', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
For the analysis of isocyanate adducts formed with Alb, enzymatichydrolyses were performed at pH 8.9 or at pH 7.4 with a Alb/pronaseratio of 3:1.	[('PMC5241710', 'I18005', 126, 133, 'ronaser')]	['For', 'the', 'analysis', 'of', 'is', '##oc', '##yana', '##te', 'add', '##uc', '##ts', 'formed', 'with', 'Al', '##b', ',', 'en', '##zy', '##matic', '##hy', '##dr', '##oly', '##ses', 'were', 'performed', 'at', 'pH', '8', '.', '9', 'or', 'at', 'pH', '7', '.', '4', 'with', 'a', 'Al', '##b', '/', 'pro', '##nas', '##era', '##ti', '##o', 'of', '3', ':', '1', '.']	[0, 4, 8, 17, 20, 22, 24, 28, 31, 34, 36, 39, 46, 51, 53, 54, 56, 58, 60, 65, 67, 69, 72, 76, 81, 91, 94, 97, 98, 99, 101, 104, 107, 110, 111, 112, 114, 119, 121, 123, 124, 125, 128, 131, 134, 136, 138, 141, 142, 143, 144]	[3, 7, 16, 19, 22, 24, 28, 30, 34, 36, 38, 45, 50, 53, 54, 55, 58, 60, 65, 67, 69, 72, 75, 80, 90, 93, 96, 98, 99, 100, 103, 106, 109, 111, 112, 113, 118, 120, 123, 124, 125, 128, 131, 134, 136, 137, 140, 142, 143, 144, 145]	['For', 'the', 'analysis', 'of', 'isocyanate', 'adducts', 'formed', 'with', 'Alb', ',', 'enzymatichydrolyses', 'were', 'performed', 'at', 'pH', '8.9', 'or', 'at', 'pH', '7.4', 'with', 'a', 'Alb', '/', 'pronaseratio', 'of', '3', ':', '1', '.']	[1, 1, 1, 1, 4, 3, 1, 1, 2, 1, 7, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alb contains 17intrachain disulfide bonds, which makes the protein resistant to denaturation.2,17 For digestion with trypsin or other serine proteases, Alb is commonlydenatured by heat treatment at 50–60 °C, and internaldisulfide bonds are reduced with dithiothreitol or tris(2-carboxyethyl)phosphinein the presence of denaturants, followed by alkylation of the newlyformed sulfhydryl groups with iodoacetamide, to expose as many sitesas possible prior to proteolytic digestion.122,123 The proteolytic digestion of Alb produces polypeptides of variouslengths according to the specificity of the enzymes employed.	[('PMC5241710', 'I19000', 135, 151, 'erine proteases,')]	['Al', '##b', 'contains', '17', '##int', '##rac', '##hai', '##n', 'di', '##sul', '##fi', '##de', 'bonds', ',', 'which', 'makes', 'the', 'protein', 'resistant', 'to', 'den', '##at', '##uration', '.', '2', ',', '17', 'For', 'dig', '##est', '##ion', 'with', 'try', '##ps', '##in', 'or', 'other', 'se', '##rine', 'pro', '##te', '##ases', ',', 'Al', '##b', 'is', 'commonly', '##den', '##ature', '##d', 'by', 'heat', 'treatment', 'at', '50', '–', '60', '°C', ',', 'and', 'internal', '##dis', '##ulf', '##ide', 'bonds', 'are', 'reduced', 'with', 'di', '##thi', '##oth', '##re', '##ito', '##l', 'or', 't', '##ris', '(', '2', '-', 'car', '##box', '##ye', '##thy', '##l', ')', 'p', '##hos', '##phine', '##in', 'the', 'presence', 'of', 'den', '##at', '##ura', '##nts', ',', 'followed', 'by', 'al', '##ky', '##lation', 'of', 'the', 'newly', '##formed', 'su', '##lf', '##hy', '##dr', '##yl', 'groups', 'with', 'i', '##od', '##oa', '##ce', '##tam', '##ide', ',', 'to', 'expose', 'as', 'many', 'sites', '##as', 'possible', 'prior', 'to', 'pro', '##te', '##oly', '##tic', 'dig', '##est', '##ion', '.', '122', ',', '123', 'The', 'pro', '##te', '##oly', '##tic', 'dig', '##est', '##ion', 'of', 'Al', '##b', 'produces', 'p', '##oly', '##pe', '##pt', '##ides', 'of', 'various', '##len', '##gth', '##s', 'according', 'to', 'the', 'specific', '##ity', 'of', 'the', 'enzymes', 'employed', '.']	[0, 2, 4, 13, 15, 18, 21, 24, 26, 28, 31, 33, 36, 41, 43, 49, 55, 59, 67, 77, 80, 83, 85, 92, 93, 94, 95, 98, 102, 105, 108, 112, 117, 120, 122, 125, 128, 134, 136, 141, 144, 146, 150, 152, 154, 156, 159, 167, 170, 175, 177, 180, 185, 195, 198, 200, 201, 204, 206, 208, 212, 220, 223, 226, 230, 236, 240, 248, 253, 255, 258, 261, 263, 266, 268, 271, 272, 275, 276, 277, 278, 281, 284, 286, 289, 290, 291, 292, 295, 300, 303, 307, 316, 319, 322, 324, 327, 330, 332, 341, 344, 346, 348, 355, 358, 362, 367, 374, 376, 378, 380, 382, 385, 392, 397, 398, 400, 402, 404, 407, 410, 412, 415, 422, 425, 430, 435, 438, 447, 453, 456, 459, 461, 464, 468, 471, 474, 477, 478, 481, 482, 486, 490, 493, 495, 498, 502, 505, 508, 512, 515, 517, 519, 528, 529, 532, 534, 536, 541, 544, 551, 554, 557, 559, 569, 572, 576, 584, 588, 591, 595, 603, 611]	[2, 3, 12, 15, 18, 21, 24, 25, 28, 31, 33, 35, 41, 42, 48, 54, 58, 66, 76, 79, 83, 85, 92, 93, 94, 95, 97, 101, 105, 108, 111, 116, 120, 122, 124, 127, 133, 136, 140, 144, 146, 150, 151, 154, 155, 158, 167, 170, 175, 176, 179, 184, 194, 197, 200, 201, 203, 206, 207, 211, 220, 223, 226, 229, 235, 239, 247, 252, 255, 258, 261, 263, 266, 267, 270, 272, 275, 276, 277, 278, 281, 284, 286, 289, 290, 291, 292, 295, 300, 302, 306, 315, 318, 322, 324, 327, 330, 331, 340, 343, 346, 348, 354, 357, 361, 367, 373, 376, 378, 380, 382, 384, 391, 396, 398, 400, 402, 404, 407, 410, 411, 414, 421, 424, 429, 435, 437, 446, 452, 455, 459, 461, 464, 467, 471, 474, 477, 478, 481, 482, 485, 489, 493, 495, 498, 501, 505, 508, 511, 514, 517, 518, 527, 529, 532, 534, 536, 540, 543, 551, 554, 557, 558, 568, 571, 575, 584, 587, 590, 594, 602, 611, 612]	['Alb', 'contains', '17intrachain', 'disulfide', 'bonds', ',', 'which', 'makes', 'the', 'protein', 'resistant', 'to', 'denaturation.2', ',', '17', 'For', 'digestion', 'with', 'trypsin', 'or', 'other', 'serine', 'proteases', ',', 'Alb', 'is', 'commonlydenatured', 'by', 'heat', 'treatment', 'at', '50–', '60', '°C', ',', 'and', 'internaldisulfide', 'bonds', 'are', 'reduced', 'with', 'dithiothreitol', 'or', 'tris(2-carboxyethyl)phosphinein', 'the', 'presence', 'of', 'denaturants', ',', 'followed', 'by', 'alkylation', 'of', 'the', 'newlyformed', 'sulfhydryl', 'groups', 'with', 'iodoacetamide', ',', 'to', 'expose', 'as', 'many', 'sitesas', 'possible', 'prior', 'to', 'proteolytic', 'digestion.122', ',', '123', 'The', 'proteolytic', 'digestion', 'of', 'Alb', 'produces', 'polypeptides', 'of', 'variouslengths', 'according', 'to', 'the', 'specificity', 'of', 'the', 'enzymes', 'employed', '.']	[2, 1, 5, 4, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 3, 1, 1, 2, 3, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 6, 1, 15, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 2, 5, 1, 1, 6, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 5, 1, 1, 1, 4, 3, 1, 2, 1, 5, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proteolysis of proteins, including Alb adducts in MS-basedproteomics, is most commonly done with trypsin as an alternative todigestion with protease mixtures.	[('PMC5241710', 'I20000', 146, 154, 'otease m')]	['The', 'pro', '##te', '##oly', '##sis', 'of', 'proteins', ',', 'including', 'Al', '##b', 'add', '##uc', '##ts', 'in', 'MS', '-', 'based', '##p', '##rote', '##omi', '##cs', ',', 'is', 'most', 'commonly', 'done', 'with', 'try', '##ps', '##in', 'as', 'an', 'alternative', 'to', '##di', '##ges', '##tion', 'with', 'pro', '##te', '##ase', 'mixture', '##s', '.']	[0, 4, 7, 9, 12, 16, 19, 27, 29, 39, 41, 43, 46, 48, 51, 54, 56, 57, 62, 63, 67, 70, 72, 74, 77, 82, 91, 96, 101, 104, 106, 109, 112, 115, 127, 129, 131, 134, 139, 144, 147, 149, 153, 160, 161]	[3, 7, 9, 12, 15, 18, 27, 28, 38, 41, 42, 46, 48, 50, 53, 56, 57, 62, 63, 67, 70, 72, 73, 76, 81, 90, 95, 100, 104, 106, 108, 111, 114, 126, 129, 131, 134, 138, 143, 147, 149, 152, 160, 161, 162]	['The', 'proteolysis', 'of', 'proteins', ',', 'including', 'Alb', 'adducts', 'in', 'MS', '-', 'basedproteomics', ',', 'is', 'most', 'commonly', 'done', 'with', 'trypsin', 'as', 'an', 'alternative', 'todigestion', 'with', 'protease', 'mixtures', '.']	[1, 4, 1, 1, 1, 1, 2, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O']
The selective digestion of Alb withsingle proteases can permit the identification of the specific sitesof toxicant adduction by performing collision induced dissociation (CID)of the peptides to form the b-ion, y-ion, and a-ion series.126,127 The identification of common sites or “hot-spots”(see Supporting Information, Table S1)of adduct formation can be used to establish a database of nucleophilicsites of Alb for specific classes of toxicants and serve as a basisto develop strategies for adductomics.	[('PMC5241710', 'I20001', 43, 52, 'roteases ')]	['The', 'selective', 'dig', '##est', '##ion', 'of', 'Al', '##b', 'with', '##sing', '##le', 'pro', '##te', '##ases', 'can', 'permit', 'the', 'identification', 'of', 'the', 'specific', 'sites', '##of', 'toxic', '##ant', 'add', '##uction', 'by', 'performing', 'collision', 'induced', 'di', '##sso', '##ciation', '(', 'C', '##ID', ')', 'of', 'the', 'p', '##eptide', '##s', 'to', 'form', 'the', 'b', '-', 'ion', ',', 'y', '-', 'ion', ',', 'and', 'a', '-', 'ion', 'series', '.', '126', ',', '127', 'The', 'identification', 'of', 'common', 'sites', 'or', '“', 'hot', '-', 'spots', '”', '(', 'see', 'Supporting', 'Information', ',', 'Table', 'S', '##1', ')', 'of', 'add', '##uc', '##t', 'formation', 'can', 'be', 'used', 'to', 'establish', 'a', 'database', 'of', 'n', '##uc', '##leo', '##phi', '##lic', '##site', '##s', 'of', 'Al', '##b', 'for', 'specific', 'classes', 'of', 'toxic', '##ants', 'and', 'serve', 'as', 'a', 'basis', '##to', 'develop', 'strategies', 'for', 'add', '##uc', '##tom', '##ics', '.']	[0, 4, 14, 17, 20, 24, 27, 29, 31, 35, 39, 42, 45, 47, 52, 56, 63, 67, 82, 85, 89, 98, 103, 106, 111, 115, 118, 125, 128, 139, 149, 157, 159, 162, 170, 171, 172, 174, 175, 178, 182, 183, 189, 191, 194, 199, 203, 204, 205, 208, 210, 211, 212, 215, 217, 221, 222, 223, 227, 233, 234, 237, 238, 242, 246, 261, 264, 271, 277, 280, 281, 284, 285, 290, 291, 292, 296, 307, 318, 320, 326, 327, 328, 329, 332, 335, 337, 339, 349, 353, 356, 361, 364, 374, 376, 385, 388, 389, 391, 394, 397, 400, 404, 406, 409, 411, 413, 417, 426, 434, 437, 442, 447, 451, 457, 460, 462, 467, 470, 478, 489, 493, 496, 498, 501, 504]	[3, 13, 17, 20, 23, 26, 29, 30, 35, 39, 41, 45, 47, 51, 55, 62, 66, 81, 84, 88, 97, 103, 105, 111, 114, 118, 124, 127, 138, 148, 156, 159, 162, 169, 171, 172, 174, 175, 177, 181, 183, 189, 190, 193, 198, 202, 204, 205, 208, 209, 211, 212, 215, 216, 220, 222, 223, 226, 233, 234, 237, 238, 241, 245, 260, 263, 270, 276, 279, 281, 284, 285, 290, 291, 292, 295, 306, 318, 319, 325, 327, 328, 329, 331, 335, 337, 338, 348, 352, 355, 360, 363, 373, 375, 384, 387, 389, 391, 394, 397, 400, 404, 405, 408, 411, 412, 416, 425, 433, 436, 442, 446, 450, 456, 459, 461, 467, 469, 477, 488, 492, 496, 498, 501, 504, 505]	['The', 'selective', 'digestion', 'of', 'Alb', 'withsingle', 'proteases', 'can', 'permit', 'the', 'identification', 'of', 'the', 'specific', 'sitesof', 'toxicant', 'adduction', 'by', 'performing', 'collision', 'induced', 'dissociation', '(CID)of', 'the', 'peptides', 'to', 'form', 'the', 'b-ion', ',', 'y-ion', ',', 'and', 'a-ion', 'series.126', ',', '127', 'The', 'identification', 'of', 'common', 'sites', 'or', '“', 'hot-spots”(see', 'Supporting', 'Information', ',', 'Table', 'S1)of', 'adduct', 'formation', 'can', 'be', 'used', 'to', 'establish', 'a', 'database', 'of', 'nucleophilicsites', 'of', 'Alb', 'for', 'specific', 'classes', 'of', 'toxicants', 'and', 'serve', 'as', 'a', 'basisto', 'develop', 'strategies', 'for', 'adductomics', '.']	[1, 1, 3, 1, 2, 3, 3, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 1, 1, 1, 1, 3, 5, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Trypsin is a serine proteaseand cleaves peptides on the C-terminal side of Lysand Arg residues except for when a proline residue is on the carboxylside of the cleavage site in which case the cleavage will not occur.	[('PMC5241710', 'I20002', 13, 28, 'serine protease')]	['Try', '##ps', '##in', 'is', 'a', 'se', '##rine', 'pro', '##te', '##ase', '##and', 'c', '##lea', '##ves', 'p', '##eptide', '##s', 'on', 'the', 'C', '-', 'terminal', 'side', 'of', 'L', '##ys', '##and', 'A', '##rg', 'residues', 'except', 'for', 'when', 'a', 'pro', '##line', 'residue', 'is', 'on', 'the', 'car', '##box', '##yl', '##side', 'of', 'the', 'c', '##lea', '##vage', 'site', 'in', 'which', 'case', 'the', 'c', '##lea', '##vage', 'will', 'not', 'occur', '.']	[0, 3, 5, 8, 11, 13, 15, 20, 23, 25, 28, 32, 33, 36, 40, 41, 47, 49, 52, 56, 57, 58, 67, 72, 75, 76, 78, 82, 83, 86, 95, 102, 106, 111, 113, 116, 121, 129, 132, 135, 139, 142, 145, 147, 152, 155, 159, 160, 163, 168, 173, 176, 182, 187, 191, 192, 195, 200, 205, 209, 214]	[3, 5, 7, 10, 12, 15, 19, 23, 25, 28, 31, 33, 36, 39, 41, 47, 48, 51, 55, 57, 58, 66, 71, 74, 76, 78, 81, 83, 85, 94, 101, 105, 110, 112, 116, 120, 128, 131, 134, 138, 142, 145, 147, 151, 154, 158, 160, 163, 167, 172, 175, 181, 186, 190, 192, 195, 199, 204, 208, 214, 215]	['Trypsin', 'is', 'a', 'serine', 'proteaseand', 'cleaves', 'peptides', 'on', 'the', 'C-', 'terminal', 'side', 'of', 'Lysand', 'Arg', 'residues', 'except', 'for', 'when', 'a', 'proline', 'residue', 'is', 'on', 'the', 'carboxylside', 'of', 'the', 'cleavage', 'site', 'in', 'which', 'case', 'the', 'cleavage', 'will', 'not', 'occur', '.']	[3, 1, 1, 2, 4, 3, 3, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[M+2H]2+ or triply charged species [M+3H]3+ which favors the formationof y-ions by ESI/MS.128,129 Other serineproteases including Lys-C, which retains activity in strong denaturants,(cleaves Lys following Pro to decrease missed cleavages); chymotrypsin(cleaves C-terminal of Phe, Tyr, Leu, Trp, and Met);	[]	['[', 'M', '+', '2', '##H', ']', '2', '+', 'or', 'trip', '##ly', 'charged', 'species', '[', 'M', '+', '3', '##H', ']', '3', '+', 'which', 'favors', 'the', 'formation', '##of', 'y', '-', 'ions', 'by', 'E', '##SI', '/', 'MS', '.', '128', ',', '129', 'Other', 'se', '##rine', '##p', '##rote', '##ases', 'including', 'L', '##ys', '-', 'C', ',', 'which', 'retains', 'activity', 'in', 'strong', 'den', '##at', '##ura', '##nts', ',', '(', 'c', '##lea', '##ves', 'L', '##ys', 'following', 'Pro', 'to', 'decrease', 'missed', 'c', '##lea', '##vage', '##s', ')', ';', 'ch', '##ym', '##ot', '##ry', '##ps', '##in', '(', 'c', '##lea', '##ves', 'C', '-', 'terminal', 'of', 'Ph', '##e', ',', 'Ty', '##r', ',', 'Le', '##u', ',', 'T', '##rp', ',', 'and', 'Met', ')', ';']	[0, 1, 2, 3, 4, 5, 6, 7, 9, 12, 16, 19, 27, 35, 36, 37, 38, 39, 40, 41, 42, 44, 50, 57, 61, 70, 73, 74, 75, 80, 83, 84, 86, 87, 89, 90, 93, 94, 98, 104, 106, 110, 111, 115, 120, 130, 131, 133, 134, 135, 137, 143, 151, 160, 163, 170, 173, 175, 178, 181, 182, 183, 184, 187, 191, 192, 195, 205, 209, 212, 221, 228, 229, 232, 236, 237, 238, 240, 242, 244, 246, 248, 250, 252, 253, 254, 257, 261, 262, 263, 272, 275, 277, 278, 280, 282, 283, 285, 287, 288, 290, 291, 293, 295, 299, 302, 303]	[1, 2, 3, 4, 5, 6, 7, 8, 11, 16, 18, 26, 34, 36, 37, 38, 39, 40, 41, 42, 43, 49, 56, 60, 70, 72, 74, 75, 79, 82, 84, 86, 87, 89, 90, 93, 94, 97, 103, 106, 110, 111, 115, 119, 129, 131, 133, 134, 135, 136, 142, 150, 159, 162, 169, 173, 175, 178, 181, 182, 183, 184, 187, 190, 192, 194, 204, 208, 211, 220, 227, 229, 232, 236, 237, 238, 239, 242, 244, 246, 248, 250, 252, 253, 254, 257, 260, 262, 263, 271, 274, 277, 278, 279, 282, 283, 284, 287, 288, 289, 291, 293, 294, 298, 302, 303, 304]	['[', 'M', '+', '2H]2+', 'or', 'triply', 'charged', 'species', '[', 'M', '+', '3H]3+', 'which', 'favors', 'the', 'formationof', 'y', '-', 'ions', 'by', 'ESI', '/', 'MS.128', ',', '129', 'Other', 'serineproteases', 'including', 'Lys-C', ',', 'which', 'retains', 'activity', 'in', 'strong', 'denaturants', ',', '(', 'cleaves', 'Lys', 'following', 'Pro', 'to', 'decrease', 'missed', 'cleavages', ')', ';', 'chymotrypsin(cleaves', 'C-', 'terminal', 'of', 'Phe', ',', 'Tyr', ',', 'Leu', ',', 'Trp', ',', 'and', 'Met', ')', ';']	[1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 2, 1, 1, 1, 1, 1, 4, 1, 1, 10, 2, 1, 1, 2, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The selection of proteases depends upon the siteof toxicant adduction, the specificity of the protease, and the conditionsincluding the buffers and denaturation reagents required for digestion.129 Different proteases yield different peptidesequences, some of which may prove to be more sensitive toward ESIthan tryptic peptides.130 The responsesof signals of peptides under ESI can vary by up to 50-fold.125,131,132	[]	['The', 'selection', 'of', 'pro', '##te', '##ases', 'depends', 'upon', 'the', 'site', '##of', 'toxic', '##ant', 'add', '##uction', ',', 'the', 'specific', '##ity', 'of', 'the', 'pro', '##te', '##ase', ',', 'and', 'the', 'conditions', '##in', '##c', '##lu', '##ding', 'the', 'buffer', '##s', 'and', 'den', '##at', '##uration', 're', '##age', '##nts', 'required', 'for', 'dig', '##est', '##ion', '.', '129', 'Different', 'pro', '##te', '##ases', 'yield', 'different', 'p', '##eptide', '##se', '##quence', '##s', ',', 'some', 'of', 'which', 'may', 'prove', 'to', 'be', 'more', 'sensitive', 'toward', 'E', '##SI', '##than', 'try', '##ptic', 'p', '##eptide', '##s', '.', '130', 'The', 'responses', '##of', 'signals', 'of', 'p', '##eptide', '##s', 'under', 'E', '##SI', 'can', 'vary', 'by', 'up', 'to', '50', '-', 'fold', '.', '125', ',', '131', ',', '132']	[0, 4, 14, 17, 20, 22, 27, 35, 40, 44, 48, 51, 56, 60, 63, 69, 71, 75, 83, 87, 90, 94, 97, 99, 102, 104, 108, 112, 122, 124, 125, 127, 132, 136, 142, 144, 148, 151, 153, 161, 163, 166, 170, 179, 183, 186, 189, 192, 193, 197, 207, 210, 212, 217, 223, 233, 234, 240, 242, 248, 249, 251, 256, 259, 265, 269, 275, 278, 281, 286, 296, 303, 304, 306, 311, 314, 319, 320, 326, 327, 328, 332, 336, 345, 348, 356, 359, 360, 366, 368, 374, 375, 378, 382, 387, 390, 393, 396, 398, 399, 403, 404, 407, 408, 411, 412]	[3, 13, 16, 20, 22, 26, 34, 39, 43, 48, 50, 56, 59, 63, 69, 70, 74, 83, 86, 89, 93, 97, 99, 102, 103, 107, 111, 122, 124, 125, 127, 131, 135, 142, 143, 147, 151, 153, 160, 163, 166, 169, 178, 182, 186, 189, 192, 193, 196, 206, 210, 212, 216, 222, 232, 234, 240, 242, 248, 249, 250, 255, 258, 264, 268, 274, 277, 280, 285, 295, 302, 304, 306, 310, 314, 318, 320, 326, 327, 328, 331, 335, 345, 347, 355, 358, 360, 366, 367, 373, 375, 377, 381, 386, 389, 392, 395, 398, 399, 403, 404, 407, 408, 411, 412, 415]	['The', 'selection', 'of', 'proteases', 'depends', 'upon', 'the', 'siteof', 'toxicant', 'adduction', ',', 'the', 'specificity', 'of', 'the', 'protease', ',', 'and', 'the', 'conditionsincluding', 'the', 'buffers', 'and', 'denaturation', 'reagents', 'required', 'for', 'digestion.129', 'Different', 'proteases', 'yield', 'different', 'peptidesequences', ',', 'some', 'of', 'which', 'may', 'prove', 'to', 'be', 'more', 'sensitive', 'toward', 'ESIthan', 'tryptic', 'peptides.130', 'The', 'responsesof', 'signals', 'of', 'peptides', 'under', 'ESI', 'can', 'vary', 'by', 'up', 'to', '50-fold.125,131,132']	[1, 1, 1, 3, 1, 1, 1, 2, 2, 2, 1, 1, 2, 1, 1, 3, 1, 1, 1, 5, 1, 2, 1, 3, 3, 1, 1, 5, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 5, 1, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 9]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In some instances, a combinationof trypsin plus chymotrypsin may be used for proteolysis since somemodified Lys residues are not recognized by trypsin, resulting ina missed-cleavage and an increase in the molecular weight and thelength of the adducted peptides so that the peptides are not suitablefor LC–MS analysis.81	[]	['In', 'some', 'instances', ',', 'a', 'combination', '##of', 'try', '##ps', '##in', 'plus', 'ch', '##ym', '##ot', '##ry', '##ps', '##in', 'may', 'be', 'used', 'for', 'pro', '##te', '##oly', '##sis', 'since', 'some', '##mo', '##dified', 'L', '##ys', 'residues', 'are', 'not', 'recognized', 'by', 'try', '##ps', '##in', ',', 'resulting', 'in', '##a', 'missed', '-', 'c', '##lea', '##vage', 'and', 'an', 'increase', 'in', 'the', 'molecular', 'weight', 'and', 'the', '##len', '##gth', 'of', 'the', 'add', '##uc', '##ted', 'p', '##eptide', '##s', 'so', 'that', 'the', 'p', '##eptide', '##s', 'are', 'not', 'suitable', '##fo', '##r', 'L', '##C', '–', 'MS', 'analysis', '.', '81']	[0, 3, 8, 17, 19, 21, 32, 35, 38, 40, 43, 48, 50, 52, 54, 56, 58, 61, 65, 68, 73, 77, 80, 82, 85, 89, 95, 99, 101, 108, 109, 112, 121, 125, 129, 140, 143, 146, 148, 150, 152, 162, 164, 166, 172, 173, 174, 177, 182, 186, 189, 198, 201, 205, 215, 222, 226, 229, 232, 236, 239, 243, 246, 248, 252, 253, 259, 261, 264, 269, 273, 274, 280, 282, 286, 290, 298, 300, 302, 303, 304, 305, 308, 316, 317]	[2, 7, 17, 18, 20, 32, 34, 38, 40, 42, 47, 50, 52, 54, 56, 58, 60, 64, 67, 72, 76, 80, 82, 85, 88, 94, 99, 101, 107, 109, 111, 120, 124, 128, 139, 142, 146, 148, 150, 151, 161, 164, 165, 172, 173, 174, 177, 181, 185, 188, 197, 200, 204, 214, 221, 225, 229, 232, 235, 238, 242, 246, 248, 251, 253, 259, 260, 263, 268, 272, 274, 280, 281, 285, 289, 298, 300, 301, 303, 304, 305, 307, 316, 317, 319]	['In', 'some', 'instances', ',', 'a', 'combinationof', 'trypsin', 'plus', 'chymotrypsin', 'may', 'be', 'used', 'for', 'proteolysis', 'since', 'somemodified', 'Lys', 'residues', 'are', 'not', 'recognized', 'by', 'trypsin', ',', 'resulting', 'ina', 'missed', '-', 'cleavage', 'and', 'an', 'increase', 'in', 'the', 'molecular', 'weight', 'and', 'thelength', 'of', 'the', 'adducted', 'peptides', 'so', 'that', 'the', 'peptides', 'are', 'not', 'suitablefor', 'LC', '–', 'MS', 'analysis.81']	[1, 1, 1, 1, 1, 2, 3, 1, 6, 1, 1, 1, 1, 4, 1, 3, 2, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 3, 1, 1, 3, 2, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Subsequently, the sulfate esters of severalcarcinogenic arylhydroxamic acids, including N-sulfonyloxy-N-acetyl-4-aminobiphenyl, N-hydroxy-N-acetyl-2-aminofluorene, and N-hydroxy-N,N′-diacetylbenzidine were reported to bind to thesole Trp214 residue of human Alb in vitro.79 The cooked meat carcinogen PhIP and the non-nucleoside reverse transcriptaseinhibitor Nevaripine also form adducts at the Trp214 of human Alb in vitro.195−197 Since rat and human Alb contain only a single tryptophan residueat Trp214 situated in a hydrophobic drug-binding site, its high selectivityfor carcinogen binding suggests a unique role for Alb inthe detoxification and/or transport of ultimate carcinogenic/toxicmetabolites.80	[]	['Subsequently', ',', 'the', 'su', '##lf', '##ate', 'est', '##ers', 'of', 'several', '##car', '##cin', '##ogenic', 'a', '##ryl', '##hy', '##dr', '##ox', '##ami', '##c', 'acids', ',', 'including', 'N', '-', 'su', '##lf', '##ony', '##lo', '##xy', '-', 'N', '-', 'ace', '##ty', '##l', '-', '4', '-', 'amino', '##bi', '##phe', '##ny', '##l', ',', 'N', '-', 'h', '##ydro', '##xy', '-', 'N', '-', 'ace', '##ty', '##l', '-', '2', '-', 'amino', '##f', '##lu', '##ore', '##ne', ',', 'and', 'N', '-', 'h', '##ydro', '##xy', '-', 'N', ',', 'N', '′', '-', 'di', '##ace', '##ty', '##l', '##ben', '##zi', '##dine', 'were', 'reported', 'to', 'bind', 'to', 'the', '##sol', '##e', 'T', '##rp', '##21', '##4', 'residue', 'of', 'human', 'Al', '##b', 'in', 'v', '##it', '##ro', '.', '79', 'The', 'cooked', 'meat', 'car', '##cin', '##ogen', 'Ph', '##IP', 'and', 'the', 'non', '-', 'n', '##uc', '##leo', '##side', 'reverse', 'trans', '##cript', '##ase', '##in', '##hibit', '##or', 'N', '##eva', '##rip', '##ine', 'also', 'form', 'add', '##uc', '##ts', 'at', 'the', 'T', '##rp', '##21', '##4', 'of', 'human', 'Al', '##b', 'in', 'v', '##it', '##ro', '.', '195', '##−', '##19', '##7', 'Since', 'rat', 'and', 'human', 'Al', '##b', 'contain', 'only', 'a', 'single', 'try', '##pt', '##op', '##han', 'residue', '##at', 'T', '##rp', '##21', '##4', 'situated', 'in', 'a', 'h', '##ydro', '##phobic', 'drug', '-', 'binding', 'site', ',', 'its', 'high', 'select', '##ivity', '##fo', '##r', 'car', '##cin', '##ogen', 'binding', 'suggests', 'a', 'unique', 'role', 'for', 'Al', '##b', 'in', '##the', 'de', '##to', '##xi', '##fication', 'and', '/', 'or', 'transport', 'of', 'ultimate', 'car', '##cin', '##ogenic', '/', 'toxic', '##met', '##ab', '##oli', '##tes', '.', '80']	[0, 12, 14, 18, 20, 22, 26, 29, 33, 36, 43, 46, 49, 56, 57, 60, 62, 64, 66, 69, 71, 76, 78, 88, 89, 90, 92, 94, 97, 99, 101, 102, 103, 104, 107, 109, 110, 111, 112, 113, 118, 120, 123, 125, 126, 128, 129, 130, 131, 135, 137, 138, 139, 140, 143, 145, 146, 147, 148, 149, 154, 155, 157, 160, 162, 164, 168, 169, 170, 171, 175, 177, 178, 179, 180, 181, 182, 183, 185, 188, 190, 191, 194, 196, 201, 206, 215, 218, 223, 226, 229, 232, 234, 235, 237, 239, 241, 249, 252, 258, 260, 262, 265, 266, 268, 270, 271, 274, 278, 285, 290, 293, 296, 301, 303, 306, 310, 314, 317, 318, 319, 321, 324, 329, 337, 342, 347, 350, 352, 357, 360, 361, 364, 367, 371, 376, 381, 384, 386, 389, 392, 396, 397, 399, 401, 403, 406, 412, 414, 416, 419, 420, 422, 424, 425, 428, 429, 431, 433, 439, 443, 447, 453, 455, 457, 465, 470, 472, 479, 482, 484, 486, 490, 497, 500, 501, 503, 505, 507, 516, 519, 521, 522, 526, 533, 537, 538, 546, 550, 552, 556, 561, 567, 572, 574, 576, 579, 582, 587, 595, 604, 606, 613, 618, 622, 624, 626, 628, 632, 634, 636, 638, 647, 650, 651, 654, 664, 667, 676, 679, 682, 688, 689, 694, 697, 699, 702, 705, 706]	[12, 13, 17, 20, 22, 25, 29, 32, 35, 43, 46, 49, 55, 57, 60, 62, 64, 66, 69, 70, 76, 77, 87, 89, 90, 92, 94, 97, 99, 101, 102, 103, 104, 107, 109, 110, 111, 112, 113, 118, 120, 123, 125, 126, 127, 129, 130, 131, 135, 137, 138, 139, 140, 143, 145, 146, 147, 148, 149, 154, 155, 157, 160, 162, 163, 167, 169, 170, 171, 175, 177, 178, 179, 180, 181, 182, 183, 185, 188, 190, 191, 194, 196, 200, 205, 214, 217, 222, 225, 229, 232, 233, 235, 237, 239, 240, 248, 251, 257, 260, 261, 264, 266, 268, 270, 271, 273, 277, 284, 289, 293, 296, 300, 303, 305, 309, 313, 317, 318, 319, 321, 324, 328, 336, 342, 347, 350, 352, 357, 359, 361, 364, 367, 370, 375, 380, 384, 386, 388, 391, 395, 397, 399, 401, 402, 405, 411, 414, 415, 418, 420, 422, 424, 425, 428, 429, 431, 432, 438, 442, 446, 452, 455, 456, 464, 469, 471, 478, 482, 484, 486, 489, 497, 499, 501, 503, 505, 506, 515, 518, 520, 522, 526, 532, 537, 538, 545, 550, 551, 555, 560, 567, 572, 574, 575, 579, 582, 586, 594, 603, 605, 612, 617, 621, 624, 625, 628, 631, 634, 636, 638, 646, 650, 651, 653, 663, 666, 675, 679, 682, 688, 689, 694, 697, 699, 702, 705, 706, 708]	['Subsequently', ',', 'the', 'sulfate', 'esters', 'of', 'severalcarcinogenic', 'arylhydroxamic', 'acids', ',', 'including', 'N-sulfonyloxy-N-acetyl-4-aminobiphenyl', ',', 'N-hydroxy-N-acetyl-2-aminofluorene', ',', 'and', 'N-hydroxy-N,N′-diacetylbenzidine', 'were', 'reported', 'to', 'bind', 'to', 'thesole', 'Trp214', 'residue', 'of', 'human', 'Alb', 'in', 'vitro.79', 'The', 'cooked', 'meat', 'carcinogen', 'PhIP', 'and', 'the', 'non', '-', 'nucleoside', 'reverse', 'transcriptaseinhibitor', 'Nevaripine', 'also', 'form', 'adducts', 'at', 'the', 'Trp214', 'of', 'human', 'Alb', 'in', 'vitro.195−197', 'Since', 'rat', 'and', 'human', 'Alb', 'contain', 'only', 'a', 'single', 'tryptophan', 'residueat', 'Trp214', 'situated', 'in', 'a', 'hydrophobic', 'drug', '-', 'binding', 'site', ',', 'its', 'high', 'selectivityfor', 'carcinogen', 'binding', 'suggests', 'a', 'unique', 'role', 'for', 'Alb', 'inthe', 'detoxification', 'and', '/', 'or', 'transport', 'of', 'ultimate', 'carcinogenic', '/', 'toxicmetabolites.80']	[1, 1, 1, 3, 2, 1, 4, 7, 1, 1, 1, 21, 1, 19, 1, 1, 18, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 2, 1, 5, 1, 1, 1, 3, 2, 1, 1, 1, 1, 4, 1, 6, 4, 1, 1, 3, 1, 1, 4, 1, 1, 2, 1, 8, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 2, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 2, 2, 4, 1, 1, 1, 1, 1, 1, 3, 1, 7]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The structure of theacid-labile sulfinamide Alb adduct of IQ, a carcinogenic HAA,124 formed in rat was characterized by 1H NMR and MS.88 Alb of [3H]-IQmale-treated Sprague–Dawley rats was isolated and digestedwith pronase.	[('PMC5241710', 'I45000', 217, 224, 'nase.')]	['The', 'structure', 'of', 'the', '##ac', '##id', '-', 'lab', '##ile', 'su', '##lf', '##ina', '##mi', '##de', 'Al', '##b', 'add', '##uc', '##t', 'of', 'I', '##Q', ',', 'a', 'car', '##cin', '##ogenic', 'H', '##AA', ',', '124', 'formed', 'in', 'rat', 'was', 'characterized', 'by', '1', '##H', 'N', '##MR', 'and', 'MS', '.', '88', 'Al', '##b', 'of', '[', '3', '##H', ']', '-', 'I', '##Q', '##mal', '##e', '-', 'treated', 'S', '##pra', '##gue', '–', 'Da', '##wley', 'rats', 'was', 'isolated', 'and', 'dig', '##ested', '##with', 'pro', '##nas', '##e', '.']	[0, 4, 14, 17, 20, 22, 24, 25, 28, 32, 34, 36, 39, 41, 44, 46, 48, 51, 53, 55, 58, 59, 60, 62, 64, 67, 70, 77, 78, 80, 81, 85, 92, 95, 99, 103, 117, 120, 121, 123, 124, 127, 131, 133, 134, 137, 139, 141, 144, 145, 146, 147, 148, 149, 150, 151, 154, 155, 156, 164, 165, 168, 171, 172, 174, 179, 184, 188, 197, 201, 204, 209, 214, 217, 220, 221]	[3, 13, 16, 20, 22, 24, 25, 28, 31, 34, 36, 39, 41, 43, 46, 47, 51, 53, 54, 57, 59, 60, 61, 63, 67, 70, 76, 78, 80, 81, 84, 91, 94, 98, 102, 116, 119, 121, 122, 124, 126, 130, 133, 134, 136, 139, 140, 143, 145, 146, 147, 148, 149, 150, 151, 154, 155, 156, 163, 165, 168, 171, 172, 174, 178, 183, 187, 196, 200, 204, 209, 213, 217, 220, 221, 222]	['The', 'structure', 'of', 'theacid', '-', 'labile', 'sulfinamide', 'Alb', 'adduct', 'of', 'IQ', ',', 'a', 'carcinogenic', 'HAA', ',', '124', 'formed', 'in', 'rat', 'was', 'characterized', 'by', '1H', 'NMR', 'and', 'MS.88', 'Alb', 'of', '[3H]-IQmale', '-', 'treated', 'Sprague', '–', 'Dawley', 'rats', 'was', 'isolated', 'and', 'digestedwith', 'pronase', '.']	[1, 1, 1, 3, 1, 2, 5, 2, 3, 1, 2, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 2, 1, 9, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I']
The radioactivityassociated with Alb following administration of 14C-AFBto rats was cleared with a half-life of 2.5 days, which is not significantlydifferent from the half-life of unmodified Alb in the rat.71 The product isolated from a pronase digest ofin vivo modified Alb was identical to the synthetic product.	[('PMC5241710', 'I48000', 240, 247, 'nase di')]	['The', 'radio', '##act', '##ivity', '##ass', '##oc', '##iated', 'with', 'Al', '##b', 'following', 'administration', 'of', '14', '##C', '-', 'AFB', '##to', 'rats', 'was', 'cleared', 'with', 'a', 'half', '-', 'life', 'of', '2', '.', '5', 'days', ',', 'which', 'is', 'not', 'significantly', '##different', 'from', 'the', 'half', '-', 'life', 'of', 'un', '##mo', '##dified', 'Al', '##b', 'in', 'the', 'rat', '.', '71', 'The', 'product', 'isolated', 'from', 'a', 'pro', '##nas', '##e', 'dig', '##est', 'of', '##in', 'v', '##ivo', 'modified', 'Al', '##b', 'was', 'identical', 'to', 'the', 'synthetic', 'product', '.']	[0, 4, 9, 12, 17, 20, 22, 28, 33, 35, 37, 47, 62, 65, 67, 68, 69, 72, 75, 80, 84, 92, 97, 99, 103, 104, 109, 112, 113, 114, 116, 120, 122, 128, 131, 135, 148, 158, 163, 167, 171, 172, 177, 180, 182, 184, 191, 193, 195, 198, 202, 205, 206, 209, 213, 221, 230, 235, 237, 240, 243, 245, 248, 252, 254, 257, 258, 262, 271, 273, 275, 279, 289, 292, 296, 306, 313]	[3, 9, 12, 17, 20, 22, 27, 32, 35, 36, 46, 61, 64, 67, 68, 69, 72, 74, 79, 83, 91, 96, 98, 103, 104, 108, 111, 113, 114, 115, 120, 121, 127, 130, 134, 148, 157, 162, 166, 171, 172, 176, 179, 182, 184, 190, 193, 194, 197, 201, 205, 206, 208, 212, 220, 229, 234, 236, 240, 243, 244, 248, 251, 254, 256, 258, 261, 270, 273, 274, 278, 288, 291, 295, 305, 313, 314]	['The', 'radioactivityassociated', 'with', 'Alb', 'following', 'administration', 'of', '14C-AFBto', 'rats', 'was', 'cleared', 'with', 'a', 'half', '-', 'life', 'of', '2.5', 'days', ',', 'which', 'is', 'not', 'significantlydifferent', 'from', 'the', 'half', '-', 'life', 'of', 'unmodified', 'Alb', 'in', 'the', 'rat.71', 'The', 'product', 'isolated', 'from', 'a', 'pronase', 'digest', 'ofin', 'vivo', 'modified', 'Alb', 'was', 'identical', 'to', 'the', 'synthetic', 'product', '.']	[1, 6, 1, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 3, 1, 1, 1, 1, 1, 3, 2, 2, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The syntheticproduct was obtained by the acylase catalyzed deacetylation of thereaction product of Nα-acetyl-l-lysine with AFB-dibromo and characterized by UV, fluorescence, 1H NMR, 13C NMR,120 andfast atom bombardment mass spectrometry.71 AFB-dibromo (in vitro) or AFB-epoxide (in vivo) react first withwater to yield the same intermediate, the AFB-diol.	[('PMC5241710', 'I48001', 42, 49, 'cylase ')]	['The', 'synthetic', '##p', '##rod', '##uc', '##t', 'was', 'obtained', 'by', 'the', 'a', '##cy', '##lase', 'cat', '##aly', '##zed', 'de', '##ace', '##ty', '##lation', 'of', 'there', '##action', 'product', 'of', 'N', '##α', '-', 'ace', '##ty', '##l', '-', 'l', '-', 'l', '##ys', '##ine', 'with', 'AFB', '-', 'di', '##bro', '##mo', 'and', 'characterized', 'by', 'UV', ',', 'flu', '##ores', '##cence', ',', '1', '##H', 'N', '##MR', ',', '13', '##C', 'N', '##MR', ',', '120', 'and', '##fast', 'atom', 'bombardment', 'mass', 's', '##pect', '##rome', '##try', '.', '71', 'AFB', '-', 'di', '##bro', '##mo', '(', 'in', 'v', '##it', '##ro', ')', 'or', 'AFB', '-', 'e', '##pox', '##ide', '(', 'in', 'v', '##ivo', ')', 'react', 'first', 'with', '##water', 'to', 'yield', 'the', 'same', 'intermediate', ',', 'the', 'AFB', '-', 'di', '##ol', '.']	[0, 4, 13, 14, 17, 19, 21, 25, 34, 37, 41, 42, 44, 49, 52, 55, 59, 61, 64, 66, 73, 76, 81, 88, 96, 99, 100, 101, 102, 105, 107, 108, 109, 110, 111, 112, 114, 118, 123, 126, 127, 129, 132, 135, 139, 153, 156, 158, 160, 163, 167, 172, 174, 175, 177, 178, 180, 182, 184, 186, 187, 189, 190, 194, 197, 202, 207, 219, 224, 225, 229, 233, 236, 237, 240, 243, 244, 246, 249, 252, 253, 256, 257, 259, 261, 263, 266, 269, 270, 271, 274, 278, 279, 282, 283, 286, 288, 294, 300, 304, 310, 313, 319, 323, 328, 340, 342, 346, 349, 350, 352, 354]	[3, 13, 14, 17, 19, 20, 24, 33, 36, 40, 42, 44, 48, 52, 55, 58, 61, 64, 66, 72, 75, 81, 87, 95, 98, 100, 101, 102, 105, 107, 108, 109, 110, 111, 112, 114, 117, 122, 126, 127, 129, 132, 134, 138, 152, 155, 158, 159, 163, 167, 172, 173, 175, 176, 178, 180, 181, 184, 185, 187, 189, 190, 193, 197, 201, 206, 218, 223, 225, 229, 233, 236, 237, 239, 243, 244, 246, 249, 251, 253, 255, 257, 259, 261, 262, 265, 269, 270, 271, 274, 277, 279, 281, 283, 286, 287, 293, 299, 304, 309, 312, 318, 322, 327, 340, 341, 345, 349, 350, 352, 354, 355]	['The', 'syntheticproduct', 'was', 'obtained', 'by', 'the', 'acylase', 'catalyzed', 'deacetylation', 'of', 'thereaction', 'product', 'of', 'Nα-acetyl-l-lysine', 'with', 'AFB-dibromo', 'and', 'characterized', 'by', 'UV', ',', 'fluorescence', ',', '1H', 'NMR', ',', '13C', 'NMR', ',', '120', 'andfast', 'atom', 'bombardment', 'mass', 'spectrometry.71', 'AFB-dibromo', '(', 'in', 'vitro', ')', 'or', 'AFB-epoxide', '(', 'in', 'vivo', ')', 'react', 'first', 'withwater', 'to', 'yield', 'the', 'same', 'intermediate', ',', 'the', 'AFB-diol', '.']	[1, 5, 1, 1, 1, 1, 3, 3, 4, 1, 2, 1, 1, 12, 1, 5, 1, 1, 1, 1, 1, 3, 1, 2, 2, 1, 2, 2, 1, 1, 2, 1, 1, 1, 6, 5, 1, 1, 3, 1, 1, 5, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In human samples, AFB-Lys was not found in Alb depleted plasma, demonstratingthat binding occurred almost exclusively to Alb.203 Therefore, whole serum was digested with pronase, and theadducts were purified using an AFB- monoclonal antibody immunoaffinitychromatography and quantified by HPLC with fluorescence detection.	[('PMC5241710', 'I51000', 171, 178, 'ronase,')]	['In', 'human', 'samples', ',', 'AFB', '-', 'L', '##ys', 'was', 'not', 'found', 'in', 'Al', '##b', 'depleted', 'plasma', ',', 'demonstrating', '##tha', '##t', 'binding', 'occurred', 'almost', 'exclusively', 'to', 'Al', '##b', '.', '203', 'Therefore', ',', 'whole', 'serum', 'was', 'dig', '##ested', 'with', 'pro', '##nas', '##e', ',', 'and', 'the', '##ad', '##duct', '##s', 'were', 'pu', '##rified', 'using', 'an', 'AFB', '-', 'mon', '##oc', '##lon', '##al', 'anti', '##body', 'im', '##mu', '##no', '##af', '##finity', '##ch', '##roma', '##tography', 'and', 'q', '##uant', '##ified', 'by', 'HP', '##LC', 'with', 'flu', '##ores', '##cence', 'detection', '.']	[0, 3, 9, 16, 18, 21, 22, 23, 26, 30, 34, 40, 43, 45, 47, 56, 62, 64, 77, 80, 82, 90, 99, 106, 118, 121, 123, 124, 125, 129, 138, 140, 146, 152, 156, 159, 165, 170, 173, 176, 177, 179, 183, 186, 188, 192, 194, 199, 201, 208, 214, 217, 220, 222, 225, 227, 230, 233, 237, 242, 244, 246, 248, 250, 256, 258, 262, 271, 275, 276, 280, 286, 289, 291, 294, 299, 302, 306, 312, 321]	[2, 8, 16, 17, 21, 22, 23, 25, 29, 33, 39, 42, 45, 46, 55, 62, 63, 77, 80, 81, 89, 98, 105, 117, 120, 123, 124, 125, 128, 138, 139, 145, 151, 155, 159, 164, 169, 173, 176, 177, 178, 182, 186, 188, 192, 193, 198, 201, 207, 213, 216, 220, 221, 225, 227, 230, 232, 237, 241, 244, 246, 248, 250, 256, 258, 262, 270, 274, 276, 280, 285, 288, 291, 293, 298, 302, 306, 311, 321, 322]	['In', 'human', 'samples', ',', 'AFB-Lys', 'was', 'not', 'found', 'in', 'Alb', 'depleted', 'plasma', ',', 'demonstratingthat', 'binding', 'occurred', 'almost', 'exclusively', 'to', 'Alb.203', 'Therefore', ',', 'whole', 'serum', 'was', 'digested', 'with', 'pronase', ',', 'and', 'theadducts', 'were', 'purified', 'using', 'an', 'AFB-', 'monoclonal', 'antibody', 'immunoaffinitychromatography', 'and', 'quantified', 'by', 'HPLC', 'with', 'fluorescence', 'detection', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 4, 1, 2, 1, 1, 2, 4, 2, 8, 1, 3, 1, 2, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Many OP pesticides possess structural features incommon to the nerve agents sarin and soman, which phosphylate a serineresidue in the active site Acetylcholinesterase (AChE), resulting in inactivation of theenzyme as the mode of toxicity.118,164,242 OPs also phosphylate Lys, and Tyr residues of proteins,resulting neurotoxicity, but independent of AChE activity.243 The underlying mechanisms for OP neurotoxicityand the target proteins, are still unclear, but the mode of actionmost likely involves chemical modification of proteins.	[]	['Many', 'O', '##P', 'p', '##est', '##icides', 'possess', 'structural', 'features', 'in', '##com', '##mon', 'to', 'the', 'nerve', 'agents', 'sa', '##rin', 'and', 'so', '##man', ',', 'which', 'p', '##hos', '##phy', '##late', 'a', 'se', '##rine', '##res', '##id', '##ue', 'in', 'the', 'active', 'site', 'Ace', '##ty', '##l', '##cho', '##lines', '##tera', '##se', '(', 'AC', '##h', '##E', ')', ',', 'resulting', 'in', 'in', '##act', '##ivation', 'of', 'thee', '##nz', '##yme', 'as', 'the', 'mode', 'of', 'toxicity', '.', '118', ',', '164', ',', '242', 'O', '##Ps', 'also', 'p', '##hos', '##phy', '##late', 'L', '##ys', ',', 'and', 'Ty', '##r', 'residues', 'of', 'proteins', ',', 'resulting', 'ne', '##uro', '##to', '##xi', '##city', ',', 'but', 'independent', 'of', 'AC', '##h', '##E', 'activity', '.', '243', 'The', 'underlying', 'mechanisms', 'for', 'O', '##P', 'ne', '##uro', '##to', '##xi', '##city', '##and', 'the', 'target', 'proteins', ',', 'are', 'still', 'unclear', ',', 'but', 'the', 'mode', 'of', 'action', '##most', 'likely', 'involves', 'chemical', 'modification', 'of', 'proteins', '.']	[0, 5, 6, 8, 9, 12, 19, 27, 38, 47, 49, 52, 56, 59, 63, 69, 76, 78, 82, 86, 88, 91, 93, 99, 100, 103, 106, 111, 113, 115, 119, 122, 124, 127, 130, 134, 141, 146, 149, 151, 152, 155, 160, 164, 167, 168, 170, 171, 172, 173, 175, 185, 188, 190, 193, 201, 204, 208, 210, 214, 217, 221, 226, 229, 237, 238, 241, 242, 245, 246, 250, 251, 254, 259, 260, 263, 266, 271, 272, 274, 276, 280, 282, 284, 293, 296, 304, 305, 315, 317, 320, 322, 324, 328, 330, 334, 346, 349, 351, 352, 354, 362, 363, 367, 371, 382, 393, 397, 398, 400, 402, 405, 407, 409, 413, 417, 421, 428, 436, 438, 442, 448, 455, 457, 461, 465, 470, 473, 479, 484, 491, 500, 509, 522, 525, 533]	[4, 6, 7, 9, 12, 18, 26, 37, 46, 49, 52, 55, 58, 62, 68, 75, 78, 81, 85, 88, 91, 92, 98, 100, 103, 106, 110, 112, 115, 119, 122, 124, 126, 129, 133, 140, 145, 149, 151, 152, 155, 160, 164, 166, 168, 170, 171, 172, 173, 174, 184, 187, 190, 193, 200, 203, 208, 210, 213, 216, 220, 225, 228, 237, 238, 241, 242, 245, 246, 249, 251, 253, 258, 260, 263, 266, 270, 272, 274, 275, 279, 282, 283, 292, 295, 304, 305, 314, 317, 320, 322, 324, 328, 329, 333, 345, 348, 351, 352, 353, 362, 363, 366, 370, 381, 392, 396, 398, 399, 402, 405, 407, 409, 413, 416, 420, 427, 436, 437, 441, 447, 455, 456, 460, 464, 469, 472, 479, 483, 490, 499, 508, 521, 524, 533, 534]	['Many', 'OP', 'pesticides', 'possess', 'structural', 'features', 'incommon', 'to', 'the', 'nerve', 'agents', 'sarin', 'and', 'soman', ',', 'which', 'phosphylate', 'a', 'serineresidue', 'in', 'the', 'active', 'site', 'Acetylcholinesterase', '(', 'AChE', ')', ',', 'resulting', 'in', 'inactivation', 'of', 'theenzyme', 'as', 'the', 'mode', 'of', 'toxicity.118', ',', '164', ',', '242', 'OPs', 'also', 'phosphylate', 'Lys', ',', 'and', 'Tyr', 'residues', 'of', 'proteins', ',', 'resulting', 'neurotoxicity', ',', 'but', 'independent', 'of', 'AChE', 'activity.243', 'The', 'underlying', 'mechanisms', 'for', 'OP', 'neurotoxicityand', 'the', 'target', 'proteins', ',', 'are', 'still', 'unclear', ',', 'but', 'the', 'mode', 'of', 'actionmost', 'likely', 'involves', 'chemical', 'modification', 'of', 'proteins', '.']	[1, 2, 3, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 2, 1, 1, 4, 1, 5, 1, 1, 1, 1, 7, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 4, 2, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 2, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
UDP-glucuronosyltransferases (UGTs) are importantconjugation enzymes and catalyze the glucuronidation of numerous drugs,endobiotics, and procarcinogens.279 TheUGT-mediated glucuronide (Gluc) conjugation of chemicals is generallyconsidered as a mechanism of detoxication, and the Gluc conjugatesare generally less biologically or chemically reactive than theirparent compounds.85 However, many carboxylicacid containing drugs including NSAIDS are metabolized by UGTs toform β-1-O-acyl glucuronides (AGs), which areable to form adducts with nucleophiles in proteins and may contributeto toxicity of NSAIDS.276 Evidence forthe covalent binding of AGs to Alb by MALDI TOF MS and by CID witha four-sector tandem mass spectrometer was provided by Ding et	[('PMC5241710', 'I67000', 0, 28, 'UDP-glucuronosyltransferases')]	['U', '##DP', '-', 'g', '##lu', '##cu', '##ron', '##osy', '##lt', '##ran', '##s', '##fer', '##ases', '(', 'U', '##G', '##T', '##s', ')', 'are', 'important', '##con', '##ju', '##gation', 'enzymes', 'and', 'cat', '##aly', '##ze', 'the', 'g', '##lu', '##cu', '##ron', '##ida', '##tion', 'of', 'numerous', 'drugs', ',', 'end', '##ob', '##iot', '##ics', ',', 'and', 'pro', '##car', '##cin', '##ogen', '##s', '.', '27', '##9', 'The', '##U', '##G', '##T', '-', 'mediated', 'g', '##lu', '##cu', '##ron', '##ide', '(', 'G', '##lu', '##c', ')', 'con', '##ju', '##gation', 'of', 'chemicals', 'is', 'generally', '##con', '##side', '##red', 'as', 'a', 'mechanism', 'of', 'de', '##to', '##xi', '##cation', ',', 'and', 'the', 'G', '##lu', '##c', 'con', '##ju', '##gate', '##sar', '##e', 'generally', 'less', 'biological', '##ly', 'or', 'chemical', '##ly', 'reactive', 'than', 'their', '##par', '##ent', 'compounds', '.', '85', 'However', ',', 'many', 'car', '##box', '##yl', '##ica', '##cid', 'containing', 'drugs', 'including', 'NSA', '##ID', '##S', 'are', 'meta', '##bol', '##ized', 'by', 'U', '##G', '##T', '##s', 'to', '##form', 'β', '-', '1', '-', 'O', '-', 'a', '##cy', '##l', 'g', '##lu', '##cu', '##ron', '##ides', '(', 'AG', '##s', ')', ',', 'which', 'area', '##ble', 'to', 'form', 'add', '##uc', '##ts', 'with', 'n', '##uc', '##leo', '##phi', '##les', 'in', 'proteins', 'and', 'may', 'contribute', '##to', 'toxicity', 'of', 'NSA', '##ID', '##S', '.', '27', '##6', 'Evidence', 'forth', '##e', 'co', '##valent', 'binding', 'of', 'AG', '##s', 'to', 'Al', '##b', 'by', 'MA', '##LD', '##I', 'TO', '##F', 'MS', 'and', 'by', 'C', '##ID', 'with', '##a', 'four', '-', 'sector', 'tandem', 'mass', 's', '##pect', '##rome', '##ter', 'was', 'provided', 'by', 'Din', '##g', 'et']	[0, 1, 3, 4, 5, 7, 9, 12, 15, 17, 20, 21, 24, 29, 30, 31, 32, 33, 34, 36, 40, 49, 52, 54, 61, 69, 73, 76, 79, 82, 86, 87, 89, 91, 94, 97, 102, 105, 114, 119, 120, 123, 125, 128, 131, 133, 137, 140, 143, 146, 150, 151, 152, 154, 156, 159, 160, 161, 162, 163, 172, 173, 175, 177, 180, 184, 185, 186, 188, 189, 191, 194, 196, 203, 206, 216, 219, 228, 231, 235, 239, 242, 244, 254, 257, 259, 261, 263, 269, 271, 275, 279, 280, 282, 284, 287, 289, 293, 296, 298, 308, 313, 323, 326, 329, 337, 340, 349, 354, 359, 362, 366, 375, 376, 379, 386, 388, 393, 396, 399, 401, 404, 408, 419, 425, 435, 438, 440, 442, 446, 450, 453, 458, 461, 462, 463, 464, 466, 468, 473, 474, 475, 476, 477, 478, 479, 480, 482, 484, 485, 487, 489, 492, 497, 498, 500, 501, 502, 504, 510, 514, 518, 521, 526, 529, 531, 534, 539, 540, 542, 545, 548, 552, 555, 564, 568, 572, 582, 585, 594, 597, 600, 602, 603, 604, 606, 608, 617, 622, 624, 626, 633, 641, 644, 646, 648, 651, 653, 655, 658, 660, 662, 664, 666, 668, 671, 675, 678, 679, 682, 686, 688, 692, 693, 700, 707, 712, 713, 717, 721, 725, 729, 738, 741, 744, 746]	[1, 3, 4, 5, 7, 9, 12, 15, 17, 20, 21, 24, 28, 30, 31, 32, 33, 34, 35, 39, 49, 52, 54, 60, 68, 72, 76, 79, 81, 85, 87, 89, 91, 94, 97, 101, 104, 113, 119, 120, 123, 125, 128, 131, 132, 136, 140, 143, 146, 150, 151, 152, 154, 155, 159, 160, 161, 162, 163, 171, 173, 175, 177, 180, 183, 185, 186, 188, 189, 190, 194, 196, 202, 205, 215, 218, 228, 231, 235, 238, 241, 243, 253, 256, 259, 261, 263, 269, 270, 274, 278, 280, 282, 283, 287, 289, 293, 296, 297, 307, 312, 323, 325, 328, 337, 339, 348, 353, 359, 362, 365, 375, 376, 378, 386, 387, 392, 396, 399, 401, 404, 407, 418, 424, 434, 438, 440, 441, 445, 450, 453, 457, 460, 462, 463, 464, 465, 468, 472, 474, 475, 476, 477, 478, 479, 480, 482, 483, 485, 487, 489, 492, 496, 498, 500, 501, 502, 503, 509, 514, 517, 520, 525, 529, 531, 533, 538, 540, 542, 545, 548, 551, 554, 563, 567, 571, 582, 584, 593, 596, 600, 602, 603, 604, 606, 607, 616, 622, 623, 626, 632, 640, 643, 646, 647, 650, 653, 654, 657, 660, 662, 663, 666, 667, 670, 674, 677, 679, 681, 686, 687, 692, 693, 699, 706, 711, 713, 717, 721, 724, 728, 737, 740, 744, 745, 748]	['UDP-glucuronosyltransferases', '(', 'UGTs', ')', 'are', 'importantconjugation', 'enzymes', 'and', 'catalyze', 'the', 'glucuronidation', 'of', 'numerous', 'drugs', ',', 'endobiotics', ',', 'and', 'procarcinogens.279', 'TheUGT', '-', 'mediated', 'glucuronide', '(', 'Gluc', ')', 'conjugation', 'of', 'chemicals', 'is', 'generallyconsidered', 'as', 'a', 'mechanism', 'of', 'detoxication', ',', 'and', 'the', 'Gluc', 'conjugatesare', 'generally', 'less', 'biologically', 'or', 'chemically', 'reactive', 'than', 'theirparent', 'compounds.85', 'However', ',', 'many', 'carboxylicacid', 'containing', 'drugs', 'including', 'NSAIDS', 'are', 'metabolized', 'by', 'UGTs', 'toform', 'β-1-O-acyl', 'glucuronides', '(', 'AGs', ')', ',', 'which', 'areable', 'to', 'form', 'adducts', 'with', 'nucleophiles', 'in', 'proteins', 'and', 'may', 'contributeto', 'toxicity', 'of', 'NSAIDS.276', 'Evidence', 'forthe', 'covalent', 'binding', 'of', 'AGs', 'to', 'Alb', 'by', 'MALDI', 'TOF', 'MS', 'and', 'by', 'CID', 'witha', 'four', '-', 'sector', 'tandem', 'mass', 'spectrometer', 'was', 'provided', 'by', 'Ding', 'et']	[13, 1, 4, 1, 1, 4, 1, 1, 3, 1, 6, 1, 1, 1, 1, 4, 1, 1, 8, 4, 1, 1, 5, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 3, 5, 1, 1, 2, 1, 2, 1, 1, 3, 3, 1, 1, 1, 5, 1, 1, 1, 3, 1, 3, 1, 4, 2, 9, 5, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 5, 1, 1, 1, 1, 2, 1, 1, 6, 1, 2, 2, 1, 1, 2, 1, 2, 1, 3, 2, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
NVP is a non-nucleosidereverse transcriptase inhibitor used against human immunodeficiencyvirus type-1 (HIV-1).	[('PMC5241710', 'I70000', 24, 45, 'everse transcriptase ')]	['N', '##VP', 'is', 'a', 'non', '-', 'n', '##uc', '##leo', '##side', '##re', '##verse', 'trans', '##cript', '##ase', 'inhibitor', 'used', 'against', 'human', 'im', '##mu', '##no', '##de', '##ficiency', '##virus', 'type', '-', '1', '(', 'HIV', '-', '1', ')', '.']	[0, 1, 4, 7, 9, 12, 13, 14, 16, 19, 23, 25, 31, 36, 41, 45, 55, 60, 68, 74, 76, 78, 80, 82, 90, 96, 100, 101, 103, 104, 107, 108, 109, 110]	[1, 3, 6, 8, 12, 13, 14, 16, 19, 23, 25, 30, 36, 41, 44, 54, 59, 67, 73, 76, 78, 80, 82, 90, 95, 100, 101, 102, 104, 107, 108, 109, 110, 111]	['NVP', 'is', 'a', 'non', '-', 'nucleosidereverse', 'transcriptase', 'inhibitor', 'used', 'against', 'human', 'immunodeficiencyvirus', 'type-1', '(', 'HIV-1', ')', '.']	[2, 1, 1, 1, 1, 6, 3, 1, 1, 1, 1, 6, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast,the majority of protein binding in rodent liver model appears to beattributed to the quinone methide, which is the direct P450 oxidationproduct of NVP.288 Single amino acid adductswere synthesized with 12-mesyloxy-NVP.289 Meng et al. examined the reactivity of 12-sulfoxy-NVP with Alb andfound that at a 50-fold mol excess, the drug bound selectively toHis146, His242, His338, and Cys34, but no Lys adducts were detected(Table S1 of the Supporting Information).143 When equimolar concentration of12-sulfoxy-NVP was reacted with Alb, His146 was the primary site ofadduct formation.	[]	['In', 'contrast', ',', 'the', 'majority', 'of', 'protein', 'binding', 'in', 'rode', '##nt', 'liver', 'model', 'appears', 'to', 'beat', '##tri', '##buted', 'to', 'the', 'q', '##uin', '##one', 'met', '##hi', '##de', ',', 'which', 'is', 'the', 'direct', 'P', '##45', '##0', 'oxidation', '##p', '##rod', '##uc', '##t', 'of', 'N', '##VP', '.', '288', 'Single', 'amino', 'acid', 'add', '##uc', '##ts', '##wer', '##e', 'synthesized', 'with', '12', '-', 'me', '##sy', '##lo', '##xy', '-', 'N', '##VP', '.', '28', '##9', 'Men', '##g', 'et', 'al', '.', 'examined', 'the', 'react', '##ivity', 'of', '12', '-', 'su', '##lf', '##ox', '##y', '-', 'N', '##VP', 'with', 'Al', '##b', 'and', '##found', 'that', 'at', 'a', '50', '-', 'fold', 'm', '##ol', 'excess', ',', 'the', 'drug', 'bound', 'selective', '##ly', 'to', '##H', '##is', '##14', '##6', ',', 'His', '##24', '##2', ',', 'His', '##33', '##8', ',', 'and', 'Cy', '##s', '##34', ',', 'but', 'no', 'L', '##ys', 'add', '##uc', '##ts', 'were', 'detected', '(', 'Table', 'S', '##1', 'of', 'the', 'Supporting', 'Information', ')', '.', '143', 'When', 'e', '##qui', '##mo', '##lar', 'concentration', 'of', '##12', '-', 'su', '##lf', '##ox', '##y', '-', 'N', '##VP', 'was', 'reacted', 'with', 'Al', '##b', ',', 'His', '##14', '##6', 'was', 'the', 'primary', 'site', 'of', '##ad', '##duct', 'formation', '.']	[0, 3, 11, 12, 16, 25, 28, 36, 44, 47, 51, 54, 60, 66, 74, 77, 81, 84, 90, 93, 97, 98, 101, 105, 108, 110, 112, 114, 120, 123, 127, 134, 135, 137, 139, 148, 149, 152, 154, 156, 159, 160, 162, 163, 167, 174, 180, 185, 188, 190, 192, 195, 197, 209, 214, 216, 217, 219, 221, 223, 225, 226, 227, 229, 230, 232, 234, 237, 239, 242, 244, 246, 255, 259, 264, 270, 273, 275, 276, 278, 280, 282, 283, 284, 285, 288, 293, 295, 297, 300, 306, 311, 314, 316, 318, 319, 324, 325, 328, 334, 336, 340, 345, 351, 360, 363, 365, 366, 368, 370, 371, 373, 376, 378, 379, 381, 384, 386, 387, 389, 393, 395, 396, 398, 400, 404, 407, 408, 411, 414, 416, 419, 424, 432, 433, 439, 440, 442, 445, 449, 460, 471, 472, 473, 477, 482, 483, 486, 488, 492, 506, 508, 510, 511, 513, 515, 517, 518, 519, 520, 523, 527, 535, 540, 542, 543, 545, 548, 550, 552, 556, 560, 568, 573, 575, 577, 582, 591]	[2, 11, 12, 15, 24, 27, 35, 43, 46, 51, 53, 59, 65, 73, 76, 81, 84, 89, 92, 96, 98, 101, 104, 108, 110, 112, 113, 119, 122, 126, 133, 135, 137, 138, 148, 149, 152, 154, 155, 158, 160, 162, 163, 166, 173, 179, 184, 188, 190, 192, 195, 196, 208, 213, 216, 217, 219, 221, 223, 225, 226, 227, 229, 230, 232, 233, 237, 238, 241, 244, 245, 254, 258, 264, 269, 272, 275, 276, 278, 280, 282, 283, 284, 285, 287, 292, 295, 296, 300, 305, 310, 313, 315, 318, 319, 323, 325, 327, 334, 335, 339, 344, 350, 360, 362, 365, 366, 368, 370, 371, 372, 376, 378, 379, 380, 384, 386, 387, 388, 392, 395, 396, 398, 399, 403, 406, 408, 410, 414, 416, 418, 423, 432, 433, 438, 440, 441, 444, 448, 459, 471, 472, 473, 476, 481, 483, 486, 488, 491, 505, 508, 510, 511, 513, 515, 517, 518, 519, 520, 522, 526, 534, 539, 542, 543, 544, 548, 550, 551, 555, 559, 567, 572, 575, 577, 581, 591, 592]	['In', 'contrast', ',', 'the', 'majority', 'of', 'protein', 'binding', 'in', 'rodent', 'liver', 'model', 'appears', 'to', 'beattributed', 'to', 'the', 'quinone', 'methide', ',', 'which', 'is', 'the', 'direct', 'P450', 'oxidationproduct', 'of', 'NVP.288', 'Single', 'amino', 'acid', 'adductswere', 'synthesized', 'with', '12-mesyloxy-NVP.289', 'Meng', 'et', 'al', '.', 'examined', 'the', 'reactivity', 'of', '12-sulfoxy-NVP', 'with', 'Alb', 'andfound', 'that', 'at', 'a', '50-fold', 'mol', 'excess', ',', 'the', 'drug', 'bound', 'selectively', 'toHis146', ',', 'His242', ',', 'His338', ',', 'and', 'Cys34', ',', 'but', 'no', 'Lys', 'adducts', 'were', 'detected(Table', 'S1', 'of', 'the', 'Supporting', 'Information).143', 'When', 'equimolar', 'concentration', 'of12-sulfoxy-NVP', 'was', 'reacted', 'with', 'Alb', ',', 'His146', 'was', 'the', 'primary', 'site', 'ofadduct', 'formation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 5, 1, 4, 1, 1, 1, 5, 1, 1, 12, 2, 1, 1, 1, 1, 1, 2, 1, 9, 1, 2, 2, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 2, 5, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 2, 3, 1, 3, 2, 1, 1, 1, 4, 1, 4, 1, 10, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Antunes and co-workers used a 100-fold mol excessof 12-mesyloxy-NVP and found adducts at Trp214, Cys34, and severalLys residues.143,197	[]	['An', '##tun', '##es', 'and', 'co', '-', 'workers', 'used', 'a', '100', '-', 'fold', 'm', '##ol', 'excess', '##of', '12', '-', 'me', '##sy', '##lo', '##xy', '-', 'N', '##VP', 'and', 'found', 'add', '##uc', '##ts', 'at', 'T', '##rp', '##21', '##4', ',', 'Cy', '##s', '##34', ',', 'and', 'several', '##L', '##ys', 'residues', '.', '143', ',', '197']	[0, 2, 5, 8, 12, 14, 15, 23, 28, 30, 33, 34, 39, 40, 43, 49, 52, 54, 55, 57, 59, 61, 63, 64, 65, 68, 72, 78, 81, 83, 86, 89, 90, 92, 94, 95, 97, 99, 100, 102, 104, 108, 115, 116, 119, 127, 128, 131, 132]	[2, 5, 7, 11, 14, 15, 22, 27, 29, 33, 34, 38, 40, 42, 49, 51, 54, 55, 57, 59, 61, 63, 64, 65, 67, 71, 77, 81, 83, 85, 88, 90, 92, 94, 95, 96, 99, 100, 102, 103, 107, 115, 116, 118, 127, 128, 131, 132, 135]	['Antunes', 'and', 'co', '-', 'workers', 'used', 'a', '100-fold', 'mol', 'excessof', '12-mesyloxy-NVP', 'and', 'found', 'adducts', 'at', 'Trp214', ',', 'Cys34', ',', 'and', 'severalLys', 'residues.143', ',', '197']	[3, 1, 1, 1, 1, 1, 1, 3, 2, 2, 9, 1, 1, 3, 1, 4, 1, 3, 1, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus far, the successesin measuring Alb-carcinogen adducts in humans have largely been withthose adducts that are cleaved from Alb by acid or base treatment(i.e., Cys-BQ or BAP tetraols), or by the extensive digestion of Albwith a mixture of proteases to produce mono-amino acid adducts (AFB-Lysadducts).	[('PMC5241710', 'I78000', 246, 255, 'eases to ')]	['Thus', 'far', ',', 'the', 'successes', '##in', 'measuring', 'Al', '##b', '-', 'car', '##cin', '##ogen', 'add', '##uc', '##ts', 'in', 'humans', 'have', 'largely', 'been', 'with', '##th', '##ose', 'add', '##uc', '##ts', 'that', 'are', 'c', '##lea', '##ved', 'from', 'Al', '##b', 'by', 'acid', 'or', 'base', 'treatment', '(', 'i', '.', 'e', '.', ',', 'Cy', '##s', '-', 'B', '##Q', 'or', 'BA', '##P', 'te', '##tra', '##ols', ')', ',', 'or', 'by', 'the', 'extensive', 'dig', '##est', '##ion', 'of', 'Al', '##b', '##with', 'a', 'mixture', 'of', 'pro', '##te', '##ases', 'to', 'produce', 'mon', '##o', '-', 'amino', 'acid', 'add', '##uc', '##ts', '(', 'AFB', '-', 'L', '##ys', '##ad', '##duct', '##s', ')', '.']	[0, 5, 8, 10, 14, 23, 26, 36, 38, 39, 40, 43, 46, 51, 54, 56, 59, 62, 69, 74, 82, 87, 91, 93, 97, 100, 102, 105, 110, 114, 115, 118, 122, 127, 129, 131, 134, 139, 142, 147, 156, 157, 158, 159, 160, 161, 163, 165, 166, 167, 168, 170, 173, 175, 177, 179, 182, 185, 186, 188, 191, 194, 198, 208, 211, 214, 218, 221, 223, 224, 229, 231, 239, 242, 245, 247, 252, 255, 263, 266, 267, 268, 274, 279, 282, 284, 287, 288, 291, 292, 293, 295, 297, 301, 302, 303]	[4, 8, 9, 13, 23, 25, 35, 38, 39, 40, 43, 46, 50, 54, 56, 58, 61, 68, 73, 81, 86, 91, 93, 96, 100, 102, 104, 109, 113, 115, 118, 121, 126, 129, 130, 133, 138, 141, 146, 156, 157, 158, 159, 160, 161, 162, 165, 166, 167, 168, 169, 172, 175, 176, 179, 182, 185, 186, 187, 190, 193, 197, 207, 211, 214, 217, 220, 223, 224, 228, 230, 238, 241, 245, 247, 251, 254, 262, 266, 267, 268, 273, 278, 282, 284, 286, 288, 291, 292, 293, 295, 297, 301, 302, 303, 304]	['Thus', 'far', ',', 'the', 'successesin', 'measuring', 'Alb', '-', 'carcinogen', 'adducts', 'in', 'humans', 'have', 'largely', 'been', 'withthose', 'adducts', 'that', 'are', 'cleaved', 'from', 'Alb', 'by', 'acid', 'or', 'base', 'treatment(i.e', '.', ',', 'Cys-BQ', 'or', 'BAP', 'tetraols', ')', ',', 'or', 'by', 'the', 'extensive', 'digestion', 'of', 'Albwith', 'a', 'mixture', 'of', 'proteases', 'to', 'produce', 'mono', '-', 'amino', 'acid', 'adducts', '(', 'AFB-Lysadducts', ')', '.']	[1, 1, 1, 1, 2, 1, 2, 1, 3, 3, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1, 2, 1, 1, 1, 1, 5, 1, 1, 5, 1, 2, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteases, such as trypsin, can produce longpeptides such as the T3 tryptic peptide A21LVLIAFAQYLQQCPFEDHVK40, whereas pronase digestion yields mono-, di-, or tripetideCys containing adducts.	[('PMC5241710', 'I79000', 0, 9, 'Proteases')]	['Pro', '##te', '##ases', ',', 'such', 'as', 'try', '##ps', '##in', ',', 'can', 'produce', 'long', '##pe', '##pt', '##ides', 'such', 'as', 'the', 'T', '##3', 'try', '##ptic', 'p', '##eptide', 'A2', '##1', '##L', '##V', '##L', '##IA', '##FA', '##Q', '##Y', '##L', '##Q', '##Q', '##CP', '##F', '##ED', '##H', '##V', '##K', '##40', ',', 'whereas', 'pro', '##nas', '##e', 'dig', '##est', '##ion', 'yields', 'mon', '##o', '-', ',', 'di', '-', ',', 'or', 'trip', '##eti', '##de', '##C', '##ys', 'containing', 'add', '##uc', '##ts', '.']	[0, 3, 5, 9, 11, 16, 19, 22, 24, 26, 28, 32, 40, 44, 46, 48, 53, 58, 61, 65, 66, 68, 71, 76, 77, 84, 86, 87, 88, 89, 90, 92, 94, 95, 96, 97, 98, 99, 101, 102, 104, 105, 106, 107, 109, 111, 119, 122, 125, 127, 130, 133, 137, 144, 147, 148, 149, 151, 153, 154, 156, 159, 163, 166, 168, 169, 172, 183, 186, 188, 190]	[3, 5, 9, 10, 15, 18, 22, 24, 26, 27, 31, 39, 44, 46, 48, 52, 57, 60, 64, 66, 67, 71, 75, 77, 83, 86, 87, 88, 89, 90, 92, 94, 95, 96, 97, 98, 99, 101, 102, 104, 105, 106, 107, 109, 110, 118, 122, 125, 126, 130, 133, 136, 143, 147, 148, 149, 150, 153, 154, 155, 158, 163, 166, 168, 169, 171, 182, 186, 188, 190, 191]	['Proteases', ',', 'such', 'as', 'trypsin', ',', 'can', 'produce', 'longpeptides', 'such', 'as', 'the', 'T3', 'tryptic', 'peptide', 'A21LVLIAFAQYLQQCPFEDHVK40', ',', 'whereas', 'pronase', 'digestion', 'yields', 'mono-', ',', 'di-', ',', 'or', 'tripetideCys', 'containing', 'adducts', '.']	[3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 2, 2, 2, 19, 1, 1, 3, 3, 1, 3, 1, 2, 1, 1, 5, 1, 3, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
N2,N2-dimethylguanosine is found in the majority of tRNAs at position 26, upstream of the anticodon sequence at positions 34 to 36, and promotes the folding of tRNAs toward the classical cloverleaf structure.24 N1-methylinosine is found 3′ adjacent to the anticodon at position 37 of eukaryotic tRNAs and is formed from inosine by a specific S-adenosylmethionine–dependent methylase.25 Increased serum and urine levels of N2,N2-dimethylguanosine, as well as pseudouridine and 1-methylinosine, have been observed in multiple solid tumor malignancies26 and may reflect the general upregulation of the translational apparatus, including tRNA turnover, in hyperproliferative cancerous cells.27 Increased circulating 1-methyladenosine has also been shown to be an early indicator of oxidative stress, cell damage, and mortality in kidney disease.28	[]	['N', '##2', ',', 'N', '##2', '-', 'dim', '##eth', '##yl', '##gua', '##nos', '##ine', 'is', 'found', 'in', 'the', 'majority', 'of', 't', '##RNA', '##s', 'at', 'position', '26', ',', 'upstream', 'of', 'the', 'anti', '##co', '##don', 'sequence', 'at', 'positions', '34', 'to', '36', ',', 'and', 'promotes', 'the', 'folding', 'of', 't', '##RNA', '##s', 'toward', 'the', 'classical', 'c', '##lover', '##leaf', 'structure', '.', '24', 'N', '##1', '-', 'met', '##hyl', '##ino', '##sin', '##e', 'is', 'found', '3', '′', 'adjacent', 'to', 'the', 'anti', '##co', '##don', 'at', 'position', '37', 'of', 'e', '##uka', '##ryo', '##tic', 't', '##RNA', '##s', 'and', 'is', 'formed', 'from', 'in', '##os', '##ine', 'by', 'a', 'specific', 'S', '-', 'ad', '##eno', '##sy', '##lm', '##eth', '##ion', '##ine', '–', 'dependent', 'met', '##hyl', '##ase', '.', '25', 'Inc', '##reased', 'serum', 'and', 'urine', 'levels', 'of', 'N', '##2', ',', 'N', '##2', '-', 'dim', '##eth', '##yl', '##gua', '##nos', '##ine', ',', 'as', 'well', 'as', 'pseudo', '##uri', '##dine', 'and', '1', '-', 'met', '##hyl', '##ino', '##sin', '##e', ',', 'have', 'been', 'observed', 'in', 'multiple', 'solid', 'tumor', 'ma', '##li', '##gna', '##ncies', '##26', 'and', 'may', 'reflect', 'the', 'general', 'up', '##re', '##gu', '##lation', 'of', 'the', 'translation', '##al', 'apparatus', ',', 'including', 't', '##RNA', 'turnover', ',', 'in', 'h', '##yper', '##p', '##rol', '##ifer', '##ative', 'cancer', '##ous', 'cells', '.', '27', 'Inc', '##reased', 'circulating', '1', '-', 'met', '##hyl', '##ade', '##nos', '##ine', 'has', 'also', 'been', 'shown', 'to', 'be', 'an', 'early', 'indicator', 'of', 'o', '##xi', '##da', '##tive', 'stress', ',', 'cell', 'damage', ',', 'and', 'mortality', 'in', 'kidney', 'disease', '.', '28']	[0, 1, 2, 3, 4, 5, 6, 9, 12, 14, 17, 20, 24, 27, 33, 36, 40, 49, 52, 53, 56, 58, 61, 70, 72, 74, 83, 86, 90, 94, 96, 100, 109, 112, 122, 125, 128, 130, 132, 136, 145, 149, 157, 160, 161, 164, 166, 173, 177, 187, 188, 193, 198, 207, 208, 211, 212, 213, 214, 217, 220, 223, 226, 228, 231, 237, 238, 240, 249, 252, 256, 260, 262, 266, 269, 278, 281, 284, 285, 288, 291, 295, 296, 299, 301, 305, 308, 315, 320, 322, 324, 328, 331, 333, 342, 343, 344, 346, 349, 351, 353, 356, 359, 362, 363, 373, 376, 379, 382, 383, 386, 389, 396, 402, 406, 412, 419, 422, 423, 424, 425, 426, 427, 428, 431, 434, 436, 439, 442, 445, 447, 450, 455, 458, 464, 467, 472, 476, 477, 478, 481, 484, 487, 490, 491, 493, 498, 503, 512, 515, 524, 530, 536, 538, 540, 543, 548, 551, 555, 559, 567, 571, 579, 581, 583, 585, 592, 595, 599, 610, 613, 622, 624, 634, 635, 639, 647, 649, 652, 653, 657, 658, 661, 665, 671, 677, 681, 686, 687, 690, 693, 700, 712, 713, 714, 717, 720, 723, 726, 730, 734, 739, 744, 750, 753, 756, 759, 765, 775, 778, 779, 781, 783, 788, 794, 796, 801, 807, 809, 813, 823, 826, 833, 840, 841]	[1, 2, 3, 4, 5, 6, 9, 12, 14, 17, 20, 23, 26, 32, 35, 39, 48, 51, 53, 56, 57, 60, 69, 72, 73, 82, 85, 89, 94, 96, 99, 108, 111, 121, 124, 127, 130, 131, 135, 144, 148, 156, 159, 161, 164, 165, 172, 176, 186, 188, 193, 197, 207, 208, 210, 212, 213, 214, 217, 220, 223, 226, 227, 230, 236, 238, 239, 248, 251, 255, 260, 262, 265, 268, 277, 280, 283, 285, 288, 291, 294, 296, 299, 300, 304, 307, 314, 319, 322, 324, 327, 330, 332, 341, 343, 344, 346, 349, 351, 353, 356, 359, 362, 363, 372, 376, 379, 382, 383, 385, 389, 395, 401, 405, 411, 418, 421, 423, 424, 425, 426, 427, 428, 431, 434, 436, 439, 442, 445, 446, 449, 454, 457, 464, 467, 471, 475, 477, 478, 481, 484, 487, 490, 491, 492, 497, 502, 511, 514, 523, 529, 535, 538, 540, 543, 548, 550, 554, 558, 566, 570, 578, 581, 583, 585, 591, 594, 598, 610, 612, 622, 623, 633, 635, 638, 647, 648, 651, 653, 657, 658, 661, 665, 670, 677, 680, 686, 687, 689, 693, 699, 711, 713, 714, 717, 720, 723, 726, 729, 733, 738, 743, 749, 752, 755, 758, 764, 774, 777, 779, 781, 783, 787, 794, 795, 800, 807, 808, 812, 822, 825, 832, 840, 841, 843]	['N2', ',', 'N2-dimethylguanosine', 'is', 'found', 'in', 'the', 'majority', 'of', 'tRNAs', 'at', 'position', '26', ',', 'upstream', 'of', 'the', 'anticodon', 'sequence', 'at', 'positions', '34', 'to', '36', ',', 'and', 'promotes', 'the', 'folding', 'of', 'tRNAs', 'toward', 'the', 'classical', 'cloverleaf', 'structure.24', 'N1-methylinosine', 'is', 'found', '3′', 'adjacent', 'to', 'the', 'anticodon', 'at', 'position', '37', 'of', 'eukaryotic', 'tRNAs', 'and', 'is', 'formed', 'from', 'inosine', 'by', 'a', 'specific', 'S-adenosylmethionine–', 'dependent', 'methylase.25', 'Increased', 'serum', 'and', 'urine', 'levels', 'of', 'N2', ',', 'N2-dimethylguanosine', ',', 'as', 'well', 'as', 'pseudouridine', 'and', '1-methylinosine', ',', 'have', 'been', 'observed', 'in', 'multiple', 'solid', 'tumor', 'malignancies26', 'and', 'may', 'reflect', 'the', 'general', 'upregulation', 'of', 'the', 'translational', 'apparatus', ',', 'including', 'tRNA', 'turnover', ',', 'in', 'hyperproliferative', 'cancerous', 'cells.27', 'Increased', 'circulating', '1-methyladenosine', 'has', 'also', 'been', 'shown', 'to', 'be', 'an', 'early', 'indicator', 'of', 'oxidative', 'stress', ',', 'cell', 'damage', ',', 'and', 'mortality', 'in', 'kidney', 'disease.28']	[2, 1, 9, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 3, 8, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 3, 1, 1, 1, 10, 1, 5, 2, 1, 1, 1, 1, 1, 2, 1, 9, 1, 1, 1, 1, 3, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 6, 2, 3, 2, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, stress-induced cleavage of tRNA produces fragments that propagate the stress response and interfere with eukaryotic initiation factors-4G and -4F.21 Furthermore, eukaryotic initiation factor-2α kinase-4 (GCN2), which prevents eukaryotic initiation factor-2α from interacting with the initiating Met-tRNA, suppressing general protein synthesis and activating stress-inducible transcription factors, is mutated and causally implicated in some cases of pulmonary vascular disease.29 Mutations in tRNA genes themselves have also been reported to cause pulmonary hypertension driven by mitochondrial dysfunction.30	[]	['In', 'addition', ',', 'stress', '-', 'induced', 'c', '##lea', '##vage', 'of', 't', '##RNA', 'produces', 'fragments', 'that', 'prop', '##aga', '##te', 'the', 'stress', 'response', 'and', 'interfere', 'with', 'e', '##uka', '##ryo', '##tic', 'initiation', 'factors', '-', '4', '##G', 'and', '-', '4', '##F', '.', '21', 'Furthermore', ',', 'e', '##uka', '##ryo', '##tic', 'initiation', 'factor', '-', '2', '##α', 'kinase', '-', '4', '(', 'G', '##C', '##N', '##2', ')', ',', 'which', 'prevents', 'e', '##uka', '##ryo', '##tic', 'initiation', 'factor', '-', '2', '##α', 'from', 'interacting', 'with', 'the', 'in', '##iti', '##ating', 'Met', '-', 't', '##RNA', ',', 'suppress', '##ing', 'general', 'protein', 'synthesis', 'and', 'act', '##ivating', 'stress', '-', 'in', '##du', '##cible', 'transcription', 'factors', ',', 'is', 'm', '##uta', '##ted', 'and', 'ca', '##usal', '##ly', 'implicated', 'in', 'some', 'cases', 'of', 'pulmonary', 'vascular', 'disease', '.', '29', 'Mu', '##tations', 'in', 't', '##RNA', 'genes', 'themselves', 'have', 'also', 'been', 'reported', 'to', 'cause', 'pulmonary', 'h', '##yper', '##tens', '##ion', 'driven', 'by', 'mitochondrial', 'd', '##ys', '##function', '.', '30']	[0, 3, 11, 13, 19, 20, 28, 29, 32, 37, 40, 41, 45, 54, 64, 69, 73, 76, 79, 83, 90, 99, 103, 113, 118, 119, 122, 125, 129, 140, 147, 148, 149, 151, 155, 156, 157, 158, 159, 162, 173, 175, 176, 179, 182, 186, 197, 203, 204, 205, 207, 213, 214, 216, 217, 218, 219, 220, 221, 222, 224, 230, 239, 240, 243, 246, 250, 261, 267, 268, 269, 271, 276, 288, 293, 297, 299, 302, 308, 311, 312, 313, 316, 318, 326, 330, 338, 346, 356, 360, 363, 371, 377, 378, 380, 382, 388, 402, 409, 411, 414, 415, 418, 422, 426, 428, 432, 435, 446, 449, 454, 460, 463, 473, 482, 489, 490, 493, 495, 503, 506, 507, 511, 517, 528, 533, 538, 543, 552, 555, 561, 571, 572, 576, 580, 584, 591, 594, 608, 609, 611, 619, 620]	[2, 11, 12, 19, 20, 27, 29, 32, 36, 39, 41, 44, 53, 63, 68, 73, 76, 78, 82, 89, 98, 102, 112, 117, 119, 122, 125, 128, 139, 147, 148, 149, 150, 154, 156, 157, 158, 159, 161, 173, 174, 176, 179, 182, 185, 196, 203, 204, 205, 206, 213, 214, 215, 217, 218, 219, 220, 221, 222, 223, 229, 238, 240, 243, 246, 249, 260, 267, 268, 269, 270, 275, 287, 292, 296, 299, 302, 307, 311, 312, 313, 316, 317, 326, 329, 337, 345, 355, 359, 363, 370, 377, 378, 380, 382, 387, 401, 409, 410, 413, 415, 418, 421, 425, 428, 432, 434, 445, 448, 453, 459, 462, 472, 481, 489, 490, 492, 495, 502, 505, 507, 510, 516, 527, 532, 537, 542, 551, 554, 560, 570, 572, 576, 580, 583, 590, 593, 607, 609, 611, 619, 620, 622]	['In', 'addition', ',', 'stress', '-', 'induced', 'cleavage', 'of', 'tRNA', 'produces', 'fragments', 'that', 'propagate', 'the', 'stress', 'response', 'and', 'interfere', 'with', 'eukaryotic', 'initiation', 'factors-4G', 'and', '-', '4F.21', 'Furthermore', ',', 'eukaryotic', 'initiation', 'factor-2α', 'kinase-4', '(', 'GCN2', ')', ',', 'which', 'prevents', 'eukaryotic', 'initiation', 'factor-2α', 'from', 'interacting', 'with', 'the', 'initiating', 'Met-tRNA', ',', 'suppressing', 'general', 'protein', 'synthesis', 'and', 'activating', 'stress', '-', 'inducible', 'transcription', 'factors', ',', 'is', 'mutated', 'and', 'causally', 'implicated', 'in', 'some', 'cases', 'of', 'pulmonary', 'vascular', 'disease.29', 'Mutations', 'in', 'tRNA', 'genes', 'themselves', 'have', 'also', 'been', 'reported', 'to', 'cause', 'pulmonary', 'hypertension', 'driven', 'by', 'mitochondrial', 'dysfunction.30']	[1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 4, 1, 1, 4, 1, 4, 3, 1, 4, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sphingomyelins are the most abundant subclass of sphingolipids, with other subclasses including sphinogosines, ceramides, and glycophospholipids.42 In patients with chronic obstructive pulmonary disease, low plasma levels of several sphingomyelins relate to disease severity.43 As a membrane constituent, sphingomyelins are implicated in transmembrane signaling and are generated from phosphatidylcholine and ceramide by sphingomyelin synthase, the knockout of which leads to mitochondrial dysfunction and reduced insulin release.44 Sphingomyelins may also be considered a source of ceramide, which directly (and indirectly through other active lipid products) regulates cell proliferation, apoptosis, cell migration, and autophagy.45	[]	['S', '##phi', '##ngo', '##my', '##elin', '##s', 'are', 'the', 'most', 'abundant', 'sub', '##c', '##lass', 'of', 's', '##phi', '##ngo', '##lip', '##ids', ',', 'with', 'other', 'sub', '##c', '##lass', '##es', 'including', 's', '##phi', '##no', '##gos', '##ines', ',', 'c', '##era', '##mi', '##des', ',', 'and', 'g', '##ly', '##co', '##ph', '##os', '##ph', '##oli', '##pid', '##s', '.', '42', 'In', 'patients', 'with', 'chronic', 'o', '##bs', '##truct', '##ive', 'pulmonary', 'disease', ',', 'low', 'plasma', 'levels', 'of', 'several', 's', '##phi', '##ngo', '##my', '##elin', '##s', 'relate', 'to', 'disease', 'severity', '.', '43', 'As', 'a', 'membrane', 'constituent', ',', 's', '##phi', '##ngo', '##my', '##elin', '##s', 'are', 'implicated', 'in', 'trans', '##me', '##mb', '##rane', 'signaling', 'and', 'are', 'generated', 'from', 'p', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##line', 'and', 'c', '##era', '##mi', '##de', 'by', 's', '##phi', '##ngo', '##my', '##elin', 's', '##ynth', '##ase', ',', 'the', 'knockout', 'of', 'which', 'leads', 'to', 'mitochondrial', 'd', '##ys', '##function', 'and', 'reduced', 'insulin', 'release', '.', '44', 'S', '##phi', '##ngo', '##my', '##elin', '##s', 'may', 'also', 'be', 'considered', 'a', 'source', 'of', 'c', '##era', '##mi', '##de', ',', 'which', 'directly', '(', 'and', 'indirectly', 'through', 'other', 'active', 'lip', '##id', 'products', ')', 'regulate', '##s', 'cell', 'proliferation', ',', 'a', '##pop', '##tosis', ',', 'cell', 'migration', ',', 'and', 'auto', '##pha', '##gy', '.', '45']	[0, 1, 4, 7, 9, 13, 15, 19, 23, 28, 37, 40, 41, 46, 49, 50, 53, 56, 59, 62, 64, 69, 75, 78, 79, 83, 86, 96, 97, 100, 102, 105, 109, 111, 112, 115, 117, 120, 122, 126, 127, 129, 131, 133, 135, 137, 140, 143, 144, 145, 148, 151, 160, 165, 173, 174, 176, 181, 185, 195, 202, 204, 208, 215, 222, 225, 233, 234, 237, 240, 242, 246, 248, 255, 258, 266, 274, 275, 278, 281, 283, 292, 303, 305, 306, 309, 312, 314, 318, 320, 324, 335, 338, 343, 345, 347, 352, 362, 366, 370, 380, 385, 386, 389, 392, 394, 396, 397, 400, 405, 409, 410, 413, 415, 418, 421, 422, 425, 428, 430, 435, 436, 440, 443, 445, 449, 458, 461, 467, 473, 476, 490, 491, 493, 502, 506, 514, 522, 529, 530, 533, 534, 537, 540, 542, 546, 548, 552, 557, 560, 571, 573, 580, 583, 584, 587, 589, 591, 593, 599, 608, 609, 613, 624, 632, 638, 645, 648, 651, 659, 661, 669, 671, 676, 689, 691, 692, 695, 700, 702, 707, 716, 718, 722, 726, 729, 731, 732]	[1, 4, 7, 9, 13, 14, 18, 22, 27, 36, 40, 41, 45, 48, 50, 53, 56, 59, 62, 63, 68, 74, 78, 79, 83, 85, 95, 97, 100, 102, 105, 109, 110, 112, 115, 117, 120, 121, 125, 127, 129, 131, 133, 135, 137, 140, 143, 144, 145, 147, 150, 159, 164, 172, 174, 176, 181, 184, 194, 202, 203, 207, 214, 221, 224, 232, 234, 237, 240, 242, 246, 247, 254, 257, 265, 274, 275, 277, 280, 282, 291, 303, 304, 306, 309, 312, 314, 318, 319, 323, 334, 337, 343, 345, 347, 351, 361, 365, 369, 379, 384, 386, 389, 392, 394, 396, 397, 400, 404, 408, 410, 413, 415, 417, 420, 422, 425, 428, 430, 434, 436, 440, 443, 444, 448, 457, 460, 466, 472, 475, 489, 491, 493, 501, 505, 513, 521, 529, 530, 532, 534, 537, 540, 542, 546, 547, 551, 556, 559, 570, 572, 579, 582, 584, 587, 589, 591, 592, 598, 607, 609, 612, 623, 631, 637, 644, 648, 650, 659, 660, 669, 670, 675, 689, 690, 692, 695, 700, 701, 706, 716, 717, 721, 726, 729, 731, 732, 734]	['Sphingomyelins', 'are', 'the', 'most', 'abundant', 'subclass', 'of', 'sphingolipids', ',', 'with', 'other', 'subclasses', 'including', 'sphinogosines', ',', 'ceramides', ',', 'and', 'glycophospholipids.42', 'In', 'patients', 'with', 'chronic', 'obstructive', 'pulmonary', 'disease', ',', 'low', 'plasma', 'levels', 'of', 'several', 'sphingomyelins', 'relate', 'to', 'disease', 'severity.43', 'As', 'a', 'membrane', 'constituent', ',', 'sphingomyelins', 'are', 'implicated', 'in', 'transmembrane', 'signaling', 'and', 'are', 'generated', 'from', 'phosphatidylcholine', 'and', 'ceramide', 'by', 'sphingomyelin', 'synthase', ',', 'the', 'knockout', 'of', 'which', 'leads', 'to', 'mitochondrial', 'dysfunction', 'and', 'reduced', 'insulin', 'release.44', 'Sphingomyelins', 'may', 'also', 'be', 'considered', 'a', 'source', 'of', 'ceramide', ',', 'which', 'directly', '(', 'and', 'indirectly', 'through', 'other', 'active', 'lipid', 'products', ')', 'regulates', 'cell', 'proliferation', ',', 'apoptosis', ',', 'cell', 'migration', ',', 'and', 'autophagy.45']	[6, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 4, 1, 5, 1, 4, 1, 1, 11, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 3, 1, 1, 1, 1, 1, 6, 1, 1, 1, 4, 1, 1, 1, 1, 1, 8, 1, 4, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 6, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Modified nucleosides can be released into the circulation during stress after cleavage of transfer RNAs (tRNAs) by the ribonuclease angiogenin.21 To determine whether this mechanism was relevant to PAH, we measured plasma angiogenin in a representative subset of age- and sex-matched healthy control subjects and patients with PAH from the discovery analysis (Table V in the online-only Data Supplement).	[('PMC5287439', 'R10000', 119, 131, 'ribonuclease')]	['Mo', '##dified', 'n', '##uc', '##leo', '##side', '##s', 'can', 'be', 'released', 'into', 'the', 'circulation', 'during', 'stress', 'after', 'c', '##lea', '##vage', 'of', 'transfer', 'RNA', '##s', '(', 't', '##RNA', '##s', ')', 'by', 'the', 'rib', '##on', '##uc', '##lea', '##se', 'an', '##gio', '##gen', '##in', '.', '21', 'To', 'determine', 'whether', 'this', 'mechanism', 'was', 'relevant', 'to', 'PA', '##H', ',', 'we', 'measured', 'plasma', 'an', '##gio', '##gen', '##in', 'in', 'a', 'representative', 'subset', 'of', 'age', '-', 'and', 'sex', '-', 'matched', 'healthy', 'control', 'subjects', 'and', 'patients', 'with', 'PA', '##H', 'from', 'the', 'discovery', 'analysis', '(', 'Table', 'V', 'in', 'the', 'online', '-', 'only', 'Data', 'Su', '##pp', '##lement', ')', '.']	[0, 2, 9, 10, 12, 15, 19, 21, 25, 28, 37, 42, 46, 58, 65, 72, 78, 79, 82, 87, 90, 99, 102, 104, 105, 106, 109, 110, 112, 115, 119, 122, 124, 126, 129, 132, 134, 137, 140, 142, 143, 146, 149, 159, 167, 172, 182, 186, 195, 198, 200, 201, 203, 206, 215, 222, 224, 227, 230, 233, 236, 238, 253, 260, 263, 266, 268, 272, 275, 276, 284, 292, 300, 309, 313, 322, 327, 329, 331, 336, 340, 350, 359, 360, 366, 368, 371, 375, 381, 382, 387, 392, 394, 396, 402, 403]	[2, 8, 10, 12, 15, 19, 20, 24, 27, 36, 41, 45, 57, 64, 71, 77, 79, 82, 86, 89, 98, 102, 103, 105, 106, 109, 110, 111, 114, 118, 122, 124, 126, 129, 131, 134, 137, 140, 142, 143, 145, 148, 158, 166, 171, 181, 185, 194, 197, 200, 201, 202, 205, 214, 221, 224, 227, 230, 232, 235, 237, 252, 259, 262, 266, 267, 271, 275, 276, 283, 291, 299, 308, 312, 321, 326, 329, 330, 335, 339, 349, 358, 360, 365, 367, 370, 374, 381, 382, 386, 391, 394, 396, 402, 403, 404]	['Modified', 'nucleosides', 'can', 'be', 'released', 'into', 'the', 'circulation', 'during', 'stress', 'after', 'cleavage', 'of', 'transfer', 'RNAs', '(', 'tRNAs', ')', 'by', 'the', 'ribonuclease', 'angiogenin.21', 'To', 'determine', 'whether', 'this', 'mechanism', 'was', 'relevant', 'to', 'PAH', ',', 'we', 'measured', 'plasma', 'angiogenin', 'in', 'a', 'representative', 'subset', 'of', 'age-', 'and', 'sex', '-', 'matched', 'healthy', 'control', 'subjects', 'and', 'patients', 'with', 'PAH', 'from', 'the', 'discovery', 'analysis', '(', 'Table', 'V', 'in', 'the', 'online', '-', 'only', 'Data', 'Supplement', ')', '.']	[2, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 5, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cytosolic acetyl-CoA acetyltransferase (ACAT2), apolipoprotein B, (APOB), beta-1,4-galactosyltransferase 1 (B4GALT1), fatty-acid synthase (FASN), fructose-1,6-bisphosphatase 1 (FBP1), α-L-fucosidase (FUCA1), glutathione synthetase (GSS) and gamma-glutamyltranspeptidase 1 (GGT1) antibodies were purchased from Santa Cruz Biotechnology Inc., (Dallas, TX, USA).	[('PMC5302745', 'M08000', 10, 38, 'acetyl-CoA acetyltransferase')]	['Cy', '##tos', '##olic', 'ace', '##ty', '##l', '-', 'Co', '##A', 'ace', '##ty', '##lt', '##ran', '##s', '##fer', '##ase', '(', 'AC', '##AT', '##2', ')', ',', 'a', '##poli', '##pop', '##rote', '##in', 'B', ',', '(', 'AP', '##O', '##B', ')', ',', 'beta', '-', '1', ',', '4', '-', 'gal', '##act', '##osy', '##lt', '##ran', '##s', '##fer', '##ase', '1', '(', 'B', '##4', '##GA', '##LT', '##1', ')', ',', 'fatty', '-', 'acid', 's', '##ynth', '##ase', '(', 'FA', '##SN', ')', ',', 'f', '##ru', '##ct', '##ose', '-', '1', ',', '6', '-', 'bi', '##sp', '##hos', '##pha', '##tase', '1', '(', 'F', '##B', '##P', '##1', ')', ',', 'α', '-', 'L', '-', 'f', '##uc', '##os', '##idas', '##e', '(', 'F', '##UC', '##A', '##1', ')', ',', 'g', '##lut', '##ath', '##ione', 's', '##ynth', '##eta', '##se', '(', 'G', '##SS', ')', 'and', 'gamma', '-', 'g', '##lut', '##am', '##yl', '##tra', '##ns', '##pe', '##pt', '##idas', '##e', '1', '(', 'G', '##G', '##T', '##1', ')', 'antibodies', 'were', 'purchased', 'from', 'Santa', 'Cruz', 'B', '##iot', '##ech', '##nology', 'Inc', '.', ',', '(', 'Dallas', ',', 'TX', ',', 'USA', ')', '.']	[0, 2, 5, 10, 13, 15, 16, 17, 19, 21, 24, 26, 28, 31, 32, 35, 39, 40, 42, 44, 45, 46, 48, 49, 53, 56, 60, 63, 64, 66, 67, 69, 70, 71, 72, 74, 78, 79, 80, 81, 82, 83, 86, 89, 92, 94, 97, 98, 101, 105, 107, 108, 109, 110, 112, 114, 115, 116, 118, 123, 124, 129, 130, 134, 138, 139, 141, 143, 144, 146, 147, 149, 151, 154, 155, 156, 157, 158, 159, 161, 163, 166, 169, 174, 176, 177, 178, 179, 180, 181, 182, 184, 185, 186, 187, 188, 189, 191, 193, 197, 199, 200, 201, 203, 204, 205, 206, 208, 209, 212, 215, 220, 221, 225, 228, 231, 232, 233, 235, 237, 241, 246, 247, 248, 251, 253, 255, 258, 260, 262, 264, 268, 270, 272, 273, 274, 275, 276, 277, 279, 290, 295, 305, 310, 316, 321, 322, 325, 328, 335, 338, 339, 341, 342, 348, 350, 352, 354, 357, 358]	[2, 5, 9, 13, 15, 16, 17, 19, 20, 24, 26, 28, 31, 32, 35, 38, 40, 42, 44, 45, 46, 47, 49, 53, 56, 60, 62, 64, 65, 67, 69, 70, 71, 72, 73, 78, 79, 80, 81, 82, 83, 86, 89, 92, 94, 97, 98, 101, 104, 106, 108, 109, 110, 112, 114, 115, 116, 117, 123, 124, 128, 130, 134, 137, 139, 141, 143, 144, 145, 147, 149, 151, 154, 155, 156, 157, 158, 159, 161, 163, 166, 169, 173, 175, 177, 178, 179, 180, 181, 182, 183, 185, 186, 187, 188, 189, 191, 193, 197, 198, 200, 201, 203, 204, 205, 206, 207, 209, 212, 215, 219, 221, 225, 228, 230, 232, 233, 235, 236, 240, 246, 247, 248, 251, 253, 255, 258, 260, 262, 264, 268, 269, 271, 273, 274, 275, 276, 277, 278, 289, 294, 304, 309, 315, 320, 322, 325, 328, 334, 338, 339, 340, 342, 348, 349, 352, 353, 357, 358, 359]	['Cytosolic', 'acetyl-CoA', 'acetyltransferase', '(', 'ACAT2', ')', ',', 'apolipoprotein', 'B', ',', '(', 'APOB', ')', ',', 'beta-1,4-galactosyltransferase', '1', '(', 'B4GALT1', ')', ',', 'fatty', '-', 'acid', 'synthase', '(', 'FASN', ')', ',', 'fructose-1,6-bisphosphatase', '1', '(', 'FBP1', ')', ',', 'α-L-fucosidase', '(', 'FUCA1', ')', ',', 'glutathione', 'synthetase', '(', 'GSS', ')', 'and', 'gamma', '-', 'glutamyltranspeptidase', '1', '(', 'GGT1', ')', 'antibodies', 'were', 'purchased', 'from', 'Santa', 'Cruz', 'Biotechnology', 'Inc', '.', ',', '(', 'Dallas', ',', 'TX', ',', 'USA', ')', '.']	[3, 6, 7, 1, 3, 1, 1, 5, 1, 1, 1, 3, 1, 1, 14, 1, 1, 5, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 14, 1, 1, 4, 1, 1, 9, 1, 4, 1, 1, 4, 4, 1, 2, 1, 1, 1, 1, 10, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lysosomal sialidase (NEU1), β-galactosidase (GLB1), β-hexosaminidase subunit α/β (HEXA/HEXB) and α-l-fucosidase (FUCA1) catalyze the removal of Neu/NeuNAc, β-d-Gal, GlcNAc and Fuc, respectively, from the non-core structure of N-glycans (Figure 4a).	[]	['L', '##ys', '##oso', '##mal', 'si', '##ali', '##das', '##e', '(', 'NE', '##U', '##1', ')', ',', 'β', '-', 'gal', '##act', '##os', '##idas', '##e', '(', 'G', '##L', '##B', '##1', ')', ',', 'β', '-', 'he', '##x', '##osa', '##mini', '##das', '##e', 'subunit', 'α', '/', 'β', '(', 'H', '##EX', '##A', '/', 'H', '##EX', '##B', ')', 'and', 'α', '-', 'l', '-', 'f', '##uc', '##os', '##idas', '##e', '(', 'F', '##UC', '##A', '##1', ')', 'cat', '##aly', '##ze', 'the', 'removal', 'of', 'N', '##eu', '/', 'N', '##eu', '##NA', '##c', ',', 'β', '-', 'd', '-', 'G', '##al', ',', 'G', '##l', '##c', '##NA', '##c', 'and', 'Fu', '##c', ',', 'respectively', ',', 'from', 'the', 'non', '-', 'core', 'structure', 'of', 'N', '-', 'g', '##ly', '##cans', '(', 'Figure', '4', '##a', ')', '.']	[0, 1, 3, 6, 10, 12, 15, 18, 20, 21, 23, 24, 25, 26, 28, 29, 30, 33, 36, 38, 42, 44, 45, 46, 47, 48, 49, 50, 52, 53, 54, 56, 57, 60, 64, 67, 69, 77, 78, 79, 81, 82, 83, 85, 86, 87, 88, 90, 91, 93, 97, 98, 99, 100, 101, 102, 104, 106, 110, 112, 113, 114, 116, 117, 118, 120, 123, 126, 129, 133, 141, 144, 145, 147, 148, 149, 151, 153, 154, 156, 157, 158, 159, 160, 161, 163, 165, 166, 167, 168, 170, 172, 176, 178, 179, 181, 193, 195, 200, 204, 207, 208, 213, 223, 226, 227, 228, 229, 231, 236, 237, 244, 245, 246, 247]	[1, 3, 6, 9, 12, 15, 18, 19, 21, 23, 24, 25, 26, 27, 29, 30, 33, 36, 38, 42, 43, 45, 46, 47, 48, 49, 50, 51, 53, 54, 56, 57, 60, 64, 67, 68, 76, 78, 79, 80, 82, 83, 85, 86, 87, 88, 90, 91, 92, 96, 98, 99, 100, 101, 102, 104, 106, 110, 111, 113, 114, 116, 117, 118, 119, 123, 126, 128, 132, 140, 143, 145, 147, 148, 149, 151, 153, 154, 155, 157, 158, 159, 160, 161, 163, 164, 166, 167, 168, 170, 171, 175, 178, 179, 180, 193, 194, 199, 203, 207, 208, 212, 222, 225, 227, 228, 229, 231, 235, 237, 243, 245, 246, 247, 248]	['Lysosomal', 'sialidase', '(', 'NEU1', ')', ',', 'β-galactosidase', '(', 'GLB1', ')', ',', 'β-hexosaminidase', 'subunit', 'α', '/', 'β', '(', 'HEXA', '/', 'HEXB', ')', 'and', 'α-l-fucosidase', '(', 'FUCA1', ')', 'catalyze', 'the', 'removal', 'of', 'Neu', '/', 'NeuNAc', ',', 'β-d-Gal', ',', 'GlcNAc', 'and', 'Fuc', ',', 'respectively', ',', 'from', 'the', 'non', '-', 'core', 'structure', 'of', 'N-glycans', '(', 'Figure', '4a', ')', '.']	[4, 4, 1, 3, 1, 1, 7, 1, 4, 1, 1, 8, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 9, 1, 4, 1, 3, 1, 1, 1, 2, 1, 4, 1, 6, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lysosomal α-mannosidase (MAN2B1) and lysosomal β	[]	['L', '##ys', '##oso', '##mal', 'α', '-', 'man', '##nos', '##idas', '##e', '(', 'MA', '##N', '##2', '##B', '##1', ')', 'and', 'l', '##ys', '##oso', '##mal', 'β']	[0, 1, 3, 6, 10, 11, 12, 15, 18, 22, 24, 25, 27, 28, 29, 30, 31, 33, 37, 38, 40, 43, 47]	[1, 3, 6, 9, 11, 12, 15, 18, 22, 23, 25, 27, 28, 29, 30, 31, 32, 36, 38, 40, 43, 46, 48]	['Lysosomal', 'α-mannosidase', '(', 'MAN2B1', ')', 'and', 'lysosomal', 'β']	[4, 6, 1, 5, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glycosylasparaginase (AGA) and di-N-acetylchitobiase (CTBS), both which cleave the Glc-Asn bond which joins N-glycans to proteins, were also identified.	[]	['G', '##ly', '##cos', '##yla', '##sp', '##ara', '##gin', '##ase', '(', 'AG', '##A', ')', 'and', 'di', '-', 'N', '-', 'ace', '##ty', '##l', '##chi', '##to', '##bia', '##se', '(', 'CT', '##BS', ')', ',', 'both', 'which', 'c', '##lea', '##ve', 'the', 'G', '##l', '##c', '-', 'As', '##n', 'bond', 'which', 'joins', 'N', '-', 'g', '##ly', '##cans', 'to', 'proteins', ',', 'were', 'also', 'identified', '.']	[0, 1, 3, 6, 9, 11, 14, 17, 21, 22, 24, 25, 27, 31, 33, 34, 35, 36, 39, 41, 42, 45, 47, 50, 53, 54, 56, 58, 59, 61, 66, 72, 73, 76, 79, 83, 84, 85, 86, 87, 89, 91, 96, 102, 108, 109, 110, 111, 113, 118, 121, 129, 131, 136, 141, 151]	[1, 3, 6, 9, 11, 14, 17, 20, 22, 24, 25, 26, 30, 33, 34, 35, 36, 39, 41, 42, 45, 47, 50, 52, 54, 56, 58, 59, 60, 65, 71, 73, 76, 78, 82, 84, 85, 86, 87, 89, 90, 95, 101, 107, 109, 110, 111, 113, 117, 120, 129, 130, 135, 140, 151, 152]	['Glycosylasparaginase', '(', 'AGA', ')', 'and', 'di-N-acetylchitobiase', '(', 'CTBS', ')', ',', 'both', 'which', 'cleave', 'the', 'Glc-Asn', 'bond', 'which', 'joins', 'N-glycans', 'to', 'proteins', ',', 'were', 'also', 'identified', '.']	[8, 1, 2, 1, 1, 11, 1, 2, 1, 1, 1, 1, 3, 1, 6, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among them, FUCA1, HEXB, MAN2B1 and NEU1 were found to be upregulated in later lactation (Figure 4b).	[]	['Among', 'them', ',', 'F', '##UC', '##A', '##1', ',', 'H', '##EX', '##B', ',', 'MA', '##N', '##2', '##B', '##1', 'and', 'NE', '##U', '##1', 'were', 'found', 'to', 'be', 'up', '##re', '##gu', '##lated', 'in', 'later', 'la', '##ct', '##ation', '(', 'Figure', '4', '##b', ')', '.']	[0, 6, 10, 12, 13, 15, 16, 17, 19, 20, 22, 23, 25, 27, 28, 29, 30, 32, 36, 38, 39, 41, 46, 52, 55, 58, 60, 62, 64, 70, 73, 79, 81, 83, 89, 90, 97, 98, 99, 100]	[5, 10, 11, 13, 15, 16, 17, 18, 20, 22, 23, 24, 27, 28, 29, 30, 31, 35, 38, 39, 40, 45, 51, 54, 57, 60, 62, 64, 69, 72, 78, 81, 83, 88, 90, 96, 98, 99, 100, 101]	['Among', 'them', ',', 'FUCA1', ',', 'HEXB', ',', 'MAN2B1', 'and', 'NEU1', 'were', 'found', 'to', 'be', 'upregulated', 'in', 'later', 'lactation', '(', 'Figure', '4b', ')', '.']	[1, 1, 1, 4, 1, 3, 1, 5, 1, 3, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The drug class of 3-hydroxymethyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, better known as “statins”, are widely prescribed and effective for the prevention and management of cardiovascular disease (CVD).[1] While the major CVD benefit of statins is due to reduction in plasma low density lipoprotein cholesterol (LDL-C)[2], statins also produce moderate increases, ranging from 4 to 10%, in levels of high density lipoprotein cholesterol (HDL-C).[3, 4]	[('PMC5309131', 'I00000', 18, 81, '3-hydroxymethyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase')]	['The', 'drug', 'class', 'of', '3', '-', 'h', '##ydro', '##xy', '##met', '##hyl', '-', '3', '-', 'met', '##hyl', '##g', '##lut', '##ary', '##l', 'co', '##en', '##zy', '##me', 'A', '(', 'HM', '##G', '-', 'Co', '##A', ')', 'red', '##uc', '##tase', 'inhibitor', '##s', ',', 'better', 'known', 'as', '“', 's', '##tat', '##ins', '”', ',', 'are', 'widely', 'prescribed', 'and', 'effective', 'for', 'the', 'prevention', 'and', 'management', 'of', 'card', '##iovascular', 'disease', '(', 'C', '##VD', ')', '.', '[', '1', ']', 'While', 'the', 'major', 'C', '##VD', 'benefit', 'of', 's', '##tat', '##ins', 'is', 'due', 'to', 'reduction', 'in', 'plasma', 'low', 'density', 'lip', '##op', '##rote', '##in', 'ch', '##ole', '##ster', '##ol', '(', 'L', '##D', '##L', '-', 'C', ')', '[', '2', ']', ',', 's', '##tat', '##ins', 'also', 'produce', 'moderate', 'increases', ',', 'ranging', 'from', '4', 'to', '10', '%', ',', 'in', 'levels', 'of', 'high', 'density', 'lip', '##op', '##rote', '##in', 'ch', '##ole', '##ster', '##ol', '(', 'HD', '##L', '-', 'C', ')', '.', '[', '3', ',', '4', ']']	[0, 4, 9, 15, 18, 19, 20, 21, 25, 27, 30, 33, 34, 35, 36, 39, 42, 43, 46, 49, 51, 53, 55, 57, 60, 62, 63, 65, 66, 67, 69, 70, 72, 75, 77, 82, 91, 92, 94, 101, 107, 110, 111, 112, 115, 118, 119, 121, 125, 132, 143, 147, 157, 161, 165, 176, 180, 191, 194, 198, 209, 217, 218, 219, 221, 222, 223, 224, 225, 227, 233, 237, 243, 244, 247, 255, 258, 259, 262, 266, 269, 273, 276, 286, 289, 296, 300, 308, 311, 313, 317, 320, 322, 325, 329, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 344, 345, 348, 352, 357, 365, 374, 383, 385, 393, 398, 400, 403, 405, 406, 408, 411, 418, 421, 426, 434, 437, 439, 443, 446, 448, 451, 455, 458, 459, 461, 462, 463, 464, 465, 466, 467, 468, 470, 471]	[3, 8, 14, 17, 19, 20, 21, 25, 27, 30, 33, 34, 35, 36, 39, 42, 43, 46, 49, 50, 53, 55, 57, 59, 61, 63, 65, 66, 67, 69, 70, 71, 75, 77, 81, 91, 92, 93, 100, 106, 109, 111, 112, 115, 118, 119, 120, 124, 131, 142, 146, 156, 160, 164, 175, 179, 190, 193, 198, 208, 216, 218, 219, 221, 222, 223, 224, 225, 226, 232, 236, 242, 244, 246, 254, 257, 259, 262, 265, 268, 272, 275, 285, 288, 295, 299, 307, 311, 313, 317, 319, 322, 325, 329, 331, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 345, 348, 351, 356, 364, 373, 383, 384, 392, 397, 399, 402, 405, 406, 407, 410, 417, 420, 425, 433, 437, 439, 443, 445, 448, 451, 455, 457, 459, 461, 462, 463, 464, 465, 466, 467, 468, 469, 471, 472]	['The', 'drug', 'class', 'of', '3-hydroxymethyl-3-methylglutaryl', 'coenzyme', 'A', '(', 'HMG-CoA', ')', 'reductase', 'inhibitors', ',', 'better', 'known', 'as', '“', 'statins', '”', ',', 'are', 'widely', 'prescribed', 'and', 'effective', 'for', 'the', 'prevention', 'and', 'management', 'of', 'cardiovascular', 'disease', '(CVD).[1]', 'While', 'the', 'major', 'CVD', 'benefit', 'of', 'statins', 'is', 'due', 'to', 'reduction', 'in', 'plasma', 'low', 'density', 'lipoprotein', 'cholesterol', '(LDL-C)[2]', ',', 'statins', 'also', 'produce', 'moderate', 'increases', ',', 'ranging', 'from', '4', 'to', '10%', ',', 'in', 'levels', 'of', 'high', 'density', 'lipoprotein', 'cholesterol', '(', 'HDL-C).[3', ',', '4', ']']	[1, 1, 1, 1, 16, 4, 1, 1, 5, 1, 3, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 8, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 10, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 4, 1, 8, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our study did not detect significant changes in the levels of genes for both dihydropteroate synthase and dihydrofolate reductase in the transplant, which are targets of trimethoprim/sulfamethoxazole.	[('PMC5344767', 'D05000', 77, 101, 'dihydropteroate synthase')]	['Our', 'study', 'did', 'not', 'detect', 'significant', 'changes', 'in', 'the', 'levels', 'of', 'genes', 'for', 'both', 'di', '##hy', '##dr', '##op', '##tero', '##ate', 's', '##ynth', '##ase', 'and', 'di', '##hy', '##dr', '##of', '##olate', 'red', '##uc', '##tase', 'in', 'the', 'transplant', ',', 'which', 'are', 'targets', 'of', 'trim', '##eth', '##op', '##rim', '/', 'su', '##lf', '##ame', '##th', '##ox', '##az', '##ole', '.']	[0, 4, 10, 14, 18, 25, 37, 45, 48, 52, 59, 62, 68, 72, 77, 79, 81, 83, 85, 89, 93, 94, 98, 102, 106, 108, 110, 112, 114, 120, 123, 125, 130, 133, 137, 147, 149, 155, 159, 167, 170, 174, 177, 179, 182, 183, 185, 187, 190, 192, 194, 196, 199]	[3, 9, 13, 17, 24, 36, 44, 47, 51, 58, 61, 67, 71, 76, 79, 81, 83, 85, 89, 92, 94, 98, 101, 105, 108, 110, 112, 114, 119, 123, 125, 129, 132, 136, 147, 148, 154, 158, 166, 169, 174, 177, 179, 182, 183, 185, 187, 190, 192, 194, 196, 199, 200]	['Our', 'study', 'did', 'not', 'detect', 'significant', 'changes', 'in', 'the', 'levels', 'of', 'genes', 'for', 'both', 'dihydropteroate', 'synthase', 'and', 'dihydrofolate', 'reductase', 'in', 'the', 'transplant', ',', 'which', 'are', 'targets', 'of', 'trimethoprim', '/', 'sulfamethoxazole', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 3, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 7, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, dihydrofolate synthase/folylpolyglutamate synthase, which has the potential to promote folate production from THF-polyglutamate by enzymes not directly inhibited by trimethoprim/sulfamethoxazole is produced in the transplant group.	[('PMC5344767', 'D05001', 9, 31, 'dihydrofolate synthase')]	['However', ',', 'di', '##hy', '##dr', '##of', '##olate', 's', '##ynth', '##ase', '/', 'f', '##oly', '##l', '##pol', '##y', '##g', '##lut', '##ama', '##te', 's', '##ynth', '##ase', ',', 'which', 'has', 'the', 'potential', 'to', 'promote', 'f', '##olate', 'production', 'from', 'T', '##HF', '-', 'p', '##oly', '##g', '##lut', '##ama', '##te', 'by', 'enzymes', 'not', 'directly', 'in', '##hibit', '##ed', 'by', 'trim', '##eth', '##op', '##rim', '/', 'su', '##lf', '##ame', '##th', '##ox', '##az', '##ole', 'is', 'produced', 'in', 'the', 'transplant', 'group', '.']	[0, 7, 9, 11, 13, 15, 17, 23, 24, 28, 31, 32, 33, 36, 37, 40, 41, 42, 45, 48, 51, 52, 56, 59, 61, 67, 71, 75, 85, 88, 96, 97, 103, 114, 119, 120, 122, 123, 124, 127, 128, 131, 134, 137, 140, 148, 152, 161, 163, 168, 171, 174, 178, 181, 183, 186, 187, 189, 191, 194, 196, 198, 200, 204, 207, 216, 219, 223, 234, 239]	[7, 8, 11, 13, 15, 17, 22, 24, 28, 31, 32, 33, 36, 37, 40, 41, 42, 45, 48, 50, 52, 56, 59, 60, 66, 70, 74, 84, 87, 95, 97, 102, 113, 118, 120, 122, 123, 124, 127, 128, 131, 134, 136, 139, 147, 151, 160, 163, 168, 170, 173, 178, 181, 183, 186, 187, 189, 191, 194, 196, 198, 200, 203, 206, 215, 218, 222, 233, 239, 240]	['However', ',', 'dihydrofolate', 'synthase', '/', 'folylpolyglutamate', 'synthase', ',', 'which', 'has', 'the', 'potential', 'to', 'promote', 'folate', 'production', 'from', 'THF-polyglutamate', 'by', 'enzymes', 'not', 'directly', 'inhibited', 'by', 'trimethoprim', '/', 'sulfamethoxazole', 'is', 'produced', 'in', 'the', 'transplant', 'group', '.']	[1, 1, 5, 3, 1, 9, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 9, 1, 1, 1, 1, 3, 1, 4, 1, 7, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, we detected a significant effect of year of sampling (F1,69 = 3.03, P < 0.004), likely because some subtypes occurred only in certain years, and the interaction between HA and NA subtype and the year that the mallards were sampled was significant (F1,69 = 2.14, P = 0.007).	[]	['In', 'addition', ',', 'we', 'detected', 'a', 'significant', 'effect', 'of', 'year', 'of', 'sampling', '(', 'F1', ',', '69', '=', '3', '.', '03', ',', 'P', '<', '0', '.', '00', '##4', ')', ',', 'likely', 'because', 'some', 'sub', '##type', '##s', 'occurred', 'only', 'in', 'certain', 'years', ',', 'and', 'the', 'interaction', 'between', 'H', '##A', 'and', 'N', '##A', 'sub', '##type', 'and', 'the', 'year', 'that', 'the', 'mall', '##ards', 'were', 'sampled', 'was', 'significant', '(', 'F1', ',', '69', '=', '2', '.', '14', ',', 'P', '=', '0', '.', '00', '##7', ')', '.']	[0, 3, 11, 13, 16, 25, 27, 39, 46, 49, 54, 57, 66, 67, 69, 70, 73, 75, 76, 77, 79, 81, 83, 85, 86, 87, 89, 90, 91, 93, 100, 108, 113, 116, 120, 122, 131, 136, 139, 147, 152, 154, 158, 162, 174, 182, 183, 185, 189, 190, 192, 195, 200, 204, 208, 213, 218, 222, 226, 231, 236, 244, 248, 260, 261, 263, 264, 267, 269, 270, 271, 273, 275, 277, 279, 280, 281, 283, 284, 285]	[2, 11, 12, 15, 24, 26, 38, 45, 48, 53, 56, 65, 67, 69, 70, 72, 74, 76, 77, 79, 80, 82, 84, 86, 87, 89, 90, 91, 92, 99, 107, 112, 116, 120, 121, 130, 135, 138, 146, 152, 153, 157, 161, 173, 181, 183, 184, 188, 190, 191, 195, 199, 203, 207, 212, 217, 221, 226, 230, 235, 243, 247, 259, 261, 263, 264, 266, 268, 270, 271, 273, 274, 276, 278, 280, 281, 283, 284, 285, 286]	['In', 'addition', ',', 'we', 'detected', 'a', 'significant', 'effect', 'of', 'year', 'of', 'sampling', '(', 'F1', ',', '69', '=', '3.03', ',', 'P', '<', '0.004', ')', ',', 'likely', 'because', 'some', 'subtypes', 'occurred', 'only', 'in', 'certain', 'years', ',', 'and', 'the', 'interaction', 'between', 'HA', 'and', 'NA', 'subtype', 'and', 'the', 'year', 'that', 'the', 'mallards', 'were', 'sampled', 'was', 'significant', '(', 'F1', ',', '69', '=', '2.14', ',', 'P', '=', '0.007', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Compared with the healthy group, patients with NAFLD and NASH had much higher concentrations of glycosylated hemoglobin (HbA1c), low-density lipoprotein-cholesterol (LDL), triglycerides (TG), total cholesterol (TC), ALT, aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and total bilirubin (TBiL).	[('PMC5403757', 'R01000', 221, 247, 'aspartate aminotransferase')]	['Compared', 'with', 'the', 'healthy', 'group', ',', 'patients', 'with', 'N', '##AF', '##LD', 'and', 'NAS', '##H', 'had', 'much', 'higher', 'concentrations', 'of', 'g', '##ly', '##cos', '##yla', '##ted', 'hem', '##og', '##lo', '##bin', '(', 'H', '##b', '##A', '##1', '##c', ')', ',', 'low', '-', 'density', 'lip', '##op', '##rote', '##in', '-', 'ch', '##ole', '##ster', '##ol', '(', 'L', '##D', '##L', ')', ',', 't', '##rig', '##ly', '##cer', '##ides', '(', 'T', '##G', ')', ',', 'total', 'ch', '##ole', '##ster', '##ol', '(', 'T', '##C', ')', ',', 'AL', '##T', ',', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'gamma', '-', 'g', '##lut', '##am', '##yl', 'transfer', '##ase', '(', 'G', '##G', '##T', ')', ',', 'and', 'total', 'bi', '##li', '##ru', '##bin', '(', 'T', '##B', '##i', '##L', ')', '.']	[0, 9, 14, 18, 26, 31, 33, 42, 47, 48, 50, 53, 57, 60, 62, 66, 71, 78, 93, 96, 97, 99, 102, 105, 109, 112, 114, 116, 120, 121, 122, 123, 124, 125, 126, 127, 129, 132, 133, 141, 144, 146, 150, 152, 153, 155, 158, 162, 165, 166, 167, 168, 169, 170, 172, 173, 176, 178, 181, 186, 187, 188, 189, 190, 192, 198, 200, 203, 207, 210, 211, 212, 213, 214, 216, 218, 219, 221, 223, 226, 231, 236, 239, 241, 244, 248, 249, 251, 252, 253, 255, 260, 261, 262, 265, 267, 270, 278, 282, 283, 284, 285, 286, 287, 289, 293, 299, 301, 303, 305, 309, 310, 311, 312, 313, 314, 315]	[8, 13, 17, 25, 31, 32, 41, 46, 48, 50, 52, 56, 60, 61, 65, 70, 77, 92, 95, 97, 99, 102, 105, 108, 112, 114, 116, 119, 121, 122, 123, 124, 125, 126, 127, 128, 132, 133, 140, 144, 146, 150, 152, 153, 155, 158, 162, 164, 166, 167, 168, 169, 170, 171, 173, 176, 178, 181, 185, 187, 188, 189, 190, 191, 197, 200, 203, 207, 209, 211, 212, 213, 214, 215, 218, 219, 220, 223, 226, 230, 236, 239, 241, 244, 247, 249, 251, 252, 253, 254, 260, 261, 262, 265, 267, 269, 278, 281, 283, 284, 285, 286, 287, 288, 292, 298, 301, 303, 305, 308, 310, 311, 312, 313, 314, 315, 316]	['Compared', 'with', 'the', 'healthy', 'group', ',', 'patients', 'with', 'NAFLD', 'and', 'NASH', 'had', 'much', 'higher', 'concentrations', 'of', 'glycosylated', 'hemoglobin', '(', 'HbA1c', ')', ',', 'low', '-', 'density', 'lipoprotein', '-', 'cholesterol', '(', 'LDL', ')', ',', 'triglycerides', '(', 'TG', ')', ',', 'total', 'cholesterol', '(', 'TC', ')', ',', 'ALT', ',', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'gamma', '-', 'glutamyl', 'transferase', '(', 'GGT', ')', ',', 'and', 'total', 'bilirubin', '(', 'TBiL', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 5, 4, 1, 5, 1, 1, 1, 1, 1, 4, 1, 4, 1, 3, 1, 1, 5, 1, 2, 1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 3, 5, 1, 2, 1, 1, 1, 1, 4, 2, 1, 3, 1, 1, 1, 1, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In pathway analysis, the observed genetic variants were significantly enriched for canonical pathways that might be involved in the biological regulation of echocardiographic traits: protein kinase A signaling (P = 5.8 × 10–6), death receptor signaling (P = 6.9 × 10–5), the Wnt/Ca2+ pathway (P = 2.2 × 10–4), and P2Y purigenic receptor signaling (P = 4.1 × 10–4, Supplemental Tables 13 and 14, Supplemental Figure 20, and refs.	[('PMC5409098', 'R05000', 183, 199, 'protein kinase A')]	['In', 'pathway', 'analysis', ',', 'the', 'observed', 'genetic', 'variants', 'were', 'significantly', 'en', '##rich', '##ed', 'for', 'canonical', 'pathways', 'that', 'might', 'be', 'involved', 'in', 'the', 'biological', 'regulation', 'of', 'echo', '##card', '##io', '##graphic', 'traits', ':', 'protein', 'kinase', 'A', 'signaling', '(', 'P', '=', '5', '.', '8', '×', '10', '–', '6', ')', ',', 'death', 'receptor', 'signaling', '(', 'P', '=', '6', '.', '9', '×', '10', '–', '5', ')', ',', 'the', 'W', '##nt', '/', 'C', '##a', '##2', '+', 'pathway', '(', 'P', '=', '2', '.', '2', '×', '10', '–', '4', ')', ',', 'and', 'P', '##2', '##Y', 'pu', '##rig', '##eni', '##c', 'receptor', 'signaling', '(', 'P', '=', '4', '.', '1', '×', '10', '–', '4', ',', 'Su', '##pp', '##lement', '##al', 'Table', '##s', '13', 'and', '14', ',', 'Su', '##pp', '##lement', '##al', 'Figure', '20', ',', 'and', 're', '##fs', '.']	[0, 3, 11, 19, 21, 25, 34, 42, 51, 56, 70, 72, 76, 79, 83, 93, 102, 107, 113, 116, 125, 128, 132, 143, 154, 157, 161, 165, 167, 175, 181, 183, 191, 198, 200, 210, 211, 213, 215, 216, 217, 219, 221, 223, 224, 225, 226, 228, 234, 243, 253, 254, 256, 258, 259, 260, 262, 264, 266, 267, 268, 269, 271, 275, 276, 278, 279, 280, 281, 282, 284, 292, 293, 295, 297, 298, 299, 301, 303, 305, 306, 307, 308, 310, 314, 315, 316, 318, 320, 323, 326, 328, 337, 347, 348, 350, 352, 353, 354, 356, 358, 360, 361, 362, 364, 366, 368, 374, 377, 382, 384, 387, 391, 393, 395, 397, 399, 405, 408, 415, 417, 419, 423, 425, 427]	[2, 10, 19, 20, 24, 33, 41, 50, 55, 69, 72, 76, 78, 82, 92, 101, 106, 112, 115, 124, 127, 131, 142, 153, 156, 161, 165, 167, 174, 181, 182, 190, 197, 199, 209, 211, 212, 214, 216, 217, 218, 220, 223, 224, 225, 226, 227, 233, 242, 252, 254, 255, 257, 259, 260, 261, 263, 266, 267, 268, 269, 270, 274, 276, 278, 279, 280, 281, 282, 283, 291, 293, 294, 296, 298, 299, 300, 302, 305, 306, 307, 308, 309, 313, 315, 316, 317, 320, 323, 326, 327, 336, 346, 348, 349, 351, 353, 354, 355, 357, 360, 361, 362, 363, 366, 368, 374, 376, 382, 383, 386, 390, 393, 394, 397, 399, 405, 407, 414, 417, 418, 422, 425, 427, 428]	['In', 'pathway', 'analysis', ',', 'the', 'observed', 'genetic', 'variants', 'were', 'significantly', 'enriched', 'for', 'canonical', 'pathways', 'that', 'might', 'be', 'involved', 'in', 'the', 'biological', 'regulation', 'of', 'echocardiographic', 'traits', ':', 'protein', 'kinase', 'A', 'signaling', '(', 'P', '=', '5.8', '×', '10–', '6', ')', ',', 'death', 'receptor', 'signaling', '(', 'P', '=', '6.9', '×', '10–', '5', ')', ',', 'the', 'Wnt', '/', 'Ca2+', 'pathway', '(', 'P', '=', '2.2', '×', '10–', '4', ')', ',', 'and', 'P2Y', 'purigenic', 'receptor', 'signaling', '(', 'P', '=', '4.1', '×', '10–', '4', ',', 'Supplemental', 'Tables', '13', 'and', '14', ',', 'Supplemental', 'Figure', '20', ',', 'and', 'refs', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 4, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
When investigating the potential regulatory effect of the top loci using Encyclopedia of DNA Elements (ENCODE) data (17), 4 SNPs (rs10774625, rs6702619, rs17608766, and rs11207426) were located within enhancer histone marks and 4 (rs806322, rs6702619, rs7127129, and rs17608766) within DNase-hypersensitive sites.	[('PMC5409098', 'R06000', 286, 291, 'DNase')]	['When', 'investigating', 'the', 'potential', 'regulatory', 'effect', 'of', 'the', 'top', 'lo', '##ci', 'using', 'Encyclopedia', 'of', 'DNA', 'Elements', '(', 'E', '##NC', '##OD', '##E', ')', 'data', '(', '17', ')', ',', '4', 'S', '##NP', '##s', '(', 'r', '##s', '##10', '##7', '##7', '##46', '##25', ',', 'r', '##s', '##6', '##70', '##26', '##19', ',', 'r', '##s', '##17', '##60', '##8', '##7', '##6', '##6', ',', 'and', 'r', '##s', '##11', '##20', '##7', '##42', '##6', ')', 'were', 'located', 'within', 'enhance', '##r', 'his', '##tone', 'marks', 'and', '4', '(', 'r', '##s', '##80', '##6', '##32', '##2', ',', 'r', '##s', '##6', '##70', '##26', '##19', ',', 'r', '##s', '##7', '##12', '##7', '##12', '##9', ',', 'and', 'r', '##s', '##17', '##60', '##8', '##7', '##6', '##6', ')', 'within', 'D', '##N', '##ase', '-', 'h', '##yper', '##sen', '##sitive', 'sites', '.']	[0, 5, 19, 23, 33, 44, 51, 54, 58, 62, 64, 67, 73, 86, 89, 93, 102, 103, 104, 106, 108, 109, 111, 116, 117, 119, 120, 122, 124, 125, 127, 129, 130, 131, 132, 134, 135, 136, 138, 140, 142, 143, 144, 145, 147, 149, 151, 153, 154, 155, 157, 159, 160, 161, 162, 163, 165, 169, 170, 171, 173, 175, 176, 178, 179, 181, 186, 194, 201, 208, 210, 213, 218, 224, 228, 230, 231, 232, 233, 235, 236, 238, 239, 241, 242, 243, 244, 246, 248, 250, 252, 253, 254, 255, 257, 258, 260, 261, 263, 267, 268, 269, 271, 273, 274, 275, 276, 277, 279, 286, 287, 288, 291, 292, 293, 297, 300, 307, 312]	[4, 18, 22, 32, 43, 50, 53, 57, 61, 64, 66, 72, 85, 88, 92, 101, 103, 104, 106, 108, 109, 110, 115, 117, 119, 120, 121, 123, 125, 127, 128, 130, 131, 132, 134, 135, 136, 138, 140, 141, 143, 144, 145, 147, 149, 151, 152, 154, 155, 157, 159, 160, 161, 162, 163, 164, 168, 170, 171, 173, 175, 176, 178, 179, 180, 185, 193, 200, 208, 209, 213, 217, 223, 227, 229, 231, 232, 233, 235, 236, 238, 239, 240, 242, 243, 244, 246, 248, 250, 251, 253, 254, 255, 257, 258, 260, 261, 262, 266, 268, 269, 271, 273, 274, 275, 276, 277, 278, 285, 287, 288, 291, 292, 293, 297, 300, 306, 312, 313]	['When', 'investigating', 'the', 'potential', 'regulatory', 'effect', 'of', 'the', 'top', 'loci', 'using', 'Encyclopedia', 'of', 'DNA', 'Elements', '(', 'ENCODE', ')', 'data', '(', '17', ')', ',', '4', 'SNPs', '(', 'rs10774625', ',', 'rs6702619', ',', 'rs17608766', ',', 'and', 'rs11207426', ')', 'were', 'located', 'within', 'enhancer', 'histone', 'marks', 'and', '4', '(', 'rs806322', ',', 'rs6702619', ',', 'rs7127129', ',', 'and', 'rs17608766', ')', 'within', 'DNase', '-', 'hypersensitive', 'sites', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 7, 1, 6, 1, 8, 1, 1, 7, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 6, 1, 6, 1, 7, 1, 1, 8, 1, 1, 3, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our data showed 4 SNPs that were significantly associated with cis transcripts in both datasets (whole blood and monocytes, Supplemental Table 16): rs10774625 with SH2B adaptor protein 3 (SH2B3, P = 8.15 × 10–20 and P = 1.83 × 10–4), rs17696696 with craniofacial development protein 1 (CFDP1, P = 6.21 × 10–11 and P = 7.59 × 10–5), rs7127129 with Fas-associated death domain–containing protein (FADD, P = 1.61 × 10–37 and P = 2.71 × 10–4), and rs1532292 with serine racemase (SRR, P = 3.40 × 10–20 and P = 4.63 × 10–10).	[('PMC5409098', 'R07000', 459, 474, 'serine racemase')]	['Our', 'data', 'showed', '4', 'S', '##NP', '##s', 'that', 'were', 'significantly', 'associated', 'with', 'c', '##is', 'trans', '##cripts', 'in', 'both', 'data', '##sets', '(', 'whole', 'blood', 'and', 'mon', '##ocytes', ',', 'Su', '##pp', '##lement', '##al', 'Table', '16', ')', ':', 'r', '##s', '##10', '##7', '##7', '##46', '##25', 'with', 'SH', '##2', '##B', 'adapt', '##or', 'protein', '3', '(', 'SH', '##2', '##B', '##3', ',', 'P', '=', '8', '.', '15', '×', '10', '–', '20', 'and', 'P', '=', '1', '.', '83', '×', '10', '–', '4', ')', ',', 'r', '##s', '##17', '##6', '##9', '##6', '##6', '##9', '##6', 'with', 'c', '##rani', '##of', '##ac', '##ial', 'development', 'protein', '1', '(', 'CF', '##DP', '##1', ',', 'P', '=', '6', '.', '21', '×', '10', '–', '11', 'and', 'P', '=', '7', '.', '59', '×', '10', '–', '5', ')', ',', 'r', '##s', '##7', '##12', '##7', '##12', '##9', 'with', 'F', '##as', '-', 'associated', 'death', 'domain', '–', 'containing', 'protein', '(', 'FA', '##D', '##D', ',', 'P', '=', '1', '.', '61', '×', '10', '–', '37', 'and', 'P', '=', '2', '.', '71', '×', '10', '–', '4', ')', ',', 'and', 'r', '##s', '##15', '##32', '##29', '##2', 'with', 'se', '##rine', 'race', '##mas', '##e', '(', 'SR', '##R', ',', 'P', '=', '3', '.', '40', '×', '10', '–', '20', 'and', 'P', '=', '4', '.', '63', '×', '10', '–', '10', ')', '.']	[0, 4, 9, 16, 18, 19, 21, 23, 28, 33, 47, 58, 63, 64, 67, 72, 79, 82, 87, 91, 96, 97, 103, 109, 113, 116, 122, 124, 126, 128, 134, 137, 143, 145, 146, 148, 149, 150, 152, 153, 154, 156, 159, 164, 166, 167, 169, 174, 177, 185, 187, 188, 190, 191, 192, 193, 195, 197, 199, 200, 201, 204, 206, 208, 209, 212, 216, 218, 220, 221, 222, 225, 227, 229, 230, 231, 232, 234, 235, 236, 238, 239, 240, 241, 242, 243, 245, 250, 251, 255, 257, 259, 263, 275, 283, 285, 286, 288, 290, 291, 293, 295, 297, 298, 299, 302, 304, 306, 307, 310, 314, 316, 318, 319, 320, 323, 325, 327, 328, 329, 330, 332, 333, 334, 335, 337, 338, 340, 342, 347, 348, 350, 351, 362, 368, 374, 375, 386, 394, 395, 397, 398, 399, 401, 403, 405, 406, 407, 410, 412, 414, 415, 418, 422, 424, 426, 427, 428, 431, 433, 435, 436, 437, 438, 440, 444, 445, 446, 448, 450, 452, 454, 459, 461, 466, 470, 473, 475, 476, 478, 479, 481, 483, 485, 486, 487, 490, 492, 494, 495, 498, 502, 504, 506, 507, 508, 511, 513, 515, 516, 518, 519]	[3, 8, 15, 17, 19, 21, 22, 27, 32, 46, 57, 62, 64, 66, 72, 78, 81, 86, 91, 95, 97, 102, 108, 112, 116, 122, 123, 126, 128, 134, 136, 142, 145, 146, 147, 149, 150, 152, 153, 154, 156, 158, 163, 166, 167, 168, 174, 176, 184, 186, 188, 190, 191, 192, 193, 194, 196, 198, 200, 201, 203, 205, 208, 209, 211, 215, 217, 219, 221, 222, 224, 226, 229, 230, 231, 232, 233, 235, 236, 238, 239, 240, 241, 242, 243, 244, 249, 251, 255, 257, 259, 262, 274, 282, 284, 286, 288, 290, 291, 292, 294, 296, 298, 299, 301, 303, 306, 307, 309, 313, 315, 317, 319, 320, 322, 324, 327, 328, 329, 330, 331, 333, 334, 335, 337, 338, 340, 341, 346, 348, 350, 351, 361, 367, 374, 375, 385, 393, 395, 397, 398, 399, 400, 402, 404, 406, 407, 409, 411, 414, 415, 417, 421, 423, 425, 427, 428, 430, 432, 435, 436, 437, 438, 439, 443, 445, 446, 448, 450, 452, 453, 458, 461, 465, 470, 473, 474, 476, 478, 479, 480, 482, 484, 486, 487, 489, 491, 494, 495, 497, 501, 503, 505, 507, 508, 510, 512, 515, 516, 518, 519, 520]	['Our', 'data', 'showed', '4', 'SNPs', 'that', 'were', 'significantly', 'associated', 'with', 'cis', 'transcripts', 'in', 'both', 'datasets', '(', 'whole', 'blood', 'and', 'monocytes', ',', 'Supplemental', 'Table', '16', ')', ':', 'rs10774625', 'with', 'SH2B', 'adaptor', 'protein', '3', '(', 'SH2B3', ',', 'P', '=', '8.15', '×', '10–', '20', 'and', 'P', '=', '1.83', '×', '10–', '4', ')', ',', 'rs17696696', 'with', 'craniofacial', 'development', 'protein', '1', '(', 'CFDP1', ',', 'P', '=', '6.21', '×', '10–', '11', 'and', 'P', '=', '7.59', '×', '10–', '5', ')', ',', 'rs7127129', 'with', 'Fas', '-', 'associated', 'death', 'domain', '–', 'containing', 'protein', '(', 'FADD', ',', 'P', '=', '1.61', '×', '10–', '37', 'and', 'P', '=', '2.71', '×', '10–', '4', ')', ',', 'and', 'rs1532292', 'with', 'serine', 'racemase', '(', 'SRR', ',', 'P', '=', '3.40', '×', '10–', '20', 'and', 'P', '=', '4.63', '×', '10–', '10', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 7, 1, 3, 2, 1, 1, 1, 4, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 9, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 6, 1, 2, 3, 1, 2, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenerative disease of autosomal recessive inheritance.	[]	['In', '##fant', '##ile', 'c', '##ere', '##bella', '##r', '-', 're', '##tina', '##l', 'de', '##gene', '##ration', 'associated', 'with', 'mutations', 'in', 'the', 'mitochondrial', 'a', '##con', '##itas', '##e', '2', 'gene', '(', 'AC', '##O', '##2', ')', 'has', 'been', 'recently', 'described', 'as', 'a', 'ne', '##uro', '##de', '##gene', '##rative', 'disease', 'of', 'auto', '##so', '##mal', 're', '##cess', '##ive', 'inheritance', '.']	[0, 2, 6, 10, 11, 14, 19, 20, 21, 23, 27, 29, 31, 35, 42, 53, 58, 68, 71, 75, 89, 90, 93, 97, 99, 101, 106, 107, 109, 110, 111, 113, 117, 122, 131, 141, 144, 146, 148, 151, 153, 157, 164, 172, 175, 179, 181, 185, 187, 191, 195, 206]	[2, 6, 9, 11, 14, 19, 20, 21, 23, 27, 28, 31, 35, 41, 52, 57, 67, 70, 74, 88, 90, 93, 97, 98, 100, 105, 107, 109, 110, 111, 112, 116, 121, 130, 140, 143, 145, 148, 151, 153, 157, 163, 171, 174, 179, 181, 184, 187, 191, 194, 206, 207]	['Infantile', 'cerebellar', '-', 'retinal', 'degeneration', 'associated', 'with', 'mutations', 'in', 'the', 'mitochondrial', 'aconitase', '2', 'gene', '(', 'ACO2', ')', 'has', 'been', 'recently', 'described', 'as', 'a', 'neurodegenerative', 'disease', 'of', 'autosomal', 'recessive', 'inheritance', '.']	[3, 4, 1, 3, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The enzyme aconitase (aconitate hydratase; EC 4.2.1.3) exists as cytosolic (ACO1) and mitochondrial (ACO2) isoforms, both of which catalyze the reversible isomerization of citrate to isocitrate (S1 Fig).	[('PMC5413020', 'D00000', 11, 20, 'aconitase')]	['The', 'enzyme', 'a', '##con', '##itas', '##e', '(', 'a', '##con', '##itate', 'h', '##yd', '##rata', '##se', ';', 'EC', '4', '.', '2', '.', '1', '.', '3', ')', 'exists', 'as', 'c', '##yt', '##oso', '##lic', '(', 'AC', '##O', '##1', ')', 'and', 'mitochondrial', '(', 'AC', '##O', '##2', ')', 'is', '##of', '##orms', ',', 'both', 'of', 'which', 'cat', '##aly', '##ze', 'the', 're', '##versible', 'is', '##omer', '##ization', 'of', 'c', '##it', '##rate', 'to', 'is', '##oc', '##it', '##rate', '(', 'S', '##1', 'Fi', '##g', ')', '.']	[0, 4, 11, 12, 15, 19, 21, 22, 23, 26, 32, 33, 35, 39, 41, 43, 46, 47, 48, 49, 50, 51, 52, 53, 55, 62, 65, 66, 68, 71, 75, 76, 78, 79, 80, 82, 86, 100, 101, 103, 104, 105, 107, 109, 111, 115, 117, 122, 125, 131, 134, 137, 140, 144, 146, 155, 157, 161, 169, 172, 173, 175, 180, 183, 185, 187, 189, 194, 195, 196, 198, 200, 201, 202]	[3, 10, 12, 15, 19, 20, 22, 23, 26, 31, 33, 35, 39, 41, 42, 45, 47, 48, 49, 50, 51, 52, 53, 54, 61, 64, 66, 68, 71, 74, 76, 78, 79, 80, 81, 85, 99, 101, 103, 104, 105, 106, 109, 111, 115, 116, 121, 124, 130, 134, 137, 139, 143, 146, 154, 157, 161, 168, 171, 173, 175, 179, 182, 185, 187, 189, 193, 195, 196, 197, 200, 201, 202, 203]	['The', 'enzyme', 'aconitase', '(', 'aconitate', 'hydratase', ';', 'EC', '4.2.1.3', ')', 'exists', 'as', 'cytosolic', '(', 'ACO1', ')', 'and', 'mitochondrial', '(', 'ACO2', ')', 'isoforms', ',', 'both', 'of', 'which', 'catalyze', 'the', 'reversible', 'isomerization', 'of', 'citrate', 'to', 'isocitrate', '(', 'S1', 'Fig', ')', '.']	[1, 1, 4, 1, 3, 4, 1, 1, 7, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 2, 3, 1, 3, 1, 4, 1, 2, 2, 1, 1]	['O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Mitochondrial aconitase catalyzes the stereospecific isomerization of citrate to isocitrate.	[('PMC5413020', 'D06000', 14, 23, 'aconitase')]	['Mi', '##to', '##cho', '##nd', '##rial', 'a', '##con', '##itas', '##e', 'cat', '##aly', '##zes', 'the', 'stereo', '##sp', '##ec', '##ific', 'is', '##omer', '##ization', 'of', 'c', '##it', '##rate', 'to', 'is', '##oc', '##it', '##rate', '.']	[0, 2, 4, 7, 9, 14, 15, 18, 22, 24, 27, 30, 34, 38, 44, 46, 48, 53, 55, 59, 67, 70, 71, 73, 78, 81, 83, 85, 87, 91]	[2, 4, 7, 9, 13, 15, 18, 22, 23, 27, 30, 33, 37, 44, 46, 48, 52, 55, 59, 66, 69, 71, 73, 77, 80, 83, 85, 87, 91, 92]	['Mitochondrial', 'aconitase', 'catalyzes', 'the', 'stereospecific', 'isomerization', 'of', 'citrate', 'to', 'isocitrate', '.']	[5, 4, 3, 1, 4, 3, 1, 3, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acon-knockdown flies showed significantly decreased intermediate metabolites of glycolysis, namely glucose-1-phosphate, glucose-6-phosphate, fructose-6-phosphate, glyceraldehyde-3-phosphate, 2-phosphoglycerate, 3-phosphoglycerate, phosphoenolpyruvate (PEP) and pyruvate [22].	[]	['A', '##con', '-', 'knock', '##down', 'flies', 'showed', 'significantly', 'decreased', 'intermediate', 'meta', '##bol', '##ites', 'of', 'g', '##ly', '##co', '##lysis', ',', 'namely', 'glucose', '-', '1', '-', 'phosphate', ',', 'glucose', '-', '6', '-', 'phosphate', ',', 'f', '##ru', '##ct', '##ose', '-', '6', '-', 'phosphate', ',', 'g', '##ly', '##cer', '##ald', '##eh', '##yd', '##e', '-', '3', '-', 'phosphate', ',', '2', '-', 'p', '##hos', '##ph', '##og', '##ly', '##cer', '##ate', ',', '3', '-', 'p', '##hos', '##ph', '##og', '##ly', '##cer', '##ate', ',', 'p', '##hos', '##ph', '##oe', '##no', '##l', '##py', '##ru', '##vate', '(', 'P', '##EP', ')', 'and', 'p', '##yr', '##u', '##vate', '[', '22', ']', '.']	[0, 1, 4, 5, 10, 15, 21, 28, 42, 52, 65, 69, 72, 77, 80, 81, 83, 85, 90, 92, 99, 106, 107, 108, 109, 118, 120, 127, 128, 129, 130, 139, 141, 142, 144, 146, 149, 150, 151, 152, 161, 163, 164, 166, 169, 172, 174, 176, 177, 178, 179, 180, 189, 191, 192, 193, 194, 197, 199, 201, 203, 206, 209, 211, 212, 213, 214, 217, 219, 221, 223, 226, 229, 231, 232, 235, 237, 239, 241, 242, 244, 246, 251, 252, 253, 255, 257, 261, 262, 264, 265, 270, 271, 273, 274]	[1, 4, 5, 10, 14, 20, 27, 41, 51, 64, 69, 72, 76, 79, 81, 83, 85, 90, 91, 98, 106, 107, 108, 109, 118, 119, 127, 128, 129, 130, 139, 140, 142, 144, 146, 149, 150, 151, 152, 161, 162, 164, 166, 169, 172, 174, 176, 177, 178, 179, 180, 189, 190, 192, 193, 194, 197, 199, 201, 203, 206, 209, 210, 212, 213, 214, 217, 219, 221, 223, 226, 229, 230, 232, 235, 237, 239, 241, 242, 244, 246, 250, 252, 253, 255, 256, 260, 262, 264, 265, 269, 271, 273, 274, 275]	['Acon', '-', 'knockdown', 'flies', 'showed', 'significantly', 'decreased', 'intermediate', 'metabolites', 'of', 'glycolysis', ',', 'namely', 'glucose-1-phosphate', ',', 'glucose-6-phosphate', ',', 'fructose-6-phosphate', ',', 'glyceraldehyde-3-phosphate', ',', '2-phosphoglycerate', ',', '3-phosphoglycerate', ',', 'phosphoenolpyruvate', '(', 'PEP', ')', 'and', 'pyruvate', '[', '22', ']', '.']	[2, 1, 2, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 5, 1, 5, 1, 8, 1, 11, 1, 9, 1, 9, 1, 9, 1, 2, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Citrate also promotes fatty acid synthesis through allosteric activation of acetyl-CoA carboxylase [32, 33].	[('PMC5413020', 'D07000', 76, 98, 'acetyl-CoA carboxylase')]	['C', '##it', '##rate', 'also', 'promotes', 'fatty', 'acid', 'synthesis', 'through', 'all', '##ost', '##eric', 'activation', 'of', 'ace', '##ty', '##l', '-', 'Co', '##A', 'car', '##box', '##yla', '##se', '[', '32', ',', '33', ']', '.']	[0, 1, 3, 8, 13, 22, 28, 33, 43, 51, 54, 57, 62, 73, 76, 79, 81, 82, 83, 85, 87, 90, 93, 96, 99, 100, 102, 104, 106, 107]	[1, 3, 7, 12, 21, 27, 32, 42, 50, 54, 57, 61, 72, 75, 79, 81, 82, 83, 85, 86, 90, 93, 96, 98, 100, 102, 103, 106, 107, 108]	['Citrate', 'also', 'promotes', 'fatty', 'acid', 'synthesis', 'through', 'allosteric', 'activation', 'of', 'acetyl-CoA', 'carboxylase', '[', '32', ',', '33', ']', '.']	[3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 6, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Acetyl-CoA carboxylase generates malonyl-CoA, an allosteric inhibitor of carnitine palmitoyltransferase-1 that controls the influx of long chain fatty acids into mitochondria for β-oxidation [34, 35].	[('PMC5413020', 'D07001', 0, 22, 'Acetyl-CoA carboxylase')]	['Ace', '##ty', '##l', '-', 'Co', '##A', 'car', '##box', '##yla', '##se', 'generates', 'ma', '##lon', '##yl', '-', 'Co', '##A', ',', 'an', 'all', '##ost', '##eric', 'inhibitor', 'of', 'car', '##ni', '##tine', 'palm', '##ito', '##yl', '##tra', '##ns', '##fer', '##ase', '-', '1', 'that', 'controls', 'the', 'influx', 'of', 'long', 'chain', 'fatty', 'acids', 'into', 'mit', '##och', '##ond', '##ria', 'for', 'β', '-', 'oxidation', '[', '34', ',', '35', ']', '.']	[0, 3, 5, 6, 7, 9, 11, 14, 17, 20, 23, 33, 35, 38, 40, 41, 43, 44, 46, 49, 52, 55, 60, 70, 73, 76, 78, 83, 87, 90, 92, 95, 97, 100, 103, 104, 106, 111, 120, 124, 131, 134, 139, 145, 151, 157, 162, 165, 168, 171, 175, 179, 180, 181, 191, 192, 194, 196, 198, 199]	[3, 5, 6, 7, 9, 10, 14, 17, 20, 22, 32, 35, 38, 40, 41, 43, 44, 45, 48, 52, 55, 59, 69, 72, 76, 78, 82, 87, 90, 92, 95, 97, 100, 103, 104, 105, 110, 119, 123, 130, 133, 138, 144, 150, 156, 161, 165, 168, 171, 174, 178, 180, 181, 190, 192, 194, 195, 198, 199, 200]	['Acetyl-CoA', 'carboxylase', 'generates', 'malonyl-CoA', ',', 'an', 'allosteric', 'inhibitor', 'of', 'carnitine', 'palmitoyltransferase-1', 'that', 'controls', 'the', 'influx', 'of', 'long', 'chain', 'fatty', 'acids', 'into', 'mitochondria', 'for', 'β-oxidation', '[', '34', ',', '35', ']', '.']	[6, 4, 1, 6, 1, 1, 3, 1, 1, 3, 9, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Infantile cerebellar-retinal degeneration associated with mutations in the mitochondrial aconitase 2 gene (ACO2) has been recently described in eight individuals from two unrelated Arab families [2] and three patients of French or Algerian descent [3].	[('PMC5413020', 'I02000', 89, 100, 'aconitase 2')]	['In', '##fant', '##ile', 'c', '##ere', '##bella', '##r', '-', 're', '##tina', '##l', 'de', '##gene', '##ration', 'associated', 'with', 'mutations', 'in', 'the', 'mitochondrial', 'a', '##con', '##itas', '##e', '2', 'gene', '(', 'AC', '##O', '##2', ')', 'has', 'been', 'recently', 'described', 'in', 'eight', 'individuals', 'from', 'two', 'unrelated', 'Arab', 'families', '[', '2', ']', 'and', 'three', 'patients', 'of', 'French', 'or', 'Algerian', 'descent', '[', '3', ']', '.']	[0, 2, 6, 10, 11, 14, 19, 20, 21, 23, 27, 29, 31, 35, 42, 53, 58, 68, 71, 75, 89, 90, 93, 97, 99, 101, 106, 107, 109, 110, 111, 113, 117, 122, 131, 141, 144, 150, 162, 167, 171, 181, 186, 195, 196, 197, 199, 203, 209, 218, 221, 228, 231, 240, 248, 249, 250, 251]	[2, 6, 9, 11, 14, 19, 20, 21, 23, 27, 28, 31, 35, 41, 52, 57, 67, 70, 74, 88, 90, 93, 97, 98, 100, 105, 107, 109, 110, 111, 112, 116, 121, 130, 140, 143, 149, 161, 166, 170, 180, 185, 194, 196, 197, 198, 202, 208, 217, 220, 227, 230, 239, 247, 249, 250, 251, 252]	['Infantile', 'cerebellar', '-', 'retinal', 'degeneration', 'associated', 'with', 'mutations', 'in', 'the', 'mitochondrial', 'aconitase', '2', 'gene', '(', 'ACO2', ')', 'has', 'been', 'recently', 'described', 'in', 'eight', 'individuals', 'from', 'two', 'unrelated', 'Arab', 'families', '[', '2', ']', 'and', 'three', 'patients', 'of', 'French', 'or', 'Algerian', 'descent', '[', '3', ']', '.']	[3, 4, 1, 3, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A much-needed area of progress is the application of innovative methods to enable detection of IDH mutation intraoperatively to guide extent of resection while avoiding the need for a second high-risk cranial surgery.	[]	['A', 'much', '-', 'needed', 'area', 'of', 'progress', 'is', 'the', 'application', 'of', 'innovative', 'methods', 'to', 'enable', 'detection', 'of', 'ID', '##H', 'mutation', 'in', '##tra', '##oper', '##ative', '##ly', 'to', 'guide', 'extent', 'of', 're', '##section', 'while', 'avoiding', 'the', 'need', 'for', 'a', 'second', 'high', '-', 'risk', 'c', '##rani', '##al', 'surgery', '.']	[0, 2, 6, 7, 14, 19, 22, 31, 34, 38, 50, 53, 64, 72, 75, 82, 92, 95, 97, 99, 108, 110, 113, 117, 122, 125, 128, 134, 141, 144, 146, 154, 160, 169, 173, 178, 182, 184, 191, 195, 196, 201, 202, 206, 209, 216]	[1, 6, 7, 13, 18, 21, 30, 33, 37, 49, 52, 63, 71, 74, 81, 91, 94, 97, 98, 107, 110, 113, 117, 122, 124, 127, 133, 140, 143, 146, 153, 159, 168, 172, 177, 181, 183, 190, 195, 196, 200, 202, 206, 208, 216, 217]	['A', 'much', '-', 'needed', 'area', 'of', 'progress', 'is', 'the', 'application', 'of', 'innovative', 'methods', 'to', 'enable', 'detection', 'of', 'IDH', 'mutation', 'intraoperatively', 'to', 'guide', 'extent', 'of', 'resection', 'while', 'avoiding', 'the', 'need', 'for', 'a', 'second', 'high', '-', 'risk', 'cranial', 'surgery', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Remission induction therapy for acute lymphoblastic leukemia (ALL) includes medications that may cause hepatotoxicity, including asparaginase.	[('PMC5511775', 'A00000', 129, 141, 'asparaginase')]	['Re', '##mission', 'induction', 'therapy', 'for', 'acute', 'l', '##ymph', '##ob', '##lastic', 'le', '##uke', '##mia', '(', 'AL', '##L', ')', 'includes', 'medications', 'that', 'may', 'cause', 'he', '##pa', '##to', '##to', '##xi', '##city', ',', 'including', 'as', '##par', '##agi', '##nas', '##e', '.']	[0, 2, 10, 20, 28, 32, 38, 39, 43, 45, 52, 54, 57, 61, 62, 64, 65, 67, 76, 88, 93, 97, 103, 105, 107, 109, 111, 113, 117, 119, 129, 131, 134, 137, 140, 141]	[2, 9, 19, 27, 31, 37, 39, 43, 45, 51, 54, 57, 60, 62, 64, 65, 66, 75, 87, 92, 96, 102, 105, 107, 109, 111, 113, 117, 118, 128, 131, 134, 137, 140, 141, 142]	['Remission', 'induction', 'therapy', 'for', 'acute', 'lymphoblastic', 'leukemia', '(', 'ALL', ')', 'includes', 'medications', 'that', 'may', 'cause', 'hepatotoxicity', ',', 'including', 'asparaginase', '.']	[2, 1, 1, 1, 1, 4, 3, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
We used a genome-wide association study (GWAS) to identify loci associated with elevated alanine transaminase (ALT) levels after induction therapy in children with ALL enrolled on St. Jude Children’s Research Hospital (SJCRH) protocols.	[('PMC5511775', 'A00001', 89, 109, 'alanine transaminase')]	['We', 'used', 'a', 'genome', '-', 'wide', 'association', 'study', '(', 'G', '##WA', '##S', ')', 'to', 'identify', 'lo', '##ci', 'associated', 'with', 'elevated', 'al', '##ani', '##ne', 'trans', '##ami', '##nas', '##e', '(', 'AL', '##T', ')', 'levels', 'after', 'induction', 'therapy', 'in', 'children', 'with', 'AL', '##L', 'enrolled', 'on', 'St', '.', 'Jude', 'Children', '’', 's', 'Research', 'Hospital', '(', 'S', '##J', '##CR', '##H', ')', 'protocols', '.']	[0, 3, 8, 10, 16, 17, 22, 34, 40, 41, 42, 44, 45, 47, 50, 59, 61, 64, 75, 80, 89, 91, 94, 97, 102, 105, 108, 110, 111, 113, 114, 116, 123, 129, 139, 147, 150, 159, 164, 166, 168, 177, 180, 182, 184, 189, 197, 198, 200, 209, 218, 219, 220, 221, 223, 224, 226, 235]	[2, 7, 9, 16, 17, 21, 33, 39, 41, 42, 44, 45, 46, 49, 58, 61, 63, 74, 79, 88, 91, 94, 96, 102, 105, 108, 109, 111, 113, 114, 115, 122, 128, 138, 146, 149, 158, 163, 166, 167, 176, 179, 182, 183, 188, 197, 198, 199, 208, 217, 219, 220, 221, 223, 224, 225, 235, 236]	['We', 'used', 'a', 'genome', '-', 'wide', 'association', 'study', '(', 'GWAS', ')', 'to', 'identify', 'loci', 'associated', 'with', 'elevated', 'alanine', 'transaminase', '(', 'ALT', ')', 'levels', 'after', 'induction', 'therapy', 'in', 'children', 'with', 'ALL', 'enrolled', 'on', 'St', '.', 'Jude', 'Children’s', 'Research', 'Hospital', '(', 'SJCRH', ')', 'protocols', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Adjusting for age, body mass index, ancestry, asparaginase preparation and dosage, the PNPLA3 rs738409 (C>G) I148M variant, previously associated with fatty liver disease risk, had the strongest genetic association with ALT (P = 2.5×10−8).	[]	['Ad', '##ju', '##sting', 'for', 'age', ',', 'body', 'mass', 'index', ',', 'ancestry', ',', 'as', '##par', '##agi', '##nas', '##e', 'preparation', 'and', 'dos', '##age', ',', 'the', 'P', '##NP', '##LA', '##3', 'r', '##s', '##7', '##38', '##40', '##9', '(', 'C', '>', 'G', ')', 'I', '##14', '##8', '##M', 'variant', ',', 'previously', 'associated', 'with', 'fatty', 'liver', 'disease', 'risk', ',', 'had', 'the', 'strongest', 'genetic', 'association', 'with', 'AL', '##T', '(', 'P', '=', '2', '.', '5', '##×', '##10', '##−', '##8', ')', '.']	[0, 2, 4, 10, 14, 17, 19, 24, 29, 34, 36, 44, 46, 48, 51, 54, 57, 59, 71, 75, 78, 81, 83, 87, 88, 90, 92, 94, 95, 96, 97, 99, 101, 103, 104, 105, 106, 107, 109, 110, 112, 113, 115, 122, 124, 135, 146, 151, 157, 163, 171, 175, 177, 181, 185, 195, 203, 215, 220, 222, 224, 225, 227, 229, 230, 231, 232, 233, 235, 236, 237, 238]	[2, 4, 9, 13, 17, 18, 23, 28, 34, 35, 44, 45, 48, 51, 54, 57, 58, 70, 74, 78, 81, 82, 86, 88, 90, 92, 93, 95, 96, 97, 99, 101, 102, 104, 105, 106, 107, 108, 110, 112, 113, 114, 122, 123, 134, 145, 150, 156, 162, 170, 175, 176, 180, 184, 194, 202, 214, 219, 222, 223, 225, 226, 228, 230, 231, 232, 233, 235, 236, 237, 238, 239]	['Adjusting', 'for', 'age', ',', 'body', 'mass', 'index', ',', 'ancestry', ',', 'asparaginase', 'preparation', 'and', 'dosage', ',', 'the', 'PNPLA3', 'rs738409', '(', 'C', '>', 'G', ')', 'I148M', 'variant', ',', 'previously', 'associated', 'with', 'fatty', 'liver', 'disease', 'risk', ',', 'had', 'the', 'strongest', 'genetic', 'association', 'with', 'ALT', '(', 'P', '=', '2.5×10−8', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 4, 6, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patients with ALL are at increased risk for the development of toxicities, including hepatotoxicity, which is partly reflected by elevated serum aminotransferase levels.(3)	[('PMC5511775', 'D00000', 145, 161, 'aminotransferase')]	['Pat', '##ients', 'with', 'AL', '##L', 'are', 'at', 'increased', 'risk', 'for', 'the', 'development', 'of', 'toxic', '##ities', ',', 'including', 'he', '##pa', '##to', '##to', '##xi', '##city', ',', 'which', 'is', 'partly', 'reflected', 'by', 'elevated', 'serum', 'amino', '##tra', '##ns', '##fer', '##ase', 'levels', '.', '(', '3', ')']	[0, 3, 9, 14, 16, 18, 22, 25, 35, 40, 44, 48, 60, 63, 68, 73, 75, 85, 87, 89, 91, 93, 95, 99, 101, 107, 110, 117, 127, 130, 139, 145, 150, 153, 155, 158, 162, 168, 169, 170, 171]	[3, 8, 13, 16, 17, 21, 24, 34, 39, 43, 47, 59, 62, 68, 73, 74, 84, 87, 89, 91, 93, 95, 99, 100, 106, 109, 116, 126, 129, 138, 144, 150, 153, 155, 158, 161, 168, 169, 170, 171, 172]	['Patients', 'with', 'ALL', 'are', 'at', 'increased', 'risk', 'for', 'the', 'development', 'of', 'toxicities', ',', 'including', 'hepatotoxicity', ',', 'which', 'is', 'partly', 'reflected', 'by', 'elevated', 'serum', 'aminotransferase', 'levels.(3)']	[2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 5, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Patatin-like Phospholipase Domain Containing Protein 3 (PNPLA3 or adiponutrin) is a member of the family of patatin-like lipolytic enzymes involved in triacylglycerol metabolism and signaling.(23)	[('PMC5511775', 'D02000', 13, 26, 'Phospholipase')]	['Pat', '##ati', '##n', '-', 'like', 'Ph', '##os', '##ph', '##oli', '##pas', '##e', 'Domain', 'Con', '##taining', 'Pro', '##tein', '3', '(', 'P', '##NP', '##LA', '##3', 'or', 'ad', '##ip', '##on', '##ut', '##rin', ')', 'is', 'a', 'member', 'of', 'the', 'family', 'of', 'pat', '##ati', '##n', '-', 'like', 'lip', '##oly', '##tic', 'enzymes', 'involved', 'in', 't', '##ria', '##cy', '##l', '##gly', '##cer', '##ol', 'metabolism', 'and', 'signaling', '.', '(', '23', ')']	[0, 3, 6, 7, 8, 13, 15, 17, 19, 22, 25, 27, 34, 37, 45, 48, 53, 55, 56, 57, 59, 61, 63, 66, 68, 70, 72, 74, 77, 79, 82, 84, 91, 94, 98, 105, 108, 111, 114, 115, 116, 121, 124, 127, 131, 139, 148, 151, 152, 155, 157, 158, 161, 164, 167, 178, 182, 191, 192, 193, 195]	[3, 6, 7, 8, 12, 15, 17, 19, 22, 25, 26, 33, 37, 44, 48, 52, 54, 56, 57, 59, 61, 62, 65, 68, 70, 72, 74, 77, 78, 81, 83, 90, 93, 97, 104, 107, 111, 114, 115, 116, 120, 124, 127, 130, 138, 147, 150, 152, 155, 157, 158, 161, 164, 166, 177, 181, 191, 192, 193, 195, 196]	['Patatin', '-', 'like', 'Phospholipase', 'Domain', 'Containing', 'Protein', '3', '(', 'PNPLA3', 'or', 'adiponutrin', ')', 'is', 'a', 'member', 'of', 'the', 'family', 'of', 'patatin', '-', 'like', 'lipolytic', 'enzymes', 'involved', 'in', 'triacylglycerol', 'metabolism', 'and', 'signaling.(23)']	[3, 1, 1, 6, 1, 2, 2, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 7, 1, 1, 5]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We confirmed that asparaginase exposure in mice indeed led to an accumulation of hepatic lipids and neutral triglycerides (Figure S7).	[('PMC5511775', 'D03000', 18, 30, 'asparaginase')]	['We', 'confirmed', 'that', 'as', '##par', '##agi', '##nas', '##e', 'exposure', 'in', 'mice', 'indeed', 'led', 'to', 'an', 'accumulation', 'of', 'he', '##pa', '##tic', 'lip', '##ids', 'and', 'neutral', 't', '##rig', '##ly', '##cer', '##ides', '(', 'Figure', 'S', '##7', ')', '.']	[0, 3, 13, 18, 20, 23, 26, 29, 31, 40, 43, 48, 55, 59, 62, 65, 78, 81, 83, 85, 89, 92, 96, 100, 108, 109, 112, 114, 117, 122, 123, 130, 131, 132, 133]	[2, 12, 17, 20, 23, 26, 29, 30, 39, 42, 47, 54, 58, 61, 64, 77, 80, 83, 85, 88, 92, 95, 99, 107, 109, 112, 114, 117, 121, 123, 129, 131, 132, 133, 134]	['We', 'confirmed', 'that', 'asparaginase', 'exposure', 'in', 'mice', 'indeed', 'led', 'to', 'an', 'accumulation', 'of', 'hepatic', 'lipids', 'and', 'neutral', 'triglycerides', '(', 'Figure', 'S7', ')', '.']	[1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 5, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The results suggest that the mechanism of asparaginase-induced hepatotoxicity may be similar to that of hepatic steatosis, and may be attenuated by therapies that can mitigate hepatic triglyceride accumulation.	[('PMC5511775', 'D03001', 42, 54, 'asparaginase')]	['The', 'results', 'suggest', 'that', 'the', 'mechanism', 'of', 'as', '##par', '##agi', '##nas', '##e', '-', 'induced', 'he', '##pa', '##to', '##to', '##xi', '##city', 'may', 'be', 'similar', 'to', 'that', 'of', 'he', '##pa', '##tic', 's', '##te', '##ato', '##sis', ',', 'and', 'may', 'be', 'at', '##ten', '##uated', 'by', 'the', '##rap', '##ies', 'that', 'can', 'mit', '##igate', 'he', '##pa', '##tic', 't', '##rig', '##ly', '##cer', '##ide', 'accumulation', '.']	[0, 4, 12, 20, 25, 29, 39, 42, 44, 47, 50, 53, 54, 55, 63, 65, 67, 69, 71, 73, 78, 82, 85, 93, 96, 101, 104, 106, 108, 112, 113, 115, 118, 121, 123, 127, 131, 134, 136, 139, 145, 148, 151, 154, 158, 163, 167, 170, 176, 178, 180, 184, 185, 188, 190, 193, 197, 209]	[3, 11, 19, 24, 28, 38, 41, 44, 47, 50, 53, 54, 55, 62, 65, 67, 69, 71, 73, 77, 81, 84, 92, 95, 100, 103, 106, 108, 111, 113, 115, 118, 121, 122, 126, 130, 133, 136, 139, 144, 147, 151, 154, 157, 162, 166, 170, 175, 178, 180, 183, 185, 188, 190, 193, 196, 209, 210]	['The', 'results', 'suggest', 'that', 'the', 'mechanism', 'of', 'asparaginase', '-', 'induced', 'hepatotoxicity', 'may', 'be', 'similar', 'to', 'that', 'of', 'hepatic', 'steatosis', ',', 'and', 'may', 'be', 'attenuated', 'by', 'therapies', 'that', 'can', 'mitigate', 'hepatic', 'triglyceride', 'accumulation', '.']	[1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 6, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 3, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These results may have particular implications for adults with ALL, in whom hepatotoxicity is common.(26) Interestingly, an early postmortem study from 31 pediatric ALL patients that received native E. coli asparaginase found that 87% had developed steatosis after exposure to asparaginase.(27)	[('PMC5511775', 'D03002', 207, 219, 'asparaginase')]	['These', 'results', 'may', 'have', 'particular', 'implications', 'for', 'adults', 'with', 'AL', '##L', ',', 'in', 'whom', 'he', '##pa', '##to', '##to', '##xi', '##city', 'is', 'common', '.', '(', '26', ')', 'Interest', '##ingly', ',', 'an', 'early', 'post', '##mor', '##tem', 'study', 'from', '31', 'p', '##ediatric', 'AL', '##L', 'patients', 'that', 'received', 'native', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', 'found', 'that', '87', '%', 'had', 'developed', 's', '##te', '##ato', '##sis', 'after', 'exposure', 'to', 'as', '##par', '##agi', '##nas', '##e', '.', '(', '27', ')']	[0, 6, 14, 18, 23, 34, 47, 51, 58, 63, 65, 66, 68, 71, 76, 78, 80, 82, 84, 86, 91, 94, 100, 101, 102, 104, 106, 114, 119, 121, 124, 130, 134, 137, 141, 147, 152, 155, 156, 165, 167, 169, 178, 183, 192, 199, 200, 202, 204, 207, 209, 212, 215, 218, 220, 226, 231, 233, 235, 239, 249, 250, 252, 255, 259, 265, 274, 277, 279, 282, 285, 288, 289, 290, 291, 293]	[5, 13, 17, 22, 33, 46, 50, 57, 62, 65, 66, 67, 70, 75, 78, 80, 82, 84, 86, 90, 93, 100, 101, 102, 104, 105, 114, 119, 120, 123, 129, 134, 137, 140, 146, 151, 154, 156, 164, 167, 168, 177, 182, 191, 198, 200, 201, 204, 206, 209, 212, 215, 218, 219, 225, 230, 233, 234, 238, 248, 250, 252, 255, 258, 264, 273, 276, 279, 282, 285, 288, 289, 290, 291, 293, 294]	['These', 'results', 'may', 'have', 'particular', 'implications', 'for', 'adults', 'with', 'ALL', ',', 'in', 'whom', 'hepatotoxicity', 'is', 'common.(26)', 'Interestingly', ',', 'an', 'early', 'postmortem', 'study', 'from', '31', 'pediatric', 'ALL', 'patients', 'that', 'received', 'native', 'E', '.', 'coli', 'asparaginase', 'found', 'that', '87%', 'had', 'developed', 'steatosis', 'after', 'exposure', 'to', 'asparaginase.(27)']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 5, 2, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 2, 1, 1, 4, 1, 1, 1, 9]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although we think asparaginase was the most likely cause of post-induction ALT elevations in this study, we acknowledge that other elements of ALL induction therapy can also cause increases in ALT.	[('PMC5511775', 'D06000', 18, 30, 'asparaginase')]	['Although', 'we', 'think', 'as', '##par', '##agi', '##nas', '##e', 'was', 'the', 'most', 'likely', 'cause', 'of', 'post', '-', 'induction', 'AL', '##T', 'elevations', 'in', 'this', 'study', ',', 'we', 'acknowledge', 'that', 'other', 'elements', 'of', 'AL', '##L', 'induction', 'therapy', 'can', 'also', 'cause', 'increases', 'in', 'AL', '##T', '.']	[0, 9, 12, 18, 20, 23, 26, 29, 31, 35, 39, 44, 51, 57, 60, 64, 65, 75, 77, 79, 90, 93, 98, 103, 105, 108, 120, 125, 131, 140, 143, 145, 147, 157, 165, 169, 174, 180, 190, 193, 195, 196]	[8, 11, 17, 20, 23, 26, 29, 30, 34, 38, 43, 50, 56, 59, 64, 65, 74, 77, 78, 89, 92, 97, 103, 104, 107, 119, 124, 130, 139, 142, 145, 146, 156, 164, 168, 173, 179, 189, 192, 195, 196, 197]	['Although', 'we', 'think', 'asparaginase', 'was', 'the', 'most', 'likely', 'cause', 'of', 'post', '-', 'induction', 'ALT', 'elevations', 'in', 'this', 'study', ',', 'we', 'acknowledge', 'that', 'other', 'elements', 'of', 'ALL', 'induction', 'therapy', 'can', 'also', 'cause', 'increases', 'in', 'ALT', '.']	[1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In summary, we have identified that elevated post-induction chemotherapy ALT levels were likely due primarily to asparaginase, and we found that the same PNPLA3 I148M variant that was previously shown to be the most important determinant of NAFLD in a general population of adults is associated with drug-induced increases in serum ALT.	[('PMC5511775', 'D08000', 113, 125, 'asparaginase')]	['In', 'summary', ',', 'we', 'have', 'identified', 'that', 'elevated', 'post', '-', 'induction', 'ch', '##em', '##otherapy', 'AL', '##T', 'levels', 'were', 'likely', 'due', 'primarily', 'to', 'as', '##par', '##agi', '##nas', '##e', ',', 'and', 'we', 'found', 'that', 'the', 'same', 'P', '##NP', '##LA', '##3', 'I', '##14', '##8', '##M', 'variant', 'that', 'was', 'previously', 'shown', 'to', 'be', 'the', 'most', 'important', 'de', '##ter', '##mina', '##nt', 'of', 'N', '##AF', '##LD', 'in', 'a', 'general', 'population', 'of', 'adults', 'is', 'associated', 'with', 'drug', '-', 'induced', 'increases', 'in', 'serum', 'AL', '##T', '.']	[0, 3, 10, 12, 15, 20, 31, 36, 45, 49, 50, 60, 62, 64, 73, 75, 77, 84, 89, 96, 100, 110, 113, 115, 118, 121, 124, 125, 127, 131, 134, 140, 145, 149, 154, 155, 157, 159, 161, 162, 164, 165, 167, 175, 180, 184, 195, 201, 204, 207, 211, 216, 226, 228, 231, 235, 238, 241, 242, 244, 247, 250, 252, 260, 271, 274, 281, 284, 295, 300, 304, 305, 313, 323, 326, 332, 334, 335]	[2, 10, 11, 14, 19, 30, 35, 44, 49, 50, 59, 62, 64, 72, 75, 76, 83, 88, 95, 99, 109, 112, 115, 118, 121, 124, 125, 126, 130, 133, 139, 144, 148, 153, 155, 157, 159, 160, 162, 164, 165, 166, 174, 179, 183, 194, 200, 203, 206, 210, 215, 225, 228, 231, 235, 237, 240, 242, 244, 246, 249, 251, 259, 270, 273, 280, 283, 294, 299, 304, 305, 312, 322, 325, 331, 334, 335, 336]	['In', 'summary', ',', 'we', 'have', 'identified', 'that', 'elevated', 'post', '-', 'induction', 'chemotherapy', 'ALT', 'levels', 'were', 'likely', 'due', 'primarily', 'to', 'asparaginase', ',', 'and', 'we', 'found', 'that', 'the', 'same', 'PNPLA3', 'I148M', 'variant', 'that', 'was', 'previously', 'shown', 'to', 'be', 'the', 'most', 'important', 'determinant', 'of', 'NAFLD', 'in', 'a', 'general', 'population', 'of', 'adults', 'is', 'associated', 'with', 'drug', '-', 'induced', 'increases', 'in', 'serum', 'ALT', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Some treatment regimens for adults with ALL avoid using and/or dose modify asparaginase and high-dose methotrexate in order to minimize treatment-related hepatotoxicity,(8, 9) which may contribute to the lower cure rates for adults with ALL.	[('PMC5511775', 'I01000', 75, 87, 'asparaginase')]	['Some', 'treatment', 'regime', '##ns', 'for', 'adults', 'with', 'AL', '##L', 'avoid', 'using', 'and', '/', 'or', 'dose', 'modify', 'as', '##par', '##agi', '##nas', '##e', 'and', 'high', '-', 'dose', 'met', '##hot', '##re', '##xa', '##te', 'in', 'order', 'to', 'minimize', 'treatment', '-', 'related', 'he', '##pa', '##to', '##to', '##xi', '##city', ',', '(', '8', ',', '9', ')', 'which', 'may', 'contribute', 'to', 'the', 'lower', 'cure', 'rates', 'for', 'adults', 'with', 'AL', '##L', '.']	[0, 5, 15, 21, 24, 28, 35, 40, 42, 44, 50, 56, 59, 60, 63, 68, 75, 77, 80, 83, 86, 88, 92, 96, 97, 102, 105, 108, 110, 112, 115, 118, 124, 127, 136, 145, 146, 154, 156, 158, 160, 162, 164, 168, 169, 170, 171, 173, 174, 176, 182, 186, 197, 200, 204, 210, 215, 221, 225, 232, 237, 239, 240]	[4, 14, 21, 23, 27, 34, 39, 42, 43, 49, 55, 59, 60, 62, 67, 74, 77, 80, 83, 86, 87, 91, 96, 97, 101, 105, 108, 110, 112, 114, 117, 123, 126, 135, 145, 146, 153, 156, 158, 160, 162, 164, 168, 169, 170, 171, 172, 174, 175, 181, 185, 196, 199, 203, 209, 214, 220, 224, 231, 236, 239, 240, 241]	['Some', 'treatment', 'regimens', 'for', 'adults', 'with', 'ALL', 'avoid', 'using', 'and', '/', 'or', 'dose', 'modify', 'asparaginase', 'and', 'high', '-', 'dose', 'methotrexate', 'in', 'order', 'to', 'minimize', 'treatment', '-', 'related', 'hepatotoxicity', ',', '(', '8', ',', '9', ')', 'which', 'may', 'contribute', 'to', 'the', 'lower', 'cure', 'rates', 'for', 'adults', 'with', 'ALL', '.']	[1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We investigated coding and non-coding genetic variants associated with the elevation of alanine aminotransferase (ALT) after remission induction therapy.	[('PMC5511775', 'I02000', 88, 112, 'alanine aminotransferase')]	['We', 'investigated', 'coding', 'and', 'non', '-', 'coding', 'genetic', 'variants', 'associated', 'with', 'the', 'elevation', 'of', 'al', '##ani', '##ne', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AL', '##T', ')', 'after', 're', '##mission', 'induction', 'therapy', '.']	[0, 3, 16, 23, 27, 30, 31, 38, 46, 55, 66, 71, 75, 85, 88, 90, 93, 96, 101, 104, 106, 109, 113, 114, 116, 117, 119, 125, 127, 135, 145, 152]	[2, 15, 22, 26, 30, 31, 37, 45, 54, 65, 70, 74, 84, 87, 90, 93, 95, 101, 104, 106, 109, 112, 114, 116, 117, 118, 124, 127, 134, 144, 152, 153]	['We', 'investigated', 'coding', 'and', 'non', '-', 'coding', 'genetic', 'variants', 'associated', 'with', 'the', 'elevation', 'of', 'alanine', 'aminotransferase', '(', 'ALT', ')', 'after', 'remission', 'induction', 'therapy', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
During induction therapy, patients enrolled on the SJCRH Total XV or Total XVI protocols received asparaginase, prednisone, vincristine, daunorubicin, cyclophosphamide, cytarabine, and thiopurine (Table 1, Figure S9).(39, 40) Total XV patients received native E. coli asparaginase (Elspar) at 10,000 units/m2 IM, three times weekly for six doses and Total XVI patients received a single dose of PEGylated E. coli asparaginase (Oncaspar) at 3,000 units/m2 IV.	[('PMC5511775', 'M03000', 98, 110, 'asparaginase')]	['During', 'induction', 'therapy', ',', 'patients', 'enrolled', 'on', 'the', 'S', '##J', '##CR', '##H', 'Total', 'XV', 'or', 'Total', 'XVI', 'protocols', 'received', 'as', '##par', '##agi', '##nas', '##e', ',', 'pre', '##dn', '##ison', '##e', ',', 'v', '##in', '##c', '##rist', '##ine', ',', 'da', '##uno', '##ru', '##bic', '##in', ',', 'c', '##y', '##c', '##lop', '##hos', '##pha', '##mi', '##de', ',', 'c', '##yt', '##ara', '##bine', ',', 'and', 'th', '##io', '##pur', '##ine', '(', 'Table', '1', ',', 'Figure', 'S', '##9', ')', '.', '(', '39', ',', '40', ')', 'Total', 'XV', 'patients', 'received', 'native', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', '(', 'El', '##sp', '##ar', ')', 'at', '10', ',', '000', 'units', '/', 'm', '##2', 'I', '##M', ',', 'three', 'times', 'weekly', 'for', 'six', 'doses', 'and', 'Total', 'XVI', 'patients', 'received', 'a', 'single', 'dose', 'of', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', '(', 'On', '##cas', '##par', ')', 'at', '3', ',', '000', 'units', '/', 'm', '##2', 'IV', '.']	[0, 7, 17, 24, 26, 35, 44, 47, 51, 52, 53, 55, 57, 63, 66, 69, 75, 79, 89, 98, 100, 103, 106, 109, 110, 112, 115, 117, 121, 122, 124, 125, 127, 128, 132, 135, 137, 139, 142, 144, 147, 149, 151, 152, 153, 154, 157, 160, 163, 165, 167, 169, 170, 172, 175, 179, 181, 185, 187, 189, 192, 196, 197, 203, 204, 206, 213, 214, 215, 216, 217, 218, 220, 222, 224, 226, 232, 235, 244, 253, 260, 261, 263, 265, 268, 270, 273, 276, 279, 281, 282, 284, 286, 288, 290, 293, 295, 296, 300, 305, 306, 307, 309, 310, 311, 313, 319, 325, 332, 336, 340, 346, 350, 356, 360, 369, 378, 380, 387, 392, 395, 396, 398, 401, 405, 406, 408, 410, 413, 415, 418, 421, 424, 426, 427, 429, 432, 435, 437, 440, 441, 442, 446, 451, 452, 453, 455, 457]	[6, 16, 24, 25, 34, 43, 46, 50, 52, 53, 55, 56, 62, 65, 68, 74, 78, 88, 97, 100, 103, 106, 109, 110, 111, 115, 117, 121, 122, 123, 125, 127, 128, 132, 135, 136, 139, 142, 144, 147, 149, 150, 152, 153, 154, 157, 160, 163, 165, 167, 168, 170, 172, 175, 179, 180, 184, 187, 189, 192, 195, 197, 202, 204, 205, 212, 214, 215, 216, 217, 218, 220, 221, 224, 225, 231, 234, 243, 252, 259, 261, 262, 265, 267, 270, 273, 276, 279, 280, 282, 284, 286, 288, 289, 292, 295, 296, 299, 305, 306, 307, 308, 310, 311, 312, 318, 324, 331, 335, 339, 345, 349, 355, 359, 368, 377, 379, 386, 391, 394, 396, 398, 401, 404, 406, 407, 410, 412, 415, 418, 421, 424, 425, 427, 429, 432, 435, 436, 439, 441, 442, 445, 451, 452, 453, 454, 457, 458]	['During', 'induction', 'therapy', ',', 'patients', 'enrolled', 'on', 'the', 'SJCRH', 'Total', 'XV', 'or', 'Total', 'XVI', 'protocols', 'received', 'asparaginase', ',', 'prednisone', ',', 'vincristine', ',', 'daunorubicin', ',', 'cyclophosphamide', ',', 'cytarabine', ',', 'and', 'thiopurine', '(', 'Table', '1', ',', 'Figure', 'S9).(39', ',', '40', ')', 'Total', 'XV', 'patients', 'received', 'native', 'E', '.', 'coli', 'asparaginase', '(', 'Elspar', ')', 'at', '10', ',', '000', 'units', '/', 'm2', 'IM', ',', 'three', 'times', 'weekly', 'for', 'six', 'doses', 'and', 'Total', 'XVI', 'patients', 'received', 'a', 'single', 'dose', 'of', 'PEGylated', 'E', '.', 'coli', 'asparaginase', '(', 'Oncaspar', ')', 'at', '3', ',', '000', 'units', '/', 'm2', 'IV', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 5, 1, 4, 1, 5, 1, 5, 1, 8, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patients on Total XV with day 19 MRD ≥ 5% received three additional doses of native E. coli asparaginase over a week’s period, and patients on Total XVI with day 15 MRD ≥ 1% received an additional dose of PEGylated E. coli asparaginase (Table 1, Figure S9).	[('PMC5511775', 'M03001', 92, 104, 'asparaginase')]	['Pat', '##ients', 'on', 'Total', 'XV', 'with', 'day', '19', 'MR', '##D', '≥', '5', '%', 'received', 'three', 'additional', 'doses', 'of', 'native', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', 'over', 'a', 'week', '’', 's', 'period', ',', 'and', 'patients', 'on', 'Total', 'XVI', 'with', 'day', '15', 'MR', '##D', '≥', '1', '%', 'received', 'an', 'additional', 'dose', 'of', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', '(', 'Table', '1', ',', 'Figure', 'S', '##9', ')', '.']	[0, 3, 9, 12, 18, 21, 26, 30, 33, 35, 37, 39, 40, 42, 51, 57, 68, 74, 77, 84, 85, 87, 89, 92, 94, 97, 100, 103, 105, 110, 112, 116, 117, 119, 125, 127, 131, 140, 143, 149, 153, 158, 162, 165, 167, 169, 171, 172, 174, 183, 186, 197, 202, 205, 206, 208, 211, 215, 216, 218, 220, 223, 225, 228, 231, 234, 236, 237, 243, 244, 246, 253, 254, 255, 256]	[3, 8, 11, 17, 20, 25, 29, 32, 35, 36, 38, 40, 41, 50, 56, 67, 73, 76, 83, 85, 86, 89, 91, 94, 97, 100, 103, 104, 109, 111, 116, 117, 118, 125, 126, 130, 139, 142, 148, 152, 157, 161, 164, 167, 168, 170, 172, 173, 182, 185, 196, 201, 204, 206, 208, 211, 214, 216, 217, 220, 222, 225, 228, 231, 234, 235, 237, 242, 244, 245, 252, 254, 255, 256, 257]	['Patients', 'on', 'Total', 'XV', 'with', 'day', '19', 'MRD', '≥', '5%', 'received', 'three', 'additional', 'doses', 'of', 'native', 'E', '.', 'coli', 'asparaginase', 'over', 'a', 'week’s', 'period', ',', 'and', 'patients', 'on', 'Total', 'XVI', 'with', 'day', '15', 'MRD', '≥', '1%', 'received', 'an', 'additional', 'dose', 'of', 'PEGylated', 'E', '.', 'coli', 'asparaginase', '(', 'Table', '1', ',', 'Figure', 'S9', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 2, 5, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
During induction therapy, patients enrolled on COG AALL0232 received vincristine, daunorubicin, dexamethasone or prednisone, and PEGylated E. coli asparaginase.(43)	[('PMC5511775', 'M04000', 147, 159, 'asparaginase')]	['During', 'induction', 'therapy', ',', 'patients', 'enrolled', 'on', 'CO', '##G', 'AA', '##LL', '##0', '##23', '##2', 'received', 'v', '##in', '##c', '##rist', '##ine', ',', 'da', '##uno', '##ru', '##bic', '##in', ',', 'de', '##xa', '##met', '##has', '##one', 'or', 'pre', '##dn', '##ison', '##e', ',', 'and', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', '.', '(', '43', ')']	[0, 7, 17, 24, 26, 35, 44, 47, 49, 51, 53, 55, 56, 58, 60, 69, 70, 72, 73, 77, 80, 82, 84, 87, 89, 92, 94, 96, 98, 100, 103, 106, 110, 113, 116, 118, 122, 123, 125, 129, 130, 132, 135, 139, 140, 142, 144, 147, 149, 152, 155, 158, 159, 160, 161, 163]	[6, 16, 24, 25, 34, 43, 46, 49, 50, 53, 55, 56, 58, 59, 68, 70, 72, 73, 77, 80, 81, 84, 87, 89, 92, 94, 95, 98, 100, 103, 106, 109, 112, 116, 118, 122, 123, 124, 128, 130, 132, 135, 138, 140, 141, 144, 146, 149, 152, 155, 158, 159, 160, 161, 163, 164]	['During', 'induction', 'therapy', ',', 'patients', 'enrolled', 'on', 'COG', 'AALL0232', 'received', 'vincristine', ',', 'daunorubicin', ',', 'dexamethasone', 'or', 'prednisone', ',', 'and', 'PEGylated', 'E', '.', 'coli', 'asparaginase.(43)']	[1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 5, 1, 5, 1, 5, 1, 4, 1, 1, 4, 1, 1, 2, 9]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Patients with day 29 MRD between 1% and 25% received extended induction consisting of additional doses of vincristine, daunorubicin, dexamethasone or prednisone, and PEGylated E. coli asparaginase.	[('PMC5511775', 'M04001', 184, 196, 'asparaginase')]	['Pat', '##ients', 'with', 'day', '29', 'MR', '##D', 'between', '1', '%', 'and', '25', '%', 'received', 'extended', 'induction', 'consisting', 'of', 'additional', 'doses', 'of', 'v', '##in', '##c', '##rist', '##ine', ',', 'da', '##uno', '##ru', '##bic', '##in', ',', 'de', '##xa', '##met', '##has', '##one', 'or', 'pre', '##dn', '##ison', '##e', ',', 'and', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', '.']	[0, 3, 9, 14, 18, 21, 23, 25, 33, 34, 36, 40, 42, 44, 53, 62, 72, 83, 86, 97, 103, 106, 107, 109, 110, 114, 117, 119, 121, 124, 126, 129, 131, 133, 135, 137, 140, 143, 147, 150, 153, 155, 159, 160, 162, 166, 167, 169, 172, 176, 177, 179, 181, 184, 186, 189, 192, 195, 196]	[3, 8, 13, 17, 20, 23, 24, 32, 34, 35, 39, 42, 43, 52, 61, 71, 82, 85, 96, 102, 105, 107, 109, 110, 114, 117, 118, 121, 124, 126, 129, 131, 132, 135, 137, 140, 143, 146, 149, 153, 155, 159, 160, 161, 165, 167, 169, 172, 175, 177, 178, 181, 183, 186, 189, 192, 195, 196, 197]	['Patients', 'with', 'day', '29', 'MRD', 'between', '1%', 'and', '25%', 'received', 'extended', 'induction', 'consisting', 'of', 'additional', 'doses', 'of', 'vincristine', ',', 'daunorubicin', ',', 'dexamethasone', 'or', 'prednisone', ',', 'and', 'PEGylated', 'E', '.', 'coli', 'asparaginase', '.']	[2, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 1, 5, 1, 4, 1, 1, 4, 1, 1, 2, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
During consolidation, patients received cytarabine, vincristine, cyclophosphamide, mercaptopurine, and PEGylated E. coli asparaginase (Table S7).	[('PMC5511775', 'M04002', 121, 133, 'asparaginase')]	['During', 'consolidation', ',', 'patients', 'received', 'c', '##yt', '##ara', '##bine', ',', 'v', '##in', '##c', '##rist', '##ine', ',', 'c', '##y', '##c', '##lop', '##hos', '##pha', '##mi', '##de', ',', 'me', '##rca', '##pt', '##op', '##uri', '##ne', ',', 'and', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', '(', 'Table', 'S', '##7', ')', '.']	[0, 7, 20, 22, 31, 40, 41, 43, 46, 50, 52, 53, 55, 56, 60, 63, 65, 66, 67, 68, 71, 74, 77, 79, 81, 83, 85, 88, 90, 92, 95, 97, 99, 103, 104, 106, 109, 113, 114, 116, 118, 121, 123, 126, 129, 132, 134, 135, 141, 142, 143, 144]	[6, 20, 21, 30, 39, 41, 43, 46, 50, 51, 53, 55, 56, 60, 63, 64, 66, 67, 68, 71, 74, 77, 79, 81, 82, 85, 88, 90, 92, 95, 97, 98, 102, 104, 106, 109, 112, 114, 115, 118, 120, 123, 126, 129, 132, 133, 135, 140, 142, 143, 144, 145]	['During', 'consolidation', ',', 'patients', 'received', 'cytarabine', ',', 'vincristine', ',', 'cyclophosphamide', ',', 'mercaptopurine', ',', 'and', 'PEGylated', 'E', '.', 'coli', 'asparaginase', '(', 'Table', 'S7', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 5, 1, 8, 1, 6, 1, 1, 4, 1, 1, 2, 5, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Male Balb/cJ mice (4-week-old) (Jackson Laboratories, Bar Harbor, ME) received 1,500 IU/kg of PEGylated E. coli asparaginase by intraperitoneal injection twice weekly for 6 weeks.	[('PMC5511775', 'M07000', 112, 124, 'asparaginase')]	['Male', 'Ba', '##l', '##b', '/', 'c', '##J', 'mice', '(', '4', '-', 'week', '-', 'old', ')', '(', 'Jackson', 'Laboratories', ',', 'Bar', 'Harbor', ',', 'ME', ')', 'received', '1', ',', '500', 'I', '##U', '/', 'kg', 'of', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', 'by', 'in', '##tra', '##per', '##ito', '##nea', '##l', 'injection', 'twice', 'weekly', 'for', '6', 'weeks', '.']	[0, 5, 7, 8, 9, 10, 11, 13, 18, 19, 20, 21, 25, 26, 29, 31, 32, 40, 52, 54, 58, 64, 66, 68, 70, 79, 80, 81, 85, 86, 87, 88, 91, 94, 95, 97, 100, 104, 105, 107, 109, 112, 114, 117, 120, 123, 125, 128, 130, 133, 136, 139, 142, 144, 154, 160, 167, 171, 173, 178]	[4, 7, 8, 9, 10, 11, 12, 17, 19, 20, 21, 25, 26, 29, 30, 32, 39, 52, 53, 57, 64, 65, 68, 69, 78, 80, 81, 84, 86, 87, 88, 90, 93, 95, 97, 100, 103, 105, 106, 109, 111, 114, 117, 120, 123, 124, 127, 130, 133, 136, 139, 142, 143, 153, 159, 166, 170, 172, 178, 179]	['Male', 'Balb', '/', 'cJ', 'mice', '(', '4-week-', 'old', ')', '(', 'Jackson', 'Laboratories', ',', 'Bar', 'Harbor', ',', 'ME', ')', 'received', '1', ',', '500', 'IU', '/', 'kg', 'of', 'PEGylated', 'E', '.', 'coli', 'asparaginase', 'by', 'intraperitoneal', 'injection', 'twice', 'weekly', 'for', '6', 'weeks', '.']	[1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 2, 5, 1, 6, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patients enrolled on Total XV received mercaptopurine, whereas most on Total XVI received thioguanine; those on Total XV received pre-induction window therapy with methotrexate, whereas those on Total XVI did not (Table 1).	[]	['Pat', '##ients', 'enrolled', 'on', 'Total', 'XV', 'received', 'me', '##rca', '##pt', '##op', '##uri', '##ne', ',', 'whereas', 'most', 'on', 'Total', 'XVI', 'received', 'th', '##io', '##gua', '##nine', ';', 'those', 'on', 'Total', 'XV', 'received', 'pre', '-', 'induction', 'window', 'therapy', 'with', 'met', '##hot', '##re', '##xa', '##te', ',', 'whereas', 'those', 'on', 'Total', 'XVI', 'did', 'not', '(', 'Table', '1', ')', '.']	[0, 3, 9, 18, 21, 27, 30, 39, 41, 44, 46, 48, 51, 53, 55, 63, 68, 71, 77, 81, 90, 92, 94, 97, 101, 103, 109, 112, 118, 121, 130, 133, 134, 144, 151, 159, 164, 167, 170, 172, 174, 176, 178, 186, 192, 195, 201, 205, 209, 213, 214, 220, 221, 222]	[3, 8, 17, 20, 26, 29, 38, 41, 44, 46, 48, 51, 53, 54, 62, 67, 70, 76, 80, 89, 92, 94, 97, 101, 102, 108, 111, 117, 120, 129, 133, 134, 143, 150, 158, 163, 167, 170, 172, 174, 176, 177, 185, 191, 194, 200, 204, 208, 212, 214, 219, 221, 222, 223]	['Patients', 'enrolled', 'on', 'Total', 'XV', 'received', 'mercaptopurine', ',', 'whereas', 'most', 'on', 'Total', 'XVI', 'received', 'thioguanine', ';', 'those', 'on', 'Total', 'XV', 'received', 'pre', '-', 'induction', 'window', 'therapy', 'with', 'methotrexate', ',', 'whereas', 'those', 'on', 'Total', 'XVI', 'did', 'not', '(', 'Table', '1', ')', '.']	[2, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In both protocols, patients with higher minimal residual disease (MRD) at day 15–19 of induction received additional asparaginase compared to those without.	[]	['In', 'both', 'protocols', ',', 'patients', 'with', 'higher', 'minimal', 'residual', 'disease', '(', 'MR', '##D', ')', 'at', 'day', '15', '–', '19', 'of', 'induction', 'received', 'additional', 'as', '##par', '##agi', '##nas', '##e', 'compared', 'to', 'those', 'without', '.']	[0, 3, 8, 17, 19, 28, 33, 40, 48, 57, 65, 66, 68, 69, 71, 74, 78, 80, 81, 84, 87, 97, 106, 117, 119, 122, 125, 128, 130, 139, 142, 148, 155]	[2, 7, 17, 18, 27, 32, 39, 47, 56, 64, 66, 68, 69, 70, 73, 77, 80, 81, 83, 86, 96, 105, 116, 119, 122, 125, 128, 129, 138, 141, 147, 155, 156]	['In', 'both', 'protocols', ',', 'patients', 'with', 'higher', 'minimal', 'residual', 'disease', '(', 'MRD', ')', 'at', 'day', '15–', '19', 'of', 'induction', 'received', 'additional', 'asparaginase', 'compared', 'to', 'those', 'without', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
By univariate analysis (Table S1), treatment protocol (Figure 1A), additional asparaginase during induction (Figure 1B), race group (Figure 1C), age (Figure 1D), body mass index (BMI) percentile (Figure 1E), and gender were associated with post-induction ALT levels.	[]	['By', 'un', '##iva', '##ria', '##te', 'analysis', '(', 'Table', 'S', '##1', ')', ',', 'treatment', 'protocol', '(', 'Figure', '1A', ')', ',', 'additional', 'as', '##par', '##agi', '##nas', '##e', 'during', 'induction', '(', 'Figure', '1', '##B', ')', ',', 'race', 'group', '(', 'Figure', '1', '##C', ')', ',', 'age', '(', 'Figure', '1', '##D', ')', ',', 'body', 'mass', 'index', '(', 'B', '##MI', ')', 'percent', '##ile', '(', 'Figure', '1', '##E', ')', ',', 'and', 'gender', 'were', 'associated', 'with', 'post', '-', 'induction', 'AL', '##T', 'levels', '.']	[0, 3, 5, 8, 11, 14, 23, 24, 30, 31, 32, 33, 35, 45, 54, 55, 62, 64, 65, 67, 78, 80, 83, 86, 89, 91, 98, 108, 109, 116, 117, 118, 119, 121, 126, 132, 133, 140, 141, 142, 143, 145, 149, 150, 157, 158, 159, 160, 162, 167, 172, 178, 179, 180, 182, 184, 191, 195, 196, 203, 204, 205, 206, 208, 212, 219, 224, 235, 240, 244, 245, 255, 257, 259, 265]	[2, 5, 8, 11, 13, 22, 24, 29, 31, 32, 33, 34, 44, 53, 55, 61, 64, 65, 66, 77, 80, 83, 86, 89, 90, 97, 107, 109, 115, 117, 118, 119, 120, 125, 131, 133, 139, 141, 142, 143, 144, 148, 150, 156, 158, 159, 160, 161, 166, 171, 177, 179, 180, 182, 183, 191, 194, 196, 202, 204, 205, 206, 207, 211, 218, 223, 234, 239, 244, 245, 254, 257, 258, 265, 266]	['By', 'univariate', 'analysis', '(', 'Table', 'S1', ')', ',', 'treatment', 'protocol', '(', 'Figure', '1A', ')', ',', 'additional', 'asparaginase', 'during', 'induction', '(', 'Figure', '1B', ')', ',', 'race', 'group', '(', 'Figure', '1C', ')', ',', 'age', '(', 'Figure', '1D', ')', ',', 'body', 'mass', 'index', '(', 'BMI', ')', 'percentile', '(', 'Figure', '1E', ')', ',', 'and', 'gender', 'were', 'associated', 'with', 'post', '-', 'induction', 'ALT', 'levels', '.']	[1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In multivariate analysis (Table 3), higher ALT levels were associated with Total XVI treatment protocol (P = 0.041), receiving additional induction asparaginase (P = 2.7×10−4), non-black race (P = 8.7×10−13 for whites and P = 2.6×10−7 for Hispanics), older age (P = 1.4×10−6), and higher BMI (P = 2.9×10−3).	[]	['In', 'multi', '##var', '##iate', 'analysis', '(', 'Table', '3', ')', ',', 'higher', 'AL', '##T', 'levels', 'were', 'associated', 'with', 'Total', 'XVI', 'treatment', 'protocol', '(', 'P', '=', '0', '.', '04', '##1', ')', ',', 'receiving', 'additional', 'induction', 'as', '##par', '##agi', '##nas', '##e', '(', 'P', '=', '2', '.', '7', '##×', '##10', '##−', '##4', ')', ',', 'non', '-', 'black', 'race', '(', 'P', '=', '8', '.', '7', '##×', '##10', '##−', '##13', 'for', 'whites', 'and', 'P', '=', '2', '.', '6', '##×', '##10', '##−', '##7', 'for', 'Hispanic', '##s', ')', ',', 'older', 'age', '(', 'P', '=', '1', '.', '4', '##×', '##10', '##−', '##6', ')', ',', 'and', 'higher', 'B', '##MI', '(', 'P', '=', '2', '.', '9', '##×', '##10', '##−', '##3', ')', '.']	[0, 3, 8, 11, 16, 25, 26, 32, 33, 34, 36, 43, 45, 47, 54, 59, 70, 75, 81, 85, 95, 104, 105, 107, 109, 110, 111, 113, 114, 115, 117, 127, 138, 148, 150, 153, 156, 159, 161, 162, 164, 166, 167, 168, 169, 170, 172, 173, 174, 175, 177, 180, 181, 187, 192, 193, 195, 197, 198, 199, 200, 201, 203, 204, 207, 211, 218, 222, 224, 226, 227, 228, 229, 230, 232, 233, 235, 239, 247, 248, 249, 251, 257, 261, 262, 264, 266, 267, 268, 269, 270, 272, 273, 274, 275, 277, 281, 288, 289, 292, 293, 295, 297, 298, 299, 300, 301, 303, 304, 305, 306]	[2, 8, 11, 15, 24, 26, 31, 33, 34, 35, 42, 45, 46, 53, 58, 69, 74, 80, 84, 94, 103, 105, 106, 108, 110, 111, 113, 114, 115, 116, 126, 137, 147, 150, 153, 156, 159, 160, 162, 163, 165, 167, 168, 169, 170, 172, 173, 174, 175, 176, 180, 181, 186, 191, 193, 194, 196, 198, 199, 200, 201, 203, 204, 206, 210, 217, 221, 223, 225, 227, 228, 229, 230, 232, 233, 234, 238, 247, 248, 249, 250, 256, 260, 262, 263, 265, 267, 268, 269, 270, 272, 273, 274, 275, 276, 280, 287, 289, 291, 293, 294, 296, 298, 299, 300, 301, 303, 304, 305, 306, 307]	['In', 'multivariate', 'analysis', '(', 'Table', '3', ')', ',', 'higher', 'ALT', 'levels', 'were', 'associated', 'with', 'Total', 'XVI', 'treatment', 'protocol', '(', 'P', '=', '0.041', ')', ',', 'receiving', 'additional', 'induction', 'asparaginase', '(', 'P', '=', '2.7×10−4', ')', ',', 'non', '-', 'black', 'race', '(', 'P', '=', '8.7×10−13', 'for', 'whites', 'and', 'P', '=', '2.6×10−7', 'for', 'Hispanics', ')', ',', 'older', 'age', '(', 'P', '=', '1.4×10−6', ')', ',', 'and', 'higher', 'BMI', '(', 'P', '=', '2.9×10−3', ')', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 2, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To identify genetic variants associated with post-induction ALT levels in the SJCRH discovery cohort, we used a multivariate linear regression model including treatment protocol, use of additional asparaginase doses, percentage of Northern European ancestry, West African ancestry and Native American ancestry, age, and BMI percentile as covariates along with genotypes.	[('PMC5511775', 'R02000', 197, 209, 'asparaginase')]	['To', 'identify', 'genetic', 'variants', 'associated', 'with', 'post', '-', 'induction', 'AL', '##T', 'levels', 'in', 'the', 'S', '##J', '##CR', '##H', 'discovery', 'co', '##hor', '##t', ',', 'we', 'used', 'a', 'multi', '##var', '##iate', 'linear', 're', '##gression', 'model', 'including', 'treatment', 'protocol', ',', 'use', 'of', 'additional', 'as', '##par', '##agi', '##nas', '##e', 'doses', ',', 'percentage', 'of', 'Northern', 'European', 'ancestry', ',', 'West', 'African', 'ancestry', 'and', 'Native', 'American', 'ancestry', ',', 'age', ',', 'and', 'B', '##MI', 'percent', '##ile', 'as', 'co', '##var', '##iate', '##s', 'along', 'with', 'g', '##eno', '##type', '##s', '.']	[0, 3, 12, 20, 29, 40, 45, 49, 50, 60, 62, 64, 71, 74, 78, 79, 80, 82, 84, 94, 96, 99, 100, 102, 105, 110, 112, 117, 120, 125, 132, 134, 143, 149, 159, 169, 177, 179, 183, 186, 197, 199, 202, 205, 208, 210, 215, 217, 228, 231, 240, 249, 257, 259, 264, 272, 281, 285, 292, 301, 309, 311, 314, 316, 320, 321, 324, 331, 335, 338, 340, 343, 347, 349, 355, 360, 361, 364, 368, 369]	[2, 11, 19, 28, 39, 44, 49, 50, 59, 62, 63, 70, 73, 77, 79, 80, 82, 83, 93, 96, 99, 100, 101, 104, 109, 111, 117, 120, 124, 131, 134, 142, 148, 158, 168, 177, 178, 182, 185, 196, 199, 202, 205, 208, 209, 215, 216, 227, 230, 239, 248, 257, 258, 263, 271, 280, 284, 291, 300, 309, 310, 314, 315, 319, 321, 323, 331, 334, 337, 340, 343, 347, 348, 354, 359, 361, 364, 368, 369, 370]	['To', 'identify', 'genetic', 'variants', 'associated', 'with', 'post', '-', 'induction', 'ALT', 'levels', 'in', 'the', 'SJCRH', 'discovery', 'cohort', ',', 'we', 'used', 'a', 'multivariate', 'linear', 'regression', 'model', 'including', 'treatment', 'protocol', ',', 'use', 'of', 'additional', 'asparaginase', 'doses', ',', 'percentage', 'of', 'Northern', 'European', 'ancestry', ',', 'West', 'African', 'ancestry', 'and', 'Native', 'American', 'ancestry', ',', 'age', ',', 'and', 'BMI', 'percentile', 'as', 'covariates', 'along', 'with', 'genotypes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 4, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Because the PNPLA3 variant rs738409 has been previously linked to elevated ALT levels and to the development of hepatic steatosis in the general population,(13) its association with elevated ALT after remission induction therapy suggested that asparaginase may influence blood ALT levels through dysregulation of hepatic lipids.	[('PMC5511775', 'R06000', 244, 256, 'asparaginase')]	['Because', 'the', 'P', '##NP', '##LA', '##3', 'variant', 'r', '##s', '##7', '##38', '##40', '##9', 'has', 'been', 'previously', 'linked', 'to', 'elevated', 'AL', '##T', 'levels', 'and', 'to', 'the', 'development', 'of', 'he', '##pa', '##tic', 's', '##te', '##ato', '##sis', 'in', 'the', 'general', 'population', ',', '(', '13', ')', 'its', 'association', 'with', 'elevated', 'AL', '##T', 'after', 're', '##mission', 'induction', 'therapy', 'suggested', 'that', 'as', '##par', '##agi', '##nas', '##e', 'may', 'influence', 'blood', 'AL', '##T', 'levels', 'through', 'd', '##ys', '##re', '##gu', '##lation', 'of', 'he', '##pa', '##tic', 'lip', '##ids', '.']	[0, 8, 12, 13, 15, 17, 19, 27, 28, 29, 30, 32, 34, 36, 40, 45, 56, 63, 66, 75, 77, 79, 86, 90, 93, 97, 109, 112, 114, 116, 120, 121, 123, 126, 130, 133, 137, 145, 155, 156, 157, 159, 161, 165, 177, 182, 191, 193, 195, 201, 203, 211, 221, 229, 239, 244, 246, 249, 252, 255, 257, 261, 271, 277, 279, 281, 288, 296, 297, 299, 301, 303, 310, 313, 315, 317, 321, 324, 327]	[7, 11, 13, 15, 17, 18, 26, 28, 29, 30, 32, 34, 35, 39, 44, 55, 62, 65, 74, 77, 78, 85, 89, 92, 96, 108, 111, 114, 116, 119, 121, 123, 126, 129, 132, 136, 144, 155, 156, 157, 159, 160, 164, 176, 181, 190, 193, 194, 200, 203, 210, 220, 228, 238, 243, 246, 249, 252, 255, 256, 260, 270, 276, 279, 280, 287, 295, 297, 299, 301, 303, 309, 312, 315, 317, 320, 324, 327, 328]	['Because', 'the', 'PNPLA3', 'variant', 'rs738409', 'has', 'been', 'previously', 'linked', 'to', 'elevated', 'ALT', 'levels', 'and', 'to', 'the', 'development', 'of', 'hepatic', 'steatosis', 'in', 'the', 'general', 'population', ',', '(', '13', ')', 'its', 'association', 'with', 'elevated', 'ALT', 'after', 'remission', 'induction', 'therapy', 'suggested', 'that', 'asparaginase', 'may', 'influence', 'blood', 'ALT', 'levels', 'through', 'dysregulation', 'of', 'hepatic', 'lipids', '.']	[1, 1, 4, 1, 6, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 5, 1, 3, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We confirmed that PEGylated E. coli asparaginase caused hepatic steatosis in mice, as evidenced by a doubling in Oil-red O (ORO) staining in livers of mice treated with the drug compared to control (Figure S7).	[('PMC5511775', 'R06001', 36, 48, 'asparaginase')]	['We', 'confirmed', 'that', 'P', '##EG', '##yla', '##ted', 'E', '.', 'co', '##li', 'as', '##par', '##agi', '##nas', '##e', 'caused', 'he', '##pa', '##tic', 's', '##te', '##ato', '##sis', 'in', 'mice', ',', 'as', 'evidenced', 'by', 'a', 'doubling', 'in', 'Oil', '-', 'red', 'O', '(', 'OR', '##O', ')', 'stain', '##ing', 'in', 'liver', '##s', 'of', 'mice', 'treated', 'with', 'the', 'drug', 'compared', 'to', 'control', '(', 'Figure', 'S', '##7', ')', '.']	[0, 3, 13, 18, 19, 21, 24, 28, 29, 31, 33, 36, 38, 41, 44, 47, 49, 56, 58, 60, 64, 65, 67, 70, 74, 77, 81, 83, 86, 96, 99, 101, 110, 113, 116, 117, 121, 123, 124, 126, 127, 129, 134, 138, 141, 146, 148, 151, 156, 164, 169, 173, 178, 187, 190, 198, 199, 206, 207, 208, 209]	[2, 12, 17, 19, 21, 24, 27, 29, 30, 33, 35, 38, 41, 44, 47, 48, 55, 58, 60, 63, 65, 67, 70, 73, 76, 81, 82, 85, 95, 98, 100, 109, 112, 116, 117, 120, 122, 124, 126, 127, 128, 134, 137, 140, 146, 147, 150, 155, 163, 168, 172, 177, 186, 189, 197, 199, 205, 207, 208, 209, 210]	['We', 'confirmed', 'that', 'PEGylated', 'E', '.', 'coli', 'asparaginase', 'caused', 'hepatic', 'steatosis', 'in', 'mice', ',', 'as', 'evidenced', 'by', 'a', 'doubling', 'in', 'Oil', '-', 'red', 'O', '(', 'ORO', ')', 'staining', 'in', 'livers', 'of', 'mice', 'treated', 'with', 'the', 'drug', 'compared', 'to', 'control', '(', 'Figure', 'S7', ')', '.']	[1, 1, 1, 4, 1, 1, 2, 5, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Table 2 shows the characteristic aa motifs conserved in all caliciviruses: 2C-like NTPase motif ; VPg motifs KGKTK and ; 3C-like protease motif GDCG; 3D-like RdRP motifs WKGL, KDEL, DYSKWDST, GLPSG and YGDD; and VP1 motif PPG.	[('PMC5520483', 'R01000', 75, 89, '2C-like NTPase')]	['Table', '2', 'shows', 'the', 'characteristic', 'a', '##a', 'motifs', 'conserved', 'in', 'all', 'ca', '##lic', '##iv', '##ir', '##uses', ':', '2', '##C', '-', 'like', 'N', '##TP', '##ase', 'motif', ';', 'VP', '##g', 'motifs', 'K', '##G', '##K', '##T', '##K', 'and', ';', '3', '##C', '-', 'like', 'pro', '##te', '##ase', 'motif', 'G', '##DC', '##G', ';', '3D', '-', 'like', 'Rd', '##RP', 'motifs', 'W', '##K', '##G', '##L', ',', 'K', '##DE', '##L', ',', 'D', '##Y', '##S', '##K', '##WD', '##ST', ',', 'G', '##LP', '##S', '##G', 'and', 'Y', '##G', '##D', '##D', ';', 'and', 'VP', '##1', 'motif', 'PP', '##G', '.']	[0, 6, 8, 14, 18, 33, 34, 36, 43, 53, 56, 60, 62, 65, 67, 69, 73, 75, 76, 77, 78, 83, 84, 86, 90, 96, 98, 100, 102, 109, 110, 111, 112, 113, 115, 119, 121, 122, 123, 124, 129, 132, 134, 138, 144, 145, 147, 148, 150, 152, 153, 158, 160, 163, 170, 171, 172, 173, 174, 176, 177, 179, 180, 182, 183, 184, 185, 186, 188, 190, 192, 193, 195, 196, 198, 202, 203, 204, 205, 206, 208, 212, 214, 216, 222, 224, 225]	[5, 7, 13, 17, 32, 34, 35, 42, 52, 55, 59, 62, 65, 67, 69, 73, 74, 76, 77, 78, 82, 84, 86, 89, 95, 97, 100, 101, 108, 110, 111, 112, 113, 114, 118, 120, 122, 123, 124, 128, 132, 134, 137, 143, 145, 147, 148, 149, 152, 153, 157, 160, 162, 169, 171, 172, 173, 174, 175, 177, 179, 180, 181, 183, 184, 185, 186, 188, 190, 191, 193, 195, 196, 197, 201, 203, 204, 205, 206, 207, 211, 214, 215, 221, 224, 225, 226]	['Table', '2', 'shows', 'the', 'characteristic', 'aa', 'motifs', 'conserved', 'in', 'all', 'caliciviruses', ':', '2C', '-', 'like', 'NTPase', 'motif', ';', 'VPg', 'motifs', 'KGKTK', 'and', ';', '3C', '-', 'like', 'protease', 'motif', 'GDCG', ';', '3D-', 'like', 'RdRP', 'motifs', 'WKGL', ',', 'KDEL', ',', 'DYSKWDST', ',', 'GLPSG', 'and', 'YGDD', ';', 'and', 'VP1', 'motif', 'PPG', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 2, 1, 1, 3, 1, 1, 2, 1, 5, 1, 1, 2, 1, 1, 3, 1, 3, 1, 2, 1, 2, 1, 4, 1, 3, 1, 6, 1, 4, 1, 4, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Only minor deviations were observed in the novel SaVs: in the 2C-like NTPase motif (), the A is replaced with either I or P and in the VPg motif (), the last D is replaced by an E in all the novel sequences.	[('PMC5520483', 'R01001', 62, 76, '2C-like NTPase')]	['Only', 'minor', 'de', '##viation', '##s', 'were', 'observed', 'in', 'the', 'novel', 'Sa', '##Vs', ':', 'in', 'the', '2', '##C', '-', 'like', 'N', '##TP', '##ase', 'motif', '(', ')', ',', 'the', 'A', 'is', 'replaced', 'with', 'either', 'I', 'or', 'P', 'and', 'in', 'the', 'VP', '##g', 'motif', '(', ')', ',', 'the', 'last', 'D', 'is', 'replaced', 'by', 'an', 'E', 'in', 'all', 'the', 'novel', 'sequences', '.']	[0, 5, 11, 13, 20, 22, 27, 36, 39, 43, 49, 51, 53, 55, 58, 62, 63, 64, 65, 70, 71, 73, 77, 83, 84, 85, 87, 91, 93, 96, 105, 110, 117, 119, 122, 124, 128, 131, 135, 137, 139, 145, 146, 147, 149, 153, 158, 160, 163, 172, 175, 178, 180, 183, 187, 191, 197, 206]	[4, 10, 13, 20, 21, 26, 35, 38, 42, 48, 51, 53, 54, 57, 61, 63, 64, 65, 69, 71, 73, 76, 82, 84, 85, 86, 90, 92, 95, 104, 109, 116, 118, 121, 123, 127, 130, 134, 137, 138, 144, 146, 147, 148, 152, 157, 159, 162, 171, 174, 177, 179, 182, 186, 190, 196, 206, 207]	['Only', 'minor', 'deviations', 'were', 'observed', 'in', 'the', 'novel', 'SaVs', ':', 'in', 'the', '2C', '-', 'like', 'NTPase', 'motif', '()', ',', 'the', 'A', 'is', 'replaced', 'with', 'either', 'I', 'or', 'P', 'and', 'in', 'the', 'VPg', 'motif', '()', ',', 'the', 'last', 'D', 'is', 'replaced', 'by', 'an', 'E', 'in', 'all', 'the', 'novel', 'sequences', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Total RNA was treated with DNase (TURBO DNA-free, Life Technologies) according to the instructions of the supplier.	[('PMC5529966', 'M09000', 27, 32, 'DNase')]	['Total', 'RNA', 'was', 'treated', 'with', 'D', '##N', '##ase', '(', 'T', '##UR', '##BO', 'DNA', '-', 'free', ',', 'Life', 'Technologies', ')', 'according', 'to', 'the', 'instructions', 'of', 'the', 'supplier', '.']	[0, 6, 10, 14, 22, 27, 28, 29, 33, 34, 35, 37, 40, 43, 44, 48, 50, 55, 67, 69, 79, 82, 86, 99, 102, 106, 114]	[5, 9, 13, 21, 26, 28, 29, 32, 34, 35, 37, 39, 43, 44, 48, 49, 54, 67, 68, 78, 81, 85, 98, 101, 105, 114, 115]	['Total', 'RNA', 'was', 'treated', 'with', 'DNase', '(', 'TURBO', 'DNA-free', ',', 'Life', 'Technologies', ')', 'according', 'to', 'the', 'instructions', 'of', 'the', 'supplier', '.']	[1, 1, 1, 1, 1, 3, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Real-time quantitative PCR (RT-qPCR) was carried out on a LightCycler 480 (Roche) targeting several genes published as being putatively involved in inflammation and cancer progression using primers and probes designed with the Universal ProbeLibrary Assay Design Center (Roche).	[]	['Real', '-', 'time', 'quantitative', 'PC', '##R', '(', 'R', '##T', '-', 'q', '##PC', '##R', ')', 'was', 'carried', 'out', 'on', 'a', 'Light', '##C', '##ycle', '##r', '480', '(', 'Roche', ')', 'targeting', 'several', 'genes', 'published', 'as', 'being', 'put', '##ative', '##ly', 'involved', 'in', 'inflammation', 'and', 'cancer', 'progression', 'using', 'prime', '##rs', 'and', 'probe', '##s', 'designed', 'with', 'the', 'Universal', 'Pro', '##be', '##L', '##ib', '##rary', 'As', '##say', 'Design', 'Center', '(', 'Roche', ')', '.']	[0, 4, 5, 10, 23, 25, 27, 28, 29, 30, 31, 32, 34, 35, 37, 41, 49, 53, 56, 58, 63, 64, 68, 70, 74, 75, 80, 82, 92, 100, 106, 116, 119, 125, 128, 133, 136, 145, 148, 161, 165, 172, 184, 190, 195, 198, 202, 207, 209, 218, 223, 227, 237, 240, 242, 243, 245, 250, 252, 256, 263, 270, 271, 276, 277]	[4, 5, 9, 22, 25, 26, 28, 29, 30, 31, 32, 34, 35, 36, 40, 48, 52, 55, 57, 63, 64, 68, 69, 73, 75, 80, 81, 91, 99, 105, 115, 118, 124, 128, 133, 135, 144, 147, 160, 164, 171, 183, 189, 195, 197, 201, 207, 208, 217, 222, 226, 236, 240, 242, 243, 245, 249, 252, 255, 262, 269, 271, 276, 277, 278]	['Real', '-', 'time', 'quantitative', 'PCR', '(', 'RT-qPCR', ')', 'was', 'carried', 'out', 'on', 'a', 'LightCycler', '480', '(', 'Roche', ')', 'targeting', 'several', 'genes', 'published', 'as', 'being', 'putatively', 'involved', 'in', 'inflammation', 'and', 'cancer', 'progression', 'using', 'primers', 'and', 'probes', 'designed', 'with', 'the', 'Universal', 'ProbeLibrary', 'Assay', 'Design', 'Center', '(', 'Roche', ')', '.']	[1, 1, 1, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 5, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For primer sequences, see online supplementary table S2.	[]	['For', 'prime', '##r', 'sequences', ',', 'see', 'online', 'supplement', '##ary', 'table', 'S', '##2', '.']	[0, 4, 9, 11, 20, 22, 26, 33, 43, 47, 53, 54, 55]	[3, 9, 10, 20, 21, 25, 32, 43, 46, 52, 54, 55, 56]	['For', 'primer', 'sequences', ',', 'see', 'online', 'supplementary', 'table', 'S2', '.']	[1, 2, 1, 1, 1, 1, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The qPCR-based analysis of the resistome confirms previous metagenomic studies, in showing that tetracycline and aminoglycoside resistance genes and bacteroidal β-lactamases are widespread in the human intestinal microbiota [14, 15, 18, 20].	[('PMC5554972', 'D04000', 161, 173, 'β-lactamases')]	['The', 'q', '##PC', '##R', '-', 'based', 'analysis', 'of', 'the', 'resist', '##ome', 'confirms', 'previous', 'meta', '##gen', '##omi', '##c', 'studies', ',', 'in', 'showing', 'that', 'te', '##tra', '##cy', '##cline', 'and', 'amino', '##gly', '##cos', '##ide', 'resistance', 'genes', 'and', 'b', '##act', '##ero', '##idal', 'β', '-', 'la', '##ct', '##ama', '##ses', 'are', 'widespread', 'in', 'the', 'human', 'in', '##test', '##inal', 'micro', '##bio', '##ta', '[', '14', ',', '15', ',', '18', ',', '20', ']', '.']	[0, 4, 5, 7, 8, 9, 15, 24, 27, 31, 37, 41, 50, 59, 63, 66, 69, 71, 78, 80, 83, 91, 96, 98, 101, 103, 109, 113, 118, 121, 124, 128, 139, 145, 149, 150, 153, 156, 161, 162, 163, 165, 167, 170, 174, 178, 189, 192, 196, 202, 204, 208, 213, 218, 221, 224, 225, 227, 229, 231, 233, 235, 237, 239, 240]	[3, 5, 7, 8, 9, 14, 23, 26, 30, 37, 40, 49, 58, 63, 66, 69, 70, 78, 79, 82, 90, 95, 98, 101, 103, 108, 112, 118, 121, 124, 127, 138, 144, 148, 150, 153, 156, 160, 162, 163, 165, 167, 170, 173, 177, 188, 191, 195, 201, 204, 208, 212, 218, 221, 223, 225, 227, 228, 231, 232, 235, 236, 239, 240, 241]	['The', 'qPCR', '-', 'based', 'analysis', 'of', 'the', 'resistome', 'confirms', 'previous', 'metagenomic', 'studies', ',', 'in', 'showing', 'that', 'tetracycline', 'and', 'aminoglycoside', 'resistance', 'genes', 'and', 'bacteroidal', 'β-lactamases', 'are', 'widespread', 'in', 'the', 'human', 'intestinal', 'microbiota', '[', '14', ',', '15', ',', '18', ',', '20', ']', '.']	[1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 4, 6, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The carbapenemase blaKPC was detected in a single patient (patient #180), but only in the first sample (collected after five days in the ICU) and not in the second sample, which was collected after 16 days of ICU hospitalization.	[]	['The', 'car', '##ba', '##pen', '##ema', '##se', 'b', '##la', '##K', '##PC', 'was', 'detected', 'in', 'a', 'single', 'patient', '(', 'patient', '#', '180', ')', ',', 'but', 'only', 'in', 'the', 'first', 'sample', '(', 'collected', 'after', 'five', 'days', 'in', 'the', 'I', '##CU', ')', 'and', 'not', 'in', 'the', 'second', 'sample', ',', 'which', 'was', 'collected', 'after', '16', 'days', 'of', 'I', '##CU', 'hospital', '##ization', '.']	[0, 4, 7, 9, 12, 15, 18, 19, 21, 22, 25, 29, 38, 41, 43, 50, 58, 59, 67, 68, 71, 72, 74, 78, 83, 86, 90, 96, 103, 104, 114, 120, 125, 130, 133, 137, 138, 140, 142, 146, 150, 153, 157, 164, 170, 172, 178, 182, 192, 198, 201, 206, 209, 210, 213, 221, 228]	[3, 7, 9, 12, 15, 17, 19, 21, 22, 24, 28, 37, 40, 42, 49, 57, 59, 66, 68, 71, 72, 73, 77, 82, 85, 89, 95, 102, 104, 113, 119, 124, 129, 132, 136, 138, 140, 141, 145, 149, 152, 156, 163, 170, 171, 177, 181, 191, 197, 200, 205, 208, 210, 212, 221, 228, 229]	['The', 'carbapenemase', 'blaKPC', 'was', 'detected', 'in', 'a', 'single', 'patient', '(', 'patient', '#180', ')', ',', 'but', 'only', 'in', 'the', 'first', 'sample', '(', 'collected', 'after', 'five', 'days', 'in', 'the', 'ICU', ')', 'and', 'not', 'in', 'the', 'second', 'sample', ',', 'which', 'was', 'collected', 'after', '16', 'days', 'of', 'ICU', 'hospitalization', '.']	[1, 5, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PIs were metabolized by 1-phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) to generate phosphatidylinositol 5-phosphate, which was further metabolized by 1-phosphatidylinositol-5-phosphate 4-kinase (PIP4K2) to generate phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2)	[]	['P', '##I', '##s', 'were', 'meta', '##bol', '##ized', 'by', '1', '-', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '-', '3', '-', 'phosphate', '5', '-', 'kinase', '(', 'P', '##I', '##K', '##fy', '##ve', ')', 'to', 'generate', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '5', '-', 'phosphate', ',', 'which', 'was', 'further', 'meta', '##bol', '##ized', 'by', '1', '-', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '-', '5', '-', 'phosphate', '4', '-', 'kinase', '(', 'P', '##IP', '##4', '##K', '##2', ')', 'to', 'generate', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '-', '4', ',', '5', '-', 'bi', '##sp', '##hos', '##phate', '(', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', ')']	[0, 1, 2, 4, 9, 13, 16, 21, 24, 25, 26, 27, 30, 33, 35, 37, 41, 43, 45, 46, 47, 48, 49, 59, 60, 61, 68, 69, 70, 71, 72, 74, 76, 78, 81, 90, 91, 94, 97, 99, 101, 105, 107, 109, 111, 112, 113, 122, 124, 130, 134, 142, 146, 149, 154, 157, 158, 159, 160, 163, 166, 168, 170, 174, 176, 178, 179, 180, 181, 182, 192, 193, 194, 201, 202, 203, 205, 206, 207, 208, 210, 213, 222, 223, 226, 229, 231, 233, 237, 239, 241, 242, 243, 244, 245, 246, 247, 249, 251, 254, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270]	[1, 2, 3, 8, 13, 16, 20, 23, 25, 26, 27, 30, 33, 35, 37, 41, 43, 45, 46, 47, 48, 49, 58, 60, 61, 67, 69, 70, 71, 72, 74, 76, 77, 80, 89, 91, 94, 97, 99, 101, 105, 107, 109, 110, 112, 113, 122, 123, 129, 133, 141, 146, 149, 153, 156, 158, 159, 160, 163, 166, 168, 170, 174, 176, 178, 179, 180, 181, 182, 191, 193, 194, 200, 202, 203, 205, 206, 207, 208, 209, 212, 221, 223, 226, 229, 231, 233, 237, 239, 241, 242, 243, 244, 245, 246, 247, 249, 251, 254, 259, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271]	['PIs', 'were', 'metabolized', 'by', '1-phosphatidylinositol-3-phosphate', '5-kinase', '(', 'PIKfyve', ')', 'to', 'generate', 'phosphatidylinositol', '5-phosphate', ',', 'which', 'was', 'further', 'metabolized', 'by', '1-phosphatidylinositol-5-phosphate', '4-kinase', '(', 'PIP4K2', ')', 'to', 'generate', 'phosphatidylinositol-4,5-bisphosphate', '(', 'PI(4,5)P2', ')']	[3, 1, 3, 1, 15, 3, 1, 5, 1, 1, 1, 9, 3, 1, 1, 1, 1, 3, 1, 15, 3, 1, 5, 1, 1, 1, 18, 1, 9, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recent studies have shown that the PI3K/AKT pathway was frequently disturbed in ovarian cancer, and had a vital role in the resistance of ovarian cancer cells to cisplatin and recurrence of ovarian cancer [34, 35].	[]	['Recent', 'studies', 'have', 'shown', 'that', 'the', 'P', '##I', '##3', '##K', '/', 'AK', '##T', 'pathway', 'was', 'frequently', 'disturbed', 'in', 'o', '##var', '##ian', 'cancer', ',', 'and', 'had', 'a', 'vital', 'role', 'in', 'the', 'resistance', 'of', 'o', '##var', '##ian', 'cancer', 'cells', 'to', 'c', '##is', '##p', '##lat', '##in', 'and', 're', '##cu', '##rrence', 'of', 'o', '##var', '##ian', 'cancer', '[', '34', ',', '35', ']', '.']	[0, 7, 15, 20, 26, 31, 35, 36, 37, 38, 39, 40, 42, 44, 52, 56, 67, 77, 80, 81, 84, 88, 94, 96, 100, 104, 106, 112, 117, 120, 124, 135, 138, 139, 142, 146, 153, 159, 162, 163, 165, 166, 169, 172, 176, 178, 180, 187, 190, 191, 194, 198, 205, 206, 208, 210, 212, 213]	[6, 14, 19, 25, 30, 34, 36, 37, 38, 39, 40, 42, 43, 51, 55, 66, 76, 79, 81, 84, 87, 94, 95, 99, 103, 105, 111, 116, 119, 123, 134, 137, 139, 142, 145, 152, 158, 161, 163, 165, 166, 169, 171, 175, 178, 180, 186, 189, 191, 194, 197, 204, 206, 208, 209, 212, 213, 214]	['Recent', 'studies', 'have', 'shown', 'that', 'the', 'PI3K', '/', 'AKT', 'pathway', 'was', 'frequently', 'disturbed', 'in', 'ovarian', 'cancer', ',', 'and', 'had', 'a', 'vital', 'role', 'in', 'the', 'resistance', 'of', 'ovarian', 'cancer', 'cells', 'to', 'cisplatin', 'and', 'recurrence', 'of', 'ovarian', 'cancer', '[', '34', ',', '35', ']', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Four proteins were by more than 2-fold lower in responders, i.e., apolipoprotein A-IV, carboxypeptidase B2, complement component C7 and serine/threonine-protein kinase Chk1.	[('PMC5583163', 'R02000', 87, 106, 'carboxypeptidase B2')]	['Four', 'proteins', 'were', 'by', 'more', 'than', '2', '-', 'fold', 'lower', 'in', 'respond', '##ers', ',', 'i', '.', 'e', '.', ',', 'a', '##poli', '##pop', '##rote', '##in', 'A', '-', 'IV', ',', 'car', '##box', '##ype', '##pt', '##idas', '##e', 'B', '##2', ',', 'complement', 'component', 'C', '##7', 'and', 'se', '##rine', '/', 'th', '##re', '##oni', '##ne', '-', 'protein', 'kinase', 'Ch', '##k', '##1', '.']	[0, 5, 14, 19, 22, 27, 32, 33, 34, 39, 45, 48, 55, 58, 60, 61, 62, 63, 64, 66, 67, 71, 74, 78, 81, 82, 83, 85, 87, 90, 93, 96, 98, 102, 104, 105, 106, 108, 119, 129, 130, 132, 136, 138, 142, 143, 145, 147, 150, 152, 153, 161, 168, 170, 171, 172]	[4, 13, 18, 21, 26, 31, 33, 34, 38, 44, 47, 55, 58, 59, 61, 62, 63, 64, 65, 67, 71, 74, 78, 80, 82, 83, 85, 86, 90, 93, 96, 98, 102, 103, 105, 106, 107, 118, 128, 130, 131, 135, 138, 142, 143, 145, 147, 150, 152, 153, 160, 167, 170, 171, 172, 173]	['Four', 'proteins', 'were', 'by', 'more', 'than', '2-fold', 'lower', 'in', 'responders', ',', 'i.e', '.', ',', 'apolipoprotein', 'A-IV', ',', 'carboxypeptidase', 'B2', ',', 'complement', 'component', 'C7', 'and', 'serine', '/', 'threonine', '-', 'protein', 'kinase', 'Chk1', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 5, 3, 1, 6, 2, 1, 1, 1, 2, 1, 2, 1, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In 25 healthy and 25 constipated females we evaluated the sigmoid colonic mucosal and fecal microbiota using 16S rRNA gene sequencing, abundance of hydrogenogenic FeFe (FeFe-hydA) and hydrogenotrophic (methyl coenzyme M reductase	[]	['In', '25', 'healthy', 'and', '25', 'con', '##st', '##ip', '##ated', 'females', 'we', 'evaluated', 'the', 'si', '##g', '##mo', '##id', 'co', '##lon', '##ic', 'm', '##uc', '##osa', '##l', 'and', 'f', '##eca', '##l', 'micro', '##bio', '##ta', 'using', '16', '##S', 'r', '##RNA', 'gene', 'se', '##quencing', ',', 'abundance', 'of', 'hydrogen', '##ogenic', 'Fe', '##F', '##e', '(', 'Fe', '##F', '##e', '-', 'h', '##yd', '##A', ')', 'and', 'hydrogen', '##ot', '##rop', '##hic', '(', 'met', '##hyl', 'co', '##en', '##zy', '##me', 'M', 'red', '##uc', '##tase']	[0, 3, 6, 14, 18, 21, 24, 26, 28, 33, 41, 44, 54, 58, 60, 61, 63, 66, 68, 71, 74, 75, 77, 80, 82, 86, 87, 90, 92, 97, 100, 103, 109, 111, 113, 114, 118, 123, 125, 133, 135, 145, 148, 156, 163, 165, 166, 168, 169, 171, 172, 173, 174, 175, 177, 178, 180, 184, 192, 194, 197, 201, 202, 205, 209, 211, 213, 215, 218, 220, 223, 225]	[2, 5, 13, 17, 20, 24, 26, 28, 32, 40, 43, 53, 57, 60, 61, 63, 65, 68, 71, 73, 75, 77, 80, 81, 85, 87, 90, 91, 97, 100, 102, 108, 111, 112, 114, 117, 122, 125, 133, 134, 144, 147, 156, 162, 165, 166, 167, 169, 171, 172, 173, 174, 175, 177, 178, 179, 183, 192, 194, 197, 200, 202, 205, 208, 211, 213, 215, 217, 219, 223, 225, 229]	['In', '25', 'healthy', 'and', '25', 'constipated', 'females', 'we', 'evaluated', 'the', 'sigmoid', 'colonic', 'mucosal', 'and', 'fecal', 'microbiota', 'using', '16S', 'rRNA', 'gene', 'sequencing', ',', 'abundance', 'of', 'hydrogenogenic', 'FeFe', '(', 'FeFe-hydA', ')', 'and', 'hydrogenotrophic', '(', 'methyl', 'coenzyme', 'M', 'reductase']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 3, 4, 1, 3, 3, 1, 2, 2, 1, 2, 1, 1, 1, 2, 3, 1, 7, 1, 1, 4, 1, 2, 4, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A [mrcA] and dissimilatory sulfite reductase	[]	['A', '[', 'm', '##rc', '##A', ']', 'and', 'di', '##ssi', '##mi', '##lator', '##y', 'su', '##lf', '##ite', 'red', '##uc', '##tase']	[0, 2, 3, 4, 6, 7, 9, 13, 15, 18, 20, 25, 27, 29, 31, 35, 38, 40]	[1, 3, 4, 6, 7, 8, 12, 15, 18, 20, 25, 26, 29, 31, 34, 38, 40, 44]	['A', '[', 'mrcA', ']', 'and', 'dissimilatory', 'sulfite', 'reductase']	[1, 1, 3, 1, 1, 5, 3, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Microbial hydrogenogenesis and hydrogenotrophy involves the reversible oxidation of H2 by hydrogenase harboring organisms.	[('PMC5593760', 'I02000', 90, 101, 'hydrogenase')]	['Micro', '##bial', 'hydrogen', '##ogen', '##esis', 'and', 'hydrogen', '##ot', '##rop', '##hy', 'involves', 'the', 're', '##versible', 'oxidation', 'of', 'H', '##2', 'by', 'hydrogen', '##ase', 'harbor', '##ing', 'organisms', '.']	[0, 5, 10, 18, 22, 27, 31, 39, 41, 44, 47, 56, 60, 62, 71, 81, 84, 85, 87, 90, 98, 102, 108, 112, 121]	[5, 9, 18, 22, 26, 30, 39, 41, 44, 46, 55, 59, 62, 70, 80, 83, 85, 86, 89, 98, 101, 108, 111, 121, 122]	['Microbial', 'hydrogenogenesis', 'and', 'hydrogenotrophy', 'involves', 'the', 'reversible', 'oxidation', 'of', 'H2', 'by', 'hydrogenase', 'harboring', 'organisms', '.']	[2, 3, 1, 4, 1, 1, 2, 1, 1, 2, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O']
Categorized by their metal functional cores, hydrogenases are phylogenetically widespread and functionally diverse and include both hydrogen evolving and hydrogen uptake [NiFe] hydrogenases, hydrogen evolving [FeFe] hydrogenases, and hydrogen uptake [Fe]-only hydrogenases (10).	[('PMC5593760', 'I02001', 45, 57, 'hydrogenases')]	['Cat', '##ego', '##riz', '##ed', 'by', 'their', 'metal', 'functional', 'core', '##s', ',', 'hydrogen', '##ases', 'are', 'phylogenetic', '##ally', 'widespread', 'and', 'functional', '##ly', 'diverse', 'and', 'include', 'both', 'hydrogen', 'evolving', 'and', 'hydrogen', 'up', '##take', '[', 'Ni', '##F', '##e', ']', 'hydrogen', '##ases', ',', 'hydrogen', 'evolving', '[', 'Fe', '##F', '##e', ']', 'hydrogen', '##ases', ',', 'and', 'hydrogen', 'up', '##take', '[', 'Fe', ']', '-', 'only', 'hydrogen', '##ases', '(', '10', ')', '.']	[0, 3, 6, 9, 12, 15, 21, 27, 38, 42, 43, 45, 53, 58, 62, 74, 79, 90, 94, 104, 107, 115, 119, 127, 132, 141, 150, 154, 163, 165, 170, 171, 173, 174, 175, 177, 185, 189, 191, 200, 209, 210, 212, 213, 214, 216, 224, 228, 230, 234, 243, 245, 250, 251, 253, 254, 255, 260, 268, 273, 274, 276, 277]	[3, 6, 9, 11, 14, 20, 26, 37, 42, 43, 44, 53, 57, 61, 74, 78, 89, 93, 104, 106, 114, 118, 126, 131, 140, 149, 153, 162, 165, 169, 171, 173, 174, 175, 176, 185, 189, 190, 199, 208, 210, 212, 213, 214, 215, 224, 228, 229, 233, 242, 245, 249, 251, 253, 254, 255, 259, 268, 272, 274, 276, 277, 278]	['Categorized', 'by', 'their', 'metal', 'functional', 'cores', ',', 'hydrogenases', 'are', 'phylogenetically', 'widespread', 'and', 'functionally', 'diverse', 'and', 'include', 'both', 'hydrogen', 'evolving', 'and', 'hydrogen', 'uptake', '[', 'NiFe', ']', 'hydrogenases', ',', 'hydrogen', 'evolving', '[', 'FeFe', ']', 'hydrogenases', ',', 'and', 'hydrogen', 'uptake', '[', 'Fe', ']', '-', 'only', 'hydrogenases', '(', '10', ')', '.']	[4, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cirrhotic patients have significantly elevated levels of alanine transaminase (ALT), aspartate transaminase (AST), creatinine (CREA), direct bilirubin (DBIL), total bilirubin (TBIL) and total bile acids (TBA) while have significantly decreased levels of albumin (ALB), cholesterol (CHOL), triglyceride (TG), high density lipoprotein-cholesterol (HDL-C), and low density lipoprotein-cholesterol (LDL-C) as compared to healthy controls in both discovery set and validation set.	[]	['C', '##ir', '##r', '##hot', '##ic', 'patients', 'have', 'significantly', 'elevated', 'levels', 'of', 'al', '##ani', '##ne', 'trans', '##ami', '##nas', '##e', '(', 'AL', '##T', ')', ',', 'as', '##par', '##tate', 'trans', '##ami', '##nas', '##e', '(', 'AS', '##T', ')', ',', 'c', '##rea', '##tin', '##ine', '(', 'CR', '##EA', ')', ',', 'direct', 'bi', '##li', '##ru', '##bin', '(', 'DB', '##IL', ')', ',', 'total', 'bi', '##li', '##ru', '##bin', '(', 'T', '##BI', '##L', ')', 'and', 'total', 'bi', '##le', 'acids', '(', 'T', '##BA', ')', 'while', 'have', 'significantly', 'decreased', 'levels', 'of', 'album', '##in', '(', 'AL', '##B', ')', ',', 'ch', '##ole', '##ster', '##ol', '(', 'CH', '##OL', ')', ',', 't', '##rig', '##ly', '##cer', '##ide', '(', 'T', '##G', ')', ',', 'high', 'density', 'lip', '##op', '##rote', '##in', '-', 'ch', '##ole', '##ster', '##ol', '(', 'HD', '##L', '-', 'C', ')', ',', 'and', 'low', 'density', 'lip', '##op', '##rote', '##in', '-', 'ch', '##ole', '##ster', '##ol', '(', 'L', '##D', '##L', '-', 'C', ')', 'as', 'compared', 'to', 'healthy', 'controls', 'in', 'both', 'discovery', 'set', 'and', 'valid', '##ation', 'set', '.']	[0, 1, 3, 4, 7, 10, 19, 24, 38, 47, 54, 57, 59, 62, 65, 70, 73, 76, 78, 79, 81, 82, 83, 85, 87, 90, 95, 100, 103, 106, 108, 109, 111, 112, 113, 115, 116, 119, 122, 126, 127, 129, 131, 132, 134, 141, 143, 145, 147, 151, 152, 154, 156, 157, 159, 165, 167, 169, 171, 175, 176, 177, 179, 180, 182, 186, 192, 194, 197, 203, 204, 205, 207, 209, 215, 220, 234, 244, 251, 254, 259, 262, 263, 265, 266, 267, 269, 271, 274, 278, 281, 282, 284, 286, 287, 289, 290, 293, 295, 298, 302, 303, 304, 305, 306, 308, 313, 321, 324, 326, 330, 332, 333, 335, 338, 342, 345, 346, 348, 349, 350, 351, 352, 354, 358, 362, 370, 373, 375, 379, 381, 382, 384, 387, 391, 394, 395, 396, 397, 398, 399, 400, 402, 405, 414, 417, 425, 434, 437, 442, 452, 456, 460, 465, 471, 474]	[1, 3, 4, 7, 9, 18, 23, 37, 46, 53, 56, 59, 62, 64, 70, 73, 76, 77, 79, 81, 82, 83, 84, 87, 90, 94, 100, 103, 106, 107, 109, 111, 112, 113, 114, 116, 119, 122, 125, 127, 129, 131, 132, 133, 140, 143, 145, 147, 150, 152, 154, 156, 157, 158, 164, 167, 169, 171, 174, 176, 177, 179, 180, 181, 185, 191, 194, 196, 202, 204, 205, 207, 208, 214, 219, 233, 243, 250, 253, 259, 261, 263, 265, 266, 267, 268, 271, 274, 278, 280, 282, 284, 286, 287, 288, 290, 293, 295, 298, 301, 303, 304, 305, 306, 307, 312, 320, 324, 326, 330, 332, 333, 335, 338, 342, 344, 346, 348, 349, 350, 351, 352, 353, 357, 361, 369, 373, 375, 379, 381, 382, 384, 387, 391, 393, 395, 396, 397, 398, 399, 400, 401, 404, 413, 416, 424, 433, 436, 441, 451, 455, 459, 465, 470, 474, 475]	['Cirrhotic', 'patients', 'have', 'significantly', 'elevated', 'levels', 'of', 'alanine', 'transaminase', '(', 'ALT', ')', ',', 'aspartate', 'transaminase', '(', 'AST', ')', ',', 'creatinine', '(', 'CREA', ')', ',', 'direct', 'bilirubin', '(', 'DBIL', ')', ',', 'total', 'bilirubin', '(', 'TBIL', ')', 'and', 'total', 'bile', 'acids', '(', 'TBA', ')', 'while', 'have', 'significantly', 'decreased', 'levels', 'of', 'albumin', '(', 'ALB', ')', ',', 'cholesterol', '(', 'CHOL', ')', ',', 'triglyceride', '(', 'TG', ')', ',', 'high', 'density', 'lipoprotein', '-', 'cholesterol', '(', 'HDL-C', ')', ',', 'and', 'low', 'density', 'lipoprotein', '-', 'cholesterol', '(', 'LDL-C', ')', 'as', 'compared', 'to', 'healthy', 'controls', 'in', 'both', 'discovery', 'set', 'and', 'validation', 'set', '.']	[5, 1, 1, 1, 1, 1, 1, 3, 4, 1, 2, 1, 1, 3, 4, 1, 2, 1, 1, 4, 1, 2, 1, 1, 1, 4, 1, 2, 1, 1, 1, 4, 1, 3, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 4, 1, 2, 1, 1, 5, 1, 2, 1, 1, 1, 1, 4, 1, 4, 1, 4, 1, 1, 1, 1, 1, 4, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The levels of indirect bilirubin (IBIL), gamma-glutamyl transferase (GGT), globin (GLB), alkaline phosphatase (ALP), and mean corpuscular hemoglobin (MCH), mean platelet volume (MPV), platelet distribution width (PDW) were increased while the levels of blood urea nitrogen (BUN), hematocrit (HCT), hemoglobin (HGB), prealbumin (PALB), mean corpuscular hemoglobin concentration (MCHC), plateletocrit (PCT), platelet (PLT), total protein (TP), red blood cell (RBC) and white blood cell (WBC) were decreased in cirrhotic patients as compared to healthy controls in the discovery set.	[]	['The', 'levels', 'of', 'indirect', 'bi', '##li', '##ru', '##bin', '(', 'I', '##BI', '##L', ')', ',', 'gamma', '-', 'g', '##lut', '##am', '##yl', 'transfer', '##ase', '(', 'G', '##G', '##T', ')', ',', 'g', '##lo', '##bin', '(', 'G', '##L', '##B', ')', ',', 'al', '##kal', '##ine', 'p', '##hos', '##pha', '##tase', '(', 'AL', '##P', ')', ',', 'and', 'mean', 'corpus', '##cular', 'hem', '##og', '##lo', '##bin', '(', 'MC', '##H', ')', ',', 'mean', 'plate', '##let', 'volume', '(', 'MP', '##V', ')', ',', 'plate', '##let', 'distribution', 'width', '(', 'PD', '##W', ')', 'were', 'increased', 'while', 'the', 'levels', 'of', 'blood', 'u', '##rea', 'nitrogen', '(', 'B', '##UN', ')', ',', 'hem', '##ato', '##c', '##rit', '(', 'HC', '##T', ')', ',', 'hem', '##og', '##lo', '##bin', '(', 'H', '##GB', ')', ',', 'pre', '##al', '##bu', '##min', '(', 'PA', '##L', '##B', ')', ',', 'mean', 'corpus', '##cular', 'hem', '##og', '##lo', '##bin', 'concentration', '(', 'MC', '##HC', ')', ',', 'plate', '##let', '##oc', '##rit', '(', 'PC', '##T', ')', ',', 'plate', '##let', '(', 'P', '##LT', ')', ',', 'total', 'protein', '(', 'T', '##P', ')', ',', 'red', 'blood', 'cell', '(', 'RB', '##C', ')', 'and', 'white', 'blood', 'cell', '(', 'W', '##BC', ')', 'were', 'decreased', 'in', 'c', '##ir', '##r', '##hot', '##ic', 'patients', 'as', 'compared', 'to', 'healthy', 'controls', 'in', 'the', 'discovery', 'set', '.']	[0, 4, 11, 14, 23, 25, 27, 29, 33, 34, 35, 37, 38, 39, 41, 46, 47, 48, 51, 53, 56, 64, 68, 69, 70, 71, 72, 73, 75, 76, 78, 82, 83, 84, 85, 86, 87, 89, 91, 94, 98, 99, 102, 105, 110, 111, 113, 114, 115, 117, 121, 126, 132, 138, 141, 143, 145, 149, 150, 152, 153, 154, 156, 161, 166, 170, 177, 178, 180, 181, 182, 184, 189, 193, 206, 212, 213, 215, 216, 218, 223, 233, 239, 243, 250, 253, 259, 260, 264, 273, 274, 275, 277, 278, 280, 283, 286, 287, 291, 292, 294, 295, 296, 298, 301, 303, 305, 309, 310, 311, 313, 314, 316, 319, 321, 323, 327, 328, 330, 331, 332, 333, 335, 340, 346, 352, 355, 357, 359, 363, 377, 378, 380, 382, 383, 385, 390, 393, 395, 399, 400, 402, 403, 404, 406, 411, 415, 416, 417, 419, 420, 422, 428, 436, 437, 438, 439, 440, 442, 446, 452, 457, 458, 460, 461, 463, 467, 473, 479, 484, 485, 486, 488, 490, 495, 505, 508, 509, 511, 512, 515, 518, 527, 530, 539, 542, 550, 559, 562, 566, 576, 579]	[3, 10, 13, 22, 25, 27, 29, 32, 34, 35, 37, 38, 39, 40, 46, 47, 48, 51, 53, 55, 64, 67, 69, 70, 71, 72, 73, 74, 76, 78, 81, 83, 84, 85, 86, 87, 88, 91, 94, 97, 99, 102, 105, 109, 111, 113, 114, 115, 116, 120, 125, 132, 137, 141, 143, 145, 148, 150, 152, 153, 154, 155, 160, 166, 169, 176, 178, 180, 181, 182, 183, 189, 192, 205, 211, 213, 215, 216, 217, 222, 232, 238, 242, 249, 252, 258, 260, 263, 272, 274, 275, 277, 278, 279, 283, 286, 287, 290, 292, 294, 295, 296, 297, 301, 303, 305, 308, 310, 311, 313, 314, 315, 319, 321, 323, 326, 328, 330, 331, 332, 333, 334, 339, 346, 351, 355, 357, 359, 362, 376, 378, 380, 382, 383, 384, 390, 393, 395, 398, 400, 402, 403, 404, 405, 411, 414, 416, 417, 419, 420, 421, 427, 435, 437, 438, 439, 440, 441, 445, 451, 456, 458, 460, 461, 462, 466, 472, 478, 483, 485, 486, 488, 489, 494, 504, 507, 509, 511, 512, 515, 517, 526, 529, 538, 541, 549, 558, 561, 565, 575, 579, 580]	['The', 'levels', 'of', 'indirect', 'bilirubin', '(', 'IBIL', ')', ',', 'gamma', '-', 'glutamyl', 'transferase', '(', 'GGT', ')', ',', 'globin', '(', 'GLB', ')', ',', 'alkaline', 'phosphatase', '(', 'ALP', ')', ',', 'and', 'mean', 'corpuscular', 'hemoglobin', '(', 'MCH', ')', ',', 'mean', 'platelet', 'volume', '(', 'MPV', ')', ',', 'platelet', 'distribution', 'width', '(', 'PDW', ')', 'were', 'increased', 'while', 'the', 'levels', 'of', 'blood', 'urea', 'nitrogen', '(', 'BUN', ')', ',', 'hematocrit', '(', 'HCT', ')', ',', 'hemoglobin', '(', 'HGB', ')', ',', 'prealbumin', '(', 'PALB', ')', ',', 'mean', 'corpuscular', 'hemoglobin', 'concentration', '(', 'MCHC', ')', ',', 'plateletocrit', '(', 'PCT', ')', ',', 'platelet', '(', 'PLT', ')', ',', 'total', 'protein', '(', 'TP', ')', ',', 'red', 'blood', 'cell', '(', 'RBC', ')', 'and', 'white', 'blood', 'cell', '(', 'WBC', ')', 'were', 'decreased', 'in', 'cirrhotic', 'patients', 'as', 'compared', 'to', 'healthy', 'controls', 'in', 'the', 'discovery', 'set', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 4, 2, 1, 3, 1, 1, 3, 1, 3, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 2, 4, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 4, 1, 2, 1, 1, 4, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 2, 4, 1, 1, 2, 1, 1, 4, 1, 2, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Variable drug responses depend on individual variation in the activity of drug-metabolizing enzymes, including cytochrome P450 enzymes (CYP).	[('PMC5697442', 'A00000', 111, 134, 'cytochrome P450 enzymes')]	['V', '##aria', '##ble', 'drug', 'responses', 'depend', 'on', 'individual', 'variation', 'in', 'the', 'activity', 'of', 'drug', '-', 'meta', '##bol', '##izing', 'enzymes', ',', 'including', 'c', '##yt', '##och', '##rome', 'P', '##45', '##0', 'enzymes', '(', 'C', '##YP', ')', '.']	[0, 1, 5, 9, 14, 24, 31, 34, 45, 55, 58, 62, 71, 74, 78, 79, 83, 86, 92, 99, 101, 111, 112, 114, 117, 122, 123, 125, 127, 135, 136, 137, 139, 140]	[1, 5, 8, 13, 23, 30, 33, 44, 54, 57, 61, 70, 73, 78, 79, 83, 86, 91, 99, 100, 110, 112, 114, 117, 121, 123, 125, 126, 134, 136, 137, 139, 140, 141]	['Variable', 'drug', 'responses', 'depend', 'on', 'individual', 'variation', 'in', 'the', 'activity', 'of', 'drug', '-', 'metabolizing', 'enzymes', ',', 'including', 'cytochrome', 'P450', 'enzymes', '(', 'CYP', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
CYP2C9*2 (restriction enzyme analysis with AvaII on a 241 base pair (bp) polymerase chain reaction fragment flanking the single-nucleotide polymorphism [SNP]), CYP2C9*3 (Sanger sequencing of a 259-bp fragment flanking the SNP), CYP2C19*2 (restriction enzyme analysis with BstNI of a 201-bp fragment flanking the SNP), CYP2C19*17 (Sanger sequencing of a 201-bp fragment flanking the SNP), CYP3A4*1b (Sanger sequencing of a 216-bp fragment flanking the SNP), and CYP3A5*3 (Sanger sequencing of a 182-bp fragment flanking the SNP) typings were performed on all participants.	[('PMC5697442', 'M04000', 73, 83, 'polymerase')]	['C', '##YP', '##2', '##C', '##9', '*', '2', '(', 'restriction', 'enzyme', 'analysis', 'with', 'Ava', '##II', 'on', 'a', '241', 'base', 'pair', '(', 'b', '##p', ')', 'polymer', '##ase', 'chain', 'reaction', 'fragment', 'flank', '##ing', 'the', 'single', '-', 'n', '##uc', '##leo', '##tide', 'p', '##oly', '##mor', '##phism', '[', 'S', '##NP', ']', ')', ',', 'C', '##YP', '##2', '##C', '##9', '*', '3', '(', 'Sang', '##er', 'se', '##quencing', 'of', 'a', '25', '##9', '-', 'b', '##p', 'fragment', 'flank', '##ing', 'the', 'S', '##NP', ')', ',', 'C', '##YP', '##2', '##C', '##19', '*', '2', '(', 'restriction', 'enzyme', 'analysis', 'with', 'B', '##st', '##NI', 'of', 'a', '201', '-', 'b', '##p', 'fragment', 'flank', '##ing', 'the', 'S', '##NP', ')', ',', 'C', '##YP', '##2', '##C', '##19', '*', '17', '(', 'Sang', '##er', 'se', '##quencing', 'of', 'a', '201', '-', 'b', '##p', 'fragment', 'flank', '##ing', 'the', 'S', '##NP', ')', ',', 'C', '##YP', '##3', '##A', '##4', '*', '1', '##b', '(', 'Sang', '##er', 'se', '##quencing', 'of', 'a', '216', '-', 'b', '##p', 'fragment', 'flank', '##ing', 'the', 'S', '##NP', ')', ',', 'and', 'C', '##YP', '##3', '##A', '##5', '*', '3', '(', 'Sang', '##er', 'se', '##quencing', 'of', 'a', '182', '-', 'b', '##p', 'fragment', 'flank', '##ing', 'the', 'S', '##NP', ')', 'typing', '##s', 'were', 'performed', 'on', 'all', 'participants', '.']	[0, 1, 3, 4, 5, 6, 7, 9, 10, 22, 29, 38, 43, 46, 49, 52, 54, 58, 63, 68, 69, 70, 71, 73, 80, 84, 90, 99, 108, 113, 117, 121, 127, 128, 129, 131, 134, 139, 140, 143, 146, 152, 153, 154, 156, 157, 158, 160, 161, 163, 164, 165, 166, 167, 169, 170, 174, 177, 179, 188, 191, 193, 195, 196, 197, 198, 200, 209, 214, 218, 222, 223, 225, 226, 228, 229, 231, 232, 233, 235, 236, 238, 239, 251, 258, 267, 272, 273, 275, 278, 281, 283, 286, 287, 288, 290, 299, 304, 308, 312, 313, 315, 316, 318, 319, 321, 322, 323, 325, 326, 329, 330, 334, 337, 339, 348, 351, 353, 356, 357, 358, 360, 369, 374, 378, 382, 383, 385, 386, 388, 389, 391, 392, 393, 394, 395, 396, 398, 399, 403, 406, 408, 417, 420, 422, 425, 426, 427, 429, 438, 443, 447, 451, 452, 454, 455, 457, 461, 462, 464, 465, 466, 467, 468, 470, 471, 475, 478, 480, 489, 492, 494, 497, 498, 499, 501, 510, 515, 519, 523, 524, 526, 528, 534, 536, 541, 551, 554, 558, 570]	[1, 3, 4, 5, 6, 7, 8, 10, 21, 28, 37, 42, 46, 48, 51, 53, 57, 62, 67, 69, 70, 71, 72, 80, 83, 89, 98, 107, 113, 116, 120, 127, 128, 129, 131, 134, 138, 140, 143, 146, 151, 153, 154, 156, 157, 158, 159, 161, 163, 164, 165, 166, 167, 168, 170, 174, 176, 179, 187, 190, 192, 195, 196, 197, 198, 199, 208, 214, 217, 221, 223, 225, 226, 227, 229, 231, 232, 233, 235, 236, 237, 239, 250, 257, 266, 271, 273, 275, 277, 280, 282, 286, 287, 288, 289, 298, 304, 307, 311, 313, 315, 316, 317, 319, 321, 322, 323, 325, 326, 328, 330, 334, 336, 339, 347, 350, 352, 356, 357, 358, 359, 368, 374, 377, 381, 383, 385, 386, 387, 389, 391, 392, 393, 394, 395, 396, 397, 399, 403, 405, 408, 416, 419, 421, 425, 426, 427, 428, 437, 443, 446, 450, 452, 454, 455, 456, 460, 462, 464, 465, 466, 467, 468, 469, 471, 475, 477, 480, 488, 491, 493, 497, 498, 499, 500, 509, 515, 518, 522, 524, 526, 527, 534, 535, 540, 550, 553, 557, 570, 571]	['CYP2C9*2', '(', 'restriction', 'enzyme', 'analysis', 'with', 'AvaII', 'on', 'a', '241', 'base', 'pair', '(', 'bp', ')', 'polymerase', 'chain', 'reaction', 'fragment', 'flanking', 'the', 'single', '-', 'nucleotide', 'polymorphism', '[', 'SNP', ']', ')', ',', 'CYP2C9*3', '(', 'Sanger', 'sequencing', 'of', 'a', '259-bp', 'fragment', 'flanking', 'the', 'SNP', ')', ',', 'CYP2C19*2', '(', 'restriction', 'enzyme', 'analysis', 'with', 'BstNI', 'of', 'a', '201-bp', 'fragment', 'flanking', 'the', 'SNP', ')', ',', 'CYP2C19*17', '(', 'Sanger', 'sequencing', 'of', 'a', '201-bp', 'fragment', 'flanking', 'the', 'SNP', ')', ',', 'CYP3A4*1b', '(', 'Sanger', 'sequencing', 'of', 'a', '216-bp', 'fragment', 'flanking', 'the', 'SNP', ')', ',', 'and', 'CYP3A5*3', '(', 'Sanger', 'sequencing', 'of', 'a', '182-bp', 'fragment', 'flanking', 'the', 'SNP', ')', 'typings', 'were', 'performed', 'on', 'all', 'participants', '.']	[7, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 4, 1, 2, 1, 1, 1, 7, 1, 2, 2, 1, 1, 5, 1, 2, 1, 2, 1, 1, 7, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 2, 1, 2, 1, 1, 7, 1, 2, 2, 1, 1, 4, 1, 2, 1, 2, 1, 1, 8, 1, 2, 2, 1, 1, 4, 1, 2, 1, 2, 1, 1, 1, 7, 1, 2, 2, 1, 1, 4, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The lysates were analyzed for luciferaseactivity according to Promega’s dual-luciferase reporter assaysystem protocol using BioTek (Winooski, VT) synergy H4 hybrid multi-modemicroplate reader.6 For experiments withICI 182,780 in MCF-7 cells, the cells were pretreated with ICI 182,780for 2 h and incubated with compounds for an additional 24 h beforethe cells were lysed and analyzed for luciferase activity.	[]	['The', 'l', '##ys', '##ates', 'were', 'analyzed', 'for', 'l', '##uc', '##ifer', '##ase', '##act', '##ivity', 'according', 'to', 'Pro', '##me', '##ga', '’', 's', 'dual', '-', 'l', '##uc', '##ifer', '##ase', 'reporter', 'ass', '##ays', '##ys', '##tem', 'protocol', 'using', 'B', '##io', '##T', '##ek', '(', 'Win', '##oos', '##ki', ',', 'V', '##T', ')', 's', '##yne', '##rgy', 'H', '##4', 'hybrid', 'multi', '-', 'mode', '##mic', '##rop', '##late', 'reader', '.', '6', 'For', 'experiments', 'with', '##IC', '##I', '182', ',', '78', '##0', 'in', 'MC', '##F', '-', '7', 'cells', ',', 'the', 'cells', 'were', 'pre', '##tre', '##ated', 'with', 'I', '##CI', '182', ',', '78', '##0', '##fo', '##r', '2', 'h', 'and', 'in', '##cu', '##bate', '##d', 'with', 'compounds', 'for', 'an', 'additional', '24', 'h', 'before', '##the', 'cells', 'were', 'l', '##ys', '##ed', 'and', 'analyzed', 'for', 'l', '##uc', '##ifer', '##ase', 'activity', '.']	[0, 4, 5, 7, 12, 17, 26, 30, 31, 33, 37, 40, 43, 49, 59, 62, 65, 67, 69, 70, 72, 76, 77, 78, 80, 84, 88, 97, 100, 103, 105, 109, 118, 124, 125, 127, 128, 131, 132, 135, 138, 140, 142, 143, 144, 146, 147, 150, 154, 155, 157, 164, 169, 170, 174, 177, 180, 185, 191, 192, 194, 198, 210, 214, 216, 218, 221, 222, 224, 226, 229, 231, 232, 233, 235, 240, 242, 246, 252, 257, 260, 263, 268, 273, 274, 277, 280, 281, 283, 284, 286, 288, 290, 292, 296, 298, 300, 304, 306, 311, 321, 325, 328, 339, 342, 344, 350, 354, 360, 365, 366, 368, 371, 375, 384, 388, 389, 391, 395, 399, 407]	[3, 5, 7, 11, 16, 25, 29, 31, 33, 37, 40, 43, 48, 58, 61, 65, 67, 69, 70, 71, 76, 77, 78, 80, 84, 87, 96, 100, 103, 105, 108, 117, 123, 125, 127, 128, 130, 132, 135, 138, 140, 141, 143, 144, 145, 147, 150, 153, 155, 156, 163, 169, 170, 174, 177, 180, 184, 191, 192, 193, 197, 209, 214, 216, 217, 221, 222, 224, 225, 228, 231, 232, 233, 234, 240, 241, 245, 251, 256, 260, 263, 267, 272, 274, 276, 280, 281, 283, 284, 286, 287, 289, 291, 295, 298, 300, 304, 305, 310, 320, 324, 327, 338, 341, 343, 350, 353, 359, 364, 366, 368, 370, 374, 383, 387, 389, 391, 395, 398, 407, 408]	['The', 'lysates', 'were', 'analyzed', 'for', 'luciferaseactivity', 'according', 'to', 'Promega’s', 'dual', '-', 'luciferase', 'reporter', 'assaysystem', 'protocol', 'using', 'BioTek', '(', 'Winooski', ',', 'VT', ')', 'synergy', 'H4', 'hybrid', 'multi', '-', 'modemicroplate', 'reader.6', 'For', 'experiments', 'withICI', '182', ',', '780', 'in', 'MCF-7', 'cells', ',', 'the', 'cells', 'were', 'pretreated', 'with', 'ICI', '182', ',', '780for', '2', 'h', 'and', 'incubated', 'with', 'compounds', 'for', 'an', 'additional', '24', 'h', 'beforethe', 'cells', 'were', 'lysed', 'and', 'analyzed', 'for', 'luciferase', 'activity', '.']	[1, 3, 1, 1, 1, 6, 1, 1, 5, 1, 1, 4, 1, 4, 1, 1, 4, 1, 3, 1, 2, 1, 3, 2, 1, 1, 1, 4, 3, 1, 1, 3, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To further elucidate mechanistic differences between the testedisoflavones and to compare AhR transcriptional activation by isoflavones,XRE-luciferase reporter activity was analyzed (Figures ​Figures66A and S2).	[('PMC5698877', 'R04000', 142, 152, 'ciferase r')]	['To', 'further', 'el', '##uc', '##ida', '##te', 'me', '##chan', '##istic', 'differences', 'between', 'the', 'tested', '##is', '##of', '##lav', '##ones', 'and', 'to', 'compare', 'Ah', '##R', 'transcription', '##al', 'activation', 'by', 'is', '##of', '##lav', '##ones', ',', 'X', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'reporter', 'activity', 'was', 'analyzed', '(', 'Figure', '##s', 'Figure', '##s', '##6', '##6', '##A', 'and', 'S', '##2', ')', '.']	[0, 3, 11, 13, 15, 18, 21, 23, 27, 33, 45, 53, 57, 63, 65, 67, 70, 75, 79, 82, 90, 92, 94, 107, 110, 121, 124, 126, 128, 131, 135, 136, 137, 139, 140, 141, 143, 147, 151, 160, 169, 173, 182, 183, 189, 192, 198, 199, 200, 201, 203, 207, 208, 209, 210]	[2, 10, 13, 15, 18, 20, 23, 27, 32, 44, 52, 56, 63, 65, 67, 70, 74, 78, 81, 89, 92, 93, 107, 109, 120, 123, 126, 128, 131, 135, 136, 137, 139, 140, 141, 143, 147, 150, 159, 168, 172, 181, 183, 189, 190, 198, 199, 200, 201, 202, 206, 208, 209, 210, 211]	['To', 'further', 'elucidate', 'mechanistic', 'differences', 'between', 'the', 'testedisoflavones', 'and', 'to', 'compare', 'AhR', 'transcriptional', 'activation', 'by', 'isoflavones', ',', 'XRE-luciferase', 'reporter', 'activity', 'was', 'analyzed', '(', 'Figures', '\u200bFigures66A', 'and', 'S2', ')', '.']	[1, 1, 4, 3, 1, 1, 1, 5, 1, 1, 1, 2, 2, 1, 1, 4, 1, 7, 1, 1, 1, 1, 1, 2, 5, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
HC-04cells were transfected with an XRE-luciferase reporter plasmid andtreated with isoflavones for 24 h. Both GN and DZ had no significanteffect, while BA and FN significantly increased activity to 5- and7-fold.	[('PMC5698877', 'R04001', 41, 51, 'uciferase ')]	['HC', '-', '04', '##cell', '##s', 'were', 'trans', '##fected', 'with', 'an', 'X', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'reporter', 'p', '##las', '##mi', '##d', 'and', '##tre', '##ated', 'with', 'is', '##of', '##lav', '##ones', 'for', '24', 'h', '.', 'Both', 'G', '##N', 'and', 'D', '##Z', 'had', 'no', 'significant', '##ef', '##fect', ',', 'while', 'BA', 'and', 'F', '##N', 'significantly', 'increased', 'activity', 'to', '5', '-', 'and', '##7', '-', 'fold', '.']	[0, 2, 3, 5, 9, 11, 16, 21, 28, 33, 36, 37, 39, 40, 41, 43, 47, 51, 60, 61, 64, 66, 68, 71, 74, 79, 84, 86, 88, 91, 96, 100, 103, 104, 106, 111, 112, 114, 118, 119, 121, 125, 128, 139, 141, 145, 147, 153, 156, 160, 161, 163, 177, 187, 196, 199, 200, 202, 205, 206, 207, 211]	[2, 3, 5, 9, 10, 15, 21, 27, 32, 35, 37, 39, 40, 41, 43, 47, 50, 59, 61, 64, 66, 67, 71, 74, 78, 83, 86, 88, 91, 95, 99, 102, 104, 105, 110, 112, 113, 117, 119, 120, 124, 127, 139, 141, 145, 146, 152, 155, 159, 161, 162, 176, 186, 195, 198, 200, 201, 205, 206, 207, 211, 212]	['HC-04cells', 'were', 'transfected', 'with', 'an', 'XRE-luciferase', 'reporter', 'plasmid', 'andtreated', 'with', 'isoflavones', 'for', '24', 'h', '.', 'Both', 'GN', 'and', 'DZ', 'had', 'no', 'significanteffect', ',', 'while', 'BA', 'and', 'FN', 'significantly', 'increased', 'activity', 'to', '5-', 'and7-fold', '.']	[5, 1, 2, 1, 1, 7, 1, 4, 3, 1, 4, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
XRE-luciferase activity was also measured in MCF-7 cells;however, only FN had a significant effect (Figure ​Figure66B).	[('PMC5698877', 'R04002', 4, 14, 'luciferase')]	['X', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'activity', 'was', 'also', 'measured', 'in', 'MC', '##F', '-', '7', 'cells', ';', 'however', ',', 'only', 'F', '##N', 'had', 'a', 'significant', 'effect', '(', 'Figure', 'Figure', '##6', '##6', '##B', ')', '.']	[0, 1, 3, 4, 5, 7, 11, 15, 24, 28, 33, 42, 45, 47, 48, 49, 51, 56, 57, 64, 66, 71, 72, 74, 78, 80, 92, 99, 100, 108, 114, 115, 116, 117, 118]	[1, 3, 4, 5, 7, 11, 14, 23, 27, 32, 41, 44, 47, 48, 49, 50, 56, 57, 64, 65, 70, 72, 73, 77, 79, 91, 98, 100, 106, 114, 115, 116, 117, 118, 119]	['XRE-luciferase', 'activity', 'was', 'also', 'measured', 'in', 'MCF-7', 'cells', ';', 'however', ',', 'only', 'FN', 'had', 'a', 'significant', 'effect', '(', 'Figure', '\u200bFigure66B', ')', '.']	[7, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Because ERα can suppress AhR activation,23 the MCF-7 cells were pretreated with ICI 182,780before isoflavone treatments and XRE-luciferase activity was determined.	[('PMC5698877', 'R04003', 129, 139, 'uciferase ')]	['Because', 'ER', '##α', 'can', 'suppress', 'Ah', '##R', 'activation', ',', '23', 'the', 'MC', '##F', '-', '7', 'cells', 'were', 'pre', '##tre', '##ated', 'with', 'I', '##CI', '182', ',', '78', '##0', '##be', '##fo', '##re', 'is', '##of', '##lav', '##one', 'treatments', 'and', 'X', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'activity', 'was', 'determined', '.']	[0, 8, 10, 12, 16, 25, 27, 29, 39, 40, 43, 47, 49, 50, 51, 53, 59, 64, 67, 70, 75, 80, 81, 84, 87, 88, 90, 91, 93, 95, 98, 100, 102, 105, 109, 120, 124, 125, 127, 128, 129, 131, 135, 139, 148, 152, 162]	[7, 10, 11, 15, 24, 27, 28, 39, 40, 42, 46, 49, 50, 51, 52, 58, 63, 67, 70, 74, 79, 81, 83, 87, 88, 90, 91, 93, 95, 97, 100, 102, 105, 108, 119, 123, 125, 127, 128, 129, 131, 135, 138, 147, 151, 162, 163]	['Because', 'ERα', 'can', 'suppress', 'AhR', 'activation', ',', '23', 'the', 'MCF-7', 'cells', 'were', 'pretreated', 'with', 'ICI', '182', ',', '780before', 'isoflavone', 'treatments', 'and', 'XRE-luciferase', 'activity', 'was', 'determined', '.']	[1, 2, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 3, 1, 2, 1, 1, 5, 4, 1, 1, 7, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'E', 'O', 'O', 'O']
Interestingly, the XRE-luciferase fold induction by isoflavone treatmentmore than doubled with ICI 182,780 pretreatment (Figure ​Figure66B).	[]	['Interest', '##ingly', ',', 'the', 'X', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'fold', 'induction', 'by', 'is', '##of', '##lav', '##one', 'treatment', '##more', 'than', 'doubled', 'with', 'I', '##CI', '182', ',', '78', '##0', 'pre', '##tre', '##at', '##ment', '(', 'Figure', 'Figure', '##6', '##6', '##B', ')', '.']	[0, 8, 13, 15, 19, 20, 22, 23, 24, 26, 30, 34, 39, 49, 52, 54, 56, 59, 63, 72, 77, 82, 90, 95, 96, 99, 102, 103, 105, 107, 110, 113, 115, 120, 121, 129, 135, 136, 137, 138, 139]	[8, 13, 14, 18, 20, 22, 23, 24, 26, 30, 33, 38, 48, 51, 54, 56, 59, 62, 72, 76, 81, 89, 94, 96, 98, 102, 103, 105, 106, 110, 113, 115, 119, 121, 127, 135, 136, 137, 138, 139, 140]	['Interestingly', ',', 'the', 'XRE-luciferase', 'fold', 'induction', 'by', 'isoflavone', 'treatmentmore', 'than', 'doubled', 'with', 'ICI', '182', ',', '780', 'pretreatment', '(', 'Figure', '\u200bFigure66B', ')', '.']	[2, 1, 1, 7, 1, 1, 1, 4, 2, 1, 1, 1, 2, 1, 1, 2, 4, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
ICI 182,780 alone had noeffect on XRE-luciferase reporter activity.	[]	['I', '##CI', '182', ',', '78', '##0', 'alone', 'had', 'no', '##ef', '##fect', 'on', 'X', '##RE', '-', 'l', '##uc', '##ifer', '##ase', 'reporter', 'activity', '.']	[0, 1, 4, 7, 8, 10, 12, 18, 22, 24, 26, 31, 34, 35, 37, 38, 39, 41, 45, 49, 58, 66]	[1, 3, 7, 8, 10, 11, 17, 21, 24, 26, 30, 33, 35, 37, 38, 39, 41, 45, 48, 57, 66, 67]	['ICI', '182', ',', '780', 'alone', 'had', 'noeffect', 'on', 'XRE-luciferase', 'reporter', 'activity', '.']	[2, 1, 1, 2, 1, 1, 3, 1, 7, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For a targeted search of arsenic metabolism related microbial genes, we mapped whole genome shotgun sequencing reads to known genes involved in arsenic metabolism genes (Arsenic efflux pump protein (ArsB), arsenic resistance protein ArsH, arsenical pump-driving ATPase (EC 3.6.3.16) (arsA), arsenical resistance operon repressor (arsR), arsenical resistance operon trans-acting repressor ArsD, arsenical-resistance protein ACR3) and compared their abundance between high and low arsenic groups.	[('PMC5718612', 'R08000', 249, 268, 'pump-driving ATPase')]	['For', 'a', 'targeted', 'search', 'of', 'a', '##rsen', '##ic', 'metabolism', 'related', 'micro', '##bial', 'genes', ',', 'we', 'mapped', 'whole', 'genome', 'shotgun', 'se', '##quencing', 'reads', 'to', 'known', 'genes', 'involved', 'in', 'a', '##rsen', '##ic', 'metabolism', 'genes', '(', 'A', '##rsen', '##ic', 'e', '##ff', '##lux', 'pump', 'protein', '(', 'A', '##rs', '##B', ')', ',', 'a', '##rsen', '##ic', 'resistance', 'protein', 'A', '##rs', '##H', ',', 'a', '##rsen', '##ical', 'pump', '-', 'driving', 'ATP', '##ase', '(', 'EC', '3', '.', '6', '.', '3', '.', '16', ')', '(', 'a', '##rs', '##A', ')', ',', 'a', '##rsen', '##ical', 'resistance', 'op', '##eron', 're', '##press', '##or', '(', 'a', '##rs', '##R', ')', ',', 'a', '##rsen', '##ical', 'resistance', 'op', '##eron', 'trans', '-', 'acting', 're', '##press', '##or', 'A', '##rs', '##D', ',', 'a', '##rsen', '##ical', '-', 'resistance', 'protein', 'AC', '##R', '##3', ')', 'and', 'compared', 'their', 'abundance', 'between', 'high', 'and', 'low', 'a', '##rsen', '##ic', 'groups', '.']	[0, 4, 6, 15, 22, 25, 26, 30, 33, 44, 52, 57, 62, 67, 69, 72, 79, 85, 92, 100, 102, 111, 117, 120, 126, 132, 141, 144, 145, 149, 152, 163, 169, 170, 171, 175, 178, 179, 181, 185, 190, 198, 199, 200, 202, 203, 204, 206, 207, 211, 214, 225, 233, 234, 236, 237, 239, 240, 244, 249, 253, 254, 262, 265, 269, 270, 273, 274, 275, 276, 277, 278, 279, 281, 283, 284, 285, 287, 288, 289, 291, 292, 296, 301, 312, 314, 319, 321, 326, 329, 330, 331, 333, 334, 335, 337, 338, 342, 347, 358, 360, 365, 370, 371, 378, 380, 385, 388, 389, 391, 392, 394, 395, 399, 403, 404, 415, 423, 425, 426, 427, 429, 433, 442, 448, 458, 466, 471, 475, 479, 480, 484, 487, 493]	[3, 5, 14, 21, 24, 26, 30, 32, 43, 51, 57, 61, 67, 68, 71, 78, 84, 91, 99, 102, 110, 116, 119, 125, 131, 140, 143, 145, 149, 151, 162, 168, 170, 171, 175, 177, 179, 181, 184, 189, 197, 199, 200, 202, 203, 204, 205, 207, 211, 213, 224, 232, 234, 236, 237, 238, 240, 244, 248, 253, 254, 261, 265, 268, 270, 272, 274, 275, 276, 277, 278, 279, 281, 282, 284, 285, 287, 288, 289, 290, 292, 296, 300, 311, 314, 318, 321, 326, 328, 330, 331, 333, 334, 335, 336, 338, 342, 346, 357, 360, 364, 370, 371, 377, 380, 385, 387, 389, 391, 392, 393, 395, 399, 403, 404, 414, 422, 425, 426, 427, 428, 432, 441, 447, 457, 465, 470, 474, 478, 480, 484, 486, 493, 494]	['For', 'a', 'targeted', 'search', 'of', 'arsenic', 'metabolism', 'related', 'microbial', 'genes', ',', 'we', 'mapped', 'whole', 'genome', 'shotgun', 'sequencing', 'reads', 'to', 'known', 'genes', 'involved', 'in', 'arsenic', 'metabolism', 'genes', '(', 'Arsenic', 'efflux', 'pump', 'protein', '(', 'ArsB', ')', ',', 'arsenic', 'resistance', 'protein', 'ArsH', ',', 'arsenical', 'pump', '-', 'driving', 'ATPase', '(', 'EC', '3.6.3.16', ')', '(', 'arsA', ')', ',', 'arsenical', 'resistance', 'operon', 'repressor', '(', 'arsR', ')', ',', 'arsenical', 'resistance', 'operon', 'trans-', 'acting', 'repressor', 'ArsD', ',', 'arsenical', '-', 'resistance', 'protein', 'ACR3', ')', 'and', 'compared', 'their', 'abundance', 'between', 'high', 'and', 'low', 'arsenic', 'groups', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 2, 1, 1, 7, 1, 1, 3, 1, 1, 3, 1, 2, 3, 1, 3, 1, 1, 3, 1, 2, 2, 1, 3, 3, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the difference did not reach statistical significance, there was a moderate increase in abundance of ArsB (arsenic efflux pump protein), ArsC (arsenate reductase), and ACR3 (arsenical resistance protein) in the high exposure group (data not shown).	[('PMC5718612', 'R08001', 146, 150, 'ArsC')]	['Although', 'the', 'difference', 'did', 'not', 'reach', 'statistical', 'significance', ',', 'there', 'was', 'a', 'moderate', 'increase', 'in', 'abundance', 'of', 'A', '##rs', '##B', '(', 'a', '##rsen', '##ic', 'e', '##ff', '##lux', 'pump', 'protein', ')', ',', 'A', '##rs', '##C', '(', 'a', '##rsen', '##ate', 'red', '##uc', '##tase', ')', ',', 'and', 'AC', '##R', '##3', '(', 'a', '##rsen', '##ical', 'resistance', 'protein', ')', 'in', 'the', 'high', 'exposure', 'group', '(', 'data', 'not', 'shown', ')', '.']	[0, 9, 13, 24, 28, 32, 38, 50, 62, 64, 70, 74, 76, 85, 94, 97, 107, 110, 111, 113, 115, 116, 117, 121, 124, 125, 127, 131, 136, 143, 144, 146, 147, 149, 151, 152, 153, 157, 161, 164, 166, 170, 171, 173, 177, 179, 180, 182, 183, 184, 188, 193, 204, 211, 213, 216, 220, 225, 234, 240, 241, 246, 250, 255, 256]	[8, 12, 23, 27, 31, 37, 49, 62, 63, 69, 73, 75, 84, 93, 96, 106, 109, 111, 113, 114, 116, 117, 121, 123, 125, 127, 130, 135, 143, 144, 145, 147, 149, 150, 152, 153, 157, 160, 164, 166, 170, 171, 172, 176, 179, 180, 181, 183, 184, 188, 192, 203, 211, 212, 215, 219, 224, 233, 239, 241, 245, 249, 255, 256, 257]	['Although', 'the', 'difference', 'did', 'not', 'reach', 'statistical', 'significance', ',', 'there', 'was', 'a', 'moderate', 'increase', 'in', 'abundance', 'of', 'ArsB', '(', 'arsenic', 'efflux', 'pump', 'protein', ')', ',', 'ArsC', '(', 'arsenate', 'reductase', ')', ',', 'and', 'ACR3', '(', 'arsenical', 'resistance', 'protein', ')', 'in', 'the', 'high', 'exposure', 'group', '(', 'data', 'not', 'shown', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 3, 1, 1, 1, 1, 3, 1, 3, 3, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We then designed primers for ArsB and ArsC genes in one of the E.coli Ars operons (ArsRBCRP from strain ST2747) to quantify their levels.	[('PMC5718612', 'R11000', 38, 42, 'ArsC')]	['We', 'then', 'designed', 'prime', '##rs', 'for', 'A', '##rs', '##B', 'and', 'A', '##rs', '##C', 'genes', 'in', 'one', 'of', 'the', 'E', '.', 'co', '##li', 'A', '##rs', 'op', '##eron', '##s', '(', 'A', '##rs', '##RB', '##CR', '##P', 'from', 'strain', 'ST', '##27', '##47', ')', 'to', 'q', '##uant', '##ify', 'their', 'levels', '.']	[0, 3, 8, 17, 22, 25, 29, 30, 32, 34, 38, 39, 41, 43, 49, 52, 56, 59, 63, 64, 65, 67, 70, 71, 74, 76, 80, 82, 83, 84, 86, 88, 90, 92, 97, 104, 106, 108, 110, 112, 115, 116, 120, 124, 130, 136]	[2, 7, 16, 22, 24, 28, 30, 32, 33, 37, 39, 41, 42, 48, 51, 55, 58, 62, 64, 65, 67, 69, 71, 73, 76, 80, 81, 83, 84, 86, 88, 90, 91, 96, 103, 106, 108, 110, 111, 114, 116, 120, 123, 129, 136, 137]	['We', 'then', 'designed', 'primers', 'for', 'ArsB', 'and', 'ArsC', 'genes', 'in', 'one', 'of', 'the', 'E.coli', 'Ars', 'operons', '(', 'ArsRBCRP', 'from', 'strain', 'ST2747', ')', 'to', 'quantify', 'their', 'levels', '.']	[1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 4, 2, 3, 1, 5, 1, 1, 3, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The result shows that the abundances of both ArsB and ArsC were significantly higher in the high arsenic exposed group than that in the low arsenic exposure group (Fig 4C).	[('PMC5718612', 'R11001', 54, 58, 'ArsC')]	['The', 'result', 'shows', 'that', 'the', 'abundance', '##s', 'of', 'both', 'A', '##rs', '##B', 'and', 'A', '##rs', '##C', 'were', 'significantly', 'higher', 'in', 'the', 'high', 'a', '##rsen', '##ic', 'exposed', 'group', 'than', 'that', 'in', 'the', 'low', 'a', '##rsen', '##ic', 'exposure', 'group', '(', 'Fi', '##g', '4', '##C', ')', '.']	[0, 4, 11, 17, 22, 26, 35, 37, 40, 45, 46, 48, 50, 54, 55, 57, 59, 64, 78, 85, 88, 92, 97, 98, 102, 105, 113, 119, 124, 129, 132, 136, 140, 141, 145, 148, 157, 163, 164, 166, 168, 169, 170, 171]	[3, 10, 16, 21, 25, 35, 36, 39, 44, 46, 48, 49, 53, 55, 57, 58, 63, 77, 84, 87, 91, 96, 98, 102, 104, 112, 118, 123, 128, 131, 135, 139, 141, 145, 147, 156, 162, 164, 166, 167, 169, 170, 171, 172]	['The', 'result', 'shows', 'that', 'the', 'abundances', 'of', 'both', 'ArsB', 'and', 'ArsC', 'were', 'significantly', 'higher', 'in', 'the', 'high', 'arsenic', 'exposed', 'group', 'than', 'that', 'in', 'the', 'low', 'arsenic', 'exposure', 'group', '(', 'Fig', '4C', ')', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An assay that reliably distinguishes serum estradiol concentrations in the low postmenopausal range (<110 pmol/L; <30 pg/mL), and at the even lower concentrations found in women being treated for breast cancer with aromatase inhibitors (~4 pmol/L; ~1 pg/mL), can be an important prognostic tool in the management of breast cancer, osteoporosis and bone fracture, cardiovascular disease, and possibly cognitive dysfunction (32,33).	[]	['An', 'ass', '##ay', 'that', 're', '##lia', '##bly', 'distinguish', '##es', 'serum', 'est', '##rad', '##iol', 'concentrations', 'in', 'the', 'low', 'post', '##men', '##op', '##aus', '##al', 'range', '(', '<', '110', 'pm', '##ol', '/', 'L', ';', '<', '30', 'p', '##g', '/', 'm', '##L', ')', ',', 'and', 'at', 'the', 'even', 'lower', 'concentrations', 'found', 'in', 'women', 'being', 'treated', 'for', 'breast', 'cancer', 'with', 'a', '##roma', '##tase', 'inhibitor', '##s', '(', '~', '4', 'pm', '##ol', '/', 'L', ';', '~', '1', 'p', '##g', '/', 'm', '##L', ')', ',', 'can', 'be', 'an', 'important', 'pro', '##gno', '##stic', 'tool', 'in', 'the', 'management', 'of', 'breast', 'cancer', ',', 'o', '##ste', '##op', '##oro', '##sis', 'and', 'bone', 'fracture', ',', 'card', '##iovascular', 'disease', ',', 'and', 'possibly', 'cognitive', 'd', '##ys', '##function', '(', '32', ',', '33', ')', '.']	[0, 3, 6, 9, 14, 16, 19, 23, 34, 37, 43, 46, 49, 53, 68, 71, 75, 79, 83, 86, 88, 91, 94, 100, 101, 102, 106, 108, 110, 111, 112, 114, 115, 118, 119, 120, 121, 122, 123, 124, 126, 130, 133, 137, 142, 148, 163, 169, 172, 178, 184, 192, 196, 203, 210, 215, 216, 220, 225, 234, 236, 237, 238, 240, 242, 244, 245, 246, 248, 249, 251, 252, 253, 254, 255, 256, 257, 259, 263, 266, 269, 279, 282, 285, 290, 295, 298, 302, 313, 316, 323, 329, 331, 332, 335, 337, 340, 344, 348, 353, 361, 363, 367, 378, 385, 387, 391, 400, 410, 411, 413, 422, 423, 425, 426, 428, 429]	[2, 6, 8, 13, 16, 19, 22, 34, 36, 42, 46, 49, 52, 67, 70, 74, 78, 83, 86, 88, 91, 93, 99, 101, 102, 105, 108, 110, 111, 112, 113, 115, 117, 119, 120, 121, 122, 123, 124, 125, 129, 132, 136, 141, 147, 162, 168, 171, 177, 183, 191, 195, 202, 209, 214, 216, 220, 224, 234, 235, 237, 238, 239, 242, 244, 245, 246, 247, 249, 250, 252, 253, 254, 255, 256, 257, 258, 262, 265, 268, 278, 282, 285, 289, 294, 297, 301, 312, 315, 322, 329, 330, 332, 335, 337, 340, 343, 347, 352, 361, 362, 367, 377, 385, 386, 390, 399, 409, 411, 413, 421, 423, 425, 426, 428, 429, 430]	['An', 'assay', 'that', 'reliably', 'distinguishes', 'serum', 'estradiol', 'concentrations', 'in', 'the', 'low', 'postmenopausal', 'range', '(', '<', '110', 'pmol', '/', 'L', ';', '<', '30', 'pg', '/', 'mL', ')', ',', 'and', 'at', 'the', 'even', 'lower', 'concentrations', 'found', 'in', 'women', 'being', 'treated', 'for', 'breast', 'cancer', 'with', 'aromatase', 'inhibitors', '(', '~4', 'pmol', '/', 'L', ';', '~1', 'pg', '/', 'mL', ')', ',', 'can', 'be', 'an', 'important', 'prognostic', 'tool', 'in', 'the', 'management', 'of', 'breast', 'cancer', ',', 'osteoporosis', 'and', 'bone', 'fracture', ',', 'cardiovascular', 'disease', ',', 'and', 'possibly', 'cognitive', 'dysfunction', '(', '32', ',', '33', ')', '.']	[1, 2, 1, 3, 2, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 2, 1, 1, 1, 2, 2, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Chronic inflammation-induced matrix deposition around the small airways causes the small airway wall thickening.26 Bronchial wall thickening in large or intermediate airways on HRCT reflects the wall thickening in smaller airways.27	[]	['Ch', '##ronic', 'inflammation', '-', 'induced', 'matrix', 'deposition', 'around', 'the', 'small', 'air', '##ways', 'causes', 'the', 'small', 'air', '##way', 'wall', 'thick', '##ening', '.', '26', 'B', '##ron', '##chia', '##l', 'wall', 'thick', '##ening', 'in', 'large', 'or', 'intermediate', 'air', '##ways', 'on', 'H', '##RC', '##T', 'reflects', 'the', 'wall', 'thick', '##ening', 'in', 'smaller', 'air', '##ways', '.', '27']	[0, 2, 8, 20, 21, 29, 36, 47, 54, 58, 64, 67, 72, 79, 83, 89, 92, 96, 101, 106, 111, 112, 115, 116, 119, 123, 125, 130, 135, 141, 144, 150, 153, 166, 169, 174, 177, 178, 180, 182, 191, 195, 200, 205, 211, 214, 222, 225, 229, 230]	[2, 7, 20, 21, 28, 35, 46, 53, 57, 63, 67, 71, 78, 82, 88, 92, 95, 100, 106, 111, 112, 114, 116, 119, 123, 124, 129, 135, 140, 143, 149, 152, 165, 169, 173, 176, 178, 180, 181, 190, 194, 199, 205, 210, 213, 221, 225, 229, 230, 232]	['Chronic', 'inflammation', '-', 'induced', 'matrix', 'deposition', 'around', 'the', 'small', 'airways', 'causes', 'the', 'small', 'airway', 'wall', 'thickening.26', 'Bronchial', 'wall', 'thickening', 'in', 'large', 'or', 'intermediate', 'airways', 'on', 'HRCT', 'reflects', 'the', 'wall', 'thickening', 'in', 'smaller', 'airways.27']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 4, 4, 1, 2, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 4]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The extracted microRNA was polyadenylated with poly (A) polymerase in a 20-μl volume, and 6 μl of the poly (A) reaction solution was reversely transcribed to cDNA in another 20 μl with miRcute microRNA The First-strand cDNA	[('PMC5752483', 'M09000', 56, 66, 'polymerase')]	['The', 'extracted', 'micro', '##RNA', 'was', 'p', '##oly', '##ade', '##ny', '##lated', 'with', 'p', '##oly', '(', 'A', ')', 'polymer', '##ase', 'in', 'a', '20', '-', 'μ', '##l', 'volume', ',', 'and', '6', 'μ', '##l', 'of', 'the', 'p', '##oly', '(', 'A', ')', 'reaction', 'solution', 'was', 'reverse', '##ly', 'trans', '##cribed', 'to', 'c', '##D', '##NA', 'in', 'another', '20', 'μ', '##l', 'with', 'mi', '##R', '##cute', 'micro', '##RNA', 'The', 'First', '-', 'strand', 'c', '##D', '##NA']	[0, 4, 14, 19, 23, 27, 28, 31, 34, 36, 42, 47, 48, 52, 53, 54, 56, 63, 67, 70, 72, 74, 75, 76, 78, 84, 86, 90, 92, 93, 95, 98, 102, 103, 107, 108, 109, 111, 120, 129, 133, 140, 143, 148, 155, 158, 159, 160, 163, 166, 174, 177, 178, 180, 185, 187, 188, 193, 198, 202, 206, 211, 212, 219, 220, 221]	[3, 13, 19, 22, 26, 28, 31, 34, 36, 41, 46, 48, 51, 53, 54, 55, 63, 66, 69, 71, 74, 75, 76, 77, 84, 85, 89, 91, 93, 94, 97, 101, 103, 106, 108, 109, 110, 119, 128, 132, 140, 142, 148, 154, 157, 159, 160, 162, 165, 173, 176, 178, 179, 184, 187, 188, 192, 198, 201, 205, 211, 212, 218, 220, 221, 223]	['The', 'extracted', 'microRNA', 'was', 'polyadenylated', 'with', 'poly', '(', 'A', ')', 'polymerase', 'in', 'a', '20-μl', 'volume', ',', 'and', '6', 'μl', 'of', 'the', 'poly', '(', 'A', ')', 'reaction', 'solution', 'was', 'reversely', 'transcribed', 'to', 'cDNA', 'in', 'another', '20', 'μl', 'with', 'miRcute', 'microRNA', 'The', 'First', '-', 'strand', 'cDNA']	[1, 1, 2, 1, 5, 1, 2, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The results of the quantitative reverse-transcription polymerase chain reaction (qRT-PCR) indicated that the serum levels of miR-21, miR-106b and miR-125b in the HCC patients were significantly higher than those in HCs, while those of miR-182 and miR-224 were significantly lower.	[]	['The', 'results', 'of', 'the', 'quantitative', 'reverse', '-', 'transcription', 'polymer', '##ase', 'chain', 'reaction', '(', 'q', '##RT', '-', 'PC', '##R', ')', 'indicated', 'that', 'the', 'serum', 'levels', 'of', 'mi', '##R', '-', '21', ',', 'mi', '##R', '-', '106', '##b', 'and', 'mi', '##R', '-', '125', '##b', 'in', 'the', 'HC', '##C', 'patients', 'were', 'significantly', 'higher', 'than', 'those', 'in', 'HC', '##s', ',', 'while', 'those', 'of', 'mi', '##R', '-', '182', 'and', 'mi', '##R', '-', '224', 'were', 'significantly', 'lower', '.']	[0, 4, 12, 15, 19, 32, 39, 40, 54, 61, 65, 71, 80, 81, 82, 84, 85, 87, 88, 90, 100, 105, 109, 115, 122, 125, 127, 128, 129, 131, 133, 135, 136, 137, 140, 142, 146, 148, 149, 150, 153, 155, 158, 162, 164, 166, 175, 180, 194, 201, 206, 212, 215, 217, 218, 220, 226, 232, 235, 237, 238, 239, 243, 247, 249, 250, 251, 255, 260, 274, 279]	[3, 11, 14, 18, 31, 39, 40, 53, 61, 64, 70, 79, 81, 82, 84, 85, 87, 88, 89, 99, 104, 108, 114, 121, 124, 127, 128, 129, 131, 132, 135, 136, 137, 140, 141, 145, 148, 149, 150, 153, 154, 157, 161, 164, 165, 174, 179, 193, 200, 205, 211, 214, 217, 218, 219, 225, 231, 234, 237, 238, 239, 242, 246, 249, 250, 251, 254, 259, 273, 279, 280]	['The', 'results', 'of', 'the', 'quantitative', 'reverse', '-', 'transcription', 'polymerase', 'chain', 'reaction', '(', 'qRT-PCR', ')', 'indicated', 'that', 'the', 'serum', 'levels', 'of', 'miR-21', ',', 'miR-106b', 'and', 'miR-125b', 'in', 'the', 'HCC', 'patients', 'were', 'significantly', 'higher', 'than', 'those', 'in', 'HCs', ',', 'while', 'those', 'of', 'miR-182', 'and', 'miR-224', 'were', 'significantly', 'lower', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After lung injury, dipalmitoylphosphatidylcholine (DPPC), as major surfactant lipid component, is degraded to LysoPC by phospholipase A2 activity by type 2 alveolar epithelial cells [50].	[]	['After', 'lung', 'injury', ',', 'dip', '##al', '##mit', '##oy', '##l', '##ph', '##os', '##pha', '##ti', '##dy', '##l', '##cho', '##line', '(', 'D', '##PP', '##C', ')', ',', 'as', 'major', 'surf', '##act', '##ant', 'lip', '##id', 'component', ',', 'is', 'de', '##graded', 'to', 'L', '##ys', '##o', '##PC', 'by', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'A2', 'activity', 'by', 'type', '2', 'al', '##ve', '##olar', 'e', '##pit', '##hel', '##ial', 'cells', '[', '50', ']', '.']	[0, 6, 11, 17, 19, 22, 24, 27, 29, 30, 32, 34, 37, 39, 41, 42, 45, 50, 51, 52, 54, 55, 56, 58, 61, 67, 71, 74, 78, 81, 84, 93, 95, 98, 100, 107, 110, 111, 113, 114, 117, 120, 121, 124, 126, 129, 132, 134, 137, 146, 149, 154, 156, 158, 160, 165, 166, 169, 172, 176, 182, 183, 185, 186]	[5, 10, 17, 18, 22, 24, 27, 29, 30, 32, 34, 37, 39, 41, 42, 45, 49, 51, 52, 54, 55, 56, 57, 60, 66, 71, 74, 77, 81, 83, 93, 94, 97, 100, 106, 109, 111, 113, 114, 116, 119, 121, 124, 126, 129, 132, 133, 136, 145, 148, 153, 155, 158, 160, 164, 166, 169, 172, 175, 181, 183, 185, 186, 187]	['After', 'lung', 'injury', ',', 'dipalmitoylphosphatidylcholine', '(', 'DPPC', ')', ',', 'as', 'major', 'surfactant', 'lipid', 'component', ',', 'is', 'degraded', 'to', 'LysoPC', 'by', 'phospholipase', 'A2', 'activity', 'by', 'type', '2', 'alveolar', 'epithelial', 'cells', '[', '50', ']', '.']	[1, 1, 1, 1, 13, 1, 3, 1, 1, 1, 1, 3, 2, 1, 1, 1, 2, 1, 4, 1, 6, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Previous studies showed increased level of LPA in the bronchoalveolar lavage fluid and exhaled breath condensate of IPF patients [42, 54].	[]	['Previous', 'studies', 'showed', 'increased', 'level', 'of', 'LP', '##A', 'in', 'the', 'br', '##on', '##cho', '##al', '##ve', '##olar', 'lava', '##ge', 'fluid', 'and', 'exhaled', 'breath', 'con', '##den', '##sat', '##e', 'of', 'IP', '##F', 'patients', '[', '42', ',', '54', ']', '.']	[0, 9, 17, 24, 34, 40, 43, 45, 47, 50, 54, 56, 58, 61, 63, 65, 70, 74, 77, 83, 87, 95, 102, 105, 108, 111, 113, 116, 118, 120, 129, 130, 132, 134, 136, 137]	[8, 16, 23, 33, 39, 42, 45, 46, 49, 53, 56, 58, 61, 63, 65, 69, 74, 76, 82, 86, 94, 101, 105, 108, 111, 112, 115, 118, 119, 128, 130, 132, 133, 136, 137, 138]	['Previous', 'studies', 'showed', 'increased', 'level', 'of', 'LPA', 'in', 'the', 'bronchoalveolar', 'lavage', 'fluid', 'and', 'exhaled', 'breath', 'condensate', 'of', 'IPF', 'patients', '[', '42', ',', '54', ']', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 6, 2, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Functional HMO alternatives such as galacto-oligosaccharides (GOS) are produced by glycoside hydrolases (GH) using lactose as substrate (Torres et al., 2010) and fructo-oligosaccharides (FOS), can be produced through transfructosylation of sucrose or hydrolysis of inulin by endoinulinases (Singh & Singh, 2010), are the main prebiotics currently added to infant formula (Rinne et al., 2005).	[('PMC5777374', 'I07000', 83, 103, 'glycoside hydrolases')]	['Fun', '##ctional', 'HM', '##O', 'alternatives', 'such', 'as', 'gal', '##act', '##o', '-', 'o', '##li', '##gos', '##ac', '##cha', '##ride', '##s', '(', 'GO', '##S', ')', 'are', 'produced', 'by', 'g', '##ly', '##cos', '##ide', 'h', '##ydro', '##lase', '##s', '(', 'G', '##H', ')', 'using', 'la', '##ct', '##ose', 'as', 'substrate', '(', 'Torres', 'et', 'al', '.', ',', '2010', ')', 'and', 'f', '##ru', '##ct', '##o', '-', 'o', '##li', '##gos', '##ac', '##cha', '##ride', '##s', '(', 'F', '##OS', ')', ',', 'can', 'be', 'produced', 'through', 'trans', '##f', '##ru', '##ct', '##osy', '##lation', 'of', 'su', '##c', '##rose', 'or', 'h', '##ydro', '##lysis', 'of', 'in', '##ulin', 'by', 'end', '##oi', '##nu', '##lina', '##ses', '(', 'Singh', '&', 'Singh', ',', '2010', ')', ',', 'are', 'the', 'main', 'pre', '##biotics', 'currently', 'added', 'to', 'infant', 'formula', '(', 'R', '##inn', '##e', 'et', 'al', '.', ',', '2005', ')', '.']	[0, 3, 11, 13, 15, 28, 33, 36, 39, 42, 43, 44, 45, 47, 50, 52, 55, 59, 61, 62, 64, 65, 67, 71, 80, 83, 84, 86, 89, 93, 94, 98, 102, 104, 105, 106, 107, 109, 115, 117, 119, 123, 126, 136, 137, 144, 147, 149, 150, 152, 156, 158, 162, 163, 165, 167, 168, 169, 170, 172, 175, 177, 180, 184, 186, 187, 188, 190, 191, 193, 197, 200, 209, 217, 222, 223, 225, 227, 230, 237, 240, 242, 243, 248, 251, 252, 256, 262, 265, 267, 272, 275, 278, 280, 282, 286, 290, 291, 297, 299, 304, 306, 310, 311, 313, 317, 321, 326, 329, 337, 347, 353, 356, 363, 371, 372, 373, 376, 378, 381, 383, 384, 386, 390, 391]	[3, 10, 13, 14, 27, 32, 35, 39, 42, 43, 44, 45, 47, 50, 52, 55, 59, 60, 62, 64, 65, 66, 70, 79, 82, 84, 86, 89, 92, 94, 98, 102, 103, 105, 106, 107, 108, 114, 117, 119, 122, 125, 135, 137, 143, 146, 149, 150, 151, 156, 157, 161, 163, 165, 167, 168, 169, 170, 172, 175, 177, 180, 184, 185, 187, 188, 190, 191, 192, 196, 199, 208, 216, 222, 223, 225, 227, 230, 236, 239, 242, 243, 247, 250, 252, 256, 261, 264, 267, 271, 274, 278, 280, 282, 286, 289, 291, 296, 298, 304, 305, 310, 311, 312, 316, 320, 325, 329, 336, 346, 352, 355, 362, 370, 372, 373, 376, 377, 380, 383, 384, 385, 390, 391, 392]	['Functional', 'HMO', 'alternatives', 'such', 'as', 'galacto', '-', 'oligosaccharides', '(', 'GOS', ')', 'are', 'produced', 'by', 'glycoside', 'hydrolases', '(', 'GH', ')', 'using', 'lactose', 'as', 'substrate', '(', 'Torres', 'et', 'al', '.', ',', '2010', ')', 'and', 'fructo', '-', 'oligosaccharides', '(', 'FOS', ')', ',', 'can', 'be', 'produced', 'through', 'transfructosylation', 'of', 'sucrose', 'or', 'hydrolysis', 'of', 'inulin', 'by', 'endoinulinases', '(', 'Singh', '&', 'Singh', ',', '2010', ')', ',', 'are', 'the', 'main', 'prebiotics', 'currently', 'added', 'to', 'infant', 'formula', '(', 'Rinne', 'et', 'al', '.', ',', '2005', ')', '.']	[2, 2, 1, 1, 1, 3, 1, 7, 1, 2, 1, 1, 1, 1, 4, 4, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 3, 1, 3, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
GARFIELD employs a non-parametric analysis to calculate fold enrichment values for regulatory marks, at given significance thresholds, and then tests them for significance via permutation testing while accounting for LD, MAF, and local gene density.32 We used data regarding DNase-I hypersensitive sites, transcription factor binding sites, histone modifications, and chromatin states (ENCODE and Roadmap Epigenomics) from 424 cell types and tissues to capture and characterize possible cell-type-specific patterns of enrichment, as provided in the GARFIELD software (Web Resources).	[]	['GA', '##R', '##FI', '##EL', '##D', 'employs', 'a', 'non', '-', 'para', '##metric', 'analysis', 'to', 'calculate', 'fold', 'en', '##rich', '##ment', 'values', 'for', 'regulatory', 'marks', ',', 'at', 'given', 'significance', 'threshold', '##s', ',', 'and', 'then', 'tests', 'them', 'for', 'significance', 'via', 'per', '##mu', '##tation', 'testing', 'while', 'accounting', 'for', 'L', '##D', ',', 'MA', '##F', ',', 'and', 'local', 'gene', 'density', '.', '32', 'We', 'used', 'data', 'regarding', 'D', '##N', '##ase', '-', 'I', 'h', '##yper', '##sen', '##sitive', 'sites', ',', 'transcription', 'factor', 'binding', 'sites', ',', 'his', '##tone', 'modifications', ',', 'and', 'ch', '##roma', '##tin', 'states', '(', 'E', '##NC', '##OD', '##E', 'and', 'Road', '##ma', '##p', 'E', '##pi', '##gen', '##omi', '##cs', ')', 'from', '42', '##4', 'cell', 'types', 'and', 'tissues', 'to', 'capture', 'and', 'character', '##ize', 'possible', 'cell', '-', 'type', '-', 'specific', 'patterns', 'of', 'en', '##rich', '##ment', ',', 'as', 'provided', 'in', 'the', 'GA', '##R', '##FI', '##EL', '##D', 'software', '(', 'Web', 'Resources', ')', '.']	[0, 2, 3, 5, 7, 9, 17, 19, 22, 23, 27, 34, 43, 46, 56, 61, 63, 67, 72, 79, 83, 94, 99, 101, 104, 110, 123, 132, 133, 135, 139, 144, 150, 155, 159, 172, 176, 179, 181, 188, 196, 202, 213, 217, 218, 219, 221, 223, 224, 226, 230, 236, 241, 248, 249, 252, 255, 260, 265, 275, 276, 277, 280, 281, 283, 284, 288, 291, 298, 303, 305, 319, 326, 334, 339, 341, 344, 349, 362, 364, 368, 370, 374, 378, 385, 386, 387, 389, 391, 393, 397, 401, 403, 405, 406, 408, 411, 414, 416, 418, 423, 425, 427, 432, 438, 442, 450, 453, 461, 465, 474, 478, 487, 491, 492, 496, 497, 506, 515, 518, 520, 524, 528, 530, 533, 542, 545, 549, 551, 552, 554, 556, 558, 567, 568, 572, 581, 582]	[2, 3, 5, 7, 8, 16, 18, 22, 23, 27, 33, 42, 45, 55, 60, 63, 67, 71, 78, 82, 93, 99, 100, 103, 109, 122, 132, 133, 134, 138, 143, 149, 154, 158, 171, 175, 179, 181, 187, 195, 201, 212, 216, 218, 219, 220, 223, 224, 225, 229, 235, 240, 248, 249, 251, 254, 259, 264, 274, 276, 277, 280, 281, 282, 284, 288, 291, 297, 303, 304, 318, 325, 333, 339, 340, 344, 348, 362, 363, 367, 370, 374, 377, 384, 386, 387, 389, 391, 392, 396, 401, 403, 404, 406, 408, 411, 414, 416, 417, 422, 425, 426, 431, 437, 441, 449, 452, 460, 464, 474, 477, 486, 491, 492, 496, 497, 505, 514, 517, 520, 524, 528, 529, 532, 541, 544, 548, 551, 552, 554, 556, 557, 566, 568, 571, 581, 582, 583]	['GARFIELD', 'employs', 'a', 'non', '-', 'parametric', 'analysis', 'to', 'calculate', 'fold', 'enrichment', 'values', 'for', 'regulatory', 'marks', ',', 'at', 'given', 'significance', 'thresholds', ',', 'and', 'then', 'tests', 'them', 'for', 'significance', 'via', 'permutation', 'testing', 'while', 'accounting', 'for', 'LD', ',', 'MAF', ',', 'and', 'local', 'gene', 'density.32', 'We', 'used', 'data', 'regarding', 'DNase-I', 'hypersensitive', 'sites', ',', 'transcription', 'factor', 'binding', 'sites', ',', 'histone', 'modifications', ',', 'and', 'chromatin', 'states', '(', 'ENCODE', 'and', 'Roadmap', 'Epigenomics', ')', 'from', '424', 'cell', 'types', 'and', 'tissues', 'to', 'capture', 'and', 'characterize', 'possible', 'cell', '-', 'type', '-', 'specific', 'patterns', 'of', 'enrichment', ',', 'as', 'provided', 'in', 'the', 'GARFIELD', 'software', '(', 'Web', 'Resources', ')', '.']	[5, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 5, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 3, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The observed increased abundance of antioxidant and chaperone proteins in thalassemic EVs was also observed by Ferru et al, who detected alterations of Hsp70, PRDX2, and catalase.13	[('PMC5787864', 'D01000', 170, 178, 'catalase')]	['The', 'observed', 'increased', 'abundance', 'of', 'anti', '##ox', '##ida', '##nt', 'and', 'ch', '##aper', '##one', 'proteins', 'in', 'th', '##ala', '##sse', '##mic', 'E', '##Vs', 'was', 'also', 'observed', 'by', 'Fe', '##rr', '##u', 'et', 'al', ',', 'who', 'detected', 'alterations', 'of', 'H', '##sp', '##70', ',', 'PR', '##D', '##X', '##2', ',', 'and', 'cat', '##ala', '##se', '.', '13']	[0, 4, 13, 23, 33, 36, 40, 42, 45, 48, 52, 54, 58, 62, 71, 74, 76, 79, 82, 86, 87, 90, 94, 99, 108, 111, 113, 115, 117, 120, 122, 124, 128, 137, 149, 152, 153, 155, 157, 159, 161, 162, 163, 164, 166, 170, 173, 176, 178, 179]	[3, 12, 22, 32, 35, 40, 42, 45, 47, 51, 54, 58, 61, 70, 73, 76, 79, 82, 85, 87, 89, 93, 98, 107, 110, 113, 115, 116, 119, 122, 123, 127, 136, 148, 151, 153, 155, 157, 158, 161, 162, 163, 164, 165, 169, 173, 176, 178, 179, 181]	['The', 'observed', 'increased', 'abundance', 'of', 'antioxidant', 'and', 'chaperone', 'proteins', 'in', 'thalassemic', 'EVs', 'was', 'also', 'observed', 'by', 'Ferru', 'et', 'al', ',', 'who', 'detected', 'alterations', 'of', 'Hsp70', ',', 'PRDX2', ',', 'and', 'catalase.13']	[1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 4, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Previous studies of the proteomics profile in EVs in the plasma released from the platelets and RBCs of β-thalassemic patients reported a higher level of proteins involved in the oxidative stress response, for example, catalase, peroxiredoxin 2 (PRDX2), and heat shock proteins 70 (Hsp70) when compared with healthy individuals.13,14	[('PMC5787864', 'I01000', 219, 227, 'catalase')]	['Previous', 'studies', 'of', 'the', 'pro', '##te', '##omi', '##cs', 'profile', 'in', 'E', '##Vs', 'in', 'the', 'plasma', 'released', 'from', 'the', 'plate', '##lets', 'and', 'RB', '##Cs', 'of', 'β', '-', 'th', '##ala', '##sse', '##mic', 'patients', 'reported', 'a', 'higher', 'level', 'of', 'proteins', 'involved', 'in', 'the', 'o', '##xi', '##da', '##tive', 'stress', 'response', ',', 'for', 'example', ',', 'cat', '##ala', '##se', ',', 'per', '##ox', '##ired', '##ox', '##in', '2', '(', 'PR', '##D', '##X', '##2', ')', ',', 'and', 'heat', 'shock', 'proteins', '70', '(', 'H', '##sp', '##70', ')', 'when', 'compared', 'with', 'healthy', 'individuals', '.', '13', ',', '14']	[0, 9, 17, 20, 24, 27, 29, 32, 35, 43, 46, 47, 50, 53, 57, 64, 73, 78, 82, 87, 92, 96, 98, 101, 104, 105, 106, 108, 111, 114, 118, 127, 136, 138, 145, 151, 154, 163, 172, 175, 179, 180, 182, 184, 189, 196, 204, 206, 210, 217, 219, 222, 225, 227, 229, 232, 234, 238, 240, 243, 245, 246, 248, 249, 250, 251, 252, 254, 258, 263, 269, 278, 281, 282, 283, 285, 287, 289, 294, 303, 308, 316, 327, 328, 330, 331]	[8, 16, 19, 23, 27, 29, 32, 34, 42, 45, 47, 49, 52, 56, 63, 72, 77, 81, 87, 91, 95, 98, 100, 103, 105, 106, 108, 111, 114, 117, 126, 135, 137, 144, 150, 153, 162, 171, 174, 178, 180, 182, 184, 188, 195, 204, 205, 209, 217, 218, 222, 225, 227, 228, 232, 234, 238, 240, 242, 244, 246, 248, 249, 250, 251, 252, 253, 257, 262, 268, 277, 280, 282, 283, 285, 287, 288, 293, 302, 307, 315, 327, 328, 330, 331, 333]	['Previous', 'studies', 'of', 'the', 'proteomics', 'profile', 'in', 'EVs', 'in', 'the', 'plasma', 'released', 'from', 'the', 'platelets', 'and', 'RBCs', 'of', 'β-thalassemic', 'patients', 'reported', 'a', 'higher', 'level', 'of', 'proteins', 'involved', 'in', 'the', 'oxidative', 'stress', 'response', ',', 'for', 'example', ',', 'catalase', ',', 'peroxiredoxin', '2', '(', 'PRDX2', ')', ',', 'and', 'heat', 'shock', 'proteins', '70', '(', 'Hsp70', ')', 'when', 'compared', 'with', 'healthy', 'individuals.13', ',', '14']	[1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Antibodies used for immunoblotting were: anti-α-hemoglobin–stabilizing protein (anti-AHSP) antibody, a gift from R. Griffiths (National Health Service Blood and Transplant [NHSBT] Filton); the anti-catalase (ab16731), anti-hemopexin (ab90947), and anti-haptoglobin (ab131236), antibodies were all obtained from Abcam (Cambridge, United Kingdom).	[('PMC5787864', 'M08000', 198, 206, 'catalase')]	['Anti', '##bo', '##dies', 'used', 'for', 'im', '##mu', '##nob', '##lot', '##ting', 'were', ':', 'anti', '-', 'α', '-', 'hem', '##og', '##lo', '##bin', '–', 'stab', '##ili', '##zing', 'protein', '(', 'anti', '-', 'A', '##HS', '##P', ')', 'anti', '##body', ',', 'a', 'gift', 'from', 'R', '.', 'Griffiths', '(', 'National', 'Health', 'Service', 'Blood', 'and', 'Trans', '##p', '##lant', '[', 'NHS', '##B', '##T', ']', 'Fi', '##lton', ')', ';', 'the', 'anti', '-', 'cat', '##ala', '##se', '(', 'a', '##b', '##16', '##7', '##31', ')', ',', 'anti', '-', 'hem', '##ope', '##xin', '(', 'a', '##b', '##90', '##9', '##47', ')', ',', 'and', 'anti', '-', 'ha', '##pt', '##og', '##lo', '##bin', '(', 'a', '##b', '##13', '##12', '##36', ')', ',', 'antibodies', 'were', 'all', 'obtained', 'from', 'A', '##b', '##cam', '(', 'Cambridge', ',', 'United', 'Kingdom', ')', '.']	[0, 4, 6, 11, 16, 20, 22, 24, 27, 30, 35, 39, 41, 45, 46, 47, 48, 51, 53, 55, 58, 59, 63, 66, 71, 79, 80, 84, 85, 86, 88, 89, 91, 95, 99, 101, 103, 108, 113, 114, 116, 126, 127, 136, 143, 151, 157, 161, 166, 167, 172, 173, 176, 177, 178, 180, 182, 186, 187, 189, 193, 197, 198, 201, 204, 207, 208, 209, 210, 212, 213, 215, 216, 218, 222, 223, 226, 229, 233, 234, 235, 236, 238, 239, 241, 242, 244, 248, 252, 253, 255, 257, 259, 261, 265, 266, 267, 268, 270, 272, 274, 275, 277, 288, 293, 297, 306, 311, 312, 313, 317, 318, 327, 329, 336, 343, 344]	[4, 6, 10, 15, 19, 22, 24, 27, 30, 34, 39, 40, 45, 46, 47, 48, 51, 53, 55, 58, 59, 63, 66, 70, 78, 80, 84, 85, 86, 88, 89, 90, 95, 99, 100, 102, 107, 112, 114, 115, 125, 127, 135, 142, 150, 156, 160, 166, 167, 171, 173, 176, 177, 178, 179, 182, 186, 187, 188, 192, 197, 198, 201, 204, 206, 208, 209, 210, 212, 213, 215, 216, 217, 222, 223, 226, 229, 232, 234, 235, 236, 238, 239, 241, 242, 243, 247, 252, 253, 255, 257, 259, 261, 264, 266, 267, 268, 270, 272, 274, 275, 276, 287, 292, 296, 305, 310, 312, 313, 316, 318, 327, 328, 335, 343, 344, 345]	['Antibodies', 'used', 'for', 'immunoblotting', 'were', ':', 'anti-α-hemoglobin–', 'stabilizing', 'protein', '(', 'anti-AHSP', ')', 'antibody', ',', 'a', 'gift', 'from', 'R', '.', 'Griffiths', '(', 'National', 'Health', 'Service', 'Blood', 'and', 'Transplant', '[', 'NHSBT', ']', 'Filton', ')', ';', 'the', 'anti-', 'catalase', '(', 'ab16731', ')', ',', 'anti-', 'hemopexin', '(', 'ab90947', ')', ',', 'and', 'anti-', 'haptoglobin', '(', 'ab131236', ')', ',', 'antibodies', 'were', 'all', 'obtained', 'from', 'Abcam', '(', 'Cambridge', ',', 'United', 'Kingdom', ')', '.']	[3, 1, 1, 5, 1, 1, 9, 3, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 2, 1, 1, 1, 2, 3, 1, 5, 1, 1, 2, 3, 1, 5, 1, 1, 1, 2, 5, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The alterations in abundance of catalase, AHSP, hemopexin, and haptoglobin were also confirmed in individual samples by western blot analysis.	[('PMC5787864', 'R04000', 32, 40, 'catalase')]	['The', 'alterations', 'in', 'abundance', 'of', 'cat', '##ala', '##se', ',', 'A', '##HS', '##P', ',', 'hem', '##ope', '##xin', ',', 'and', 'ha', '##pt', '##og', '##lo', '##bin', 'were', 'also', 'confirmed', 'in', 'individual', 'samples', 'by', 'western', 'b', '##lot', 'analysis', '.']	[0, 4, 16, 19, 29, 32, 35, 38, 40, 42, 43, 45, 46, 48, 51, 54, 57, 59, 63, 65, 67, 69, 71, 75, 80, 85, 95, 98, 109, 117, 120, 128, 129, 133, 141]	[3, 15, 18, 28, 31, 35, 38, 40, 41, 43, 45, 46, 47, 51, 54, 57, 58, 62, 65, 67, 69, 71, 74, 79, 84, 94, 97, 108, 116, 119, 127, 129, 132, 141, 142]	['The', 'alterations', 'in', 'abundance', 'of', 'catalase', ',', 'AHSP', ',', 'hemopexin', ',', 'and', 'haptoglobin', 'were', 'also', 'confirmed', 'in', 'individual', 'samples', 'by', 'western', 'blot', 'analysis', '.']	[1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The role of cholesterol and its metabolites in breast cancer onset and therapy outcome currently receives increasing attention due to the fact that breast cancer patients have higher cholesterol levels than healthy controls (Nelson 2013), and enzymes of cholesterol biosynthesis and the synthesis of the oxysterols 25-hydroxycholesterol and 27-hydroxycholesterol contribute to endocrine therapy (e.g., tamoxifen or aromatase inhibitors) resistance in breast cancer models in vitro (Simigdala 2016).	[('PMC5792305', 'I02000', 415, 424, 'aromatase')]	['The', 'role', 'of', 'ch', '##ole', '##ster', '##ol', 'and', 'its', 'meta', '##bol', '##ites', 'in', 'breast', 'cancer', 'onset', 'and', 'therapy', 'outcome', 'currently', 'receives', 'increasing', 'attention', 'due', 'to', 'the', 'fact', 'that', 'breast', 'cancer', 'patients', 'have', 'higher', 'ch', '##ole', '##ster', '##ol', 'levels', 'than', 'healthy', 'controls', '(', 'Nelson', '2013', ')', ',', 'and', 'enzymes', 'of', 'ch', '##ole', '##ster', '##ol', 'bio', '##sy', '##nt', '##hesis', 'and', 'the', 'synthesis', 'of', 'the', 'o', '##xy', '##ster', '##ols', '25', '-', 'h', '##ydro', '##xy', '##cho', '##les', '##tero', '##l', 'and', '27', '-', 'h', '##ydro', '##xy', '##cho', '##les', '##tero', '##l', 'contribute', 'to', 'end', '##oc', '##rine', 'therapy', '(', 'e', '.', 'g', '.', ',', 'ta', '##mo', '##xi', '##fen', 'or', 'a', '##roma', '##tase', 'inhibitor', '##s', ')', 'resistance', 'in', 'breast', 'cancer', 'models', 'in', 'v', '##it', '##ro', '(', 'Si', '##mi', '##g', '##dal', '##a', '2016', ')', '.']	[0, 4, 9, 12, 14, 17, 21, 24, 28, 32, 36, 39, 44, 47, 54, 61, 67, 71, 79, 87, 97, 106, 117, 127, 131, 134, 138, 143, 148, 155, 162, 171, 176, 183, 185, 188, 192, 195, 202, 207, 215, 224, 225, 232, 236, 237, 239, 243, 251, 254, 256, 259, 263, 266, 269, 271, 273, 279, 283, 287, 297, 300, 304, 305, 307, 311, 315, 317, 318, 319, 323, 325, 328, 331, 335, 337, 341, 343, 344, 345, 349, 351, 354, 357, 361, 363, 374, 377, 380, 382, 387, 395, 396, 397, 398, 399, 400, 402, 404, 406, 408, 412, 415, 416, 420, 425, 434, 435, 437, 448, 451, 458, 465, 472, 475, 476, 478, 481, 482, 484, 486, 487, 490, 492, 496, 497]	[3, 8, 11, 14, 17, 21, 23, 27, 31, 36, 39, 43, 46, 53, 60, 66, 70, 78, 86, 96, 105, 116, 126, 130, 133, 137, 142, 147, 154, 161, 170, 175, 182, 185, 188, 192, 194, 201, 206, 214, 223, 225, 231, 236, 237, 238, 242, 250, 253, 256, 259, 263, 265, 269, 271, 273, 278, 282, 286, 296, 299, 303, 305, 307, 311, 314, 317, 318, 319, 323, 325, 328, 331, 335, 336, 340, 343, 344, 345, 349, 351, 354, 357, 361, 362, 373, 376, 380, 382, 386, 394, 396, 397, 398, 399, 400, 401, 404, 406, 408, 411, 414, 416, 420, 424, 434, 435, 436, 447, 450, 457, 464, 471, 474, 476, 478, 480, 482, 484, 486, 487, 490, 491, 496, 497, 498]	['The', 'role', 'of', 'cholesterol', 'and', 'its', 'metabolites', 'in', 'breast', 'cancer', 'onset', 'and', 'therapy', 'outcome', 'currently', 'receives', 'increasing', 'attention', 'due', 'to', 'the', 'fact', 'that', 'breast', 'cancer', 'patients', 'have', 'higher', 'cholesterol', 'levels', 'than', 'healthy', 'controls', '(', 'Nelson', '2013', ')', ',', 'and', 'enzymes', 'of', 'cholesterol', 'biosynthesis', 'and', 'the', 'synthesis', 'of', 'the', 'oxysterols', '25-hydroxycholesterol', 'and', '27-hydroxycholesterol', 'contribute', 'to', 'endocrine', 'therapy', '(', 'e.g', '.', ',', 'tamoxifen', 'or', 'aromatase', 'inhibitors', ')', 'resistance', 'in', 'breast', 'cancer', 'models', 'in', 'vitro', '(', 'Simigdala', '2016', ')', '.']	[1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 4, 9, 1, 9, 1, 1, 3, 1, 1, 3, 1, 1, 4, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acylcarnitines are intermediates in fatty acid and amino acid breakdown generated from the conversion of acyl-CoA species by the action of carnitine palmitoyltransferase 1 (CPT1)	[('PMC5797421', 'D01000', 139, 171, 'carnitine palmitoyltransferase 1')]	['A', '##cy', '##l', '##car', '##ni', '##tine', '##s', 'are', 'intermediate', '##s', 'in', 'fatty', 'acid', 'and', 'amino', 'acid', 'breakdown', 'generated', 'from', 'the', 'conversion', 'of', 'a', '##cy', '##l', '-', 'Co', '##A', 'species', 'by', 'the', 'action', 'of', 'car', '##ni', '##tine', 'palm', '##ito', '##yl', '##tra', '##ns', '##fer', '##ase', '1', '(', 'CP', '##T', '##1', ')']	[0, 1, 3, 4, 7, 9, 13, 15, 19, 31, 33, 36, 42, 47, 51, 57, 62, 72, 82, 87, 91, 102, 105, 106, 108, 109, 110, 112, 114, 122, 125, 129, 136, 139, 142, 144, 149, 153, 156, 158, 161, 163, 166, 170, 172, 173, 175, 176, 177]	[1, 3, 4, 7, 9, 13, 14, 18, 31, 32, 35, 41, 46, 50, 56, 61, 71, 81, 86, 90, 101, 104, 106, 108, 109, 110, 112, 113, 121, 124, 128, 135, 138, 142, 144, 148, 153, 156, 158, 161, 163, 166, 169, 171, 173, 175, 176, 177, 178]	['Acylcarnitines', 'are', 'intermediates', 'in', 'fatty', 'acid', 'and', 'amino', 'acid', 'breakdown', 'generated', 'from', 'the', 'conversion', 'of', 'acyl-CoA', 'species', 'by', 'the', 'action', 'of', 'carnitine', 'palmitoyltransferase', '1', '(', 'CPT1', ')']	[7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 3, 7, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
After production of acylcarnitines by CPT1, the mitochondrial inner membrane transporter carnitine acylcarnitine translocase (CACT, or SLC25A20) transports the acylcarnitines into the mitochondrial matrix.	[]	['After', 'production', 'of', 'a', '##cy', '##l', '##car', '##ni', '##tine', '##s', 'by', 'CP', '##T', '##1', ',', 'the', 'mitochondrial', 'inner', 'membrane', 'transport', '##er', 'car', '##ni', '##tine', 'a', '##cy', '##l', '##car', '##ni', '##tine', 'trans', '##loc', '##ase', '(', 'CA', '##CT', ',', 'or', 'SL', '##C', '##25', '##A', '##20', ')', 'transports', 'the', 'a', '##cy', '##l', '##car', '##ni', '##tine', '##s', 'into', 'the', 'mitochondrial', 'matrix', '.']	[0, 6, 17, 20, 21, 23, 24, 27, 29, 33, 35, 38, 40, 41, 42, 44, 48, 62, 68, 77, 86, 89, 92, 94, 99, 100, 102, 103, 106, 108, 113, 118, 121, 125, 126, 128, 130, 132, 135, 137, 138, 140, 141, 143, 145, 156, 160, 161, 163, 164, 167, 169, 173, 175, 180, 184, 198, 204]	[5, 16, 19, 21, 23, 24, 27, 29, 33, 34, 37, 40, 41, 42, 43, 47, 61, 67, 76, 86, 88, 92, 94, 98, 100, 102, 103, 106, 108, 112, 118, 121, 124, 126, 128, 130, 131, 134, 137, 138, 140, 141, 143, 144, 155, 159, 161, 163, 164, 167, 169, 173, 174, 179, 183, 197, 204, 205]	['After', 'production', 'of', 'acylcarnitines', 'by', 'CPT1', ',', 'the', 'mitochondrial', 'inner', 'membrane', 'transporter', 'carnitine', 'acylcarnitine', 'translocase', '(', 'CACT', ',', 'or', 'SLC25A20', ')', 'transports', 'the', 'acylcarnitines', 'into', 'the', 'mitochondrial', 'matrix', '.']	[1, 1, 1, 7, 1, 3, 1, 1, 1, 1, 1, 2, 3, 6, 3, 1, 2, 1, 1, 5, 1, 1, 1, 7, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
LysoPE which is a lyso-type phospholipid, is a metabolic product of phosphatidylethanolamine (PE, a minor constituent of cell membranes) generated by phospholipase A2 [33].	[('PMC5797421', 'D06000', 150, 166, 'phospholipase A2')]	['L', '##ys', '##o', '##P', '##E', 'which', 'is', 'a', 'l', '##ys', '##o', '-', 'type', 'p', '##hos', '##ph', '##oli', '##pid', ',', 'is', 'a', 'metabolic', 'product', 'of', 'p', '##hos', '##pha', '##ti', '##dy', '##let', '##han', '##ola', '##mine', '(', 'P', '##E', ',', 'a', 'minor', 'constituent', 'of', 'cell', 'membrane', '##s', ')', 'generated', 'by', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'A2', '[', '33', ']', '.']	[0, 1, 3, 4, 5, 7, 13, 16, 18, 19, 21, 22, 23, 28, 29, 32, 34, 37, 40, 42, 45, 47, 57, 65, 68, 69, 72, 75, 77, 79, 82, 85, 88, 93, 94, 95, 96, 98, 100, 106, 118, 121, 126, 134, 135, 137, 147, 150, 151, 154, 156, 159, 162, 164, 167, 168, 170, 171]	[1, 3, 4, 5, 6, 12, 15, 17, 19, 21, 22, 23, 27, 29, 32, 34, 37, 40, 41, 44, 46, 56, 64, 67, 69, 72, 75, 77, 79, 82, 85, 88, 92, 94, 95, 96, 97, 99, 105, 117, 120, 125, 134, 135, 136, 146, 149, 151, 154, 156, 159, 162, 163, 166, 168, 170, 171, 172]	['LysoPE', 'which', 'is', 'a', 'lyso', '-', 'type', 'phospholipid', ',', 'is', 'a', 'metabolic', 'product', 'of', 'phosphatidylethanolamine', '(', 'PE', ',', 'a', 'minor', 'constituent', 'of', 'cell', 'membranes', ')', 'generated', 'by', 'phospholipase', 'A2', '[', '33', ']', '.']	[5, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 9, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Among the five candidate genes linked to lysosomal biology, two were previously identified candidate genes (GBA (glucocerebrosidase) and TMEM175 (transmembrane protein 175)), and three were newly identified candidate genes (CTSB (cathepsin B), ATP6V0A1 (ATPase H+ transporting V0 subunit a1), and GALC (galactosylceramidase)).	[]	['Among', 'the', 'five', 'candidate', 'genes', 'linked', 'to', 'l', '##ys', '##oso', '##mal', 'biology', ',', 'two', 'were', 'previously', 'identified', 'candidate', 'genes', '(', 'GB', '##A', '(', 'g', '##lu', '##co', '##cer', '##eb', '##ros', '##idas', '##e', ')', 'and', 'T', '##ME', '##M', '##17', '##5', '(', 'trans', '##me', '##mb', '##rane', 'protein', '175', ')', ')', ',', 'and', 'three', 'were', 'newly', 'identified', 'candidate', 'genes', '(', 'CT', '##SB', '(', 'cat', '##he', '##ps', '##in', 'B', ')', ',', 'ATP', '##6', '##V', '##0', '##A', '##1', '(', 'ATP', '##ase', 'H', '+', 'transporting', 'V', '##0', 'subunit', 'a', '##1', ')', ',', 'and', 'GA', '##LC', '(', 'gal', '##act', '##osy', '##l', '##cer', '##ami', '##das', '##e', ')', ')', '.']	[0, 6, 10, 15, 25, 31, 38, 41, 42, 44, 47, 51, 58, 60, 64, 69, 80, 91, 101, 107, 108, 110, 112, 113, 114, 116, 118, 121, 123, 126, 130, 131, 133, 137, 138, 140, 141, 143, 145, 146, 151, 153, 155, 160, 168, 171, 172, 173, 175, 179, 185, 190, 196, 207, 217, 223, 224, 226, 229, 230, 233, 235, 237, 240, 241, 242, 244, 247, 248, 249, 250, 251, 253, 254, 257, 261, 262, 264, 277, 278, 280, 288, 289, 290, 291, 293, 297, 299, 302, 303, 306, 309, 312, 313, 316, 319, 322, 323, 324, 325]	[5, 9, 14, 24, 30, 37, 40, 42, 44, 47, 50, 58, 59, 63, 68, 79, 90, 100, 106, 108, 110, 111, 113, 114, 116, 118, 121, 123, 126, 130, 131, 132, 136, 138, 140, 141, 143, 144, 146, 151, 153, 155, 159, 167, 171, 172, 173, 174, 178, 184, 189, 195, 206, 216, 222, 224, 226, 228, 230, 233, 235, 237, 239, 241, 242, 243, 247, 248, 249, 250, 251, 252, 254, 257, 260, 262, 263, 276, 278, 279, 287, 289, 290, 291, 292, 296, 299, 301, 303, 306, 309, 312, 313, 316, 319, 322, 323, 324, 325, 326]	['Among', 'the', 'five', 'candidate', 'genes', 'linked', 'to', 'lysosomal', 'biology', ',', 'two', 'were', 'previously', 'identified', 'candidate', 'genes', '(', 'GBA', '(', 'glucocerebrosidase', ')', 'and', 'TMEM175', '(', 'transmembrane', 'protein', '175', ')', ')', ',', 'and', 'three', 'were', 'newly', 'identified', 'candidate', 'genes', '(', 'CTSB', '(', 'cathepsin', 'B', ')', ',', 'ATP6V0A1', '(', 'ATPase', 'H+', 'transporting', 'V0', 'subunit', 'a1', ')', ',', 'and', 'GALC', '(', 'galactosylceramidase', ')', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 8, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 6, 1, 2, 2, 1, 2, 1, 2, 1, 1, 1, 2, 1, 8, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glucocerebrosidase is required for normal lysosomal activity and α-synuclein degradation.	[]	['G', '##lu', '##co', '##cer', '##eb', '##ros', '##idas', '##e', 'is', 'required', 'for', 'normal', 'l', '##ys', '##oso', '##mal', 'activity', 'and', 'α', '-', 's', '##yn', '##uc', '##lein', 'degradation', '.']	[0, 1, 3, 5, 8, 10, 13, 17, 19, 22, 31, 35, 42, 43, 45, 48, 52, 61, 65, 66, 67, 68, 70, 72, 77, 88]	[1, 3, 5, 8, 10, 13, 17, 18, 21, 30, 34, 41, 43, 45, 48, 51, 60, 64, 66, 67, 68, 70, 72, 76, 88, 89]	['Glucocerebrosidase', 'is', 'required', 'for', 'normal', 'lysosomal', 'activity', 'and', 'α-synuclein', 'degradation', '.']	[8, 1, 1, 1, 1, 4, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, GBA loss-of-function alleles are a common PD risk factor31.	[]	['In', 'addition', ',', 'GB', '##A', 'loss', '-', 'of', '-', 'function', 'all', '##ele', '##s', 'are', 'a', 'common', 'PD', 'risk', 'factor', '##31', '.']	[0, 3, 11, 13, 15, 17, 21, 22, 24, 25, 34, 37, 40, 42, 46, 48, 55, 58, 63, 69, 71]	[2, 11, 12, 15, 16, 21, 22, 24, 25, 33, 37, 40, 41, 45, 47, 54, 57, 62, 69, 71, 72]	['In', 'addition', ',', 'GBA', 'loss', '-', 'of', '-', 'function', 'alleles', 'are', 'a', 'common', 'PD', 'risk', 'factor31', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several of the PD candidate genes are within the ‘druggable’ genome42, including the previously identified serine/threonine kinase 39 (STK39) and the novel candidate gene inositol 1,4,5-trisphosphate kinase B (ITPKB).	[('PMC5812477', 'I19000', 107, 133, 'serine/threonine kinase 39')]	['Several', 'of', 'the', 'PD', 'candidate', 'genes', 'are', 'within', 'the', '‘', 'drug', '##gable', '’', 'genome', '##42', ',', 'including', 'the', 'previously', 'identified', 'se', '##rine', '/', 'th', '##re', '##oni', '##ne', 'kinase', '39', '(', 'ST', '##K', '##39', ')', 'and', 'the', 'novel', 'candidate', 'gene', 'in', '##os', '##ito', '##l', '1', ',', '4', ',', '5', '-', 't', '##ris', '##ph', '##os', '##phate', 'kinase', 'B', '(', 'IT', '##P', '##K', '##B', ')', '.']	[0, 8, 11, 15, 18, 28, 34, 38, 45, 49, 50, 54, 59, 61, 67, 69, 71, 81, 85, 96, 107, 109, 113, 114, 116, 118, 121, 124, 131, 134, 135, 137, 138, 140, 142, 146, 150, 156, 166, 171, 173, 175, 178, 180, 181, 182, 183, 184, 185, 186, 187, 190, 192, 194, 200, 207, 209, 210, 212, 213, 214, 215, 216]	[7, 10, 14, 17, 27, 33, 37, 44, 48, 50, 54, 59, 60, 67, 69, 70, 80, 84, 95, 106, 109, 113, 114, 116, 118, 121, 123, 130, 133, 135, 137, 138, 140, 141, 145, 149, 155, 165, 170, 173, 175, 178, 179, 181, 182, 183, 184, 185, 186, 187, 190, 192, 194, 199, 206, 208, 210, 212, 213, 214, 215, 216, 217]	['Several', 'of', 'the', 'PD', 'candidate', 'genes', 'are', 'within', 'the', '‘', 'druggable', '’', 'genome42', ',', 'including', 'the', 'previously', 'identified', 'serine', '/', 'threonine', 'kinase', '39', '(', 'STK39', ')', 'and', 'the', 'novel', 'candidate', 'gene', 'inositol', '1', ',', '4', ',', '5-trisphosphate', 'kinase', 'B', '(', 'ITPKB', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 7, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, levels of miR-29b-3p, the family member with the highest alterations, correlated with FEV1 in male COPD patients (r=0.62, p=0.07; data not shown), but not female COPD patients (r=0.48, p=0.16), male smokers (r=0.33, p=0.33) or female smokers (r=0.25, p=0.75).	[]	['Interest', '##ingly', ',', 'levels', 'of', 'mi', '##R', '-', '29', '##b', '-', '3', '##p', ',', 'the', 'family', 'member', 'with', 'the', 'highest', 'alterations', ',', 'correlated', 'with', 'F', '##E', '##V', '##1', 'in', 'male', 'CO', '##PD', 'patients', '(', 'r', '=', '0', '.', '62', ',', 'p', '=', '0', '.', '07', ';', 'data', 'not', 'shown', ')', ',', 'but', 'not', 'female', 'CO', '##PD', 'patients', '(', 'r', '=', '0', '.', '48', ',', 'p', '=', '0', '.', '16', ')', ',', 'male', 'smoke', '##rs', '(', 'r', '=', '0', '.', '33', ',', 'p', '=', '0', '.', '33', ')', 'or', 'female', 'smoke', '##rs', '(', 'r', '=', '0', '.', '25', ',', 'p', '=', '0', '.', '75', ')', '.']	[0, 8, 13, 15, 22, 25, 27, 28, 29, 31, 32, 33, 34, 35, 37, 41, 48, 55, 60, 64, 72, 83, 85, 96, 101, 102, 103, 104, 106, 109, 114, 116, 119, 128, 129, 130, 131, 132, 133, 135, 137, 138, 139, 140, 141, 143, 145, 150, 154, 159, 160, 162, 166, 170, 177, 179, 182, 191, 192, 193, 194, 195, 196, 198, 200, 201, 202, 203, 204, 206, 207, 209, 214, 219, 222, 223, 224, 225, 226, 227, 229, 231, 232, 233, 234, 235, 237, 239, 242, 249, 254, 257, 258, 259, 260, 261, 262, 264, 266, 267, 268, 269, 270, 272, 273]	[8, 13, 14, 21, 24, 27, 28, 29, 31, 32, 33, 34, 35, 36, 40, 47, 54, 59, 63, 71, 83, 84, 95, 100, 102, 103, 104, 105, 108, 113, 116, 118, 127, 129, 130, 131, 132, 133, 135, 136, 138, 139, 140, 141, 143, 144, 149, 153, 159, 160, 161, 165, 169, 176, 179, 181, 190, 192, 193, 194, 195, 196, 198, 199, 201, 202, 203, 204, 206, 207, 208, 213, 219, 221, 223, 224, 225, 226, 227, 229, 230, 232, 233, 234, 235, 237, 238, 241, 248, 254, 256, 258, 259, 260, 261, 262, 264, 265, 267, 268, 269, 270, 272, 273, 274]	['Interestingly', ',', 'levels', 'of', 'miR-29b-3p', ',', 'the', 'family', 'member', 'with', 'the', 'highest', 'alterations', ',', 'correlated', 'with', 'FEV1', 'in', 'male', 'COPD', 'patients', '(', 'r=0.62', ',', 'p=0.07', ';', 'data', 'not', 'shown', ')', ',', 'but', 'not', 'female', 'COPD', 'patients', '(', 'r=0.48', ',', 'p=0.16', ')', ',', 'male', 'smokers', '(', 'r=0.33', ',', 'p=0.33', ')', 'or', 'female', 'smokers', '(', 'r=0.25', ',', 'p=0.75', ')', '.']	[2, 1, 1, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 5, 1, 1, 1, 2, 1, 5, 1, 5, 1, 1, 1, 2, 1, 5, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The miR-29 family was significantly upregulated in male COPD patients compared to smokers both in BAL cells (p=0.004–0.056, fold change 1.5–2.7; figure 2d and online supplementary figure E6) and BECs (p=0.03–0.06, fold-change 2.0–2.8, online supplementary figure E6), while no alteration was detected in the corresponding female cohort (BAL p=0.78–0.90; BEC p=0.22–0.29).	[]	['The', 'mi', '##R', '-', '29', 'family', 'was', 'significantly', 'up', '##re', '##gu', '##lated', 'in', 'male', 'CO', '##PD', 'patients', 'compared', 'to', 'smoke', '##rs', 'both', 'in', 'BA', '##L', 'cells', '(', 'p', '=', '0', '.', '00', '##4', '–', '0', '.', '05', '##6', ',', 'fold', 'change', '1', '.', '5', '–', '2', '.', '7', ';', 'figure', '2d', 'and', 'online', 'supplement', '##ary', 'figure', 'E', '##6', ')', 'and', 'B', '##EC', '##s', '(', 'p', '=', '0', '.', '03', '–', '0', '.', '06', ',', 'fold', '-', 'change', '2', '.', '0', '–', '2', '.', '8', ',', 'online', 'supplement', '##ary', 'figure', 'E', '##6', ')', ',', 'while', 'no', 'alter', '##ation', 'was', 'detected', 'in', 'the', 'corresponding', 'female', 'co', '##hor', '##t', '(', 'BA', '##L', 'p', '=', '0', '.', '78', '–', '0', '.', '90', ';', 'B', '##EC', 'p', '=', '0', '.', '22', '–', '0', '.', '29', ')', '.']	[0, 4, 6, 7, 8, 11, 18, 22, 36, 38, 40, 42, 48, 51, 56, 58, 61, 70, 79, 82, 87, 90, 95, 98, 100, 102, 108, 109, 110, 111, 112, 113, 115, 116, 117, 118, 119, 121, 122, 124, 129, 136, 137, 138, 139, 140, 141, 142, 143, 145, 152, 155, 159, 166, 176, 180, 187, 188, 189, 191, 195, 196, 198, 200, 201, 202, 203, 204, 205, 207, 208, 209, 210, 212, 214, 218, 219, 226, 227, 228, 229, 230, 231, 232, 233, 235, 242, 252, 256, 263, 264, 265, 266, 268, 274, 277, 282, 288, 292, 301, 304, 308, 322, 329, 331, 334, 336, 337, 339, 341, 342, 343, 344, 345, 347, 348, 349, 350, 352, 354, 355, 358, 359, 360, 361, 362, 364, 365, 366, 367, 369, 370]	[3, 6, 7, 8, 10, 17, 21, 35, 38, 40, 42, 47, 50, 55, 58, 60, 69, 78, 81, 87, 89, 94, 97, 100, 101, 107, 109, 110, 111, 112, 113, 115, 116, 117, 118, 119, 121, 122, 123, 128, 135, 137, 138, 139, 140, 141, 142, 143, 144, 151, 154, 158, 165, 176, 179, 186, 188, 189, 190, 194, 196, 198, 199, 201, 202, 203, 204, 205, 207, 208, 209, 210, 212, 213, 218, 219, 225, 227, 228, 229, 230, 231, 232, 233, 234, 241, 252, 255, 262, 264, 265, 266, 267, 273, 276, 282, 287, 291, 300, 303, 307, 321, 328, 331, 334, 335, 337, 339, 340, 342, 343, 344, 345, 347, 348, 349, 350, 352, 353, 355, 357, 359, 360, 361, 362, 364, 365, 366, 367, 369, 370, 371]	['The', 'miR-29', 'family', 'was', 'significantly', 'upregulated', 'in', 'male', 'COPD', 'patients', 'compared', 'to', 'smokers', 'both', 'in', 'BAL', 'cells', '(', 'p=0.004', '–', '0.056', ',', 'fold', 'change', '1.5', '–', '2.7', ';', 'figure', '2d', 'and', 'online', 'supplementary', 'figure', 'E6', ')', 'and', 'BECs', '(', 'p=0.03', '–', '0.06', ',', 'fold', '-', 'change', '2.0', '–', '2.8', ',', 'online', 'supplementary', 'figure', 'E6', ')', ',', 'while', 'no', 'alteration', 'was', 'detected', 'in', 'the', 'corresponding', 'female', 'cohort', '(', 'BAL', 'p=0.78', '–', '0.90', ';', 'BEC', 'p=0.22', '–', '0.29', ')', '.']	[1, 4, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 6, 1, 4, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 3, 1, 5, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 2, 5, 1, 3, 1, 2, 5, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our study also identified a region at chromosome 16q12.2 that included two genome-wide significant SNPs (rs7184292 and rs7201620, located 169kb 3′ of the gene CHD9, which encodes chromodomain helicase DNA binding protein 9).	[('PMC5901893', 'D02000', 192, 200, 'helicase')]	['Our', 'study', 'also', 'identified', 'a', 'region', 'at', 'chromosome', '16', '##q', '##12', '.', '2', 'that', 'included', 'two', 'genome', '-', 'wide', 'significant', 'S', '##NP', '##s', '(', 'r', '##s', '##7', '##18', '##42', '##9', '##2', 'and', 'r', '##s', '##7', '##20', '##16', '##20', ',', 'located', '169', '##k', '##b', '3', '′', 'of', 'the', 'gene', 'CH', '##D', '##9', ',', 'which', 'en', '##codes', 'ch', '##rom', '##od', '##oma', '##in', 'he', '##lica', '##se', 'DNA', 'binding', 'protein', '9', ')', '.']	[0, 4, 10, 15, 26, 28, 35, 38, 49, 51, 52, 54, 55, 57, 62, 71, 75, 81, 82, 87, 99, 100, 102, 104, 105, 106, 107, 108, 110, 112, 113, 115, 119, 120, 121, 122, 124, 126, 128, 130, 138, 141, 142, 144, 145, 147, 150, 154, 159, 161, 162, 163, 165, 171, 173, 179, 181, 184, 186, 189, 192, 194, 198, 201, 205, 213, 221, 222, 223]	[3, 9, 14, 25, 27, 34, 37, 48, 51, 52, 54, 55, 56, 61, 70, 74, 81, 82, 86, 98, 100, 102, 103, 105, 106, 107, 108, 110, 112, 113, 114, 118, 120, 121, 122, 124, 126, 128, 129, 137, 141, 142, 143, 145, 146, 149, 153, 158, 161, 162, 163, 164, 170, 173, 178, 181, 184, 186, 189, 191, 194, 198, 200, 204, 212, 220, 222, 223, 224]	['Our', 'study', 'also', 'identified', 'a', 'region', 'at', 'chromosome', '16q12.2', 'that', 'included', 'two', 'genome', '-', 'wide', 'significant', 'SNPs', '(', 'rs7184292', 'and', 'rs7201620', ',', 'located', '169kb', '3′', 'of', 'the', 'gene', 'CHD9', ',', 'which', 'encodes', 'chromodomain', 'helicase', 'DNA', 'binding', 'protein', '9', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 3, 1, 7, 1, 6, 1, 1, 3, 2, 1, 1, 1, 3, 1, 1, 2, 5, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The GS-331007 monophosphate can either be dephosphorylated to form the nucleoside metabolite, which is eliminated, or be sequentially phosphorylated to form the pharmacologically active triphosphate metabolite, which acts as an alternate substrate and, ultimately, as a nonobligate chain terminator of the HCV NS5B polymerase (11).	[]	['The', 'G', '##S', '-', '33', '##100', '##7', 'mon', '##op', '##hos', '##phate', 'can', 'either', 'be', 'de', '##ph', '##os', '##ph', '##ory', '##lated', 'to', 'form', 'the', 'n', '##uc', '##leo', '##side', 'meta', '##bol', '##ite', ',', 'which', 'is', 'eliminated', ',', 'or', 'be', 'se', '##quential', '##ly', 'p', '##hos', '##ph', '##ory', '##lated', 'to', 'form', 'the', 'p', '##har', '##ma', '##cological', '##ly', 'active', 'trip', '##hos', '##phate', 'meta', '##bol', '##ite', ',', 'which', 'acts', 'as', 'an', 'alternate', 'substrate', 'and', ',', 'ultimately', ',', 'as', 'a', 'non', '##ob', '##liga', '##te', 'chain', 'term', '##inator', 'of', 'the', 'HC', '##V', 'N', '##S', '##5', '##B', 'polymer', '##ase', '(', '11', ')', '.']	[0, 4, 5, 6, 7, 9, 12, 14, 17, 19, 22, 28, 32, 39, 42, 44, 46, 48, 50, 53, 59, 62, 67, 71, 72, 74, 77, 82, 86, 89, 92, 94, 100, 103, 113, 115, 118, 121, 123, 131, 134, 135, 138, 140, 143, 149, 152, 157, 161, 162, 165, 167, 176, 179, 186, 190, 193, 199, 203, 206, 209, 211, 217, 222, 225, 228, 238, 248, 251, 253, 263, 265, 268, 270, 273, 275, 279, 282, 288, 292, 299, 302, 306, 308, 310, 311, 312, 313, 315, 322, 326, 327, 329, 330]	[3, 5, 6, 7, 9, 12, 13, 17, 19, 22, 27, 31, 38, 41, 44, 46, 48, 50, 53, 58, 61, 66, 70, 72, 74, 77, 81, 86, 89, 92, 93, 99, 102, 113, 114, 117, 120, 123, 131, 133, 135, 138, 140, 143, 148, 151, 156, 160, 162, 165, 167, 176, 178, 185, 190, 193, 198, 203, 206, 209, 210, 216, 221, 224, 227, 237, 247, 251, 252, 263, 264, 267, 269, 273, 275, 279, 281, 287, 292, 298, 301, 305, 308, 309, 311, 312, 313, 314, 322, 325, 327, 329, 330, 331]	['The', 'GS-331007', 'monophosphate', 'can', 'either', 'be', 'dephosphorylated', 'to', 'form', 'the', 'nucleoside', 'metabolite', ',', 'which', 'is', 'eliminated', ',', 'or', 'be', 'sequentially', 'phosphorylated', 'to', 'form', 'the', 'pharmacologically', 'active', 'triphosphate', 'metabolite', ',', 'which', 'acts', 'as', 'an', 'alternate', 'substrate', 'and', ',', 'ultimately', ',', 'as', 'a', 'nonobligate', 'chain', 'terminator', 'of', 'the', 'HCV', 'NS5B', 'polymerase', '(', '11', ')', '.']	[1, 6, 4, 1, 1, 1, 6, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 1, 5, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 2, 4, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The regeneration of NAD+ by lactate dehydrogenase (LDH) supports the robust glycolytic flux hallmark of Warburg metabolism, yet sustained lactate generation from glucose restricts shunting of glycolytic intermediates for biosynthetic metabolism critical to tumor growth54.	[]	['The', 'regeneration', 'of', 'N', '##AD', '+', 'by', 'la', '##ct', '##ate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'L', '##D', '##H', ')', 'supports', 'the', 'robust', 'g', '##ly', '##co', '##ly', '##tic', 'flux', 'hall', '##mark', 'of', 'War', '##burg', 'metabolism', ',', 'yet', 'sustained', 'la', '##ct', '##ate', 'generation', 'from', 'glucose', 'restrict', '##s', 's', '##hun', '##ting', 'of', 'g', '##ly', '##co', '##ly', '##tic', 'intermediate', '##s', 'for', 'bio', '##sy', '##nt', '##hetic', 'metabolism', 'critical', 'to', 'tumor', 'growth', '##5', '##4', '.']	[0, 4, 17, 20, 21, 23, 25, 28, 30, 32, 36, 38, 40, 42, 46, 50, 51, 52, 53, 54, 56, 65, 69, 76, 77, 79, 81, 83, 87, 92, 96, 101, 104, 107, 112, 122, 124, 128, 138, 140, 142, 146, 157, 162, 170, 178, 180, 181, 184, 189, 192, 193, 195, 197, 199, 203, 215, 217, 221, 224, 226, 228, 234, 245, 254, 257, 263, 269, 270, 271]	[3, 16, 19, 21, 23, 24, 27, 30, 32, 35, 38, 40, 42, 46, 49, 51, 52, 53, 54, 55, 64, 68, 75, 77, 79, 81, 83, 86, 91, 96, 100, 103, 107, 111, 122, 123, 127, 137, 140, 142, 145, 156, 161, 169, 178, 179, 181, 184, 188, 191, 193, 195, 197, 199, 202, 215, 216, 220, 224, 226, 228, 233, 244, 253, 256, 262, 269, 270, 271, 272]	['The', 'regeneration', 'of', 'NAD+', 'by', 'lactate', 'dehydrogenase', '(', 'LDH', ')', 'supports', 'the', 'robust', 'glycolytic', 'flux', 'hallmark', 'of', 'Warburg', 'metabolism', ',', 'yet', 'sustained', 'lactate', 'generation', 'from', 'glucose', 'restricts', 'shunting', 'of', 'glycolytic', 'intermediates', 'for', 'biosynthetic', 'metabolism', 'critical', 'to', 'tumor', 'growth54', '.']	[1, 1, 1, 3, 1, 3, 5, 1, 3, 1, 1, 1, 1, 5, 1, 2, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 2, 3, 1, 5, 2, 1, 4, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Through coupling 13C-acetate tracing and nuclear isolation, Bulusu et al. show a hypoxia-induced nuclear translocation of acetyl-CoA synthetase 2 that maintains pro-tumorigenic histone acetylation through the regeneration of acetyl-CoA from endogenous acetate released from histone deacetylation in breast cancer cells59.	[]	['Through', 'coupling', '13', '##C', '-', 'ace', '##tate', 'tracing', 'and', 'nuclear', 'isolation', ',', 'B', '##ulus', '##u', 'et', 'al', '.', 'show', 'a', 'h', '##y', '##pox', '##ia', '-', 'induced', 'nuclear', 'trans', '##location', 'of', 'ace', '##ty', '##l', '-', 'Co', '##A', 's', '##ynth', '##eta', '##se', '2', 'that', 'maintains', 'pro', '-', 'tumor', '##ige', '##nic', 'his', '##tone', 'ace', '##ty', '##lation', 'through', 'the', 'regeneration', 'of', 'ace', '##ty', '##l', '-', 'Co', '##A', 'from', 'end', '##ogen', '##ous', 'ace', '##tate', 'released', 'from', 'his', '##tone', 'de', '##ace', '##ty', '##lation', 'in', 'breast', 'cancer', 'cells', '##5', '##9', '.']	[0, 8, 17, 19, 20, 21, 24, 29, 37, 41, 49, 58, 60, 61, 65, 67, 70, 72, 74, 79, 81, 82, 83, 86, 88, 89, 97, 105, 110, 119, 122, 125, 127, 128, 129, 131, 133, 134, 138, 141, 144, 146, 151, 161, 164, 165, 170, 173, 177, 180, 185, 188, 190, 197, 205, 209, 222, 225, 228, 230, 231, 232, 234, 236, 241, 244, 248, 252, 255, 260, 269, 274, 277, 282, 284, 287, 289, 296, 299, 306, 313, 318, 319, 320]	[7, 16, 19, 20, 21, 24, 28, 36, 40, 48, 58, 59, 61, 65, 66, 69, 72, 73, 78, 80, 82, 83, 86, 88, 89, 96, 104, 110, 118, 121, 125, 127, 128, 129, 131, 132, 134, 138, 141, 143, 145, 150, 160, 164, 165, 170, 173, 176, 180, 184, 188, 190, 196, 204, 208, 221, 224, 228, 230, 231, 232, 234, 235, 240, 244, 248, 251, 255, 259, 268, 273, 277, 281, 284, 287, 289, 295, 298, 305, 312, 318, 319, 320, 321]	['Through', 'coupling', '13C-acetate', 'tracing', 'and', 'nuclear', 'isolation', ',', 'Bulusu', 'et', 'al', '.', 'show', 'a', 'hypoxia', '-', 'induced', 'nuclear', 'translocation', 'of', 'acetyl-CoA', 'synthetase', '2', 'that', 'maintains', 'pro', '-', 'tumorigenic', 'histone', 'acetylation', 'through', 'the', 'regeneration', 'of', 'acetyl-CoA', 'from', 'endogenous', 'acetate', 'released', 'from', 'histone', 'deacetylation', 'in', 'breast', 'cancer', 'cells59', '.']	[1, 1, 5, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 6, 4, 1, 1, 1, 1, 1, 3, 2, 3, 1, 1, 1, 1, 6, 1, 3, 2, 1, 1, 2, 4, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In a cohort of early-stage lung cancer patients, the preoperative infusion of 13C-glucose led to the discovery of enhanced pyruvate carboxylase (PC) flux in lung tumors relative to benign lung, which correlated with increased PC expression67.	[('PMC5938018', 'R21000', 123, 143, 'pyruvate carboxylase')]	['In', 'a', 'co', '##hor', '##t', 'of', 'early', '-', 'stage', 'lung', 'cancer', 'patients', ',', 'the', 'pre', '##oper', '##ative', 'in', '##fusion', 'of', '13', '##C', '-', 'glucose', 'led', 'to', 'the', 'discovery', 'of', 'enhanced', 'p', '##yr', '##u', '##vate', 'car', '##box', '##yla', '##se', '(', 'PC', ')', 'flux', 'in', 'lung', 'tumors', 'relative', 'to', 'ben', '##ign', 'lung', ',', 'which', 'correlated', 'with', 'increased', 'PC', 'expression', '##6', '##7', '.']	[0, 3, 5, 7, 10, 12, 15, 20, 21, 27, 32, 39, 47, 49, 53, 56, 60, 66, 68, 75, 78, 80, 81, 82, 90, 94, 97, 101, 111, 114, 123, 124, 126, 127, 132, 135, 138, 141, 144, 145, 147, 149, 154, 157, 162, 169, 178, 181, 184, 188, 192, 194, 200, 211, 216, 226, 229, 239, 240, 241]	[2, 4, 7, 10, 11, 14, 20, 21, 26, 31, 38, 47, 48, 52, 56, 60, 65, 68, 74, 77, 80, 81, 82, 89, 93, 96, 100, 110, 113, 122, 124, 126, 127, 131, 135, 138, 141, 143, 145, 147, 148, 153, 156, 161, 168, 177, 180, 184, 187, 192, 193, 199, 210, 215, 225, 228, 239, 240, 241, 242]	['In', 'a', 'cohort', 'of', 'early', '-', 'stage', 'lung', 'cancer', 'patients', ',', 'the', 'preoperative', 'infusion', 'of', '13C-glucose', 'led', 'to', 'the', 'discovery', 'of', 'enhanced', 'pyruvate', 'carboxylase', '(', 'PC', ')', 'flux', 'in', 'lung', 'tumors', 'relative', 'to', 'benign', 'lung', ',', 'which', 'correlated', 'with', 'increased', 'PC', 'expression67', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 4, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To detect changes in the NADPH:NADP+ ratio, Cameron et al. engineered a HomoFRET biosensor for the detection of NADP+ based on glucose-6-phosphate dehydrogenase (G6PD) homodimerization in response to NADP+ levels (Apollo-NADP+)86.	[('PMC5938018', 'R28000', 127, 160, 'glucose-6-phosphate dehydrogenase')]	['To', 'detect', 'changes', 'in', 'the', 'N', '##AD', '##P', '##H', ':', 'N', '##AD', '##P', '+', 'ratio', ',', 'Cameron', 'et', 'al', '.', 'engineered', 'a', 'Ho', '##mo', '##F', '##RE', '##T', 'bio', '##sen', '##sor', 'for', 'the', 'detection', 'of', 'N', '##AD', '##P', '+', 'based', 'on', 'glucose', '-', '6', '-', 'phosphate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'G', '##6', '##PD', ')', 'ho', '##mo', '##di', '##mer', '##ization', 'in', 'response', 'to', 'N', '##AD', '##P', '+', 'levels', '(', 'Apollo', '-', 'N', '##AD', '##P', '+', ')', '86', '.']	[0, 3, 10, 18, 21, 25, 26, 28, 29, 30, 31, 32, 34, 35, 37, 42, 44, 52, 55, 57, 59, 70, 72, 74, 76, 77, 79, 81, 84, 87, 91, 95, 99, 109, 112, 113, 115, 116, 118, 124, 127, 134, 135, 136, 137, 147, 149, 151, 153, 157, 161, 162, 163, 164, 166, 168, 170, 172, 174, 177, 185, 188, 197, 200, 201, 203, 204, 206, 213, 214, 220, 221, 222, 224, 225, 226, 227, 229]	[2, 9, 17, 20, 24, 26, 28, 29, 30, 31, 32, 34, 35, 36, 42, 43, 51, 54, 57, 58, 69, 71, 74, 76, 77, 79, 80, 84, 87, 90, 94, 98, 108, 111, 113, 115, 116, 117, 123, 126, 134, 135, 136, 137, 146, 149, 151, 153, 157, 160, 162, 163, 164, 166, 167, 170, 172, 174, 177, 184, 187, 196, 199, 201, 203, 204, 205, 212, 214, 220, 221, 222, 224, 225, 226, 227, 229, 230]	['To', 'detect', 'changes', 'in', 'the', 'NADPH', ':', 'NADP+', 'ratio', ',', 'Cameron', 'et', 'al', '.', 'engineered', 'a', 'HomoFRET', 'biosensor', 'for', 'the', 'detection', 'of', 'NADP+', 'based', 'on', 'glucose-6-phosphate', 'dehydrogenase', '(', 'G6PD', ')', 'homodimerization', 'in', 'response', 'to', 'NADP+', 'levels', '(', 'Apollo-NADP', '+', ')86', '.']	[1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 4, 1, 1, 5, 5, 1, 3, 1, 5, 1, 1, 1, 4, 1, 1, 5, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, the CRISPR–Cas9 mediated deletion of KEAP1 in a mouse model of KRAS-driven lung adenocarcinoma to activate NRF2 resulted in a marked dependence on glutaminase activity115, signifying the influence of co-occurring mutations on the divergence of metabolic phenotypes among tumors grouped based on a given genetic alteration.	[('PMC5938018', 'R37000', 160, 171, 'glutaminase')]	['In', 'contrast', ',', 'the', 'CR', '##IS', '##PR', '–', 'C', '##as', '##9', 'mediated', 'del', '##eti', '##on', 'of', 'K', '##EA', '##P', '##1', 'in', 'a', 'mouse', 'model', 'of', 'K', '##RA', '##S', '-', 'driven', 'lung', 'ad', '##eno', '##car', '##cin', '##oma', 'to', 'activate', 'N', '##R', '##F', '##2', 'resulted', 'in', 'a', 'marked', 'dependence', 'on', 'g', '##lut', '##ami', '##nas', '##e', 'activity', '##11', '##5', ',', 'sign', '##ifying', 'the', 'influence', 'of', 'co', '-', 'occurring', 'mutations', 'on', 'the', 'diver', '##gence', 'of', 'metabolic', 'p', '##hen', '##otype', '##s', 'among', 'tumors', 'grouped', 'based', 'on', 'a', 'given', 'genetic', 'alter', '##ation', '.']	[0, 3, 11, 13, 17, 19, 21, 23, 24, 25, 27, 29, 38, 41, 44, 47, 50, 51, 53, 54, 56, 59, 61, 67, 73, 76, 77, 79, 80, 81, 88, 93, 95, 98, 101, 104, 108, 111, 120, 121, 122, 123, 125, 134, 137, 139, 146, 157, 160, 161, 164, 167, 170, 172, 180, 182, 183, 185, 189, 196, 200, 210, 213, 215, 216, 226, 236, 239, 243, 248, 254, 257, 267, 268, 271, 276, 278, 284, 291, 299, 305, 308, 310, 316, 324, 329, 334]	[2, 11, 12, 16, 19, 21, 23, 24, 25, 27, 28, 37, 41, 44, 46, 49, 51, 53, 54, 55, 58, 60, 66, 72, 75, 77, 79, 80, 81, 87, 92, 95, 98, 101, 104, 107, 110, 119, 121, 122, 123, 124, 133, 136, 138, 145, 156, 159, 161, 164, 167, 170, 171, 180, 182, 183, 184, 189, 195, 199, 209, 212, 215, 216, 225, 235, 238, 242, 248, 253, 256, 266, 268, 271, 276, 277, 283, 290, 298, 304, 307, 309, 315, 323, 329, 334, 335]	['In', 'contrast', ',', 'the', 'CRISPR', '–', 'Cas9', 'mediated', 'deletion', 'of', 'KEAP1', 'in', 'a', 'mouse', 'model', 'of', 'KRAS-driven', 'lung', 'adenocarcinoma', 'to', 'activate', 'NRF2', 'resulted', 'in', 'a', 'marked', 'dependence', 'on', 'glutaminase', 'activity115', ',', 'signifying', 'the', 'influence', 'of', 'co', '-', 'occurring', 'mutations', 'on', 'the', 'divergence', 'of', 'metabolic', 'phenotypes', 'among', 'tumors', 'grouped', 'based', 'on', 'a', 'given', 'genetic', 'alteration', '.']	[1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 4, 1, 1, 1, 1, 1, 5, 1, 5, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Enzyme-linked immunosorbent assay (ELISA) (IDEXX MAP ELISA Ab Test kit, Westbrood, Maine) on serum samples and real-time polymerase chain reaction (PCR) assay (rt-PCR) (VetMAX™-Gold MAP Detection Kit, Thermofisher scientific, Waltham, Massachusetts) on fecal samples were carried out by using commercial kits.	[]	['En', '##zy', '##me', '-', 'linked', 'im', '##mu', '##nos', '##or', '##bent', 'ass', '##ay', '(', 'E', '##L', '##IS', '##A', ')', '(', 'ID', '##EX', '##X', 'MA', '##P', 'E', '##L', '##IS', '##A', 'A', '##b', 'Test', 'kit', ',', 'West', '##bro', '##od', ',', 'Maine', ')', 'on', 'serum', 'samples', 'and', 'real', '-', 'time', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'ass', '##ay', '(', 'r', '##t', '-', 'PC', '##R', ')', '(', '[UNK]', '-', 'Gold', 'MA', '##P', 'Det', '##ec', '##tion', 'Kit', ',', 'The', '##rm', '##of', '##ish', '##er', 'scientific', ',', 'Walt', '##ham', ',', 'Massachusetts', ')', 'on', 'f', '##eca', '##l', 'samples', 'were', 'carried', 'out', 'by', 'using', 'commercial', 'kits', '.']	[0, 2, 4, 6, 7, 14, 16, 18, 21, 23, 28, 31, 34, 35, 36, 37, 39, 40, 42, 43, 45, 47, 49, 51, 53, 54, 55, 57, 59, 60, 62, 67, 70, 72, 76, 79, 81, 83, 88, 90, 93, 99, 107, 111, 115, 116, 121, 128, 132, 138, 147, 148, 150, 151, 153, 156, 159, 160, 161, 162, 163, 165, 166, 168, -1, 176, 177, 182, 184, 186, 189, 191, 196, 199, 201, 204, 206, 208, 211, 214, 224, 226, 230, 233, 235, 248, 250, 253, 254, 257, 259, 267, 272, 280, 284, 287, 293, 304, 308]	[2, 4, 6, 7, 13, 16, 18, 21, 23, 27, 31, 33, 35, 36, 37, 39, 40, 41, 43, 45, 47, 48, 51, 52, 54, 55, 57, 58, 60, 61, 66, 70, 71, 76, 79, 81, 82, 88, 89, 92, 98, 106, 110, 115, 116, 120, 128, 131, 137, 146, 148, 150, 151, 152, 156, 158, 160, 161, 162, 163, 165, 166, 167, 169, 4, 177, 181, 184, 185, 189, 191, 195, 199, 200, 204, 206, 208, 211, 213, 224, 225, 230, 233, 234, 248, 249, 252, 254, 257, 258, 266, 271, 279, 283, 286, 292, 303, 308, 309]	['Enzyme', '-', 'linked', 'immunosorbent', 'assay', '(', 'ELISA', ')', '(', 'IDEXX', 'MAP', 'ELISA', 'Ab', 'Test', 'kit', ',', 'Westbrood', ',', 'Maine', ')', 'on', 'serum', 'samples', 'and', 'real', '-', 'time', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'assay', '(', 'rt-PCR', ')', '(', 'VetMAX™-Gold', 'MAP', 'Detection', 'Kit', ',', 'Thermofisher', 'scientific', ',', 'Waltham', ',', 'Massachusetts', ')', 'on', 'fecal', 'samples', 'were', 'carried', 'out', 'by', 'using', 'commercial', 'kits', '.']	[3, 1, 1, 5, 2, 1, 4, 1, 1, 3, 2, 4, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 2, 1, 5, 1, 1, 3, 2, 3, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
With regard to phosphatidylcholine metabolites, lysophosphatidylcholines were decreased while their phospholipase D (PLD) metabolites, LPA and alkyl-acyl phosphatidic acid, were increased (Figure 4) suggesting that PtdC are extensively degraded and/or their synthesis is decreased with MAP infection.	[('PMC5946597', 'R02000', 100, 115, 'phospholipase D')]	['With', 'regard', 'to', 'p', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##line', 'meta', '##bol', '##ites', ',', 'l', '##ys', '##op', '##hos', '##pha', '##ti', '##dy', '##l', '##cho', '##lines', 'were', 'decreased', 'while', 'their', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'D', '(', 'P', '##LD', ')', 'meta', '##bol', '##ites', ',', 'LP', '##A', 'and', 'al', '##ky', '##l', '-', 'a', '##cy', '##l', 'p', '##hos', '##pha', '##ti', '##dic', 'acid', ',', 'were', 'increased', '(', 'Figure', '4', ')', 'suggesting', 'that', 'P', '##t', '##d', '##C', 'are', 'extensively', 'de', '##graded', 'and', '/', 'or', 'their', 'synthesis', 'is', 'decreased', 'with', 'MA', '##P', 'infection', '.']	[0, 5, 12, 15, 16, 19, 22, 24, 26, 27, 30, 35, 39, 42, 46, 48, 49, 51, 53, 56, 59, 61, 63, 64, 67, 73, 78, 88, 94, 100, 101, 104, 106, 109, 112, 114, 116, 117, 118, 120, 122, 126, 129, 133, 135, 137, 139, 143, 145, 147, 148, 149, 150, 152, 154, 155, 158, 161, 163, 167, 171, 173, 178, 188, 189, 196, 197, 199, 210, 215, 216, 217, 218, 220, 224, 236, 238, 245, 248, 249, 252, 258, 268, 271, 281, 286, 288, 290, 299]	[4, 11, 14, 16, 19, 22, 24, 26, 27, 30, 34, 39, 42, 46, 47, 49, 51, 53, 56, 59, 61, 63, 64, 67, 72, 77, 87, 93, 99, 101, 104, 106, 109, 112, 113, 115, 117, 118, 120, 121, 126, 129, 133, 134, 137, 138, 142, 145, 147, 148, 149, 150, 152, 153, 155, 158, 161, 163, 166, 171, 172, 177, 187, 189, 195, 197, 198, 209, 214, 216, 217, 218, 219, 223, 235, 238, 244, 248, 249, 251, 257, 267, 270, 280, 285, 288, 289, 299, 300]	['With', 'regard', 'to', 'phosphatidylcholine', 'metabolites', ',', 'lysophosphatidylcholines', 'were', 'decreased', 'while', 'their', 'phospholipase', 'D', '(', 'PLD', ')', 'metabolites', ',', 'LPA', 'and', 'alkyl', '-', 'acyl', 'phosphatidic', 'acid', ',', 'were', 'increased', '(', 'Figure', '4', ')', 'suggesting', 'that', 'PtdC', 'are', 'extensively', 'degraded', 'and', '/', 'or', 'their', 'synthesis', 'is', 'decreased', 'with', 'MAP', 'infection', '.']	[1, 1, 1, 8, 3, 1, 10, 1, 1, 1, 1, 6, 1, 1, 2, 1, 3, 1, 2, 1, 3, 1, 3, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
MADD, from the MAP kinase activating death domain, encodes a protein that interacts with tumor necrosis factor alpha receptor 1 and aids in apoptosis (37).	[]	['MA', '##D', '##D', ',', 'from', 'the', 'MA', '##P', 'kinase', 'act', '##ivating', 'death', 'domain', ',', 'en', '##codes', 'a', 'protein', 'that', 'interact', '##s', 'with', 'tumor', 'ne', '##c', '##rosis', 'factor', 'alpha', 'receptor', '1', 'and', 'aids', 'in', 'a', '##pop', '##tosis', '(', '37', ')', '.']	[0, 2, 3, 4, 6, 11, 15, 17, 19, 26, 29, 37, 43, 49, 51, 53, 59, 61, 69, 74, 82, 84, 89, 95, 97, 98, 104, 111, 117, 126, 128, 132, 137, 140, 141, 144, 150, 151, 153, 154]	[2, 3, 4, 5, 10, 14, 17, 18, 25, 29, 36, 42, 49, 50, 53, 58, 60, 68, 73, 82, 83, 88, 94, 97, 98, 103, 110, 116, 125, 127, 131, 136, 139, 141, 144, 149, 151, 153, 154, 155]	['MADD', ',', 'from', 'the', 'MAP', 'kinase', 'activating', 'death', 'domain', ',', 'encodes', 'a', 'protein', 'that', 'interacts', 'with', 'tumor', 'necrosis', 'factor', 'alpha', 'receptor', '1', 'and', 'aids', 'in', 'apoptosis', '(', '37', ')', '.']	[3, 1, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In light of evidence that antibodies against citrullinated protein and peptides (ACPA) precede the clinical onset of RA by several years, have high specificity for RA at over 95%24,25 and that we previously observed antibodies characteristic of RA, including citrullinated and uncitrullinated peptides of the RA autoantigens in individuals with periodontitis3, the ability of C.curtum to degrade arginine via the arginine deiminase pathway and to produce substantial amounts of citrulline is of particular interest.	[]	['In', 'light', 'of', 'evidence', 'that', 'antibodies', 'against', 'c', '##it', '##ru', '##llin', '##ated', 'protein', 'and', 'p', '##eptide', '##s', '(', 'AC', '##PA', ')', 'pre', '##cede', 'the', 'clinical', 'onset', 'of', 'RA', 'by', 'several', 'years', ',', 'have', 'high', 'specific', '##ity', 'for', 'RA', 'at', 'over', '95', '%', '24', ',', '25', 'and', 'that', 'we', 'previously', 'observed', 'antibodies', 'characteristic', 'of', 'RA', ',', 'including', 'c', '##it', '##ru', '##llin', '##ated', 'and', 'un', '##ci', '##tr', '##ull', '##inated', 'p', '##eptide', '##s', 'of', 'the', 'RA', 'auto', '##anti', '##gens', 'in', 'individuals', 'with', 'period', '##ont', '##itis', '##3', ',', 'the', 'ability', 'of', 'C', '.', 'cu', '##rt', '##um', 'to', 'de', '##grade', 'a', '##rg', '##ini', '##ne', 'via', 'the', 'a', '##rg', '##ini', '##ne', 'dei', '##mina', '##se', 'pathway', 'and', 'to', 'produce', 'substantial', 'amounts', 'of', 'c', '##it', '##ru', '##llin', '##e', 'is', 'of', 'particular', 'interest', '.']	[0, 3, 9, 12, 21, 26, 37, 45, 46, 48, 50, 54, 59, 67, 71, 72, 78, 80, 81, 83, 85, 87, 90, 95, 99, 108, 114, 117, 120, 123, 131, 136, 138, 143, 148, 156, 160, 164, 167, 170, 175, 177, 178, 180, 181, 184, 188, 193, 196, 207, 216, 227, 242, 245, 247, 249, 259, 260, 262, 264, 268, 273, 277, 279, 281, 283, 286, 293, 294, 300, 302, 305, 309, 312, 316, 320, 325, 328, 340, 345, 351, 354, 358, 359, 361, 365, 373, 376, 377, 378, 380, 382, 385, 388, 390, 396, 397, 399, 402, 405, 409, 413, 414, 416, 419, 422, 425, 429, 432, 440, 444, 447, 455, 467, 475, 478, 479, 481, 483, 487, 489, 492, 495, 506, 514]	[2, 8, 11, 20, 25, 36, 44, 46, 48, 50, 54, 58, 66, 70, 72, 78, 79, 81, 83, 85, 86, 90, 94, 98, 107, 113, 116, 119, 122, 130, 136, 137, 142, 147, 156, 159, 163, 166, 169, 174, 177, 178, 180, 181, 183, 187, 192, 195, 206, 215, 226, 241, 244, 247, 248, 258, 260, 262, 264, 268, 272, 276, 279, 281, 283, 286, 292, 294, 300, 301, 304, 308, 311, 316, 320, 324, 327, 339, 344, 351, 354, 358, 359, 360, 364, 372, 375, 377, 378, 380, 382, 384, 387, 390, 395, 397, 399, 402, 404, 408, 412, 414, 416, 419, 421, 425, 429, 431, 439, 443, 446, 454, 466, 474, 477, 479, 481, 483, 487, 488, 491, 494, 505, 514, 515]	['In', 'light', 'of', 'evidence', 'that', 'antibodies', 'against', 'citrullinated', 'protein', 'and', 'peptides', '(', 'ACPA', ')', 'precede', 'the', 'clinical', 'onset', 'of', 'RA', 'by', 'several', 'years', ',', 'have', 'high', 'specificity', 'for', 'RA', 'at', 'over', '95%24', ',', '25', 'and', 'that', 'we', 'previously', 'observed', 'antibodies', 'characteristic', 'of', 'RA', ',', 'including', 'citrullinated', 'and', 'uncitrullinated', 'peptides', 'of', 'the', 'RA', 'autoantigens', 'in', 'individuals', 'with', 'periodontitis3', ',', 'the', 'ability', 'of', 'C.curtum', 'to', 'degrade', 'arginine', 'via', 'the', 'arginine', 'deiminase', 'pathway', 'and', 'to', 'produce', 'substantial', 'amounts', 'of', 'citrulline', 'is', 'of', 'particular', 'interest', '.']	[1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 5, 1, 2, 4, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition to karyotypically examining aneuploidy of chromosomes in cancer cells, iFISH is also uniquely capable of qualitatively and quantitatively co-detecting multiple tumor biomarkers’ expression and cytogenetic gene rearrangement, such as anaplastic lymphoma kinase (ALK) gene [66] in adenocarcinomic non-small cell lung cancer (NSCLC) cells, as shown in Figure 3 (ALK-iFISH, Cytelligen, San Diego, CA, USA).	[('PMC6023477', 'R14000', 245, 271, 'anaplastic lymphoma kinase')]	['In', 'addition', 'to', 'ka', '##ryo', '##ty', '##pical', '##ly', 'examining', 'an', '##eu', '##p', '##lo', '##idy', 'of', 'chromosome', '##s', 'in', 'cancer', 'cells', ',', 'i', '##FI', '##S', '##H', 'is', 'also', 'uniquely', 'capable', 'of', 'q', '##ual', '##itative', '##ly', 'and', 'quantitative', '##ly', 'co', '-', 'detect', '##ing', 'multiple', 'tumor', 'bio', '##mark', '##ers', '’', 'expression', 'and', 'c', '##yt', '##ogen', '##etic', 'gene', 'rear', '##rang', '##ement', ',', 'such', 'as', 'an', '##ap', '##lastic', 'l', '##ymph', '##oma', 'kinase', '(', 'AL', '##K', ')', 'gene', '[', '66', ']', 'in', 'ad', '##eno', '##car', '##cin', '##omi', '##c', 'non', '-', 'small', 'cell', 'lung', 'cancer', '(', 'N', '##SC', '##LC', ')', 'cells', ',', 'as', 'shown', 'in', 'Figure', '3', '(', 'AL', '##K', '-', 'i', '##FI', '##S', '##H', ',', 'Cy', '##tel', '##li', '##gen', ',', 'San', 'Diego', ',', 'CA', ',', 'USA', ')', '.']	[0, 3, 12, 15, 17, 20, 22, 27, 30, 40, 42, 44, 45, 47, 51, 54, 64, 66, 69, 76, 81, 83, 84, 86, 87, 89, 92, 97, 106, 114, 117, 118, 121, 128, 131, 135, 147, 150, 152, 153, 159, 163, 172, 178, 181, 185, 188, 190, 201, 205, 206, 208, 212, 217, 222, 226, 230, 235, 237, 242, 245, 247, 249, 256, 257, 261, 265, 272, 273, 275, 276, 278, 283, 284, 286, 288, 291, 293, 296, 299, 302, 305, 307, 310, 311, 317, 322, 327, 334, 335, 336, 338, 340, 342, 347, 349, 352, 358, 361, 368, 370, 371, 373, 374, 375, 376, 378, 379, 380, 382, 384, 387, 389, 392, 394, 398, 403, 405, 407, 409, 412, 413]	[2, 11, 14, 17, 20, 22, 27, 29, 39, 42, 44, 45, 47, 50, 53, 64, 65, 68, 75, 81, 82, 84, 86, 87, 88, 91, 96, 105, 113, 116, 118, 121, 128, 130, 134, 147, 149, 152, 153, 159, 162, 171, 177, 181, 185, 188, 189, 200, 204, 206, 208, 212, 216, 221, 226, 230, 235, 236, 241, 244, 247, 249, 255, 257, 261, 264, 271, 273, 275, 276, 277, 282, 284, 286, 287, 290, 293, 296, 299, 302, 305, 306, 310, 311, 316, 321, 326, 333, 335, 336, 338, 340, 341, 347, 348, 351, 357, 360, 367, 369, 371, 373, 374, 375, 376, 378, 379, 380, 381, 384, 387, 389, 392, 393, 397, 403, 404, 407, 408, 412, 413, 414]	['In', 'addition', 'to', 'karyotypically', 'examining', 'aneuploidy', 'of', 'chromosomes', 'in', 'cancer', 'cells', ',', 'iFISH', 'is', 'also', 'uniquely', 'capable', 'of', 'qualitatively', 'and', 'quantitatively', 'co', '-', 'detecting', 'multiple', 'tumor', 'biomarkers', '’', 'expression', 'and', 'cytogenetic', 'gene', 'rearrangement', ',', 'such', 'as', 'anaplastic', 'lymphoma', 'kinase', '(', 'ALK', ')', 'gene', '[', '66', ']', 'in', 'adenocarcinomic', 'non', '-', 'small', 'cell', 'lung', 'cancer', '(', 'NSCLC', ')', 'cells', ',', 'as', 'shown', 'in', 'Figure', '3', '(', 'ALK-iFISH', ',', 'Cytelligen', ',', 'San', 'Diego', ',', 'CA', ',', 'USA', ')', '.']	[1, 1, 1, 5, 1, 5, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 1, 4, 1, 3, 1, 1, 1, 3, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cancer cells secrete various factors including matrix metalloproteinases, which degrade the basal lamina, releasing tumor cells.	[('PMC6031810', 'I01000', 47, 72, 'matrix metalloproteinases')]	['Cancer', 'cells', 'secret', '##e', 'various', 'factors', 'including', 'matrix', 'metal', '##lop', '##rote', '##inas', '##es', ',', 'which', 'de', '##grade', 'the', 'basal', 'la', '##mina', ',', 'releasing', 'tumor', 'cells', '.']	[0, 7, 13, 19, 21, 29, 37, 47, 54, 59, 62, 66, 70, 72, 74, 80, 82, 88, 92, 98, 100, 104, 106, 116, 122, 127]	[6, 12, 19, 20, 28, 36, 46, 53, 59, 62, 66, 70, 72, 73, 79, 82, 87, 91, 97, 100, 104, 105, 115, 121, 127, 128]	['Cancer', 'cells', 'secrete', 'various', 'factors', 'including', 'matrix', 'metalloproteinases', ',', 'which', 'degrade', 'the', 'basal', 'lamina', ',', 'releasing', 'tumor', 'cells', '.']	[1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus, different metabolic processes, potentially the immunoregulation by indoleamine 2,3 dioxygenase-1 (IDO), which is involved in cancer development and progression supporting inflammatory processes in the tumor microenvironment and glutaminolysis, can serve as novel promising therapeutic targets in MM.	[]	['Thus', ',', 'different', 'metabolic', 'processes', ',', 'potentially', 'the', 'im', '##mu', '##nor', '##eg', '##ulation', 'by', 'in', '##do', '##leam', '##ine', '2', ',', '3', 'di', '##ox', '##y', '##gen', '##ase', '-', '1', '(', 'ID', '##O', ')', ',', 'which', 'is', 'involved', 'in', 'cancer', 'development', 'and', 'progression', 'supporting', 'inflammatory', 'processes', 'in', 'the', 'tumor', 'micro', '##en', '##vir', '##on', '##ment', 'and', 'g', '##lut', '##ami', '##no', '##lysis', ',', 'can', 'serve', 'as', 'novel', 'promising', 'therapeutic', 'targets', 'in', 'M', '##M', '.']	[0, 4, 6, 16, 26, 35, 37, 49, 53, 55, 57, 60, 62, 70, 73, 75, 77, 81, 85, 86, 87, 89, 91, 93, 94, 97, 100, 101, 103, 104, 106, 107, 108, 110, 116, 119, 128, 131, 138, 150, 154, 166, 177, 190, 200, 203, 207, 213, 218, 220, 223, 225, 230, 234, 235, 238, 241, 243, 248, 250, 254, 260, 263, 269, 279, 291, 299, 302, 303, 304]	[4, 5, 15, 25, 35, 36, 48, 52, 55, 57, 60, 62, 69, 72, 75, 77, 81, 84, 86, 87, 88, 91, 93, 94, 97, 100, 101, 102, 104, 106, 107, 108, 109, 115, 118, 127, 130, 137, 149, 153, 165, 176, 189, 199, 202, 206, 212, 218, 220, 223, 225, 229, 233, 235, 238, 241, 243, 248, 249, 253, 259, 262, 268, 278, 290, 298, 301, 303, 304, 305]	['Thus', ',', 'different', 'metabolic', 'processes', ',', 'potentially', 'the', 'immunoregulation', 'by', 'indoleamine', '2', ',', '3', 'dioxygenase-1', '(', 'IDO', ')', ',', 'which', 'is', 'involved', 'in', 'cancer', 'development', 'and', 'progression', 'supporting', 'inflammatory', 'processes', 'in', 'the', 'tumor', 'microenvironment', 'and', 'glutaminolysis', ',', 'can', 'serve', 'as', 'novel', 'promising', 'therapeutic', 'targets', 'in', 'MM', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 4, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Asymmetric dimethylarginine (ADMA), which was enriched in healthy controls, is an endogenous inhibitor of nitric oxide synthase (NOS) and is derived from methylation of arginine residues in proteins.	[('PMC6086450', 'D05000', 106, 127, 'nitric oxide synthase')]	['As', '##ym', '##metric', 'dim', '##eth', '##yla', '##rg', '##ini', '##ne', '(', 'AD', '##MA', ')', ',', 'which', 'was', 'en', '##rich', '##ed', 'in', 'healthy', 'controls', ',', 'is', 'an', 'end', '##ogen', '##ous', 'inhibitor', 'of', 'ni', '##tric', 'oxide', 's', '##ynth', '##ase', '(', 'NO', '##S', ')', 'and', 'is', 'derived', 'from', 'met', '##hyl', '##ation', 'of', 'a', '##rg', '##ini', '##ne', 'residues', 'in', 'proteins', '.']	[0, 2, 4, 11, 14, 17, 20, 22, 25, 28, 29, 31, 33, 34, 36, 42, 46, 48, 52, 55, 58, 66, 74, 76, 79, 82, 85, 89, 93, 103, 106, 108, 113, 119, 120, 124, 128, 129, 131, 132, 134, 138, 141, 149, 154, 157, 160, 166, 169, 170, 172, 175, 178, 187, 190, 198]	[2, 4, 10, 14, 17, 20, 22, 25, 27, 29, 31, 33, 34, 35, 41, 45, 48, 52, 54, 57, 65, 74, 75, 78, 81, 85, 89, 92, 102, 105, 108, 112, 118, 120, 124, 127, 129, 131, 132, 133, 137, 140, 148, 153, 157, 160, 165, 168, 170, 172, 175, 177, 186, 189, 198, 199]	['Asymmetric', 'dimethylarginine', '(', 'ADMA', ')', ',', 'which', 'was', 'enriched', 'in', 'healthy', 'controls', ',', 'is', 'an', 'endogenous', 'inhibitor', 'of', 'nitric', 'oxide', 'synthase', '(', 'NOS', ')', 'and', 'is', 'derived', 'from', 'methylation', 'of', 'arginine', 'residues', 'in', 'proteins', '.']	[3, 6, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The activation of the kynurenine pathway occurs when the activity of indoleamine 2,3 dioxygenase-1 (IDO1), which catalyzes the conversion of tryptophan to kynurenine, is increased [14, 15].	[('PMC6086450', 'R06000', 69, 98, 'indoleamine 2,3 dioxygenase-1')]	['The', 'activation', 'of', 'the', 'k', '##yn', '##uren', '##ine', 'pathway', 'occurs', 'when', 'the', 'activity', 'of', 'in', '##do', '##leam', '##ine', '2', ',', '3', 'di', '##ox', '##y', '##gen', '##ase', '-', '1', '(', 'ID', '##O', '##1', ')', ',', 'which', 'cat', '##aly', '##zes', 'the', 'conversion', 'of', 'try', '##pt', '##op', '##han', 'to', 'k', '##yn', '##uren', '##ine', ',', 'is', 'increased', '[', '14', ',', '15', ']', '.']	[0, 4, 15, 18, 22, 23, 25, 29, 33, 41, 48, 53, 57, 66, 69, 71, 73, 77, 81, 82, 83, 85, 87, 89, 90, 93, 96, 97, 99, 100, 102, 103, 104, 105, 107, 113, 116, 119, 123, 127, 138, 141, 144, 146, 148, 152, 155, 156, 158, 162, 165, 167, 170, 180, 181, 183, 185, 187, 188]	[3, 14, 17, 21, 23, 25, 29, 32, 40, 47, 52, 56, 65, 68, 71, 73, 77, 80, 82, 83, 84, 87, 89, 90, 93, 96, 97, 98, 100, 102, 103, 104, 105, 106, 112, 116, 119, 122, 126, 137, 140, 144, 146, 148, 151, 154, 156, 158, 162, 165, 166, 169, 179, 181, 183, 184, 187, 188, 189]	['The', 'activation', 'of', 'the', 'kynurenine', 'pathway', 'occurs', 'when', 'the', 'activity', 'of', 'indoleamine', '2', ',', '3', 'dioxygenase-1', '(', 'IDO1', ')', ',', 'which', 'catalyzes', 'the', 'conversion', 'of', 'tryptophan', 'to', 'kynurenine', ',', 'is', 'increased', '[', '14', ',', '15', ']', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 7, 1, 3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clinical and biochemical indices were determined for each patient, including the following: (1) liver and kidney function, including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transpeptidase (GGT), total bilirubin (TBIL), direct bilirubin (DBIL), albumin (ALB), globulin (GLB), creatinine (Cr), blood urea nitrogen (BUN) and uric acid (UA); (2) lipid profiles, including triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL); (3) clotting function, including the prothrombin time (PT); and (4) virological indicators, including hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), hepatitis Be antigen (HBeAg), hepatitis Be antibody (HBeAb), hepatitis B core antibody (HBcAb) and the HBV-DNA titers were determined for each patient.	[('PMC6092577', 'M02000', 139, 163, 'alanine aminotransferase')]	['Clinical', 'and', 'bio', '##chemical', 'in', '##dices', 'were', 'determined', 'for', 'each', 'patient', ',', 'including', 'the', 'following', ':', '(', '1', ')', 'liver', 'and', 'kidney', 'function', ',', 'including', 'serum', 'al', '##ani', '##ne', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AL', '##T', ')', ',', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'al', '##kal', '##ine', 'p', '##hos', '##pha', '##tase', '(', 'AL', '##P', ')', ',', 'γ', '-', 'g', '##lut', '##am', '##yl', 'trans', '##pe', '##pt', '##idas', '##e', '(', 'G', '##G', '##T', ')', ',', 'total', 'bi', '##li', '##ru', '##bin', '(', 'T', '##BI', '##L', ')', ',', 'direct', 'bi', '##li', '##ru', '##bin', '(', 'DB', '##IL', ')', ',', 'album', '##in', '(', 'AL', '##B', ')', ',', 'g', '##lo', '##bul', '##in', '(', 'G', '##L', '##B', ')', ',', 'c', '##rea', '##tin', '##ine', '(', 'C', '##r', ')', ',', 'blood', 'u', '##rea', 'nitrogen', '(', 'B', '##UN', ')', 'and', 'u', '##ric', 'acid', '(', 'U', '##A', ')', ';', '(', '2', ')', 'lip', '##id', 'profiles', ',', 'including', 't', '##rig', '##ly', '##cer', '##ides', '(', 'T', '##G', ')', ',', 'total', 'ch', '##ole', '##ster', '##ol', '(', 'T', '##C', ')', ',', 'high', '-', 'density', 'lip', '##op', '##rote', '##in', '(', 'HD', '##L', ')', 'and', 'low', '-', 'density', 'lip', '##op', '##rote', '##in', '(', 'L', '##D', '##L', ')', ';', '(', '3', ')', 'c', '##lot', '##ting', 'function', ',', 'including', 'the', 'pro', '##th', '##rom', '##bin', 'time', '(', 'PT', ')', ';', 'and', '(', '4', ')', 'v', '##iro', '##logical', 'indicators', ',', 'including', 'he', '##pa', '##titis', 'B', 'surface', 'anti', '##gen', '(', 'H', '##B', '##s', '##A', '##g', ')', ',', 'he', '##pa', '##titis', 'B', 'surface', 'anti', '##body', '(', 'H', '##B', '##s', '##A']	[0, 9, 13, 16, 25, 27, 33, 38, 49, 53, 58, 65, 67, 77, 81, 90, 92, 93, 94, 96, 102, 106, 113, 121, 123, 133, 139, 141, 144, 147, 152, 155, 157, 160, 164, 165, 167, 168, 169, 171, 173, 176, 181, 186, 189, 191, 194, 198, 199, 201, 202, 203, 205, 207, 210, 214, 215, 218, 221, 226, 227, 229, 230, 231, 233, 234, 235, 236, 239, 241, 244, 249, 251, 253, 257, 259, 260, 261, 262, 263, 264, 266, 272, 274, 276, 278, 282, 283, 284, 286, 287, 288, 290, 297, 299, 301, 303, 307, 308, 310, 312, 313, 315, 320, 323, 324, 326, 327, 328, 330, 331, 333, 336, 339, 340, 341, 342, 343, 344, 346, 347, 350, 353, 357, 358, 359, 360, 361, 363, 369, 370, 374, 383, 384, 385, 387, 389, 393, 394, 398, 403, 404, 405, 406, 407, 409, 410, 411, 413, 416, 419, 427, 429, 439, 440, 443, 445, 448, 453, 454, 455, 456, 457, 459, 465, 467, 470, 474, 477, 478, 479, 480, 481, 483, 487, 488, 496, 499, 501, 505, 508, 509, 511, 512, 514, 518, 521, 522, 530, 533, 535, 539, 542, 543, 544, 545, 546, 547, 549, 550, 551, 553, 554, 557, 562, 570, 572, 582, 586, 589, 591, 594, 598, 603, 604, 606, 607, 609, 613, 614, 615, 617, 618, 621, 629, 639, 641, 651, 653, 655, 661, 663, 671, 675, 679, 680, 681, 682, 683, 684, 685, 686, 688, 690, 692, 698, 700, 769, 773, 778, 779, 780, 795, 835]	[8, 12, 16, 24, 27, 32, 37, 48, 52, 57, 65, 66, 76, 80, 90, 91, 93, 94, 95, 101, 105, 112, 121, 122, 132, 138, 141, 144, 146, 152, 155, 157, 160, 163, 165, 167, 168, 169, 170, 173, 176, 180, 186, 189, 191, 194, 197, 199, 201, 202, 203, 204, 207, 210, 213, 215, 218, 221, 225, 227, 229, 230, 231, 232, 234, 235, 236, 239, 241, 243, 249, 251, 253, 257, 258, 260, 261, 262, 263, 264, 265, 271, 274, 276, 278, 281, 283, 284, 286, 287, 288, 289, 296, 299, 301, 303, 306, 308, 310, 312, 313, 314, 320, 322, 324, 326, 327, 328, 329, 331, 333, 336, 338, 340, 341, 342, 343, 344, 345, 347, 350, 353, 356, 358, 359, 360, 361, 362, 368, 370, 373, 382, 384, 385, 387, 388, 392, 394, 397, 402, 404, 405, 406, 407, 408, 410, 411, 412, 416, 418, 427, 428, 438, 440, 443, 445, 448, 452, 454, 455, 456, 457, 458, 464, 467, 470, 474, 476, 478, 479, 480, 481, 482, 487, 488, 495, 499, 501, 505, 507, 509, 511, 512, 513, 517, 521, 522, 529, 533, 535, 539, 541, 543, 544, 545, 546, 547, 548, 550, 551, 552, 554, 557, 561, 570, 571, 581, 585, 589, 591, 594, 597, 602, 604, 606, 607, 608, 612, 614, 615, 616, 618, 621, 628, 639, 640, 650, 653, 655, 660, 662, 670, 675, 678, 680, 681, 682, 683, 684, 685, 686, 687, 690, 692, 697, 699, 707, 773, 777, 779, 780, 781, 796, 836]	['Clinical', 'and', 'biochemical', 'indices', 'were', 'determined', 'for', 'each', 'patient', ',', 'including', 'the', 'following', ':', '(', '1', ')', 'liver', 'and', 'kidney', 'function', ',', 'including', 'serum', 'alanine', 'aminotransferase', '(', 'ALT', ')', ',', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'alkaline', 'phosphatase', '(', 'ALP', ')', ',', 'γ-glutamyl', 'transpeptidase', '(', 'GGT', ')', ',', 'total', 'bilirubin', '(', 'TBIL', ')', ',', 'direct', 'bilirubin', '(', 'DBIL', ')', ',', 'albumin', '(', 'ALB', ')', ',', 'globulin', '(', 'GLB', ')', ',', 'creatinine', '(', 'Cr', ')', ',', 'blood', 'urea', 'nitrogen', '(', 'BUN', ')', 'and', 'uric', 'acid', '(', 'UA', ')', ';', '(', '2', ')', 'lipid', 'profiles', ',', 'including', 'triglycerides', '(', 'TG', ')', ',', 'total', 'cholesterol', '(', 'TC', ')', ',', 'high', '-', 'density', 'lipoprotein', '(', 'HDL', ')', 'and', 'low', '-', 'density', 'lipoprotein', '(', 'LDL', ')', ';', '(', '3', ')', 'clotting', 'function', ',', 'including', 'the', 'prothrombin', 'time', '(', 'PT', ')', ';', 'and', '(', '4', ')', 'virological', 'indicators', ',', 'including', 'hepatitis', 'B', 'surface', 'antigen', '(', 'HBsAg', ')', ',', 'hepatitis', 'B', 'surface', 'antibody', '(']	[1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 5, 1, 2, 1, 1, 3, 5, 1, 2, 1, 1, 3, 4, 1, 2, 1, 1, 6, 5, 1, 3, 1, 1, 1, 4, 1, 3, 1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 2, 1, 1, 4, 1, 3, 1, 1, 4, 1, 2, 1, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 2, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 2, 1, 5, 1, 1, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The multi-step analysis unveiled five new proteins most predictive of water T2: hepatocyte growth factor, receptor tyrosine kinase FLT3, bone sialoprotein 2, glucokinase regulatory protein and endothelial cell-specific molecule 1.	[('PMC6142358', 'A02000', 115, 130, 'tyrosine kinase')]	['The', 'multi', '-', 'step', 'analysis', 'unveiled', 'five', 'new', 'proteins', 'most', 'predict', '##ive', 'of', 'water', 'T', '##2', ':', 'he', '##pa', '##to', '##cy', '##te', 'growth', 'factor', ',', 'receptor', 't', '##yr', '##os', '##ine', 'kinase', 'FL', '##T', '##3', ',', 'bone', 'si', '##alo', '##p', '##rote', '##in', '2', ',', 'g', '##lu', '##co', '##kin', '##ase', 'regulatory', 'protein', 'and', 'end', '##oth', '##eli', '##al', 'cell', '-', 'specific', 'molecule', '1', '.']	[0, 4, 9, 10, 15, 24, 33, 38, 42, 51, 56, 63, 67, 70, 76, 77, 78, 80, 82, 84, 86, 88, 91, 98, 104, 106, 115, 116, 118, 120, 124, 131, 133, 134, 135, 137, 142, 144, 147, 148, 152, 155, 156, 158, 159, 161, 163, 166, 170, 181, 189, 193, 196, 199, 202, 205, 209, 210, 219, 228, 229]	[3, 9, 10, 14, 23, 32, 37, 41, 50, 55, 63, 66, 69, 75, 77, 78, 79, 82, 84, 86, 88, 90, 97, 104, 105, 114, 116, 118, 120, 123, 130, 133, 134, 135, 136, 141, 144, 147, 148, 152, 154, 156, 157, 159, 161, 163, 166, 169, 180, 188, 192, 196, 199, 202, 204, 209, 210, 218, 227, 229, 230]	['The', 'multi', '-', 'step', 'analysis', 'unveiled', 'five', 'new', 'proteins', 'most', 'predictive', 'of', 'water', 'T2', ':', 'hepatocyte', 'growth', 'factor', ',', 'receptor', 'tyrosine', 'kinase', 'FLT3', ',', 'bone', 'sialoprotein', '2', ',', 'glucokinase', 'regulatory', 'protein', 'and', 'endothelial', 'cell', '-', 'specific', 'molecule', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 5, 1, 1, 1, 1, 4, 1, 3, 1, 1, 5, 1, 1, 5, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Three proteins were most predictive of plasma water T2: hepatocyte growth factor, receptor tyrosine kinase FLT3 (fms-like tyrosine kinase 3) and bone sialoprotein 2.	[('PMC6142358', 'D01000', 91, 106, 'tyrosine kinase')]	['Three', 'proteins', 'were', 'most', 'predict', '##ive', 'of', 'plasma', 'water', 'T', '##2', ':', 'he', '##pa', '##to', '##cy', '##te', 'growth', 'factor', ',', 'receptor', 't', '##yr', '##os', '##ine', 'kinase', 'FL', '##T', '##3', '(', 'f', '##ms', '-', 'like', 't', '##yr', '##os', '##ine', 'kinase', '3', ')', 'and', 'bone', 'si', '##alo', '##p', '##rote', '##in', '2', '.']	[0, 6, 15, 20, 25, 32, 36, 39, 46, 52, 53, 54, 56, 58, 60, 62, 64, 67, 74, 80, 82, 91, 92, 94, 96, 100, 107, 109, 110, 112, 113, 114, 116, 117, 122, 123, 125, 127, 131, 138, 139, 141, 145, 150, 152, 155, 156, 160, 163, 164]	[5, 14, 19, 24, 32, 35, 38, 45, 51, 53, 54, 55, 58, 60, 62, 64, 66, 73, 80, 81, 90, 92, 94, 96, 99, 106, 109, 110, 111, 113, 114, 116, 117, 121, 123, 125, 127, 130, 137, 139, 140, 144, 149, 152, 155, 156, 160, 162, 164, 165]	['Three', 'proteins', 'were', 'most', 'predictive', 'of', 'plasma', 'water', 'T2', ':', 'hepatocyte', 'growth', 'factor', ',', 'receptor', 'tyrosine', 'kinase', 'FLT3', '(', 'fms', '-', 'like', 'tyrosine', 'kinase', '3', ')', 'and', 'bone', 'sialoprotein', '2', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 4, 1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The hepatic growth factor receptor, also known as MET, is part of a tyrosine kinase signaling complex that functions in cell growth and survival, angiogenesis and tissue regeneration	[('PMC6142358', 'D03000', 68, 83, 'tyrosine kinase')]	['The', 'he', '##pa', '##tic', 'growth', 'factor', 'receptor', ',', 'also', 'known', 'as', 'ME', '##T', ',', 'is', 'part', 'of', 'a', 't', '##yr', '##os', '##ine', 'kinase', 'signaling', 'complex', 'that', 'functions', 'in', 'cell', 'growth', 'and', 'survival', ',', 'an', '##gio', '##genesis', 'and', 'tissue', 'regeneration']	[0, 4, 6, 8, 12, 19, 26, 34, 36, 41, 47, 50, 52, 53, 55, 58, 63, 66, 68, 69, 71, 73, 77, 84, 94, 102, 107, 117, 120, 125, 132, 136, 144, 146, 148, 151, 159, 163, 170]	[3, 6, 8, 11, 18, 25, 34, 35, 40, 46, 49, 52, 53, 54, 57, 62, 65, 67, 69, 71, 73, 76, 83, 93, 101, 106, 116, 119, 124, 131, 135, 144, 145, 148, 151, 158, 162, 169, 182]	['The', 'hepatic', 'growth', 'factor', 'receptor', ',', 'also', 'known', 'as', 'MET', ',', 'is', 'part', 'of', 'a', 'tyrosine', 'kinase', 'signaling', 'complex', 'that', 'functions', 'in', 'cell', 'growth', 'and', 'survival', ',', 'angiogenesis', 'and', 'tissue', 'regeneration']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The CART regression tree analysis for serum water T2 yielded two biomarkers: endothelial cell specific molecule 1 and glucokinase regulatory protein (GKRP).	[('PMC6142358', 'D08000', 118, 129, 'glucokinase')]	['The', 'CA', '##RT', 're', '##gression', 'tree', 'analysis', 'for', 'serum', 'water', 'T', '##2', 'yielded', 'two', 'bio', '##mark', '##ers', ':', 'end', '##oth', '##eli', '##al', 'cell', 'specific', 'molecule', '1', 'and', 'g', '##lu', '##co', '##kin', '##ase', 'regulatory', 'protein', '(', 'G', '##K', '##RP', ')', '.']	[0, 4, 6, 9, 11, 20, 25, 34, 38, 44, 50, 51, 53, 61, 65, 68, 72, 75, 77, 80, 83, 86, 89, 94, 103, 112, 114, 118, 119, 121, 123, 126, 130, 141, 149, 150, 151, 152, 154, 155]	[3, 6, 8, 11, 19, 24, 33, 37, 43, 49, 51, 52, 60, 64, 68, 72, 75, 76, 80, 83, 86, 88, 93, 102, 111, 113, 117, 119, 121, 123, 126, 129, 140, 148, 150, 151, 152, 154, 155, 156]	['The', 'CART', 'regression', 'tree', 'analysis', 'for', 'serum', 'water', 'T2', 'yielded', 'two', 'biomarkers', ':', 'endothelial', 'cell', 'specific', 'molecule', '1', 'and', 'glucokinase', 'regulatory', 'protein', '(', 'GKRP', ')', '.']	[1, 2, 2, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Glucokinase regulatory protein is a well-known inhibitor of glucokinase and a key regulator of liver glucose uptake and metabolism [62–65].	[('PMC6142358', 'D09000', 0, 11, 'Glucokinase')]	['G', '##lu', '##co', '##kin', '##ase', 'regulatory', 'protein', 'is', 'a', 'well', '-', 'known', 'inhibitor', 'of', 'g', '##lu', '##co', '##kin', '##ase', 'and', 'a', 'key', 'regulator', 'of', 'liver', 'glucose', 'up', '##take', 'and', 'metabolism', '[', '62', '–', '65', ']', '.']	[0, 1, 3, 5, 8, 12, 23, 31, 34, 36, 40, 41, 47, 57, 60, 61, 63, 65, 68, 72, 76, 78, 82, 92, 95, 101, 109, 111, 116, 120, 131, 132, 134, 135, 137, 138]	[1, 3, 5, 8, 11, 22, 30, 33, 35, 40, 41, 46, 56, 59, 61, 63, 65, 68, 71, 75, 77, 81, 91, 94, 100, 108, 111, 115, 119, 130, 132, 134, 135, 137, 138, 139]	['Glucokinase', 'regulatory', 'protein', 'is', 'a', 'well', '-', 'known', 'inhibitor', 'of', 'glucokinase', 'and', 'a', 'key', 'regulator', 'of', 'liver', 'glucose', 'uptake', 'and', 'metabolism', '[', '62–', '65', ']', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
As revealed by CART analysis, the final regression tree for plasma water T2 included three biomarkers: hepatocyte growth factor receptor, receptor tyrosine kinase FLT3 (fms-like tyrosine kinase 3), and bone sialoprotein 2 (Fig. 3).	[('PMC6142358', 'R04000', 147, 162, 'tyrosine kinase')]	['As', 'revealed', 'by', 'CA', '##RT', 'analysis', ',', 'the', 'final', 're', '##gression', 'tree', 'for', 'plasma', 'water', 'T', '##2', 'included', 'three', 'bio', '##mark', '##ers', ':', 'he', '##pa', '##to', '##cy', '##te', 'growth', 'factor', 'receptor', ',', 'receptor', 't', '##yr', '##os', '##ine', 'kinase', 'FL', '##T', '##3', '(', 'f', '##ms', '-', 'like', 't', '##yr', '##os', '##ine', 'kinase', '3', ')', ',', 'and', 'bone', 'si', '##alo', '##p', '##rote', '##in', '2', '(', 'Fi', '##g', '.', '3', ')', '.']	[0, 3, 12, 15, 17, 20, 28, 30, 34, 40, 42, 51, 56, 60, 67, 73, 74, 76, 85, 91, 94, 98, 101, 103, 105, 107, 109, 111, 114, 121, 128, 136, 138, 147, 148, 150, 152, 156, 163, 165, 166, 168, 169, 170, 172, 173, 178, 179, 181, 183, 187, 194, 195, 196, 198, 202, 207, 209, 212, 213, 217, 220, 222, 223, 225, 226, 228, 229, 230]	[2, 11, 14, 17, 19, 28, 29, 33, 39, 42, 50, 55, 59, 66, 72, 74, 75, 84, 90, 94, 98, 101, 102, 105, 107, 109, 111, 113, 120, 127, 136, 137, 146, 148, 150, 152, 155, 162, 165, 166, 167, 169, 170, 172, 173, 177, 179, 181, 183, 186, 193, 195, 196, 197, 201, 206, 209, 212, 213, 217, 219, 221, 223, 225, 226, 227, 229, 230, 231]	['As', 'revealed', 'by', 'CART', 'analysis', ',', 'the', 'final', 'regression', 'tree', 'for', 'plasma', 'water', 'T2', 'included', 'three', 'biomarkers', ':', 'hepatocyte', 'growth', 'factor', 'receptor', ',', 'receptor', 'tyrosine', 'kinase', 'FLT3', '(', 'fms', '-', 'like', 'tyrosine', 'kinase', '3', ')', ',', 'and', 'bone', 'sialoprotein', '2', '(', 'Fig', '.', '3', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 5, 1, 1, 1, 1, 1, 4, 1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The final regression tree for serum water T2 included two protein markers: endothelial cell-specific molecule 1 and glucokinase regulatory protein (Fig. 4).	[('PMC6142358', 'R04001', 116, 127, 'glucokinase')]	['The', 'final', 're', '##gression', 'tree', 'for', 'serum', 'water', 'T', '##2', 'included', 'two', 'protein', 'markers', ':', 'end', '##oth', '##eli', '##al', 'cell', '-', 'specific', 'molecule', '1', 'and', 'g', '##lu', '##co', '##kin', '##ase', 'regulatory', 'protein', '(', 'Fi', '##g', '.', '4', ')', '.']	[0, 4, 10, 12, 21, 26, 30, 36, 42, 43, 45, 54, 58, 66, 73, 75, 78, 81, 84, 87, 91, 92, 101, 110, 112, 116, 117, 119, 121, 124, 128, 139, 147, 148, 150, 151, 153, 154, 155]	[3, 9, 12, 20, 25, 29, 35, 41, 43, 44, 53, 57, 65, 73, 74, 78, 81, 84, 86, 91, 92, 100, 109, 111, 115, 117, 119, 121, 124, 127, 138, 146, 148, 150, 151, 152, 154, 155, 156]	['The', 'final', 'regression', 'tree', 'for', 'serum', 'water', 'T2', 'included', 'two', 'protein', 'markers', ':', 'endothelial', 'cell', '-', 'specific', 'molecule', '1', 'and', 'glucokinase', 'regulatory', 'protein', '(', 'Fig', '.', '4', ')', '.']	[1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thiopurine S-methyltransferase (TPMT) plays an important role in the metabolism of thiopurines used in IBD therapy, i.e., in keeping balance between active (non-methylated) and non-active (methylated) thiopurine metabolites.	[('PMC6150202', 'R14000', 0, 30, 'Thiopurine S-methyltransferase')]	['T', '##hi', '##op', '##uri', '##ne', 'S', '-', 'met', '##hyl', '##tra', '##ns', '##fer', '##ase', '(', 'T', '##PM', '##T', ')', 'plays', 'an', 'important', 'role', 'in', 'the', 'metabolism', 'of', 'th', '##io', '##pur', '##ines', 'used', 'in', 'I', '##B', '##D', 'therapy', ',', 'i', '.', 'e', '.', ',', 'in', 'keeping', 'balance', 'between', 'active', '(', 'non', '-', 'met', '##hyl', '##ated', ')', 'and', 'non', '-', 'active', '(', 'met', '##hyl', '##ated', ')', 'th', '##io', '##pur', '##ine', 'meta', '##bol', '##ites', '.']	[0, 1, 3, 5, 8, 11, 12, 13, 16, 19, 22, 24, 27, 31, 32, 33, 35, 36, 38, 44, 47, 57, 62, 65, 69, 80, 83, 85, 87, 90, 95, 100, 103, 104, 105, 107, 114, 116, 117, 118, 119, 120, 122, 125, 133, 141, 149, 156, 157, 160, 161, 164, 167, 171, 173, 177, 180, 181, 188, 189, 192, 195, 199, 201, 203, 205, 208, 212, 216, 219, 223]	[1, 3, 5, 8, 10, 12, 13, 16, 19, 22, 24, 27, 30, 32, 33, 35, 36, 37, 43, 46, 56, 61, 64, 68, 79, 82, 85, 87, 90, 94, 99, 102, 104, 105, 106, 114, 115, 117, 118, 119, 120, 121, 124, 132, 140, 148, 155, 157, 160, 161, 164, 167, 171, 172, 176, 180, 181, 187, 189, 192, 195, 199, 200, 203, 205, 208, 211, 216, 219, 223, 224]	['Thiopurine', 'S-methyltransferase', '(', 'TPMT', ')', 'plays', 'an', 'important', 'role', 'in', 'the', 'metabolism', 'of', 'thiopurines', 'used', 'in', 'IBD', 'therapy', ',', 'i.e', '.', ',', 'in', 'keeping', 'balance', 'between', 'active', '(', 'non', '-', 'methylated', ')', 'and', 'non', '-', 'active', '(', 'methylated', ')', 'thiopurine', 'metabolites', '.']	[5, 8, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 4, 3, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Platelets and coagulation proteases, interacting with circulating cells and in different vascular beds, modify several complex pathologies including atherosclerosis.	[]	['Plate', '##lets', 'and', 'co', '##agu', '##lation', 'pro', '##te', '##ases', ',', 'interacting', 'with', 'circulating', 'cells', 'and', 'in', 'different', 'vascular', 'beds', ',', 'modify', 'several', 'complex', 'path', '##ologies', 'including', 'at', '##her', '##os', '##cle', '##rosis', '.']	[0, 5, 10, 14, 16, 19, 26, 29, 31, 35, 37, 49, 54, 66, 72, 76, 79, 89, 98, 102, 104, 111, 119, 127, 131, 139, 149, 151, 154, 156, 159, 164]	[5, 9, 13, 16, 19, 25, 29, 31, 35, 36, 48, 53, 65, 71, 75, 78, 88, 97, 102, 103, 110, 118, 126, 131, 138, 148, 151, 154, 156, 159, 164, 165]	['Platelets', 'and', 'coagulation', 'proteases', ',', 'interacting', 'with', 'circulating', 'cells', 'and', 'in', 'different', 'vascular', 'beds', ',', 'modify', 'several', 'complex', 'pathologies', 'including', 'atherosclerosis', '.']	[2, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Coagulation proteases, fibrin(ogen) and thrombus form ation: The role of factor (F) XI in thrombosis including the lower margins of this factor related to safe and effective antithrombotic therapy needs to be established; FXI is a key regulator in linking platelets, thrombin generation, and inflammatory mechanisms in a renin-angiotensin dependent manner; however, the impact on thrombin-dependent PAR signaling needs further study; the fundamental mechanisms in FXIII biology and biochemistry and its impact on thrombus biophysical characteristics need to be explored; the interactions of red cells and fibrin formation and its consequences for thrombus formation and lysis need to be addressed.	[('PMC6193488', 'A03000', 12, 21, 'proteases')]	['Co', '##agu', '##lation', 'pro', '##te', '##ases', ',', 'fi', '##bri', '##n', '(', 'og', '##en', ')', 'and', 'th', '##rom', '##bus', 'form', 'at', '##ion', ':', 'The', 'role', 'of', 'factor', '(', 'F', ')', 'XI', 'in', 'th', '##rom', '##bos', '##is', 'including', 'the', 'lower', 'margins', 'of', 'this', 'factor', 'related', 'to', 'safe', 'and', 'effective', 'anti', '##th', '##rom', '##bot', '##ic', 'therapy', 'needs', 'to', 'be', 'established', ';', 'FX', '##I', 'is', 'a', 'key', 'regulator', 'in', 'linking', 'plate', '##lets', ',', 'th', '##rom', '##bin', 'generation', ',', 'and', 'inflammatory', 'mechanisms', 'in', 'a', 're', '##nin', '-', 'an', '##gio', '##tens', '##in', 'dependent', 'manner', ';', 'however', ',', 'the', 'impact', 'on', 'th', '##rom', '##bin', '-', 'dependent', 'PA', '##R', 'signaling', 'needs', 'further', 'study', ';', 'the', 'fundamental', 'mechanisms', 'in', 'FX', '##II', '##I', 'biology', 'and', 'bio', '##chemistry', 'and', 'its', 'impact', 'on', 'th', '##rom', '##bus', 'bio', '##physical', 'characteristics', 'need', 'to', 'be', 'explored', ';', 'the', 'interactions', 'of', 'red', 'cells', 'and', 'fi', '##bri', '##n', 'formation', 'and', 'its', 'consequences', 'for', 'th', '##rom', '##bus', 'formation', 'and', 'l', '##ys', '##is', 'need', 'to', 'be', 'addressed', '.']	[0, 2, 5, 12, 15, 17, 21, 23, 25, 28, 29, 30, 32, 34, 36, 40, 42, 45, 49, 54, 56, 59, 61, 65, 70, 73, 80, 81, 82, 84, 87, 90, 92, 95, 98, 101, 111, 115, 121, 129, 132, 137, 144, 152, 155, 160, 164, 174, 178, 180, 183, 186, 189, 197, 203, 206, 209, 220, 222, 224, 226, 229, 231, 235, 245, 248, 256, 261, 265, 267, 269, 272, 276, 286, 288, 292, 305, 316, 319, 321, 323, 326, 327, 329, 332, 336, 339, 349, 355, 357, 364, 366, 370, 377, 380, 382, 385, 388, 389, 399, 401, 403, 413, 419, 427, 432, 434, 438, 450, 461, 464, 466, 468, 470, 478, 482, 485, 495, 499, 503, 510, 513, 515, 518, 522, 525, 534, 550, 555, 558, 561, 569, 571, 575, 588, 591, 595, 601, 605, 607, 610, 612, 622, 626, 630, 643, 647, 649, 652, 656, 666, 670, 671, 673, 676, 681, 684, 687, 696]	[2, 5, 11, 15, 17, 21, 22, 25, 28, 29, 30, 32, 34, 35, 39, 42, 45, 48, 53, 56, 59, 60, 64, 69, 72, 79, 81, 82, 83, 86, 89, 92, 95, 98, 100, 110, 114, 120, 128, 131, 136, 143, 151, 154, 159, 163, 173, 178, 180, 183, 186, 188, 196, 202, 205, 208, 220, 221, 224, 225, 228, 230, 234, 244, 247, 255, 261, 265, 266, 269, 272, 275, 286, 287, 291, 304, 315, 318, 320, 323, 326, 327, 329, 332, 336, 338, 348, 355, 356, 364, 365, 369, 376, 379, 382, 385, 388, 389, 398, 401, 402, 412, 418, 426, 432, 433, 437, 449, 460, 463, 466, 468, 469, 477, 481, 485, 494, 498, 502, 509, 512, 515, 518, 521, 525, 533, 549, 554, 557, 560, 569, 570, 574, 587, 590, 594, 600, 604, 607, 610, 611, 621, 625, 629, 642, 646, 649, 652, 655, 665, 669, 671, 673, 675, 680, 683, 686, 696, 697]	['Coagulation', 'proteases', ',', 'fibrin(ogen)', 'and', 'thrombus', 'form', 'ation', ':', 'The', 'role', 'of', 'factor', '(', 'F', ')', 'XI', 'in', 'thrombosis', 'including', 'the', 'lower', 'margins', 'of', 'this', 'factor', 'related', 'to', 'safe', 'and', 'effective', 'antithrombotic', 'therapy', 'needs', 'to', 'be', 'established', ';', 'FXI', 'is', 'a', 'key', 'regulator', 'in', 'linking', 'platelets', ',', 'thrombin', 'generation', ',', 'and', 'inflammatory', 'mechanisms', 'in', 'a', 'renin', '-', 'angiotensin', 'dependent', 'manner', ';', 'however', ',', 'the', 'impact', 'on', 'thrombin', '-', 'dependent', 'PAR', 'signaling', 'needs', 'further', 'study', ';', 'the', 'fundamental', 'mechanisms', 'in', 'FXIII', 'biology', 'and', 'biochemistry', 'and', 'its', 'impact', 'on', 'thrombus', 'biophysical', 'characteristics', 'need', 'to', 'be', 'explored', ';', 'the', 'interactions', 'of', 'red', 'cells', 'and', 'fibrin', 'formation', 'and', 'its', 'consequences', 'for', 'thrombus', 'formation', 'and', 'lysis', 'need', 'to', 'be', 'addressed', '.']	[3, 3, 1, 7, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The role of protease-activated receptor (PAR)-4 vis á vis PAR-1 as target for antithrombotic therapy merits study; ongoing trials on platelet function test-based antiplatelet therapy adjustment support development of practically feasible tests; risk scores for patients with atrial fibrillation need refinement, taking new biomarkers including coagulation into account; risk scores that consider organ system differences in bleeding may have added value; all forms of oral anticoagulant treatment require better organization, including education and emergency access; laboratory testing still needs rapidly available sensitive tests with short turnaround time.	[]	['The', 'role', 'of', 'pro', '##te', '##ase', '-', 'activated', 'receptor', '(', 'PA', '##R', ')', '-', '4', 'v', '##is', 'á', 'v', '##is', 'PA', '##R', '-', '1', 'as', 'target', 'for', 'anti', '##th', '##rom', '##bot', '##ic', 'therapy', 'merits', 'study', ';', 'ongoing', 'trials', 'on', 'plate', '##let', 'function', 'test', '-', 'based', 'anti', '##plate', '##let', 'therapy', 'adjustment', 'support', 'development', 'of', 'practically', 'feasible', 'tests', ';', 'risk', 'scores', 'for', 'patients', 'with', 'at', '##rial', 'fi', '##bri', '##lla', '##tion', 'need', 're', '##fine', '##ment', ',', 'taking', 'new', 'bio', '##mark', '##ers', 'including', 'co', '##agu', '##lation', 'into', 'account', ';', 'risk', 'scores', 'that', 'consider', 'organ', 'system', 'differences', 'in', 'bleeding', 'may', 'have', 'added', 'value', ';', 'all', 'forms', 'of', 'oral', 'anti', '##coa', '##gu', '##lant', 'treatment', 'require', 'better', 'organization', ',', 'including', 'education', 'and', 'emergency', 'access', ';', 'laboratory', 'testing', 'still', 'needs', 'rapidly', 'available', 'sensitive', 'tests', 'with', 'short', 'turn', '##around', 'time', '.']	[0, 4, 9, 12, 15, 17, 20, 21, 31, 40, 41, 43, 44, 45, 46, 48, 49, 52, 54, 55, 58, 60, 61, 62, 64, 67, 74, 78, 82, 84, 87, 90, 93, 101, 108, 113, 115, 123, 130, 133, 138, 142, 151, 155, 156, 162, 166, 171, 175, 183, 194, 202, 214, 217, 229, 238, 243, 245, 250, 257, 261, 270, 275, 277, 282, 284, 287, 290, 295, 300, 302, 306, 310, 312, 319, 323, 326, 330, 334, 344, 346, 349, 356, 361, 368, 370, 375, 382, 387, 396, 402, 409, 421, 424, 433, 437, 442, 448, 453, 455, 459, 465, 468, 473, 477, 480, 482, 487, 497, 505, 512, 524, 526, 536, 546, 550, 560, 566, 568, 579, 587, 593, 599, 607, 617, 627, 633, 638, 644, 648, 655, 659]	[3, 8, 11, 15, 17, 20, 21, 30, 39, 41, 43, 44, 45, 46, 47, 49, 51, 53, 55, 57, 60, 61, 62, 63, 66, 73, 77, 82, 84, 87, 90, 92, 100, 107, 113, 114, 122, 129, 132, 138, 141, 150, 155, 156, 161, 166, 171, 174, 182, 193, 201, 213, 216, 228, 237, 243, 244, 249, 256, 260, 269, 274, 277, 281, 284, 287, 290, 294, 299, 302, 306, 310, 311, 318, 322, 326, 330, 333, 343, 346, 349, 355, 360, 368, 369, 374, 381, 386, 395, 401, 408, 420, 423, 432, 436, 441, 447, 453, 454, 458, 464, 467, 472, 477, 480, 482, 486, 496, 504, 511, 524, 525, 535, 545, 549, 559, 566, 567, 578, 586, 592, 598, 606, 616, 626, 632, 637, 643, 648, 654, 659, 660]	['The', 'role', 'of', 'protease', '-', 'activated', 'receptor', '(PAR)-4', 'vis', 'á', 'vis', 'PAR-1', 'as', 'target', 'for', 'antithrombotic', 'therapy', 'merits', 'study', ';', 'ongoing', 'trials', 'on', 'platelet', 'function', 'test', '-', 'based', 'antiplatelet', 'therapy', 'adjustment', 'support', 'development', 'of', 'practically', 'feasible', 'tests', ';', 'risk', 'scores', 'for', 'patients', 'with', 'atrial', 'fibrillation', 'need', 'refinement', ',', 'taking', 'new', 'biomarkers', 'including', 'coagulation', 'into', 'account', ';', 'risk', 'scores', 'that', 'consider', 'organ', 'system', 'differences', 'in', 'bleeding', 'may', 'have', 'added', 'value', ';', 'all', 'forms', 'of', 'oral', 'anticoagulant', 'treatment', 'require', 'better', 'organization', ',', 'including', 'education', 'and', 'emergency', 'access', ';', 'laboratory', 'testing', 'still', 'needs', 'rapidly', 'available', 'sensitive', 'tests', 'with', 'short', 'turnaround', 'time', '.']	[1, 1, 1, 3, 1, 1, 1, 6, 2, 1, 2, 4, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Pleiotropy of coagulation proteases, thrombus resolution and ischaemia-reperfusion: Biobanks specifically for thrombus storage and analysis are needed; further studies on novel modified activated protein C-based agents are required including its cytoprotective properties; new avenues for optimizing treatm ent of patients with ischaemic stroke are needed, also including novel agents that modify fibrinolytic activity (aimed at plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor.	[('PMC6193488', 'A05000', 26, 35, 'proteases')]	['P', '##le', '##iot', '##rop', '##y', 'of', 'co', '##agu', '##lation', 'pro', '##te', '##ases', ',', 'th', '##rom', '##bus', 'resolution', 'and', 'is', '##cha', '##emia', '-', 're', '##per', '##fusion', ':', 'B', '##io', '##bank', '##s', 'specifically', 'for', 'th', '##rom', '##bus', 'storage', 'and', 'analysis', 'are', 'needed', ';', 'further', 'studies', 'on', 'novel', 'modified', 'activated', 'protein', 'C', '-', 'based', 'agents', 'are', 'required', 'including', 'its', 'c', '##yt', '##op', '##rote', '##ctive', 'properties', ';', 'new', 'avenue', '##s', 'for', 'op', '##ti', '##mizing', 'treat', '##m', 'en', '##t', 'of', 'patients', 'with', 'is', '##cha', '##em', '##ic', 'stroke', 'are', 'needed', ',', 'also', 'including', 'novel', 'agents', 'that', 'modify', 'fi', '##bri', '##no', '##ly', '##tic', 'activity', '(', 'aimed', 'at', 'p', '##las', '##min', '##ogen', 'act', '##iva', '##tor', 'inhibitor', '-', '1', 'and', 'th', '##rom', '##bin', 'act', '##iva', '##table', 'fi', '##bri', '##no', '##lysis', 'inhibitor', '.']	[0, 1, 3, 6, 9, 11, 14, 16, 19, 26, 29, 31, 35, 37, 39, 42, 46, 57, 61, 63, 66, 70, 71, 73, 76, 82, 84, 85, 87, 91, 93, 106, 110, 112, 115, 119, 127, 131, 140, 144, 150, 152, 160, 168, 171, 177, 186, 196, 204, 205, 206, 212, 219, 223, 232, 242, 246, 247, 249, 251, 255, 261, 271, 273, 277, 283, 285, 289, 291, 293, 300, 305, 307, 309, 311, 314, 323, 328, 330, 333, 335, 338, 345, 349, 355, 357, 362, 372, 378, 385, 390, 397, 399, 402, 404, 406, 410, 419, 420, 426, 429, 430, 433, 436, 441, 444, 447, 451, 460, 461, 463, 467, 469, 472, 476, 479, 482, 488, 490, 493, 495, 501, 510]	[1, 3, 6, 9, 10, 13, 16, 19, 25, 29, 31, 35, 36, 39, 42, 45, 56, 60, 63, 66, 70, 71, 73, 76, 82, 83, 85, 87, 91, 92, 105, 109, 112, 115, 118, 126, 130, 139, 143, 150, 151, 159, 167, 170, 176, 185, 195, 203, 205, 206, 211, 218, 222, 231, 241, 245, 247, 249, 251, 255, 260, 271, 272, 276, 283, 284, 288, 291, 293, 299, 305, 306, 309, 310, 313, 322, 327, 330, 333, 335, 337, 344, 348, 355, 356, 361, 371, 377, 384, 389, 396, 399, 402, 404, 406, 409, 418, 420, 425, 428, 430, 433, 436, 440, 444, 447, 450, 460, 461, 462, 466, 469, 472, 475, 479, 482, 487, 490, 493, 495, 500, 510, 511]	['Pleiotropy', 'of', 'coagulation', 'proteases', ',', 'thrombus', 'resolution', 'and', 'ischaemia', '-', 'reperfusion', ':', 'Biobanks', 'specifically', 'for', 'thrombus', 'storage', 'and', 'analysis', 'are', 'needed', ';', 'further', 'studies', 'on', 'novel', 'modified', 'activated', 'protein', 'C-', 'based', 'agents', 'are', 'required', 'including', 'its', 'cytoprotective', 'properties', ';', 'new', 'avenues', 'for', 'optimizing', 'treatm', 'ent', 'of', 'patients', 'with', 'ischaemic', 'stroke', 'are', 'needed', ',', 'also', 'including', 'novel', 'agents', 'that', 'modify', 'fibrinolytic', 'activity', '(', 'aimed', 'at', 'plasminogen', 'activator', 'inhibitor-1', 'and', 'thrombin', 'activatable', 'fibrinolysis', 'inhibitor', '.']	[5, 1, 3, 3, 1, 3, 1, 1, 3, 1, 3, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 3, 2, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 4, 3, 3, 1, 3, 3, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One promising drug candidate currently in phase II clinical studies for treatment of ischaemic stroke is the activated protein C (APC) variant 3K3A-APC.221 APC provides natural anticoagulant function by inactivating the coagulation cofactors Va and VIIIa.	[]	['One', 'promising', 'drug', 'candidate', 'currently', 'in', 'phase', 'II', 'clinical', 'studies', 'for', 'treatment', 'of', 'is', '##cha', '##em', '##ic', 'stroke', 'is', 'the', 'activated', 'protein', 'C', '(', 'AP', '##C', ')', 'variant', '3', '##K', '##3', '##A', '-', 'AP', '##C', '.', '221', 'AP', '##C', 'provides', 'natural', 'anti', '##coa', '##gu', '##lant', 'function', 'by', 'in', '##act', '##ivating', 'the', 'co', '##agu', '##lation', 'co', '##fa', '##ctors', 'V', '##a', 'and', 'VIII', '##a', '.']	[0, 4, 14, 19, 29, 39, 42, 48, 51, 60, 68, 72, 82, 85, 87, 90, 92, 95, 102, 105, 109, 119, 127, 129, 130, 132, 133, 135, 143, 144, 145, 146, 147, 148, 150, 151, 152, 156, 158, 160, 169, 177, 181, 184, 186, 191, 200, 203, 205, 208, 216, 220, 222, 225, 232, 234, 236, 242, 243, 245, 249, 253, 254]	[3, 13, 18, 28, 38, 41, 47, 50, 59, 67, 71, 81, 84, 87, 90, 92, 94, 101, 104, 108, 118, 126, 128, 130, 132, 133, 134, 142, 144, 145, 146, 147, 148, 150, 151, 152, 155, 158, 159, 168, 176, 181, 184, 186, 190, 199, 202, 205, 208, 215, 219, 222, 225, 231, 234, 236, 241, 243, 244, 248, 253, 254, 255]	['One', 'promising', 'drug', 'candidate', 'currently', 'in', 'phase', 'II', 'clinical', 'studies', 'for', 'treatment', 'of', 'ischaemic', 'stroke', 'is', 'the', 'activated', 'protein', 'C', '(', 'APC', ')', 'variant', '3K3A-APC.221', 'APC', 'provides', 'natural', 'anticoagulant', 'function', 'by', 'inactivating', 'the', 'coagulation', 'cofactors', 'Va', 'and', 'VIIIa', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 9, 2, 1, 1, 4, 1, 1, 3, 1, 3, 3, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The standard of care for acute ischaemic stroke now involves IV alteplase (recombinant tissue-type plasminogen activator [tPA]) within 4.5 hours, followed by antiplatelet treatm ent (acetylsalicylic acid or clopidogrel) 24 hours after infusion of thrombolytics, to avoid excess risk of intracerebral haemorrhage.225,226 The major goal of thrombolytic treatm ent is to rapidly establish oxygenated blood flow to limit brain damage.	[]	['The', 'standard', 'of', 'care', 'for', 'acute', 'is', '##cha', '##em', '##ic', 'stroke', 'now', 'involves', 'IV', 'al', '##tep', '##lase', '(', 're', '##comb', '##ina', '##nt', 'tissue', '-', 'type', 'p', '##las', '##min', '##ogen', 'act', '##iva', '##tor', '[', 't', '##PA', ']', ')', 'within', '4', '.', '5', 'hours', ',', 'followed', 'by', 'anti', '##plate', '##let', 'treat', '##m', 'en', '##t', '(', 'ace', '##ty', '##ls', '##ali', '##cy', '##lic', 'acid', 'or', 'c', '##lop', '##ido', '##g', '##rel', ')', '24', 'hours', 'after', 'in', '##fusion', 'of', 'th', '##rom', '##bol', '##ytic', '##s', ',', 'to', 'avoid', 'excess', 'risk', 'of', 'in', '##tra', '##cer', '##eb', '##ral', 'ha', '##em', '##or', '##r', '##hage', '.', '225', ',', '226', 'The', 'major', 'goal', 'of', 'th', '##rom', '##bol', '##ytic', 'treat', '##m', 'en', '##t', 'is', 'to', 'rapidly', 'establish', 'oxygen', '##ated', 'blood', 'flow', 'to', 'limit', 'brain', 'damage', '.']	[0, 4, 13, 16, 21, 25, 31, 33, 36, 38, 41, 48, 52, 61, 64, 66, 69, 74, 75, 77, 81, 84, 87, 93, 94, 99, 100, 103, 106, 111, 114, 117, 121, 122, 123, 125, 126, 128, 135, 136, 137, 139, 144, 146, 155, 158, 162, 167, 171, 176, 178, 180, 182, 183, 186, 188, 190, 193, 195, 199, 204, 207, 208, 211, 214, 215, 218, 220, 223, 229, 235, 237, 244, 247, 249, 252, 255, 259, 260, 262, 265, 271, 278, 283, 286, 288, 291, 294, 296, 300, 302, 304, 306, 307, 311, 312, 315, 316, 320, 324, 330, 335, 338, 340, 343, 346, 351, 356, 358, 360, 362, 365, 368, 376, 386, 392, 397, 403, 408, 411, 417, 423, 429]	[3, 12, 15, 20, 24, 30, 33, 36, 38, 40, 47, 51, 60, 63, 66, 69, 73, 75, 77, 81, 84, 86, 93, 94, 98, 100, 103, 106, 110, 114, 117, 120, 122, 123, 125, 126, 127, 134, 136, 137, 138, 144, 145, 154, 157, 162, 167, 170, 176, 177, 180, 181, 183, 186, 188, 190, 193, 195, 198, 203, 206, 208, 211, 214, 215, 218, 219, 222, 228, 234, 237, 243, 246, 249, 252, 255, 259, 260, 261, 264, 270, 277, 282, 285, 288, 291, 294, 296, 299, 302, 304, 306, 307, 311, 312, 315, 316, 319, 323, 329, 334, 337, 340, 343, 346, 350, 356, 357, 360, 361, 364, 367, 375, 385, 392, 396, 402, 407, 410, 416, 422, 429, 430]	['The', 'standard', 'of', 'care', 'for', 'acute', 'ischaemic', 'stroke', 'now', 'involves', 'IV', 'alteplase', '(', 'recombinant', 'tissue', '-', 'type', 'plasminogen', 'activator', '[', 'tPA', ']', ')', 'within', '4.5', 'hours', ',', 'followed', 'by', 'antiplatelet', 'treatm', 'ent', '(', 'acetylsalicylic', 'acid', 'or', 'clopidogrel', ')', '24', 'hours', 'after', 'infusion', 'of', 'thrombolytics', ',', 'to', 'avoid', 'excess', 'risk', 'of', 'intracerebral', 'haemorrhage.225', ',', '226', 'The', 'major', 'goal', 'of', 'thrombolytic', 'treatm', 'ent', 'is', 'to', 'rapidly', 'establish', 'oxygenated', 'blood', 'flow', 'to', 'limit', 'brain', 'damage', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 4, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 3, 2, 2, 1, 6, 1, 1, 5, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 5, 7, 1, 1, 1, 1, 1, 1, 4, 2, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Activated protein C mutants are increasingly interesting for their cytoprotective properties (e.g. in the management of patients with ischaemic stroke).	[('PMC6193488', 'R140000', 0, 19, 'Activated protein C')]	['Act', '##ivated', 'protein', 'C', 'mutant', '##s', 'are', 'increasingly', 'interesting', 'for', 'their', 'c', '##yt', '##op', '##rote', '##ctive', 'properties', '(', 'e', '.', 'g', '.', 'in', 'the', 'management', 'of', 'patients', 'with', 'is', '##cha', '##em', '##ic', 'stroke', ')', '.']	[0, 3, 10, 18, 20, 26, 28, 32, 45, 57, 61, 67, 68, 70, 72, 76, 82, 93, 94, 95, 96, 97, 99, 102, 106, 117, 120, 129, 134, 136, 139, 141, 144, 150, 151]	[3, 9, 17, 19, 26, 27, 31, 44, 56, 60, 66, 68, 70, 72, 76, 81, 92, 94, 95, 96, 97, 98, 101, 105, 116, 119, 128, 133, 136, 139, 141, 143, 150, 151, 152]	['Activated', 'protein', 'C', 'mutants', 'are', 'increasingly', 'interesting', 'for', 'their', 'cytoprotective', 'properties', '(', 'e.g', '.', 'in', 'the', 'management', 'of', 'patients', 'with', 'ischaemic', 'stroke', ')', '.']	[2, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
C5 nevertheless is crucial for outer membrane phosphatidylserine exposure and activating TF prothrombotic activity, as previously also demonstrated for complement fixing antibodies causing thrombotic complications in stem cell therapy.51 Protein disulphide isomerase pathways are necessary for affinity maturation of TF and phosphatidylserine exposure but is not sufficient to render MV-associated TF fully prothrombotic.52 Complement-dependent release of MV from monocytes in LPS-stimulated whole blood produces TF which due to its high affinity is already in complex with its ligand FVIIa.	[]	['C', '##5', 'nevertheless', 'is', 'crucial', 'for', 'outer', 'membrane', 'p', '##hos', '##pha', '##ti', '##dy', '##ls', '##eri', '##ne', 'exposure', 'and', 'act', '##ivating', 'T', '##F', 'pro', '##th', '##rom', '##bot', '##ic', 'activity', ',', 'as', 'previously', 'also', 'demonstrated', 'for', 'complement', 'fixing', 'antibodies', 'causing', 'th', '##rom', '##bot', '##ic', 'complications', 'in', 'stem', 'cell', 'therapy', '.', '51', 'Pro', '##tein', 'di', '##sul', '##phi', '##de', 'is', '##omer', '##ase', 'pathways', 'are', 'necessary', 'for', 'affinity', 'mat', '##uration', 'of', 'T', '##F', 'and', 'p', '##hos', '##pha', '##ti', '##dy', '##ls', '##eri', '##ne', 'exposure', 'but', 'is', 'not', 'sufficient', 'to', 'render', 'MV', '-', 'associated', 'T', '##F', 'fully', 'pro', '##th', '##rom', '##bot', '##ic', '.', '52', 'Co', '##mple', '##ment', '-', 'dependent', 'release', 'of', 'MV', 'from', 'mon', '##ocytes', 'in', 'LP', '##S', '-', 'stimulate', '##d', 'whole', 'blood', 'produces', 'T', '##F', 'which', 'due', 'to', 'its', 'high', 'affinity', 'is', 'already', 'in', 'complex', 'with', 'its', 'l', '##igan', '##d', 'F', '##VI', '##I', '##a', '.']	[0, 1, 3, 16, 19, 27, 31, 37, 46, 47, 50, 53, 55, 57, 59, 62, 65, 74, 78, 81, 89, 90, 92, 95, 97, 100, 103, 106, 114, 116, 119, 130, 135, 148, 152, 163, 170, 181, 189, 191, 194, 197, 200, 214, 217, 222, 227, 234, 235, 238, 241, 246, 248, 251, 254, 257, 259, 263, 267, 276, 280, 290, 294, 303, 306, 314, 317, 318, 320, 324, 325, 328, 331, 333, 335, 337, 340, 343, 352, 356, 359, 363, 374, 377, 384, 386, 387, 398, 399, 401, 407, 410, 412, 415, 418, 420, 421, 424, 426, 430, 434, 435, 445, 453, 456, 459, 464, 467, 474, 477, 479, 480, 481, 490, 492, 498, 504, 513, 514, 516, 522, 526, 529, 533, 538, 547, 550, 558, 561, 569, 574, 578, 579, 583, 585, 586, 588, 589, 590]	[1, 2, 15, 18, 26, 30, 36, 45, 47, 50, 53, 55, 57, 59, 62, 64, 73, 77, 81, 88, 90, 91, 95, 97, 100, 103, 105, 114, 115, 118, 129, 134, 147, 151, 162, 169, 180, 188, 191, 194, 197, 199, 213, 216, 221, 226, 234, 235, 237, 241, 245, 248, 251, 254, 256, 259, 263, 266, 275, 279, 289, 293, 302, 306, 313, 316, 318, 319, 323, 325, 328, 331, 333, 335, 337, 340, 342, 351, 355, 358, 362, 373, 376, 383, 386, 387, 397, 399, 400, 406, 410, 412, 415, 418, 420, 421, 423, 426, 430, 434, 435, 444, 452, 455, 458, 463, 467, 473, 476, 479, 480, 481, 490, 491, 497, 503, 512, 514, 515, 521, 525, 528, 532, 537, 546, 549, 557, 560, 568, 573, 577, 579, 583, 584, 586, 588, 589, 590, 591]	['C5', 'nevertheless', 'is', 'crucial', 'for', 'outer', 'membrane', 'phosphatidylserine', 'exposure', 'and', 'activating', 'TF', 'prothrombotic', 'activity', ',', 'as', 'previously', 'also', 'demonstrated', 'for', 'complement', 'fixing', 'antibodies', 'causing', 'thrombotic', 'complications', 'in', 'stem', 'cell', 'therapy.51', 'Protein', 'disulphide', 'isomerase', 'pathways', 'are', 'necessary', 'for', 'affinity', 'maturation', 'of', 'TF', 'and', 'phosphatidylserine', 'exposure', 'but', 'is', 'not', 'sufficient', 'to', 'render', 'MV-associated', 'TF', 'fully', 'prothrombotic.52', 'Complement', '-', 'dependent', 'release', 'of', 'MV', 'from', 'monocytes', 'in', 'LPS-stimulated', 'whole', 'blood', 'produces', 'TF', 'which', 'due', 'to', 'its', 'high', 'affinity', 'is', 'already', 'in', 'complex', 'with', 'its', 'ligand', 'FVIIa', '.']	[2, 1, 1, 1, 1, 1, 1, 8, 1, 1, 2, 2, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 2, 4, 3, 1, 1, 1, 1, 1, 2, 1, 2, 1, 8, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 7, 3, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Further studies on novel modified activated protein C-based agents are required including its cytoprotective properties.	[('PMC6193488', 'R161000', 34, 53, 'activated protein C')]	['Further', 'studies', 'on', 'novel', 'modified', 'activated', 'protein', 'C', '-', 'based', 'agents', 'are', 'required', 'including', 'its', 'c', '##yt', '##op', '##rote', '##ctive', 'properties', '.']	[0, 8, 16, 19, 25, 34, 44, 52, 53, 54, 60, 67, 71, 80, 90, 94, 95, 97, 99, 103, 109, 119]	[7, 15, 18, 24, 33, 43, 51, 53, 54, 59, 66, 70, 79, 89, 93, 95, 97, 99, 103, 108, 119, 120]	['Further', 'studies', 'on', 'novel', 'modified', 'activated', 'protein', 'C-', 'based', 'agents', 'are', 'required', 'including', 'its', 'cytoprotective', 'properties', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast to humans, mice have two kininogen genes and ablation of kininogen 1 (mkng1–/– mice) protects from experimental arterial thrombosis without causing bleeding.106 Consistently, a patient with plasma kininogen activity of less than 1% did not bleed.106 While serine proteases are targetable by small molecule inhibitors that bind into the enzymatic pocket, strategies for interference with HK or HK expression should be further investigated.	[]	['In', 'contrast', 'to', 'humans', ',', 'mice', 'have', 'two', 'kin', '##ino', '##gen', 'genes', 'and', 'a', '##bla', '##tion', 'of', 'kin', '##ino', '##gen', '1', '(', 'm', '##k', '##ng', '##1', '–', '/', '–', 'mice', ')', 'protects', 'from', 'experimental', 'art', '##erial', 'th', '##rom', '##bos', '##is', 'without', 'causing', 'bleeding', '.', '106', 'Con', '##sist', '##ently', ',', 'a', 'patient', 'with', 'plasma', 'kin', '##ino', '##gen', 'activity', 'of', 'less', 'than', '1', '%', 'did', 'not', 'bleed', '.', '106', 'While', 'se', '##rine', 'pro', '##te', '##ases', 'are', 'target', '##able', 'by', 'small', 'molecule', 'inhibitor', '##s', 'that', 'bind', 'into', 'the', 'en', '##zy', '##matic', 'pocket', ',', 'strategies', 'for', 'interference', 'with', 'HK', 'or', 'HK', 'expression', 'should', 'be', 'further', 'investigated', '.']	[0, 3, 12, 15, 21, 23, 28, 33, 37, 40, 43, 47, 53, 57, 58, 61, 66, 69, 72, 75, 79, 81, 82, 83, 84, 86, 87, 88, 89, 91, 95, 97, 106, 111, 124, 127, 133, 135, 138, 141, 144, 152, 160, 168, 169, 173, 176, 180, 185, 187, 189, 197, 202, 209, 212, 215, 219, 228, 231, 236, 241, 242, 244, 248, 252, 257, 258, 262, 268, 270, 275, 278, 280, 285, 289, 295, 300, 303, 309, 318, 327, 329, 334, 339, 344, 348, 350, 352, 358, 364, 366, 377, 381, 394, 399, 402, 405, 408, 419, 426, 429, 437, 449]	[2, 11, 14, 21, 22, 27, 32, 36, 40, 43, 46, 52, 56, 58, 61, 65, 68, 72, 75, 78, 80, 82, 83, 84, 86, 87, 88, 89, 90, 95, 96, 105, 110, 123, 127, 132, 135, 138, 141, 143, 151, 159, 168, 169, 172, 176, 180, 185, 186, 188, 196, 201, 208, 212, 215, 218, 227, 230, 235, 240, 242, 243, 247, 251, 257, 258, 261, 267, 270, 274, 278, 280, 284, 288, 295, 299, 302, 308, 317, 327, 328, 333, 338, 343, 347, 350, 352, 357, 364, 365, 376, 380, 393, 398, 401, 404, 407, 418, 425, 428, 436, 449, 450]	['In', 'contrast', 'to', 'humans', ',', 'mice', 'have', 'two', 'kininogen', 'genes', 'and', 'ablation', 'of', 'kininogen', '1', '(', 'mkng1–', '/', '–', 'mice', ')', 'protects', 'from', 'experimental', 'arterial', 'thrombosis', 'without', 'causing', 'bleeding.106', 'Consistently', ',', 'a', 'patient', 'with', 'plasma', 'kininogen', 'activity', 'of', 'less', 'than', '1%', 'did', 'not', 'bleed.106', 'While', 'serine', 'proteases', 'are', 'targetable', 'by', 'small', 'molecule', 'inhibitors', 'that', 'bind', 'into', 'the', 'enzymatic', 'pocket', ',', 'strategies', 'for', 'interference', 'with', 'HK', 'or', 'HK', 'expression', 'should', 'be', 'further', 'investigated', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 3, 1, 2, 3, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Undertake further studies on FXI induced increased thrombin production and PAR-mediated cell signaling; these should consider upregulation of PK-mediated activation of the bradykinin pathways; population-based cohorts or large trials with anticoagulants should be explored for signals of blood pressure lowering effects or changes in incident CVD linked to FXI or other clotting protease activity.	[('PMC6193488', 'R55000', 379, 387, 'protease')]	['Under', '##take', 'further', 'studies', 'on', 'FX', '##I', 'induced', 'increased', 'th', '##rom', '##bin', 'production', 'and', 'PA', '##R', '-', 'mediated', 'cell', 'signaling', ';', 'these', 'should', 'consider', 'up', '##re', '##gu', '##lation', 'of', 'P', '##K', '-', 'mediated', 'activation', 'of', 'the', 'bra', '##dy', '##kini', '##n', 'pathways', ';', 'population', '-', 'based', 'co', '##hor', '##ts', 'or', 'large', 'trials', 'with', 'anti', '##coa', '##gu', '##lants', 'should', 'be', 'explored', 'for', 'signals', 'of', 'blood', 'pressure', 'lowering', 'effects', 'or', 'changes', 'in', 'incident', 'C', '##VD', 'linked', 'to', 'FX', '##I', 'or', 'other', 'c', '##lot', '##ting', 'pro', '##te', '##ase', 'activity', '.']	[0, 5, 10, 18, 26, 29, 31, 33, 41, 51, 53, 56, 60, 71, 75, 77, 78, 79, 88, 93, 102, 104, 110, 117, 126, 128, 130, 132, 139, 142, 143, 144, 145, 154, 165, 168, 172, 175, 177, 181, 183, 191, 193, 203, 204, 210, 212, 215, 218, 221, 227, 234, 239, 243, 246, 248, 254, 261, 264, 273, 277, 285, 288, 294, 303, 312, 320, 323, 331, 334, 343, 344, 347, 354, 357, 359, 361, 364, 370, 371, 374, 379, 382, 384, 388, 396]	[5, 9, 17, 25, 28, 31, 32, 40, 50, 53, 56, 59, 70, 74, 77, 78, 79, 87, 92, 102, 103, 109, 116, 125, 128, 130, 132, 138, 141, 143, 144, 145, 153, 164, 167, 171, 175, 177, 181, 182, 191, 192, 203, 204, 209, 212, 215, 217, 220, 226, 233, 238, 243, 246, 248, 253, 260, 263, 272, 276, 284, 287, 293, 302, 311, 319, 322, 330, 333, 342, 344, 346, 353, 356, 359, 360, 363, 369, 371, 374, 378, 382, 384, 387, 396, 397]	['Undertake', 'further', 'studies', 'on', 'FXI', 'induced', 'increased', 'thrombin', 'production', 'and', 'PAR', '-', 'mediated', 'cell', 'signaling', ';', 'these', 'should', 'consider', 'upregulation', 'of', 'PK', '-', 'mediated', 'activation', 'of', 'the', 'bradykinin', 'pathways', ';', 'population', '-', 'based', 'cohorts', 'or', 'large', 'trials', 'with', 'anticoagulants', 'should', 'be', 'explored', 'for', 'signals', 'of', 'blood', 'pressure', 'lowering', 'effects', 'or', 'changes', 'in', 'incident', 'CVD', 'linked', 'to', 'FXI', 'or', 'other', 'clotting', 'protease', 'activity', '.']	[2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
VKAs exert their anticoagulant effect by inhibiting vitamin K epoxide reductase, which requires absorption from the gut into the systemic circulation, whereas NOACs are only partially absorbed from the gut and residual drug can exert effects locally on the GI mucosa leading to bleeding.174,179,182	[]	['V', '##KA', '##s', 'ex', '##ert', 'their', 'anti', '##coa', '##gu', '##lant', 'effect', 'by', 'in', '##hibit', '##ing', 'vitamin', 'K', 'e', '##pox', '##ide', 'red', '##uc', '##tase', ',', 'which', 'requires', 'absorption', 'from', 'the', 'gut', 'into', 'the', 'systemic', 'circulation', ',', 'whereas', 'NO', '##AC', '##s', 'are', 'only', 'partially', 'absorbed', 'from', 'the', 'gut', 'and', 'residual', 'drug', 'can', 'ex', '##ert', 'effects', 'locally', 'on', 'the', 'G', '##I', 'm', '##uc', '##osa', 'leading', 'to', 'bleeding', '.', '174', ',', '179', ',', '182']	[0, 1, 3, 5, 7, 11, 17, 21, 24, 26, 31, 38, 41, 43, 48, 52, 60, 62, 63, 66, 70, 73, 75, 79, 81, 87, 96, 107, 112, 116, 120, 125, 129, 138, 149, 151, 159, 161, 163, 165, 169, 174, 184, 193, 198, 202, 206, 210, 219, 224, 228, 230, 234, 242, 250, 253, 257, 258, 260, 261, 263, 267, 275, 278, 286, 287, 290, 291, 294, 295]	[1, 3, 4, 7, 10, 16, 21, 24, 26, 30, 37, 40, 43, 48, 51, 59, 61, 63, 66, 69, 73, 75, 79, 80, 86, 95, 106, 111, 115, 119, 124, 128, 137, 149, 150, 158, 161, 163, 164, 168, 173, 183, 192, 197, 201, 205, 209, 218, 223, 227, 230, 233, 241, 249, 252, 256, 258, 259, 261, 263, 266, 274, 277, 286, 287, 290, 291, 294, 295, 298]	['VKAs', 'exert', 'their', 'anticoagulant', 'effect', 'by', 'inhibiting', 'vitamin', 'K', 'epoxide', 'reductase', ',', 'which', 'requires', 'absorption', 'from', 'the', 'gut', 'into', 'the', 'systemic', 'circulation', ',', 'whereas', 'NOACs', 'are', 'only', 'partially', 'absorbed', 'from', 'the', 'gut', 'and', 'residual', 'drug', 'can', 'exert', 'effects', 'locally', 'on', 'the', 'GI', 'mucosa', 'leading', 'to', 'bleeding.174', ',', '179', ',', '182']	[3, 2, 1, 4, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraoxonase-1 (PON1) and lipoprotein phospholipase A2 (Lp-PLA2) may exert an important protective role by preventing the oxidative transformation of high- and low-density lipoproteins (HDL and LDL, respectively).	[('PMC6247389', 'A00000', 0, 13, 'Paraoxonase-1')]	['Para', '##ox', '##ona', '##se', '-', '1', '(', 'P', '##ON', '##1', ')', 'and', 'lip', '##op', '##rote', '##in', 'p', '##hos', '##ph', '##oli', '##pas', '##e', 'A2', '(', 'L', '##p', '-', 'P', '##LA', '##2', ')', 'may', 'ex', '##ert', 'an', 'important', 'protective', 'role', 'by', 'preventing', 'the', 'o', '##xi', '##da', '##tive', 'transformation', 'of', 'high', '-', 'and', 'low', '-', 'density', 'lip', '##op', '##rote', '##ins', '(', 'HD', '##L', 'and', 'L', '##D', '##L', ',', 'respectively', ')', '.']	[0, 4, 6, 9, 11, 12, 14, 15, 16, 18, 19, 21, 25, 28, 30, 34, 37, 38, 41, 43, 46, 49, 51, 54, 55, 56, 57, 58, 59, 61, 62, 64, 68, 70, 74, 77, 87, 98, 103, 106, 117, 121, 122, 124, 126, 131, 146, 149, 153, 155, 159, 162, 163, 171, 174, 176, 180, 184, 185, 187, 189, 193, 194, 195, 196, 198, 210, 211]	[4, 6, 9, 11, 12, 13, 15, 16, 18, 19, 20, 24, 28, 30, 34, 36, 38, 41, 43, 46, 49, 50, 53, 55, 56, 57, 58, 59, 61, 62, 63, 67, 70, 73, 76, 86, 97, 102, 105, 116, 120, 122, 124, 126, 130, 145, 148, 153, 154, 158, 162, 163, 170, 174, 176, 180, 183, 185, 187, 188, 192, 194, 195, 196, 197, 210, 211, 212]	['Paraoxonase-1', '(', 'PON1', ')', 'and', 'lipoprotein', 'phospholipase', 'A2', '(', 'Lp-PLA2', ')', 'may', 'exert', 'an', 'important', 'protective', 'role', 'by', 'preventing', 'the', 'oxidative', 'transformation', 'of', 'high-', 'and', 'low', '-', 'density', 'lipoproteins', '(', 'HDL', 'and', 'LDL', ',', 'respectively', ')', '.']	[6, 1, 3, 1, 1, 4, 6, 1, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 4, 1, 2, 1, 3, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Arylesterase, but not lactonase or Lp-PLA2 activities, was inversely associated with TD2M after adjusting for potential confounding factors such as age, sex, smoking, body mass index, hypertension, and lipoprotein subclasses (odds ratio = 3.389, 95% confidence interval 1.069–14.756).	[]	['A', '##ryl', '##ester', '##ase', ',', 'but', 'not', 'la', '##cton', '##ase', 'or', 'L', '##p', '-', 'P', '##LA', '##2', 'activities', ',', 'was', 'inverse', '##ly', 'associated', 'with', 'TD', '##2', '##M', 'after', 'adjusting', 'for', 'potential', 'con', '##found', '##ing', 'factors', 'such', 'as', 'age', ',', 'sex', ',', 'smoking', ',', 'body', 'mass', 'index', ',', 'h', '##yper', '##tens', '##ion', ',', 'and', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '(', 'odds', 'ratio', '=', '3', '.', '38', '##9', ',', '95', '%', 'confidence', 'interval', '1', '.', '06', '##9', '–', '14', '.', '75', '##6', ')', '.']	[0, 1, 4, 9, 12, 14, 18, 22, 24, 28, 32, 35, 36, 37, 38, 39, 41, 43, 53, 55, 59, 66, 69, 80, 85, 87, 88, 90, 96, 106, 110, 120, 123, 128, 132, 140, 145, 148, 151, 153, 156, 158, 165, 167, 172, 177, 182, 184, 185, 189, 193, 196, 198, 202, 205, 207, 211, 214, 217, 218, 222, 225, 226, 231, 237, 239, 240, 241, 243, 244, 246, 248, 250, 261, 270, 271, 272, 274, 275, 276, 278, 279, 281, 282, 283]	[1, 4, 9, 12, 13, 17, 21, 24, 28, 31, 34, 36, 37, 38, 39, 41, 42, 53, 54, 58, 66, 68, 79, 84, 87, 88, 89, 95, 105, 109, 119, 123, 128, 131, 139, 144, 147, 151, 152, 156, 157, 165, 166, 171, 176, 182, 183, 185, 189, 193, 196, 197, 201, 205, 207, 211, 213, 217, 218, 222, 224, 226, 230, 236, 238, 240, 241, 243, 244, 245, 248, 249, 260, 269, 271, 272, 274, 275, 276, 278, 279, 281, 282, 283, 284]	['Arylesterase', ',', 'but', 'not', 'lactonase', 'or', 'Lp-PLA2', 'activities', ',', 'was', 'inversely', 'associated', 'with', 'TD2M', 'after', 'adjusting', 'for', 'potential', 'confounding', 'factors', 'such', 'as', 'age', ',', 'sex', ',', 'smoking', ',', 'body', 'mass', 'index', ',', 'hypertension', ',', 'and', 'lipoprotein', 'subclasses', '(', 'odds', 'ratio', '=', '3.389', ',', '95%', 'confidence', 'interval', '1.069', '–', '14.756', ')', '.']	[4, 1, 1, 1, 3, 1, 6, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 4, 1, 1, 1, 1, 4, 1, 2, 1, 1, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Marked difference between controls and T2DM subjects emerged from the analyses of the associations of the three enzyme activities and lipoprotein subclasses.	[]	['Mark', '##ed', 'difference', 'between', 'controls', 'and', 'T', '##2', '##DM', 'subjects', 'emerged', 'from', 'the', 'analyses', 'of', 'the', 'associations', 'of', 'the', 'three', 'enzyme', 'activities', 'and', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '.']	[0, 4, 7, 18, 26, 35, 39, 40, 41, 44, 53, 61, 66, 70, 79, 82, 86, 99, 102, 106, 112, 119, 130, 134, 137, 139, 143, 146, 149, 150, 154, 156]	[4, 6, 17, 25, 34, 38, 40, 41, 43, 52, 60, 65, 69, 78, 81, 85, 98, 101, 105, 111, 118, 129, 133, 137, 139, 143, 145, 149, 150, 154, 156, 157]	['Marked', 'difference', 'between', 'controls', 'and', 'T2DM', 'subjects', 'emerged', 'from', 'the', 'analyses', 'of', 'the', 'associations', 'of', 'the', 'three', 'enzyme', 'activities', 'and', 'lipoprotein', 'subclasses', '.']	[2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Arylesterase was independently related with large HDL-C and small intermediate-density lipoprotein cholesterol (IDL-C) in controls while, along with lactonase, it was related with small low-density lipoprotein cholesterol LDL-C, all IDL-C subspecies, and very low-density lipoprotein cholesterol (VLDL-C) in T2DM (p < 0.05 for all).	[]	['A', '##ryl', '##ester', '##ase', 'was', 'independently', 'related', 'with', 'large', 'HD', '##L', '-', 'C', 'and', 'small', 'intermediate', '-', 'density', 'lip', '##op', '##rote', '##in', 'ch', '##ole', '##ster', '##ol', '(', 'ID', '##L', '-', 'C', ')', 'in', 'controls', 'while', ',', 'along', 'with', 'la', '##cton', '##ase', ',', 'it', 'was', 'related', 'with', 'small', 'low', '-', 'density', 'lip', '##op', '##rote', '##in', 'ch', '##ole', '##ster', '##ol', 'L', '##D', '##L', '-', 'C', ',', 'all', 'ID', '##L', '-', 'C', 'subspecies', ',', 'and', 'very', 'low', '-', 'density', 'lip', '##op', '##rote', '##in', 'ch', '##ole', '##ster', '##ol', '(', 'V', '##LD', '##L', '-', 'C', ')', 'in', 'T', '##2', '##DM', '(', 'p', '<', '0', '.', '05', 'for', 'all', ')', '.']	[0, 1, 4, 9, 13, 17, 31, 39, 44, 50, 52, 53, 54, 56, 60, 66, 78, 79, 87, 90, 92, 96, 99, 101, 104, 108, 111, 112, 114, 115, 116, 117, 119, 122, 131, 136, 138, 144, 149, 151, 155, 158, 160, 163, 167, 175, 180, 186, 189, 190, 198, 201, 203, 207, 210, 212, 215, 219, 222, 223, 224, 225, 226, 227, 229, 233, 235, 236, 237, 239, 249, 251, 255, 260, 263, 264, 272, 275, 277, 281, 284, 286, 289, 293, 296, 297, 298, 300, 301, 302, 303, 305, 308, 309, 310, 313, 314, 316, 318, 319, 320, 323, 327, 330, 331]	[1, 4, 9, 12, 16, 30, 38, 43, 49, 52, 53, 54, 55, 59, 65, 78, 79, 86, 90, 92, 96, 98, 101, 104, 108, 110, 112, 114, 115, 116, 117, 118, 121, 130, 136, 137, 143, 148, 151, 155, 158, 159, 162, 166, 174, 179, 185, 189, 190, 197, 201, 203, 207, 209, 212, 215, 219, 221, 223, 224, 225, 226, 227, 228, 232, 235, 236, 237, 238, 249, 250, 254, 259, 263, 264, 271, 275, 277, 281, 283, 286, 289, 293, 295, 297, 298, 300, 301, 302, 303, 304, 307, 309, 310, 312, 314, 315, 317, 319, 320, 322, 326, 330, 331, 332]	['Arylesterase', 'was', 'independently', 'related', 'with', 'large', 'HDL-C', 'and', 'small', 'intermediate', '-', 'density', 'lipoprotein', 'cholesterol', '(', 'IDL-C', ')', 'in', 'controls', 'while', ',', 'along', 'with', 'lactonase', ',', 'it', 'was', 'related', 'with', 'small', 'low', '-', 'density', 'lipoprotein', 'cholesterol', 'LDL-C', ',', 'all', 'IDL-C', 'subspecies', ',', 'and', 'very', 'low', '-', 'density', 'lipoprotein', 'cholesterol', '(', 'VLDL-C', ')', 'in', 'T2DM', '(', 'p', '<', '0.05', 'for', 'all', ')', '.']	[4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 4, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 5, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 5, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our study showed that T2DM subjects have lower levels of PON1-arylesterase compared to controls and that T2DM occurrence may coincide with a shift of PON1 and Lp-PLA2 towards the more proatherogenic lipoprotein subclasses.	[]	['Our', 'study', 'showed', 'that', 'T', '##2', '##DM', 'subjects', 'have', 'lower', 'levels', 'of', 'P', '##ON', '##1', '-', 'a', '##ryl', '##ester', '##ase', 'compared', 'to', 'controls', 'and', 'that', 'T', '##2', '##DM', 'occurrence', 'may', 'coincide', 'with', 'a', 'shift', 'of', 'P', '##ON', '##1', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'towards', 'the', 'more', 'pro', '##ather', '##ogenic', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '.']	[0, 4, 10, 17, 22, 23, 24, 27, 36, 41, 47, 54, 57, 58, 60, 61, 62, 63, 66, 71, 75, 84, 87, 96, 100, 105, 106, 107, 110, 121, 125, 134, 139, 141, 147, 150, 151, 153, 155, 159, 160, 161, 162, 163, 165, 167, 175, 179, 184, 187, 192, 199, 202, 204, 208, 211, 214, 215, 219, 221]	[3, 9, 16, 21, 23, 24, 26, 35, 40, 46, 53, 56, 58, 60, 61, 62, 63, 66, 71, 74, 83, 86, 95, 99, 104, 106, 107, 109, 120, 124, 133, 138, 140, 146, 149, 151, 153, 154, 158, 160, 161, 162, 163, 165, 166, 174, 178, 183, 187, 192, 198, 202, 204, 208, 210, 214, 215, 219, 221, 222]	['Our', 'study', 'showed', 'that', 'T2DM', 'subjects', 'have', 'lower', 'levels', 'of', 'PON1-arylesterase', 'compared', 'to', 'controls', 'and', 'that', 'T2DM', 'occurrence', 'may', 'coincide', 'with', 'a', 'shift', 'of', 'PON1', 'and', 'Lp-PLA2', 'towards', 'the', 'more', 'proatherogenic', 'lipoprotein', 'subclasses', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 8, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 1, 1, 3, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In conclusion, the present community-based population study showed that PON1-arylesterase activity is inversely associated with T2DM.	[('PMC6247389', 'C00000', 72, 89, 'PON1-arylesterase')]	['In', 'conclusion', ',', 'the', 'present', 'community', '-', 'based', 'population', 'study', 'showed', 'that', 'P', '##ON', '##1', '-', 'a', '##ryl', '##ester', '##ase', 'activity', 'is', 'inverse', '##ly', 'associated', 'with', 'T', '##2', '##DM', '.']	[0, 3, 13, 15, 19, 27, 36, 37, 43, 54, 60, 67, 72, 73, 75, 76, 77, 78, 81, 86, 90, 99, 102, 109, 112, 123, 128, 129, 130, 132]	[2, 13, 14, 18, 26, 36, 37, 42, 53, 59, 66, 71, 73, 75, 76, 77, 78, 81, 86, 89, 98, 101, 109, 111, 122, 127, 129, 130, 132, 133]	['In', 'conclusion', ',', 'the', 'present', 'community', '-', 'based', 'population', 'study', 'showed', 'that', 'PON1-arylesterase', 'activity', 'is', 'inversely', 'associated', 'with', 'T2DM', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 2, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In overall agreement with previous reports [13, 14, 23], our study showed that PON1-arylesterase, but not PON1-lactonase or Lp-PLA2, activity was decreased in T2DM patients compared to controls.	[('PMC6247389', 'D00000', 79, 96, 'PON1-arylesterase')]	['In', 'overall', 'agreement', 'with', 'previous', 'reports', '[', '13', ',', '14', ',', '23', ']', ',', 'our', 'study', 'showed', 'that', 'P', '##ON', '##1', '-', 'a', '##ryl', '##ester', '##ase', ',', 'but', 'not', 'P', '##ON', '##1', '-', 'la', '##cton', '##ase', 'or', 'L', '##p', '-', 'P', '##LA', '##2', ',', 'activity', 'was', 'decreased', 'in', 'T', '##2', '##DM', 'patients', 'compared', 'to', 'controls', '.']	[0, 3, 11, 21, 26, 35, 43, 44, 46, 48, 50, 52, 54, 55, 57, 61, 67, 74, 79, 80, 82, 83, 84, 85, 88, 93, 96, 98, 102, 106, 107, 109, 110, 111, 113, 117, 121, 124, 125, 126, 127, 128, 130, 131, 133, 142, 146, 156, 159, 160, 161, 164, 173, 182, 185, 193]	[2, 10, 20, 25, 34, 42, 44, 46, 47, 50, 51, 54, 55, 56, 60, 66, 73, 78, 80, 82, 83, 84, 85, 88, 93, 96, 97, 101, 105, 107, 109, 110, 111, 113, 117, 120, 123, 125, 126, 127, 128, 130, 131, 132, 141, 145, 155, 158, 160, 161, 163, 172, 181, 184, 193, 194]	['In', 'overall', 'agreement', 'with', 'previous', 'reports', '[', '13', ',', '14', ',', '23', ']', ',', 'our', 'study', 'showed', 'that', 'PON1-arylesterase', ',', 'but', 'not', 'PON1-lactonase', 'or', 'Lp-PLA2', ',', 'activity', 'was', 'decreased', 'in', 'T2DM', 'patients', 'compared', 'to', 'controls', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 1, 7, 1, 6, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The subsequent analysis of the association between the enzyme activities and lipoprotein subclasses revealed that (1) Lp-pLA2 was associated with small LDL-C, large IDL-C, and VLDL-C in the T2DM group but not in controls and (2) arylesterase was associated only with large/medium HDL-C in controls and only with some of the more proatherogenic ApoB lipoproteins in T2DM subjects.	[]	['The', 'subsequent', 'analysis', 'of', 'the', 'association', 'between', 'the', 'enzyme', 'activities', 'and', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', 'revealed', 'that', '(', '1', ')', 'L', '##p', '-', 'p', '##LA', '##2', 'was', 'associated', 'with', 'small', 'L', '##D', '##L', '-', 'C', ',', 'large', 'ID', '##L', '-', 'C', ',', 'and', 'V', '##LD', '##L', '-', 'C', 'in', 'the', 'T', '##2', '##DM', 'group', 'but', 'not', 'in', 'controls', 'and', '(', '2', ')', 'a', '##ryl', '##ester', '##ase', 'was', 'associated', 'only', 'with', 'large', '/', 'medium', 'HD', '##L', '-', 'C', 'in', 'controls', 'and', 'only', 'with', 'some', 'of', 'the', 'more', 'pro', '##ather', '##ogenic', 'A', '##po', '##B', 'lip', '##op', '##rote', '##ins', 'in', 'T', '##2', '##DM', 'subjects', '.']	[0, 4, 15, 24, 27, 31, 43, 51, 55, 62, 73, 77, 80, 82, 86, 89, 92, 93, 97, 100, 109, 114, 115, 116, 118, 119, 120, 121, 122, 124, 126, 130, 141, 146, 152, 153, 154, 155, 156, 157, 159, 165, 167, 168, 169, 170, 172, 176, 177, 179, 180, 181, 183, 186, 190, 191, 192, 195, 201, 205, 209, 212, 221, 225, 226, 227, 229, 230, 233, 238, 242, 246, 257, 262, 267, 272, 273, 280, 282, 283, 284, 286, 289, 298, 302, 307, 312, 317, 320, 324, 329, 332, 337, 344, 345, 347, 349, 352, 354, 358, 362, 365, 366, 367, 370, 378]	[3, 14, 23, 26, 30, 42, 50, 54, 61, 72, 76, 80, 82, 86, 88, 92, 93, 97, 99, 108, 113, 115, 116, 117, 119, 120, 121, 122, 124, 125, 129, 140, 145, 151, 153, 154, 155, 156, 157, 158, 164, 167, 168, 169, 170, 171, 175, 177, 179, 180, 181, 182, 185, 189, 191, 192, 194, 200, 204, 208, 211, 220, 224, 226, 227, 228, 230, 233, 238, 241, 245, 256, 261, 266, 272, 273, 279, 282, 283, 284, 285, 288, 297, 301, 306, 311, 316, 319, 323, 328, 332, 337, 343, 345, 347, 348, 352, 354, 358, 361, 364, 366, 367, 369, 378, 379]	['The', 'subsequent', 'analysis', 'of', 'the', 'association', 'between', 'the', 'enzyme', 'activities', 'and', 'lipoprotein', 'subclasses', 'revealed', 'that', '(', '1', ')', 'Lp-pLA2', 'was', 'associated', 'with', 'small', 'LDL-C', ',', 'large', 'IDL-C', ',', 'and', 'VLDL-C', 'in', 'the', 'T2DM', 'group', 'but', 'not', 'in', 'controls', 'and', '(', '2', ')', 'arylesterase', 'was', 'associated', 'only', 'with', 'large', '/', 'medium', 'HDL-C', 'in', 'controls', 'and', 'only', 'with', 'some', 'of', 'the', 'more', 'proatherogenic', 'ApoB', 'lipoproteins', 'in', 'T2DM', 'subjects', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 5, 1, 1, 4, 1, 1, 5, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 4, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One of the few certainties in this confusing landscape is the intimate interaction between the lipoprotein environment surrounding PON1 or Lp-PLA2 and their activities [9, 27, 42]; these two accessory proteins are anchored to lipids and some apolipoproteins which also coordinate and modulate their catalytic activity [43].	[('PMC6247389', 'D02000', 139, 146, 'Lp-PLA2')]	['One', 'of', 'the', 'few', 'certain', '##ties', 'in', 'this', 'confusing', 'landscape', 'is', 'the', 'intimate', 'interaction', 'between', 'the', 'lip', '##op', '##rote', '##in', 'environment', 'surrounding', 'P', '##ON', '##1', 'or', 'L', '##p', '-', 'P', '##LA', '##2', 'and', 'their', 'activities', '[', '9', ',', '27', ',', '42', ']', ';', 'these', 'two', 'access', '##ory', 'proteins', 'are', 'anchored', 'to', 'lip', '##ids', 'and', 'some', 'a', '##poli', '##pop', '##rote', '##ins', 'which', 'also', 'coordinate', 'and', 'm', '##od', '##ulate', 'their', 'cat', '##alytic', 'activity', '[', '43', ']', '.']	[0, 4, 7, 11, 15, 22, 27, 30, 35, 45, 55, 58, 62, 71, 83, 91, 95, 98, 100, 104, 107, 119, 131, 132, 134, 136, 139, 140, 141, 142, 143, 145, 147, 151, 157, 168, 169, 170, 172, 174, 176, 178, 179, 181, 187, 191, 197, 201, 210, 214, 223, 226, 229, 233, 237, 242, 243, 247, 250, 254, 258, 264, 269, 280, 284, 285, 287, 293, 299, 302, 309, 318, 319, 321, 322]	[3, 6, 10, 14, 22, 26, 29, 34, 44, 54, 57, 61, 70, 82, 90, 94, 98, 100, 104, 106, 118, 130, 132, 134, 135, 138, 140, 141, 142, 143, 145, 146, 150, 156, 167, 169, 170, 171, 174, 175, 178, 179, 180, 186, 190, 197, 200, 209, 213, 222, 225, 229, 232, 236, 241, 243, 247, 250, 254, 257, 263, 268, 279, 283, 285, 287, 292, 298, 302, 308, 317, 319, 321, 322, 323]	['One', 'of', 'the', 'few', 'certainties', 'in', 'this', 'confusing', 'landscape', 'is', 'the', 'intimate', 'interaction', 'between', 'the', 'lipoprotein', 'environment', 'surrounding', 'PON1', 'or', 'Lp-PLA2', 'and', 'their', 'activities', '[', '9', ',', '27', ',', '42', ']', ';', 'these', 'two', 'accessory', 'proteins', 'are', 'anchored', 'to', 'lipids', 'and', 'some', 'apolipoproteins', 'which', 'also', 'coordinate', 'and', 'modulate', 'their', 'catalytic', 'activity', '[', '43', ']', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 5, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recent improvements in separation techniques have highlighted that PON1 and Lp-PLA2 have a preferential, but not exclusive, distribution within HDL or LDL subclasses [20, 21, 23, 26, 44].	[('PMC6247389', 'D02001', 76, 83, 'Lp-PLA2')]	['Recent', 'improvements', 'in', 'separation', 'techniques', 'have', 'highlighted', 'that', 'P', '##ON', '##1', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'have', 'a', 'prefer', '##ential', ',', 'but', 'not', 'exclusive', ',', 'distribution', 'within', 'HD', '##L', 'or', 'L', '##D', '##L', 'sub', '##c', '##lass', '##es', '[', '20', ',', '21', ',', '23', ',', '26', ',', '44', ']', '.']	[0, 7, 20, 23, 34, 45, 50, 62, 67, 68, 70, 72, 76, 77, 78, 79, 80, 82, 84, 89, 91, 97, 103, 105, 109, 113, 122, 124, 137, 144, 146, 148, 151, 152, 153, 155, 158, 159, 163, 166, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 186]	[6, 19, 22, 33, 44, 49, 61, 66, 68, 70, 71, 75, 77, 78, 79, 80, 82, 83, 88, 90, 97, 103, 104, 108, 112, 122, 123, 136, 143, 146, 147, 150, 152, 153, 154, 158, 159, 163, 165, 167, 169, 170, 173, 174, 177, 178, 181, 182, 185, 186, 187]	['Recent', 'improvements', 'in', 'separation', 'techniques', 'have', 'highlighted', 'that', 'PON1', 'and', 'Lp-PLA2', 'have', 'a', 'preferential', ',', 'but', 'not', 'exclusive', ',', 'distribution', 'within', 'HDL', 'or', 'LDL', 'subclasses', '[', '20', ',', '21', ',', '23', ',', '26', ',', '44', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 6, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This may depend on the “broad” affinity of the enzymes with various apolipoproteins and lipid subspecies that may reach the most suitable combination in the small HDL3 in the case of PON1 and small LDL for Lp-PLA2.	[('PMC6247389', 'D02002', 206, 213, 'Lp-PLA2')]	['This', 'may', 'depend', 'on', 'the', '“', 'broad', '”', 'affinity', 'of', 'the', 'enzymes', 'with', 'various', 'a', '##poli', '##pop', '##rote', '##ins', 'and', 'lip', '##id', 'subspecies', 'that', 'may', 'reach', 'the', 'most', 'suitable', 'combination', 'in', 'the', 'small', 'HD', '##L', '##3', 'in', 'the', 'case', 'of', 'P', '##ON', '##1', 'and', 'small', 'L', '##D', '##L', 'for', 'L', '##p', '-', 'P', '##LA', '##2', '.']	[0, 5, 9, 16, 19, 23, 24, 29, 31, 40, 43, 47, 55, 60, 68, 69, 73, 76, 80, 84, 88, 91, 94, 105, 110, 114, 120, 124, 129, 138, 150, 153, 157, 163, 165, 166, 168, 171, 175, 180, 183, 184, 186, 188, 192, 198, 199, 200, 202, 206, 207, 208, 209, 210, 212, 213]	[4, 8, 15, 18, 22, 24, 29, 30, 39, 42, 46, 54, 59, 67, 69, 73, 76, 80, 83, 87, 91, 93, 104, 109, 113, 119, 123, 128, 137, 149, 152, 156, 162, 165, 166, 167, 170, 174, 179, 182, 184, 186, 187, 191, 197, 199, 200, 201, 205, 207, 208, 209, 210, 212, 213, 214]	['This', 'may', 'depend', 'on', 'the', '“', 'broad', '”', 'affinity', 'of', 'the', 'enzymes', 'with', 'various', 'apolipoproteins', 'and', 'lipid', 'subspecies', 'that', 'may', 'reach', 'the', 'most', 'suitable', 'combination', 'in', 'the', 'small', 'HDL3', 'in', 'the', 'case', 'of', 'PON1', 'and', 'small', 'LDL', 'for', 'Lp-PLA2', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 6, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O']
To the best of our knowledge, this is the first study that evaluated whether the inverse association between arylesterase and T2DM is independent from such large spectrum of lipoprotein subclasses.	[('PMC6247389', 'D03000', 109, 121, 'arylesterase')]	['To', 'the', 'best', 'of', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'study', 'that', 'evaluated', 'whether', 'the', 'inverse', 'association', 'between', 'a', '##ryl', '##ester', '##ase', 'and', 'T', '##2', '##DM', 'is', 'independent', 'from', 'such', 'large', 'spectrum', 'of', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '.']	[0, 3, 7, 12, 15, 19, 28, 30, 35, 38, 42, 48, 54, 59, 69, 77, 81, 89, 101, 109, 110, 113, 118, 122, 126, 127, 128, 131, 134, 146, 151, 156, 162, 171, 174, 177, 179, 183, 186, 189, 190, 194, 196]	[2, 6, 11, 14, 18, 28, 29, 34, 37, 41, 47, 53, 58, 68, 76, 80, 88, 100, 108, 110, 113, 118, 121, 125, 127, 128, 130, 133, 145, 150, 155, 161, 170, 173, 177, 179, 183, 185, 189, 190, 194, 196, 197]	['To', 'the', 'best', 'of', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'study', 'that', 'evaluated', 'whether', 'the', 'inverse', 'association', 'between', 'arylesterase', 'and', 'T2DM', 'is', 'independent', 'from', 'such', 'large', 'spectrum', 'of', 'lipoprotein', 'subclasses', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to address the possibility of influence of the diabetic state over the distribution of Lp-PLA2 and PON1 activities across lipoprotein subspecies, we assessed the simple and adjusted correlation coefficients separately in controls and T2DM subjects.	[('PMC6247389', 'D04000', 96, 103, 'Lp-PLA2')]	['In', 'order', 'to', 'address', 'the', 'possibility', 'of', 'influence', 'of', 'the', 'di', '##abe', '##tic', 'state', 'over', 'the', 'distribution', 'of', 'L', '##p', '-', 'P', '##LA', '##2', 'and', 'P', '##ON', '##1', 'activities', 'across', 'lip', '##op', '##rote', '##in', 'subspecies', ',', 'we', 'assessed', 'the', 'simple', 'and', 'adjusted', 'correlation', 'coefficients', 'separately', 'in', 'controls', 'and', 'T', '##2', '##DM', 'subjects', '.']	[0, 3, 9, 12, 20, 24, 36, 39, 49, 52, 56, 58, 61, 65, 71, 76, 80, 93, 96, 97, 98, 99, 100, 102, 104, 108, 109, 111, 113, 124, 131, 134, 136, 140, 143, 153, 155, 158, 167, 171, 178, 182, 191, 203, 216, 227, 230, 239, 243, 244, 245, 248, 256]	[2, 8, 11, 19, 23, 35, 38, 48, 51, 55, 58, 61, 64, 70, 75, 79, 92, 95, 97, 98, 99, 100, 102, 103, 107, 109, 111, 112, 123, 130, 134, 136, 140, 142, 153, 154, 157, 166, 170, 177, 181, 190, 202, 215, 226, 229, 238, 242, 244, 245, 247, 256, 257]	['In', 'order', 'to', 'address', 'the', 'possibility', 'of', 'influence', 'of', 'the', 'diabetic', 'state', 'over', 'the', 'distribution', 'of', 'Lp-PLA2', 'and', 'PON1', 'activities', 'across', 'lipoprotein', 'subspecies', ',', 'we', 'assessed', 'the', 'simple', 'and', 'adjusted', 'correlation', 'coefficients', 'separately', 'in', 'controls', 'and', 'T2DM', 'subjects', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 6, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The finding that Lp-PLA2 was associated to the small LDL-C, one of the most important risk factors of CVD, is consistent with some studies on isolated lipoproteins showing that in healthy people [51, 52] and, mostly, in diabetics [21], the enzyme is preferentially located in this LDL subclass.	[('PMC6247389', 'D04001', 17, 24, 'Lp-PLA2')]	['The', 'finding', 'that', 'L', '##p', '-', 'P', '##LA', '##2', 'was', 'associated', 'to', 'the', 'small', 'L', '##D', '##L', '-', 'C', ',', 'one', 'of', 'the', 'most', 'important', 'risk', 'factors', 'of', 'C', '##VD', ',', 'is', 'consistent', 'with', 'some', 'studies', 'on', 'isolated', 'lip', '##op', '##rote', '##ins', 'showing', 'that', 'in', 'healthy', 'people', '[', '51', ',', '52', ']', 'and', ',', 'mostly', ',', 'in', 'di', '##abe', '##tics', '[', '21', ']', ',', 'the', 'enzyme', 'is', 'prefer', '##ential', '##ly', 'located', 'in', 'this', 'L', '##D', '##L', 'sub', '##c', '##lass', '.']	[0, 4, 12, 17, 18, 19, 20, 21, 23, 25, 29, 40, 43, 47, 53, 54, 55, 56, 57, 58, 60, 64, 67, 71, 76, 86, 91, 99, 102, 103, 105, 107, 110, 121, 126, 131, 139, 142, 151, 154, 156, 160, 164, 172, 177, 180, 188, 195, 196, 198, 200, 202, 204, 207, 209, 215, 217, 220, 222, 225, 230, 231, 233, 234, 236, 240, 247, 250, 256, 262, 265, 273, 276, 281, 282, 283, 285, 288, 289, 293]	[3, 11, 16, 18, 19, 20, 21, 23, 24, 28, 39, 42, 46, 52, 54, 55, 56, 57, 58, 59, 63, 66, 70, 75, 85, 90, 98, 101, 103, 105, 106, 109, 120, 125, 130, 138, 141, 150, 154, 156, 160, 163, 171, 176, 179, 187, 194, 196, 198, 199, 202, 203, 207, 208, 215, 216, 219, 222, 225, 229, 231, 233, 234, 235, 239, 246, 249, 256, 262, 264, 272, 275, 280, 282, 283, 284, 288, 289, 293, 294]	['The', 'finding', 'that', 'Lp-PLA2', 'was', 'associated', 'to', 'the', 'small', 'LDL-C', ',', 'one', 'of', 'the', 'most', 'important', 'risk', 'factors', 'of', 'CVD', ',', 'is', 'consistent', 'with', 'some', 'studies', 'on', 'isolated', 'lipoproteins', 'showing', 'that', 'in', 'healthy', 'people', '[', '51', ',', '52', ']', 'and', ',', 'mostly', ',', 'in', 'diabetics', '[', '21', ']', ',', 'the', 'enzyme', 'is', 'preferentially', 'located', 'in', 'this', 'LDL', 'subclass', '.']	[1, 1, 1, 6, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 3, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Failure in detecting a significant correlation of Lp-PLA2 with small LDL-C in controls may be the result of the low levels of this subclass in this group (Table 2).	[('PMC6247389', 'D04002', 50, 57, 'Lp-PLA2')]	['F', '##ail', '##ure', 'in', 'detect', '##ing', 'a', 'significant', 'correlation', 'of', 'L', '##p', '-', 'P', '##LA', '##2', 'with', 'small', 'L', '##D', '##L', '-', 'C', 'in', 'controls', 'may', 'be', 'the', 'result', 'of', 'the', 'low', 'levels', 'of', 'this', 'sub', '##c', '##lass', 'in', 'this', 'group', '(', 'Table', '2', ')', '.']	[0, 1, 4, 8, 11, 17, 21, 23, 35, 47, 50, 51, 52, 53, 54, 56, 58, 63, 69, 70, 71, 72, 73, 75, 78, 87, 91, 94, 98, 105, 108, 112, 116, 123, 126, 131, 134, 135, 140, 143, 148, 154, 155, 161, 162, 163]	[1, 4, 7, 10, 17, 20, 22, 34, 46, 49, 51, 52, 53, 54, 56, 57, 62, 68, 70, 71, 72, 73, 74, 77, 86, 90, 93, 97, 104, 107, 111, 115, 122, 125, 130, 134, 135, 139, 142, 147, 153, 155, 160, 162, 163, 164]	['Failure', 'in', 'detecting', 'a', 'significant', 'correlation', 'of', 'Lp-PLA2', 'with', 'small', 'LDL-C', 'in', 'controls', 'may', 'be', 'the', 'result', 'of', 'the', 'low', 'levels', 'of', 'this', 'subclass', 'in', 'this', 'group', '(', 'Table', '2', ')', '.']	[3, 1, 2, 1, 1, 1, 1, 6, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alternatively, it can also be hypothesized that ApoB lipoproteins may be enriched in active Lp-PLA2 in T2DM patients and this could reflect in a further selective increase in proatherosclerotic potentials of these particles.	[('PMC6247389', 'D04003', 92, 99, 'Lp-PLA2')]	['Alternatively', ',', 'it', 'can', 'also', 'be', 'h', '##y', '##pot', '##hes', '##ized', 'that', 'A', '##po', '##B', 'lip', '##op', '##rote', '##ins', 'may', 'be', 'en', '##rich', '##ed', 'in', 'active', 'L', '##p', '-', 'P', '##LA', '##2', 'in', 'T', '##2', '##DM', 'patients', 'and', 'this', 'could', 'reflect', 'in', 'a', 'further', 'selective', 'increase', 'in', 'pro', '##ather', '##os', '##cle', '##rot', '##ic', 'potential', '##s', 'of', 'these', 'particles', '.']	[0, 13, 15, 18, 22, 27, 30, 31, 32, 35, 38, 43, 48, 49, 51, 53, 56, 58, 62, 66, 70, 73, 75, 79, 82, 85, 92, 93, 94, 95, 96, 98, 100, 103, 104, 105, 108, 117, 121, 126, 132, 140, 143, 145, 153, 163, 172, 175, 178, 183, 185, 188, 191, 194, 203, 205, 208, 214, 223]	[13, 14, 17, 21, 26, 29, 31, 32, 35, 38, 42, 47, 49, 51, 52, 56, 58, 62, 65, 69, 72, 75, 79, 81, 84, 91, 93, 94, 95, 96, 98, 99, 102, 104, 105, 107, 116, 120, 125, 131, 139, 142, 144, 152, 162, 171, 174, 178, 183, 185, 188, 191, 193, 203, 204, 207, 213, 223, 224]	['Alternatively', ',', 'it', 'can', 'also', 'be', 'hypothesized', 'that', 'ApoB', 'lipoproteins', 'may', 'be', 'enriched', 'in', 'active', 'Lp-PLA2', 'in', 'T2DM', 'patients', 'and', 'this', 'could', 'reflect', 'in', 'a', 'further', 'selective', 'increase', 'in', 'proatherosclerotic', 'potentials', 'of', 'these', 'particles', '.']	[1, 1, 1, 1, 1, 1, 5, 1, 3, 4, 1, 1, 3, 1, 1, 6, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Within this assumption, the lack of correlation between arylesterase and large/medium HDL-C in the T2DM group may be the result of the marked decrease in the concentration of these subclasses (Table 2) and, thus, of the fraction of PON1 complexed with these particles.	[]	['Within', 'this', 'assumption', ',', 'the', 'lack', 'of', 'correlation', 'between', 'a', '##ryl', '##ester', '##ase', 'and', 'large', '/', 'medium', 'HD', '##L', '-', 'C', 'in', 'the', 'T', '##2', '##DM', 'group', 'may', 'be', 'the', 'result', 'of', 'the', 'marked', 'decrease', 'in', 'the', 'concentration', 'of', 'these', 'sub', '##c', '##lass', '##es', '(', 'Table', '2', ')', 'and', ',', 'thus', ',', 'of', 'the', 'fraction', 'of', 'P', '##ON', '##1', 'complex', '##ed', 'with', 'these', 'particles', '.']	[0, 7, 12, 22, 24, 28, 33, 36, 48, 56, 57, 60, 65, 69, 73, 78, 79, 86, 88, 89, 90, 92, 95, 99, 100, 101, 104, 110, 114, 117, 121, 128, 131, 135, 142, 151, 154, 158, 172, 175, 181, 184, 185, 189, 192, 193, 199, 200, 202, 205, 207, 211, 213, 216, 220, 229, 232, 233, 235, 237, 244, 247, 252, 258, 267]	[6, 11, 22, 23, 27, 32, 35, 47, 55, 57, 60, 65, 68, 72, 78, 79, 85, 88, 89, 90, 91, 94, 98, 100, 101, 103, 109, 113, 116, 120, 127, 130, 134, 141, 150, 153, 157, 171, 174, 180, 184, 185, 189, 191, 193, 198, 200, 201, 205, 206, 211, 212, 215, 219, 228, 231, 233, 235, 236, 244, 246, 251, 257, 267, 268]	['Within', 'this', 'assumption', ',', 'the', 'lack', 'of', 'correlation', 'between', 'arylesterase', 'and', 'large', '/', 'medium', 'HDL-C', 'in', 'the', 'T2DM', 'group', 'may', 'be', 'the', 'result', 'of', 'the', 'marked', 'decrease', 'in', 'the', 'concentration', 'of', 'these', 'subclasses', '(', 'Table', '2', ')', 'and', ',', 'thus', ',', 'of', 'the', 'fraction', 'of', 'PON1', 'complexed', 'with', 'these', 'particles', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
On the other hand, the exclusive association of arylesterase and lactonase with large/medium IDL, small LDL, and VLDL among T2DM patients might simply reflect the concomitant increase in the levels of these lipoproteins.	[]	['On', 'the', 'other', 'hand', ',', 'the', 'exclusive', 'association', 'of', 'a', '##ryl', '##ester', '##ase', 'and', 'la', '##cton', '##ase', 'with', 'large', '/', 'medium', 'ID', '##L', ',', 'small', 'L', '##D', '##L', ',', 'and', 'V', '##LD', '##L', 'among', 'T', '##2', '##DM', 'patients', 'might', 'simply', 'reflect', 'the', 'con', '##com', '##ita', '##nt', 'increase', 'in', 'the', 'levels', 'of', 'these', 'lip', '##op', '##rote', '##ins', '.']	[0, 3, 7, 13, 17, 19, 23, 33, 45, 48, 49, 52, 57, 61, 65, 67, 71, 75, 80, 85, 86, 93, 95, 96, 98, 104, 105, 106, 107, 109, 113, 114, 116, 118, 124, 125, 126, 129, 138, 144, 151, 159, 163, 166, 169, 172, 175, 184, 187, 191, 198, 201, 207, 210, 212, 216, 219]	[2, 6, 12, 17, 18, 22, 32, 44, 47, 49, 52, 57, 60, 64, 67, 71, 74, 79, 85, 86, 92, 95, 96, 97, 103, 105, 106, 107, 108, 112, 114, 116, 117, 123, 125, 126, 128, 137, 143, 150, 158, 162, 166, 169, 172, 174, 183, 186, 190, 197, 200, 206, 210, 212, 216, 219, 220]	['On', 'the', 'other', 'hand', ',', 'the', 'exclusive', 'association', 'of', 'arylesterase', 'and', 'lactonase', 'with', 'large', '/', 'medium', 'IDL', ',', 'small', 'LDL', ',', 'and', 'VLDL', 'among', 'T2DM', 'patients', 'might', 'simply', 'reflect', 'the', 'concomitant', 'increase', 'in', 'the', 'levels', 'of', 'these', 'lipoproteins', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In T2DM patients, PON1 is still bound in HDL, as suggested by the strong correlation between arylesterase and total HDL-C, but most likely, it is more evenly distributed among the subspecies of this lipoprotein compared to controls.	[]	['In', 'T', '##2', '##DM', 'patients', ',', 'P', '##ON', '##1', 'is', 'still', 'bound', 'in', 'HD', '##L', ',', 'as', 'suggested', 'by', 'the', 'strong', 'correlation', 'between', 'a', '##ryl', '##ester', '##ase', 'and', 'total', 'HD', '##L', '-', 'C', ',', 'but', 'most', 'likely', ',', 'it', 'is', 'more', 'evenly', 'distributed', 'among', 'the', 'subspecies', 'of', 'this', 'lip', '##op', '##rote', '##in', 'compared', 'to', 'controls', '.']	[0, 3, 4, 5, 8, 16, 18, 19, 21, 23, 26, 32, 38, 41, 43, 44, 46, 49, 59, 62, 66, 73, 85, 93, 94, 97, 102, 106, 110, 116, 118, 119, 120, 121, 123, 127, 132, 138, 140, 143, 146, 151, 158, 170, 176, 180, 191, 194, 199, 202, 204, 208, 211, 220, 223, 231]	[2, 4, 5, 7, 16, 17, 19, 21, 22, 25, 31, 37, 40, 43, 44, 45, 48, 58, 61, 65, 72, 84, 92, 94, 97, 102, 105, 109, 115, 118, 119, 120, 121, 122, 126, 131, 138, 139, 142, 145, 150, 157, 169, 175, 179, 190, 193, 198, 202, 204, 208, 210, 219, 222, 231, 232]	['In', 'T2DM', 'patients', ',', 'PON1', 'is', 'still', 'bound', 'in', 'HDL', ',', 'as', 'suggested', 'by', 'the', 'strong', 'correlation', 'between', 'arylesterase', 'and', 'total', 'HDL-C', ',', 'but', 'most', 'likely', ',', 'it', 'is', 'more', 'evenly', 'distributed', 'among', 'the', 'subspecies', 'of', 'this', 'lipoprotein', 'compared', 'to', 'controls', '.']	[1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To address this still open question, the present population-based study sought to determine the link of T2DM with PON1 and Lp-PLA2 activities and, most importantly, to evaluate whether the disease might affect the distribution of these two enzymes across lipoprotein subclasses.	[('PMC6247389', 'I04000', 123, 130, 'Lp-PLA2')]	['To', 'address', 'this', 'still', 'open', 'question', ',', 'the', 'present', 'population', '-', 'based', 'study', 'sought', 'to', 'determine', 'the', 'link', 'of', 'T', '##2', '##DM', 'with', 'P', '##ON', '##1', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'activities', 'and', ',', 'most', 'importantly', ',', 'to', 'evaluate', 'whether', 'the', 'disease', 'might', 'affect', 'the', 'distribution', 'of', 'these', 'two', 'enzymes', 'across', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '.']	[0, 3, 11, 16, 22, 27, 35, 37, 41, 49, 59, 60, 66, 72, 79, 82, 92, 96, 101, 104, 105, 106, 109, 114, 115, 117, 119, 123, 124, 125, 126, 127, 129, 131, 142, 145, 147, 152, 163, 165, 168, 177, 185, 189, 197, 203, 210, 214, 227, 230, 236, 240, 248, 255, 258, 260, 264, 267, 270, 271, 275, 277]	[2, 10, 15, 21, 26, 35, 36, 40, 48, 59, 60, 65, 71, 78, 81, 91, 95, 100, 103, 105, 106, 108, 113, 115, 117, 118, 122, 124, 125, 126, 127, 129, 130, 141, 145, 146, 151, 163, 164, 167, 176, 184, 188, 196, 202, 209, 213, 226, 229, 235, 239, 247, 254, 258, 260, 264, 266, 270, 271, 275, 277, 278]	['To', 'address', 'this', 'still', 'open', 'question', ',', 'the', 'present', 'population', '-', 'based', 'study', 'sought', 'to', 'determine', 'the', 'link', 'of', 'T2DM', 'with', 'PON1', 'and', 'Lp-PLA2', 'activities', 'and', ',', 'most', 'importantly', ',', 'to', 'evaluate', 'whether', 'the', 'disease', 'might', 'affect', 'the', 'distribution', 'of', 'these', 'two', 'enzymes', 'across', 'lipoprotein', 'subclasses', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Arylesterase and lactonase activities of PON1 and Lp-PLA2 activity in serum were measured by UV-VIS spectrophotometric assays in a 96-well plate format by using a Tecan Infinite M200 microplate reader (Tecan Group Ltd., Switzerland).	[('PMC6247389', 'M05000', 0, 12, 'Arylesterase')]	['A', '##ryl', '##ester', '##ase', 'and', 'la', '##cton', '##ase', 'activities', 'of', 'P', '##ON', '##1', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'activity', 'in', 'serum', 'were', 'measured', 'by', 'UV', '-', 'VI', '##S', 's', '##pect', '##rop', '##hot', '##ometric', 'ass', '##ays', 'in', 'a', '96', '-', 'well', 'plate', 'format', 'by', 'using', 'a', 'Te', '##can', 'Infinite', 'M', '##20', '##0', 'micro', '##plate', 'reader', '(', 'Te', '##can', 'Group', 'Ltd', '.', ',', 'Switzerland', ')', '.']	[0, 1, 4, 9, 13, 17, 19, 23, 27, 38, 41, 42, 44, 46, 50, 51, 52, 53, 54, 56, 58, 67, 70, 76, 81, 90, 93, 95, 96, 98, 100, 101, 105, 108, 111, 119, 122, 126, 129, 131, 133, 134, 139, 145, 152, 155, 161, 163, 165, 169, 178, 179, 181, 183, 188, 194, 201, 202, 204, 208, 214, 217, 218, 220, 231, 232]	[1, 4, 9, 12, 16, 19, 23, 26, 37, 40, 42, 44, 45, 49, 51, 52, 53, 54, 56, 57, 66, 69, 75, 80, 89, 92, 95, 96, 98, 99, 101, 105, 108, 111, 118, 122, 125, 128, 130, 133, 134, 138, 144, 151, 154, 160, 162, 165, 168, 177, 179, 181, 182, 188, 193, 200, 202, 204, 207, 213, 217, 218, 219, 231, 232, 233]	['Arylesterase', 'and', 'lactonase', 'activities', 'of', 'PON1', 'and', 'Lp-PLA2', 'activity', 'in', 'serum', 'were', 'measured', 'by', 'UV-VIS', 'spectrophotometric', 'assays', 'in', 'a', '96-well', 'plate', 'format', 'by', 'using', 'a', 'Tecan', 'Infinite', 'M200', 'microplate', 'reader', '(', 'Tecan', 'Group', 'Ltd', '.', ',', 'Switzerland', ')', '.']	[4, 1, 3, 1, 1, 3, 1, 6, 1, 1, 1, 1, 1, 1, 4, 5, 2, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Arylesterase activity was measured by using phenylacetate as substrate [31].	[('PMC6247389', 'M06000', 0, 12, 'Arylesterase')]	['A', '##ryl', '##ester', '##ase', 'activity', 'was', 'measured', 'by', 'using', 'p', '##hen', '##yla', '##ce', '##tate', 'as', 'substrate', '[', '31', ']', '.']	[0, 1, 4, 9, 13, 22, 26, 35, 38, 44, 45, 48, 51, 53, 58, 61, 71, 72, 74, 75]	[1, 4, 9, 12, 21, 25, 34, 37, 43, 45, 48, 51, 53, 57, 60, 70, 72, 74, 75, 76]	['Arylesterase', 'activity', 'was', 'measured', 'by', 'using', 'phenylacetate', 'as', 'substrate', '[', '31', ']', '.']	[4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lactonase activity was assessed using gamma-thiobutyrolactone (TBL) as substrate, and Ellman's procedure was used to spectrophotometrically monitor the accumulation of free sulfhydryl groups via coupling with 5,5-dithiobis (2-nitrobenzoic acid)	[('PMC6247389', 'M07000', 0, 9, 'Lactonase')]	"['Lac', '##ton', '##ase', 'activity', 'was', 'assessed', 'using', 'gamma', '-', 'th', '##io', '##but', '##yr', '##ola', '##cton', '##e', '(', 'T', '##BL', ')', 'as', 'substrate', ',', 'and', 'El', '##lman', ""'"", 's', 'procedure', 'was', 'used', 'to', 's', '##pect', '##rop', '##hot', '##ometric', '##ally', 'monitor', 'the', 'accumulation', 'of', 'free', 'su', '##lf', '##hy', '##dr', '##yl', 'groups', 'via', 'coupling', 'with', '5', ',', '5', '-', 'di', '##thi', '##ob', '##is', '(', '2', '-', 'ni', '##tro', '##ben', '##zoic', 'acid', ')']"	[0, 3, 6, 10, 19, 23, 32, 38, 43, 44, 46, 48, 51, 53, 56, 60, 62, 63, 64, 66, 68, 71, 80, 82, 86, 88, 92, 93, 95, 105, 109, 114, 117, 118, 122, 125, 128, 135, 140, 148, 152, 165, 168, 173, 175, 177, 179, 181, 184, 191, 195, 204, 209, 210, 211, 212, 213, 215, 218, 220, 223, 224, 225, 226, 228, 231, 234, 239, 243]	[3, 6, 9, 18, 22, 31, 37, 43, 44, 46, 48, 51, 53, 56, 60, 61, 63, 64, 66, 67, 70, 80, 81, 85, 88, 92, 93, 94, 104, 108, 113, 116, 118, 122, 125, 128, 135, 139, 147, 151, 164, 167, 172, 175, 177, 179, 181, 183, 190, 194, 203, 208, 210, 211, 212, 213, 215, 218, 220, 222, 224, 225, 226, 228, 231, 234, 238, 243, 244]	"['Lactonase', 'activity', 'was', 'assessed', 'using', 'gamma', '-', 'thiobutyrolactone', '(', 'TBL', ')', 'as', 'substrate', ',', 'and', ""Ellman's"", 'procedure', 'was', 'used', 'to', 'spectrophotometrically', 'monitor', 'the', 'accumulation', 'of', 'free', 'sulfhydryl', 'groups', 'via', 'coupling', 'with', '5', ',', '5-dithiobis', '(', '2-nitrobenzoic', 'acid', ')']"	[3, 1, 1, 1, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 6, 1, 6, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lp-PLA2 was assessed by using 2-thio PAF as substrate, which is hydrolyzed by the enzyme in sn-2 position, and the consequent formation of free thiols was detected by Ellman's procedure.	[('PMC6247389', 'M08000', 0, 7, 'Lp-PLA2')]	"['L', '##p', '-', 'P', '##LA', '##2', 'was', 'assessed', 'by', 'using', '2', '-', 'th', '##io', 'PA', '##F', 'as', 'substrate', ',', 'which', 'is', 'h', '##ydro', '##ly', '##zed', 'by', 'the', 'enzyme', 'in', 's', '##n', '-', '2', 'position', ',', 'and', 'the', 'con', '##se', '##quent', 'formation', 'of', 'free', 'th', '##iol', '##s', 'was', 'detected', 'by', 'El', '##lman', ""'"", 's', 'procedure', '.']"	[0, 1, 2, 3, 4, 6, 8, 12, 21, 24, 30, 31, 32, 34, 37, 39, 41, 44, 53, 55, 61, 64, 65, 69, 71, 75, 78, 82, 89, 92, 93, 94, 95, 97, 105, 107, 111, 115, 118, 120, 126, 136, 139, 144, 146, 149, 151, 155, 164, 167, 169, 173, 174, 176, 185]	[1, 2, 3, 4, 6, 7, 11, 20, 23, 29, 31, 32, 34, 36, 39, 40, 43, 53, 54, 60, 63, 65, 69, 71, 74, 77, 81, 88, 91, 93, 94, 95, 96, 105, 106, 110, 114, 118, 120, 125, 135, 138, 143, 146, 149, 150, 154, 163, 166, 169, 173, 174, 175, 185, 186]	"['Lp-PLA2', 'was', 'assessed', 'by', 'using', '2-thio', 'PAF', 'as', 'substrate', ',', 'which', 'is', 'hydrolyzed', 'by', 'the', 'enzyme', 'in', 'sn-2', 'position', ',', 'and', 'the', 'consequent', 'formation', 'of', 'free', 'thiols', 'was', 'detected', 'by', ""Ellman's"", 'procedure', '.']"	[6, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Since the distribution of arylesterase, lactonase, and Lp-PLA2 analyzed by Kolmogorov-Smirnov test was skewed, the values were log transformed in order to approximate a normal distribution before being analyzed by parametric tests.	[('PMC6247389', 'M11000', 26, 38, 'arylesterase')]	['Since', 'the', 'distribution', 'of', 'a', '##ryl', '##ester', '##ase', ',', 'la', '##cton', '##ase', ',', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'analyzed', 'by', 'Ko', '##lm', '##ogo', '##rov', '-', 'S', '##mir', '##nov', 'test', 'was', 's', '##ke', '##wed', ',', 'the', 'values', 'were', 'log', 'transformed', 'in', 'order', 'to', 'approximate', 'a', 'normal', 'distribution', 'before', 'being', 'analyzed', 'by', 'para', '##metric', 'tests', '.']	[0, 6, 10, 23, 26, 27, 30, 35, 38, 40, 42, 46, 49, 51, 55, 56, 57, 58, 59, 61, 63, 72, 75, 77, 79, 82, 85, 86, 87, 90, 94, 99, 103, 104, 106, 109, 111, 115, 122, 127, 131, 143, 146, 152, 155, 167, 169, 176, 189, 196, 202, 211, 214, 218, 225, 230]	[5, 9, 22, 25, 27, 30, 35, 38, 39, 42, 46, 49, 50, 54, 56, 57, 58, 59, 61, 62, 71, 74, 77, 79, 82, 85, 86, 87, 90, 93, 98, 102, 104, 106, 109, 110, 114, 121, 126, 130, 142, 145, 151, 154, 166, 168, 175, 188, 195, 201, 210, 213, 218, 224, 230, 231]	['Since', 'the', 'distribution', 'of', 'arylesterase', ',', 'lactonase', ',', 'and', 'Lp-PLA2', 'analyzed', 'by', 'Kolmogorov-Smirnov', 'test', 'was', 'skewed', ',', 'the', 'values', 'were', 'log', 'transformed', 'in', 'order', 'to', 'approximate', 'a', 'normal', 'distribution', 'before', 'being', 'analyzed', 'by', 'parametric', 'tests', '.']	[1, 1, 1, 1, 4, 1, 3, 1, 1, 6, 1, 1, 8, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among the three serum enzyme activities assessed in this study, only PON1-arylesterase exhibited a significant change between groups.	[('PMC6247389', 'R01000', 69, 86, 'PON1-arylesterase')]	['Among', 'the', 'three', 'serum', 'enzyme', 'activities', 'assessed', 'in', 'this', 'study', ',', 'only', 'P', '##ON', '##1', '-', 'a', '##ryl', '##ester', '##ase', 'exhibited', 'a', 'significant', 'change', 'between', 'groups', '.']	[0, 6, 10, 16, 22, 29, 40, 49, 52, 57, 62, 64, 69, 70, 72, 73, 74, 75, 78, 83, 87, 97, 99, 111, 118, 126, 132]	[5, 9, 15, 21, 28, 39, 48, 51, 56, 62, 63, 68, 70, 72, 73, 74, 75, 78, 83, 86, 96, 98, 110, 117, 125, 132, 133]	['Among', 'the', 'three', 'serum', 'enzyme', 'activities', 'assessed', 'in', 'this', 'study', ',', 'only', 'PON1-arylesterase', 'exhibited', 'a', 'significant', 'change', 'between', 'groups', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
More specifically, as compared to controls, arylesterase was significantly (p < 0.001) decreased by 20% in participants with T2DM (78 ± 25 vs. 99 ± 31 kU/L) (Figure 1(a)).	[('PMC6247389', 'R01001', 44, 56, 'arylesterase')]	['More', 'specifically', ',', 'as', 'compared', 'to', 'controls', ',', 'a', '##ryl', '##ester', '##ase', 'was', 'significantly', '(', 'p', '<', '0', '.', '00', '##1', ')', 'decreased', 'by', '20', '%', 'in', 'participants', 'with', 'T', '##2', '##DM', '(', '78', '±', '25', 'vs', '.', '99', '±', '31', 'k', '##U', '/', 'L', ')', '(', 'Figure', '1', '(', 'a', ')', ')', '.']	[0, 5, 17, 19, 22, 31, 34, 42, 44, 45, 48, 53, 57, 61, 75, 76, 78, 80, 81, 82, 84, 85, 87, 97, 100, 102, 104, 107, 120, 125, 126, 127, 130, 131, 134, 136, 139, 141, 143, 146, 148, 151, 152, 153, 154, 155, 157, 158, 165, 166, 167, 168, 169, 170]	[4, 17, 18, 21, 30, 33, 42, 43, 45, 48, 53, 56, 60, 74, 76, 77, 79, 81, 82, 84, 85, 86, 96, 99, 102, 103, 106, 119, 124, 126, 127, 129, 131, 133, 135, 138, 141, 142, 145, 147, 150, 152, 153, 154, 155, 156, 158, 164, 166, 167, 168, 169, 170, 171]	['More', 'specifically', ',', 'as', 'compared', 'to', 'controls', ',', 'arylesterase', 'was', 'significantly', '(', 'p', '<', '0.001', ')', 'decreased', 'by', '20%', 'in', 'participants', 'with', 'T2DM', '(', '78', '±', '25', 'vs', '.', '99', '±', '31', 'kU', '/', 'L', ')', '(', 'Figure', '1(a)', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, either lactonase (p = 0.220) or Lp-PLA2 (p = 0.280) was not significantly different between the two groups (Figures 1(b) and 1(c)).	[('PMC6247389', 'R01002', 20, 29, 'lactonase')]	['In', 'contrast', ',', 'either', 'la', '##cton', '##ase', '(', 'p', '=', '0', '.', '220', ')', 'or', 'L', '##p', '-', 'P', '##LA', '##2', '(', 'p', '=', '0', '.', '280', ')', 'was', 'not', 'significantly', 'different', 'between', 'the', 'two', 'groups', '(', 'Figure', '##s', '1', '(', 'b', ')', 'and', '1', '(', 'c', ')', ')', '.']	[0, 3, 11, 13, 20, 22, 26, 30, 31, 33, 35, 36, 37, 40, 42, 45, 46, 47, 48, 49, 51, 53, 54, 56, 58, 59, 60, 63, 65, 69, 73, 87, 97, 105, 109, 113, 120, 121, 127, 129, 130, 131, 132, 134, 138, 139, 140, 141, 142, 143]	[2, 11, 12, 19, 22, 26, 29, 31, 32, 34, 36, 37, 40, 41, 44, 46, 47, 48, 49, 51, 52, 54, 55, 57, 59, 60, 63, 64, 68, 72, 86, 96, 104, 108, 112, 119, 121, 127, 128, 130, 131, 132, 133, 137, 139, 140, 141, 142, 143, 144]	['In', 'contrast', ',', 'either', 'lactonase', '(', 'p', '=', '0.220', ')', 'or', 'Lp-PLA2', '(', 'p', '=', '0.280', ')', 'was', 'not', 'significantly', 'different', 'between', 'the', 'two', 'groups', '(', 'Figures', '1(b)', 'and', '1(c)', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 6, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to check whether the observed decrease in arylesterase activity was influenced by confounding factors of PON1 such as age and gender, we compared this activity between subgroups of 85 controls and 85 diabetics with similar age and prevalence of women/men (Supplementary Table 1).	[('PMC6247389', 'R02000', 51, 63, 'arylesterase')]	['In', 'order', 'to', 'check', 'whether', 'the', 'observed', 'decrease', 'in', 'a', '##ryl', '##ester', '##ase', 'activity', 'was', 'influenced', 'by', 'con', '##found', '##ing', 'factors', 'of', 'P', '##ON', '##1', 'such', 'as', 'age', 'and', 'gender', ',', 'we', 'compared', 'this', 'activity', 'between', 'subgroup', '##s', 'of', '85', 'controls', 'and', '85', 'di', '##abe', '##tics', 'with', 'similar', 'age', 'and', 'prevalence', 'of', 'women', '/', 'men', '(', 'Su', '##pp', '##lement', '##ary', 'Table', '1', ')', '.']	[0, 3, 9, 12, 18, 26, 30, 39, 48, 51, 52, 55, 60, 64, 73, 77, 88, 91, 94, 99, 103, 111, 114, 115, 117, 119, 124, 127, 131, 135, 141, 143, 146, 155, 160, 169, 177, 185, 187, 190, 193, 202, 206, 209, 211, 214, 219, 224, 232, 236, 240, 251, 254, 259, 260, 264, 265, 267, 269, 275, 279, 285, 286, 287]	[2, 8, 11, 17, 25, 29, 38, 47, 50, 52, 55, 60, 63, 72, 76, 87, 90, 94, 99, 102, 110, 113, 115, 117, 118, 123, 126, 130, 134, 141, 142, 145, 154, 159, 168, 176, 185, 186, 189, 192, 201, 205, 208, 211, 214, 218, 223, 231, 235, 239, 250, 253, 259, 260, 263, 265, 267, 269, 275, 278, 284, 286, 287, 288]	['In', 'order', 'to', 'check', 'whether', 'the', 'observed', 'decrease', 'in', 'arylesterase', 'activity', 'was', 'influenced', 'by', 'confounding', 'factors', 'of', 'PON1', 'such', 'as', 'age', 'and', 'gender', ',', 'we', 'compared', 'this', 'activity', 'between', 'subgroups', 'of', '85', 'controls', 'and', '85', 'diabetics', 'with', 'similar', 'age', 'and', 'prevalence', 'of', 'women', '/', 'men', '(', 'Supplementary', 'Table', '1', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
From this analysis, it emerged that the difference in arylesterase was less marked than that found in the whole sample (11%), but still significant (p = 0.003).	[('PMC6247389', 'R02001', 54, 66, 'arylesterase')]	['From', 'this', 'analysis', ',', 'it', 'emerged', 'that', 'the', 'difference', 'in', 'a', '##ryl', '##ester', '##ase', 'was', 'less', 'marked', 'than', 'that', 'found', 'in', 'the', 'whole', 'sample', '(', '11', '%', ')', ',', 'but', 'still', 'significant', '(', 'p', '=', '0', '.', '00', '##3', ')', '.']	[0, 5, 10, 18, 20, 23, 31, 36, 40, 51, 54, 55, 58, 63, 67, 71, 76, 83, 88, 93, 99, 102, 106, 112, 119, 120, 122, 123, 124, 126, 130, 136, 148, 149, 151, 153, 154, 155, 157, 158, 159]	[4, 9, 18, 19, 22, 30, 35, 39, 50, 53, 55, 58, 63, 66, 70, 75, 82, 87, 92, 98, 101, 105, 111, 118, 120, 122, 123, 124, 125, 129, 135, 147, 149, 150, 152, 154, 155, 157, 158, 159, 160]	['From', 'this', 'analysis', ',', 'it', 'emerged', 'that', 'the', 'difference', 'in', 'arylesterase', 'was', 'less', 'marked', 'than', 'that', 'found', 'in', 'the', 'whole', 'sample', '(', '11%', ')', ',', 'but', 'still', 'significant', '(', 'p', '=', '0.003', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The quantification of lipoprotein subfraction distribution was carried out on a subsample, Lipoprint, including 202 controls and 90 T2DM subjects, in order to (1) identify additional potential confounders of the association between arylesterase activity and T2DM and (2) explore the effect of T2DM on the distribution of PON1 activities and Lp-PLA2 on lipoprotein subclasses.	[('PMC6247389', 'R03000', 232, 244, 'arylesterase')]	['The', 'q', '##uant', '##ification', 'of', 'lip', '##op', '##rote', '##in', 'sub', '##fra', '##ction', 'distribution', 'was', 'carried', 'out', 'on', 'a', 'sub', '##sa', '##mple', ',', 'Li', '##pop', '##rin', '##t', ',', 'including', '202', 'controls', 'and', '90', 'T', '##2', '##DM', 'subjects', ',', 'in', 'order', 'to', '(', '1', ')', 'identify', 'additional', 'potential', 'con', '##found', '##ers', 'of', 'the', 'association', 'between', 'a', '##ryl', '##ester', '##ase', 'activity', 'and', 'T', '##2', '##DM', 'and', '(', '2', ')', 'explore', 'the', 'effect', 'of', 'T', '##2', '##DM', 'on', 'the', 'distribution', 'of', 'P', '##ON', '##1', 'activities', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'on', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '.']	[0, 4, 5, 9, 19, 22, 25, 27, 31, 34, 37, 40, 46, 59, 63, 71, 75, 78, 80, 83, 85, 89, 91, 93, 96, 99, 100, 102, 112, 116, 125, 129, 132, 133, 134, 137, 145, 147, 150, 156, 159, 160, 161, 163, 172, 183, 193, 196, 201, 205, 208, 212, 224, 232, 233, 236, 241, 245, 254, 258, 259, 260, 263, 267, 268, 269, 271, 279, 283, 290, 293, 294, 295, 298, 301, 305, 318, 321, 322, 324, 326, 337, 341, 342, 343, 344, 345, 347, 349, 352, 355, 357, 361, 364, 367, 368, 372, 374]	[3, 5, 9, 18, 21, 25, 27, 31, 33, 37, 40, 45, 58, 62, 70, 74, 77, 79, 83, 85, 89, 90, 93, 96, 99, 100, 101, 111, 115, 124, 128, 131, 133, 134, 136, 145, 146, 149, 155, 158, 160, 161, 162, 171, 182, 192, 196, 201, 204, 207, 211, 223, 231, 233, 236, 241, 244, 253, 257, 259, 260, 262, 266, 268, 269, 270, 278, 282, 289, 292, 294, 295, 297, 300, 304, 317, 320, 322, 324, 325, 336, 340, 342, 343, 344, 345, 347, 348, 351, 355, 357, 361, 363, 367, 368, 372, 374, 375]	['The', 'quantification', 'of', 'lipoprotein', 'subfraction', 'distribution', 'was', 'carried', 'out', 'on', 'a', 'subsample', ',', 'Lipoprint', ',', 'including', '202', 'controls', 'and', '90', 'T2DM', 'subjects', ',', 'in', 'order', 'to', '(', '1', ')', 'identify', 'additional', 'potential', 'confounders', 'of', 'the', 'association', 'between', 'arylesterase', 'activity', 'and', 'T2DM', 'and', '(', '2', ')', 'explore', 'the', 'effect', 'of', 'T2DM', 'on', 'the', 'distribution', 'of', 'PON1', 'activities', 'and', 'Lp-PLA2', 'on', 'lipoprotein', 'subclasses', '.']	[1, 3, 1, 4, 3, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 6, 1, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Arylesterase, lactonase, and Lp-PLA2 activities also followed a similar trend, with only arylesterase showing a significant (p < 0.001) decrease in diabetics compared to controls (75 ± 20 vs. 96 ± 31 kU/L) (Supplementary Table 2).	[]	['A', '##ryl', '##ester', '##ase', ',', 'la', '##cton', '##ase', ',', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'activities', 'also', 'followed', 'a', 'similar', 'trend', ',', 'with', 'only', 'a', '##ryl', '##ester', '##ase', 'showing', 'a', 'significant', '(', 'p', '<', '0', '.', '00', '##1', ')', 'decrease', 'in', 'di', '##abe', '##tics', 'compared', 'to', 'controls', '(', '75', '±', '20', 'vs', '.', '96', '±', '31', 'k', '##U', '/', 'L', ')', '(', 'Su', '##pp', '##lement', '##ary', 'Table', '2', ')', '.']	[0, 1, 4, 9, 12, 14, 16, 20, 23, 25, 29, 30, 31, 32, 33, 35, 37, 48, 53, 62, 64, 72, 77, 79, 84, 89, 90, 93, 98, 102, 110, 112, 124, 125, 127, 129, 130, 131, 133, 134, 136, 145, 148, 150, 153, 158, 167, 170, 179, 180, 183, 185, 188, 190, 192, 195, 197, 200, 201, 202, 203, 204, 206, 207, 209, 211, 217, 221, 227, 228, 229]	[1, 4, 9, 12, 13, 16, 20, 23, 24, 28, 30, 31, 32, 33, 35, 36, 47, 52, 61, 63, 71, 77, 78, 83, 88, 90, 93, 98, 101, 109, 111, 123, 125, 126, 128, 130, 131, 133, 134, 135, 144, 147, 150, 153, 157, 166, 169, 178, 180, 182, 184, 187, 190, 191, 194, 196, 199, 201, 202, 203, 204, 205, 207, 209, 211, 217, 220, 226, 228, 229, 230]	['Arylesterase', ',', 'lactonase', ',', 'and', 'Lp-PLA2', 'activities', 'also', 'followed', 'a', 'similar', 'trend', ',', 'with', 'only', 'arylesterase', 'showing', 'a', 'significant', '(', 'p', '<', '0.001', ')', 'decrease', 'in', 'diabetics', 'compared', 'to', 'controls', '(', '75', '±', '20', 'vs', '.', '96', '±', '31', 'kU', '/', 'L', ')', '(', 'Supplementary', 'Table', '2', ')', '.']	[4, 1, 3, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The above results along with the reports showing that PON1 reside in various lipoprotein subclasses [20, 23] prompted us to consider their relative serum concentration as possible confounders of the observed relationship between arylesterase and T2DM.	[('PMC6247389', 'R05000', 229, 241, 'arylesterase')]	['The', 'above', 'results', 'along', 'with', 'the', 'reports', 'showing', 'that', 'P', '##ON', '##1', 'reside', 'in', 'various', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', '[', '20', ',', '23', ']', 'prompted', 'us', 'to', 'consider', 'their', 'relative', 'serum', 'concentration', 'as', 'possible', 'con', '##found', '##ers', 'of', 'the', 'observed', 'relationship', 'between', 'a', '##ryl', '##ester', '##ase', 'and', 'T', '##2', '##DM', '.']	[0, 4, 10, 18, 24, 29, 33, 41, 49, 54, 55, 57, 59, 66, 69, 77, 80, 82, 86, 89, 92, 93, 97, 100, 101, 103, 105, 107, 109, 118, 121, 124, 133, 139, 148, 154, 168, 171, 180, 183, 188, 192, 195, 199, 208, 221, 229, 230, 233, 238, 242, 246, 247, 248, 250]	[3, 9, 17, 23, 28, 32, 40, 48, 53, 55, 57, 58, 65, 68, 76, 80, 82, 86, 88, 92, 93, 97, 99, 101, 103, 104, 107, 108, 117, 120, 123, 132, 138, 147, 153, 167, 170, 179, 183, 188, 191, 194, 198, 207, 220, 228, 230, 233, 238, 241, 245, 247, 248, 250, 251]	['The', 'above', 'results', 'along', 'with', 'the', 'reports', 'showing', 'that', 'PON1', 'reside', 'in', 'various', 'lipoprotein', 'subclasses', '[', '20', ',', '23', ']', 'prompted', 'us', 'to', 'consider', 'their', 'relative', 'serum', 'concentration', 'as', 'possible', 'confounders', 'of', 'the', 'observed', 'relationship', 'between', 'arylesterase', 'and', 'T2DM', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
We next performed multivariable logistic regression to evaluate whether the independent correlates of arylesterase that emerged from the previous analysis could influence the association between this activity and T2DM (Figure 2).	[('PMC6247389', 'R06000', 102, 114, 'arylesterase')]	['We', 'next', 'performed', 'multi', '##var', '##iable', 'log', '##istic', 're', '##gression', 'to', 'evaluate', 'whether', 'the', 'independent', 'co', '##rrel', '##ates', 'of', 'a', '##ryl', '##ester', '##ase', 'that', 'emerged', 'from', 'the', 'previous', 'analysis', 'could', 'influence', 'the', 'association', 'between', 'this', 'activity', 'and', 'T', '##2', '##DM', '(', 'Figure', '2', ')', '.']	[0, 3, 8, 18, 23, 26, 32, 35, 41, 43, 52, 55, 64, 72, 76, 88, 90, 94, 99, 102, 103, 106, 111, 115, 120, 128, 133, 137, 146, 155, 161, 171, 175, 187, 195, 200, 209, 213, 214, 215, 218, 219, 226, 227, 228]	[2, 7, 17, 23, 26, 31, 35, 40, 43, 51, 54, 63, 71, 75, 87, 90, 94, 98, 101, 103, 106, 111, 114, 119, 127, 132, 136, 145, 154, 160, 170, 174, 186, 194, 199, 208, 212, 214, 215, 217, 219, 225, 227, 228, 229]	['We', 'next', 'performed', 'multivariable', 'logistic', 'regression', 'to', 'evaluate', 'whether', 'the', 'independent', 'correlates', 'of', 'arylesterase', 'that', 'emerged', 'from', 'the', 'previous', 'analysis', 'could', 'influence', 'the', 'association', 'between', 'this', 'activity', 'and', 'T2DM', '(', 'Figure', '2', ')', '.']	[1, 1, 1, 3, 2, 2, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This analysis showed that low arylesterase (i.e., activity level in the lower quartile) confirmed the inverse association between this activity and T2DM that emerged from between-group comparison (Figure 1(a)).	[('PMC6247389', 'R06001', 30, 42, 'arylesterase')]	['This', 'analysis', 'showed', 'that', 'low', 'a', '##ryl', '##ester', '##ase', '(', 'i', '.', 'e', '.', ',', 'activity', 'level', 'in', 'the', 'lower', 'q', '##ua', '##rt', '##ile', ')', 'confirmed', 'the', 'inverse', 'association', 'between', 'this', 'activity', 'and', 'T', '##2', '##DM', 'that', 'emerged', 'from', 'between', '-', 'group', 'comparison', '(', 'Figure', '1', '(', 'a', ')', ')', '.']	[0, 5, 14, 21, 26, 30, 31, 34, 39, 43, 44, 45, 46, 47, 48, 50, 59, 65, 68, 72, 78, 79, 81, 83, 86, 88, 98, 102, 110, 122, 130, 135, 144, 148, 149, 150, 153, 158, 166, 171, 178, 179, 185, 196, 197, 204, 205, 206, 207, 208, 209]	[4, 13, 20, 25, 29, 31, 34, 39, 42, 44, 45, 46, 47, 48, 49, 58, 64, 67, 71, 77, 79, 81, 83, 86, 87, 97, 101, 109, 121, 129, 134, 143, 147, 149, 150, 152, 157, 165, 170, 178, 179, 184, 195, 197, 203, 205, 206, 207, 208, 209, 210]	['This', 'analysis', 'showed', 'that', 'low', 'arylesterase', '(', 'i.e', '.', ',', 'activity', 'level', 'in', 'the', 'lower', 'quartile', ')', 'confirmed', 'the', 'inverse', 'association', 'between', 'this', 'activity', 'and', 'T2DM', 'that', 'emerged', 'from', 'between', '-', 'group', 'comparison', '(', 'Figure', '1(a)', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To investigate the possible effect of T2DM on the distribution of PON1-arylesterase, PON1-lactonase and Lp-PLA2 across lipoprotein subclasses, we measured the correlation between these variables separately in both controls and T2DM subjects Table 4.	[('PMC6247389', 'R07000', 66, 83, 'PON1-arylesterase')]	['To', 'investigate', 'the', 'possible', 'effect', 'of', 'T', '##2', '##DM', 'on', 'the', 'distribution', 'of', 'P', '##ON', '##1', '-', 'a', '##ryl', '##ester', '##ase', ',', 'P', '##ON', '##1', '-', 'la', '##cton', '##ase', 'and', 'L', '##p', '-', 'P', '##LA', '##2', 'across', 'lip', '##op', '##rote', '##in', 'sub', '##c', '##lass', '##es', ',', 'we', 'measured', 'the', 'correlation', 'between', 'these', 'variables', 'separately', 'in', 'both', 'controls', 'and', 'T', '##2', '##DM', 'subjects', 'Table', '4', '.']	[0, 3, 15, 19, 28, 35, 38, 39, 40, 43, 46, 50, 63, 66, 67, 69, 70, 71, 72, 75, 80, 83, 85, 86, 88, 89, 90, 92, 96, 100, 104, 105, 106, 107, 108, 110, 112, 119, 122, 124, 128, 131, 134, 135, 139, 141, 143, 146, 155, 159, 171, 179, 185, 195, 206, 209, 214, 223, 227, 228, 229, 232, 241, 247, 248]	[2, 14, 18, 27, 34, 37, 39, 40, 42, 45, 49, 62, 65, 67, 69, 70, 71, 72, 75, 80, 83, 84, 86, 88, 89, 90, 92, 96, 99, 103, 105, 106, 107, 108, 110, 111, 118, 122, 124, 128, 130, 134, 135, 139, 141, 142, 145, 154, 158, 170, 178, 184, 194, 205, 208, 213, 222, 226, 228, 229, 231, 240, 246, 248, 249]	['To', 'investigate', 'the', 'possible', 'effect', 'of', 'T2DM', 'on', 'the', 'distribution', 'of', 'PON1-arylesterase', ',', 'PON1-lactonase', 'and', 'Lp-PLA2', 'across', 'lipoprotein', 'subclasses', ',', 'we', 'measured', 'the', 'correlation', 'between', 'these', 'variables', 'separately', 'in', 'both', 'controls', 'and', 'T2DM', 'subjects', 'Table', '4', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 8, 1, 7, 1, 6, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The pattern changed among DM patients, where the correlations persisted for total cholesterol and HDL-C (p < 0.05 for both), small LDL-C (p < 0.05), all three IDL-C subclasses (p < 0.01 for all), and VDL-C (p < 0.01).	[]	['The', 'pattern', 'changed', 'among', 'D', '##M', 'patients', ',', 'where', 'the', 'correlation', '##s', 'persisted', 'for', 'total', 'ch', '##ole', '##ster', '##ol', 'and', 'HD', '##L', '-', 'C', '(', 'p', '<', '0', '.', '05', 'for', 'both', ')', ',', 'small', 'L', '##D', '##L', '-', 'C', '(', 'p', '<', '0', '.', '05', ')', ',', 'all', 'three', 'ID', '##L', '-', 'C', 'sub', '##c', '##lass', '##es', '(', 'p', '<', '0', '.', '01', 'for', 'all', ')', ',', 'and', 'V', '##D', '##L', '-', 'C', '(', 'p', '<', '0', '.', '01', ')', '.']	[0, 4, 12, 20, 26, 27, 29, 37, 39, 45, 49, 60, 62, 72, 76, 82, 84, 87, 91, 94, 98, 100, 101, 102, 104, 105, 107, 109, 110, 111, 114, 118, 122, 123, 125, 131, 132, 133, 134, 135, 137, 138, 140, 142, 143, 144, 146, 147, 149, 153, 159, 161, 162, 163, 165, 168, 169, 173, 176, 177, 179, 181, 182, 183, 186, 190, 193, 194, 196, 200, 201, 202, 203, 204, 206, 207, 209, 211, 212, 213, 215, 216]	[3, 11, 19, 25, 27, 28, 37, 38, 44, 48, 60, 61, 71, 75, 81, 84, 87, 91, 93, 97, 100, 101, 102, 103, 105, 106, 108, 110, 111, 113, 117, 122, 123, 124, 130, 132, 133, 134, 135, 136, 138, 139, 141, 143, 144, 146, 147, 148, 152, 158, 161, 162, 163, 164, 168, 169, 173, 175, 177, 178, 180, 182, 183, 185, 189, 193, 194, 195, 199, 201, 202, 203, 204, 205, 207, 208, 210, 212, 213, 215, 216, 217]	['The', 'pattern', 'changed', 'among', 'DM', 'patients', ',', 'where', 'the', 'correlations', 'persisted', 'for', 'total', 'cholesterol', 'and', 'HDL-C', '(', 'p', '<', '0.05', 'for', 'both', ')', ',', 'small', 'LDL-C', '(', 'p', '<', '0.05', ')', ',', 'all', 'three', 'IDL-C', 'subclasses', '(', 'p', '<', '0.01', 'for', 'all', ')', ',', 'and', 'VDL-C', '(', 'p', '<', '0.01', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 4, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For the replication study in the Japanese population, selected SNPs were genotyped in cases from Japanese replication sets using the multiplex polymerase chain reaction (PCR)-based Invader assay (Third Wave Technologies, Madison, WI) (51).	[('PMC6251544', 'M06000', 143, 153, 'polymerase')]	['For', 'the', 'replication', 'study', 'in', 'the', 'Japanese', 'population', ',', 'selected', 'S', '##NP', '##s', 'were', 'g', '##eno', '##type', '##d', 'in', 'cases', 'from', 'Japanese', 'replication', 'sets', 'using', 'the', 'multiple', '##x', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', '-', 'based', 'In', '##vade', '##r', 'ass', '##ay', '(', 'Third', 'Wave', 'Technologies', ',', 'Madison', ',', 'W', '##I', ')', '(', '51', ')', '.']	[0, 4, 8, 20, 26, 29, 33, 42, 52, 54, 63, 64, 66, 68, 73, 74, 77, 81, 83, 86, 92, 97, 106, 118, 123, 129, 133, 141, 143, 150, 154, 160, 169, 170, 172, 173, 174, 175, 181, 183, 187, 189, 192, 195, 196, 202, 207, 219, 221, 228, 230, 231, 232, 234, 235, 237, 238]	[3, 7, 19, 25, 28, 32, 41, 52, 53, 62, 64, 66, 67, 72, 74, 77, 81, 82, 85, 91, 96, 105, 117, 122, 128, 132, 141, 142, 150, 153, 159, 168, 170, 172, 173, 174, 175, 180, 183, 187, 188, 192, 194, 196, 201, 206, 219, 220, 228, 229, 231, 232, 233, 235, 237, 238, 239]	['For', 'the', 'replication', 'study', 'in', 'the', 'Japanese', 'population', ',', 'selected', 'SNPs', 'were', 'genotyped', 'in', 'cases', 'from', 'Japanese', 'replication', 'sets', 'using', 'the', 'multiplex', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', '-', 'based', 'Invader', 'assay', '(', 'Third', 'Wave', 'Technologies', ',', 'Madison', ',', 'WI', ')', '(', '51', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Identification of HPV-derived DNA was performed by polymerase chain reaction (PCR) amplification of HPV gene sequences.	[('PMC6256731', 'M06000', 51, 61, 'polymerase')]	['I', '##dent', '##ification', 'of', 'HP', '##V', '-', 'derived', 'DNA', 'was', 'performed', 'by', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'am', '##p', '##lification', 'of', 'HP', '##V', 'gene', 'sequences', '.']	[0, 1, 5, 15, 18, 20, 21, 22, 30, 34, 38, 48, 51, 58, 62, 68, 77, 78, 80, 81, 83, 85, 86, 97, 100, 102, 104, 109, 118]	[1, 5, 14, 17, 20, 21, 22, 29, 33, 37, 47, 50, 58, 61, 67, 76, 78, 80, 81, 82, 85, 86, 96, 99, 102, 103, 108, 118, 119]	['Identification', 'of', 'HPV', '-', 'derived', 'DNA', 'was', 'performed', 'by', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', 'of', 'HPV', 'gene', 'sequences', '.']	[3, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 3, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two genomewide association study (GWAS) meta-analyses of 25(OH)D concentrations inpopulations of European ancestry have been conducted identifying loci including group-specificcomponent (vitamin D binding protein) gene (GC), nicotinamide adeninedinucleotide synthetase 1 gene(NADSYN1)/7-dehydrocholesterol reductase gene(DHCR7), vitamin D 25-hydroxylase gene (CYP2R1), andvitamin D 24-hydroxylase gene (CYP24A1).	[('PMC6276579', 'I01000', 227, 273, 'cotinamide adeninedinucleotide synthetase 1 ge')]	['Two', 'genome', '##wide', 'association', 'study', '(', 'G', '##WA', '##S', ')', 'meta', '-', 'analyses', 'of', '25', '(', 'OH', ')', 'D', 'concentrations', 'in', '##pop', '##ulation', '##s', 'of', 'European', 'ancestry', 'have', 'been', 'conducted', 'identifying', 'lo', '##ci', 'including', 'group', '-', 'specific', '##com', '##po', '##nent', '(', 'vitamin', 'D', 'binding', 'protein', ')', 'gene', '(', 'G', '##C', ')', ',', 'ni', '##cot', '##ina', '##mi', '##de', 'ad', '##eni', '##ned', '##in', '##uc', '##leo', '##tide', 's', '##ynth', '##eta', '##se', '1', 'gene', '(', 'N', '##AD', '##S', '##Y', '##N', '##1', ')', '/', '7', '-', 'de', '##hy', '##dr', '##och', '##ole', '##ster', '##ol', 'red', '##uc', '##tase', 'gene', '(', 'D', '##HC', '##R', '##7', ')', ',', 'vitamin', 'D', '25', '-', 'h', '##ydro', '##xy', '##lase', 'gene', '(', 'C', '##YP', '##2', '##R', '##1', ')', ',', 'and', '##vi', '##tam', '##in', 'D', '24', '-', 'h', '##ydro', '##xy', '##lase', 'gene', '(', 'C', '##YP', '##24', '##A', '##1', ')', '.']	[0, 4, 10, 15, 27, 33, 34, 35, 37, 38, 40, 44, 45, 54, 57, 59, 60, 62, 63, 65, 80, 82, 85, 92, 94, 97, 106, 115, 120, 125, 135, 147, 149, 152, 162, 167, 168, 176, 179, 181, 186, 187, 195, 197, 205, 212, 214, 219, 220, 221, 222, 223, 225, 227, 230, 233, 235, 238, 240, 243, 246, 248, 250, 253, 258, 259, 263, 266, 269, 271, 275, 276, 277, 279, 280, 281, 282, 283, 284, 285, 286, 287, 289, 291, 293, 296, 299, 303, 306, 309, 311, 316, 320, 321, 322, 324, 325, 326, 327, 329, 337, 339, 341, 342, 343, 347, 349, 354, 359, 360, 361, 363, 364, 365, 366, 367, 369, 372, 374, 377, 380, 382, 384, 385, 386, 390, 392, 397, 402, 403, 404, 406, 408, 409, 410, 411]	[3, 10, 14, 26, 32, 34, 35, 37, 38, 39, 44, 45, 53, 56, 59, 60, 62, 63, 64, 79, 82, 85, 92, 93, 96, 105, 114, 119, 124, 134, 146, 149, 151, 161, 167, 168, 176, 179, 181, 185, 187, 194, 196, 204, 212, 213, 218, 220, 221, 222, 223, 224, 227, 230, 233, 235, 237, 240, 243, 246, 248, 250, 253, 257, 259, 263, 266, 268, 270, 275, 276, 277, 279, 280, 281, 282, 283, 284, 285, 286, 287, 289, 291, 293, 296, 299, 303, 305, 309, 311, 315, 320, 321, 322, 324, 325, 326, 327, 328, 336, 338, 341, 342, 343, 347, 349, 353, 358, 360, 361, 363, 364, 365, 366, 367, 368, 372, 374, 377, 379, 381, 384, 385, 386, 390, 392, 396, 401, 403, 404, 406, 408, 409, 410, 411, 412]	['Two', 'genomewide', 'association', 'study', '(', 'GWAS', ')', 'meta-', 'analyses', 'of', '25(OH)D', 'concentrations', 'inpopulations', 'of', 'European', 'ancestry', 'have', 'been', 'conducted', 'identifying', 'loci', 'including', 'group', '-', 'specificcomponent', '(', 'vitamin', 'D', 'binding', 'protein', ')', 'gene', '(', 'GC', ')', ',', 'nicotinamide', 'adeninedinucleotide', 'synthetase', '1', 'gene(NADSYN1)', '/', '7-dehydrocholesterol', 'reductase', 'gene(DHCR7)', ',', 'vitamin', 'D', '25-hydroxylase', 'gene', '(', 'CYP2R1', ')', ',', 'andvitamin', 'D', '24-hydroxylase', 'gene', '(', 'CYP24A1', ')', '.']	[1, 2, 1, 1, 1, 3, 1, 2, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 7, 4, 1, 9, 1, 9, 3, 7, 1, 1, 1, 6, 1, 1, 5, 1, 1, 4, 1, 6, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Statins, HMG-CoA reductase inhibitors, are considered the first line treatment of hyperlipidemia to reduce the risk of atherosclerotic cardiovascular diseases.	[('PMC6298799', 'A00000', 9, 26, 'HMG-CoA reductase')]	['St', '##ati', '##ns', ',', 'HM', '##G', '-', 'Co', '##A', 'red', '##uc', '##tase', 'inhibitor', '##s', ',', 'are', 'considered', 'the', 'first', 'line', 'treatment', 'of', 'h', '##yper', '##lip', '##ide', '##mia', 'to', 'reduce', 'the', 'risk', 'of', 'at', '##her', '##os', '##cle', '##rot', '##ic', 'card', '##iovascular', 'diseases', '.']	[0, 2, 5, 7, 9, 11, 12, 13, 15, 17, 20, 22, 27, 36, 37, 39, 43, 54, 58, 64, 69, 79, 82, 83, 87, 90, 93, 97, 100, 107, 111, 116, 119, 121, 124, 126, 129, 132, 135, 139, 150, 158]	[2, 5, 7, 8, 11, 12, 13, 15, 16, 20, 22, 26, 36, 37, 38, 42, 53, 57, 63, 68, 78, 81, 83, 87, 90, 93, 96, 99, 106, 110, 115, 118, 121, 124, 126, 129, 132, 134, 139, 149, 158, 159]	['Statins', ',', 'HMG-CoA', 'reductase', 'inhibitors', ',', 'are', 'considered', 'the', 'first', 'line', 'treatment', 'of', 'hyperlipidemia', 'to', 'reduce', 'the', 'risk', 'of', 'atherosclerotic', 'cardiovascular', 'diseases', '.']	[3, 1, 5, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 6, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inhibition of cholesterol biosynthesis in the hepatocytes leads to the upregulation of low density lipoprotein (LDL) receptors in cell membrane of hepatocytes to maintain cholesterol homeostasis in the liver cells.	[]	['In', '##hibition', 'of', 'ch', '##ole', '##ster', '##ol', 'bio', '##sy', '##nt', '##hesis', 'in', 'the', 'he', '##pa', '##to', '##cy', '##tes', 'leads', 'to', 'the', 'up', '##re', '##gu', '##lation', 'of', 'low', 'density', 'lip', '##op', '##rote', '##in', '(', 'L', '##D', '##L', ')', 'receptors', 'in', 'cell', 'membrane', 'of', 'he', '##pa', '##to', '##cy', '##tes', 'to', 'maintain', 'ch', '##ole', '##ster', '##ol', 'home', '##ost', '##asis', 'in', 'the', 'liver', 'cells', '.']	[0, 2, 11, 14, 16, 19, 23, 26, 29, 31, 33, 39, 42, 46, 48, 50, 52, 54, 58, 64, 67, 71, 73, 75, 77, 84, 87, 91, 99, 102, 104, 108, 111, 112, 113, 114, 115, 117, 127, 130, 135, 144, 147, 149, 151, 153, 155, 159, 162, 171, 173, 176, 180, 183, 187, 190, 195, 198, 202, 208, 213]	[2, 10, 13, 16, 19, 23, 25, 29, 31, 33, 38, 41, 45, 48, 50, 52, 54, 57, 63, 66, 70, 73, 75, 77, 83, 86, 90, 98, 102, 104, 108, 110, 112, 113, 114, 115, 116, 126, 129, 134, 143, 146, 149, 151, 153, 155, 158, 161, 170, 173, 176, 180, 182, 187, 190, 194, 197, 201, 207, 213, 214]	['Inhibition', 'of', 'cholesterol', 'biosynthesis', 'in', 'the', 'hepatocytes', 'leads', 'to', 'the', 'upregulation', 'of', 'low', 'density', 'lipoprotein', '(', 'LDL', ')', 'receptors', 'in', 'cell', 'membrane', 'of', 'hepatocytes', 'to', 'maintain', 'cholesterol', 'homeostasis', 'in', 'the', 'liver', 'cells', '.']	[2, 1, 4, 4, 1, 1, 5, 1, 1, 1, 4, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 4, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The uptake of LDL by the liver leads to a decrease in LDL levels in the plasma.	[]	['The', 'up', '##take', 'of', 'L', '##D', '##L', 'by', 'the', 'liver', 'leads', 'to', 'a', 'decrease', 'in', 'L', '##D', '##L', 'levels', 'in', 'the', 'plasma', '.']	[0, 4, 6, 11, 14, 15, 16, 18, 21, 25, 31, 37, 40, 42, 51, 54, 55, 56, 58, 65, 68, 72, 78]	[3, 6, 10, 13, 15, 16, 17, 20, 24, 30, 36, 39, 41, 50, 53, 55, 56, 57, 64, 67, 71, 78, 79]	['The', 'uptake', 'of', 'LDL', 'by', 'the', 'liver', 'leads', 'to', 'a', 'decrease', 'in', 'LDL', 'levels', 'in', 'the', 'plasma', '.']	[1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In an effort to identify CXCR4 effector proteins involved in cellular migration and invasion, we performed SILAC proteomics analysis and identified PI4KIIIα as one of the proteins whose expression is tightly linked to CXCR4 in the prostate cancer cell line PC3.	[('PMC6336684', 'D00000', 148, 156, 'PI4KIIIα')]	['In', 'an', 'effort', 'to', 'identify', 'C', '##X', '##CR', '##4', 'effect', '##or', 'proteins', 'involved', 'in', 'cellular', 'migration', 'and', 'invasion', ',', 'we', 'performed', 'S', '##IL', '##AC', 'pro', '##te', '##omi', '##cs', 'analysis', 'and', 'identified', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'as', 'one', 'of', 'the', 'proteins', 'whose', 'expression', 'is', 'tightly', 'linked', 'to', 'C', '##X', '##CR', '##4', 'in', 'the', 'pro', '##state', 'cancer', 'cell', 'line', 'PC', '##3', '.']	[0, 3, 6, 13, 16, 25, 26, 27, 29, 31, 37, 40, 49, 58, 61, 70, 80, 84, 92, 94, 97, 107, 108, 110, 113, 116, 118, 121, 124, 133, 137, 148, 149, 150, 151, 152, 154, 155, 157, 160, 164, 167, 171, 180, 186, 197, 200, 208, 215, 218, 219, 220, 222, 224, 227, 231, 234, 240, 247, 252, 257, 259, 260]	[2, 5, 12, 15, 24, 26, 27, 29, 30, 37, 39, 48, 57, 60, 69, 79, 83, 92, 93, 96, 106, 108, 110, 112, 116, 118, 121, 123, 132, 136, 147, 149, 150, 151, 152, 154, 155, 156, 159, 163, 166, 170, 179, 185, 196, 199, 207, 214, 217, 219, 220, 222, 223, 226, 230, 234, 239, 246, 251, 256, 259, 260, 261]	['In', 'an', 'effort', 'to', 'identify', 'CXCR4', 'effector', 'proteins', 'involved', 'in', 'cellular', 'migration', 'and', 'invasion', ',', 'we', 'performed', 'SILAC', 'proteomics', 'analysis', 'and', 'identified', 'PI4KIIIα', 'as', 'one', 'of', 'the', 'proteins', 'whose', 'expression', 'is', 'tightly', 'linked', 'to', 'CXCR4', 'in', 'the', 'prostate', 'cancer', 'cell', 'line', 'PC3', '.']	[1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Here we have characterized the novel cross-talk between CXCR4 and PI4KIIIα, and revealed that both proteins localize to lipid rafts together, participating in cancer cell invasion.	[('PMC6336684', 'D00001', 66, 74, 'PI4KIIIα')]	['Here', 'we', 'have', 'characterized', 'the', 'novel', 'cross', '-', 'talk', 'between', 'C', '##X', '##CR', '##4', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', ',', 'and', 'revealed', 'that', 'both', 'proteins', 'local', '##ize', 'to', 'lip', '##id', 'r', '##aft', '##s', 'together', ',', 'participating', 'in', 'cancer', 'cell', 'invasion', '.']	[0, 5, 8, 13, 27, 31, 37, 42, 43, 48, 56, 57, 58, 60, 62, 66, 67, 68, 69, 70, 72, 73, 74, 76, 80, 89, 94, 99, 108, 113, 117, 120, 123, 126, 127, 130, 132, 140, 142, 156, 159, 166, 171, 179]	[4, 7, 12, 26, 30, 36, 42, 43, 47, 55, 57, 58, 60, 61, 65, 67, 68, 69, 70, 72, 73, 74, 75, 79, 88, 93, 98, 107, 113, 116, 119, 123, 125, 127, 130, 131, 140, 141, 155, 158, 165, 170, 179, 180]	['Here', 'we', 'have', 'characterized', 'the', 'novel', 'cross', '-', 'talk', 'between', 'CXCR4', 'and', 'PI4KIIIα', ',', 'and', 'revealed', 'that', 'both', 'proteins', 'localize', 'to', 'lipid', 'rafts', 'together', ',', 'participating', 'in', 'cancer', 'cell', 'invasion', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 7, 1, 1, 1, 1, 1, 1, 2, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our studies also conclude that CXCR4 does not directly bind PI4KIIIα, but interacts through PI4KIIIα adaptor proteins, EFR3 and TTC7.	[('PMC6336684', 'D00002', 60, 68, 'PI4KIIIα')]	['Our', 'studies', 'also', 'conclude', 'that', 'C', '##X', '##CR', '##4', 'does', 'not', 'directly', 'bind', 'P', '##I', '##4', '##K', '##II', '##I', '##α', ',', 'but', 'interact', '##s', 'through', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'adapt', '##or', 'proteins', ',', 'E', '##F', '##R', '##3', 'and', 'T', '##TC', '##7', '.']	[0, 4, 12, 17, 26, 31, 32, 33, 35, 37, 42, 46, 55, 60, 61, 62, 63, 64, 66, 67, 68, 70, 74, 82, 84, 92, 93, 94, 95, 96, 98, 99, 101, 106, 109, 117, 119, 120, 121, 122, 124, 128, 129, 131, 132]	[3, 11, 16, 25, 30, 32, 33, 35, 36, 41, 45, 54, 59, 61, 62, 63, 64, 66, 67, 68, 69, 73, 82, 83, 91, 93, 94, 95, 96, 98, 99, 100, 106, 108, 117, 118, 120, 121, 122, 123, 127, 129, 131, 132, 133]	['Our', 'studies', 'also', 'conclude', 'that', 'CXCR4', 'does', 'not', 'directly', 'bind', 'PI4KIIIα', ',', 'but', 'interacts', 'through', 'PI4KIIIα', 'adaptor', 'proteins', ',', 'EFR3', 'and', 'TTC7', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 7, 1, 1, 2, 1, 7, 2, 1, 1, 4, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
EFR3 and TTC7 interaction with PI4KIIIα is evolutionarily conserved (34, 35), where EFR3B is a peripheral membrane protein targeted to PM through a palmitoylated anchor (36), which interacts with soluble adaptor protein TTC7 bound PI4KIIIα.	[]	['E', '##F', '##R', '##3', 'and', 'T', '##TC', '##7', 'interaction', 'with', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'is', 'evolution', '##arily', 'conserved', '(', '34', ',', '35', ')', ',', 'where', 'E', '##F', '##R', '##3', '##B', 'is', 'a', 'peripheral', 'membrane', 'protein', 'targeted', 'to', 'PM', 'through', 'a', 'palm', '##ito', '##yla', '##ted', 'anchor', '(', '36', ')', ',', 'which', 'interact', '##s', 'with', 'soluble', 'adapt', '##or', 'protein', 'T', '##TC', '##7', 'bound', 'P', '##I', '##4', '##K', '##II', '##I', '##α', '.']	[0, 1, 2, 3, 5, 9, 10, 12, 14, 26, 31, 32, 33, 34, 35, 37, 38, 40, 43, 52, 58, 68, 69, 71, 73, 75, 76, 78, 84, 85, 86, 87, 88, 90, 93, 95, 106, 115, 123, 132, 135, 138, 146, 148, 152, 155, 158, 162, 169, 170, 172, 173, 175, 181, 189, 191, 196, 204, 209, 212, 220, 221, 223, 225, 231, 232, 233, 234, 235, 237, 238, 239]	[1, 2, 3, 4, 8, 10, 12, 13, 25, 30, 32, 33, 34, 35, 37, 38, 39, 42, 52, 57, 67, 69, 71, 72, 75, 76, 77, 83, 85, 86, 87, 88, 89, 92, 94, 105, 114, 122, 131, 134, 137, 145, 147, 152, 155, 158, 161, 168, 170, 172, 173, 174, 180, 189, 190, 195, 203, 209, 211, 219, 221, 223, 224, 230, 232, 233, 234, 235, 237, 238, 239, 240]	['EFR3', 'and', 'TTC7', 'interaction', 'with', 'PI4KIIIα', 'is', 'evolutionarily', 'conserved', '(', '34', ',', '35', ')', ',', 'where', 'EFR3B', 'is', 'a', 'peripheral', 'membrane', 'protein', 'targeted', 'to', 'PM', 'through', 'a', 'palmitoylated', 'anchor', '(', '36', ')', ',', 'which', 'interacts', 'with', 'soluble', 'adaptor', 'protein', 'TTC7', 'bound', 'PI4KIIIα', '.']	[4, 1, 3, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 3, 1, 7, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Structural studies demonstrate that TTC7 binds with both EFR3 and PI4KIIIα (26), and membrane anchored EFR3 serves as a docking site for this complex in PM.	[]	['St', '##ructural', 'studies', 'demonstrate', 'that', 'T', '##TC', '##7', 'binds', 'with', 'both', 'E', '##F', '##R', '##3', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', '(', '26', ')', ',', 'and', 'membrane', 'anchored', 'E', '##F', '##R', '##3', 'serves', 'as', 'a', 'dock', '##ing', 'site', 'for', 'this', 'complex', 'in', 'PM', '.']	[0, 2, 11, 19, 31, 36, 37, 39, 41, 47, 52, 57, 58, 59, 60, 62, 66, 67, 68, 69, 70, 72, 73, 75, 76, 78, 79, 81, 85, 94, 103, 104, 105, 106, 108, 115, 118, 120, 124, 128, 133, 137, 142, 150, 153, 155]	[2, 10, 18, 30, 35, 37, 39, 40, 46, 51, 56, 58, 59, 60, 61, 65, 67, 68, 69, 70, 72, 73, 74, 76, 78, 79, 80, 84, 93, 102, 104, 105, 106, 107, 114, 117, 119, 124, 127, 132, 136, 141, 149, 152, 155, 156]	['Structural', 'studies', 'demonstrate', 'that', 'TTC7', 'binds', 'with', 'both', 'EFR3', 'and', 'PI4KIIIα', '(', '26', ')', ',', 'and', 'membrane', 'anchored', 'EFR3', 'serves', 'as', 'a', 'docking', 'site', 'for', 'this', 'complex', 'in', 'PM', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 4, 1, 7, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Binding studies demonstrate highly specific interaction between CXCR4 and both EFR3B and TTC7B (Figure 3 and ​and4).4).	[]	['Bin', '##ding', 'studies', 'demonstrate', 'highly', 'specific', 'interaction', 'between', 'C', '##X', '##CR', '##4', 'and', 'both', 'E', '##F', '##R', '##3', '##B', 'and', 'T', '##TC', '##7', '##B', '(', 'Figure', '3', 'and', 'and', '##4', ')', '.', '4', ')', '.']	[0, 3, 8, 16, 28, 35, 44, 56, 64, 65, 66, 68, 70, 74, 79, 80, 81, 82, 83, 85, 89, 90, 92, 93, 95, 96, 103, 105, 110, 113, 114, 115, 116, 117, 118]	[3, 7, 15, 27, 34, 43, 55, 63, 65, 66, 68, 69, 73, 78, 80, 81, 82, 83, 84, 88, 90, 92, 93, 94, 96, 102, 104, 108, 113, 114, 115, 116, 117, 118, 119]	['Binding', 'studies', 'demonstrate', 'highly', 'specific', 'interaction', 'between', 'CXCR4', 'and', 'both', 'EFR3B', 'and', 'TTC7B', '(', 'Figure', '3', 'and', '\u200band4).4', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 4, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among phosphatidylinositol 4 kinases, PI4KIIIα has been demonstrated to be critical for maintenance of PI4P pools in PM (23, 40), where it serves as a major precursor for the bulk of PI(4,5)P2 and, subsequently, for PI(3,4,5)P3.	[('PMC6336684', 'D01000', 6, 36, 'phosphatidylinositol 4 kinases')]	['Among', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '4', 'kinase', '##s', ',', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'has', 'been', 'demonstrated', 'to', 'be', 'critical', 'for', 'maintenance', 'of', 'P', '##I', '##4', '##P', 'pools', 'in', 'PM', '(', '23', ',', '40', ')', ',', 'where', 'it', 'serves', 'as', 'a', 'major', 'precursor', 'for', 'the', 'bulk', 'of', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', 'and', ',', 'subsequently', ',', 'for', 'P', '##I', '(', '3', ',', '4', ',', '5', ')', 'P', '##3', '.']	[0, 6, 7, 10, 13, 15, 17, 21, 23, 25, 27, 29, 35, 36, 38, 39, 40, 41, 42, 44, 45, 47, 51, 56, 69, 72, 75, 84, 88, 100, 103, 104, 105, 106, 108, 114, 117, 120, 121, 123, 125, 127, 128, 130, 136, 139, 146, 149, 151, 157, 167, 171, 175, 180, 183, 184, 185, 186, 187, 188, 189, 190, 191, 193, 196, 198, 210, 212, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227]	[5, 7, 10, 13, 15, 17, 21, 23, 25, 26, 28, 35, 36, 37, 39, 40, 41, 42, 44, 45, 46, 50, 55, 68, 71, 74, 83, 87, 99, 102, 104, 105, 106, 107, 113, 116, 119, 121, 123, 124, 127, 128, 129, 135, 138, 145, 148, 150, 156, 166, 170, 174, 179, 182, 184, 185, 186, 187, 188, 189, 190, 191, 192, 196, 197, 210, 211, 215, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228]	['Among', 'phosphatidylinositol', '4', 'kinases', ',', 'PI4KIIIα', 'has', 'been', 'demonstrated', 'to', 'be', 'critical', 'for', 'maintenance', 'of', 'PI4P', 'pools', 'in', 'PM', '(', '23', ',', '40', ')', ',', 'where', 'it', 'serves', 'as', 'a', 'major', 'precursor', 'for', 'the', 'bulk', 'of', 'PI(4,5)P2', 'and', ',', 'subsequently', ',', 'for', 'PI(3,4,5)P3', '.']	[1, 9, 1, 2, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 9, 1, 1, 1, 1, 1, 11, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PI4KIIIα activity has been shown to be a critical determinant of plasma membrane identity by maintaining the levels of PI4P and PI(4,5)P2.	[('PMC6336684', 'D02000', 0, 8, 'PI4KIIIα')]	['P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'has', 'been', 'shown', 'to', 'be', 'a', 'critical', 'de', '##ter', '##mina', '##nt', 'of', 'plasma', 'membrane', 'identity', 'by', 'maintaining', 'the', 'levels', 'of', 'P', '##I', '##4', '##P', 'and', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', '.']	[0, 1, 2, 3, 4, 6, 7, 9, 18, 22, 27, 33, 36, 39, 41, 50, 52, 55, 59, 62, 65, 72, 81, 90, 93, 105, 109, 116, 119, 120, 121, 122, 124, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137]	[1, 2, 3, 4, 6, 7, 8, 17, 21, 26, 32, 35, 38, 40, 49, 52, 55, 59, 61, 64, 71, 80, 89, 92, 104, 108, 115, 118, 120, 121, 122, 123, 127, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138]	['PI4KIIIα', 'activity', 'has', 'been', 'shown', 'to', 'be', 'a', 'critical', 'determinant', 'of', 'plasma', 'membrane', 'identity', 'by', 'maintaining', 'the', 'levels', 'of', 'PI4P', 'and', 'PI(4,5)P2', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 9, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Embryonic fibroblasts lacking PI4KIIIα showed impairment of PI4P and PI(4,5)P2 production at plasma membrane and relocation of several of plasma membrane PI4P/PI(4,5)P2-binding proteins to internal compartments (35).	[('PMC6336684', 'D02001', 30, 38, 'PI4KIIIα')]	['Em', '##b', '##ryo', '##nic', 'fi', '##bro', '##blast', '##s', 'lacking', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'showed', 'imp', '##air', '##ment', 'of', 'P', '##I', '##4', '##P', 'and', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', 'production', 'at', 'plasma', 'membrane', 'and', 'relocation', 'of', 'several', 'of', 'plasma', 'membrane', 'P', '##I', '##4', '##P', '/', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', '-', 'binding', 'proteins', 'to', 'internal', 'compartment', '##s', '(', '35', ')', '.']	[0, 2, 3, 6, 10, 12, 15, 20, 22, 30, 31, 32, 33, 34, 36, 37, 39, 46, 49, 52, 57, 60, 61, 62, 63, 65, 69, 70, 71, 72, 73, 74, 75, 76, 77, 79, 90, 93, 100, 109, 113, 124, 127, 135, 138, 145, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 177, 186, 189, 198, 209, 211, 212, 214, 215]	[2, 3, 6, 9, 12, 15, 20, 21, 29, 31, 32, 33, 34, 36, 37, 38, 45, 49, 52, 56, 59, 61, 62, 63, 64, 68, 70, 71, 72, 73, 74, 75, 76, 77, 78, 89, 92, 99, 108, 112, 123, 126, 134, 137, 144, 153, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 176, 185, 188, 197, 209, 210, 212, 214, 215, 216]	['Embryonic', 'fibroblasts', 'lacking', 'PI4KIIIα', 'showed', 'impairment', 'of', 'PI4P', 'and', 'PI(4,5)P2', 'production', 'at', 'plasma', 'membrane', 'and', 'relocation', 'of', 'several', 'of', 'plasma', 'membrane', 'PI4P', '/', 'PI(4,5)P2', '-', 'binding', 'proteins', 'to', 'internal', 'compartments', '(', '35', ')', '.']	[4, 4, 1, 7, 1, 3, 1, 4, 1, 9, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 9, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our data indicate that PI4KIIIα activity has additional functions in prostate cancer cells, where PI4P highly localizes to invasive projections in CXCR4 overexpressing cells thereby contributing to the invasiveness of cancer cells (Figure 5).	[('PMC6336684', 'D02002', 23, 31, 'PI4KIIIα')]	['Our', 'data', 'indicate', 'that', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'has', 'additional', 'functions', 'in', 'pro', '##state', 'cancer', 'cells', ',', 'where', 'P', '##I', '##4', '##P', 'highly', 'local', '##izes', 'to', 'invasive', 'projections', 'in', 'C', '##X', '##CR', '##4', 'over', '##ex', '##pressing', 'cells', 'thereby', 'contributing', 'to', 'the', 'invasive', '##ness', 'of', 'cancer', 'cells', '(', 'Figure', '5', ')', '.']	[0, 4, 9, 18, 23, 24, 25, 26, 27, 29, 30, 32, 41, 45, 56, 66, 69, 72, 78, 85, 90, 92, 98, 99, 100, 101, 103, 110, 115, 120, 123, 132, 144, 147, 148, 149, 151, 153, 157, 159, 168, 174, 182, 195, 198, 202, 210, 215, 218, 225, 231, 232, 239, 240, 241]	[3, 8, 17, 22, 24, 25, 26, 27, 29, 30, 31, 40, 44, 55, 65, 68, 72, 77, 84, 90, 91, 97, 99, 100, 101, 102, 109, 115, 119, 122, 131, 143, 146, 148, 149, 151, 152, 157, 159, 167, 173, 181, 194, 197, 201, 210, 214, 217, 224, 230, 232, 238, 240, 241, 242]	['Our', 'data', 'indicate', 'that', 'PI4KIIIα', 'activity', 'has', 'additional', 'functions', 'in', 'prostate', 'cancer', 'cells', ',', 'where', 'PI4P', 'highly', 'localizes', 'to', 'invasive', 'projections', 'in', 'CXCR4', 'overexpressing', 'cells', 'thereby', 'contributing', 'to', 'the', 'invasiveness', 'of', 'cancer', 'cells', '(', 'Figure', '5', ')', '.']	[1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In support of this hypothesis, we show that PI4KIIIα knockdown causes a sever defect in in vitro invasion without a significant alteration in cell proliferation.	[('PMC6336684', 'D02003', 44, 52, 'PI4KIIIα')]	['In', 'support', 'of', 'this', 'hypothesis', ',', 'we', 'show', 'that', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'knock', '##down', 'causes', 'a', 'se', '##ver', 'defect', 'in', 'in', 'v', '##it', '##ro', 'invasion', 'without', 'a', 'significant', 'alter', '##ation', 'in', 'cell', 'proliferation', '.']	[0, 3, 11, 14, 19, 29, 31, 34, 39, 44, 45, 46, 47, 48, 50, 51, 53, 58, 63, 70, 72, 74, 78, 85, 88, 91, 92, 94, 97, 106, 114, 116, 128, 133, 139, 142, 147, 160]	[2, 10, 13, 18, 29, 30, 33, 38, 43, 45, 46, 47, 48, 50, 51, 52, 58, 62, 69, 71, 74, 77, 84, 87, 90, 92, 94, 96, 105, 113, 115, 127, 133, 138, 141, 146, 160, 161]	['In', 'support', 'of', 'this', 'hypothesis', ',', 'we', 'show', 'that', 'PI4KIIIα', 'knockdown', 'causes', 'a', 'sever', 'defect', 'in', 'in', 'vitro', 'invasion', 'without', 'a', 'significant', 'alteration', 'in', 'cell', 'proliferation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our data from the cellular invasion assay also demonstrate that PI4KIIIα has a broader role on cellular invasion as its knockdown significantly inhibited multiple members of chemokine mediated PC3 cell invasion (Figure 7).	[('PMC6336684', 'D02004', 64, 72, 'PI4KIIIα')]	['Our', 'data', 'from', 'the', 'cellular', 'invasion', 'ass', '##ay', 'also', 'demonstrate', 'that', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'has', 'a', 'broader', 'role', 'on', 'cellular', 'invasion', 'as', 'its', 'knock', '##down', 'significantly', 'in', '##hibit', '##ed', 'multiple', 'members', 'of', 'ch', '##em', '##oki', '##ne', 'mediated', 'PC', '##3', 'cell', 'invasion', '(', 'Figure', '7', ')', '.']	[0, 4, 9, 14, 18, 27, 36, 39, 42, 47, 59, 64, 65, 66, 67, 68, 70, 71, 73, 77, 79, 87, 92, 95, 104, 113, 116, 120, 125, 130, 144, 146, 151, 154, 163, 171, 174, 176, 178, 181, 184, 193, 195, 197, 202, 211, 212, 219, 220, 221]	[3, 8, 13, 17, 26, 35, 39, 41, 46, 58, 63, 65, 66, 67, 68, 70, 71, 72, 76, 78, 86, 91, 94, 103, 112, 115, 119, 125, 129, 143, 146, 151, 153, 162, 170, 173, 176, 178, 181, 183, 192, 195, 196, 201, 210, 212, 218, 220, 221, 222]	['Our', 'data', 'from', 'the', 'cellular', 'invasion', 'assay', 'also', 'demonstrate', 'that', 'PI4KIIIα', 'has', 'a', 'broader', 'role', 'on', 'cellular', 'invasion', 'as', 'its', 'knockdown', 'significantly', 'inhibited', 'multiple', 'members', 'of', 'chemokine', 'mediated', 'PC3', 'cell', 'invasion', '(', 'Figure', '7', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In conclusion, in this study we assign a novel role of the chemokine receptors in recruiting PI4KIIIα activity for cancer cell invasion (Figure 7).	[('PMC6336684', 'D03000', 93, 101, 'PI4KIIIα')]	['In', 'conclusion', ',', 'in', 'this', 'study', 'we', 'assign', 'a', 'novel', 'role', 'of', 'the', 'ch', '##em', '##oki', '##ne', 'receptors', 'in', 'recruiting', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'for', 'cancer', 'cell', 'invasion', '(', 'Figure', '7', ')', '.']	[0, 3, 13, 15, 18, 23, 29, 32, 39, 41, 47, 52, 55, 59, 61, 63, 66, 69, 79, 82, 93, 94, 95, 96, 97, 99, 100, 102, 111, 115, 122, 127, 136, 137, 144, 145, 146]	[2, 13, 14, 17, 22, 28, 31, 38, 40, 46, 51, 54, 58, 61, 63, 66, 68, 78, 81, 92, 94, 95, 96, 97, 99, 100, 101, 110, 114, 121, 126, 135, 137, 143, 145, 146, 147]	['In', 'conclusion', ',', 'in', 'this', 'study', 'we', 'assign', 'a', 'novel', 'role', 'of', 'the', 'chemokine', 'receptors', 'in', 'recruiting', 'PI4KIIIα', 'activity', 'for', 'cancer', 'cell', 'invasion', '(', 'Figure', '7', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
By doing so, CXCR4 regulates PI4P production on the plasma membrane via interacting with cellular PI4KIIIα machinery.	[('PMC6336684', 'D03001', 98, 106, 'PI4KIIIα')]	['By', 'doing', 'so', ',', 'C', '##X', '##CR', '##4', 'regulate', '##s', 'P', '##I', '##4', '##P', 'production', 'on', 'the', 'plasma', 'membrane', 'via', 'interacting', 'with', 'cellular', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'machinery', '.']	[0, 3, 9, 11, 13, 14, 15, 17, 19, 27, 29, 30, 31, 32, 34, 45, 48, 52, 59, 68, 72, 84, 89, 98, 99, 100, 101, 102, 104, 105, 107, 116]	[2, 8, 11, 12, 14, 15, 17, 18, 27, 28, 30, 31, 32, 33, 44, 47, 51, 58, 67, 71, 83, 88, 97, 99, 100, 101, 102, 104, 105, 106, 116, 117]	['By', 'doing', 'so', ',', 'CXCR4', 'regulates', 'PI4P', 'production', 'on', 'the', 'plasma', 'membrane', 'via', 'interacting', 'with', 'cellular', 'PI4KIIIα', 'machinery', '.']	[1, 1, 1, 1, 4, 2, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Phosphatidylinositol (PtdIns) phosphates (PIPs), or phosphoinositides (PIs), are cellular phospholipids phosphorylated at 3, 4 and/or 5 positions on the myo-inositol ring by several types of kinases specific to each position.	[('PMC6336684', 'I01000', 191, 198, 'kinases')]	['Ph', '##os', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', '(', 'P', '##t', '##d', '##I', '##ns', ')', 'phosphate', '##s', '(', 'P', '##IP', '##s', ')', ',', 'or', 'p', '##hos', '##ph', '##oi', '##nos', '##iti', '##des', '(', 'P', '##I', '##s', ')', ',', 'are', 'cellular', 'p', '##hos', '##ph', '##oli', '##pid', '##s', 'p', '##hos', '##ph', '##ory', '##lated', 'at', '3', ',', '4', 'and', '/', 'or', '5', 'positions', 'on', 'the', 'my', '##o', '-', 'in', '##os', '##ito', '##l', 'ring', 'by', 'several', 'types', 'of', 'kinase', '##s', 'specific', 'to', 'each', 'position', '.']	[0, 2, 4, 7, 9, 11, 15, 17, 19, 21, 22, 23, 24, 25, 26, 28, 30, 39, 41, 42, 43, 45, 46, 47, 49, 52, 53, 56, 58, 60, 63, 66, 70, 71, 72, 73, 74, 75, 77, 81, 90, 91, 94, 96, 99, 102, 104, 105, 108, 110, 113, 119, 122, 123, 125, 127, 130, 131, 134, 136, 146, 149, 153, 155, 156, 157, 159, 161, 164, 166, 171, 174, 182, 188, 191, 197, 199, 208, 211, 216, 224]	[2, 4, 7, 9, 11, 15, 17, 19, 20, 22, 23, 24, 25, 26, 28, 29, 39, 40, 42, 43, 45, 46, 47, 48, 51, 53, 56, 58, 60, 63, 66, 69, 71, 72, 73, 74, 75, 76, 80, 89, 91, 94, 96, 99, 102, 103, 105, 108, 110, 113, 118, 121, 123, 124, 126, 130, 131, 133, 135, 145, 148, 152, 155, 156, 157, 159, 161, 164, 165, 170, 173, 181, 187, 190, 197, 198, 207, 210, 215, 224, 225]	['Phosphatidylinositol', '(', 'PtdIns', ')', 'phosphates', '(', 'PIPs', ')', ',', 'or', 'phosphoinositides', '(', 'PIs', ')', ',', 'are', 'cellular', 'phospholipids', 'phosphorylated', 'at', '3', ',', '4', 'and', '/', 'or', '5', 'positions', 'on', 'the', 'myo', '-', 'inositol', 'ring', 'by', 'several', 'types', 'of', 'kinases', 'specific', 'to', 'each', 'position', '.']	[9, 1, 5, 1, 2, 1, 3, 1, 1, 1, 7, 1, 3, 1, 1, 1, 1, 6, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O']
The phosphatases, which dephosphorylate PIPs are fairly specific to each phosphate in the myo-inositol ring, and often localize to subcellular locations where their substrates are produced.	[]	['The', 'p', '##hos', '##pha', '##tase', '##s', ',', 'which', 'de', '##ph', '##os', '##ph', '##ory', '##late', 'P', '##IP', '##s', 'are', 'fairly', 'specific', 'to', 'each', 'phosphate', 'in', 'the', 'my', '##o', '-', 'in', '##os', '##ito', '##l', 'ring', ',', 'and', 'often', 'local', '##ize', 'to', 'sub', '##cellular', 'locations', 'where', 'their', 'substrates', 'are', 'produced', '.']	[0, 4, 5, 8, 11, 15, 16, 18, 24, 26, 28, 30, 32, 35, 40, 41, 43, 45, 49, 56, 65, 68, 73, 83, 86, 90, 92, 93, 94, 96, 98, 101, 103, 107, 109, 113, 119, 124, 128, 131, 134, 143, 153, 159, 165, 176, 180, 188]	[3, 5, 8, 11, 15, 16, 17, 23, 26, 28, 30, 32, 35, 39, 41, 43, 44, 48, 55, 64, 67, 72, 82, 85, 89, 92, 93, 94, 96, 98, 101, 102, 107, 108, 112, 118, 124, 127, 130, 134, 142, 152, 158, 164, 175, 179, 188, 189]	['The', 'phosphatases', ',', 'which', 'dephosphorylate', 'PIPs', 'are', 'fairly', 'specific', 'to', 'each', 'phosphate', 'in', 'the', 'myo', '-', 'inositol', 'ring', ',', 'and', 'often', 'localize', 'to', 'subcellular', 'locations', 'where', 'their', 'substrates', 'are', 'produced', '.']	[1, 5, 1, 1, 6, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the present study we investigate the relationship between CXCR4 and PI4KIIIα activity in terms of biochemical characterization and consequences to cancer cell invasion and metastasis.	[('PMC6336684', 'I02000', 71, 79, 'PI4KIIIα')]	['In', 'the', 'present', 'study', 'we', 'investigate', 'the', 'relationship', 'between', 'C', '##X', '##CR', '##4', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'in', 'terms', 'of', 'bio', '##chemical', 'characterization', 'and', 'consequences', 'to', 'cancer', 'cell', 'invasion', 'and', 'meta', '##sta', '##sis', '.']	[0, 3, 7, 15, 21, 24, 36, 40, 53, 61, 62, 63, 65, 67, 71, 72, 73, 74, 75, 77, 78, 80, 89, 92, 98, 101, 104, 113, 130, 134, 147, 150, 157, 162, 171, 175, 179, 182, 185]	[2, 6, 14, 20, 23, 35, 39, 52, 60, 62, 63, 65, 66, 70, 72, 73, 74, 75, 77, 78, 79, 88, 91, 97, 100, 104, 112, 129, 133, 146, 149, 156, 161, 170, 174, 179, 182, 185, 186]	['In', 'the', 'present', 'study', 'we', 'investigate', 'the', 'relationship', 'between', 'CXCR4', 'and', 'PI4KIIIα', 'activity', 'in', 'terms', 'of', 'biochemical', 'characterization', 'and', 'consequences', 'to', 'cancer', 'cell', 'invasion', 'and', 'metastasis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 7, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In vitro PI4KIIIα lipid kinase assays were performed as described earlier (22).	[('PMC6336684', 'M05000', 9, 30, 'PI4KIIIα lipid kinase')]	['In', 'v', '##it', '##ro', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'lip', '##id', 'kinase', 'ass', '##ays', 'were', 'performed', 'as', 'described', 'earlier', '(', '22', ')', '.']	[0, 3, 4, 6, 9, 10, 11, 12, 13, 15, 16, 18, 21, 24, 31, 34, 38, 43, 53, 56, 66, 74, 75, 77, 78]	[2, 4, 6, 8, 10, 11, 12, 13, 15, 16, 17, 21, 23, 30, 34, 37, 42, 52, 55, 65, 73, 75, 77, 78, 79]	['In', 'vitro', 'PI4KIIIα', 'lipid', 'kinase', 'assays', 'were', 'performed', 'as', 'described', 'earlier', '(', '22', ')', '.']	[1, 3, 7, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Post kinase assay the chloroform-extracted PI(4)P product was separated by thin-layer chromatography (TLC) in n-propanol-2M acetic acid (65:35 v/v).	[('PMC6336684', 'M05001', 5, 11, 'kinase')]	['Post', 'kinase', 'ass', '##ay', 'the', 'ch', '##lor', '##of', '##orm', '-', 'extracted', 'P', '##I', '(', '4', ')', 'P', 'product', 'was', 'separated', 'by', 'thin', '-', 'layer', 'ch', '##roma', '##tography', '(', 'T', '##LC', ')', 'in', 'n', '-', 'prop', '##ano', '##l', '-', '2', '##M', 'ace', '##tic', 'acid', '(', '65', ':', '35', 'v', '/', 'v', ')', '.']	[0, 5, 12, 15, 18, 22, 24, 27, 29, 32, 33, 43, 44, 45, 46, 47, 48, 50, 58, 62, 72, 75, 79, 80, 86, 88, 92, 101, 102, 103, 105, 107, 110, 111, 112, 116, 119, 120, 121, 122, 124, 127, 131, 136, 137, 139, 140, 143, 144, 145, 146, 147]	[4, 11, 15, 17, 21, 24, 27, 29, 32, 33, 42, 44, 45, 46, 47, 48, 49, 57, 61, 71, 74, 79, 80, 85, 88, 92, 100, 102, 103, 105, 106, 109, 111, 112, 116, 119, 120, 121, 122, 123, 127, 130, 135, 137, 139, 140, 142, 144, 145, 146, 147, 148]	['Post', 'kinase', 'assay', 'the', 'chloroform', '-', 'extracted', 'PI(4)P', 'product', 'was', 'separated', 'by', 'thin', '-', 'layer', 'chromatography', '(', 'TLC', ')', 'in', 'n-propanol-2M', 'acetic', 'acid', '(', '65', ':', '35', 'v', '/', 'v', ')', '.']	[1, 1, 2, 1, 4, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 8, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PI4KIIIα activity was set as one fold in control PC3 cells (PC3 scr and PC3 RFP) and compared with CXCR4 manipulated cells.	[]	['P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'was', 'set', 'as', 'one', 'fold', 'in', 'control', 'PC', '##3', 'cells', '(', 'PC', '##3', 's', '##c', '##r', 'and', 'PC', '##3', 'RF', '##P', ')', 'and', 'compared', 'with', 'C', '##X', '##CR', '##4', 'manipulated', 'cells', '.']	[0, 1, 2, 3, 4, 6, 7, 9, 18, 22, 26, 29, 33, 38, 41, 49, 51, 53, 59, 60, 62, 64, 65, 66, 68, 72, 74, 76, 78, 79, 81, 85, 94, 99, 100, 101, 103, 105, 117, 122]	[1, 2, 3, 4, 6, 7, 8, 17, 21, 25, 28, 32, 37, 40, 48, 51, 52, 58, 60, 62, 63, 65, 66, 67, 71, 74, 75, 78, 79, 80, 84, 93, 98, 100, 101, 103, 104, 116, 122, 123]	['PI4KIIIα', 'activity', 'was', 'set', 'as', 'one', 'fold', 'in', 'control', 'PC3', 'cells', '(', 'PC3', 'scr', 'and', 'PC3', 'RFP', ')', 'and', 'compared', 'with', 'CXCR4', 'manipulated', 'cells', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 3, 1, 2, 2, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In other prostate cancer cells PI4KIIIα activity was set as one fold in LNCaP cells and compared with activity of C4–2B and VCaP cells.	[]	['In', 'other', 'pro', '##state', 'cancer', 'cells', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'was', 'set', 'as', 'one', 'fold', 'in', 'L', '##NC', '##a', '##P', 'cells', 'and', 'compared', 'with', 'activity', 'of', 'C', '##4', '–', '2', '##B', 'and', 'VC', '##a', '##P', 'cells', '.']	[0, 3, 9, 12, 18, 25, 31, 32, 33, 34, 35, 37, 38, 40, 49, 53, 57, 60, 64, 69, 72, 73, 75, 76, 78, 84, 88, 97, 102, 111, 114, 115, 116, 117, 118, 120, 124, 126, 127, 129, 134]	[2, 8, 12, 17, 24, 30, 32, 33, 34, 35, 37, 38, 39, 48, 52, 56, 59, 63, 68, 71, 73, 75, 76, 77, 83, 87, 96, 101, 110, 113, 115, 116, 117, 118, 119, 123, 126, 127, 128, 134, 135]	['In', 'other', 'prostate', 'cancer', 'cells', 'PI4KIIIα', 'activity', 'was', 'set', 'as', 'one', 'fold', 'in', 'LNCaP', 'cells', 'and', 'compared', 'with', 'activity', 'of', 'C4–', '2B', 'and', 'VCaP', 'cells', '.']	[1, 1, 2, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Briefly, scr and PI4KIIIα siRNA transfected PC3 CXCR4 cells were cultured overnight in inositol-free cell type-specific medium and labeled for 24–48 h with 25 μCi/ml of myo-[2-3H] inositol in an inositol free medium following previously published protocols (32).	[]	['B', '##rief', '##ly', ',', 's', '##c', '##r', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'si', '##RNA', 'trans', '##fected', 'PC', '##3', 'C', '##X', '##CR', '##4', 'cells', 'were', 'culture', '##d', 'overnight', 'in', 'in', '##os', '##ito', '##l', '-', 'free', 'cell', 'type', '-', 'specific', 'medium', 'and', 'labeled', 'for', '24', '–', '48', 'h', 'with', '25', 'μ', '##C', '##i', '/', 'm', '##l', 'of', 'my', '##o', '-', '[', '2', '-', '3', '##H', ']', 'in', '##os', '##ito', '##l', 'in', 'an', 'in', '##os', '##ito', '##l', 'free', 'medium', 'following', 'previously', 'published', 'protocols', '(', '32', ')', '.']	[0, 1, 5, 7, 9, 10, 11, 13, 17, 18, 19, 20, 21, 23, 24, 26, 28, 32, 37, 44, 46, 48, 49, 50, 52, 54, 60, 65, 72, 74, 84, 87, 89, 91, 94, 95, 96, 101, 106, 110, 111, 120, 127, 131, 139, 143, 145, 146, 149, 151, 156, 159, 160, 161, 162, 163, 164, 166, 169, 171, 172, 173, 174, 175, 176, 177, 178, 180, 182, 184, 187, 189, 192, 195, 197, 199, 202, 204, 209, 216, 226, 237, 247, 257, 258, 260, 261]	[1, 5, 7, 8, 10, 11, 12, 16, 18, 19, 20, 21, 23, 24, 25, 28, 31, 37, 43, 46, 47, 49, 50, 52, 53, 59, 64, 72, 73, 83, 86, 89, 91, 94, 95, 96, 100, 105, 110, 111, 119, 126, 130, 138, 142, 145, 146, 148, 150, 155, 158, 160, 161, 162, 163, 164, 165, 168, 171, 172, 173, 174, 175, 176, 177, 178, 179, 182, 184, 187, 188, 191, 194, 197, 199, 202, 203, 208, 215, 225, 236, 246, 256, 258, 260, 261, 262]	['Briefly', ',', 'scr', 'and', 'PI4KIIIα', 'siRNA', 'transfected', 'PC3', 'CXCR4', 'cells', 'were', 'cultured', 'overnight', 'in', 'inositol', '-', 'free', 'cell', 'type', '-', 'specific', 'medium', 'and', 'labeled', 'for', '24–', '48', 'h', 'with', '25', 'μCi', '/', 'ml', 'of', 'myo-[2-3H]', 'inositol', 'in', 'an', 'inositol', 'free', 'medium', 'following', 'previously', 'published', 'protocols', '(', '32', ')', '.']	[3, 1, 3, 1, 7, 2, 2, 2, 4, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 9, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CXCR4 overexpressing cells (~50% confluent) transfected with or without 100 nM PI4KIIIα siRNA for 6 hrs in duplicate 60-mm dishes were harvested 44 hrs later and seeded in 12 wells (1×104 cells/well) of a Cell-Bind 96-well, black culture plate in complete growth medium (RPMI-1640, 10% FBS, 1% penicillin/streptomycin).	[('PMC6336684', 'M09000', 79, 87, 'PI4KIIIα')]	['C', '##X', '##CR', '##4', 'over', '##ex', '##pressing', 'cells', '(', '~', '50', '%', 'con', '##f', '##lue', '##nt', ')', 'trans', '##fected', 'with', 'or', 'without', '100', 'n', '##M', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'si', '##RNA', 'for', '6', 'h', '##rs', 'in', 'du', '##plicate', '60', '-', 'mm', 'dishes', 'were', 'harvested', '44', 'h', '##rs', 'later', 'and', 'seeded', 'in', '12', 'wells', '(', '1', '##×', '##10', '##4', 'cells', '/', 'well', ')', 'of', 'a', 'Cell', '-', 'Bin', '##d', '96', '-', 'well', ',', 'black', 'culture', 'plate', 'in', 'complete', 'growth', 'medium', '(', 'R', '##PM', '##I', '-', '1640', ',', '10', '%', 'F', '##BS', ',', '1', '%', 'pen', '##ici', '##llin', '/', 's', '##tre', '##pt', '##omy', '##cin', ')', '.']	[0, 1, 2, 4, 6, 10, 12, 21, 27, 28, 29, 31, 33, 36, 37, 40, 42, 44, 49, 56, 61, 64, 72, 76, 77, 79, 80, 81, 82, 83, 85, 86, 88, 90, 94, 98, 100, 101, 104, 107, 109, 117, 119, 120, 123, 130, 135, 145, 148, 149, 152, 158, 162, 169, 172, 175, 181, 182, 183, 184, 186, 188, 193, 194, 198, 200, 203, 205, 209, 210, 213, 215, 217, 218, 222, 224, 230, 238, 244, 247, 256, 263, 270, 271, 272, 274, 275, 276, 280, 282, 284, 286, 287, 289, 291, 292, 294, 297, 300, 304, 305, 306, 309, 311, 314, 317, 318]	[1, 2, 4, 5, 10, 12, 20, 26, 28, 29, 31, 32, 36, 37, 40, 42, 43, 49, 55, 60, 63, 71, 75, 77, 78, 80, 81, 82, 83, 85, 86, 87, 90, 93, 97, 99, 101, 103, 106, 109, 116, 119, 120, 122, 129, 134, 144, 147, 149, 151, 157, 161, 168, 171, 174, 180, 182, 183, 184, 186, 187, 193, 194, 198, 199, 202, 204, 209, 210, 213, 214, 217, 218, 222, 223, 229, 237, 243, 246, 255, 262, 269, 271, 272, 274, 275, 276, 280, 281, 284, 285, 287, 289, 290, 292, 293, 297, 300, 304, 305, 306, 309, 311, 314, 317, 318, 319]	['CXCR4', 'overexpressing', 'cells', '(', '~50%', 'confluent', ')', 'transfected', 'with', 'or', 'without', '100', 'nM', 'PI4KIIIα', 'siRNA', 'for', '6', 'hrs', 'in', 'duplicate', '60-mm', 'dishes', 'were', 'harvested', '44', 'hrs', 'later', 'and', 'seeded', 'in', '12', 'wells', '(', '1×104', 'cells', '/', 'well', ')', 'of', 'a', 'Cell-Bind', '96-well', ',', 'black', 'culture', 'plate', 'in', 'complete', 'growth', 'medium', '(', 'RPMI-1640', ',', '10%', 'FBS', ',', '1%', 'penicillin', '/', 'streptomycin', ')', '.']	[4, 3, 1, 1, 3, 4, 1, 2, 1, 1, 1, 1, 2, 7, 2, 1, 1, 2, 1, 2, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 2, 1, 2, 3, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To determine the significance of CXCR4 and PI4KIIIα association in lipid rafts, we first assessed whether CXCR4 regulates PI4KIIIα expression in prostate cancer cells.	[('PMC6336684', 'R01000', 43, 51, 'PI4KIIIα')]	['To', 'determine', 'the', 'significance', 'of', 'C', '##X', '##CR', '##4', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'association', 'in', 'lip', '##id', 'r', '##aft', '##s', ',', 'we', 'first', 'assessed', 'whether', 'C', '##X', '##CR', '##4', 'regulate', '##s', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'expression', 'in', 'pro', '##state', 'cancer', 'cells', '.']	[0, 3, 13, 17, 30, 33, 34, 35, 37, 39, 43, 44, 45, 46, 47, 49, 50, 52, 64, 67, 70, 73, 74, 77, 78, 80, 83, 89, 98, 106, 107, 108, 110, 112, 120, 122, 123, 124, 125, 126, 128, 129, 131, 142, 145, 148, 154, 161, 166]	[2, 12, 16, 29, 32, 34, 35, 37, 38, 42, 44, 45, 46, 47, 49, 50, 51, 63, 66, 70, 72, 74, 77, 78, 79, 82, 88, 97, 105, 107, 108, 110, 111, 120, 121, 123, 124, 125, 126, 128, 129, 130, 141, 144, 148, 153, 160, 166, 167]	['To', 'determine', 'the', 'significance', 'of', 'CXCR4', 'and', 'PI4KIIIα', 'association', 'in', 'lipid', 'rafts', ',', 'we', 'first', 'assessed', 'whether', 'CXCR4', 'regulates', 'PI4KIIIα', 'expression', 'in', 'prostate', 'cancer', 'cells', '.']	[1, 1, 1, 1, 1, 4, 1, 7, 1, 1, 2, 3, 1, 1, 1, 1, 1, 4, 2, 7, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Data from Western-blotting experiments in CXCR4-overexpressing cells showed approximately a 2-fold increase in PI4KIIIα levels vs. the control PC3 parent cell line (Figure 2A,B).	[('PMC6336684', 'R01001', 111, 119, 'PI4KIIIα')]	['Data', 'from', 'Western', '-', 'b', '##lot', '##ting', 'experiments', 'in', 'C', '##X', '##CR', '##4', '-', 'over', '##ex', '##pressing', 'cells', 'showed', 'approximately', 'a', '2', '-', 'fold', 'increase', 'in', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'levels', 'vs', '.', 'the', 'control', 'PC', '##3', 'parent', 'cell', 'line', '(', 'Figure', '2', '##A', ',', 'B', ')', '.']	[0, 5, 10, 17, 18, 19, 22, 27, 39, 42, 43, 44, 46, 47, 48, 52, 54, 63, 69, 76, 90, 92, 93, 94, 99, 108, 111, 112, 113, 114, 115, 117, 118, 120, 127, 129, 131, 135, 143, 145, 147, 154, 159, 164, 165, 172, 173, 174, 175, 176, 177]	[4, 9, 17, 18, 19, 22, 26, 38, 41, 43, 44, 46, 47, 48, 52, 54, 62, 68, 75, 89, 91, 93, 94, 98, 107, 110, 112, 113, 114, 115, 117, 118, 119, 126, 129, 130, 134, 142, 145, 146, 153, 158, 163, 165, 171, 173, 174, 175, 176, 177, 178]	['Data', 'from', 'Western', '-', 'blotting', 'experiments', 'in', 'CXCR4-overexpressing', 'cells', 'showed', 'approximately', 'a', '2-fold', 'increase', 'in', 'PI4KIIIα', 'levels', 'vs', '.', 'the', 'control', 'PC3', 'parent', 'cell', 'line', '(', 'Figure', '2A', ',', 'B', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 8, 1, 1, 1, 1, 3, 1, 1, 7, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Concordantly, CXCR4 knockdown cells had reduced expression of both PI4KIIIα and Sac1expression.	[('PMC6336684', 'R01002', 67, 75, 'PI4KIIIα')]	['Concord', '##antly', ',', 'C', '##X', '##CR', '##4', 'knock', '##down', 'cells', 'had', 'reduced', 'expression', 'of', 'both', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'and', 'Sa', '##c', '##1', '##ex', '##press', '##ion', '.']	[0, 7, 12, 14, 15, 16, 18, 20, 25, 30, 36, 40, 48, 59, 62, 67, 68, 69, 70, 71, 73, 74, 76, 80, 82, 83, 84, 86, 91, 94]	[7, 12, 13, 15, 16, 18, 19, 25, 29, 35, 39, 47, 58, 61, 66, 68, 69, 70, 71, 73, 74, 75, 79, 82, 83, 84, 86, 91, 94, 95]	['Concordantly', ',', 'CXCR4', 'knockdown', 'cells', 'had', 'reduced', 'expression', 'of', 'both', 'PI4KIIIα', 'and', 'Sac1expression', '.']	[2, 1, 4, 2, 1, 1, 1, 1, 1, 1, 7, 1, 6, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
QPCR analysis of PI4KIIIα and Sac1 did not show changes in gene expresssion between parental PC3 cells and CXCR4 manipulated cells (Supplementary figure 3) suggesting a post-transcriptional mode of PI4KIIIα protein elevation in CXCR4 overexpressing PC3 cells.	[('PMC6336684', 'R01003', 17, 25, 'PI4KIIIα')]	['Q', '##PC', '##R', 'analysis', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'and', 'Sa', '##c', '##1', 'did', 'not', 'show', 'changes', 'in', 'gene', 'express', '##sion', 'between', 'parental', 'PC', '##3', 'cells', 'and', 'C', '##X', '##CR', '##4', 'manipulated', 'cells', '(', 'Su', '##pp', '##lement', '##ary', 'figure', '3', ')', 'suggesting', 'a', 'post', '-', 'transcription', '##al', 'mode', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'protein', 'elevation', 'in', 'C', '##X', '##CR', '##4', 'over', '##ex', '##pressing', 'PC', '##3', 'cells', '.']	[0, 1, 3, 5, 14, 17, 18, 19, 20, 21, 23, 24, 26, 30, 32, 33, 35, 39, 43, 48, 56, 59, 64, 71, 76, 84, 93, 95, 97, 103, 107, 108, 109, 111, 113, 125, 131, 132, 134, 136, 142, 146, 153, 154, 156, 167, 169, 173, 174, 187, 190, 195, 198, 199, 200, 201, 202, 204, 205, 207, 215, 225, 228, 229, 230, 232, 234, 238, 240, 249, 251, 253, 258]	[1, 3, 4, 13, 16, 18, 19, 20, 21, 23, 24, 25, 29, 32, 33, 34, 38, 42, 47, 55, 58, 63, 71, 75, 83, 92, 95, 96, 102, 106, 108, 109, 111, 112, 124, 130, 132, 134, 136, 142, 145, 152, 154, 155, 166, 168, 173, 174, 187, 189, 194, 197, 199, 200, 201, 202, 204, 205, 206, 214, 224, 227, 229, 230, 232, 233, 238, 240, 248, 251, 252, 258, 259]	['QPCR', 'analysis', 'of', 'PI4KIIIα', 'and', 'Sac1', 'did', 'not', 'show', 'changes', 'in', 'gene', 'expresssion', 'between', 'parental', 'PC3', 'cells', 'and', 'CXCR4', 'manipulated', 'cells', '(', 'Supplementary', 'figure', '3', ')', 'suggesting', 'a', 'post', '-', 'transcriptional', 'mode', 'of', 'PI4KIIIα', 'protein', 'elevation', 'in', 'CXCR4', 'overexpressing', 'PC3', 'cells', '.']	[3, 1, 1, 7, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 7, 1, 1, 1, 4, 3, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cycloheximide treatment demonstrated that both CXCR4 and PI4KIIIα protein expression were decreased in PC3-CXCR4 cells compared to control PC3 cell which have lowere levels of both proteins; thus the overexpressed CXCR4 stabilizes PI4KIIIα in PC3 CXCR4 cells.	[('PMC6336684', 'R01004', 57, 65, 'PI4KIIIα')]	['Cy', '##c', '##lo', '##he', '##xi', '##mi', '##de', 'treatment', 'demonstrated', 'that', 'both', 'C', '##X', '##CR', '##4', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'protein', 'expression', 'were', 'decreased', 'in', 'PC', '##3', '-', 'C', '##X', '##CR', '##4', 'cells', 'compared', 'to', 'control', 'PC', '##3', 'cell', 'which', 'have', 'lower', '##e', 'levels', 'of', 'both', 'proteins', ';', 'thus', 'the', 'over', '##ex', '##pressed', 'C', '##X', '##CR', '##4', 'stab', '##ilize', '##s', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'in', 'PC', '##3', 'C', '##X', '##CR', '##4', 'cells', '.']	[0, 2, 3, 5, 7, 9, 11, 14, 24, 37, 42, 47, 48, 49, 51, 53, 57, 58, 59, 60, 61, 63, 64, 66, 74, 85, 90, 100, 103, 105, 106, 107, 108, 109, 111, 113, 119, 128, 131, 139, 141, 143, 148, 154, 159, 164, 166, 173, 176, 181, 189, 191, 196, 200, 204, 206, 214, 215, 216, 218, 220, 224, 229, 231, 232, 233, 234, 235, 237, 238, 240, 243, 245, 247, 248, 249, 251, 253, 258]	[2, 3, 5, 7, 9, 11, 13, 23, 36, 41, 46, 48, 49, 51, 52, 56, 58, 59, 60, 61, 63, 64, 65, 73, 84, 89, 99, 102, 105, 106, 107, 108, 109, 111, 112, 118, 127, 130, 138, 141, 142, 147, 153, 158, 164, 165, 172, 175, 180, 189, 190, 195, 199, 204, 206, 213, 215, 216, 218, 219, 224, 229, 230, 232, 233, 234, 235, 237, 238, 239, 242, 245, 246, 248, 249, 251, 252, 258, 259]	['Cycloheximide', 'treatment', 'demonstrated', 'that', 'both', 'CXCR4', 'and', 'PI4KIIIα', 'protein', 'expression', 'were', 'decreased', 'in', 'PC3-CXCR4', 'cells', 'compared', 'to', 'control', 'PC3', 'cell', 'which', 'have', 'lowere', 'levels', 'of', 'both', 'proteins', ';', 'thus', 'the', 'overexpressed', 'CXCR4', 'stabilizes', 'PI4KIIIα', 'in', 'PC3', 'CXCR4', 'cells', '.']	[7, 1, 1, 1, 1, 4, 1, 7, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 4, 3, 7, 1, 2, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The levels of both CXCR4 and PI4KIIIα in these cells were downregulated upon cycloheximide treatment in a similar fashion, further suggesting a post-transcriptional mode of their celllular regulation (Supplementary figure 4).	[('PMC6336684', 'R01005', 29, 37, 'PI4KIIIα')]	['The', 'levels', 'of', 'both', 'C', '##X', '##CR', '##4', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'in', 'these', 'cells', 'were', 'down', '##re', '##gu', '##lated', 'upon', 'c', '##y', '##c', '##lo', '##he', '##xi', '##mi', '##de', 'treatment', 'in', 'a', 'similar', 'fashion', ',', 'further', 'suggesting', 'a', 'post', '-', 'transcription', '##al', 'mode', 'of', 'their', 'cell', '##lu', '##lar', 'regulation', '(', 'Su', '##pp', '##lement', '##ary', 'figure', '4', ')', '.']	[0, 4, 11, 14, 19, 20, 21, 23, 25, 29, 30, 31, 32, 33, 35, 36, 38, 41, 47, 53, 58, 62, 64, 66, 72, 77, 78, 79, 80, 82, 84, 86, 88, 91, 101, 104, 106, 114, 121, 123, 131, 142, 144, 148, 149, 162, 165, 170, 173, 179, 183, 185, 189, 200, 201, 203, 205, 211, 215, 222, 223, 224]	[3, 10, 13, 18, 20, 21, 23, 24, 28, 30, 31, 32, 33, 35, 36, 37, 40, 46, 52, 57, 62, 64, 66, 71, 76, 78, 79, 80, 82, 84, 86, 88, 90, 100, 103, 105, 113, 121, 122, 130, 141, 143, 148, 149, 162, 164, 169, 172, 178, 183, 185, 188, 199, 201, 203, 205, 211, 214, 221, 223, 224, 225]	['The', 'levels', 'of', 'both', 'CXCR4', 'and', 'PI4KIIIα', 'in', 'these', 'cells', 'were', 'downregulated', 'upon', 'cycloheximide', 'treatment', 'in', 'a', 'similar', 'fashion', ',', 'further', 'suggesting', 'a', 'post', '-', 'transcriptional', 'mode', 'of', 'their', 'celllular', 'regulation', '(', 'Supplementary', 'figure', '4', ')', '.']	[1, 1, 1, 1, 4, 1, 7, 1, 1, 1, 1, 4, 1, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recent studies have indicated that CXCR4 signaling regulates the translational machinary involved in mTORC1 signaling (31), suggesting that PI4KIIIα overexpression could be due to a translational mechanism involving CXCR4/mTORC1 signaling.	[('PMC6336684', 'R01006', 140, 148, 'PI4KIIIα')]	['Recent', 'studies', 'have', 'indicated', 'that', 'C', '##X', '##CR', '##4', 'signaling', 'regulate', '##s', 'the', 'translation', '##al', 'mac', '##hin', '##ary', 'involved', 'in', 'm', '##TO', '##RC', '##1', 'signaling', '(', '31', ')', ',', 'suggesting', 'that', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'over', '##ex', '##press', '##ion', 'could', 'be', 'due', 'to', 'a', 'translation', '##al', 'mechanism', 'involving', 'C', '##X', '##CR', '##4', '/', 'm', '##TO', '##RC', '##1', 'signaling', '.']	[0, 7, 15, 20, 30, 35, 36, 37, 39, 41, 51, 59, 61, 65, 76, 79, 82, 85, 89, 98, 101, 102, 104, 106, 108, 118, 119, 121, 122, 124, 135, 140, 141, 142, 143, 144, 146, 147, 149, 153, 155, 160, 164, 170, 173, 177, 180, 182, 193, 196, 206, 216, 217, 218, 220, 221, 222, 223, 225, 227, 229, 238]	[6, 14, 19, 29, 34, 36, 37, 39, 40, 50, 59, 60, 64, 76, 78, 82, 85, 88, 97, 100, 102, 104, 106, 107, 117, 119, 121, 122, 123, 134, 139, 141, 142, 143, 144, 146, 147, 148, 153, 155, 160, 163, 169, 172, 176, 179, 181, 193, 195, 205, 215, 217, 218, 220, 221, 222, 223, 225, 227, 228, 238, 239]	['Recent', 'studies', 'have', 'indicated', 'that', 'CXCR4', 'signaling', 'regulates', 'the', 'translational', 'machinary', 'involved', 'in', 'mTORC1', 'signaling', '(', '31', ')', ',', 'suggesting', 'that', 'PI4KIIIα', 'overexpression', 'could', 'be', 'due', 'to', 'a', 'translational', 'mechanism', 'involving', 'CXCR4', '/', 'mTORC1', 'signaling', '.']	[1, 1, 1, 1, 1, 4, 1, 2, 1, 2, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 7, 4, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To identify whether the greater protein levels of PI4KIIIα is accompanied by elevated lipid kinase activity, we immunoprecipitated PI4KIIIα from prostate cancer cells with anti-PI4KIIIα antibody and subjected the immunoprecipitates to in vitro lipid kinase activity using PtdIns as a substrate.	[('PMC6336684', 'R01007', 50, 58, 'PI4KIIIα')]	['To', 'identify', 'whether', 'the', 'greater', 'protein', 'levels', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'is', 'accompanied', 'by', 'elevated', 'lip', '##id', 'kinase', 'activity', ',', 'we', 'im', '##mu', '##no', '##p', '##re', '##ci', '##pit', '##ated', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'from', 'pro', '##state', 'cancer', 'cells', 'with', 'anti', '-', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'anti', '##body', 'and', 'subjected', 'the', 'im', '##mu', '##no', '##p', '##re', '##ci', '##pit', '##ates', 'to', 'in', 'v', '##it', '##ro', 'lip', '##id', 'kinase', 'activity', 'using', 'P', '##t', '##d', '##I', '##ns', 'as', 'a', 'substrate', '.']	[0, 3, 12, 20, 24, 32, 40, 47, 50, 51, 52, 53, 54, 56, 57, 59, 62, 74, 77, 86, 89, 92, 99, 107, 109, 112, 114, 116, 118, 119, 121, 123, 126, 131, 132, 133, 134, 135, 137, 138, 140, 145, 148, 154, 161, 167, 172, 176, 177, 178, 179, 180, 181, 183, 184, 186, 190, 195, 199, 209, 213, 215, 217, 219, 220, 222, 224, 227, 232, 235, 238, 239, 241, 244, 247, 250, 257, 266, 272, 273, 274, 275, 276, 279, 282, 284, 293]	[2, 11, 19, 23, 31, 39, 46, 49, 51, 52, 53, 54, 56, 57, 58, 61, 73, 76, 85, 89, 91, 98, 107, 108, 111, 114, 116, 118, 119, 121, 123, 126, 130, 132, 133, 134, 135, 137, 138, 139, 144, 148, 153, 160, 166, 171, 176, 177, 178, 179, 180, 181, 183, 184, 185, 190, 194, 198, 208, 212, 215, 217, 219, 220, 222, 224, 227, 231, 234, 237, 239, 241, 243, 247, 249, 256, 265, 271, 273, 274, 275, 276, 278, 281, 283, 293, 294]	['To', 'identify', 'whether', 'the', 'greater', 'protein', 'levels', 'of', 'PI4KIIIα', 'is', 'accompanied', 'by', 'elevated', 'lipid', 'kinase', 'activity', ',', 'we', 'immunoprecipitated', 'PI4KIIIα', 'from', 'prostate', 'cancer', 'cells', 'with', 'anti-PI4KIIIα', 'antibody', 'and', 'subjected', 'the', 'immunoprecipitates', 'to', 'in', 'vitro', 'lipid', 'kinase', 'activity', 'using', 'PtdIns', 'as', 'a', 'substrate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 2, 1, 1, 1, 1, 8, 7, 1, 2, 1, 1, 1, 9, 2, 1, 1, 1, 8, 1, 1, 3, 2, 1, 1, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In vitro lipid kinase assays also confirmed that PI4KIIIα kinase activity was similarly elevated ~ 2 fold in the CXCR4-overexpressing cells and reduced in CXCR4 knockdown cells (Figure 2C and H).	[('PMC6336684', 'R01008', 9, 21, 'lipid kinase')]	['In', 'v', '##it', '##ro', 'lip', '##id', 'kinase', 'ass', '##ays', 'also', 'confirmed', 'that', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'kinase', 'activity', 'was', 'similarly', 'elevated', '~', '2', 'fold', 'in', 'the', 'C', '##X', '##CR', '##4', '-', 'over', '##ex', '##pressing', 'cells', 'and', 'reduced', 'in', 'C', '##X', '##CR', '##4', 'knock', '##down', 'cells', '(', 'Figure', '2', '##C', 'and', 'H', ')', '.']	[0, 3, 4, 6, 9, 12, 15, 22, 25, 29, 34, 44, 49, 50, 51, 52, 53, 55, 56, 58, 65, 74, 78, 88, 97, 99, 101, 106, 109, 113, 114, 115, 117, 118, 119, 123, 125, 134, 140, 144, 152, 155, 156, 157, 159, 161, 166, 171, 177, 178, 185, 186, 188, 192, 193, 194]	[2, 4, 6, 8, 12, 14, 21, 25, 28, 33, 43, 48, 50, 51, 52, 53, 55, 56, 57, 64, 73, 77, 87, 96, 98, 100, 105, 108, 112, 114, 115, 117, 118, 119, 123, 125, 133, 139, 143, 151, 154, 156, 157, 159, 160, 166, 170, 176, 178, 184, 186, 187, 191, 193, 194, 195]	['In', 'vitro', 'lipid', 'kinase', 'assays', 'also', 'confirmed', 'that', 'PI4KIIIα', 'kinase', 'activity', 'was', 'similarly', 'elevated', '~', '2', 'fold', 'in', 'the', 'CXCR4-overexpressing', 'cells', 'and', 'reduced', 'in', 'CXCR4', 'knockdown', 'cells', '(', 'Figure', '2C', 'and', 'H', ')', '.']	[1, 3, 2, 1, 2, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 8, 1, 1, 1, 1, 4, 2, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
SiRNA mediated knockdown of PI4KIIIα resulted in a large downregulation of PI4KIIIα and small downregulation of Sac1 (Figure 2D) without a change in PI4KIIIβ expression (Supplementary figure 5) in PC3 cells.	[('PMC6336684', 'R01009', 28, 36, 'PI4KIIIα')]	['Si', '##RNA', 'mediated', 'knock', '##down', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'resulted', 'in', 'a', 'large', 'down', '##re', '##gu', '##lation', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'and', 'small', 'down', '##re', '##gu', '##lation', 'of', 'Sa', '##c', '##1', '(', 'Figure', '2D', ')', 'without', 'a', 'change', 'in', 'P', '##I', '##4', '##K', '##II', '##I', '##β', 'expression', '(', 'Su', '##pp', '##lement', '##ary', 'figure', '5', ')', 'in', 'PC', '##3', 'cells', '.']	[0, 2, 6, 15, 20, 25, 28, 29, 30, 31, 32, 34, 35, 37, 46, 49, 51, 57, 61, 63, 65, 72, 75, 76, 77, 78, 79, 81, 82, 84, 88, 94, 98, 100, 102, 109, 112, 114, 115, 117, 118, 125, 127, 129, 137, 139, 146, 149, 150, 151, 152, 153, 155, 156, 158, 169, 170, 172, 174, 180, 184, 191, 192, 194, 197, 199, 201, 206]	[2, 5, 14, 20, 24, 27, 29, 30, 31, 32, 34, 35, 36, 45, 48, 50, 56, 61, 63, 65, 71, 74, 76, 77, 78, 79, 81, 82, 83, 87, 93, 98, 100, 102, 108, 111, 114, 115, 116, 118, 124, 127, 128, 136, 138, 145, 148, 150, 151, 152, 153, 155, 156, 157, 168, 170, 172, 174, 180, 183, 190, 192, 193, 196, 199, 200, 206, 207]	['SiRNA', 'mediated', 'knockdown', 'of', 'PI4KIIIα', 'resulted', 'in', 'a', 'large', 'downregulation', 'of', 'PI4KIIIα', 'and', 'small', 'downregulation', 'of', 'Sac1', '(', 'Figure', '2D', ')', 'without', 'a', 'change', 'in', 'PI4KIIIβ', 'expression', '(', 'Supplementary', 'figure', '5', ')', 'in', 'PC3', 'cells', '.']	[2, 1, 2, 1, 7, 1, 1, 1, 1, 4, 1, 7, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PI4KIIIα knock down experiments resulted in loss of PI4KIIIα lipid kinase activity (Figure 2E).	[('PMC6336684', 'R01010', 0, 8, 'PI4KIIIα')]	['P', '##I', '##4', '##K', '##II', '##I', '##α', 'knock', 'down', 'experiments', 'resulted', 'in', 'loss', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'lip', '##id', 'kinase', 'activity', '(', 'Figure', '2', '##E', ')', '.']	[0, 1, 2, 3, 4, 6, 7, 9, 15, 20, 32, 41, 44, 49, 52, 53, 54, 55, 56, 58, 59, 61, 64, 67, 74, 83, 84, 91, 92, 93, 94]	[1, 2, 3, 4, 6, 7, 8, 14, 19, 31, 40, 43, 48, 51, 53, 54, 55, 56, 58, 59, 60, 64, 66, 73, 82, 84, 90, 92, 93, 94, 95]	['PI4KIIIα', 'knock', 'down', 'experiments', 'resulted', 'in', 'loss', 'of', 'PI4KIIIα', 'lipid', 'kinase', 'activity', '(', 'Figure', '2E', ')', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 7, 2, 1, 1, 1, 1, 2, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Comparison of PI4KIIIα and Sac1 protein expression among three PC cell lines, namely, LNCaP, C42B and VCaP, by WB showed higher expression in VCaP cells compared to LNCaP cells (Figure 2F) and in vitro lipid kinase activity is also similarly higher in VCaP cells (Figure 2G).	[('PMC6336684', 'R01011', 14, 22, 'PI4KIIIα')]	['Co', '##mp', '##aris', '##on', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'and', 'Sa', '##c', '##1', 'protein', 'expression', 'among', 'three', 'PC', 'cell', 'lines', ',', 'namely', ',', 'L', '##NC', '##a', '##P', ',', 'C', '##42', '##B', 'and', 'VC', '##a', '##P', ',', 'by', 'W', '##B', 'showed', 'higher', 'expression', 'in', 'VC', '##a', '##P', 'cells', 'compared', 'to', 'L', '##NC', '##a', '##P', 'cells', '(', 'Figure', '2', '##F', ')', 'and', 'in', 'v', '##it', '##ro', 'lip', '##id', 'kinase', 'activity', 'is', 'also', 'similarly', 'higher', 'in', 'VC', '##a', '##P', 'cells', '(', 'Figure', '2', '##G', ')', '.']	[0, 2, 4, 8, 11, 14, 15, 16, 17, 18, 20, 21, 23, 27, 29, 30, 32, 40, 51, 57, 63, 66, 71, 76, 78, 84, 86, 87, 89, 90, 91, 93, 94, 96, 98, 102, 104, 105, 106, 108, 111, 112, 114, 121, 128, 139, 142, 144, 145, 147, 153, 162, 165, 166, 168, 169, 171, 177, 178, 185, 186, 187, 189, 193, 196, 197, 199, 202, 205, 208, 215, 224, 227, 232, 242, 249, 252, 254, 255, 257, 263, 264, 271, 272, 273, 274]	[2, 4, 8, 10, 13, 15, 16, 17, 18, 20, 21, 22, 26, 29, 30, 31, 39, 50, 56, 62, 65, 70, 76, 77, 84, 85, 87, 89, 90, 91, 92, 94, 96, 97, 101, 104, 105, 106, 107, 110, 112, 113, 120, 127, 138, 141, 144, 145, 146, 152, 161, 164, 166, 168, 169, 170, 176, 178, 184, 186, 187, 188, 192, 195, 197, 199, 201, 205, 207, 214, 223, 226, 231, 241, 248, 251, 254, 255, 256, 262, 264, 270, 272, 273, 274, 275]	['Comparison', 'of', 'PI4KIIIα', 'and', 'Sac1', 'protein', 'expression', 'among', 'three', 'PC', 'cell', 'lines', ',', 'namely', ',', 'LNCaP', ',', 'C42B', 'and', 'VCaP', ',', 'by', 'WB', 'showed', 'higher', 'expression', 'in', 'VCaP', 'cells', 'compared', 'to', 'LNCaP', 'cells', '(', 'Figure', '2F', ')', 'and', 'in', 'vitro', 'lipid', 'kinase', 'activity', 'is', 'also', 'similarly', 'higher', 'in', 'VCaP', 'cells', '(', 'Figure', '2G', ')', '.']	[4, 1, 7, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Comparision of PI4KIIIα expression and in vitro lipid kinase activity between the prostate cancer cells (LNCaP and C4–2B) and PC3 scr show that the latter have higher PI4KIIIα expression and in vitro lipid kinase activity (Figure 2A, F and H).	[('PMC6336684', 'R01012', 15, 23, 'PI4KIIIα')]	['Co', '##mp', '##aris', '##ion', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'expression', 'and', 'in', 'v', '##it', '##ro', 'lip', '##id', 'kinase', 'activity', 'between', 'the', 'pro', '##state', 'cancer', 'cells', '(', 'L', '##NC', '##a', '##P', 'and', 'C', '##4', '–', '2', '##B', ')', 'and', 'PC', '##3', 's', '##c', '##r', 'show', 'that', 'the', 'latter', 'have', 'higher', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'expression', 'and', 'in', 'v', '##it', '##ro', 'lip', '##id', 'kinase', 'activity', '(', 'Figure', '2', '##A', ',', 'F', 'and', 'H', ')', '.']	[0, 2, 4, 8, 12, 15, 16, 17, 18, 19, 21, 22, 24, 35, 39, 42, 43, 45, 48, 51, 54, 61, 70, 78, 82, 85, 91, 98, 104, 105, 106, 108, 109, 111, 115, 116, 117, 118, 119, 120, 122, 126, 128, 130, 131, 132, 134, 139, 144, 148, 155, 160, 167, 168, 169, 170, 171, 173, 174, 176, 187, 191, 194, 195, 197, 200, 203, 206, 213, 222, 223, 230, 231, 232, 234, 236, 240, 241, 242]	[2, 4, 8, 11, 14, 16, 17, 18, 19, 21, 22, 23, 34, 38, 41, 43, 45, 47, 51, 53, 60, 69, 77, 81, 85, 90, 97, 103, 105, 106, 108, 109, 110, 114, 116, 117, 118, 119, 120, 121, 125, 128, 129, 131, 132, 133, 138, 143, 147, 154, 159, 166, 168, 169, 170, 171, 173, 174, 175, 186, 190, 193, 195, 197, 199, 203, 205, 212, 221, 223, 229, 231, 232, 233, 235, 239, 241, 242, 243]	['Comparision', 'of', 'PI4KIIIα', 'expression', 'and', 'in', 'vitro', 'lipid', 'kinase', 'activity', 'between', 'the', 'prostate', 'cancer', 'cells', '(', 'LNCaP', 'and', 'C4–', '2B', ')', 'and', 'PC3', 'scr', 'show', 'that', 'the', 'latter', 'have', 'higher', 'PI4KIIIα', 'expression', 'and', 'in', 'vitro', 'lipid', 'kinase', 'activity', '(', 'Figure', '2A', ',', 'F', 'and', 'H', ')', '.']	[4, 1, 7, 1, 1, 1, 3, 2, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 3, 2, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 3, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
VCaP cells which are TMPRSS2-ERG fusion positive, where ERG factor was shown to regulate CXCR4 expression (17), had 3-fold higher PI4KIIIα lipid kinase activity vs. the other two PC cell lines (Figure 2G and H).	[('PMC6336684', 'R01013', 130, 151, 'PI4KIIIα lipid kinase')]	['VC', '##a', '##P', 'cells', 'which', 'are', 'T', '##MP', '##RS', '##S', '##2', '-', 'ER', '##G', 'fusion', 'positive', ',', 'where', 'ER', '##G', 'factor', 'was', 'shown', 'to', 'regulate', 'C', '##X', '##CR', '##4', 'expression', '(', '17', ')', ',', 'had', '3', '-', 'fold', 'higher', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'lip', '##id', 'kinase', 'activity', 'vs', '.', 'the', 'other', 'two', 'PC', 'cell', 'lines', '(', 'Figure', '2', '##G', 'and', 'H', ')', '.']	[0, 2, 3, 5, 11, 17, 21, 22, 24, 26, 27, 28, 29, 31, 33, 40, 48, 50, 56, 58, 60, 67, 71, 77, 80, 89, 90, 91, 93, 95, 106, 107, 109, 110, 112, 116, 117, 118, 123, 130, 131, 132, 133, 134, 136, 137, 139, 142, 145, 152, 161, 163, 165, 169, 175, 179, 182, 187, 193, 194, 201, 202, 204, 208, 209, 210]	[2, 3, 4, 10, 16, 20, 22, 24, 26, 27, 28, 29, 31, 32, 39, 48, 49, 55, 58, 59, 66, 70, 76, 79, 88, 90, 91, 93, 94, 105, 107, 109, 110, 111, 115, 117, 118, 122, 129, 131, 132, 133, 134, 136, 137, 138, 142, 144, 151, 160, 163, 164, 168, 174, 178, 181, 186, 192, 194, 200, 202, 203, 207, 209, 210, 211]	['VCaP', 'cells', 'which', 'are', 'TMPRSS2-ERG', 'fusion', 'positive', ',', 'where', 'ERG', 'factor', 'was', 'shown', 'to', 'regulate', 'CXCR4', 'expression', '(', '17', ')', ',', 'had', '3-fold', 'higher', 'PI4KIIIα', 'lipid', 'kinase', 'activity', 'vs', '.', 'the', 'other', 'two', 'PC', 'cell', 'lines', '(', 'Figure', '2G', 'and', 'H', ')', '.']	[3, 1, 1, 1, 8, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 7, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The higher lipid kinase activity may be reflective of the more active state of the PI4KIIIα in VCaP cells, which may be dependent on the expression of accessory proteins which bind and translocate PI4KIIIα to the membrane.	[('PMC6336684', 'R01014', 11, 23, 'lipid kinase')]	['The', 'higher', 'lip', '##id', 'kinase', 'activity', 'may', 'be', 'reflective', 'of', 'the', 'more', 'active', 'state', 'of', 'the', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'in', 'VC', '##a', '##P', 'cells', ',', 'which', 'may', 'be', 'dependent', 'on', 'the', 'expression', 'of', 'access', '##ory', 'proteins', 'which', 'bind', 'and', 'trans', '##loc', '##ate', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'to', 'the', 'membrane', '.']	[0, 4, 11, 14, 17, 24, 33, 37, 40, 51, 54, 58, 63, 70, 76, 79, 83, 84, 85, 86, 87, 89, 90, 92, 95, 97, 98, 100, 105, 107, 113, 117, 120, 130, 133, 137, 148, 151, 157, 161, 170, 176, 181, 185, 190, 193, 197, 198, 199, 200, 201, 203, 204, 206, 209, 213, 221]	[3, 10, 14, 16, 23, 32, 36, 39, 50, 53, 57, 62, 69, 75, 78, 82, 84, 85, 86, 87, 89, 90, 91, 94, 97, 98, 99, 105, 106, 112, 116, 119, 129, 132, 136, 147, 150, 157, 160, 169, 175, 180, 184, 190, 193, 196, 198, 199, 200, 201, 203, 204, 205, 208, 212, 221, 222]	['The', 'higher', 'lipid', 'kinase', 'activity', 'may', 'be', 'reflective', 'of', 'the', 'more', 'active', 'state', 'of', 'the', 'PI4KIIIα', 'in', 'VCaP', 'cells', ',', 'which', 'may', 'be', 'dependent', 'on', 'the', 'expression', 'of', 'accessory', 'proteins', 'which', 'bind', 'and', 'translocate', 'PI4KIIIα', 'to', 'the', 'membrane', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 7, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To further determine the role of PI4KIIIα activity in maintaining cellular PI4P levels, and the requirement of PI4P for the conversion to downstream PtdIns species, PI(4,5)P2 and PI(3,4,5)P3, we monitored cellular PI profiles using our previously established procedures (32, 33).	[('PMC6336684', 'R02000', 33, 41, 'PI4KIIIα')]	['To', 'further', 'determine', 'the', 'role', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'activity', 'in', 'maintaining', 'cellular', 'P', '##I', '##4', '##P', 'levels', ',', 'and', 'the', 'requirement', 'of', 'P', '##I', '##4', '##P', 'for', 'the', 'conversion', 'to', 'downstream', 'P', '##t', '##d', '##I', '##ns', 'species', ',', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', 'and', 'P', '##I', '(', '3', ',', '4', ',', '5', ')', 'P', '##3', ',', 'we', 'monitored', 'cellular', 'P', '##I', 'profiles', 'using', 'our', 'previously', 'established', 'procedures', '(', '32', ',', '33', ')', '.']	[0, 3, 11, 21, 25, 30, 33, 34, 35, 36, 37, 39, 40, 42, 51, 54, 66, 75, 76, 77, 78, 80, 86, 88, 92, 96, 108, 111, 112, 113, 114, 116, 120, 124, 135, 138, 149, 150, 151, 152, 153, 156, 163, 165, 166, 167, 168, 169, 170, 171, 172, 173, 175, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 192, 195, 205, 214, 215, 217, 226, 232, 236, 247, 259, 270, 271, 273, 275, 277, 278]	[2, 10, 20, 24, 29, 32, 34, 35, 36, 37, 39, 40, 41, 50, 53, 65, 74, 76, 77, 78, 79, 86, 87, 91, 95, 107, 110, 112, 113, 114, 115, 119, 123, 134, 137, 148, 150, 151, 152, 153, 155, 163, 164, 166, 167, 168, 169, 170, 171, 172, 173, 174, 178, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 194, 204, 213, 215, 216, 225, 231, 235, 246, 258, 269, 271, 273, 274, 277, 278, 279]	['To', 'further', 'determine', 'the', 'role', 'of', 'PI4KIIIα', 'activity', 'in', 'maintaining', 'cellular', 'PI4P', 'levels', ',', 'and', 'the', 'requirement', 'of', 'PI4P', 'for', 'the', 'conversion', 'to', 'downstream', 'PtdIns', 'species', ',', 'PI(4,5)P2', 'and', 'PI(3,4,5)P3', ',', 'we', 'monitored', 'cellular', 'PI', 'profiles', 'using', 'our', 'previously', 'established', 'procedures', '(', '32', ',', '33', ')', '.']	[1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 9, 1, 11, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PtdIns profiles were significantly altered upon PI4KIIIα knockdown; as expected total PI4P levels were reduced suggesting the major role of PI4KIIIα in maintaining PI4P levels, whereas there is an unexpected increase in total PI(4,5)P2 levels.	[]	['P', '##t', '##d', '##I', '##ns', 'profiles', 'were', 'significantly', 'altered', 'upon', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'knock', '##down', ';', 'as', 'expected', 'total', 'P', '##I', '##4', '##P', 'levels', 'were', 'reduced', 'suggesting', 'the', 'major', 'role', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'in', 'maintaining', 'P', '##I', '##4', '##P', 'levels', ',', 'whereas', 'there', 'is', 'an', 'unexpected', 'increase', 'in', 'total', 'P', '##I', '(', '4', ',', '5', ')', 'P', '##2', 'levels', '.']	[0, 1, 2, 3, 4, 7, 16, 21, 35, 43, 48, 49, 50, 51, 52, 54, 55, 57, 62, 66, 68, 71, 80, 86, 87, 88, 89, 91, 98, 103, 111, 122, 126, 132, 137, 140, 141, 142, 143, 144, 146, 147, 149, 152, 164, 165, 166, 167, 169, 175, 177, 185, 191, 194, 197, 208, 217, 220, 226, 227, 228, 229, 230, 231, 232, 233, 234, 236, 242]	[1, 2, 3, 4, 6, 15, 20, 34, 42, 47, 49, 50, 51, 52, 54, 55, 56, 62, 66, 67, 70, 79, 85, 87, 88, 89, 90, 97, 102, 110, 121, 125, 131, 136, 139, 141, 142, 143, 144, 146, 147, 148, 151, 163, 165, 166, 167, 168, 175, 176, 184, 190, 193, 196, 207, 216, 219, 225, 227, 228, 229, 230, 231, 232, 233, 234, 235, 242, 243]	['PtdIns', 'profiles', 'were', 'significantly', 'altered', 'upon', 'PI4KIIIα', 'knockdown', ';', 'as', 'expected', 'total', 'PI4P', 'levels', 'were', 'reduced', 'suggesting', 'the', 'major', 'role', 'of', 'PI4KIIIα', 'in', 'maintaining', 'PI4P', 'levels', ',', 'whereas', 'there', 'is', 'an', 'unexpected', 'increase', 'in', 'total', 'PI(4,5)P2', 'levels', '.']	[5, 1, 1, 1, 1, 1, 7, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 9, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The minor PtdIns species PI(3,4)P2 was decreased whereas PI(3,4,5)P3 wasincreased (Table 1).	[]	['The', 'minor', 'P', '##t', '##d', '##I', '##ns', 'species', 'P', '##I', '(', '3', ',', '4', ')', 'P', '##2', 'was', 'decreased', 'whereas', 'P', '##I', '(', '3', ',', '4', ',', '5', ')', 'P', '##3', 'was', '##in', '##cre', '##ase', '##d', '(', 'Table', '1', ')', '.']	[0, 4, 10, 11, 12, 13, 14, 17, 25, 26, 27, 28, 29, 30, 31, 32, 33, 35, 39, 49, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 72, 74, 77, 80, 82, 83, 89, 90, 91]	[3, 9, 11, 12, 13, 14, 16, 24, 26, 27, 28, 29, 30, 31, 32, 33, 34, 38, 48, 56, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 72, 74, 77, 80, 81, 83, 88, 90, 91, 92]	['The', 'minor', 'PtdIns', 'species', 'PI(3,4)P2', 'was', 'decreased', 'whereas', 'PI(3,4,5)P3', 'wasincreased', '(', 'Table', '1', ')', '.']	[1, 1, 5, 1, 9, 1, 1, 1, 11, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These data suggest that PI4P synthetic processes in prostate cancer cells were complexly related with steady state levels of other PtdIns species, and knockdown of PM associated PI4KIIIα levels leads to significant alterations in the cellular PtdIns profiles.	[]	['These', 'data', 'suggest', 'that', 'P', '##I', '##4', '##P', 'synthetic', 'processes', 'in', 'pro', '##state', 'cancer', 'cells', 'were', 'complex', '##ly', 'related', 'with', 'steady', 'state', 'levels', 'of', 'other', 'P', '##t', '##d', '##I', '##ns', 'species', ',', 'and', 'knock', '##down', 'of', 'PM', 'associated', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'levels', 'leads', 'to', 'significant', 'alterations', 'in', 'the', 'cellular', 'P', '##t', '##d', '##I', '##ns', 'profiles', '.']	[0, 6, 11, 19, 24, 25, 26, 27, 29, 39, 49, 52, 55, 61, 68, 74, 79, 86, 89, 97, 102, 109, 115, 122, 125, 131, 132, 133, 134, 135, 138, 145, 147, 151, 156, 161, 164, 167, 178, 179, 180, 181, 182, 184, 185, 187, 194, 200, 203, 215, 227, 230, 234, 243, 244, 245, 246, 247, 250, 258]	[5, 10, 18, 23, 25, 26, 27, 28, 38, 48, 51, 55, 60, 67, 73, 78, 86, 88, 96, 101, 108, 114, 121, 124, 130, 132, 133, 134, 135, 137, 145, 146, 150, 156, 160, 163, 166, 177, 179, 180, 181, 182, 184, 185, 186, 193, 199, 202, 214, 226, 229, 233, 242, 244, 245, 246, 247, 249, 258, 259]	['These', 'data', 'suggest', 'that', 'PI4P', 'synthetic', 'processes', 'in', 'prostate', 'cancer', 'cells', 'were', 'complexly', 'related', 'with', 'steady', 'state', 'levels', 'of', 'other', 'PtdIns', 'species', ',', 'and', 'knockdown', 'of', 'PM', 'associated', 'PI4KIIIα', 'levels', 'leads', 'to', 'significant', 'alterations', 'in', 'the', 'cellular', 'PtdIns', 'profiles', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To further determine the mechanism of CXCR4 regulation of PI4KIIIα, first we determined whether the two proteins interact with each other.	[('PMC6336684', 'R03000', 58, 66, 'PI4KIIIα')]	['To', 'further', 'determine', 'the', 'mechanism', 'of', 'C', '##X', '##CR', '##4', 'regulation', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', ',', 'first', 'we', 'determined', 'whether', 'the', 'two', 'proteins', 'interact', 'with', 'each', 'other', '.']	[0, 3, 11, 21, 25, 35, 38, 39, 40, 42, 44, 55, 58, 59, 60, 61, 62, 64, 65, 66, 68, 74, 77, 88, 96, 100, 104, 113, 122, 127, 132, 137]	[2, 10, 20, 24, 34, 37, 39, 40, 42, 43, 54, 57, 59, 60, 61, 62, 64, 65, 66, 67, 73, 76, 87, 95, 99, 103, 112, 121, 126, 131, 137, 138]	['To', 'further', 'determine', 'the', 'mechanism', 'of', 'CXCR4', 'regulation', 'of', 'PI4KIIIα', ',', 'first', 'we', 'determined', 'whether', 'the', 'two', 'proteins', 'interact', 'with', 'each', 'other', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For this purpose, we performed tagged gene transfection followed by WB analysis; data show no direct interaction between PI4KIIIα and CXCR4 (Figure 3A).	[('PMC6336684', 'R03001', 121, 129, 'PI4KIIIα')]	['For', 'this', 'purpose', ',', 'we', 'performed', 'tag', '##ged', 'gene', 'trans', '##fect', '##ion', 'followed', 'by', 'W', '##B', 'analysis', ';', 'data', 'show', 'no', 'direct', 'interaction', 'between', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'and', 'C', '##X', '##CR', '##4', '(', 'Figure', '3', '##A', ')', '.']	[0, 4, 9, 16, 18, 21, 31, 34, 38, 43, 48, 52, 56, 65, 68, 69, 71, 79, 81, 86, 91, 94, 101, 113, 121, 122, 123, 124, 125, 127, 128, 130, 134, 135, 136, 138, 140, 141, 148, 149, 150, 151]	[3, 8, 16, 17, 20, 30, 34, 37, 42, 48, 52, 55, 64, 67, 69, 70, 79, 80, 85, 90, 93, 100, 112, 120, 122, 123, 124, 125, 127, 128, 129, 133, 135, 136, 138, 139, 141, 147, 149, 150, 151, 152]	['For', 'this', 'purpose', ',', 'we', 'performed', 'tagged', 'gene', 'transfection', 'followed', 'by', 'WB', 'analysis', ';', 'data', 'show', 'no', 'direct', 'interaction', 'between', 'PI4KIIIα', 'and', 'CXCR4', '(', 'Figure', '3A', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 4, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PI4KIIIα is localized to the inner plasma membrane through two adaptor proteins, EFR3B and TTC7B. EFR3B is a membrane bound protein and TTC7B is an adaptor protein which binds with both EFR3B and PI4KIIIα.	[('PMC6336684', 'R03002', 0, 8, 'PI4KIIIα')]	['P', '##I', '##4', '##K', '##II', '##I', '##α', 'is', 'localized', 'to', 'the', 'inner', 'plasma', 'membrane', 'through', 'two', 'adapt', '##or', 'proteins', ',', 'E', '##F', '##R', '##3', '##B', 'and', 'T', '##TC', '##7', '##B', '.', 'E', '##F', '##R', '##3', '##B', 'is', 'a', 'membrane', 'bound', 'protein', 'and', 'T', '##TC', '##7', '##B', 'is', 'an', 'adapt', '##or', 'protein', 'which', 'binds', 'with', 'both', 'E', '##F', '##R', '##3', '##B', 'and', 'P', '##I', '##4', '##K', '##II', '##I', '##α', '.']	[0, 1, 2, 3, 4, 6, 7, 9, 12, 22, 25, 29, 35, 42, 51, 59, 63, 68, 71, 79, 81, 82, 83, 84, 85, 87, 91, 92, 94, 95, 96, 98, 99, 100, 101, 102, 104, 107, 109, 118, 124, 132, 136, 137, 139, 140, 142, 145, 148, 153, 156, 164, 170, 176, 181, 186, 187, 188, 189, 190, 192, 196, 197, 198, 199, 200, 202, 203, 204]	[1, 2, 3, 4, 6, 7, 8, 11, 21, 24, 28, 34, 41, 50, 58, 62, 68, 70, 79, 80, 82, 83, 84, 85, 86, 90, 92, 94, 95, 96, 97, 99, 100, 101, 102, 103, 106, 108, 117, 123, 131, 135, 137, 139, 140, 141, 144, 147, 153, 155, 163, 169, 175, 180, 185, 187, 188, 189, 190, 191, 195, 197, 198, 199, 200, 202, 203, 204, 205]	['PI4KIIIα', 'is', 'localized', 'to', 'the', 'inner', 'plasma', 'membrane', 'through', 'two', 'adaptor', 'proteins', ',', 'EFR3B', 'and', 'TTC7B', '.', 'EFR3B', 'is', 'a', 'membrane', 'bound', 'protein', 'and', 'TTC7B', 'is', 'an', 'adaptor', 'protein', 'which', 'binds', 'with', 'both', 'EFR3B', 'and', 'PI4KIIIα', '.']	[7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 5, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 7, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To determine the functional significance of PI4KIIIα mediated CXCR4 regulation and its effect on cellular invasion, we determined PI4P localization in cells and performed in vitro cellular invasion studies.	[('PMC6336684', 'R04000', 44, 52, 'PI4KIIIα')]	['To', 'determine', 'the', 'functional', 'significance', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'mediated', 'C', '##X', '##CR', '##4', 'regulation', 'and', 'its', 'effect', 'on', 'cellular', 'invasion', ',', 'we', 'determined', 'P', '##I', '##4', '##P', 'local', '##ization', 'in', 'cells', 'and', 'performed', 'in', 'v', '##it', '##ro', 'cellular', 'invasion', 'studies', '.']	[0, 3, 13, 17, 28, 41, 44, 45, 46, 47, 48, 50, 51, 53, 62, 63, 64, 66, 68, 79, 83, 87, 94, 97, 106, 114, 116, 119, 130, 131, 132, 133, 135, 140, 148, 151, 157, 161, 171, 174, 175, 177, 180, 189, 198, 205]	[2, 12, 16, 27, 40, 43, 45, 46, 47, 48, 50, 51, 52, 61, 63, 64, 66, 67, 78, 82, 86, 93, 96, 105, 114, 115, 118, 129, 131, 132, 133, 134, 140, 147, 150, 156, 160, 170, 173, 175, 177, 179, 188, 197, 205, 206]	['To', 'determine', 'the', 'functional', 'significance', 'of', 'PI4KIIIα', 'mediated', 'CXCR4', 'regulation', 'and', 'its', 'effect', 'on', 'cellular', 'invasion', ',', 'we', 'determined', 'PI4P', 'localization', 'in', 'cells', 'and', 'performed', 'in', 'vitro', 'cellular', 'invasion', 'studies', '.']	[1, 1, 1, 1, 1, 1, 7, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To determine the clinical significance of PI4KIIIα in prostate cancer progression, we extracted expression values for PI4KIIIα and Sac1 from NCBI data set GDS3289 of human PC tumor tissues.	[('PMC6336684', 'R05000', 42, 50, 'PI4KIIIα')]	['To', 'determine', 'the', 'clinical', 'significance', 'of', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'in', 'pro', '##state', 'cancer', 'progression', ',', 'we', 'extracted', 'expression', 'values', 'for', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'and', 'Sa', '##c', '##1', 'from', 'NC', '##BI', 'data', 'set', 'G', '##DS', '##32', '##8', '##9', 'of', 'human', 'PC', 'tumor', 'tissues', '.']	[0, 3, 13, 17, 26, 39, 42, 43, 44, 45, 46, 48, 49, 51, 54, 57, 63, 70, 81, 83, 86, 96, 107, 114, 118, 119, 120, 121, 122, 124, 125, 127, 131, 133, 134, 136, 141, 143, 146, 151, 155, 156, 158, 160, 161, 163, 166, 172, 175, 181, 188]	[2, 12, 16, 25, 38, 41, 43, 44, 45, 46, 48, 49, 50, 53, 57, 62, 69, 81, 82, 85, 95, 106, 113, 117, 119, 120, 121, 122, 124, 125, 126, 130, 133, 134, 135, 140, 143, 145, 150, 154, 156, 158, 160, 161, 162, 165, 171, 174, 180, 188, 189]	['To', 'determine', 'the', 'clinical', 'significance', 'of', 'PI4KIIIα', 'in', 'prostate', 'cancer', 'progression', ',', 'we', 'extracted', 'expression', 'values', 'for', 'PI4KIIIα', 'and', 'Sac1', 'from', 'NCBI', 'data', 'set', 'GDS3289', 'of', 'human', 'PC', 'tumor', 'tissues', '.']	[1, 1, 1, 1, 1, 1, 7, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 3, 1, 2, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The analysis shows that PI4KIIIα expression is significantly higher and Sac1 is lower in PC metastasis compared to either localized PC or normal adjacent tissue (Figure 6A).	[('PMC6336684', 'R05001', 24, 32, 'PI4KIIIα')]	['The', 'analysis', 'shows', 'that', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'expression', 'is', 'significantly', 'higher', 'and', 'Sa', '##c', '##1', 'is', 'lower', 'in', 'PC', 'meta', '##sta', '##sis', 'compared', 'to', 'either', 'localized', 'PC', 'or', 'normal', 'adjacent', 'tissue', '(', 'Figure', '6', '##A', ')', '.']	[0, 4, 13, 19, 24, 25, 26, 27, 28, 30, 31, 33, 44, 47, 61, 68, 72, 74, 75, 77, 80, 86, 89, 92, 96, 99, 103, 112, 115, 122, 132, 135, 138, 145, 154, 161, 162, 169, 170, 171, 172]	[3, 12, 18, 23, 25, 26, 27, 28, 30, 31, 32, 43, 46, 60, 67, 71, 74, 75, 76, 79, 85, 88, 91, 96, 99, 102, 111, 114, 121, 131, 134, 137, 144, 153, 160, 162, 168, 170, 171, 172, 173]	['The', 'analysis', 'shows', 'that', 'PI4KIIIα', 'expression', 'is', 'significantly', 'higher', 'and', 'Sac1', 'is', 'lower', 'in', 'PC', 'metastasis', 'compared', 'to', 'either', 'localized', 'PC', 'or', 'normal', 'adjacent', 'tissue', '(', 'Figure', '6A', ')', '.']	[1, 1, 1, 1, 7, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
No difference in the expression of either PI4KIIIα or Sac1 is found between low PIN and high PIN lesions in PC patients (Figure 6A).	[('PMC6336684', 'R05002', 42, 50, 'PI4KIIIα')]	['No', 'difference', 'in', 'the', 'expression', 'of', 'either', 'P', '##I', '##4', '##K', '##II', '##I', '##α', 'or', 'Sa', '##c', '##1', 'is', 'found', 'between', 'low', 'P', '##IN', 'and', 'high', 'P', '##IN', 'lesions', 'in', 'PC', 'patients', '(', 'Figure', '6', '##A', ')', '.']	[0, 3, 14, 17, 21, 32, 35, 42, 43, 44, 45, 46, 48, 49, 51, 54, 56, 57, 59, 62, 68, 76, 80, 81, 84, 88, 93, 94, 97, 105, 108, 111, 120, 121, 128, 129, 130, 131]	[2, 13, 16, 20, 31, 34, 41, 43, 44, 45, 46, 48, 49, 50, 53, 56, 57, 58, 61, 67, 75, 79, 81, 83, 87, 92, 94, 96, 104, 107, 110, 119, 121, 127, 129, 130, 131, 132]	['No', 'difference', 'in', 'the', 'expression', 'of', 'either', 'PI4KIIIα', 'or', 'Sac1', 'is', 'found', 'between', 'low', 'PIN', 'and', 'high', 'PIN', 'lesions', 'in', 'PC', 'patients', '(', 'Figure', '6A', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 7, 1, 3, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Except for Canavan disease, a genetic disorder characterized by toxic accumulation of N-acetyl aspartate caused by aspartoacylase inactivation (86), down regulation of this metabolite seems to be constant in clinical conditions that associate neuronal dysfunction, including epilepsy (87–89), multiple sclerosis (90), Alzheimer's disease (91, 92), schizophrenia (93, 94), stroke (95), brain injury (96, 97) and brain tumors (98, 99).	[]	"['Except', 'for', 'Can', '##avan', 'disease', ',', 'a', 'genetic', 'disorder', 'characterized', 'by', 'toxic', 'accumulation', 'of', 'N', '-', 'ace', '##ty', '##l', 'as', '##par', '##tate', 'caused', 'by', 'as', '##par', '##to', '##acy', '##lase', 'in', '##act', '##ivation', '(', '86', ')', ',', 'down', 'regulation', 'of', 'this', 'meta', '##bol', '##ite', 'seems', 'to', 'be', 'constant', 'in', 'clinical', 'conditions', 'that', 'associate', 'ne', '##uron', '##al', 'd', '##ys', '##function', ',', 'including', 'e', '##pile', '##psy', '(', '87', '–', '89', ')', ',', 'multiple', 's', '##cle', '##rosis', '(', '90', ')', ',', 'Alzheimer', ""'"", 's', 'disease', '(', '91', ',', '92', ')', ',', 's', '##chi', '##zophrenia', '(', '93', ',', '94', ')', ',', 'stroke', '(', '95', ')', ',', 'brain', 'injury', '(', '96', ',', '97', ')', 'and', 'brain', 'tumors', '(', '98', ',', '99', ')', '.']"	[0, 7, 11, 14, 19, 26, 28, 30, 38, 47, 61, 64, 70, 83, 86, 87, 88, 91, 93, 95, 97, 100, 105, 112, 115, 117, 120, 122, 125, 130, 132, 135, 143, 144, 146, 147, 149, 154, 165, 168, 173, 177, 180, 184, 190, 193, 196, 205, 208, 217, 228, 233, 243, 245, 249, 252, 253, 255, 263, 265, 275, 276, 280, 284, 285, 287, 288, 290, 291, 293, 302, 303, 306, 312, 313, 315, 316, 318, 327, 328, 330, 338, 339, 341, 343, 345, 346, 348, 349, 352, 362, 363, 365, 367, 369, 370, 372, 379, 380, 382, 383, 385, 391, 398, 399, 401, 403, 405, 407, 411, 417, 424, 425, 427, 429, 431, 432]	[6, 10, 14, 18, 26, 27, 29, 37, 46, 60, 63, 69, 82, 85, 87, 88, 91, 93, 94, 97, 100, 104, 111, 114, 117, 120, 122, 125, 129, 132, 135, 142, 144, 146, 147, 148, 153, 164, 167, 172, 177, 180, 183, 189, 192, 195, 204, 207, 216, 227, 232, 242, 245, 249, 251, 253, 255, 263, 264, 274, 276, 280, 283, 285, 287, 288, 290, 291, 292, 301, 303, 306, 311, 313, 315, 316, 317, 327, 328, 329, 337, 339, 341, 342, 345, 346, 347, 349, 352, 361, 363, 365, 366, 369, 370, 371, 378, 380, 382, 383, 384, 390, 397, 399, 401, 402, 405, 406, 410, 416, 423, 425, 427, 428, 431, 432, 433]	"['Except', 'for', 'Canavan', 'disease', ',', 'a', 'genetic', 'disorder', 'characterized', 'by', 'toxic', 'accumulation', 'of', 'N-acetyl', 'aspartate', 'caused', 'by', 'aspartoacylase', 'inactivation', '(', '86', ')', ',', 'down', 'regulation', 'of', 'this', 'metabolite', 'seems', 'to', 'be', 'constant', 'in', 'clinical', 'conditions', 'that', 'associate', 'neuronal', 'dysfunction', ',', 'including', 'epilepsy', '(', '87–', '89', ')', ',', 'multiple', 'sclerosis', '(', '90', ')', ',', ""Alzheimer's"", 'disease', '(', '91', ',', '92', ')', ',', 'schizophrenia', '(', '93', ',', '94', ')', ',', 'stroke', '(', '95', ')', ',', 'brain', 'injury', '(', '96', ',', '97', ')', 'and', 'brain', 'tumors', '(', '98', ',', '99', ')', '.']"	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aspartate is a metabolite of the urea cycle, involved in gluconeogenesis, being derived from asparaginase.	[('PMC6345099', 'D12000', 93, 105, 'asparaginase')]	['As', '##par', '##tate', 'is', 'a', 'meta', '##bol', '##ite', 'of', 'the', 'u', '##rea', 'cycle', ',', 'involved', 'in', 'g', '##lu', '##con', '##eo', '##genesis', ',', 'being', 'derived', 'from', 'as', '##par', '##agi', '##nas', '##e', '.']	[0, 2, 5, 10, 13, 15, 19, 22, 26, 29, 33, 34, 38, 43, 45, 54, 57, 58, 60, 63, 65, 72, 74, 80, 88, 93, 95, 98, 101, 104, 105]	[2, 5, 9, 12, 14, 19, 22, 25, 28, 32, 34, 37, 43, 44, 53, 56, 58, 60, 63, 65, 72, 73, 79, 87, 92, 95, 98, 101, 104, 105, 106]	['Aspartate', 'is', 'a', 'metabolite', 'of', 'the', 'urea', 'cycle', ',', 'involved', 'in', 'gluconeogenesis', ',', 'being', 'derived', 'from', 'asparaginase', '.']	[3, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O']
The concentration of this metabolite is decreased in malignant cells, being synthesized from oxaloacetate by aminotransferase activity (121).	[('PMC6345099', 'D12001', 109, 125, 'aminotransferase')]	['The', 'concentration', 'of', 'this', 'meta', '##bol', '##ite', 'is', 'decreased', 'in', 'ma', '##li', '##gnant', 'cells', ',', 'being', 'synthesized', 'from', 'o', '##xa', '##lo', '##ace', '##tate', 'by', 'amino', '##tra', '##ns', '##fer', '##ase', 'activity', '(', '121', ')', '.']	[0, 4, 18, 21, 26, 30, 33, 37, 40, 50, 53, 55, 57, 63, 68, 70, 76, 88, 93, 94, 96, 98, 101, 106, 109, 114, 117, 119, 122, 126, 135, 136, 139, 140]	[3, 17, 20, 25, 30, 33, 36, 39, 49, 52, 55, 57, 62, 68, 69, 75, 87, 92, 94, 96, 98, 101, 105, 108, 114, 117, 119, 122, 125, 134, 136, 139, 140, 141]	['The', 'concentration', 'of', 'this', 'metabolite', 'is', 'decreased', 'in', 'malignant', 'cells', ',', 'being', 'synthesized', 'from', 'oxaloacetate', 'by', 'aminotransferase', 'activity', '(', '121', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
The identification of estrogen metabolites and 17-ketosteroids in the urine of patients with PRL-secreting adenomas is most likely to be due to decreased activity of 3 beta-hydroxysteroid dehydrogenase and 5α-reductase that occurs among these patients (66).	[('PMC6345099', 'D14000', 166, 201, '3 beta-hydroxysteroid dehydrogenase')]	['The', 'identification', 'of', 'est', '##rogen', 'meta', '##bol', '##ites', 'and', '17', '-', 'k', '##eto', '##ster', '##oids', 'in', 'the', 'urine', 'of', 'patients', 'with', 'PR', '##L', '-', 'secret', '##ing', 'ad', '##eno', '##mas', 'is', 'most', 'likely', 'to', 'be', 'due', 'to', 'decreased', 'activity', 'of', '3', 'beta', '-', 'h', '##ydro', '##xy', '##ster', '##oid', 'de', '##hy', '##dr', '##ogen', '##ase', 'and', '5', '##α', '-', 'red', '##uc', '##tase', 'that', 'occurs', 'among', 'these', 'patients', '(', '66', ')', '.']	[0, 4, 19, 22, 25, 31, 35, 38, 43, 47, 49, 50, 51, 54, 58, 63, 66, 70, 76, 79, 88, 93, 95, 96, 97, 103, 107, 109, 112, 116, 119, 124, 131, 134, 137, 141, 144, 154, 163, 166, 168, 172, 173, 174, 178, 180, 184, 188, 190, 192, 194, 198, 202, 206, 207, 208, 209, 212, 214, 219, 224, 231, 237, 243, 252, 253, 255, 256]	[3, 18, 21, 25, 30, 35, 38, 42, 46, 49, 50, 51, 54, 58, 62, 65, 69, 75, 78, 87, 92, 95, 96, 97, 103, 106, 109, 112, 115, 118, 123, 130, 133, 136, 140, 143, 153, 162, 165, 167, 172, 173, 174, 178, 180, 184, 187, 190, 192, 194, 198, 201, 205, 207, 208, 209, 212, 214, 218, 223, 230, 236, 242, 251, 253, 255, 256, 257]	['The', 'identification', 'of', 'estrogen', 'metabolites', 'and', '17-ketosteroids', 'in', 'the', 'urine', 'of', 'patients', 'with', 'PRL-secreting', 'adenomas', 'is', 'most', 'likely', 'to', 'be', 'due', 'to', 'decreased', 'activity', 'of', '3', 'beta', '-', 'hydroxysteroid', 'dehydrogenase', 'and', '5α-reductase', 'that', 'occurs', 'among', 'these', 'patients', '(', '66', ')', '.']	[1, 1, 1, 2, 3, 1, 6, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 5, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteobacteria are pathobionts, meaning that they may expand as a result of a microbial imbalance and exert pathogenic effects on the host and are consistently reported enriched in IBD.31–33 Our CD patients with a complicated phenotype had high abundance of Proteobacteria, in accordance with the previous reports.	[]	['Pro', '##te', '##ob', '##act', '##eria', 'are', 'path', '##ob', '##ion', '##ts', ',', 'meaning', 'that', 'they', 'may', 'expand', 'as', 'a', 'result', 'of', 'a', 'micro', '##bial', 'im', '##bal', '##ance', 'and', 'ex', '##ert', 'path', '##ogenic', 'effects', 'on', 'the', 'host', 'and', 'are', 'consistently', 'reported', 'en', '##rich', '##ed', 'in', 'I', '##B', '##D', '.', '31', '–', '33', 'Our', 'CD', 'patients', 'with', 'a', 'complicated', 'p', '##hen', '##otype', 'had', 'high', 'abundance', 'of', 'Pro', '##te', '##ob', '##act', '##eria', ',', 'in', 'accordance', 'with', 'the', 'previous', 'reports', '.']	[0, 3, 5, 7, 10, 15, 19, 23, 25, 28, 30, 32, 40, 45, 50, 54, 61, 64, 66, 73, 76, 78, 83, 88, 90, 93, 98, 102, 104, 108, 112, 119, 127, 130, 134, 139, 143, 147, 160, 169, 171, 175, 178, 181, 182, 183, 184, 185, 187, 188, 191, 195, 198, 207, 212, 214, 226, 227, 230, 236, 240, 245, 255, 258, 261, 263, 265, 268, 272, 274, 277, 288, 293, 297, 306, 313]	[3, 5, 7, 10, 14, 18, 23, 25, 28, 30, 31, 39, 44, 49, 53, 60, 63, 65, 72, 75, 77, 83, 87, 90, 93, 97, 101, 104, 107, 112, 118, 126, 129, 133, 138, 142, 146, 159, 168, 171, 175, 177, 180, 182, 183, 184, 185, 187, 188, 190, 194, 197, 206, 211, 213, 225, 227, 230, 235, 239, 244, 254, 257, 261, 263, 265, 268, 272, 273, 276, 287, 292, 296, 305, 313, 314]	['Proteobacteria', 'are', 'pathobionts', ',', 'meaning', 'that', 'they', 'may', 'expand', 'as', 'a', 'result', 'of', 'a', 'microbial', 'imbalance', 'and', 'exert', 'pathogenic', 'effects', 'on', 'the', 'host', 'and', 'are', 'consistently', 'reported', 'enriched', 'in', 'IBD.31', '–', '33', 'Our', 'CD', 'patients', 'with', 'a', 'complicated', 'phenotype', 'had', 'high', 'abundance', 'of', 'Proteobacteria', ',', 'in', 'accordance', 'with', 'the', 'previous', 'reports', '.']	[5, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rifaximin, an oral non-systemic GI-targeted antibiotic, has in vitro activity against a variety of gram-negative and gram-positive bacteria.22-24 Binding of rifaximin to the β subunit of bacterial DNA-dependent RNA polymerase inhibits transcription and bacterial RNA synthesis.22,25 However, the mechanism of action of rifaximin may extend beyond its antimicrobial activity.	[('PMC6363070', 'I02000', 211, 225, 'RNA polymerase')]	['R', '##if', '##ax', '##im', '##in', ',', 'an', 'oral', 'non', '-', 'systemic', 'G', '##I', '-', 'targeted', 'anti', '##biotic', ',', 'has', 'in', 'v', '##it', '##ro', 'activity', 'against', 'a', 'variety', 'of', 'gram', '-', 'negative', 'and', 'gram', '-', 'positive', 'bacteria', '.', '22', '-', '24', 'Bin', '##ding', 'of', 'r', '##if', '##ax', '##im', '##in', 'to', 'the', 'β', 'subunit', 'of', 'bacterial', 'DNA', '-', 'dependent', 'RNA', 'polymer', '##ase', 'in', '##hibit', '##s', 'transcription', 'and', 'bacterial', 'RNA', 'synthesis', '.', '22', ',', '25', 'However', ',', 'the', 'mechanism', 'of', 'action', 'of', 'r', '##if', '##ax', '##im', '##in', 'may', 'extend', 'beyond', 'its', 'anti', '##mic', '##ro', '##bial', 'activity', '.']	[0, 1, 3, 5, 7, 9, 11, 14, 19, 22, 23, 32, 33, 34, 35, 44, 48, 54, 56, 60, 63, 64, 66, 69, 78, 86, 88, 96, 99, 103, 104, 113, 117, 121, 122, 131, 139, 140, 142, 143, 146, 149, 154, 157, 158, 160, 162, 164, 167, 170, 174, 176, 184, 187, 197, 200, 201, 211, 215, 222, 226, 228, 233, 235, 249, 253, 263, 267, 276, 277, 279, 280, 283, 290, 292, 296, 306, 309, 316, 319, 320, 322, 324, 326, 329, 333, 340, 347, 351, 355, 358, 360, 365, 373]	[1, 3, 5, 7, 9, 10, 13, 18, 22, 23, 31, 33, 34, 35, 43, 48, 54, 55, 59, 62, 64, 66, 68, 77, 85, 87, 95, 98, 103, 104, 112, 116, 121, 122, 130, 139, 140, 142, 143, 145, 149, 153, 156, 158, 160, 162, 164, 166, 169, 173, 175, 183, 186, 196, 200, 201, 210, 214, 222, 225, 228, 233, 234, 248, 252, 262, 266, 276, 277, 279, 280, 282, 290, 291, 295, 305, 308, 315, 318, 320, 322, 324, 326, 328, 332, 339, 346, 350, 355, 358, 360, 364, 373, 374]	['Rifaximin', ',', 'an', 'oral', 'non', '-', 'systemic', 'GI-targeted', 'antibiotic', ',', 'has', 'in', 'vitro', 'activity', 'against', 'a', 'variety', 'of', 'gram', '-', 'negative', 'and', 'gram', '-', 'positive', 'bacteria.22-24', 'Binding', 'of', 'rifaximin', 'to', 'the', 'β', 'subunit', 'of', 'bacterial', 'DNA-dependent', 'RNA', 'polymerase', 'inhibits', 'transcription', 'and', 'bacterial', 'RNA', 'synthesis.22', ',', '25', 'However', ',', 'the', 'mechanism', 'of', 'action', 'of', 'rifaximin', 'may', 'extend', 'beyond', 'its', 'antimicrobial', 'activity', '.']	[5, 1, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1, 5, 1, 1, 1, 1, 1, 1, 3, 1, 2, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, they were harbored within more genes associated with carbohydrate metabolism: eight SNPs were located in seven carbohydrate metabolism genes including those encoding β-galactosidase, α-N-arabinofuranosidase, α-1, 2-mannosidase, rhamnulokinase, Rhamnogalacturonides degradation protein, β-galactosidase and D-lactate dehydrogenase (Table S9).	[]	['Interest', '##ingly', ',', 'they', 'were', 'harbor', '##ed', 'within', 'more', 'genes', 'associated', 'with', 'car', '##bo', '##hy', '##dra', '##te', 'metabolism', ':', 'eight', 'S', '##NP', '##s', 'were', 'located', 'in', 'seven', 'car', '##bo', '##hy', '##dra', '##te', 'metabolism', 'genes', 'including', 'those', 'encoding', 'β', '-', 'gal', '##act', '##os', '##idas', '##e', ',', 'α', '-', 'N', '-', 'a', '##rab', '##ino', '##fu', '##rano', '##si', '##das', '##e', ',', 'α', '-', '1', ',', '2', '-', 'man', '##nos', '##idas', '##e', ',', 'r', '##ham', '##nu', '##lo', '##kin', '##ase', ',', 'R', '##ham', '##no', '##gal', '##act', '##uron', '##ides', 'degradation', 'protein', ',', 'β', '-', 'gal', '##act', '##os', '##idas', '##e', 'and', 'D', '-', 'la', '##ct', '##ate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'Table', 'S', '##9', ')', '.']	[0, 8, 13, 15, 20, 25, 31, 34, 41, 46, 52, 63, 68, 71, 73, 75, 78, 81, 91, 93, 99, 100, 102, 104, 109, 117, 120, 126, 129, 131, 133, 136, 139, 150, 156, 166, 172, 181, 182, 183, 186, 189, 191, 195, 196, 198, 199, 200, 201, 202, 203, 206, 209, 211, 215, 217, 220, 221, 223, 224, 225, 226, 228, 229, 230, 233, 236, 240, 241, 243, 244, 247, 249, 251, 254, 257, 259, 260, 263, 265, 268, 271, 275, 280, 292, 299, 301, 302, 303, 306, 309, 311, 315, 317, 321, 322, 323, 325, 327, 331, 333, 335, 337, 341, 345, 346, 352, 353, 354, 355]	[8, 13, 14, 19, 24, 31, 33, 40, 45, 51, 62, 67, 71, 73, 75, 78, 80, 91, 92, 98, 100, 102, 103, 108, 116, 119, 125, 129, 131, 133, 136, 138, 149, 155, 165, 171, 180, 182, 183, 186, 189, 191, 195, 196, 197, 199, 200, 201, 202, 203, 206, 209, 211, 215, 217, 220, 221, 222, 224, 225, 226, 227, 229, 230, 233, 236, 240, 241, 242, 244, 247, 249, 251, 254, 257, 258, 260, 263, 265, 268, 271, 275, 279, 291, 299, 300, 302, 303, 306, 309, 311, 315, 316, 320, 322, 323, 325, 327, 330, 333, 335, 337, 341, 344, 346, 351, 353, 354, 355, 356]	['Interestingly', ',', 'they', 'were', 'harbored', 'within', 'more', 'genes', 'associated', 'with', 'carbohydrate', 'metabolism', ':', 'eight', 'SNPs', 'were', 'located', 'in', 'seven', 'carbohydrate', 'metabolism', 'genes', 'including', 'those', 'encoding', 'β-galactosidase', ',', 'α-N-arabinofuranosidase', ',', 'α-1', ',', '2-mannosidase', ',', 'rhamnulokinase', ',', 'Rhamnogalacturonides', 'degradation', 'protein', ',', 'β-galactosidase', 'and', 'D-lactate', 'dehydrogenase', '(', 'Table', 'S9', ')', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 7, 1, 12, 1, 3, 1, 6, 1, 6, 1, 7, 1, 1, 1, 7, 1, 5, 5, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These results may suggest an altered carbohydrate preference and a resulting different carbohydrate metabolism patterns in the gut bacteria of TB patients.	[]	['These', 'results', 'may', 'suggest', 'an', 'altered', 'car', '##bo', '##hy', '##dra', '##te', 'preference', 'and', 'a', 'resulting', 'different', 'car', '##bo', '##hy', '##dra', '##te', 'metabolism', 'patterns', 'in', 'the', 'gut', 'bacteria', 'of', 'T', '##B', 'patients', '.']	[0, 6, 14, 18, 26, 29, 37, 40, 42, 44, 47, 50, 61, 65, 67, 77, 87, 90, 92, 94, 97, 100, 111, 120, 123, 127, 131, 140, 143, 144, 146, 154]	[5, 13, 17, 25, 28, 36, 40, 42, 44, 47, 49, 60, 64, 66, 76, 86, 90, 92, 94, 97, 99, 110, 119, 122, 126, 130, 139, 142, 144, 145, 154, 155]	['These', 'results', 'may', 'suggest', 'an', 'altered', 'carbohydrate', 'preference', 'and', 'a', 'resulting', 'different', 'carbohydrate', 'metabolism', 'patterns', 'in', 'the', 'gut', 'bacteria', 'of', 'TB', 'patients', '.']	[1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For participants with GPA, a detailed disease history was obtained including antineutrophil cytoplasmic antibody (ANCA) type by ELISA (proteinase-3 [PR3], myeloperoxidase [MPO], or negative), disease status determined by the Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis20 (BVAS/WG; BVAS/WG > 0 indicates active disease and BVAS/WG = 0 indicates disease remission), and sinonasal damage according to the ear, nose, and throat items on the Vasculitis Damage Index (VDI)21.	[]	['For', 'participants', 'with', 'GP', '##A', ',', 'a', 'detailed', 'disease', 'history', 'was', 'obtained', 'including', 'anti', '##ne', '##ut', '##rop', '##hil', 'c', '##yt', '##op', '##las', '##mic', 'anti', '##body', '(', 'AN', '##CA', ')', 'type', 'by', 'E', '##L', '##IS', '##A', '(', 'protein', '##ase', '-', '3', '[', 'PR', '##3', ']', ',', 'my', '##elo', '##per', '##ox', '##idas', '##e', '[', 'MP', '##O', ']', ',', 'or', 'negative', ')', ',', 'disease', 'status', 'determined', 'by', 'the', 'Birmingham', 'V', '##as', '##cu', '##lit', '##is', 'Act', '##ivity', 'Score', 'for', 'We', '##gene', '##r', '’', 's', 'Gran', '##ulo', '##mat', '##osis', '##20', '(', 'B', '##VA', '##S', '/', 'W', '##G', ';', 'B', '##VA', '##S', '/', 'W', '##G', '>', '0', 'indicates', 'active', 'disease', 'and', 'B', '##VA', '##S', '/', 'W', '##G', '=', '0', 'indicates', 'disease', 're', '##mission', ')', ',', 'and', 'sin', '##ona', '##sal', 'damage', 'according', 'to', 'the', 'ear', ',', 'nose', ',', 'and', 'throat', 'items', 'on', 'the', 'V', '##as', '##cu', '##lit', '##is', 'Dam', '##age', 'Index', '(', 'V', '##DI', ')', '21', '.']	[0, 4, 17, 22, 24, 25, 27, 29, 38, 46, 54, 58, 67, 77, 81, 83, 85, 88, 92, 93, 95, 97, 100, 104, 108, 113, 114, 116, 118, 120, 125, 128, 129, 130, 132, 134, 135, 142, 145, 146, 148, 149, 151, 152, 153, 155, 157, 160, 163, 165, 169, 171, 172, 174, 175, 176, 178, 181, 189, 190, 192, 200, 207, 218, 221, 225, 236, 237, 239, 241, 244, 247, 250, 256, 262, 266, 268, 272, 273, 274, 276, 280, 283, 286, 290, 293, 294, 295, 297, 298, 299, 300, 301, 303, 304, 306, 307, 308, 309, 311, 313, 315, 325, 332, 340, 344, 345, 347, 348, 349, 350, 352, 354, 356, 366, 374, 376, 383, 384, 386, 390, 393, 396, 400, 407, 417, 420, 424, 427, 429, 433, 435, 439, 446, 452, 455, 459, 460, 462, 464, 467, 470, 473, 477, 483, 484, 485, 487, 488, 490]	[3, 16, 21, 24, 25, 26, 28, 37, 45, 53, 57, 66, 76, 81, 83, 85, 88, 91, 93, 95, 97, 100, 103, 108, 112, 114, 116, 118, 119, 124, 127, 129, 130, 132, 133, 135, 142, 145, 146, 147, 149, 151, 152, 153, 154, 157, 160, 163, 165, 169, 170, 172, 174, 175, 176, 177, 180, 189, 190, 191, 199, 206, 217, 220, 224, 235, 237, 239, 241, 244, 246, 250, 255, 261, 265, 268, 272, 273, 274, 275, 280, 283, 286, 290, 292, 294, 295, 297, 298, 299, 300, 301, 302, 304, 306, 307, 308, 309, 310, 312, 314, 324, 331, 339, 343, 345, 347, 348, 349, 350, 351, 353, 355, 365, 373, 376, 383, 384, 385, 389, 393, 396, 399, 406, 416, 419, 423, 427, 428, 433, 434, 438, 445, 451, 454, 458, 460, 462, 464, 467, 469, 473, 476, 482, 484, 485, 487, 488, 490, 491]	['For', 'participants', 'with', 'GPA', ',', 'a', 'detailed', 'disease', 'history', 'was', 'obtained', 'including', 'antineutrophil', 'cytoplasmic', 'antibody', '(', 'ANCA', ')', 'type', 'by', 'ELISA', '(', 'proteinase-3', '[', 'PR3', ']', ',', 'myeloperoxidase', '[', 'MPO', ']', ',', 'or', 'negative', ')', ',', 'disease', 'status', 'determined', 'by', 'the', 'Birmingham', 'Vasculitis', 'Activity', 'Score', 'for', 'Wegener’s', 'Granulomatosis20', '(', 'BVAS', '/', 'WG', ';', 'BVAS', '/', 'WG', '>', '0', 'indicates', 'active', 'disease', 'and', 'BVAS', '/', 'WG', '=', '0', 'indicates', 'disease', 'remission', ')', ',', 'and', 'sinonasal', 'damage', 'according', 'to', 'the', 'ear', ',', 'nose', ',', 'and', 'throat', 'items', 'on', 'the', 'Vasculitis', 'Damage', 'Index', '(VDI)21', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 5, 2, 1, 2, 1, 1, 1, 4, 1, 4, 1, 2, 1, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1, 1, 5, 5, 1, 3, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
e.g. apolipoprotein A-I (APOA1) and E (APOE)], in apoptosis and immune response [e.g. CD5 antigen-like (CD5L), clusterin (CLUS) and C-C motif chemokine 14 (CCL14)], in transcription (e.g. protein SSX3 and signal transducer and activator of transcription 3 (STAT3)], in invasion and metastasis (e.g. alpha-2-HS-glycoprotein (FETUA)], in estrogen synthesis [aromatase (CYP19A1)] and other diverse biological roles [e.g. actin-related protein 2/3 complex subunit 4 (ARPC4), dual specificity mitogen-activated protein kinase kinase 4 (MP2K4), ectoderm-neural cortex protein 1 (ENC1), and matrix metalloproteinase-27 (MMP27)].	[]	['e', '.', 'g', '.', 'a', '##poli', '##pop', '##rote', '##in', 'A', '-', 'I', '(', 'AP', '##OA', '##1', ')', 'and', 'E', '(', 'AP', '##OE', ')', ']', ',', 'in', 'a', '##pop', '##tosis', 'and', 'immune', 'response', '[', 'e', '.', 'g', '.', 'CD', '##5', 'anti', '##gen', '-', 'like', '(', 'CD', '##5', '##L', ')', ',', 'cluster', '##in', '(', 'C', '##L', '##US', ')', 'and', 'C', '-', 'C', 'motif', 'ch', '##em', '##oki', '##ne', '14', '(', 'CC', '##L', '##14', ')', ']', ',', 'in', 'transcription', '(', 'e', '.', 'g', '.', 'protein', 'SS', '##X', '##3', 'and', 'signal', 'trans', '##du', '##cer', 'and', 'act', '##iva', '##tor', 'of', 'transcription', '3', '(', 'ST', '##AT', '##3', ')', ']', ',', 'in', 'invasion', 'and', 'meta', '##sta', '##sis', '(', 'e', '.', 'g', '.', 'alpha', '-', '2', '-', 'H', '##S', '-', 'g', '##ly', '##co', '##p', '##rote', '##in', '(', 'F', '##ET', '##U', '##A', ')', ']', ',', 'in', 'est', '##rogen', 'synthesis', '[', 'a', '##roma', '##tase', '(', 'C', '##YP', '##19', '##A', '##1', ')', ']', 'and', 'other', 'diverse', 'biological', 'roles', '[', 'e', '.', 'g', '.', 'act', '##in', '-', 'related', 'protein', '2', '/', '3', 'complex', 'subunit', '4', '(', 'AR', '##PC', '##4', ')', ',', 'dual', 'specific', '##ity', 'mit', '##ogen', '-', 'activated', 'protein', 'kinase', 'kinase', '4', '(', 'MP', '##2', '##K', '##4', ')', ',', 'e', '##ct', '##ode', '##rm', '-', 'neural', 'cortex', 'protein', '1', '(', 'E', '##NC', '##1', ')', ',', 'and', 'matrix', 'metal', '##lop', '##rote', '##inas', '##e', '-', '27', '(', 'M', '##MP', '##27', ')', ']', '.']	[0, 1, 2, 3, 5, 6, 10, 13, 17, 20, 21, 22, 24, 25, 27, 29, 30, 32, 36, 38, 39, 41, 43, 44, 45, 47, 50, 51, 54, 60, 64, 71, 80, 81, 82, 83, 84, 86, 88, 90, 94, 97, 98, 103, 104, 106, 107, 108, 109, 111, 118, 121, 122, 123, 124, 126, 128, 132, 133, 134, 136, 142, 144, 146, 149, 152, 155, 156, 158, 159, 161, 162, 163, 165, 168, 182, 183, 184, 185, 186, 188, 196, 198, 199, 201, 205, 212, 217, 219, 223, 227, 230, 233, 237, 240, 254, 256, 257, 259, 261, 262, 263, 264, 266, 269, 278, 282, 286, 289, 293, 294, 295, 296, 297, 299, 304, 305, 306, 307, 308, 309, 310, 311, 313, 315, 316, 320, 323, 324, 325, 327, 328, 329, 330, 331, 333, 336, 339, 345, 355, 356, 357, 361, 366, 367, 368, 370, 372, 373, 374, 375, 377, 381, 387, 395, 406, 412, 413, 414, 415, 416, 418, 421, 423, 424, 432, 440, 441, 442, 444, 452, 460, 462, 463, 465, 467, 468, 469, 471, 476, 484, 488, 491, 495, 496, 506, 514, 521, 528, 530, 531, 533, 534, 535, 536, 537, 539, 540, 542, 545, 547, 548, 555, 562, 570, 572, 573, 574, 576, 577, 578, 580, 584, 591, 596, 599, 603, 607, 608, 609, 612, 613, 614, 616, 618, 619, 620]	[1, 2, 3, 4, 6, 10, 13, 17, 19, 21, 22, 23, 25, 27, 29, 30, 31, 35, 37, 39, 41, 43, 44, 45, 46, 49, 51, 54, 59, 63, 70, 79, 81, 82, 83, 84, 85, 88, 89, 94, 97, 98, 102, 104, 106, 107, 108, 109, 110, 118, 120, 122, 123, 124, 126, 127, 131, 133, 134, 135, 141, 144, 146, 149, 151, 154, 156, 158, 159, 161, 162, 163, 164, 167, 181, 183, 184, 185, 186, 187, 195, 198, 199, 200, 204, 211, 217, 219, 222, 226, 230, 233, 236, 239, 253, 255, 257, 259, 261, 262, 263, 264, 265, 268, 277, 281, 286, 289, 292, 294, 295, 296, 297, 298, 304, 305, 306, 307, 308, 309, 310, 311, 313, 315, 316, 320, 322, 324, 325, 327, 328, 329, 330, 331, 332, 335, 339, 344, 354, 356, 357, 361, 365, 367, 368, 370, 372, 373, 374, 375, 376, 380, 386, 394, 405, 411, 413, 414, 415, 416, 417, 421, 423, 424, 431, 439, 441, 442, 443, 451, 459, 461, 463, 465, 467, 468, 469, 470, 475, 484, 487, 491, 495, 496, 505, 513, 520, 527, 529, 531, 533, 534, 535, 536, 537, 538, 540, 542, 545, 547, 548, 554, 561, 569, 571, 573, 574, 576, 577, 578, 579, 583, 590, 596, 599, 603, 607, 608, 609, 611, 613, 614, 616, 618, 619, 620, 621]	['e.g', '.', 'apolipoprotein', 'A-I', '(', 'APOA1', ')', 'and', 'E', '(', 'APOE', ')', ']', ',', 'in', 'apoptosis', 'and', 'immune', 'response', '[', 'e.g', '.', 'CD5', 'antigen', '-', 'like', '(', 'CD5L', ')', ',', 'clusterin', '(', 'CLUS', ')', 'and', 'C-C', 'motif', 'chemokine', '14', '(', 'CCL14', ')', ']', ',', 'in', 'transcription', '(', 'e.g', '.', 'protein', 'SSX3', 'and', 'signal', 'transducer', 'and', 'activator', 'of', 'transcription', '3', '(', 'STAT3', ')', ']', ',', 'in', 'invasion', 'and', 'metastasis', '(', 'e.g', '.', 'alpha-2-HS-glycoprotein', '(', 'FETUA', ')', ']', ',', 'in', 'estrogen', 'synthesis', '[', 'aromatase', '(', 'CYP19A1', ')', ']', 'and', 'other', 'diverse', 'biological', 'roles', '[', 'e.g', '.', 'actin', '-', 'related', 'protein', '2', '/', '3', 'complex', 'subunit', '4', '(', 'ARPC4', ')', ',', 'dual', 'specificity', 'mitogen', '-', 'activated', 'protein', 'kinase', 'kinase', '4', '(', 'MP2K4', ')', ',', 'ectoderm', '-', 'neural', 'cortex', 'protein', '1', '(', 'ENC1', ')', ',', 'and', 'matrix', 'metalloproteinase-27', '(', 'MMP27', ')', ']', '.']	[3, 1, 5, 3, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 2, 2, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 3, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 13, 1, 4, 1, 1, 1, 1, 2, 1, 1, 3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 7, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Conclusion: These findings provide valuable insight into the distinct clinicopathological features of MBC and indicate that select serum proteomic markers may help improve MBC management.	[]	['Con', '##c', '##lusion', ':', 'These', 'findings', 'provide', 'valuable', 'insight', 'into', 'the', 'distinct', 'clinic', '##op', '##ath', '##ological', 'features', 'of', 'MB', '##C', 'and', 'indicate', 'that', 'select', 'serum', 'pro', '##te', '##omi', '##c', 'markers', 'may', 'help', 'improve', 'MB', '##C', 'management', '.']	[0, 3, 4, 10, 12, 18, 27, 35, 44, 52, 57, 61, 70, 76, 78, 81, 90, 99, 102, 104, 106, 110, 119, 124, 131, 137, 140, 142, 145, 147, 155, 159, 164, 172, 174, 176, 186]	[3, 4, 10, 11, 17, 26, 34, 43, 51, 56, 60, 69, 76, 78, 81, 89, 98, 101, 104, 105, 109, 118, 123, 130, 136, 140, 142, 145, 146, 154, 158, 163, 171, 174, 175, 186, 187]	['Conclusion', ':', 'These', 'findings', 'provide', 'valuable', 'insight', 'into', 'the', 'distinct', 'clinicopathological', 'features', 'of', 'MBC', 'and', 'indicate', 'that', 'select', 'serum', 'proteomic', 'markers', 'may', 'help', 'improve', 'MBC', 'management', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Consequently, high expression levels of ALDH directly correlate with poor clinical outcome in patients with breast cancer, since cancer stem cell s have been implicated in breast tumor initiation, metastatic spread and recurrence (19).	[]	['Consequently', ',', 'high', 'expression', 'levels', 'of', 'AL', '##D', '##H', 'directly', 'co', '##rrel', '##ate', 'with', 'poor', 'clinical', 'outcome', 'in', 'patients', 'with', 'breast', 'cancer', ',', 'since', 'cancer', 'stem', 'cell', 's', 'have', 'been', 'implicated', 'in', 'breast', 'tumor', 'initiation', ',', 'meta', '##static', 'spread', 'and', 're', '##cu', '##rrence', '(', '19', ')', '.']	[0, 12, 14, 19, 30, 37, 40, 42, 43, 45, 54, 56, 60, 64, 69, 74, 83, 91, 94, 103, 108, 115, 121, 123, 129, 136, 141, 146, 148, 153, 158, 169, 172, 179, 185, 195, 197, 201, 208, 215, 219, 221, 223, 230, 231, 233, 234]	[12, 13, 18, 29, 36, 39, 42, 43, 44, 53, 56, 60, 63, 68, 73, 82, 90, 93, 102, 107, 114, 121, 122, 128, 135, 140, 145, 147, 152, 157, 168, 171, 178, 184, 195, 196, 201, 207, 214, 218, 221, 223, 229, 231, 233, 234, 235]	['Consequently', ',', 'high', 'expression', 'levels', 'of', 'ALDH', 'directly', 'correlate', 'with', 'poor', 'clinical', 'outcome', 'in', 'patients', 'with', 'breast', 'cancer', ',', 'since', 'cancer', 'stem', 'cell', 's', 'have', 'been', 'implicated', 'in', 'breast', 'tumor', 'initiation', ',', 'metastatic', 'spread', 'and', 'recurrence', '(', '19', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aromatase (CYP19A1) is responsible for the transformation of androgen precursors into estrogens.	[('PMC6489687', 'D06000', 0, 9, 'Aromatase')]	['A', '##roma', '##tase', '(', 'C', '##YP', '##19', '##A', '##1', ')', 'is', 'responsible', 'for', 'the', 'transformation', 'of', 'and', '##rogen', 'precursor', '##s', 'into', 'est', '##rogen', '##s', '.']	[0, 1, 5, 10, 11, 12, 14, 16, 17, 18, 20, 23, 35, 39, 43, 58, 61, 64, 70, 79, 81, 86, 89, 94, 95]	[1, 5, 9, 11, 12, 14, 16, 17, 18, 19, 22, 34, 38, 42, 57, 60, 64, 69, 79, 80, 85, 89, 94, 95, 96]	['Aromatase', '(', 'CYP19A1', ')', 'is', 'responsible', 'for', 'the', 'transformation', 'of', 'androgen', 'precursors', 'into', 'estrogens', '.']	[3, 1, 5, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Finally, four proteins were detected only in the MBC group and not in the control samples: actin-related protein 2/3 complex subunit 4 (ARPC4), dual specificity mitogen-activated protein kinase kinase 4 (MP2K4), ectoderm-neural cortex protein 1 (ENC1), and matrix metalloproteinase-27 (MMP27).	[('PMC6489687', 'D07000', 161, 202, 'mitogen-activated protein kinase kinase 4')]	['Finally', ',', 'four', 'proteins', 'were', 'detected', 'only', 'in', 'the', 'MB', '##C', 'group', 'and', 'not', 'in', 'the', 'control', 'samples', ':', 'act', '##in', '-', 'related', 'protein', '2', '/', '3', 'complex', 'subunit', '4', '(', 'AR', '##PC', '##4', ')', ',', 'dual', 'specific', '##ity', 'mit', '##ogen', '-', 'activated', 'protein', 'kinase', 'kinase', '4', '(', 'MP', '##2', '##K', '##4', ')', ',', 'e', '##ct', '##ode', '##rm', '-', 'neural', 'cortex', 'protein', '1', '(', 'E', '##NC', '##1', ')', ',', 'and', 'matrix', 'metal', '##lop', '##rote', '##inas', '##e', '-', '27', '(', 'M', '##MP', '##27', ')', '.']	[0, 7, 9, 14, 23, 28, 37, 42, 45, 49, 51, 53, 59, 63, 67, 70, 74, 82, 89, 91, 94, 96, 97, 105, 113, 114, 115, 117, 125, 133, 135, 136, 138, 140, 141, 142, 144, 149, 157, 161, 164, 168, 169, 179, 187, 194, 201, 203, 204, 206, 207, 208, 209, 210, 212, 213, 215, 218, 220, 221, 228, 235, 243, 245, 246, 247, 249, 250, 251, 253, 257, 264, 269, 272, 276, 280, 281, 282, 285, 286, 287, 289, 291, 292]	[7, 8, 13, 22, 27, 36, 41, 44, 48, 51, 52, 58, 62, 66, 69, 73, 81, 89, 90, 94, 96, 97, 104, 112, 114, 115, 116, 124, 132, 134, 136, 138, 140, 141, 142, 143, 148, 157, 160, 164, 168, 169, 178, 186, 193, 200, 202, 204, 206, 207, 208, 209, 210, 211, 213, 215, 218, 220, 221, 227, 234, 242, 244, 246, 247, 249, 250, 251, 252, 256, 263, 269, 272, 276, 280, 281, 282, 284, 286, 287, 289, 291, 292, 293]	['Finally', ',', 'four', 'proteins', 'were', 'detected', 'only', 'in', 'the', 'MBC', 'group', 'and', 'not', 'in', 'the', 'control', 'samples', ':', 'actin', '-', 'related', 'protein', '2', '/', '3', 'complex', 'subunit', '4', '(', 'ARPC4', ')', ',', 'dual', 'specificity', 'mitogen', '-', 'activated', 'protein', 'kinase', 'kinase', '4', '(', 'MP2K4', ')', ',', 'ectoderm', '-', 'neural', 'cortex', 'protein', '1', '(', 'ENC1', ')', ',', 'and', 'matrix', 'metalloproteinase-27', '(', 'MMP27', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 7, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aromatase ELISA kit was purchased from Fine Biotech (EH2665; Fine Test, Wuhan, Hubei, P. R. China).	[]	['A', '##roma', '##tase', 'E', '##L', '##IS', '##A', 'kit', 'was', 'purchased', 'from', 'Fine', 'B', '##iot', '##ech', '(', 'E', '##H', '##26', '##65', ';', 'Fine', 'Test', ',', 'Wu', '##han', ',', 'Hu', '##bei', ',', 'P', '.', 'R', '.', 'China', ')', '.']	[0, 1, 5, 10, 11, 12, 14, 16, 20, 24, 34, 39, 44, 45, 48, 52, 53, 54, 55, 57, 59, 61, 66, 70, 72, 74, 77, 79, 81, 84, 86, 87, 89, 90, 92, 97, 98]	[1, 5, 9, 11, 12, 14, 15, 19, 23, 33, 38, 43, 45, 48, 51, 53, 54, 55, 57, 59, 60, 65, 70, 71, 74, 77, 78, 81, 84, 85, 87, 88, 90, 91, 97, 98, 99]	['Aromatase', 'ELISA', 'kit', 'was', 'purchased', 'from', 'Fine', 'Biotech', '(', 'EH2665', ';', 'Fine', 'Test', ',', 'Wuhan', ',', 'Hubei', ',', 'P', '.', 'R', '.', 'China', ')', '.']	[3, 4, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum aromatase (CYP19A1) concentrations in patients with MBC and healthy controls were measured using ELISA since CYP19A1 is an endoplasmic reticulum enzyme also detected in the serum.	[]	['Ser', '##um', 'a', '##roma', '##tase', '(', 'C', '##YP', '##19', '##A', '##1', ')', 'concentrations', 'in', 'patients', 'with', 'MB', '##C', 'and', 'healthy', 'controls', 'were', 'measured', 'using', 'E', '##L', '##IS', '##A', 'since', 'C', '##YP', '##19', '##A', '##1', 'is', 'an', 'end', '##op', '##las', '##mic', 're', '##tic', '##ulum', 'enzyme', 'also', 'detected', 'in', 'the', 'serum', '.']	[0, 3, 6, 7, 11, 16, 17, 18, 20, 22, 23, 24, 26, 41, 44, 53, 58, 60, 62, 66, 74, 83, 88, 97, 103, 104, 105, 107, 109, 115, 116, 118, 120, 121, 123, 126, 129, 132, 134, 137, 141, 143, 146, 151, 158, 163, 172, 175, 179, 184]	[3, 5, 7, 11, 15, 17, 18, 20, 22, 23, 24, 25, 40, 43, 52, 57, 60, 61, 65, 73, 82, 87, 96, 102, 104, 105, 107, 108, 114, 116, 118, 120, 121, 122, 125, 128, 132, 134, 137, 140, 143, 146, 150, 157, 162, 171, 174, 178, 184, 185]	['Serum', 'aromatase', '(', 'CYP19A1', ')', 'concentrations', 'in', 'patients', 'with', 'MBC', 'and', 'healthy', 'controls', 'were', 'measured', 'using', 'ELISA', 'since', 'CYP19A1', 'is', 'an', 'endoplasmic', 'reticulum', 'enzyme', 'also', 'detected', 'in', 'the', 'serum', '.']	[2, 3, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
These 3 glycoside hydrolases predominantly originated from Prevotella copri (42 ± 11.1%, Figure S3B), supporting the hypothesis that loss of Prevotella strains following U.S. immigration drove loss of plant fiber degradation capability.	[('PMC6498444', 'R09000', 8, 28, 'glycoside hydrolases')]	['These', '3', 'g', '##ly', '##cos', '##ide', 'h', '##ydro', '##lase', '##s', 'predominantly', 'originated', 'from', 'Pre', '##vo', '##tel', '##la', 'cop', '##ri', '(', '42', '±', '11', '.', '1', '%', ',', 'Figure', 'S', '##3', '##B', ')', ',', 'supporting', 'the', 'hypothesis', 'that', 'loss', 'of', 'Pre', '##vo', '##tel', '##la', 'strains', 'following', 'U', '.', 'S', '.', 'immigration', 'drove', 'loss', 'of', 'plant', 'fiber', 'degradation', 'capability', '.']	[0, 6, 8, 9, 11, 14, 18, 19, 23, 27, 29, 43, 54, 59, 62, 64, 67, 70, 73, 76, 77, 80, 82, 84, 85, 86, 87, 89, 96, 97, 98, 99, 100, 102, 113, 117, 128, 133, 138, 141, 144, 146, 149, 152, 160, 170, 171, 172, 173, 175, 187, 193, 198, 201, 207, 213, 225, 235]	[5, 7, 9, 11, 14, 17, 19, 23, 27, 28, 42, 53, 58, 62, 64, 67, 69, 73, 75, 77, 79, 81, 84, 85, 86, 87, 88, 95, 97, 98, 99, 100, 101, 112, 116, 127, 132, 137, 140, 144, 146, 149, 151, 159, 169, 171, 172, 173, 174, 186, 192, 197, 200, 206, 212, 224, 235, 236]	['These', '3', 'glycoside', 'hydrolases', 'predominantly', 'originated', 'from', 'Prevotella', 'copri', '(', '42', '±', '11.1%', ',', 'Figure', 'S3B', ')', ',', 'supporting', 'the', 'hypothesis', 'that', 'loss', 'of', 'Prevotella', 'strains', 'following', 'U.S', '.', 'immigration', 'drove', 'loss', 'of', 'plant', 'fiber', 'degradation', 'capability', '.']	[1, 1, 4, 4, 1, 1, 1, 4, 2, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We also observed a loss of GH5 and GH26 glycoside hydrolases from HmongThai to Hmong1st and U.S. controls, which indicates a loss of cellulose, beta-mannan and possible xyloglucan degradative potential.	[('PMC6498444', 'R09001', 40, 60, 'glycoside hydrolases')]	['We', 'also', 'observed', 'a', 'loss', 'of', 'G', '##H', '##5', 'and', 'G', '##H', '##26', 'g', '##ly', '##cos', '##ide', 'h', '##ydro', '##lase', '##s', 'from', 'H', '##mon', '##g', '##T', '##hai', 'to', 'H', '##mon', '##g', '##1', '##st', 'and', 'U', '.', 'S', '.', 'controls', ',', 'which', 'indicates', 'a', 'loss', 'of', 'cell', '##ulos', '##e', ',', 'beta', '-', 'man', '##nan', 'and', 'possible', 'x', '##yl', '##og', '##lu', '##can', 'de', '##grad', '##ative', 'potential', '.']	[0, 3, 8, 17, 19, 24, 27, 28, 29, 31, 35, 36, 37, 40, 41, 43, 46, 50, 51, 55, 59, 61, 66, 67, 70, 71, 72, 76, 79, 80, 83, 84, 85, 88, 92, 93, 94, 95, 97, 105, 107, 113, 123, 125, 130, 133, 137, 141, 142, 144, 148, 149, 152, 156, 160, 169, 170, 172, 174, 176, 180, 182, 186, 192, 201]	[2, 7, 16, 18, 23, 26, 28, 29, 30, 34, 36, 37, 39, 41, 43, 46, 49, 51, 55, 59, 60, 65, 67, 70, 71, 72, 75, 78, 80, 83, 84, 85, 87, 91, 93, 94, 95, 96, 105, 106, 112, 122, 124, 129, 132, 137, 141, 142, 143, 148, 149, 152, 155, 159, 168, 170, 172, 174, 176, 179, 182, 186, 191, 201, 202]	['We', 'also', 'observed', 'a', 'loss', 'of', 'GH5', 'and', 'GH26', 'glycoside', 'hydrolases', 'from', 'HmongThai', 'to', 'Hmong1st', 'and', 'U.S', '.', 'controls', ',', 'which', 'indicates', 'a', 'loss', 'of', 'cellulose', ',', 'beta', '-', 'mannan', 'and', 'possible', 'xyloglucan', 'degradative', 'potential', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 3, 4, 4, 1, 5, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 5, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Indole is an important bacterial quorum signaling molecule exclusively catabolized from tryptophan by commensal bacteria that express tryptophanase [16].	[('PMC6499899', 'I02000', 134, 147, 'tryptophanase')]	['Indo', '##le', 'is', 'an', 'important', 'bacterial', 'q', '##uo', '##rum', 'signaling', 'molecule', 'exclusively', 'cat', '##ab', '##oli', '##zed', 'from', 'try', '##pt', '##op', '##han', 'by', 'com', '##men', '##sal', 'bacteria', 'that', 'express', 'try', '##pt', '##op', '##hana', '##se', '[', '16', ']', '.']	[0, 4, 7, 10, 13, 23, 33, 34, 36, 40, 50, 59, 71, 74, 76, 79, 83, 88, 91, 93, 95, 99, 102, 105, 108, 112, 121, 126, 134, 137, 139, 141, 145, 148, 149, 151, 152]	[4, 6, 9, 12, 22, 32, 34, 36, 39, 49, 58, 70, 74, 76, 79, 82, 87, 91, 93, 95, 98, 101, 105, 108, 111, 120, 125, 133, 137, 139, 141, 145, 147, 149, 151, 152, 153]	['Indole', 'is', 'an', 'important', 'bacterial', 'quorum', 'signaling', 'molecule', 'exclusively', 'catabolized', 'from', 'tryptophan', 'by', 'commensal', 'bacteria', 'that', 'express', 'tryptophanase', '[', '16', ']', '.']	[2, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 4, 1, 3, 1, 1, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Pyruvate dehydrogenase kinase (PDK) is a Ser/Thr kinase that inactivates mitochondrial pyruvate dehydrogenase and serves a key role in aerobic glycolysis, which is a hallmark of cancer cells.	[('PMC6507336', 'A00000', 0, 29, 'Pyruvate dehydrogenase kinase')]	['P', '##yr', '##u', '##vate', 'de', '##hy', '##dr', '##ogen', '##ase', 'kinase', '(', 'PD', '##K', ')', 'is', 'a', 'Ser', '/', 'T', '##hr', 'kinase', 'that', 'in', '##act', '##ivate', '##s', 'mitochondrial', 'p', '##yr', '##u', '##vate', 'de', '##hy', '##dr', '##ogen', '##ase', 'and', 'serves', 'a', 'key', 'role', 'in', 'a', '##ero', '##bic', 'g', '##ly', '##co', '##lysis', ',', 'which', 'is', 'a', 'hall', '##mark', 'of', 'cancer', 'cells', '.']	[0, 1, 3, 4, 9, 11, 13, 15, 19, 23, 30, 31, 33, 34, 36, 39, 41, 44, 45, 46, 49, 56, 61, 63, 66, 71, 73, 87, 88, 90, 91, 96, 98, 100, 102, 106, 110, 114, 121, 123, 127, 132, 135, 136, 139, 143, 144, 146, 148, 153, 155, 161, 164, 166, 170, 175, 178, 185, 190]	[1, 3, 4, 8, 11, 13, 15, 19, 22, 29, 31, 33, 34, 35, 38, 40, 44, 45, 46, 48, 55, 60, 63, 66, 71, 72, 86, 88, 90, 91, 95, 98, 100, 102, 106, 109, 113, 120, 122, 126, 131, 134, 136, 139, 142, 144, 146, 148, 153, 154, 160, 163, 165, 170, 174, 177, 184, 190, 191]	['Pyruvate', 'dehydrogenase', 'kinase', '(', 'PDK', ')', 'is', 'a', 'Ser', '/', 'Thr', 'kinase', 'that', 'inactivates', 'mitochondrial', 'pyruvate', 'dehydrogenase', 'and', 'serves', 'a', 'key', 'role', 'in', 'aerobic', 'glycolysis', ',', 'which', 'is', 'a', 'hallmark', 'of', 'cancer', 'cells', '.']	[4, 5, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 4, 5, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The sections were washed in 1X PBS-T and incubated with 150 µl undiluted goat anti-rabbit immunoglobulin G (IgG) antibody with the EnVision System (Dako; Agilent Technologies, Inc., Santa Clara, CA, USA) for 1 h and the signal was developed with diamino-benzidine (Dako; Agilent Technologies, Inc.) for 5 min in the dark.	[]	['The', 'sections', 'were', 'washed', 'in', '1', '##X', 'PBS', '-', 'T', 'and', 'in', '##cu', '##bate', '##d', 'with', '150', 'µ', '##l', 'und', '##il', '##uted', 'goat', 'anti', '-', 'rabbit', 'im', '##mu', '##no', '##g', '##lo', '##bul', '##in', 'G', '(', 'I', '##g', '##G', ')', 'anti', '##body', 'with', 'the', 'En', '##V', '##ision', 'System', '(', 'Da', '##ko', ';', 'A', '##gi', '##lent', 'Technologies', ',', 'Inc', '.', ',', 'Santa', 'Clara', ',', 'CA', ',', 'USA', ')', 'for', '1', 'h', 'and', 'the', 'signal', 'was', 'developed', 'with', 'di', '##ami', '##no', '-', 'ben', '##zi', '##dine', '(', 'Da', '##ko', ';', 'A', '##gi', '##lent', 'Technologies', ',', 'Inc', '.', ')', 'for', '5', 'min', 'in', 'the', 'dark', '.']	[0, 4, 13, 18, 25, 28, 29, 31, 34, 35, 37, 41, 43, 45, 49, 51, 56, 60, 61, 63, 66, 68, 73, 78, 82, 83, 90, 92, 94, 96, 97, 99, 102, 105, 107, 108, 109, 110, 111, 113, 117, 122, 127, 131, 133, 134, 140, 147, 148, 150, 152, 154, 155, 157, 162, 174, 176, 179, 180, 182, 188, 193, 195, 197, 199, 202, 204, 208, 210, 212, 216, 220, 227, 231, 241, 246, 248, 251, 253, 254, 257, 259, 264, 265, 267, 269, 271, 272, 274, 279, 291, 293, 296, 297, 299, 303, 305, 309, 312, 316, 320]	[3, 12, 17, 24, 27, 29, 30, 34, 35, 36, 40, 43, 45, 49, 50, 55, 59, 61, 62, 66, 68, 72, 77, 82, 83, 89, 92, 94, 96, 97, 99, 102, 104, 106, 108, 109, 110, 111, 112, 117, 121, 126, 130, 133, 134, 139, 146, 148, 150, 152, 153, 155, 157, 161, 174, 175, 179, 180, 181, 187, 193, 194, 197, 198, 202, 203, 207, 209, 211, 215, 219, 226, 230, 240, 245, 248, 251, 253, 254, 257, 259, 263, 265, 267, 269, 270, 272, 274, 278, 291, 292, 296, 297, 298, 302, 304, 308, 311, 315, 320, 321]	['The', 'sections', 'were', 'washed', 'in', '1X', 'PBS-T', 'and', 'incubated', 'with', '150', 'µl', 'undiluted', 'goat', 'anti-', 'rabbit', 'immunoglobulin', 'G', '(', 'IgG', ')', 'antibody', 'with', 'the', 'EnVision', 'System', '(', 'Dako', ';', 'Agilent', 'Technologies', ',', 'Inc', '.', ',', 'Santa', 'Clara', ',', 'CA', ',', 'USA', ')', 'for', '1', 'h', 'and', 'the', 'signal', 'was', 'developed', 'with', 'diamino', '-', 'benzidine', '(', 'Dako', ';', 'Agilent', 'Technologies', ',', 'Inc', '.', ')', 'for', '5', 'min', 'in', 'the', 'dark', '.']	[1, 1, 1, 1, 1, 2, 3, 1, 4, 1, 1, 2, 3, 1, 2, 1, 7, 1, 1, 3, 1, 2, 1, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This fragment was amplified from 20 DPA endosperm RNA using primers QF18 and QR18 described in Altenbach and Kothari (2007), inserted in opposite orientations on either side of a 146 bp intron from a wheat starch synthase gene, then placed under the regulatory control of the HMW-GS Dy10 promoter and the HMW-GS Dx5 terminator as described in Altenbach and Allen (2011).	[]	['This', 'fragment', 'was', 'am', '##plified', 'from', '20', 'D', '##PA', 'end', '##os', '##per', '##m', 'RNA', 'using', 'prime', '##rs', 'Q', '##F', '##18', 'and', 'Q', '##R', '##18', 'described', 'in', 'Alt', '##enbach', 'and', 'Ko', '##tha', '##ri', '(', '2007', ')', ',', 'inserted', 'in', 'opposite', 'orientation', '##s', 'on', 'either', 'side', 'of', 'a', '146', 'b', '##p', 'intro', '##n', 'from', 'a', 'wheat', 'star', '##ch', 's', '##ynth', '##ase', 'gene', ',', 'then', 'placed', 'under', 'the', 'regulatory', 'control', 'of', 'the', 'HM', '##W', '-', 'G', '##S', 'D', '##y', '##10', 'promoter', 'and', 'the', 'HM', '##W', '-', 'G', '##S', 'D', '##x', '##5', 'term', '##inator', 'as', 'described', 'in', 'Alt', '##enbach', 'and', 'Allen', '(', '2011', ')', '.']	[0, 5, 14, 18, 20, 28, 33, 36, 37, 40, 43, 45, 48, 50, 54, 60, 65, 68, 69, 70, 73, 77, 78, 79, 82, 92, 95, 98, 105, 109, 111, 114, 117, 118, 122, 123, 125, 134, 137, 146, 157, 159, 162, 169, 174, 177, 179, 183, 184, 186, 191, 193, 198, 200, 206, 210, 213, 214, 218, 222, 226, 228, 233, 240, 246, 250, 261, 269, 272, 276, 278, 279, 280, 281, 283, 284, 285, 288, 297, 301, 305, 307, 308, 309, 310, 312, 313, 314, 316, 320, 327, 330, 340, 343, 346, 353, 357, 363, 364, 368, 369]	[4, 13, 17, 20, 27, 32, 35, 37, 39, 43, 45, 48, 49, 53, 59, 65, 67, 69, 70, 72, 76, 78, 79, 81, 91, 94, 98, 104, 108, 111, 114, 116, 118, 122, 123, 124, 133, 136, 145, 157, 158, 161, 168, 173, 176, 178, 182, 184, 185, 191, 192, 197, 199, 205, 210, 212, 214, 218, 221, 226, 227, 232, 239, 245, 249, 260, 268, 271, 275, 278, 279, 280, 281, 282, 284, 285, 287, 296, 300, 304, 307, 308, 309, 310, 311, 313, 314, 315, 320, 326, 329, 339, 342, 346, 352, 356, 362, 364, 368, 369, 370]	['This', 'fragment', 'was', 'amplified', 'from', '20', 'DPA', 'endosperm', 'RNA', 'using', 'primers', 'QF18', 'and', 'QR18', 'described', 'in', 'Altenbach', 'and', 'Kothari', '(', '2007', ')', ',', 'inserted', 'in', 'opposite', 'orientations', 'on', 'either', 'side', 'of', 'a', '146', 'bp', 'intron', 'from', 'a', 'wheat', 'starch', 'synthase', 'gene', ',', 'then', 'placed', 'under', 'the', 'regulatory', 'control', 'of', 'the', 'HMW-GS', 'Dy10', 'promoter', 'and', 'the', 'HMW-GS', 'Dx5', 'terminator', 'as', 'described', 'in', 'Altenbach', 'and', 'Allen', '(', '2011', ')', '.']	[1, 1, 1, 2, 1, 1, 2, 4, 1, 1, 2, 3, 1, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 5, 3, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our results suggest that the number of rounds of PCR and to a lesser degree the choice of DNA polymerase impact the analysis of 16S rRNA gene sequence data from bacterial communities.	[('PMC6531881', 'D00000', 90, 104, 'DNA polymerase')]	['Our', 'results', 'suggest', 'that', 'the', 'number', 'of', 'rounds', 'of', 'PC', '##R', 'and', 'to', 'a', 'lesser', 'degree', 'the', 'choice', 'of', 'DNA', 'polymer', '##ase', 'impact', 'the', 'analysis', 'of', '16', '##S', 'r', '##RNA', 'gene', 'sequence', 'data', 'from', 'bacterial', 'communities', '.']	[0, 4, 12, 20, 25, 29, 36, 39, 46, 49, 51, 53, 57, 60, 62, 69, 76, 80, 87, 90, 94, 101, 105, 112, 116, 125, 128, 130, 132, 133, 137, 142, 151, 156, 161, 171, 182]	[3, 11, 19, 24, 28, 35, 38, 45, 48, 51, 52, 56, 59, 61, 68, 75, 79, 86, 89, 93, 101, 104, 111, 115, 124, 127, 130, 131, 133, 136, 141, 150, 155, 160, 170, 182, 183]	['Our', 'results', 'suggest', 'that', 'the', 'number', 'of', 'rounds', 'of', 'PCR', 'and', 'to', 'a', 'lesser', 'degree', 'the', 'choice', 'of', 'DNA', 'polymerase', 'impact', 'the', 'analysis', 'of', '16S', 'rRNA', 'gene', 'sequence', 'data', 'from', 'bacterial', 'communities', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The observed sequencing error rates and alpha diversity metrics followed the manufacturers’ measurements of their polymerases’ fidelity (Fig. 1).	[('PMC6531881', 'D01000', 114, 125, 'polymerases')]	['The', 'observed', 'se', '##quencing', 'error', 'rates', 'and', 'alpha', 'diversity', 'metric', '##s', 'followed', 'the', 'manufacturers', '’', 'measurements', 'of', 'their', 'polymer', '##ases', '’', 'fi', '##delity', '(', 'Fi', '##g', '.', '1', ')', '.']	[0, 4, 13, 15, 24, 30, 36, 40, 46, 56, 62, 64, 73, 77, 90, 92, 105, 108, 114, 121, 125, 127, 129, 136, 137, 139, 140, 142, 143, 144]	[3, 12, 15, 23, 29, 35, 39, 45, 55, 62, 63, 72, 76, 90, 91, 104, 107, 113, 121, 125, 126, 129, 135, 137, 139, 140, 141, 143, 144, 145]	['The', 'observed', 'sequencing', 'error', 'rates', 'and', 'alpha', 'diversity', 'metrics', 'followed', 'the', 'manufacturers', '’', 'measurements', 'of', 'their', 'polymerases', '’', 'fidelity', '(', 'Fig', '.', '1', ')', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, in our experience and despite efforts to optimize the yield with the KAPA polymerase, the reactions typically had a high proportion of primer-dimer products and low yield of correctly sized products.	[]	['However', ',', 'in', 'our', 'experience', 'and', 'despite', 'efforts', 'to', 'op', '##ti', '##mize', 'the', 'yield', 'with', 'the', 'K', '##AP', '##A', 'polymer', '##ase', ',', 'the', 'reactions', 'typically', 'had', 'a', 'high', 'proportion', 'of', 'prime', '##r', '-', 'dim', '##er', 'products', 'and', 'low', 'yield', 'of', 'correctly', 'sized', 'products', '.']	[0, 7, 9, 12, 16, 27, 31, 39, 47, 50, 52, 54, 59, 63, 69, 74, 78, 79, 81, 83, 90, 93, 95, 99, 109, 119, 123, 125, 130, 141, 144, 149, 150, 151, 154, 157, 166, 170, 174, 180, 183, 193, 199, 207]	[7, 8, 11, 15, 26, 30, 38, 46, 49, 52, 54, 58, 62, 68, 73, 77, 79, 81, 82, 90, 93, 94, 98, 108, 118, 122, 124, 129, 140, 143, 149, 150, 151, 154, 156, 165, 169, 173, 179, 182, 192, 198, 207, 208]	['However', ',', 'in', 'our', 'experience', 'and', 'despite', 'efforts', 'to', 'optimize', 'the', 'yield', 'with', 'the', 'KAPA', 'polymerase', ',', 'the', 'reactions', 'typically', 'had', 'a', 'high', 'proportion', 'of', 'primer', '-', 'dimer', 'products', 'and', 'low', 'yield', 'of', 'correctly', 'sized', 'products', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Considering that polymerase development is an active area of commercial development with potential new polymerases becoming available, it is important for researchers to understand how changing the polymerase impacts downstream analyses for their type of samples.	[]	['Considering', 'that', 'polymer', '##ase', 'development', 'is', 'an', 'active', 'area', 'of', 'commercial', 'development', 'with', 'potential', 'new', 'polymer', '##ases', 'becoming', 'available', ',', 'it', 'is', 'important', 'for', 'researchers', 'to', 'understand', 'how', 'changing', 'the', 'polymer', '##ase', 'impacts', 'downstream', 'analyses', 'for', 'their', 'type', 'of', 'samples', '.']	[0, 12, 17, 24, 28, 40, 43, 46, 53, 58, 61, 72, 84, 89, 99, 103, 110, 115, 124, 133, 135, 138, 141, 151, 155, 167, 170, 181, 185, 194, 198, 205, 209, 217, 228, 237, 241, 247, 252, 255, 262]	[11, 16, 24, 27, 39, 42, 45, 52, 57, 60, 71, 83, 88, 98, 102, 110, 114, 123, 133, 134, 137, 140, 150, 154, 166, 169, 180, 184, 193, 197, 205, 208, 216, 227, 236, 240, 246, 251, 254, 262, 263]	['Considering', 'that', 'polymerase', 'development', 'is', 'an', 'active', 'area', 'of', 'commercial', 'development', 'with', 'potential', 'new', 'polymerases', 'becoming', 'available', ',', 'it', 'is', 'important', 'for', 'researchers', 'to', 'understand', 'how', 'changing', 'the', 'polymerase', 'impacts', 'downstream', 'analyses', 'for', 'their', 'type', 'of', 'samples', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Beyond the imperfections of the best polymerases, sometimes difficult to lyse organisms require stringent lysis steps and low biomass samples require additional rounds of PCR.	[]	['Beyond', 'the', 'imp', '##er', '##fect', '##ions', 'of', 'the', 'best', 'polymer', '##ases', ',', 'sometimes', 'difficult', 'to', 'l', '##ys', '##e', 'organisms', 'require', 'string', '##ent', 'l', '##ys', '##is', 'steps', 'and', 'low', 'bio', '##mass', 'samples', 'require', 'additional', 'rounds', 'of', 'PC', '##R', '.']	[0, 7, 11, 14, 16, 20, 25, 28, 32, 37, 44, 48, 50, 60, 70, 73, 74, 76, 78, 88, 96, 102, 106, 107, 109, 112, 118, 122, 126, 129, 134, 142, 150, 161, 168, 171, 173, 174]	[6, 10, 14, 16, 20, 24, 27, 31, 36, 44, 48, 49, 59, 69, 72, 74, 76, 77, 87, 95, 102, 105, 107, 109, 111, 117, 121, 125, 129, 133, 141, 149, 160, 167, 170, 173, 174, 175]	['Beyond', 'the', 'imperfections', 'of', 'the', 'best', 'polymerases', ',', 'sometimes', 'difficult', 'to', 'lyse', 'organisms', 'require', 'stringent', 'lysis', 'steps', 'and', 'low', 'biomass', 'samples', 'require', 'additional', 'rounds', 'of', 'PCR', '.']	[1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The influence that the choice of DNA polymerase has on the formation of PCR artifacts has not been well studied.	[('PMC6531881', 'I02000', 33, 47, 'DNA polymerase')]	['The', 'influence', 'that', 'the', 'choice', 'of', 'DNA', 'polymer', '##ase', 'has', 'on', 'the', 'formation', 'of', 'PC', '##R', 'artifacts', 'has', 'not', 'been', 'well', 'studied', '.']	[0, 4, 14, 19, 23, 30, 33, 37, 44, 48, 52, 55, 59, 69, 72, 74, 76, 86, 90, 94, 99, 104, 111]	[3, 13, 18, 22, 29, 32, 36, 44, 47, 51, 54, 58, 68, 71, 74, 75, 85, 89, 93, 98, 103, 111, 112]	['The', 'influence', 'that', 'the', 'choice', 'of', 'DNA', 'polymerase', 'has', 'on', 'the', 'formation', 'of', 'PCR', 'artifacts', 'has', 'not', 'been', 'well', 'studied', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There has been recent interest in how the choice of the hypervariable region and data analysis pipeline impact the sequencing error rate (15, 18,–20); however, these studies use the same DNA polymerase in the PCR step and implicitly assume that the rate of nucleotide misincorporation from PCR are significantly smaller than those from the sequencing phase.	[('PMC6531881', 'I02001', 187, 201, 'DNA polymerase')]	['There', 'has', 'been', 'recent', 'interest', 'in', 'how', 'the', 'choice', 'of', 'the', 'h', '##yper', '##var', '##iable', 'region', 'and', 'data', 'analysis', 'pipeline', 'impact', 'the', 'se', '##quencing', 'error', 'rate', '(', '15', ',', '18', ',', '–', '20', ')', ';', 'however', ',', 'these', 'studies', 'use', 'the', 'same', 'DNA', 'polymer', '##ase', 'in', 'the', 'PC', '##R', 'step', 'and', 'imp', '##licit', '##ly', 'assume', 'that', 'the', 'rate', 'of', 'n', '##uc', '##leo', '##tide', 'mi', '##sin', '##cor', '##por', '##ation', 'from', 'PC', '##R', 'are', 'significantly', 'smaller', 'than', 'those', 'from', 'the', 'se', '##quencing', 'phase', '.']	[0, 6, 10, 15, 22, 31, 34, 38, 42, 49, 52, 56, 57, 61, 64, 70, 77, 81, 86, 95, 104, 111, 115, 117, 126, 132, 137, 138, 140, 142, 144, 145, 146, 148, 149, 151, 158, 160, 166, 174, 178, 182, 187, 191, 198, 202, 205, 209, 211, 213, 218, 222, 225, 230, 233, 240, 245, 249, 254, 257, 258, 260, 263, 268, 270, 273, 276, 279, 285, 290, 292, 294, 298, 312, 320, 325, 331, 336, 340, 342, 351, 356]	[5, 9, 14, 21, 30, 33, 37, 41, 48, 51, 55, 57, 61, 64, 69, 76, 80, 85, 94, 103, 110, 114, 117, 125, 131, 136, 138, 140, 141, 144, 145, 146, 148, 149, 150, 158, 159, 165, 173, 177, 181, 186, 190, 198, 201, 204, 208, 211, 212, 217, 221, 225, 230, 232, 239, 244, 248, 253, 256, 258, 260, 263, 267, 270, 273, 276, 279, 284, 289, 292, 293, 297, 311, 319, 324, 330, 335, 339, 342, 350, 356, 357]	['There', 'has', 'been', 'recent', 'interest', 'in', 'how', 'the', 'choice', 'of', 'the', 'hypervariable', 'region', 'and', 'data', 'analysis', 'pipeline', 'impact', 'the', 'sequencing', 'error', 'rate', '(', '15', ',', '18', ',', '–20', ')', ';', 'however', ',', 'these', 'studies', 'use', 'the', 'same', 'DNA', 'polymerase', 'in', 'the', 'PCR', 'step', 'and', 'implicitly', 'assume', 'that', 'the', 'rate', 'of', 'nucleotide', 'misincorporation', 'from', 'PCR', 'are', 'significantly', 'smaller', 'than', 'those', 'from', 'the', 'sequencing', 'phase', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 4, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
There has been more limited interest in the impact that DNA polymerase choice has on the formation of chimeras (23, 38).	[('PMC6531881', 'I02002', 56, 70, 'DNA polymerase')]	['There', 'has', 'been', 'more', 'limited', 'interest', 'in', 'the', 'impact', 'that', 'DNA', 'polymer', '##ase', 'choice', 'has', 'on', 'the', 'formation', 'of', 'ch', '##ime', '##ras', '(', '23', ',', '38', ')', '.']	[0, 6, 10, 15, 20, 28, 37, 40, 44, 51, 56, 60, 67, 71, 78, 82, 85, 89, 99, 102, 104, 107, 111, 112, 114, 116, 118, 119]	[5, 9, 14, 19, 27, 36, 39, 43, 50, 55, 59, 67, 70, 77, 81, 84, 88, 98, 101, 104, 107, 110, 112, 114, 115, 118, 119, 120]	['There', 'has', 'been', 'more', 'limited', 'interest', 'in', 'the', 'impact', 'that', 'DNA', 'polymerase', 'choice', 'has', 'on', 'the', 'formation', 'of', 'chimeras', '(', '23', ',', '38', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A recent study found differences in the number of operational taxonomic units (OTUs) and chimeras between normal and high fidelity DNA polymerases (38).	[('PMC6531881', 'I02003', 131, 146, 'DNA polymerases')]	['A', 'recent', 'study', 'found', 'differences', 'in', 'the', 'number', 'of', 'operational', 'tax', '##ono', '##mic', 'units', '(', 'O', '##TU', '##s', ')', 'and', 'ch', '##ime', '##ras', 'between', 'normal', 'and', 'high', 'fi', '##delity', 'DNA', 'polymer', '##ases', '(', '38', ')', '.']	[0, 2, 9, 15, 21, 33, 36, 40, 47, 50, 62, 65, 68, 72, 78, 79, 80, 82, 83, 85, 89, 91, 94, 98, 106, 113, 117, 122, 124, 131, 135, 142, 147, 148, 150, 151]	[1, 8, 14, 20, 32, 35, 39, 46, 49, 61, 65, 68, 71, 77, 79, 80, 82, 83, 84, 88, 91, 94, 97, 105, 112, 116, 121, 124, 130, 134, 142, 146, 148, 150, 151, 152]	['A', 'recent', 'study', 'found', 'differences', 'in', 'the', 'number', 'of', 'operational', 'taxonomic', 'units', '(', 'OTUs', ')', 'and', 'chimeras', 'between', 'normal', 'and', 'high', 'fidelity', 'DNA', 'polymerases', '(', '38', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O']
The authors of the study reduced the difference between two polymerases by optimizing the annealing and extension steps within the PCR protocol (38).	[('PMC6531881', 'I02004', 60, 71, 'polymerases')]	['The', 'authors', 'of', 'the', 'study', 'reduced', 'the', 'difference', 'between', 'two', 'polymer', '##ases', 'by', 'op', '##ti', '##mizing', 'the', 'an', '##nea', '##ling', 'and', 'extension', 'steps', 'within', 'the', 'PC', '##R', 'protocol', '(', '38', ')', '.']	[0, 4, 12, 15, 19, 25, 33, 37, 48, 56, 60, 67, 72, 75, 77, 79, 86, 90, 92, 95, 100, 104, 114, 120, 127, 131, 133, 135, 144, 145, 147, 148]	[3, 11, 14, 18, 24, 32, 36, 47, 55, 59, 67, 71, 74, 77, 79, 85, 89, 92, 95, 99, 103, 113, 119, 126, 130, 133, 134, 143, 145, 147, 148, 149]	['The', 'authors', 'of', 'the', 'study', 'reduced', 'the', 'difference', 'between', 'two', 'polymerases', 'by', 'optimizing', 'the', 'annealing', 'and', 'extension', 'steps', 'within', 'the', 'PCR', 'protocol', '(', '38', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Yet this optimization was specific for the community they were analyzing (i.e., captive and semicaptive red-shanked doucs) and assumed that if the two polymerases generate the same community structure that the community structure was correct.	[('PMC6531881', 'I02005', 151, 162, 'polymerases')]	['Yet', 'this', 'optimization', 'was', 'specific', 'for', 'the', 'community', 'they', 'were', 'analyzing', '(', 'i', '.', 'e', '.', ',', 'captive', 'and', 'semi', '##cap', '##tive', 'red', '-', 's', '##han', '##ked', 'do', '##uc', '##s', ')', 'and', 'assumed', 'that', 'if', 'the', 'two', 'polymer', '##ases', 'generate', 'the', 'same', 'community', 'structure', 'that', 'the', 'community', 'structure', 'was', 'correct', '.']	[0, 4, 9, 22, 26, 35, 39, 43, 53, 58, 63, 73, 74, 75, 76, 77, 78, 80, 88, 92, 96, 99, 104, 107, 108, 109, 112, 116, 118, 120, 121, 123, 127, 135, 140, 143, 147, 151, 158, 163, 172, 176, 181, 191, 201, 206, 210, 220, 230, 234, 241]	[3, 8, 21, 25, 34, 38, 42, 52, 57, 62, 72, 74, 75, 76, 77, 78, 79, 87, 91, 96, 99, 103, 107, 108, 109, 112, 115, 118, 120, 121, 122, 126, 134, 139, 142, 146, 150, 158, 162, 171, 175, 180, 190, 200, 205, 209, 219, 229, 233, 241, 242]	['Yet', 'this', 'optimization', 'was', 'specific', 'for', 'the', 'community', 'they', 'were', 'analyzing', '(', 'i.e', '.', ',', 'captive', 'and', 'semicaptive', 'red', '-', 'shanked', 'doucs', ')', 'and', 'assumed', 'that', 'if', 'the', 'two', 'polymerases', 'generate', 'the', 'same', 'community', 'structure', 'that', 'the', 'community', 'structure', 'was', 'correct', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This study investigated the impact of choice of high fidelity DNA polymerase and the number of rounds of amplification on the formation of PCR artifacts using a mock community and human stool samples.	[('PMC6531881', 'I03000', 62, 76, 'DNA polymerase')]	['This', 'study', 'investigated', 'the', 'impact', 'of', 'choice', 'of', 'high', 'fi', '##delity', 'DNA', 'polymer', '##ase', 'and', 'the', 'number', 'of', 'rounds', 'of', 'am', '##p', '##lification', 'on', 'the', 'formation', 'of', 'PC', '##R', 'artifacts', 'using', 'a', 'mock', 'community', 'and', 'human', 'stool', 'samples', '.']	[0, 5, 11, 24, 28, 35, 38, 45, 48, 53, 55, 62, 66, 73, 77, 81, 85, 92, 95, 102, 105, 107, 108, 119, 122, 126, 136, 139, 141, 143, 153, 159, 161, 166, 176, 180, 186, 192, 199]	[4, 10, 23, 27, 34, 37, 44, 47, 52, 55, 61, 65, 73, 76, 80, 84, 91, 94, 101, 104, 107, 108, 118, 121, 125, 135, 138, 141, 142, 152, 158, 160, 165, 175, 179, 185, 191, 199, 200]	['This', 'study', 'investigated', 'the', 'impact', 'of', 'choice', 'of', 'high', 'fidelity', 'DNA', 'polymerase', 'and', 'the', 'number', 'of', 'rounds', 'of', 'amplification', 'on', 'the', 'formation', 'of', 'PCR', 'artifacts', 'using', 'a', 'mock', 'community', 'and', 'human', 'stool', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We tested (i) the effect of the polymerase on the error rate of the bases represented in the final sequences, (ii) the fraction of sequences that appeared to be chimeras and the ability to detect those chimeras, (iii) the bias of preferentially amplifying one fragment over another in a mixed pool of templates, and (iv) intersample variation in community structure of samples amplified with the same polymerase across the amplification process.	[]	['We', 'tested', '(', 'i', ')', 'the', 'effect', 'of', 'the', 'polymer', '##ase', 'on', 'the', 'error', 'rate', 'of', 'the', 'bases', 'represented', 'in', 'the', 'final', 'sequences', ',', '(', 'ii', ')', 'the', 'fraction', 'of', 'sequences', 'that', 'appeared', 'to', 'be', 'ch', '##ime', '##ras', 'and', 'the', 'ability', 'to', 'detect', 'those', 'ch', '##ime', '##ras', ',', '(', 'ii', '##i', ')', 'the', 'bias', 'of', 'prefer', '##ential', '##ly', 'am', '##p', '##lify', '##ing', 'one', 'fragment', 'over', 'another', 'in', 'a', 'mixed', 'pool', 'of', 'template', '##s', ',', 'and', '(', 'i', '##v', ')', 'inter', '##sa', '##mple', 'variation', 'in', 'community', 'structure', 'of', 'samples', 'am', '##plified', 'with', 'the', 'same', 'polymer', '##ase', 'across', 'the', 'am', '##p', '##lification', 'process', '.']	[0, 3, 10, 11, 12, 14, 18, 25, 28, 32, 39, 43, 46, 50, 56, 61, 64, 68, 74, 86, 89, 93, 99, 108, 110, 111, 113, 115, 119, 128, 131, 141, 146, 155, 158, 161, 163, 166, 170, 174, 178, 186, 189, 196, 202, 204, 207, 210, 212, 213, 215, 216, 218, 222, 227, 230, 236, 242, 245, 247, 248, 252, 256, 260, 269, 274, 282, 285, 287, 293, 298, 301, 309, 310, 312, 316, 317, 318, 319, 321, 326, 328, 333, 343, 346, 356, 366, 369, 377, 379, 387, 392, 396, 401, 408, 412, 419, 423, 425, 426, 437, 444]	[2, 9, 11, 12, 13, 17, 24, 27, 31, 39, 42, 45, 49, 55, 60, 63, 67, 73, 85, 88, 92, 98, 108, 109, 111, 113, 114, 118, 127, 130, 140, 145, 154, 157, 160, 163, 166, 169, 173, 177, 185, 188, 195, 201, 204, 207, 210, 211, 213, 215, 216, 217, 221, 226, 229, 236, 242, 244, 247, 248, 252, 255, 259, 268, 273, 281, 284, 286, 292, 297, 300, 309, 310, 311, 315, 317, 318, 319, 320, 326, 328, 332, 342, 345, 355, 365, 368, 376, 379, 386, 391, 395, 400, 408, 411, 418, 422, 425, 426, 436, 444, 445]	['We', 'tested', '(i)', 'the', 'effect', 'of', 'the', 'polymerase', 'on', 'the', 'error', 'rate', 'of', 'the', 'bases', 'represented', 'in', 'the', 'final', 'sequences', ',', '(ii)', 'the', 'fraction', 'of', 'sequences', 'that', 'appeared', 'to', 'be', 'chimeras', 'and', 'the', 'ability', 'to', 'detect', 'those', 'chimeras', ',', '(iii)', 'the', 'bias', 'of', 'preferentially', 'amplifying', 'one', 'fragment', 'over', 'another', 'in', 'a', 'mixed', 'pool', 'of', 'templates', ',', 'and', '(iv)', 'intersample', 'variation', 'in', 'community', 'structure', 'of', 'samples', 'amplified', 'with', 'the', 'same', 'polymerase', 'across', 'the', 'amplification', 'process', '.']	[1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To characterize these factors, we sequenced a mock community of 8 organisms with known sequences and community structure and human fecal samples with unknown sequences and community structures.	[]	['To', 'character', '##ize', 'these', 'factors', ',', 'we', 'sequence', '##d', 'a', 'mock', 'community', 'of', '8', 'organisms', 'with', 'known', 'sequences', 'and', 'community', 'structure', 'and', 'human', 'f', '##eca', '##l', 'samples', 'with', 'unknown', 'sequences', 'and', 'community', 'structures', '.']	[0, 3, 12, 16, 22, 29, 31, 34, 42, 44, 46, 51, 61, 64, 66, 76, 81, 87, 97, 101, 111, 121, 125, 131, 132, 135, 137, 145, 150, 158, 168, 172, 182, 192]	[2, 12, 15, 21, 29, 30, 33, 42, 43, 45, 50, 60, 63, 65, 75, 80, 86, 96, 100, 110, 120, 124, 130, 132, 135, 136, 144, 149, 157, 167, 171, 181, 192, 193]	['To', 'characterize', 'these', 'factors', ',', 'we', 'sequenced', 'a', 'mock', 'community', 'of', '8', 'organisms', 'with', 'known', 'sequences', 'and', 'community', 'structure', 'and', 'human', 'fecal', 'samples', 'with', 'unknown', 'sequences', 'and', 'community', 'structures', '.']	[1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five high fidelity DNA polymerases were tested, including AccuPrime (ThermoFisher, MA, USA), KAPA HIFI (Roche, IN, USA), Phusion (New England Biolabs, MA, USA), Platinum (ThermoFisher, MA, USA), and Q5 (New England Biolabs, MA, USA).	[('PMC6531881', 'M02000', 19, 34, 'DNA polymerases')]	['Five', 'high', 'fi', '##delity', 'DNA', 'polymer', '##ases', 'were', 'tested', ',', 'including', 'A', '##cc', '##u', '##P', '##rim', '##e', '(', 'The', '##rm', '##o', '##F', '##ish', '##er', ',', 'MA', ',', 'USA', ')', ',', 'K', '##AP', '##A', 'H', '##IF', '##I', '(', 'Roche', ',', 'IN', ',', 'USA', ')', ',', 'Ph', '##usion', '(', 'New', 'England', 'B', '##iol', '##ab', '##s', ',', 'MA', ',', 'USA', ')', ',', 'Platinum', '(', 'The', '##rm', '##o', '##F', '##ish', '##er', ',', 'MA', ',', 'USA', ')', ',', 'and', 'Q', '##5', '(', 'New', 'England', 'B', '##iol', '##ab', '##s', ',', 'MA', ',', 'USA', ')', '.']	[0, 5, 10, 12, 19, 23, 30, 35, 40, 46, 48, 58, 59, 61, 62, 63, 66, 68, 69, 72, 74, 75, 76, 79, 81, 83, 85, 87, 90, 91, 93, 94, 96, 98, 99, 101, 103, 104, 109, 111, 113, 115, 118, 119, 121, 123, 129, 130, 134, 142, 143, 146, 148, 149, 151, 153, 155, 158, 159, 161, 170, 171, 174, 176, 177, 178, 181, 183, 185, 187, 189, 192, 193, 195, 199, 200, 202, 203, 207, 215, 216, 219, 221, 222, 224, 226, 228, 231, 232]	[4, 9, 12, 18, 22, 30, 34, 39, 46, 47, 57, 59, 61, 62, 63, 66, 67, 69, 72, 74, 75, 76, 79, 81, 82, 85, 86, 90, 91, 92, 94, 96, 97, 99, 101, 102, 104, 109, 110, 113, 114, 118, 119, 120, 123, 128, 130, 133, 141, 143, 146, 148, 149, 150, 153, 154, 158, 159, 160, 169, 171, 174, 176, 177, 178, 181, 183, 184, 187, 188, 192, 193, 194, 198, 200, 201, 203, 206, 214, 216, 219, 221, 222, 223, 226, 227, 231, 232, 233]	['Five', 'high', 'fidelity', 'DNA', 'polymerases', 'were', 'tested', ',', 'including', 'AccuPrime', '(', 'ThermoFisher', ',', 'MA', ',', 'USA', ')', ',', 'KAPA', 'HIFI', '(', 'Roche', ',', 'IN', ',', 'USA', ')', ',', 'Phusion', '(', 'New', 'England', 'Biolabs', ',', 'MA', ',', 'USA', ')', ',', 'Platinum', '(', 'ThermoFisher', ',', 'MA', ',', 'USA', ')', ',', 'and', 'Q5', '(', 'New', 'England', 'Biolabs', ',', 'MA', ',', 'USA', ')', '.']	[1, 1, 2, 1, 2, 1, 1, 1, 1, 6, 1, 6, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Each PCR condition (i.e., combination of polymerase and number of rounds of PCR) was replicated four times for the mock community and one time for each fecal sample.	[('PMC6531881', 'M03000', 41, 51, 'polymerase')]	['Each', 'PC', '##R', 'condition', '(', 'i', '.', 'e', '.', ',', 'combination', 'of', 'polymer', '##ase', 'and', 'number', 'of', 'rounds', 'of', 'PC', '##R', ')', 'was', 'replica', '##ted', 'four', 'times', 'for', 'the', 'mock', 'community', 'and', 'one', 'time', 'for', 'each', 'f', '##eca', '##l', 'sample', '.']	[0, 5, 7, 9, 19, 20, 21, 22, 23, 24, 26, 38, 41, 48, 52, 56, 63, 66, 73, 76, 78, 79, 81, 85, 92, 96, 101, 107, 111, 115, 120, 130, 134, 138, 143, 147, 152, 153, 156, 158, 164]	[4, 7, 8, 18, 20, 21, 22, 23, 24, 25, 37, 40, 48, 51, 55, 62, 65, 72, 75, 78, 79, 80, 84, 92, 95, 100, 106, 110, 114, 119, 129, 133, 137, 142, 146, 151, 153, 156, 157, 164, 165]	['Each', 'PCR', 'condition', '(', 'i.e', '.', ',', 'combination', 'of', 'polymerase', 'and', 'number', 'of', 'rounds', 'of', 'PCR', ')', 'was', 'replicated', 'four', 'times', 'for', 'the', 'mock', 'community', 'and', 'one', 'time', 'for', 'each', 'fecal', 'sample', '.']	[1, 2, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
With the exception of the sequence data generated using the KAPA polymerase, the ratios of the two Salmonella enterica V4 sequences from the mock community were lower than the expected ratio of 6:1.	[('PMC6531881', 'R04000', 60, 75, 'KAPA polymerase')]	['With', 'the', 'exception', 'of', 'the', 'sequence', 'data', 'generated', 'using', 'the', 'K', '##AP', '##A', 'polymer', '##ase', ',', 'the', 'ratios', 'of', 'the', 'two', 'Salmon', '##ella', 'enter', '##ica', 'V', '##4', 'sequences', 'from', 'the', 'mock', 'community', 'were', 'lower', 'than', 'the', 'expected', 'ratio', 'of', '6', ':', '1', '.']	[0, 5, 9, 19, 22, 26, 35, 40, 50, 56, 60, 61, 63, 65, 72, 75, 77, 81, 88, 91, 95, 99, 105, 110, 115, 119, 120, 122, 132, 137, 141, 146, 156, 161, 167, 172, 176, 185, 191, 194, 195, 196, 197]	[4, 8, 18, 21, 25, 34, 39, 49, 55, 59, 61, 63, 64, 72, 75, 76, 80, 87, 90, 94, 98, 105, 109, 115, 118, 120, 121, 131, 136, 140, 145, 155, 160, 166, 171, 175, 184, 190, 193, 195, 196, 197, 198]	['With', 'the', 'exception', 'of', 'the', 'sequence', 'data', 'generated', 'using', 'the', 'KAPA', 'polymerase', ',', 'the', 'ratios', 'of', 'the', 'two', 'Salmonella', 'enterica', 'V4', 'sequences', 'from', 'the', 'mock', 'community', 'were', 'lower', 'than', 'the', 'expected', 'ratio', 'of', '6', ':', '1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 2, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Because the variation in bias between polymerases and across rounds of PCR could be artificially inflated due to sequencing errors and chimeras, we analyzed the alpha and beta diversity of the mock community data at different phases of the sequence curation pipeline (Fig. 4).	[('PMC6531881', 'R05000', 38, 49, 'polymerases')]	['Because', 'the', 'variation', 'in', 'bias', 'between', 'polymer', '##ases', 'and', 'across', 'rounds', 'of', 'PC', '##R', 'could', 'be', 'artificial', '##ly', 'in', '##f', '##lated', 'due', 'to', 'se', '##quencing', 'errors', 'and', 'ch', '##ime', '##ras', ',', 'we', 'analyzed', 'the', 'alpha', 'and', 'beta', 'diversity', 'of', 'the', 'mock', 'community', 'data', 'at', 'different', 'phases', 'of', 'the', 'sequence', 'cu', '##ration', 'pipeline', '(', 'Fi', '##g', '.', '4', ')', '.']	[0, 8, 12, 22, 25, 30, 38, 45, 50, 54, 61, 68, 71, 73, 75, 81, 84, 94, 97, 99, 100, 106, 110, 113, 115, 124, 131, 135, 137, 140, 143, 145, 148, 157, 161, 167, 171, 176, 186, 189, 193, 198, 208, 213, 216, 226, 233, 236, 240, 249, 251, 258, 267, 268, 270, 271, 273, 274, 275]	[7, 11, 21, 24, 29, 37, 45, 49, 53, 60, 67, 70, 73, 74, 80, 83, 94, 96, 99, 100, 105, 109, 112, 115, 123, 130, 134, 137, 140, 143, 144, 147, 156, 160, 166, 170, 175, 185, 188, 192, 197, 207, 212, 215, 225, 232, 235, 239, 248, 251, 257, 266, 268, 270, 271, 272, 274, 275, 276]	['Because', 'the', 'variation', 'in', 'bias', 'between', 'polymerases', 'and', 'across', 'rounds', 'of', 'PCR', 'could', 'be', 'artificially', 'inflated', 'due', 'to', 'sequencing', 'errors', 'and', 'chimeras', ',', 'we', 'analyzed', 'the', 'alpha', 'and', 'beta', 'diversity', 'of', 'the', 'mock', 'community', 'data', 'at', 'different', 'phases', 'of', 'the', 'sequence', 'curation', 'pipeline', '(', 'Fig', '.', '4', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 2, 3, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Samples positive for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) by polymerase chain reaction and culture underwent 16S rRNA gene sequence analysis; relative abundance of the operational taxonomic unit containing KPC-Kp was determined.	[]	['Sam', '##ples', 'positive', 'for', 'K', '##le', '##bs', '##iel', '##la', 'pneumonia', '##e', 'car', '##ba', '##pen', '##ema', '##se', '-', 'producing', 'K', '##le', '##bs', '##iel', '##la', 'pneumonia', '##e', '(', 'K', '##PC', '-', 'K', '##p', ')', 'by', 'polymer', '##ase', 'chain', 'reaction', 'and', 'culture', 'underwent', '16', '##S', 'r', '##RNA', 'gene', 'sequence', 'analysis', ';', 'relative', 'abundance', 'of', 'the', 'operational', 'tax', '##ono', '##mic', 'unit', 'containing', 'K', '##PC', '-', 'K', '##p', 'was', 'determined', '.']	[0, 3, 8, 17, 21, 22, 24, 26, 29, 32, 41, 43, 46, 48, 51, 54, 56, 57, 67, 68, 70, 72, 75, 78, 87, 89, 90, 91, 93, 94, 95, 96, 98, 101, 108, 112, 118, 127, 131, 139, 149, 151, 153, 154, 158, 163, 172, 180, 182, 191, 201, 204, 208, 220, 223, 226, 230, 235, 246, 247, 249, 250, 251, 253, 257, 267]	[3, 7, 16, 20, 22, 24, 26, 29, 31, 41, 42, 46, 48, 51, 54, 56, 57, 66, 68, 70, 72, 75, 77, 87, 88, 90, 91, 93, 94, 95, 96, 97, 100, 108, 111, 117, 126, 130, 138, 148, 151, 152, 154, 157, 162, 171, 180, 181, 190, 200, 203, 207, 219, 223, 226, 229, 234, 245, 247, 249, 250, 251, 252, 256, 267, 268]	['Samples', 'positive', 'for', 'Klebsiella', 'pneumoniae', 'carbapenemase', '-', 'producing', 'Klebsiella', 'pneumoniae', '(', 'KPC-Kp', ')', 'by', 'polymerase', 'chain', 'reaction', 'and', 'culture', 'underwent', '16S', 'rRNA', 'gene', 'sequence', 'analysis', ';', 'relative', 'abundance', 'of', 'the', 'operational', 'taxonomic', 'unit', 'containing', 'KPC-Kp', 'was', 'determined', '.']	[2, 1, 1, 5, 2, 5, 1, 1, 5, 2, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All rectal swab samples were screened for KPC-Kp by polymerase chain reaction (PCR)	[('PMC6541703', 'M01000', 52, 62, 'polymerase')]	['All', 're', '##ct', '##al', 's', '##wab', 'samples', 'were', 'screened', 'for', 'K', '##PC', '-', 'K', '##p', 'by', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')']	[0, 4, 6, 8, 11, 12, 16, 24, 29, 38, 42, 43, 45, 46, 47, 49, 52, 59, 63, 69, 78, 79, 81, 82]	[3, 6, 8, 10, 12, 15, 23, 28, 37, 41, 43, 45, 46, 47, 48, 51, 59, 62, 68, 77, 79, 81, 82, 83]	['All', 'rectal', 'swab', 'samples', 'were', 'screened', 'for', 'KPC-Kp', 'by', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')']	[1, 3, 2, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Mucoid, lactose-positive, oxidase-negative colonies underwent identification to the species level and were determined to be resistant to carbapenems by the MicroScan Walkaway System (Beckman Coulter, Indianapolis, IN).	[]	['Mu', '##co', '##id', ',', 'la', '##ct', '##ose', '-', 'positive', ',', 'o', '##xi', '##das', '##e', '-', 'negative', 'colonies', 'underwent', 'identification', 'to', 'the', 'species', 'level', 'and', 'were', 'determined', 'to', 'be', 'resistant', 'to', 'car', '##ba', '##pen', '##ems', 'by', 'the', 'Micro', '##S', '##can', 'Walk', '##away', 'System', '(', 'Beck', '##man', 'Co', '##ulter', ',', 'Indianapolis', ',', 'IN', ')', '.']	[0, 2, 4, 6, 8, 10, 12, 15, 16, 24, 26, 27, 29, 32, 33, 34, 43, 52, 62, 77, 80, 84, 92, 98, 102, 107, 118, 121, 124, 134, 137, 140, 142, 145, 149, 152, 156, 161, 162, 166, 170, 175, 182, 183, 187, 191, 193, 198, 200, 212, 214, 216, 217]	[2, 4, 6, 7, 10, 12, 15, 16, 24, 25, 27, 29, 32, 33, 34, 42, 51, 61, 76, 79, 83, 91, 97, 101, 106, 117, 120, 123, 133, 136, 140, 142, 145, 148, 151, 155, 161, 162, 165, 170, 174, 181, 183, 187, 190, 193, 198, 199, 212, 213, 216, 217, 218]	['Mucoid', ',', 'lactose', '-', 'positive', ',', 'oxidase', '-', 'negative', 'colonies', 'underwent', 'identification', 'to', 'the', 'species', 'level', 'and', 'were', 'determined', 'to', 'be', 'resistant', 'to', 'carbapenems', 'by', 'the', 'MicroScan', 'Walkaway', 'System', '(', 'Beckman', 'Coulter', ',', 'Indianapolis', ',', 'IN', ')', '.']	[3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 2, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The V4 region of the bacterial 16S rRNA gene was amplified by quantitative real-time polymerase chain reaction (qPCR) with the bar-coded primers V4F (5′-GTGTGYCAGCMGCCGCGGTAA-3′) and V4R (5′-CCGGACTACNVGGGTWTCTAAT-3′) using a LightCycler 480 II real-time fluorescence quantitative PCR system (Roche Diagnostics Ltd., Switzerland).	[('PMC6544929', 'M02000', 85, 95, 'polymerase')]	['The', 'V', '##4', 'region', 'of', 'the', 'bacterial', '16', '##S', 'r', '##RNA', 'gene', 'was', 'am', '##plified', 'by', 'quantitative', 'real', '-', 'time', 'polymer', '##ase', 'chain', 'reaction', '(', 'q', '##PC', '##R', ')', 'with', 'the', 'bar', '-', 'coded', 'prime', '##rs', 'V', '##4', '##F', '(', '5', '′', '-', 'GT', '##G', '##T', '##G', '##Y', '##CA', '##GC', '##MG', '##CC', '##GC', '##G', '##G', '##TA', '##A', '-', '3', '′', ')', 'and', 'V', '##4', '##R', '(', '5', '′', '-', 'CC', '##G', '##GA', '##CT', '##AC', '##N', '##V', '##G', '##G', '##G', '##T', '##W', '##TC', '##TA', '##AT', '-', '3', '′', ')', 'using', 'a', 'Light', '##C', '##ycle', '##r', '480', 'II', 'real', '-', 'time', 'flu', '##ores', '##cence', 'quantitative', 'PC', '##R', 'system', '(', 'Roche', 'Di', '##ag', '##nos', '##tics', 'Ltd', '.', ',', 'Switzerland', ')', '.']	[0, 4, 5, 7, 14, 17, 21, 31, 33, 35, 36, 40, 45, 49, 51, 59, 62, 75, 79, 80, 85, 92, 96, 102, 111, 112, 113, 115, 116, 118, 123, 127, 130, 131, 137, 142, 145, 146, 147, 149, 150, 151, 152, 153, 155, 156, 157, 158, 159, 161, 163, 165, 167, 169, 170, 171, 173, 174, 175, 176, 177, 179, 183, 184, 185, 187, 188, 189, 190, 191, 193, 194, 196, 198, 200, 201, 202, 203, 204, 205, 206, 207, 209, 211, 213, 214, 215, 216, 218, 224, 226, 231, 232, 236, 238, 242, 245, 249, 250, 255, 258, 262, 268, 281, 283, 285, 292, 293, 299, 301, 303, 306, 311, 314, 315, 317, 328, 329]	[3, 5, 6, 13, 16, 20, 30, 33, 34, 36, 39, 44, 48, 51, 58, 61, 74, 79, 80, 84, 92, 95, 101, 110, 112, 113, 115, 116, 117, 122, 126, 130, 131, 136, 142, 144, 146, 147, 148, 150, 151, 152, 153, 155, 156, 157, 158, 159, 161, 163, 165, 167, 169, 170, 171, 173, 174, 175, 176, 177, 178, 182, 184, 185, 186, 188, 189, 190, 191, 193, 194, 196, 198, 200, 201, 202, 203, 204, 205, 206, 207, 209, 211, 213, 214, 215, 216, 217, 223, 225, 231, 232, 236, 237, 241, 244, 249, 250, 254, 258, 262, 267, 280, 283, 284, 291, 293, 298, 301, 303, 306, 310, 314, 315, 316, 328, 329, 330]	['The', 'V4', 'region', 'of', 'the', 'bacterial', '16S', 'rRNA', 'gene', 'was', 'amplified', 'by', 'quantitative', 'real', '-', 'time', 'polymerase', 'chain', 'reaction', '(', 'qPCR', ')', 'with', 'the', 'bar', '-', 'coded', 'primers', 'V4F', '(', '5′-GTGTGYCAGCMGCCGCGGTAA-3′', ')', 'and', 'V4R', '(', '5′-CCGGACTACNVGGGTWTCTAAT-3′', ')', 'using', 'a', 'LightCycler', '480', 'II', 'real', '-', 'time', 'fluorescence', 'quantitative', 'PCR', 'system', '(', 'Roche', 'Diagnostics', 'Ltd', '.', ',', 'Switzerland', ')', '.']	[1, 2, 1, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 3, 1, 20, 1, 1, 3, 1, 21, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Acetate can be synthesised by a number of enteric bacteria52 mainly via the CoA-transferase pathway, involving the combined activities of phosphotransacetylase (PTA) and acetate kinase (AckA).53 Acetate production in healthy controls was positively correlated with the relative abundance of Anaerostipes and Dorea genera; taxa that were substantially less prevalent in post-fermentation CF microbiota.	[]	['Ace', '##tate', 'can', 'be', 'synthesis', '##ed', 'by', 'a', 'number', 'of', 'enter', '##ic', 'bacteria', '##5', '##2', 'mainly', 'via', 'the', 'Co', '##A', '-', 'transfer', '##ase', 'pathway', ',', 'involving', 'the', 'combined', 'activities', 'of', 'p', '##hos', '##ph', '##ot', '##ran', '##sace', '##ty', '##lase', '(', 'PT', '##A', ')', 'and', 'ace', '##tate', 'kinase', '(', 'A', '##ck', '##A', ')', '.', '53', 'Ace', '##tate', 'production', 'in', 'healthy', 'controls', 'was', 'positively', 'correlated', 'with', 'the', 'relative', 'abundance', 'of', 'Ana', '##ero', '##st', '##ip', '##es', 'and', 'Do', '##rea', 'genera', ';', 'taxa', 'that', 'were', 'substantially', 'less', 'prevalent', 'in', 'post', '-', 'f', '##er', '##mentation', 'CF', 'micro', '##bio', '##ta', '.']	[0, 3, 8, 12, 15, 24, 27, 30, 32, 39, 42, 47, 50, 58, 59, 61, 68, 72, 76, 78, 79, 80, 88, 92, 99, 101, 111, 115, 124, 135, 138, 139, 142, 144, 146, 149, 153, 155, 160, 161, 163, 164, 166, 170, 173, 178, 185, 186, 187, 189, 190, 191, 192, 195, 198, 203, 214, 217, 225, 234, 238, 249, 260, 265, 269, 278, 288, 291, 294, 297, 299, 301, 304, 308, 310, 314, 320, 322, 327, 332, 337, 351, 356, 366, 369, 373, 374, 375, 377, 387, 390, 395, 398, 400]	[3, 7, 11, 14, 24, 26, 29, 31, 38, 41, 47, 49, 58, 59, 60, 67, 71, 75, 78, 79, 80, 88, 91, 99, 100, 110, 114, 123, 134, 137, 139, 142, 144, 146, 149, 153, 155, 159, 161, 163, 164, 165, 169, 173, 177, 184, 186, 187, 189, 190, 191, 192, 194, 198, 202, 213, 216, 224, 233, 237, 248, 259, 264, 268, 277, 287, 290, 294, 297, 299, 301, 303, 307, 310, 313, 320, 321, 326, 331, 336, 350, 355, 365, 368, 373, 374, 375, 377, 386, 389, 395, 398, 400, 401]	['Acetate', 'can', 'be', 'synthesised', 'by', 'a', 'number', 'of', 'enteric', 'bacteria52', 'mainly', 'via', 'the', 'CoA-transferase', 'pathway', ',', 'involving', 'the', 'combined', 'activities', 'of', 'phosphotransacetylase', '(', 'PTA', ')', 'and', 'acetate', 'kinase', '(AckA).53', 'Acetate', 'production', 'in', 'healthy', 'controls', 'was', 'positively', 'correlated', 'with', 'the', 'relative', 'abundance', 'of', 'Anaerostipes', 'and', 'Dorea', 'genera', ';', 'taxa', 'that', 'were', 'substantially', 'less', 'prevalent', 'in', 'post', '-', 'fermentation', 'CF', 'microbiota', '.']	[2, 1, 1, 2, 1, 1, 1, 1, 2, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 8, 1, 2, 1, 1, 2, 1, 7, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A polysaccharide lyase AlyP1400, with high activity against alginate substrate, has been purified from marine bacterium Pseudoalteromonas sp. 1400.	[('PMC6562671', 'C00000', 2, 22, 'polysaccharide lyase')]	['A', 'p', '##oly', '##sa', '##cc', '##hari', '##de', 'l', '##yas', '##e', 'Al', '##y', '##P', '##14', '##00', ',', 'with', 'high', 'activity', 'against', 'al', '##gin', '##ate', 'substrate', ',', 'has', 'been', 'pu', '##rified', 'from', 'marine', 'bacterium', 'P', '##se', '##udo', '##al', '##tero', '##mona', '##s', 's', '##p', '.', '1400', '.']	[0, 2, 3, 6, 8, 10, 14, 17, 18, 21, 23, 25, 26, 27, 29, 31, 33, 38, 43, 52, 60, 62, 65, 69, 78, 80, 84, 89, 91, 98, 103, 110, 120, 121, 123, 126, 128, 132, 136, 138, 139, 140, 142, 146]	[1, 3, 6, 8, 10, 14, 16, 18, 21, 22, 25, 26, 27, 29, 31, 32, 37, 42, 51, 59, 62, 65, 68, 78, 79, 83, 88, 91, 97, 102, 109, 119, 121, 123, 126, 128, 132, 136, 137, 139, 140, 141, 146, 147]	['A', 'polysaccharide', 'lyase', 'AlyP1400', ',', 'with', 'high', 'activity', 'against', 'alginate', 'substrate', ',', 'has', 'been', 'purified', 'from', 'marine', 'bacterium', 'Pseudoalteromonas', 'sp', '.', '1400', '.']	[1, 6, 3, 5, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 7, 2, 1, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This enzyme had a molecular mass at 23 KDa and revealed a broad pH range for high enzyme activity and thermo-stability with a bifunctional lyase activity for both poly-M and poly-G degradation.	[('PMC6562671', 'C00001', 139, 144, 'lyase')]	['This', 'enzyme', 'had', 'a', 'molecular', 'mass', 'at', '23', 'K', '##D', '##a', 'and', 'revealed', 'a', 'broad', 'pH', 'range', 'for', 'high', 'enzyme', 'activity', 'and', 'the', '##rm', '##o', '-', 'stability', 'with', 'a', 'bi', '##function', '##al', 'l', '##yas', '##e', 'activity', 'for', 'both', 'p', '##oly', '-', 'M', 'and', 'p', '##oly', '-', 'G', 'degradation', '.']	[0, 5, 12, 16, 18, 28, 33, 36, 39, 40, 41, 43, 47, 56, 58, 64, 67, 73, 77, 82, 89, 98, 102, 105, 107, 108, 109, 119, 124, 126, 128, 136, 139, 140, 143, 145, 154, 158, 163, 164, 167, 168, 170, 174, 175, 178, 179, 181, 192]	[4, 11, 15, 17, 27, 32, 35, 38, 40, 41, 42, 46, 55, 57, 63, 66, 72, 76, 81, 88, 97, 101, 105, 107, 108, 109, 118, 123, 125, 128, 136, 138, 140, 143, 144, 153, 157, 162, 164, 167, 168, 169, 173, 175, 178, 179, 180, 192, 193]	['This', 'enzyme', 'had', 'a', 'molecular', 'mass', 'at', '23', 'KDa', 'and', 'revealed', 'a', 'broad', 'pH', 'range', 'for', 'high', 'enzyme', 'activity', 'and', 'thermo', '-', 'stability', 'with', 'a', 'bifunctional', 'lyase', 'activity', 'for', 'both', 'poly-M', 'and', 'poly-G', 'degradation', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 3, 1, 1, 1, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
AlyP1400 efficiently diminished P. aeruginosa PA14 biofilms when combined with conventional antibiotic, as the biofilm thickness, biovolume and surface area were reduced after treatment with carbenicillin or ciprofloxacin combined with the lyase enzyme.	[('PMC6562671', 'C00002', 240, 245, 'lyase')]	['Al', '##y', '##P', '##14', '##00', 'efficiently', 'diminished', 'P', '.', 'a', '##er', '##ug', '##ino', '##sa', 'PA', '##14', 'bio', '##film', '##s', 'when', 'combined', 'with', 'conventional', 'anti', '##biotic', ',', 'as', 'the', 'bio', '##film', 'thickness', ',', 'bio', '##vo', '##lume', 'and', 'surface', 'area', 'were', 'reduced', 'after', 'treatment', 'with', 'car', '##ben', '##ici', '##llin', 'or', 'c', '##ip', '##ro', '##f', '##lo', '##xa', '##cin', 'combined', 'with', 'the', 'l', '##yas', '##e', 'enzyme', '.']	[0, 2, 3, 4, 6, 9, 21, 32, 33, 35, 36, 38, 40, 43, 46, 48, 51, 54, 58, 60, 65, 74, 79, 92, 96, 102, 104, 107, 111, 114, 119, 128, 130, 133, 135, 140, 144, 152, 157, 162, 170, 176, 186, 191, 194, 197, 200, 205, 208, 209, 211, 213, 214, 216, 218, 222, 231, 236, 240, 241, 244, 246, 252]	[2, 3, 4, 6, 8, 20, 31, 33, 34, 36, 38, 40, 43, 45, 48, 50, 54, 58, 59, 64, 73, 78, 91, 96, 102, 103, 106, 110, 114, 118, 128, 129, 133, 135, 139, 143, 151, 156, 161, 169, 175, 185, 190, 194, 197, 200, 204, 207, 209, 211, 213, 214, 216, 218, 221, 230, 235, 239, 241, 244, 245, 252, 253]	['AlyP1400', 'efficiently', 'diminished', 'P', '.', 'aeruginosa', 'PA14', 'biofilms', 'when', 'combined', 'with', 'conventional', 'antibiotic', ',', 'as', 'the', 'biofilm', 'thickness', ',', 'biovolume', 'and', 'surface', 'area', 'were', 'reduced', 'after', 'treatment', 'with', 'carbenicillin', 'or', 'ciprofloxacin', 'combined', 'with', 'the', 'lyase', 'enzyme', '.']	[5, 1, 1, 1, 1, 5, 2, 3, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 7, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Recently, alginate lyase activity received much attention, because the alginate enzymatic degradation expands the potential application of this polysaccharide, not only through the industrial applications, but also for curing life threatening infections	[('PMC6562671', 'D01000', 10, 24, 'alginate lyase')]	['Recently', ',', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', 'received', 'much', 'attention', ',', 'because', 'the', 'al', '##gin', '##ate', 'en', '##zy', '##matic', 'degradation', 'expands', 'the', 'potential', 'application', 'of', 'this', 'p', '##oly', '##sa', '##cc', '##hari', '##de', ',', 'not', 'only', 'through', 'the', 'industrial', 'applications', ',', 'but', 'also', 'for', 'cu', '##ring', 'life', 'threatening', 'infections']	[0, 8, 10, 12, 15, 19, 20, 23, 25, 34, 43, 48, 57, 59, 67, 71, 73, 76, 80, 82, 84, 90, 102, 110, 114, 124, 136, 139, 144, 145, 148, 150, 152, 156, 158, 160, 164, 169, 177, 181, 192, 204, 206, 210, 215, 219, 221, 226, 231, 243]	[8, 9, 12, 15, 18, 20, 23, 24, 33, 42, 47, 57, 58, 66, 70, 73, 76, 79, 82, 84, 89, 101, 109, 113, 123, 135, 138, 143, 145, 148, 150, 152, 156, 158, 159, 163, 168, 176, 180, 191, 204, 205, 209, 214, 218, 221, 225, 230, 242, 253]	['Recently', ',', 'alginate', 'lyase', 'activity', 'received', 'much', 'attention', ',', 'because', 'the', 'alginate', 'enzymatic', 'degradation', 'expands', 'the', 'potential', 'application', 'of', 'this', 'polysaccharide', ',', 'not', 'only', 'through', 'the', 'industrial', 'applications', ',', 'but', 'also', 'for', 'curing', 'life', 'threatening', 'infections']	[1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Extracting alginate lyase enzymes from marine bacteria that possessed alginate depolymerization activity could shift chronic infection treatment strategies.	[]	['Extra', '##cting', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'enzymes', 'from', 'marine', 'bacteria', 'that', 'possessed', 'al', '##gin', '##ate', 'de', '##pol', '##yme', '##riz', '##ation', 'activity', 'could', 'shift', 'chronic', 'infection', 'treatment', 'strategies', '.']	[0, 5, 11, 13, 16, 20, 21, 24, 26, 34, 39, 46, 55, 60, 70, 72, 75, 79, 81, 84, 87, 90, 96, 105, 111, 117, 125, 135, 145, 155]	[5, 10, 13, 16, 19, 21, 24, 25, 33, 38, 45, 54, 59, 69, 72, 75, 78, 81, 84, 87, 90, 95, 104, 110, 116, 124, 134, 144, 155, 156]	['Extracting', 'alginate', 'lyase', 'enzymes', 'from', 'marine', 'bacteria', 'that', 'possessed', 'alginate', 'depolymerization', 'activity', 'could', 'shift', 'chronic', 'infection', 'treatment', 'strategies', '.']	[2, 3, 3, 1, 1, 1, 1, 1, 1, 3, 5, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This is due to the alginate lyase activity, which degrades the alginate to un-saturated uronic acid-containing oligosaccharides via β-elimination of 1,4-glycosidic [42,43].	[]	['This', 'is', 'due', 'to', 'the', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', ',', 'which', 'de', '##grade', '##s', 'the', 'al', '##gin', '##ate', 'to', 'un', '-', 'saturated', 'u', '##ronic', 'acid', '-', 'containing', 'o', '##li', '##gos', '##ac', '##cha', '##ride', '##s', 'via', 'β', '-', 'elimination', 'of', '1', ',', '4', '-', 'g', '##ly', '##cos', '##id', '##ic', '[', '42', ',', '43', ']', '.']	[0, 5, 8, 12, 15, 19, 21, 24, 28, 29, 32, 34, 42, 44, 50, 52, 57, 59, 63, 65, 68, 72, 75, 77, 78, 88, 89, 95, 99, 100, 111, 112, 114, 117, 119, 122, 126, 128, 132, 133, 134, 146, 149, 150, 151, 152, 153, 154, 156, 159, 161, 164, 165, 167, 168, 170, 171]	[4, 7, 11, 14, 18, 21, 24, 27, 29, 32, 33, 42, 43, 49, 52, 57, 58, 62, 65, 68, 71, 74, 77, 78, 87, 89, 94, 99, 100, 110, 112, 114, 117, 119, 122, 126, 127, 131, 133, 134, 145, 148, 150, 151, 152, 153, 154, 156, 159, 161, 163, 165, 167, 168, 170, 171, 172]	['This', 'is', 'due', 'to', 'the', 'alginate', 'lyase', 'activity', ',', 'which', 'degrades', 'the', 'alginate', 'to', 'un', '-', 'saturated', 'uronic', 'acid', '-', 'containing', 'oligosaccharides', 'via', 'β-elimination', 'of', '1', ',', '4-glycosidic', '[', '42', ',', '43', ']', '.']	[1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 7, 1, 3, 1, 1, 1, 7, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Targeting mucoid biofilms with the alginate lyase enzymatic activity can reduce viscosity in clinical strains, and in CF specimens, thereby increasing the phagocytosis activities and enhance the antipseudomonal antibiotics’ effects.	[]	['Target', '##ing', 'm', '##uc', '##oid', 'bio', '##film', '##s', 'with', 'the', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'en', '##zy', '##matic', 'activity', 'can', 'reduce', 'v', '##isco', '##sity', 'in', 'clinical', 'strains', ',', 'and', 'in', 'CF', 'specimens', ',', 'thereby', 'increasing', 'the', 'p', '##ha', '##go', '##cy', '##tosis', 'activities', 'and', 'enhance', 'the', 'anti', '##pse', '##udo', '##mona', '##l', 'anti', '##biotics', '’', 'effects', '.']	[0, 6, 10, 11, 13, 17, 20, 24, 26, 31, 35, 37, 40, 44, 45, 48, 50, 52, 54, 60, 69, 73, 80, 81, 85, 90, 93, 102, 109, 111, 115, 118, 121, 130, 132, 140, 151, 155, 156, 158, 160, 162, 168, 179, 183, 191, 195, 199, 202, 205, 209, 211, 215, 222, 224, 231]	[6, 9, 11, 13, 16, 20, 24, 25, 30, 34, 37, 40, 43, 45, 48, 49, 52, 54, 59, 68, 72, 79, 81, 85, 89, 92, 101, 109, 110, 114, 117, 120, 130, 131, 139, 150, 154, 156, 158, 160, 162, 167, 178, 182, 190, 194, 199, 202, 205, 209, 210, 215, 222, 223, 231, 232]	['Targeting', 'mucoid', 'biofilms', 'with', 'the', 'alginate', 'lyase', 'enzymatic', 'activity', 'can', 'reduce', 'viscosity', 'in', 'clinical', 'strains', ',', 'and', 'in', 'CF', 'specimens', ',', 'thereby', 'increasing', 'the', 'phagocytosis', 'activities', 'and', 'enhance', 'the', 'antipseudomonal', 'antibiotics', '’', 'effects', '.']	[2, 3, 3, 1, 1, 3, 3, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 5, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using the purified alginate lyase of Pseudoalteromonas sp. 1400 under static and dynamic conditions against P. aeruginosa biofilms on polystyrene and glass surfaces, it was revealed that AlyP1400 impaired biofilm development, compared to the non-treated biofilms and led to subsequent biofilm detachment.	[('PMC6562671', 'D02000', 19, 33, 'alginate lyase')]	['Using', 'the', 'pu', '##rified', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'of', 'P', '##se', '##udo', '##al', '##tero', '##mona', '##s', 's', '##p', '.', '1400', 'under', 'static', 'and', 'dynamic', 'conditions', 'against', 'P', '.', 'a', '##er', '##ug', '##ino', '##sa', 'bio', '##film', '##s', 'on', 'p', '##oly', '##sty', '##rene', 'and', 'glass', 'surfaces', ',', 'it', 'was', 'revealed', 'that', 'Al', '##y', '##P', '##14', '##00', 'impaired', 'bio', '##film', 'development', ',', 'compared', 'to', 'the', 'non', '-', 'treated', 'bio', '##film', '##s', 'and', 'led', 'to', 'subsequent', 'bio', '##film', 'detachment', '.']	[0, 6, 10, 12, 19, 21, 24, 28, 29, 32, 34, 37, 38, 40, 43, 45, 49, 53, 55, 56, 57, 59, 64, 70, 77, 81, 89, 100, 108, 109, 111, 112, 114, 116, 119, 122, 125, 129, 131, 134, 135, 138, 141, 146, 150, 156, 164, 166, 169, 173, 182, 187, 189, 190, 191, 193, 196, 205, 208, 213, 224, 226, 235, 238, 242, 245, 246, 254, 257, 261, 263, 267, 271, 274, 285, 288, 293, 303]	[5, 9, 12, 18, 21, 24, 27, 29, 32, 33, 36, 38, 40, 43, 45, 49, 53, 54, 56, 57, 58, 63, 69, 76, 80, 88, 99, 107, 109, 110, 112, 114, 116, 119, 121, 125, 129, 130, 133, 135, 138, 141, 145, 149, 155, 164, 165, 168, 172, 181, 186, 189, 190, 191, 193, 195, 204, 208, 212, 224, 225, 234, 237, 241, 245, 246, 253, 257, 261, 262, 266, 270, 273, 284, 288, 292, 303, 304]	['Using', 'the', 'purified', 'alginate', 'lyase', 'of', 'Pseudoalteromonas', 'sp', '.', '1400', 'under', 'static', 'and', 'dynamic', 'conditions', 'against', 'P', '.', 'aeruginosa', 'biofilms', 'on', 'polystyrene', 'and', 'glass', 'surfaces', ',', 'it', 'was', 'revealed', 'that', 'AlyP1400', 'impaired', 'biofilm', 'development', ',', 'compared', 'to', 'the', 'non', '-', 'treated', 'biofilms', 'and', 'led', 'to', 'subsequent', 'biofilm', 'detachment', '.']	[1, 1, 2, 3, 3, 1, 7, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
[29], DNase (NucB) that hydrolyzes the eDNA within the extracellular matrix [30], and glycoside hydrolase that hydrolyzes the biofilm exopolysaccharide [31] have all been shown to act against P. aeruginosa biofilm.	[]	['[', '29', ']', ',', 'D', '##N', '##ase', '(', 'N', '##uc', '##B', ')', 'that', 'h', '##ydro', '##ly', '##zes', 'the', 'e', '##D', '##NA', 'within', 'the', 'extra', '##cellular', 'matrix', '[', '30', ']', ',', 'and', 'g', '##ly', '##cos', '##ide', 'h', '##ydro', '##lase', 'that', 'h', '##ydro', '##ly', '##zes', 'the', 'bio', '##film', 'ex', '##op', '##oly', '##sa', '##cc', '##hari', '##de', '[', '31', ']', 'have', 'all', 'been', 'shown', 'to', 'act', 'against', 'P', '.', 'a', '##er', '##ug', '##ino', '##sa', 'bio', '##film', '.']	[0, 1, 3, 4, 6, 7, 8, 12, 13, 14, 16, 17, 19, 24, 25, 29, 31, 35, 39, 40, 41, 44, 51, 55, 60, 69, 76, 77, 79, 80, 82, 86, 87, 89, 92, 96, 97, 101, 106, 111, 112, 116, 118, 122, 126, 129, 134, 136, 138, 141, 143, 145, 149, 152, 153, 155, 157, 162, 166, 171, 177, 180, 184, 192, 193, 195, 196, 198, 200, 203, 206, 209, 213]	[1, 3, 4, 5, 7, 8, 11, 13, 14, 16, 17, 18, 23, 25, 29, 31, 34, 38, 40, 41, 43, 50, 54, 60, 68, 75, 77, 79, 80, 81, 85, 87, 89, 92, 95, 97, 101, 105, 110, 112, 116, 118, 121, 125, 129, 133, 136, 138, 141, 143, 145, 149, 151, 153, 155, 156, 161, 165, 170, 176, 179, 183, 191, 193, 194, 196, 198, 200, 203, 205, 209, 213, 214]	['[', '29', ']', ',', 'DNase', '(', 'NucB', ')', 'that', 'hydrolyzes', 'the', 'eDNA', 'within', 'the', 'extracellular', 'matrix', '[', '30', ']', ',', 'and', 'glycoside', 'hydrolase', 'that', 'hydrolyzes', 'the', 'biofilm', 'exopolysaccharide', '[', '31', ']', 'have', 'all', 'been', 'shown', 'to', 'act', 'against', 'P', '.', 'aeruginosa', 'biofilm', '.']	[1, 1, 1, 1, 3, 1, 3, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 3, 1, 4, 1, 2, 7, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The overproduction of the polysaccharide alginate is the major cause for the mucoid phenotype of P. aeruginosa that is associated with a decline in lung function.	[]	['The', 'over', '##p', '##rod', '##uction', 'of', 'the', 'p', '##oly', '##sa', '##cc', '##hari', '##de', 'al', '##gin', '##ate', 'is', 'the', 'major', 'cause', 'for', 'the', 'm', '##uc', '##oid', 'p', '##hen', '##otype', 'of', 'P', '.', 'a', '##er', '##ug', '##ino', '##sa', 'that', 'is', 'associated', 'with', 'a', 'decline', 'in', 'lung', 'function', '.']	[0, 4, 8, 9, 12, 19, 22, 26, 27, 30, 32, 34, 38, 41, 43, 46, 50, 53, 57, 63, 69, 73, 77, 78, 80, 84, 85, 88, 94, 97, 98, 100, 101, 103, 105, 108, 111, 116, 119, 130, 135, 137, 145, 148, 153, 161]	[3, 8, 9, 12, 18, 21, 25, 27, 30, 32, 34, 38, 40, 43, 46, 49, 52, 56, 62, 68, 72, 76, 78, 80, 83, 85, 88, 93, 96, 98, 99, 101, 103, 105, 108, 110, 115, 118, 129, 134, 136, 144, 147, 152, 161, 162]	['The', 'overproduction', 'of', 'the', 'polysaccharide', 'alginate', 'is', 'the', 'major', 'cause', 'for', 'the', 'mucoid', 'phenotype', 'of', 'P', '.', 'aeruginosa', 'that', 'is', 'associated', 'with', 'a', 'decline', 'in', 'lung', 'function', '.']	[1, 4, 1, 1, 6, 3, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
(GPS coordinates: 44°38′05.3″N 64°01′40.6″W) at 22.5 °C and pH 8.11, were used for culturing bacterial isolates with alginate lyase activity, as follows: 10 ml water was shaken in 90 ml enrichment medium (0.5% peptone, 0.1% yeast extract, 0.5% sodium alginate, 3% NaCl, pH 6.5)	[]	['(', 'GPS', 'coordinates', ':', '44', '##°', '##38', '′', '05', '.', '3', '″', 'N', '64', '##°', '##01', '′', '40', '.', '6', '″', 'W', ')', 'at', '22', '.', '5', '°C', 'and', 'pH', '8', '.', '11', ',', 'were', 'used', 'for', 'cult', '##uring', 'bacterial', 'is', '##olate', '##s', 'with', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', ',', 'as', 'follows', ':', '10', 'm', '##l', 'water', 'was', 'shaken', 'in', '90', 'm', '##l', 'en', '##rich', '##ment', 'medium', '(', '0', '.', '5', '%', 'p', '##ept', '##one', ',', '0', '.', '1', '%', 'yeast', 'extract', ',', '0', '.', '5', '%', 'sodium', 'al', '##gin', '##ate', ',', '3', '%', 'Na', '##C', '##l', ',', 'pH', '6', '.', '5', ')']	[0, 1, 5, 16, 18, 20, 21, 23, 24, 26, 27, 28, 29, 31, 33, 34, 36, 37, 39, 40, 41, 42, 43, 45, 48, 50, 51, 53, 56, 60, 63, 64, 65, 67, 69, 74, 79, 83, 87, 93, 103, 105, 110, 112, 117, 119, 122, 126, 127, 130, 132, 140, 142, 145, 152, 154, 157, 158, 160, 166, 170, 177, 180, 183, 184, 186, 188, 192, 197, 204, 205, 206, 207, 208, 210, 211, 214, 217, 219, 220, 221, 222, 224, 230, 237, 239, 240, 241, 242, 244, 251, 253, 256, 259, 261, 262, 264, 266, 267, 268, 270, 273, 274, 275, 276]	[1, 4, 16, 17, 20, 21, 23, 24, 26, 27, 28, 29, 30, 33, 34, 36, 37, 39, 40, 41, 42, 43, 44, 47, 50, 51, 52, 55, 59, 62, 64, 65, 67, 68, 73, 78, 82, 87, 92, 102, 105, 110, 111, 116, 119, 122, 125, 127, 130, 131, 140, 141, 144, 152, 153, 156, 158, 159, 165, 169, 176, 179, 182, 184, 185, 188, 192, 196, 203, 205, 206, 207, 208, 209, 211, 214, 217, 218, 220, 221, 222, 223, 229, 237, 238, 240, 241, 242, 243, 250, 253, 256, 259, 260, 262, 263, 266, 267, 268, 269, 272, 274, 275, 276, 277]	['(', 'GPS', 'coordinates', ':', '44°38′05.3″N', '64°01′40.6″W', ')', 'at', '22.5', '°C', 'and', 'pH', '8.11', ',', 'were', 'used', 'for', 'culturing', 'bacterial', 'isolates', 'with', 'alginate', 'lyase', 'activity', ',', 'as', 'follows', ':', '10', 'ml', 'water', 'was', 'shaken', 'in', '90', 'ml', 'enrichment', 'medium', '(', '0.5%', 'peptone', ',', '0.1%', 'yeast', 'extract', ',', '0.5%', 'sodium', 'alginate', ',', '3%', 'NaCl', ',', 'pH', '6.5', ')']	[1, 1, 1, 1, 9, 9, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 3, 1, 3, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 3, 1, 1, 4, 3, 1, 4, 1, 1, 1, 4, 1, 3, 1, 2, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacterial colonies with the highest lyase activity in the clear zone assay above (4.2) were selected for testing their alginolytic activity as follows: three milliliter overnight (16–18 h) bacterial culture (OD at 600 nm adjusted to 1.0) was inoculated into a 97 mL fermentation medium (selection medium with 1.8% sodium alginate) and incubated at 28 °C and 150 rpm for 24 h. After the fermentation and centrifugation for 30 min at 12,096× g at 4 °C, cell-free supernatants were filtered through 0.22 µm non-pyrogenic filters and kept at −20 °C.	[('PMC6562671', 'M05000', 36, 41, 'lyase')]	['Ba', '##cter', '##ial', 'colonies', 'with', 'the', 'highest', 'l', '##yas', '##e', 'activity', 'in', 'the', 'clear', 'zone', 'ass', '##ay', 'above', '(', '4', '.', '2', ')', 'were', 'selected', 'for', 'testing', 'their', 'al', '##gin', '##oly', '##tic', 'activity', 'as', 'follows', ':', 'three', 'mill', '##ili', '##ter', 'overnight', '(', '16', '–', '18', 'h', ')', 'bacterial', 'culture', '(', 'O', '##D', 'at', '600', 'nm', 'adjusted', 'to', '1', '.', '0', ')', 'was', 'in', '##oc', '##ulated', 'into', 'a', '97', 'm', '##L', 'f', '##er', '##mentation', 'medium', '(', 'selection', 'medium', 'with', '1', '.', '8', '%', 'sodium', 'al', '##gin', '##ate', ')', 'and', 'in', '##cu', '##bate', '##d', 'at', '28', '°C', 'and', '150', 'rpm', 'for', '24', 'h', '.', 'After', 'the', 'f', '##er', '##mentation', 'and', 'cent', '##ri', '##fu', '##gation', 'for', '30', 'min', 'at', '12', ',', '09', '##6', '##×', 'g', 'at', '4', '°C', ',', 'cell', '-', 'free', 'super', '##nat', '##ants', 'were', 'filtered', 'through', '0', '.', '22', 'µ', '##m', 'non', '-', 'p', '##yr', '##ogenic', 'filters', 'and', 'kept', 'at', '−', '##20', '°C', '.']	[0, 2, 6, 10, 19, 24, 28, 36, 37, 40, 42, 51, 54, 58, 64, 69, 72, 75, 81, 82, 83, 84, 85, 87, 92, 101, 105, 113, 119, 121, 124, 127, 131, 140, 143, 150, 152, 158, 162, 165, 169, 179, 180, 182, 183, 186, 187, 189, 199, 207, 208, 209, 211, 214, 218, 221, 230, 233, 234, 235, 236, 238, 242, 244, 246, 253, 258, 260, 263, 264, 266, 267, 269, 279, 286, 287, 297, 304, 309, 310, 311, 312, 314, 321, 323, 326, 329, 331, 335, 337, 339, 343, 345, 348, 351, 354, 358, 362, 366, 370, 373, 374, 376, 382, 386, 387, 389, 399, 403, 407, 409, 411, 418, 422, 425, 429, 432, 434, 435, 437, 438, 440, 442, 445, 447, 449, 451, 455, 456, 461, 466, 469, 474, 479, 488, 496, 497, 498, 501, 502, 504, 507, 508, 509, 511, 518, 526, 530, 535, 538, 539, 542, 544]	[2, 6, 9, 18, 23, 27, 35, 37, 40, 41, 50, 53, 57, 63, 68, 72, 74, 80, 82, 83, 84, 85, 86, 91, 100, 104, 112, 118, 121, 124, 127, 130, 139, 142, 150, 151, 157, 162, 165, 168, 178, 180, 182, 183, 185, 187, 188, 198, 206, 208, 209, 210, 213, 217, 220, 229, 232, 234, 235, 236, 237, 241, 244, 246, 252, 257, 259, 262, 264, 265, 267, 269, 278, 285, 287, 296, 303, 308, 310, 311, 312, 313, 320, 323, 326, 329, 330, 334, 337, 339, 343, 344, 347, 350, 353, 357, 361, 365, 369, 372, 374, 375, 381, 385, 387, 389, 398, 402, 407, 409, 411, 417, 421, 424, 428, 431, 434, 435, 437, 438, 439, 441, 444, 446, 449, 450, 455, 456, 460, 466, 469, 473, 478, 487, 495, 497, 498, 500, 502, 503, 507, 508, 509, 511, 517, 525, 529, 534, 537, 539, 541, 544, 545]	['Bacterial', 'colonies', 'with', 'the', 'highest', 'lyase', 'activity', 'in', 'the', 'clear', 'zone', 'assay', 'above', '(', '4.2', ')', 'were', 'selected', 'for', 'testing', 'their', 'alginolytic', 'activity', 'as', 'follows', ':', 'three', 'milliliter', 'overnight', '(', '16–', '18', 'h', ')', 'bacterial', 'culture', '(', 'OD', 'at', '600', 'nm', 'adjusted', 'to', '1.0', ')', 'was', 'inoculated', 'into', 'a', '97', 'mL', 'fermentation', 'medium', '(', 'selection', 'medium', 'with', '1.8%', 'sodium', 'alginate', ')', 'and', 'incubated', 'at', '28', '°C', 'and', '150', 'rpm', 'for', '24', 'h', '.', 'After', 'the', 'fermentation', 'and', 'centrifugation', 'for', '30', 'min', 'at', '12', ',', '096×', 'g', 'at', '4', '°C', ',', 'cell', '-', 'free', 'supernatants', 'were', 'filtered', 'through', '0.22', 'µm', 'non', '-', 'pyrogenic', 'filters', 'and', 'kept', 'at', '−20', '°C', '.']	[3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 2, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alginate lyase activities were measured using an absorbance assay at the wavelength of 235 nm.	[('PMC6562671', 'M07000', 0, 14, 'Alginate lyase')]	['Al', '##gin', '##ate', 'l', '##yas', '##e', 'activities', 'were', 'measured', 'using', 'an', 'absorb', '##ance', 'ass', '##ay', 'at', 'the', 'wavelength', 'of', '235', 'nm', '.']	[0, 2, 5, 9, 10, 13, 15, 26, 31, 40, 46, 49, 55, 60, 63, 66, 69, 73, 84, 87, 91, 93]	[2, 5, 8, 10, 13, 14, 25, 30, 39, 45, 48, 55, 59, 63, 65, 68, 72, 83, 86, 90, 93, 94]	['Alginate', 'lyase', 'activities', 'were', 'measured', 'using', 'an', 'absorbance', 'assay', 'at', 'the', 'wavelength', 'of', '235', 'nm', '.']	[3, 3, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The absorbance of sodium alginate solution was increased due to the formation of a carbon-carbon double bond at the end of the product generated from lyase-mediated cleavage of alginate.	[('PMC6562671', 'M07001', 150, 155, 'lyase')]	['The', 'absorb', '##ance', 'of', 'sodium', 'al', '##gin', '##ate', 'solution', 'was', 'increased', 'due', 'to', 'the', 'formation', 'of', 'a', 'carbon', '-', 'carbon', 'double', 'bond', 'at', 'the', 'end', 'of', 'the', 'product', 'generated', 'from', 'l', '##yas', '##e', '-', 'mediated', 'c', '##lea', '##vage', 'of', 'al', '##gin', '##ate', '.']	[0, 4, 10, 15, 18, 25, 27, 30, 34, 43, 47, 57, 61, 64, 68, 78, 81, 83, 89, 90, 97, 104, 109, 112, 116, 120, 123, 127, 135, 145, 150, 151, 154, 155, 156, 165, 166, 169, 174, 177, 179, 182, 185]	[3, 10, 14, 17, 24, 27, 30, 33, 42, 46, 56, 60, 63, 67, 77, 80, 82, 89, 90, 96, 103, 108, 111, 115, 119, 122, 126, 134, 144, 149, 151, 154, 155, 156, 164, 166, 169, 173, 176, 179, 182, 185, 186]	['The', 'absorbance', 'of', 'sodium', 'alginate', 'solution', 'was', 'increased', 'due', 'to', 'the', 'formation', 'of', 'a', 'carbon', '-', 'carbon', 'double', 'bond', 'at', 'the', 'end', 'of', 'the', 'product', 'generated', 'from', 'lyase', '-', 'mediated', 'cleavage', 'of', 'alginate', '.']	[1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to extract sufficient quantities of lyase, we cultured isolate 1400 under different temperatures, covering the range of 10–45 °C, and pHs, covering the range of 4.0–10 in order to determine the optimum culture conditions to purify the enzyme.	[('PMC6562671', 'M10000', 45, 50, 'lyase')]	['In', 'order', 'to', 'extract', 'sufficient', 'quantities', 'of', 'l', '##yas', '##e', ',', 'we', 'culture', '##d', 'is', '##olate', '1400', 'under', 'different', 'temperatures', ',', 'covering', 'the', 'range', 'of', '10', '–', '45', '°C', ',', 'and', 'pH', '##s', ',', 'covering', 'the', 'range', 'of', '4', '.', '0', '–', '10', 'in', 'order', 'to', 'determine', 'the', 'op', '##ti', '##mum', 'culture', 'conditions', 'to', 'pu', '##ri', '##fy', 'the', 'enzyme', '.']	[0, 3, 9, 12, 20, 31, 42, 45, 46, 49, 50, 52, 55, 62, 64, 66, 72, 77, 83, 93, 105, 107, 116, 120, 126, 129, 131, 132, 135, 137, 139, 143, 145, 146, 148, 157, 161, 167, 170, 171, 172, 173, 174, 177, 180, 186, 189, 199, 203, 205, 207, 211, 219, 230, 233, 235, 237, 240, 244, 250]	[2, 8, 11, 19, 30, 41, 44, 46, 49, 50, 51, 54, 62, 63, 66, 71, 76, 82, 92, 105, 106, 115, 119, 125, 128, 131, 132, 134, 137, 138, 142, 145, 146, 147, 156, 160, 166, 169, 171, 172, 173, 174, 176, 179, 185, 188, 198, 202, 205, 207, 210, 218, 229, 232, 235, 237, 239, 243, 250, 251]	['In', 'order', 'to', 'extract', 'sufficient', 'quantities', 'of', 'lyase', ',', 'we', 'cultured', 'isolate', '1400', 'under', 'different', 'temperatures', ',', 'covering', 'the', 'range', 'of', '10–', '45', '°C', ',', 'and', 'pHs', ',', 'covering', 'the', 'range', 'of', '4.0', '–', '10', 'in', 'order', 'to', 'determine', 'the', 'optimum', 'culture', 'conditions', 'to', 'purify', 'the', 'enzyme', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Both the total and specific alginate lyase enzyme activities were measured as described by Zhu and colleagues [59], and the temperature and pH resulting in the highest enzyme activities were utilized for the following purification procedures.	[('PMC6562671', 'M10001', 28, 42, 'alginate lyase')]	['Both', 'the', 'total', 'and', 'specific', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'enzyme', 'activities', 'were', 'measured', 'as', 'described', 'by', 'Zhu', 'and', 'colleagues', '[', '59', ']', ',', 'and', 'the', 'temperature', 'and', 'pH', 'resulting', 'in', 'the', 'highest', 'enzyme', 'activities', 'were', 'utilized', 'for', 'the', 'following', 'pu', '##rification', 'procedures', '.']	[0, 5, 9, 15, 19, 28, 30, 33, 37, 38, 41, 43, 50, 61, 66, 75, 78, 88, 91, 95, 99, 110, 111, 113, 114, 116, 120, 124, 136, 140, 143, 153, 156, 160, 168, 175, 186, 191, 200, 204, 208, 218, 220, 231, 241]	[4, 8, 14, 18, 27, 30, 33, 36, 38, 41, 42, 49, 60, 65, 74, 77, 87, 90, 94, 98, 109, 111, 113, 114, 115, 119, 123, 135, 139, 142, 152, 155, 159, 167, 174, 185, 190, 199, 203, 207, 217, 220, 230, 241, 242]	['Both', 'the', 'total', 'and', 'specific', 'alginate', 'lyase', 'enzyme', 'activities', 'were', 'measured', 'as', 'described', 'by', 'Zhu', 'and', 'colleagues', '[', '59', ']', ',', 'and', 'the', 'temperature', 'and', 'pH', 'resulting', 'in', 'the', 'highest', 'enzyme', 'activities', 'were', 'utilized', 'for', 'the', 'following', 'purification', 'procedures', '.']	[1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alginate lyase thermo-stability was determined by incubating the purified enzyme 60 µg protein/mL with sodium alginate (0.1%) in Tris-HCl buffer (pH 7.0) at different temperature (10–45 °C).	[('PMC6562671', 'M11000', 0, 14, 'Alginate lyase')]	['Al', '##gin', '##ate', 'l', '##yas', '##e', 'the', '##rm', '##o', '-', 'stability', 'was', 'determined', 'by', 'in', '##cu', '##bat', '##ing', 'the', 'pu', '##rified', 'enzyme', '60', 'µ', '##g', 'protein', '/', 'm', '##L', 'with', 'sodium', 'al', '##gin', '##ate', '(', '0', '.', '1', '%', ')', 'in', 'Tri', '##s', '-', 'HC', '##l', 'buffer', '(', 'pH', '7', '.', '0', ')', 'at', 'different', 'temperature', '(', '10', '–', '45', '°C', ')', '.']	[0, 2, 5, 9, 10, 13, 15, 18, 20, 21, 22, 32, 36, 47, 50, 52, 54, 57, 61, 65, 67, 74, 81, 84, 85, 87, 94, 95, 96, 98, 103, 110, 112, 115, 119, 120, 121, 122, 123, 124, 126, 129, 132, 133, 134, 136, 138, 145, 146, 149, 150, 151, 152, 154, 157, 167, 179, 180, 182, 183, 186, 188, 189]	[2, 5, 8, 10, 13, 14, 18, 20, 21, 22, 31, 35, 46, 49, 52, 54, 57, 60, 64, 67, 73, 80, 83, 85, 86, 94, 95, 96, 97, 102, 109, 112, 115, 118, 120, 121, 122, 123, 124, 125, 128, 132, 133, 134, 136, 137, 144, 146, 148, 150, 151, 152, 153, 156, 166, 178, 180, 182, 183, 185, 188, 189, 190]	['Alginate', 'lyase', 'thermo', '-', 'stability', 'was', 'determined', 'by', 'incubating', 'the', 'purified', 'enzyme', '60', 'µg', 'protein', '/', 'mL', 'with', 'sodium', 'alginate', '(', '0.1%', ')', 'in', 'Tris-HCl', 'buffer', '(', 'pH', '7.0', ')', 'at', 'different', 'temperature', '(', '10–', '45', '°C', ')', '.']	[3, 3, 3, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 4, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The purified alginate lyase was resolved on a 10% SDS separating gel using the SDS-PAGE analysis.	[('PMC6562671', 'M12000', 13, 27, 'alginate lyase')]	['The', 'pu', '##rified', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'was', 'resolved', 'on', 'a', '10', '%', 'SD', '##S', 'separating', 'gel', 'using', 'the', 'SD', '##S', '-', 'PA', '##GE', 'analysis', '.']	[0, 4, 6, 13, 15, 18, 22, 23, 26, 28, 32, 41, 44, 46, 48, 50, 52, 54, 65, 69, 75, 79, 81, 82, 83, 85, 88, 96]	[3, 6, 12, 15, 18, 21, 23, 26, 27, 31, 40, 43, 45, 48, 49, 52, 53, 64, 68, 74, 78, 81, 82, 83, 85, 87, 96, 97]	['The', 'purified', 'alginate', 'lyase', 'was', 'resolved', 'on', 'a', '10%', 'SDS', 'separating', 'gel', 'using', 'the', 'SDS-PAGE', 'analysis', '.']	[1, 2, 3, 3, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After confirming PA14 alginate production and AlyP1400 alginate lyase activity on the alginate, the inhibitory effects of AlyP1400 with and without antibiotics was assessed against established biofilms formed in dynamic conditions.	[('PMC6562671', 'M15000', 55, 69, 'alginate lyase')]	['After', 'confirming', 'PA', '##14', 'al', '##gin', '##ate', 'production', 'and', 'Al', '##y', '##P', '##14', '##00', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', 'on', 'the', 'al', '##gin', '##ate', ',', 'the', 'inhibitor', '##y', 'effects', 'of', 'Al', '##y', '##P', '##14', '##00', 'with', 'and', 'without', 'anti', '##biotics', 'was', 'assessed', 'against', 'established', 'bio', '##film', '##s', 'formed', 'in', 'dynamic', 'conditions', '.']	[0, 6, 17, 19, 22, 24, 27, 31, 42, 46, 48, 49, 50, 52, 55, 57, 60, 64, 65, 68, 70, 79, 82, 86, 88, 91, 94, 96, 100, 109, 111, 119, 122, 124, 125, 126, 128, 131, 136, 140, 148, 152, 160, 164, 173, 181, 193, 196, 200, 202, 209, 212, 220, 230]	[5, 16, 19, 21, 24, 27, 30, 41, 45, 48, 49, 50, 52, 54, 57, 60, 63, 65, 68, 69, 78, 81, 85, 88, 91, 94, 95, 99, 109, 110, 118, 121, 124, 125, 126, 128, 130, 135, 139, 147, 152, 159, 163, 172, 180, 192, 196, 200, 201, 208, 211, 219, 230, 231]	['After', 'confirming', 'PA14', 'alginate', 'production', 'and', 'AlyP1400', 'alginate', 'lyase', 'activity', 'on', 'the', 'alginate', ',', 'the', 'inhibitory', 'effects', 'of', 'AlyP1400', 'with', 'and', 'without', 'antibiotics', 'was', 'assessed', 'against', 'established', 'biofilms', 'formed', 'in', 'dynamic', 'conditions', '.']	[1, 1, 2, 3, 1, 1, 5, 3, 3, 1, 1, 1, 3, 1, 1, 2, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A total of 36 bacterial strains with alginate lyase activity were isolated after enrichment on bacterial agar plates containing sodium alginate and selected for 16S rRNA sequencing (GenBank accession numbers MK377259 through MK377294).	[('PMC6562671', 'R00000', 37, 51, 'alginate lyase')]	['A', 'total', 'of', '36', 'bacterial', 'strains', 'with', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', 'were', 'isolated', 'after', 'en', '##rich', '##ment', 'on', 'bacterial', 'a', '##gar', 'plates', 'containing', 'sodium', 'al', '##gin', '##ate', 'and', 'selected', 'for', '16', '##S', 'r', '##RNA', 'se', '##quencing', '(', 'Gen', '##B', '##an', '##k', 'accession', 'numbers', 'M', '##K', '##37', '##7', '##25', '##9', 'through', 'M', '##K', '##37', '##7', '##29', '##4', ')', '.']	[0, 2, 8, 11, 14, 24, 32, 37, 39, 42, 46, 47, 50, 52, 61, 66, 75, 81, 83, 87, 92, 95, 105, 106, 110, 117, 128, 135, 137, 140, 144, 148, 157, 161, 163, 165, 166, 170, 172, 181, 182, 185, 186, 188, 190, 200, 208, 209, 210, 212, 213, 215, 217, 225, 226, 227, 229, 230, 232, 233, 234]	[1, 7, 10, 13, 23, 31, 36, 39, 42, 45, 47, 50, 51, 60, 65, 74, 80, 83, 87, 91, 94, 104, 106, 109, 116, 127, 134, 137, 140, 143, 147, 156, 160, 163, 164, 166, 169, 172, 180, 182, 185, 186, 188, 189, 199, 207, 209, 210, 212, 213, 215, 216, 224, 226, 227, 229, 230, 232, 233, 234, 235]	['A', 'total', 'of', '36', 'bacterial', 'strains', 'with', 'alginate', 'lyase', 'activity', 'were', 'isolated', 'after', 'enrichment', 'on', 'bacterial', 'agar', 'plates', 'containing', 'sodium', 'alginate', 'and', 'selected', 'for', '16S', 'rRNA', 'sequencing', '(', 'GenBank', 'accession', 'numbers', 'MK377259', 'through', 'MK377294', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 2, 2, 1, 4, 1, 1, 6, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The cell-free supernatant of medium that had been used to culture this strain contained a total alginolytic activity of 70.09 ± 1.72 U/mL (Figure 1a) and significantly (P < 0.0001) reduced sodium alginate solution viscosity to 2.23 ± 0.25 centipoise with 90.81% liquefaction after 24 h incubation (Figure 1a), while sodium alginate solution (the blank) viscosity was 24.28 ± 1.12 centipoise (Figure 1b).	[]	['The', 'cell', '-', 'free', 'super', '##nat', '##ant', 'of', 'medium', 'that', 'had', 'been', 'used', 'to', 'culture', 'this', 'strain', 'contained', 'a', 'total', 'al', '##gin', '##oly', '##tic', 'activity', 'of', '70', '.', '09', '±', '1', '.', '72', 'U', '/', 'm', '##L', '(', 'Figure', '1', '##a', ')', 'and', 'significantly', '(', 'P', '<', '0', '.', '000', '##1', ')', 'reduced', 'sodium', 'al', '##gin', '##ate', 'solution', 'v', '##isco', '##sity', 'to', '2', '.', '23', '±', '0', '.', '25', 'cent', '##ip', '##oise', 'with', '90', '.', '81', '%', 'l', '##ique', '##fa', '##ction', 'after', '24', 'h', 'in', '##cu', '##bation', '(', 'Figure', '1', '##a', ')', ',', 'while', 'sodium', 'al', '##gin', '##ate', 'solution', '(', 'the', 'blank', ')', 'v', '##isco', '##sity', 'was', '24', '.', '28', '±', '1', '.', '12', 'cent', '##ip', '##oise', '(', 'Figure', '1', '##b', ')', '.']	[0, 4, 8, 9, 14, 19, 22, 26, 29, 36, 41, 45, 50, 55, 58, 66, 71, 78, 88, 90, 96, 98, 101, 104, 108, 117, 120, 122, 123, 126, 128, 129, 130, 133, 134, 135, 136, 138, 139, 146, 147, 148, 150, 154, 168, 169, 171, 173, 174, 175, 178, 179, 181, 189, 196, 198, 201, 205, 214, 215, 219, 224, 227, 228, 229, 232, 234, 235, 236, 239, 243, 245, 250, 255, 257, 258, 260, 262, 263, 267, 269, 275, 281, 284, 286, 288, 290, 297, 298, 305, 306, 307, 308, 310, 316, 323, 325, 328, 332, 341, 342, 346, 351, 353, 354, 358, 363, 367, 369, 370, 373, 375, 376, 377, 380, 384, 386, 391, 392, 399, 400, 401, 402]	[3, 8, 9, 13, 19, 22, 25, 28, 35, 40, 44, 49, 54, 57, 65, 70, 77, 87, 89, 95, 98, 101, 104, 107, 116, 119, 122, 123, 125, 127, 129, 130, 132, 134, 135, 136, 137, 139, 145, 147, 148, 149, 153, 167, 169, 170, 172, 174, 175, 178, 179, 180, 188, 195, 198, 201, 204, 213, 215, 219, 223, 226, 228, 229, 231, 233, 235, 236, 238, 243, 245, 249, 254, 257, 258, 260, 261, 263, 267, 269, 274, 280, 283, 285, 288, 290, 296, 298, 304, 306, 307, 308, 309, 315, 322, 325, 328, 331, 340, 342, 345, 351, 352, 354, 358, 362, 366, 369, 370, 372, 374, 376, 377, 379, 384, 386, 390, 392, 398, 400, 401, 402, 403]	['The', 'cell', '-', 'free', 'supernatant', 'of', 'medium', 'that', 'had', 'been', 'used', 'to', 'culture', 'this', 'strain', 'contained', 'a', 'total', 'alginolytic', 'activity', 'of', '70.09', '±', '1.72', 'U', '/', 'mL', '(', 'Figure', '1a', ')', 'and', 'significantly', '(', 'P', '<', '0.0001', ')', 'reduced', 'sodium', 'alginate', 'solution', 'viscosity', 'to', '2.23', '±', '0.25', 'centipoise', 'with', '90.81%', 'liquefaction', 'after', '24', 'h', 'incubation', '(', 'Figure', '1a', ')', ',', 'while', 'sodium', 'alginate', 'solution', '(', 'the', 'blank', ')', 'viscosity', 'was', '24.28', '±', '1.12', 'centipoise', '(', 'Figure', '1b', ')', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 3, 1, 3, 1, 3, 3, 1, 4, 4, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 3, 1, 3, 3, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After covering the alginate agar plate with 1 M CaCl2 solution, enzymes acting on poly-mannuronate (poly-M) will show a white halo due to gelation of the degradation products caused by the reaction of lyase with poly-M. Meanwhile, poly-guluronate (poly-G) substrate will show a white ring, due to the depolymerization of alginate to uronic acid.	[]	['After', 'covering', 'the', 'al', '##gin', '##ate', 'a', '##gar', 'plate', 'with', '1', 'M', 'C', '##a', '##C', '##l', '##2', 'solution', ',', 'enzymes', 'acting', 'on', 'p', '##oly', '-', 'man', '##nu', '##rona', '##te', '(', 'p', '##oly', '-', 'M', ')', 'will', 'show', 'a', 'white', 'ha', '##lo', 'due', 'to', 'gel', '##ation', 'of', 'the', 'degradation', 'products', 'caused', 'by', 'the', 'reaction', 'of', 'l', '##yas', '##e', 'with', 'p', '##oly', '-', 'M', '.', 'Meanwhile', ',', 'p', '##oly', '-', 'g', '##ulu', '##rona', '##te', '(', 'p', '##oly', '-', 'G', ')', 'substrate', 'will', 'show', 'a', 'white', 'ring', ',', 'due', 'to', 'the', 'de', '##pol', '##yme', '##riz', '##ation', 'of', 'al', '##gin', '##ate', 'to', 'u', '##ronic', 'acid', '.']	[0, 6, 15, 19, 21, 24, 28, 29, 33, 39, 44, 46, 48, 49, 50, 51, 52, 54, 62, 64, 72, 79, 82, 83, 86, 87, 90, 92, 96, 99, 100, 101, 104, 105, 106, 108, 113, 118, 120, 126, 128, 131, 135, 138, 141, 147, 150, 154, 166, 175, 182, 185, 189, 198, 201, 202, 205, 207, 212, 213, 216, 217, 218, 220, 229, 231, 232, 235, 236, 237, 240, 244, 247, 248, 249, 252, 253, 254, 256, 266, 271, 276, 278, 284, 288, 290, 294, 297, 301, 303, 306, 309, 312, 318, 321, 323, 326, 330, 333, 334, 340, 344]	[5, 14, 18, 21, 24, 27, 29, 32, 38, 43, 45, 47, 49, 50, 51, 52, 53, 62, 63, 71, 78, 81, 83, 86, 87, 90, 92, 96, 98, 100, 101, 104, 105, 106, 107, 112, 117, 119, 125, 128, 130, 134, 137, 141, 146, 149, 153, 165, 174, 181, 184, 188, 197, 200, 202, 205, 206, 211, 213, 216, 217, 218, 219, 229, 230, 232, 235, 236, 237, 240, 244, 246, 248, 249, 252, 253, 254, 255, 265, 270, 275, 277, 283, 288, 289, 293, 296, 300, 303, 306, 309, 312, 317, 320, 323, 326, 329, 332, 334, 339, 344, 345]	['After', 'covering', 'the', 'alginate', 'agar', 'plate', 'with', '1', 'M', 'CaCl2', 'solution', ',', 'enzymes', 'acting', 'on', 'poly', '-', 'mannuronate', '(', 'poly-M', ')', 'will', 'show', 'a', 'white', 'halo', 'due', 'to', 'gelation', 'of', 'the', 'degradation', 'products', 'caused', 'by', 'the', 'reaction', 'of', 'lyase', 'with', 'poly-M', '.', 'Meanwhile', ',', 'poly', '-', 'guluronate', '(', 'poly-G', ')', 'substrate', 'will', 'show', 'a', 'white', 'ring', ',', 'due', 'to', 'the', 'depolymerization', 'of', 'alginate', 'to', 'uronic', 'acid', '.']	[1, 1, 1, 3, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 4, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 2, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Isolate 1400 was selected for subsequent enzyme purification and characterization because it demonstrated the best and highest alginate lyase activity as shown by having the largest clearance zone (Table 1) and enzyme production measured in U/mL (Figure 1a).	[('PMC6562671', 'R02000', 127, 141, 'alginate lyase')]	['Is', '##olate', '1400', 'was', 'selected', 'for', 'subsequent', 'enzyme', 'pu', '##rification', 'and', 'characterization', 'because', 'it', 'demonstrated', 'the', 'best', 'and', 'highest', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', 'as', 'shown', 'by', 'having', 'the', 'largest', 'clearance', 'zone', '(', 'Table', '1', ')', 'and', 'enzyme', 'production', 'measured', 'in', 'U', '/', 'm', '##L', '(', 'Figure', '1', '##a', ')', '.']	[0, 2, 8, 13, 17, 26, 30, 41, 48, 50, 61, 65, 82, 90, 93, 106, 110, 115, 119, 127, 129, 132, 136, 137, 140, 142, 151, 154, 160, 163, 170, 174, 182, 192, 197, 198, 204, 205, 207, 211, 218, 229, 238, 241, 242, 243, 244, 246, 247, 254, 255, 256, 257]	[2, 7, 12, 16, 25, 29, 40, 47, 50, 60, 64, 81, 89, 92, 105, 109, 114, 118, 126, 129, 132, 135, 137, 140, 141, 150, 153, 159, 162, 169, 173, 181, 191, 196, 198, 203, 205, 206, 210, 217, 228, 237, 240, 242, 243, 244, 245, 247, 253, 255, 256, 257, 258]	['Isolate', '1400', 'was', 'selected', 'for', 'subsequent', 'enzyme', 'purification', 'and', 'characterization', 'because', 'it', 'demonstrated', 'the', 'best', 'and', 'highest', 'alginate', 'lyase', 'activity', 'as', 'shown', 'by', 'having', 'the', 'largest', 'clearance', 'zone', '(', 'Table', '1', ')', 'and', 'enzyme', 'production', 'measured', 'in', 'U', '/', 'mL', '(', 'Figure', '1a', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
First, we set to optimize the growth conditions (including temperature and medium pH), under which Pseudoalteromonas sp. 1400 produced the highest alginate lyase activity in the supernatant.	[('PMC6562671', 'R02001', 147, 161, 'alginate lyase')]	['First', ',', 'we', 'set', 'to', 'op', '##ti', '##mize', 'the', 'growth', 'conditions', '(', 'including', 'temperature', 'and', 'medium', 'pH', ')', ',', 'under', 'which', 'P', '##se', '##udo', '##al', '##tero', '##mona', '##s', 's', '##p', '.', '1400', 'produced', 'the', 'highest', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', 'in', 'the', 'super', '##nat', '##ant', '.']	[0, 5, 7, 10, 14, 17, 19, 21, 26, 30, 37, 48, 49, 59, 71, 75, 82, 84, 85, 87, 93, 99, 100, 102, 105, 107, 111, 115, 117, 118, 119, 121, 126, 135, 139, 147, 149, 152, 156, 157, 160, 162, 171, 174, 178, 183, 186, 189]	[5, 6, 9, 13, 16, 19, 21, 25, 29, 36, 47, 49, 58, 70, 74, 81, 84, 85, 86, 92, 98, 100, 102, 105, 107, 111, 115, 116, 118, 119, 120, 125, 134, 138, 146, 149, 152, 155, 157, 160, 161, 170, 173, 177, 183, 186, 189, 190]	['First', ',', 'we', 'set', 'to', 'optimize', 'the', 'growth', 'conditions', '(', 'including', 'temperature', 'and', 'medium', 'pH', ')', ',', 'under', 'which', 'Pseudoalteromonas', 'sp', '.', '1400', 'produced', 'the', 'highest', 'alginate', 'lyase', 'activity', 'in', 'the', 'supernatant', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 2, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
On the other hand, Pseudoalteromonas sp. 1400 grown at pH 8.0 released the highest amount of alginate lyase with specific activity of 32.85 U/mg protein and 56.5 ± 0.71 U/mL total activity, whereas we noticed that the lowest specific enzyme activity (5.92 U/mg protein) was recorded at pH 5.0 and pH 6.0.	[]	['On', 'the', 'other', 'hand', ',', 'P', '##se', '##udo', '##al', '##tero', '##mona', '##s', 's', '##p', '.', '1400', 'grown', 'at', 'pH', '8', '.', '0', 'released', 'the', 'highest', 'amount', 'of', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'with', 'specific', 'activity', 'of', '32', '.', '85', 'U', '/', 'mg', 'protein', 'and', '56', '.', '5', '±', '0', '.', '71', 'U', '/', 'm', '##L', 'total', 'activity', ',', 'whereas', 'we', 'noticed', 'that', 'the', 'lowest', 'specific', 'enzyme', 'activity', '(', '5', '.', '92', 'U', '/', 'mg', 'protein', ')', 'was', 'recorded', 'at', 'pH', '5', '.', '0', 'and', 'pH', '6', '.', '0', '.']	[0, 3, 7, 13, 17, 19, 20, 22, 25, 27, 31, 35, 37, 38, 39, 41, 46, 52, 55, 58, 59, 60, 62, 71, 75, 83, 90, 93, 95, 98, 102, 103, 106, 108, 113, 122, 131, 134, 136, 137, 140, 141, 142, 145, 153, 157, 159, 160, 162, 164, 165, 166, 169, 170, 171, 172, 174, 180, 188, 190, 198, 201, 209, 214, 218, 225, 234, 241, 250, 251, 252, 253, 256, 257, 258, 261, 268, 270, 274, 283, 286, 289, 290, 291, 293, 297, 300, 301, 302, 303]	[2, 6, 12, 17, 18, 20, 22, 25, 27, 31, 35, 36, 38, 39, 40, 45, 51, 54, 57, 59, 60, 61, 70, 74, 82, 89, 92, 95, 98, 101, 103, 106, 107, 112, 121, 130, 133, 136, 137, 139, 141, 142, 144, 152, 156, 159, 160, 161, 163, 165, 166, 168, 170, 171, 172, 173, 179, 188, 189, 197, 200, 208, 213, 217, 224, 233, 240, 249, 251, 252, 253, 255, 257, 258, 260, 268, 269, 273, 282, 285, 288, 290, 291, 292, 296, 299, 301, 302, 303, 304]	['On', 'the', 'other', 'hand', ',', 'Pseudoalteromonas', 'sp', '.', '1400', 'grown', 'at', 'pH', '8.0', 'released', 'the', 'highest', 'amount', 'of', 'alginate', 'lyase', 'with', 'specific', 'activity', 'of', '32.85', 'U', '/', 'mg', 'protein', 'and', '56.5', '±', '0.71', 'U', '/', 'mL', 'total', 'activity', ',', 'whereas', 'we', 'noticed', 'that', 'the', 'lowest', 'specific', 'enzyme', 'activity', '(', '5.92', 'U', '/', 'mg', 'protein', ')', 'was', 'recorded', 'at', 'pH', '5.0', 'and', 'pH', '6.0', '.']	[1, 1, 1, 1, 1, 7, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Based on the optimal alginate lyase production conditions, we set to purify this enzyme (AlyP1400) from Pseudoalteromonas sp.	[('PMC6562671', 'R03000', 21, 35, 'alginate lyase')]	['Based', 'on', 'the', 'optimal', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'production', 'conditions', ',', 'we', 'set', 'to', 'pu', '##ri', '##fy', 'this', 'enzyme', '(', 'Al', '##y', '##P', '##14', '##00', ')', 'from', 'P', '##se', '##udo', '##al', '##tero', '##mona', '##s', 's', '##p', '.']	[0, 6, 9, 13, 21, 23, 26, 30, 31, 34, 36, 47, 57, 59, 62, 66, 69, 71, 73, 76, 81, 88, 89, 91, 92, 93, 95, 97, 99, 104, 105, 107, 110, 112, 116, 120, 122, 123, 124]	[5, 8, 12, 20, 23, 26, 29, 31, 34, 35, 46, 57, 58, 61, 65, 68, 71, 73, 75, 80, 87, 89, 91, 92, 93, 95, 97, 98, 103, 105, 107, 110, 112, 116, 120, 121, 123, 124, 125]	['Based', 'on', 'the', 'optimal', 'alginate', 'lyase', 'production', 'conditions', ',', 'we', 'set', 'to', 'purify', 'this', 'enzyme', '(', 'AlyP1400', ')', 'from', 'Pseudoalteromonas', 'sp', '.']	[1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 1, 7, 2, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
During the first 120 minutes of purification time, no lyase activity was observed with the collected fractions through the bio-gel column chromatography eluate with 0.2 M sodium chloride.	[]	['During', 'the', 'first', '120', 'minutes', 'of', 'pu', '##rification', 'time', ',', 'no', 'l', '##yas', '##e', 'activity', 'was', 'observed', 'with', 'the', 'collected', 'fraction', '##s', 'through', 'the', 'bio', '-', 'gel', 'column', 'ch', '##roma', '##tography', 'el', '##uate', 'with', '0', '.', '2', 'M', 'sodium', 'chloride', '.']	[0, 7, 11, 17, 21, 29, 32, 34, 45, 49, 51, 54, 55, 58, 60, 69, 73, 82, 87, 91, 101, 109, 111, 119, 123, 126, 127, 131, 138, 140, 144, 153, 155, 160, 165, 166, 167, 169, 171, 178, 186]	[6, 10, 16, 20, 28, 31, 34, 44, 49, 50, 53, 55, 58, 59, 68, 72, 81, 86, 90, 100, 109, 110, 118, 122, 126, 127, 130, 137, 140, 144, 152, 155, 159, 164, 166, 167, 168, 170, 177, 186, 187]	['During', 'the', 'first', '120', 'minutes', 'of', 'purification', 'time', ',', 'no', 'lyase', 'activity', 'was', 'observed', 'with', 'the', 'collected', 'fractions', 'through', 'the', 'bio', '-', 'gel', 'column', 'chromatography', 'eluate', 'with', '0.2', 'M', 'sodium', 'chloride', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
AlyP1400 was active for both poly-M and poly-G degradation, indicating that it is a bifunctional alginate lyase (data not shown).	[('PMC6562671', 'R05000', 97, 111, 'alginate lyase')]	['Al', '##y', '##P', '##14', '##00', 'was', 'active', 'for', 'both', 'p', '##oly', '-', 'M', 'and', 'p', '##oly', '-', 'G', 'degradation', ',', 'indicating', 'that', 'it', 'is', 'a', 'bi', '##function', '##al', 'al', '##gin', '##ate', 'l', '##yas', '##e', '(', 'data', 'not', 'shown', ')', '.']	[0, 2, 3, 4, 6, 9, 13, 20, 24, 29, 30, 33, 34, 36, 40, 41, 44, 45, 47, 58, 60, 71, 76, 79, 82, 84, 86, 94, 97, 99, 102, 106, 107, 110, 112, 113, 118, 122, 127, 128]	[2, 3, 4, 6, 8, 12, 19, 23, 28, 30, 33, 34, 35, 39, 41, 44, 45, 46, 58, 59, 70, 75, 78, 81, 83, 86, 94, 96, 99, 102, 105, 107, 110, 111, 113, 117, 121, 127, 128, 129]	['AlyP1400', 'was', 'active', 'for', 'both', 'poly-M', 'and', 'poly-G', 'degradation', ',', 'indicating', 'that', 'it', 'is', 'a', 'bifunctional', 'alginate', 'lyase', '(', 'data', 'not', 'shown', ')', '.']	[5, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 3, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
The AlyP1400 band identified in the SDS-PAGE with alginate lyase activity was excised, subjected to trypsin digestion and analyzed by LC-MS/MS.	[('PMC6562671', 'R06000', 50, 64, 'alginate lyase')]	['The', 'Al', '##y', '##P', '##14', '##00', 'band', 'identified', 'in', 'the', 'SD', '##S', '-', 'PA', '##GE', 'with', 'al', '##gin', '##ate', 'l', '##yas', '##e', 'activity', 'was', 'ex', '##cise', '##d', ',', 'subjected', 'to', 'try', '##ps', '##in', 'dig', '##est', '##ion', 'and', 'analyzed', 'by', 'L', '##C', '-', 'MS', '/', 'MS', '.']	[0, 4, 6, 7, 8, 10, 13, 18, 29, 32, 36, 38, 39, 40, 42, 45, 50, 52, 55, 59, 60, 63, 65, 74, 78, 80, 84, 85, 87, 97, 100, 103, 105, 108, 111, 114, 118, 122, 131, 134, 135, 136, 137, 139, 140, 142]	[3, 6, 7, 8, 10, 12, 17, 28, 31, 35, 38, 39, 40, 42, 44, 49, 52, 55, 58, 60, 63, 64, 73, 77, 80, 84, 85, 86, 96, 99, 103, 105, 107, 111, 114, 117, 121, 130, 133, 135, 136, 137, 139, 140, 142, 143]	['The', 'AlyP1400', 'band', 'identified', 'in', 'the', 'SDS-PAGE', 'with', 'alginate', 'lyase', 'activity', 'was', 'excised', ',', 'subjected', 'to', 'trypsin', 'digestion', 'and', 'analyzed', 'by', 'LC-MS', '/', 'MS', '.']	[1, 5, 1, 1, 1, 1, 5, 1, 3, 3, 1, 1, 3, 1, 1, 1, 3, 3, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Formation of GTP-derived urinary metabolites: Absorbed EGC, either directly from the GTP supplement, or from the hydrolysis of EGCG, likely underwent COMT-mediated methylation followed by uridine 5’-diphospho-glucuronosyltransferase (UGT)-mediated glucuronidation to form methyl epigallocatechin glucuronide (Vu).	[('PMC6571926', 'D03000', 188, 232, 'uridine 5’-diphospho-glucuronosyltransferase')]	['Formation', 'of', 'GT', '##P', '-', 'derived', 'u', '##rina', '##ry', 'meta', '##bol', '##ites', ':', 'A', '##bs', '##or', '##bed', 'E', '##GC', ',', 'either', 'directly', 'from', 'the', 'GT', '##P', 'supplement', ',', 'or', 'from', 'the', 'h', '##ydro', '##lysis', 'of', 'E', '##GC', '##G', ',', 'likely', 'underwent', 'CO', '##MT', '-', 'mediated', 'met', '##hyl', '##ation', 'followed', 'by', 'u', '##rid', '##ine', '5', '’', '-', 'dip', '##hos', '##ph', '##o', '-', 'g', '##lu', '##cu', '##ron', '##osy', '##lt', '##ran', '##s', '##fer', '##ase', '(', 'U', '##G', '##T', ')', '-', 'mediated', 'g', '##lu', '##cu', '##ron', '##ida', '##tion', 'to', 'form', 'met', '##hyl', 'e', '##pi', '##gall', '##oc', '##ate', '##chin', 'g', '##lu', '##cu', '##ron', '##ide', '(', 'V', '##u', ')', '.']	[0, 10, 13, 15, 16, 17, 25, 26, 30, 33, 37, 40, 44, 46, 47, 49, 51, 55, 56, 58, 60, 67, 76, 81, 85, 87, 89, 99, 101, 104, 109, 113, 114, 118, 124, 127, 128, 130, 131, 133, 140, 150, 152, 154, 155, 164, 167, 170, 176, 185, 188, 189, 192, 196, 197, 198, 199, 202, 205, 207, 208, 209, 210, 212, 214, 217, 220, 222, 225, 226, 229, 233, 234, 235, 236, 237, 238, 239, 248, 249, 251, 253, 256, 259, 264, 267, 272, 275, 279, 280, 282, 286, 288, 291, 296, 297, 299, 301, 304, 308, 309, 310, 311, 312]	[9, 12, 15, 16, 17, 24, 26, 30, 32, 37, 40, 44, 45, 47, 49, 51, 54, 56, 58, 59, 66, 75, 80, 84, 87, 88, 99, 100, 103, 108, 112, 114, 118, 123, 126, 128, 130, 131, 132, 139, 149, 152, 154, 155, 163, 167, 170, 175, 184, 187, 189, 192, 195, 197, 198, 199, 202, 205, 207, 208, 209, 210, 212, 214, 217, 220, 222, 225, 226, 229, 232, 234, 235, 236, 237, 238, 239, 247, 249, 251, 253, 256, 259, 263, 266, 271, 275, 278, 280, 282, 286, 288, 291, 295, 297, 299, 301, 304, 307, 309, 310, 311, 312, 313]	['Formation', 'of', 'GTP', '-', 'derived', 'urinary', 'metabolites', ':', 'Absorbed', 'EGC', ',', 'either', 'directly', 'from', 'the', 'GTP', 'supplement', ',', 'or', 'from', 'the', 'hydrolysis', 'of', 'EGCG', ',', 'likely', 'underwent', 'COMT', '-', 'mediated', 'methylation', 'followed', 'by', 'uridine', '5’-diphospho', '-', 'glucuronosyltransferase', '(', 'UGT', ')', '-', 'mediated', 'glucuronidation', 'to', 'form', 'methyl', 'epigallocatechin', 'glucuronide', '(', 'Vu', ')', '.']	[1, 1, 2, 1, 1, 3, 3, 1, 4, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 2, 1, 1, 3, 1, 1, 3, 7, 1, 10, 1, 3, 1, 1, 1, 6, 1, 1, 2, 6, 5, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similarly, absorbed EC was metabolized by COMT-mediated methylation and sulfotransferase (SULT)-mediated sulfation reactions to form methyl epicatechin sulfate (IVu).	[('PMC6571926', 'D03001', 72, 88, 'sulfotransferase')]	['Similarly', ',', 'absorbed', 'EC', 'was', 'meta', '##bol', '##ized', 'by', 'CO', '##MT', '-', 'mediated', 'met', '##hyl', '##ation', 'and', 'su', '##lf', '##ot', '##ran', '##s', '##fer', '##ase', '(', 'S', '##U', '##LT', ')', '-', 'mediated', 'su', '##lf', '##ation', 'reactions', 'to', 'form', 'met', '##hyl', 'epic', '##ate', '##chin', 'su', '##lf', '##ate', '(', 'IV', '##u', ')', '.']	[0, 9, 11, 20, 23, 27, 31, 34, 39, 42, 44, 46, 47, 56, 59, 62, 68, 72, 74, 76, 78, 81, 82, 85, 89, 90, 91, 92, 94, 95, 96, 105, 107, 109, 115, 125, 128, 133, 136, 140, 144, 147, 152, 154, 156, 160, 161, 163, 164, 165]	[9, 10, 19, 22, 26, 31, 34, 38, 41, 44, 46, 47, 55, 59, 62, 67, 71, 74, 76, 78, 81, 82, 85, 88, 90, 91, 92, 94, 95, 96, 104, 107, 109, 114, 124, 127, 132, 136, 139, 144, 147, 151, 154, 156, 159, 161, 163, 164, 165, 166]	['Similarly', ',', 'absorbed', 'EC', 'was', 'metabolized', 'by', 'COMT', '-', 'mediated', 'methylation', 'and', 'sulfotransferase', '(', 'SULT', ')', '-', 'mediated', 'sulfation', 'reactions', 'to', 'form', 'methyl', 'epicatechin', 'sulfate', '(', 'IVu', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 3, 1, 7, 1, 3, 1, 1, 1, 3, 1, 1, 1, 2, 3, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The sequences of microbial rRNA that can reflect the flora composition and diversity were used as targets, and sample-specific barcode sequences were used for PCR amplification of the variable regions of the 16S rRNA gene (Q5 HiFi DNA polymerase; NEB, Ipswich, MA, USA).	[('PMC6590206', 'M04000', 231, 245, 'DNA polymerase')]	['The', 'sequences', 'of', 'micro', '##bial', 'r', '##RNA', 'that', 'can', 'reflect', 'the', 'flora', 'composition', 'and', 'diversity', 'were', 'used', 'as', 'targets', ',', 'and', 'sample', '-', 'specific', 'bar', '##code', 'sequences', 'were', 'used', 'for', 'PC', '##R', 'am', '##p', '##lification', 'of', 'the', 'variable', 'regions', 'of', 'the', '16', '##S', 'r', '##RNA', 'gene', '(', 'Q', '##5', 'Hi', '##F', '##i', 'DNA', 'polymer', '##ase', ';', 'NE', '##B', ',', 'Ipswich', ',', 'MA', ',', 'USA', ')', '.']	[0, 4, 14, 17, 22, 27, 28, 32, 37, 41, 49, 53, 59, 71, 75, 85, 90, 95, 98, 105, 107, 111, 117, 118, 127, 130, 135, 145, 150, 155, 159, 161, 163, 165, 166, 177, 180, 184, 193, 201, 204, 208, 210, 212, 213, 217, 222, 223, 224, 226, 228, 229, 231, 235, 242, 245, 247, 249, 250, 252, 259, 261, 263, 265, 268, 269]	[3, 13, 16, 22, 26, 28, 31, 36, 40, 48, 52, 58, 70, 74, 84, 89, 94, 97, 105, 106, 110, 117, 118, 126, 130, 134, 144, 149, 154, 158, 161, 162, 165, 166, 176, 179, 183, 192, 200, 203, 207, 210, 211, 213, 216, 221, 223, 224, 225, 228, 229, 230, 234, 242, 245, 246, 249, 250, 251, 259, 260, 263, 264, 268, 269, 270]	['The', 'sequences', 'of', 'microbial', 'rRNA', 'that', 'can', 'reflect', 'the', 'flora', 'composition', 'and', 'diversity', 'were', 'used', 'as', 'targets', ',', 'and', 'sample', '-', 'specific', 'barcode', 'sequences', 'were', 'used', 'for', 'PCR', 'amplification', 'of', 'the', 'variable', 'regions', 'of', 'the', '16S', 'rRNA', 'gene', '(', 'Q5', 'HiFi', 'DNA', 'polymerase', ';', 'NEB', ',', 'Ipswich', ',', 'MA', ',', 'USA', ')', '.']	[1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 2, 3, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cystathionine β-synthase deficiency (CBS), an inborn error of metabolism, is associated with vascular thromboembolism, the major cause of morbidity and mortality in affected patients.	[]	['Cy', '##sta', '##thi', '##oni', '##ne', 'β', '-', 's', '##ynth', '##ase', 'deficiency', '(', 'CBS', ')', ',', 'an', 'in', '##born', 'error', 'of', 'metabolism', ',', 'is', 'associated', 'with', 'vascular', 'th', '##rom', '##boe', '##mbo', '##lis', '##m', ',', 'the', 'major', 'cause', 'of', 'm', '##or', '##bid', '##ity', 'and', 'mortality', 'in', 'affected', 'patients', '.']	[0, 2, 5, 8, 11, 14, 15, 16, 17, 21, 25, 36, 37, 40, 41, 43, 46, 48, 53, 59, 62, 72, 74, 77, 88, 93, 102, 104, 107, 110, 113, 116, 117, 119, 123, 129, 135, 138, 139, 141, 144, 148, 152, 162, 165, 174, 182]	[2, 5, 8, 11, 13, 15, 16, 17, 21, 24, 35, 37, 40, 41, 42, 45, 48, 52, 58, 61, 72, 73, 76, 87, 92, 101, 104, 107, 110, 113, 116, 117, 118, 122, 128, 134, 137, 139, 141, 144, 147, 151, 161, 164, 173, 182, 183]	['Cystathionine', 'β-synthase', 'deficiency', '(', 'CBS', ')', ',', 'an', 'inborn', 'error', 'of', 'metabolism', ',', 'is', 'associated', 'with', 'vascular', 'thromboembolism', ',', 'the', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', 'in', 'affected', 'patients', '.']	[5, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The individuals with cystathionine β-synthase (CBS) deficiency, a rare inborn error of metabolism, have 50% chance of vascular thromboembolism by the age of 30, which is the major cause of morbidity and mortality [5].	[('PMC6627068', 'I01000', 21, 45, 'cystathionine β-synthase')]	['The', 'individuals', 'with', 'c', '##ys', '##tat', '##hi', '##oni', '##ne', 'β', '-', 's', '##ynth', '##ase', '(', 'CBS', ')', 'deficiency', ',', 'a', 'rare', 'in', '##born', 'error', 'of', 'metabolism', ',', 'have', '50', '%', 'chance', 'of', 'vascular', 'th', '##rom', '##boe', '##mbo', '##lis', '##m', 'by', 'the', 'age', 'of', '30', ',', 'which', 'is', 'the', 'major', 'cause', 'of', 'm', '##or', '##bid', '##ity', 'and', 'mortality', '[', '5', ']', '.']	[0, 4, 16, 21, 22, 24, 27, 29, 32, 35, 36, 37, 38, 42, 46, 47, 50, 52, 62, 64, 66, 71, 73, 78, 84, 87, 97, 99, 104, 106, 108, 115, 118, 127, 129, 132, 135, 138, 141, 143, 146, 150, 154, 157, 159, 161, 167, 170, 174, 180, 186, 189, 190, 192, 195, 199, 203, 213, 214, 215, 216]	[3, 15, 20, 22, 24, 27, 29, 32, 34, 36, 37, 38, 42, 45, 47, 50, 51, 62, 63, 65, 70, 73, 77, 83, 86, 97, 98, 103, 106, 107, 114, 117, 126, 129, 132, 135, 138, 141, 142, 145, 149, 153, 156, 159, 160, 166, 169, 173, 179, 185, 188, 190, 192, 195, 198, 202, 212, 214, 215, 216, 217]	['The', 'individuals', 'with', 'cystathionine', 'β-synthase', '(', 'CBS', ')', 'deficiency', ',', 'a', 'rare', 'inborn', 'error', 'of', 'metabolism', ',', 'have', '50%', 'chance', 'of', 'vascular', 'thromboembolism', 'by', 'the', 'age', 'of', '30', ',', 'which', 'is', 'the', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', '[', '5', ']', '.']	[1, 1, 1, 6, 5, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To quantify the bacterial load in salivary samples, we performed real-time PCR using LightCycler 480 instrument (Roche) and SYBR Premix ExTaq (Tli RNaseH Plus) (Takara Bio Europe).	[('PMC6627446', 'M06000', 147, 153, 'RNaseH')]	['To', 'q', '##uant', '##ify', 'the', 'bacterial', 'load', 'in', 'sa', '##liva', '##ry', 'samples', ',', 'we', 'performed', 'real', '-', 'time', 'PC', '##R', 'using', 'Light', '##C', '##ycle', '##r', '480', 'instrument', '(', 'Roche', ')', 'and', 'S', '##Y', '##BR', 'Pre', '##mi', '##x', 'Ex', '##T', '##aq', '(', 'T', '##li', 'R', '##N', '##ase', '##H', 'Plus', ')', '(', 'Ta', '##kara', 'B', '##io', 'Europe', ')', '.']	[0, 3, 4, 8, 12, 16, 26, 31, 34, 36, 40, 43, 50, 52, 55, 65, 69, 70, 75, 77, 79, 85, 90, 91, 95, 97, 101, 112, 113, 118, 120, 124, 125, 126, 129, 132, 134, 136, 138, 139, 142, 143, 144, 147, 148, 149, 152, 154, 158, 160, 161, 163, 168, 169, 172, 178, 179]	[2, 4, 8, 11, 15, 25, 30, 33, 36, 40, 42, 50, 51, 54, 64, 69, 70, 74, 77, 78, 84, 90, 91, 95, 96, 100, 111, 113, 118, 119, 123, 125, 126, 128, 132, 134, 135, 138, 139, 141, 143, 144, 146, 148, 149, 152, 153, 158, 159, 161, 163, 167, 169, 171, 178, 179, 180]	['To', 'quantify', 'the', 'bacterial', 'load', 'in', 'salivary', 'samples', ',', 'we', 'performed', 'real', '-', 'time', 'PCR', 'using', 'LightCycler', '480', 'instrument', '(', 'Roche', ')', 'and', 'SYBR', 'Premix', 'ExTaq', '(', 'Tli', 'RNaseH', 'Plus', ')', '(', 'Takara', 'Bio', 'Europe', ')', '.']	[1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 3, 3, 3, 1, 2, 4, 1, 1, 1, 2, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The metabolism pathway of vinorelbine primarily involves liver CYP3A4 enzymes to form inactive metabolites, except for, 4′-O-deacetylvinorelbine, the only active metabolite likely formed by carboxyl-esterases [17].	[('PMC6647192', 'I03000', 190, 208, 'carboxyl-esterases')]	['The', 'metabolism', 'pathway', 'of', 'v', '##ino', '##rel', '##bine', 'primarily', 'involves', 'liver', 'C', '##YP', '##3', '##A', '##4', 'enzymes', 'to', 'form', 'inactive', 'meta', '##bol', '##ites', ',', 'except', 'for', ',', '4', '′', '-', 'O', '-', 'de', '##ace', '##ty', '##lvin', '##ore', '##l', '##bine', ',', 'the', 'only', 'active', 'meta', '##bol', '##ite', 'likely', 'formed', 'by', 'car', '##box', '##yl', '-', 'est', '##era', '##ses', '[', '17', ']', '.']	[0, 4, 15, 23, 26, 27, 30, 33, 38, 48, 57, 63, 64, 66, 67, 68, 70, 78, 81, 86, 95, 99, 102, 106, 108, 115, 118, 120, 121, 122, 123, 124, 125, 127, 130, 132, 136, 139, 140, 144, 146, 150, 155, 162, 166, 169, 173, 180, 187, 190, 193, 196, 198, 199, 202, 205, 209, 210, 212, 213]	[3, 14, 22, 25, 27, 30, 33, 37, 47, 56, 62, 64, 66, 67, 68, 69, 77, 80, 85, 94, 99, 102, 106, 107, 114, 118, 119, 121, 122, 123, 124, 125, 127, 130, 132, 136, 139, 140, 144, 145, 149, 154, 161, 166, 169, 172, 179, 186, 189, 193, 196, 198, 199, 202, 205, 208, 210, 212, 213, 214]	['The', 'metabolism', 'pathway', 'of', 'vinorelbine', 'primarily', 'involves', 'liver', 'CYP3A4', 'enzymes', 'to', 'form', 'inactive', 'metabolites', ',', 'except', 'for', ',', '4′-O-deacetylvinorelbine', ',', 'the', 'only', 'active', 'metabolite', 'likely', 'formed', 'by', 'carboxyl', '-', 'esterases', '[', '17', ']', '.']	[1, 1, 1, 1, 4, 1, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 12, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
Other examination items that were evaluated included: age, duration of disease, body mass index, clinical disease type (inflammatory, stricturing, penetrating), disease location range (small intestine, small and large intestine, large intestine), presence of anal lesions, surgical history (small bowel resection, ileocecal resection), disease activity (Crohn’s disease activity index: CDAI), blood test results (albumin, total cholesterol, triglyceride, cholinesterase, calcium, C-reactive protein, intact parathyroid hormone, uc-OC, PIVKA-II, folic acid, vitamin B12, and homocysteine), and therapeutic regimen (antibiotics: cefepime/metronidazole/clarithromycin, probiotics, immunosuppressants, biologics).	[]	['Other', 'examination', 'items', 'that', 'were', 'evaluated', 'included', ':', 'age', ',', 'duration', 'of', 'disease', ',', 'body', 'mass', 'index', ',', 'clinical', 'disease', 'type', '(', 'inflammatory', ',', 'strict', '##uring', ',', 'penetrating', ')', ',', 'disease', 'location', 'range', '(', 'small', 'in', '##test', '##ine', ',', 'small', 'and', 'large', 'in', '##test', '##ine', ',', 'large', 'in', '##test', '##ine', ')', ',', 'presence', 'of', 'anal', 'lesions', ',', 'surgical', 'history', '(', 'small', 'bow', '##el', 're', '##section', ',', 'il', '##eo', '##ce', '##cal', 're', '##section', ')', ',', 'disease', 'activity', '(', 'C', '##ro', '##hn', '’', 's', 'disease', 'activity', 'index', ':', 'CD', '##A', '##I', ')', ',', 'blood', 'test', 'results', '(', 'album', '##in', ',', 'total', 'ch', '##ole', '##ster', '##ol', ',', 't', '##rig', '##ly', '##cer', '##ide', ',', 'ch', '##olin', '##ester', '##ase', ',', 'calcium', ',', 'C', '-', 'reactive', 'protein', ',', 'intact', 'para', '##thy', '##roid', 'hormone', ',', 'u', '##c', '-', 'O', '##C', ',', 'P', '##I', '##V', '##KA', '-', 'II', ',', 'f', '##olic', 'acid', ',', 'vitamin', 'B', '##12', ',', 'and', 'ho', '##mo', '##cy', '##stein', '##e', ')', ',', 'and', 'therapeutic', 'regime', '##n', '(', 'anti', '##biotics', ':', 'c', '##ef', '##ep', '##ime', '/', 'metro', '##ni', '##da', '##zo', '##le', '/', 'c', '##lar', '##ith', '##rom', '##y', '##cin', ',', 'pro', '##biotics', ',', 'im', '##mu', '##nos', '##up', '##press', '##ants', ',', 'bio', '##log', '##ics', ')', '.']	[0, 6, 18, 24, 29, 34, 44, 52, 54, 57, 59, 68, 71, 78, 80, 85, 90, 95, 97, 106, 114, 119, 120, 132, 134, 140, 145, 147, 158, 159, 161, 169, 178, 184, 185, 191, 193, 197, 200, 202, 208, 212, 218, 220, 224, 227, 229, 235, 237, 241, 244, 245, 247, 256, 259, 264, 271, 273, 282, 290, 291, 297, 300, 303, 305, 312, 314, 316, 318, 320, 324, 326, 333, 334, 336, 344, 353, 354, 355, 357, 359, 360, 362, 370, 379, 384, 386, 388, 389, 390, 391, 393, 399, 404, 412, 413, 418, 420, 422, 428, 430, 433, 437, 439, 441, 442, 445, 447, 450, 453, 455, 457, 461, 466, 469, 471, 478, 480, 481, 482, 491, 498, 500, 507, 511, 514, 519, 526, 528, 529, 530, 531, 532, 533, 535, 536, 537, 538, 540, 541, 543, 545, 546, 551, 555, 557, 565, 566, 568, 570, 574, 576, 578, 580, 585, 586, 587, 589, 593, 605, 611, 613, 614, 618, 625, 627, 628, 630, 632, 635, 636, 641, 643, 645, 647, 649, 650, 651, 654, 657, 660, 661, 664, 666, 669, 676, 678, 680, 682, 685, 687, 692, 696, 698, 701, 704, 707, 708]	[5, 17, 23, 28, 33, 43, 52, 53, 57, 58, 67, 70, 78, 79, 84, 89, 95, 96, 105, 113, 118, 120, 132, 133, 140, 145, 146, 158, 159, 160, 168, 177, 183, 185, 190, 193, 197, 200, 201, 207, 211, 217, 220, 224, 227, 228, 234, 237, 241, 244, 245, 246, 255, 258, 263, 271, 272, 281, 289, 291, 296, 300, 302, 305, 312, 313, 316, 318, 320, 323, 326, 333, 334, 335, 343, 352, 354, 355, 357, 359, 360, 361, 369, 378, 384, 385, 388, 389, 390, 391, 392, 398, 403, 411, 413, 418, 420, 421, 427, 430, 433, 437, 439, 440, 442, 445, 447, 450, 453, 454, 457, 461, 466, 469, 470, 478, 479, 481, 482, 490, 498, 499, 506, 511, 514, 518, 526, 527, 529, 530, 531, 532, 533, 534, 536, 537, 538, 540, 541, 543, 544, 546, 550, 555, 556, 564, 566, 568, 569, 573, 576, 578, 580, 585, 586, 587, 588, 592, 604, 611, 612, 614, 618, 625, 626, 628, 630, 632, 635, 636, 641, 643, 645, 647, 649, 650, 651, 654, 657, 660, 661, 664, 665, 669, 676, 677, 680, 682, 685, 687, 692, 696, 697, 701, 704, 707, 708, 709]	['Other', 'examination', 'items', 'that', 'were', 'evaluated', 'included', ':', 'age', ',', 'duration', 'of', 'disease', ',', 'body', 'mass', 'index', ',', 'clinical', 'disease', 'type', '(', 'inflammatory', ',', 'stricturing', ',', 'penetrating', ')', ',', 'disease', 'location', 'range', '(', 'small', 'intestine', ',', 'small', 'and', 'large', 'intestine', ',', 'large', 'intestine', ')', ',', 'presence', 'of', 'anal', 'lesions', ',', 'surgical', 'history', '(', 'small', 'bowel', 'resection', ',', 'ileocecal', 'resection', ')', ',', 'disease', 'activity', '(', 'Crohn’s', 'disease', 'activity', 'index', ':', 'CDAI', ')', ',', 'blood', 'test', 'results', '(', 'albumin', ',', 'total', 'cholesterol', ',', 'triglyceride', ',', 'cholinesterase', ',', 'calcium', ',', 'C-reactive', 'protein', ',', 'intact', 'parathyroid', 'hormone', ',', 'uc-OC', ',', 'PIVKA-II', ',', 'folic', 'acid', ',', 'vitamin', 'B12', ',', 'and', 'homocysteine', ')', ',', 'and', 'therapeutic', 'regimen', '(', 'antibiotics', ':', 'cefepime', '/', 'metronidazole', '/', 'clarithromycin', ',', 'probiotics', ',', 'immunosuppressants', ',', 'biologics', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 4, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 5, 1, 4, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 5, 1, 6, 1, 2, 1, 1, 1, 2, 1, 1, 5, 1, 1, 1, 1, 2, 1, 2, 1, 4, 1, 5, 1, 6, 1, 2, 1, 6, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sequencing libraries were prepared by amplifying the V3–V4 region of the 16 S rRNA gene using the 341f-805 r primers, as described earlier.10 After the initial amplification, PCR (Polymerase chain reaction) products were confirmed with gel electrophoresis and purified using Agencourt AMPure XP magnetic beads (Beckham Coulter Inc., Bromma, Sweden).	[('PMC6683645', 'M03000', 180, 190, 'Polymerase')]	['Se', '##quencing', 'libraries', 'were', 'prepared', 'by', 'am', '##p', '##lify', '##ing', 'the', 'V', '##3', '–', 'V', '##4', 'region', 'of', 'the', '16', 'S', 'r', '##RNA', 'gene', 'using', 'the', '34', '##1', '##f', '-', '80', '##5', 'r', 'prime', '##rs', ',', 'as', 'described', 'earlier', '.', '10', 'After', 'the', 'initial', 'am', '##p', '##lification', ',', 'PC', '##R', '(', 'Pol', '##yme', '##rase', 'chain', 'reaction', ')', 'products', 'were', 'confirmed', 'with', 'gel', 'electro', '##ph', '##ores', '##is', 'and', 'pu', '##rified', 'using', 'Age', '##nco', '##urt', 'AM', '##P', '##ure', 'X', '##P', 'magnetic', 'beads', '(', 'Beck', '##ham', 'Co', '##ulter', 'Inc', '.', ',', 'B', '##rom', '##ma', ',', 'Sweden', ')', '.']	[0, 2, 11, 21, 26, 35, 38, 40, 41, 45, 49, 53, 54, 55, 56, 57, 59, 66, 69, 73, 76, 78, 79, 83, 88, 94, 98, 100, 101, 102, 103, 105, 107, 109, 114, 116, 118, 121, 131, 138, 139, 142, 148, 152, 160, 162, 163, 173, 175, 177, 179, 180, 183, 186, 191, 197, 205, 207, 216, 221, 231, 236, 240, 247, 249, 253, 256, 260, 262, 269, 275, 278, 281, 285, 287, 288, 292, 293, 295, 304, 310, 311, 315, 319, 321, 327, 330, 331, 333, 334, 337, 339, 341, 347, 348]	[2, 10, 20, 25, 34, 37, 40, 41, 45, 48, 52, 54, 55, 56, 57, 58, 65, 68, 72, 75, 77, 79, 82, 87, 93, 97, 100, 101, 102, 103, 105, 106, 108, 114, 116, 117, 120, 130, 138, 139, 141, 147, 151, 159, 162, 163, 173, 174, 177, 178, 180, 183, 186, 190, 196, 205, 206, 215, 220, 230, 235, 239, 247, 249, 253, 255, 259, 262, 268, 274, 278, 281, 284, 287, 288, 291, 293, 294, 303, 309, 311, 315, 318, 321, 326, 330, 331, 332, 334, 337, 339, 340, 347, 348, 349]	['Sequencing', 'libraries', 'were', 'prepared', 'by', 'amplifying', 'the', 'V3–V4', 'region', 'of', 'the', '16', 'S', 'rRNA', 'gene', 'using', 'the', '341f-805', 'r', 'primers', ',', 'as', 'described', 'earlier.10', 'After', 'the', 'initial', 'amplification', ',', 'PCR', '(', 'Polymerase', 'chain', 'reaction', ')', 'products', 'were', 'confirmed', 'with', 'gel', 'electrophoresis', 'and', 'purified', 'using', 'Agencourt', 'AMPure', 'XP', 'magnetic', 'beads', '(', 'Beckham', 'Coulter', 'Inc', '.', ',', 'Bromma', ',', 'Sweden', ')', '.']	[2, 1, 1, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 6, 1, 2, 1, 1, 1, 3, 1, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 3, 3, 2, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An enzyme spiking solution was prepared weekly by gently dissolving β-glucuronidase in 0.2 M potassium phosphate buffer (pH = 6.8 ± 0.1) such that a 300-μL spike in 200 μL of urine contained 1 Fishman unit per microliter of urine.	[('PMC6691966', 'M04000', 68, 83, 'β-glucuronidase')]	['An', 'enzyme', 's', '##pi', '##king', 'solution', 'was', 'prepared', 'weekly', 'by', 'gently', 'di', '##sso', '##lving', 'β', '-', 'g', '##lu', '##cu', '##ron', '##idas', '##e', 'in', '0', '.', '2', 'M', 'potassium', 'phosphate', 'buffer', '(', 'pH', '=', '6', '.', '8', '±', '0', '.', '1', ')', 'such', 'that', 'a', '300', '-', 'μ', '##L', 'spike', 'in', '200', 'μ', '##L', 'of', 'urine', 'contained', '1', 'Fish', '##man', 'unit', 'per', 'micro', '##lite', '##r', 'of', 'urine', '.']	[0, 3, 10, 11, 13, 18, 27, 31, 40, 47, 50, 57, 59, 62, 68, 69, 70, 71, 73, 75, 78, 82, 84, 87, 88, 89, 91, 93, 103, 113, 120, 121, 124, 126, 127, 128, 130, 132, 133, 134, 135, 137, 142, 147, 149, 152, 153, 154, 156, 162, 165, 169, 170, 172, 175, 181, 191, 193, 197, 201, 206, 210, 215, 219, 221, 224, 229]	[2, 9, 11, 13, 17, 26, 30, 39, 46, 49, 56, 59, 62, 67, 69, 70, 71, 73, 75, 78, 82, 83, 86, 88, 89, 90, 92, 102, 112, 119, 121, 123, 125, 127, 128, 129, 131, 133, 134, 135, 136, 141, 146, 148, 152, 153, 154, 155, 161, 164, 168, 170, 171, 174, 180, 190, 192, 197, 200, 205, 209, 215, 219, 220, 223, 229, 230]	['An', 'enzyme', 'spiking', 'solution', 'was', 'prepared', 'weekly', 'by', 'gently', 'dissolving', 'β-glucuronidase', 'in', '0.2', 'M', 'potassium', 'phosphate', 'buffer', '(', 'pH', '=', '6.8', '±', '0.1', ')', 'such', 'that', 'a', '300-μL', 'spike', 'in', '200', 'μL', 'of', 'urine', 'contained', '1', 'Fishman', 'unit', 'per', 'microliter', 'of', 'urine', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 8, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However paradoxically, studies also suggest that activated TLRs regulate beneficial commensal-host interactions, such as promoting commensal colonization (Round et al., 2011), balancing inflammatory response, limiting bacteria penetration (Vaishnava et al., 2008), inducing tolerance in the host immune system, and establishing epithelial barrier function (Hooper and Macpherson, 2010; Kubinak and Round, 2012).	[]	['However', 'para', '##dox', '##ically', ',', 'studies', 'also', 'suggest', 'that', 'activated', 'T', '##LR', '##s', 'regulate', 'beneficial', 'com', '##men', '##sal', '-', 'host', 'interactions', ',', 'such', 'as', 'promoting', 'com', '##men', '##sal', 'colonization', '(', 'Round', 'et', 'al', '.', ',', '2011', ')', ',', 'balancing', 'inflammatory', 'response', ',', 'limiting', 'bacteria', 'penetration', '(', 'V', '##ais', '##hn', '##ava', 'et', 'al', '.', ',', '2008', ')', ',', 'in', '##ducing', 'tolerance', 'in', 'the', 'host', 'immune', 'system', ',', 'and', 'establishing', 'e', '##pit', '##hel', '##ial', 'barrier', 'function', '(', 'Hooper', 'and', 'Mac', '##pher', '##son', ',', '2010', ';', 'Ku', '##bina', '##k', 'and', 'Round', ',', '2012', ')', '.']	[0, 8, 12, 15, 21, 23, 31, 36, 44, 49, 59, 60, 62, 64, 73, 84, 87, 90, 93, 94, 99, 111, 113, 118, 121, 131, 134, 137, 141, 154, 155, 161, 164, 166, 167, 169, 173, 174, 176, 186, 199, 207, 209, 218, 227, 239, 240, 241, 244, 246, 250, 253, 255, 256, 258, 262, 263, 265, 267, 274, 284, 287, 291, 296, 303, 309, 311, 315, 328, 329, 332, 335, 339, 347, 356, 357, 364, 368, 371, 375, 378, 380, 384, 386, 388, 392, 394, 398, 403, 405, 409, 410]	[7, 12, 15, 21, 22, 30, 35, 43, 48, 58, 60, 62, 63, 72, 83, 87, 90, 93, 94, 98, 111, 112, 117, 120, 130, 134, 137, 140, 153, 155, 160, 163, 166, 167, 168, 173, 174, 175, 185, 198, 207, 208, 217, 226, 238, 240, 241, 244, 246, 249, 252, 255, 256, 257, 262, 263, 264, 267, 273, 283, 286, 290, 295, 302, 309, 310, 314, 327, 329, 332, 335, 338, 346, 355, 357, 363, 367, 371, 375, 378, 379, 384, 385, 388, 392, 393, 397, 403, 404, 409, 410, 411]	['However', 'paradoxically', ',', 'studies', 'also', 'suggest', 'that', 'activated', 'TLRs', 'regulate', 'beneficial', 'commensal', '-', 'host', 'interactions', ',', 'such', 'as', 'promoting', 'commensal', 'colonization', '(', 'Round', 'et', 'al', '.', ',', '2011', ')', ',', 'balancing', 'inflammatory', 'response', ',', 'limiting', 'bacteria', 'penetration', '(', 'Vaishnava', 'et', 'al', '.', ',', '2008', ')', ',', 'inducing', 'tolerance', 'in', 'the', 'host', 'immune', 'system', ',', 'and', 'establishing', 'epithelial', 'barrier', 'function', '(', 'Hooper', 'and', 'Macpherson', ',', '2010', ';', 'Kubinak', 'and', 'Round', ',', '2012', ')', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several studies suggested that besides improving the cognitive performance and ability of daily living in individuals with AD, acetylcholinesterase inhibitors (ChEIs), like donepezil, galantamine, and rivastigmine, also improved the mental behavioral symptoms and sleep quality of these patients [19–21].	[('PMC6701140', 'I03000', 127, 147, 'acetylcholinesterase')]	['Several', 'studies', 'suggested', 'that', 'besides', 'improving', 'the', 'cognitive', 'performance', 'and', 'ability', 'of', 'daily', 'living', 'in', 'individuals', 'with', 'AD', ',', 'ace', '##ty', '##l', '##cho', '##lines', '##tera', '##se', 'inhibitor', '##s', '(', 'Ch', '##EI', '##s', ')', ',', 'like', 'done', '##pe', '##zi', '##l', ',', 'gal', '##ant', '##amine', ',', 'and', 'r', '##iva', '##st', '##ig', '##mine', ',', 'also', 'improved', 'the', 'mental', 'behavioral', 'symptoms', 'and', 'sleep', 'quality', 'of', 'these', 'patients', '[', '19', '–', '21', ']', '.']	[0, 8, 16, 26, 31, 39, 49, 53, 63, 75, 79, 87, 90, 96, 103, 106, 118, 123, 125, 127, 130, 132, 133, 136, 141, 145, 148, 157, 159, 160, 162, 164, 165, 166, 168, 173, 177, 179, 181, 182, 184, 187, 190, 195, 197, 201, 202, 205, 207, 209, 213, 215, 220, 229, 233, 240, 251, 260, 264, 270, 278, 281, 287, 296, 297, 299, 300, 302, 303]	[7, 15, 25, 30, 38, 48, 52, 62, 74, 78, 86, 89, 95, 102, 105, 117, 122, 125, 126, 130, 132, 133, 136, 141, 145, 147, 157, 158, 160, 162, 164, 165, 166, 167, 172, 177, 179, 181, 182, 183, 187, 190, 195, 196, 200, 202, 205, 207, 209, 213, 214, 219, 228, 232, 239, 250, 259, 263, 269, 277, 280, 286, 295, 297, 299, 300, 302, 303, 304]	['Several', 'studies', 'suggested', 'that', 'besides', 'improving', 'the', 'cognitive', 'performance', 'and', 'ability', 'of', 'daily', 'living', 'in', 'individuals', 'with', 'AD', ',', 'acetylcholinesterase', 'inhibitors', '(', 'ChEIs', ')', ',', 'like', 'donepezil', ',', 'galantamine', ',', 'and', 'rivastigmine', ',', 'also', 'improved', 'the', 'mental', 'behavioral', 'symptoms', 'and', 'sleep', 'quality', 'of', 'these', 'patients', '[', '19–', '21', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 2, 1, 3, 1, 1, 1, 4, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After polymerase chain reaction (PCR) amplification, DNA fragments will be sequenced on an Illumina HiSeq 2500 instrument and an Illumina HiSeq X instrument for 16S ribosomal DNA (16S rDNA) and metagenomics analyses (which will be chosen from some representative samples in the results of the 16S rDNA analysis), respectively, at Biomarker Technologies Co, Ltd. (Beijing, China) to analyze the differences in gut microbiome between patients with aMCI and individuals with normal cognition.	[]	['After', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'am', '##p', '##lification', ',', 'DNA', 'fragments', 'will', 'be', 'sequence', '##d', 'on', 'an', 'Il', '##lum', '##ina', 'Hi', '##S', '##e', '##q', '250', '##0', 'instrument', 'and', 'an', 'Il', '##lum', '##ina', 'Hi', '##S', '##e', '##q', 'X', 'instrument', 'for', '16', '##S', 'rib', '##oso', '##mal', 'DNA', '(', '16', '##S', 'r', '##D', '##NA', ')', 'and', 'meta', '##gen', '##omi', '##cs', 'analyses', '(', 'which', 'will', 'be', 'chosen', 'from', 'some', 'representative', 'samples', 'in', 'the', 'results', 'of', 'the', '16', '##S', 'r', '##D', '##NA', 'analysis', ')', ',', 'respectively', ',', 'at', 'B', '##io', '##mark', '##er', 'Technologies', 'Co', ',', 'Ltd', '.', '(', 'Beijing', ',', 'China', ')', 'to', 'analyze', 'the', 'differences', 'in', 'gut', 'micro', '##bio', '##me', 'between', 'patients', 'with', 'a', '##MC', '##I', 'and', 'individuals', 'with', 'normal', 'co', '##gnition', '.']	[0, 6, 13, 17, 23, 32, 33, 35, 36, 38, 40, 41, 51, 53, 57, 67, 72, 75, 83, 85, 88, 91, 93, 96, 100, 102, 103, 104, 106, 109, 111, 122, 126, 129, 131, 134, 138, 140, 141, 142, 144, 146, 157, 161, 163, 165, 168, 171, 175, 179, 180, 182, 184, 185, 186, 188, 190, 194, 198, 201, 204, 207, 216, 217, 223, 228, 231, 238, 243, 248, 263, 271, 274, 278, 286, 289, 293, 295, 297, 298, 299, 302, 310, 311, 313, 325, 327, 330, 331, 333, 337, 340, 353, 355, 357, 360, 362, 363, 370, 372, 377, 379, 382, 390, 394, 406, 409, 413, 418, 421, 424, 432, 441, 446, 447, 449, 451, 455, 467, 472, 479, 481, 488]	[5, 13, 16, 22, 31, 33, 35, 36, 37, 40, 41, 51, 52, 56, 66, 71, 74, 83, 84, 87, 90, 93, 96, 99, 102, 103, 104, 105, 109, 110, 121, 125, 128, 131, 134, 137, 140, 141, 142, 143, 145, 156, 160, 163, 164, 168, 171, 174, 178, 180, 182, 183, 185, 186, 188, 189, 193, 198, 201, 204, 206, 215, 217, 222, 227, 230, 237, 242, 247, 262, 270, 273, 277, 285, 288, 292, 295, 296, 298, 299, 301, 310, 311, 312, 325, 326, 329, 331, 333, 337, 339, 352, 355, 356, 360, 361, 363, 370, 371, 377, 378, 381, 389, 393, 405, 408, 412, 418, 421, 423, 431, 440, 445, 447, 449, 450, 454, 466, 471, 478, 481, 488, 489]	['After', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', ',', 'DNA', 'fragments', 'will', 'be', 'sequenced', 'on', 'an', 'Illumina', 'HiSeq', '2500', 'instrument', 'and', 'an', 'Illumina', 'HiSeq', 'X', 'instrument', 'for', '16S', 'ribosomal', 'DNA', '(', '16S', 'rDNA', ')', 'and', 'metagenomics', 'analyses', '(', 'which', 'will', 'be', 'chosen', 'from', 'some', 'representative', 'samples', 'in', 'the', 'results', 'of', 'the', '16S', 'rDNA', 'analysis', ')', ',', 'respectively', ',', 'at', 'Biomarker', 'Technologies', 'Co', ',', 'Ltd', '.', '(', 'Beijing', ',', 'China', ')', 'to', 'analyze', 'the', 'differences', 'in', 'gut', 'microbiome', 'between', 'patients', 'with', 'aMCI', 'and', 'individuals', 'with', 'normal', 'cognition', '.']	[1, 2, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 3, 4, 2, 1, 1, 1, 3, 4, 1, 1, 1, 2, 3, 1, 1, 2, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
By virtue of inhibition of ribonucleotide reductase and DNA polymerase, fludarabine induces apoptosis and cell death [15].	[('PMC6708594', 'R05000', 27, 51, 'ribonucleotide reductase')]	['By', 'virtue', 'of', 'in', '##hibition', 'of', 'rib', '##on', '##uc', '##leo', '##tide', 'red', '##uc', '##tase', 'and', 'DNA', 'polymer', '##ase', ',', 'flu', '##dar', '##abi', '##ne', 'induce', '##s', 'a', '##pop', '##tosis', 'and', 'cell', 'death', '[', '15', ']', '.']	[0, 3, 10, 13, 15, 24, 27, 30, 32, 34, 37, 42, 45, 47, 52, 56, 60, 67, 70, 72, 75, 78, 81, 84, 90, 92, 93, 96, 102, 106, 111, 117, 118, 120, 121]	[2, 9, 12, 15, 23, 26, 30, 32, 34, 37, 41, 45, 47, 51, 55, 59, 67, 70, 71, 75, 78, 81, 83, 90, 91, 93, 96, 101, 105, 110, 116, 118, 120, 121, 122]	['By', 'virtue', 'of', 'inhibition', 'of', 'ribonucleotide', 'reductase', 'and', 'DNA', 'polymerase', ',', 'fludarabine', 'induces', 'apoptosis', 'and', 'cell', 'death', '[', '15', ']', '.']	[1, 1, 1, 2, 1, 5, 3, 1, 1, 2, 1, 4, 2, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several classes of DHA-derived LMs, arising from different lipoxygenases as well as aspirin-inactivated cyclooxygenase-2 (COX-2), such as resolvins (Serhan et al., 2002), protectins (Marcheselli et al., 2003; Serhan et al., 2011), and maresins (Serhan et al., 2009), and their aspirin-triggered epimers, have been identified as potentially important factors in the resolution phase of the inflammatory reaction (Serhan, 2014).	[('PMC6716427', 'I02000', 59, 72, 'lipoxygenases')]	['Several', 'classes', 'of', 'D', '##HA', '-', 'derived', 'L', '##Ms', ',', 'arising', 'from', 'different', 'lip', '##ox', '##y', '##gen', '##ases', 'as', 'well', 'as', 'as', '##pi', '##rin', '-', 'inactivated', 'c', '##y', '##c', '##lo', '##ox', '##y', '##gen', '##ase', '-', '2', '(', 'CO', '##X', '-', '2', ')', ',', 'such', 'as', 're', '##sol', '##vin', '##s', '(', 'Ser', '##han', 'et', 'al', '.', ',', '2002', ')', ',', 'protect', '##ins', '(', 'March', '##ese', '##lli', 'et', 'al', '.', ',', '2003', ';', 'Ser', '##han', 'et', 'al', '.', ',', '2011', ')', ',', 'and', 'mare', '##sin', '##s', '(', 'Ser', '##han', 'et', 'al', '.', ',', '2009', ')', ',', 'and', 'their', 'as', '##pi', '##rin', '-', 'triggered', 'e', '##pi', '##mers', ',', 'have', 'been', 'identified', 'as', 'potentially', 'important', 'factors', 'in', 'the', 'resolution', 'phase', 'of', 'the', 'inflammatory', 'reaction', '(', 'Ser', '##han', ',', '2014', ')', '.']	[0, 8, 16, 19, 20, 22, 23, 31, 32, 34, 36, 44, 49, 59, 62, 64, 65, 68, 73, 76, 81, 84, 86, 88, 91, 92, 104, 105, 106, 107, 109, 111, 112, 115, 118, 119, 121, 122, 124, 125, 126, 127, 128, 130, 135, 138, 140, 143, 146, 148, 149, 152, 156, 159, 161, 162, 164, 168, 169, 171, 178, 182, 183, 188, 191, 195, 198, 200, 201, 203, 207, 209, 212, 216, 219, 221, 222, 224, 228, 229, 231, 235, 239, 242, 244, 245, 248, 252, 255, 257, 258, 260, 264, 265, 267, 271, 277, 279, 281, 284, 285, 295, 296, 298, 302, 304, 309, 314, 325, 328, 340, 350, 358, 361, 365, 376, 382, 385, 389, 402, 411, 412, 415, 418, 420, 424, 425]	[7, 15, 18, 20, 22, 23, 30, 32, 34, 35, 43, 48, 58, 62, 64, 65, 68, 72, 75, 80, 83, 86, 88, 91, 92, 103, 105, 106, 107, 109, 111, 112, 115, 118, 119, 120, 122, 124, 125, 126, 127, 128, 129, 134, 137, 140, 143, 146, 147, 149, 152, 155, 158, 161, 162, 163, 168, 169, 170, 178, 181, 183, 188, 191, 194, 197, 200, 201, 202, 207, 208, 212, 215, 218, 221, 222, 223, 228, 229, 230, 234, 239, 242, 243, 245, 248, 251, 254, 257, 258, 259, 264, 265, 266, 270, 276, 279, 281, 284, 285, 294, 296, 298, 302, 303, 308, 313, 324, 327, 339, 349, 357, 360, 364, 375, 381, 384, 388, 401, 410, 412, 415, 418, 419, 424, 425, 426]	['Several', 'classes', 'of', 'DHA', '-', 'derived', 'LMs', ',', 'arising', 'from', 'different', 'lipoxygenases', 'as', 'well', 'as', 'aspirin', '-', 'inactivated', 'cyclooxygenase-2', '(', 'COX-2', ')', ',', 'such', 'as', 'resolvins', '(', 'Serhan', 'et', 'al', '.', ',', '2002', ')', ',', 'protectins', '(', 'Marcheselli', 'et', 'al', '.', ',', '2003', ';', 'Serhan', 'et', 'al', '.', ',', '2011', ')', ',', 'and', 'maresins', '(', 'Serhan', 'et', 'al', '.', ',', '2009', ')', ',', 'and', 'their', 'aspirin', '-', 'triggered', 'epimers', ',', 'have', 'been', 'identified', 'as', 'potentially', 'important', 'factors', 'in', 'the', 'resolution', 'phase', 'of', 'the', 'inflammatory', 'reaction', '(', 'Serhan', ',', '2014', ')', '.']	[1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 10, 1, 4, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Butyrate has histone deacetylase activity and signals via GRP43 and GRP109a, thereby influencing brain function or structure [53].	[]	['But', '##yra', '##te', 'has', 'his', '##tone', 'de', '##ace', '##ty', '##lase', 'activity', 'and', 'signals', 'via', 'G', '##RP', '##43', 'and', 'G', '##RP', '##10', '##9', '##a', ',', 'thereby', 'in', '##f', '##lue', '##ncing', 'brain', 'function', 'or', 'structure', '[', '53', ']', '.']	[0, 3, 6, 9, 13, 16, 21, 23, 26, 28, 33, 42, 46, 54, 58, 59, 61, 64, 68, 69, 71, 73, 74, 75, 77, 85, 87, 88, 91, 97, 103, 112, 115, 125, 126, 128, 129]	[3, 6, 8, 12, 16, 20, 23, 26, 28, 32, 41, 45, 53, 57, 59, 61, 63, 67, 69, 71, 73, 74, 75, 76, 84, 87, 88, 91, 96, 102, 111, 114, 124, 126, 128, 129, 130]	['Butyrate', 'has', 'histone', 'deacetylase', 'activity', 'and', 'signals', 'via', 'GRP43', 'and', 'GRP109a', ',', 'thereby', 'influencing', 'brain', 'function', 'or', 'structure', '[', '53', ']', '.']	[3, 1, 2, 4, 1, 1, 1, 1, 3, 1, 5, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In this study, Faecalibacterium was negatively correlated with UA, TG, LDL, and APOB.	[]	['In', 'this', 'study', ',', 'F', '##ae', '##cal', '##iba', '##cter', '##ium', 'was', 'negatively', 'correlated', 'with', 'U', '##A', ',', 'T', '##G', ',', 'L', '##D', '##L', ',', 'and', 'AP', '##O', '##B', '.']	[0, 3, 8, 13, 15, 16, 18, 21, 24, 28, 32, 36, 47, 58, 63, 64, 65, 67, 68, 69, 71, 72, 73, 74, 76, 80, 82, 83, 84]	[2, 7, 13, 14, 16, 18, 21, 24, 28, 31, 35, 46, 57, 62, 64, 65, 66, 68, 69, 70, 72, 73, 74, 75, 79, 82, 83, 84, 85]	['In', 'this', 'study', ',', 'Faecalibacterium', 'was', 'negatively', 'correlated', 'with', 'UA', ',', 'TG', ',', 'LDL', ',', 'and', 'APOB', '.']	[1, 1, 1, 1, 6, 1, 1, 1, 1, 2, 1, 2, 1, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We selected the following factors for redundancy analysis (RDA)/correspondence analysis (CCA): age, BMI, alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, UA, creatinine (CR), glucose (GLU), TG, TCHO, HDL, LDL, APOA1, APOB, LPA, and NEFA (Supplementary File 2).	[('PMC6731442', 'R06000', 105, 129, 'alanine aminotransferase')]	['We', 'selected', 'the', 'following', 'factors', 'for', 'red', '##unda', '##ncy', 'analysis', '(', 'R', '##DA', ')', '/', 'correspondence', 'analysis', '(', 'CC', '##A', ')', ':', 'age', ',', 'B', '##MI', ',', 'al', '##ani', '##ne', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AL', '##T', ')', ',', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'u', '##rea', ',', 'U', '##A', ',', 'c', '##rea', '##tin', '##ine', '(', 'CR', ')', ',', 'glucose', '(', 'G', '##L', '##U', ')', ',', 'T', '##G', ',', 'T', '##CH', '##O', ',', 'HD', '##L', ',', 'L', '##D', '##L', ',', 'AP', '##OA', '##1', ',', 'AP', '##O', '##B', ',', 'LP', '##A', ',', 'and', 'NE', '##FA', '(', 'Su', '##pp', '##lement', '##ary', 'File', '2', ')', '.']	[0, 3, 12, 16, 26, 34, 38, 41, 45, 49, 58, 59, 60, 62, 63, 64, 79, 88, 89, 91, 92, 93, 95, 98, 100, 101, 103, 105, 107, 110, 113, 118, 121, 123, 126, 130, 131, 133, 134, 135, 137, 139, 142, 147, 152, 155, 157, 160, 164, 165, 167, 168, 169, 171, 172, 175, 177, 178, 179, 181, 182, 185, 188, 192, 193, 195, 196, 198, 206, 207, 208, 209, 210, 211, 213, 214, 215, 217, 218, 220, 221, 223, 225, 226, 228, 229, 230, 231, 233, 235, 237, 238, 240, 242, 243, 244, 246, 248, 249, 251, 255, 257, 260, 261, 263, 265, 271, 275, 280, 281, 282]	[2, 11, 15, 25, 33, 37, 41, 45, 48, 57, 59, 60, 62, 63, 64, 78, 87, 89, 91, 92, 93, 94, 98, 99, 101, 103, 104, 107, 110, 112, 118, 121, 123, 126, 129, 131, 133, 134, 135, 136, 139, 142, 146, 152, 155, 157, 160, 163, 165, 167, 168, 169, 170, 172, 175, 176, 178, 179, 180, 182, 185, 188, 191, 193, 195, 196, 197, 205, 207, 208, 209, 210, 211, 212, 214, 215, 216, 218, 220, 221, 222, 225, 226, 227, 229, 230, 231, 232, 235, 237, 238, 239, 242, 243, 244, 245, 248, 249, 250, 254, 257, 259, 261, 263, 265, 271, 274, 279, 281, 282, 283]	['We', 'selected', 'the', 'following', 'factors', 'for', 'redundancy', 'analysis', '(', 'RDA', ')', '/', 'correspondence', 'analysis', '(', 'CCA', ')', ':', 'age', ',', 'BMI', ',', 'alanine', 'aminotransferase', '(', 'ALT', ')', ',', 'aspartate', 'aminotransferase', '(', 'AST', ')', ',', 'urea', ',', 'UA', ',', 'creatinine', '(', 'CR', ')', ',', 'glucose', '(', 'GLU', ')', ',', 'TG', ',', 'TCHO', ',', 'HDL', ',', 'LDL', ',', 'APOA1', ',', 'APOB', ',', 'LPA', ',', 'and', 'NEFA', '(', 'Supplementary', 'File', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 3, 5, 1, 2, 1, 1, 3, 5, 1, 2, 1, 1, 2, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 3, 1, 2, 1, 3, 1, 3, 1, 3, 1, 2, 1, 1, 2, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To assess the functional capacity for sulfate reduction among individual participants, the relative abundances of sulfate adenylyltransferase (EC 2.7.7.4) and adenylylsulfate reductase (EC 1.8.99.2) were specifically investigated among individual participants.	[('PMC6748593', 'R05000', 114, 141, 'sulfate adenylyltransferase')]	['To', 'assess', 'the', 'functional', 'capacity', 'for', 'su', '##lf', '##ate', 'reduction', 'among', 'individual', 'participants', ',', 'the', 'relative', 'abundance', '##s', 'of', 'su', '##lf', '##ate', 'ad', '##en', '##yl', '##yl', '##tra', '##ns', '##fer', '##ase', '(', 'EC', '2', '.', '7', '.', '7', '.', '4', ')', 'and', 'ad', '##en', '##yl', '##yl', '##sul', '##fa', '##te', 'red', '##uc', '##tase', '(', 'EC', '1', '.', '8', '.', '99', '.', '2', ')', 'were', 'specifically', 'investigated', 'among', 'individual', 'participants', '.']	[0, 3, 10, 14, 25, 34, 38, 40, 42, 46, 56, 62, 73, 85, 87, 91, 100, 109, 111, 114, 116, 118, 122, 124, 126, 128, 130, 133, 135, 138, 142, 143, 146, 147, 148, 149, 150, 151, 152, 153, 155, 159, 161, 163, 165, 167, 170, 172, 175, 178, 180, 185, 186, 189, 190, 191, 192, 193, 195, 196, 197, 199, 204, 217, 230, 236, 247, 259]	[2, 9, 13, 24, 33, 37, 40, 42, 45, 55, 61, 72, 85, 86, 90, 99, 109, 110, 113, 116, 118, 121, 124, 126, 128, 130, 133, 135, 138, 141, 143, 145, 147, 148, 149, 150, 151, 152, 153, 154, 158, 161, 163, 165, 167, 170, 172, 174, 178, 180, 184, 186, 188, 190, 191, 192, 193, 195, 196, 197, 198, 203, 216, 229, 235, 246, 259, 260]	['To', 'assess', 'the', 'functional', 'capacity', 'for', 'sulfate', 'reduction', 'among', 'individual', 'participants', ',', 'the', 'relative', 'abundances', 'of', 'sulfate', 'adenylyltransferase', '(', 'EC', '2.7.7.4', ')', 'and', 'adenylylsulfate', 'reductase', '(', 'EC', '1.8.99.2', ')', 'were', 'specifically', 'investigated', 'among', 'individual', 'participants', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 8, 1, 1, 7, 1, 1, 7, 3, 1, 1, 7, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
While the relative abundance of sulfate adenylyltransferase was significantly greater in participant 02 (post-hoc P ≤ 0.020) than all other participants, no other significant differences among individuals or dietary arm were noted, and other genes known to be involved in dissimilatory sulfate reduction could not be identified.	[('PMC6748593', 'R05001', 32, 59, 'sulfate adenylyltransferase')]	['While', 'the', 'relative', 'abundance', 'of', 'su', '##lf', '##ate', 'ad', '##en', '##yl', '##yl', '##tra', '##ns', '##fer', '##ase', 'was', 'significantly', 'greater', 'in', 'participant', '02', '(', 'post', '-', 'ho', '##c', 'P', '≤', '0', '.', '02', '##0', ')', 'than', 'all', 'other', 'participants', ',', 'no', 'other', 'significant', 'differences', 'among', 'individuals', 'or', 'diet', '##ary', 'arm', 'were', 'noted', ',', 'and', 'other', 'genes', 'known', 'to', 'be', 'involved', 'in', 'di', '##ssi', '##mi', '##lator', '##y', 'su', '##lf', '##ate', 'reduction', 'could', 'not', 'be', 'identified', '.']	[0, 6, 10, 19, 29, 32, 34, 36, 40, 42, 44, 46, 48, 51, 53, 56, 60, 64, 78, 86, 89, 101, 104, 105, 109, 110, 112, 114, 116, 118, 119, 120, 122, 123, 125, 130, 134, 140, 152, 154, 157, 163, 175, 187, 193, 205, 208, 212, 216, 220, 225, 230, 232, 236, 242, 248, 254, 257, 260, 269, 272, 274, 277, 279, 284, 286, 288, 290, 294, 304, 310, 314, 317, 327]	[5, 9, 18, 28, 31, 34, 36, 39, 42, 44, 46, 48, 51, 53, 56, 59, 63, 77, 85, 88, 100, 103, 105, 109, 110, 112, 113, 115, 117, 119, 120, 122, 123, 124, 129, 133, 139, 152, 153, 156, 162, 174, 186, 192, 204, 207, 212, 215, 219, 224, 230, 231, 235, 241, 247, 253, 256, 259, 268, 271, 274, 277, 279, 284, 285, 288, 290, 293, 303, 309, 313, 316, 327, 328]	['While', 'the', 'relative', 'abundance', 'of', 'sulfate', 'adenylyltransferase', 'was', 'significantly', 'greater', 'in', 'participant', '02', '(', 'post', '-', 'hoc', 'P', '≤', '0.020', ')', 'than', 'all', 'other', 'participants', ',', 'no', 'other', 'significant', 'differences', 'among', 'individuals', 'or', 'dietary', 'arm', 'were', 'noted', ',', 'and', 'other', 'genes', 'known', 'to', 'be', 'involved', 'in', 'dissimilatory', 'sulfate', 'reduction', 'could', 'not', 'be', 'identified', '.']	[1, 1, 1, 1, 1, 3, 8, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Prior studies have documented that the expression and activity of key genes in the fatty acid metabolism pathway, including ATP citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), fatty acid synthase, and stearoyl-coenzyme A desaturase, are observed in various tumors and are closely related to poor prognosis of these patients.[48–50]	[]	['Prior', 'studies', 'have', 'documented', 'that', 'the', 'expression', 'and', 'activity', 'of', 'key', 'genes', 'in', 'the', 'fatty', 'acid', 'metabolism', 'pathway', ',', 'including', 'ATP', 'c', '##it', '##rate', 'l', '##yas', '##e', '(', 'AC', '##L', '##Y', ')', ',', 'ace', '##ty', '##l', '-', 'Co', '##A', 'car', '##box', '##yla', '##se', '(', 'ACC', ')', ',', 'fatty', 'acid', 's', '##ynth', '##ase', ',', 'and', 's', '##te', '##aro', '##yl', '-', 'co', '##en', '##zy', '##me', 'A', 'des', '##at', '##ura', '##se', ',', 'are', 'observed', 'in', 'various', 'tumors', 'and', 'are', 'closely', 'related', 'to', 'poor', 'pro', '##gno', '##sis', 'of', 'these', 'patients', '.', '[', '48', '–', '50', ']']	[0, 6, 14, 19, 30, 35, 39, 50, 54, 63, 66, 70, 76, 79, 83, 89, 94, 105, 112, 114, 124, 128, 129, 131, 136, 137, 140, 142, 143, 145, 146, 147, 148, 150, 153, 155, 156, 157, 159, 161, 164, 167, 170, 173, 174, 177, 178, 180, 186, 191, 192, 196, 199, 201, 205, 206, 208, 211, 213, 214, 216, 218, 220, 223, 225, 228, 230, 233, 235, 237, 241, 250, 253, 261, 268, 272, 276, 284, 292, 295, 300, 303, 306, 310, 313, 319, 327, 328, 329, 331, 332, 334]	[5, 13, 18, 29, 34, 38, 49, 53, 62, 65, 69, 75, 78, 82, 88, 93, 104, 112, 113, 123, 127, 129, 131, 135, 137, 140, 141, 143, 145, 146, 147, 148, 149, 153, 155, 156, 157, 159, 160, 164, 167, 170, 172, 174, 177, 178, 179, 185, 190, 192, 196, 199, 200, 204, 206, 208, 211, 213, 214, 216, 218, 220, 222, 224, 228, 230, 233, 235, 236, 240, 249, 252, 260, 267, 271, 275, 283, 291, 294, 299, 303, 306, 309, 312, 318, 327, 328, 329, 331, 332, 334, 335]	['Prior', 'studies', 'have', 'documented', 'that', 'the', 'expression', 'and', 'activity', 'of', 'key', 'genes', 'in', 'the', 'fatty', 'acid', 'metabolism', 'pathway', ',', 'including', 'ATP', 'citrate', 'lyase', '(', 'ACLY', ')', ',', 'acetyl-CoA', 'carboxylase', '(', 'ACC', ')', ',', 'fatty', 'acid', 'synthase', ',', 'and', 'stearoyl', '-', 'coenzyme', 'A', 'desaturase', ',', 'are', 'observed', 'in', 'various', 'tumors', 'and', 'are', 'closely', 'related', 'to', 'poor', 'prognosis', 'of', 'these', 'patients.[48–50]']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 3, 1, 1, 6, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 7]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, the growth of tumor could be inhibited by reducing the expression of these metabolic enzymes or using specific inhibitors to inhibit the activity of metabolic enzymes.[51]	[]	['Moreover', ',', 'the', 'growth', 'of', 'tumor', 'could', 'be', 'in', '##hibit', '##ed', 'by', 'reducing', 'the', 'expression', 'of', 'these', 'metabolic', 'enzymes', 'or', 'using', 'specific', 'inhibitor', '##s', 'to', 'in', '##hibit', 'the', 'activity', 'of', 'metabolic', 'enzymes', '.', '[', '51', ']']	[0, 8, 10, 14, 21, 24, 30, 36, 39, 41, 46, 49, 52, 61, 65, 76, 79, 85, 95, 103, 106, 112, 121, 130, 132, 135, 137, 143, 147, 156, 159, 169, 176, 177, 178, 180]	[8, 9, 13, 20, 23, 29, 35, 38, 41, 46, 48, 51, 60, 64, 75, 78, 84, 94, 102, 105, 111, 120, 130, 131, 134, 137, 142, 146, 155, 158, 168, 176, 177, 178, 180, 181]	['Moreover', ',', 'the', 'growth', 'of', 'tumor', 'could', 'be', 'inhibited', 'by', 'reducing', 'the', 'expression', 'of', 'these', 'metabolic', 'enzymes', 'or', 'using', 'specific', 'inhibitors', 'to', 'inhibit', 'the', 'activity', 'of', 'metabolic', 'enzymes.[51]']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 5]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
With the advent of microarray techniques, many pathological processes can be explored and monitored in a global view by the aid of omics-driven, high-throughput technologies.[15] In several genomics, transcriptomics, and proteomics researches, a series of genes and protein molecules (parathyroid hormone-related protein, nuclear factor Ib, zinc finger protein-14, glutathione peroxidase 1, etc) have been found to be abnormally expressed in GCT patients,[16–19] which were also expected to be potential biomarkers for GCT.	[('PMC6783185', 'I02000', 365, 389, 'glutathione peroxidase 1')]	['With', 'the', 'advent', 'of', 'micro', '##arra', '##y', 'techniques', ',', 'many', 'path', '##ological', 'processes', 'can', 'be', 'explored', 'and', 'monitored', 'in', 'a', 'global', 'view', 'by', 'the', 'aid', 'of', 'o', '##mic', '##s', '-', 'driven', ',', 'high', '-', 'through', '##put', 'technologies', '.', '[', '15', ']', 'In', 'several', 'g', '##eno', '##mic', '##s', ',', 'trans', '##cript', '##omi', '##cs', ',', 'and', 'pro', '##te', '##omi', '##cs', 'research', '##es', ',', 'a', 'series', 'of', 'genes', 'and', 'protein', 'molecules', '(', 'para', '##thy', '##roid', 'hormone', '-', 'related', 'protein', ',', 'nuclear', 'factor', 'I', '##b', ',', 'zinc', 'finger', 'protein', '-', '14', ',', 'g', '##lut', '##ath', '##ione', 'per', '##ox', '##idas', '##e', '1', ',', 'etc', ')', 'have', 'been', 'found', 'to', 'be', 'abnormal', '##ly', 'expressed', 'in', 'G', '##CT', 'patients', ',', '[', '16', '–', '19', ']', 'which', 'were', 'also', 'expected', 'to', 'be', 'potential', 'bio', '##mark', '##ers', 'for', 'G', '##CT', '.']	[0, 5, 9, 16, 19, 24, 28, 30, 40, 42, 47, 51, 60, 70, 74, 77, 86, 90, 100, 103, 105, 112, 117, 120, 124, 128, 131, 132, 135, 136, 137, 143, 145, 149, 150, 157, 161, 173, 174, 175, 177, 179, 182, 190, 191, 194, 197, 198, 200, 205, 210, 213, 215, 217, 221, 224, 226, 229, 232, 240, 242, 244, 246, 253, 256, 262, 266, 274, 284, 285, 289, 292, 297, 304, 305, 313, 320, 322, 330, 337, 338, 339, 341, 346, 353, 360, 361, 363, 365, 366, 369, 372, 377, 380, 382, 386, 388, 389, 391, 394, 396, 401, 406, 412, 415, 418, 426, 429, 439, 442, 443, 446, 454, 455, 456, 458, 459, 461, 463, 469, 474, 479, 488, 491, 494, 504, 507, 511, 515, 519, 520, 522]	[4, 8, 15, 18, 24, 28, 29, 40, 41, 46, 51, 59, 69, 73, 76, 85, 89, 99, 102, 104, 111, 116, 119, 123, 127, 130, 132, 135, 136, 137, 143, 144, 149, 150, 157, 160, 173, 174, 175, 177, 178, 181, 189, 191, 194, 197, 198, 199, 205, 210, 213, 215, 216, 220, 224, 226, 229, 231, 240, 242, 243, 245, 252, 255, 261, 265, 273, 283, 285, 289, 292, 296, 304, 305, 312, 320, 321, 329, 336, 338, 339, 340, 345, 352, 360, 361, 363, 364, 366, 369, 372, 376, 380, 382, 386, 387, 389, 390, 394, 395, 400, 405, 411, 414, 417, 426, 428, 438, 441, 443, 445, 454, 455, 456, 458, 459, 461, 462, 468, 473, 478, 487, 490, 493, 503, 507, 511, 514, 518, 520, 522, 523]	['With', 'the', 'advent', 'of', 'microarray', 'techniques', ',', 'many', 'pathological', 'processes', 'can', 'be', 'explored', 'and', 'monitored', 'in', 'a', 'global', 'view', 'by', 'the', 'aid', 'of', 'omics', '-', 'driven', ',', 'high', '-', 'throughput', 'technologies.[15]', 'In', 'several', 'genomics', ',', 'transcriptomics', ',', 'and', 'proteomics', 'researches', ',', 'a', 'series', 'of', 'genes', 'and', 'protein', 'molecules', '(', 'parathyroid', 'hormone', '-', 'related', 'protein', ',', 'nuclear', 'factor', 'Ib', ',', 'zinc', 'finger', 'protein-14', ',', 'glutathione', 'peroxidase', '1', ',', 'etc', ')', 'have', 'been', 'found', 'to', 'be', 'abnormally', 'expressed', 'in', 'GCT', 'patients', ',', '[', '16–', '19', ']', 'which', 'were', 'also', 'expected', 'to', 'be', 'potential', 'biomarkers', 'for', 'GCT', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 5, 1, 1, 4, 1, 4, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 4, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although several studies have shown that soluble urokinase plasminogen-type activator receptor (suPAR) levels increase in primary FSGS2, there are reports that it is associated with decreased renal function rather than FSGS itself.	[]	['Although', 'several', 'studies', 'have', 'shown', 'that', 'soluble', 'u', '##rok', '##inas', '##e', 'p', '##las', '##min', '##ogen', '-', 'type', 'act', '##iva', '##tor', 'receptor', '(', 'su', '##PA', '##R', ')', 'levels', 'increase', 'in', 'primary', 'F', '##S', '##GS', '##2', ',', 'there', 'are', 'reports', 'that', 'it', 'is', 'associated', 'with', 'decreased', 're', '##nal', 'function', 'rather', 'than', 'F', '##S', '##GS', 'itself', '.']	[0, 9, 17, 25, 30, 36, 41, 49, 50, 53, 57, 59, 60, 63, 66, 70, 71, 76, 79, 82, 86, 95, 96, 98, 100, 101, 103, 110, 119, 122, 130, 131, 132, 134, 135, 137, 143, 147, 155, 160, 163, 166, 177, 182, 192, 194, 198, 207, 214, 219, 220, 221, 224, 230]	[8, 16, 24, 29, 35, 40, 48, 50, 53, 57, 58, 60, 63, 66, 70, 71, 75, 79, 82, 85, 94, 96, 98, 100, 101, 102, 109, 118, 121, 129, 131, 132, 134, 135, 136, 142, 146, 154, 159, 162, 165, 176, 181, 191, 194, 197, 206, 213, 218, 220, 221, 223, 230, 231]	['Although', 'several', 'studies', 'have', 'shown', 'that', 'soluble', 'urokinase', 'plasminogen', '-', 'type', 'activator', 'receptor', '(', 'suPAR', ')', 'levels', 'increase', 'in', 'primary', 'FSGS2', ',', 'there', 'are', 'reports', 'that', 'it', 'is', 'associated', 'with', 'decreased', 'renal', 'function', 'rather', 'than', 'FSGS', 'itself', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Primary antibodies targeting glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Cell Signaling, Danvers, MA, USA), synaptopodin (Progen, Heidelberg, Germany), and ZO-1 (Cell Signaling) were used.	[]	['Primary', 'antibodies', 'targeting', 'g', '##ly', '##cer', '##ald', '##eh', '##yd', '##e', '3', '-', 'phosphate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'GA', '##PD', '##H', ',', 'Cell', 'Signal', '##ing', ',', 'Dan', '##vers', ',', 'MA', ',', 'USA', ')', ',', 's', '##yna', '##pt', '##op', '##od', '##in', '(', 'Pro', '##gen', ',', 'Heidelberg', ',', 'Germany', ')', ',', 'and', 'Z', '##O', '-', '1', '(', 'Cell', 'Signal', '##ing', ')', 'were', 'used', '.']	[0, 8, 19, 29, 30, 32, 35, 38, 40, 42, 44, 45, 46, 56, 58, 60, 62, 66, 70, 71, 73, 75, 76, 78, 83, 89, 92, 94, 97, 101, 103, 105, 107, 110, 111, 113, 114, 117, 119, 121, 123, 126, 127, 130, 133, 135, 145, 147, 154, 155, 157, 161, 162, 163, 164, 166, 167, 172, 178, 181, 183, 188, 192]	[7, 18, 28, 30, 32, 35, 38, 40, 42, 43, 45, 46, 55, 58, 60, 62, 66, 69, 71, 73, 75, 76, 77, 82, 89, 92, 93, 97, 101, 102, 105, 106, 110, 111, 112, 114, 117, 119, 121, 123, 125, 127, 130, 133, 134, 145, 146, 154, 155, 156, 160, 162, 163, 164, 165, 167, 171, 178, 181, 182, 187, 192, 193]	['Primary', 'antibodies', 'targeting', 'glyceraldehyde', '3-phosphate', 'dehydrogenase', '(', 'GAPDH', ',', 'Cell', 'Signaling', ',', 'Danvers', ',', 'MA', ',', 'USA', ')', ',', 'synaptopodin', '(', 'Progen', ',', 'Heidelberg', ',', 'Germany', ')', ',', 'and', 'ZO-1', '(', 'Cell', 'Signaling', ')', 'were', 'used', '.']	[1, 1, 1, 7, 3, 5, 1, 3, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Staining was performed using polyclonal MIOX antibody (1:1000; Thermo Fisher Scientific, Waltham, MA, USA) at 4 °C overnight, followed by incubation with dextran polymer conjugated with horseradish peroxidase (GBI Labs, Bothell, WA, USA) for 5 minutes at room temperature.	[]	['St', '##ain', '##ing', 'was', 'performed', 'using', 'p', '##oly', '##c', '##lon', '##al', 'MI', '##OX', 'anti', '##body', '(', '1', ':', '1000', ';', 'The', '##rm', '##o', 'Fisher', 'Scientific', ',', 'Walt', '##ham', ',', 'MA', ',', 'USA', ')', 'at', '4', '°C', 'overnight', ',', 'followed', 'by', 'in', '##cu', '##bation', 'with', 'de', '##x', '##tra', '##n', 'polymer', 'con', '##ju', '##gated', 'with', 'horse', '##rad', '##ish', 'per', '##ox', '##idas', '##e', '(', 'GB', '##I', 'Labs', ',', 'Both', '##ell', ',', 'WA', ',', 'USA', ')', 'for', '5', 'minutes', 'at', 'room', 'temperature', '.']	[0, 2, 5, 9, 13, 23, 29, 30, 33, 34, 37, 40, 42, 45, 49, 54, 55, 56, 57, 61, 63, 66, 68, 70, 77, 87, 89, 93, 96, 98, 100, 102, 105, 107, 110, 112, 115, 124, 126, 135, 138, 140, 142, 149, 154, 156, 157, 160, 162, 170, 173, 175, 181, 186, 191, 194, 198, 201, 203, 207, 209, 210, 212, 214, 218, 220, 224, 227, 229, 231, 233, 236, 238, 242, 244, 252, 255, 260, 271]	[2, 5, 8, 12, 22, 28, 30, 33, 34, 37, 39, 42, 44, 49, 53, 55, 56, 57, 61, 62, 66, 68, 69, 76, 87, 88, 93, 96, 97, 100, 101, 105, 106, 109, 111, 114, 124, 125, 134, 137, 140, 142, 148, 153, 156, 157, 160, 161, 169, 173, 175, 180, 185, 191, 194, 197, 201, 203, 207, 208, 210, 212, 213, 218, 219, 224, 227, 228, 231, 232, 236, 237, 241, 243, 251, 254, 259, 271, 272]	['Staining', 'was', 'performed', 'using', 'polyclonal', 'MIOX', 'antibody', '(', '1', ':', '1000', ';', 'Thermo', 'Fisher', 'Scientific', ',', 'Waltham', ',', 'MA', ',', 'USA', ')', 'at', '4', '°C', 'overnight', ',', 'followed', 'by', 'incubation', 'with', 'dextran', 'polymer', 'conjugated', 'with', 'horseradish', 'peroxidase', '(', 'GBI', 'Labs', ',', 'Bothell', ',', 'WA', ',', 'USA', ')', 'for', '5', 'minutes', 'at', 'room', 'temperature', '.']	[3, 1, 1, 1, 5, 2, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 3, 1, 3, 4, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Next, we examined the expression of myo-inositol oxygenase (MIOX), which is primarily expressed in the kidneys and is known to be a part of the inositol catabolism pathway, in patients with FSGS and MCD.	[('PMC6789025', 'R10000', 36, 58, 'myo-inositol oxygenase')]	['Next', ',', 'we', 'examined', 'the', 'expression', 'of', 'my', '##o', '-', 'in', '##os', '##ito', '##l', 'oxygen', '##ase', '(', 'MI', '##OX', ')', ',', 'which', 'is', 'primarily', 'expressed', 'in', 'the', 'kidney', '##s', 'and', 'is', 'known', 'to', 'be', 'a', 'part', 'of', 'the', 'in', '##os', '##ito', '##l', 'cat', '##ab', '##olis', '##m', 'pathway', ',', 'in', 'patients', 'with', 'F', '##S', '##GS', 'and', 'MC', '##D', '.']	[0, 4, 6, 9, 18, 22, 33, 36, 38, 39, 40, 42, 44, 47, 49, 55, 59, 60, 62, 64, 65, 67, 73, 76, 86, 96, 99, 103, 109, 111, 115, 118, 124, 127, 130, 132, 137, 140, 144, 146, 148, 151, 153, 156, 158, 162, 164, 171, 173, 176, 185, 190, 191, 192, 195, 199, 201, 202]	[4, 5, 8, 17, 21, 32, 35, 38, 39, 40, 42, 44, 47, 48, 55, 58, 60, 62, 64, 65, 66, 72, 75, 85, 95, 98, 102, 109, 110, 114, 117, 123, 126, 129, 131, 136, 139, 143, 146, 148, 151, 152, 156, 158, 162, 163, 171, 172, 175, 184, 189, 191, 192, 194, 198, 201, 202, 203]	['Next', ',', 'we', 'examined', 'the', 'expression', 'of', 'myo', '-', 'inositol', 'oxygenase', '(', 'MIOX', ')', ',', 'which', 'is', 'primarily', 'expressed', 'in', 'the', 'kidneys', 'and', 'is', 'known', 'to', 'be', 'a', 'part', 'of', 'the', 'inositol', 'catabolism', 'pathway', ',', 'in', 'patients', 'with', 'FSGS', 'and', 'MCD', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 3, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In all EG patients the concentrations of valproic acid in serum were in the therapeutic range, the patients had normal liver and renal functions and the serum transaminases levels were normal.	[('PMC6803684', 'M04000', 153, 172, 'serum transaminases')]	['In', 'all', 'E', '##G', 'patients', 'the', 'concentrations', 'of', 'v', '##al', '##p', '##roi', '##c', 'acid', 'in', 'serum', 'were', 'in', 'the', 'therapeutic', 'range', ',', 'the', 'patients', 'had', 'normal', 'liver', 'and', 're', '##nal', 'functions', 'and', 'the', 'serum', 'trans', '##ami', '##nas', '##es', 'levels', 'were', 'normal', '.']	[0, 3, 7, 8, 10, 19, 23, 38, 41, 42, 44, 45, 48, 50, 55, 58, 64, 69, 72, 76, 88, 93, 95, 99, 108, 112, 119, 125, 129, 131, 135, 145, 149, 153, 159, 164, 167, 170, 173, 180, 185, 191]	[2, 6, 8, 9, 18, 22, 37, 40, 42, 44, 45, 48, 49, 54, 57, 63, 68, 71, 75, 87, 93, 94, 98, 107, 111, 118, 124, 128, 131, 134, 144, 148, 152, 158, 164, 167, 170, 172, 179, 184, 191, 192]	['In', 'all', 'EG', 'patients', 'the', 'concentrations', 'of', 'valproic', 'acid', 'in', 'serum', 'were', 'in', 'the', 'therapeutic', 'range', ',', 'the', 'patients', 'had', 'normal', 'liver', 'and', 'renal', 'functions', 'and', 'the', 'serum', 'transaminases', 'levels', 'were', 'normal', '.']	[1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O']
This finding is consistent with previous studies implicating high CTSB and CTSL protein abundance in aggressive ovarian cancers; however, no previous studies have probed protease activity or tumor compartment-specific activity (37–39).	[]	['This', 'finding', 'is', 'consistent', 'with', 'previous', 'studies', 'imp', '##lica', '##ting', 'high', 'CT', '##SB', 'and', 'CT', '##SL', 'protein', 'abundance', 'in', 'aggressive', 'o', '##var', '##ian', 'cancer', '##s', ';', 'however', ',', 'no', 'previous', 'studies', 'have', 'probe', '##d', 'pro', '##te', '##ase', 'activity', 'or', 'tumor', 'compartment', '-', 'specific', 'activity', '(', '37', '–', '39', ')', '.']	[0, 5, 13, 16, 27, 32, 41, 49, 52, 56, 61, 66, 68, 71, 75, 77, 80, 88, 98, 101, 112, 113, 116, 120, 126, 127, 129, 136, 138, 141, 150, 158, 163, 168, 170, 173, 175, 179, 188, 191, 197, 208, 209, 218, 227, 228, 230, 231, 233, 234]	[4, 12, 15, 26, 31, 40, 48, 52, 56, 60, 65, 68, 70, 74, 77, 79, 87, 97, 100, 111, 113, 116, 119, 126, 127, 128, 136, 137, 140, 149, 157, 162, 168, 169, 173, 175, 178, 187, 190, 196, 208, 209, 217, 226, 228, 230, 231, 233, 234, 235]	['This', 'finding', 'is', 'consistent', 'with', 'previous', 'studies', 'implicating', 'high', 'CTSB', 'and', 'CTSL', 'protein', 'abundance', 'in', 'aggressive', 'ovarian', 'cancers', ';', 'however', ',', 'no', 'previous', 'studies', 'have', 'probed', 'protease', 'activity', 'or', 'tumor', 'compartment', '-', 'specific', 'activity', '(', '37–', '39', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The relatively high activity in the primary tumor site is in agreement with the roles of microenvironment remodeling factors and proteases during the epithelial-to-mesenchymal transition in primary metastatic tumors (40), and also could be related to microenvironmental conditions in the primary tumor that may promote the activity of these enzymes.	[]	['The', 'relatively', 'high', 'activity', 'in', 'the', 'primary', 'tumor', 'site', 'is', 'in', 'agreement', 'with', 'the', 'roles', 'of', 'micro', '##en', '##vir', '##on', '##ment', 're', '##mo', '##del', '##ing', 'factors', 'and', 'pro', '##te', '##ases', 'during', 'the', 'e', '##pit', '##hel', '##ial', '-', 'to', '-', 'me', '##sen', '##chy', '##mal', 'transition', 'in', 'primary', 'meta', '##static', 'tumors', '(', '40', ')', ',', 'and', 'also', 'could', 'be', 'related', 'to', 'micro', '##en', '##vir', '##on', '##mental', 'conditions', 'in', 'the', 'primary', 'tumor', 'that', 'may', 'promote', 'the', 'activity', 'of', 'these', 'enzymes', '.']	[0, 4, 15, 20, 29, 32, 36, 44, 50, 55, 58, 61, 71, 76, 80, 86, 89, 94, 96, 99, 101, 106, 108, 110, 113, 117, 125, 129, 132, 134, 139, 146, 150, 151, 154, 157, 160, 161, 163, 164, 166, 169, 172, 176, 187, 190, 198, 202, 209, 216, 217, 219, 220, 222, 226, 231, 237, 240, 248, 251, 256, 258, 261, 263, 270, 281, 284, 288, 296, 302, 307, 311, 319, 323, 332, 335, 341, 348]	[3, 14, 19, 28, 31, 35, 43, 49, 54, 57, 60, 70, 75, 79, 85, 88, 94, 96, 99, 101, 105, 108, 110, 113, 116, 124, 128, 132, 134, 138, 145, 149, 151, 154, 157, 160, 161, 163, 164, 166, 169, 172, 175, 186, 189, 197, 202, 208, 215, 217, 219, 220, 221, 225, 230, 236, 239, 247, 250, 256, 258, 261, 263, 269, 280, 283, 287, 295, 301, 306, 310, 318, 322, 331, 334, 340, 348, 349]	['The', 'relatively', 'high', 'activity', 'in', 'the', 'primary', 'tumor', 'site', 'is', 'in', 'agreement', 'with', 'the', 'roles', 'of', 'microenvironment', 'remodeling', 'factors', 'and', 'proteases', 'during', 'the', 'epithelial', '-', 'to', '-', 'mesenchymal', 'transition', 'in', 'primary', 'metastatic', 'tumors', '(', '40', ')', ',', 'and', 'also', 'could', 'be', 'related', 'to', 'microenvironmental', 'conditions', 'in', 'the', 'primary', 'tumor', 'that', 'may', 'promote', 'the', 'activity', 'of', 'these', 'enzymes', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 4, 1, 1, 3, 1, 1, 4, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Importantly, protein and mRNA abundance measurements alone could not detect this context-specific change in activity.	[]	['Important', '##ly', ',', 'protein', 'and', 'm', '##RNA', 'abundance', 'measurements', 'alone', 'could', 'not', 'detect', 'this', 'context', '-', 'specific', 'change', 'in', 'activity', '.']	[0, 9, 11, 13, 21, 25, 26, 30, 40, 53, 59, 65, 69, 76, 81, 88, 89, 98, 105, 108, 116]	[9, 11, 12, 20, 24, 26, 29, 39, 52, 58, 64, 68, 75, 80, 88, 89, 97, 104, 107, 116, 117]	['Importantly', ',', 'protein', 'and', 'mRNA', 'abundance', 'measurements', 'alone', 'could', 'not', 'detect', 'this', 'context', '-', 'specific', 'change', 'in', 'activity', '.']	[2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Family-wide chemical proteomic probes are particularly useful because they can report on the activity of large swaths of the active proteome simultaneously, with published examples available for serine hydrolases (6, 7), kinases (8, 9), metalloproteases (10), cysteine proteases (11), and other functionalities that regulate protein activity (12–14).	[('PMC6815137', 'I01000', 195, 212, 'serine hydrolases')]	['Family', '-', 'wide', 'chemical', 'pro', '##te', '##omi', '##c', 'probe', '##s', 'are', 'particularly', 'useful', 'because', 'they', 'can', 'report', 'on', 'the', 'activity', 'of', 'large', 's', '##wat', '##hs', 'of', 'the', 'active', 'pro', '##te', '##ome', 'simultaneously', ',', 'with', 'published', 'examples', 'available', 'for', 'se', '##rine', 'h', '##ydro', '##lase', '##s', '(', '6', ',', '7', ')', ',', 'kinase', '##s', '(', '8', ',', '9', ')', ',', 'metal', '##lop', '##rote', '##ases', '(', '10', ')', ',', 'c', '##ys', '##tein', '##e', 'pro', '##te', '##ases', '(', '11', ')', ',', 'and', 'other', 'functional', '##ities', 'that', 'regulate', 'protein', 'activity', '(', '12', '–', '14', ')', '.']	[0, 6, 7, 12, 21, 24, 26, 29, 31, 36, 38, 42, 55, 62, 70, 75, 79, 86, 89, 93, 102, 105, 111, 112, 115, 118, 121, 125, 132, 135, 137, 141, 155, 157, 162, 172, 181, 191, 195, 197, 202, 203, 207, 211, 213, 214, 215, 217, 218, 219, 221, 227, 229, 230, 231, 233, 234, 235, 237, 242, 245, 249, 254, 255, 257, 258, 260, 261, 263, 267, 269, 272, 274, 279, 280, 282, 283, 285, 289, 295, 305, 311, 316, 325, 333, 342, 343, 345, 346, 348, 349]	[6, 7, 11, 20, 24, 26, 29, 30, 36, 37, 41, 54, 61, 69, 74, 78, 85, 88, 92, 101, 104, 110, 112, 115, 117, 120, 124, 131, 135, 137, 140, 155, 156, 161, 171, 180, 190, 194, 197, 201, 203, 207, 211, 212, 214, 215, 216, 218, 219, 220, 227, 228, 230, 231, 232, 234, 235, 236, 242, 245, 249, 253, 255, 257, 258, 259, 261, 263, 267, 268, 272, 274, 278, 280, 282, 283, 284, 288, 294, 305, 310, 315, 324, 332, 341, 343, 345, 346, 348, 349, 350]	['Family', '-', 'wide', 'chemical', 'proteomic', 'probes', 'are', 'particularly', 'useful', 'because', 'they', 'can', 'report', 'on', 'the', 'activity', 'of', 'large', 'swaths', 'of', 'the', 'active', 'proteome', 'simultaneously', ',', 'with', 'published', 'examples', 'available', 'for', 'serine', 'hydrolases', '(', '6', ',', '7', ')', ',', 'kinases', '(', '8', ',', '9', ')', ',', 'metalloproteases', '(', '10', ')', ',', 'cysteine', 'proteases', '(', '11', ')', ',', 'and', 'other', 'functionalities', 'that', 'regulate', 'protein', 'activity', '(', '12–', '14', ')', '.']	[1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To pilot sADPL, we targeted proteins associated with cancer phenotypes in 2 well-characterized enzyme families, serine hydrolase and cathepsin cysteine protease enzymes, using widely available fluorophosphonate-biotin (FP-Bio) (15) and an acyloxymethylketone-based cathepsin probe (19), respectively.	[('PMC6815137', 'R01000', 112, 128, 'serine hydrolase')]	['To', 'pilot', 's', '##AD', '##PL', ',', 'we', 'targeted', 'proteins', 'associated', 'with', 'cancer', 'p', '##hen', '##otype', '##s', 'in', '2', 'well', '-', 'characterized', 'enzyme', 'families', ',', 'se', '##rine', 'h', '##ydro', '##lase', 'and', 'cat', '##he', '##ps', '##in', 'c', '##ys', '##tein', '##e', 'pro', '##te', '##ase', 'enzymes', ',', 'using', 'widely', 'available', 'flu', '##oro', '##ph', '##os', '##phon', '##ate', '-', 'bio', '##tin', '(', 'F', '##P', '-', 'B', '##io', ')', '(', '15', ')', 'and', 'an', 'a', '##cy', '##lo', '##xy', '##met', '##hyl', '##ket', '##one', '-', 'based', 'cat', '##he', '##ps', '##in', 'probe', '(', '19', ')', ',', 'respectively', '.']	[0, 3, 9, 10, 12, 14, 16, 19, 28, 37, 48, 53, 60, 61, 64, 69, 71, 74, 76, 80, 81, 95, 102, 110, 112, 114, 119, 120, 124, 129, 133, 136, 138, 140, 143, 144, 146, 150, 152, 155, 157, 161, 168, 170, 176, 183, 193, 196, 199, 201, 203, 207, 210, 211, 214, 218, 219, 220, 221, 222, 223, 225, 227, 228, 230, 232, 236, 239, 240, 242, 244, 246, 249, 252, 255, 258, 259, 265, 268, 270, 272, 275, 281, 282, 284, 285, 287, 299]	[2, 8, 10, 12, 14, 15, 18, 27, 36, 47, 52, 59, 61, 64, 69, 70, 73, 75, 80, 81, 94, 101, 110, 111, 114, 118, 120, 124, 128, 132, 136, 138, 140, 142, 144, 146, 150, 151, 155, 157, 160, 168, 169, 175, 182, 192, 196, 199, 201, 203, 207, 210, 211, 214, 217, 219, 220, 221, 222, 223, 225, 226, 228, 230, 231, 235, 238, 240, 242, 244, 246, 249, 252, 255, 258, 259, 264, 268, 270, 272, 274, 280, 282, 284, 285, 286, 299, 300]	['To', 'pilot', 'sADPL', ',', 'we', 'targeted', 'proteins', 'associated', 'with', 'cancer', 'phenotypes', 'in', '2', 'well', '-', 'characterized', 'enzyme', 'families', ',', 'serine', 'hydrolase', 'and', 'cathepsin', 'cysteine', 'protease', 'enzymes', ',', 'using', 'widely', 'available', 'fluorophosphonate', '-', 'biotin', '(', 'FP-Bio', ')', '(', '15', ')', 'and', 'an', 'acyloxymethylketone', '-', 'based', 'cathepsin', 'probe', '(', '19', ')', ',', 'respectively', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 4, 3, 1, 1, 1, 1, 1, 6, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 8, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using monoacylglycerol lipase (MGLL) as a model enzyme, we optimized the absolute and relative concentrations of Ab-oligo and SA-oligo conjugates required for the sADPL signal and dynamic range in whole-cell proteome (SI Appendix, Fig. S2).	[]	['Using', 'mon', '##oa', '##cy', '##l', '##gly', '##cer', '##ol', 'lip', '##ase', '(', 'MG', '##LL', ')', 'as', 'a', 'model', 'enzyme', ',', 'we', 'op', '##ti', '##mized', 'the', 'absolute', 'and', 'relative', 'concentrations', 'of', 'A', '##b', '-', 'o', '##li', '##go', 'and', 'SA', '-', 'o', '##li', '##go', 'con', '##ju', '##gate', '##s', 'required', 'for', 'the', 's', '##AD', '##PL', 'signal', 'and', 'dynamic', 'range', 'in', 'whole', '-', 'cell', 'pro', '##te', '##ome', '(', 'S', '##I', 'A', '##ppe', '##ndi', '##x', ',', 'Fi', '##g', '.', 'S', '##2', ')', '.']	[0, 6, 9, 11, 13, 14, 17, 20, 23, 26, 30, 31, 33, 35, 37, 40, 42, 48, 54, 56, 59, 61, 63, 69, 73, 82, 86, 95, 110, 113, 114, 115, 116, 117, 119, 122, 126, 128, 129, 130, 132, 135, 138, 140, 144, 146, 155, 159, 163, 164, 166, 169, 176, 180, 188, 194, 197, 202, 203, 208, 211, 213, 217, 218, 219, 221, 222, 225, 228, 229, 231, 233, 234, 236, 237, 238, 239]	[5, 9, 11, 13, 14, 17, 20, 22, 26, 29, 31, 33, 35, 36, 39, 41, 47, 54, 55, 58, 61, 63, 68, 72, 81, 85, 94, 109, 112, 114, 115, 116, 117, 119, 121, 125, 128, 129, 130, 132, 134, 138, 140, 144, 145, 154, 158, 162, 164, 166, 168, 175, 179, 187, 193, 196, 202, 203, 207, 211, 213, 216, 218, 219, 220, 222, 225, 228, 229, 230, 233, 234, 235, 237, 238, 239, 240]	['Using', 'monoacylglycerol', 'lipase', '(', 'MGLL', ')', 'as', 'a', 'model', 'enzyme', ',', 'we', 'optimized', 'the', 'absolute', 'and', 'relative', 'concentrations', 'of', 'Ab-oligo', 'and', 'SA-oligo', 'conjugates', 'required', 'for', 'the', 'sADPL', 'signal', 'and', 'dynamic', 'range', 'in', 'whole', '-', 'cell', 'proteome', '(', 'SI', 'Appendix', ',', 'Fig', '.', 'S2', ')', '.']	[1, 7, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 6, 1, 5, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 4, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Linear discriminant analysis (LDA) effect size (LEfSe) algorithm was performed with the Galaxy software package of the Huttenhower lab to identify differential abundances of microbes in the UVB treated samples (Segata et al., 2011).	[]	['Line', '##ar', 'disc', '##rim', '##ina', '##nt', 'analysis', '(', 'L', '##DA', ')', 'effect', 'size', '(', 'L', '##E', '##f', '##S', '##e', ')', 'algorithm', 'was', 'performed', 'with', 'the', 'Galaxy', 'software', 'package', 'of', 'the', 'Hu', '##tten', '##how', '##er', 'lab', 'to', 'identify', 'differential', 'abundance', '##s', 'of', 'micro', '##bes', 'in', 'the', 'UV', '##B', 'treated', 'samples', '(', 'Sega', '##ta', 'et', 'al', '.', ',', '2011', ')', '.']	[0, 4, 7, 11, 14, 17, 20, 29, 30, 31, 33, 35, 42, 47, 48, 49, 50, 51, 52, 53, 55, 65, 69, 79, 84, 88, 95, 104, 112, 115, 119, 121, 125, 128, 131, 135, 138, 147, 160, 169, 171, 174, 179, 183, 186, 190, 192, 194, 202, 210, 211, 215, 218, 221, 223, 224, 226, 230, 231]	[4, 6, 11, 14, 17, 19, 28, 30, 31, 33, 34, 41, 46, 48, 49, 50, 51, 52, 53, 54, 64, 68, 78, 83, 87, 94, 103, 111, 114, 118, 121, 125, 128, 130, 134, 137, 146, 159, 169, 170, 173, 179, 182, 185, 189, 192, 193, 201, 209, 211, 215, 217, 220, 223, 224, 225, 230, 231, 232]	['Linear', 'discriminant', 'analysis', '(', 'LDA', ')', 'effect', 'size', '(', 'LEfSe', ')', 'algorithm', 'was', 'performed', 'with', 'the', 'Galaxy', 'software', 'package', 'of', 'the', 'Huttenhower', 'lab', 'to', 'identify', 'differential', 'abundances', 'of', 'microbes', 'in', 'the', 'UVB', 'treated', 'samples', '(', 'Segata', 'et', 'al', '.', ',', '2011', ')', '.']	[2, 4, 1, 1, 2, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The V3 and V4 variables of the 16S rRNA region were amplified and the sequence library was generated by Polymerase chain reaction (PCR) using the following primer pair:	[('PMC6827100', 'M02000', 104, 114, 'Polymerase')]	['The', 'V', '##3', 'and', 'V', '##4', 'variables', 'of', 'the', '16', '##S', 'r', '##RNA', 'region', 'were', 'am', '##plified', 'and', 'the', 'sequence', 'library', 'was', 'generated', 'by', 'Pol', '##yme', '##rase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'using', 'the', 'following', 'prime', '##r', 'pair', ':']	[0, 4, 5, 7, 11, 12, 14, 24, 27, 31, 33, 35, 36, 40, 47, 52, 54, 62, 66, 70, 79, 87, 91, 101, 104, 107, 110, 115, 121, 130, 131, 133, 134, 136, 142, 146, 156, 161, 163, 167]	[3, 5, 6, 10, 12, 13, 23, 26, 30, 33, 34, 36, 39, 46, 51, 54, 61, 65, 69, 78, 86, 90, 100, 103, 107, 110, 114, 120, 129, 131, 133, 134, 135, 141, 145, 155, 161, 162, 167, 168]	['The', 'V3', 'and', 'V4', 'variables', 'of', 'the', '16S', 'rRNA', 'region', 'were', 'amplified', 'and', 'the', 'sequence', 'library', 'was', 'generated', 'by', 'Polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'using', 'the', 'following', 'primer', 'pair', ':']	[1, 2, 1, 2, 1, 1, 1, 2, 2, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The amplification, sequencing, and library preparation workflow were conducted using Herculase II fusion DNA polymerase Nextera XT Index Kit V2, following the 16S metagenomic sequencing library preparation Part # 15044223 Rev. B protocol in Illumina® MiSeq® platform at Macrogen (Seoul, South Korea) yielding paired-end reads.	[('PMC6827100', 'M05000', 105, 119, 'DNA polymerase')]	['The', 'am', '##p', '##lification', ',', 'se', '##quencing', ',', 'and', 'library', 'preparation', 'work', '##flow', 'were', 'conducted', 'using', 'Her', '##cula', '##se', 'II', 'fusion', 'DNA', 'polymer', '##ase', 'Next', '##era', 'X', '##T', 'Index', 'Kit', 'V', '##2', ',', 'following', 'the', '16', '##S', 'meta', '##gen', '##omi', '##c', 'se', '##quencing', 'library', 'preparation', 'Part', '#', '150', '##44', '##22', '##3', 'Rev', '.', 'B', 'protocol', 'in', 'Il', '##lum', '##ina', '®', 'Mi', '##S', '##e', '##q', '®', 'platform', 'at', 'Mac', '##rogen', '(', 'Seoul', ',', 'South', 'Korea', ')', 'yielding', 'paired', '-', 'end', 'reads', '.']	[0, 4, 6, 7, 17, 19, 21, 29, 31, 35, 43, 55, 59, 64, 69, 79, 85, 88, 92, 95, 98, 105, 109, 116, 120, 124, 128, 129, 131, 137, 141, 142, 143, 145, 155, 159, 161, 163, 167, 170, 173, 175, 177, 186, 194, 206, 211, 213, 216, 218, 220, 222, 225, 227, 229, 238, 241, 243, 246, 249, 251, 253, 254, 255, 256, 258, 267, 270, 273, 279, 280, 285, 287, 293, 298, 300, 309, 315, 316, 320, 325]	[3, 6, 7, 17, 18, 21, 29, 30, 34, 42, 54, 59, 63, 68, 78, 84, 88, 92, 94, 97, 104, 108, 116, 119, 124, 127, 129, 130, 136, 140, 142, 143, 144, 154, 158, 161, 162, 167, 170, 173, 174, 177, 185, 193, 205, 210, 212, 216, 218, 220, 221, 225, 226, 228, 237, 240, 243, 246, 249, 250, 253, 254, 255, 256, 257, 266, 269, 273, 278, 280, 285, 286, 292, 298, 299, 308, 315, 316, 319, 325, 326]	['The', 'amplification', ',', 'sequencing', ',', 'and', 'library', 'preparation', 'workflow', 'were', 'conducted', 'using', 'Herculase', 'II', 'fusion', 'DNA', 'polymerase', 'Nextera', 'XT', 'Index', 'Kit', 'V2', ',', 'following', 'the', '16S', 'metagenomic', 'sequencing', 'library', 'preparation', 'Part', '#', '15044223', 'Rev', '.', 'B', 'protocol', 'in', 'Illumina', '®', 'MiSeq', '®', 'platform', 'at', 'Macrogen', '(', 'Seoul', ',', 'South', 'Korea', ')', 'yielding', 'paired', '-', 'end', 'reads', '.']	[1, 3, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 2, 2, 2, 1, 1, 2, 1, 1, 1, 2, 4, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The increase in the concentration of succinic, α-ketoglutaric, and fumaric acids in the blood suggests that the inhibition of dehydrogenases occurs in the part of the TCA cycle that involves the successive oxidation of α-ketoglutaric into succinic acid and then succinic into fumaric acid.	[('PMC6835733', 'D03000', 126, 140, 'dehydrogenases')]	['The', 'increase', 'in', 'the', 'concentration', 'of', 'su', '##cci', '##nic', ',', 'α', '-', 'k', '##eto', '##g', '##lut', '##ari', '##c', ',', 'and', 'f', '##uma', '##ric', 'acids', 'in', 'the', 'blood', 'suggests', 'that', 'the', 'in', '##hibition', 'of', 'de', '##hy', '##dr', '##ogen', '##ases', 'occurs', 'in', 'the', 'part', 'of', 'the', 'T', '##CA', 'cycle', 'that', 'involves', 'the', 'successive', 'oxidation', 'of', 'α', '-', 'k', '##eto', '##g', '##lut', '##ari', '##c', 'into', 'su', '##cci', '##nic', 'acid', 'and', 'then', 'su', '##cci', '##nic', 'into', 'f', '##uma', '##ric', 'acid', '.']	[0, 4, 13, 16, 20, 34, 37, 39, 42, 45, 47, 48, 49, 50, 53, 54, 57, 60, 61, 63, 67, 68, 71, 75, 81, 84, 88, 94, 103, 108, 112, 114, 123, 126, 128, 130, 132, 136, 141, 148, 151, 155, 160, 163, 167, 168, 171, 177, 182, 191, 195, 206, 216, 219, 220, 221, 222, 225, 226, 229, 232, 234, 239, 241, 244, 248, 253, 257, 262, 264, 267, 271, 276, 277, 280, 284, 288]	[3, 12, 15, 19, 33, 36, 39, 42, 45, 46, 48, 49, 50, 53, 54, 57, 60, 61, 62, 66, 68, 71, 74, 80, 83, 87, 93, 102, 107, 111, 114, 122, 125, 128, 130, 132, 136, 140, 147, 150, 154, 159, 162, 166, 168, 170, 176, 181, 190, 194, 205, 215, 218, 220, 221, 222, 225, 226, 229, 232, 233, 238, 241, 244, 247, 252, 256, 261, 264, 267, 270, 275, 277, 280, 283, 288, 289]	['The', 'increase', 'in', 'the', 'concentration', 'of', 'succinic', ',', 'α-ketoglutaric', ',', 'and', 'fumaric', 'acids', 'in', 'the', 'blood', 'suggests', 'that', 'the', 'inhibition', 'of', 'dehydrogenases', 'occurs', 'in', 'the', 'part', 'of', 'the', 'TCA', 'cycle', 'that', 'involves', 'the', 'successive', 'oxidation', 'of', 'α-ketoglutaric', 'into', 'succinic', 'acid', 'and', 'then', 'succinic', 'into', 'fumaric', 'acid', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 8, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 8, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Methods for DNA extraction, polymerase chain reaction (PCR) amplification, and sequencing were previously described in detail.[12, 14, 15, 17] Briefly, DNA extraction, PCR amplification of the V4 region of the 16S rRNA gene, and amplicon preparation were performed as described by Caporaso et al.[17], using the universal bacterial primer set 515F/806R,[17, 18] and can be found on the Earth Microbiome Project website (http://www.earthmicrobiome.org/emp-standard-protocols/dna-extraction-protocol/).	[('PMC6860998', 'M04000', 28, 38, 'polymerase')]	['Method', '##s', 'for', 'DNA', 'extraction', ',', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'am', '##p', '##lification', ',', 'and', 'se', '##quencing', 'were', 'previously', 'described', 'in', 'detail', '.', '[', '12', ',', '14', ',', '15', ',', '17', ']', 'B', '##rief', '##ly', ',', 'DNA', 'extraction', ',', 'PC', '##R', 'am', '##p', '##lification', 'of', 'the', 'V', '##4', 'region', 'of', 'the', '16', '##S', 'r', '##RNA', 'gene', ',', 'and', 'am', '##p', '##lic', '##on', 'preparation', 'were', 'performed', 'as', 'described', 'by', 'Cap', '##ora', '##so', 'et', 'al', '.', '[', '17', ']', ',', 'using', 'the', 'universal', 'bacterial', 'prime', '##r', 'set', '51', '##5', '##F', '/', '80', '##6', '##R', ',', '[', '17', ',', '18', ']', 'and', 'can', 'be', 'found', 'on', 'the', 'Earth', 'Micro', '##bio', '##me', 'Project', 'website', '(', 'http', ':', '/', '/', 'www', '.', 'earth', '##mic', '##ro', '##bio', '##me', '.', 'org', '/', 'em', '##p', '-', 'standard', '-', 'protocols', '/', 'd', '##na', '-', 'extraction', '-', 'protocol', '/', ')', '.']	[0, 6, 8, 12, 16, 26, 28, 35, 39, 45, 54, 55, 57, 58, 60, 62, 63, 73, 75, 79, 81, 90, 95, 106, 116, 119, 125, 126, 127, 129, 131, 133, 135, 137, 139, 141, 143, 144, 148, 150, 152, 156, 166, 168, 170, 172, 174, 175, 186, 189, 193, 194, 196, 203, 206, 210, 212, 214, 215, 219, 223, 225, 229, 231, 232, 235, 238, 250, 255, 265, 268, 278, 281, 284, 287, 290, 293, 295, 296, 297, 299, 300, 302, 308, 312, 322, 332, 337, 339, 343, 345, 346, 347, 348, 350, 351, 352, 353, 354, 356, 358, 360, 362, 366, 370, 373, 379, 382, 386, 392, 397, 400, 403, 411, 419, 420, 424, 425, 426, 427, 430, 431, 436, 439, 441, 444, 446, 447, 450, 451, 453, 454, 455, 463, 464, 473, 474, 475, 477, 478, 488, 489, 497, 498, 499]	[6, 7, 11, 15, 26, 27, 35, 38, 44, 53, 55, 57, 58, 59, 62, 63, 73, 74, 78, 81, 89, 94, 105, 115, 118, 125, 126, 127, 129, 130, 133, 134, 137, 138, 141, 142, 144, 148, 150, 151, 155, 166, 167, 170, 171, 174, 175, 185, 188, 192, 194, 195, 202, 205, 209, 212, 213, 215, 218, 223, 224, 228, 231, 232, 235, 237, 249, 254, 264, 267, 277, 280, 284, 287, 289, 292, 295, 296, 297, 299, 300, 301, 307, 311, 321, 331, 337, 338, 342, 345, 346, 347, 348, 350, 351, 352, 353, 354, 356, 357, 360, 361, 365, 369, 372, 378, 381, 385, 391, 397, 400, 402, 410, 418, 420, 424, 425, 426, 427, 430, 431, 436, 439, 441, 444, 446, 447, 450, 451, 453, 454, 455, 463, 464, 473, 474, 475, 477, 478, 488, 489, 497, 498, 499, 500]	['Methods', 'for', 'DNA', 'extraction', ',', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', ',', 'and', 'sequencing', 'were', 'previously', 'described', 'in', 'detail.[12', ',', '14', ',', '15', ',', '17', ']', 'Briefly', ',', 'DNA', 'extraction', ',', 'PCR', 'amplification', 'of', 'the', 'V4', 'region', 'of', 'the', '16S', 'rRNA', 'gene', ',', 'and', 'amplicon', 'preparation', 'were', 'performed', 'as', 'described', 'by', 'Caporaso', 'et', 'al.[17]', ',', 'using', 'the', 'universal', 'bacterial', 'primer', 'set', '515F', '/', '806R', ',', '[', '17', ',', '18', ']', 'and', 'can', 'be', 'found', 'on', 'the', 'Earth', 'Microbiome', 'Project', 'website', '(', 'http', ':', '/', '/', 'www.earthmicrobiome.org', '/', 'emp', '-', 'standard', '-', 'protocols', '/', 'dna-extraction-protocol/', ')', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 3, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 2, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 9, 1, 2, 1, 1, 1, 1, 1, 7, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All polymerase chain reaction (PCR) reactions were carried out with Phusion® High-Fidelity PCR Master Mix (New England Biolabs, Ipswich, MA, USA), and mixture PCR products were purified with Qiagen Gel Extraction Kit (Qiagen, Hilden, Germany).	[]	['All', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'reactions', 'were', 'carried', 'out', 'with', 'Ph', '##usion', '®', 'High', '-', 'Fi', '##delity', 'PC', '##R', 'Master', 'Mix', '(', 'New', 'England', 'B', '##iol', '##ab', '##s', ',', 'Ipswich', ',', 'MA', ',', 'USA', ')', ',', 'and', 'mixture', 'PC', '##R', 'products', 'were', 'pu', '##rified', 'with', 'Qi', '##age', '##n', 'G', '##el', 'Extra', '##ction', 'Kit', '(', 'Qi', '##age', '##n', ',', 'Hi', '##lde', '##n', ',', 'Germany', ')', '.']	[0, 4, 11, 15, 21, 30, 31, 33, 34, 36, 46, 51, 59, 63, 68, 70, 75, 77, 81, 82, 84, 91, 93, 95, 102, 106, 107, 111, 119, 120, 123, 125, 126, 128, 135, 137, 139, 141, 144, 145, 147, 151, 159, 161, 163, 172, 177, 179, 186, 191, 193, 196, 198, 199, 202, 207, 213, 217, 218, 220, 223, 224, 226, 228, 231, 232, 234, 241, 242]	[3, 11, 14, 20, 29, 31, 33, 34, 35, 45, 50, 58, 62, 67, 70, 75, 76, 81, 82, 84, 90, 93, 94, 101, 105, 107, 110, 118, 120, 123, 125, 126, 127, 135, 136, 139, 140, 144, 145, 146, 150, 158, 161, 162, 171, 176, 179, 185, 190, 193, 196, 197, 199, 201, 207, 212, 216, 218, 220, 223, 224, 225, 228, 231, 232, 233, 241, 242, 243]	['All', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'reactions', 'were', 'carried', 'out', 'with', 'Phusion', '®', 'High-Fidelity', 'PCR', 'Master', 'Mix', '(', 'New', 'England', 'Biolabs', ',', 'Ipswich', ',', 'MA', ',', 'USA', ')', ',', 'and', 'mixture', 'PCR', 'products', 'were', 'purified', 'with', 'Qiagen', 'Gel', 'Extraction', 'Kit', '(', 'Qiagen', ',', 'Hilden', ',', 'Germany', ')', '.']	[1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 2, 1, 4, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 3, 2, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We were worried that adding a nuclease for reduction of host DNA would destroy free microbial DNA as well and skew the picture of microbial communities compared to extraction kits without this step.	[]	['We', 'were', 'worried', 'that', 'adding', 'a', 'n', '##uc', '##lea', '##se', 'for', 'reduction', 'of', 'host', 'DNA', 'would', 'destroy', 'free', 'micro', '##bial', 'DNA', 'as', 'well', 'and', 's', '##ke', '##w', 'the', 'picture', 'of', 'micro', '##bial', 'communities', 'compared', 'to', 'extraction', 'kits', 'without', 'this', 'step', '.']	[0, 3, 8, 16, 21, 28, 30, 31, 33, 36, 39, 43, 53, 56, 61, 65, 71, 79, 84, 89, 94, 98, 101, 106, 110, 111, 113, 115, 119, 127, 130, 135, 140, 152, 161, 164, 175, 180, 188, 193, 197]	[2, 7, 15, 20, 27, 29, 31, 33, 36, 38, 42, 52, 55, 60, 64, 70, 78, 83, 89, 93, 97, 100, 105, 109, 111, 113, 114, 118, 126, 129, 135, 139, 151, 160, 163, 174, 179, 187, 192, 197, 198]	['We', 'were', 'worried', 'that', 'adding', 'a', 'nuclease', 'for', 'reduction', 'of', 'host', 'DNA', 'would', 'destroy', 'free', 'microbial', 'DNA', 'as', 'well', 'and', 'skew', 'the', 'picture', 'of', 'microbial', 'communities', 'compared', 'to', 'extraction', 'kits', 'without', 'this', 'step', '.']	[1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Samples were incubated in an enzymatic cocktail containing lysozyme (0.2 mg/mL) and proteinase K (0.4 mg/mL) followed by bead beating using a Biospec Products Mini-BeadBeater-8™ (BioSpec Products, Inc.).	[]	['Sam', '##ples', 'were', 'in', '##cu', '##bate', '##d', 'in', 'an', 'en', '##zy', '##matic', 'cocktail', 'containing', 'l', '##ys', '##oz', '##yme', '(', '0', '.', '2', 'mg', '/', 'm', '##L', ')', 'and', 'protein', '##ase', 'K', '(', '0', '.', '4', 'mg', '/', 'm', '##L', ')', 'followed', 'by', 'be', '##ad', 'beating', 'using', 'a', 'B', '##ios', '##pec', 'Products', 'Mini', '-', 'Be', '##ad', '##B', '##eat', '##er', '-', '8', '[UNK]', '(', 'B', '##io', '##S', '##pec', 'Products', ',', 'Inc', '.', ')', '.']	[0, 3, 8, 13, 15, 17, 21, 23, 26, 29, 31, 33, 39, 48, 59, 60, 62, 64, 68, 69, 70, 71, 73, 75, 76, 77, 78, 80, 84, 91, 95, 97, 98, 99, 100, 102, 104, 105, 106, 107, 109, 118, 121, 123, 126, 134, 140, 142, 143, 146, 150, 159, 163, 164, 166, 168, 169, 172, 174, 175, -1, 178, 179, 180, 182, 183, 187, 195, 197, 200, 201, 202]	[3, 7, 12, 15, 17, 21, 22, 25, 28, 31, 33, 38, 47, 58, 60, 62, 64, 67, 69, 70, 71, 72, 75, 76, 77, 78, 79, 83, 91, 94, 96, 98, 99, 100, 101, 104, 105, 106, 107, 108, 117, 120, 123, 125, 133, 139, 141, 143, 146, 149, 158, 163, 164, 166, 168, 169, 172, 174, 175, 176, 4, 179, 180, 182, 183, 186, 195, 196, 200, 201, 202, 203]	['Samples', 'were', 'incubated', 'in', 'an', 'enzymatic', 'cocktail', 'containing', 'lysozyme', '(', '0.2', 'mg', '/', 'mL', ')', 'and', 'proteinase', 'K', '(', '0.4', 'mg', '/', 'mL', ')', 'followed', 'by', 'bead', 'beating', 'using', 'a', 'Biospec', 'Products', 'Mini-BeadBeater-8', '™', '(', 'BioSpec', 'Products', ',', 'Inc', '.', ')', '.']	[2, 1, 4, 1, 1, 3, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 2, 1, 1, 3, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 9, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Polymerase chain reaction (PCR) amplification was performed using the V3 forward primer 5′CCTACGGGGNGGCWGCAG-3′ and V4 reverse primer 5′GACTACHVGGGTATCTAATCC-3′, producing a 300-bp amplicon spanning the highly variable V3–V4 region of the 16S rRNA gene.	[('PMC6912393', 'M04000', 0, 10, 'Polymerase')]	['Pol', '##yme', '##rase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'am', '##p', '##lification', 'was', 'performed', 'using', 'the', 'V', '##3', 'forward', 'prime', '##r', '5', '′', 'CC', '##TA', '##C', '##G', '##G', '##G', '##G', '##NG', '##GC', '##W', '##GC', '##AG', '-', '3', '′', 'and', 'V', '##4', 'reverse', 'prime', '##r', '5', '′', 'GA', '##CT', '##AC', '##H', '##V', '##G', '##G', '##G', '##TA', '##TC', '##TA', '##AT', '##CC', '-', '3', '′', ',', 'producing', 'a', '300', '-', 'b', '##p', 'am', '##p', '##lic', '##on', 'spanning', 'the', 'highly', 'variable', 'V', '##3', '–', 'V', '##4', 'region', 'of', 'the', '16', '##S', 'r', '##RNA', 'gene', '.']	[0, 3, 6, 11, 17, 26, 27, 29, 30, 32, 34, 35, 46, 50, 60, 66, 70, 71, 73, 81, 86, 88, 89, 90, 92, 94, 95, 96, 97, 98, 99, 101, 103, 104, 106, 108, 109, 110, 112, 116, 117, 119, 127, 132, 134, 135, 136, 138, 140, 142, 143, 144, 145, 146, 147, 149, 151, 153, 155, 157, 158, 159, 160, 162, 172, 174, 177, 178, 179, 181, 183, 184, 187, 190, 199, 203, 210, 219, 220, 221, 222, 223, 225, 232, 235, 239, 241, 243, 244, 248, 252]	[3, 6, 10, 16, 25, 27, 29, 30, 31, 34, 35, 45, 49, 59, 65, 69, 71, 72, 80, 86, 87, 89, 90, 92, 94, 95, 96, 97, 98, 99, 101, 103, 104, 106, 108, 109, 110, 111, 115, 117, 118, 126, 132, 133, 135, 136, 138, 140, 142, 143, 144, 145, 146, 147, 149, 151, 153, 155, 157, 158, 159, 160, 161, 171, 173, 177, 178, 179, 180, 183, 184, 187, 189, 198, 202, 209, 218, 220, 221, 222, 223, 224, 231, 234, 238, 241, 242, 244, 247, 252, 253]	['Polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', 'was', 'performed', 'using', 'the', 'V3', 'forward', 'primer', '5′CCTACGGGGNGGCWGCAG-3′', 'and', 'V4', 'reverse', 'primer', '5′GACTACHVGGGTATCTAATCC-3′', ',', 'producing', 'a', '300-bp', 'amplicon', 'spanning', 'the', 'highly', 'variable', 'V3–V4', 'region', 'of', 'the', '16S', 'rRNA', 'gene', '.']	[3, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 2, 1, 2, 17, 1, 2, 1, 2, 18, 1, 1, 1, 4, 4, 1, 1, 1, 1, 5, 1, 1, 1, 2, 2, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The hypotaurine–taurine metabolism pathway starts with cystamine production via cystine decarboxylation, which is then reduced to cysteamine followed by oxidation to hypotaurine (by the enzyme cysteamine dioxygenase).	[('PMC6918408', 'D03000', 193, 215, 'cysteamine dioxygenase')]	['The', 'h', '##y', '##pot', '##au', '##rine', '–', 'ta', '##uri', '##ne', 'metabolism', 'pathway', 'starts', 'with', 'c', '##ys', '##tamine', 'production', 'via', 'c', '##ys', '##tine', 'de', '##car', '##box', '##yla', '##tion', ',', 'which', 'is', 'then', 'reduced', 'to', 'c', '##ys', '##te', '##amine', 'followed', 'by', 'oxidation', 'to', 'h', '##y', '##pot', '##au', '##rine', '(', 'by', 'the', 'enzyme', 'c', '##ys', '##te', '##amine', 'di', '##ox', '##y', '##gen', '##ase', ')', '.']	[0, 4, 5, 6, 9, 11, 15, 16, 18, 21, 24, 35, 43, 50, 55, 56, 58, 65, 76, 80, 81, 83, 88, 90, 93, 96, 99, 103, 105, 111, 114, 119, 127, 130, 131, 133, 135, 141, 150, 153, 163, 166, 167, 168, 171, 173, 178, 179, 182, 186, 193, 194, 196, 198, 204, 206, 208, 209, 212, 215, 216]	[3, 5, 6, 9, 11, 15, 16, 18, 21, 23, 34, 42, 49, 54, 56, 58, 64, 75, 79, 81, 83, 87, 90, 93, 96, 99, 103, 104, 110, 113, 118, 126, 129, 131, 133, 135, 140, 149, 152, 162, 165, 167, 168, 171, 173, 177, 179, 181, 185, 192, 194, 196, 198, 203, 206, 208, 209, 212, 215, 216, 217]	['The', 'hypotaurine', '–', 'taurine', 'metabolism', 'pathway', 'starts', 'with', 'cystamine', 'production', 'via', 'cystine', 'decarboxylation', ',', 'which', 'is', 'then', 'reduced', 'to', 'cysteamine', 'followed', 'by', 'oxidation', 'to', 'hypotaurine', '(', 'by', 'the', 'enzyme', 'cysteamine', 'dioxygenase', ')', '.']	[1, 5, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 5, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 5, 1, 1, 1, 1, 4, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O']
Hypotaurine is finally oxidized to the final product taurine by hypotaurine dehydrogenase, which is then excreted out of the body or used within.	[('PMC6918408', 'D03001', 64, 89, 'hypotaurine dehydrogenase')]	['H', '##y', '##pot', '##au', '##rine', 'is', 'finally', 'o', '##xi', '##dized', 'to', 'the', 'final', 'product', 'ta', '##uri', '##ne', 'by', 'h', '##y', '##pot', '##au', '##rine', 'de', '##hy', '##dr', '##ogen', '##ase', ',', 'which', 'is', 'then', 'ex', '##cre', '##ted', 'out', 'of', 'the', 'body', 'or', 'used', 'within', '.']	[0, 1, 2, 5, 7, 12, 15, 23, 24, 26, 32, 35, 39, 45, 53, 55, 58, 61, 64, 65, 66, 69, 71, 76, 78, 80, 82, 86, 89, 91, 97, 100, 105, 107, 110, 114, 118, 121, 125, 130, 133, 138, 144]	[1, 2, 5, 7, 11, 14, 22, 24, 26, 31, 34, 38, 44, 52, 55, 58, 60, 63, 65, 66, 69, 71, 75, 78, 80, 82, 86, 89, 90, 96, 99, 104, 107, 110, 113, 117, 120, 124, 129, 132, 137, 144, 145]	['Hypotaurine', 'is', 'finally', 'oxidized', 'to', 'the', 'final', 'product', 'taurine', 'by', 'hypotaurine', 'dehydrogenase', ',', 'which', 'is', 'then', 'excreted', 'out', 'of', 'the', 'body', 'or', 'used', 'within', '.']	[5, 1, 1, 3, 1, 1, 1, 1, 3, 1, 5, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Dihydrobiopterin (BH2) [m/z 278.0650] is a product of the oxidation of Tetrahydrobiopterin (BH4), an important cofactor for NO synthase (NOS).	[('PMC6993102', 'D01000', 124, 135, 'NO synthase')]	['Di', '##hy', '##dr', '##ob', '##io', '##pt', '##eri', '##n', '(', 'B', '##H', '##2', ')', '[', 'm', '/', 'z', '278', '.', '06', '##50', ']', 'is', 'a', 'product', 'of', 'the', 'oxidation', 'of', 'Te', '##tra', '##hy', '##dr', '##ob', '##io', '##pt', '##eri', '##n', '(', 'B', '##H', '##4', ')', ',', 'an', 'important', 'co', '##fa', '##ctor', 'for', 'NO', 's', '##ynth', '##ase', '(', 'NO', '##S', ')', '.']	[0, 2, 4, 6, 8, 10, 12, 15, 17, 18, 19, 20, 21, 23, 24, 25, 26, 28, 31, 32, 34, 36, 38, 41, 43, 51, 54, 58, 68, 71, 73, 76, 78, 80, 82, 84, 86, 89, 91, 92, 93, 94, 95, 96, 98, 101, 111, 113, 115, 120, 124, 127, 128, 132, 136, 137, 139, 140, 141]	[2, 4, 6, 8, 10, 12, 15, 16, 18, 19, 20, 21, 22, 24, 25, 26, 27, 31, 32, 34, 36, 37, 40, 42, 50, 53, 57, 67, 70, 73, 76, 78, 80, 82, 84, 86, 89, 90, 92, 93, 94, 95, 96, 97, 100, 110, 113, 115, 119, 123, 126, 128, 132, 135, 137, 139, 140, 141, 142]	['Dihydrobiopterin', '(', 'BH2', ')', '[', 'm', '/', 'z', '278.0650', ']', 'is', 'a', 'product', 'of', 'the', 'oxidation', 'of', 'Tetrahydrobiopterin', '(', 'BH4', ')', ',', 'an', 'important', 'cofactor', 'for', 'NO', 'synthase', '(', 'NOS', ')', '.']	[8, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 9, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
In an inflammatory environment, the enzyme Phospholipase A2 catalyzes the esterified AA present in the phospholipid membrane into free AA, which may be then oxidized in four different pathways: lipoxygenase (LOX), cyclooxygenase (COX), epoxygenase (CYTP450) and isoprostane.	[]	['In', 'an', 'inflammatory', 'environment', ',', 'the', 'enzyme', 'Ph', '##os', '##ph', '##oli', '##pas', '##e', 'A2', 'cat', '##aly', '##zes', 'the', 'est', '##eri', '##fied', 'AA', 'present', 'in', 'the', 'p', '##hos', '##ph', '##oli', '##pid', 'membrane', 'into', 'free', 'AA', ',', 'which', 'may', 'be', 'then', 'o', '##xi', '##dized', 'in', 'four', 'different', 'pathways', ':', 'lip', '##ox', '##y', '##gen', '##ase', '(', 'L', '##OX', ')', ',', 'c', '##y', '##c', '##lo', '##ox', '##y', '##gen', '##ase', '(', 'CO', '##X', ')', ',', 'e', '##pox', '##y', '##gen', '##ase', '(', 'C', '##Y', '##TP', '##45', '##0', ')', 'and', 'is', '##op', '##ros', '##tan', '##e', '.']	[0, 3, 6, 19, 30, 32, 36, 43, 45, 47, 49, 52, 55, 57, 60, 63, 66, 70, 74, 77, 80, 85, 88, 96, 99, 103, 104, 107, 109, 112, 116, 125, 130, 135, 137, 139, 145, 149, 152, 157, 158, 160, 166, 169, 174, 184, 192, 194, 197, 199, 200, 203, 207, 208, 209, 211, 212, 214, 215, 216, 217, 219, 221, 222, 225, 229, 230, 232, 233, 234, 236, 237, 240, 241, 244, 248, 249, 250, 251, 253, 255, 256, 258, 262, 264, 266, 269, 272, 273]	[2, 5, 18, 30, 31, 35, 42, 45, 47, 49, 52, 55, 56, 59, 63, 66, 69, 73, 77, 80, 84, 87, 95, 98, 102, 104, 107, 109, 112, 115, 124, 129, 134, 137, 138, 144, 148, 151, 156, 158, 160, 165, 168, 173, 183, 192, 193, 197, 199, 200, 203, 206, 208, 209, 211, 212, 213, 215, 216, 217, 219, 221, 222, 225, 228, 230, 232, 233, 234, 235, 237, 240, 241, 244, 247, 249, 250, 251, 253, 255, 256, 257, 261, 264, 266, 269, 272, 273, 274]	['In', 'an', 'inflammatory', 'environment', ',', 'the', 'enzyme', 'Phospholipase', 'A2', 'catalyzes', 'the', 'esterified', 'AA', 'present', 'in', 'the', 'phospholipid', 'membrane', 'into', 'free', 'AA', ',', 'which', 'may', 'be', 'then', 'oxidized', 'in', 'four', 'different', 'pathways', ':', 'lipoxygenase', '(', 'LOX', ')', ',', 'cyclooxygenase', '(', 'COX', ')', ',', 'epoxygenase', '(', 'CYTP450', ')', 'and', 'isoprostane', '.']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 3, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 8, 1, 2, 1, 1, 5, 1, 5, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Prostaglandins are produced through the COX pathway, and leukotrienes through the LOX pathway.	[]	['Pro', '##sta', '##g', '##land', '##ins', 'are', 'produced', 'through', 'the', 'CO', '##X', 'pathway', ',', 'and', 'le', '##uk', '##ot', '##rien', '##es', 'through', 'the', 'L', '##OX', 'pathway', '.']	[0, 3, 6, 7, 11, 15, 19, 28, 36, 40, 42, 44, 51, 53, 57, 59, 61, 63, 67, 70, 78, 82, 83, 86, 93]	[3, 6, 7, 11, 14, 18, 27, 35, 39, 42, 43, 51, 52, 56, 59, 61, 63, 67, 69, 77, 81, 83, 85, 93, 94]	['Prostaglandins', 'are', 'produced', 'through', 'the', 'COX', 'pathway', ',', 'and', 'leukotrienes', 'through', 'the', 'LOX', 'pathway', '.']	[5, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two markers found in the plasma of the case group are AA metabolites: Prostaglandin B2 [m/z 299.2017] and Carboxy-Leukotriene B4 [m/z 389.1935], indicating that at least two AA oxidation pathways are putatively more active in the case group.	[]	['Two', 'markers', 'found', 'in', 'the', 'plasma', 'of', 'the', 'case', 'group', 'are', 'AA', 'meta', '##bol', '##ites', ':', 'Pro', '##sta', '##g', '##land', '##in', 'B', '##2', '[', 'm', '/', 'z', '29', '##9', '.', '2017', ']', 'and', 'Car', '##box', '##y', '-', 'Le', '##uk', '##ot', '##rien', '##e', 'B', '##4', '[', 'm', '/', 'z', '38', '##9', '.', '1935', ']', ',', 'indicating', 'that', 'at', 'least', 'two', 'AA', 'oxidation', 'pathways', 'are', 'put', '##ative', '##ly', 'more', 'active', 'in', 'the', 'case', 'group', '.']	[0, 4, 12, 18, 21, 25, 32, 35, 39, 44, 50, 54, 57, 61, 64, 68, 70, 73, 76, 77, 81, 84, 85, 87, 88, 89, 90, 92, 94, 95, 96, 100, 102, 106, 109, 112, 113, 114, 116, 118, 120, 124, 126, 127, 129, 130, 131, 132, 134, 136, 137, 138, 142, 143, 145, 156, 161, 164, 170, 174, 177, 187, 196, 200, 203, 208, 211, 216, 223, 226, 230, 235, 240]	[3, 11, 17, 20, 24, 31, 34, 38, 43, 49, 53, 56, 61, 64, 68, 69, 73, 76, 77, 81, 83, 85, 86, 88, 89, 90, 91, 94, 95, 96, 100, 101, 105, 109, 112, 113, 114, 116, 118, 120, 124, 125, 127, 128, 130, 131, 132, 133, 136, 137, 138, 142, 143, 144, 155, 160, 163, 169, 173, 176, 186, 195, 199, 203, 208, 210, 215, 222, 225, 229, 234, 240, 241]	['Two', 'markers', 'found', 'in', 'the', 'plasma', 'of', 'the', 'case', 'group', 'are', 'AA', 'metabolites', ':', 'Prostaglandin', 'B2', '[', 'm', '/', 'z', '299.2017', ']', 'and', 'Carboxy-Leukotriene', 'B4', '[', 'm', '/', 'z', '389.1935', ']', ',', 'indicating', 'that', 'at', 'least', 'two', 'AA', 'oxidation', 'pathways', 'are', 'putatively', 'more', 'active', 'in', 'the', 'case', 'group', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 5, 2, 1, 1, 1, 1, 4, 1, 1, 9, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For determination of iron oxidation potential, we included the candidate iron oxidase from acidophilic and neutrophilic iron-oxidizing bacteria, Cyc2 (Barco et al., 2015).	[('PMC7005843', 'M05000', 73, 85, 'iron oxidase')]	['For', 'determination', 'of', 'iron', 'oxidation', 'potential', ',', 'we', 'included', 'the', 'candidate', 'iron', 'o', '##xi', '##das', '##e', 'from', 'acid', '##op', '##hil', '##ic', 'and', 'ne', '##ut', '##rop', '##hil', '##ic', 'iron', '-', 'o', '##xi', '##di', '##zing', 'bacteria', ',', 'Cy', '##c', '##2', '(', 'Bar', '##co', 'et', 'al', '.', ',', '2015', ')', '.']	[0, 4, 18, 21, 26, 36, 45, 47, 50, 59, 63, 73, 78, 79, 81, 84, 86, 91, 95, 97, 100, 103, 107, 109, 111, 114, 117, 120, 124, 125, 126, 128, 130, 135, 143, 145, 147, 148, 150, 151, 154, 157, 160, 162, 163, 165, 169, 170]	[3, 17, 20, 25, 35, 45, 46, 49, 58, 62, 72, 77, 79, 81, 84, 85, 90, 95, 97, 100, 102, 106, 109, 111, 114, 117, 119, 124, 125, 126, 128, 130, 134, 143, 144, 147, 148, 149, 151, 154, 156, 159, 162, 163, 164, 169, 170, 171]	['For', 'determination', 'of', 'iron', 'oxidation', 'potential', ',', 'we', 'included', 'the', 'candidate', 'iron', 'oxidase', 'from', 'acidophilic', 'and', 'neutrophilic', 'iron', '-', 'oxidizing', 'bacteria', ',', 'Cyc2', '(', 'Barco', 'et', 'al', '.', ',', '2015', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 5, 1, 1, 4, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Heme oxygenase and transport genes define another strategy that microorganisms, especially pathogens, use to obtain iron from their environment.	[('PMC7005843', 'M12000', 0, 14, 'Heme oxygenase')]	['He', '##me', 'oxygen', '##ase', 'and', 'transport', 'genes', 'define', 'another', 'strategy', 'that', 'micro', '##or', '##gan', '##isms', ',', 'especially', 'path', '##ogen', '##s', ',', 'use', 'to', 'obtain', 'iron', 'from', 'their', 'environment', '.']	[0, 2, 5, 11, 15, 19, 29, 35, 42, 50, 59, 64, 69, 71, 74, 78, 80, 91, 95, 99, 100, 102, 106, 109, 116, 121, 126, 132, 143]	[2, 4, 11, 14, 18, 28, 34, 41, 49, 58, 63, 69, 71, 74, 78, 79, 90, 95, 99, 100, 101, 105, 108, 115, 120, 125, 131, 143, 144]	['Heme', 'oxygenase', 'and', 'transport', 'genes', 'define', 'another', 'strategy', 'that', 'microorganisms', ',', 'especially', 'pathogens', ',', 'use', 'to', 'obtain', 'iron', 'from', 'their', 'environment', '.']	[2, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In particular, heme oxygenases enable pathogens to obtain iron from a host through oxidative cleavage of heme, thereby releasing iron (Wilks and Heinzl, 2014).	[('PMC7005843', 'M12001', 15, 30, 'heme oxygenases')]	['In', 'particular', ',', 'hem', '##e', 'oxygen', '##ases', 'enable', 'path', '##ogen', '##s', 'to', 'obtain', 'iron', 'from', 'a', 'host', 'through', 'o', '##xi', '##da', '##tive', 'c', '##lea', '##vage', 'of', 'hem', '##e', ',', 'thereby', 'releasing', 'iron', '(', 'W', '##il', '##ks', 'and', 'Heinz', '##l', ',', '2014', ')', '.']	[0, 3, 13, 15, 18, 20, 26, 31, 38, 42, 46, 48, 51, 58, 63, 68, 70, 75, 83, 84, 86, 88, 93, 94, 97, 102, 105, 108, 109, 111, 119, 129, 134, 135, 136, 138, 141, 145, 150, 151, 153, 157, 158]	[2, 13, 14, 18, 19, 26, 30, 37, 42, 46, 47, 50, 57, 62, 67, 69, 74, 82, 84, 86, 88, 92, 94, 97, 101, 104, 108, 109, 110, 118, 128, 133, 135, 136, 138, 140, 144, 150, 151, 152, 157, 158, 159]	['In', 'particular', ',', 'heme', 'oxygenases', 'enable', 'pathogens', 'to', 'obtain', 'iron', 'from', 'a', 'host', 'through', 'oxidative', 'cleavage', 'of', 'heme', ',', 'thereby', 'releasing', 'iron', '(', 'Wilks', 'and', 'Heinzl', ',', '2014', ')', '.']	[1, 1, 1, 2, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1, 2, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Heme oxygenases are categorized into two groups: (1) “canonical” heme oxygenases (HmuO, PigA, and HemO), which degrade heme to biliverdin and carbon monoxide, and (2) “non-canonical” heme oxygenases (IsdG, IsdI, MhuD, and Isd-LmHde), which degrade heme to products like staphylobilin (IsdG and IsdI) and mycobilin (MhuD) (Wilks and Heinzl, 2014).	[('PMC7005843', 'M12002', 0, 15, 'Heme oxygenases')]	['He', '##me', 'oxygen', '##ases', 'are', 'categorized', 'into', 'two', 'groups', ':', '(', '1', ')', '“', 'canonical', '”', 'hem', '##e', 'oxygen', '##ases', '(', 'H', '##mu', '##O', ',', 'Pig', '##A', ',', 'and', 'He', '##m', '##O', ')', ',', 'which', 'de', '##grade', 'hem', '##e', 'to', 'bi', '##li', '##ver', '##din', 'and', 'carbon', 'mon', '##oxide', ',', 'and', '(', '2', ')', '“', 'non', '-', 'canonical', '”', 'hem', '##e', 'oxygen', '##ases', '(', 'Is', '##d', '##G', ',', 'Is', '##d', '##I', ',', 'M', '##hu', '##D', ',', 'and', 'Is', '##d', '-', 'L', '##m', '##H', '##de', ')', ',', 'which', 'de', '##grade', 'hem', '##e', 'to', 'products', 'like', 's', '##ta', '##phy', '##lo', '##bil', '##in', '(', 'Is', '##d', '##G', 'and', 'Is', '##d', '##I', ')', 'and', 'my', '##co', '##bil', '##in', '(', 'M', '##hu', '##D', ')', '(', 'W', '##il', '##ks', 'and', 'Heinz', '##l', ',', '2014', ')', '.']	[0, 2, 5, 11, 16, 20, 32, 37, 41, 47, 49, 50, 51, 53, 54, 63, 65, 68, 70, 76, 81, 82, 83, 85, 86, 88, 91, 92, 94, 98, 100, 101, 102, 103, 105, 111, 113, 119, 122, 124, 127, 129, 131, 134, 138, 142, 149, 152, 157, 159, 163, 164, 165, 167, 168, 171, 172, 181, 183, 186, 188, 194, 199, 200, 202, 203, 204, 206, 208, 209, 210, 212, 213, 215, 216, 218, 222, 224, 225, 226, 227, 228, 229, 231, 232, 234, 240, 242, 248, 251, 253, 256, 265, 270, 271, 273, 276, 278, 281, 284, 285, 287, 288, 290, 294, 296, 297, 298, 300, 304, 306, 308, 311, 314, 315, 316, 318, 319, 321, 322, 323, 325, 328, 332, 337, 338, 340, 344, 345]	[2, 4, 11, 15, 19, 31, 36, 40, 47, 48, 50, 51, 52, 54, 63, 64, 68, 69, 76, 80, 82, 83, 85, 86, 87, 91, 92, 93, 97, 100, 101, 102, 103, 104, 110, 113, 118, 122, 123, 126, 129, 131, 134, 137, 141, 148, 152, 157, 158, 162, 164, 165, 166, 168, 171, 172, 181, 182, 186, 187, 194, 198, 200, 202, 203, 204, 205, 208, 209, 210, 211, 213, 215, 216, 217, 221, 224, 225, 226, 227, 228, 229, 231, 232, 233, 239, 242, 247, 251, 252, 255, 264, 269, 271, 273, 276, 278, 281, 283, 285, 287, 288, 289, 293, 296, 297, 298, 299, 303, 306, 308, 311, 313, 315, 316, 318, 319, 320, 322, 323, 325, 327, 331, 337, 338, 339, 344, 345, 346]	['Heme', 'oxygenases', 'are', 'categorized', 'into', 'two', 'groups', ':', '(', '1', ')', '“', 'canonical', '”', 'heme', 'oxygenases', '(', 'HmuO', ',', 'PigA', ',', 'and', 'HemO', ')', ',', 'which', 'degrade', 'heme', 'to', 'biliverdin', 'and', 'carbon', 'monoxide', ',', 'and', '(', '2', ')', '“', 'non', '-', 'canonical', '”', 'heme', 'oxygenases', '(', 'IsdG', ',', 'IsdI', ',', 'MhuD', ',', 'and', 'Isd-LmHde', ')', ',', 'which', 'degrade', 'heme', 'to', 'products', 'like', 'staphylobilin', '(', 'IsdG', 'and', 'IsdI', ')', 'and', 'mycobilin', '(', 'MhuD', ')', '(', 'Wilks', 'and', 'Heinzl', ',', '2014', ')', '.']	[2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 1, 2, 1, 1, 3, 1, 1, 1, 2, 2, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 3, 1, 3, 1, 3, 1, 1, 7, 1, 1, 1, 2, 2, 1, 1, 1, 6, 1, 3, 1, 3, 1, 1, 4, 1, 3, 1, 1, 3, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All these heme oxygenase genes are included in FeGenie’s HMM library.	[('PMC7005843', 'M12003', 10, 24, 'heme oxygenase')]	['All', 'these', 'hem', '##e', 'oxygen', '##ase', 'genes', 'are', 'included', 'in', 'Fe', '##G', '##eni', '##e', '’', 's', 'HM', '##M', 'library', '.']	[0, 4, 10, 13, 15, 21, 25, 31, 35, 44, 47, 49, 50, 53, 54, 55, 57, 59, 61, 68]	[3, 9, 13, 14, 21, 24, 30, 34, 43, 46, 49, 50, 53, 54, 55, 56, 59, 60, 68, 69]	['All', 'these', 'heme', 'oxygenase', 'genes', 'are', 'included', 'in', 'FeGenie’s', 'HMM', 'library', '.']	[1, 1, 2, 2, 1, 1, 1, 1, 6, 2, 1, 1]	['O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Extracytoplasmic-function (ECF) sigma factors are sensitive to signals from outside of the cell, and they bind and recruit RNA-polymerase to specific regions of the genome (Brooks and Buchanan, 2008).	[('PMC7005843', 'M14000', 123, 137, 'RNA-polymerase')]	['Extra', '##cy', '##top', '##las', '##mic', '-', 'function', '(', 'EC', '##F', ')', 'si', '##gma', 'factors', 'are', 'sensitive', 'to', 'signals', 'from', 'outside', 'of', 'the', 'cell', ',', 'and', 'they', 'bind', 'and', 'recruit', 'RNA', '-', 'polymer', '##ase', 'to', 'specific', 'regions', 'of', 'the', 'genome', '(', 'Brooks', 'and', 'Buchanan', ',', '2008', ')', '.']	[0, 5, 7, 10, 13, 16, 17, 26, 27, 29, 30, 32, 34, 38, 46, 50, 60, 63, 71, 76, 84, 87, 91, 95, 97, 101, 106, 111, 115, 123, 126, 127, 134, 138, 141, 150, 158, 161, 165, 172, 173, 180, 184, 192, 194, 198, 199]	[5, 7, 10, 13, 16, 17, 25, 27, 29, 30, 31, 34, 37, 45, 49, 59, 62, 70, 75, 83, 86, 90, 95, 96, 100, 105, 110, 114, 122, 126, 127, 134, 137, 140, 149, 157, 160, 164, 171, 173, 179, 183, 192, 193, 198, 199, 200]	['Extracytoplasmic', '-', 'function', '(', 'ECF', ')', 'sigma', 'factors', 'are', 'sensitive', 'to', 'signals', 'from', 'outside', 'of', 'the', 'cell', ',', 'and', 'they', 'bind', 'and', 'recruit', 'RNA-polymerase', 'to', 'specific', 'regions', 'of', 'the', 'genome', '(', 'Brooks', 'and', 'Buchanan', ',', '2008', ')', '.']	[5, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
FeGenie was also used to identify iron acquisition and transport genes in model microorganisms, including siderophore transport and synthesis genes, heme transport and oxygenases, and Fe(II)/Fe(III) transport.	[('PMC7005843', 'R05000', 168, 178, 'oxygenases')]	['Fe', '##G', '##eni', '##e', 'was', 'also', 'used', 'to', 'identify', 'iron', 'acquisition', 'and', 'transport', 'genes', 'in', 'model', 'micro', '##or', '##gan', '##isms', ',', 'including', 'side', '##rop', '##hore', 'transport', 'and', 'synthesis', 'genes', ',', 'hem', '##e', 'transport', 'and', 'oxygen', '##ases', ',', 'and', 'Fe', '(', 'II', ')', '/', 'Fe', '(', 'III', ')', 'transport', '.']	[0, 2, 3, 6, 8, 12, 17, 22, 25, 34, 39, 51, 55, 65, 71, 74, 80, 85, 87, 90, 94, 96, 106, 110, 113, 118, 128, 132, 142, 147, 149, 152, 154, 164, 168, 174, 178, 180, 184, 186, 187, 189, 190, 191, 193, 194, 197, 199, 208]	[2, 3, 6, 7, 11, 16, 21, 24, 33, 38, 50, 54, 64, 70, 73, 79, 85, 87, 90, 94, 95, 105, 110, 113, 117, 127, 131, 141, 147, 148, 152, 153, 163, 167, 174, 178, 179, 183, 186, 187, 189, 190, 191, 193, 194, 197, 198, 208, 209]	['FeGenie', 'was', 'also', 'used', 'to', 'identify', 'iron', 'acquisition', 'and', 'transport', 'genes', 'in', 'model', 'microorganisms', ',', 'including', 'siderophore', 'transport', 'and', 'synthesis', 'genes', ',', 'heme', 'transport', 'and', 'oxygenases', ',', 'and', 'Fe', '(II)', '/', 'Fe', '(III)', 'transport', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We used this protocol (including a proteinase K pretreatment) to get an estimate of cells able to resist harsh conditions that fecal transplants may face during a freezing period and then, once released in the host intestine by FMT; these include the presence of host antimicrobial proteins and peptides, bacteriocins and antibacterial metabolites of bacterial origin (Ostaff et al., 2013; Kanjan and Hongpattarakere, 2016; Dicks et al., 2018).	[]	['We', 'used', 'this', 'protocol', '(', 'including', 'a', 'protein', '##ase', 'K', 'pre', '##tre', '##at', '##ment', ')', 'to', 'get', 'an', 'estimate', 'of', 'cells', 'able', 'to', 'resist', 'harsh', 'conditions', 'that', 'f', '##eca', '##l', 'transplant', '##s', 'may', 'face', 'during', 'a', 'freezing', 'period', 'and', 'then', ',', 'once', 'released', 'in', 'the', 'host', 'in', '##test', '##ine', 'by', 'FM', '##T', ';', 'these', 'include', 'the', 'presence', 'of', 'host', 'anti', '##mic', '##ro', '##bial', 'proteins', 'and', 'p', '##eptide', '##s', ',', 'b', '##act', '##eri', '##oc', '##ins', 'and', 'anti', '##ba', '##cter', '##ial', 'meta', '##bol', '##ites', 'of', 'bacterial', 'origin', '(', 'O', '##sta', '##ff', 'et', 'al', '.', ',', '2013', ';', 'Ka', '##nja', '##n', 'and', 'Hong', '##pa', '##tta', '##rak', '##ere', ',', '2016', ';', 'Dick', '##s', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 3, 8, 13, 22, 23, 33, 35, 42, 46, 48, 51, 54, 56, 60, 62, 65, 69, 72, 81, 84, 90, 95, 98, 105, 111, 122, 127, 128, 131, 133, 143, 145, 149, 154, 161, 163, 172, 179, 183, 187, 189, 194, 203, 206, 210, 215, 217, 221, 225, 228, 230, 231, 233, 239, 247, 251, 260, 263, 268, 272, 275, 277, 282, 291, 295, 296, 302, 303, 305, 306, 309, 312, 314, 318, 322, 326, 328, 332, 336, 340, 343, 348, 351, 361, 368, 369, 370, 373, 376, 379, 381, 382, 384, 388, 390, 392, 395, 397, 401, 405, 407, 410, 413, 416, 418, 422, 424, 428, 430, 433, 435, 436, 438, 442, 443]	[2, 7, 12, 21, 23, 32, 34, 42, 45, 47, 51, 54, 56, 60, 61, 64, 68, 71, 80, 83, 89, 94, 97, 104, 110, 121, 126, 128, 131, 132, 143, 144, 148, 153, 160, 162, 171, 178, 182, 187, 188, 193, 202, 205, 209, 214, 217, 221, 224, 227, 230, 231, 232, 238, 246, 250, 259, 262, 267, 272, 275, 277, 281, 290, 294, 296, 302, 303, 304, 306, 309, 312, 314, 317, 321, 326, 328, 332, 335, 340, 343, 347, 350, 360, 367, 369, 370, 373, 375, 378, 381, 382, 383, 388, 389, 392, 395, 396, 400, 405, 407, 410, 413, 416, 417, 422, 423, 428, 429, 432, 435, 436, 437, 442, 443, 444]	['We', 'used', 'this', 'protocol', '(', 'including', 'a', 'proteinase', 'K', 'pretreatment', ')', 'to', 'get', 'an', 'estimate', 'of', 'cells', 'able', 'to', 'resist', 'harsh', 'conditions', 'that', 'fecal', 'transplants', 'may', 'face', 'during', 'a', 'freezing', 'period', 'and', 'then', ',', 'once', 'released', 'in', 'the', 'host', 'intestine', 'by', 'FMT', ';', 'these', 'include', 'the', 'presence', 'of', 'host', 'antimicrobial', 'proteins', 'and', 'peptides', ',', 'bacteriocins', 'and', 'antibacterial', 'metabolites', 'of', 'bacterial', 'origin', '(', 'Ostaff', 'et', 'al', '.', ',', '2013', ';', 'Kanjan', 'and', 'Hongpattarakere', ',', '2016', ';', 'Dicks', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 5, 1, 4, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the MOLZ procedure, according to the manufacturer guidelines, the proteinase K treatment is adapted to solubilize solid human tissues and release bacterial biofilm, whereas the CM buffer, containing a chaotropic agent, selectively disrupts human cells.	[]	['In', 'the', 'M', '##OL', '##Z', 'procedure', ',', 'according', 'to', 'the', 'manufacturer', 'guidelines', ',', 'the', 'protein', '##ase', 'K', 'treatment', 'is', 'adapted', 'to', 'so', '##lub', '##ilize', 'solid', 'human', 'tissues', 'and', 'release', 'bacterial', 'bio', '##film', ',', 'whereas', 'the', 'C', '##M', 'buffer', ',', 'containing', 'a', 'ch', '##ao', '##tro', '##pic', 'agent', ',', 'selective', '##ly', 'disrupt', '##s', 'human', 'cells', '.']	[0, 3, 7, 8, 10, 12, 21, 23, 33, 36, 40, 53, 63, 65, 69, 76, 80, 82, 92, 95, 103, 106, 108, 111, 117, 123, 129, 137, 141, 149, 159, 162, 166, 168, 176, 180, 181, 183, 189, 191, 202, 204, 206, 208, 211, 215, 220, 222, 231, 234, 241, 243, 249, 254]	[2, 6, 8, 10, 11, 21, 22, 32, 35, 39, 52, 63, 64, 68, 76, 79, 81, 91, 94, 102, 105, 108, 111, 116, 122, 128, 136, 140, 148, 158, 162, 166, 167, 175, 179, 181, 182, 189, 190, 201, 203, 206, 208, 211, 214, 220, 221, 231, 233, 241, 242, 248, 254, 255]	['In', 'the', 'MOLZ', 'procedure', ',', 'according', 'to', 'the', 'manufacturer', 'guidelines', ',', 'the', 'proteinase', 'K', 'treatment', 'is', 'adapted', 'to', 'solubilize', 'solid', 'human', 'tissues', 'and', 'release', 'bacterial', 'biofilm', ',', 'whereas', 'the', 'CM', 'buffer', ',', 'containing', 'a', 'chaotropic', 'agent', ',', 'selectively', 'disrupts', 'human', 'cells', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 4, 1, 1, 2, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similarly, the CM buffer (the composition of which is not fully disclosed for proprietary reasons) contains substantial proportion of a chaotropic agent (guanidine hydrochloride) that has greater efficacy in lysing Gram-negative bacteria and mammalian cells than Gram-positive bacteria (Boom et al., 1990).	[]	['Similarly', ',', 'the', 'C', '##M', 'buffer', '(', 'the', 'composition', 'of', 'which', 'is', 'not', 'fully', 'disclosed', 'for', 'proprietary', 'reasons', ')', 'contains', 'substantial', 'proportion', 'of', 'a', 'ch', '##ao', '##tro', '##pic', 'agent', '(', 'g', '##uan', '##id', '##ine', 'h', '##ydro', '##ch', '##lor', '##ide', ')', 'that', 'has', 'greater', 'efficacy', 'in', 'l', '##ys', '##ing', 'Gram', '-', 'negative', 'bacteria', 'and', 'ma', '##mmal', '##ian', 'cells', 'than', 'Gram', '-', 'positive', 'bacteria', '(', 'Boom', 'et', 'al', '.', ',', '1990', ')', '.']	[0, 9, 11, 15, 16, 18, 25, 26, 30, 42, 45, 51, 54, 58, 64, 74, 78, 90, 97, 99, 108, 120, 131, 134, 136, 138, 140, 143, 147, 153, 154, 155, 158, 160, 164, 165, 169, 171, 174, 177, 179, 184, 188, 196, 205, 208, 209, 211, 215, 219, 220, 229, 238, 242, 244, 248, 252, 258, 263, 267, 268, 277, 286, 287, 292, 295, 297, 298, 300, 304, 305]	[9, 10, 14, 16, 17, 24, 26, 29, 41, 44, 50, 53, 57, 63, 73, 77, 89, 97, 98, 107, 119, 130, 133, 135, 138, 140, 143, 146, 152, 154, 155, 158, 160, 163, 165, 169, 171, 174, 177, 178, 183, 187, 195, 204, 207, 209, 211, 214, 219, 220, 228, 237, 241, 244, 248, 251, 257, 262, 267, 268, 276, 285, 287, 291, 294, 297, 298, 299, 304, 305, 306]	['Similarly', ',', 'the', 'CM', 'buffer', '(', 'the', 'composition', 'of', 'which', 'is', 'not', 'fully', 'disclosed', 'for', 'proprietary', 'reasons', ')', 'contains', 'substantial', 'proportion', 'of', 'a', 'chaotropic', 'agent', '(', 'guanidine', 'hydrochloride', ')', 'that', 'has', 'greater', 'efficacy', 'in', 'lysing', 'Gram', '-', 'negative', 'bacteria', 'and', 'mammalian', 'cells', 'than', 'Gram', '-', 'positive', 'bacteria', '(', 'Boom', 'et', 'al', '.', ',', '1990', ')', '.']	[1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 5, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After the extraction of total DNA of the samples, primers were designed according to the conserved region, and sequencing adaptors were attached to the ends of the primers for polymerase chain reaction (PCR) amplification.	[('PMC7060658', 'M01000', 176, 186, 'polymerase')]	['After', 'the', 'extraction', 'of', 'total', 'DNA', 'of', 'the', 'samples', ',', 'prime', '##rs', 'were', 'designed', 'according', 'to', 'the', 'conserved', 'region', ',', 'and', 'se', '##quencing', 'adapt', '##ors', 'were', 'attached', 'to', 'the', 'ends', 'of', 'the', 'prime', '##rs', 'for', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'am', '##p', '##lification', '.']	[0, 6, 10, 21, 24, 30, 34, 37, 41, 48, 50, 55, 58, 63, 72, 82, 85, 89, 99, 105, 107, 111, 113, 122, 127, 131, 136, 145, 148, 152, 157, 160, 164, 169, 172, 176, 183, 187, 193, 202, 203, 205, 206, 208, 210, 211, 221]	[5, 9, 20, 23, 29, 33, 36, 40, 48, 49, 55, 57, 62, 71, 81, 84, 88, 98, 105, 106, 110, 113, 121, 127, 130, 135, 144, 147, 151, 156, 159, 163, 169, 171, 175, 183, 186, 192, 201, 203, 205, 206, 207, 210, 211, 221, 222]	['After', 'the', 'extraction', 'of', 'total', 'DNA', 'of', 'the', 'samples', ',', 'primers', 'were', 'designed', 'according', 'to', 'the', 'conserved', 'region', ',', 'and', 'sequencing', 'adaptors', 'were', 'attached', 'to', 'the', 'ends', 'of', 'the', 'primers', 'for', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'amplification', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 2, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using the literature and databases, the gut microbiota with bile salt hydrolase (BSH) activity were screened at different levels.	[('PMC7060658', 'R06000', 60, 79, 'bile salt hydrolase')]	['Using', 'the', 'literature', 'and', 'databases', ',', 'the', 'gut', 'micro', '##bio', '##ta', 'with', 'bi', '##le', 'salt', 'h', '##ydro', '##lase', '(', 'BS', '##H', ')', 'activity', 'were', 'screened', 'at', 'different', 'levels', '.']	[0, 6, 10, 21, 25, 34, 36, 40, 44, 49, 52, 55, 60, 62, 65, 70, 71, 75, 80, 81, 83, 84, 86, 95, 100, 109, 112, 122, 128]	[5, 9, 20, 24, 34, 35, 39, 43, 49, 52, 54, 59, 62, 64, 69, 71, 75, 79, 81, 83, 84, 85, 94, 99, 108, 111, 121, 128, 129]	['Using', 'the', 'literature', 'and', 'databases', ',', 'the', 'gut', 'microbiota', 'with', 'bile', 'salt', 'hydrolase', '(', 'BSH', ')', 'activity', 'were', 'screened', 'at', 'different', 'levels', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
According to the KEGG function classification analysis, focal adhesion, cell adhesion molecules, the phosphatidylinositide 3-kinase-protein kinase B (PI3K-Akt) signalling pathway, extracellular matrix (ECM)-receptor interactions, platelet activation, complement and coagulation cascades, cholesterol metabolism, and regulation of the actin cytoskeleton were among the top 20 enriched pathways (Fig. 3).	[]	['According', 'to', 'the', 'K', '##EG', '##G', 'function', 'classification', 'analysis', ',', 'focal', 'ad', '##hesion', ',', 'cell', 'ad', '##hesion', 'molecules', ',', 'the', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##tide', '3', '-', 'kinase', '-', 'protein', 'kinase', 'B', '(', 'P', '##I', '##3', '##K', '-', 'A', '##kt', ')', 'signalling', 'pathway', ',', 'extra', '##cellular', 'matrix', '(', 'EC', '##M', ')', '-', 'receptor', 'interactions', ',', 'plate', '##let', 'activation', ',', 'complement', 'and', 'co', '##agu', '##lation', 'ca', '##sca', '##des', ',', 'ch', '##ole', '##ster', '##ol', 'metabolism', ',', 'and', 'regulation', 'of', 'the', 'act', '##in', 'c', '##yt', '##os', '##kel', '##eton', 'were', 'among', 'the', 'top', '20', 'en', '##rich', '##ed', 'pathways', '(', 'Fi', '##g', '.', '3', ')', '.']	[0, 10, 13, 17, 18, 20, 22, 31, 46, 54, 56, 62, 64, 70, 72, 77, 79, 86, 95, 97, 101, 102, 105, 108, 110, 112, 116, 118, 123, 124, 125, 131, 132, 140, 147, 149, 150, 151, 152, 153, 154, 155, 156, 158, 160, 171, 178, 180, 185, 194, 201, 202, 204, 205, 206, 207, 216, 228, 230, 235, 239, 249, 251, 262, 266, 268, 271, 278, 280, 283, 286, 288, 290, 293, 297, 300, 310, 312, 316, 327, 330, 334, 337, 340, 341, 343, 345, 348, 353, 358, 364, 368, 372, 375, 377, 381, 384, 393, 394, 396, 397, 399, 400, 401]	[9, 12, 16, 18, 20, 21, 30, 45, 54, 55, 61, 64, 70, 71, 76, 79, 85, 95, 96, 100, 102, 105, 108, 110, 112, 116, 118, 122, 124, 125, 131, 132, 139, 146, 148, 150, 151, 152, 153, 154, 155, 156, 158, 159, 170, 178, 179, 185, 193, 200, 202, 204, 205, 206, 207, 215, 228, 229, 235, 238, 249, 250, 261, 265, 268, 271, 277, 280, 283, 286, 287, 290, 293, 297, 299, 310, 311, 315, 326, 329, 333, 337, 339, 341, 343, 345, 348, 352, 357, 363, 367, 371, 374, 377, 381, 383, 392, 394, 396, 397, 398, 400, 401, 402]	['According', 'to', 'the', 'KEGG', 'function', 'classification', 'analysis', ',', 'focal', 'adhesion', ',', 'cell', 'adhesion', 'molecules', ',', 'the', 'phosphatidylinositide', '3-kinase-', 'protein', 'kinase', 'B', '(', 'PI3K-Akt', ')', 'signalling', 'pathway', ',', 'extracellular', 'matrix', '(ECM)-receptor', 'interactions', ',', 'platelet', 'activation', ',', 'complement', 'and', 'coagulation', 'cascades', ',', 'cholesterol', 'metabolism', ',', 'and', 'regulation', 'of', 'the', 'actin', 'cytoskeleton', 'were', 'among', 'the', 'top', '20', 'enriched', 'pathways', '(', 'Fig', '.', '3', ')', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 8, 4, 1, 1, 1, 1, 7, 1, 1, 1, 1, 2, 1, 6, 1, 1, 2, 1, 1, 1, 1, 3, 3, 1, 4, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PCR setup and cycling conditions for the primary amplification were as follows: 3 µl of template DNA, 15.05 µl of nuclease and DNA free water (VWR International, Darmstadt, Germany), 5 µl of 5 × KAPA High Fidelity Buffer (KAPA Biosystems, Wilmington, USA), 0.6 µl of 10 mM KAPA dNTP Mix, 0.25 µl of 20 mg/ml BSA (Life Technologies GmbH), 0.5 µl of KAPA High Fidelity Hot Start Polymerase, 0.3 µl of forward (10 µM) and 0.3 µl of reverse primer (10 µM).	[]	['PC', '##R', 'setup', 'and', 'cycling', 'conditions', 'for', 'the', 'primary', 'am', '##p', '##lification', 'were', 'as', 'follows', ':', '3', 'µ', '##l', 'of', 'template', 'DNA', ',', '15', '.', '05', 'µ', '##l', 'of', 'n', '##uc', '##lea', '##se', 'and', 'DNA', 'free', 'water', '(', 'V', '##WR', 'International', ',', 'Dar', '##ms', '##tadt', ',', 'Germany', ')', ',', '5', 'µ', '##l', 'of', '5', '×', 'K', '##AP', '##A', 'High', 'Fi', '##delity', 'B', '##uff', '##er', '(', 'K', '##AP', '##A', 'B', '##ios', '##ys', '##tem', '##s', ',', 'Wilmington', ',', 'USA', ')', ',', '0', '.', '6', 'µ', '##l', 'of', '10', 'm', '##M', 'K', '##AP', '##A', 'd', '##NT', '##P', 'Mix', ',', '0', '.', '25', 'µ', '##l', 'of', '20', 'mg', '/', 'm', '##l', 'BS', '##A', '(', 'Life', 'Technologies', 'GmbH', ')', ',', '0', '.', '5', 'µ', '##l', 'of', 'K', '##AP', '##A', 'High', 'Fi', '##delity', 'Hot', 'Start', 'Pol', '##yme', '##rase', ',', '0', '.', '3', 'µ', '##l', 'of', 'forward', '(', '10', 'µ', '##M', ')', 'and', '0', '.', '3', 'µ', '##l', 'of', 'reverse', 'prime', '##r', '(', '10', 'µ', '##M', ')', '.']	[0, 2, 4, 10, 14, 22, 33, 37, 41, 49, 51, 52, 63, 68, 71, 78, 80, 82, 83, 85, 88, 97, 100, 102, 104, 105, 108, 109, 111, 114, 115, 117, 120, 123, 127, 131, 136, 142, 143, 144, 147, 160, 162, 165, 167, 171, 173, 180, 181, 183, 185, 186, 188, 191, 193, 195, 196, 198, 200, 205, 207, 214, 215, 218, 221, 222, 223, 225, 227, 228, 231, 233, 236, 237, 239, 249, 251, 254, 255, 257, 258, 259, 261, 262, 264, 267, 270, 271, 273, 274, 276, 278, 279, 281, 283, 286, 288, 289, 290, 293, 294, 296, 299, 302, 304, 305, 306, 308, 310, 312, 313, 318, 331, 335, 336, 338, 339, 340, 342, 343, 345, 348, 349, 351, 353, 358, 360, 367, 371, 377, 380, 383, 387, 389, 390, 391, 393, 394, 396, 399, 407, 408, 411, 412, 413, 415, 419, 420, 421, 423, 424, 426, 429, 437, 442, 444, 445, 448, 449, 450, 451]	[2, 3, 9, 13, 21, 32, 36, 40, 48, 51, 52, 62, 67, 70, 78, 79, 81, 83, 84, 87, 96, 100, 101, 104, 105, 107, 109, 110, 113, 115, 117, 120, 122, 126, 130, 135, 141, 143, 144, 146, 160, 161, 165, 167, 171, 172, 180, 181, 182, 184, 186, 187, 190, 192, 194, 196, 198, 199, 204, 207, 213, 215, 218, 220, 222, 223, 225, 226, 228, 231, 233, 236, 237, 238, 249, 250, 254, 255, 256, 258, 259, 260, 262, 263, 266, 269, 271, 272, 274, 276, 277, 279, 281, 282, 286, 287, 289, 290, 292, 294, 295, 298, 301, 304, 305, 306, 307, 310, 311, 313, 317, 330, 335, 336, 337, 339, 340, 341, 343, 344, 347, 349, 351, 352, 357, 360, 366, 370, 376, 380, 383, 387, 388, 390, 391, 392, 394, 395, 398, 406, 408, 410, 412, 413, 414, 418, 420, 421, 422, 424, 425, 428, 436, 442, 443, 445, 447, 449, 450, 451, 452]	['PCR', 'setup', 'and', 'cycling', 'conditions', 'for', 'the', 'primary', 'amplification', 'were', 'as', 'follows', ':', '3', 'µl', 'of', 'template', 'DNA', ',', '15.05', 'µl', 'of', 'nuclease', 'and', 'DNA', 'free', 'water', '(', 'VWR', 'International', ',', 'Darmstadt', ',', 'Germany', ')', ',', '5', 'µl', 'of', '5', '×', 'KAPA', 'High', 'Fidelity', 'Buffer', '(', 'KAPA', 'Biosystems', ',', 'Wilmington', ',', 'USA', ')', ',', '0.6', 'µl', 'of', '10', 'mM', 'KAPA', 'dNTP', 'Mix', ',', '0.25', 'µl', 'of', '20', 'mg', '/', 'ml', 'BSA', '(', 'Life', 'Technologies', 'GmbH', ')', ',', '0.5', 'µl', 'of', 'KAPA', 'High', 'Fidelity', 'Hot', 'Start', 'Polymerase', ',', '0.3', 'µl', 'of', 'forward', '(', '10', 'µM', ')', 'and', '0.3', 'µl', 'of', 'reverse', 'primer', '(', '10', 'µM', ')', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 2, 3, 1, 3, 5, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 2, 3, 3, 1, 1, 3, 2, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 3, 2, 1, 3, 1, 2, 1, 1, 3, 1, 3, 2, 1, 1, 1, 1, 2, 1, 1, 3, 2, 1, 1, 2, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
25.6 µl of nuclease and DNA free water, 10 µl of 5 × KAPA High Fidelity Buffer (KAPA Biosystems), 1.2 µl of dNTP Mix (10 mM) and 0.2 µl of KAPA High Fidelity Hot Start DNA Polymerase were added.	[]	['25', '.', '6', 'µ', '##l', 'of', 'n', '##uc', '##lea', '##se', 'and', 'DNA', 'free', 'water', ',', '10', 'µ', '##l', 'of', '5', '×', 'K', '##AP', '##A', 'High', 'Fi', '##delity', 'B', '##uff', '##er', '(', 'K', '##AP', '##A', 'B', '##ios', '##ys', '##tem', '##s', ')', ',', '1', '.', '2', 'µ', '##l', 'of', 'd', '##NT', '##P', 'Mix', '(', '10', 'm', '##M', ')', 'and', '0', '.', '2', 'µ', '##l', 'of', 'K', '##AP', '##A', 'High', 'Fi', '##delity', 'Hot', 'Start', 'DNA', 'Pol', '##yme', '##rase', 'were', 'added', '.']	[0, 2, 3, 5, 6, 8, 11, 12, 14, 17, 20, 24, 28, 33, 38, 40, 43, 44, 46, 49, 51, 53, 54, 56, 58, 63, 65, 72, 73, 76, 79, 80, 81, 83, 85, 86, 89, 91, 94, 95, 96, 98, 99, 100, 102, 103, 105, 108, 109, 111, 113, 117, 118, 121, 122, 123, 125, 129, 130, 131, 133, 134, 136, 139, 140, 142, 144, 149, 151, 158, 162, 168, 172, 175, 178, 183, 188, 193]	[2, 3, 4, 6, 7, 10, 12, 14, 17, 19, 23, 27, 32, 38, 39, 42, 44, 45, 48, 50, 52, 54, 56, 57, 62, 65, 71, 73, 76, 78, 80, 81, 83, 84, 86, 89, 91, 94, 95, 96, 97, 99, 100, 101, 103, 104, 107, 109, 111, 112, 116, 118, 120, 122, 123, 124, 128, 130, 131, 132, 134, 135, 138, 140, 142, 143, 148, 151, 157, 161, 167, 171, 175, 178, 182, 187, 193, 194]	['25.6', 'µl', 'of', 'nuclease', 'and', 'DNA', 'free', 'water', ',', '10', 'µl', 'of', '5', '×', 'KAPA', 'High', 'Fidelity', 'Buffer', '(', 'KAPA', 'Biosystems', ')', ',', '1.2', 'µl', 'of', 'dNTP', 'Mix', '(', '10', 'mM', ')', 'and', '0.2', 'µl', 'of', 'KAPA', 'High', 'Fidelity', 'Hot', 'Start', 'DNA', 'Polymerase', 'were', 'added', '.']	[3, 2, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 2, 3, 1, 3, 5, 1, 1, 3, 2, 1, 3, 1, 1, 1, 2, 1, 1, 3, 2, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cycling started at 98 °C initial denaturation for 3 min, followed by 8 cycles of 98 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s and a final extension at 72 °C for 5 min.	[]	['Cycling', 'started', 'at', '98', '°C', 'initial', 'den', '##at', '##uration', 'for', '3', 'min', ',', 'followed', 'by', '8', 'cycles', 'of', '98', '°C', 'for', '30', 's', ',', '55', '°C', 'for', '30', 's', ',', '72', '°C', 'for', '30', 's', 'and', 'a', 'final', 'extension', 'at', '72', '°C', 'for', '5', 'min', '.']	[0, 8, 16, 19, 22, 25, 33, 36, 38, 46, 50, 52, 55, 57, 66, 69, 71, 78, 81, 84, 87, 91, 94, 95, 97, 100, 103, 107, 110, 111, 113, 116, 119, 123, 126, 128, 132, 134, 140, 150, 153, 156, 159, 163, 165, 168]	[7, 15, 18, 21, 24, 32, 36, 38, 45, 49, 51, 55, 56, 65, 68, 70, 77, 80, 83, 86, 90, 93, 95, 96, 99, 102, 106, 109, 111, 112, 115, 118, 122, 125, 127, 131, 133, 139, 149, 152, 155, 158, 162, 164, 168, 169]	['Cycling', 'started', 'at', '98', '°C', 'initial', 'denaturation', 'for', '3', 'min', ',', 'followed', 'by', '8', 'cycles', 'of', '98', '°C', 'for', '30', 's', ',', '55', '°C', 'for', '30', 's', ',', '72', '°C', 'for', '30', 's', 'and', 'a', 'final', 'extension', 'at', '72', '°C', 'for', '5', 'min', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the present study, in addition to the bacterial culture, we performed a multiplex polymerase chain reaction (PCR) to detect viruses and a clone library analysis of the bacterial 16S rRNA gene sequence using sputum samples to clarify the microbiological characteristics of LRTIs in NMD patients.	[('PMC7105058', 'I01000', 85, 95, 'polymerase')]	['In', 'the', 'present', 'study', ',', 'in', 'addition', 'to', 'the', 'bacterial', 'culture', ',', 'we', 'performed', 'a', 'multiple', '##x', 'polymer', '##ase', 'chain', 'reaction', '(', 'PC', '##R', ')', 'to', 'detect', 'viruses', 'and', 'a', 'clone', 'library', 'analysis', 'of', 'the', 'bacterial', '16', '##S', 'r', '##RNA', 'gene', 'sequence', 'using', 's', '##put', '##um', 'samples', 'to', 'c', '##lar', '##ify', 'the', 'micro', '##bio', '##logical', 'characteristics', 'of', 'L', '##RT', '##I', '##s', 'in', 'N', '##MD', 'patients', '.']	[0, 3, 7, 15, 20, 22, 25, 34, 37, 41, 51, 58, 60, 63, 73, 75, 83, 85, 92, 96, 102, 111, 112, 114, 115, 117, 120, 127, 135, 139, 141, 147, 155, 164, 167, 171, 181, 183, 185, 186, 190, 195, 204, 210, 211, 214, 217, 225, 228, 229, 232, 236, 240, 245, 248, 256, 272, 275, 276, 278, 279, 281, 284, 285, 288, 296]	[2, 6, 14, 20, 21, 24, 33, 36, 40, 50, 58, 59, 62, 72, 74, 83, 84, 92, 95, 101, 110, 112, 114, 115, 116, 119, 126, 134, 138, 140, 146, 154, 163, 166, 170, 180, 183, 184, 186, 189, 194, 203, 209, 211, 214, 216, 224, 227, 229, 232, 235, 239, 245, 248, 255, 271, 274, 276, 278, 279, 280, 283, 285, 287, 296, 297]	['In', 'the', 'present', 'study', ',', 'in', 'addition', 'to', 'the', 'bacterial', 'culture', ',', 'we', 'performed', 'a', 'multiplex', 'polymerase', 'chain', 'reaction', '(', 'PCR', ')', 'to', 'detect', 'viruses', 'and', 'a', 'clone', 'library', 'analysis', 'of', 'the', 'bacterial', '16S', 'rRNA', 'gene', 'sequence', 'using', 'sputum', 'samples', 'to', 'clarify', 'the', 'microbiological', 'characteristics', 'of', 'LRTIs', 'in', 'NMD', 'patients', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 4, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Baseline clinical information such as age, gender, etiology (HBV, HCV), and aspartate Aminotransferase (AST), alanine Aminotransferase (ALT), AST/ALT and the Fibrosis 4 score (FIB-4)6 were retrieved from chart records.	[('PMC7331577', 'M01000', 76, 102, 'aspartate Aminotransferase')]	['Basel', '##ine', 'clinical', 'information', 'such', 'as', 'age', ',', 'gender', ',', 'et', '##iology', '(', 'H', '##B', '##V', ',', 'HC', '##V', ')', ',', 'and', 'as', '##par', '##tate', 'Am', '##ino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', ',', 'al', '##ani', '##ne', 'Am', '##ino', '##tra', '##ns', '##fer', '##ase', '(', 'AL', '##T', ')', ',', 'AS', '##T', '/', 'AL', '##T', 'and', 'the', 'Fi', '##bro', '##sis', '4', 'score', '(', 'F', '##IB', '-', '4', ')', '6', 'were', 'retrieved', 'from', 'chart', 'records', '.']	[0, 5, 9, 18, 30, 35, 38, 41, 43, 49, 51, 53, 60, 61, 62, 63, 64, 66, 68, 69, 70, 72, 76, 78, 81, 86, 88, 91, 94, 96, 99, 103, 104, 106, 107, 108, 110, 112, 115, 118, 120, 123, 126, 128, 131, 135, 136, 138, 139, 140, 142, 144, 145, 146, 148, 150, 154, 158, 160, 163, 167, 169, 175, 176, 177, 179, 180, 181, 182, 184, 189, 199, 204, 210, 217]	[5, 8, 17, 29, 34, 37, 41, 42, 49, 50, 53, 59, 61, 62, 63, 64, 65, 68, 69, 70, 71, 75, 78, 81, 85, 88, 91, 94, 96, 99, 102, 104, 106, 107, 108, 109, 112, 115, 117, 120, 123, 126, 128, 131, 134, 136, 138, 139, 140, 141, 144, 145, 146, 148, 149, 153, 157, 160, 163, 166, 168, 174, 176, 177, 179, 180, 181, 182, 183, 188, 198, 203, 209, 217, 218]	['Baseline', 'clinical', 'information', 'such', 'as', 'age', ',', 'gender', ',', 'etiology', '(', 'HBV', ',', 'HCV', ')', ',', 'and', 'aspartate', 'Aminotransferase', '(', 'AST', ')', ',', 'alanine', 'Aminotransferase', '(', 'ALT', ')', ',', 'AST', '/', 'ALT', 'and', 'the', 'Fibrosis', '4', 'score', '(FIB-4)6', 'were', 'retrieved', 'from', 'chart', 'records', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 2, 1, 1, 1, 3, 6, 1, 2, 1, 1, 3, 6, 1, 2, 1, 1, 2, 1, 2, 1, 1, 3, 1, 1, 7, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Patient characteristics of this cohort was summarized in Table ​Table1,1, including age, gender, etiology (hepatitis B virus [HBV] or hepatitis C virus [HCV] infection), aspartate transaminase (AST), alanine transaminase (ALT), AST/ALT ratio, platelet counts and fibrosis-4 (FIB-4) index6.	[('PMC7331577', 'R00000', 170, 192, 'aspartate transaminase')]	['Pat', '##ient', 'characteristics', 'of', 'this', 'co', '##hor', '##t', 'was', 'summarized', 'in', 'Table', 'Table', '##1', ',', '1', ',', 'including', 'age', ',', 'gender', ',', 'et', '##iology', '(', 'he', '##pa', '##titis', 'B', 'virus', '[', 'H', '##B', '##V', ']', 'or', 'he', '##pa', '##titis', 'C', 'virus', '[', 'HC', '##V', ']', 'infection', ')', ',', 'as', '##par', '##tate', 'trans', '##ami', '##nas', '##e', '(', 'AS', '##T', ')', ',', 'al', '##ani', '##ne', 'trans', '##ami', '##nas', '##e', '(', 'AL', '##T', ')', ',', 'AS', '##T', '/', 'AL', '##T', 'ratio', ',', 'plate', '##let', 'counts', 'and', 'fi', '##bro', '##sis', '-', '4', '(', 'F', '##IB', '-', '4', ')', 'index', '##6', '.']	[0, 3, 8, 24, 27, 32, 34, 37, 39, 43, 54, 57, 64, 69, 70, 71, 72, 74, 84, 87, 89, 95, 97, 99, 106, 107, 109, 111, 117, 119, 125, 126, 127, 128, 129, 131, 134, 136, 138, 144, 146, 152, 153, 155, 156, 158, 167, 168, 170, 172, 175, 180, 185, 188, 191, 193, 194, 196, 197, 198, 200, 202, 205, 208, 213, 216, 219, 221, 222, 224, 225, 226, 228, 230, 231, 232, 234, 236, 241, 243, 248, 252, 259, 263, 265, 268, 271, 272, 274, 275, 276, 278, 279, 280, 282, 287, 288]	[3, 7, 23, 26, 31, 34, 37, 38, 42, 53, 56, 62, 69, 70, 71, 72, 73, 83, 87, 88, 95, 96, 99, 105, 107, 109, 111, 116, 118, 124, 126, 127, 128, 129, 130, 133, 136, 138, 143, 145, 151, 153, 155, 156, 157, 167, 168, 169, 172, 175, 179, 185, 188, 191, 192, 194, 196, 197, 198, 199, 202, 205, 207, 213, 216, 219, 220, 222, 224, 225, 226, 227, 230, 231, 232, 234, 235, 241, 242, 248, 251, 258, 262, 265, 268, 271, 272, 273, 275, 276, 278, 279, 280, 281, 287, 288, 289]	['Patient', 'characteristics', 'of', 'this', 'cohort', 'was', 'summarized', 'in', 'Table', '\u200bTable1', ',', '1', ',', 'including', 'age', ',', 'gender', ',', 'etiology', '(', 'hepatitis', 'B', 'virus', '[', 'HBV', ']', 'or', 'hepatitis', 'C', 'virus', '[', 'HCV', ']', 'infection', ')', ',', 'aspartate', 'transaminase', '(', 'AST', ')', ',', 'alanine', 'transaminase', '(', 'ALT', ')', ',', 'AST', '/', 'ALT', 'ratio', ',', 'platelet', 'counts', 'and', 'fibrosis-4', '(', 'FIB-4', ')', 'index6', '.']	[2, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 3, 4, 1, 2, 1, 1, 3, 4, 1, 2, 1, 1, 2, 1, 2, 1, 1, 2, 1, 1, 5, 1, 4, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Proteomic analysis revealed an increased abundance of proteins associated with an oxidative stress response, such as the glutathione s-transferase family protein (+8.43-fold), heat shock protein Hsp30/Hsp42 (+2.02-fold) and 5-demethoxyubiquinone hydroxylase, mitochondrial (+1.73-fold), as well as secondary metabolites such as isocyanide synthase A icsA (+8.52-fold) and non-ribosomal peptide synthetase fmpE (+3.06-fold).	[]	['Pro', '##te', '##omi', '##c', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'proteins', 'associated', 'with', 'an', 'o', '##xi', '##da', '##tive', 'stress', 'response', ',', 'such', 'as', 'the', 'g', '##lut', '##ath', '##ione', 's', '-', 'transfer', '##ase', 'family', 'protein', '(', '+', '8', '.', '43', '-', 'fold', ')', ',', 'heat', 'shock', 'protein', 'H', '##sp', '##30', '/', 'H', '##sp', '##42', '(', '+', '2', '.', '02', '-', 'fold', ')', 'and', '5', '-', 'dem', '##eth', '##ox', '##yu', '##bi', '##quin', '##one', 'h', '##ydro', '##xy', '##lase', ',', 'mitochondrial', '(', '+', '1', '.', '73', '-', 'fold', ')', ',', 'as', 'well', 'as', 'secondary', 'meta', '##bol', '##ites', 'such', 'as', 'is', '##oc', '##yan', '##ide', 's', '##ynth', '##ase', 'A', 'i', '##cs', '##A', '(', '+', '8', '.', '52', '-', 'fold', ')', 'and', 'non', '-', 'rib', '##oso', '##mal', 'p', '##eptide', 's', '##ynth', '##eta', '##se', 'f', '##mp', '##E', '(', '+', '3', '.', '06', '-', 'fold', ')', '.']	[0, 3, 5, 8, 10, 19, 28, 31, 41, 51, 54, 63, 74, 79, 82, 83, 85, 87, 92, 99, 107, 109, 114, 117, 121, 122, 125, 128, 133, 134, 135, 143, 147, 154, 162, 163, 164, 165, 166, 168, 169, 173, 174, 176, 181, 187, 195, 196, 198, 200, 201, 202, 204, 207, 208, 209, 210, 211, 213, 214, 218, 220, 224, 225, 226, 229, 232, 234, 236, 238, 242, 246, 247, 251, 253, 257, 259, 273, 274, 275, 276, 277, 279, 280, 284, 285, 287, 290, 295, 298, 308, 312, 315, 320, 325, 328, 330, 332, 335, 339, 340, 344, 348, 350, 351, 353, 355, 356, 357, 358, 359, 361, 362, 366, 368, 372, 375, 376, 379, 382, 386, 387, 394, 395, 399, 402, 405, 406, 408, 410, 411, 412, 413, 414, 416, 417, 421, 422]	[3, 5, 8, 9, 18, 27, 30, 40, 50, 53, 62, 73, 78, 81, 83, 85, 87, 91, 98, 107, 108, 113, 116, 120, 122, 125, 128, 132, 134, 135, 143, 146, 153, 161, 163, 164, 165, 166, 168, 169, 173, 174, 175, 180, 186, 194, 196, 198, 200, 201, 202, 204, 206, 208, 209, 210, 211, 213, 214, 218, 219, 223, 225, 226, 229, 232, 234, 236, 238, 242, 245, 247, 251, 253, 257, 258, 272, 274, 275, 276, 277, 279, 280, 284, 285, 286, 289, 294, 297, 307, 312, 315, 319, 324, 327, 330, 332, 335, 338, 340, 344, 347, 349, 351, 353, 354, 356, 357, 358, 359, 361, 362, 366, 367, 371, 375, 376, 379, 382, 385, 387, 393, 395, 399, 402, 404, 406, 408, 409, 411, 412, 413, 414, 416, 417, 421, 422, 423]	['Proteomic', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'proteins', 'associated', 'with', 'an', 'oxidative', 'stress', 'response', ',', 'such', 'as', 'the', 'glutathione', 's-transferase', 'family', 'protein', '(', '+8.43-fold', ')', ',', 'heat', 'shock', 'protein', 'Hsp30', '/', 'Hsp42', '(', '+2.02-fold', ')', 'and', '5-demethoxyubiquinone', 'hydroxylase', ',', 'mitochondrial', '(', '+1.73-fold', ')', ',', 'as', 'well', 'as', 'secondary', 'metabolites', 'such', 'as', 'isocyanide', 'synthase', 'A', 'icsA', '(', '+8.52-fold', ')', 'and', 'non', '-', 'ribosomal', 'peptide', 'synthetase', 'fmpE', '(', '+3.06-fold', ')', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 6, 1, 1, 1, 1, 1, 3, 1, 3, 1, 6, 1, 1, 9, 4, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 3, 1, 3, 1, 6, 1, 1, 1, 1, 3, 2, 4, 3, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Statins are widely used for the control of cholesterol and function by inhibiting the action of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase [26,27].	[('PMC7344724', 'D00000', 96, 146, '3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase')]	['St', '##ati', '##ns', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'ch', '##ole', '##ster', '##ol', 'and', 'function', 'by', 'in', '##hibit', '##ing', 'the', 'action', 'of', '3', '-', 'h', '##ydro', '##xy', '-', '3', '-', 'met', '##hyl', '##g', '##lut', '##ary', '##l', '-', 'Co', '##A', '(', 'HM', '##G', '-', 'Co', '##A', ')', 'red', '##uc', '##tase', '[', '26', ',', '27', ']', '.']	[0, 2, 5, 8, 12, 19, 24, 28, 32, 40, 43, 45, 48, 52, 55, 59, 68, 71, 73, 78, 82, 86, 93, 96, 97, 98, 99, 103, 105, 106, 107, 108, 111, 114, 115, 118, 121, 122, 123, 125, 127, 128, 130, 131, 132, 134, 135, 137, 140, 142, 147, 148, 150, 151, 153, 154]	[2, 5, 7, 11, 18, 23, 27, 31, 39, 42, 45, 48, 52, 54, 58, 67, 70, 73, 78, 81, 85, 92, 95, 97, 98, 99, 103, 105, 106, 107, 108, 111, 114, 115, 118, 121, 122, 123, 125, 126, 128, 130, 131, 132, 134, 135, 136, 140, 142, 146, 148, 150, 151, 153, 154, 155]	['Statins', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'cholesterol', 'and', 'function', 'by', 'inhibiting', 'the', 'action', 'of', '3-hydroxy-3-methylglutaryl-CoA', '(', 'HMG-CoA', ')', 'reductase', '[', '26', ',', '27', ']', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 17, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
Proteomic analysis revealed an increased abundance of a range of proteins involved in dealing with oxidative stress, including pyoverdine/dityrosine biosynthesis (+8.52-fold), 5-demethoxyubiquinone hydroxylase, mitochondrial (+1.74-fold) and alcohol dehydrogenase (+1.61-fold).	[('PMC7344724', 'D02000', 176, 209, '5-demethoxyubiquinone hydroxylase')]	['Pro', '##te', '##omi', '##c', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'a', 'range', 'of', 'proteins', 'involved', 'in', 'dealing', 'with', 'o', '##xi', '##da', '##tive', 'stress', ',', 'including', 'p', '##yo', '##ver', '##dine', '/', 'di', '##ty', '##ros', '##ine', 'bio', '##sy', '##nt', '##hesis', '(', '+', '8', '.', '52', '-', 'fold', ')', ',', '5', '-', 'dem', '##eth', '##ox', '##yu', '##bi', '##quin', '##one', 'h', '##ydro', '##xy', '##lase', ',', 'mitochondrial', '(', '+', '1', '.', '74', '-', 'fold', ')', 'and', 'alcohol', 'de', '##hy', '##dr', '##ogen', '##ase', '(', '+', '1', '.', '61', '-', 'fold', ')', '.']	[0, 3, 5, 8, 10, 19, 28, 31, 41, 51, 54, 56, 62, 65, 74, 83, 86, 94, 99, 100, 102, 104, 109, 115, 117, 127, 128, 130, 133, 137, 138, 140, 142, 145, 149, 152, 154, 156, 162, 163, 164, 165, 166, 168, 169, 173, 174, 176, 177, 178, 181, 184, 186, 188, 190, 194, 198, 199, 203, 205, 209, 211, 225, 226, 227, 228, 229, 231, 232, 236, 238, 242, 250, 252, 254, 256, 260, 264, 265, 266, 267, 268, 270, 271, 275, 276]	[3, 5, 8, 9, 18, 27, 30, 40, 50, 53, 55, 61, 64, 73, 82, 85, 93, 98, 100, 102, 104, 108, 115, 116, 126, 128, 130, 133, 137, 138, 140, 142, 145, 148, 152, 154, 156, 161, 163, 164, 165, 166, 168, 169, 173, 174, 175, 177, 178, 181, 184, 186, 188, 190, 194, 197, 199, 203, 205, 209, 210, 224, 226, 227, 228, 229, 231, 232, 236, 237, 241, 249, 252, 254, 256, 260, 263, 265, 266, 267, 268, 270, 271, 275, 276, 277]	['Proteomic', 'analysis', 'revealed', 'an', 'increased', 'abundance', 'of', 'a', 'range', 'of', 'proteins', 'involved', 'in', 'dealing', 'with', 'oxidative', 'stress', ',', 'including', 'pyoverdine', '/', 'dityrosine', 'biosynthesis', '(', '+8.52-fold', ')', ',', '5-demethoxyubiquinone', 'hydroxylase', ',', 'mitochondrial', '(', '+1.74-fold', ')', 'and', 'alcohol', 'dehydrogenase', '(', '+1.61-fold', ')', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 4, 1, 4, 4, 1, 6, 1, 1, 9, 4, 1, 1, 1, 6, 1, 1, 1, 5, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Deletion of fmpE in A. fumigatus resulted in reduced growth and sporulation of the mutant strains but virulence was not altered as compared to the WT strain in a murine infection model [35].	[]	['Del', '##eti', '##on', 'of', 'f', '##mp', '##E', 'in', 'A', '.', 'f', '##umi', '##gat', '##us', 'resulted', 'in', 'reduced', 'growth', 'and', 's', '##por', '##ulation', 'of', 'the', 'mutant', 'strains', 'but', 'v', '##ir', '##ule', '##nce', 'was', 'not', 'altered', 'as', 'compared', 'to', 'the', 'W', '##T', 'strain', 'in', 'a', 'm', '##uri', '##ne', 'infection', 'model', '[', '35', ']', '.']	[0, 3, 6, 9, 12, 13, 15, 17, 20, 21, 23, 24, 27, 30, 33, 42, 45, 53, 60, 64, 65, 68, 76, 79, 83, 90, 98, 102, 103, 105, 108, 112, 116, 120, 128, 131, 140, 143, 147, 148, 150, 157, 160, 162, 163, 166, 169, 179, 185, 186, 188, 189]	[3, 6, 8, 11, 13, 15, 16, 19, 21, 22, 24, 27, 30, 32, 41, 44, 52, 59, 63, 65, 68, 75, 78, 82, 89, 97, 101, 103, 105, 108, 111, 115, 119, 127, 130, 139, 142, 146, 148, 149, 156, 159, 161, 163, 166, 168, 178, 184, 186, 188, 189, 190]	['Deletion', 'of', 'fmpE', 'in', 'A', '.', 'fumigatus', 'resulted', 'in', 'reduced', 'growth', 'and', 'sporulation', 'of', 'the', 'mutant', 'strains', 'but', 'virulence', 'was', 'not', 'altered', 'as', 'compared', 'to', 'the', 'WT', 'strain', 'in', 'a', 'murine', 'infection', 'model', '[', '35', ']', '.']	[3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Statins are widely used for the control of cholesterol and act by inhibiting the action of 3-hydroxy-3-methylglutaryl-CoA (HMG-Co A) reductase and thus block cholesterol biosynthesis [13,14].	[('PMC7344724', 'I03000', 91, 142, '3-hydroxy-3-methylglutaryl-CoA (HMG-Co A) reductase')]	['St', '##ati', '##ns', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'ch', '##ole', '##ster', '##ol', 'and', 'act', 'by', 'in', '##hibit', '##ing', 'the', 'action', 'of', '3', '-', 'h', '##ydro', '##xy', '-', '3', '-', 'met', '##hyl', '##g', '##lut', '##ary', '##l', '-', 'Co', '##A', '(', 'HM', '##G', '-', 'Co', 'A', ')', 'red', '##uc', '##tase', 'and', 'thus', 'block', 'ch', '##ole', '##ster', '##ol', 'bio', '##sy', '##nt', '##hesis', '[', '13', ',', '14', ']', '.']	[0, 2, 5, 8, 12, 19, 24, 28, 32, 40, 43, 45, 48, 52, 55, 59, 63, 66, 68, 73, 77, 81, 88, 91, 92, 93, 94, 98, 100, 101, 102, 103, 106, 109, 110, 113, 116, 117, 118, 120, 122, 123, 125, 126, 127, 130, 131, 133, 136, 138, 143, 147, 152, 158, 160, 163, 167, 170, 173, 175, 177, 183, 184, 186, 187, 189, 190]	[2, 5, 7, 11, 18, 23, 27, 31, 39, 42, 45, 48, 52, 54, 58, 62, 65, 68, 73, 76, 80, 87, 90, 92, 93, 94, 98, 100, 101, 102, 103, 106, 109, 110, 113, 116, 117, 118, 120, 121, 123, 125, 126, 127, 129, 131, 132, 136, 138, 142, 146, 151, 157, 160, 163, 167, 169, 173, 175, 177, 182, 184, 186, 187, 189, 190, 191]	['Statins', 'are', 'widely', 'used', 'for', 'the', 'control', 'of', 'cholesterol', 'and', 'act', 'by', 'inhibiting', 'the', 'action', 'of', '3-hydroxy-3-methylglutaryl-CoA', '(', 'HMG-Co', 'A', ')', 'reductase', 'and', 'thus', 'block', 'cholesterol', 'biosynthesis', '[', '13', ',', '14', ']', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 17, 1, 4, 1, 1, 3, 1, 1, 1, 4, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The main enzyme classes that were altered in abundance in A. fumigatus treated with atorvastatin were oxidoreductases, transferases and hydrolases (Figure S4).	[('PMC7344724', 'R05000', 102, 117, 'oxidoreductases')]	['The', 'main', 'enzyme', 'classes', 'that', 'were', 'altered', 'in', 'abundance', 'in', 'A', '.', 'f', '##umi', '##gat', '##us', 'treated', 'with', 'at', '##or', '##vas', '##tat', '##in', 'were', 'o', '##xi', '##dor', '##ed', '##uc', '##tase', '##s', ',', 'transfer', '##ases', 'and', 'h', '##ydro', '##lase', '##s', '(', 'Figure', 'S', '##4', ')', '.']	[0, 4, 9, 16, 24, 29, 34, 42, 45, 55, 58, 59, 61, 62, 65, 68, 71, 79, 84, 86, 88, 91, 94, 97, 102, 103, 105, 108, 110, 112, 116, 117, 119, 127, 132, 136, 137, 141, 145, 147, 148, 155, 156, 157, 158]	[3, 8, 15, 23, 28, 33, 41, 44, 54, 57, 59, 60, 62, 65, 68, 70, 78, 83, 86, 88, 91, 94, 96, 101, 103, 105, 108, 110, 112, 116, 117, 118, 127, 131, 135, 137, 141, 145, 146, 148, 154, 156, 157, 158, 159]	['The', 'main', 'enzyme', 'classes', 'that', 'were', 'altered', 'in', 'abundance', 'in', 'A', '.', 'fumigatus', 'treated', 'with', 'atorvastatin', 'were', 'oxidoreductases', ',', 'transferases', 'and', 'hydrolases', '(', 'Figure', 'S4', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 7, 1, 2, 1, 4, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Oxidoreductase enzymes that increased in abundance in atorvastatin treatment of A fumigatus were pyoverdine/dityrosine biosynthesis family protein (+8.52-fold), 5-demethoxyubiquinone hydroxylase, mitochondrial (+1.73-fold), alcohol dehydrogenase, putative (+1.6-fold) and Psi-producing oxygenase A (+1.55-fold).	[('PMC7344724', 'R05001', 0, 14, 'Oxidoreductase')]	['O', '##xi', '##dor', '##ed', '##uc', '##tase', 'enzymes', 'that', 'increased', 'in', 'abundance', 'in', 'at', '##or', '##vas', '##tat', '##in', 'treatment', 'of', 'A', 'f', '##umi', '##gat', '##us', 'were', 'p', '##yo', '##ver', '##dine', '/', 'di', '##ty', '##ros', '##ine', 'bio', '##sy', '##nt', '##hesis', 'family', 'protein', '(', '+', '8', '.', '52', '-', 'fold', ')', ',', '5', '-', 'dem', '##eth', '##ox', '##yu', '##bi', '##quin', '##one', 'h', '##ydro', '##xy', '##lase', ',', 'mitochondrial', '(', '+', '1', '.', '73', '-', 'fold', ')', ',', 'alcohol', 'de', '##hy', '##dr', '##ogen', '##ase', ',', 'put', '##ative', '(', '+', '1', '.', '6', '-', 'fold', ')', 'and', 'P', '##si', '-', 'producing', 'oxygen', '##ase', 'A', '(', '+', '1', '.', '55', '-', 'fold', ')', '.']	[0, 1, 3, 6, 8, 10, 15, 23, 28, 38, 41, 51, 54, 56, 58, 61, 64, 67, 77, 80, 82, 83, 86, 89, 92, 97, 98, 100, 103, 107, 108, 110, 112, 115, 119, 122, 124, 126, 132, 139, 147, 148, 149, 150, 151, 153, 154, 158, 159, 161, 162, 163, 166, 169, 171, 173, 175, 179, 183, 184, 188, 190, 194, 196, 210, 211, 212, 213, 214, 216, 217, 221, 222, 224, 232, 234, 236, 238, 242, 245, 247, 250, 256, 257, 258, 259, 260, 261, 262, 266, 268, 272, 273, 275, 276, 286, 292, 296, 298, 299, 300, 301, 302, 304, 305, 309, 310]	[1, 3, 6, 8, 10, 14, 22, 27, 37, 40, 50, 53, 56, 58, 61, 64, 66, 76, 79, 81, 83, 86, 89, 91, 96, 98, 100, 103, 107, 108, 110, 112, 115, 118, 122, 124, 126, 131, 138, 146, 148, 149, 150, 151, 153, 154, 158, 159, 160, 162, 163, 166, 169, 171, 173, 175, 179, 182, 184, 188, 190, 194, 195, 209, 211, 212, 213, 214, 216, 217, 221, 222, 223, 231, 234, 236, 238, 242, 245, 246, 250, 255, 257, 258, 259, 260, 261, 262, 266, 267, 271, 273, 275, 276, 285, 292, 295, 297, 299, 300, 301, 302, 304, 305, 309, 310, 311]	['Oxidoreductase', 'enzymes', 'that', 'increased', 'in', 'abundance', 'in', 'atorvastatin', 'treatment', 'of', 'A', 'fumigatus', 'were', 'pyoverdine', '/', 'dityrosine', 'biosynthesis', 'family', 'protein', '(', '+8.52-fold', ')', ',', '5-demethoxyubiquinone', 'hydroxylase', ',', 'mitochondrial', '(', '+1.73-fold', ')', ',', 'alcohol', 'dehydrogenase', ',', 'putative', '(', '+1.6-fold', ')', 'and', 'Psi', '-', 'producing', 'oxygenase', 'A', '(', '+1.55-fold', ')', '.']	[6, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 4, 1, 4, 1, 4, 4, 1, 1, 1, 6, 1, 1, 9, 4, 1, 1, 1, 6, 1, 1, 1, 5, 1, 2, 1, 6, 1, 1, 2, 1, 1, 2, 1, 1, 6, 1, 1]	['B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thirteen oxidoreductase enzymes showed a decrease in abundance and included aflatoxin B1-aldehyde reductase GliO-like, putative (−2.86-fold), aryl-alcohol dehydrogenase, putative (−1.52-fold) and NADH-dependent flavin oxidoreductase, putative (−1.50-fold).	[('PMC7344724', 'R05002', 9, 23, 'oxidoreductase')]	['Thirteen', 'o', '##xi', '##dor', '##ed', '##uc', '##tase', 'enzymes', 'showed', 'a', 'decrease', 'in', 'abundance', 'and', 'included', 'a', '##f', '##lat', '##ox', '##in', 'B', '##1', '-', 'al', '##de', '##hy', '##de', 'red', '##uc', '##tase', 'G', '##li', '##O', '-', 'like', ',', 'put', '##ative', '(', '−', '##2', '.', '86', '-', 'fold', ')', ',', 'a', '##ryl', '-', 'alcohol', 'de', '##hy', '##dr', '##ogen', '##ase', ',', 'put', '##ative', '(', '−', '##1', '.', '52', '-', 'fold', ')', 'and', 'N', '##AD', '##H', '-', 'dependent', 'fl', '##avi', '##n', 'o', '##xi', '##dor', '##ed', '##uc', '##tase', ',', 'put', '##ative', '(', '−', '##1', '.', '50', '-', 'fold', ')', '.']	[0, 9, 10, 12, 15, 17, 19, 24, 32, 39, 41, 50, 53, 63, 67, 76, 77, 78, 81, 83, 86, 87, 88, 89, 91, 93, 95, 98, 101, 103, 108, 109, 111, 112, 113, 117, 119, 122, 128, 129, 130, 131, 132, 134, 135, 139, 140, 142, 143, 146, 147, 155, 157, 159, 161, 165, 168, 170, 173, 179, 180, 181, 182, 183, 185, 186, 190, 192, 196, 197, 199, 200, 201, 211, 213, 216, 218, 219, 221, 224, 226, 228, 232, 234, 237, 243, 244, 245, 246, 247, 249, 250, 254, 255]	[8, 10, 12, 15, 17, 19, 23, 31, 38, 40, 49, 52, 62, 66, 75, 77, 78, 81, 83, 85, 87, 88, 89, 91, 93, 95, 97, 101, 103, 107, 109, 111, 112, 113, 117, 118, 122, 127, 129, 130, 131, 132, 134, 135, 139, 140, 141, 143, 146, 147, 154, 157, 159, 161, 165, 168, 169, 173, 178, 180, 181, 182, 183, 185, 186, 190, 191, 195, 197, 199, 200, 201, 210, 213, 216, 217, 219, 221, 224, 226, 228, 232, 233, 237, 242, 244, 245, 246, 247, 249, 250, 254, 255, 256]	['Thirteen', 'oxidoreductase', 'enzymes', 'showed', 'a', 'decrease', 'in', 'abundance', 'and', 'included', 'aflatoxin', 'B1-aldehyde', 'reductase', 'GliO', '-', 'like', ',', 'putative', '(', '−2.86-fold', ')', ',', 'aryl', '-', 'alcohol', 'dehydrogenase', ',', 'putative', '(', '−1.52-fold', ')', 'and', 'NADH-dependent', 'flavin', 'oxidoreductase', ',', 'putative', '(', '−1.50-fold', ')', '.']	[1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 5, 7, 3, 3, 1, 1, 1, 2, 1, 6, 1, 1, 2, 1, 1, 5, 1, 2, 1, 6, 1, 1, 5, 3, 6, 1, 2, 1, 6, 1, 1]	['O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Enzymes with transferase activity increased in abundance included glutathione S-transferase family protein (+8.43-fold), phosphatidylinositol transporter, putative (+2.00-fold) and allergen Asp f 4 (+1.42-fold), while O-methyltransferase (−3.68-fold), malate synthase (−2.40-fold) and GNAT family acetyltransferase, putative (−2.25-fold) were decreased in abundance.	[('PMC7344724', 'R05003', 13, 24, 'transferase')]	['En', '##zy', '##mes', 'with', 'transfer', '##ase', 'activity', 'increased', 'in', 'abundance', 'included', 'g', '##lut', '##ath', '##ione', 'S', '-', 'transfer', '##ase', 'family', 'protein', '(', '+', '8', '.', '43', '-', 'fold', ')', ',', 'p', '##hos', '##pha', '##ti', '##dy', '##lino', '##si', '##to', '##l', 'transport', '##er', ',', 'put', '##ative', '(', '+', '2', '.', '00', '-', 'fold', ')', 'and', 'all', '##er', '##gen', 'As', '##p', 'f', '4', '(', '+', '1', '.', '42', '-', 'fold', ')', ',', 'while', 'O', '-', 'met', '##hyl', '##tra', '##ns', '##fer', '##ase', '(', '−', '##3', '.', '68', '-', 'fold', ')', ',', 'ma', '##late', 's', '##ynth', '##ase', '(', '−', '##2', '.', '40', '-', 'fold', ')', 'and', 'G', '##NA', '##T', 'family', 'ace', '##ty', '##lt', '##ran', '##s', '##fer', '##ase', ',', 'put', '##ative', '(', '−', '##2', '.', '25', '-', 'fold', ')', 'were', 'decreased', 'in', 'abundance', '.']	[0, 2, 4, 8, 13, 21, 25, 34, 44, 47, 57, 66, 67, 70, 73, 78, 79, 80, 88, 92, 99, 107, 108, 109, 110, 111, 113, 114, 118, 119, 121, 122, 125, 128, 130, 132, 136, 138, 140, 142, 151, 153, 155, 158, 164, 165, 166, 167, 168, 170, 171, 175, 177, 181, 184, 186, 190, 192, 194, 196, 198, 199, 200, 201, 202, 204, 205, 209, 210, 212, 218, 219, 220, 223, 226, 229, 231, 234, 238, 239, 240, 241, 242, 244, 245, 249, 250, 252, 254, 259, 260, 264, 268, 269, 270, 271, 272, 274, 275, 279, 281, 285, 286, 288, 290, 297, 300, 302, 304, 307, 308, 311, 314, 316, 319, 325, 326, 327, 328, 329, 331, 332, 336, 338, 343, 353, 356, 365]	[2, 4, 7, 12, 21, 24, 33, 43, 46, 56, 65, 67, 70, 73, 77, 79, 80, 88, 91, 98, 106, 108, 109, 110, 111, 113, 114, 118, 119, 120, 122, 125, 128, 130, 132, 136, 138, 140, 141, 151, 153, 154, 158, 163, 165, 166, 167, 168, 170, 171, 175, 176, 180, 184, 186, 189, 192, 193, 195, 197, 199, 200, 201, 202, 204, 205, 209, 210, 211, 217, 219, 220, 223, 226, 229, 231, 234, 237, 239, 240, 241, 242, 244, 245, 249, 250, 251, 254, 258, 260, 264, 267, 269, 270, 271, 272, 274, 275, 279, 280, 284, 286, 288, 289, 296, 300, 302, 304, 307, 308, 311, 314, 315, 319, 324, 326, 327, 328, 329, 331, 332, 336, 337, 342, 352, 355, 365, 366]	['Enzymes', 'with', 'transferase', 'activity', 'increased', 'in', 'abundance', 'included', 'glutathione', 'S-transferase', 'family', 'protein', '(', '+8.43-fold', ')', ',', 'phosphatidylinositol', 'transporter', ',', 'putative', '(', '+2.00-fold', ')', 'and', 'allergen', 'Asp', 'f', '4', '(', '+1.42-fold', ')', ',', 'while', 'O-methyltransferase', '(', '−3.68-fold', ')', ',', 'malate', 'synthase', '(', '−2.40-fold', ')', 'and', 'GNAT', 'family', 'acetyltransferase', ',', 'putative', '(', '−2.25-fold', ')', 'were', 'decreased', 'in', 'abundance', '.']	[3, 1, 2, 1, 1, 1, 1, 1, 4, 4, 1, 1, 1, 6, 1, 1, 9, 2, 1, 2, 1, 6, 1, 1, 3, 2, 1, 1, 1, 6, 1, 1, 1, 8, 1, 6, 1, 1, 2, 3, 1, 6, 1, 1, 3, 1, 7, 1, 2, 1, 6, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Nine hydrolytic enzymes were increased in abundance and these included kynureninase (4.48-fold), amidase putative (+2.77-fold), lipase/esterase putative (+2.12-fold) and methionine aminopeptidase 2-2 (+1.83-fold).	[('PMC7344724', 'R05004', 71, 83, 'kynureninase')]	['Nine', 'h', '##ydro', '##ly', '##tic', 'enzymes', 'were', 'increased', 'in', 'abundance', 'and', 'these', 'included', 'k', '##yn', '##uren', '##inas', '##e', '(', '4', '.', '48', '-', 'fold', ')', ',', 'amid', '##ase', 'put', '##ative', '(', '+', '2', '.', '77', '-', 'fold', ')', ',', 'lip', '##ase', '/', 'est', '##era', '##se', 'put', '##ative', '(', '+', '2', '.', '12', '-', 'fold', ')', 'and', 'met', '##hi', '##oni', '##ne', 'amino', '##pe', '##pt', '##idas', '##e', '2', '-', '2', '(', '+', '1', '.', '83', '-', 'fold', ')', '.']	[0, 5, 6, 10, 12, 16, 24, 29, 39, 42, 52, 56, 62, 71, 72, 74, 78, 82, 84, 85, 86, 87, 89, 90, 94, 95, 97, 101, 105, 108, 114, 115, 116, 117, 118, 120, 121, 125, 126, 128, 131, 134, 135, 138, 141, 144, 147, 153, 154, 155, 156, 157, 159, 160, 164, 166, 170, 173, 175, 178, 181, 186, 188, 190, 194, 196, 197, 198, 200, 201, 202, 203, 204, 206, 207, 211, 212]	[4, 6, 10, 12, 15, 23, 28, 38, 41, 51, 55, 61, 70, 72, 74, 78, 82, 83, 85, 86, 87, 89, 90, 94, 95, 96, 101, 104, 108, 113, 115, 116, 117, 118, 120, 121, 125, 126, 127, 131, 134, 135, 138, 141, 143, 147, 152, 154, 155, 156, 157, 159, 160, 164, 165, 169, 173, 175, 178, 180, 186, 188, 190, 194, 195, 197, 198, 199, 201, 202, 203, 204, 206, 207, 211, 212, 213]	['Nine', 'hydrolytic', 'enzymes', 'were', 'increased', 'in', 'abundance', 'and', 'these', 'included', 'kynureninase', '(', '4.48-fold', ')', ',', 'amidase', 'putative', '(', '+2.77-fold', ')', ',', 'lipase', '/', 'esterase', 'putative', '(', '+2.12-fold', ')', 'and', 'methionine', 'aminopeptidase', '2-2', '(', '+1.83-fold', ')', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 5, 1, 1, 2, 2, 1, 6, 1, 1, 2, 1, 3, 2, 1, 6, 1, 1, 4, 5, 3, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast two hydrolytic enzymes were reduced in abundance (haloalkanoic acid dehalogenase, putative (−2.99-fold) and phytase, putative (−1.42-fold).	[('PMC7344724', 'R05005', 62, 92, 'haloalkanoic acid dehalogenase')]	['In', 'contrast', 'two', 'h', '##ydro', '##ly', '##tic', 'enzymes', 'were', 'reduced', 'in', 'abundance', '(', 'ha', '##lo', '##alk', '##ano', '##ic', 'acid', 'de', '##hal', '##ogen', '##ase', ',', 'put', '##ative', '(', '−', '##2', '.', '99', '-', 'fold', ')', 'and', 'p', '##hy', '##tase', ',', 'put', '##ative', '(', '−', '##1', '.', '42', '-', 'fold', ')', '.']	[0, 3, 12, 16, 17, 21, 23, 27, 35, 40, 48, 51, 61, 62, 64, 66, 69, 72, 75, 80, 82, 85, 89, 92, 94, 97, 103, 104, 105, 106, 107, 109, 110, 114, 116, 120, 121, 123, 127, 129, 132, 138, 139, 140, 141, 142, 144, 145, 149, 150]	[2, 11, 15, 17, 21, 23, 26, 34, 39, 47, 50, 60, 62, 64, 66, 69, 72, 74, 79, 82, 85, 89, 92, 93, 97, 102, 104, 105, 106, 107, 109, 110, 114, 115, 119, 121, 123, 127, 128, 132, 137, 139, 140, 141, 142, 144, 145, 149, 150, 151]	['In', 'contrast', 'two', 'hydrolytic', 'enzymes', 'were', 'reduced', 'in', 'abundance', '(', 'haloalkanoic', 'acid', 'dehalogenase', ',', 'putative', '(', '−2.99-fold', ')', 'and', 'phytase', ',', 'putative', '(', '−1.42-fold', ')', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 4, 1, 2, 1, 6, 1, 1, 3, 1, 2, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The amyloid beta A4 protein, apolipoprotein A-IV, gelsolin, contactin-1, gamma-glutamyl hydrolase, and complement factor H-related protein 1 (CFHR1) were selected for further analysis.	[]	['The', 'am', '##yl', '##oid', 'beta', 'A', '##4', 'protein', ',', 'a', '##poli', '##pop', '##rote', '##in', 'A', '-', 'IV', ',', 'gel', '##sol', '##in', ',', 'contact', '##in', '-', '1', ',', 'gamma', '-', 'g', '##lut', '##am', '##yl', 'h', '##ydro', '##lase', ',', 'and', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CF', '##H', '##R', '##1', ')', 'were', 'selected', 'for', 'further', 'analysis', '.']	[0, 4, 6, 8, 12, 17, 18, 20, 27, 29, 30, 34, 37, 41, 44, 45, 46, 48, 50, 53, 56, 58, 60, 67, 69, 70, 71, 73, 78, 79, 80, 83, 85, 88, 89, 93, 97, 99, 103, 114, 121, 122, 123, 131, 139, 141, 142, 144, 145, 146, 147, 149, 154, 163, 167, 175, 183]	[3, 6, 8, 11, 16, 18, 19, 27, 28, 30, 34, 37, 41, 43, 45, 46, 48, 49, 53, 56, 58, 59, 67, 69, 70, 71, 72, 78, 79, 80, 83, 85, 87, 89, 93, 97, 98, 102, 113, 120, 122, 123, 130, 138, 140, 142, 144, 145, 146, 147, 148, 153, 162, 166, 174, 183, 184]	['The', 'amyloid', 'beta', 'A4', 'protein', ',', 'apolipoprotein', 'A-IV', ',', 'gelsolin', ',', 'contactin-1', ',', 'gamma', '-', 'glutamyl', 'hydrolase', ',', 'and', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CFHR1', ')', 'were', 'selected', 'for', 'further', 'analysis', '.']	[1, 3, 1, 2, 1, 1, 5, 3, 1, 3, 1, 4, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
CFHR1 blocks C5 convertase activity and interferes with C5b surface association to regulate the complement system (Hannan et al., 2016).	[('PMC7346861', 'D04000', 13, 26, 'C5 convertase')]	['CF', '##H', '##R', '##1', 'blocks', 'C', '##5', 'convert', '##ase', 'activity', 'and', 'interfere', '##s', 'with', 'C', '##5', '##b', 'surface', 'association', 'to', 'regulate', 'the', 'complement', 'system', '(', 'Hanna', '##n', 'et', 'al', '.', ',', '2016', ')', '.']	[0, 2, 3, 4, 6, 13, 14, 16, 23, 27, 36, 40, 49, 51, 56, 57, 58, 60, 68, 80, 83, 92, 96, 107, 114, 115, 120, 122, 125, 127, 128, 130, 134, 135]	[2, 3, 4, 5, 12, 14, 15, 23, 26, 35, 39, 49, 50, 55, 57, 58, 59, 67, 79, 82, 91, 95, 106, 113, 115, 120, 121, 124, 127, 128, 129, 134, 135, 136]	['CFHR1', 'blocks', 'C5', 'convertase', 'activity', 'and', 'interferes', 'with', 'C5b', 'surface', 'association', 'to', 'regulate', 'the', 'complement', 'system', '(', 'Hannan', 'et', 'al', '.', ',', '2016', ')', '.']	[4, 1, 2, 2, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A human complement factor H-related protein 1 (CFHR1) enzyme-linked immunosorbent assay (ELISA) kit (Catalog No: IC-CFHR1-Hu), human contactin 1 (CNTN1) ELISA kit (Catalog No: IC-CNTN1-Hu), human gelsolin ELISA kit (Catalog No: IC-GS-Hu), human amyloid precursor protein ELISA kit (Catalog No: DL-APP-Hu), and human gamma-glutamyl hydrolase ELISA kit (Catalog No: CSB-EL009389HU) were used to validate whether these proteins were differentially expressed in large numbers of samples.	[('PMC7346861', 'M04000', 316, 340, 'gamma-glutamyl hydrolase')]	['A', 'human', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CF', '##H', '##R', '##1', ')', 'enzyme', '-', 'linked', 'im', '##mu', '##nos', '##or', '##bent', 'ass', '##ay', '(', 'E', '##L', '##IS', '##A', ')', 'kit', '(', 'Cat', '##alog', 'No', ':', 'I', '##C', '-', 'CF', '##H', '##R', '##1', '-', 'Hu', ')', ',', 'human', 'contact', '##in', '1', '(', 'C', '##NT', '##N', '##1', ')', 'E', '##L', '##IS', '##A', 'kit', '(', 'Cat', '##alog', 'No', ':', 'I', '##C', '-', 'C', '##NT', '##N', '##1', '-', 'Hu', ')', ',', 'human', 'gel', '##sol', '##in', 'E', '##L', '##IS', '##A', 'kit', '(', 'Cat', '##alog', 'No', ':', 'I', '##C', '-', 'G', '##S', '-', 'Hu', ')', ',', 'human', 'am', '##yl', '##oid', 'precursor', 'protein', 'E', '##L', '##IS', '##A', 'kit', '(', 'Cat', '##alog', 'No', ':', 'DL', '-', 'AP', '##P', '-', 'Hu', ')', ',', 'and', 'human', 'gamma', '-', 'g', '##lut', '##am', '##yl', 'h', '##ydro', '##lase', 'E', '##L', '##IS', '##A', 'kit', '(', 'Cat', '##alog', 'No', ':', 'CS', '##B', '-', 'E', '##L', '##00', '##9', '##38', '##9', '##H', '##U', ')', 'were', 'used', 'to', 'valid', '##ate', 'whether', 'these', 'proteins', 'were', 'differential', '##ly', 'expressed', 'in', 'large', 'numbers', 'of', 'samples', '.']	[0, 2, 8, 19, 26, 27, 28, 36, 44, 46, 47, 49, 50, 51, 52, 54, 60, 61, 68, 70, 72, 75, 77, 82, 85, 88, 89, 90, 91, 93, 94, 96, 100, 101, 104, 109, 111, 113, 114, 115, 116, 118, 119, 120, 121, 122, 124, 125, 127, 133, 140, 143, 145, 146, 147, 149, 150, 151, 153, 154, 155, 157, 159, 163, 164, 167, 172, 174, 176, 177, 178, 179, 180, 182, 183, 184, 185, 187, 188, 190, 196, 199, 202, 205, 206, 207, 209, 211, 215, 216, 219, 224, 226, 228, 229, 230, 231, 232, 233, 234, 236, 237, 239, 245, 247, 249, 253, 263, 271, 272, 273, 275, 277, 281, 282, 285, 290, 292, 294, 296, 297, 299, 300, 301, 303, 304, 306, 310, 316, 321, 322, 323, 326, 328, 331, 332, 336, 341, 342, 343, 345, 347, 351, 352, 355, 360, 362, 364, 366, 367, 368, 369, 370, 372, 373, 375, 376, 377, 378, 380, 385, 390, 393, 398, 402, 410, 416, 425, 430, 442, 445, 455, 458, 464, 472, 475, 482]	[1, 7, 18, 25, 27, 28, 35, 43, 45, 47, 49, 50, 51, 52, 53, 60, 61, 67, 70, 72, 75, 77, 81, 85, 87, 89, 90, 91, 93, 94, 95, 99, 101, 104, 108, 111, 112, 114, 115, 116, 118, 119, 120, 121, 122, 124, 125, 126, 132, 140, 142, 144, 146, 147, 149, 150, 151, 152, 154, 155, 157, 158, 162, 164, 167, 171, 174, 175, 177, 178, 179, 180, 182, 183, 184, 185, 187, 188, 189, 195, 199, 202, 204, 206, 207, 209, 210, 214, 216, 219, 223, 226, 227, 229, 230, 231, 232, 233, 234, 236, 237, 238, 244, 247, 249, 252, 262, 270, 272, 273, 275, 276, 280, 282, 285, 289, 292, 293, 296, 297, 299, 300, 301, 303, 304, 305, 309, 315, 321, 322, 323, 326, 328, 330, 332, 336, 340, 342, 343, 345, 346, 350, 352, 355, 359, 362, 363, 366, 367, 368, 369, 370, 372, 373, 375, 376, 377, 378, 379, 384, 389, 392, 398, 401, 409, 415, 424, 429, 442, 444, 454, 457, 463, 471, 474, 482, 483]	['A', 'human', 'complement', 'factor', 'H', '-', 'related', 'protein', '1', '(', 'CFHR1', ')', 'enzyme', '-', 'linked', 'immunosorbent', 'assay', '(', 'ELISA', ')', 'kit', '(', 'Catalog', 'No', ':', 'IC-CFHR1-Hu', ')', ',', 'human', 'contactin', '1', '(', 'CNTN1', ')', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'IC-CNTN1-Hu', ')', ',', 'human', 'gelsolin', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'IC-GS-Hu', ')', ',', 'human', 'amyloid', 'precursor', 'protein', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'DL-APP-Hu', ')', ',', 'and', 'human', 'gamma', '-', 'glutamyl', 'hydrolase', 'ELISA', 'kit', '(', 'Catalog', 'No', ':', 'CSB-EL009389HU', ')', 'were', 'used', 'to', 'validate', 'whether', 'these', 'proteins', 'were', 'differentially', 'expressed', 'in', 'large', 'numbers', 'of', 'samples', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 5, 2, 1, 4, 1, 1, 1, 2, 1, 1, 9, 1, 1, 1, 2, 1, 1, 4, 1, 4, 1, 1, 2, 1, 1, 9, 1, 1, 1, 3, 4, 1, 1, 2, 1, 1, 7, 1, 1, 1, 3, 1, 1, 4, 1, 1, 2, 1, 1, 6, 1, 1, 1, 1, 1, 1, 4, 3, 4, 1, 1, 2, 1, 1, 11, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Gelsolin and contactin-1 have been reported to be expressed during TC (Kim et al., 2007; Shi et al., 2015), but their role as potential serum protein markers has not yet been studied.	[]	['G', '##els', '##olin', 'and', 'contact', '##in', '-', '1', 'have', 'been', 'reported', 'to', 'be', 'expressed', 'during', 'T', '##C', '(', 'Kim', 'et', 'al', '.', ',', '2007', ';', 'Shi', 'et', 'al', '.', ',', '2015', ')', ',', 'but', 'their', 'role', 'as', 'potential', 'serum', 'protein', 'markers', 'has', 'not', 'yet', 'been', 'studied', '.']	[0, 1, 4, 9, 13, 20, 22, 23, 25, 30, 35, 44, 47, 50, 60, 67, 68, 70, 71, 75, 78, 80, 81, 83, 87, 89, 93, 96, 98, 99, 101, 105, 106, 108, 112, 118, 123, 126, 136, 142, 150, 158, 162, 166, 170, 175, 182]	[1, 4, 8, 12, 20, 22, 23, 24, 29, 34, 43, 46, 49, 59, 66, 68, 69, 71, 74, 77, 80, 81, 82, 87, 88, 92, 95, 98, 99, 100, 105, 106, 107, 111, 117, 122, 125, 135, 141, 149, 157, 161, 165, 169, 174, 182, 183]	['Gelsolin', 'and', 'contactin-1', 'have', 'been', 'reported', 'to', 'be', 'expressed', 'during', 'TC', '(', 'Kim', 'et', 'al', '.', ',', '2007', ';', 'Shi', 'et', 'al', '.', ',', '2015', ')', ',', 'but', 'their', 'role', 'as', 'potential', 'serum', 'protein', 'markers', 'has', 'not', 'yet', 'been', 'studied', '.']	[3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An aliquot of 1.0 mL urine was added to a 2.0 mL glass vial containing 1.0 mL of 0.5 M NaOAc buffer (pH 5), β-glucuronidase (1000 units) and arylsulfatase (8000 units), and 5 pmol of [13C6]Phe-1,2-D as internal standard.	[]	['An', 'al', '##iq', '##uo', '##t', 'of', '1', '.', '0', 'm', '##L', 'urine', 'was', 'added', 'to', 'a', '2', '.', '0', 'm', '##L', 'glass', 'via', '##l', 'containing', '1', '.', '0', 'm', '##L', 'of', '0', '.', '5', 'M', 'Na', '##OA', '##c', 'buffer', '(', 'pH', '5', ')', ',', 'β', '-', 'g', '##lu', '##cu', '##ron', '##idas', '##e', '(', '1000', 'units', ')', 'and', 'a', '##ryl', '##sul', '##fa', '##tase', '(', '800', '##0', 'units', ')', ',', 'and', '5', 'pm', '##ol', 'of', '[', '13', '##C', '##6', ']', 'Ph', '##e', '-', '1', ',', '2', '-', 'D', 'as', 'internal', 'standard', '.']	[0, 3, 5, 7, 9, 11, 14, 15, 16, 18, 19, 21, 27, 31, 37, 40, 42, 43, 44, 46, 47, 49, 55, 58, 60, 71, 72, 73, 75, 76, 78, 81, 82, 83, 85, 87, 89, 91, 93, 100, 101, 104, 105, 106, 108, 109, 110, 111, 113, 115, 118, 122, 124, 125, 130, 135, 137, 141, 142, 145, 148, 150, 155, 156, 159, 161, 166, 167, 169, 173, 175, 177, 180, 183, 184, 186, 187, 188, 189, 191, 192, 193, 194, 195, 196, 197, 199, 202, 211, 219]	[2, 5, 7, 9, 10, 13, 15, 16, 17, 19, 20, 26, 30, 36, 39, 41, 43, 44, 45, 47, 48, 54, 58, 59, 70, 72, 73, 74, 76, 77, 80, 82, 83, 84, 86, 89, 91, 92, 99, 101, 103, 105, 106, 107, 109, 110, 111, 113, 115, 118, 122, 123, 125, 129, 135, 136, 140, 142, 145, 148, 150, 154, 156, 159, 160, 166, 167, 168, 172, 174, 177, 179, 182, 184, 186, 187, 188, 189, 191, 192, 193, 194, 195, 196, 197, 198, 201, 210, 219, 220]	['An', 'aliquot', 'of', '1.0', 'mL', 'urine', 'was', 'added', 'to', 'a', '2.0', 'mL', 'glass', 'vial', 'containing', '1.0', 'mL', 'of', '0.5', 'M', 'NaOAc', 'buffer', '(', 'pH', '5', ')', ',', 'β-glucuronidase', '(', '1000', 'units', ')', 'and', 'arylsulfatase', '(', '8000', 'units', ')', ',', 'and', '5', 'pmol', 'of', '[13C6]Phe-1,2-D', 'as', 'internal', 'standard', '.']	[1, 4, 1, 3, 2, 1, 1, 1, 1, 1, 3, 2, 1, 2, 1, 3, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 8, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 1, 1, 1, 2, 1, 13, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Using the BIA-MS approach, mucin-binding cytoplasmic proteins (PK, GroEL, EF-Tu, PGK, Tal, and Hsp20) were isolated from B. longum NCC2705 EV fractions.	[('PMC7499026', 'D03000', 86, 89, 'Tal')]	['Using', 'the', 'B', '##IA', '-', 'MS', 'approach', ',', 'm', '##uc', '##in', '-', 'binding', 'c', '##yt', '##op', '##las', '##mic', 'proteins', '(', 'P', '##K', ',', 'G', '##ro', '##EL', ',', 'E', '##F', '-', 'Tu', ',', 'P', '##G', '##K', ',', 'Ta', '##l', ',', 'and', 'H', '##sp', '##20', ')', 'were', 'isolated', 'from', 'B', '.', 'long', '##um', 'NC', '##C', '##27', '##0', '##5', 'E', '##V', 'fraction', '##s', '.']	[0, 6, 10, 11, 13, 14, 17, 25, 27, 28, 30, 32, 33, 41, 42, 44, 46, 49, 53, 62, 63, 64, 65, 67, 68, 70, 72, 74, 75, 76, 77, 79, 81, 82, 83, 84, 86, 88, 89, 91, 95, 96, 98, 100, 102, 107, 116, 121, 122, 124, 128, 131, 133, 134, 136, 137, 139, 140, 142, 150, 151]	[5, 9, 11, 13, 14, 16, 25, 26, 28, 30, 32, 33, 40, 42, 44, 46, 49, 52, 61, 63, 64, 65, 66, 68, 70, 72, 73, 75, 76, 77, 79, 80, 82, 83, 84, 85, 88, 89, 90, 94, 96, 98, 100, 101, 106, 115, 120, 122, 123, 128, 130, 133, 134, 136, 137, 138, 140, 141, 150, 151, 152]	['Using', 'the', 'BIA-MS', 'approach', ',', 'mucin', '-', 'binding', 'cytoplasmic', 'proteins', '(', 'PK', ',', 'GroEL', ',', 'EF-Tu', ',', 'PGK', ',', 'Tal', ',', 'and', 'Hsp20', ')', 'were', 'isolated', 'from', 'B', '.', 'longum', 'NCC2705', 'EV', 'fractions', '.']	[1, 1, 4, 1, 1, 3, 1, 1, 5, 1, 1, 2, 1, 3, 1, 4, 1, 3, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 5, 2, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Genes (bl0959, groEL, tuf, pgk, tal, and bl0576) were amplified by PCR with Ex Taq DNA polymerase (TaKaRa BIO) using B. longum NCC2705 genomic DNA as a template (primer pairs are listed in Table S2).	[]	['Gene', '##s', '(', 'b', '##l', '##0', '##9', '##5', '##9', ',', 'g', '##ro', '##EL', ',', 't', '##uf', ',', 'p', '##g', '##k', ',', 'ta', '##l', ',', 'and', 'b', '##l', '##0', '##5', '##7', '##6', ')', 'were', 'am', '##plified', 'by', 'PC', '##R', 'with', 'Ex', 'Ta', '##q', 'DNA', 'polymer', '##ase', '(', 'Ta', '##K', '##a', '##R', '##a', 'B', '##IO', ')', 'using', 'B', '.', 'long', '##um', 'NC', '##C', '##27', '##0', '##5', 'g', '##eno', '##mic', 'DNA', 'as', 'a', 'template', '(', 'prime', '##r', 'pairs', 'are', 'listed', 'in', 'Table', 'S', '##2', ')', '.']	[0, 4, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 18, 20, 22, 23, 25, 27, 28, 29, 30, 32, 34, 35, 37, 41, 42, 43, 44, 45, 46, 47, 49, 54, 56, 64, 67, 69, 71, 76, 79, 81, 83, 87, 94, 98, 99, 101, 102, 103, 104, 106, 107, 109, 111, 117, 118, 120, 124, 127, 129, 130, 132, 133, 135, 136, 139, 143, 147, 150, 152, 161, 162, 167, 169, 175, 179, 186, 189, 195, 196, 197, 198]	[4, 5, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18, 20, 21, 23, 25, 26, 28, 29, 30, 31, 34, 35, 36, 40, 42, 43, 44, 45, 46, 47, 48, 53, 56, 63, 66, 69, 70, 75, 78, 81, 82, 86, 94, 97, 99, 101, 102, 103, 104, 105, 107, 109, 110, 116, 118, 119, 124, 126, 129, 130, 132, 133, 134, 136, 139, 142, 146, 149, 151, 160, 162, 167, 168, 174, 178, 185, 188, 194, 196, 197, 198, 199]	['Genes', '(', 'bl0959', ',', 'groEL', ',', 'tuf', ',', 'pgk', ',', 'tal', ',', 'and', 'bl0576', ')', 'were', 'amplified', 'by', 'PCR', 'with', 'Ex', 'Taq', 'DNA', 'polymerase', '(', 'TaKaRa', 'BIO', ')', 'using', 'B', '.', 'longum', 'NCC2705', 'genomic', 'DNA', 'as', 'a', 'template', '(', 'primer', 'pairs', 'are', 'listed', 'in', 'Table', 'S2', ')', '.']	[2, 1, 6, 1, 3, 1, 2, 1, 3, 1, 2, 1, 1, 6, 1, 1, 2, 1, 2, 1, 1, 2, 1, 2, 1, 5, 2, 1, 1, 1, 1, 2, 5, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For the quantification of microbead fecal shedding, 100 μl of recombinant GroEL- or Tal-immobilized beads or control beads (approximately 108 particles) was administered per mouse by gavage.	[('PMC7499026', 'M14000', 84, 87, 'Tal')]	['For', 'the', 'q', '##uant', '##ification', 'of', 'micro', '##be', '##ad', 'f', '##eca', '##l', 'shed', '##ding', ',', '100', 'μ', '##l', 'of', 're', '##comb', '##ina', '##nt', 'G', '##ro', '##EL', '-', 'or', 'Ta', '##l', '-', 'im', '##mo', '##bil', '##ized', 'beads', 'or', 'control', 'beads', '(', 'approximately', '108', 'particles', ')', 'was', 'administered', 'per', 'mouse', 'by', 'g', '##ava', '##ge', '.']	[0, 4, 8, 9, 13, 23, 26, 31, 33, 36, 37, 40, 42, 46, 50, 52, 56, 57, 59, 62, 64, 68, 71, 74, 75, 77, 79, 81, 84, 86, 87, 88, 90, 92, 95, 100, 106, 109, 117, 123, 124, 138, 142, 151, 153, 157, 170, 174, 180, 183, 184, 187, 189]	[3, 7, 9, 13, 22, 25, 31, 33, 35, 37, 40, 41, 46, 50, 51, 55, 57, 58, 61, 64, 68, 71, 73, 75, 77, 79, 80, 83, 86, 87, 88, 90, 92, 95, 99, 105, 108, 116, 122, 124, 137, 141, 151, 152, 156, 169, 173, 179, 182, 184, 187, 189, 190]	['For', 'the', 'quantification', 'of', 'microbead', 'fecal', 'shedding', ',', '100', 'μl', 'of', 'recombinant', 'GroEL-', 'or', 'Tal', '-', 'immobilized', 'beads', 'or', 'control', 'beads', '(', 'approximately', '108', 'particles', ')', 'was', 'administered', 'per', 'mouse', 'by', 'gavage', '.']	[1, 1, 3, 1, 3, 3, 2, 1, 1, 2, 1, 4, 4, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Sphingosine (Sph) can be generated under the action of ceramase and further be phosphorylated into S1P by Sphingosine kinase 1 (SphK1) (Figure 1).	[]	['S', '##phi', '##ngo', '##sin', '##e', '(', 'S', '##ph', ')', 'can', 'be', 'generated', 'under', 'the', 'action', 'of', 'c', '##era', '##mas', '##e', 'and', 'further', 'be', 'p', '##hos', '##ph', '##ory', '##lated', 'into', 'S', '##1', '##P', 'by', 'S', '##phi', '##ngo', '##sin', '##e', 'kinase', '1', '(', 'S', '##ph', '##K', '##1', ')', '(', 'Figure', '1', ')', '.']	[0, 1, 4, 7, 10, 12, 13, 14, 16, 18, 22, 25, 35, 41, 45, 52, 55, 56, 59, 62, 64, 68, 76, 79, 80, 83, 85, 88, 94, 99, 100, 101, 103, 106, 107, 110, 113, 116, 118, 125, 127, 128, 129, 131, 132, 133, 135, 136, 143, 144, 145]	[1, 4, 7, 10, 11, 13, 14, 16, 17, 21, 24, 34, 40, 44, 51, 54, 56, 59, 62, 63, 67, 75, 78, 80, 83, 85, 88, 93, 98, 100, 101, 102, 105, 107, 110, 113, 116, 117, 124, 126, 128, 129, 131, 132, 133, 134, 136, 142, 144, 145, 146]	['Sphingosine', '(', 'Sph', ')', 'can', 'be', 'generated', 'under', 'the', 'action', 'of', 'ceramase', 'and', 'further', 'be', 'phosphorylated', 'into', 'S1P', 'by', 'Sphingosine', 'kinase', '1', '(', 'SphK1', ')', '(', 'Figure', '1', ')', '.']	[5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 5, 1, 3, 1, 5, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Cumulative evidences have demonstrated that S1P can promote tumor proliferation, migration, transformation, and participate in the growth and invasion of cancer cells (36–38).	[]	['C', '##um', '##ula', '##tive', 'evidence', '##s', 'have', 'demonstrated', 'that', 'S', '##1', '##P', 'can', 'promote', 'tumor', 'proliferation', ',', 'migration', ',', 'transformation', ',', 'and', 'participate', 'in', 'the', 'growth', 'and', 'invasion', 'of', 'cancer', 'cells', '(', '36', '–', '38', ')', '.']	[0, 1, 3, 6, 11, 19, 21, 26, 39, 44, 45, 46, 48, 52, 60, 66, 79, 81, 90, 92, 106, 108, 112, 124, 127, 131, 138, 142, 151, 154, 161, 167, 168, 170, 171, 173, 174]	[1, 3, 6, 10, 19, 20, 25, 38, 43, 45, 46, 47, 51, 59, 65, 79, 80, 90, 91, 106, 107, 111, 123, 126, 130, 137, 141, 150, 153, 160, 166, 168, 170, 171, 173, 174, 175]	['Cumulative', 'evidences', 'have', 'demonstrated', 'that', 'S1P', 'can', 'promote', 'tumor', 'proliferation', ',', 'migration', ',', 'transformation', ',', 'and', 'participate', 'in', 'the', 'growth', 'and', 'invasion', 'of', 'cancer', 'cells', '(', '36–', '38', ')', '.']	[4, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured using an Olympus Automatic Biochemical Analyzer AU5400 (Olympus, Tokyo, Japan).	[('PMC7506152', 'M03000', 0, 24, 'Alanine aminotransferase')]	['Alan', '##ine', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AL', '##T', ')', 'and', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', '(', 'AS', '##T', ')', 'were', 'measured', 'using', 'an', 'O', '##ly', '##mpus', 'Automatic', 'B', '##io', '##chemical', 'Ana', '##ly', '##zer', 'AU', '##5', '##40', '##0', '(', 'O', '##ly', '##mpus', ',', 'Tokyo', ',', 'Japan', ')', '.']	[0, 4, 8, 13, 16, 18, 21, 25, 26, 28, 29, 31, 35, 37, 40, 45, 50, 53, 55, 58, 62, 63, 65, 66, 68, 73, 82, 88, 91, 92, 94, 99, 109, 110, 112, 121, 124, 126, 130, 132, 133, 135, 137, 138, 139, 141, 145, 147, 152, 154, 159, 160]	[4, 7, 13, 16, 18, 21, 24, 26, 28, 29, 30, 34, 37, 40, 44, 50, 53, 55, 58, 61, 63, 65, 66, 67, 72, 81, 87, 90, 92, 94, 98, 108, 110, 112, 120, 124, 126, 129, 132, 133, 135, 136, 138, 139, 141, 145, 146, 152, 153, 159, 160, 161]	['Alanine', 'aminotransferase', '(', 'ALT', ')', 'and', 'aspartate', 'aminotransferase', '(', 'AST', ')', 'were', 'measured', 'using', 'an', 'Olympus', 'Automatic', 'Biochemical', 'Analyzer', 'AU5400', '(', 'Olympus', ',', 'Tokyo', ',', 'Japan', ')', '.']	[2, 5, 1, 2, 1, 1, 3, 5, 1, 2, 1, 1, 1, 1, 1, 3, 1, 3, 3, 4, 1, 3, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Various non-invasive markers, such as model for end-stage liver disease (MELD), fibrosis 4 index (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) (24, 28), were assessed in this study, which were calculated according to clinical and laboratory parameters at the time of inclusion.	[('PMC7506152', 'M04000', 110, 136, 'aspartate aminotransferase')]	['Various', 'non', '-', 'invasive', 'markers', ',', 'such', 'as', 'model', 'for', 'end', '-', 'stage', 'liver', 'disease', '(', 'ME', '##LD', ')', ',', 'fi', '##bro', '##sis', '4', 'index', '(', 'F', '##IB', '-', '4', ')', ',', 'and', 'as', '##par', '##tate', 'amino', '##tra', '##ns', '##fer', '##ase', 'to', 'plate', '##let', 'ratio', 'index', '(', 'AP', '##RI', ')', '(', '24', ',', '28', ')', ',', 'were', 'assessed', 'in', 'this', 'study', ',', 'which', 'were', 'calculated', 'according', 'to', 'clinical', 'and', 'laboratory', 'parameters', 'at', 'the', 'time', 'of', 'inclusion', '.']	[0, 8, 11, 12, 21, 28, 30, 35, 38, 44, 48, 51, 52, 58, 64, 72, 73, 75, 77, 78, 80, 82, 85, 89, 91, 97, 98, 99, 101, 102, 103, 104, 106, 110, 112, 115, 120, 125, 128, 130, 133, 137, 140, 145, 149, 155, 161, 162, 164, 166, 168, 169, 171, 173, 175, 176, 178, 183, 192, 195, 200, 205, 207, 213, 218, 229, 239, 242, 251, 255, 266, 277, 280, 284, 289, 292, 301]	[7, 11, 12, 20, 28, 29, 34, 37, 43, 47, 51, 52, 57, 63, 71, 73, 75, 77, 78, 79, 82, 85, 88, 90, 96, 98, 99, 101, 102, 103, 104, 105, 109, 112, 115, 119, 125, 128, 130, 133, 136, 139, 145, 148, 154, 160, 162, 164, 166, 167, 169, 171, 172, 175, 176, 177, 182, 191, 194, 199, 205, 206, 212, 217, 228, 238, 241, 250, 254, 265, 276, 279, 283, 288, 291, 301, 302]	['Various', 'non', '-', 'invasive', 'markers', ',', 'such', 'as', 'model', 'for', 'end', '-', 'stage', 'liver', 'disease', '(', 'MELD', ')', ',', 'fibrosis', '4', 'index', '(', 'FIB-4', ')', ',', 'and', 'aspartate', 'aminotransferase', 'to', 'platelet', 'ratio', 'index', '(', 'APRI', ')', '(', '24', ',', '28', ')', ',', 'were', 'assessed', 'in', 'this', 'study', ',', 'which', 'were', 'calculated', 'according', 'to', 'clinical', 'and', 'laboratory', 'parameters', 'at', 'the', 'time', 'of', 'inclusion', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 3, 5, 1, 2, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, Venn and network analyses showed no interactions between the DEG and downregulated genes (Fig. 11C and ​andD),D), and they suggest that citral does not affect the normal growth and metabolism of A. baumannii.	[]	['Furthermore', ',', 'V', '##en', '##n', 'and', 'network', 'analyses', 'showed', 'no', 'interactions', 'between', 'the', 'DE', '##G', 'and', 'down', '##re', '##gu', '##lated', 'genes', '(', 'Fi', '##g', '.', '11', '##C', 'and', 'and', '##D', ')', ',', 'D', ')', ',', 'and', 'they', 'suggest', 'that', 'c', '##it', '##ral', 'does', 'not', 'affect', 'the', 'normal', 'growth', 'and', 'metabolism', 'of', 'A', '.', 'b', '##au', '##mann', '##ii', '.']	[0, 11, 13, 14, 16, 18, 22, 30, 39, 46, 49, 62, 70, 74, 76, 78, 82, 86, 88, 90, 96, 102, 103, 105, 106, 108, 110, 112, 117, 120, 121, 122, 123, 124, 125, 127, 131, 136, 144, 149, 150, 152, 156, 161, 165, 172, 176, 183, 190, 194, 205, 208, 209, 211, 212, 214, 218, 220]	[11, 12, 14, 16, 17, 21, 29, 38, 45, 48, 61, 69, 73, 76, 77, 81, 86, 88, 90, 95, 101, 103, 105, 106, 107, 110, 111, 115, 120, 121, 122, 123, 124, 125, 126, 130, 135, 143, 148, 150, 152, 155, 160, 164, 171, 175, 182, 189, 193, 204, 207, 209, 210, 212, 214, 218, 220, 221]	['Furthermore', ',', 'Venn', 'and', 'network', 'analyses', 'showed', 'no', 'interactions', 'between', 'the', 'DEG', 'and', 'downregulated', 'genes', '(', 'Fig', '.', '11C', 'and', '\u200bandD', ')', ',', 'D', ')', ',', 'and', 'they', 'suggest', 'that', 'citral', 'does', 'not', 'affect', 'the', 'normal', 'growth', 'and', 'metabolism', 'of', 'A', '.', 'baumannii', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 4, 1, 1, 2, 1, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For catalase activity, after electrophoresis, the gel (8%) was washed three times with 50 mM KPi buffer.	[('PMC7677002', 'M22000', 4, 12, 'catalase')]	['For', 'cat', '##ala', '##se', 'activity', ',', 'after', 'electro', '##ph', '##ores', '##is', ',', 'the', 'gel', '(', '8', '%', ')', 'was', 'washed', 'three', 'times', 'with', '50', 'm', '##M', 'K', '##P', '##i', 'buffer', '.']	[0, 4, 7, 10, 13, 21, 23, 29, 36, 38, 42, 44, 46, 50, 54, 55, 56, 57, 59, 63, 70, 76, 82, 87, 90, 91, 93, 94, 95, 97, 103]	[3, 7, 10, 12, 21, 22, 28, 36, 38, 42, 44, 45, 49, 53, 55, 56, 57, 58, 62, 69, 75, 81, 86, 89, 91, 92, 94, 95, 96, 103, 104]	['For', 'catalase', 'activity', ',', 'after', 'electrophoresis', ',', 'the', 'gel', '(', '8%', ')', 'was', 'washed', 'three', 'times', 'with', '50', 'mM', 'KPi', 'buffer', '.']	[1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The extracellular lipase production of control and citral-treated A. baumannii was assessed using p-nitrophenyl palmitate (pNPP) as the substrate.	[('PMC7677002', 'M26000', 18, 24, 'lipase')]	['The', 'extra', '##cellular', 'lip', '##ase', 'production', 'of', 'control', 'and', 'c', '##it', '##ral', '-', 'treated', 'A', '.', 'b', '##au', '##mann', '##ii', 'was', 'assessed', 'using', 'p', '-', 'ni', '##tro', '##phe', '##ny', '##l', 'palm', '##itate', '(', 'p', '##NP', '##P', ')', 'as', 'the', 'substrate', '.']	[0, 4, 9, 18, 21, 25, 36, 39, 47, 51, 52, 54, 57, 58, 66, 67, 69, 70, 72, 76, 79, 83, 92, 98, 99, 100, 102, 105, 108, 110, 112, 116, 122, 123, 124, 126, 127, 129, 132, 136, 145]	[3, 9, 17, 21, 24, 35, 38, 46, 50, 52, 54, 57, 58, 65, 67, 68, 70, 72, 76, 78, 82, 91, 97, 99, 100, 102, 105, 108, 110, 111, 116, 121, 123, 124, 126, 127, 128, 131, 135, 145, 146]	['The', 'extracellular', 'lipase', 'production', 'of', 'control', 'and', 'citral', '-', 'treated', 'A', '.', 'baumannii', 'was', 'assessed', 'using', 'p-nitrophenyl', 'palmitate', '(', 'pNPP', ')', 'as', 'the', 'substrate', '.']	[1, 2, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 7, 2, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The proteolytic activity of A. baumannii control and citral-treated samples was analyzed by mixing 100 ml of a protease substrate solution (0.2% azocasein dissolved in 0.05 M Tris-hydrochloride) with 100 ml of the CFCS of A. baumannii samples, and the mixture was incubated at 37°C for 30 min.	[('PMC7677002', 'M27000', 111, 119, 'protease')]	['The', 'pro', '##te', '##oly', '##tic', 'activity', 'of', 'A', '.', 'b', '##au', '##mann', '##ii', 'control', 'and', 'c', '##it', '##ral', '-', 'treated', 'samples', 'was', 'analyzed', 'by', 'mixing', '100', 'm', '##l', 'of', 'a', 'pro', '##te', '##ase', 'substrate', 'solution', '(', '0', '.', '2', '%', 'a', '##zo', '##case', '##in', 'dissolved', 'in', '0', '.', '05', 'M', 'Tri', '##s', '-', 'h', '##ydro', '##ch', '##lor', '##ide', ')', 'with', '100', 'm', '##l', 'of', 'the', 'CF', '##CS', 'of', 'A', '.', 'b', '##au', '##mann', '##ii', 'samples', ',', 'and', 'the', 'mixture', 'was', 'in', '##cu', '##bate', '##d', 'at', '37', '##°', '##C', 'for', '30', 'min', '.']	[0, 4, 7, 9, 12, 16, 25, 28, 29, 31, 32, 34, 38, 41, 49, 53, 54, 56, 59, 60, 68, 76, 80, 89, 92, 99, 103, 104, 106, 109, 111, 114, 116, 120, 130, 139, 140, 141, 142, 143, 145, 146, 148, 152, 155, 165, 168, 169, 170, 173, 175, 178, 179, 180, 181, 185, 187, 190, 193, 195, 200, 204, 205, 207, 210, 214, 216, 219, 222, 223, 225, 226, 228, 232, 235, 242, 244, 248, 252, 260, 264, 266, 268, 272, 274, 277, 279, 280, 282, 286, 289, 292]	[3, 7, 9, 12, 15, 24, 27, 29, 30, 32, 34, 38, 40, 48, 52, 54, 56, 59, 60, 67, 75, 79, 88, 91, 98, 102, 104, 105, 108, 110, 114, 116, 119, 129, 138, 140, 141, 142, 143, 144, 146, 148, 152, 154, 164, 167, 169, 170, 172, 174, 178, 179, 180, 181, 185, 187, 190, 193, 194, 199, 203, 205, 206, 209, 213, 216, 218, 221, 223, 224, 226, 228, 232, 234, 242, 243, 247, 251, 259, 263, 266, 268, 272, 273, 276, 279, 280, 281, 285, 288, 292, 293]	['The', 'proteolytic', 'activity', 'of', 'A', '.', 'baumannii', 'control', 'and', 'citral', '-', 'treated', 'samples', 'was', 'analyzed', 'by', 'mixing', '100', 'ml', 'of', 'a', 'protease', 'substrate', 'solution', '(', '0.2%', 'azocasein', 'dissolved', 'in', '0.05', 'M', 'Tris', '-', 'hydrochloride', ')', 'with', '100', 'ml', 'of', 'the', 'CFCS', 'of', 'A', '.', 'baumannii', 'samples', ',', 'and', 'the', 'mixture', 'was', 'incubated', 'at', '37°C', 'for', '30', 'min', '.']	[1, 4, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 4, 4, 1, 1, 3, 1, 2, 1, 5, 1, 1, 1, 2, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Native PAGE was performed to assess the effect of citral on catalase and superoxide dismutase (SOD) production in A. baumannii.	[('PMC7677002', 'R13000', 60, 68, 'catalase')]	['Native', 'PA', '##GE', 'was', 'performed', 'to', 'assess', 'the', 'effect', 'of', 'c', '##it', '##ral', 'on', 'cat', '##ala', '##se', 'and', 'super', '##oxide', 'di', '##sm', '##uta', '##se', '(', 'S', '##OD', ')', 'production', 'in', 'A', '.', 'b', '##au', '##mann', '##ii', '.']	[0, 7, 9, 12, 16, 26, 29, 36, 40, 47, 50, 51, 53, 57, 60, 63, 66, 69, 73, 78, 84, 86, 88, 91, 94, 95, 96, 98, 100, 111, 114, 115, 117, 118, 120, 124, 126]	[6, 9, 11, 15, 25, 28, 35, 39, 46, 49, 51, 53, 56, 59, 63, 66, 68, 72, 78, 83, 86, 88, 91, 93, 95, 96, 98, 99, 110, 113, 115, 116, 118, 120, 124, 126, 127]	['Native', 'PAGE', 'was', 'performed', 'to', 'assess', 'the', 'effect', 'of', 'citral', 'on', 'catalase', 'and', 'superoxide', 'dismutase', '(', 'SOD', ')', 'production', 'in', 'A', '.', 'baumannii', '.']	[1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 2, 4, 1, 2, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The band intensity was reduced for catalase (Fig. 13A) and SOD (Fig. 13B) in citral-treated samples compared to the control samples.	[('PMC7677002', 'R13001', 35, 43, 'catalase')]	['The', 'band', 'intensity', 'was', 'reduced', 'for', 'cat', '##ala', '##se', '(', 'Fi', '##g', '.', '13', '##A', ')', 'and', 'S', '##OD', '(', 'Fi', '##g', '.', '13', '##B', ')', 'in', 'c', '##it', '##ral', '-', 'treated', 'samples', 'compared', 'to', 'the', 'control', 'samples', '.']	[0, 4, 9, 19, 23, 31, 35, 38, 41, 44, 45, 47, 48, 50, 52, 53, 55, 59, 60, 63, 64, 66, 67, 69, 71, 72, 74, 77, 78, 80, 83, 84, 92, 100, 109, 112, 116, 124, 131]	[3, 8, 18, 22, 30, 34, 38, 41, 43, 45, 47, 48, 49, 52, 53, 54, 58, 60, 62, 64, 66, 67, 68, 71, 72, 73, 76, 78, 80, 83, 84, 91, 99, 108, 111, 115, 123, 131, 132]	['The', 'band', 'intensity', 'was', 'reduced', 'for', 'catalase', '(', 'Fig', '.', '13A', ')', 'and', 'SOD', '(', 'Fig', '.', '13B', ')', 'in', 'citral', '-', 'treated', 'samples', 'compared', 'to', 'the', 'control', 'samples', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 2, 1, 1, 2, 1, 2, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacteria produce extracellular lipase as a virulence factor.	[('PMC7677002', 'R15000', 31, 37, 'lipase')]	['Ba', '##cter', '##ia', 'produce', 'extra', '##cellular', 'lip', '##ase', 'as', 'a', 'v', '##ir', '##ule', '##nce', 'factor', '.']	[0, 2, 6, 9, 17, 22, 31, 34, 38, 41, 43, 44, 46, 49, 53, 59]	[2, 6, 8, 16, 22, 30, 34, 37, 40, 42, 44, 46, 49, 52, 59, 60]	['Bacteria', 'produce', 'extracellular', 'lipase', 'as', 'a', 'virulence', 'factor', '.']	[3, 1, 2, 2, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In this study, the effect of citral on lipase production by A. baumannii was investigated.	[('PMC7677002', 'R15001', 39, 45, 'lipase')]	['In', 'this', 'study', ',', 'the', 'effect', 'of', 'c', '##it', '##ral', 'on', 'lip', '##ase', 'production', 'by', 'A', '.', 'b', '##au', '##mann', '##ii', 'was', 'investigated', '.']	[0, 3, 8, 13, 15, 19, 26, 29, 30, 32, 36, 39, 42, 46, 57, 60, 61, 63, 64, 66, 70, 73, 77, 89]	[2, 7, 13, 14, 18, 25, 28, 30, 32, 35, 38, 42, 45, 56, 59, 61, 62, 64, 66, 70, 72, 76, 89, 90]	['In', 'this', 'study', ',', 'the', 'effect', 'of', 'citral', 'on', 'lipase', 'production', 'by', 'A', '.', 'baumannii', 'was', 'investigated', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Citral reduced lipase production by 70% compared to control cells (Fig. 13D).	[('PMC7677002', 'R15002', 15, 21, 'lipase')]	['C', '##it', '##ral', 'reduced', 'lip', '##ase', 'production', 'by', '70', '%', 'compared', 'to', 'control', 'cells', '(', 'Fi', '##g', '.', '13', '##D', ')', '.']	[0, 1, 3, 7, 15, 18, 22, 33, 36, 38, 40, 49, 52, 60, 66, 67, 69, 70, 72, 74, 75, 76]	[1, 3, 6, 14, 18, 21, 32, 35, 38, 39, 48, 51, 59, 65, 67, 69, 70, 71, 74, 75, 76, 77]	['Citral', 'reduced', 'lipase', 'production', 'by', '70%', 'compared', 'to', 'control', 'cells', '(', 'Fig', '.', '13D', ')', '.']	[3, 1, 2, 1, 1, 2, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In terms of host factors, we focused on human protease inhibitors and immunoglobulins.	[('PMC7805185', 'D04000', 40, 54, 'human protease')]	['In', 'terms', 'of', 'host', 'factors', ',', 'we', 'focused', 'on', 'human', 'pro', '##te', '##ase', 'inhibitor', '##s', 'and', 'im', '##mu', '##no', '##g', '##lo', '##bul', '##ins', '.']	[0, 3, 9, 12, 17, 24, 26, 29, 37, 40, 46, 49, 51, 55, 64, 66, 70, 72, 74, 76, 77, 79, 82, 85]	[2, 8, 11, 16, 24, 25, 28, 36, 39, 45, 49, 51, 54, 64, 65, 69, 72, 74, 76, 77, 79, 82, 85, 86]	['In', 'terms', 'of', 'host', 'factors', ',', 'we', 'focused', 'on', 'human', 'protease', 'inhibitors', 'and', 'immunoglobulins', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 7, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Generally, intestinal protease activity increases in IBD and protease inhibition has been proposed as new therapeutic strategy for IBD	[('PMC7805185', 'D04001', 22, 30, 'protease')]	['Generally', ',', 'in', '##test', '##inal', 'pro', '##te', '##ase', 'activity', 'increases', 'in', 'I', '##B', '##D', 'and', 'pro', '##te', '##ase', 'in', '##hibition', 'has', 'been', 'proposed', 'as', 'new', 'therapeutic', 'strategy', 'for', 'I', '##B', '##D']	[0, 9, 11, 13, 17, 22, 25, 27, 31, 40, 50, 53, 54, 55, 57, 61, 64, 66, 70, 72, 81, 85, 90, 99, 102, 106, 118, 127, 131, 132, 133]	[9, 10, 13, 17, 21, 25, 27, 30, 39, 49, 52, 54, 55, 56, 60, 64, 66, 69, 72, 80, 84, 89, 98, 101, 105, 117, 126, 130, 132, 133, 134]	['Generally', ',', 'intestinal', 'protease', 'activity', 'increases', 'in', 'IBD', 'and', 'protease', 'inhibition', 'has', 'been', 'proposed', 'as', 'new', 'therapeutic', 'strategy', 'for', 'IBD']	[1, 1, 3, 3, 1, 1, 1, 3, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In our analysis, we found human endogenous protease inhibitors such as Serpins A1 significantly increased in IBD (particularly CD) fecal and MLI samples (Additional file 1: Fig.	[]	['In', 'our', 'analysis', ',', 'we', 'found', 'human', 'end', '##ogen', '##ous', 'pro', '##te', '##ase', 'inhibitor', '##s', 'such', 'as', 'Ser', '##pin', '##s', 'A1', 'significantly', 'increased', 'in', 'I', '##B', '##D', '(', 'particularly', 'CD', ')', 'f', '##eca', '##l', 'and', 'M', '##L', '##I', 'samples', '(', 'Additional', 'file', '1', ':', 'Fi', '##g', '.']	[0, 3, 7, 15, 17, 20, 26, 32, 35, 39, 43, 46, 48, 52, 61, 63, 68, 71, 74, 77, 79, 82, 96, 106, 109, 110, 111, 113, 114, 127, 129, 131, 132, 135, 137, 141, 142, 143, 145, 153, 154, 165, 170, 171, 173, 175, 176]	[2, 6, 15, 16, 19, 25, 31, 35, 39, 42, 46, 48, 51, 61, 62, 67, 70, 74, 77, 78, 81, 95, 105, 108, 110, 111, 112, 114, 126, 129, 130, 132, 135, 136, 140, 142, 143, 144, 152, 154, 164, 169, 171, 172, 175, 176, 177]	['In', 'our', 'analysis', ',', 'we', 'found', 'human', 'endogenous', 'protease', 'inhibitors', 'such', 'as', 'Serpins', 'A1', 'significantly', 'increased', 'in', 'IBD', '(', 'particularly', 'CD', ')', 'fecal', 'and', 'MLI', 'samples', '(', 'Additional', 'file', '1', ':', 'Fig', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 3, 2, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
S7a), probably because the increased protease activity triggers the production of a higher level of protease inhibitors in order to control the destructive nature of protease.	[]	['S', '##7', '##a', ')', ',', 'probably', 'because', 'the', 'increased', 'pro', '##te', '##ase', 'activity', 'trigger', '##s', 'the', 'production', 'of', 'a', 'higher', 'level', 'of', 'pro', '##te', '##ase', 'inhibitor', '##s', 'in', 'order', 'to', 'control', 'the', 'destructive', 'nature', 'of', 'pro', '##te', '##ase', '.']	[0, 1, 2, 3, 4, 6, 15, 23, 27, 37, 40, 42, 46, 55, 62, 64, 68, 79, 82, 84, 91, 97, 100, 103, 105, 109, 118, 120, 123, 129, 132, 140, 144, 156, 163, 166, 169, 171, 174]	[1, 2, 3, 4, 5, 14, 22, 26, 36, 40, 42, 45, 54, 62, 63, 67, 78, 81, 83, 90, 96, 99, 103, 105, 108, 118, 119, 122, 128, 131, 139, 143, 155, 162, 165, 169, 171, 174, 175]	['S7a', ')', ',', 'probably', 'because', 'the', 'increased', 'protease', 'activity', 'triggers', 'the', 'production', 'of', 'a', 'higher', 'level', 'of', 'protease', 'inhibitors', 'in', 'order', 'to', 'control', 'the', 'destructive', 'nature', 'of', 'protease', '.']	[3, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
At enzyme level, 3-hydroxybutyryl-CoA dehydrogenase, which is involved in butyrate metabolism, showed the highest NRASP (median value > 3), followed by 3-hydroxyacyl-CoA dehydrogenase involved in fatty acid beta-oxidation, glycine C-acetyltransferase involved in L-threonine degradation, phosphoenolpyruvate carboxykinase (ATP) involved in gluconeogenesis, ketol-acid reductoisomerase (NADP(+)) involved in the biosynthesis of branched-chain amino acids (BCAA), and superoxide dismutase involved in tolerance to oxidant stress (median NRASP of 2–3, Fig. ​Fig.22c).	[('PMC7805185', 'R09000', 17, 51, '3-hydroxybutyryl-CoA dehydrogenase')]	['At', 'enzyme', 'level', ',', '3', '-', 'h', '##ydro', '##xy', '##but', '##yr', '##yl', '-', 'Co', '##A', 'de', '##hy', '##dr', '##ogen', '##ase', ',', 'which', 'is', 'involved', 'in', 'but', '##yra', '##te', 'metabolism', ',', 'showed', 'the', 'highest', 'N', '##RA', '##SP', '(', 'median', 'value', '>', '3', ')', ',', 'followed', 'by', '3', '-', 'h', '##ydro', '##xy', '##acy', '##l', '-', 'Co', '##A', 'de', '##hy', '##dr', '##ogen', '##ase', 'involved', 'in', 'fatty', 'acid', 'beta', '-', 'oxidation', ',', 'g', '##ly', '##cine', 'C', '-', 'ace', '##ty', '##lt', '##ran', '##s', '##fer', '##ase', 'involved', 'in', 'L', '-', 'th', '##re', '##oni', '##ne', 'degradation', ',', 'p', '##hos', '##ph', '##oe', '##no', '##l', '##py', '##ru', '##vate', 'car', '##box', '##yk', '##inas', '##e', '(', 'ATP', ')', 'involved', 'in', 'g', '##lu', '##con', '##eo', '##genesis', ',', 'k', '##eto', '##l', '-', 'acid', 'red', '##uc', '##to', '##is', '##omer', '##ase', '(', 'N', '##AD', '##P', '(', '+', ')', ')', 'involved', 'in', 'the', 'bio', '##sy', '##nt', '##hesis', 'of', 'branched', '-', 'chain', 'amino', 'acids', '(', 'BC', '##AA', ')', ',', 'and', 'super', '##oxide', 'di', '##sm', '##uta', '##se', 'involved', 'in', 'tolerance', 'to', 'o', '##xi', '##dant', 'stress', '(', 'median', 'N', '##RA', '##SP', 'of', '2', '–', '3', ',', 'Fi', '##g', '.', 'Fi', '##g', '.', '22', '##c', ')', '.']	[0, 3, 10, 15, 17, 18, 19, 20, 24, 26, 29, 31, 33, 34, 36, 38, 40, 42, 44, 48, 51, 53, 59, 62, 71, 74, 77, 80, 83, 93, 95, 102, 106, 114, 115, 117, 120, 121, 128, 134, 136, 137, 138, 140, 149, 152, 153, 154, 155, 159, 161, 164, 165, 166, 168, 170, 172, 174, 176, 180, 184, 193, 196, 202, 207, 211, 212, 221, 223, 224, 226, 231, 232, 233, 236, 238, 240, 243, 244, 247, 251, 260, 263, 264, 265, 267, 269, 272, 275, 286, 288, 289, 292, 294, 296, 298, 299, 301, 303, 308, 311, 314, 316, 320, 322, 323, 326, 328, 337, 340, 341, 343, 346, 348, 355, 357, 358, 361, 362, 363, 368, 371, 373, 375, 377, 381, 385, 386, 387, 389, 390, 391, 392, 393, 395, 404, 407, 411, 414, 416, 418, 424, 427, 435, 436, 442, 448, 454, 455, 457, 459, 460, 462, 466, 471, 477, 479, 481, 484, 487, 496, 499, 509, 512, 513, 515, 520, 527, 528, 535, 536, 538, 541, 544, 545, 546, 547, 549, 551, 552, 555, 557, 558, 559, 561, 562, 563]	[2, 9, 15, 16, 18, 19, 20, 24, 26, 29, 31, 33, 34, 36, 37, 40, 42, 44, 48, 51, 52, 58, 61, 70, 73, 77, 80, 82, 93, 94, 101, 105, 113, 115, 117, 119, 121, 127, 133, 135, 137, 138, 139, 148, 151, 153, 154, 155, 159, 161, 164, 165, 166, 168, 169, 172, 174, 176, 180, 183, 192, 195, 201, 206, 211, 212, 221, 222, 224, 226, 230, 232, 233, 236, 238, 240, 243, 244, 247, 250, 259, 262, 264, 265, 267, 269, 272, 274, 286, 287, 289, 292, 294, 296, 298, 299, 301, 303, 307, 311, 314, 316, 320, 321, 323, 326, 327, 336, 339, 341, 343, 346, 348, 355, 356, 358, 361, 362, 363, 367, 371, 373, 375, 377, 381, 384, 386, 387, 389, 390, 391, 392, 393, 394, 403, 406, 410, 414, 416, 418, 423, 426, 435, 436, 441, 447, 453, 455, 457, 459, 460, 461, 465, 471, 476, 479, 481, 484, 486, 495, 498, 508, 511, 513, 515, 519, 526, 528, 534, 536, 538, 540, 543, 545, 546, 547, 548, 551, 552, 553, 557, 558, 559, 561, 562, 563, 564]	['At', 'enzyme', 'level', ',', '3-hydroxybutyryl-CoA', 'dehydrogenase', ',', 'which', 'is', 'involved', 'in', 'butyrate', 'metabolism', ',', 'showed', 'the', 'highest', 'NRASP', '(', 'median', 'value', '>', '3', ')', ',', 'followed', 'by', '3-hydroxyacyl-CoA', 'dehydrogenase', 'involved', 'in', 'fatty', 'acid', 'beta', '-', 'oxidation', ',', 'glycine', 'C-acetyltransferase', 'involved', 'in', 'L-threonine', 'degradation', ',', 'phosphoenolpyruvate', 'carboxykinase', '(', 'ATP', ')', 'involved', 'in', 'gluconeogenesis', ',', 'ketol', '-', 'acid', 'reductoisomerase', '(', 'NADP(', '+', ')', ')', 'involved', 'in', 'the', 'biosynthesis', 'of', 'branched', '-', 'chain', 'amino', 'acids', '(', 'BCAA', ')', ',', 'and', 'superoxide', 'dismutase', 'involved', 'in', 'tolerance', 'to', 'oxidant', 'stress', '(', 'median', 'NRASP', 'of', '2–', '3', ',', 'Fig', '.', '\u200bFig.22c', ')', '.']	[1, 1, 1, 1, 11, 5, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 10, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 9, 1, 1, 6, 1, 1, 9, 5, 1, 1, 1, 1, 1, 5, 1, 3, 1, 1, 6, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 4, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 2, 1, 1, 2, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To further investigate the effect of host factors on gut microbial proteolysis, we also analyzed the correlations between gut microbial proteolysis pattern and host immunoglobulins.	[]	['To', 'further', 'investigate', 'the', 'effect', 'of', 'host', 'factors', 'on', 'gut', 'micro', '##bial', 'pro', '##te', '##oly', '##sis', ',', 'we', 'also', 'analyzed', 'the', 'correlation', '##s', 'between', 'gut', 'micro', '##bial', 'pro', '##te', '##oly', '##sis', 'pattern', 'and', 'host', 'im', '##mu', '##no', '##g', '##lo', '##bul', '##ins', '.']	[0, 3, 11, 23, 27, 34, 37, 42, 50, 53, 57, 62, 67, 70, 72, 75, 78, 80, 83, 88, 97, 101, 112, 114, 122, 126, 131, 136, 139, 141, 144, 148, 156, 160, 165, 167, 169, 171, 172, 174, 177, 180]	[2, 10, 22, 26, 33, 36, 41, 49, 52, 56, 62, 66, 70, 72, 75, 78, 79, 82, 87, 96, 100, 112, 113, 121, 125, 131, 135, 139, 141, 144, 147, 155, 159, 164, 167, 169, 171, 172, 174, 177, 180, 181]	['To', 'further', 'investigate', 'the', 'effect', 'of', 'host', 'factors', 'on', 'gut', 'microbial', 'proteolysis', ',', 'we', 'also', 'analyzed', 'the', 'correlations', 'between', 'gut', 'microbial', 'proteolysis', 'pattern', 'and', 'host', 'immunoglobulins', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 1, 1, 1, 1, 2, 1, 1, 2, 4, 1, 1, 1, 7, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
IgG1, IgG4, and IgM were negatively correlated with PCo1 (− 0.44	[]	['I', '##g', '##G', '##1', ',', 'I', '##g', '##G', '##4', ',', 'and', 'I', '##g', '##M', 'were', 'negatively', 'correlated', 'with', 'PC', '##o', '##1', '(', '−', '0', '.', '44']	[0, 1, 2, 3, 4, 6, 7, 8, 9, 10, 12, 16, 17, 18, 20, 25, 36, 47, 52, 54, 55, 57, 58, 60, 61, 62]	[1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 15, 17, 18, 19, 24, 35, 46, 51, 54, 55, 56, 58, 59, 61, 62, 64]	['IgG1', ',', 'IgG4', ',', 'and', 'IgM', 'were', 'negatively', 'correlated', 'with', 'PCo1', '(', '−', '0.44']	[4, 1, 4, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 3]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the cerebrospinal fluid (CSF) of patients with probable idiopathic normal‐pressure hydrocephalus (iNPH) by proteome analysis.	[('PMC7821334', 'A00000', 0, 28, 'Protein tyrosine phosphatase')]	['Pro', '##tein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'receptor', 'type', 'Q', '(', 'PT', '##PR', '##Q', ')', 'was', 'extracted', 'from', 'the', 'c', '##ere', '##bro', '##sp', '##inal', 'fluid', '(', 'CS', '##F', ')', 'of', 'patients', 'with', 'probable', 'id', '##io', '##pathic', 'normal', '‐', 'pressure', 'h', '##ydro', '##ce', '##pha', '##lus', '(', 'i', '##NP', '##H', ')', 'by', 'pro', '##te', '##ome', 'analysis', '.']	[0, 3, 8, 9, 11, 13, 17, 18, 21, 24, 29, 38, 43, 45, 46, 48, 50, 51, 53, 57, 67, 72, 76, 77, 80, 83, 85, 90, 96, 97, 99, 100, 102, 105, 114, 119, 128, 130, 132, 139, 145, 146, 155, 156, 160, 162, 165, 169, 170, 171, 173, 174, 176, 179, 182, 184, 188, 196]	[3, 7, 9, 11, 13, 16, 18, 21, 24, 28, 37, 42, 44, 46, 48, 50, 51, 52, 56, 66, 71, 75, 77, 80, 83, 85, 89, 95, 97, 99, 100, 101, 104, 113, 118, 127, 130, 132, 138, 145, 146, 154, 156, 160, 162, 165, 168, 170, 171, 173, 174, 175, 178, 182, 184, 187, 196, 197]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTPRQ', ')', 'was', 'extracted', 'from', 'the', 'cerebrospinal', 'fluid', '(', 'CSF', ')', 'of', 'patients', 'with', 'probable', 'idiopathic', 'normal', '‐', 'pressure', 'hydrocephalus', '(', 'iNPH', ')', 'by', 'proteome', 'analysis', '.']	[2, 4, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 5, 1, 3, 1, 1, 3, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatase receptor type Q (PTPRQ) extracted from CSF of patients with probable idiopathic normal pressure hydrocephalus (iNPH) by proteome analysis was evaluated as potential biomarker for this condition.	[('PMC7821334', 'A04000', 0, 28, 'Protein tyrosine phosphatase')]	['Pro', '##tein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'receptor', 'type', 'Q', '(', 'PT', '##PR', '##Q', ')', 'extracted', 'from', 'CS', '##F', 'of', 'patients', 'with', 'probable', 'id', '##io', '##pathic', 'normal', 'pressure', 'h', '##ydro', '##ce', '##pha', '##lus', '(', 'i', '##NP', '##H', ')', 'by', 'pro', '##te', '##ome', 'analysis', 'was', 'evaluated', 'as', 'potential', 'bio', '##mark', '##er', 'for', 'this', 'condition', '.']	[0, 3, 8, 9, 11, 13, 17, 18, 21, 24, 29, 38, 43, 45, 46, 48, 50, 51, 53, 63, 68, 70, 72, 75, 84, 89, 98, 100, 102, 109, 116, 125, 126, 130, 132, 135, 139, 140, 141, 143, 144, 146, 149, 152, 154, 158, 167, 171, 181, 184, 194, 197, 201, 204, 208, 213, 222]	[3, 7, 9, 11, 13, 16, 18, 21, 24, 28, 37, 42, 44, 46, 48, 50, 51, 52, 62, 67, 70, 71, 74, 83, 88, 97, 100, 102, 108, 115, 124, 126, 130, 132, 135, 138, 140, 141, 143, 144, 145, 148, 152, 154, 157, 166, 170, 180, 183, 193, 197, 201, 203, 207, 212, 222, 223]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTPRQ', ')', 'extracted', 'from', 'CSF', 'of', 'patients', 'with', 'probable', 'idiopathic', 'normal', 'pressure', 'hydrocephalus', '(', 'iNPH', ')', 'by', 'proteome', 'analysis', 'was', 'evaluated', 'as', 'potential', 'biomarker', 'for', 'this', 'condition', '.']	[2, 4, 4, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 5, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Recently, protein tyrosine phosphatase receptor type Q (PTPRQ) was extracted from the CSF of patients with iNPH by proteome analysis.	[('PMC7821334', 'I02000', 10, 38, 'protein tyrosine phosphatase')]	['Recently', ',', 'protein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'receptor', 'type', 'Q', '(', 'PT', '##PR', '##Q', ')', 'was', 'extracted', 'from', 'the', 'CS', '##F', 'of', 'patients', 'with', 'i', '##NP', '##H', 'by', 'pro', '##te', '##ome', 'analysis', '.']	[0, 8, 10, 18, 19, 21, 23, 27, 28, 31, 34, 39, 48, 53, 55, 56, 58, 60, 61, 63, 67, 77, 82, 86, 88, 90, 93, 102, 107, 108, 110, 112, 115, 118, 120, 124, 132]	[8, 9, 17, 19, 21, 23, 26, 28, 31, 34, 38, 47, 52, 54, 56, 58, 60, 61, 62, 66, 76, 81, 85, 88, 89, 92, 101, 106, 108, 110, 111, 114, 118, 120, 123, 132, 133]	['Recently', ',', 'protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', '(', 'PTPRQ', ')', 'was', 'extracted', 'from', 'the', 'CSF', 'of', 'patients', 'with', 'iNPH', 'by', 'proteome', 'analysis', '.']	[1, 1, 1, 4, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 3, 1, 1]	['O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein tyrosine phosphatase receptor type Q staining was viewed under an E800 microscope (Nikon, Tokyo, Japan), and images were captured with an AxioCam HRc CCD camera using AxioVison Rel 4.7.2.0 imaging processing software (Carl Zeiss, Microimaging GmbH, Jena, Germany).	[('PMC7821334', 'M14000', 0, 28, 'Protein tyrosine phosphatase')]	['Pro', '##tein', 't', '##yr', '##os', '##ine', 'p', '##hos', '##pha', '##tase', 'receptor', 'type', 'Q', 'stain', '##ing', 'was', 'viewed', 'under', 'an', 'E', '##80', '##0', 'micro', '##scope', '(', 'Nik', '##on', ',', 'Tokyo', ',', 'Japan', ')', ',', 'and', 'images', 'were', 'captured', 'with', 'an', 'A', '##xi', '##o', '##C', '##am', 'H', '##R', '##c', 'CC', '##D', 'camera', 'using', 'A', '##xi', '##o', '##V', '##ison', 'Re', '##l', '4', '.', '7', '.', '2', '.', '0', 'imaging', 'processing', 'software', '(', 'Carl', 'Z', '##ei', '##ss', ',', 'Micro', '##ima', '##ging', 'GmbH', ',', 'Jen', '##a', ',', 'Germany', ')', '.']	[0, 3, 8, 9, 11, 13, 17, 18, 21, 24, 29, 38, 43, 45, 50, 54, 58, 65, 71, 74, 75, 77, 79, 84, 90, 91, 94, 96, 98, 103, 105, 110, 111, 113, 117, 124, 129, 138, 143, 146, 147, 149, 150, 151, 154, 155, 156, 158, 160, 162, 169, 175, 176, 178, 179, 180, 185, 187, 189, 190, 191, 192, 193, 194, 195, 197, 205, 216, 225, 226, 231, 232, 234, 236, 238, 243, 246, 251, 255, 257, 260, 261, 263, 270, 271]	[3, 7, 9, 11, 13, 16, 18, 21, 24, 28, 37, 42, 44, 50, 53, 57, 64, 70, 73, 75, 77, 78, 84, 89, 91, 94, 96, 97, 103, 104, 110, 111, 112, 116, 123, 128, 137, 142, 145, 147, 149, 150, 151, 153, 155, 156, 157, 160, 161, 168, 174, 176, 178, 179, 180, 184, 187, 188, 190, 191, 192, 193, 194, 195, 196, 204, 215, 224, 226, 230, 232, 234, 236, 237, 243, 246, 250, 255, 256, 260, 261, 262, 270, 271, 272]	['Protein', 'tyrosine', 'phosphatase', 'receptor', 'type', 'Q', 'staining', 'was', 'viewed', 'under', 'an', 'E800', 'microscope', '(', 'Nikon', ',', 'Tokyo', ',', 'Japan', ')', ',', 'and', 'images', 'were', 'captured', 'with', 'an', 'AxioCam', 'HRc', 'CCD', 'camera', 'using', 'AxioVison', 'Rel', '4.7.2.0', 'imaging', 'processing', 'software', '(', 'Carl', 'Zeiss', ',', 'Microimaging', 'GmbH', ',', 'Jena', ',', 'Germany', ')', '.']	[2, 4, 4, 1, 1, 1, 2, 1, 1, 1, 1, 3, 2, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 3, 2, 1, 1, 5, 2, 7, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Since lungs are the primary infection site, we integrate human lung gene expression profile along with the host regulatory network to demonstrate the altered host signalling mechanism in viral infection.	[]	['Since', 'lungs', 'are', 'the', 'primary', 'infection', 'site', ',', 'we', 'integrate', 'human', 'lung', 'gene', 'expression', 'profile', 'along', 'with', 'the', 'host', 'regulatory', 'network', 'to', 'demonstrate', 'the', 'altered', 'host', 'signalling', 'mechanism', 'in', 'viral', 'infection', '.']	[0, 6, 12, 16, 20, 28, 38, 42, 44, 47, 57, 63, 68, 73, 84, 92, 98, 103, 107, 112, 123, 131, 134, 146, 150, 158, 163, 174, 184, 187, 193, 202]	[5, 11, 15, 19, 27, 37, 42, 43, 46, 56, 62, 67, 72, 83, 91, 97, 102, 106, 111, 122, 130, 133, 145, 149, 157, 162, 173, 183, 186, 192, 202, 203]	['Since', 'lungs', 'are', 'the', 'primary', 'infection', 'site', ',', 'we', 'integrate', 'human', 'lung', 'gene', 'expression', 'profile', 'along', 'with', 'the', 'host', 'regulatory', 'network', 'to', 'demonstrate', 'the', 'altered', 'host', 'signalling', 'mechanism', 'in', 'viral', 'infection', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The clinical outcome of ARDS has now well supported by the reports from patients with COVID-19 disease severity, observed with increased interleukin (IL)-2, IL-7, macrophage inflammatory protein 1-α, interferon-γ inducible protein 10, granulocyte-colony stimulating factor, monocyte chemoattractant protein 1, ferritin and tumor necrosis factor-α levels, resulting from viral induced hyperinflammation (Huang et al. 2020).	[]	['The', 'clinical', 'outcome', 'of', 'AR', '##DS', 'has', 'now', 'well', 'supported', 'by', 'the', 'reports', 'from', 'patients', 'with', 'CO', '##VI', '##D', '-', '19', 'disease', 'severity', ',', 'observed', 'with', 'increased', 'inter', '##le', '##uki', '##n', '(', 'IL', ')', '-', '2', ',', 'IL', '-', '7', ',', 'mac', '##rop', '##hage', 'inflammatory', 'protein', '1', '-', 'α', ',', 'inter', '##fer', '##on', '-', 'γ', 'in', '##du', '##cible', 'protein', '10', ',', 'g', '##ran', '##ulo', '##cy', '##te', '-', 'colony', 's', '##ti', '##mulating', 'factor', ',', 'mon', '##oc', '##yte', 'ch', '##em', '##oat', '##tract', '##ant', 'protein', '1', ',', 'f', '##er', '##rit', '##in', 'and', 'tumor', 'ne', '##c', '##rosis', 'factor', '-', 'α', 'levels', ',', 'resulting', 'from', 'viral', 'induced', 'h', '##yper', '##in', '##f', '##lam', '##mation', '(', 'Huang', 'et', 'al', '.', '2020', ')', '.']	[0, 4, 13, 21, 24, 26, 29, 33, 37, 42, 52, 55, 59, 67, 72, 81, 86, 88, 90, 91, 92, 95, 103, 111, 113, 122, 127, 137, 142, 144, 147, 149, 150, 152, 153, 154, 155, 157, 159, 160, 161, 163, 166, 169, 174, 187, 195, 196, 197, 198, 200, 205, 208, 210, 211, 213, 215, 217, 223, 231, 233, 235, 236, 239, 242, 244, 246, 247, 254, 255, 257, 266, 272, 274, 277, 279, 283, 285, 287, 290, 295, 299, 307, 308, 310, 311, 313, 316, 319, 323, 329, 331, 332, 338, 344, 345, 347, 353, 355, 365, 370, 376, 384, 385, 389, 391, 392, 395, 402, 403, 409, 412, 414, 416, 420, 421]	[3, 12, 20, 23, 26, 28, 32, 36, 41, 51, 54, 58, 66, 71, 80, 85, 88, 90, 91, 92, 94, 102, 111, 112, 121, 126, 136, 142, 144, 147, 148, 150, 152, 153, 154, 155, 156, 159, 160, 161, 162, 166, 169, 173, 186, 194, 196, 197, 198, 199, 205, 208, 210, 211, 212, 215, 217, 222, 230, 233, 234, 236, 239, 242, 244, 246, 247, 253, 255, 257, 265, 272, 273, 277, 279, 282, 285, 287, 290, 295, 298, 306, 308, 309, 311, 313, 316, 318, 322, 328, 331, 332, 337, 344, 345, 346, 353, 354, 364, 369, 375, 383, 385, 389, 391, 392, 395, 401, 403, 408, 411, 414, 415, 420, 421, 422]	['The', 'clinical', 'outcome', 'of', 'ARDS', 'has', 'now', 'well', 'supported', 'by', 'the', 'reports', 'from', 'patients', 'with', 'COVID-19', 'disease', 'severity', ',', 'observed', 'with', 'increased', 'interleukin', '(IL)-2', ',', 'IL-7', ',', 'macrophage', 'inflammatory', 'protein', '1-α', ',', 'interferon-γ', 'inducible', 'protein', '10', ',', 'granulocyte', '-', 'colony', 'stimulating', 'factor', ',', 'monocyte', 'chemoattractant', 'protein', '1', ',', 'ferritin', 'and', 'tumor', 'necrosis', 'factor-α', 'levels', ',', 'resulting', 'from', 'viral', 'induced', 'hyperinflammation', '(', 'Huang', 'et', 'al', '.', '2020', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 4, 5, 1, 3, 1, 3, 1, 1, 3, 1, 5, 3, 1, 1, 1, 5, 1, 1, 3, 1, 1, 3, 5, 1, 1, 1, 4, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Besides this, molecular function such as type 1 angiotensin receptor binding (AGTR1), G-protein coupled receptor, insulin receptor, ribonucleotide, chemokine and cytokine receptor binding were observed to be altered by the modulation in the regulatory network.	[]	['Besides', 'this', ',', 'molecular', 'function', 'such', 'as', 'type', '1', 'an', '##gio', '##tens', '##in', 'receptor', 'binding', '(', 'AG', '##TR', '##1', ')', ',', 'G', '-', 'protein', 'coupled', 'receptor', ',', 'insulin', 'receptor', ',', 'rib', '##on', '##uc', '##leo', '##tide', ',', 'ch', '##em', '##oki', '##ne', 'and', 'c', '##yt', '##oki', '##ne', 'receptor', 'binding', 'were', 'observed', 'to', 'be', 'altered', 'by', 'the', 'm', '##od', '##ulation', 'in', 'the', 'regulatory', 'network', '.']	[0, 8, 12, 14, 24, 33, 38, 41, 46, 48, 50, 53, 57, 60, 69, 77, 78, 80, 82, 83, 84, 86, 87, 88, 96, 104, 112, 114, 122, 130, 132, 135, 137, 139, 142, 146, 148, 150, 152, 155, 158, 162, 163, 165, 168, 171, 180, 188, 193, 202, 205, 208, 216, 219, 223, 224, 226, 234, 237, 241, 252, 259]	[7, 12, 13, 23, 32, 37, 40, 45, 47, 50, 53, 57, 59, 68, 76, 78, 80, 82, 83, 84, 85, 87, 88, 95, 103, 112, 113, 121, 130, 131, 135, 137, 139, 142, 146, 147, 150, 152, 155, 157, 161, 163, 165, 168, 170, 179, 187, 192, 201, 204, 207, 215, 218, 222, 224, 226, 233, 236, 240, 251, 259, 260]	['Besides', 'this', ',', 'molecular', 'function', 'such', 'as', 'type', '1', 'angiotensin', 'receptor', 'binding', '(', 'AGTR1', ')', ',', 'G', '-', 'protein', 'coupled', 'receptor', ',', 'insulin', 'receptor', ',', 'ribonucleotide', ',', 'chemokine', 'and', 'cytokine', 'receptor', 'binding', 'were', 'observed', 'to', 'be', 'altered', 'by', 'the', 'modulation', 'in', 'the', 'regulatory', 'network', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
One of the most represented groups of proteins we found in the egg proteome were those related to energy and metabolism and included proteins associated with glycolysis (enolase and glyceraldehyde-3-phosphate dehydrogenase (GADPH), gluconeogenesis (triosephosphate isomerase and phosphoenolpyruvate carboxykinase GTP) and other metabolic enzymes such as alpha-1,4 glucan phosphorylase and malic enzyme (S1 Table).	[]	['One', 'of', 'the', 'most', 'represented', 'groups', 'of', 'proteins', 'we', 'found', 'in', 'the', 'egg', 'pro', '##te', '##ome', 'were', 'those', 'related', 'to', 'energy', 'and', 'metabolism', 'and', 'included', 'proteins', 'associated', 'with', 'g', '##ly', '##co', '##lysis', '(', 'en', '##ola', '##se', 'and', 'g', '##ly', '##cer', '##ald', '##eh', '##yd', '##e', '-', '3', '-', 'phosphate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'GA', '##DP', '##H', ')', ',', 'g', '##lu', '##con', '##eo', '##genesis', '(', 'trio', '##se', '##ph', '##os', '##phate', 'is', '##omer', '##ase', 'and', 'p', '##hos', '##ph', '##oe', '##no', '##l', '##py', '##ru', '##vate', 'car', '##box', '##yk', '##inas', '##e', 'GT', '##P', ')', 'and', 'other', 'metabolic', 'enzymes', 'such', 'as', 'alpha', '-', '1', ',', '4', 'g', '##lu', '##can', 'p', '##hos', '##ph', '##ory', '##lase', 'and', 'ma', '##lic', 'enzyme', '(', 'S', '##1', 'Table', ')', '.']	[0, 4, 7, 11, 16, 28, 35, 38, 47, 50, 56, 59, 63, 67, 70, 72, 76, 81, 87, 95, 98, 105, 109, 120, 124, 133, 142, 153, 158, 159, 161, 163, 169, 170, 172, 175, 178, 182, 183, 185, 188, 191, 193, 195, 196, 197, 198, 199, 209, 211, 213, 215, 219, 223, 224, 226, 228, 229, 230, 232, 233, 235, 238, 240, 248, 249, 253, 255, 257, 259, 265, 267, 271, 275, 279, 280, 283, 285, 287, 289, 290, 292, 294, 299, 302, 305, 307, 311, 313, 315, 316, 318, 322, 328, 338, 346, 351, 354, 359, 360, 361, 362, 364, 365, 367, 371, 372, 375, 377, 380, 385, 389, 391, 395, 402, 403, 404, 406, 411, 412]	[3, 6, 10, 15, 27, 34, 37, 46, 49, 55, 58, 62, 66, 70, 72, 75, 80, 86, 94, 97, 104, 108, 119, 123, 132, 141, 152, 157, 159, 161, 163, 168, 170, 172, 175, 177, 181, 183, 185, 188, 191, 193, 195, 196, 197, 198, 199, 208, 211, 213, 215, 219, 222, 224, 226, 228, 229, 230, 231, 233, 235, 238, 240, 247, 249, 253, 255, 257, 259, 264, 267, 271, 274, 278, 280, 283, 285, 287, 289, 290, 292, 294, 298, 302, 305, 307, 311, 312, 315, 316, 317, 321, 327, 337, 345, 350, 353, 359, 360, 361, 362, 363, 365, 367, 370, 372, 375, 377, 380, 384, 388, 391, 394, 401, 403, 404, 405, 411, 412, 413]	['One', 'of', 'the', 'most', 'represented', 'groups', 'of', 'proteins', 'we', 'found', 'in', 'the', 'egg', 'proteome', 'were', 'those', 'related', 'to', 'energy', 'and', 'metabolism', 'and', 'included', 'proteins', 'associated', 'with', 'glycolysis', '(', 'enolase', 'and', 'glyceraldehyde-3-phosphate', 'dehydrogenase', '(', 'GADPH', ')', ',', 'gluconeogenesis', '(', 'triosephosphate', 'isomerase', 'and', 'phosphoenolpyruvate', 'carboxykinase', 'GTP', ')', 'and', 'other', 'metabolic', 'enzymes', 'such', 'as', 'alpha-1,4', 'glucan', 'phosphorylase', 'and', 'malic', 'enzyme', '(', 'S1', 'Table', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 11, 5, 1, 3, 1, 1, 5, 1, 5, 3, 1, 9, 5, 2, 1, 1, 1, 1, 1, 1, 1, 5, 3, 5, 1, 2, 1, 1, 2, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The Cu/Zn superoxide dismutase (Cu/Zn-SOD) was found in the EE proteome (S1 Table) and has also been identified on the adult surface and larval extracts (secreted and somatic) of Toxocara canis [38], in the somatic extract of adults of Fasciola hepatica, and the S. mansoni egg secretome	[]	['The', 'C', '##u', '/', 'Z', '##n', 'super', '##oxide', 'di', '##sm', '##uta', '##se', '(', 'C', '##u', '/', 'Z', '##n', '-', 'S', '##OD', ')', 'was', 'found', 'in', 'the', 'E', '##E', 'pro', '##te', '##ome', '(', 'S', '##1', 'Table', ')', 'and', 'has', 'also', 'been', 'identified', 'on', 'the', 'adult', 'surface', 'and', 'la', '##rva', '##l', 'extract', '##s', '(', 'secret', '##ed', 'and', 'so', '##matic', ')', 'of', 'To', '##x', '##oc', '##ara', 'can', '##is', '[', '38', ']', ',', 'in', 'the', 'so', '##matic', 'extract', 'of', 'adults', 'of', 'F', '##as', '##cio', '##la', 'he', '##pa', '##tica', ',', 'and', 'the', 'S', '.', 'man', '##son', '##i', 'egg', 'secret', '##ome']	[0, 4, 5, 6, 7, 8, 10, 15, 21, 23, 25, 28, 31, 32, 33, 34, 35, 36, 37, 38, 39, 41, 43, 47, 53, 56, 60, 61, 63, 66, 68, 72, 73, 74, 76, 81, 83, 87, 91, 96, 101, 112, 115, 119, 125, 133, 137, 139, 142, 144, 151, 153, 154, 160, 163, 167, 169, 174, 176, 179, 181, 182, 184, 188, 191, 194, 195, 197, 198, 200, 203, 207, 209, 215, 223, 226, 233, 236, 237, 239, 242, 245, 247, 249, 253, 255, 259, 263, 264, 266, 269, 272, 274, 278, 284]	[3, 5, 6, 7, 8, 9, 15, 20, 23, 25, 28, 30, 32, 33, 34, 35, 36, 37, 38, 39, 41, 42, 46, 52, 55, 59, 61, 62, 66, 68, 71, 73, 74, 75, 81, 82, 86, 90, 95, 100, 111, 114, 118, 124, 132, 136, 139, 142, 143, 151, 152, 154, 160, 162, 166, 169, 174, 175, 178, 181, 182, 184, 187, 191, 193, 195, 197, 198, 199, 202, 206, 209, 214, 222, 225, 232, 235, 237, 239, 242, 244, 247, 249, 253, 254, 258, 262, 264, 265, 269, 272, 273, 277, 284, 287]	['The', 'Cu', '/', 'Zn', 'superoxide', 'dismutase', '(', 'Cu', '/', 'Zn-SOD', ')', 'was', 'found', 'in', 'the', 'EE', 'proteome', '(', 'S1', 'Table', ')', 'and', 'has', 'also', 'been', 'identified', 'on', 'the', 'adult', 'surface', 'and', 'larval', 'extracts', '(', 'secreted', 'and', 'somatic', ')', 'of', 'Toxocara', 'canis', '[', '38', ']', ',', 'in', 'the', 'somatic', 'extract', 'of', 'adults', 'of', 'Fasciola', 'hepatica', ',', 'and', 'the', 'S', '.', 'mansoni', 'egg', 'secretome']	[1, 2, 1, 2, 2, 4, 1, 2, 1, 5, 1, 1, 1, 1, 1, 2, 3, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 2, 1, 2, 1, 2, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 3, 1, 2]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We identified certain glycolytic enzymes such as enolase and GAPDH, as immunoactive components of the T. trichiura EE and FE.	[('PMC8021180', 'D13000', 49, 56, 'enolase')]	['We', 'identified', 'certain', 'g', '##ly', '##co', '##ly', '##tic', 'enzymes', 'such', 'as', 'en', '##ola', '##se', 'and', 'GA', '##PD', '##H', ',', 'as', 'im', '##mu', '##no', '##active', 'components', 'of', 'the', 'T', '.', 't', '##rich', '##iu', '##ra', 'E', '##E', 'and', 'F', '##E', '.']	[0, 3, 14, 22, 23, 25, 27, 29, 33, 41, 46, 49, 51, 54, 57, 61, 63, 65, 66, 68, 71, 73, 75, 77, 84, 95, 98, 102, 103, 105, 106, 110, 112, 115, 116, 118, 122, 123, 124]	[2, 13, 21, 23, 25, 27, 29, 32, 40, 45, 48, 51, 54, 56, 60, 63, 65, 66, 67, 70, 73, 75, 77, 83, 94, 97, 101, 103, 104, 106, 110, 112, 114, 116, 117, 121, 123, 124, 125]	['We', 'identified', 'certain', 'glycolytic', 'enzymes', 'such', 'as', 'enolase', 'and', 'GAPDH', ',', 'as', 'immunoactive', 'components', 'of', 'the', 'T', '.', 'trichiura', 'EE', 'and', 'FE', '.']	[1, 1, 1, 5, 1, 1, 1, 3, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 4, 2, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, enolase plays a vital role in the degradation of the intracellular matrix through the activation of plasminogen facilitating the invasion, migration, and fixation in the host [15,17,33,44] all essential mechanisms to ensure T. trichiura prolonged survival.	[]	['Furthermore', ',', 'en', '##ola', '##se', 'plays', 'a', 'vital', 'role', 'in', 'the', 'degradation', 'of', 'the', 'in', '##tra', '##cellular', 'matrix', 'through', 'the', 'activation', 'of', 'p', '##las', '##min', '##ogen', 'f', '##ac', '##ilitating', 'the', 'invasion', ',', 'migration', ',', 'and', 'fix', '##ation', 'in', 'the', 'host', '[', '15', ',', '17', ',', '33', ',', '44', ']', 'all', 'essential', 'mechanisms', 'to', 'ensure', 'T', '.', 't', '##rich', '##iu', '##ra', 'prolonged', 'survival', '.']	[0, 11, 13, 15, 18, 21, 27, 29, 35, 40, 43, 47, 59, 62, 66, 68, 71, 80, 87, 95, 99, 110, 113, 114, 117, 120, 125, 126, 128, 138, 142, 150, 152, 161, 163, 167, 170, 176, 179, 183, 188, 189, 191, 192, 194, 195, 197, 198, 200, 202, 206, 216, 227, 230, 237, 238, 240, 241, 245, 247, 250, 260, 268]	[11, 12, 15, 18, 20, 26, 28, 34, 39, 42, 46, 58, 61, 65, 68, 71, 79, 86, 94, 98, 109, 112, 114, 117, 120, 124, 126, 128, 137, 141, 150, 151, 161, 162, 166, 170, 175, 178, 182, 187, 189, 191, 192, 194, 195, 197, 198, 200, 201, 205, 215, 226, 229, 236, 238, 239, 241, 245, 247, 249, 259, 268, 269]	['Furthermore', ',', 'enolase', 'plays', 'a', 'vital', 'role', 'in', 'the', 'degradation', 'of', 'the', 'intracellular', 'matrix', 'through', 'the', 'activation', 'of', 'plasminogen', 'facilitating', 'the', 'invasion', ',', 'migration', ',', 'and', 'fixation', 'in', 'the', 'host', '[', '15', ',', '17', ',', '33', ',', '44', ']', 'all', 'essential', 'mechanisms', 'to', 'ensure', 'T', '.', 'trichiura', 'prolonged', 'survival', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Analysis of band 2W identified poly-cysteine and histidine-tailed protein isoform 2 (PCHTP-2), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), actin, actin 5C, enolase, and epididymal secretory protein E1 (Table 2) and confirmatory analysis with LC-MS/MS also indicating there were other proteins present such as phosphoglycerate kinase, the dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48 kDa subunit, adenosylhomocysteinase, tubulointerstitial nephritis antigen, calponin domain containing protein, 3 ketoacyl coenzyme A thiolase, elongation factor 1-alpha and serpin domain containing protein (Table 3) while actin 5C and epididymal secretory protein E1 were not confirmed.	[('PMC8021180', 'R08000', 95, 135, 'glyceraldehyde-3-phosphate dehydrogenase')]	['Analysis', 'of', 'band', '2', '##W', 'identified', 'p', '##oly', '-', 'c', '##ys', '##tein', '##e', 'and', 'his', '##ti', '##dine', '-', 'tailed', 'protein', 'is', '##of', '##orm', '2', '(', 'PC', '##HT', '##P', '-', '2', ')', ',', 'g', '##ly', '##cer', '##ald', '##eh', '##yd', '##e', '-', '3', '-', 'phosphate', 'de', '##hy', '##dr', '##ogen', '##ase', '(', 'GA', '##PD', '##H', ')', ',', 'act', '##in', ',', 'act', '##in', '5', '##C', ',', 'en', '##ola', '##se', ',', 'and', 'e', '##pid', '##idy', '##mal', 'secret', '##ory', 'protein', 'E', '##1', '(', 'Table', '2', ')', 'and', 'confirm', '##atory', 'analysis', 'with', 'L', '##C', '-', 'MS', '/', 'MS', 'also', 'indicating', 'there', 'were', 'other', 'proteins', 'present', 'such', 'as', 'p', '##hos', '##ph', '##og', '##ly', '##cer', '##ate', 'kinase', ',', 'the', 'do', '##lich', '##yl', '-', 'dip', '##hos', '##ph', '##ool', '##igo', '##sa', '##cc', '##hari', '##de', '-', 'protein', 'g', '##ly', '##cos', '##yl', '##tra', '##ns', '##fer', '##ase', '48', 'k', '##D', '##a', 'subunit', ',', 'ad', '##eno', '##sy', '##l', '##hom', '##oc', '##ys', '##tein', '##ase', ',', 'tub', '##ulo', '##int', '##ers', '##ti', '##tial', 'ne', '##ph', '##rit', '##is', 'anti', '##gen', ',', 'ca', '##l', '##po', '##nin', 'domain', 'containing', 'protein', ',', '3', 'k', '##eto', '##acy', '##l', 'co', '##en', '##zy', '##me', 'A', 'th', '##iol', '##ase', ',', 'el', '##ong', '##ation', 'factor', '1', '-', 'alpha', 'and', 'se', '##rp', '##in', 'domain', 'containing', 'protein', '(', 'Table', '3', ')', 'while', 'act', '##in', '5', '##C', 'and', 'e', '##pid', '##idy', '##mal', 'secret', '##ory', 'protein', 'E', '##1', 'were', 'not', 'confirmed', '.']	[0, 9, 12, 17, 18, 20, 31, 32, 35, 36, 37, 39, 43, 45, 49, 52, 54, 58, 59, 66, 74, 76, 78, 82, 84, 85, 87, 89, 90, 91, 92, 93, 95, 96, 98, 101, 104, 106, 108, 109, 110, 111, 112, 122, 124, 126, 128, 132, 136, 137, 139, 141, 142, 143, 145, 148, 150, 152, 155, 158, 159, 160, 162, 164, 167, 169, 171, 175, 176, 179, 182, 186, 192, 196, 204, 205, 207, 208, 214, 215, 217, 221, 228, 234, 243, 248, 249, 250, 251, 253, 254, 257, 262, 273, 279, 284, 290, 299, 307, 312, 315, 316, 319, 321, 323, 325, 328, 332, 338, 340, 344, 346, 350, 352, 353, 356, 359, 361, 364, 367, 369, 371, 375, 377, 378, 386, 387, 389, 392, 394, 397, 399, 402, 406, 409, 410, 411, 413, 420, 422, 424, 427, 429, 430, 433, 435, 437, 441, 444, 446, 449, 452, 455, 458, 460, 465, 467, 469, 472, 475, 479, 482, 484, 486, 487, 489, 493, 500, 511, 518, 520, 522, 523, 526, 529, 531, 533, 535, 537, 540, 542, 544, 547, 550, 552, 554, 557, 563, 570, 571, 572, 578, 582, 584, 586, 589, 596, 607, 615, 616, 622, 623, 625, 631, 634, 637, 638, 640, 644, 645, 648, 651, 655, 661, 665, 673, 674, 676, 681, 685, 694]	[8, 11, 16, 18, 19, 30, 32, 35, 36, 37, 39, 43, 44, 48, 52, 54, 58, 59, 65, 73, 76, 78, 81, 83, 85, 87, 89, 90, 91, 92, 93, 94, 96, 98, 101, 104, 106, 108, 109, 110, 111, 112, 121, 124, 126, 128, 132, 135, 137, 139, 141, 142, 143, 144, 148, 150, 151, 155, 157, 159, 160, 161, 164, 167, 169, 170, 174, 176, 179, 182, 185, 192, 195, 203, 205, 206, 208, 213, 215, 216, 220, 228, 233, 242, 247, 249, 250, 251, 253, 254, 256, 261, 272, 278, 283, 289, 298, 306, 311, 314, 316, 319, 321, 323, 325, 328, 331, 338, 339, 343, 346, 350, 352, 353, 356, 359, 361, 364, 367, 369, 371, 375, 377, 378, 385, 387, 389, 392, 394, 397, 399, 402, 405, 408, 410, 411, 412, 420, 421, 424, 427, 429, 430, 433, 435, 437, 441, 444, 445, 449, 452, 455, 458, 460, 464, 467, 469, 472, 474, 479, 482, 483, 486, 487, 489, 492, 499, 510, 518, 519, 521, 523, 526, 529, 530, 533, 535, 537, 539, 541, 544, 547, 550, 551, 554, 557, 562, 569, 571, 572, 577, 581, 584, 586, 588, 595, 606, 614, 616, 621, 623, 624, 630, 634, 636, 638, 639, 643, 645, 648, 651, 654, 661, 664, 672, 674, 675, 680, 684, 694, 695]	['Analysis', 'of', 'band', '2W', 'identified', 'poly', '-', 'cysteine', 'and', 'histidine', '-', 'tailed', 'protein', 'isoform', '2', '(', 'PCHTP-2', ')', ',', 'glyceraldehyde-3-phosphate', 'dehydrogenase', '(', 'GAPDH', ')', ',', 'actin', ',', 'actin', '5C', ',', 'enolase', ',', 'and', 'epididymal', 'secretory', 'protein', 'E1', '(', 'Table', '2', ')', 'and', 'confirmatory', 'analysis', 'with', 'LC-MS', '/', 'MS', 'also', 'indicating', 'there', 'were', 'other', 'proteins', 'present', 'such', 'as', 'phosphoglycerate', 'kinase', ',', 'the', 'dolichyl', '-', 'diphosphooligosaccharide', '-', 'protein', 'glycosyltransferase', '48', 'kDa', 'subunit', ',', 'adenosylhomocysteinase', ',', 'tubulointerstitial', 'nephritis', 'antigen', ',', 'calponin', 'domain', 'containing', 'protein', ',', '3', 'ketoacyl', 'coenzyme', 'A', 'thiolase', ',', 'elongation', 'factor', '1-alpha', 'and', 'serpin', 'domain', 'containing', 'protein', '(', 'Table', '3', ')', 'while', 'actin', '5C', 'and', 'epididymal', 'secretory', 'protein', 'E1', 'were', 'not', 'confirmed', '.']	[1, 1, 1, 2, 1, 2, 1, 4, 1, 3, 1, 1, 1, 3, 1, 1, 5, 1, 1, 11, 5, 1, 3, 1, 1, 2, 1, 2, 2, 1, 3, 1, 1, 4, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 3, 1, 9, 1, 1, 8, 1, 3, 1, 1, 9, 1, 6, 4, 2, 1, 4, 1, 1, 1, 1, 1, 4, 4, 1, 3, 1, 3, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 4, 2, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Samples were lysed for 45 min at 4 °C in a lysis buffer containing 20 mM Tris, 150 mM NaCl, 5 mM EDTA, 0.002% NaN3, 1% Triton X-100, 0.2% BSA, and phosphatase (Sigma-Aldrich, St. Louis, MO, USA) and protease inhibitor cocktails (Roche Diagnostics, Basel, Switzerland).	[]	['Sam', '##ples', 'were', 'l', '##ys', '##ed', 'for', '45', 'min', 'at', '4', '°C', 'in', 'a', 'l', '##ys', '##is', 'buffer', 'containing', '20', 'm', '##M', 'Tri', '##s', ',', '150', 'm', '##M', 'Na', '##C', '##l', ',', '5', 'm', '##M', 'E', '##D', '##TA', ',', '0', '.', '00', '##2', '%', 'Na', '##N', '##3', ',', '1', '%', 'Tri', '##ton', 'X', '-', '100', ',', '0', '.', '2', '%', 'BS', '##A', ',', 'and', 'p', '##hos', '##pha', '##tase', '(', 'Sigma', '-', 'Al', '##dric', '##h', ',', 'St', '.', 'Louis', ',', 'M', '##O', ',', 'USA', ')', 'and', 'pro', '##te', '##ase', 'inhibitor', 'cocktail', '##s', '(', 'Roche', 'Di', '##ag', '##nos', '##tics', ',', 'Basel', ',', 'Switzerland', ')', '.']	[0, 3, 8, 13, 14, 16, 19, 23, 26, 30, 33, 35, 38, 41, 43, 44, 46, 49, 56, 67, 70, 71, 73, 76, 77, 79, 83, 84, 86, 88, 89, 90, 92, 94, 95, 97, 98, 99, 101, 103, 104, 105, 107, 108, 110, 112, 113, 114, 116, 117, 119, 122, 126, 127, 128, 131, 133, 134, 135, 136, 138, 140, 141, 143, 147, 148, 151, 154, 159, 160, 165, 166, 168, 172, 173, 175, 177, 179, 184, 186, 187, 188, 190, 193, 195, 199, 202, 204, 208, 218, 226, 228, 229, 235, 237, 239, 242, 246, 248, 253, 255, 266, 267]	[3, 7, 12, 14, 16, 18, 22, 25, 29, 32, 34, 37, 40, 42, 44, 46, 48, 55, 66, 69, 71, 72, 76, 77, 78, 82, 84, 85, 88, 89, 90, 91, 93, 95, 96, 98, 99, 101, 102, 104, 105, 107, 108, 109, 112, 113, 114, 115, 117, 118, 122, 125, 127, 128, 131, 132, 134, 135, 136, 137, 140, 141, 142, 146, 148, 151, 154, 158, 160, 165, 166, 168, 172, 173, 174, 177, 178, 184, 185, 187, 188, 189, 193, 194, 198, 202, 204, 207, 217, 226, 227, 229, 234, 237, 239, 242, 246, 247, 253, 254, 266, 267, 268]	['Samples', 'were', 'lysed', 'for', '45', 'min', 'at', '4', '°C', 'in', 'a', 'lysis', 'buffer', 'containing', '20', 'mM', 'Tris', ',', '150', 'mM', 'NaCl', ',', '5', 'mM', 'EDTA', ',', '0.002%', 'NaN3', ',', '1%', 'Triton', 'X-100', ',', '0.2%', 'BSA', ',', 'and', 'phosphatase', '(', 'Sigma-Aldrich', ',', 'St', '.', 'Louis', ',', 'MO', ',', 'USA', ')', 'and', 'protease', 'inhibitor', 'cocktails', '(', 'Roche', 'Diagnostics', ',', 'Basel', ',', 'Switzerland', ')', '.']	[2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 2, 1, 1, 2, 3, 1, 1, 2, 3, 1, 5, 3, 1, 2, 2, 3, 1, 4, 2, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 2, 1, 1, 4, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lysates containing the Laemmli buffer and 5% β-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA) were size-separated in 8% SDS-PAGE and transferred on a nitrocellulose membrane (Whatman-Protan, Dassel, Germany).	[]	['L', '##ys', '##ates', 'containing', 'the', 'La', '##em', '##m', '##li', 'buffer', 'and', '5', '%', 'β', '-', 'me', '##rca', '##pt', '##oe', '##than', '##ol', '(', 'Sigma', '-', 'Al', '##dric', '##h', ',', 'St', '.', 'Louis', ',', 'M', '##O', ',', 'USA', ')', 'were', 'size', '-', 'separated', 'in', '8', '%', 'SD', '##S', '-', 'PA', '##GE', 'and', 'transferred', 'on', 'a', 'ni', '##tro', '##cell', '##ulos', '##e', 'membrane', '(', 'What', '##man', '-', 'Pro', '##tan', ',', 'Das', '##sel', ',', 'Germany', ')', '.']	[0, 1, 3, 8, 19, 23, 25, 27, 28, 31, 38, 42, 43, 45, 46, 47, 49, 52, 54, 56, 60, 63, 64, 69, 70, 72, 76, 77, 79, 81, 83, 88, 90, 91, 92, 94, 97, 99, 104, 108, 109, 119, 122, 123, 125, 127, 128, 129, 131, 134, 138, 150, 153, 155, 157, 160, 164, 168, 170, 179, 180, 184, 187, 188, 191, 194, 196, 199, 202, 204, 211, 212]	[1, 3, 7, 18, 22, 25, 27, 28, 30, 37, 41, 43, 44, 46, 47, 49, 52, 54, 56, 60, 62, 64, 69, 70, 72, 76, 77, 78, 81, 82, 88, 89, 91, 92, 93, 97, 98, 103, 108, 109, 118, 121, 123, 124, 127, 128, 129, 131, 133, 137, 149, 152, 154, 157, 160, 164, 168, 169, 178, 180, 184, 187, 188, 191, 194, 195, 199, 202, 203, 211, 212, 213]	['Lysates', 'containing', 'the', 'Laemmli', 'buffer', 'and', '5%', 'β-mercaptoethanol', '(', 'Sigma-Aldrich', ',', 'St', '.', 'Louis', ',', 'MO', ',', 'USA', ')', 'were', 'size', '-', 'separated', 'in', '8%', 'SDS-PAGE', 'and', 'transferred', 'on', 'a', 'nitrocellulose', 'membrane', '(', 'Whatman-Protan', ',', 'Dassel', ',', 'Germany', ')', '.']	[3, 1, 1, 4, 1, 1, 2, 8, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 5, 1, 1, 1, 1, 5, 1, 1, 5, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
MPN RBC samples treated ex vivo with ruxolitinib displayed high PS exposure levels measured by flow cytometry, with an average of 19% PS-positive RBCs (range: 10–30%) compared to DMSO-treated cells (15% PS-positive RBCs, range: 8–28%, p = 0.0005) (Figure 3B,C), suggesting the import of ruxolitinib into the RBCs.	[]	['MP', '##N', 'RB', '##C', 'samples', 'treated', 'ex', 'v', '##ivo', 'with', 'r', '##ux', '##oli', '##tin', '##ib', 'displayed', 'high', 'PS', 'exposure', 'levels', 'measured', 'by', 'flow', 'c', '##yt', '##ome', '##try', ',', 'with', 'an', 'average', 'of', '19', '%', 'PS', '-', 'positive', 'RB', '##Cs', '(', 'range', ':', '10', '–', '30', '%', ')', 'compared', 'to', 'D', '##MS', '##O', '-', 'treated', 'cells', '(', '15', '%', 'PS', '-', 'positive', 'RB', '##Cs', ',', 'range', ':', '8', '–', '28', '%', ',', 'p', '=', '0', '.', '000', '##5', ')', '(', 'Figure', '3', '##B', ',', 'C', ')', ',', 'suggesting', 'the', 'import', 'of', 'r', '##ux', '##oli', '##tin', '##ib', 'into', 'the', 'RB', '##Cs', '.']	[0, 2, 4, 6, 8, 16, 24, 27, 28, 32, 37, 38, 40, 43, 46, 49, 59, 64, 67, 76, 83, 92, 95, 100, 101, 103, 106, 109, 111, 116, 119, 127, 130, 132, 134, 136, 137, 146, 148, 151, 152, 157, 159, 161, 162, 164, 165, 167, 176, 179, 180, 182, 183, 184, 192, 198, 199, 201, 203, 205, 206, 215, 217, 219, 221, 226, 228, 229, 230, 232, 233, 235, 237, 239, 240, 241, 244, 245, 247, 248, 255, 256, 257, 258, 259, 260, 262, 273, 277, 284, 287, 288, 290, 293, 296, 299, 304, 308, 310, 312]	[2, 3, 6, 7, 15, 23, 26, 28, 31, 36, 38, 40, 43, 46, 48, 58, 63, 66, 75, 82, 91, 94, 99, 101, 103, 106, 109, 110, 115, 118, 126, 129, 132, 133, 136, 137, 145, 148, 150, 152, 157, 158, 161, 162, 164, 165, 166, 175, 178, 180, 182, 183, 184, 191, 197, 199, 201, 202, 205, 206, 214, 217, 219, 220, 226, 227, 229, 230, 232, 233, 234, 236, 238, 240, 241, 244, 245, 246, 248, 254, 256, 257, 258, 259, 260, 261, 272, 276, 283, 286, 288, 290, 293, 296, 298, 303, 307, 310, 312, 313]	['MPN', 'RBC', 'samples', 'treated', 'ex', 'vivo', 'with', 'ruxolitinib', 'displayed', 'high', 'PS', 'exposure', 'levels', 'measured', 'by', 'flow', 'cytometry', ',', 'with', 'an', 'average', 'of', '19%', 'PS-positive', 'RBCs', '(', 'range', ':', '10–', '30%', ')', 'compared', 'to', 'DMSO', '-', 'treated', 'cells', '(', '15%', 'PS-positive', 'RBCs', ',', 'range', ':', '8–', '28%', ',', 'p', '=', '0.0005', ')', '(', 'Figure', '3B', ',', 'C', ')', ',', 'suggesting', 'the', 'import', 'of', 'ruxolitinib', 'into', 'the', 'RBCs', '.']	[2, 2, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 3, 2, 1, 1, 1, 2, 2, 1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 2, 1, 1, 1, 2, 2, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraoxonase 1 (PON1) enzyme has antioxidative properties and is present in mammalian blood and several other body fluids.	[('PMC8045895', 'A00000', 0, 13, 'Paraoxonase 1')]	['Para', '##ox', '##ona', '##se', '1', '(', 'P', '##ON', '##1', ')', 'enzyme', 'has', 'anti', '##ox', '##ida', '##tive', 'properties', 'and', 'is', 'present', 'in', 'ma', '##mmal', '##ian', 'blood', 'and', 'several', 'other', 'body', 'fluids', '.']	[0, 4, 6, 9, 12, 14, 15, 16, 18, 19, 21, 28, 32, 36, 38, 41, 46, 57, 61, 64, 72, 75, 77, 81, 85, 91, 95, 103, 109, 114, 120]	[4, 6, 9, 11, 13, 15, 16, 18, 19, 20, 27, 31, 36, 38, 41, 45, 56, 60, 63, 71, 74, 77, 81, 84, 90, 94, 102, 108, 113, 120, 121]	['Paraoxonase', '1', '(', 'PON1', ')', 'enzyme', 'has', 'antioxidative', 'properties', 'and', 'is', 'present', 'in', 'mammalian', 'blood', 'and', 'several', 'other', 'body', 'fluids', '.']	[4, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The PON1 enzyme activities measured with different substrates tend to be falsely assumed as being equivalent in the literature, although there are poor or weak correlations among the PON1 enzyme activities with different substrates.	[]	['The', 'P', '##ON', '##1', 'enzyme', 'activities', 'measured', 'with', 'different', 'substrates', 'tend', 'to', 'be', 'falsely', 'assumed', 'as', 'being', 'equivalent', 'in', 'the', 'literature', ',', 'although', 'there', 'are', 'poor', 'or', 'weak', 'correlation', '##s', 'among', 'the', 'P', '##ON', '##1', 'enzyme', 'activities', 'with', 'different', 'substrates', '.']	[0, 4, 5, 7, 9, 16, 27, 36, 41, 51, 62, 67, 70, 73, 81, 89, 92, 98, 109, 112, 116, 126, 128, 137, 143, 147, 152, 155, 160, 171, 173, 179, 183, 184, 186, 188, 195, 206, 211, 221, 231]	[3, 5, 7, 8, 15, 26, 35, 40, 50, 61, 66, 69, 72, 80, 88, 91, 97, 108, 111, 115, 126, 127, 136, 142, 146, 151, 154, 159, 171, 172, 178, 182, 184, 186, 187, 194, 205, 210, 220, 231, 232]	['The', 'PON1', 'enzyme', 'activities', 'measured', 'with', 'different', 'substrates', 'tend', 'to', 'be', 'falsely', 'assumed', 'as', 'being', 'equivalent', 'in', 'the', 'literature', ',', 'although', 'there', 'are', 'poor', 'or', 'weak', 'correlations', 'among', 'the', 'PON1', 'enzyme', 'activities', 'with', 'different', 'substrates', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In addition, and despite our knowledge of the factors influencing PON1 paraoxonase and arylesterase activities, there is little knowledge of PON1 lactonase activity variations and attendant mechanisms.	[]	['In', 'addition', ',', 'and', 'despite', 'our', 'knowledge', 'of', 'the', 'factors', 'in', '##f', '##lue', '##ncing', 'P', '##ON', '##1', 'para', '##ox', '##ona', '##se', 'and', 'a', '##ryl', '##ester', '##ase', 'activities', ',', 'there', 'is', 'little', 'knowledge', 'of', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'variations', 'and', 'attendant', 'mechanisms', '.']	[0, 3, 11, 13, 17, 25, 29, 39, 42, 46, 54, 56, 57, 60, 66, 67, 69, 71, 75, 77, 80, 83, 87, 88, 91, 96, 100, 110, 112, 118, 121, 128, 138, 141, 142, 144, 146, 148, 152, 156, 165, 176, 180, 190, 200]	[2, 11, 12, 16, 24, 28, 38, 41, 45, 53, 56, 57, 60, 65, 67, 69, 70, 75, 77, 80, 82, 86, 88, 91, 96, 99, 110, 111, 117, 120, 127, 137, 140, 142, 144, 145, 148, 152, 155, 164, 175, 179, 189, 200, 201]	['In', 'addition', ',', 'and', 'despite', 'our', 'knowledge', 'of', 'the', 'factors', 'influencing', 'PON1', 'paraoxonase', 'and', 'arylesterase', 'activities', ',', 'there', 'is', 'little', 'knowledge', 'of', 'PON1', 'lactonase', 'activity', 'variations', 'and', 'attendant', 'mechanisms', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To the best of our knowledge, this is the first multi-omics analysis of PON1 lactonase activity with an eye to future applications in basic life sciences and translational medicine and the nuances of critically interpreting PON1 function with lactones as substrates.	[]	['To', 'the', 'best', 'of', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'multi', '-', 'o', '##mic', '##s', 'analysis', 'of', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'with', 'an', 'eye', 'to', 'future', 'applications', 'in', 'basic', 'life', 'sciences', 'and', 'translation', '##al', 'medicine', 'and', 'the', 'n', '##uan', '##ces', 'of', 'critically', 'interpret', '##ing', 'P', '##ON', '##1', 'function', 'with', 'la', '##cton', '##es', 'as', 'substrates', '.']	[0, 3, 7, 12, 15, 19, 28, 30, 35, 38, 42, 48, 53, 54, 55, 58, 60, 69, 72, 73, 75, 77, 79, 83, 87, 96, 101, 104, 108, 111, 118, 131, 134, 140, 145, 154, 158, 169, 172, 181, 185, 189, 190, 193, 197, 200, 211, 220, 224, 225, 227, 229, 238, 243, 245, 249, 252, 255, 265]	[2, 6, 11, 14, 18, 28, 29, 34, 37, 41, 47, 53, 54, 55, 58, 59, 68, 71, 73, 75, 76, 79, 83, 86, 95, 100, 103, 107, 110, 117, 130, 133, 139, 144, 153, 157, 169, 171, 180, 184, 188, 190, 193, 196, 199, 210, 220, 223, 225, 227, 228, 237, 242, 245, 249, 251, 254, 265, 266]	['To', 'the', 'best', 'of', 'our', 'knowledge', ',', 'this', 'is', 'the', 'first', 'multi', '-', 'omics', 'analysis', 'of', 'PON1', 'lactonase', 'activity', 'with', 'an', 'eye', 'to', 'future', 'applications', 'in', 'basic', 'life', 'sciences', 'and', 'translational', 'medicine', 'and', 'the', 'nuances', 'of', 'critically', 'interpreting', 'PON1', 'function', 'with', 'lactones', 'as', 'substrates', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraoxonase activity, with the eponymous substrate, and arylesterase activity, with phenlyacetate as a substrate, had been used to characterize serum PON1 since the 1980s.	[('PMC8045895', 'C00000', 0, 11, 'Paraoxonase')]	['Para', '##ox', '##ona', '##se', 'activity', ',', 'with', 'the', 'eponymous', 'substrate', ',', 'and', 'a', '##ryl', '##ester', '##ase', 'activity', ',', 'with', 'p', '##hen', '##lya', '##ce', '##tate', 'as', 'a', 'substrate', ',', 'had', 'been', 'used', 'to', 'character', '##ize', 'serum', 'P', '##ON', '##1', 'since', 'the', '1980s', '.']	[0, 4, 6, 9, 12, 20, 22, 27, 31, 41, 50, 52, 56, 57, 60, 65, 69, 77, 79, 84, 85, 88, 91, 93, 98, 101, 103, 112, 114, 118, 123, 128, 131, 140, 144, 150, 151, 153, 155, 161, 165, 170]	[4, 6, 9, 11, 20, 21, 26, 30, 40, 50, 51, 55, 57, 60, 65, 68, 77, 78, 83, 85, 88, 91, 93, 97, 100, 102, 112, 113, 117, 122, 127, 130, 140, 143, 149, 151, 153, 154, 160, 164, 170, 171]	['Paraoxonase', 'activity', ',', 'with', 'the', 'eponymous', 'substrate', ',', 'and', 'arylesterase', 'activity', ',', 'with', 'phenlyacetate', 'as', 'a', 'substrate', ',', 'had', 'been', 'used', 'to', 'characterize', 'serum', 'PON1', 'since', 'the', '1980s', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lactonase activity measurements only began to be used in the mid-2000s, after a series of articles, which suggested that lactonase is the native activity of PON1 and which launched several promising artificial lactone substrates of PON1 (Khersonsky and Tawfik, 2006).	[('PMC8045895', 'C00001', 0, 9, 'Lactonase')]	['Lac', '##ton', '##ase', 'activity', 'measurements', 'only', 'began', 'to', 'be', 'used', 'in', 'the', 'mid', '-', '2000s', ',', 'after', 'a', 'series', 'of', 'articles', ',', 'which', 'suggested', 'that', 'la', '##cton', '##ase', 'is', 'the', 'native', 'activity', 'of', 'P', '##ON', '##1', 'and', 'which', 'launched', 'several', 'promising', 'artificial', 'la', '##cton', '##e', 'substrates', 'of', 'P', '##ON', '##1', '(', 'K', '##hers', '##ons', '##ky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2006', ')', '.']	[0, 3, 6, 10, 19, 32, 37, 43, 46, 49, 54, 57, 61, 64, 65, 70, 72, 78, 80, 87, 90, 98, 100, 106, 116, 121, 123, 127, 131, 134, 138, 145, 154, 157, 158, 160, 162, 166, 172, 181, 189, 199, 210, 212, 216, 218, 229, 232, 233, 235, 237, 238, 239, 243, 246, 249, 253, 255, 256, 258, 259, 261, 265, 266]	[3, 6, 9, 18, 31, 36, 42, 45, 48, 53, 56, 60, 64, 65, 70, 71, 77, 79, 86, 89, 98, 99, 105, 115, 120, 123, 127, 130, 133, 137, 144, 153, 156, 158, 160, 161, 165, 171, 180, 188, 198, 209, 212, 216, 217, 228, 231, 233, 235, 236, 238, 239, 243, 246, 248, 252, 255, 256, 258, 259, 260, 265, 266, 267]	['Lactonase', 'activity', 'measurements', 'only', 'began', 'to', 'be', 'used', 'in', 'the', 'mid-2000s', ',', 'after', 'a', 'series', 'of', 'articles', ',', 'which', 'suggested', 'that', 'lactonase', 'is', 'the', 'native', 'activity', 'of', 'PON1', 'and', 'which', 'launched', 'several', 'promising', 'artificial', 'lactone', 'substrates', 'of', 'PON1', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2006', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 4, 1, 4, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Measuring PON1 lactonase activity has always been sidelined by paraoxonase and arylesterase activities.	[('PMC8045895', 'C01000', 15, 24, 'lactonase')]	['Me', '##as', '##uring', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'has', 'always', 'been', 'side', '##lined', 'by', 'para', '##ox', '##ona', '##se', 'and', 'a', '##ryl', '##ester', '##ase', 'activities', '.']	[0, 2, 4, 10, 11, 13, 15, 17, 21, 25, 34, 38, 45, 50, 54, 60, 63, 67, 69, 72, 75, 79, 80, 83, 88, 92, 102]	[2, 4, 9, 11, 13, 14, 17, 21, 24, 33, 37, 44, 49, 54, 59, 62, 67, 69, 72, 74, 78, 80, 83, 88, 91, 102, 103]	['Measuring', 'PON1', 'lactonase', 'activity', 'has', 'always', 'been', 'sidelined', 'by', 'paraoxonase', 'and', 'arylesterase', 'activities', '.']	[3, 3, 3, 1, 1, 1, 1, 2, 1, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All the studies in question included at least one substrate for paraoxonase activity and at least one for arylesterase activity; however, the authors of the meta-analysis could not find a single study in which a lactone substrate would be tested.	[]	['All', 'the', 'studies', 'in', 'question', 'included', 'at', 'least', 'one', 'substrate', 'for', 'para', '##ox', '##ona', '##se', 'activity', 'and', 'at', 'least', 'one', 'for', 'a', '##ryl', '##ester', '##ase', 'activity', ';', 'however', ',', 'the', 'authors', 'of', 'the', 'meta', '-', 'analysis', 'could', 'not', 'find', 'a', 'single', 'study', 'in', 'which', 'a', 'la', '##cton', '##e', 'substrate', 'would', 'be', 'tested', '.']	[0, 4, 8, 16, 19, 28, 37, 40, 46, 50, 60, 64, 68, 70, 73, 76, 85, 89, 92, 98, 102, 106, 107, 110, 115, 119, 127, 129, 136, 138, 142, 150, 153, 157, 161, 162, 171, 177, 181, 186, 188, 195, 201, 204, 210, 212, 214, 218, 220, 230, 236, 239, 245]	[3, 7, 15, 18, 27, 36, 39, 45, 49, 59, 63, 68, 70, 73, 75, 84, 88, 91, 97, 101, 105, 107, 110, 115, 118, 127, 128, 136, 137, 141, 149, 152, 156, 161, 162, 170, 176, 180, 185, 187, 194, 200, 203, 209, 211, 214, 218, 219, 229, 235, 238, 245, 246]	['All', 'the', 'studies', 'in', 'question', 'included', 'at', 'least', 'one', 'substrate', 'for', 'paraoxonase', 'activity', 'and', 'at', 'least', 'one', 'for', 'arylesterase', 'activity', ';', 'however', ',', 'the', 'authors', 'of', 'the', 'meta-', 'analysis', 'could', 'not', 'find', 'a', 'single', 'study', 'in', 'which', 'a', 'lactone', 'substrate', 'would', 'be', 'tested', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clinical researchers should also include measurements of lactonase activity in future PON1 studies, and studies carried out before 2000 would benefit from a remake with lactone substrate participation.	[]	['Clinical', 'researchers', 'should', 'also', 'include', 'measurements', 'of', 'la', '##cton', '##ase', 'activity', 'in', 'future', 'P', '##ON', '##1', 'studies', ',', 'and', 'studies', 'carried', 'out', 'before', '2000', 'would', 'benefit', 'from', 'a', 'remake', 'with', 'la', '##cton', '##e', 'substrate', 'participation', '.']	[0, 9, 21, 28, 33, 41, 54, 57, 59, 63, 67, 76, 79, 86, 87, 89, 91, 98, 100, 104, 112, 120, 124, 131, 136, 142, 150, 155, 157, 164, 169, 171, 175, 177, 187, 200]	[8, 20, 27, 32, 40, 53, 56, 59, 63, 66, 75, 78, 85, 87, 89, 90, 98, 99, 103, 111, 119, 123, 130, 135, 141, 149, 154, 156, 163, 168, 171, 175, 176, 186, 200, 201]	['Clinical', 'researchers', 'should', 'also', 'include', 'measurements', 'of', 'lactonase', 'activity', 'in', 'future', 'PON1', 'studies', ',', 'and', 'studies', 'carried', 'out', 'before', '2000', 'would', 'benefit', 'from', 'a', 'remake', 'with', 'lactone', 'substrate', 'participation', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
(3) Researchers focusing on PON1 lactonase activity in humans are advised to conduct genotyping as well.	[('PMC8045895', 'C06000', 33, 42, 'lactonase')]	['(', '3', ')', 'Researchers', 'focusing', 'on', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'in', 'humans', 'are', 'advised', 'to', 'conduct', 'g', '##eno', '##ty', '##ping', 'as', 'well', '.']	[0, 1, 2, 4, 16, 25, 28, 29, 31, 33, 35, 39, 43, 52, 55, 62, 66, 74, 77, 85, 86, 89, 91, 96, 99, 103]	[1, 2, 3, 15, 24, 27, 29, 31, 32, 35, 39, 42, 51, 54, 61, 65, 73, 76, 84, 86, 89, 91, 95, 98, 103, 104]	['(', '3', ')', 'Researchers', 'focusing', 'on', 'PON1', 'lactonase', 'activity', 'in', 'humans', 'are', 'advised', 'to', 'conduct', 'genotyping', 'as', 'well', '.']	[1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
(4) When investigating the association of PON1 lactonase activity, and other PON1 activities, with specific medical conditions, it is advisable to account for other comorbidities, especially the ones that have been associated with PON1 lactonase activity.	[('PMC8045895', 'C07000', 47, 56, 'lactonase')]	['(', '4', ')', 'When', 'investigating', 'the', 'association', 'of', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', ',', 'and', 'other', 'P', '##ON', '##1', 'activities', ',', 'with', 'specific', 'medical', 'conditions', ',', 'it', 'is', 'ad', '##vis', '##able', 'to', 'account', 'for', 'other', 'com', '##or', '##bid', '##ities', ',', 'especially', 'the', 'ones', 'that', 'have', 'been', 'associated', 'with', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', '.']	[0, 1, 2, 4, 9, 23, 27, 39, 42, 43, 45, 47, 49, 53, 57, 65, 67, 71, 77, 78, 80, 82, 92, 94, 99, 108, 116, 126, 128, 131, 134, 136, 139, 144, 147, 155, 159, 165, 168, 170, 173, 178, 180, 191, 195, 200, 205, 210, 215, 226, 231, 232, 234, 236, 238, 242, 246, 254]	[1, 2, 3, 8, 22, 26, 38, 41, 43, 45, 46, 49, 53, 56, 65, 66, 70, 76, 78, 80, 81, 92, 93, 98, 107, 115, 126, 127, 130, 133, 136, 139, 143, 146, 154, 158, 164, 168, 170, 173, 178, 179, 190, 194, 199, 204, 209, 214, 225, 230, 232, 234, 235, 238, 242, 245, 254, 255]	['(', '4', ')', 'When', 'investigating', 'the', 'association', 'of', 'PON1', 'lactonase', 'activity', ',', 'and', 'other', 'PON1', 'activities', ',', 'with', 'specific', 'medical', 'conditions', ',', 'it', 'is', 'advisable', 'to', 'account', 'for', 'other', 'comorbidities', ',', 'especially', 'the', 'ones', 'that', 'have', 'been', 'associated', 'with', 'PON1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
(5) More generally, the different multi-omics factors that can influence PON1 lactonase activity should be kept in mind by researchers.	[('PMC8045895', 'C08000', 78, 87, 'lactonase')]	['(', '5', ')', 'More', 'generally', ',', 'the', 'different', 'multi', '-', 'o', '##mic', '##s', 'factors', 'that', 'can', 'influence', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'should', 'be', 'kept', 'in', 'mind', 'by', 'researchers', '.']	[0, 1, 2, 4, 9, 18, 20, 24, 34, 39, 40, 41, 44, 46, 54, 59, 63, 73, 74, 76, 78, 80, 84, 88, 97, 104, 107, 112, 115, 120, 123, 134]	[1, 2, 3, 8, 18, 19, 23, 33, 39, 40, 41, 44, 45, 53, 58, 62, 72, 74, 76, 77, 80, 84, 87, 96, 103, 106, 111, 114, 119, 122, 134, 135]	['(', '5', ')', 'More', 'generally', ',', 'the', 'different', 'multi', '-', 'omics', 'factors', 'that', 'can', 'influence', 'PON1', 'lactonase', 'activity', 'should', 'be', 'kept', 'in', 'mind', 'by', 'researchers', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
This study contributes to better understanding of the associations among all three PON1 enzyme activities and different diseases/conditions while highlighting the importance of measuring lactonase activity in clinical studies.	[('PMC8045895', 'C09000', 187, 196, 'lactonase')]	['This', 'study', 'contributes', 'to', 'better', 'understanding', 'of', 'the', 'associations', 'among', 'all', 'three', 'P', '##ON', '##1', 'enzyme', 'activities', 'and', 'different', 'diseases', '/', 'conditions', 'while', 'highlighting', 'the', 'importance', 'of', 'measuring', 'la', '##cton', '##ase', 'activity', 'in', 'clinical', 'studies', '.']	[0, 5, 11, 23, 26, 33, 47, 50, 54, 67, 73, 77, 83, 84, 86, 88, 95, 106, 110, 120, 128, 129, 140, 146, 159, 163, 174, 177, 187, 189, 193, 197, 206, 209, 218, 225]	[4, 10, 22, 25, 32, 46, 49, 53, 66, 72, 76, 82, 84, 86, 87, 94, 105, 109, 119, 128, 129, 139, 145, 158, 162, 173, 176, 186, 189, 193, 196, 205, 208, 217, 225, 226]	['This', 'study', 'contributes', 'to', 'better', 'understanding', 'of', 'the', 'associations', 'among', 'all', 'three', 'PON1', 'enzyme', 'activities', 'and', 'different', 'diseases', '/', 'conditions', 'while', 'highlighting', 'the', 'importance', 'of', 'measuring', 'lactonase', 'activity', 'in', 'clinical', 'studies', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Numerous articles have been published in the last decades about serum paraoxonase 1 (PON1), an enzyme found in different mammal species and other animals, including fishes, amphibians, and birds, and its association with various medical conditions in humans.	[('PMC8045895', 'I00000', 70, 83, 'paraoxonase 1')]	['Numerous', 'articles', 'have', 'been', 'published', 'in', 'the', 'last', 'decades', 'about', 'serum', 'para', '##ox', '##ona', '##se', '1', '(', 'P', '##ON', '##1', ')', ',', 'an', 'enzyme', 'found', 'in', 'different', 'ma', '##mmal', 'species', 'and', 'other', 'animals', ',', 'including', 'fishes', ',', 'am', '##phi', '##bian', '##s', ',', 'and', 'birds', ',', 'and', 'its', 'association', 'with', 'various', 'medical', 'conditions', 'in', 'humans', '.']	[0, 9, 18, 23, 28, 38, 41, 45, 50, 58, 64, 70, 74, 76, 79, 82, 84, 85, 86, 88, 89, 90, 92, 95, 102, 108, 111, 121, 123, 128, 136, 140, 146, 153, 155, 165, 171, 173, 175, 178, 182, 183, 185, 189, 194, 196, 200, 204, 216, 221, 229, 237, 248, 251, 257]	[8, 17, 22, 27, 37, 40, 44, 49, 57, 63, 69, 74, 76, 79, 81, 83, 85, 86, 88, 89, 90, 91, 94, 101, 107, 110, 120, 123, 127, 135, 139, 145, 153, 154, 164, 171, 172, 175, 178, 182, 183, 184, 188, 194, 195, 199, 203, 215, 220, 228, 236, 247, 250, 257, 258]	['Numerous', 'articles', 'have', 'been', 'published', 'in', 'the', 'last', 'decades', 'about', 'serum', 'paraoxonase', '1', '(', 'PON1', ')', ',', 'an', 'enzyme', 'found', 'in', 'different', 'mammal', 'species', 'and', 'other', 'animals', ',', 'including', 'fishes', ',', 'amphibians', ',', 'and', 'birds', ',', 'and', 'its', 'association', 'with', 'various', 'medical', 'conditions', 'in', 'humans', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The three main activities of PON1 are aryldialkylphosphatase, more commonly known as paraoxonase activity, arylesterase and lactonase activity (Harel et al., 2004).	[('PMC8045895', 'I02000', 38, 60, 'aryldialkylphosphatase')]	['The', 'three', 'main', 'activities', 'of', 'P', '##ON', '##1', 'are', 'a', '##ryl', '##dial', '##ky', '##l', '##ph', '##os', '##pha', '##tase', ',', 'more', 'commonly', 'known', 'as', 'para', '##ox', '##ona', '##se', 'activity', ',', 'a', '##ryl', '##ester', '##ase', 'and', 'la', '##cton', '##ase', 'activity', '(', 'Hare', '##l', 'et', 'al', '.', ',', '2004', ')', '.']	[0, 4, 10, 15, 26, 29, 30, 32, 34, 38, 39, 42, 46, 48, 49, 51, 53, 56, 60, 62, 67, 76, 82, 85, 89, 91, 94, 97, 105, 107, 108, 111, 116, 120, 124, 126, 130, 134, 143, 144, 148, 150, 153, 155, 156, 158, 162, 163]	[3, 9, 14, 25, 28, 30, 32, 33, 37, 39, 42, 46, 48, 49, 51, 53, 56, 60, 61, 66, 75, 81, 84, 89, 91, 94, 96, 105, 106, 108, 111, 116, 119, 123, 126, 130, 133, 142, 144, 148, 149, 152, 155, 156, 157, 162, 163, 164]	['The', 'three', 'main', 'activities', 'of', 'PON1', 'are', 'aryldialkylphosphatase', ',', 'more', 'commonly', 'known', 'as', 'paraoxonase', 'activity', ',', 'arylesterase', 'and', 'lactonase', 'activity', '(', 'Harel', 'et', 'al', '.', ',', '2004', ')', '.']	[1, 1, 1, 1, 1, 3, 1, 9, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Paraoxonase activity is unlikely to be a native activity of PON1, as organophosphates are uncommon in nature (Khersonsky and Tawfik, 2005; Metcalf and Bruno, 2016).	[('PMC8045895', 'I03000', 0, 11, 'Paraoxonase')]	['Para', '##ox', '##ona', '##se', 'activity', 'is', 'unlikely', 'to', 'be', 'a', 'native', 'activity', 'of', 'P', '##ON', '##1', ',', 'as', 'organ', '##op', '##hos', '##phate', '##s', 'are', 'uncommon', 'in', 'nature', '(', 'K', '##hers', '##ons', '##ky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2005', ';', 'Met', '##cal', '##f', 'and', 'Bruno', ',', '2016', ')', '.']	[0, 4, 6, 9, 12, 21, 24, 33, 36, 39, 41, 48, 57, 60, 61, 63, 64, 66, 69, 74, 76, 79, 84, 86, 90, 99, 102, 109, 110, 111, 115, 118, 121, 125, 127, 128, 130, 131, 133, 137, 139, 142, 145, 147, 151, 156, 158, 162, 163]	[4, 6, 9, 11, 20, 23, 32, 35, 38, 40, 47, 56, 59, 61, 63, 64, 65, 68, 74, 76, 79, 84, 85, 89, 98, 101, 108, 110, 111, 115, 118, 120, 124, 127, 128, 130, 131, 132, 137, 138, 142, 145, 146, 150, 156, 157, 162, 163, 164]	['Paraoxonase', 'activity', 'is', 'unlikely', 'to', 'be', 'a', 'native', 'activity', 'of', 'PON1', ',', 'as', 'organophosphates', 'are', 'uncommon', 'in', 'nature', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2005', ';', 'Metcalf', 'and', 'Bruno', ',', '2016', ')', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Structure-reactivity studies suggest that the primary function of PON1 in terms of evolutionary development is lactonase activity (Khersonsky and Tawfik, 2005).	[('PMC8045895', 'I03001', 111, 120, 'lactonase')]	['Structure', '-', 'react', '##ivity', 'studies', 'suggest', 'that', 'the', 'primary', 'function', 'of', 'P', '##ON', '##1', 'in', 'terms', 'of', 'evolutionary', 'development', 'is', 'la', '##cton', '##ase', 'activity', '(', 'K', '##hers', '##ons', '##ky', 'and', 'Ta', '##w', '##fi', '##k', ',', '2005', ')', '.']	[0, 9, 10, 15, 21, 29, 37, 42, 46, 54, 63, 66, 67, 69, 71, 74, 80, 83, 96, 108, 111, 113, 117, 121, 130, 131, 132, 136, 139, 142, 146, 148, 149, 151, 152, 154, 158, 159]	[9, 10, 15, 20, 28, 36, 41, 45, 53, 62, 65, 67, 69, 70, 73, 79, 82, 95, 107, 110, 113, 117, 120, 129, 131, 132, 136, 139, 141, 145, 148, 149, 151, 152, 153, 158, 159, 160]	['Structure', '-', 'reactivity', 'studies', 'suggest', 'that', 'the', 'primary', 'function', 'of', 'PON1', 'in', 'terms', 'of', 'evolutionary', 'development', 'is', 'lactonase', 'activity', '(', 'Khersonsky', 'and', 'Tawfik', ',', '2005', ')', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Especially paraoxonase activity is often poorly correlated with the other two enzymatic activities (Gugliucci et al., 2015; Kowalska et al., 2018; Martinelli et al., 2013; Romani et al., 2009; Rosenblat et al., 2006).	[('PMC8045895', 'I03002', 11, 22, 'paraoxonase')]	['Especially', 'para', '##ox', '##ona', '##se', 'activity', 'is', 'often', 'poorly', 'correlated', 'with', 'the', 'other', 'two', 'en', '##zy', '##matic', 'activities', '(', 'G', '##ug', '##li', '##ucci', 'et', 'al', '.', ',', '2015', ';', 'Ko', '##wal', '##ska', 'et', 'al', '.', ',', '2018', ';', 'Martin', '##elli', 'et', 'al', '.', ',', '2013', ';', 'Romani', 'et', 'al', '.', ',', '2009', ';', 'Rosen', '##bla', '##t', 'et', 'al', '.', ',', '2006', ')', '.']	[0, 11, 15, 17, 20, 23, 32, 35, 41, 48, 59, 64, 68, 74, 78, 80, 82, 88, 99, 100, 101, 103, 105, 110, 113, 115, 116, 118, 122, 124, 126, 129, 133, 136, 138, 139, 141, 145, 147, 153, 158, 161, 163, 164, 166, 170, 172, 179, 182, 184, 185, 187, 191, 193, 198, 201, 203, 206, 208, 209, 211, 215, 216]	[10, 15, 17, 20, 22, 31, 34, 40, 47, 58, 63, 67, 73, 77, 80, 82, 87, 98, 100, 101, 103, 105, 109, 112, 115, 116, 117, 122, 123, 126, 129, 132, 135, 138, 139, 140, 145, 146, 153, 157, 160, 163, 164, 165, 170, 171, 178, 181, 184, 185, 186, 191, 192, 198, 201, 202, 205, 208, 209, 210, 215, 216, 217]	['Especially', 'paraoxonase', 'activity', 'is', 'often', 'poorly', 'correlated', 'with', 'the', 'other', 'two', 'enzymatic', 'activities', '(', 'Gugliucci', 'et', 'al', '.', ',', '2015', ';', 'Kowalska', 'et', 'al', '.', ',', '2018', ';', 'Martinelli', 'et', 'al', '.', ',', '2013', ';', 'Romani', 'et', 'al', '.', ',', '2009', ';', 'Rosenblat', 'et', 'al', '.', ',', '2006', ')', '.']	[1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An extensive review on paraoxonase and arylesterase activities has already been published (Dardiotis et al., 2019).	[('PMC8045895', 'I04000', 23, 34, 'paraoxonase')]	['An', 'extensive', 'review', 'on', 'para', '##ox', '##ona', '##se', 'and', 'a', '##ryl', '##ester', '##ase', 'activities', 'has', 'already', 'been', 'published', '(', 'Dar', '##dio', '##tis', 'et', 'al', '.', ',', '2019', ')', '.']	[0, 3, 13, 20, 23, 27, 29, 32, 35, 39, 40, 43, 48, 52, 63, 67, 75, 80, 90, 91, 94, 97, 101, 104, 106, 107, 109, 113, 114]	[2, 12, 19, 22, 27, 29, 32, 34, 38, 40, 43, 48, 51, 62, 66, 74, 79, 89, 91, 94, 97, 100, 103, 106, 107, 108, 113, 114, 115]	['An', 'extensive', 'review', 'on', 'paraoxonase', 'and', 'arylesterase', 'activities', 'has', 'already', 'been', 'published', '(', 'Dardiotis', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, the literature lacks analyses on PON1's native (lactonase) activity.	[('PMC8045895', 'I04001', 57, 66, 'lactonase')]	"['However', ',', 'the', 'literature', 'lacks', 'analyses', 'on', 'P', '##ON', '##1', ""'"", 's', 'native', '(', 'la', '##cton', '##ase', ')', 'activity', '.']"	[0, 7, 9, 13, 24, 30, 39, 42, 43, 45, 46, 47, 49, 56, 57, 59, 63, 66, 68, 76]	[7, 8, 12, 23, 29, 38, 41, 43, 45, 46, 47, 48, 55, 57, 59, 63, 66, 67, 76, 77]	"['However', ',', 'the', 'literature', 'lacks', 'analyses', 'on', ""PON1's"", 'native', '(', 'lactonase', ')', 'activity', '.']"	[1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'B', 'I', 'E', 'O', 'O', 'O']
In this analysis, we also examine and synthesize the associations between various medical conditions and the lactonase activity of PON1.	[('PMC8045895', 'I05000', 109, 118, 'lactonase')]	['In', 'this', 'analysis', ',', 'we', 'also', 'examine', 'and', 's', '##ynth', '##esi', '##ze', 'the', 'associations', 'between', 'various', 'medical', 'conditions', 'and', 'the', 'la', '##cton', '##ase', 'activity', 'of', 'P', '##ON', '##1', '.']	[0, 3, 8, 16, 18, 21, 26, 34, 38, 39, 43, 46, 49, 53, 66, 74, 82, 90, 101, 105, 109, 111, 115, 119, 128, 131, 132, 134, 135]	[2, 7, 16, 17, 20, 25, 33, 37, 39, 43, 46, 48, 52, 65, 73, 81, 89, 100, 104, 108, 111, 115, 118, 127, 130, 132, 134, 135, 136]	['In', 'this', 'analysis', ',', 'we', 'also', 'examine', 'and', 'synthesize', 'the', 'associations', 'between', 'various', 'medical', 'conditions', 'and', 'the', 'lactonase', 'activity', 'of', 'PON1', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O']
As PON1 has antioxidative activity, its lactonase activity may be correlated with oxidative stress- and inflammation-related diseases, primarily those associated with aging.	[('PMC8045895', 'I05001', 40, 49, 'lactonase')]	['As', 'P', '##ON', '##1', 'has', 'anti', '##ox', '##ida', '##tive', 'activity', ',', 'its', 'la', '##cton', '##ase', 'activity', 'may', 'be', 'correlated', 'with', 'o', '##xi', '##da', '##tive', 'stress', '-', 'and', 'inflammation', '-', 'related', 'diseases', ',', 'primarily', 'those', 'associated', 'with', 'aging', '.']	[0, 3, 4, 6, 8, 12, 16, 18, 21, 26, 34, 36, 40, 42, 46, 50, 59, 63, 66, 77, 82, 83, 85, 87, 92, 98, 100, 104, 116, 117, 125, 133, 135, 145, 151, 162, 167, 172]	[2, 4, 6, 7, 11, 16, 18, 21, 25, 34, 35, 39, 42, 46, 49, 58, 62, 65, 76, 81, 83, 85, 87, 91, 98, 99, 103, 116, 117, 124, 133, 134, 144, 150, 161, 166, 172, 173]	['As', 'PON1', 'has', 'antioxidative', 'activity', ',', 'its', 'lactonase', 'activity', 'may', 'be', 'correlated', 'with', 'oxidative', 'stress-', 'and', 'inflammation', '-', 'related', 'diseases', ',', 'primarily', 'those', 'associated', 'with', 'aging', '.']	[1, 3, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Most of the research on PON1 lactonase activity has been performed on humans; however, some research groups also investigated lactonase activity in mice, rats, and cows (Farid et al., 2013;	[('PMC8045895', 'I06000', 29, 38, 'lactonase')]	['Most', 'of', 'the', 'research', 'on', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'has', 'been', 'performed', 'on', 'humans', ';', 'however', ',', 'some', 'research', 'groups', 'also', 'investigated', 'la', '##cton', '##ase', 'activity', 'in', 'mice', ',', 'rats', ',', 'and', 'cows', '(', 'Far', '##id', 'et', 'al', '.', ',', '2013', ';']	[0, 5, 8, 12, 21, 24, 25, 27, 29, 31, 35, 39, 48, 52, 57, 67, 70, 76, 78, 85, 87, 92, 101, 108, 113, 126, 128, 132, 136, 145, 148, 152, 154, 158, 160, 164, 169, 170, 173, 176, 179, 181, 182, 184, 188]	[4, 7, 11, 20, 23, 25, 27, 28, 31, 35, 38, 47, 51, 56, 66, 69, 76, 77, 85, 86, 91, 100, 107, 112, 125, 128, 132, 135, 144, 147, 152, 153, 158, 159, 163, 168, 170, 173, 175, 178, 181, 182, 183, 188, 189]	['Most', 'of', 'the', 'research', 'on', 'PON1', 'lactonase', 'activity', 'has', 'been', 'performed', 'on', 'humans', ';', 'however', ',', 'some', 'research', 'groups', 'also', 'investigated', 'lactonase', 'activity', 'in', 'mice', ',', 'rats', ',', 'and', 'cows', '(', 'Farid', 'et', 'al', '.', ',', '2013', ';']	[1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Two different articles provided numbers for the percentage of variation of activity that is explained by each of the main parameters, such as genetic variations and sex, affecting PON1 lactonase activity (Quillen et al., 2012; Rainwater et al., 2009).	[('PMC8045895', 'R03000', 185, 194, 'lactonase')]	['Two', 'different', 'articles', 'provided', 'numbers', 'for', 'the', 'percentage', 'of', 'variation', 'of', 'activity', 'that', 'is', 'explained', 'by', 'each', 'of', 'the', 'main', 'parameters', ',', 'such', 'as', 'genetic', 'variations', 'and', 'sex', ',', 'affecting', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', '(', 'Q', '##uil', '##len', 'et', 'al', '.', ',', '2012', ';', 'Rain', '##water', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 4, 14, 23, 32, 40, 44, 48, 59, 62, 72, 75, 84, 89, 92, 102, 105, 110, 113, 117, 122, 132, 134, 139, 142, 150, 161, 165, 168, 170, 180, 181, 183, 185, 187, 191, 195, 204, 205, 206, 209, 213, 216, 218, 219, 221, 225, 227, 231, 237, 240, 242, 243, 245, 249, 250]	[3, 13, 22, 31, 39, 43, 47, 58, 61, 71, 74, 83, 88, 91, 101, 104, 109, 112, 116, 121, 132, 133, 138, 141, 149, 160, 164, 168, 169, 179, 181, 183, 184, 187, 191, 194, 203, 205, 206, 209, 212, 215, 218, 219, 220, 225, 226, 231, 236, 239, 242, 243, 244, 249, 250, 251]	['Two', 'different', 'articles', 'provided', 'numbers', 'for', 'the', 'percentage', 'of', 'variation', 'of', 'activity', 'that', 'is', 'explained', 'by', 'each', 'of', 'the', 'main', 'parameters', ',', 'such', 'as', 'genetic', 'variations', 'and', 'sex', ',', 'affecting', 'PON1', 'lactonase', 'activity', '(', 'Quillen', 'et', 'al', '.', ',', '2012', ';', 'Rainwater', 'et', 'al', '.', ',', '2009', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It was shown that low levels of Linc-OIP5 correspond to lower levels of PON1 expression and lactonase activity, whereas high levels of miR-616 gene expression had the opposite effect and decreased PON1 expression and lactonase activity.	[]	['It', 'was', 'shown', 'that', 'low', 'levels', 'of', 'Lin', '##c', '-', 'O', '##IP', '##5', 'correspond', 'to', 'lower', 'levels', 'of', 'P', '##ON', '##1', 'expression', 'and', 'la', '##cton', '##ase', 'activity', ',', 'whereas', 'high', 'levels', 'of', 'mi', '##R', '-', '61', '##6', 'gene', 'expression', 'had', 'the', 'opposite', 'effect', 'and', 'decreased', 'P', '##ON', '##1', 'expression', 'and', 'la', '##cton', '##ase', 'activity', '.']	[0, 3, 7, 13, 18, 22, 29, 32, 35, 36, 37, 38, 40, 42, 53, 56, 62, 69, 72, 73, 75, 77, 88, 92, 94, 98, 102, 110, 112, 120, 125, 132, 135, 137, 138, 139, 141, 143, 148, 159, 163, 167, 176, 183, 187, 197, 198, 200, 202, 213, 217, 219, 223, 227, 235]	[2, 6, 12, 17, 21, 28, 31, 35, 36, 37, 38, 40, 41, 52, 55, 61, 68, 71, 73, 75, 76, 87, 91, 94, 98, 101, 110, 111, 119, 124, 131, 134, 137, 138, 139, 141, 142, 147, 158, 162, 166, 175, 182, 186, 196, 198, 200, 201, 212, 216, 219, 223, 226, 235, 236]	['It', 'was', 'shown', 'that', 'low', 'levels', 'of', 'Linc-OIP5', 'correspond', 'to', 'lower', 'levels', 'of', 'PON1', 'expression', 'and', 'lactonase', 'activity', ',', 'whereas', 'high', 'levels', 'of', 'miR-616', 'gene', 'expression', 'had', 'the', 'opposite', 'effect', 'and', 'decreased', 'PON1', 'expression', 'and', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A similar analysis was carried out investigating the effect of in vitro homocysteinylation of HDL particles, which is known to occur in vivo, on PON1 lactonase activity (Ferretti et al., 2010).	[('PMC8045895', 'R08000', 150, 159, 'lactonase')]	['A', 'similar', 'analysis', 'was', 'carried', 'out', 'investigating', 'the', 'effect', 'of', 'in', 'v', '##it', '##ro', 'ho', '##mo', '##cy', '##stein', '##yla', '##tion', 'of', 'HD', '##L', 'particles', ',', 'which', 'is', 'known', 'to', 'occur', 'in', 'v', '##ivo', ',', 'on', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', '(', 'Fe', '##rre', '##tti', 'et', 'al', '.', ',', '2010', ')', '.']	[0, 2, 10, 19, 23, 31, 35, 49, 53, 60, 63, 66, 67, 69, 72, 74, 76, 78, 83, 86, 91, 94, 96, 98, 107, 109, 115, 118, 124, 127, 133, 136, 137, 140, 142, 145, 146, 148, 150, 152, 156, 160, 169, 170, 172, 175, 179, 182, 184, 185, 187, 191, 192]	[1, 9, 18, 22, 30, 34, 48, 52, 59, 62, 65, 67, 69, 71, 74, 76, 78, 83, 86, 90, 93, 96, 97, 107, 108, 114, 117, 123, 126, 132, 135, 137, 140, 141, 144, 146, 148, 149, 152, 156, 159, 168, 170, 172, 175, 178, 181, 184, 185, 186, 191, 192, 193]	['A', 'similar', 'analysis', 'was', 'carried', 'out', 'investigating', 'the', 'effect', 'of', 'in', 'vitro', 'homocysteinylation', 'of', 'HDL', 'particles', ',', 'which', 'is', 'known', 'to', 'occur', 'in', 'vivo', ',', 'on', 'PON1', 'lactonase', 'activity', '(', 'Ferretti', 'et', 'al', '.', ',', '2010', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 6, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors demonstrated a decrease in lactonase activity with increasing addition of homocystein thiolactone.	[('PMC8045895', 'R08001', 39, 48, 'lactonase')]	['The', 'authors', 'demonstrated', 'a', 'decrease', 'in', 'la', '##cton', '##ase', 'activity', 'with', 'increasing', 'addition', 'of', 'ho', '##mo', '##cy', '##stein', 'th', '##iol', '##act', '##one', '.']	[0, 4, 12, 25, 27, 36, 39, 41, 45, 49, 58, 63, 74, 83, 86, 88, 90, 92, 98, 100, 103, 106, 109]	[3, 11, 24, 26, 35, 38, 41, 45, 48, 57, 62, 73, 82, 85, 88, 90, 92, 97, 100, 103, 106, 109, 110]	['The', 'authors', 'demonstrated', 'a', 'decrease', 'in', 'lactonase', 'activity', 'with', 'increasing', 'addition', 'of', 'homocystein', 'thiolactone', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The concentrations they used were from 10 to 1000 μM, and the last of them led to a two-third decrease in lactonase activity compared with the control HDL, where HcyT was absent.	[('PMC8045895', 'R08002', 106, 115, 'lactonase')]	['The', 'concentrations', 'they', 'used', 'were', 'from', '10', 'to', '1000', 'μ', '##M', ',', 'and', 'the', 'last', 'of', 'them', 'led', 'to', 'a', 'two', '-', 'third', 'decrease', 'in', 'la', '##cton', '##ase', 'activity', 'compared', 'with', 'the', 'control', 'HD', '##L', ',', 'where', 'H', '##cy', '##T', 'was', 'absent', '.']	[0, 4, 19, 24, 29, 34, 39, 42, 45, 50, 51, 52, 54, 58, 62, 67, 70, 75, 79, 82, 84, 87, 88, 94, 103, 106, 108, 112, 116, 125, 134, 139, 143, 151, 153, 154, 156, 162, 163, 165, 167, 171, 177]	[3, 18, 23, 28, 33, 38, 41, 44, 49, 51, 52, 53, 57, 61, 66, 69, 74, 78, 81, 83, 87, 88, 93, 102, 105, 108, 112, 115, 124, 133, 138, 142, 150, 153, 154, 155, 161, 163, 165, 166, 170, 177, 178]	['The', 'concentrations', 'they', 'used', 'were', 'from', '10', 'to', '1000', 'μM', ',', 'and', 'the', 'last', 'of', 'them', 'led', 'to', 'a', 'two', '-', 'third', 'decrease', 'in', 'lactonase', 'activity', 'compared', 'with', 'the', 'control', 'HDL', ',', 'where', 'HcyT', 'was', 'absent', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The lipidomic context of PON1 lactonase activity was investigated with DHC as a substrate in two articles (Rosenblat et al., 2006, 2012).	[('PMC8045895', 'R09000', 30, 39, 'lactonase')]	['The', 'lip', '##ido', '##mic', 'context', 'of', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'was', 'investigated', 'with', 'D', '##HC', 'as', 'a', 'substrate', 'in', 'two', 'articles', '(', 'Rosen', '##bla', '##t', 'et', 'al', '.', ',', '2006', ',', '2012', ')', '.']	[0, 4, 7, 10, 14, 22, 25, 26, 28, 30, 32, 36, 40, 49, 53, 66, 71, 72, 75, 78, 80, 90, 93, 97, 106, 107, 112, 115, 117, 120, 122, 123, 125, 129, 131, 135, 136]	[3, 7, 10, 13, 21, 24, 26, 28, 29, 32, 36, 39, 48, 52, 65, 70, 72, 74, 77, 79, 89, 92, 96, 105, 107, 112, 115, 116, 119, 122, 123, 124, 129, 130, 135, 136, 137]	['The', 'lipidomic', 'context', 'of', 'PON1', 'lactonase', 'activity', 'was', 'investigated', 'with', 'DHC', 'as', 'a', 'substrate', 'in', 'two', 'articles', '(', 'Rosenblat', 'et', 'al', '.', ',', '2006', ',', '2012', ')', '.']	[1, 3, 1, 1, 3, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
They analyzed arylesterase, paraoxonase, and lactonase activities, and as expected, no activity was observed in very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), whereas all three activities were observed in the HDL fraction.	[]	['They', 'analyzed', 'a', '##ryl', '##ester', '##ase', ',', 'para', '##ox', '##ona', '##se', ',', 'and', 'la', '##cton', '##ase', 'activities', ',', 'and', 'as', 'expected', ',', 'no', 'activity', 'was', 'observed', 'in', 'very', '-', 'low', '-', 'density', 'lip', '##op', '##rote', '##in', '(', 'V', '##LD', '##L', ')', 'and', 'low', '-', 'density', 'lip', '##op', '##rote', '##in', '(', 'L', '##D', '##L', ')', ',', 'whereas', 'all', 'three', 'activities', 'were', 'observed', 'in', 'the', 'HD', '##L', 'fraction', '.']	[0, 5, 14, 15, 18, 23, 26, 28, 32, 34, 37, 39, 41, 45, 47, 51, 55, 65, 67, 71, 74, 82, 84, 87, 96, 100, 109, 112, 116, 117, 120, 121, 129, 132, 134, 138, 141, 142, 143, 145, 146, 148, 152, 155, 156, 164, 167, 169, 173, 176, 177, 178, 179, 180, 181, 183, 191, 195, 201, 212, 217, 226, 229, 233, 235, 237, 245]	[4, 13, 15, 18, 23, 26, 27, 32, 34, 37, 39, 40, 44, 47, 51, 54, 65, 66, 70, 73, 82, 83, 86, 95, 99, 108, 111, 116, 117, 120, 121, 128, 132, 134, 138, 140, 142, 143, 145, 146, 147, 151, 155, 156, 163, 167, 169, 173, 175, 177, 178, 179, 180, 181, 182, 190, 194, 200, 211, 216, 225, 228, 232, 235, 236, 245, 246]	['They', 'analyzed', 'arylesterase', ',', 'paraoxonase', ',', 'and', 'lactonase', 'activities', ',', 'and', 'as', 'expected', ',', 'no', 'activity', 'was', 'observed', 'in', 'very', '-', 'low', '-', 'density', 'lipoprotein', '(', 'VLDL', ')', 'and', 'low', '-', 'density', 'lipoprotein', '(', 'LDL', ')', ',', 'whereas', 'all', 'three', 'activities', 'were', 'observed', 'in', 'the', 'HDL', 'fraction', '.']	[1, 1, 4, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of interest, paraoxonase activity was similar in HDL and LPDS, whereas arylesterase and lactonase activities were significantly higher in HDL compared with LPDS.	[('PMC8045895', 'R11000', 13, 24, 'paraoxonase')]	['Of', 'interest', ',', 'para', '##ox', '##ona', '##se', 'activity', 'was', 'similar', 'in', 'HD', '##L', 'and', 'LP', '##DS', ',', 'whereas', 'a', '##ryl', '##ester', '##ase', 'and', 'la', '##cton', '##ase', 'activities', 'were', 'significantly', 'higher', 'in', 'HD', '##L', 'compared', 'with', 'LP', '##DS', '.']	[0, 3, 11, 13, 17, 19, 22, 25, 34, 38, 46, 49, 51, 53, 57, 59, 61, 63, 71, 72, 75, 80, 84, 88, 90, 94, 98, 109, 114, 128, 135, 138, 140, 142, 151, 156, 158, 160]	[2, 11, 12, 17, 19, 22, 24, 33, 37, 45, 48, 51, 52, 56, 59, 61, 62, 70, 72, 75, 80, 83, 87, 90, 94, 97, 108, 113, 127, 134, 137, 140, 141, 150, 155, 158, 160, 161]	['Of', 'interest', ',', 'paraoxonase', 'activity', 'was', 'similar', 'in', 'HDL', 'and', 'LPDS', ',', 'whereas', 'arylesterase', 'and', 'lactonase', 'activities', 'were', 'significantly', 'higher', 'in', 'HDL', 'compared', 'with', 'LPDS', '.']	[1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 2, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
With lactonase, the difference in activity between HDL and LPDS was greatest.	[('PMC8045895', 'R11001', 5, 14, 'lactonase')]	['With', 'la', '##cton', '##ase', ',', 'the', 'difference', 'in', 'activity', 'between', 'HD', '##L', 'and', 'LP', '##DS', 'was', 'greatest', '.']	[0, 5, 7, 11, 14, 16, 20, 31, 34, 43, 51, 53, 55, 59, 61, 64, 68, 76]	[4, 7, 11, 14, 15, 19, 30, 33, 42, 50, 53, 54, 58, 61, 63, 67, 76, 77]	['With', 'lactonase', ',', 'the', 'difference', 'in', 'activity', 'between', 'HDL', 'and', 'LPDS', 'was', 'greatest', '.']	[1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rosenblat et al. (2006) suggested that the environment in HDL stabilizes PON1's structure; displacement from HDL causes conformational changes that reduce lactonase and arylesterase activity, whereas paraoxonase activity is less sensitive to such changes.	[('PMC8045895', 'R11002', 155, 164, 'lactonase')]	"['Rosen', '##bla', '##t', 'et', 'al', '.', '(', '2006', ')', 'suggested', 'that', 'the', 'environment', 'in', 'HD', '##L', 'stab', '##ilize', '##s', 'P', '##ON', '##1', ""'"", 's', 'structure', ';', 'displacement', 'from', 'HD', '##L', 'causes', 'conform', '##ational', 'changes', 'that', 'reduce', 'la', '##cton', '##ase', 'and', 'a', '##ryl', '##ester', '##ase', 'activity', ',', 'whereas', 'para', '##ox', '##ona', '##se', 'activity', 'is', 'less', 'sensitive', 'to', 'such', 'changes', '.']"	[0, 5, 8, 10, 13, 15, 17, 18, 22, 24, 34, 39, 43, 55, 58, 60, 62, 66, 71, 73, 74, 76, 77, 78, 80, 89, 91, 104, 109, 111, 113, 120, 127, 135, 143, 148, 155, 157, 161, 165, 169, 170, 173, 178, 182, 190, 192, 200, 204, 206, 209, 212, 221, 224, 229, 239, 242, 247, 254]	[5, 8, 9, 12, 15, 16, 18, 22, 23, 33, 38, 42, 54, 57, 60, 61, 66, 71, 72, 74, 76, 77, 78, 79, 89, 90, 103, 108, 111, 112, 119, 127, 134, 142, 147, 154, 157, 161, 164, 168, 170, 173, 178, 181, 190, 191, 199, 204, 206, 209, 211, 220, 223, 228, 238, 241, 246, 254, 255]	"['Rosenblat', 'et', 'al', '.', '(', '2006', ')', 'suggested', 'that', 'the', 'environment', 'in', 'HDL', 'stabilizes', ""PON1's"", 'structure', ';', 'displacement', 'from', 'HDL', 'causes', 'conformational', 'changes', 'that', 'reduce', 'lactonase', 'and', 'arylesterase', 'activity', ',', 'whereas', 'paraoxonase', 'activity', 'is', 'less', 'sensitive', 'to', 'such', 'changes', '.']"	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 5, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 3, 1, 4, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors reported the effect of VLDL with rePON1 as well, which indicates that neighboring proteins and lipids in HDL are not necessary for the mediation of VLDL-induced inhibition.	[]	['The', 'authors', 'reported', 'the', 'effect', 'of', 'V', '##LD', '##L', 'with', 're', '##PO', '##N', '##1', 'as', 'well', ',', 'which', 'indicates', 'that', 'neighboring', 'proteins', 'and', 'lip', '##ids', 'in', 'HD', '##L', 'are', 'not', 'necessary', 'for', 'the', 'media', '##tion', 'of', 'V', '##LD', '##L', '-', 'induced', 'in', '##hibition', '.']	[0, 4, 12, 21, 25, 32, 35, 36, 38, 40, 45, 47, 49, 50, 52, 55, 59, 61, 67, 77, 82, 94, 103, 107, 110, 114, 117, 119, 121, 125, 129, 139, 143, 147, 152, 157, 160, 161, 163, 164, 165, 173, 175, 183]	[3, 11, 20, 24, 31, 34, 36, 38, 39, 44, 47, 49, 50, 51, 54, 59, 60, 66, 76, 81, 93, 102, 106, 110, 113, 116, 119, 120, 124, 128, 138, 142, 146, 152, 156, 159, 161, 163, 164, 165, 172, 175, 183, 184]	['The', 'authors', 'reported', 'the', 'effect', 'of', 'VLDL', 'with', 'rePON1', 'as', 'well', ',', 'which', 'indicates', 'that', 'neighboring', 'proteins', 'and', 'lipids', 'in', 'HDL', 'are', 'not', 'necessary', 'for', 'the', 'mediation', 'of', 'VLDL-induced', 'inhibition', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 1, 5, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also investigated bezafibrate as a compound, which reverses the effect of VLDL on paraoxonase and arylesterase activity (Rosenblat et al., 2012).	[]	['The', 'authors', 'also', 'investigated', 'be', '##za', '##fi', '##bra', '##te', 'as', 'a', 'compound', ',', 'which', 'reverse', '##s', 'the', 'effect', 'of', 'V', '##LD', '##L', 'on', 'para', '##ox', '##ona', '##se', 'and', 'a', '##ryl', '##ester', '##ase', 'activity', '(', 'Rosen', '##bla', '##t', 'et', 'al', '.', ',', '2012', ')', '.']	[0, 4, 12, 17, 30, 32, 34, 36, 39, 42, 45, 47, 55, 57, 63, 70, 72, 76, 83, 86, 87, 89, 91, 94, 98, 100, 103, 106, 110, 111, 114, 119, 123, 132, 133, 138, 141, 143, 146, 148, 149, 151, 155, 156]	[3, 11, 16, 29, 32, 34, 36, 39, 41, 44, 46, 55, 56, 62, 70, 71, 75, 82, 85, 87, 89, 90, 93, 98, 100, 103, 105, 109, 111, 114, 119, 122, 131, 133, 138, 141, 142, 145, 148, 149, 150, 155, 156, 157]	['The', 'authors', 'also', 'investigated', 'bezafibrate', 'as', 'a', 'compound', ',', 'which', 'reverses', 'the', 'effect', 'of', 'VLDL', 'on', 'paraoxonase', 'and', 'arylesterase', 'activity', '(', 'Rosenblat', 'et', 'al', '.', ',', '2012', ')', '.']	[1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 4, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
All the macroscopic, behavioral, and personal parameters with which researchers have attempted to explain interindividual variation in PON1 lactonase activity, such as age, gender, exercise, diet/nutriomics, medications, and exposure to chemicals, were grouped together as “Environmental/Social effects.”	[('PMC8045895', 'R13000', 140, 149, 'lactonase')]	['All', 'the', 'mac', '##ros', '##copic', ',', 'behavioral', ',', 'and', 'personal', 'parameters', 'with', 'which', 'researchers', 'have', 'attempted', 'to', 'explain', 'inter', '##ind', '##iv', '##id', '##ual', 'variation', 'in', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', ',', 'such', 'as', 'age', ',', 'gender', ',', 'exercise', ',', 'diet', '/', 'nut', '##rio', '##mic', '##s', ',', 'medications', ',', 'and', 'exposure', 'to', 'chemicals', ',', 'were', 'grouped', 'together', 'as', '“', 'Environmental', '/', 'Social', 'effects', '.', '”']	[0, 4, 8, 11, 14, 19, 21, 31, 33, 37, 46, 57, 62, 68, 80, 85, 95, 98, 106, 111, 114, 116, 118, 122, 132, 135, 136, 138, 140, 142, 146, 150, 158, 160, 165, 168, 171, 173, 179, 181, 189, 191, 195, 196, 199, 202, 205, 206, 208, 219, 221, 225, 234, 237, 246, 248, 253, 261, 270, 273, 274, 287, 288, 295, 302, 303]	[3, 7, 11, 14, 19, 20, 31, 32, 36, 45, 56, 61, 67, 79, 84, 94, 97, 105, 111, 114, 116, 118, 121, 131, 134, 136, 138, 139, 142, 146, 149, 158, 159, 164, 167, 171, 172, 179, 180, 189, 190, 195, 196, 199, 202, 205, 206, 207, 219, 220, 224, 233, 236, 246, 247, 252, 260, 269, 272, 274, 287, 288, 294, 302, 303, 304]	['All', 'the', 'macroscopic', ',', 'behavioral', ',', 'and', 'personal', 'parameters', 'with', 'which', 'researchers', 'have', 'attempted', 'to', 'explain', 'interindividual', 'variation', 'in', 'PON1', 'lactonase', 'activity', ',', 'such', 'as', 'age', ',', 'gender', ',', 'exercise', ',', 'diet', '/', 'nutriomics', ',', 'medications', ',', 'and', 'exposure', 'to', 'chemicals', ',', 'were', 'grouped', 'together', 'as', '“', 'Environmental', '/', 'Social', 'effects', '.', '”']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the influence of age on PON1 activity in humans is still not entirely clear for adolescents and adults, it has been shown that neonatal PON1 arylesterase activity is much lower than that of toddlers (Cole et al, 2003).	[('PMC8045895', 'R14000', 150, 162, 'arylesterase')]	['Although', 'the', 'influence', 'of', 'age', 'on', 'P', '##ON', '##1', 'activity', 'in', 'humans', 'is', 'still', 'not', 'entirely', 'clear', 'for', 'adolescent', '##s', 'and', 'adults', ',', 'it', 'has', 'been', 'shown', 'that', 'neon', '##ata', '##l', 'P', '##ON', '##1', 'a', '##ryl', '##ester', '##ase', 'activity', 'is', 'much', 'lower', 'than', 'that', 'of', 'to', '##ddler', '##s', '(', 'Cole', 'et', 'al', ',', '2003', ')', '.']	[0, 9, 13, 23, 26, 30, 33, 34, 36, 38, 47, 50, 57, 60, 66, 70, 79, 85, 89, 99, 101, 105, 111, 113, 116, 120, 125, 131, 136, 140, 143, 145, 146, 148, 150, 151, 154, 159, 163, 172, 175, 180, 186, 191, 196, 199, 201, 206, 208, 209, 214, 217, 219, 221, 225, 226]	[8, 12, 22, 25, 29, 32, 34, 36, 37, 46, 49, 56, 59, 65, 69, 78, 84, 88, 99, 100, 104, 111, 112, 115, 119, 124, 130, 135, 140, 143, 144, 146, 148, 149, 151, 154, 159, 162, 171, 174, 179, 185, 190, 195, 198, 201, 206, 207, 209, 213, 216, 219, 220, 225, 226, 227]	['Although', 'the', 'influence', 'of', 'age', 'on', 'PON1', 'activity', 'in', 'humans', 'is', 'still', 'not', 'entirely', 'clear', 'for', 'adolescents', 'and', 'adults', ',', 'it', 'has', 'been', 'shown', 'that', 'neonatal', 'PON1', 'arylesterase', 'activity', 'is', 'much', 'lower', 'than', 'that', 'of', 'toddlers', '(', 'Cole', 'et', 'al', ',', '2003', ')', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For lactonase activity, Gugliucci et al.	[('PMC8045895', 'R14001', 4, 13, 'lactonase')]	['For', 'la', '##cton', '##ase', 'activity', ',', 'G', '##ug', '##li', '##ucci', 'et', 'al', '.']	[0, 4, 6, 10, 14, 22, 24, 25, 27, 29, 34, 37, 39]	[3, 6, 10, 13, 22, 23, 25, 27, 29, 33, 36, 39, 40]	['For', 'lactonase', 'activity', ',', 'Gugliucci', 'et', 'al', '.']	[1, 3, 1, 1, 4, 1, 1, 1]	['O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In several articles, the authors grouped their results on lactonase activity into categories, including age.	[('PMC8045895', 'R15000', 58, 67, 'lactonase')]	['In', 'several', 'articles', ',', 'the', 'authors', 'grouped', 'their', 'results', 'on', 'la', '##cton', '##ase', 'activity', 'into', 'categories', ',', 'including', 'age', '.']	[0, 3, 11, 19, 21, 25, 33, 41, 47, 55, 58, 60, 64, 68, 77, 82, 92, 94, 104, 107]	[2, 10, 19, 20, 24, 32, 40, 46, 54, 57, 60, 64, 67, 76, 81, 92, 93, 103, 107, 108]	['In', 'several', 'articles', ',', 'the', 'authors', 'grouped', 'their', 'results', 'on', 'lactonase', 'activity', 'into', 'categories', ',', 'including', 'age', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
An example of such a study is the genome-wide association approach by Quillen et al. (2012), where the authors identified that age accounts for 1.4% of interindividual variation in PON1 lactonase activity (Quillen et al., 2012).	[('PMC8045895', 'R15001', 186, 195, 'lactonase')]	['An', 'example', 'of', 'such', 'a', 'study', 'is', 'the', 'genome', '-', 'wide', 'association', 'approach', 'by', 'Q', '##uil', '##len', 'et', 'al', '.', '(', '2012', ')', ',', 'where', 'the', 'authors', 'identified', 'that', 'age', 'accounts', 'for', '1', '.', '4', '%', 'of', 'inter', '##ind', '##iv', '##id', '##ual', 'variation', 'in', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', '(', 'Q', '##uil', '##len', 'et', 'al', '.', ',', '2012', ')', '.']	[0, 3, 11, 14, 19, 21, 27, 30, 34, 40, 41, 46, 58, 67, 70, 71, 74, 78, 81, 83, 85, 86, 90, 91, 93, 99, 103, 111, 122, 127, 131, 140, 144, 145, 146, 147, 149, 152, 157, 160, 162, 164, 168, 178, 181, 182, 184, 186, 188, 192, 196, 205, 206, 207, 210, 214, 217, 219, 220, 222, 226, 227]	[2, 10, 13, 18, 20, 26, 29, 33, 40, 41, 45, 57, 66, 69, 71, 74, 77, 80, 83, 84, 86, 90, 91, 92, 98, 102, 110, 121, 126, 130, 139, 143, 145, 146, 147, 148, 151, 157, 160, 162, 164, 167, 177, 180, 182, 184, 185, 188, 192, 195, 204, 206, 207, 210, 213, 216, 219, 220, 221, 226, 227, 228]	['An', 'example', 'of', 'such', 'a', 'study', 'is', 'the', 'genome', '-', 'wide', 'association', 'approach', 'by', 'Quillen', 'et', 'al', '.', '(', '2012', ')', ',', 'where', 'the', 'authors', 'identified', 'that', 'age', 'accounts', 'for', '1.4%', 'of', 'interindividual', 'variation', 'in', 'PON1', 'lactonase', 'activity', '(', 'Quillen', 'et', 'al', '.', ',', '2012', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among other factors that influence PON1 activity, Quillen et al. (2012) also focused on the effect of gender on lactonase activity.	[('PMC8045895', 'R16000', 112, 121, 'lactonase')]	['Among', 'other', 'factors', 'that', 'influence', 'P', '##ON', '##1', 'activity', ',', 'Q', '##uil', '##len', 'et', 'al', '.', '(', '2012', ')', 'also', 'focused', 'on', 'the', 'effect', 'of', 'gender', 'on', 'la', '##cton', '##ase', 'activity', '.']	[0, 6, 12, 20, 25, 35, 36, 38, 40, 48, 50, 51, 54, 58, 61, 63, 65, 66, 70, 72, 77, 85, 88, 92, 99, 102, 109, 112, 114, 118, 122, 130]	[5, 11, 19, 24, 34, 36, 38, 39, 48, 49, 51, 54, 57, 60, 63, 64, 66, 70, 71, 76, 84, 87, 91, 98, 101, 108, 111, 114, 118, 121, 130, 131]	['Among', 'other', 'factors', 'that', 'influence', 'PON1', 'activity', ',', 'Quillen', 'et', 'al', '.', '(', '2012', ')', 'also', 'focused', 'on', 'the', 'effect', 'of', 'gender', 'on', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Although the authors' model indicates that 0.4% of the interindividual difference in both paraoxonase and arylesterase activities can be explained by gender, we suggest that gender does not appreciably explain interindividual variation in DHC lactonase activity.	[('PMC8045895', 'R16001', 90, 101, 'paraoxonase')]	"['Although', 'the', 'authors', ""'"", 'model', 'indicates', 'that', '0', '.', '4', '%', 'of', 'the', 'inter', '##ind', '##iv', '##id', '##ual', 'difference', 'in', 'both', 'para', '##ox', '##ona', '##se', 'and', 'a', '##ryl', '##ester', '##ase', 'activities', 'can', 'be', 'explained', 'by', 'gender', ',', 'we', 'suggest', 'that', 'gender', 'does', 'not', 'app', '##re', '##cia', '##bly', 'explain', 'inter', '##ind', '##iv', '##id', '##ual', 'variation', 'in', 'D', '##HC', 'la', '##cton', '##ase', 'activity', '.']"	[0, 9, 13, 20, 22, 28, 38, 43, 44, 45, 46, 48, 51, 55, 60, 63, 65, 67, 71, 82, 85, 90, 94, 96, 99, 102, 106, 107, 110, 115, 119, 130, 134, 137, 147, 150, 156, 158, 161, 169, 174, 181, 186, 190, 193, 195, 198, 202, 210, 215, 218, 220, 222, 226, 236, 239, 240, 243, 245, 249, 253, 261]	[8, 12, 20, 21, 27, 37, 42, 44, 45, 46, 47, 50, 54, 60, 63, 65, 67, 70, 81, 84, 89, 94, 96, 99, 101, 105, 107, 110, 115, 118, 129, 133, 136, 146, 149, 156, 157, 160, 168, 173, 180, 185, 189, 193, 195, 198, 201, 209, 215, 218, 220, 222, 225, 235, 238, 240, 242, 245, 249, 252, 261, 262]	"['Although', 'the', 'authors', ""'"", 'model', 'indicates', 'that', '0.4%', 'of', 'the', 'interindividual', 'difference', 'in', 'both', 'paraoxonase', 'and', 'arylesterase', 'activities', 'can', 'be', 'explained', 'by', 'gender', ',', 'we', 'suggest', 'that', 'gender', 'does', 'not', 'appreciably', 'explain', 'interindividual', 'variation', 'in', 'DHC', 'lactonase', 'activity', '.']"	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 5, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A more recent article also focused on the influence of gender on PON1, with TBL as a substrate, and concludes that gender does influence lactonase activity (Trentini et al., 2019).	[('PMC8045895', 'R17000', 137, 146, 'lactonase')]	['A', 'more', 'recent', 'article', 'also', 'focused', 'on', 'the', 'influence', 'of', 'gender', 'on', 'P', '##ON', '##1', ',', 'with', 'T', '##BL', 'as', 'a', 'substrate', ',', 'and', 'concludes', 'that', 'gender', 'does', 'influence', 'la', '##cton', '##ase', 'activity', '(', 'Trent', '##ini', 'et', 'al', '.', ',', '2019', ')', '.']	[0, 2, 7, 14, 22, 27, 35, 38, 42, 52, 55, 62, 65, 66, 68, 69, 71, 76, 77, 80, 83, 85, 94, 96, 100, 110, 115, 122, 127, 137, 139, 143, 147, 156, 157, 162, 166, 169, 171, 172, 174, 178, 179]	[1, 6, 13, 21, 26, 34, 37, 41, 51, 54, 61, 64, 66, 68, 69, 70, 75, 77, 79, 82, 84, 94, 95, 99, 109, 114, 121, 126, 136, 139, 143, 146, 155, 157, 162, 165, 168, 171, 172, 173, 178, 179, 180]	['A', 'more', 'recent', 'article', 'also', 'focused', 'on', 'the', 'influence', 'of', 'gender', 'on', 'PON1', ',', 'with', 'TBL', 'as', 'a', 'substrate', ',', 'and', 'concludes', 'that', 'gender', 'does', 'influence', 'lactonase', 'activity', '(', 'Trentini', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Trentini et al. detected higher PON1 lactonase activity among women than among men, even after accounting for confounders such as concentrations of HDL and cholesterol, age, smoking, body mass index, and waist circumference.	[('PMC8045895', 'R17001', 37, 46, 'lactonase')]	['Trent', '##ini', 'et', 'al', '.', 'detected', 'higher', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'among', 'women', 'than', 'among', 'men', ',', 'even', 'after', 'accounting', 'for', 'con', '##found', '##ers', 'such', 'as', 'concentrations', 'of', 'HD', '##L', 'and', 'ch', '##ole', '##ster', '##ol', ',', 'age', ',', 'smoking', ',', 'body', 'mass', 'index', ',', 'and', 'waist', 'c', '##ir', '##cum', '##ference', '.']	[0, 5, 9, 12, 14, 16, 25, 32, 33, 35, 37, 39, 43, 47, 56, 62, 68, 73, 79, 82, 84, 89, 95, 106, 110, 113, 118, 122, 127, 130, 145, 148, 150, 152, 156, 158, 161, 165, 167, 169, 172, 174, 181, 183, 188, 193, 198, 200, 204, 210, 211, 213, 216, 223]	[5, 8, 11, 14, 15, 24, 31, 33, 35, 36, 39, 43, 46, 55, 61, 67, 72, 78, 82, 83, 88, 94, 105, 109, 113, 118, 121, 126, 129, 144, 147, 150, 151, 155, 158, 161, 165, 167, 168, 172, 173, 181, 182, 187, 192, 198, 199, 203, 209, 211, 213, 216, 223, 224]	['Trentini', 'et', 'al', '.', 'detected', 'higher', 'PON1', 'lactonase', 'activity', 'among', 'women', 'than', 'among', 'men', ',', 'even', 'after', 'accounting', 'for', 'confounders', 'such', 'as', 'concentrations', 'of', 'HDL', 'and', 'cholesterol', ',', 'age', ',', 'smoking', ',', 'body', 'mass', 'index', ',', 'and', 'waist', 'circumference', '.']	[2, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors reported a significant difference between genders for both lactonase and arylesterase activities (Trentini et al., 2019).	[('PMC8045895', 'R17002', 71, 80, 'lactonase')]	['The', 'authors', 'reported', 'a', 'significant', 'difference', 'between', 'gender', '##s', 'for', 'both', 'la', '##cton', '##ase', 'and', 'a', '##ryl', '##ester', '##ase', 'activities', '(', 'Trent', '##ini', 'et', 'al', '.', ',', '2019', ')', '.']	[0, 4, 12, 21, 23, 35, 46, 54, 60, 62, 66, 71, 73, 77, 81, 85, 86, 89, 94, 98, 109, 110, 115, 119, 122, 124, 125, 127, 131, 132]	[3, 11, 20, 22, 34, 45, 53, 60, 61, 65, 70, 73, 77, 80, 84, 86, 89, 94, 97, 108, 110, 115, 118, 121, 124, 125, 126, 131, 132, 133]	['The', 'authors', 'reported', 'a', 'significant', 'difference', 'between', 'genders', 'for', 'both', 'lactonase', 'and', 'arylesterase', 'activities', '(', 'Trentini', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Aviram and Rosenblat (2012) also investigated how the consumption of several different juices impacts PON1 lactonase activity for DHC.	[('PMC8045895', 'R19000', 107, 116, 'lactonase')]	['A', '##vir', '##am', 'and', 'Rosen', '##bla', '##t', '(', '2012', ')', 'also', 'investigated', 'how', 'the', 'consumption', 'of', 'several', 'different', 'juice', '##s', 'impacts', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'for', 'D', '##HC', '.']	[0, 1, 4, 7, 11, 16, 19, 21, 22, 26, 28, 33, 46, 50, 54, 66, 69, 77, 87, 92, 94, 102, 103, 105, 107, 109, 113, 117, 126, 130, 131, 133]	[1, 4, 6, 10, 16, 19, 20, 22, 26, 27, 32, 45, 49, 53, 65, 68, 76, 86, 92, 93, 101, 103, 105, 106, 109, 113, 116, 125, 129, 131, 133, 134]	['Aviram', 'and', 'Rosenblat', '(', '2012', ')', 'also', 'investigated', 'how', 'the', 'consumption', 'of', 'several', 'different', 'juices', 'impacts', 'PON1', 'lactonase', 'activity', 'for', 'DHC', '.']	[3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
They found that in healthy subjects, consumption of currant juice and pomegranate juice both led to an increase in PON1 lactonase activity after 1 week.	[('PMC8045895', 'R19001', 120, 129, 'lactonase')]	['They', 'found', 'that', 'in', 'healthy', 'subjects', ',', 'consumption', 'of', 'cu', '##rra', '##nt', 'juice', 'and', 'p', '##ome', '##gra', '##nate', 'juice', 'both', 'led', 'to', 'an', 'increase', 'in', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'after', '1', 'week', '.']	[0, 5, 11, 16, 19, 27, 35, 37, 49, 52, 54, 57, 60, 66, 70, 71, 74, 77, 82, 88, 93, 97, 100, 103, 112, 115, 116, 118, 120, 122, 126, 130, 139, 145, 147, 151]	[4, 10, 15, 18, 26, 35, 36, 48, 51, 54, 57, 59, 65, 69, 71, 74, 77, 81, 87, 92, 96, 99, 102, 111, 114, 116, 118, 119, 122, 126, 129, 138, 144, 146, 151, 152]	['They', 'found', 'that', 'in', 'healthy', 'subjects', ',', 'consumption', 'of', 'currant', 'juice', 'and', 'pomegranate', 'juice', 'both', 'led', 'to', 'an', 'increase', 'in', 'PON1', 'lactonase', 'activity', 'after', '1', 'week', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Kameyama et al. (2016) studied the impact of diet on PON1 lactonase activity.	[('PMC8045895', 'R20000', 58, 67, 'lactonase')]	['Ka', '##me', '##yama', 'et', 'al', '.', '(', '2016', ')', 'studied', 'the', 'impact', 'of', 'diet', 'on', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', '.']	[0, 2, 4, 9, 12, 14, 16, 17, 21, 23, 31, 35, 42, 45, 50, 53, 54, 56, 58, 60, 64, 68, 76]	[2, 4, 8, 11, 14, 15, 17, 21, 22, 30, 34, 41, 44, 49, 52, 54, 56, 57, 60, 64, 67, 76, 77]	['Kameyama', 'et', 'al', '.', '(', '2016', ')', 'studied', 'the', 'impact', 'of', 'diet', 'on', 'PON1', 'lactonase', 'activity', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
In their study, male volunteers who consumed three different meals and lactonase activity, with TBBL as a substrate, was determined after consumption of these meals.	[('PMC8045895', 'R20001', 71, 80, 'lactonase')]	['In', 'their', 'study', ',', 'male', 'volunteers', 'who', 'consumed', 'three', 'different', 'meals', 'and', 'la', '##cton', '##ase', 'activity', ',', 'with', 'T', '##BB', '##L', 'as', 'a', 'substrate', ',', 'was', 'determined', 'after', 'consumption', 'of', 'these', 'meals', '.']	[0, 3, 9, 14, 16, 21, 32, 36, 45, 51, 61, 67, 71, 73, 77, 81, 89, 91, 96, 97, 99, 101, 104, 106, 115, 117, 121, 132, 138, 150, 153, 159, 164]	[2, 8, 14, 15, 20, 31, 35, 44, 50, 60, 66, 70, 73, 77, 80, 89, 90, 95, 97, 99, 100, 103, 105, 115, 116, 120, 131, 137, 149, 152, 158, 164, 165]	['In', 'their', 'study', ',', 'male', 'volunteers', 'who', 'consumed', 'three', 'different', 'meals', 'and', 'lactonase', 'activity', ',', 'with', 'TBBL', 'as', 'a', 'substrate', ',', 'was', 'determined', 'after', 'consumption', 'of', 'these', 'meals', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Model organisms have also been used to perform experiments about the impact of diet high in polyunsaturated fatty acids (PUFA) on PON1 lactonase activity.	[('PMC8045895', 'R21000', 135, 144, 'lactonase')]	['Model', 'organisms', 'have', 'also', 'been', 'used', 'to', 'perform', 'experiments', 'about', 'the', 'impact', 'of', 'diet', 'high', 'in', 'p', '##oly', '##uns', '##at', '##ura', '##ted', 'fatty', 'acids', '(', 'P', '##U', '##FA', ')', 'on', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', '.']	[0, 6, 16, 21, 26, 31, 36, 39, 47, 59, 65, 69, 76, 79, 84, 89, 92, 93, 96, 99, 101, 104, 108, 114, 120, 121, 122, 123, 125, 127, 130, 131, 133, 135, 137, 141, 145, 153]	[5, 15, 20, 25, 30, 35, 38, 46, 58, 64, 68, 75, 78, 83, 88, 91, 93, 96, 99, 101, 104, 107, 113, 119, 121, 122, 123, 125, 126, 129, 131, 133, 134, 137, 141, 144, 153, 154]	['Model', 'organisms', 'have', 'also', 'been', 'used', 'to', 'perform', 'experiments', 'about', 'the', 'impact', 'of', 'diet', 'high', 'in', 'polyunsaturated', 'fatty', 'acids', '(', 'PUFA', ')', 'on', 'PON1', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 3, 1, 1, 3, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
No significant difference in lactonase activity of rat serum before and after a PUFA-rich meal has been demonstrated.	[('PMC8045895', 'R21001', 29, 38, 'lactonase')]	['No', 'significant', 'difference', 'in', 'la', '##cton', '##ase', 'activity', 'of', 'rat', 'serum', 'before', 'and', 'after', 'a', 'P', '##U', '##FA', '-', 'rich', 'meal', 'has', 'been', 'demonstrated', '.']	[0, 3, 15, 26, 29, 31, 35, 39, 48, 51, 55, 61, 68, 72, 78, 80, 81, 82, 84, 85, 90, 95, 99, 104, 116]	[2, 14, 25, 28, 31, 35, 38, 47, 50, 54, 60, 67, 71, 77, 79, 81, 82, 84, 85, 89, 94, 98, 103, 116, 117]	['No', 'significant', 'difference', 'in', 'lactonase', 'activity', 'of', 'rat', 'serum', 'before', 'and', 'after', 'a', 'PUFA-rich', 'meal', 'has', 'been', 'demonstrated', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Moreover, authors also found no difference in lactonase activity between the nondiabetic control without oil administration and the diabetic group (Kopál et al., 2014).	[('PMC8045895', 'R21002', 46, 55, 'lactonase')]	['Moreover', ',', 'authors', 'also', 'found', 'no', 'difference', 'in', 'la', '##cton', '##ase', 'activity', 'between', 'the', 'non', '##dia', '##bet', '##ic', 'control', 'without', 'oil', 'administration', 'and', 'the', 'di', '##abe', '##tic', 'group', '(', 'Ko', '##p', '##á', '##l', 'et', 'al', '.', ',', '2014', ')', '.']	[0, 8, 10, 18, 23, 29, 32, 43, 46, 48, 52, 56, 65, 73, 77, 80, 83, 86, 89, 97, 105, 109, 124, 128, 132, 134, 137, 141, 147, 148, 150, 151, 152, 154, 157, 159, 160, 162, 166, 167]	[8, 9, 17, 22, 28, 31, 42, 45, 48, 52, 55, 64, 72, 76, 80, 83, 86, 88, 96, 104, 108, 123, 127, 131, 134, 137, 140, 146, 148, 150, 151, 152, 153, 156, 159, 160, 161, 166, 167, 168]	['Moreover', ',', 'authors', 'also', 'found', 'no', 'difference', 'in', 'lactonase', 'activity', 'between', 'the', 'nondiabetic', 'control', 'without', 'oil', 'administration', 'and', 'the', 'diabetic', 'group', '(', 'Kopál', 'et', 'al', '.', ',', '2014', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Although the interactions of PON1 with various mediations have been established and are displayed in databases such as DrugBank (Wishart et al., 2017), only few of these studies investigated lactonase activity.	[('PMC8045895', 'R22000', 191, 200, 'lactonase')]	['Although', 'the', 'interactions', 'of', 'P', '##ON', '##1', 'with', 'various', 'media', '##tions', 'have', 'been', 'established', 'and', 'are', 'displayed', 'in', 'databases', 'such', 'as', 'Drug', '##B', '##an', '##k', '(', 'Wish', '##art', 'et', 'al', '.', ',', '2017', ')', ',', 'only', 'few', 'of', 'these', 'studies', 'investigated', 'la', '##cton', '##ase', 'activity', '.']	[0, 9, 13, 26, 29, 30, 32, 34, 39, 47, 52, 58, 63, 68, 80, 84, 88, 98, 101, 111, 116, 119, 123, 124, 126, 128, 129, 133, 137, 140, 142, 143, 145, 149, 150, 152, 157, 161, 164, 170, 178, 191, 193, 197, 201, 209]	[8, 12, 25, 28, 30, 32, 33, 38, 46, 52, 57, 62, 67, 79, 83, 87, 97, 100, 110, 115, 118, 123, 124, 126, 127, 129, 133, 136, 139, 142, 143, 144, 149, 150, 151, 156, 160, 163, 169, 177, 190, 193, 197, 200, 209, 210]	['Although', 'the', 'interactions', 'of', 'PON1', 'with', 'various', 'mediations', 'have', 'been', 'established', 'and', 'are', 'displayed', 'in', 'databases', 'such', 'as', 'DrugBank', '(', 'Wishart', 'et', 'al', '.', ',', '2017', ')', ',', 'only', 'few', 'of', 'these', 'studies', 'investigated', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
For example, of the 12 articles focusing on association of PON1 activity and medications for schizophrenia, which were analyzed in a recent review (Moreira et al., 2018), only Gilca et al. (2014) investigated lactonase activity using DHC as a substrate.	[('PMC8045895', 'R22001', 209, 218, 'lactonase')]	['For', 'example', ',', 'of', 'the', '12', 'articles', 'focusing', 'on', 'association', 'of', 'P', '##ON', '##1', 'activity', 'and', 'medications', 'for', 's', '##chi', '##zophrenia', ',', 'which', 'were', 'analyzed', 'in', 'a', 'recent', 'review', '(', 'More', '##ira', 'et', 'al', '.', ',', '2018', ')', ',', 'only', 'Gil', '##ca', 'et', 'al', '.', '(', '2014', ')', 'investigated', 'la', '##cton', '##ase', 'activity', 'using', 'D', '##HC', 'as', 'a', 'substrate', '.']	[0, 4, 11, 13, 16, 20, 23, 32, 41, 44, 56, 59, 60, 62, 64, 73, 77, 89, 93, 94, 97, 106, 108, 114, 119, 128, 131, 133, 140, 147, 148, 152, 156, 159, 161, 162, 164, 168, 169, 171, 176, 179, 182, 185, 187, 189, 190, 194, 196, 209, 211, 215, 219, 228, 234, 235, 238, 241, 243, 252]	[3, 11, 12, 15, 19, 22, 31, 40, 43, 55, 58, 60, 62, 63, 72, 76, 88, 92, 94, 97, 106, 107, 113, 118, 127, 130, 132, 139, 146, 148, 152, 155, 158, 161, 162, 163, 168, 169, 170, 175, 179, 181, 184, 187, 188, 190, 194, 195, 208, 211, 215, 218, 227, 233, 235, 237, 240, 242, 252, 253]	['For', 'example', ',', 'of', 'the', '12', 'articles', 'focusing', 'on', 'association', 'of', 'PON1', 'activity', 'and', 'medications', 'for', 'schizophrenia', ',', 'which', 'were', 'analyzed', 'in', 'a', 'recent', 'review', '(', 'Moreira', 'et', 'al', '.', ',', '2018', ')', ',', 'only', 'Gilca', 'et', 'al', '.', '(', '2014', ')', 'investigated', 'lactonase', 'activity', 'using', 'DHC', 'as', 'a', 'substrate', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
compared lactonase activity in patients taking clozapine, patients taking risperidone, and with healthy individuals.	[]	['compared', 'la', '##cton', '##ase', 'activity', 'in', 'patients', 'taking', 'c', '##lo', '##za', '##pine', ',', 'patients', 'taking', 'r', '##is', '##per', '##ido', '##ne', ',', 'and', 'with', 'healthy', 'individuals', '.']	[0, 9, 11, 15, 19, 28, 31, 40, 47, 48, 50, 52, 56, 58, 67, 74, 75, 77, 80, 83, 85, 87, 91, 96, 104, 115]	[8, 11, 15, 18, 27, 30, 39, 46, 48, 50, 52, 56, 57, 66, 73, 75, 77, 80, 83, 85, 86, 90, 95, 103, 115, 116]	['compared', 'lactonase', 'activity', 'in', 'patients', 'taking', 'clozapine', ',', 'patients', 'taking', 'risperidone', ',', 'and', 'with', 'healthy', 'individuals', '.']	[1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors demonstrated that taking risperidone resulted in significantly lower lactonase activity than the healthy control group.	[]	['The', 'authors', 'demonstrated', 'that', 'taking', 'r', '##is', '##per', '##ido', '##ne', 'resulted', 'in', 'significantly', 'lower', 'la', '##cton', '##ase', 'activity', 'than', 'the', 'healthy', 'control', 'group', '.']	[0, 4, 12, 25, 30, 37, 38, 40, 43, 46, 49, 58, 61, 75, 81, 83, 87, 91, 100, 105, 109, 117, 125, 130]	[3, 11, 24, 29, 36, 38, 40, 43, 46, 48, 57, 60, 74, 80, 83, 87, 90, 99, 104, 108, 116, 124, 130, 131]	['The', 'authors', 'demonstrated', 'that', 'taking', 'risperidone', 'resulted', 'in', 'significantly', 'lower', 'lactonase', 'activity', 'than', 'the', 'healthy', 'control', 'group', '.']	[1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also showed that the patients taking clozapine in turn had a significantly lower lactonase activity than the patients taking risperidone.	[]	['The', 'authors', 'also', 'showed', 'that', 'the', 'patients', 'taking', 'c', '##lo', '##za', '##pine', 'in', 'turn', 'had', 'a', 'significantly', 'lower', 'la', '##cton', '##ase', 'activity', 'than', 'the', 'patients', 'taking', 'r', '##is', '##per', '##ido', '##ne', '.']	[0, 4, 12, 17, 24, 29, 33, 42, 49, 50, 52, 54, 59, 62, 67, 71, 73, 87, 93, 95, 99, 103, 112, 117, 121, 130, 137, 138, 140, 143, 146, 148]	[3, 11, 16, 23, 28, 32, 41, 48, 50, 52, 54, 58, 61, 66, 70, 72, 86, 92, 95, 99, 102, 111, 116, 120, 129, 136, 138, 140, 143, 146, 148, 149]	['The', 'authors', 'also', 'showed', 'that', 'the', 'patients', 'taking', 'clozapine', 'in', 'turn', 'had', 'a', 'significantly', 'lower', 'lactonase', 'activity', 'than', 'the', 'patients', 'taking', 'risperidone', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another group of medications, which has been associated with PON1 lactonase activity in one study, are oral contraceptives (Kowalska et al., 2018).	[('PMC8045895', 'R24000', 66, 75, 'lactonase')]	['Another', 'group', 'of', 'medications', ',', 'which', 'has', 'been', 'associated', 'with', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'in', 'one', 'study', ',', 'are', 'oral', 'con', '##tra', '##ceptive', '##s', '(', 'Ko', '##wal', '##ska', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 8, 14, 17, 28, 30, 36, 40, 45, 56, 61, 62, 64, 66, 68, 72, 76, 85, 88, 92, 97, 99, 103, 108, 111, 114, 121, 123, 124, 126, 129, 133, 136, 138, 139, 141, 145, 146]	[7, 13, 16, 28, 29, 35, 39, 44, 55, 60, 62, 64, 65, 68, 72, 75, 84, 87, 91, 97, 98, 102, 107, 111, 114, 121, 122, 124, 126, 129, 132, 135, 138, 139, 140, 145, 146, 147]	['Another', 'group', 'of', 'medications', ',', 'which', 'has', 'been', 'associated', 'with', 'PON1', 'lactonase', 'activity', 'in', 'one', 'study', ',', 'are', 'oral', 'contraceptives', '(', 'Kowalska', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that taking contraceptives correlated with a significant increase in lactonase and arylesterase activity, but with a significant decrease in paraoxonase activity.	[('PMC8045895', 'R24001', 91, 100, 'lactonase')]	['The', 'authors', 'concluded', 'that', 'taking', 'con', '##tra', '##ceptive', '##s', 'correlated', 'with', 'a', 'significant', 'increase', 'in', 'la', '##cton', '##ase', 'and', 'a', '##ryl', '##ester', '##ase', 'activity', ',', 'but', 'with', 'a', 'significant', 'decrease', 'in', 'para', '##ox', '##ona', '##se', 'activity', '.']	[0, 4, 12, 22, 27, 34, 37, 40, 47, 49, 60, 65, 67, 79, 88, 91, 93, 97, 101, 105, 106, 109, 114, 118, 126, 128, 132, 137, 139, 151, 160, 163, 167, 169, 172, 175, 183]	[3, 11, 21, 26, 33, 37, 40, 47, 48, 59, 64, 66, 78, 87, 90, 93, 97, 100, 104, 106, 109, 114, 117, 126, 127, 131, 136, 138, 150, 159, 162, 167, 169, 172, 174, 183, 184]	['The', 'authors', 'concluded', 'that', 'taking', 'contraceptives', 'correlated', 'with', 'a', 'significant', 'increase', 'in', 'lactonase', 'and', 'arylesterase', 'activity', ',', 'but', 'with', 'a', 'significant', 'decrease', 'in', 'paraoxonase', 'activity', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that while lactonase activity is not significantly affected by the amount of exposure to pesticides, there is a significant decrease in lactonase activity in greenhouse workers in comparison with the healthy controls with no occupational exposure to pesticides.	[]	['The', 'authors', 'concluded', 'that', 'while', 'la', '##cton', '##ase', 'activity', 'is', 'not', 'significantly', 'affected', 'by', 'the', 'amount', 'of', 'exposure', 'to', 'p', '##est', '##icides', ',', 'there', 'is', 'a', 'significant', 'decrease', 'in', 'la', '##cton', '##ase', 'activity', 'in', 'greenhouse', 'workers', 'in', 'comparison', 'with', 'the', 'healthy', 'controls', 'with', 'no', 'occupational', 'exposure', 'to', 'p', '##est', '##icides', '.']	[0, 4, 12, 22, 27, 33, 35, 39, 43, 52, 55, 59, 73, 82, 85, 89, 96, 99, 108, 111, 112, 115, 121, 123, 129, 132, 134, 146, 155, 158, 160, 164, 168, 177, 180, 191, 199, 202, 213, 218, 222, 230, 239, 244, 247, 260, 269, 272, 273, 276, 282]	[3, 11, 21, 26, 32, 35, 39, 42, 51, 54, 58, 72, 81, 84, 88, 95, 98, 107, 110, 112, 115, 121, 122, 128, 131, 133, 145, 154, 157, 160, 164, 167, 176, 179, 190, 198, 201, 212, 217, 221, 229, 238, 243, 246, 259, 268, 271, 273, 276, 282, 283]	['The', 'authors', 'concluded', 'that', 'while', 'lactonase', 'activity', 'is', 'not', 'significantly', 'affected', 'by', 'the', 'amount', 'of', 'exposure', 'to', 'pesticides', ',', 'there', 'is', 'a', 'significant', 'decrease', 'in', 'lactonase', 'activity', 'in', 'greenhouse', 'workers', 'in', 'comparison', 'with', 'the', 'healthy', 'controls', 'with', 'no', 'occupational', 'exposure', 'to', 'pesticides', '.']	[1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors tested several different organophosphate substrates and reported that higher exposure to pesticides did however lead to a significant decrease in arylesterase activity and, interestingly, to a nonsignificant increase in paraoxonase activity (Lozano-Paniagua et al., 2016).	[]	['The', 'authors', 'tested', 'several', 'different', 'organ', '##op', '##hos', '##phate', 'substrates', 'and', 'reported', 'that', 'higher', 'exposure', 'to', 'p', '##est', '##icides', 'did', 'however', 'lead', 'to', 'a', 'significant', 'decrease', 'in', 'a', '##ryl', '##ester', '##ase', 'activity', 'and', ',', 'interesting', '##ly', ',', 'to', 'a', 'non', '##sign', '##ificant', 'increase', 'in', 'para', '##ox', '##ona', '##se', 'activity', '(', 'Lo', '##zano', '-', 'Pan', '##ia', '##gua', 'et', 'al', '.', ',', '2016', ')', '.']	[0, 4, 12, 19, 27, 37, 42, 44, 47, 53, 64, 68, 77, 82, 89, 98, 101, 102, 105, 112, 116, 124, 129, 132, 134, 146, 155, 158, 159, 162, 167, 171, 180, 183, 185, 196, 198, 200, 203, 205, 208, 212, 220, 229, 232, 236, 238, 241, 244, 253, 254, 256, 260, 261, 264, 266, 270, 273, 275, 276, 278, 282, 283]	[3, 11, 18, 26, 36, 42, 44, 47, 52, 63, 67, 76, 81, 88, 97, 100, 102, 105, 111, 115, 123, 128, 131, 133, 145, 154, 157, 159, 162, 167, 170, 179, 183, 184, 196, 198, 199, 202, 204, 208, 212, 219, 228, 231, 236, 238, 241, 243, 252, 254, 256, 260, 261, 264, 266, 269, 272, 275, 276, 277, 282, 283, 284]	['The', 'authors', 'tested', 'several', 'different', 'organophosphate', 'substrates', 'and', 'reported', 'that', 'higher', 'exposure', 'to', 'pesticides', 'did', 'however', 'lead', 'to', 'a', 'significant', 'decrease', 'in', 'arylesterase', 'activity', 'and', ',', 'interestingly', ',', 'to', 'a', 'nonsignificant', 'increase', 'in', 'paraoxonase', 'activity', '(', 'Lozano-Paniagua', 'et', 'al', '.', ',', '2016', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A study followed the effects of an exercise regimen in a group of obese human subjects on the DHC lactonase and paraoxonase activities of their serum PON1 (Russo et al., 2018).	[('PMC8045895', 'R26000', 98, 107, 'lactonase')]	['A', 'study', 'followed', 'the', 'effects', 'of', 'an', 'exercise', 'regime', '##n', 'in', 'a', 'group', 'of', 'o', '##bes', '##e', 'human', 'subjects', 'on', 'the', 'D', '##HC', 'la', '##cton', '##ase', 'and', 'para', '##ox', '##ona', '##se', 'activities', 'of', 'their', 'serum', 'P', '##ON', '##1', '(', 'Russo', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 2, 8, 17, 21, 29, 32, 35, 44, 50, 52, 55, 57, 63, 66, 67, 70, 72, 78, 87, 90, 94, 95, 98, 100, 104, 108, 112, 116, 118, 121, 124, 135, 138, 144, 150, 151, 153, 155, 156, 162, 165, 167, 168, 170, 174, 175]	[1, 7, 16, 20, 28, 31, 34, 43, 50, 51, 54, 56, 62, 65, 67, 70, 71, 77, 86, 89, 93, 95, 97, 100, 104, 107, 111, 116, 118, 121, 123, 134, 137, 143, 149, 151, 153, 154, 156, 161, 164, 167, 168, 169, 174, 175, 176]	['A', 'study', 'followed', 'the', 'effects', 'of', 'an', 'exercise', 'regimen', 'in', 'a', 'group', 'of', 'obese', 'human', 'subjects', 'on', 'the', 'DHC', 'lactonase', 'and', 'paraoxonase', 'activities', 'of', 'their', 'serum', 'PON1', '(', 'Russo', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 1, 4, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PON1 lactonase activity has been studied regarding several diseases and other medical conditions.	[('PMC8045895', 'R28000', 5, 14, 'lactonase')]	['P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'has', 'been', 'studied', 'regarding', 'several', 'diseases', 'and', 'other', 'medical', 'conditions', '.']	[0, 1, 3, 5, 7, 11, 15, 24, 28, 33, 41, 51, 59, 68, 72, 78, 86, 96]	[1, 3, 4, 7, 11, 14, 23, 27, 32, 40, 50, 58, 67, 71, 77, 85, 96, 97]	['PON1', 'lactonase', 'activity', 'has', 'been', 'studied', 'regarding', 'several', 'diseases', 'and', 'other', 'medical', 'conditions', '.']	[3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Many articles have been published investigating the association of these with PON1, including six articles that included lactonase activity, four of which have been carried out on humans (Gugliucci et al., 2015; Martinelli et al., 2009; Murillo-González et al., 2020; Ponce-Ruiz et al., 2020) and two on animals (De Keyzer et al., 2009; Zhang et al., 2010).	[]	['Many', 'articles', 'have', 'been', 'published', 'investigating', 'the', 'association', 'of', 'these', 'with', 'P', '##ON', '##1', ',', 'including', 'six', 'articles', 'that', 'included', 'la', '##cton', '##ase', 'activity', ',', 'four', 'of', 'which', 'have', 'been', 'carried', 'out', 'on', 'humans', '(', 'G', '##ug', '##li', '##ucci', 'et', 'al', '.', ',', '2015', ';', 'Martin', '##elli', 'et', 'al', '.', ',', '2009', ';', 'Mu', '##rill', '##o', '-', 'González', 'et', 'al', '.', ',', '2020', ';', 'Ponce', '-', 'Ruiz', 'et', 'al', '.', ',', '2020', ')', 'and', 'two', 'on', 'animals', '(', 'De', 'Key', '##zer', 'et', 'al', '.', ',', '2009', ';', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[0, 5, 14, 19, 24, 34, 48, 52, 64, 67, 73, 78, 79, 81, 82, 84, 94, 98, 107, 112, 121, 123, 127, 131, 139, 141, 146, 149, 155, 160, 165, 173, 177, 180, 187, 188, 189, 191, 193, 198, 201, 203, 204, 206, 210, 212, 218, 223, 226, 228, 229, 231, 235, 237, 239, 243, 244, 245, 254, 257, 259, 260, 262, 266, 268, 273, 274, 279, 282, 284, 285, 287, 291, 293, 297, 301, 304, 312, 313, 316, 319, 323, 326, 328, 329, 331, 335, 337, 343, 346, 348, 349, 351, 355, 356]	[4, 13, 18, 23, 33, 47, 51, 63, 66, 72, 77, 79, 81, 82, 83, 93, 97, 106, 111, 120, 123, 127, 130, 139, 140, 145, 148, 154, 159, 164, 172, 176, 179, 186, 188, 189, 191, 193, 197, 200, 203, 204, 205, 210, 211, 218, 222, 225, 228, 229, 230, 235, 236, 239, 243, 244, 245, 253, 256, 259, 260, 261, 266, 267, 273, 274, 278, 281, 284, 285, 286, 291, 292, 296, 300, 303, 311, 313, 315, 319, 322, 325, 328, 329, 330, 335, 336, 342, 345, 348, 349, 350, 355, 356, 357]	['Many', 'articles', 'have', 'been', 'published', 'investigating', 'the', 'association', 'of', 'these', 'with', 'PON1', ',', 'including', 'six', 'articles', 'that', 'included', 'lactonase', 'activity', ',', 'four', 'of', 'which', 'have', 'been', 'carried', 'out', 'on', 'humans', '(', 'Gugliucci', 'et', 'al', '.', ',', '2015', ';', 'Martinelli', 'et', 'al', '.', ',', '2009', ';', 'Murillo-González', 'et', 'al', '.', ',', '2020', ';', 'Ponce-Ruiz', 'et', 'al', '.', ',', '2020', ')', 'and', 'two', 'on', 'animals', '(', 'De', 'Keyzer', 'et', 'al', '.', ',', '2009', ';', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors then normalized TBBL activity by dividing it with 7-O-diethyl phosphoryl,3-cyano,4-methyl,7-hydroxycoumarin (DEPCyMC) activity, which has been indicated as a surrogate marker for determining PON1 concentration (Gaidukov and Tawfik, 2007).	[]	['The', 'authors', 'then', 'normal', '##ized', 'T', '##BB', '##L', 'activity', 'by', 'dividing', 'it', 'with', '7', '-', 'O', '-', 'diet', '##hyl', 'p', '##hos', '##ph', '##ory', '##l', ',', '3', '-', 'c', '##yan', '##o', ',', '4', '-', 'met', '##hyl', ',', '7', '-', 'h', '##ydro', '##xy', '##co', '##uma', '##rin', '(', 'DE', '##PC', '##y', '##MC', ')', 'activity', ',', 'which', 'has', 'been', 'indicated', 'as', 'a', 'sur', '##rogate', 'marker', 'for', 'determining', 'P', '##ON', '##1', 'concentration', '(', 'G', '##aid', '##uk', '##ov', 'and', 'Ta', '##w', '##fi', '##k', ',', '2007', ')', '.']	[0, 4, 12, 17, 23, 28, 29, 31, 33, 42, 45, 54, 57, 62, 63, 64, 65, 66, 70, 74, 75, 78, 80, 83, 84, 85, 86, 87, 88, 91, 92, 93, 94, 95, 98, 101, 102, 103, 104, 105, 109, 111, 113, 116, 120, 121, 123, 125, 126, 128, 130, 138, 140, 146, 150, 155, 165, 168, 170, 173, 180, 187, 191, 203, 204, 206, 208, 222, 223, 224, 227, 229, 232, 236, 238, 239, 241, 242, 244, 248, 249]	[3, 11, 16, 23, 27, 29, 31, 32, 41, 44, 53, 56, 61, 63, 64, 65, 66, 70, 73, 75, 78, 80, 83, 84, 85, 86, 87, 88, 91, 92, 93, 94, 95, 98, 101, 102, 103, 104, 105, 109, 111, 113, 116, 119, 121, 123, 125, 126, 128, 129, 138, 139, 145, 149, 154, 164, 167, 169, 173, 179, 186, 190, 202, 204, 206, 207, 221, 223, 224, 227, 229, 231, 235, 238, 239, 241, 242, 243, 248, 249, 250]	['The', 'authors', 'then', 'normalized', 'TBBL', 'activity', 'by', 'dividing', 'it', 'with', '7-O-diethyl', 'phosphoryl', ',', '3-cyano,4-methyl,7-hydroxycoumarin', '(', 'DEPCyMC', ')', 'activity', ',', 'which', 'has', 'been', 'indicated', 'as', 'a', 'surrogate', 'marker', 'for', 'determining', 'PON1', 'concentration', '(', 'Gaidukov', 'and', 'Tawfik', ',', '2007', ')', '.']	[1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 6, 5, 1, 19, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The resulting normalized lactonase activity was significantly higher in the group with CAD, especially noticeable in individuals with the PON1 192QQ genotype.	[('PMC8045895', 'R32000', 25, 34, 'lactonase')]	['The', 'resulting', 'normal', '##ized', 'la', '##cton', '##ase', 'activity', 'was', 'significantly', 'higher', 'in', 'the', 'group', 'with', 'CA', '##D', ',', 'especially', 'noticeable', 'in', 'individuals', 'with', 'the', 'P', '##ON', '##1', '192', '##Q', '##Q', 'g', '##eno', '##type', '.']	[0, 4, 14, 20, 25, 27, 31, 35, 44, 48, 62, 69, 72, 76, 82, 87, 89, 90, 92, 103, 114, 117, 129, 134, 138, 139, 141, 143, 146, 147, 149, 150, 153, 157]	[3, 13, 20, 24, 27, 31, 34, 43, 47, 61, 68, 71, 75, 81, 86, 89, 90, 91, 102, 113, 116, 128, 133, 137, 139, 141, 142, 146, 147, 148, 150, 153, 157, 158]	['The', 'resulting', 'normalized', 'lactonase', 'activity', 'was', 'significantly', 'higher', 'in', 'the', 'group', 'with', 'CAD', ',', 'especially', 'noticeable', 'in', 'individuals', 'with', 'the', 'PON1', '192QQ', 'genotype', '.']	[1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 3, 3, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
When they grouped the CAD patients into those with and without myocardial infarction, however, they found no significant difference for any measure of lactonase activity.	[('PMC8045895', 'R32001', 151, 160, 'lactonase')]	['When', 'they', 'grouped', 'the', 'CA', '##D', 'patients', 'into', 'those', 'with', 'and', 'without', 'my', '##oc', '##ard', '##ial', 'in', '##far', '##ction', ',', 'however', ',', 'they', 'found', 'no', 'significant', 'difference', 'for', 'any', 'measure', 'of', 'la', '##cton', '##ase', 'activity', '.']	[0, 5, 10, 18, 22, 24, 26, 35, 40, 46, 51, 55, 63, 65, 67, 70, 74, 76, 79, 84, 86, 93, 95, 100, 106, 109, 121, 132, 136, 140, 148, 151, 153, 157, 161, 169]	[4, 9, 17, 21, 24, 25, 34, 39, 45, 50, 54, 62, 65, 67, 70, 73, 76, 79, 84, 85, 93, 94, 99, 105, 108, 120, 131, 135, 139, 147, 150, 153, 157, 160, 169, 170]	['When', 'they', 'grouped', 'the', 'CAD', 'patients', 'into', 'those', 'with', 'and', 'without', 'myocardial', 'infarction', ',', 'however', ',', 'they', 'found', 'no', 'significant', 'difference', 'for', 'any', 'measure', 'of', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Another study investigated PON1 activity in apolipoprotein-deficient mice expressing human PON1 by adenovirus-mediated insertion of human paraoxonase 1 (hPON1) into mice cells (Zhang et al., 2010).	[('PMC8045895', 'R34000', 138, 151, 'paraoxonase 1')]	['Another', 'study', 'investigated', 'P', '##ON', '##1', 'activity', 'in', 'a', '##poli', '##pop', '##rote', '##in', '-', 'def', '##icient', 'mice', 'expressing', 'human', 'P', '##ON', '##1', 'by', 'ad', '##eno', '##virus', '-', 'mediated', 'insertion', 'of', 'human', 'para', '##ox', '##ona', '##se', '1', '(', 'h', '##PO', '##N', '##1', ')', 'into', 'mice', 'cells', '(', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[0, 8, 14, 27, 28, 30, 32, 41, 44, 45, 49, 52, 56, 58, 59, 62, 69, 74, 85, 91, 92, 94, 96, 99, 101, 104, 109, 110, 119, 129, 132, 138, 142, 144, 147, 150, 152, 153, 154, 156, 157, 158, 160, 165, 170, 176, 177, 183, 186, 188, 189, 191, 195, 196]	[7, 13, 26, 28, 30, 31, 40, 43, 45, 49, 52, 56, 58, 59, 62, 68, 73, 84, 90, 92, 94, 95, 98, 101, 104, 109, 110, 118, 128, 131, 137, 142, 144, 147, 149, 151, 153, 154, 156, 157, 158, 159, 164, 169, 175, 177, 182, 185, 188, 189, 190, 195, 196, 197]	['Another', 'study', 'investigated', 'PON1', 'activity', 'in', 'apolipoprotein', '-', 'deficient', 'mice', 'expressing', 'human', 'PON1', 'by', 'adenovirus', '-', 'mediated', 'insertion', 'of', 'human', 'paraoxonase', '1', '(', 'hPON1', ')', 'into', 'mice', 'cells', '(', 'Zhang', 'et', 'al', '.', ',', '2010', ')', '.']	[1, 1, 1, 3, 1, 1, 5, 1, 2, 1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors investigated the size of atherosclerotic lesions, which are a risk factor for CVD, and found that transgenic mice with overexpressed hPON1 had significantly higher DHC lactonase activity in their serum, and reduced atherosclerotic lesion size.	[('PMC8045895', 'R34001', 180, 189, 'lactonase')]	['The', 'authors', 'investigated', 'the', 'size', 'of', 'at', '##her', '##os', '##cle', '##rot', '##ic', 'lesions', ',', 'which', 'are', 'a', 'risk', 'factor', 'for', 'C', '##VD', ',', 'and', 'found', 'that', 'trans', '##genic', 'mice', 'with', 'over', '##ex', '##pressed', 'h', '##PO', '##N', '##1', 'had', 'significantly', 'higher', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'in', 'their', 'serum', ',', 'and', 'reduced', 'at', '##her', '##os', '##cle', '##rot', '##ic', 'les', '##ion', 'size', '.']	[0, 4, 12, 25, 29, 34, 37, 39, 42, 44, 47, 50, 53, 60, 62, 68, 72, 74, 79, 86, 90, 91, 93, 95, 99, 105, 110, 115, 121, 126, 131, 135, 137, 145, 146, 148, 149, 151, 155, 169, 176, 177, 180, 182, 186, 190, 199, 202, 208, 213, 215, 219, 227, 229, 232, 234, 237, 240, 243, 246, 250, 254]	[3, 11, 24, 28, 33, 36, 39, 42, 44, 47, 50, 52, 60, 61, 67, 71, 73, 78, 85, 89, 91, 93, 94, 98, 104, 109, 115, 120, 125, 130, 135, 137, 144, 146, 148, 149, 150, 154, 168, 175, 177, 179, 182, 186, 189, 198, 201, 207, 213, 214, 218, 226, 229, 232, 234, 237, 240, 242, 246, 249, 254, 255]	['The', 'authors', 'investigated', 'the', 'size', 'of', 'atherosclerotic', 'lesions', ',', 'which', 'are', 'a', 'risk', 'factor', 'for', 'CVD', ',', 'and', 'found', 'that', 'transgenic', 'mice', 'with', 'overexpressed', 'hPON1', 'had', 'significantly', 'higher', 'DHC', 'lactonase', 'activity', 'in', 'their', 'serum', ',', 'and', 'reduced', 'atherosclerotic', 'lesion', 'size', '.']	[1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 4, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 6, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PON1 lactonase activity has also been investigated in association with liver illnesses.	[('PMC8045895', 'R36000', 5, 14, 'lactonase')]	['P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'has', 'also', 'been', 'investigated', 'in', 'association', 'with', 'liver', 'illness', '##es', '.']	[0, 1, 3, 5, 7, 11, 15, 24, 28, 33, 38, 51, 54, 66, 71, 77, 84, 86]	[1, 3, 4, 7, 11, 14, 23, 27, 32, 37, 50, 53, 65, 70, 76, 84, 86, 87]	['PON1', 'lactonase', 'activity', 'has', 'also', 'been', 'investigated', 'in', 'association', 'with', 'liver', 'illnesses', '.']	[3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
It was found that PON1 lactonase activity for DHC was significantly lower in alcoholic hepatitis compared with controls, and being significantly lower in viral hepatitis compared with alcoholic hepatitis.	[]	['It', 'was', 'found', 'that', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'for', 'D', '##HC', 'was', 'significantly', 'lower', 'in', 'alcoholic', 'he', '##pa', '##titis', 'compared', 'with', 'controls', ',', 'and', 'being', 'significantly', 'lower', 'in', 'viral', 'he', '##pa', '##titis', 'compared', 'with', 'alcoholic', 'he', '##pa', '##titis', '.']	[0, 3, 7, 13, 18, 19, 21, 23, 25, 29, 33, 42, 46, 47, 50, 54, 68, 74, 77, 87, 89, 91, 97, 106, 111, 119, 121, 125, 131, 145, 151, 154, 160, 162, 164, 170, 179, 184, 194, 196, 198, 203]	[2, 6, 12, 17, 19, 21, 22, 25, 29, 32, 41, 45, 47, 49, 53, 67, 73, 76, 86, 89, 91, 96, 105, 110, 119, 120, 124, 130, 144, 150, 153, 159, 162, 164, 169, 178, 183, 193, 196, 198, 203, 204]	['It', 'was', 'found', 'that', 'PON1', 'lactonase', 'activity', 'for', 'DHC', 'was', 'significantly', 'lower', 'in', 'alcoholic', 'hepatitis', 'compared', 'with', 'controls', ',', 'and', 'being', 'significantly', 'lower', 'in', 'viral', 'hepatitis', 'compared', 'with', 'alcoholic', 'hepatitis', '.']	[1, 1, 1, 1, 3, 3, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In another article, the authors investigated TBBL lactonase activity of PON1 in individuals with liver cirrhosis and patients with mild-to-moderate changes in liver function (Marsillach et al., 2009).	[('PMC8045895', 'R37000', 50, 59, 'lactonase')]	['In', 'another', 'article', ',', 'the', 'authors', 'investigated', 'T', '##BB', '##L', 'la', '##cton', '##ase', 'activity', 'of', 'P', '##ON', '##1', 'in', 'individuals', 'with', 'liver', 'c', '##ir', '##r', '##hos', '##is', 'and', 'patients', 'with', 'mild', '-', 'to', '-', 'moderate', 'changes', 'in', 'liver', 'function', '(', 'Mars', '##illa', '##ch', 'et', 'al', '.', ',', '2009', ')', '.']	[0, 3, 11, 18, 20, 24, 32, 45, 46, 48, 50, 52, 56, 60, 69, 72, 73, 75, 77, 80, 92, 97, 103, 104, 106, 107, 110, 113, 117, 126, 131, 135, 136, 138, 139, 148, 156, 159, 165, 174, 175, 179, 183, 186, 189, 191, 192, 194, 198, 199]	[2, 10, 18, 19, 23, 31, 44, 46, 48, 49, 52, 56, 59, 68, 71, 73, 75, 76, 79, 91, 96, 102, 104, 106, 107, 110, 112, 116, 125, 130, 135, 136, 138, 139, 147, 155, 158, 164, 173, 175, 179, 183, 185, 188, 191, 192, 193, 198, 199, 200]	['In', 'another', 'article', ',', 'the', 'authors', 'investigated', 'TBBL', 'lactonase', 'activity', 'of', 'PON1', 'in', 'individuals', 'with', 'liver', 'cirrhosis', 'and', 'patients', 'with', 'mild', '-', 'to', '-', 'moderate', 'changes', 'in', 'liver', 'function', '(', 'Marsillach', 'et', 'al', '.', ',', '2009', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Serum lactonase activity for DHC was also investigated in dairy cows (Samir Farid et al., 2013).	[('PMC8045895', 'R38000', 6, 15, 'lactonase')]	['Ser', '##um', 'la', '##cton', '##ase', 'activity', 'for', 'D', '##HC', 'was', 'also', 'investigated', 'in', 'dairy', 'cows', '(', 'Sami', '##r', 'Far', '##id', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 3, 6, 8, 12, 16, 25, 29, 30, 33, 37, 42, 55, 58, 64, 69, 70, 74, 76, 79, 82, 85, 87, 88, 90, 94, 95]	[3, 5, 8, 12, 15, 24, 28, 30, 32, 36, 41, 54, 57, 63, 68, 70, 74, 75, 79, 81, 84, 87, 88, 89, 94, 95, 96]	['Serum', 'lactonase', 'activity', 'for', 'DHC', 'was', 'also', 'investigated', 'in', 'dairy', 'cows', '(', 'Samir', 'Farid', 'et', 'al', '.', ',', '2013', ')', '.']	[2, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that paraoxonase, DHC lactonase, and arylesterase activity were all significantly lower in animals with fatty liver compared with the control group.	[]	['The', 'authors', 'concluded', 'that', 'para', '##ox', '##ona', '##se', ',', 'D', '##HC', 'la', '##cton', '##ase', ',', 'and', 'a', '##ryl', '##ester', '##ase', 'activity', 'were', 'all', 'significantly', 'lower', 'in', 'animals', 'with', 'fatty', 'liver', 'compared', 'with', 'the', 'control', 'group', '.']	[0, 4, 12, 22, 27, 31, 33, 36, 38, 40, 41, 44, 46, 50, 53, 55, 59, 60, 63, 68, 72, 81, 86, 90, 104, 110, 113, 121, 126, 132, 138, 147, 152, 156, 164, 169]	[3, 11, 21, 26, 31, 33, 36, 38, 39, 41, 43, 46, 50, 53, 54, 58, 60, 63, 68, 71, 80, 85, 89, 103, 109, 112, 120, 125, 131, 137, 146, 151, 155, 163, 169, 170]	['The', 'authors', 'concluded', 'that', 'paraoxonase', ',', 'DHC', 'lactonase', ',', 'and', 'arylesterase', 'activity', 'were', 'all', 'significantly', 'lower', 'in', 'animals', 'with', 'fatty', 'liver', 'compared', 'with', 'the', 'control', 'group', '.']	[1, 1, 1, 1, 4, 1, 2, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Another factor that has been thoroughly studied in association with PON1 lactonase activity is body weight.	[('PMC8045895', 'R39000', 73, 82, 'lactonase')]	['Another', 'factor', 'that', 'has', 'been', 'thoroughly', 'studied', 'in', 'association', 'with', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'is', 'body', 'weight', '.']	[0, 8, 15, 20, 24, 29, 40, 48, 51, 63, 68, 69, 71, 73, 75, 79, 83, 92, 95, 100, 106]	[7, 14, 19, 23, 28, 39, 47, 50, 62, 67, 69, 71, 72, 75, 79, 82, 91, 94, 99, 106, 107]	['Another', 'factor', 'that', 'has', 'been', 'thoroughly', 'studied', 'in', 'association', 'with', 'PON1', 'lactonase', 'activity', 'is', 'body', 'weight', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Three articles reported on the association between body weight and DHC lactonase activity (Alaminos-Castillo et al., 2019; Bacchetti et al., 2019; Rupérez et al., 2013), Ferré et al. (2013) investigated TBBL and Cervellati et al.	[('PMC8045895', 'R39001', 71, 80, 'lactonase')]	['Three', 'articles', 'reported', 'on', 'the', 'association', 'between', 'body', 'weight', 'and', 'D', '##HC', 'la', '##cton', '##ase', 'activity', '(', 'Al', '##ami', '##nos', '-', 'Castillo', 'et', 'al', '.', ',', '2019', ';', 'Ba', '##cc', '##he', '##tti', 'et', 'al', '.', ',', '2019', ';', 'R', '##up', '##é', '##rez', 'et', 'al', '.', ',', '2013', ')', ',', 'Fe', '##rr', '##é', 'et', 'al', '.', '(', '2013', ')', 'investigated', 'T', '##BB', '##L', 'and', 'Ce', '##rve', '##lla', '##ti', 'et', 'al', '.']	[0, 6, 15, 24, 27, 31, 43, 51, 56, 63, 67, 68, 71, 73, 77, 81, 90, 91, 93, 96, 99, 100, 109, 112, 114, 115, 117, 121, 123, 125, 127, 129, 133, 136, 138, 139, 141, 145, 147, 148, 150, 151, 155, 158, 160, 161, 163, 167, 168, 170, 172, 174, 176, 179, 181, 183, 184, 188, 190, 203, 204, 206, 208, 212, 214, 217, 220, 223, 226, 228]	[5, 14, 23, 26, 30, 42, 50, 55, 62, 66, 68, 70, 73, 77, 80, 89, 91, 93, 96, 99, 100, 108, 111, 114, 115, 116, 121, 122, 125, 127, 129, 132, 135, 138, 139, 140, 145, 146, 148, 150, 151, 154, 157, 160, 161, 162, 167, 168, 169, 172, 174, 175, 178, 181, 182, 184, 188, 189, 202, 204, 206, 207, 211, 214, 217, 220, 222, 225, 228, 229]	['Three', 'articles', 'reported', 'on', 'the', 'association', 'between', 'body', 'weight', 'and', 'DHC', 'lactonase', 'activity', '(', 'Alaminos-Castillo', 'et', 'al', '.', ',', '2019', ';', 'Bacchetti', 'et', 'al', '.', ',', '2019', ';', 'Rupérez', 'et', 'al', '.', ',', '2013', ')', ',', 'Ferré', 'et', 'al', '.', '(', '2013', ')', 'investigated', 'TBBL', 'and', 'Cervellati', 'et', 'al', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 5, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Of these five articles, three of them found a significant correlation between PON1 lactonase activity and obesity (Alaminos-Castillo et al., 2019; Bacchetti et al., 2019; Ferré et al., 2013).	[]	['Of', 'these', 'five', 'articles', ',', 'three', 'of', 'them', 'found', 'a', 'significant', 'correlation', 'between', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'and', 'o', '##besity', '(', 'Al', '##ami', '##nos', '-', 'Castillo', 'et', 'al', '.', ',', '2019', ';', 'Ba', '##cc', '##he', '##tti', 'et', 'al', '.', ',', '2019', ';', 'Fe', '##rr', '##é', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 3, 9, 14, 22, 24, 30, 33, 38, 44, 46, 58, 70, 78, 79, 81, 83, 85, 89, 93, 102, 106, 107, 114, 115, 117, 120, 123, 124, 133, 136, 138, 139, 141, 145, 147, 149, 151, 153, 157, 160, 162, 163, 165, 169, 171, 173, 175, 177, 180, 182, 183, 185, 189, 190]	[2, 8, 13, 22, 23, 29, 32, 37, 43, 45, 57, 69, 77, 79, 81, 82, 85, 89, 92, 101, 105, 107, 113, 115, 117, 120, 123, 124, 132, 135, 138, 139, 140, 145, 146, 149, 151, 153, 156, 159, 162, 163, 164, 169, 170, 173, 175, 176, 179, 182, 183, 184, 189, 190, 191]	['Of', 'these', 'five', 'articles', ',', 'three', 'of', 'them', 'found', 'a', 'significant', 'correlation', 'between', 'PON1', 'lactonase', 'activity', 'and', 'obesity', '(', 'Alaminos-Castillo', 'et', 'al', '.', ',', '2019', ';', 'Bacchetti', 'et', 'al', '.', ',', '2019', ';', 'Ferré', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alaminos-Castillo et al. (2019) reported that DHC lactonase activity is significantly decreased in obese subjects compared with nonobese controls, and increases after surgery.	[('PMC8045895', 'R40000', 50, 59, 'lactonase')]	['Al', '##ami', '##nos', '-', 'Castillo', 'et', 'al', '.', '(', '2019', ')', 'reported', 'that', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'is', 'significantly', 'decreased', 'in', 'o', '##bes', '##e', 'subjects', 'compared', 'with', 'non', '##obe', '##se', 'controls', ',', 'and', 'increases', 'after', 'surgery', '.']	[0, 2, 5, 8, 9, 18, 21, 23, 25, 26, 30, 32, 41, 46, 47, 50, 52, 56, 60, 69, 72, 86, 96, 99, 100, 103, 105, 114, 123, 128, 131, 134, 137, 145, 147, 151, 161, 167, 174]	[2, 5, 8, 9, 17, 20, 23, 24, 26, 30, 31, 40, 45, 47, 49, 52, 56, 59, 68, 71, 85, 95, 98, 100, 103, 104, 113, 122, 127, 131, 134, 136, 145, 146, 150, 160, 166, 174, 175]	['Alaminos-Castillo', 'et', 'al', '.', '(', '2019', ')', 'reported', 'that', 'DHC', 'lactonase', 'activity', 'is', 'significantly', 'decreased', 'in', 'obese', 'subjects', 'compared', 'with', 'nonobese', 'controls', ',', 'and', 'increases', 'after', 'surgery', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bacchetti et al. (2019) grouped cases into two categories, overweight women and obese women, and detected that DHC lactonase activity is significantly decreased in each subsequent category compared with healthy individuals (Bacchetti et al., 2019).	[('PMC8045895', 'R40001', 115, 124, 'lactonase')]	['Ba', '##cc', '##he', '##tti', 'et', 'al', '.', '(', '2019', ')', 'grouped', 'cases', 'into', 'two', 'categories', ',', 'over', '##weight', 'women', 'and', 'o', '##bes', '##e', 'women', ',', 'and', 'detected', 'that', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'is', 'significantly', 'decreased', 'in', 'each', 'subsequent', 'category', 'compared', 'with', 'healthy', 'individuals', '(', 'Ba', '##cc', '##he', '##tti', 'et', 'al', '.', ',', '2019', ')', '.']	[0, 2, 4, 6, 10, 13, 15, 17, 18, 22, 24, 32, 38, 43, 47, 57, 59, 63, 70, 76, 80, 81, 84, 86, 91, 93, 97, 106, 111, 112, 115, 117, 121, 125, 134, 137, 151, 161, 164, 169, 180, 189, 198, 203, 211, 223, 224, 226, 228, 230, 234, 237, 239, 240, 242, 246, 247]	[2, 4, 6, 9, 12, 15, 16, 18, 22, 23, 31, 37, 42, 46, 57, 58, 63, 69, 75, 79, 81, 84, 85, 91, 92, 96, 105, 110, 112, 114, 117, 121, 124, 133, 136, 150, 160, 163, 168, 179, 188, 197, 202, 210, 222, 224, 226, 228, 230, 233, 236, 239, 240, 241, 246, 247, 248]	['Bacchetti', 'et', 'al', '.', '(', '2019', ')', 'grouped', 'cases', 'into', 'two', 'categories', ',', 'overweight', 'women', 'and', 'obese', 'women', ',', 'and', 'detected', 'that', 'DHC', 'lactonase', 'activity', 'is', 'significantly', 'decreased', 'in', 'each', 'subsequent', 'category', 'compared', 'with', 'healthy', 'individuals', '(', 'Bacchetti', 'et', 'al', '.', ',', '2019', ')', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Ferré et al. (2013) showed a significant decrease in TBBL lactonase activity in obese children compared with nonobese controls.	[('PMC8045895', 'R40002', 58, 67, 'lactonase')]	['Fe', '##rr', '##é', 'et', 'al', '.', '(', '2013', ')', 'showed', 'a', 'significant', 'decrease', 'in', 'T', '##BB', '##L', 'la', '##cton', '##ase', 'activity', 'in', 'o', '##bes', '##e', 'children', 'compared', 'with', 'non', '##obe', '##se', 'controls', '.']	[0, 2, 4, 6, 9, 11, 13, 14, 18, 20, 27, 29, 41, 50, 53, 54, 56, 58, 60, 64, 68, 77, 80, 81, 84, 86, 95, 104, 109, 112, 115, 118, 126]	[2, 4, 5, 8, 11, 12, 14, 18, 19, 26, 28, 40, 49, 52, 54, 56, 57, 60, 64, 67, 76, 79, 81, 84, 85, 94, 103, 108, 112, 115, 117, 126, 127]	['Ferré', 'et', 'al', '.', '(', '2013', ')', 'showed', 'a', 'significant', 'decrease', 'in', 'TBBL', 'lactonase', 'activity', 'in', 'obese', 'children', 'compared', 'with', 'nonobese', 'controls', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Rupérez et al (2013) did not find an association between PON1 lactonase activity and obesity.	[('PMC8045895', 'R41000', 62, 71, 'lactonase')]	['R', '##up', '##é', '##rez', 'et', 'al', '(', '2013', ')', 'did', 'not', 'find', 'an', 'association', 'between', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'and', 'o', '##besity', '.']	[0, 1, 3, 4, 8, 11, 14, 15, 19, 21, 25, 29, 34, 37, 49, 57, 58, 60, 62, 64, 68, 72, 81, 85, 86, 92]	[1, 3, 4, 7, 10, 13, 15, 19, 20, 24, 28, 33, 36, 48, 56, 58, 60, 61, 64, 68, 71, 80, 84, 86, 92, 93]	['Rupérez', 'et', 'al', '(', '2013', ')', 'did', 'not', 'find', 'an', 'association', 'between', 'PON1', 'lactonase', 'activity', 'and', 'obesity', '.']	[4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 2, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O']
Although the authors did not find an association between childhood obesity and any of PON1's enzymatic activities, they did find a positive correlation of DHC lactonase activity with HDL, as well as with concentration of antioxidants.	[('PMC8045895', 'R41001', 159, 168, 'lactonase')]	"['Although', 'the', 'authors', 'did', 'not', 'find', 'an', 'association', 'between', 'childhood', 'o', '##besity', 'and', 'any', 'of', 'P', '##ON', '##1', ""'"", 's', 'en', '##zy', '##matic', 'activities', ',', 'they', 'did', 'find', 'a', 'positive', 'correlation', 'of', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'with', 'HD', '##L', ',', 'as', 'well', 'as', 'with', 'concentration', 'of', 'anti', '##ox', '##ida', '##nts', '.']"	[0, 9, 13, 21, 25, 29, 34, 37, 49, 57, 67, 68, 75, 79, 83, 86, 87, 89, 90, 91, 93, 95, 97, 103, 113, 115, 120, 124, 129, 131, 140, 152, 155, 156, 159, 161, 165, 169, 178, 183, 185, 186, 188, 191, 196, 199, 204, 218, 221, 225, 227, 230, 233]	[8, 12, 20, 24, 28, 33, 36, 48, 56, 66, 68, 74, 78, 82, 85, 87, 89, 90, 91, 92, 95, 97, 102, 113, 114, 119, 123, 128, 130, 139, 151, 154, 156, 158, 161, 165, 168, 177, 182, 185, 186, 187, 190, 195, 198, 203, 217, 220, 225, 227, 230, 233, 234]	"['Although', 'the', 'authors', 'did', 'not', 'find', 'an', 'association', 'between', 'childhood', 'obesity', 'and', 'any', 'of', ""PON1's"", 'enzymatic', 'activities', ',', 'they', 'did', 'find', 'a', 'positive', 'correlation', 'of', 'DHC', 'lactonase', 'activity', 'with', 'HDL', ',', 'as', 'well', 'as', 'with', 'concentration', 'of', 'antioxidants', '.']"	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
demonstrated a significant decrease in arylesterase activity in very obese subjects; however, they did not show any difference in paraoxonase activity and TBBL lactonase activity between the groups.	[]	['demonstrated', 'a', 'significant', 'decrease', 'in', 'a', '##ryl', '##ester', '##ase', 'activity', 'in', 'very', 'o', '##bes', '##e', 'subjects', ';', 'however', ',', 'they', 'did', 'not', 'show', 'any', 'difference', 'in', 'para', '##ox', '##ona', '##se', 'activity', 'and', 'T', '##BB', '##L', 'la', '##cton', '##ase', 'activity', 'between', 'the', 'groups', '.']	[0, 13, 15, 27, 36, 39, 40, 43, 48, 52, 61, 64, 69, 70, 73, 75, 83, 85, 92, 94, 99, 103, 107, 112, 116, 127, 130, 134, 136, 139, 142, 151, 155, 156, 158, 160, 162, 166, 170, 179, 187, 191, 197]	[12, 14, 26, 35, 38, 40, 43, 48, 51, 60, 63, 68, 70, 73, 74, 83, 84, 92, 93, 98, 102, 106, 111, 115, 126, 129, 134, 136, 139, 141, 150, 154, 156, 158, 159, 162, 166, 169, 178, 186, 190, 197, 198]	['demonstrated', 'a', 'significant', 'decrease', 'in', 'arylesterase', 'activity', 'in', 'very', 'obese', 'subjects', ';', 'however', ',', 'they', 'did', 'not', 'show', 'any', 'difference', 'in', 'paraoxonase', 'activity', 'and', 'TBBL', 'lactonase', 'activity', 'between', 'the', 'groups', '.']	[1, 1, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 3, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Five articles reported on PON1 lactonase activity in the context of diabetes (Craciun et al., 2016, Rosenblat et al., 2006, Passaro et al., 2018, Zhou et al., 2020a, 2020b).	[('PMC8045895', 'R42000', 31, 40, 'lactonase')]	['Five', 'articles', 'reported', 'on', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'in', 'the', 'context', 'of', 'diabetes', '(', 'C', '##rac', '##iu', '##n', 'et', 'al', '.', ',', '2016', ',', 'Rosen', '##bla', '##t', 'et', 'al', '.', ',', '2006', ',', 'Pass', '##aro', 'et', 'al', '.', ',', '2018', ',', 'Zhou', 'et', 'al', '.', ',', '2020', '##a', ',', '2020', '##b', ')', '.']	[0, 5, 14, 23, 26, 27, 29, 31, 33, 37, 41, 50, 53, 57, 65, 68, 77, 78, 79, 82, 84, 86, 89, 91, 92, 94, 98, 100, 105, 108, 110, 113, 115, 116, 118, 122, 124, 128, 132, 135, 137, 138, 140, 144, 146, 151, 154, 156, 157, 159, 163, 164, 166, 170, 171, 172]	[4, 13, 22, 25, 27, 29, 30, 33, 37, 40, 49, 52, 56, 64, 67, 76, 78, 79, 82, 84, 85, 88, 91, 92, 93, 98, 99, 105, 108, 109, 112, 115, 116, 117, 122, 123, 128, 131, 134, 137, 138, 139, 144, 145, 150, 153, 156, 157, 158, 163, 164, 165, 170, 171, 172, 173]	['Five', 'articles', 'reported', 'on', 'PON1', 'lactonase', 'activity', 'in', 'the', 'context', 'of', 'diabetes', '(', 'Craciun', 'et', 'al', '.', ',', '2016', ',', 'Rosenblat', 'et', 'al', '.', ',', '2006', ',', 'Passaro', 'et', 'al', '.', ',', '2018', ',', 'Zhou', 'et', 'al', '.', ',', '2020a', ',', '2020b', ')', '.']	[1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In women with gestational diabetes mellitus, no significant difference was found in either TBBL lactonase activity or PON1 concentration between women with diabetes and healthy controls (Zhou et al., 2020a).	[('PMC8045895', 'R43000', 96, 105, 'lactonase')]	['In', 'women', 'with', 'g', '##esta', '##tional', 'diabetes', 'me', '##lli', '##tus', ',', 'no', 'significant', 'difference', 'was', 'found', 'in', 'either', 'T', '##BB', '##L', 'la', '##cton', '##ase', 'activity', 'or', 'P', '##ON', '##1', 'concentration', 'between', 'women', 'with', 'diabetes', 'and', 'healthy', 'controls', '(', 'Zhou', 'et', 'al', '.', ',', '2020', '##a', ')', '.']	[0, 3, 9, 14, 15, 19, 26, 35, 37, 40, 43, 45, 48, 60, 71, 75, 81, 84, 91, 92, 94, 96, 98, 102, 106, 115, 118, 119, 121, 123, 137, 145, 151, 156, 165, 169, 177, 186, 187, 192, 195, 197, 198, 200, 204, 205, 206]	[2, 8, 13, 15, 19, 25, 34, 37, 40, 43, 44, 47, 59, 70, 74, 80, 83, 90, 92, 94, 95, 98, 102, 105, 114, 117, 119, 121, 122, 136, 144, 150, 155, 164, 168, 176, 185, 187, 191, 194, 197, 198, 199, 204, 205, 206, 207]	['In', 'women', 'with', 'gestational', 'diabetes', 'mellitus', ',', 'no', 'significant', 'difference', 'was', 'found', 'in', 'either', 'TBBL', 'lactonase', 'activity', 'or', 'PON1', 'concentration', 'between', 'women', 'with', 'diabetes', 'and', 'healthy', 'controls', '(', 'Zhou', 'et', 'al', '.', ',', '2020a', ')', '.']	[1, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A significant decrease in δ-valerolactone lactonase activity was noted between controls and patients who had both type 1 diabetes and a high amount of hemoglobin glycation.	[]	['A', 'significant', 'decrease', 'in', 'δ', '-', 'v', '##ale', '##rol', '##act', '##one', 'la', '##cton', '##ase', 'activity', 'was', 'noted', 'between', 'controls', 'and', 'patients', 'who', 'had', 'both', 'type', '1', 'diabetes', 'and', 'a', 'high', 'amount', 'of', 'hem', '##og', '##lo', '##bin', 'g', '##ly', '##cation', '.']	[0, 2, 14, 23, 26, 27, 28, 29, 32, 35, 38, 42, 44, 48, 52, 61, 65, 71, 79, 88, 92, 101, 105, 109, 114, 119, 121, 130, 134, 136, 141, 148, 151, 154, 156, 158, 162, 163, 165, 171]	[1, 13, 22, 25, 27, 28, 29, 32, 35, 38, 41, 44, 48, 51, 60, 64, 70, 78, 87, 91, 100, 104, 108, 113, 118, 120, 129, 133, 135, 140, 147, 150, 154, 156, 158, 161, 163, 165, 171, 172]	['A', 'significant', 'decrease', 'in', 'δ-valerolactone', 'lactonase', 'activity', 'was', 'noted', 'between', 'controls', 'and', 'patients', 'who', 'had', 'both', 'type', '1', 'diabetes', 'and', 'a', 'high', 'amount', 'of', 'hemoglobin', 'glycation', '.']	[1, 1, 1, 1, 7, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
DHC lactonase activity was also investigated in a study that compared patients with diabetes, patients with hypercholesterolemia, and healthy controls.	[('PMC8045895', 'R45000', 4, 13, 'lactonase')]	['D', '##HC', 'la', '##cton', '##ase', 'activity', 'was', 'also', 'investigated', 'in', 'a', 'study', 'that', 'compared', 'patients', 'with', 'diabetes', ',', 'patients', 'with', 'h', '##yper', '##cho', '##les', '##tero', '##lem', '##ia', ',', 'and', 'healthy', 'controls', '.']	[0, 1, 4, 6, 10, 14, 23, 27, 32, 45, 48, 50, 56, 61, 70, 79, 84, 92, 94, 103, 108, 109, 113, 116, 119, 123, 126, 128, 130, 134, 142, 150]	[1, 3, 6, 10, 13, 22, 26, 31, 44, 47, 49, 55, 60, 69, 78, 83, 92, 93, 102, 107, 109, 113, 116, 119, 123, 126, 128, 129, 133, 141, 150, 151]	['DHC', 'lactonase', 'activity', 'was', 'also', 'investigated', 'in', 'a', 'study', 'that', 'compared', 'patients', 'with', 'diabetes', ',', 'patients', 'with', 'hypercholesterolemia', ',', 'and', 'healthy', 'controls', '.']	[2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 7, 1, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The conclusion was that lactonase activity was significantly reduced in both groups of patients, where diabetic patients had the lowest activity.	[('PMC8045895', 'R45001', 24, 33, 'lactonase')]	['The', 'conclusion', 'was', 'that', 'la', '##cton', '##ase', 'activity', 'was', 'significantly', 'reduced', 'in', 'both', 'groups', 'of', 'patients', ',', 'where', 'di', '##abe', '##tic', 'patients', 'had', 'the', 'lowest', 'activity', '.']	[0, 4, 15, 19, 24, 26, 30, 34, 43, 47, 61, 69, 72, 77, 84, 87, 95, 97, 103, 105, 108, 112, 121, 125, 129, 136, 144]	[3, 14, 18, 23, 26, 30, 33, 42, 46, 60, 68, 71, 76, 83, 86, 95, 96, 102, 105, 108, 111, 120, 124, 128, 135, 144, 145]	['The', 'conclusion', 'was', 'that', 'lactonase', 'activity', 'was', 'significantly', 'reduced', 'in', 'both', 'groups', 'of', 'patients', ',', 'where', 'diabetic', 'patients', 'had', 'the', 'lowest', 'activity', '.']	[1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The same results were acquired for both paraoxonase activity and arylesterase activity (Rosenblat et al., 2006).	[('PMC8045895', 'R45002', 40, 51, 'paraoxonase')]	['The', 'same', 'results', 'were', 'acquired', 'for', 'both', 'para', '##ox', '##ona', '##se', 'activity', 'and', 'a', '##ryl', '##ester', '##ase', 'activity', '(', 'Rosen', '##bla', '##t', 'et', 'al', '.', ',', '2006', ')', '.']	[0, 4, 9, 17, 22, 31, 35, 40, 44, 46, 49, 52, 61, 65, 66, 69, 74, 78, 87, 88, 93, 96, 98, 101, 103, 104, 106, 110, 111]	[3, 8, 16, 21, 30, 34, 39, 44, 46, 49, 51, 60, 64, 66, 69, 74, 77, 86, 88, 93, 96, 97, 100, 103, 104, 105, 110, 111, 112]	['The', 'same', 'results', 'were', 'acquired', 'for', 'both', 'paraoxonase', 'activity', 'and', 'arylesterase', 'activity', '(', 'Rosenblat', 'et', 'al', '.', ',', '2006', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that there is no correlation between lactonase activity and presence of diabetes, whereas diabetic patients on average had significantly lower arylesterase activity than healthy controls (Passaro et al., 2018).	[]	['The', 'authors', 'concluded', 'that', 'there', 'is', 'no', 'correlation', 'between', 'la', '##cton', '##ase', 'activity', 'and', 'presence', 'of', 'diabetes', ',', 'whereas', 'di', '##abe', '##tic', 'patients', 'on', 'average', 'had', 'significantly', 'lower', 'a', '##ryl', '##ester', '##ase', 'activity', 'than', 'healthy', 'controls', '(', 'Pass', '##aro', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 4, 12, 22, 27, 33, 36, 39, 51, 59, 61, 65, 69, 78, 82, 91, 94, 102, 104, 112, 114, 117, 121, 130, 133, 141, 145, 159, 165, 166, 169, 174, 178, 187, 192, 200, 209, 210, 214, 218, 221, 223, 224, 226, 230, 231]	[3, 11, 21, 26, 32, 35, 38, 50, 58, 61, 65, 68, 77, 81, 90, 93, 102, 103, 111, 114, 117, 120, 129, 132, 140, 144, 158, 164, 166, 169, 174, 177, 186, 191, 199, 208, 210, 214, 217, 220, 223, 224, 225, 230, 231, 232]	['The', 'authors', 'concluded', 'that', 'there', 'is', 'no', 'correlation', 'between', 'lactonase', 'activity', 'and', 'presence', 'of', 'diabetes', ',', 'whereas', 'diabetic', 'patients', 'on', 'average', 'had', 'significantly', 'lower', 'arylesterase', 'activity', 'than', 'healthy', 'controls', '(', 'Passaro', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
compared PON1 lactonase activity for TBBL in neonates with diabetic mothers and in neonates with mothers without diabetes (Zhou et al., 2020b).	[]	['compared', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'for', 'T', '##BB', '##L', 'in', 'neon', '##ates', 'with', 'di', '##abe', '##tic', 'mothers', 'and', 'in', 'neon', '##ates', 'with', 'mothers', 'without', 'diabetes', '(', 'Zhou', 'et', 'al', '.', ',', '2020', '##b', ')', '.']	[0, 9, 10, 12, 14, 16, 20, 24, 33, 37, 38, 40, 42, 45, 49, 54, 59, 61, 64, 68, 76, 80, 83, 87, 92, 97, 105, 113, 122, 123, 128, 131, 133, 134, 136, 140, 141, 142]	[8, 10, 12, 13, 16, 20, 23, 32, 36, 38, 40, 41, 44, 49, 53, 58, 61, 64, 67, 75, 79, 82, 87, 91, 96, 104, 112, 121, 123, 127, 130, 133, 134, 135, 140, 141, 142, 143]	['compared', 'PON1', 'lactonase', 'activity', 'for', 'TBBL', 'in', 'neonates', 'with', 'diabetic', 'mothers', 'and', 'in', 'neonates', 'with', 'mothers', 'without', 'diabetes', '(', 'Zhou', 'et', 'al', '.', ',', '2020b', ')', '.']	[1, 3, 3, 1, 1, 3, 1, 2, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
They found a significant increase in both lactonase activity and DEPCyMC-normalized lactonase activity in children of diabetic patients compared with healthy controls.	[]	['They', 'found', 'a', 'significant', 'increase', 'in', 'both', 'la', '##cton', '##ase', 'activity', 'and', 'DE', '##PC', '##y', '##MC', '-', 'normal', '##ized', 'la', '##cton', '##ase', 'activity', 'in', 'children', 'of', 'di', '##abe', '##tic', 'patients', 'compared', 'with', 'healthy', 'controls', '.']	[0, 5, 11, 13, 25, 34, 37, 42, 44, 48, 52, 61, 65, 67, 69, 70, 72, 73, 79, 84, 86, 90, 94, 103, 106, 115, 118, 120, 123, 127, 136, 145, 150, 158, 166]	[4, 10, 12, 24, 33, 36, 41, 44, 48, 51, 60, 64, 67, 69, 70, 72, 73, 79, 83, 86, 90, 93, 102, 105, 114, 117, 120, 123, 126, 135, 144, 149, 157, 166, 167]	['They', 'found', 'a', 'significant', 'increase', 'in', 'both', 'lactonase', 'activity', 'and', 'DEPCyMC-normalized', 'lactonase', 'activity', 'in', 'children', 'of', 'diabetic', 'patients', 'compared', 'with', 'healthy', 'controls', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 7, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
PON1 lactonase activity for DHC was also compared for Alzheimer's disease (AD) patients and healthy controls.	[('PMC8045895', 'R48000', 5, 14, 'lactonase')]	"['P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'for', 'D', '##HC', 'was', 'also', 'compared', 'for', 'Alzheimer', ""'"", 's', 'disease', '(', 'AD', ')', 'patients', 'and', 'healthy', 'controls', '.']"	[0, 1, 3, 5, 7, 11, 15, 24, 28, 29, 32, 36, 41, 50, 54, 63, 64, 66, 74, 75, 77, 79, 88, 92, 100, 108]	[1, 3, 4, 7, 11, 14, 23, 27, 29, 31, 35, 40, 49, 53, 63, 64, 65, 73, 75, 77, 78, 87, 91, 99, 108, 109]	"['PON1', 'lactonase', 'activity', 'for', 'DHC', 'was', 'also', 'compared', 'for', ""Alzheimer's"", 'disease', '(', 'AD', ')', 'patients', 'and', 'healthy', 'controls', '.']"	[3, 3, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The researchers measured lactonase activity and calculated the quotients lactonase activity/HDL concentration and lactonase activity/LDL concentration.	[('PMC8045895', 'R48001', 25, 34, 'lactonase')]	['The', 'researchers', 'measured', 'la', '##cton', '##ase', 'activity', 'and', 'calculated', 'the', 'q', '##uo', '##tien', '##ts', 'la', '##cton', '##ase', 'activity', '/', 'HD', '##L', 'concentration', 'and', 'la', '##cton', '##ase', 'activity', '/', 'L', '##D', '##L', 'concentration', '.']	[0, 4, 16, 25, 27, 31, 35, 44, 48, 59, 63, 64, 66, 70, 73, 75, 79, 83, 91, 92, 94, 96, 110, 114, 116, 120, 124, 132, 133, 134, 135, 137, 150]	[3, 15, 24, 27, 31, 34, 43, 47, 58, 62, 64, 66, 70, 72, 75, 79, 82, 91, 92, 94, 95, 109, 113, 116, 120, 123, 132, 133, 134, 135, 136, 150, 151]	['The', 'researchers', 'measured', 'lactonase', 'activity', 'and', 'calculated', 'the', 'quotients', 'lactonase', 'activity', '/', 'HDL', 'concentration', 'and', 'lactonase', 'activity', '/', 'LDL', 'concentration', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 4, 3, 1, 1, 2, 1, 1, 3, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Several other medical conditions were studied in association with PON1 lactonase activity: among them are intestinal cancer, psoriasis, celiac disease, hereditary hemochromatosis, chronic kidney disease (CKD), renal disease, chronic obstructive pulmonary disease (COPB), bronchial asthma, and acute pancreatitis.	[('PMC8045895', 'R49000', 71, 80, 'lactonase')]	['Several', 'other', 'medical', 'conditions', 'were', 'studied', 'in', 'association', 'with', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', ':', 'among', 'them', 'are', 'in', '##test', '##inal', 'cancer', ',', 'ps', '##oria', '##sis', ',', 'c', '##eli', '##ac', 'disease', ',', 'hereditary', 'hem', '##och', '##roma', '##tosis', ',', 'chronic', 'kidney', 'disease', '(', 'C', '##K', '##D', ')', ',', 're', '##nal', 'disease', ',', 'chronic', 'o', '##bs', '##truct', '##ive', 'pulmonary', 'disease', '(', 'CO', '##P', '##B', ')', ',', 'br', '##on', '##chia', '##l', 'as', '##th', '##ma', ',', 'and', 'acute', 'pan', '##cre', '##ati', '##tis', '.']	[0, 8, 14, 22, 33, 38, 46, 49, 61, 66, 67, 69, 71, 73, 77, 81, 89, 91, 97, 102, 106, 108, 112, 117, 123, 125, 127, 131, 134, 136, 137, 140, 143, 150, 152, 163, 166, 169, 173, 178, 180, 188, 195, 203, 204, 205, 206, 207, 208, 210, 212, 216, 223, 225, 233, 234, 236, 241, 245, 255, 263, 264, 266, 267, 268, 269, 271, 273, 275, 279, 281, 283, 285, 287, 289, 293, 299, 302, 305, 308, 311]	[7, 13, 21, 32, 37, 45, 48, 60, 65, 67, 69, 70, 73, 77, 80, 89, 90, 96, 101, 105, 108, 112, 116, 123, 124, 127, 131, 134, 135, 137, 140, 142, 150, 151, 162, 166, 169, 173, 178, 179, 187, 194, 202, 204, 205, 206, 207, 208, 209, 212, 215, 223, 224, 232, 234, 236, 241, 244, 254, 262, 264, 266, 267, 268, 269, 270, 273, 275, 279, 280, 283, 285, 287, 288, 292, 298, 302, 305, 308, 311, 312]	['Several', 'other', 'medical', 'conditions', 'were', 'studied', 'in', 'association', 'with', 'PON1', 'lactonase', 'activity', ':', 'among', 'them', 'are', 'intestinal', 'cancer', ',', 'psoriasis', ',', 'celiac', 'disease', ',', 'hereditary', 'hemochromatosis', ',', 'chronic', 'kidney', 'disease', '(', 'CKD', ')', ',', 'renal', 'disease', ',', 'chronic', 'obstructive', 'pulmonary', 'disease', '(', 'COPB', ')', ',', 'bronchial', 'asthma', ',', 'and', 'acute', 'pancreatitis', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 4, 3, 1, 1, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Bains et al. (2019) compared PON1 lactonase activity in patients with intestinal cancer before and after treatment.	[('PMC8045895', 'R50000', 34, 43, 'lactonase')]	['Bai', '##ns', 'et', 'al', '.', '(', '2019', ')', 'compared', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'in', 'patients', 'with', 'in', '##test', '##inal', 'cancer', 'before', 'and', 'after', 'treatment', '.']	[0, 3, 6, 9, 11, 13, 14, 18, 20, 29, 30, 32, 34, 36, 40, 44, 53, 56, 65, 70, 72, 76, 81, 88, 95, 99, 105, 114]	[3, 5, 8, 11, 12, 14, 18, 19, 28, 30, 32, 33, 36, 40, 43, 52, 55, 64, 69, 72, 76, 80, 87, 94, 98, 104, 114, 115]	['Bains', 'et', 'al', '.', '(', '2019', ')', 'compared', 'PON1', 'lactonase', 'activity', 'in', 'patients', 'with', 'intestinal', 'cancer', 'before', 'and', 'after', 'treatment', '.']	[2, 1, 1, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors concluded that both arylesterase and DHC lactonase activity significantly decreased after the surgery (compared with before treatment), and then increased again with time (Bains et al., 2019).	[('PMC8045895', 'R50001', 32, 44, 'arylesterase')]	['The', 'authors', 'concluded', 'that', 'both', 'a', '##ryl', '##ester', '##ase', 'and', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'significantly', 'decreased', 'after', 'the', 'surgery', '(', 'compared', 'with', 'before', 'treatment', ')', ',', 'and', 'then', 'increased', 'again', 'with', 'time', '(', 'Bai', '##ns', 'et', 'al', '.', ',', '2019', ')', '.']	[0, 4, 12, 22, 27, 32, 33, 36, 41, 45, 49, 50, 53, 55, 59, 63, 72, 86, 96, 102, 106, 114, 115, 124, 129, 136, 145, 146, 148, 152, 157, 167, 173, 178, 183, 184, 187, 190, 193, 195, 196, 198, 202, 203]	[3, 11, 21, 26, 31, 33, 36, 41, 44, 48, 50, 52, 55, 59, 62, 71, 85, 95, 101, 105, 113, 115, 123, 128, 135, 145, 146, 147, 151, 156, 166, 172, 177, 182, 184, 187, 189, 192, 195, 196, 197, 202, 203, 204]	['The', 'authors', 'concluded', 'that', 'both', 'arylesterase', 'and', 'DHC', 'lactonase', 'activity', 'significantly', 'decreased', 'after', 'the', 'surgery', '(', 'compared', 'with', 'before', 'treatment', ')', ',', 'and', 'then', 'increased', 'again', 'with', 'time', '(', 'Bains', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 1, 1, 1, 1, 4, 1, 2, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In psoriatic children, DHC lactonase activity of PON1, as well as arylesterase and paraoxonase activities were found to all be significantly reduced compared with healthy controls (Bacchetti et al., 2020).	[('PMC8045895', 'R51000', 27, 36, 'lactonase')]	['In', 'ps', '##oria', '##tic', 'children', ',', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'of', 'P', '##ON', '##1', ',', 'as', 'well', 'as', 'a', '##ryl', '##ester', '##ase', 'and', 'para', '##ox', '##ona', '##se', 'activities', 'were', 'found', 'to', 'all', 'be', 'significantly', 'reduced', 'compared', 'with', 'healthy', 'controls', '(', 'Ba', '##cc', '##he', '##tti', 'et', 'al', '.', ',', '2020', ')', '.']	[0, 3, 5, 9, 13, 21, 23, 24, 27, 29, 33, 37, 46, 49, 50, 52, 53, 55, 58, 63, 66, 67, 70, 75, 79, 83, 87, 89, 92, 95, 106, 111, 117, 120, 124, 127, 141, 149, 158, 163, 171, 180, 181, 183, 185, 187, 191, 194, 196, 197, 199, 203, 204]	[2, 5, 9, 12, 21, 22, 24, 26, 29, 33, 36, 45, 48, 50, 52, 53, 54, 57, 62, 65, 67, 70, 75, 78, 82, 87, 89, 92, 94, 105, 110, 116, 119, 123, 126, 140, 148, 157, 162, 170, 179, 181, 183, 185, 187, 190, 193, 196, 197, 198, 203, 204, 205]	['In', 'psoriatic', 'children', ',', 'DHC', 'lactonase', 'activity', 'of', 'PON1', ',', 'as', 'well', 'as', 'arylesterase', 'and', 'paraoxonase', 'activities', 'were', 'found', 'to', 'all', 'be', 'significantly', 'reduced', 'compared', 'with', 'healthy', 'controls', '(', 'Bacchetti', 'et', 'al', '.', ',', '2020', ')', '.']	[1, 3, 1, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 4, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also measured the concentration of myeloperoxidase (MPO), another enzyme in HDL, which can interact with PON1 and influence its activity.	[('PMC8045895', 'R51001', 47, 62, 'myeloperoxidase')]	['The', 'authors', 'also', 'measured', 'the', 'concentration', 'of', 'my', '##elo', '##per', '##ox', '##idas', '##e', '(', 'MP', '##O', ')', ',', 'another', 'enzyme', 'in', 'HD', '##L', ',', 'which', 'can', 'interact', 'with', 'P', '##ON', '##1', 'and', 'influence', 'its', 'activity', '.']	[0, 4, 12, 17, 26, 30, 44, 47, 49, 52, 55, 57, 61, 63, 64, 66, 67, 68, 70, 78, 85, 88, 90, 91, 93, 99, 103, 112, 117, 118, 120, 122, 126, 136, 140, 148]	[3, 11, 16, 25, 29, 43, 46, 49, 52, 55, 57, 61, 62, 64, 66, 67, 68, 69, 77, 84, 87, 90, 91, 92, 98, 102, 111, 116, 118, 120, 121, 125, 135, 139, 148, 149]	['The', 'authors', 'also', 'measured', 'the', 'concentration', 'of', 'myeloperoxidase', '(', 'MPO', ')', ',', 'another', 'enzyme', 'in', 'HDL', ',', 'which', 'can', 'interact', 'with', 'PON1', 'and', 'influence', 'its', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 6, 1, 2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A significant decrease in PON1 DHC lactonase activity was shown in celiac disease (Ferretti et al., 2012).	[('PMC8045895', 'R52000', 35, 44, 'lactonase')]	['A', 'significant', 'decrease', 'in', 'P', '##ON', '##1', 'D', '##HC', 'la', '##cton', '##ase', 'activity', 'was', 'shown', 'in', 'c', '##eli', '##ac', 'disease', '(', 'Fe', '##rre', '##tti', 'et', 'al', '.', ',', '2012', ')', '.']	[0, 2, 14, 23, 26, 27, 29, 31, 32, 35, 37, 41, 45, 54, 58, 64, 67, 68, 71, 74, 82, 83, 85, 88, 92, 95, 97, 98, 100, 104, 105]	[1, 13, 22, 25, 27, 29, 30, 32, 34, 37, 41, 44, 53, 57, 63, 66, 68, 71, 73, 81, 83, 85, 88, 91, 94, 97, 98, 99, 104, 105, 106]	['A', 'significant', 'decrease', 'in', 'PON1', 'DHC', 'lactonase', 'activity', 'was', 'shown', 'in', 'celiac', 'disease', '(', 'Ferretti', 'et', 'al', '.', ',', '2012', ')', '.']	[1, 1, 1, 1, 3, 2, 3, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Lactonase activity was lower in diet-treated patients compared with healthy controls, and even lower in patients at diagnosis, when they had not yet begun their diet.	[('PMC8045895', 'R52001', 0, 9, 'Lactonase')]	['Lac', '##ton', '##ase', 'activity', 'was', 'lower', 'in', 'diet', '-', 'treated', 'patients', 'compared', 'with', 'healthy', 'controls', ',', 'and', 'even', 'lower', 'in', 'patients', 'at', 'diagnosis', ',', 'when', 'they', 'had', 'not', 'yet', 'begun', 'their', 'diet', '.']	[0, 3, 6, 10, 19, 23, 29, 32, 36, 37, 45, 54, 63, 68, 76, 84, 86, 90, 95, 101, 104, 113, 116, 125, 127, 132, 137, 141, 145, 149, 155, 161, 165]	[3, 6, 9, 18, 22, 28, 31, 36, 37, 44, 53, 62, 67, 75, 84, 85, 89, 94, 100, 103, 112, 115, 125, 126, 131, 136, 140, 144, 148, 154, 160, 165, 166]	['Lactonase', 'activity', 'was', 'lower', 'in', 'diet', '-', 'treated', 'patients', 'compared', 'with', 'healthy', 'controls', ',', 'and', 'even', 'lower', 'in', 'patients', 'at', 'diagnosis', ',', 'when', 'they', 'had', 'not', 'yet', 'begun', 'their', 'diet', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Similar results were obtained for PON1 arylesterase and paraoxonase activities.	[('PMC8045895', 'R52002', 39, 51, 'arylesterase')]	['Similar', 'results', 'were', 'obtained', 'for', 'P', '##ON', '##1', 'a', '##ryl', '##ester', '##ase', 'and', 'para', '##ox', '##ona', '##se', 'activities', '.']	[0, 8, 16, 21, 30, 34, 35, 37, 39, 40, 43, 48, 52, 56, 60, 62, 65, 68, 78]	[7, 15, 20, 29, 33, 35, 37, 38, 40, 43, 48, 51, 55, 60, 62, 65, 67, 78, 79]	['Similar', 'results', 'were', 'obtained', 'for', 'PON1', 'arylesterase', 'and', 'paraoxonase', 'activities', '.']	[1, 1, 1, 1, 1, 3, 4, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In hereditary hemochromatosis, PON1 paraoxonase activity was significantly decreased in patients with the condition compared with healthy controls, but DHC lactonase and arylesterase activities were not decreased significantly (Martinelli et al., 2013).	[('PMC8045895', 'R53000', 36, 47, 'paraoxonase')]	['In', 'hereditary', 'hem', '##och', '##roma', '##tosis', ',', 'P', '##ON', '##1', 'para', '##ox', '##ona', '##se', 'activity', 'was', 'significantly', 'decreased', 'in', 'patients', 'with', 'the', 'condition', 'compared', 'with', 'healthy', 'controls', ',', 'but', 'D', '##HC', 'la', '##cton', '##ase', 'and', 'a', '##ryl', '##ester', '##ase', 'activities', 'were', 'not', 'decreased', 'significantly', '(', 'Martin', '##elli', 'et', 'al', '.', ',', '2013', ')', '.']	[0, 3, 14, 17, 20, 24, 29, 31, 32, 34, 36, 40, 42, 45, 48, 57, 61, 75, 85, 88, 97, 102, 106, 116, 125, 130, 138, 146, 148, 152, 153, 156, 158, 162, 166, 170, 171, 174, 179, 183, 194, 199, 203, 213, 227, 228, 234, 239, 242, 244, 245, 247, 251, 252]	[2, 13, 17, 20, 24, 29, 30, 32, 34, 35, 40, 42, 45, 47, 56, 60, 74, 84, 87, 96, 101, 105, 115, 124, 129, 137, 146, 147, 151, 153, 155, 158, 162, 165, 169, 171, 174, 179, 182, 193, 198, 202, 212, 226, 228, 234, 238, 241, 244, 245, 246, 251, 252, 253]	['In', 'hereditary', 'hemochromatosis', ',', 'PON1', 'paraoxonase', 'activity', 'was', 'significantly', 'decreased', 'in', 'patients', 'with', 'the', 'condition', 'compared', 'with', 'healthy', 'controls', ',', 'but', 'DHC', 'lactonase', 'and', 'arylesterase', 'activities', 'were', 'not', 'decreased', 'significantly', '(', 'Martinelli', 'et', 'al', '.', ',', '2013', ')', '.']	[1, 1, 4, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 3, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In CKD, a significant decrease in PON1 benzopiran-2-one lactonase activity was reported in cases compared with healthy controls (Mohammed et al., 2019).	[('PMC8045895', 'R54000', 39, 65, 'benzopiran-2-one lactonase')]	['In', 'C', '##K', '##D', ',', 'a', 'significant', 'decrease', 'in', 'P', '##ON', '##1', 'ben', '##zo', '##pi', '##ran', '-', '2', '-', 'one', 'la', '##cton', '##ase', 'activity', 'was', 'reported', 'in', 'cases', 'compared', 'with', 'healthy', 'controls', '(', 'Mohammed', 'et', 'al', '.', ',', '2019', ')', '.']	[0, 3, 4, 5, 6, 8, 10, 22, 31, 34, 35, 37, 39, 42, 44, 46, 49, 50, 51, 52, 56, 58, 62, 66, 75, 79, 88, 91, 97, 106, 111, 119, 128, 129, 138, 141, 143, 144, 146, 150, 151]	[2, 4, 5, 6, 7, 9, 21, 30, 33, 35, 37, 38, 42, 44, 46, 49, 50, 51, 52, 55, 58, 62, 65, 74, 78, 87, 90, 96, 105, 110, 118, 127, 129, 137, 140, 143, 144, 145, 150, 151, 152]	['In', 'CKD', ',', 'a', 'significant', 'decrease', 'in', 'PON1', 'benzopiran-2-one', 'lactonase', 'activity', 'was', 'reported', 'in', 'cases', 'compared', 'with', 'healthy', 'controls', '(', 'Mohammed', 'et', 'al', '.', ',', '2019', ')', '.']	[1, 3, 1, 1, 1, 1, 1, 3, 8, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
After adjusting for concentration, the authors showed that lactonase activity was significantly higher in patients compared with non-CKD controls.	[('PMC8045895', 'R54001', 59, 68, 'lactonase')]	['After', 'adjusting', 'for', 'concentration', ',', 'the', 'authors', 'showed', 'that', 'la', '##cton', '##ase', 'activity', 'was', 'significantly', 'higher', 'in', 'patients', 'compared', 'with', 'non', '-', 'C', '##K', '##D', 'controls', '.']	[0, 6, 16, 20, 33, 35, 39, 47, 54, 59, 61, 65, 69, 78, 82, 96, 103, 106, 115, 124, 129, 132, 133, 134, 135, 137, 145]	[5, 15, 19, 33, 34, 38, 46, 53, 58, 61, 65, 68, 77, 81, 95, 102, 105, 114, 123, 128, 132, 133, 134, 135, 136, 145, 146]	['After', 'adjusting', 'for', 'concentration', ',', 'the', 'authors', 'showed', 'that', 'lactonase', 'activity', 'was', 'significantly', 'higher', 'in', 'patients', 'compared', 'with', 'non-CKD', 'controls', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors also compared the groups of CKD patients with high and low lactonase activity in terms of survival rate and reported that patients with higher lactonase activity also had a higher survival rate.	[('PMC8045895', 'R54002', 71, 80, 'lactonase')]	['The', 'authors', 'also', 'compared', 'the', 'groups', 'of', 'C', '##K', '##D', 'patients', 'with', 'high', 'and', 'low', 'la', '##cton', '##ase', 'activity', 'in', 'terms', 'of', 'survival', 'rate', 'and', 'reported', 'that', 'patients', 'with', 'higher', 'la', '##cton', '##ase', 'activity', 'also', 'had', 'a', 'higher', 'survival', 'rate', '.']	[0, 4, 12, 17, 26, 30, 37, 40, 41, 42, 44, 53, 58, 63, 67, 71, 73, 77, 81, 90, 93, 99, 102, 111, 116, 120, 129, 134, 143, 148, 155, 157, 161, 165, 174, 179, 183, 185, 192, 201, 205]	[3, 11, 16, 25, 29, 36, 39, 41, 42, 43, 52, 57, 62, 66, 70, 73, 77, 80, 89, 92, 98, 101, 110, 115, 119, 128, 133, 142, 147, 154, 157, 161, 164, 173, 178, 182, 184, 191, 200, 205, 206]	['The', 'authors', 'also', 'compared', 'the', 'groups', 'of', 'CKD', 'patients', 'with', 'high', 'and', 'low', 'lactonase', 'activity', 'in', 'terms', 'of', 'survival', 'rate', 'and', 'reported', 'that', 'patients', 'with', 'higher', 'lactonase', 'activity', 'also', 'had', 'a', 'higher', 'survival', 'rate', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
For end-stage renal patients, a study compared DHC lactonase before and after dialysis and found that activity increases significantly after dialysis, as do arylesterase and paraoxonase activities (Gugliucci et al., 2011).	[('PMC8045895', 'R55000', 51, 60, 'lactonase')]	['For', 'end', '-', 'stage', 're', '##nal', 'patients', ',', 'a', 'study', 'compared', 'D', '##HC', 'la', '##cton', '##ase', 'before', 'and', 'after', 'dial', '##ys', '##is', 'and', 'found', 'that', 'activity', 'increases', 'significantly', 'after', 'dial', '##ys', '##is', ',', 'as', 'do', 'a', '##ryl', '##ester', '##ase', 'and', 'para', '##ox', '##ona', '##se', 'activities', '(', 'G', '##ug', '##li', '##ucci', 'et', 'al', '.', ',', '2011', ')', '.']	[0, 4, 7, 8, 14, 16, 20, 28, 30, 32, 38, 47, 48, 51, 53, 57, 61, 68, 72, 78, 82, 84, 87, 91, 97, 102, 111, 121, 135, 141, 145, 147, 149, 151, 154, 157, 158, 161, 166, 170, 174, 178, 180, 183, 186, 197, 198, 199, 201, 203, 208, 211, 213, 214, 216, 220, 221]	[3, 7, 8, 13, 16, 19, 28, 29, 31, 37, 46, 48, 50, 53, 57, 60, 67, 71, 77, 82, 84, 86, 90, 96, 101, 110, 120, 134, 140, 145, 147, 149, 150, 153, 156, 158, 161, 166, 169, 173, 178, 180, 183, 185, 196, 198, 199, 201, 203, 207, 210, 213, 214, 215, 220, 221, 222]	['For', 'end', '-', 'stage', 'renal', 'patients', ',', 'a', 'study', 'compared', 'DHC', 'lactonase', 'before', 'and', 'after', 'dialysis', 'and', 'found', 'that', 'activity', 'increases', 'significantly', 'after', 'dialysis', ',', 'as', 'do', 'arylesterase', 'and', 'paraoxonase', 'activities', '(', 'Gugliucci', 'et', 'al', '.', ',', '2011', ')', '.']	[1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 4, 1, 4, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In the case of bronchial asthma, both arylesterase and DHC lactonase PON1 activities were shown to be lower in asthmatics compared with healthy controls (Chen et al., 2018).	[('PMC8045895', 'R57000', 38, 50, 'arylesterase')]	['In', 'the', 'case', 'of', 'br', '##on', '##chia', '##l', 'as', '##th', '##ma', ',', 'both', 'a', '##ryl', '##ester', '##ase', 'and', 'D', '##HC', 'la', '##cton', '##ase', 'P', '##ON', '##1', 'activities', 'were', 'shown', 'to', 'be', 'lower', 'in', 'as', '##th', '##matic', '##s', 'compared', 'with', 'healthy', 'controls', '(', 'Chen', 'et', 'al', '.', ',', '2018', ')', '.']	[0, 3, 7, 12, 15, 17, 19, 23, 25, 27, 29, 31, 33, 38, 39, 42, 47, 51, 55, 56, 59, 61, 65, 69, 70, 72, 74, 85, 90, 96, 99, 102, 108, 111, 113, 115, 120, 122, 131, 136, 144, 153, 154, 159, 162, 164, 165, 167, 171, 172]	[2, 6, 11, 14, 17, 19, 23, 24, 27, 29, 31, 32, 37, 39, 42, 47, 50, 54, 56, 58, 61, 65, 68, 70, 72, 73, 84, 89, 95, 98, 101, 107, 110, 113, 115, 120, 121, 130, 135, 143, 152, 154, 158, 161, 164, 165, 166, 171, 172, 173]	['In', 'the', 'case', 'of', 'bronchial', 'asthma', ',', 'both', 'arylesterase', 'and', 'DHC', 'lactonase', 'PON1', 'activities', 'were', 'shown', 'to', 'be', 'lower', 'in', 'asthmatics', 'compared', 'with', 'healthy', 'controls', '(', 'Chen', 'et', 'al', '.', ',', '2018', ')', '.']	[1, 1, 1, 1, 4, 3, 1, 1, 4, 1, 2, 3, 3, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The authors verified this by addition of PON1 to the serum sample, which resulted in a very significant rise in lactonase activity.	[('PMC8045895', 'R57001', 112, 121, 'lactonase')]	['The', 'authors', 'verified', 'this', 'by', 'addition', 'of', 'P', '##ON', '##1', 'to', 'the', 'serum', 'sample', ',', 'which', 'resulted', 'in', 'a', 'very', 'significant', 'rise', 'in', 'la', '##cton', '##ase', 'activity', '.']	[0, 4, 12, 21, 26, 29, 38, 41, 42, 44, 46, 49, 53, 59, 65, 67, 73, 82, 85, 87, 92, 104, 109, 112, 114, 118, 122, 130]	[3, 11, 20, 25, 28, 37, 40, 42, 44, 45, 48, 52, 58, 65, 66, 72, 81, 84, 86, 91, 103, 108, 111, 114, 118, 121, 130, 131]	['The', 'authors', 'verified', 'this', 'by', 'addition', 'of', 'PON1', 'to', 'the', 'serum', 'sample', ',', 'which', 'resulted', 'in', 'a', 'very', 'significant', 'rise', 'in', 'lactonase', 'activity', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Different approaches for measuring PON1 lactonase activity do not produce the same results.	[('PMC8045895', 'R59000', 40, 49, 'lactonase')]	['Different', 'approaches', 'for', 'measuring', 'P', '##ON', '##1', 'la', '##cton', '##ase', 'activity', 'do', 'not', 'produce', 'the', 'same', 'results', '.']	[0, 10, 21, 25, 35, 36, 38, 40, 42, 46, 50, 59, 62, 66, 74, 78, 83, 90]	[9, 20, 24, 34, 36, 38, 39, 42, 46, 49, 58, 61, 65, 73, 77, 82, 90, 91]	['Different', 'approaches', 'for', 'measuring', 'PON1', 'lactonase', 'activity', 'do', 'not', 'produce', 'the', 'same', 'results', '.']	[1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A gene expression study of 28 responders and non-responders to AML-stabilizing treatment ATRA/VP identified subsets of differentially expressed genes involved in transcriptional regulation (i.e., DNA/RNA binding proteins, transcription factors and nucleases), protein degradation/activation/modulation and metabolism [30] (data available at the Gene Expression Omnibus data repository with accession code GSE106096).	[('PMC8125016', 'D06000', 248, 257, 'nucleases')]	['A', 'gene', 'expression', 'study', 'of', '28', 'respond', '##ers', 'and', 'non', '-', 'respond', '##ers', 'to', 'AM', '##L', '-', 'stab', '##ili', '##zing', 'treatment', 'AT', '##RA', '/', 'VP', 'identified', 'subset', '##s', 'of', 'differential', '##ly', 'expressed', 'genes', 'involved', 'in', 'transcription', '##al', 'regulation', '(', 'i', '.', 'e', '.', ',', 'DNA', '/', 'RNA', 'binding', 'proteins', ',', 'transcription', 'factors', 'and', 'n', '##uc', '##lea', '##ses', ')', ',', 'protein', 'degradation', '/', 'activation', '/', 'm', '##od', '##ulation', 'and', 'metabolism', '[', '30', ']', '(', 'data', 'available', 'at', 'the', 'Gene', 'Express', '##ion', 'O', '##m', '##ni', '##bus', 'data', 're', '##pository', 'with', 'accession', 'code', 'G', '##SE', '##10', '##60', '##9', '##6', ')', '.']	[0, 2, 7, 18, 24, 27, 30, 37, 41, 45, 48, 49, 56, 60, 63, 65, 66, 67, 71, 74, 79, 89, 91, 93, 94, 97, 108, 114, 116, 119, 131, 134, 144, 150, 159, 162, 175, 178, 189, 190, 191, 192, 193, 194, 196, 199, 200, 204, 212, 220, 222, 236, 244, 248, 249, 251, 254, 257, 258, 260, 268, 279, 280, 290, 291, 292, 294, 302, 306, 317, 318, 320, 322, 323, 328, 338, 341, 345, 350, 357, 361, 362, 363, 365, 369, 374, 376, 385, 390, 400, 405, 406, 408, 410, 412, 413, 414, 415]	[1, 6, 17, 23, 26, 29, 37, 40, 44, 48, 49, 56, 59, 62, 65, 66, 67, 71, 74, 78, 88, 91, 93, 94, 96, 107, 114, 115, 118, 131, 133, 143, 149, 158, 161, 175, 177, 188, 190, 191, 192, 193, 194, 195, 199, 200, 203, 211, 220, 221, 235, 243, 247, 249, 251, 254, 257, 258, 259, 267, 279, 280, 290, 291, 292, 294, 301, 305, 316, 318, 320, 321, 323, 327, 337, 340, 344, 349, 357, 360, 362, 363, 365, 368, 373, 376, 384, 389, 399, 404, 406, 408, 410, 412, 413, 414, 415, 416]	['A', 'gene', 'expression', 'study', 'of', '28', 'responders', 'and', 'non', '-', 'responders', 'to', 'AML-stabilizing', 'treatment', 'ATRA', '/', 'VP', 'identified', 'subsets', 'of', 'differentially', 'expressed', 'genes', 'involved', 'in', 'transcriptional', 'regulation', '(', 'i.e', '.', ',', 'DNA', '/', 'RNA', 'binding', 'proteins', ',', 'transcription', 'factors', 'and', 'nucleases', ')', ',', 'protein', 'degradation', '/', 'activation', '/', 'modulation', 'and', 'metabolism', '[', '30', ']', '(', 'data', 'available', 'at', 'the', 'Gene', 'Expression', 'Omnibus', 'data', 'repository', 'with', 'accession', 'code', 'GSE106096', ')', '.']	[1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 6, 1, 2, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 4, 1, 2, 1, 1, 1, 6, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Our observations suggest that the DNA methylation status is not decisive for the effect of our present strategy of epigenetic targeting in the treatment of human AML and DNA methylation profiling cannot be used to predict the response to ATRA/VP therapy.	[]	['Our', 'observations', 'suggest', 'that', 'the', 'DNA', 'met', '##hyl', '##ation', 'status', 'is', 'not', 'decisive', 'for', 'the', 'effect', 'of', 'our', 'present', 'strategy', 'of', 'e', '##pi', '##gene', '##tic', 'targeting', 'in', 'the', 'treatment', 'of', 'human', 'AM', '##L', 'and', 'DNA', 'met', '##hyl', '##ation', 'pro', '##fi', '##ling', 'cannot', 'be', 'used', 'to', 'predict', 'the', 'response', 'to', 'AT', '##RA', '/', 'VP', 'therapy', '.']	[0, 4, 17, 25, 30, 34, 38, 41, 44, 50, 57, 60, 64, 73, 77, 81, 88, 91, 95, 103, 112, 115, 116, 118, 122, 126, 136, 139, 143, 153, 156, 162, 164, 166, 170, 174, 177, 180, 186, 189, 191, 196, 203, 206, 211, 214, 222, 226, 235, 238, 240, 242, 243, 246, 253]	[3, 16, 24, 29, 33, 37, 41, 44, 49, 56, 59, 63, 72, 76, 80, 87, 90, 94, 102, 111, 114, 116, 118, 122, 125, 135, 138, 142, 152, 155, 161, 164, 165, 169, 173, 177, 180, 185, 189, 191, 195, 202, 205, 210, 213, 221, 225, 234, 237, 240, 242, 243, 245, 253, 254]	['Our', 'observations', 'suggest', 'that', 'the', 'DNA', 'methylation', 'status', 'is', 'not', 'decisive', 'for', 'the', 'effect', 'of', 'our', 'present', 'strategy', 'of', 'epigenetic', 'targeting', 'in', 'the', 'treatment', 'of', 'human', 'AML', 'and', 'DNA', 'methylation', 'profiling', 'cannot', 'be', 'used', 'to', 'predict', 'the', 'response', 'to', 'ATRA', '/', 'VP', 'therapy', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Protein acetylation is regulated by the balance between histone acetyltransferases (HATs) and histone deacetylases (HDACs)	[('PMC8125016', 'I02000', 56, 82, 'histone acetyltransferases')]	['Pro', '##tein', 'ace', '##ty', '##lation', 'is', 'regulated', 'by', 'the', 'balance', 'between', 'his', '##tone', 'ace', '##ty', '##lt', '##ran', '##s', '##fer', '##ases', '(', 'H', '##AT', '##s', ')', 'and', 'his', '##tone', 'de', '##ace', '##ty', '##lase', '##s', '(', 'HD', '##AC', '##s', ')']	[0, 3, 8, 11, 13, 20, 23, 33, 36, 40, 48, 56, 59, 64, 67, 69, 71, 74, 75, 78, 83, 84, 85, 87, 88, 90, 94, 97, 102, 104, 107, 109, 113, 115, 116, 118, 120, 121]	[3, 7, 11, 13, 19, 22, 32, 35, 39, 47, 55, 59, 63, 67, 69, 71, 74, 75, 78, 82, 84, 85, 87, 88, 89, 93, 97, 101, 104, 107, 109, 113, 114, 116, 118, 120, 121, 122]	['Protein', 'acetylation', 'is', 'regulated', 'by', 'the', 'balance', 'between', 'histone', 'acetyltransferases', '(', 'HATs', ')', 'and', 'histone', 'deacetylases', '(', 'HDACs', ')']	[2, 3, 1, 1, 1, 1, 1, 1, 2, 7, 1, 3, 1, 1, 2, 5, 1, 3, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The systemic lupus erythematosus Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, which represents proteins involved in the production of IgG autoantibodies that are specific for self-antigens such as DNA or nuclear proteins, was also enriched in the PRE-R patient group.	[]	['The', 'systemic', 'l', '##up', '##us', 'er', '##yt', '##hem', '##ato', '##sus', 'Kyoto', 'Encyclopedia', 'of', 'Gene', '##s', 'and', 'Gen', '##ome', '##s', '(', 'K', '##EG', '##G', ')', 'pathway', ',', 'which', 'represents', 'proteins', 'involved', 'in', 'the', 'production', 'of', 'I', '##g', '##G', 'auto', '##anti', '##bo', '##dies', 'that', 'are', 'specific', 'for', 'self', '-', 'anti', '##gens', 'such', 'as', 'DNA', 'or', 'nuclear', 'proteins', ',', 'was', 'also', 'en', '##rich', '##ed', 'in', 'the', 'PR', '##E', '-', 'R', 'patient', 'group', '.']	[0, 4, 13, 14, 16, 19, 21, 23, 26, 29, 33, 39, 52, 55, 59, 61, 65, 68, 71, 73, 74, 75, 77, 78, 80, 87, 89, 95, 106, 115, 124, 127, 131, 142, 145, 146, 147, 149, 153, 157, 159, 164, 169, 173, 182, 186, 190, 191, 195, 200, 205, 208, 212, 215, 223, 231, 233, 237, 242, 244, 248, 251, 254, 258, 260, 261, 262, 264, 272, 277]	[3, 12, 14, 16, 18, 21, 23, 26, 29, 32, 38, 51, 54, 59, 60, 64, 68, 71, 72, 74, 75, 77, 78, 79, 87, 88, 94, 105, 114, 123, 126, 130, 141, 144, 146, 147, 148, 153, 157, 159, 163, 168, 172, 181, 185, 190, 191, 195, 199, 204, 207, 211, 214, 222, 231, 232, 236, 241, 244, 248, 250, 253, 257, 260, 261, 262, 263, 271, 277, 278]	['The', 'systemic', 'lupus', 'erythematosus', 'Kyoto', 'Encyclopedia', 'of', 'Genes', 'and', 'Genomes', '(', 'KEGG', ')', 'pathway', ',', 'which', 'represents', 'proteins', 'involved', 'in', 'the', 'production', 'of', 'IgG', 'autoantibodies', 'that', 'are', 'specific', 'for', 'self', '-', 'antigens', 'such', 'as', 'DNA', 'or', 'nuclear', 'proteins', ',', 'was', 'also', 'enriched', 'in', 'the', 'PRE-R', 'patient', 'group', '.']	[1, 1, 3, 5, 1, 1, 1, 2, 1, 3, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Identified proteins belonging to this pathway are ELANE, cathepsin G (CTSG), H2BC21, H2A.Z variant histone 2 (H2AZ2) and H2B clustered histone 14 (H2BC14).	[]	['I', '##dent', '##ified', 'proteins', 'belonging', 'to', 'this', 'pathway', 'are', 'E', '##LA', '##NE', ',', 'cat', '##he', '##ps', '##in', 'G', '(', 'CT', '##S', '##G', ')', ',', 'H', '##2', '##BC', '##21', ',', 'H', '##2', '##A', '.', 'Z', 'variant', 'his', '##tone', '2', '(', 'H', '##2', '##A', '##Z', '##2', ')', 'and', 'H', '##2', '##B', 'cluster', '##ed', 'his', '##tone', '14', '(', 'H', '##2', '##BC', '##14', ')', '.']	[0, 1, 5, 11, 20, 30, 33, 38, 46, 50, 51, 53, 55, 57, 60, 62, 64, 67, 69, 70, 72, 73, 74, 75, 77, 78, 79, 81, 83, 85, 86, 87, 88, 89, 91, 99, 102, 107, 109, 110, 111, 112, 113, 114, 115, 117, 121, 122, 123, 125, 132, 135, 138, 143, 146, 147, 148, 149, 151, 153, 154]	[1, 5, 10, 19, 29, 32, 37, 45, 49, 51, 53, 55, 56, 60, 62, 64, 66, 68, 70, 72, 73, 74, 75, 76, 78, 79, 81, 83, 84, 86, 87, 88, 89, 90, 98, 102, 106, 108, 110, 111, 112, 113, 114, 115, 116, 120, 122, 123, 124, 132, 134, 138, 142, 145, 147, 148, 149, 151, 153, 154, 155]	['Identified', 'proteins', 'belonging', 'to', 'this', 'pathway', 'are', 'ELANE', ',', 'cathepsin', 'G', '(', 'CTSG', ')', ',', 'H2BC21', ',', 'H2A.Z', 'variant', 'histone', '2', '(', 'H2AZ2', ')', 'and', 'H2B', 'clustered', 'histone', '14', '(', 'H2BC14', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 1, 3, 1, 1, 4, 1, 5, 1, 2, 1, 1, 5, 1, 1, 3, 2, 2, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In contrast, levels of proteins involved in processes such as hematopoietic or lymphoid organ development (e.g., sphingosine-1-phosphate lyase 1, SGPL1; SBDS ribosome maturation factor, SBDS), transcription by RNA polymerase II and cell death were higher in PRE-NR patients (Figure 2b, bottom plot; Table 2).	[('PMC8125016', 'R06000', 113, 144, 'sphingosine-1-phosphate lyase 1')]	['In', 'contrast', ',', 'levels', 'of', 'proteins', 'involved', 'in', 'processes', 'such', 'as', 'hem', '##ato', '##po', '##iet', '##ic', 'or', 'l', '##ymph', '##oid', 'organ', 'development', '(', 'e', '.', 'g', '.', ',', 's', '##phi', '##ngo', '##sin', '##e', '-', '1', '-', 'phosphate', 'l', '##yas', '##e', '1', ',', 'S', '##GP', '##L', '##1', ';', 'S', '##B', '##DS', 'rib', '##oso', '##me', 'mat', '##uration', 'factor', ',', 'S', '##B', '##DS', ')', ',', 'transcription', 'by', 'RNA', 'polymer', '##ase', 'II', 'and', 'cell', 'death', 'were', 'higher', 'in', 'PR', '##E', '-', 'N', '##R', 'patients', '(', 'Figure', '2', '##b', ',', 'bottom', 'plot', ';', 'Table', '2', ')', '.']	[0, 3, 11, 13, 20, 23, 32, 41, 44, 54, 59, 62, 65, 68, 70, 73, 76, 79, 80, 84, 88, 94, 106, 107, 108, 109, 110, 111, 113, 114, 117, 120, 123, 124, 125, 126, 127, 137, 138, 141, 143, 144, 146, 147, 149, 150, 151, 153, 154, 155, 158, 161, 164, 167, 170, 178, 184, 186, 187, 188, 190, 191, 193, 207, 210, 214, 221, 225, 228, 232, 237, 243, 248, 255, 258, 260, 261, 262, 263, 265, 274, 275, 282, 283, 284, 286, 293, 297, 299, 305, 306, 307]	[2, 11, 12, 19, 22, 31, 40, 43, 53, 58, 61, 65, 68, 70, 73, 75, 78, 80, 84, 87, 93, 105, 107, 108, 109, 110, 111, 112, 114, 117, 120, 123, 124, 125, 126, 127, 136, 138, 141, 142, 144, 145, 147, 149, 150, 151, 152, 154, 155, 157, 161, 164, 166, 170, 177, 184, 185, 187, 188, 190, 191, 192, 206, 209, 213, 221, 224, 227, 231, 236, 242, 247, 254, 257, 260, 261, 262, 263, 264, 273, 275, 281, 283, 284, 285, 292, 297, 298, 304, 306, 307, 308]	['In', 'contrast', ',', 'levels', 'of', 'proteins', 'involved', 'in', 'processes', 'such', 'as', 'hematopoietic', 'or', 'lymphoid', 'organ', 'development', '(', 'e.g', '.', ',', 'sphingosine-1-phosphate', 'lyase', '1', ',', 'SGPL1', ';', 'SBDS', 'ribosome', 'maturation', 'factor', ',', 'SBDS', ')', ',', 'transcription', 'by', 'RNA', 'polymerase', 'II', 'and', 'cell', 'death', 'were', 'higher', 'in', 'PRE-NR', 'patients', '(', 'Figure', '2b', ',', 'bottom', 'plot', ';', 'Table', '2', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 1, 1, 1, 3, 1, 1, 9, 3, 1, 1, 4, 1, 3, 3, 2, 1, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
A sequence logo of the amino acid sequence windows surrounding the phosphorylation sites of the splicing factor network (Figure S1) identified the SP and the SXR/K motifs for mitogen-activated protein kinases (MAPKs) and protein kinase C delta/protein kinase cAMP-activated catalytic subunit alpha PRKCD/PRKACA, respectively, although RNA polymerase II subunit A (POLR2A) S1920 and SRSF11 S207 are phosphorylated by cyclin dependent kinase (CDK)1 and CDK2, respectively [46].	[]	['A', 'sequence', 'logo', 'of', 'the', 'amino', 'acid', 'sequence', 'windows', 'surrounding', 'the', 'p', '##hos', '##ph', '##ory', '##lation', 'sites', 'of', 'the', 's', '##p', '##licing', 'factor', 'network', '(', 'Figure', 'S', '##1', ')', 'identified', 'the', 'SP', 'and', 'the', 'S', '##X', '##R', '/', 'K', 'motifs', 'for', 'mit', '##ogen', '-', 'activated', 'protein', 'kinase', '##s', '(', 'MA', '##P', '##K', '##s', ')', 'and', 'protein', 'kinase', 'C', 'delta', '/', 'protein', 'kinase', 'c', '##AM', '##P', '-', 'activated', 'cat', '##alytic', 'subunit', 'alpha', 'PR', '##K', '##CD', '/', 'PR', '##KA', '##CA', ',', 'respectively', ',', 'although', 'RNA', 'polymer', '##ase', 'II', 'subunit', 'A', '(', 'P', '##OL', '##R', '##2', '##A', ')', 'S', '##19', '##20', 'and', 'SR', '##SF', '##11', 'S', '##20', '##7', 'are', 'p', '##hos', '##ph', '##ory', '##lated', 'by', 'c', '##y', '##c', '##lin', 'dependent', 'kinase', '(', 'CD', '##K', ')', '1', 'and', 'CD', '##K', '##2', ',', 'respectively', '[', '46', ']', '.']	[0, 2, 11, 16, 19, 23, 29, 34, 43, 51, 63, 67, 68, 71, 73, 76, 83, 89, 92, 96, 97, 98, 105, 112, 120, 121, 128, 129, 130, 132, 143, 147, 150, 154, 158, 159, 160, 161, 162, 164, 171, 175, 178, 182, 183, 193, 201, 207, 209, 210, 212, 213, 214, 215, 217, 221, 229, 236, 238, 243, 244, 252, 259, 260, 262, 263, 264, 274, 277, 284, 292, 298, 300, 301, 303, 304, 306, 308, 310, 312, 324, 326, 335, 339, 346, 350, 353, 361, 363, 364, 365, 367, 368, 369, 370, 372, 373, 375, 378, 382, 384, 386, 389, 390, 392, 394, 398, 399, 402, 404, 407, 413, 416, 417, 418, 419, 423, 433, 440, 441, 443, 444, 445, 447, 451, 453, 454, 455, 457, 470, 471, 473, 474]	[1, 10, 15, 18, 22, 28, 33, 42, 50, 62, 66, 68, 71, 73, 76, 82, 88, 91, 95, 97, 98, 104, 111, 119, 121, 127, 129, 130, 131, 142, 146, 149, 153, 157, 159, 160, 161, 162, 163, 170, 174, 178, 182, 183, 192, 200, 207, 208, 210, 212, 213, 214, 215, 216, 220, 228, 235, 237, 243, 244, 251, 258, 260, 262, 263, 264, 273, 277, 283, 291, 297, 300, 301, 303, 304, 306, 308, 310, 311, 324, 325, 334, 338, 346, 349, 352, 360, 362, 364, 365, 367, 368, 369, 370, 371, 373, 375, 377, 381, 384, 386, 388, 390, 392, 393, 397, 399, 402, 404, 407, 412, 415, 417, 418, 419, 422, 432, 439, 441, 443, 444, 445, 446, 450, 453, 454, 455, 456, 469, 471, 473, 474, 475]	['A', 'sequence', 'logo', 'of', 'the', 'amino', 'acid', 'sequence', 'windows', 'surrounding', 'the', 'phosphorylation', 'sites', 'of', 'the', 'splicing', 'factor', 'network', '(', 'Figure', 'S1', ')', 'identified', 'the', 'SP', 'and', 'the', 'SXR', '/', 'K', 'motifs', 'for', 'mitogen', '-', 'activated', 'protein', 'kinases', '(', 'MAPKs', ')', 'and', 'protein', 'kinase', 'C', 'delta', '/', 'protein', 'kinase', 'cAMP-activated', 'catalytic', 'subunit', 'alpha', 'PRKCD', '/', 'PRKACA', ',', 'respectively', ',', 'although', 'RNA', 'polymerase', 'II', 'subunit', 'A', '(', 'POLR2A', ')', 'S1920', 'and', 'SRSF11', 'S207', 'are', 'phosphorylated', 'by', 'cyclin', 'dependent', 'kinase', '(CDK)1', 'and', 'CDK2', ',', 'respectively', '[', '46', ']', '.']	[1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1, 1, 3, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 5, 1, 3, 1, 3, 3, 1, 5, 1, 4, 1, 1, 5, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The phosphorylation of RPS6 at S236 by several members of the ribosomal protein S6 kinase family (i.e., RPS6KA1, RPS6KA3 or RPS6KB1) facilitates the assembly of the translation preinitiation complex [57] whereas polo like kinase 1 (PLK1) phosphorylation at RIOK2 S380 regulates mitotic progression [58].	[]	['The', 'p', '##hos', '##ph', '##ory', '##lation', 'of', 'R', '##PS', '##6', 'at', 'S', '##23', '##6', 'by', 'several', 'members', 'of', 'the', 'rib', '##oso', '##mal', 'protein', 'S', '##6', 'kinase', 'family', '(', 'i', '.', 'e', '.', ',', 'R', '##PS', '##6', '##KA', '##1', ',', 'R', '##PS', '##6', '##KA', '##3', 'or', 'R', '##PS', '##6', '##K', '##B', '##1', ')', 'facilitate', '##s', 'the', 'assembly', 'of', 'the', 'translation', 'pre', '##ini', '##tia', '##tion', 'complex', '[', '57', ']', 'whereas', 'polo', 'like', 'kinase', '1', '(', 'P', '##L', '##K', '##1', ')', 'p', '##hos', '##ph', '##ory', '##lation', 'at', 'R', '##IO', '##K', '##2', 'S', '##38', '##0', 'regulate', '##s', 'mit', '##otic', 'progression', '[', '58', ']', '.']	[0, 4, 5, 8, 10, 13, 20, 23, 24, 26, 28, 31, 32, 34, 36, 39, 47, 55, 58, 62, 65, 68, 72, 80, 81, 83, 90, 97, 98, 99, 100, 101, 102, 104, 105, 107, 108, 110, 111, 113, 114, 116, 117, 119, 121, 124, 125, 127, 128, 129, 130, 131, 133, 143, 145, 149, 158, 161, 165, 177, 180, 183, 186, 191, 199, 200, 202, 204, 212, 217, 222, 229, 231, 232, 233, 234, 235, 236, 238, 239, 242, 244, 247, 254, 257, 258, 260, 261, 263, 264, 266, 268, 276, 278, 281, 286, 298, 299, 301, 302]	[3, 5, 8, 10, 13, 19, 22, 24, 26, 27, 30, 32, 34, 35, 38, 46, 54, 57, 61, 65, 68, 71, 79, 81, 82, 89, 96, 98, 99, 100, 101, 102, 103, 105, 107, 108, 110, 111, 112, 114, 116, 117, 119, 120, 123, 125, 127, 128, 129, 130, 131, 132, 143, 144, 148, 157, 160, 164, 176, 180, 183, 186, 190, 198, 200, 202, 203, 211, 216, 221, 228, 230, 232, 233, 234, 235, 236, 237, 239, 242, 244, 247, 253, 256, 258, 260, 261, 262, 264, 266, 267, 276, 277, 281, 285, 297, 299, 301, 302, 303]	['The', 'phosphorylation', 'of', 'RPS6', 'at', 'S236', 'by', 'several', 'members', 'of', 'the', 'ribosomal', 'protein', 'S6', 'kinase', 'family', '(', 'i.e', '.', ',', 'RPS6KA1', ',', 'RPS6KA3', 'or', 'RPS6KB1', ')', 'facilitates', 'the', 'assembly', 'of', 'the', 'translation', 'preinitiation', 'complex', '[', '57', ']', 'whereas', 'polo', 'like', 'kinase', '1', '(', 'PLK1', ')', 'phosphorylation', 'at', 'RIOK2', 'S380', 'regulates', 'mitotic', 'progression', '[', '58', ']', '.']	[1, 5, 1, 3, 1, 3, 1, 1, 1, 1, 1, 3, 1, 2, 1, 1, 1, 3, 1, 1, 5, 1, 5, 1, 6, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 4, 3, 2, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Four phosphoproteins belonging to the apoptotic execution phase Reactome pathway II showed higher phosphorylation in PRE-R than in PRE-NR patients.	[]	['Four', 'p', '##hos', '##ph', '##op', '##rote', '##ins', 'belonging', 'to', 'the', 'a', '##pop', '##to', '##tic', 'execution', 'phase', 'Re', '##act', '##ome', 'pathway', 'II', 'showed', 'higher', 'p', '##hos', '##ph', '##ory', '##lation', 'in', 'PR', '##E', '-', 'R', 'than', 'in', 'PR', '##E', '-', 'N', '##R', 'patients', '.']	[0, 5, 6, 9, 11, 13, 17, 21, 31, 34, 38, 39, 42, 44, 48, 58, 64, 66, 69, 73, 81, 84, 91, 98, 99, 102, 104, 107, 114, 117, 119, 120, 121, 123, 128, 131, 133, 134, 135, 136, 138, 146]	[4, 6, 9, 11, 13, 17, 20, 30, 33, 37, 39, 42, 44, 47, 57, 63, 66, 69, 72, 80, 83, 90, 97, 99, 102, 104, 107, 113, 116, 119, 120, 121, 122, 127, 130, 133, 134, 135, 136, 137, 146, 147]	['Four', 'phosphoproteins', 'belonging', 'to', 'the', 'apoptotic', 'execution', 'phase', 'Reactome', 'pathway', 'II', 'showed', 'higher', 'phosphorylation', 'in', 'PRE-R', 'than', 'in', 'PRE-NR', 'patients', '.']	[1, 6, 1, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 5, 1, 4, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The residue S18 is part of one of the five (S/T)P(K/A)K motifs found in the H1.5 linker histone, cluster member (H1-5) sequence which becomes phosphorylated, possibly by CDKs, during chromatin decondensation [59].	[]	['The', 'residue', 'S', '##18', 'is', 'part', 'of', 'one', 'of', 'the', 'five', '(', 'S', '/', 'T', ')', 'P', '(', 'K', '/', 'A', ')', 'K', 'motifs', 'found', 'in', 'the', 'H', '##1', '.', '5', 'link', '##er', 'his', '##tone', ',', 'cluster', 'member', '(', 'H', '##1', '-', '5', ')', 'sequence', 'which', 'becomes', 'p', '##hos', '##ph', '##ory', '##lated', ',', 'possibly', 'by', 'CD', '##K', '##s', ',', 'during', 'ch', '##roma', '##tin', 'de', '##con', '##den', '##sation', '[', '59', ']', '.']	[0, 4, 12, 13, 16, 19, 24, 27, 31, 34, 38, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 56, 63, 69, 72, 76, 77, 78, 79, 81, 85, 88, 91, 95, 97, 105, 112, 113, 114, 115, 116, 117, 119, 128, 134, 142, 143, 146, 148, 151, 156, 158, 167, 170, 172, 173, 174, 176, 183, 185, 189, 193, 195, 198, 201, 208, 209, 211, 212]	[3, 11, 13, 15, 18, 23, 26, 30, 33, 37, 42, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 62, 68, 71, 75, 77, 78, 79, 80, 85, 87, 91, 95, 96, 104, 111, 113, 114, 115, 116, 117, 118, 127, 133, 141, 143, 146, 148, 151, 156, 157, 166, 169, 172, 173, 174, 175, 182, 185, 189, 192, 195, 198, 201, 207, 209, 211, 212, 213]	['The', 'residue', 'S18', 'is', 'part', 'of', 'one', 'of', 'the', 'five', '(', 'S', '/', 'T)P(K', '/', 'A)K', 'motifs', 'found', 'in', 'the', 'H1.5', 'linker', 'histone', ',', 'cluster', 'member', '(', 'H1-5', ')', 'sequence', 'which', 'becomes', 'phosphorylated', ',', 'possibly', 'by', 'CDKs', ',', 'during', 'chromatin', 'decondensation', '[', '59', ']', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 3, 1, 1, 1, 1, 4, 2, 2, 1, 1, 1, 1, 4, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 3, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters consisted of components of the histone deacetylation complex (i.e., nuclear receptor corepressor 1 and 2, NCOR1/2), and of RNA synthesis/elongation were observed in diseases of signal transduction and TP53 regulates transcription of DNA repair genes enriched Reactome pathways III and IV, respectively.	[]	['C', '##luster', '##s', 'consisted', 'of', 'components', 'of', 'the', 'his', '##tone', 'de', '##ace', '##ty', '##lation', 'complex', '(', 'i', '.', 'e', '.', ',', 'nuclear', 'receptor', 'core', '##press', '##or', '1', 'and', '2', ',', 'NC', '##OR', '##1', '/', '2', ')', ',', 'and', 'of', 'RNA', 'synthesis', '/', 'el', '##ong', '##ation', 'were', 'observed', 'in', 'diseases', 'of', 'signal', 'trans', '##duction', 'and', 'T', '##P', '##53', 'regulate', '##s', 'transcription', 'of', 'DNA', 'repair', 'genes', 'en', '##rich', '##ed', 'Re', '##act', '##ome', 'pathways', 'III', 'and', 'IV', ',', 'respectively', '.']	[0, 1, 7, 9, 19, 22, 33, 36, 40, 43, 48, 50, 53, 55, 62, 70, 71, 72, 73, 74, 75, 77, 85, 94, 98, 103, 106, 108, 112, 113, 115, 117, 119, 120, 121, 122, 123, 125, 129, 132, 136, 145, 146, 148, 151, 157, 162, 171, 174, 183, 186, 193, 198, 206, 210, 211, 212, 215, 223, 225, 239, 242, 246, 253, 259, 261, 265, 268, 270, 273, 277, 286, 290, 294, 296, 298, 310]	[1, 7, 8, 18, 21, 32, 35, 39, 43, 47, 50, 53, 55, 61, 69, 71, 72, 73, 74, 75, 76, 84, 93, 98, 103, 105, 107, 111, 113, 114, 117, 119, 120, 121, 122, 123, 124, 128, 131, 135, 145, 146, 148, 151, 156, 161, 170, 173, 182, 185, 192, 198, 205, 209, 211, 212, 214, 223, 224, 238, 241, 245, 252, 258, 261, 265, 267, 270, 273, 276, 285, 289, 293, 296, 297, 310, 311]	['Clusters', 'consisted', 'of', 'components', 'of', 'the', 'histone', 'deacetylation', 'complex', '(', 'i.e', '.', ',', 'nuclear', 'receptor', 'corepressor', '1', 'and', '2', ',', 'NCOR1', '/', '2', ')', ',', 'and', 'of', 'RNA', 'synthesis', '/', 'elongation', 'were', 'observed', 'in', 'diseases', 'of', 'signal', 'transduction', 'and', 'TP53', 'regulates', 'transcription', 'of', 'DNA', 'repair', 'genes', 'enriched', 'Reactome', 'pathways', 'III', 'and', 'IV', ',', 'respectively', '.']	[3, 1, 1, 1, 1, 1, 2, 4, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 2, 1, 3, 2, 1, 1, 1, 1, 1, 3, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The F-actin depolymerizing activity of CFL1 is inactivated by phosphorylation on S3 by NIK related kinase (NRK)/NIK-like embryo-specific kinase (NESK), testis associated actin remodeling kinase 1 (TESK1), protein kinase D1 (PRKD1) and LIM domain kinase 1/2 (LIMK1/LIMK2)	[('PMC8125016', 'R13000', 87, 105, 'NIK related kinase')]	['The', 'F', '-', 'act', '##in', 'de', '##pol', '##yme', '##riz', '##ing', 'activity', 'of', 'CFL', '##1', 'is', 'inactivated', 'by', 'p', '##hos', '##ph', '##ory', '##lation', 'on', 'S', '##3', 'by', 'N', '##I', '##K', 'related', 'kinase', '(', 'N', '##R', '##K', ')', '/', 'N', '##I', '##K', '-', 'like', 'em', '##b', '##ryo', '-', 'specific', 'kinase', '(', 'NE', '##S', '##K', ')', ',', 'test', '##is', 'associated', 'act', '##in', 're', '##mo', '##del', '##ing', 'kinase', '1', '(', 'T', '##ES', '##K', '##1', ')', ',', 'protein', 'kinase', 'D', '##1', '(', 'PR', '##K', '##D', '##1', ')', 'and', 'L', '##IM', 'domain', 'kinase', '1', '/', '2', '(', 'L', '##IM', '##K', '##1', '/', 'L', '##IM', '##K', '##2', ')']	[0, 4, 5, 6, 9, 12, 14, 17, 20, 23, 27, 36, 39, 42, 44, 47, 59, 62, 63, 66, 68, 71, 78, 81, 82, 84, 87, 88, 89, 91, 99, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 121, 123, 124, 127, 128, 137, 144, 145, 147, 148, 149, 150, 152, 156, 159, 170, 173, 176, 178, 180, 183, 187, 194, 196, 197, 198, 200, 201, 202, 203, 205, 213, 220, 221, 223, 224, 226, 227, 228, 229, 231, 235, 236, 239, 246, 253, 254, 255, 257, 258, 259, 261, 262, 263, 264, 265, 267, 268, 269]	[3, 5, 6, 9, 11, 14, 17, 20, 23, 26, 35, 38, 42, 43, 46, 58, 61, 63, 66, 68, 71, 77, 80, 82, 83, 86, 88, 89, 90, 98, 105, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 120, 123, 124, 127, 128, 136, 143, 145, 147, 148, 149, 150, 151, 156, 158, 169, 173, 175, 178, 180, 183, 186, 193, 195, 197, 198, 200, 201, 202, 203, 204, 212, 219, 221, 222, 224, 226, 227, 228, 229, 230, 234, 236, 238, 245, 252, 254, 255, 256, 258, 259, 261, 262, 263, 264, 265, 267, 268, 269, 270]	['The', 'F-actin', 'depolymerizing', 'activity', 'of', 'CFL1', 'is', 'inactivated', 'by', 'phosphorylation', 'on', 'S3', 'by', 'NIK', 'related', 'kinase', '(', 'NRK', ')', '/', 'NIK', '-', 'like', 'embryo', '-', 'specific', 'kinase', '(', 'NESK', ')', ',', 'testis', 'associated', 'actin', 'remodeling', 'kinase', '1', '(', 'TESK1', ')', ',', 'protein', 'kinase', 'D1', '(', 'PRKD1', ')', 'and', 'LIM', 'domain', 'kinase', '1', '/', '2', '(', 'LIMK1', '/', 'LIMK2', ')']	[1, 4, 5, 1, 1, 2, 1, 1, 1, 5, 1, 2, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 1, 2, 1, 2, 4, 1, 1, 1, 4, 1, 1, 1, 1, 2, 1, 4, 1, 1, 2, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Interestingly, some of these kinases were predicted to be activated in the PRE-R group by kinase–substrate enrichment analysis (KSEA) (Figure 3e, see results below).	[]	['Interest', '##ingly', ',', 'some', 'of', 'these', 'kinase', '##s', 'were', 'predicted', 'to', 'be', 'activated', 'in', 'the', 'PR', '##E', '-', 'R', 'group', 'by', 'kinase', '–', 'substrate', 'en', '##rich', '##ment', 'analysis', '(', 'K', '##SE', '##A', ')', '(', 'Figure', '3', '##e', ',', 'see', 'results', 'below', ')', '.']	[0, 8, 13, 15, 20, 23, 29, 35, 37, 42, 52, 55, 58, 68, 71, 75, 77, 78, 79, 81, 87, 90, 96, 97, 107, 109, 113, 118, 127, 128, 129, 131, 132, 134, 135, 142, 143, 144, 146, 150, 158, 163, 164]	[8, 13, 14, 19, 22, 28, 35, 36, 41, 51, 54, 57, 67, 70, 74, 77, 78, 79, 80, 86, 89, 96, 97, 106, 109, 113, 117, 126, 128, 129, 131, 132, 133, 135, 141, 143, 144, 145, 149, 157, 163, 164, 165]	['Interestingly', ',', 'some', 'of', 'these', 'kinases', 'were', 'predicted', 'to', 'be', 'activated', 'in', 'the', 'PRE-R', 'group', 'by', 'kinase', '–', 'substrate', 'enrichment', 'analysis', '(', 'KSEA', ')', '(', 'Figure', '3e', ',', 'see', 'results', 'below', ')', '.']	[2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
In order to determine whether the protein phosphorylation levels were due to changes in protein abundance or to kinase activation, we investigated the expression of 85 phosphoproteins to the 107 differentially regulated phosphosites.	[('PMC8125016', 'R16000', 112, 118, 'kinase')]	['In', 'order', 'to', 'determine', 'whether', 'the', 'protein', 'p', '##hos', '##ph', '##ory', '##lation', 'levels', 'were', 'due', 'to', 'changes', 'in', 'protein', 'abundance', 'or', 'to', 'kinase', 'activation', ',', 'we', 'investigated', 'the', 'expression', 'of', '85', 'p', '##hos', '##ph', '##op', '##rote', '##ins', 'to', 'the', '107', 'differential', '##ly', 'regulated', 'p', '##hos', '##ph', '##os', '##ites', '.']	[0, 3, 9, 12, 22, 30, 34, 42, 43, 46, 48, 51, 58, 65, 70, 74, 77, 85, 88, 96, 106, 109, 112, 119, 129, 131, 134, 147, 151, 162, 165, 168, 169, 172, 174, 176, 180, 184, 187, 191, 195, 207, 210, 220, 221, 224, 226, 228, 232]	[2, 8, 11, 21, 29, 33, 41, 43, 46, 48, 51, 57, 64, 69, 73, 76, 84, 87, 95, 105, 108, 111, 118, 129, 130, 133, 146, 150, 161, 164, 167, 169, 172, 174, 176, 180, 183, 186, 190, 194, 207, 209, 219, 221, 224, 226, 228, 232, 233]	['In', 'order', 'to', 'determine', 'whether', 'the', 'protein', 'phosphorylation', 'levels', 'were', 'due', 'to', 'changes', 'in', 'protein', 'abundance', 'or', 'to', 'kinase', 'activation', ',', 'we', 'investigated', 'the', 'expression', 'of', '85', 'phosphoproteins', 'to', 'the', '107', 'differentially', 'regulated', 'phosphosites', '.']	[1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 2, 1, 5, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To identify protein kinases differentially activated in the PRE-R and PRE-NR groups, we performed phosphorylation site motif analysis (IceLogo)	[('PMC8125016', 'R17000', 12, 27, 'protein kinases')]	['To', 'identify', 'protein', 'kinase', '##s', 'differential', '##ly', 'activated', 'in', 'the', 'PR', '##E', '-', 'R', 'and', 'PR', '##E', '-', 'N', '##R', 'groups', ',', 'we', 'performed', 'p', '##hos', '##ph', '##ory', '##lation', 'site', 'motif', 'analysis', '(', 'Ice', '##L', '##ogo', ')']	[0, 3, 12, 20, 26, 28, 40, 43, 53, 56, 60, 62, 63, 64, 66, 70, 72, 73, 74, 75, 77, 83, 85, 88, 98, 99, 102, 104, 107, 114, 119, 125, 134, 135, 138, 139, 142]	[2, 11, 19, 26, 27, 40, 42, 52, 55, 59, 62, 63, 64, 65, 69, 72, 73, 74, 75, 76, 83, 84, 87, 97, 99, 102, 104, 107, 113, 118, 124, 133, 135, 138, 139, 142, 143]	['To', 'identify', 'protein', 'kinases', 'differentially', 'activated', 'in', 'the', 'PRE-R', 'and', 'PRE-NR', 'groups', ',', 'we', 'performed', 'phosphorylation', 'site', 'motif', 'analysis', '(', 'IceLogo', ')']	[1, 1, 1, 2, 2, 1, 1, 1, 4, 1, 5, 1, 1, 1, 1, 5, 1, 1, 1, 1, 3, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
We found basophilic RXXpS/pT and RPPS motifs characteristics of PRKCA/PRKCD and dual specificity tyrosine phosphorylation regulated kinase 2 (DYRK2), respectively, in PRE-R patient samples when compared to the PRE-NR group (Figure 3d).	[]	['We', 'found', 'b', '##as', '##op', '##hil', '##ic', 'R', '##X', '##X', '##p', '##S', '/', 'p', '##T', 'and', 'R', '##PP', '##S', 'motifs', 'characteristics', 'of', 'PR', '##K', '##CA', '/', 'PR', '##K', '##CD', 'and', 'dual', 'specific', '##ity', 't', '##yr', '##os', '##ine', 'p', '##hos', '##ph', '##ory', '##lation', 'regulated', 'kinase', '2', '(', 'D', '##Y', '##R', '##K', '##2', ')', ',', 'respectively', ',', 'in', 'PR', '##E', '-', 'R', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'PR', '##E', '-', 'N', '##R', 'group', '(', 'Figure', '3', '##d', ')', '.']	[0, 3, 9, 10, 12, 14, 17, 20, 21, 22, 23, 24, 25, 26, 27, 29, 33, 34, 36, 38, 45, 61, 64, 66, 67, 69, 70, 72, 73, 76, 80, 85, 93, 97, 98, 100, 102, 106, 107, 110, 112, 115, 122, 132, 139, 141, 142, 143, 144, 145, 146, 147, 148, 150, 162, 164, 167, 169, 170, 171, 173, 181, 189, 194, 203, 206, 210, 212, 213, 214, 215, 217, 223, 224, 231, 232, 233, 234]	[2, 8, 10, 12, 14, 17, 19, 21, 22, 23, 24, 25, 26, 27, 28, 32, 34, 36, 37, 44, 60, 63, 66, 67, 69, 70, 72, 73, 75, 79, 84, 93, 96, 98, 100, 102, 105, 107, 110, 112, 115, 121, 131, 138, 140, 142, 143, 144, 145, 146, 147, 148, 149, 162, 163, 166, 169, 170, 171, 172, 180, 188, 193, 202, 205, 209, 212, 213, 214, 215, 216, 222, 224, 230, 232, 233, 234, 235]	['We', 'found', 'basophilic', 'RXXpS', '/', 'pT', 'and', 'RPPS', 'motifs', 'characteristics', 'of', 'PRKCA', '/', 'PRKCD', 'and', 'dual', 'specificity', 'tyrosine', 'phosphorylation', 'regulated', 'kinase', '2', '(', 'DYRK2', ')', ',', 'respectively', ',', 'in', 'PRE-R', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'PRE-NR', 'group', '(', 'Figure', '3d', ')', '.']	[1, 1, 5, 5, 1, 2, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 2, 4, 5, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Furthermore, the KSEA [44,45], which is based on phosphorylation FCs to estimate kinase’s activity, confirmed the higher activity of these kinases together with LIMK1/2 and CDK2 in the PRE-R group (Figure 3e).	[]	['Furthermore', ',', 'the', 'K', '##SE', '##A', '[', '44', ',', '45', ']', ',', 'which', 'is', 'based', 'on', 'p', '##hos', '##ph', '##ory', '##lation', 'FC', '##s', 'to', 'estimate', 'kinase', '’', 's', 'activity', ',', 'confirmed', 'the', 'higher', 'activity', 'of', 'these', 'kinase', '##s', 'together', 'with', 'L', '##IM', '##K', '##1', '/', '2', 'and', 'CD', '##K', '##2', 'in', 'the', 'PR', '##E', '-', 'R', 'group', '(', 'Figure', '3', '##e', ')', '.']	[0, 11, 13, 17, 18, 20, 22, 23, 25, 26, 28, 29, 31, 37, 40, 46, 49, 50, 53, 55, 58, 65, 67, 69, 72, 81, 87, 88, 90, 98, 100, 110, 114, 121, 130, 133, 139, 145, 147, 156, 161, 162, 164, 165, 166, 167, 169, 173, 175, 176, 178, 181, 185, 187, 188, 189, 191, 197, 198, 205, 206, 207, 208]	[11, 12, 16, 18, 20, 21, 23, 25, 26, 28, 29, 30, 36, 39, 45, 48, 50, 53, 55, 58, 64, 67, 68, 71, 80, 87, 88, 89, 98, 99, 109, 113, 120, 129, 132, 138, 145, 146, 155, 160, 162, 164, 165, 166, 167, 168, 172, 175, 176, 177, 180, 184, 187, 188, 189, 190, 196, 198, 204, 206, 207, 208, 209]	['Furthermore', ',', 'the', 'KSEA', '[', '44', ',', '45', ']', ',', 'which', 'is', 'based', 'on', 'phosphorylation', 'FCs', 'to', 'estimate', 'kinase’s', 'activity', ',', 'confirmed', 'the', 'higher', 'activity', 'of', 'these', 'kinases', 'together', 'with', 'LIMK1', '/', '2', 'and', 'CDK2', 'in', 'the', 'PRE-R', 'group', '(', 'Figure', '3e', ')', '.']	[1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 4, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Only two kinases, protein kinase cGMP-dependent 2 (PRKG2) and microtubule affinity regulating kinase 1 (MARK1) involved in the activation of the extracellular signal-regulated kinases in osteoblasts and cell polarity, respectively [64,65], were predicted to be more active in the PRE-NR group.	[]	['Only', 'two', 'kinase', '##s', ',', 'protein', 'kinase', 'c', '##GM', '##P', '-', 'dependent', '2', '(', 'PR', '##K', '##G', '##2', ')', 'and', 'micro', '##tub', '##ule', 'affinity', 'regulating', 'kinase', '1', '(', 'MA', '##R', '##K', '##1', ')', 'involved', 'in', 'the', 'activation', 'of', 'the', 'extra', '##cellular', 'signal', '-', 'regulated', 'kinase', '##s', 'in', 'o', '##ste', '##ob', '##last', '##s', 'and', 'cell', 'polar', '##ity', ',', 'respectively', '[', '64', ',', '65', ']', ',', 'were', 'predicted', 'to', 'be', 'more', 'active', 'in', 'the', 'PR', '##E', '-', 'N', '##R', 'group', '.']	[0, 5, 9, 15, 16, 18, 26, 33, 34, 36, 37, 38, 48, 50, 51, 53, 54, 55, 56, 58, 62, 67, 70, 74, 83, 94, 101, 103, 104, 106, 107, 108, 109, 111, 120, 123, 127, 138, 141, 145, 150, 159, 165, 166, 176, 182, 184, 187, 188, 191, 193, 197, 199, 203, 208, 213, 216, 218, 231, 232, 234, 235, 237, 238, 240, 245, 255, 258, 261, 266, 273, 276, 280, 282, 283, 284, 285, 287, 292]	[4, 8, 15, 16, 17, 25, 32, 34, 36, 37, 38, 47, 49, 51, 53, 54, 55, 56, 57, 61, 67, 70, 73, 82, 93, 100, 102, 104, 106, 107, 108, 109, 110, 119, 122, 126, 137, 140, 144, 150, 158, 165, 166, 175, 182, 183, 186, 188, 191, 193, 197, 198, 202, 207, 213, 216, 217, 230, 232, 234, 235, 237, 238, 239, 244, 254, 257, 260, 265, 272, 275, 279, 282, 283, 284, 285, 286, 292, 293]	['Only', 'two', 'kinases', ',', 'protein', 'kinase', 'cGMP-dependent', '2', '(', 'PRKG2', ')', 'and', 'microtubule', 'affinity', 'regulating', 'kinase', '1', '(', 'MARK1', ')', 'involved', 'in', 'the', 'activation', 'of', 'the', 'extracellular', 'signal', '-', 'regulated', 'kinases', 'in', 'osteoblasts', 'and', 'cell', 'polarity', ',', 'respectively', '[', '64', ',', '65', ']', ',', 'were', 'predicted', 'to', 'be', 'more', 'active', 'in', 'the', 'PRE-NR', 'group', '.']	[1, 1, 2, 1, 1, 1, 5, 1, 1, 4, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 2, 1, 5, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The prediction of phosphorylation sites by a novel deep learning architecture based on multi-layer convolution neural networks (i.e., DeepPhos) installed in the piNET web platform [48,49] confirmed the higher number of activated kinases on substrates more phosphorylated in PRE-R patients when compared with the PRE-NR group (Figure S3) as previously observed in the KSEA analysis.	[]	['The', 'prediction', 'of', 'p', '##hos', '##ph', '##ory', '##lation', 'sites', 'by', 'a', 'novel', 'deep', 'learning', 'architecture', 'based', 'on', 'multi', '-', 'layer', 'con', '##vo', '##lution', 'neural', 'networks', '(', 'i', '.', 'e', '.', ',', 'Deep', '##P', '##hos', ')', 'installed', 'in', 'the', 'p', '##i', '##NE', '##T', 'web', 'platform', '[', '48', ',', '49', ']', 'confirmed', 'the', 'higher', 'number', 'of', 'activated', 'kinase', '##s', 'on', 'substrates', 'more', 'p', '##hos', '##ph', '##ory', '##lated', 'in', 'PR', '##E', '-', 'R', 'patients', 'when', 'compared', 'with', 'the', 'PR', '##E', '-', 'N', '##R', 'group', '(', 'Figure', 'S', '##3', ')', 'as', 'previously', 'observed', 'in', 'the', 'K', '##SE', '##A', 'analysis', '.']	[0, 4, 15, 18, 19, 22, 24, 27, 34, 40, 43, 45, 51, 56, 65, 78, 84, 87, 92, 93, 99, 102, 104, 111, 118, 127, 128, 129, 130, 131, 132, 134, 138, 139, 142, 144, 154, 157, 161, 162, 163, 165, 167, 171, 180, 181, 183, 184, 186, 188, 198, 202, 209, 216, 219, 229, 235, 237, 240, 251, 256, 257, 260, 262, 265, 271, 274, 276, 277, 278, 280, 289, 294, 303, 308, 312, 314, 315, 316, 317, 319, 325, 326, 333, 334, 335, 337, 340, 351, 360, 363, 367, 368, 370, 372, 380]	[3, 14, 17, 19, 22, 24, 27, 33, 39, 42, 44, 50, 55, 64, 77, 83, 86, 92, 93, 98, 102, 104, 110, 117, 126, 128, 129, 130, 131, 132, 133, 138, 139, 142, 143, 153, 156, 160, 162, 163, 165, 166, 170, 179, 181, 183, 184, 186, 187, 197, 201, 208, 215, 218, 228, 235, 236, 239, 250, 255, 257, 260, 262, 265, 270, 273, 276, 277, 278, 279, 288, 293, 302, 307, 311, 314, 315, 316, 317, 318, 324, 326, 332, 334, 335, 336, 339, 350, 359, 362, 366, 368, 370, 371, 380, 381]	['The', 'prediction', 'of', 'phosphorylation', 'sites', 'by', 'a', 'novel', 'deep', 'learning', 'architecture', 'based', 'on', 'multi', '-', 'layer', 'convolution', 'neural', 'networks', '(', 'i.e', '.', ',', 'DeepPhos', ')', 'installed', 'in', 'the', 'piNET', 'web', 'platform', '[', '48', ',', '49', ']', 'confirmed', 'the', 'higher', 'number', 'of', 'activated', 'kinases', 'on', 'substrates', 'more', 'phosphorylated', 'in', 'PRE-R', 'patients', 'when', 'compared', 'with', 'the', 'PRE-NR', 'group', '(', 'Figure', 'S3', ')', 'as', 'previously', 'observed', 'in', 'the', 'KSEA', 'analysis', '.']	[1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Among them, CDK1/2, MAPK4 (displayed as ERK1 in the figure) and PRKCD were again predicted to be more activated in the PRE-R group.	[]	['Among', 'them', ',', 'CD', '##K', '##1', '/', '2', ',', 'MA', '##P', '##K', '##4', '(', 'displayed', 'as', 'ER', '##K', '##1', 'in', 'the', 'figure', ')', 'and', 'PR', '##K', '##CD', 'were', 'again', 'predicted', 'to', 'be', 'more', 'activated', 'in', 'the', 'PR', '##E', '-', 'R', 'group', '.']	[0, 6, 10, 12, 14, 15, 16, 17, 18, 20, 22, 23, 24, 26, 27, 37, 40, 42, 43, 45, 48, 52, 58, 60, 64, 66, 67, 70, 75, 81, 91, 94, 97, 102, 112, 115, 119, 121, 122, 123, 125, 130]	[5, 10, 11, 14, 15, 16, 17, 18, 19, 22, 23, 24, 25, 27, 36, 39, 42, 43, 44, 47, 51, 58, 59, 63, 66, 67, 69, 74, 80, 90, 93, 96, 101, 111, 114, 118, 121, 122, 123, 124, 130, 131]	['Among', 'them', ',', 'CDK1', '/', '2', ',', 'MAPK4', '(', 'displayed', 'as', 'ERK1', 'in', 'the', 'figure', ')', 'and', 'PRKCD', 'were', 'again', 'predicted', 'to', 'be', 'more', 'activated', 'in', 'the', 'PRE-R', 'group', '.']	[1, 1, 1, 3, 1, 1, 1, 4, 1, 1, 1, 3, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The search of our phosphosite dataset by the kinase activation loop tool (see Materials and Methods) did not find any phosphorylated residue in the domain activation loops.	[('PMC8125016', 'R19000', 45, 51, 'kinase')]	['The', 'search', 'of', 'our', 'p', '##hos', '##ph', '##os', '##ite', 'data', '##set', 'by', 'the', 'kinase', 'activation', 'loop', 'tool', '(', 'see', 'Materials', 'and', 'Method', '##s', ')', 'did', 'not', 'find', 'any', 'p', '##hos', '##ph', '##ory', '##lated', 'residue', 'in', 'the', 'domain', 'activation', 'loops', '.']	[0, 4, 11, 14, 18, 19, 22, 24, 26, 30, 34, 38, 41, 45, 52, 63, 68, 73, 74, 78, 88, 92, 98, 99, 101, 105, 109, 114, 118, 119, 122, 124, 127, 133, 141, 144, 148, 155, 166, 171]	[3, 10, 13, 17, 19, 22, 24, 26, 29, 34, 37, 40, 44, 51, 62, 67, 72, 74, 77, 87, 91, 98, 99, 100, 104, 108, 113, 117, 119, 122, 124, 127, 132, 140, 143, 147, 154, 165, 171, 172]	['The', 'search', 'of', 'our', 'phosphosite', 'dataset', 'by', 'the', 'kinase', 'activation', 'loop', 'tool', '(', 'see', 'Materials', 'and', 'Methods', ')', 'did', 'not', 'find', 'any', 'phosphorylated', 'residue', 'in', 'the', 'domain', 'activation', 'loops', '.']	[1, 1, 1, 1, 5, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
However, we identified two kinases (in addition to the RIOK2 identified previously), CDK13 and pre-mRNA processing factor 4B (PRPF4B) more phosphorylated at S395 and S397 in PRE-NR and at S578 and S580 in PRE-R patients, respectively.	[('PMC8125016', 'R19001', 27, 34, 'kinases')]	['However', ',', 'we', 'identified', 'two', 'kinase', '##s', '(', 'in', 'addition', 'to', 'the', 'R', '##IO', '##K', '##2', 'identified', 'previously', ')', ',', 'CD', '##K', '##13', 'and', 'pre', '-', 'm', '##RNA', 'processing', 'factor', '4', '##B', '(', 'PR', '##P', '##F', '##4', '##B', ')', 'more', 'p', '##hos', '##ph', '##ory', '##lated', 'at', 'S', '##39', '##5', 'and', 'S', '##39', '##7', 'in', 'PR', '##E', '-', 'N', '##R', 'and', 'at', 'S', '##5', '##7', '##8', 'and', 'S', '##5', '##80', 'in', 'PR', '##E', '-', 'R', 'patients', ',', 'respectively', '.']	[0, 7, 9, 12, 23, 27, 33, 35, 36, 39, 48, 51, 55, 56, 58, 59, 61, 72, 82, 83, 85, 87, 88, 91, 95, 98, 99, 100, 104, 115, 122, 123, 125, 126, 128, 129, 130, 131, 132, 134, 139, 140, 143, 145, 148, 154, 157, 158, 160, 162, 166, 167, 169, 171, 174, 176, 177, 178, 179, 181, 185, 188, 189, 190, 191, 193, 197, 198, 199, 202, 205, 207, 208, 209, 211, 219, 221, 233]	[7, 8, 11, 22, 26, 33, 34, 36, 38, 47, 50, 54, 56, 58, 59, 60, 71, 82, 83, 84, 87, 88, 90, 94, 98, 99, 100, 103, 114, 121, 123, 124, 126, 128, 129, 130, 131, 132, 133, 138, 140, 143, 145, 148, 153, 156, 158, 160, 161, 165, 167, 169, 170, 173, 176, 177, 178, 179, 180, 184, 187, 189, 190, 191, 192, 196, 198, 199, 201, 204, 207, 208, 209, 210, 219, 220, 233, 234]	['However', ',', 'we', 'identified', 'two', 'kinases', '(', 'in', 'addition', 'to', 'the', 'RIOK2', 'identified', 'previously', ')', ',', 'CDK13', 'and', 'pre-mRNA', 'processing', 'factor', '4B', '(', 'PRPF4B', ')', 'more', 'phosphorylated', 'at', 'S395', 'and', 'S397', 'in', 'PRE-NR', 'and', 'at', 'S578', 'and', 'S580', 'in', 'PRE-R', 'patients', ',', 'respectively', '.']	[1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 3, 1, 4, 1, 1, 2, 1, 5, 1, 1, 5, 1, 3, 1, 3, 1, 5, 1, 1, 4, 1, 3, 1, 4, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'B', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters corresponding to ten different response patterns were identified in the responder group; two of them with low site-specific phosphorylation at 8D (cluster 1–4) were enriched with RNA processing, mRNA splicing, via spliceosome (e.g., SRRM1/2; RNA binding motif protein 15, RBM15; serine and arginine rich splicing factor 2, SRSF2) and nuclear speck (e.g., SRSF1; RB binding protein 6, ubiquitin ligase, RBBP6) GO terms whereas clusters with high site-specific phosphorylation at 8D (cluster 5–7) were enriched with Rho GTPase binding, cytoplasmic mRNA processing body assembly and actin filament binding (Figure 6a, right plot).	[]	['C', '##luster', '##s', 'corresponding', 'to', 'ten', 'different', 'response', 'patterns', 'were', 'identified', 'in', 'the', 'respond', '##er', 'group', ';', 'two', 'of', 'them', 'with', 'low', 'site', '-', 'specific', 'p', '##hos', '##ph', '##ory', '##lation', 'at', '8', '##D', '(', 'cluster', '1', '–', '4', ')', 'were', 'en', '##rich', '##ed', 'with', 'RNA', 'processing', ',', 'm', '##RNA', 's', '##p', '##licing', ',', 'via', 's', '##p', '##lice', '##oso', '##me', '(', 'e', '.', 'g', '.', ',', 'SR', '##R', '##M', '##1', '/', '2', ';', 'RNA', 'binding', 'motif', 'protein', '15', ',', 'RB', '##M', '##15', ';', 'se', '##rine', 'and', 'a', '##rg', '##ini', '##ne', 'rich', 's', '##p', '##licing', 'factor', '2', ',', 'SR', '##SF', '##2', ')', 'and', 'nuclear', 's', '##pec', '##k', '(', 'e', '.', 'g', '.', ',', 'SR', '##SF', '##1', ';', 'RB', 'binding', 'protein', '6', ',', 'u', '##bi', '##qui', '##tin', 'l', '##iga', '##se', ',', 'RB', '##B', '##P', '##6', ')', 'GO', 'terms', 'whereas', 'clusters', 'with', 'high', 'site', '-', 'specific', 'p', '##hos', '##ph', '##ory', '##lation', 'at', '8', '##D', '(', 'cluster', '5', '–', '7', ')', 'were', 'en', '##rich', '##ed', 'with', 'R', '##ho', 'GT', '##P', '##ase', 'binding', ',', 'c', '##yt', '##op', '##las', '##mic', 'm', '##RNA', 'processing', 'body', 'assembly', 'and', 'act', '##in', 'fi', '##lam', '##ent', 'binding', '(', 'Figure', '6', '##a', ',', 'right', 'plot', ')', '.']	[0, 1, 7, 9, 23, 26, 30, 40, 49, 58, 63, 74, 77, 81, 88, 91, 96, 98, 102, 105, 110, 115, 119, 123, 124, 133, 134, 137, 139, 142, 149, 152, 153, 155, 156, 164, 165, 166, 167, 169, 174, 176, 180, 183, 188, 192, 202, 204, 205, 209, 210, 211, 217, 219, 223, 224, 225, 229, 232, 235, 236, 237, 238, 239, 240, 242, 244, 245, 246, 247, 248, 249, 251, 255, 263, 269, 277, 279, 281, 283, 284, 286, 288, 290, 295, 299, 300, 302, 305, 308, 313, 314, 315, 322, 329, 330, 332, 334, 336, 337, 339, 343, 351, 352, 355, 357, 358, 359, 360, 361, 362, 364, 366, 368, 369, 371, 374, 382, 390, 391, 393, 394, 396, 399, 403, 404, 407, 409, 411, 413, 414, 415, 416, 418, 421, 427, 435, 444, 449, 454, 458, 459, 468, 469, 472, 474, 477, 484, 487, 488, 490, 491, 499, 500, 501, 502, 504, 509, 511, 515, 518, 523, 524, 527, 529, 530, 534, 541, 543, 544, 546, 548, 551, 555, 556, 560, 571, 576, 585, 589, 592, 595, 597, 600, 604, 612, 613, 620, 621, 622, 624, 630, 634, 635]	[1, 7, 8, 22, 25, 29, 39, 48, 57, 62, 73, 76, 80, 88, 90, 96, 97, 101, 104, 109, 114, 118, 123, 124, 132, 134, 137, 139, 142, 148, 151, 153, 154, 156, 163, 165, 166, 167, 168, 173, 176, 180, 182, 187, 191, 202, 203, 205, 208, 210, 211, 217, 218, 222, 224, 225, 229, 232, 234, 236, 237, 238, 239, 240, 241, 244, 245, 246, 247, 248, 249, 250, 254, 262, 268, 276, 279, 280, 283, 284, 286, 287, 290, 294, 298, 300, 302, 305, 307, 312, 314, 315, 321, 328, 330, 331, 334, 336, 337, 338, 342, 350, 352, 355, 356, 358, 359, 360, 361, 362, 363, 366, 368, 369, 370, 373, 381, 389, 391, 392, 394, 396, 399, 402, 404, 407, 409, 410, 413, 414, 415, 416, 417, 420, 426, 434, 443, 448, 453, 458, 459, 467, 469, 472, 474, 477, 483, 486, 488, 489, 491, 498, 500, 501, 502, 503, 508, 511, 515, 517, 522, 524, 526, 529, 530, 533, 541, 542, 544, 546, 548, 551, 554, 556, 559, 570, 575, 584, 588, 592, 594, 597, 600, 603, 611, 613, 619, 621, 622, 623, 629, 634, 635, 636]	['Clusters', 'corresponding', 'to', 'ten', 'different', 'response', 'patterns', 'were', 'identified', 'in', 'the', 'responder', 'group', ';', 'two', 'of', 'them', 'with', 'low', 'site', '-', 'specific', 'phosphorylation', 'at', '8D', '(', 'cluster', '1–', '4', ')', 'were', 'enriched', 'with', 'RNA', 'processing', ',', 'mRNA', 'splicing', ',', 'via', 'spliceosome', '(', 'e.g', '.', ',', 'SRRM1', '/', '2', ';', 'RNA', 'binding', 'motif', 'protein', '15', ',', 'RBM15', ';', 'serine', 'and', 'arginine', 'rich', 'splicing', 'factor', '2', ',', 'SRSF2', ')', 'and', 'nuclear', 'speck', '(', 'e.g', '.', ',', 'SRSF1', ';', 'RB', 'binding', 'protein', '6', ',', 'ubiquitin', 'ligase', ',', 'RBBP6', ')', 'GO', 'terms', 'whereas', 'clusters', 'with', 'high', 'site', '-', 'specific', 'phosphorylation', 'at', '8D', '(', 'cluster', '5–', '7', ')', 'were', 'enriched', 'with', 'Rho', 'GTPase', 'binding', ',', 'cytoplasmic', 'mRNA', 'processing', 'body', 'assembly', 'and', 'actin', 'filament', 'binding', '(', 'Figure', '6a', ',', 'right', 'plot', ')', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 2, 3, 1, 1, 5, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 2, 1, 4, 1, 3, 1, 1, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 2, 1, 1, 1, 3, 1, 2, 3, 1, 1, 5, 2, 1, 1, 1, 1, 2, 3, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters with high and low site-specific phosphorylation at 3D were enriched with the negative regulation of vasculature development/RNA polymerase I core binding (e.g., PML nuclear body scaffold, PML; programmed cell death 4, PDCD4; nucleolar and coiled-body phosphoprotein 1, NOLC1) and cyclin/CDK positive transcription elongation (i.e., RB transcriptional corepressor 1, RB1; CDK12) GO terms, respectively.	[]	['C', '##luster', '##s', 'with', 'high', 'and', 'low', 'site', '-', 'specific', 'p', '##hos', '##ph', '##ory', '##lation', 'at', '3D', 'were', 'en', '##rich', '##ed', 'with', 'the', 'negative', 'regulation', 'of', 'v', '##as', '##cula', '##ture', 'development', '/', 'RNA', 'polymer', '##ase', 'I', 'core', 'binding', '(', 'e', '.', 'g', '.', ',', 'PM', '##L', 'nuclear', 'body', 's', '##ca', '##ff', '##old', ',', 'PM', '##L', ';', 'programmed', 'cell', 'death', '4', ',', 'PD', '##CD', '##4', ';', 'n', '##uc', '##leo', '##lar', 'and', 'coil', '##ed', '-', 'body', 'p', '##hos', '##ph', '##op', '##rote', '##in', '1', ',', 'NO', '##LC', '##1', ')', 'and', 'c', '##y', '##c', '##lin', '/', 'CD', '##K', 'positive', 'transcription', 'el', '##ong', '##ation', '(', 'i', '.', 'e', '.', ',', 'RB', 'transcription', '##al', 'core', '##press', '##or', '1', ',', 'RB', '##1', ';', 'CD', '##K', '##12', ')', 'GO', 'terms', ',', 'respectively', '.']	[0, 1, 7, 9, 14, 19, 23, 27, 31, 32, 41, 42, 45, 47, 50, 57, 60, 63, 68, 70, 74, 77, 82, 86, 95, 106, 109, 110, 112, 116, 121, 132, 133, 137, 144, 148, 150, 155, 163, 164, 165, 166, 167, 168, 170, 172, 174, 182, 187, 188, 190, 192, 195, 197, 199, 200, 202, 213, 218, 224, 225, 227, 229, 231, 232, 234, 235, 237, 240, 244, 248, 252, 254, 255, 260, 261, 264, 266, 268, 272, 275, 276, 278, 280, 282, 283, 285, 289, 290, 291, 292, 295, 296, 298, 300, 309, 323, 325, 328, 334, 335, 336, 337, 338, 339, 341, 344, 357, 360, 364, 369, 372, 373, 375, 377, 378, 380, 382, 383, 385, 387, 390, 395, 397, 409]	[1, 7, 8, 13, 18, 22, 26, 31, 32, 40, 42, 45, 47, 50, 56, 59, 62, 67, 70, 74, 76, 81, 85, 94, 105, 108, 110, 112, 116, 120, 132, 133, 136, 144, 147, 149, 154, 162, 164, 165, 166, 167, 168, 169, 172, 173, 181, 186, 188, 190, 192, 195, 196, 199, 200, 201, 212, 217, 223, 225, 226, 229, 231, 232, 233, 235, 237, 240, 243, 247, 252, 254, 255, 259, 261, 264, 266, 268, 272, 274, 276, 277, 280, 282, 283, 284, 288, 290, 291, 292, 295, 296, 298, 299, 308, 322, 325, 328, 333, 335, 336, 337, 338, 339, 340, 343, 357, 359, 364, 369, 371, 373, 374, 377, 378, 379, 382, 383, 385, 386, 389, 395, 396, 409, 410]	['Clusters', 'with', 'high', 'and', 'low', 'site', '-', 'specific', 'phosphorylation', 'at', '3D', 'were', 'enriched', 'with', 'the', 'negative', 'regulation', 'of', 'vasculature', 'development', '/', 'RNA', 'polymerase', 'I', 'core', 'binding', '(', 'e.g', '.', ',', 'PML', 'nuclear', 'body', 'scaffold', ',', 'PML', ';', 'programmed', 'cell', 'death', '4', ',', 'PDCD4', ';', 'nucleolar', 'and', 'coiled', '-', 'body', 'phosphoprotein', '1', ',', 'NOLC1', ')', 'and', 'cyclin', '/', 'CDK', 'positive', 'transcription', 'elongation', '(', 'i.e', '.', ',', 'RB', 'transcriptional', 'corepressor', '1', ',', 'RB1', ';', 'CDK12', ')', 'GO', 'terms', ',', 'respectively', '.']	[3, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 3, 1, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 4, 1, 2, 1, 1, 6, 1, 1, 3, 1, 1, 4, 1, 2, 1, 1, 3, 1, 3, 1, 1, 1, 2, 3, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To identify protein kinases differentially activated in the temporal pair-wise comparisons we performed phosphorylation site motif analysis with WebLogo [43].	[('PMC8125016', 'R31000', 12, 27, 'protein kinases')]	['To', 'identify', 'protein', 'kinase', '##s', 'differential', '##ly', 'activated', 'in', 'the', 'temporal', 'pair', '-', 'wise', 'comparisons', 'we', 'performed', 'p', '##hos', '##ph', '##ory', '##lation', 'site', 'motif', 'analysis', 'with', 'Web', '##L', '##ogo', '[', '43', ']', '.']	[0, 3, 12, 20, 26, 28, 40, 43, 53, 56, 60, 69, 73, 74, 79, 91, 94, 104, 105, 108, 110, 113, 120, 125, 131, 140, 145, 148, 149, 153, 154, 156, 157]	[2, 11, 19, 26, 27, 40, 42, 52, 55, 59, 68, 73, 74, 78, 90, 93, 103, 105, 108, 110, 113, 119, 124, 130, 139, 144, 148, 149, 152, 154, 156, 157, 158]	['To', 'identify', 'protein', 'kinases', 'differentially', 'activated', 'in', 'the', 'temporal', 'pair', '-', 'wise', 'comparisons', 'we', 'performed', 'phosphorylation', 'site', 'motif', 'analysis', 'with', 'WebLogo', '[', '43', ']', '.']	[1, 1, 1, 2, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 3, 1, 1, 1, 1]	['O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
To briefly summarize the important observations from this part of our study, we observed again that the triple combination altered the phosphorylation of proteins, especially those involved in the regulation of translation/transcription/RNA metabolism, but additional effects were also observed for cytoskeletal/actin proteins and Rho GTPase binding.	[('PMC8125016', 'R32000', 335, 341, 'GTPase')]	['To', 'briefly', 'sum', '##mar', '##ize', 'the', 'important', 'observations', 'from', 'this', 'part', 'of', 'our', 'study', ',', 'we', 'observed', 'again', 'that', 'the', 'triple', 'combination', 'altered', 'the', 'p', '##hos', '##ph', '##ory', '##lation', 'of', 'proteins', ',', 'especially', 'those', 'involved', 'in', 'the', 'regulation', 'of', 'translation', '/', 'transcription', '/', 'RNA', 'metabolism', ',', 'but', 'additional', 'effects', 'were', 'also', 'observed', 'for', 'c', '##yt', '##os', '##kel', '##etal', '/', 'act', '##in', 'proteins', 'and', 'R', '##ho', 'GT', '##P', '##ase', 'binding', '.']	[0, 3, 11, 14, 17, 21, 25, 35, 48, 53, 58, 63, 66, 70, 75, 77, 80, 89, 95, 100, 104, 111, 123, 131, 135, 136, 139, 141, 144, 151, 154, 162, 164, 175, 181, 190, 193, 197, 208, 211, 222, 223, 236, 237, 241, 251, 253, 257, 268, 276, 281, 286, 295, 299, 300, 302, 304, 307, 311, 312, 315, 318, 327, 331, 332, 335, 337, 338, 342, 349]	[2, 10, 14, 17, 20, 24, 34, 47, 52, 57, 62, 65, 69, 75, 76, 79, 88, 94, 99, 103, 110, 122, 130, 134, 136, 139, 141, 144, 150, 153, 162, 163, 174, 180, 189, 192, 196, 207, 210, 222, 223, 236, 237, 240, 251, 252, 256, 267, 275, 280, 285, 294, 298, 300, 302, 304, 307, 311, 312, 315, 317, 326, 330, 332, 334, 337, 338, 341, 349, 350]	['To', 'briefly', 'summarize', 'the', 'important', 'observations', 'from', 'this', 'part', 'of', 'our', 'study', ',', 'we', 'observed', 'again', 'that', 'the', 'triple', 'combination', 'altered', 'the', 'phosphorylation', 'of', 'proteins', ',', 'especially', 'those', 'involved', 'in', 'the', 'regulation', 'of', 'translation', '/', 'transcription', '/', 'RNA', 'metabolism', ',', 'but', 'additional', 'effects', 'were', 'also', 'observed', 'for', 'cytoskeletal', '/', 'actin', 'proteins', 'and', 'Rho', 'GTPase', 'binding', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 2, 1, 1, 2, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O']
Clusters with an increasing temporal phosphorylation profiling (clusters 1 and 8), i.e., from PRE to 8D, in the non-responder phosphoproteome were enriched with CDK activity (e.g., CDK1, CDK2, CDK11B, CDK12) and RNA splicing (e.g., DEAH-box helicase 16, DHX16) whereas clusters with a decreasing temporal phosphorylation profiling (clusters 2 and 5) were enriched with G-protein coupled receptor signaling pathway (e.g., IQ motif containing GTPase activating protein 2, IGGAP2; Rho guanine nucleotide exchange factor 7, ARHGEF7) and RNA polymerase II transcription factor activity (e.g., high mobility group protein HMG-I/HMG-Y and HMGA1) GO terms (Figure 7a, right plot).	[]	['C', '##luster', '##s', 'with', 'an', 'increasing', 'temporal', 'p', '##hos', '##ph', '##ory', '##lation', 'pro', '##fi', '##ling', '(', 'clusters', '1', 'and', '8', ')', ',', 'i', '.', 'e', '.', ',', 'from', 'PR', '##E', 'to', '8', '##D', ',', 'in', 'the', 'non', '-', 'respond', '##er', 'p', '##hos', '##ph', '##op', '##rote', '##ome', 'were', 'en', '##rich', '##ed', 'with', 'CD', '##K', 'activity', '(', 'e', '.', 'g', '.', ',', 'CD', '##K', '##1', ',', 'CD', '##K', '##2', ',', 'CD', '##K', '##11', '##B', ',', 'CD', '##K', '##12', ')', 'and', 'RNA', 's', '##p', '##licing', '(', 'e', '.', 'g', '.', ',', 'DE', '##A', '##H', '-', 'box', 'he', '##lica', '##se', '16', ',', 'D', '##H', '##X', '##16', ')', 'whereas', 'clusters', 'with', 'a', 'decreasing', 'temporal', 'p', '##hos', '##ph', '##ory', '##lation', 'pro', '##fi', '##ling', '(', 'clusters', '2', 'and', '5', ')', 'were', 'en', '##rich', '##ed', 'with', 'G', '-', 'protein', 'coupled', 'receptor', 'signaling', 'pathway', '(', 'e', '.', 'g', '.', ',', 'I', '##Q', 'motif', 'containing', 'GT', '##P', '##ase', 'act', '##ivating', 'protein', '2', ',', 'I', '##G', '##GA', '##P', '##2', ';', 'R', '##ho', 'g', '##uan', '##ine', 'n', '##uc', '##leo', '##tide', 'exchange', 'factor', '7', ',', 'AR', '##H', '##GE', '##F', '##7', ')', 'and', 'RNA', 'polymer', '##ase', 'II', 'transcription', 'factor', 'activity', '(', 'e', '.', 'g', '.', ',', 'high', 'mobility', 'group', 'protein', 'HM', '##G', '-', 'I', '/', 'HM', '##G', '-', 'Y', 'and', 'HM', '##GA', '##1', ')', 'GO', 'terms', '(', 'Figure', '7', '##a', ',', 'right', 'plot', ')', '.']	[0, 1, 7, 9, 14, 17, 28, 37, 38, 41, 43, 46, 53, 56, 58, 63, 64, 73, 75, 79, 80, 81, 83, 84, 85, 86, 87, 89, 94, 96, 98, 101, 102, 103, 105, 108, 112, 115, 116, 123, 126, 127, 130, 132, 134, 138, 142, 147, 149, 153, 156, 161, 163, 165, 174, 175, 176, 177, 178, 179, 181, 183, 184, 185, 187, 189, 190, 191, 193, 195, 196, 198, 199, 201, 203, 204, 206, 208, 212, 216, 217, 218, 225, 226, 227, 228, 229, 230, 232, 234, 235, 236, 237, 241, 243, 247, 250, 252, 254, 255, 256, 257, 259, 261, 269, 278, 283, 285, 296, 305, 306, 309, 311, 314, 321, 324, 326, 331, 332, 341, 343, 347, 348, 350, 355, 357, 361, 364, 369, 370, 371, 379, 387, 396, 406, 414, 415, 416, 417, 418, 419, 421, 422, 424, 430, 441, 443, 444, 448, 451, 459, 467, 468, 470, 471, 472, 474, 475, 476, 478, 479, 482, 483, 486, 490, 491, 493, 496, 501, 510, 517, 518, 520, 522, 523, 525, 526, 527, 529, 533, 537, 544, 548, 551, 565, 572, 581, 582, 583, 584, 585, 586, 588, 593, 602, 608, 616, 618, 619, 620, 621, 622, 624, 625, 626, 628, 632, 634, 636, 637, 639, 642, 648, 649, 656, 657, 658, 660, 666, 670, 671]	[1, 7, 8, 13, 16, 27, 36, 38, 41, 43, 46, 52, 56, 58, 62, 64, 72, 74, 78, 80, 81, 82, 84, 85, 86, 87, 88, 93, 96, 97, 100, 102, 103, 104, 107, 111, 115, 116, 123, 125, 127, 130, 132, 134, 138, 141, 146, 149, 153, 155, 160, 163, 164, 173, 175, 176, 177, 178, 179, 180, 183, 184, 185, 186, 189, 190, 191, 192, 195, 196, 198, 199, 200, 203, 204, 206, 207, 211, 215, 217, 218, 224, 226, 227, 228, 229, 230, 231, 234, 235, 236, 237, 240, 243, 247, 249, 252, 253, 255, 256, 257, 259, 260, 268, 277, 282, 284, 295, 304, 306, 309, 311, 314, 320, 324, 326, 330, 332, 340, 342, 346, 348, 349, 354, 357, 361, 363, 368, 370, 371, 378, 386, 395, 405, 413, 415, 416, 417, 418, 419, 420, 422, 423, 429, 440, 443, 444, 447, 451, 458, 466, 468, 469, 471, 472, 474, 475, 476, 477, 479, 481, 483, 486, 489, 491, 493, 496, 500, 509, 516, 518, 519, 522, 523, 525, 526, 527, 528, 532, 536, 544, 547, 550, 564, 571, 580, 582, 583, 584, 585, 586, 587, 592, 601, 607, 615, 618, 619, 620, 621, 622, 624, 625, 626, 627, 631, 634, 636, 637, 638, 641, 647, 649, 655, 657, 658, 659, 665, 670, 671, 672]	['Clusters', 'with', 'an', 'increasing', 'temporal', 'phosphorylation', 'profiling', '(', 'clusters', '1', 'and', '8', ')', ',', 'i.e', '.', ',', 'from', 'PRE', 'to', '8D', ',', 'in', 'the', 'non', '-', 'responder', 'phosphoproteome', 'were', 'enriched', 'with', 'CDK', 'activity', '(', 'e.g', '.', ',', 'CDK1', ',', 'CDK2', ',', 'CDK11B', ',', 'CDK12', ')', 'and', 'RNA', 'splicing', '(', 'e.g', '.', ',', 'DEAH-box', 'helicase', '16', ',', 'DHX16', ')', 'whereas', 'clusters', 'with', 'a', 'decreasing', 'temporal', 'phosphorylation', 'profiling', '(', 'clusters', '2', 'and', '5', ')', 'were', 'enriched', 'with', 'G', '-', 'protein', 'coupled', 'receptor', 'signaling', 'pathway', '(', 'e.g', '.', ',', 'IQ', 'motif', 'containing', 'GTPase', 'activating', 'protein', '2', ',', 'IGGAP2', ';', 'Rho', 'guanine', 'nucleotide', 'exchange', 'factor', '7', ',', 'ARHGEF7', ')', 'and', 'RNA', 'polymerase', 'II', 'transcription', 'factor', 'activity', '(', 'e.g', '.', ',', 'high', 'mobility', 'group', 'protein', 'HMG-I', '/', 'HMG-Y', 'and', 'HMGA1', ')', 'GO', 'terms', '(', 'Figure', '7a', ',', 'right', 'plot', ')', '.']	[3, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 2, 1, 2, 1, 1, 1, 1, 1, 2, 6, 1, 3, 1, 2, 1, 1, 3, 1, 1, 3, 1, 3, 1, 4, 1, 3, 1, 1, 1, 3, 1, 3, 1, 1, 5, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 5, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 3, 2, 1, 1, 1, 5, 1, 2, 3, 4, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 3, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Clusters with the highest protein phosphorylation at 3D (cluster 3, 4 and 6) were enriched with RNA splicing, protein–DNA complex assembly (e.g., H1.4 linker histone, cluster member, H1-4; heterochromatin protein 1 binding protein 3, HP1BP3; remodeling and spacing factor 1, Rsf-1, RSF1) and the sites of the DNA damage (e.g., replication timing regulatory factor 1, RIF1) GO terms, whereas clusters with the lowest protein phosphorylation at 3D (clusters 7, 9 and 10) were enriched with a negative regulation of the cellular catabolic process (e.g., PML, dyskerin pseudouridine synthase 1, DKC1), nuclear chromosome, telomeric region and the negative regulation of T cell activation (e.g., CD74 molecule, CD74; sialophorin, SPN) when compared to pre-treatment and 8D conditions.	[('PMC8125016', 'R34000', 556, 589, 'dyskerin pseudouridine synthase 1')]	['C', '##luster', '##s', 'with', 'the', 'highest', 'protein', 'p', '##hos', '##ph', '##ory', '##lation', 'at', '3D', '(', 'cluster', '3', ',', '4', 'and', '6', ')', 'were', 'en', '##rich', '##ed', 'with', 'RNA', 's', '##p', '##licing', ',', 'protein', '–', 'DNA', 'complex', 'assembly', '(', 'e', '.', 'g', '.', ',', 'H', '##1', '.', '4', 'link', '##er', 'his', '##tone', ',', 'cluster', 'member', ',', 'H', '##1', '-', '4', ';', 'he', '##tero', '##ch', '##roma', '##tin', 'protein', '1', 'binding', 'protein', '3', ',', 'HP', '##1', '##B', '##P', '##3', ';', 're', '##mo', '##del', '##ing', 'and', 'spa', '##cing', 'factor', '1', ',', 'Rs', '##f', '-', '1', ',', 'RS', '##F', '##1', ')', 'and', 'the', 'sites', 'of', 'the', 'DNA', 'damage', '(', 'e', '.', 'g', '.', ',', 'replication', 'timing', 'regulatory', 'factor', '1', ',', 'R', '##IF', '##1', ')', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'the', 'lowest', 'protein', 'p', '##hos', '##ph', '##ory', '##lation', 'at', '3D', '(', 'clusters', '7', ',', '9', 'and', '10', ')', 'were', 'en', '##rich', '##ed', 'with', 'a', 'negative', 'regulation', 'of', 'the', 'cellular', 'cat', '##ab', '##olic', 'process', '(', 'e', '.', 'g', '.', ',', 'PM', '##L', ',', 'd', '##ys', '##ker', '##in', 'pseudo', '##uri', '##dine', 's', '##ynth', '##ase', '1', ',', 'D', '##K', '##C', '##1', ')', ',', 'nuclear', 'chromosome', ',', 'te', '##lo', '##mer', '##ic', 'region', 'and', 'the', 'negative', 'regulation', 'of', 'T', 'cell', 'activation', '(', 'e', '.', 'g', '.', ',', 'CD', '##7', '##4', 'molecule', ',', 'CD', '##7', '##4', ';', 'si', '##alo', '##ph', '##ori', '##n', ',', 'SP', '##N', ')', 'when', 'compared', 'to', 'pre', '-', 'treatment', 'and', '8', '##D', 'conditions', '.']	[0, 1, 7, 9, 14, 18, 26, 34, 35, 38, 40, 43, 50, 53, 56, 57, 65, 66, 68, 70, 74, 75, 77, 82, 84, 88, 91, 96, 100, 101, 102, 108, 110, 117, 118, 122, 130, 139, 140, 141, 142, 143, 144, 146, 147, 148, 149, 151, 155, 158, 161, 165, 167, 175, 181, 183, 184, 185, 186, 187, 189, 191, 195, 197, 201, 205, 213, 215, 223, 231, 232, 234, 236, 237, 238, 239, 240, 242, 244, 246, 249, 253, 257, 260, 265, 272, 273, 275, 277, 278, 279, 280, 282, 284, 285, 286, 288, 292, 296, 302, 305, 309, 313, 320, 321, 322, 323, 324, 325, 327, 339, 346, 357, 364, 365, 367, 368, 370, 371, 373, 376, 381, 383, 391, 400, 405, 409, 416, 424, 425, 428, 430, 433, 440, 443, 446, 447, 456, 457, 459, 461, 465, 467, 469, 474, 476, 480, 483, 488, 490, 499, 510, 513, 517, 526, 529, 531, 536, 544, 545, 546, 547, 548, 549, 551, 553, 554, 556, 557, 559, 562, 565, 571, 574, 579, 580, 584, 588, 589, 591, 592, 593, 594, 595, 596, 598, 606, 616, 618, 620, 622, 625, 628, 635, 639, 643, 652, 663, 666, 668, 673, 684, 685, 686, 687, 688, 689, 691, 693, 694, 696, 704, 706, 708, 709, 710, 712, 714, 717, 719, 722, 723, 725, 727, 728, 730, 735, 744, 747, 750, 751, 761, 765, 766, 768, 778]	[1, 7, 8, 13, 17, 25, 33, 35, 38, 40, 43, 49, 52, 55, 57, 64, 66, 67, 69, 73, 75, 76, 81, 84, 88, 90, 95, 99, 101, 102, 108, 109, 117, 118, 121, 129, 138, 140, 141, 142, 143, 144, 145, 147, 148, 149, 150, 155, 157, 161, 165, 166, 174, 181, 182, 184, 185, 186, 187, 188, 191, 195, 197, 201, 204, 212, 214, 222, 230, 232, 233, 236, 237, 238, 239, 240, 241, 244, 246, 249, 252, 256, 260, 264, 271, 273, 274, 277, 278, 279, 280, 281, 284, 285, 286, 287, 291, 295, 301, 304, 308, 312, 319, 321, 322, 323, 324, 325, 326, 338, 345, 356, 363, 365, 366, 368, 370, 371, 372, 375, 381, 382, 390, 399, 404, 408, 415, 423, 425, 428, 430, 433, 439, 442, 445, 447, 455, 457, 458, 460, 464, 467, 468, 473, 476, 480, 482, 487, 489, 498, 509, 512, 516, 525, 529, 531, 535, 543, 545, 546, 547, 548, 549, 550, 553, 554, 555, 557, 559, 562, 564, 571, 574, 578, 580, 584, 587, 589, 590, 592, 593, 594, 595, 596, 597, 605, 616, 617, 620, 622, 625, 627, 634, 638, 642, 651, 662, 665, 667, 672, 683, 685, 686, 687, 688, 689, 690, 693, 694, 695, 704, 705, 708, 709, 710, 711, 714, 717, 719, 722, 723, 724, 727, 728, 729, 734, 743, 746, 750, 751, 760, 764, 766, 767, 778, 779]	['Clusters', 'with', 'the', 'highest', 'protein', 'phosphorylation', 'at', '3D', '(', 'cluster', '3', ',', '4', 'and', '6', ')', 'were', 'enriched', 'with', 'RNA', 'splicing', ',', 'protein', '–', 'DNA', 'complex', 'assembly', '(', 'e.g', '.', ',', 'H1.4', 'linker', 'histone', ',', 'cluster', 'member', ',', 'H1-4', ';', 'heterochromatin', 'protein', '1', 'binding', 'protein', '3', ',', 'HP1BP3', ';', 'remodeling', 'and', 'spacing', 'factor', '1', ',', 'Rsf-1', ',', 'RSF1', ')', 'and', 'the', 'sites', 'of', 'the', 'DNA', 'damage', '(', 'e.g', '.', ',', 'replication', 'timing', 'regulatory', 'factor', '1', ',', 'RIF1', ')', 'GO', 'terms', ',', 'whereas', 'clusters', 'with', 'the', 'lowest', 'protein', 'phosphorylation', 'at', '3D', '(', 'clusters', '7', ',', '9', 'and', '10', ')', 'were', 'enriched', 'with', 'a', 'negative', 'regulation', 'of', 'the', 'cellular', 'catabolic', 'process', '(', 'e.g', '.', ',', 'PML', ',', 'dyskerin', 'pseudouridine', 'synthase', '1', ',', 'DKC1', ')', ',', 'nuclear', 'chromosome', ',', 'telomeric', 'region', 'and', 'the', 'negative', 'regulation', 'of', 'T', 'cell', 'activation', '(', 'e.g', '.', ',', 'CD74', 'molecule', ',', 'CD74', ';', 'sialophorin', ',', 'SPN', ')', 'when', 'compared', 'to', 'pre', '-', 'treatment', 'and', '8D', 'conditions', '.']	[3, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 4, 2, 2, 1, 1, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 5, 1, 4, 1, 2, 1, 1, 1, 4, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 2, 1, 4, 3, 3, 1, 1, 4, 1, 1, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 3, 1, 1, 3, 1, 5, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The analysis of kinase substrates using the WebLogo tool found an enrichment of basophilic R/KXpS/pT and the SP motif characteristics of PRKCA/PRKCD and MAPK3/1, respectively, in the 3D-NR and 8D-NR patient samples when compared to the pre-treatment group (Figure 7c, left and middle plot).	[('PMC8125016', 'R36000', 16, 22, 'kinase')]	['The', 'analysis', 'of', 'kinase', 'substrates', 'using', 'the', 'Web', '##L', '##ogo', 'tool', 'found', 'an', 'en', '##rich', '##ment', 'of', 'b', '##as', '##op', '##hil', '##ic', 'R', '/', 'K', '##X', '##p', '##S', '/', 'p', '##T', 'and', 'the', 'SP', 'motif', 'characteristics', 'of', 'PR', '##K', '##CA', '/', 'PR', '##K', '##CD', 'and', 'MA', '##P', '##K', '##3', '/', '1', ',', 'respectively', ',', 'in', 'the', '3D', '-', 'N', '##R', 'and', '8', '##D', '-', 'N', '##R', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'group', '(', 'Figure', '7', '##c', ',', 'left', 'and', 'middle', 'plot', ')', '.']	[0, 4, 13, 16, 23, 34, 40, 44, 47, 48, 52, 57, 63, 66, 68, 72, 77, 80, 81, 83, 85, 88, 91, 92, 93, 94, 95, 96, 97, 98, 99, 101, 105, 109, 112, 118, 134, 137, 139, 140, 142, 143, 145, 146, 149, 153, 155, 156, 157, 158, 159, 160, 162, 174, 176, 179, 183, 185, 186, 187, 189, 193, 194, 195, 196, 197, 199, 207, 215, 220, 229, 232, 236, 239, 240, 250, 256, 257, 264, 265, 266, 268, 273, 277, 284, 288, 289]	[3, 12, 15, 22, 33, 39, 43, 47, 48, 51, 56, 62, 65, 68, 72, 76, 79, 81, 83, 85, 88, 90, 92, 93, 94, 95, 96, 97, 98, 99, 100, 104, 108, 111, 117, 133, 136, 139, 140, 142, 143, 145, 146, 148, 152, 155, 156, 157, 158, 159, 160, 161, 174, 175, 178, 182, 185, 186, 187, 188, 192, 194, 195, 196, 197, 198, 206, 214, 219, 228, 231, 235, 239, 240, 249, 255, 257, 263, 265, 266, 267, 272, 276, 283, 288, 289, 290]	['The', 'analysis', 'of', 'kinase', 'substrates', 'using', 'the', 'WebLogo', 'tool', 'found', 'an', 'enrichment', 'of', 'basophilic', 'R', '/', 'KXpS', '/', 'pT', 'and', 'the', 'SP', 'motif', 'characteristics', 'of', 'PRKCA', '/', 'PRKCD', 'and', 'MAPK3', '/', '1', ',', 'respectively', ',', 'in', 'the', '3D-NR', 'and', '8D-NR', 'patient', 'samples', 'when', 'compared', 'to', 'the', 'pre', '-', 'treatment', 'group', '(', 'Figure', '7c', ',', 'left', 'and', 'middle', 'plot', ')', '.']	[1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 3, 1, 5, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
The acidic SXD/ED/E kinase motif of CSNK2A1 was clearly observed in the 8D-NR when compared to the 3D-NR group (Figure 7c, right plot).	[('PMC8125016', 'R36001', 20, 26, 'kinase')]	['The', 'acidic', 'S', '##X', '##D', '/', 'E', '##D', '/', 'E', 'kinase', 'motif', 'of', 'CS', '##N', '##K', '##2', '##A', '##1', 'was', 'clearly', 'observed', 'in', 'the', '8', '##D', '-', 'N', '##R', 'when', 'compared', 'to', 'the', '3D', '-', 'N', '##R', 'group', '(', 'Figure', '7', '##c', ',', 'right', 'plot', ')', '.']	[0, 4, 11, 12, 13, 14, 15, 16, 17, 18, 20, 27, 33, 36, 38, 39, 40, 41, 42, 44, 48, 56, 65, 68, 72, 73, 74, 75, 76, 78, 83, 92, 95, 99, 101, 102, 103, 105, 111, 112, 119, 120, 121, 123, 129, 133, 134]	[3, 10, 12, 13, 14, 15, 16, 17, 18, 19, 26, 32, 35, 38, 39, 40, 41, 42, 43, 47, 55, 64, 67, 71, 73, 74, 75, 76, 77, 82, 91, 94, 98, 101, 102, 103, 104, 110, 112, 118, 120, 121, 122, 128, 133, 134, 135]	['The', 'acidic', 'SXD', '/', 'ED', '/', 'E', 'kinase', 'motif', 'of', 'CSNK2A1', 'was', 'clearly', 'observed', 'in', 'the', '8D-NR', 'when', 'compared', 'to', 'the', '3D-NR', 'group', '(', 'Figure', '7c', ',', 'right', 'plot', ')', '.']	[1, 1, 3, 1, 2, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1, 4, 1, 1, 1, 2, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'S', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Taken together, the non-responder group differed from the responders both with regard to the phosphorylation events on the actin/cytoskeleton but also with regard to transcriptional regulation and GTPase/G-protein coupled signaling.	[('PMC8125016', 'R37000', 197, 203, 'GTPase')]	['Take', '##n', 'together', ',', 'the', 'non', '-', 'respond', '##er', 'group', 'differed', 'from', 'the', 'respond', '##ers', 'both', 'with', 'regard', 'to', 'the', 'p', '##hos', '##ph', '##ory', '##lation', 'events', 'on', 'the', 'act', '##in', '/', 'c', '##yt', '##os', '##kel', '##eton', 'but', 'also', 'with', 'regard', 'to', 'transcription', '##al', 'regulation', 'and', 'GT', '##P', '##ase', '/', 'G', '-', 'protein', 'coupled', 'signaling', '.']	[0, 4, 6, 14, 16, 20, 23, 24, 31, 34, 40, 49, 54, 58, 65, 69, 74, 79, 86, 89, 93, 94, 97, 99, 102, 109, 116, 119, 123, 126, 128, 129, 130, 132, 134, 137, 142, 146, 151, 156, 163, 166, 179, 182, 193, 197, 199, 200, 203, 204, 205, 206, 214, 222, 231]	[4, 5, 14, 15, 19, 23, 24, 31, 33, 39, 48, 53, 57, 65, 68, 73, 78, 85, 88, 92, 94, 97, 99, 102, 108, 115, 118, 122, 126, 128, 129, 130, 132, 134, 137, 141, 145, 150, 155, 162, 165, 179, 181, 192, 196, 199, 200, 203, 204, 205, 206, 213, 221, 231, 232]	['Taken', 'together', ',', 'the', 'non', '-', 'responder', 'group', 'differed', 'from', 'the', 'responders', 'both', 'with', 'regard', 'to', 'the', 'phosphorylation', 'events', 'on', 'the', 'actin', '/', 'cytoskeleton', 'but', 'also', 'with', 'regard', 'to', 'transcriptional', 'regulation', 'and', 'GTPase', '/', 'G', '-', 'protein', 'coupled', 'signaling', '.']	[2, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 5, 1, 1, 1, 2, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
L-PGDS is expressed in various tissues, such as the brain, retina, cochlea, and male reproductive organs, and it is found in different biological fluids, such as cerebrospinal fluid (CSF), ascites, seminal plasma, serum, urine, and amniotic fluid.	[]	['L', '-', 'P', '##G', '##DS', 'is', 'expressed', 'in', 'various', 'tissues', ',', 'such', 'as', 'the', 'brain', ',', 're', '##tina', ',', 'co', '##ch', '##lea', ',', 'and', 'male', 'reproductive', 'organs', ',', 'and', 'it', 'is', 'found', 'in', 'different', 'biological', 'fluids', ',', 'such', 'as', 'c', '##ere', '##bro', '##sp', '##inal', 'fluid', '(', 'CS', '##F', ')', ',', 'as', '##cite', '##s', ',', 'seminal', 'plasma', ',', 'serum', ',', 'urine', ',', 'and', 'am', '##nio', '##tic', 'fluid', '.']	[0, 1, 2, 3, 4, 7, 10, 20, 23, 31, 38, 40, 45, 48, 52, 57, 59, 61, 65, 67, 69, 71, 74, 76, 80, 85, 98, 104, 106, 110, 113, 116, 122, 125, 135, 146, 152, 154, 159, 162, 163, 166, 169, 171, 176, 182, 183, 185, 186, 187, 189, 191, 195, 196, 198, 206, 212, 214, 219, 221, 226, 228, 232, 234, 237, 241, 246]	[1, 2, 3, 4, 6, 9, 19, 22, 30, 38, 39, 44, 47, 51, 57, 58, 61, 65, 66, 69, 71, 74, 75, 79, 84, 97, 104, 105, 109, 112, 115, 121, 124, 134, 145, 152, 153, 158, 161, 163, 166, 169, 171, 175, 181, 183, 185, 186, 187, 188, 191, 195, 196, 197, 205, 212, 213, 219, 220, 226, 227, 231, 234, 237, 240, 246, 247]	['L-PGDS', 'is', 'expressed', 'in', 'various', 'tissues', ',', 'such', 'as', 'the', 'brain', ',', 'retina', ',', 'cochlea', ',', 'and', 'male', 'reproductive', 'organs', ',', 'and', 'it', 'is', 'found', 'in', 'different', 'biological', 'fluids', ',', 'such', 'as', 'cerebrospinal', 'fluid', '(', 'CSF', ')', ',', 'ascites', ',', 'seminal', 'plasma', ',', 'serum', ',', 'urine', ',', 'and', 'amniotic', 'fluid', '.']	[5, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 2, 1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Alpha-1 antitrypsin (A1AT), also known as alpha-1 proteinase inhibitor, is an acute phase reactant and serine protease inhibitor (serpin) whose targets are elastase, plasmin, thrombin, trypsin, chymotrypsin, plasminogen activator, and is mostly produced in the liver and expressed by hepatocytes [76].	[('PMC8396559', 'D05000', 42, 60, 'alpha-1 proteinase')]	['Alpha', '-', '1', 'anti', '##try', '##ps', '##in', '(', 'A1', '##AT', ')', ',', 'also', 'known', 'as', 'alpha', '-', '1', 'protein', '##ase', 'inhibitor', ',', 'is', 'an', 'acute', 'phase', 'react', '##ant', 'and', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', '(', 'se', '##rp', '##in', ')', 'whose', 'targets', 'are', 'el', '##ast', '##ase', ',', 'p', '##las', '##min', ',', 'th', '##rom', '##bin', ',', 'try', '##ps', '##in', ',', 'ch', '##ym', '##ot', '##ry', '##ps', '##in', ',', 'p', '##las', '##min', '##ogen', 'act', '##iva', '##tor', ',', 'and', 'is', 'mostly', 'produced', 'in', 'the', 'liver', 'and', 'expressed', 'by', 'he', '##pa', '##to', '##cy', '##tes', '[', '76', ']', '.']	[0, 5, 6, 8, 12, 15, 17, 20, 21, 23, 25, 26, 28, 33, 39, 42, 47, 48, 50, 57, 61, 70, 72, 75, 78, 84, 90, 95, 99, 103, 105, 110, 113, 115, 119, 129, 130, 132, 134, 136, 138, 144, 152, 156, 158, 161, 164, 166, 167, 170, 173, 175, 177, 180, 183, 185, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 209, 212, 215, 220, 223, 226, 229, 231, 235, 238, 245, 254, 257, 261, 267, 271, 281, 284, 286, 288, 290, 292, 296, 297, 299, 300]	[5, 6, 7, 12, 15, 17, 19, 21, 23, 25, 26, 27, 32, 38, 41, 47, 48, 49, 57, 60, 70, 71, 74, 77, 83, 89, 95, 98, 102, 105, 109, 113, 115, 118, 128, 130, 132, 134, 136, 137, 143, 151, 155, 158, 161, 164, 165, 167, 170, 173, 174, 177, 180, 183, 184, 188, 190, 192, 193, 196, 198, 200, 202, 204, 206, 207, 209, 212, 215, 219, 223, 226, 229, 230, 234, 237, 244, 253, 256, 260, 266, 270, 280, 283, 286, 288, 290, 292, 295, 297, 299, 300, 301]	['Alpha-1', 'antitrypsin', '(', 'A1AT', ')', ',', 'also', 'known', 'as', 'alpha-1', 'proteinase', 'inhibitor', ',', 'is', 'an', 'acute', 'phase', 'reactant', 'and', 'serine', 'protease', 'inhibitor', '(', 'serpin', ')', 'whose', 'targets', 'are', 'elastase', ',', 'plasmin', ',', 'thrombin', ',', 'trypsin', ',', 'chymotrypsin', ',', 'plasminogen', 'activator', ',', 'and', 'is', 'mostly', 'produced', 'in', 'the', 'liver', 'and', 'expressed', 'by', 'hepatocytes', '[', '76', ']', '.']	[3, 4, 1, 2, 1, 1, 1, 1, 1, 3, 2, 1, 1, 1, 1, 1, 1, 2, 1, 2, 3, 1, 1, 3, 1, 1, 1, 1, 3, 1, 3, 1, 3, 1, 3, 1, 6, 1, 4, 3, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Inter-alpha-trypsin heavy chain H4 (ITIH4) is a liver-produced glycoprotein belonging to the liver-restricted serine protease inhibitor family.	[('PMC8396559', 'D13000', 110, 125, 'serine protease')]	['Inter', '-', 'alpha', '-', 'try', '##ps', '##in', 'heavy', 'chain', 'H', '##4', '(', 'IT', '##I', '##H', '##4', ')', 'is', 'a', 'liver', '-', 'produced', 'g', '##ly', '##co', '##p', '##rote', '##in', 'belonging', 'to', 'the', 'liver', '-', 'restricted', 'se', '##rine', 'pro', '##te', '##ase', 'inhibitor', 'family', '.']	[0, 5, 6, 11, 12, 15, 17, 20, 26, 32, 33, 35, 36, 38, 39, 40, 41, 43, 46, 48, 53, 54, 63, 64, 66, 68, 69, 73, 76, 86, 89, 93, 98, 99, 110, 112, 117, 120, 122, 126, 136, 142]	[5, 6, 11, 12, 15, 17, 19, 25, 31, 33, 34, 36, 38, 39, 40, 41, 42, 45, 47, 53, 54, 62, 64, 66, 68, 69, 73, 75, 85, 88, 92, 98, 99, 109, 112, 116, 120, 122, 125, 135, 142, 143]	['Inter', '-', 'alpha', '-', 'trypsin', 'heavy', 'chain', 'H4', '(', 'ITIH4', ')', 'is', 'a', 'liver', '-', 'produced', 'glycoprotein', 'belonging', 'to', 'the', 'liver', '-', 'restricted', 'serine', 'protease', 'inhibitor', 'family', '.']	[1, 1, 1, 1, 3, 1, 1, 2, 1, 4, 1, 1, 1, 1, 1, 1, 6, 1, 1, 1, 1, 1, 1, 2, 3, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'E', 'O', 'O', 'O']
Nonsecretory ribonuclease (RNAS2) is a pyrimidine specific nuclease with a slight preference for cytotoxin and helminthotoxin.	[('PMC8396559', 'D15000', 0, 25, 'Nonsecretory ribonuclease')]	['Non', '##se', '##cre', '##tory', 'rib', '##on', '##uc', '##lea', '##se', '(', 'RNA', '##S', '##2', ')', 'is', 'a', 'p', '##yr', '##im', '##id', '##ine', 'specific', 'n', '##uc', '##lea', '##se', 'with', 'a', 'slight', 'preference', 'for', 'c', '##yt', '##oto', '##xin', 'and', 'helm', '##int', '##hot', '##ox', '##in', '.']	[0, 3, 5, 8, 13, 16, 18, 20, 23, 26, 27, 30, 31, 32, 34, 37, 39, 40, 42, 44, 46, 50, 59, 60, 62, 65, 68, 73, 75, 82, 93, 97, 98, 100, 103, 107, 111, 115, 118, 121, 123, 125]	[3, 5, 8, 12, 16, 18, 20, 23, 25, 27, 30, 31, 32, 33, 36, 38, 40, 42, 44, 46, 49, 58, 60, 62, 65, 67, 72, 74, 81, 92, 96, 98, 100, 103, 106, 110, 115, 118, 121, 123, 125, 126]	['Nonsecretory', 'ribonuclease', '(', 'RNAS2', ')', 'is', 'a', 'pyrimidine', 'specific', 'nuclease', 'with', 'a', 'slight', 'preference', 'for', 'cytotoxin', 'and', 'helminthotoxin', '.']	[4, 5, 1, 3, 1, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1, 4, 1, 5, 1]	['B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus, Bellei et al. (2017) demonstrated overexpressed serum proteins, particularly alpha-1-macroglobulin (A1MG), vitamin D-binding protein (VDBP), apolipoprotein A1 (APOA1), apolipoprotein E (APOE), prostaglandin-H2-D-isomerase (PTGDS), transthyretin (TTR), which can be involved in the expression or mediation of chronic pain, on a rat model after chronic constriction injury (CCI) of the sciatic nerve [24].	[]	['Thus', ',', 'Belle', '##i', 'et', 'al', '.', '(', '2017', ')', 'demonstrated', 'over', '##ex', '##pressed', 'serum', 'proteins', ',', 'particularly', 'alpha', '-', '1', '-', 'mac', '##rog', '##lo', '##bul', '##in', '(', 'A1', '##MG', ')', ',', 'vitamin', 'D', '-', 'binding', 'protein', '(', 'V', '##D', '##B', '##P', ')', ',', 'a', '##poli', '##pop', '##rote', '##in', 'A1', '(', 'AP', '##OA', '##1', ')', ',', 'a', '##poli', '##pop', '##rote', '##in', 'E', '(', 'AP', '##OE', ')', ',', 'pro', '##sta', '##g', '##land', '##in', '-', 'H', '##2', '-', 'D', '-', 'is', '##omer', '##ase', '(', 'PT', '##G', '##DS', ')', ',', 'trans', '##thy', '##ret', '##in', '(', 'T', '##TR', ')', ',', 'which', 'can', 'be', 'involved', 'in', 'the', 'expression', 'or', 'media', '##tion', 'of', 'chronic', 'pain', ',', 'on', 'a', 'rat', 'model', 'after', 'chronic', 'con', '##st', '##ric', '##tion', 'injury', '(', 'CC', '##I', ')', 'of', 'the', 's', '##cia', '##tic', 'nerve', '[', '24', ']', '.']	[0, 4, 6, 11, 13, 16, 18, 20, 21, 25, 27, 40, 44, 46, 54, 60, 68, 70, 83, 88, 89, 90, 91, 94, 97, 99, 102, 105, 106, 108, 110, 111, 113, 121, 122, 123, 131, 139, 140, 141, 142, 143, 144, 145, 147, 148, 152, 155, 159, 162, 165, 166, 168, 170, 171, 172, 174, 175, 179, 182, 186, 189, 191, 192, 194, 196, 197, 199, 202, 205, 206, 210, 212, 213, 214, 215, 216, 217, 218, 220, 224, 228, 229, 231, 232, 234, 235, 237, 242, 245, 248, 251, 252, 253, 255, 256, 258, 264, 268, 271, 280, 283, 287, 298, 301, 306, 311, 314, 322, 326, 328, 331, 333, 337, 343, 349, 357, 360, 362, 365, 370, 377, 378, 380, 381, 383, 386, 390, 391, 394, 398, 404, 405, 407, 408]	[4, 5, 11, 12, 15, 18, 19, 21, 25, 26, 39, 44, 46, 53, 59, 68, 69, 82, 88, 89, 90, 91, 94, 97, 99, 102, 104, 106, 108, 110, 111, 112, 120, 122, 123, 130, 138, 140, 141, 142, 143, 144, 145, 146, 148, 152, 155, 159, 161, 164, 166, 168, 170, 171, 172, 173, 175, 179, 182, 186, 188, 190, 192, 194, 196, 197, 198, 202, 205, 206, 210, 212, 213, 214, 215, 216, 217, 218, 220, 224, 227, 229, 231, 232, 234, 235, 236, 242, 245, 248, 250, 252, 253, 255, 256, 257, 263, 267, 270, 279, 282, 286, 297, 300, 306, 310, 313, 321, 326, 327, 330, 332, 336, 342, 348, 356, 360, 362, 365, 369, 376, 378, 380, 381, 382, 385, 389, 391, 394, 397, 403, 405, 407, 408, 409]	['Thus', ',', 'Bellei', 'et', 'al', '.', '(', '2017', ')', 'demonstrated', 'overexpressed', 'serum', 'proteins', ',', 'particularly', 'alpha-1-macroglobulin', '(', 'A1MG', ')', ',', 'vitamin', 'D-', 'binding', 'protein', '(', 'VDBP', ')', ',', 'apolipoprotein', 'A1', '(', 'APOA1', ')', ',', 'apolipoprotein', 'E', '(', 'APOE', ')', ',', 'prostaglandin-H2-D', '-', 'isomerase', '(', 'PTGDS', ')', ',', 'transthyretin', '(', 'TTR', ')', ',', 'which', 'can', 'be', 'involved', 'in', 'the', 'expression', 'or', 'mediation', 'of', 'chronic', 'pain', ',', 'on', 'a', 'rat', 'model', 'after', 'chronic', 'constriction', 'injury', '(', 'CCI', ')', 'of', 'the', 'sciatic', 'nerve', '[', '24', ']', '.']	[1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 3, 1, 1, 1, 1, 9, 1, 2, 1, 1, 1, 2, 1, 1, 1, 4, 1, 1, 5, 1, 1, 3, 1, 1, 5, 1, 1, 2, 1, 1, 10, 1, 3, 1, 3, 1, 1, 4, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 2, 1, 1, 1, 3, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Few studies have shown the potential biomarkers of headache chronicity caused by medication overuse, such as SNVs of the angiotensin-converting enzyme, brain-derived neurotropic factor, catechol-O-methyltransferase genes, altered neurotransmitters metabolism, neurophysiological and neuroimaging changes [27].	[]	['Few', 'studies', 'have', 'shown', 'the', 'potential', 'bio', '##mark', '##ers', 'of', 'headache', 'chronic', '##ity', 'caused', 'by', 'medication', 'over', '##use', ',', 'such', 'as', 'S', '##N', '##Vs', 'of', 'the', 'an', '##gio', '##tens', '##in', '-', 'converting', 'enzyme', ',', 'brain', '-', 'derived', 'ne', '##uro', '##tro', '##pic', 'factor', ',', 'cat', '##ech', '##ol', '-', 'O', '-', 'met', '##hyl', '##tra', '##ns', '##fer', '##ase', 'genes', ',', 'altered', 'ne', '##uro', '##tra', '##ns', '##mit', '##ters', 'metabolism', ',', 'ne', '##uro', '##phy', '##sio', '##logical', 'and', 'ne', '##uro', '##ima', '##ging', 'changes', '[', '27', ']', '.']	[0, 4, 12, 17, 23, 27, 37, 40, 44, 48, 51, 60, 67, 71, 78, 81, 92, 96, 99, 101, 106, 109, 110, 111, 114, 117, 121, 123, 126, 130, 132, 133, 144, 150, 152, 157, 158, 166, 168, 171, 174, 178, 184, 186, 189, 192, 194, 195, 196, 197, 200, 203, 206, 208, 211, 215, 220, 222, 230, 232, 235, 238, 240, 243, 248, 258, 260, 262, 265, 268, 271, 279, 283, 285, 288, 291, 296, 304, 305, 307, 308]	[3, 11, 16, 22, 26, 36, 40, 44, 47, 50, 59, 67, 70, 77, 80, 91, 96, 99, 100, 105, 108, 110, 111, 113, 116, 120, 123, 126, 130, 132, 133, 143, 150, 151, 157, 158, 165, 168, 171, 174, 177, 184, 185, 189, 192, 194, 195, 196, 197, 200, 203, 206, 208, 211, 214, 220, 221, 229, 232, 235, 238, 240, 243, 247, 258, 259, 262, 265, 268, 271, 278, 282, 285, 288, 291, 295, 303, 305, 307, 308, 309]	['Few', 'studies', 'have', 'shown', 'the', 'potential', 'biomarkers', 'of', 'headache', 'chronicity', 'caused', 'by', 'medication', 'overuse', ',', 'such', 'as', 'SNVs', 'of', 'the', 'angiotensin', '-', 'converting', 'enzyme', ',', 'brain', '-', 'derived', 'neurotropic', 'factor', ',', 'catechol-O-methyltransferase', 'genes', ',', 'altered', 'neurotransmitters', 'metabolism', ',', 'neurophysiological', 'and', 'neuroimaging', 'changes', '[', '27', ']', '.']	[1, 1, 1, 1, 1, 1, 3, 1, 1, 2, 1, 1, 1, 2, 1, 1, 1, 3, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 4, 1, 1, 12, 1, 1, 1, 6, 1, 1, 5, 1, 4, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Thus, Pellesi et al. (2019) showed the overexpression of lipocalin-type prostaglandin D2 synthase (L-PGDS) in the serum of MOH patients compared to healthy controls (219.2 ± 58.2 vs. 188.7 ± 39.2 ng/mL, p = 0.0038) and a not significant increase of apolipoprotein A1 (APOA1) (49.8 ± 23.7 vs. 46.9 ± 17.5 μg/mL, p = 0.546).	[('PMC8396559', 'R02000', 57, 97, 'lipocalin-type prostaglandin D2 synthase')]	['Thus', ',', 'P', '##elles', '##i', 'et', 'al', '.', '(', '2019', ')', 'showed', 'the', 'over', '##ex', '##press', '##ion', 'of', 'lip', '##oc', '##ali', '##n', '-', 'type', 'pro', '##sta', '##g', '##land', '##in', 'D', '##2', 's', '##ynth', '##ase', '(', 'L', '-', 'P', '##G', '##DS', ')', 'in', 'the', 'serum', 'of', 'M', '##OH', 'patients', 'compared', 'to', 'healthy', 'controls', '(', '219', '.', '2', '±', '58', '.', '2', 'vs', '.', '188', '.', '7', '±', '39', '.', '2', 'ng', '/', 'm', '##L', ',', 'p', '=', '0', '.', '00', '##38', ')', 'and', 'a', 'not', 'significant', 'increase', 'of', 'a', '##poli', '##pop', '##rote', '##in', 'A1', '(', 'AP', '##OA', '##1', ')', '(', '49', '.', '8', '±', '23', '.', '7', 'vs', '.', '46', '.', '9', '±', '17', '.', '5', 'μ', '##g', '/', 'm', '##L', ',', 'p', '=', '0', '.', '54', '##6', ')', '.']	[0, 4, 6, 7, 12, 14, 17, 19, 21, 22, 26, 28, 35, 39, 43, 45, 50, 54, 57, 60, 62, 65, 66, 67, 72, 75, 78, 79, 83, 86, 87, 89, 90, 94, 98, 99, 100, 101, 102, 103, 105, 107, 110, 114, 120, 123, 124, 127, 136, 145, 148, 156, 165, 166, 169, 170, 172, 174, 176, 177, 179, 181, 183, 186, 187, 189, 191, 193, 194, 196, 198, 199, 200, 201, 203, 205, 207, 208, 209, 211, 213, 215, 219, 221, 225, 237, 246, 249, 250, 254, 257, 261, 264, 267, 268, 270, 272, 273, 275, 276, 278, 279, 281, 283, 285, 286, 288, 290, 292, 294, 295, 297, 299, 301, 302, 304, 305, 306, 307, 308, 309, 311, 313, 315, 316, 317, 319, 320, 321]	[4, 5, 7, 12, 13, 16, 19, 20, 22, 26, 27, 34, 38, 43, 45, 50, 53, 56, 60, 62, 65, 66, 67, 71, 75, 78, 79, 83, 85, 87, 88, 90, 94, 97, 99, 100, 101, 102, 103, 105, 106, 109, 113, 119, 122, 124, 126, 135, 144, 147, 155, 164, 166, 169, 170, 171, 173, 176, 177, 178, 181, 182, 186, 187, 188, 190, 193, 194, 195, 198, 199, 200, 201, 202, 204, 206, 208, 209, 211, 213, 214, 218, 220, 224, 236, 245, 248, 250, 254, 257, 261, 263, 266, 268, 270, 272, 273, 274, 276, 278, 279, 280, 282, 285, 286, 287, 290, 291, 294, 295, 296, 298, 301, 302, 303, 305, 306, 307, 308, 309, 310, 312, 314, 316, 317, 319, 320, 321, 322]	['Thus', ',', 'Pellesi', 'et', 'al', '.', '(', '2019', ')', 'showed', 'the', 'overexpression', 'of', 'lipocalin', '-', 'type', 'prostaglandin', 'D2', 'synthase', '(', 'L-PGDS', ')', 'in', 'the', 'serum', 'of', 'MOH', 'patients', 'compared', 'to', 'healthy', 'controls', '(', '219.2', '±', '58.2', 'vs', '.', '188.7', '±', '39.2', 'ng', '/', 'mL', ',', 'p', '=', '0.0038', ')', 'and', 'a', 'not', 'significant', 'increase', 'of', 'apolipoprotein', 'A1', '(', 'APOA1', ')', '(', '49.8', '±', '23.7', 'vs', '.', '46.9', '±', '17.5', 'μg', '/', 'mL', ',', 'p', '=', '0.546', ')', '.']	[1, 1, 3, 1, 1, 1, 1, 1, 1, 1, 1, 4, 1, 4, 1, 1, 5, 2, 3, 1, 5, 1, 1, 1, 1, 1, 2, 1, 1, 1, 1, 1, 1, 3, 1, 3, 1, 1, 3, 1, 3, 1, 1, 2, 1, 1, 1, 4, 1, 1, 1, 1, 1, 1, 1, 5, 1, 1, 3, 1, 1, 3, 1, 3, 1, 1, 3, 1, 3, 2, 1, 2, 1, 1, 1, 4, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'I', 'E', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
Preliminary studies involving 13C-labeled acetate suggest that appreciable butyrate may be derived from exogenous acetate in mixed fecal fermentations (S. H. Duncan et al., unpublished data).	[]	['Preliminary', 'studies', 'involving', '13', '##C', '-', 'labeled', 'ace', '##tate', 'suggest', 'that', 'app', '##re', '##cia', '##ble', 'but', '##yra', '##te', 'may', 'be', 'derived', 'from', 'ex', '##ogen', '##ous', 'ace', '##tate', 'in', 'mixed', 'f', '##eca', '##l', 'f', '##er', '##mentation', '##s', '(', 'S', '.', 'H', '.', 'Duncan', 'et', 'al', '.', ',', 'unpublished', 'data', ')', '.']	[0, 12, 20, 30, 32, 33, 34, 42, 45, 50, 58, 63, 66, 68, 71, 75, 78, 81, 84, 88, 91, 99, 104, 106, 110, 114, 117, 122, 125, 131, 132, 135, 137, 138, 140, 149, 151, 152, 153, 155, 156, 158, 165, 168, 170, 171, 173, 185, 189, 190]	[11, 19, 29, 32, 33, 34, 41, 45, 49, 57, 62, 66, 68, 71, 74, 78, 81, 83, 87, 90, 98, 103, 106, 110, 113, 117, 121, 124, 130, 132, 135, 136, 138, 140, 149, 150, 152, 153, 154, 156, 157, 164, 167, 170, 171, 172, 184, 189, 190, 191]	['Preliminary', 'studies', 'involving', '13C-labeled', 'acetate', 'suggest', 'that', 'appreciable', 'butyrate', 'may', 'be', 'derived', 'from', 'exogenous', 'acetate', 'in', 'mixed', 'fecal', 'fermentations', '(', 'S', '.', 'H', '.', 'Duncan', 'et', 'al', '.', ',', 'unpublished', 'data', ')', '.']	[1, 1, 1, 4, 2, 1, 1, 4, 3, 1, 1, 1, 1, 3, 2, 1, 1, 3, 4, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1]	['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']
